PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	SWIFT, M; MORRELL, D; MASSEY, RB; CHASE, CL				SWIFT, M; MORRELL, D; MASSEY, RB; CHASE, CL			INCIDENCE OF CANCER IN 161 FAMILIES AFFECTED BY ATAXIA-TELANGIECTASIA	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BREAST-CANCER; FLUOROSCOPIC EXAMINATIONS; FEMALE BREAST; HETEROZYGOTES; IRRADIATION; TUBERCULOSIS; MORTALITY; CHEST; WOMEN; RADIOSENSITIVITY	Background. Ataxia-telangiectasia is an autosomal recessive syndrome in which cancers develop in affected homozygotes at a rate approximately 100 times higher than in unaffected age-matched subjects. Retrospective studies have shown that persons heterozygous for the ataxia-telangiectasia gene, who make up about 1 percent of the general population, also have an excess risk of cancer, particularly breast cancer in women. Patients with ataxia-telangiectasia and cells derived from homozygotes and heterozygotes are unusually sensitive to ionizing radiation. Methods. Cancer incidence and mortality, mortality from ischemic heart disease, and mortality from all causes were compared prospectively for a mean of 6.4 years in 1599 adult blood relatives of patients with ataxia-telangiectasia and 821 of their spouses, who served as controls, in 161 families affected by ataxia-telangiectasia. In a case-control substudy, we compared documented occupational and fluoroscopic diagnostic exposures to radiation in the 19 female blood relatives in whom breast cancer was first diagnosed during the period of prospective observation with the exposures in 57 matched blood relatives who did not have breast cancer. Results. Cancer rates were significantly higher in the group of blood relatives than in their spouses, specifically in the subgroup of 294 blood relatives who were known to be heterozygous for the ataxia-telangiectasia gene. The estimated risk of cancer of all types among heterozygotes as compared with noncarriers was 3.8 in men and 3.5 in women, and that for breast cancer in women was 5.1. Among the blood relatives, women with breast cancer were more likely to have been exposed to selected sources of ionizing radiation than controls without cancer (odds ratio = 5.8, P = 0.005). Male and female blood relatives also had 3-fold and 2.6-fold excess mortality from all causes, respectively, from the ages of 20 through 59 years. Conclusions. The ataxia-telangiectasia gene predisposes heterozygotes to cancer, particularly breast cancer in women. There is also excess mortality from all causes in adults under the age of 60. Diagnostic or occupational exposure to ionizing radiation probably increases the risk of breast cancer in women heterozygous for ataxia-telangiectasia.	UNIV N CAROLINA,DEPT MED,CHAPEL HILL,NC 27514; UNIV N CAROLINA,DEPT EPIDEMIOL,CHAPEL HILL,NC 27514	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	SWIFT, M (corresponding author), UNIV N CAROLINA,BIOL SCI RES CTR,CB 7250,CHAPEL HILL,NC 27599, USA.				NATIONAL CANCER INSTITUTE [R01CA014235] Funding Source: NIH RePORTER; NCI NIH HHS [CA14235] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BAINES CJ, 1989, CANCER, V63, P1816; BOICE JD, 1978, RADIAT RES, V73, P373, DOI 10.2307/3574828; BOICE JD, 1977, J NATL CANCER I, V59, P823, DOI 10.1093/jnci/59.3.823; BORRESEN AL, 1990, GENE CHROMOSOME CANC, V2, P339, DOI 10.1002/gcc.2870020412; COLE J, 1988, INT J RADIAT BIOL, V54, P929, DOI 10.1080/09553008814552331; CUNLIFFE PN, 1975, BRIT J RADIOL, V48, P374, DOI 10.1259/0007-1285-48-569-374; DELARUE NC, 1975, CAN MED ASSOC J, V112, P1405; GOTOFF SP, 1967, AM J DIS CHILD, V114, P617, DOI 10.1001/archpedi.1967.02090270073006; HEGGIE J C P, 1990, Australasian Physical and Engineering Sciences in Medicine, V13, P71; HENDRICK RE, 1990, RADIOLOGY, V174, P648, DOI 10.1148/radiology.174.3.2305044; HILDRETH NG, 1989, NEW ENGL J MED, V321, P1281, DOI 10.1056/NEJM198911093211901; HOWE GR, 1982, CANCER DETECT PREV, V5, P175; HUDA W, 1990, RADIOLOGY, V177, P813, DOI 10.1148/radiology.177.3.2243994; JANKOWSKI J, 1984, Health Physics, V46, P228; KLEINBAUM DG, 1982, EPIDEMIOLOGIC RES PR, P336; MANTEL N, 1959, J NATL CANCER I, V22, P719; MCCONVILLE CM, 1990, HUM GENET, V85, P215; MILLER AB, 1989, NEW ENGL J MED, V321, P1285, DOI 10.1056/NEJM198911093211902; MORGAN JL, 1968, AM J DIS CHILD, V116, P557, DOI 10.1001/archpedi.1968.02100020561022; MORRELL D, 1990, CANCER GENET CYTOGEN, V50, P119, DOI 10.1016/0165-4608(90)90245-6; MORRELL D, 1986, J NATL CANCER I, V77, P89; PADOVANI R, 1987, BRIT J RADIOL, V60, P155, DOI 10.1259/0007-1285-60-710-155; PIPPARD EC, 1988, CANCER RES, V48, P2929; ROTHMAN KJ, 1979, NIH DHEW791649 PUBL; SHORE RE, 1977, JNCI-J NATL CANCER I, V59, P813, DOI 10.1093/jnci/59.3.813; SWIFT M, 1976, CANCER RES, V36, P209; SWIFT M, 1983, LANCET, V1, P1049; SWIFT M, 1990, CANCER GENET CYTOGEN, V46, P21, DOI 10.1016/0165-4608(90)90004-T; SWIFT M, 1987, NEW ENGL J MED, V316, P1289, DOI 10.1056/NEJM198705213162101; SWIFT M, 1986, AM J HUM GENET, V39, P573; SWIFT M, 1974, AM J HUM GENET, V26, P304; SWIFT M, 1990, AM J HUM GENET, V47, P226; TAYLOR AMR, 1975, NATURE, V258, P427, DOI 10.1038/258427a0; TOKUNAGA M, 1987, RADIAT RES, V112, P243, DOI 10.2307/3577254; 1967, PHS PUBLICATION, V1693; 1981, GAO EMD811 GEN ACC O	36	746	764	0	9	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 26	1991	325	26					1831	1836		10.1056/NEJM199112263252602	http://dx.doi.org/10.1056/NEJM199112263252602			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GW528	1961222				2022-12-24	WOS:A1991GW52800002
J	WHEAT, LJ; CONNOLLYSTRINGFIELD, P; BLAIR, R; CONNOLLY, K; GARRINGER, T; KATZ, BP				WHEAT, LJ; CONNOLLYSTRINGFIELD, P; BLAIR, R; CONNOLLY, K; GARRINGER, T; KATZ, BP			HISTOPLASMOSIS RELAPSE IN PATIENTS WITH AIDS - DETECTION USING HISTOPLASMA-CAPSULATUM VARIETY CAPSULATUM ANTIGEN LEVELS	ANNALS OF INTERNAL MEDICINE			English	Article							ACQUIRED IMMUNODEFICIENCY SYNDROME; DIAGNOSIS	Objective: To assess the accuracy of Histoplasma capsulatum variety capsulatum polysaccharide antigen testing for the identification of histoplasmosis relapse in patients with the acquired immunodeficiency syndrome (AIDS). Design: A retrospective study using stored specimens. Setting. A referral center and several private hospitals. Patients: Twenty episodes of histoplasmosis relapse were evaluated in 17 patients with AIDS from November 1987 to August 1990. Controls included 30 patients with AIDS and histoplasmosis who did not have a relapse during maintenance therapy and who were initially tested during the same week as the patients with relapse. A second control group included seven patients with AIDS and histoplasmosis who were evaluated for relapse on 23 occasions; relapse, however, was excluded on each occasion. Measurements: To avoid interassay variability, specimens were tested for H.c. var. capsulatum polysaccharide antigen with the same radioimmunoassay. Main Outcome Measure: The change in the Hc. var. capsulatum polysaccharide antigen level during successful as opposed to unsuccessful maintenance therapy for the prevention of histoplasmosis relapse. Main Results: For the 20 episodes of relapse (17 patients), Hc. var. capsulatum antigen levels increased by at least 2 radioimmunoassay units in 12 of 14 serum specimens tested (85.7%; 95% Cl, 57.2% to 98.2%) and in 17 of 18 urine specimens tested (94.4%; Cl, 72.7% to 99.9%). Antigen levels increased in the urine or serum in 1 of 83 specimens (1.2%; Cl, 0.03% to 6.6%) obtained on 56 occasions (1.8%; Cl, 0.04% to 9.6%) from controls (specificity, 98.2%; Cl, 90.4% to 99.96%). In three cases of relapse, antigen levels increased before clinical relapse was suspected. Complement fixation titers increased by at least 2 dilutions in 4 of 11 cases (36.4%; Cl, 10.9% to 69.2%) but in 0 of 9 control patients (Cl, 0% to 28.3%). Conclusion: An increase in Hc. var. capsulatum polysaccharide antigen levels of 2 units or more strongly suggests histoplasmosis relapse. The presence of increasing titers of anti-Hc. var. capsulatum antibodies by complement fixation is less accurate for the diagnosis of relapse.	INDIANA UNIV, SCH MED, DEPT INTERNAL MED, INDIANAPOLIS, IN 46202 USA; REGENSTRIEF INST HLTH CARE, INDIANAPOLIS, IN USA; RICHARD L ROUNDBUSH VET ADM HOSP, INDIANAPOLIS, IN USA	Indiana University System; Indiana University-Purdue University Indianapolis; Indiana University System; Indiana University-Purdue University Indianapolis; Regenstrief Institute Inc								MCKINSEY DS, 1989, ANN INTERN MED, V111, P655, DOI 10.7326/0003-4819-111-8-655; NETER J, 1974, APPLIED LINEAR STATI, P605; WHEAT J, 1982, ANN INTERN MED, V97, P680, DOI 10.7326/0003-4819-97-5-680; WHEAT LJ, 1986, NEW ENGL J MED, V314, P83, DOI 10.1056/NEJM198601093140205; WHEAT LJ, 1990, MEDICINE, V69, P361, DOI 10.1097/00005792-199011000-00004; WHEAT LJ, 1989, AM J MED, V87, P396, DOI 10.1016/S0002-9343(89)80820-4	6	98	99	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 15	1991	115	12					936	941		10.7326/0003-4819-115-12-936	http://dx.doi.org/10.7326/0003-4819-115-12-936			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU417	1952490				2022-12-24	WOS:A1991GU41700004
J	MUDER, RR; BRENNEN, C; WAGENER, MM; VICKERS, RM; RIHS, JD; HANCOCK, GA; YEE, YC; MILLER, JM; YU, VL				MUDER, RR; BRENNEN, C; WAGENER, MM; VICKERS, RM; RIHS, JD; HANCOCK, GA; YEE, YC; MILLER, JM; YU, VL			METHICILLIN-RESISTANT STAPHYLOCOCCAL COLONIZATION AND INFECTION IN A LONG-TERM CARE FACILITY	ANNALS OF INTERNAL MEDICINE			English	Article							AUREUS NASAL CARRIAGE; NOSOCOMIAL INFECTIONS; NURSING-HOMES; STRAIN; CIPROFLOXACIN; HEMODIALYSIS; PROPHYLAXIS; OUTBREAK	Objective: To determine the natural history of colonization by methicillin-resistant Staphylococcus aureus (MRSA) among patients in a long-term care facility. We specifically sought to determine if MRSA colonization was predictive of subsequent infection. Design: Cohort study. Setting: Long-term Veterans Affairs Medical Center. Patients: A total of 197 patients residing on two units were followed with regular surveillance cultures of the anterior nares. Main Outcome Measurement: The development of staphylococcal infection. Results: Thirty-two patients were persistent carriers of MRSA and 44 were persistent carriers of methicillin-susceptible strains (MSSA). Twenty-five percent of MRSA carriers had an episode of staphylococcal infection compared with 4% of MSSA carriers and 4.5% of non-carriers (P < 0.01; relative risk 3.8%; 95% CI, 2.0 to 6.4). The rate of development of infection among MRSA carriers was 15% for every 100 days of carriage. Using logistic regression analysis, persistent MRSA carriage was the most significant predictor of infection (P < 0.001; odds ratio, 3.7). Seventy-three percent of all MRSA infections occurred among MRSA carriers. Isolates of MRSA from 7 patients were typed. Colonizing and infecting strains had the same phage type in all 7 patients and the same pattern of plasmid EcoRI restriction endonuclease fragments in 5 patients. Conclusions: Colonization of the anterior nares by MRSA predicts the development of staphylococcal infection in long-term care patients; most infections arise from endogenously carried strains. Colonization by MRSA indicates a significantly greater risk for infection than does colonization by MSSA. The results offer a theoretic rationale for reduction in MRSA infections by interventions aimed at eliminating the carrier state.	UNIV PITTSBURGH, SCH MED, PITTSBURGH, PA 15261 USA; CTR DIS CONTROL, ATLANTA, GA 30333 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Centers for Disease Control & Prevention - USA	MUDER, RR (corresponding author), PITTSBURGH VET AFFAIRS MED CTR, INFECT DIS SECT, UNIV DR C, PITTSBURGH, PA 15240 USA.							AEILTS GD, 1982, J CLIN MICROBIOL, V16, P218, DOI 10.1128/JCM.16.2.218-223.1982; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; BOYCE JM, 1981, INFECT CONT HOSP EP, V2, P110, DOI 10.1017/S0195941700053881; BRENNEN C, 1990, AM J MED, V88, pN14; BRUMFITT W, 1989, NEW ENGL J MED, V320, P1188, DOI 10.1056/NEJM198905043201806; CEDERNA JE, 1990, INFECT CONT HOSP EP, V11, P13, DOI 10.1086/646072; CHOW JW, 1989, ARCH INTERN MED, V149, P1258, DOI 10.1001/archinte.149.6.1258; COLEMAN DC, 1986, J HOSP INFECT, V7, P29, DOI 10.1016/0195-6701(86)90005-8; CRAVEN DE, 1981, AM J MED, V71, P53, DOI 10.1016/0002-9343(81)90258-8; CROSSLEY KB, 1985, JAMA-J AM MED ASSOC, V254, P2918, DOI 10.1001/jama.254.20.2918; GARIBALDI RA, 1981, NEW ENGL J MED, V305, P731, DOI 10.1056/NEJM198109243051304; GARNER JS, 1988, AM J INFECT CONTROL, V16, P128, DOI 10.1016/0196-6553(88)90053-3; HALEY RW, 1982, ANN INTERN MED, V97, P297, DOI 10.7326/0003-4819-97-3-297; HSU CCS, 1988, ARCH INTERN MED, V148, P569, DOI 10.1001/archinte.148.3.569; ISCHHOROWICZ D, 1984, NUCLEIC ACIDS RES, V9, P2989; Kloos W, 1985, MANUAL CLIN MICROBIO, P143; LACEY RW, 1987, J HOSP INFECT, V9, P103, DOI 10.1016/0195-6701(87)90046-6; LINNEMANN CC, 1982, AM J EPIDEMIOL, V115, P941, DOI 10.1093/oxfordjournals.aje.a113381; LUZAR MA, 1990, NEW ENGL J MED, V322, P505, DOI 10.1056/NEJM199002223220804; MACRINA FL, 1978, PLASMID, V1, P417, DOI 10.1016/0147-619X(78)90056-2; MULLIGAN ME, 1987, AM J MED, V82, P215; PEACOCK JE, 1981, J INFECT DIS, V144, P575, DOI 10.1093/infdis/144.6.575; PRICE LE, 1985, INFECT CONT HOSP EP, V6, P437, DOI 10.1017/S0195941700064778; ROCCAFORTE JS, 1988, AM J INFECT CONTROL, V16, P141, DOI 10.1016/0196-6553(88)90024-7; SMITH PB, 1972, STAPHYLOCOCCI, P431; SMITH SM, 1989, ANTIMICROB AGENTS CH, V33, P181, DOI 10.1128/AAC.33.2.181; STORCH GA, 1987, INFECT CONT HOSP EP, V8, P24, DOI 10.1017/S0195941700066947; THOMAS JC, 1989, INFECT CONT HOSP EP, V10, P106, DOI 10.1086/645976; THOMPSON RL, 1982, ANN INTERN MED, V97, P309, DOI 10.7326/0003-4819-97-3-309; THORNSBERRY C, 1983, J CLIN MICROBIOL, V18, P1084, DOI 10.1128/JCM.18.5.1084-1091.1983; TUAZON CU, 1975, ANN INTERN MED, V82, P788, DOI 10.7326/0003-4819-82-6-788; WRIGHT CE, 1989, 29TH INT C ANT AG CH; YU VL, 1986, NEW ENGL J MED, V315, P91, DOI 10.1056/NEJM198607103150204	33	304	305	0	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 15	1991	114	2					107	112		10.7326/0003-4819-114-2-1-107	http://dx.doi.org/10.7326/0003-4819-114-2-1-107			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ER534	1984384				2022-12-24	WOS:A1991ER53400002
J	ZARCHY, TM; ERSHOFF, D				ZARCHY, TM; ERSHOFF, D			WHICH CLINICAL-VARIABLES PREDICT AN ABNORMAL DOUBLE-CONTRAST BARIUM ENEMA RESULT	ANNALS OF INTERNAL MEDICINE			English	Article							CANCER	Objective: To determine the relations among patient history, symptoms, objective indicators, and abnormal double-contrast barium enema results in outpatients. Patients and Setting: Seven hundred and ninety-four patients receiving care in a large multispecialty medical group. Design: Physicians completed a form before ordering a double-contrast barium enema, listing information about patient history, symptoms, and objective findings, including the results of a complete blood count, stool hemoccult, and sigmoidoscopy. Measurements and Main Results: Outcome measures were colon cancer and any abnormal finding. The results of 18.6% of the barium enemas were abnormal. The most frequent positive findings were of polyps (8.8%) and colon cancer (2.9%). Over 50% of the barium enemas were ordered solely on the basis of symptoms, yet there was no statistical correlation between symptoms and colon cancer or any positive finding. Using logistic regression, four variables were shown to be significant predictors of colon cancer (P < 0.05): abnormal sigmoidoscopy, iron deficiency anemia, positive stool hemoccult results, and relevant history. The respective odds ratios of these variables were 3.76 (95% CI, 2.89 to 4.90); 2.86 (CI, 2.13 to 3.74); 1.87 (CI, 1.46 to 2.39); and 1.91 (CI, 1.44 to 2.52), respectively. In a patient without any of these indicators, the predicted probability of having colon cancer was only 0.7%. In a patient with at least two objective indicators, the probability of having colon cancer was greater than 15%. Conclusions: Symptoms without objective indicators or pertinent risk factors do not correlate with an abnormal double-contrast barium enema result. Objective indicators are useful predictors of an abnormal barium enema result, particularly when looking for colon cancer.	HAWTHORNE COMMUNITY MED GRP, LOS ANGELES, CA USA; SO CALIF PERMANENTE MED GRP, PASADENA, CA USA	Kaiser Permanente; Southern California Permanente Medical Group (SCPMG); Permanente Medical Groups								BARRY MJ, 1987, GASTROENTEROLOGY, V93, P301, DOI 10.1016/0016-5085(87)91019-5; DEVROEDE G, 1989, GASTROINTESTINAL DIS, P331; DROSSMAN DA, 1988, HOSP PRACT, V23, P119; DROSSMAN DA, 1989, ANN INTERN MED, V111, P627, DOI 10.7326/0003-4819-111-8-627; EDDY DM, 1990, ANN INTERN MED, V113, P373, DOI 10.7326/0003-4819-113-5-373; FLEISCHER DE, 1989, JAMA-J AM MED ASSOC, V261, P580, DOI 10.1001/jama.261.4.580; GERSON DE, 1979, RADIOLOGY, V130, P297, DOI 10.1148/130.2.297; GROSSMAN S, 1988, GASTROENTEROLOGY, V94, P395, DOI 10.1016/0016-5085(88)90427-1; HARVEY RF, 1987, LANCET, V1, P963; LODD DD, 1985, CARCINOMA LARGE BOWE, P133; MACEWAN DW, 1978, RADIOLOGY, V126, P39, DOI 10.1148/126.1.39; OTT DJ, 1985, SOUTHERN MED J, V78, P1033, DOI 10.1097/00007611-198509000-00002; TEDESCO FJ, 1978, ANN INTERN MED, V89, P907, DOI 10.7326/0003-4819-89-6-907; ZARCHY TM, 1984, GASTROENTEROLOGY, V86, P1307; 1987, MEDICARE BARIUM ENEM	15	13	13	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 15	1991	114	2					137	141		10.7326/0003-4819-114-2-137	http://dx.doi.org/10.7326/0003-4819-114-2-137			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ER534	1984389				2022-12-24	WOS:A1991ER53400007
J	CHUN, JJM; SCHATZ, DG; OETTINGER, MA; JAENISCH, R; BALTIMORE, D				CHUN, JJM; SCHATZ, DG; OETTINGER, MA; JAENISCH, R; BALTIMORE, D			THE RECOMBINATION ACTIVATING GENE-1 (RAG-1) TRANSCRIPT IS PRESENT IN THE MURINE CENTRAL-NERVOUS-SYSTEM	CELL			English	Article							DENTATE GYRUS; ORIGIN; TIME; SUPERFAMILY; NEURONS; SUBSETS; CORTEX; BRAIN; MICE; RAT	The recombination activating genes, RAG-1 and RAG-2, are likely to encode components of the V(D)J site-specific recombination machinery. We report here the detection of low levels of the RAG-1 transcript in the murine central nervous system by polymerase chain reaction, in situ hybridization, and Northern blot analyses. In contrast, an authentic RAG-2 transcript could not be detected reproducibly in the central nervous system. The RAG-1 transcript was found to be widespread in embryonic and postnatal neurons, with transcription being most apparent in regions of the postnatal brain with a high neuronal cell density (the cerebellum and the hippocampal formation). The results suggest that RAG-1 functions in neurons, where its role might be to recombine elements of the neuronal genome site-specifically, or to prevent detrimental alterations of the genome in these long-lived cells.	MIT, DEPT BIOL, CAMBRIDGE, MA 02139 USA; ROCKEFELLER UNIV, NEW YORK, NY 10021 USA	Massachusetts Institute of Technology (MIT); Rockefeller University	CHUN, JJM (corresponding author), WHITEHEAD INST BIOMED RES, 9 CAMBRIDGE CTR, CAMBRIDGE, MA 02142 USA.		Schatz, David/A-6748-2013	Schatz, David/0000-0002-5669-1176	NATIONAL CANCER INSTITUTE [R35CA044339] Funding Source: NIH RePORTER; NCI NIH HHS [5R35-CA 44339, CA51466] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AGUILERA A, 1990, MOL CELL BIOL, V10, P1439, DOI 10.1128/MCB.10.4.1439; ALT FW, 1984, EMBO J, V3, P1209, DOI 10.1002/j.1460-2075.1984.tb01955.x; ALTMAN J, 1972, J COMP NEUROL, V145, P353, DOI 10.1002/cne.901450305; ANGEVINE JAY B., 1965, EXP NEUROL SUPPL, V2, P1; ANGEVINE JB, 1961, NATURE, V192, P766, DOI 10.1038/192766b0; Ausubel F, 1989, MOL REPROD DEV, V1, P146; BOSMA GC, 1983, NATURE, V301, P527, DOI 10.1038/301527a0; BRAITENBERG V, 1958, J COMP NEUROL, V109, P1, DOI 10.1002/cne.901090102; CARLSON LM, 1991, CELL, V64, P201, DOI 10.1016/0092-8674(91)90221-J; CAVINESS VS, 1982, DEV BRAIN RES, V4, P293, DOI 10.1016/0165-3806(82)90141-9; CAVINESS VS, 1973, J COMP NEUROL, V151, P113, DOI 10.1002/cne.901510203; CHUN JJM, 1989, J NEUROSCI, V9, P1648; CLAYTON DF, 1988, NEURON, V1, P249, DOI 10.1016/0896-6273(88)90146-8; DREYER WJ, 1967, COLD SPRING HARB SYM, V32, P353, DOI 10.1101/SQB.1967.032.01.048; EDWARDS MKS, 1983, DEV BIOL, V98, P187, DOI 10.1016/0012-1606(83)90348-2; ENOCH T, 1986, MOL CELL BIOL, V6, P801, DOI 10.1128/MCB.6.3.801; FARRAR WL, 1987, IMMUNOL REV, V100, P361, DOI 10.1111/j.1600-065X.1987.tb00539.x; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FULOP GM, 1990, NATURE, V347, P479, DOI 10.1038/347479a0; Goetzl E J, 1990, Adv Immunol, V48, P161, DOI 10.1016/S0065-2776(08)60754-3; HUNKAPILLER T, 1989, ADV IMMUNOL, V44, P1; JONESVILLENEUVE EMV, 1983, MOL CELL BIOL, V3, P2271, DOI 10.1128/MCB.3.12.2271; JONESVILLENEUVE EMV, 1982, J CELL BIOL, V94, P253, DOI 10.1083/jcb.94.2.253; LIEBER MR, 1987, GENE DEV, V1, P751, DOI 10.1101/gad.1.8.751; Maniatis T., 1982, MOL CLONING; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; PARNES JR, 1987, IMMUNOL REV, V100, P109, DOI 10.1111/j.1600-065X.1987.tb00529.x; RAKIC P, 1977, PHILOS T R SOC B, V278, P245, DOI 10.1098/rstb.1977.0040; RALPH P, 1979, IMMUNOL REV, V48, P107, DOI 10.1111/j.1600-065X.1979.tb00300.x; Runnicki M.A., 1987, TERATOCARCINOMAS EMB, P19; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; SCHATZ DG, 1988, CELL, V53, P107, DOI 10.1016/0092-8674(88)90492-8; SCHLESSINGER AR, 1978, ANAT EMBRYOL, V154, P153, DOI 10.1007/BF00304660; SCHLESSINGER AR, 1975, J COMP NEUROL, V159, P149, DOI 10.1002/cne.901590202; SCHULER W, 1990, MOL BASIS B CELL DEV, V3, P132; SEED B, 1987, NATURE, V329, P840, DOI 10.1038/329840a0; WANG JC, 1990, CELL, V62, P403, DOI 10.1016/0092-8674(90)90002-V	37	252	259	0	8	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 11	1991	64	1					189	200		10.1016/0092-8674(91)90220-S	http://dx.doi.org/10.1016/0092-8674(91)90220-S			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ET175	1986864				2022-12-24	WOS:A1991ET17500020
J	BEARD, KC; KRISHTALKA, L; STUCKY, RK				BEARD, KC; KRISHTALKA, L; STUCKY, RK			1ST SKULLS OF THE EARLY EOCENE PRIMATE SHOSHONIUS-COOPERI AND THE ANTHROPOID-TARSIER DICHOTOMY	NATURE			English	Article							ORIGINS; OMOMYIDAE; EVOLUTION; TARSIIDAE; AFRICA	THE phylogenetic relationships of living tarsiers and extinct omomyid primates are critical for deciphering the origin and relationships of primate higher taxa, particularly anthropoids1-6. Three competing phylogenetic hypotheses are: (1) tarsiers are most closely related to early Cenozoic Omomyidae5-8, particularly genera such as Necrolemur from the late Eocene of Europe9-11; (2) tarsiers share a more recent common ancestry with anthropoids than they do with any known omoyid2-4,12,13; (3) tarsiers and/or omoyids are most closely related to strepsirhines14. The anatomy of four skulls of the early Eocene omomyid Shoshonius cooperi-the first cranial material recovered for this genus-strongly suggests that Schoshonius shares a more recent common ancestry with Tarsius than do either anthropoids or other Eocene omomyids for which cranial anatomy is known. If the primate suborder Haplorhini (anthropoids, omomyids, tarsiids) is monophyletic, the phylogenetic position of Shoshonius requires that anthropoids and Tarsius diverged by at least the early Eocene, some 15 million years before the first appearance of anthropoids in the fossil record15-17.	DENVER MUSEUM NAT HIST,DEPT EARTH SCI,DENVER,CO 80205		BEARD, KC (corresponding author), CARNEGIE MUSEUM NAT HIST,VERTEBRATE PALEONTOL SECT,4400 FORBES AVE,PITTSBURGH,PA 15213, USA.		Beard, K. Christopher/AAQ-4438-2021	Beard, K. Christopher/0000-0002-6279-9837				Cartmill M., 1980, P243; CARTMILL M, 1981, AM J PHYS ANTHROPOL, V56, P3; Cartmill M., 1978, RECENT ADV PRIMATOL, P205; CONROY GC, 1980, AM J PHYS ANTHROPOL, V52, P443, DOI 10.1002/ajpa.1330520316; DEBONIS L, 1988, CR ACAD SCI II, V306, P929; DEJONG WW, 1988, J HUM EVOL, V17, P575, DOI 10.1016/0047-2484(88)90085-1; DZELUSNIAK J, 1990, CURRENT MAMMALOGY, V2, P545; FLEAGLE JG, 1987, J HUM EVOL, V16, P483, DOI 10.1016/0047-2484(87)90036-4; GEBO DL, 1986, J HUM EVOL, V15, P421, DOI 10.1016/S0047-2484(86)80025-2; GINGERICH PD, 1981, J HUM EVOL, V10, P345, DOI 10.1016/S0047-2484(81)80057-7; GINSBURG L, 1987, CR ACAD SCI II, V304, P1213; KOOP BF, 1989, J BIOL CHEM, V264, P68; Krishtalka L., 1987, P77; Luckett WP., 1975, PHYLOGENY PRIMATES, P157, DOI [10.1007/978-1-4684-2166-8, DOI 10.1007/978-1-4684-2166-8]; MacPhee R.D.E., 1981, Contributions to Primatology, V18, P1; MacPhee R. D. E., 1986, COMP PRIM B, V1, P219; Martin R.D., 1990, PRIMATE ORIGINS EVOL; POCOCK RI, 1918, P ZOOL SOC LOND, P19; POLLOCK JI, 1987, AM J PHYS ANTHROPOL, V73, P65, DOI 10.1002/ajpa.1330730106; RASMUSSEN DT, 1986, J HUM EVOL, V15, P1, DOI 10.1016/S0047-2484(86)80060-4; Rosenberger A.L., 1980, P139; ROSENBERGER AL, 1985, FOLIA PRIMATOL, V45, P179, DOI 10.1159/000156227; SCHMID P, 1981, PRIMATE EVOLUTIONARY, P6; SCHWARTZ JH, 1987, J HUM EVOL, V16, P23, DOI 10.1016/0047-2484(87)90059-5; SIMONS EL, 1990, SCIENCE, V247, P1567, DOI 10.1126/science.2108499; SIMONS EL, 1985, NATURE, V313, P475, DOI 10.1038/313475a0; SIMONS EL, 1989, AM J PHYS ANTHROPOL, V79, P1, DOI 10.1002/ajpa.1330790103; SIMONS EL, 1989, P NATL ACAD SCI USA, V86, P9956, DOI 10.1073/pnas.86.24.9956; SIMONS ELWYN L., 1961, BULL BRIT MUS [NAT HIST] GEOL, V5, P43; STUCKY RK, 1990, GEOL SOC AM SPEC PAP, V243, P169; SZALAY F S, 1976, Bulletin of the American Museum of Natural History, V156, P157; SZALAY FS, 1976, FOLIA PRIMATOL, V25, P288, DOI 10.1159/000155721	32	59	65	0	14	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JAN 3	1991	349	6304					64	67		10.1038/349064a0	http://dx.doi.org/10.1038/349064a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EQ601	1985267				2022-12-24	WOS:A1991EQ60100051
J	MALONE, PS; RANSLEY, PG; KIELY, EM				MALONE, PS; RANSLEY, PG; KIELY, EM			PRELIMINARY-REPORT - THE ANTEGRADE CONTINENCE ENEMA	LANCET			English	Article									HOSP SICK CHILDREN,DEPT UROL,LONDON WC1N 3JH,ENGLAND; HOSP SICK CHILDREN,DEPT PAEDIAT SURG,LONDON WC1N 3JH,ENGLAND	University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust	MALONE, PS (corresponding author), SOUTHAMPTON GEN HOSP,WESSEX REG CTR PAEDIAT SURG,TREMONA RD,SOUTHAMPTON SO9 4XY,HANTS,ENGLAND.							DUDLEY HAF, 1980, BRIT J SURG, V67, P80, DOI 10.1002/bjs.1800670203; HEWITT J, 1973, LANCET, V2, P337; MITROFANOFF P, 1980, CHIR PEDIATR, V21, P297; MUIR EG, 1968, J ROYAL SOC MED, V61, P401; RADCLIFFE AG, 1983, SURG GYNECOL OBSTET, V156, P721; SHANDLING B, 1987, J PEDIATR SURG, V22, P271, DOI 10.1016/S0022-3468(87)80345-7	6	564	582	0	3	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 17	1990	336	8725					1217	1218		10.1016/0140-6736(90)92834-5	http://dx.doi.org/10.1016/0140-6736(90)92834-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ064	1978072				2022-12-24	WOS:A1990EJ06400005
J	CASSIDY, MJD; GASKIN, G; SAVILL, J; PUSEY, CD; REES, AJ				CASSIDY, MJD; GASKIN, G; SAVILL, J; PUSEY, CD; REES, AJ			TOWARDS A MORE RAPID DIAGNOSIS OF RAPIDLY PROGRESSIVE GLOMERULONEPHRITIS	BRITISH MEDICAL JOURNAL			English	Article									HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,MRC,LONDON W12 0HS,ENGLAND	Imperial College London	CASSIDY, MJD (corresponding author), HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,DEPT MED,LONDON W12 0HS,ENGLAND.							HIND CKR, 1983, LANCET, V2, P263; PINCHING AJ, 1983, Q J MED, V208, P435; PUSEY CD, 1989, KIDNEY INT, V35, P929, DOI 10.1038/ki.1989.77; SAVAGE COS, 1985, Q J MED, V56, P467; VANDERWOUDE FJ, 1989, CLIN EXP IMMUNOL, V78, P143	5	10	11	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	AUG 11	1990	301	6747					329	331		10.1136/bmj.301.6747.329	http://dx.doi.org/10.1136/bmj.301.6747.329			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU040	1975508	Green Published, Bronze			2022-12-24	WOS:A1990DU04000020
J	VONBOEHMER, H; KISIELOW, P				VONBOEHMER, H; KISIELOW, P			SELF-NONSELF DISCRIMINATION BY T-CELLS	SCIENCE			English	Article									POLISH ACAD SCI, INST IMMUNOL & EXPTL THERAPY, PL-53114 WROCLAW, POLAND	Polish Academy of Sciences; Hirszfeld Institute of Immunology & Experimental Therapy of the Polish Academy of Sciences	VONBOEHMER, H (corresponding author), BASEL INST IMMUNOL, CH-4005 BASEL, SWITZERLAND.							ALLISON JP, 1987, ANNU REV IMMUNOL, V5, P503, DOI 10.1146/annurev.iy.05.040187.002443; BENOIST C, 1989, CELL, V58, P1027, DOI 10.1016/0092-8674(89)90501-1; BERG LJ, 1989, NATURE, V340, P559, DOI 10.1038/340559a0; BERG LJ, 1989, CELL, V58, P1035, DOI 10.1016/0092-8674(89)90502-3; BILL J, 1989, NATURE, V341, P649, DOI 10.1038/341649a0; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; BLACKMAN MA, 1989, SCIENCE, V244, P214, DOI 10.1126/science.2784868; BRENNER MB, 1988, ADV IMMUNOL, V43, P133; CEREDIG R, 1983, J EXP MED, V158, P1654, DOI 10.1084/jem.158.5.1654; DEMBIC Z, 1987, NATURE, V326, P510, DOI 10.1038/326510a0; DOYLE C, 1987, NATURE, V330, P256, DOI 10.1038/330256a0; FINKEL TH, 1989, CELL, V58, P1047, DOI 10.1016/0092-8674(89)90503-5; FOWLKES BJ, 1985, J EXP MED, V162, P802, DOI 10.1084/jem.162.3.802; FOWLKES BJ, 1988, NATURE, V334, P620, DOI 10.1038/334620a0; GABERT J, 1987, CELL, V50, P545, DOI 10.1016/0092-8674(87)90027-4; JANEWAY CA, 1989, IMMUNOL REV, V107, P61, DOI 10.1111/j.1600-065X.1989.tb00003.x; JERNE NK, 1955, P NATL ACAD SCI USA, V41, P849, DOI 10.1073/pnas.41.11.849; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; KISIELOW P, 1982, EUR J IMMUNOL, V12, P463, DOI 10.1002/eji.1830120603; KISIELOW P, 1988, NATURE, V335, P730, DOI 10.1038/335730a0; KISIELOW P, 1975, NATURE, V253, P219, DOI 10.1038/253219a0; KISIELOW P, 1984, J IMMUNOL, V133, P1117; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; LEDERBERG J, 1959, SCIENCE, V129, P1649, DOI 10.1126/science.129.3364.1649; LO D, 1986, NATURE, V319, P672, DOI 10.1038/319672a0; MACDONALD HR, 1988, NATURE, V336, P471, DOI 10.1038/336471a0; MACDONALD HR, 1988, NATURE, V335, P174, DOI 10.1038/335174a0; MATZINGER P, 1981, NATURE, V292, P497, DOI 10.1038/292497a0; NORMENT AM, 1988, NATURE, V336, P79, DOI 10.1038/336079a0; PENIT C, 1986, J IMMUNOL, V137, P2115; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; RAMSDELL F, 1989, SCIENCE, V246, P1038, DOI 10.1126/science.2511629; SCOTT B, 1989, NATURE, V338, P591, DOI 10.1038/338591a0; SCOTT B, UNPUB; SHA WC, 1988, NATURE, V336, P73, DOI 10.1038/336073a0; SHA WC, 1988, NATURE, V335, P271, DOI 10.1038/335271a0; SHORTMAN K, 1974, CELL IMMUNOL, V12, P230, DOI 10.1016/0008-8749(74)90075-6; TEH HS, 1988, NATURE, V335, P229, DOI 10.1038/335229a0; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; VONBOEHMER H, 1986, IMMUNOL TODAY, V7, P333; VONBOEHMER H, 1988, IMMUNOL REV, V101, P21; VONBOEHMER H, 1989, IMMUNOL TODAY, V10, P57, DOI 10.1016/0167-5699(89)90307-1; VONBOEHMER H, 1990, ANNU REV IMMUNOL, V8, P531, DOI 10.1146/annurev.iy.08.040190.002531; VONBOEHMER H, 1985, RECOGNITION REGULATI; WAGNER H, 1981, IMMUNOL REV, V58, P95, DOI 10.1111/j.1600-065X.1981.tb00351.x; WHITE J, 1989, CELL, V56, P27, DOI 10.1016/0092-8674(89)90980-X; ZUNIGAPFLUCKER JC, 1989, NATURE, V338, P76, DOI 10.1038/338076a0	48	293	299	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 15	1990	248	4961					1369	1373		10.1126/science.1972594	http://dx.doi.org/10.1126/science.1972594			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ501	1972594				2022-12-24	WOS:A1990DJ50100031
J	BULT, H; BOECKXSTAENS, GE; PELCKMANS, PA; JORDAENS, FH; VANMAERCKE, YM; HERMAN, AG				BULT, H; BOECKXSTAENS, GE; PELCKMANS, PA; JORDAENS, FH; VANMAERCKE, YM; HERMAN, AG			NITRIC-OXIDE AS AN INHIBITORY NONADRENERGIC NONCHOLINERGIC NEUROTRANSMITTER	NATURE			English	Article									UNIV INSTELLING ANTWERP,FAC MED,DIV GASTROENTEROL,B-2610 WILRIJK,BELGIUM	University of Antwerp	BULT, H (corresponding author), UNIV INSTELLING ANTWERP,FAC MED,DIV PHARMACOL,B-2610 WILRIJK,BELGIUM.		Boeckxstaens, Guy/AAP-2502-2020; Bult, Hidde/J-5342-2013	Boeckxstaens, Guy/0000-0001-8267-5797				BULT H, 1988, BRIT J PHARMACOL, V95, P1308, DOI 10.1111/j.1476-5381.1988.tb11769.x; GARTHWAITE J, 1988, NATURE, V336, P385, DOI 10.1038/336385a0; GILLESPIE JS, 1989, BRIT J PHARMACOL, V98, P1080, DOI 10.1111/j.1476-5381.1989.tb12650.x; GRYGLEWSKI RJ, 1986, NATURE, V320, P454, DOI 10.1038/320454a0; IGNARRO LJ, 1987, P NATL ACAD SCI USA, V84, P9265, DOI 10.1073/pnas.84.24.9265; KELM M, 1988, BIOCHEM BIOPH RES CO, V154, P236, DOI 10.1016/0006-291X(88)90675-4; KNOWLES RG, 1989, P NATL ACAD SCI USA, V86, P5159, DOI 10.1073/pnas.86.13.5159; MONCADA S, 1989, BIOCHEM PHARMACOL, V38, P1709, DOI 10.1016/0006-2952(89)90403-6; MULSCH A, 1990, N-S ARCH PHARMACOL, V341, P143; PALMER RMJ, 1987, NATURE, V327, P524, DOI 10.1038/327524a0; PELCKMANS PA, 1989, EUR J PHARMACOL, V170, P235, DOI 10.1016/0014-2999(89)90544-X; RAMAGOPAL MV, 1989, EUR J PHARMACOL, V174, P297, DOI 10.1016/0014-2999(89)90325-7; RUBANYI GM, 1986, AM J PHYSIOL, V250, pH822, DOI 10.1152/ajpheart.1986.250.5.H822	13	974	994	1	17	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAY 24	1990	345	6273					346	347		10.1038/345346a0	http://dx.doi.org/10.1038/345346a0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF149	1971425				2022-12-24	WOS:A1990DF14900066
J	DAVIES, SW; RANJADAYALAN, K; WICKENS, DG; DORMANDY, TL; TIMMIS, AD				DAVIES, SW; RANJADAYALAN, K; WICKENS, DG; DORMANDY, TL; TIMMIS, AD			LIPID-PEROXIDATION ASSOCIATED WITH SUCCESSFUL THROMBOLYSIS	LANCET			English	Article									NEWHAM DIST GEN HOSP, LONDON, ENGLAND; WHITTINGTON HOSP, LONDON N19 5NF, ENGLAND	University of London; University College London	DAVIES, SW (corresponding author), LONDON CHEST HOSP, DEPT CARDIAC, BONNER RD, LONDON E2, ENGLAND.							[Anonymous], 1988, LANCET, V2, P349; [Anonymous], 1986, Lancet, V1, P397; BORER JS, 1980, AM J CARDIOL, V46, P1, DOI 10.1016/0002-9149(80)90598-6; BOROW KM, 1980, AM J MED, V68, P655, DOI 10.1016/0002-9343(80)90251-X; BRAUNWALD E, 1982, CIRCULATION, V66, P1146, DOI 10.1161/01.CIR.66.6.1146; BURRELL CJ, 1989, BRIT HEART J, V61, P4; CAWOOD P, 1984, OXYGEN RADICALS CHEM, P355; CHESEBRO JH, 1987, CIRCULATION, V76, P142, DOI 10.1161/01.CIR.76.1.142; DAVIES SW, 1989, FREE RADICALS DISEAS, P97; DELNIDO PJ, 1987, CIRCULATION, V76, P174; FERREIRA R, 1988, AM HEART J, V115, P307, DOI 10.1016/0002-8703(88)90475-9; FORMAN MB, 1988, CIRCULATION, V78, P202, DOI 10.1161/01.CIR.78.1.202; FUSTER V, 1981, AM J CARDIOL, V47, P525, DOI 10.1016/0002-9149(81)90534-8; GARLICK PB, 1987, CIRC RES, V61, P757, DOI 10.1161/01.RES.61.5.757; GUARNIERI C, 1978, J MOL CELL CARDIOL, V10, P893, DOI 10.1016/0022-2828(78)90336-X; GUARNIERI C, 1980, J MOL CELL CARDIOL, V12, P797, DOI 10.1016/0022-2828(80)90081-4; HEARSE DJ, 1988, J MOL CELL CARDIOL, V20, P213, DOI 10.1016/S0022-2828(88)80054-3; HESS ML, 1981, J MOL CELL CARDIOL, V13, P767, DOI 10.1016/0022-2828(81)90258-3; IVERSEN SA, 1985, ANN CLIN BIOCHEM, V22, P137, DOI 10.1177/000456328502200204; KUSAM Y, 1988, CIRCULATION S2, V78, P2; MATHUR VS, 1975, AM J CARDIOL, V36, P252, DOI 10.1016/0002-9149(75)90534-2; MEERSON F Z, 1981, Byulleten' Eksperimental'noi Biologii i Meditsiny, V92, P281; OLSON HG, 1986, AM HEART J, V111, P1021, DOI 10.1016/0002-8703(86)90001-3; REIMER KA, 1979, LAB INVEST, V40, P633; RITCHIE JL, 1984, CIRCULATION, V70, P867, DOI 10.1161/01.CIR.70.5.867; SCHEIBER TL, 1986, AM J CARDIOL, V58, P47; SCHRODER R, 1986, NEW ENGL J MED, V314, P1465; VANDEWERF F, 1989, LANCET, V1, P1367; WESTLIN W, 1988, CIRCULATION, V77, P30; WHITE HD, 1987, NEW ENGL J MED, V317, P850, DOI 10.1056/NEJM198710013171402; YAGI K, 1982, LIPID PEROXIDES BIOL, P223	31	112	116	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 31	1990	335	8692					741	743						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW994	1969508				2022-12-24	WOS:A1990CW99400001
J	HEATH, DA; SENIOR, PV; VARLEY, JM; BECK, F				HEATH, DA; SENIOR, PV; VARLEY, JM; BECK, F			PARATHYROID-HORMONE-RELATED PROTEIN IN TUMORS ASSOCIATED WITH HYPERCALCEMIA	LANCET			English	Article									UNIV LEICESTER,DEPT ANAT,LEICESTER LE1 7RH,ENGLAND; UNIV LEICESTER,DEPT PATHOL,LEICESTER LE1 7RH,ENGLAND	University of Leicester; University of Leicester	HEATH, DA (corresponding author), QUEEN ELIZABETH HOSP,DEPT MED,BIRMINGHAM B15 2TH,W MIDLANDS,ENGLAND.							BENDER RA, 1974, ANN INTERN MED, V80, P205, DOI 10.7326/0003-4819-80-2-205; BUDAYR AA, 1989, 71ST ANN M END SOC S, P42; CONNOR TB, 1956, J CLIN INVEST, V35, P697; DANKS JA, 1989, J BONE MINER RES, V4, P273; DOCHERTY HM, 1989, J MOL ENDOCRINOL, V2, P11, DOI 10.1677/jme.0.0020011; DOCHERTY HM, 1988, J ENDOCRINOL, V123, P487; FISKEN RA, 1980, Q J MED, V49, P405; GARDNER B, 1969, SURG GYNECOL OBSTETR, V128, P369; GLASKO CSB, 1971, BR MEDJ, V2, P573; HORIUCHI N, 1987, SCIENCE, V238, P1566, DOI 10.1126/science.3685994; IKEDA K, 1988, MOL ENDOCRINOL, V2, P1230, DOI 10.1210/mend-2-12-1230; KEMP BE, 1987, SCIENCE, V238, P1568, DOI 10.1126/science.3685995; LOVERIDGE N, 1980, CLIN ENDOCRINOL, V22, P135; MUNDY GR, 1982, METABOLISM, V31, P1247, DOI 10.1016/0026-0495(82)90012-9; MUNDY GR, 1988, J CLIN INVEST, V82, P1, DOI 10.1172/JCI113555; OMARTA M, 1987, LIVER, V1, P33; PLIMPTON CH, 1956, AM J MED, V21, P750; SENIOR PV, 1988, DEVELOPMENT, V104, P431; THIEDE MA, 1988, SCIENCE, V242, P278, DOI 10.1126/science.3175653; WALKER RA, 1989, J PATHOL, V158, P97, DOI 10.1002/path.1711580204	20	47	47	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JAN 13	1990	335	8681					66	69		10.1016/0140-6736(90)90537-F	http://dx.doi.org/10.1016/0140-6736(90)90537-F			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH516	1967417				2022-12-24	WOS:A1990CH51600002
J	GATES, G				GATES, G			SUBMANDIBULAR CALCULI	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter											GATES, G (corresponding author), WASHINGTON UNIV,SCH MED,ST LOUIS,MO 63110, USA.								0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	1991	265	5					650	650						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EV718	1987419				2022-12-24	WOS:A1991EV71800027
J	YEH, HJ; RUIT, KG; WANG, YX; PARKS, WC; SNIDER, WD; DEUEL, TF				YEH, HJ; RUIT, KG; WANG, YX; PARKS, WC; SNIDER, WD; DEUEL, TF			PDGF A-CHAIN GENE IS EXPRESSED BY MAMMALIAN NEURONS DURING DEVELOPMENT AND IN MATURITY	CELL			English	Article							CENTRAL NERVOUS-SYSTEM; RAT OPTIC-NERVE; GROWTH-FACTOR; PROGENITOR-CELL; PLATELET; ASTROCYTE; DIFFERENTIATION; CULTURE; TRANSFORMATION; FIBROBLASTS	Platelet-derived growth factor (PDGF) may be a critical factor in the temporal differentiation of glial elements in the mammalian central nervous system. We have used in situ hybridization and immunoperoxidase staining to investigate the localization of PDGF A and have observed high levels of PDGF A-chain mRNA and immunoreactive PDGF A in neurons of embryonic and adult mice. PDGF A-chain expression was shown to be developmentally regulated and tissue specific. Every neuronal population examined in the central and peripheral nervous systems expresses PDGF A transcripts. Variable, significantly weaker signals are observed in glial cells. In contrast to known neurotrophic factors, the PDGF A transcripts are widely distributed among neurons. This generalized distribution of PDGF A transcripts, together with the known effects of PDGF on glial cells in vitro, suggests a unique role of neurons in regulating the proliferation and differentiation of glial cells in vivo.	WASHINGTON UNIV,MED CTR,DEPT NEUROL,ST LOUIS,MO 63110; WASHINGTON UNIV,MED CTR,DEPT BIOCHEM & MOLEC BIOPHYS,ST LOUIS,MO 63110; JEWISH HOSP ST LOUIS,ST LOUIS,MO 63110; CHINESE ACAD SCI,SHANGHAI INST CELL BIOL,SHANGHAI,PEOPLES R CHINA	Washington University (WUSTL); Washington University (WUSTL); Barnes-Jewish Hospital; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	YEH, HJ (corresponding author), WASHINGTON UNIV,MED CTR,DEPT MED,ST LOUIS,MO 63110, USA.		Parks, William C./AAH-6786-2021		NCI NIH HHS [CA49712] Funding Source: Medline; NHLBI NIH HHS [HL14147, HL31102] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA049712] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R37HL031102, R01HL031102, P50HL014147] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BEJCEK BE, 1989, SCIENCE, V245, P1496, DOI 10.1126/science.2551043; BOWENPOPE DF, 1984, P NATL ACAD SCI-BIOL, V81, P2396, DOI 10.1073/pnas.81.8.2396; BRESSLER JP, 1985, BRAIN RES, V344, P249, DOI 10.1016/0006-8993(85)90802-9; DEUEL TF, 1987, ANNU REV CELL BIOL, V3, P443, DOI 10.1146/annurev.cb.03.110187.002303; DEUEL TF, 1982, J CLIN INVEST, V69, P1046, DOI 10.1172/JCI110509; ERNFORS P, 1990, P NATL ACAD SCI USA, V87, P5454, DOI 10.1073/pnas.87.14.5454; GROTENDORST GR, 1981, P NATL ACAD SCI-BIOL, V78, P3669, DOI 10.1073/pnas.78.6.3669; HELDIN CH, 1986, NATURE, V319, P511, DOI 10.1038/319511a0; HUANG JS, 1984, CELL, V39, P79, DOI 10.1016/0092-8674(84)90193-4; HUGHES SM, 1988, NATURE, V335, P70, DOI 10.1038/335070a0; LILLIEN LE, 1988, NEURON, V1, P485, DOI 10.1016/0896-6273(88)90179-1; LILLIEN LE, 1990, NEURON, V5, P111, DOI 10.1016/0896-6273(90)90301-U; LILLIEN LE, 1990, NEURON, V4, P525, DOI 10.1016/0896-6273(90)90110-2; MILLER RH, 1985, DEV BIOL, V111, P35, DOI 10.1016/0012-1606(85)90432-4; Nauta W.J.H., 1986, FUNDAMENTAL NEUROANA, P33; NOBLE M, 1988, NATURE, V333, P560, DOI 10.1038/333560a0; POMEROY SL, 1988, J CELL BIOL, V107, P1167, DOI 10.1083/jcb.107.3.1167; PRINGLE N, 1988, EMBO J, V18, P1049; PROSSER IW, 1989, AM J PATHOL, V135, P1073; RAFF MC, 1985, CELL, V42, P61, DOI 10.1016/S0092-8674(85)80101-X; RAFF MC, 1988, NATURE, V333, P562, DOI 10.1038/333562a0; RAFF MC, 1983, NATURE, V303, P390, DOI 10.1038/303390a0; RAFF MC, 1989, SCIENCE, V243, P1450, DOI 10.1126/science.2648568; RICHARDSON WD, 1988, CELL, V53, P309, DOI 10.1016/0092-8674(88)90392-3; SENIOR RM, 1983, J CELL BIOL, V96, P382, DOI 10.1083/jcb.96.2.382; SEPPA H, 1982, J CELL BIOL, V92, P584, DOI 10.1083/jcb.92.2.584; SNIDER WD, 1989, ANN NEUROL, V26, P489, DOI 10.1002/ana.410260402; TONG BD, 1987, NATURE, V328, P619, DOI 10.1038/328619a0; WALICKE PA, 1988, J NEUROSCI, V8, P2618; WANAKA A, 1990, NEURON, V5, P267, DOI 10.1016/0896-6273(90)90164-B; WHITTEMORE SR, 1987, BRAIN RES REV, V12, P439, DOI 10.1016/0165-0173(87)90008-7	31	335	338	0	9	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	JAN 11	1991	64	1					209	216		10.1016/0092-8674(91)90222-K	http://dx.doi.org/10.1016/0092-8674(91)90222-K			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ET175	1986867				2022-12-24	WOS:A1991ET17500022
J	WATSON, SR; FENNIE, C; LASKY, LA				WATSON, SR; FENNIE, C; LASKY, LA			NEUTROPHIL INFLUX INTO AN INFLAMMATORY SITE INHIBITED BY A SOLUBLE HOMING RECEPTOR-IGG CHIMERA	NATURE			English	Article							MONOCLONAL-ANTIBODY; GLYCOPROTEIN; INVIVO; LYMPHOCYTES; PREVENTION; PLATELETS; ADHESION; PROTEINS; CLONING	Neutrophil-mediated inflammation is involved in a number of human clinical manifestations, including the adult respiratory distress syndrome, multi-organ failure and reperfusion injury 1. One way of inhibiting this type of inflammatory response would be to block competitively the adhesive interactions between neutrophils and the endothelium adjacent to the inflamed region 2. The lectin-containing 3,4 murine adhesion molecule gp90MET, the homing receptor, is found on all leukocytic cells, including neutrophils. 5 MEL 14, a monoclonal antibody directed against this adhesion molecule, blocks lymphocyte traffic to lymph nodes 6 and extravasation of neutrophils from blood to inflammatory sites 7. Here we show that administration to mice of a soluble immunoglobulin chimaera containing the murine homing receptor extracellular domain significantly decreases the number of neutrophils that migrate to the peritoneum in response to the inflammatory irritant thioglycollate. These results indicate that soluble forms of a single type of adhesion molecule, the homing receptor, could be clinically effective compounds for the inhibition of neutrophil-mediated inflammation.			WATSON, SR (corresponding author), GENENTECH INC,DEPT IMMUNOBIOL,460 POINT SAN BRUNO BLVD,S SAN FRANCISCO,CA 94080, USA.							ARFORS KE, 1987, BLOOD, V69, P338; BEVILACQUA MP, 1989, SCIENCE, V243, P1160, DOI 10.1126/science.2466335; BOWEN B, 1990, J CELL BIOL, V110, P421; CAPON DJ, 1989, NATURE, V337, P525, DOI 10.1038/337525a0; COSIMI AB, 1990, J IMMUNOL, V144, P4604; FANSLOW WC, 1990, SCIENCE, V248, P739, DOI 10.1126/science.2139736; FISCHER A, 1986, LANCET, V2, P1058; GALLATIN M, 1986, CELL, V44, P673, DOI 10.1016/0092-8674(86)90832-9; GALLATIN WM, 1983, NATURE, V304, P30, DOI 10.1038/304030a0; Goldstein I., 1988, INFLAMMATION BASIC P; IMAI Y, UNPUB J CELL BIOL; JOHNSTON GI, 1989, CELL, V56, P1033, DOI 10.1016/0092-8674(89)90636-3; JUTILA MA, 1989, J IMMUNOL, V143, P3318; LARSEN E, 1989, CELL, V59, P305, DOI 10.1016/0092-8674(89)90292-4; LASKY LA, 1989, CELL, V56, P1045, DOI 10.1016/0092-8674(89)90637-5; LASKY LA, 1986, SCIENCE, V233, P209, DOI 10.1126/science.3014647; LEWINSOHN DM, 1987, J IMMUNOL, V138, P4313; MARLIN SD, 1990, NATURE, V344, P70, DOI 10.1038/344070a0; MOUNTZ JD, 1988, J IMMUNOL, V140, P2943; SIEGELMAN MH, 1989, SCIENCE, V243, P1165, DOI 10.1126/science.2646713; SPRINGER T, 1990, NATURE, V436, P425; STREETER PR, 1988, J CELL BIOL, V107, P1853, DOI 10.1083/jcb.107.5.1853; WATSON SR, 1990, J CELL BIOL, V110, P2221, DOI 10.1083/jcb.110.6.2221	23	297	351	0	0	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JAN 10	1991	349	6305					164	166		10.1038/349164a0	http://dx.doi.org/10.1038/349164a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER418	1986307				2022-12-24	WOS:A1991ER41800061
J	SMITH, JM; DOWSON, CG; SPRATT, BG				SMITH, JM; DOWSON, CG; SPRATT, BG			LOCALIZED SEX IN BACTERIA	NATURE			English	Review							PENICILLIN-BINDING PROTEINS; ESCHERICHIA-COLI; NEISSERIA-MENINGITIDIS; HEMOPHILUS-INFLUENZAE; GENETIC DIVERSITY; STRAINS; DNA; TRANSFORMATION; RECOMBINATION; GONORRHOEAE	Electrophoretic studies suggest that bacterial populations consist of a number of independent clones and that genetic recombination is rare in nature. But DNA sequencing reveals that individual bacterial genes have a mosaic structure that could have arisen only by recombination. How can these observations be reconciled and what is their relevance to prokaryotic evolution?			SMITH, JM (corresponding author), UNIV SUSSEX,SCH BIOL SCI,BRIGHTON BN1 9QG,E SUSSEX,ENGLAND.		Spratt, Brian G/A-1676-2009; Dowson, Christopher/ABG-5083-2021; Dowson, Chris/N-6195-2014	Dowson, Christopher/0000-0002-8294-8836; Dowson, Chris/0000-0002-8294-8836				ARTHUR M, 1990, INFECT IMMUN, V58, P471, DOI 10.1128/IAI.58.2.471-479.1990; BELTRAN P, 1988, P NATL ACAD SCI USA, V85, P7753, DOI 10.1073/pnas.85.20.7753; CAUGANT DA, 1987, J BACTERIOL, V169, P2781, DOI 10.1128/jb.169.6.2781-2792.1987; CAUGANT DA, 1986, P NATL ACAD SCI USA, V83, P4927, DOI 10.1073/pnas.83.13.4927; CERRITELLI S, 1989, P NATL ACAD SCI USA, V86, P9223, DOI 10.1073/pnas.86.23.9223; DOWSON CG, 1989, P NATL ACAD SCI USA, V86, P8842, DOI 10.1073/pnas.86.22.8842; DOWSON CG, 1990, P NATL ACAD SCI USA, V87, P5858, DOI 10.1073/pnas.87.15.5858; DUBOSE RF, 1988, P NATL ACAD SCI USA, V85, P7036, DOI 10.1073/pnas.85.18.7036; DYKHUIZEN DE, 1986, GENETICS, V113, P871; GIBBS CP, 1989, NATURE, V338, P651, DOI 10.1038/338651a0; Griffith F, 1928, J HYG-CAMBRIDGE, V27, P113, DOI 10.1017/S0022172400031879; KROLL JS, 1990, J BACTERIOL, V172, P1374, DOI 10.1128/jb.172.3.1374-1379.1990; LACKS SA, 1986, CELL, V46, P993, DOI 10.1016/0092-8674(86)90698-7; Levin B. R., 1988, EVOLUTION SEX, P194; MARCA RL, IN PRESS ANTIMICROB; MICHOD RE, 1988, GENETICS, V118, P31; MILKMAN R, 1983, SCIENCE, V221, P378, DOI 10.1126/science.6346486; MUSSER JM, 1988, P NATL ACAD SCI USA, V85, P7758, DOI 10.1073/pnas.85.20.7758; MUSSER JM, 1985, P NATL ACAD SCI USA, V82, P5078, DOI 10.1073/pnas.82.15.5078; OLYHOEK T, 1987, REV INFECT DIS, V9, P665; ORSKOV F, 1983, J INFECT DIS, V148, P346, DOI 10.1093/infdis/148.2.346; PLOS K, 1989, INFECT IMMUN, V57, P1604, DOI 10.1128/IAI.57.5.1604-1611.1989; RAYSSIGUIER C, 1989, NATURE, V342, P396, DOI 10.1038/342396a0; SAWYER S, 1989, MOL BIOL EVOL, V6, P526; SEIFERT HS, 1988, NATURE, V336, P392, DOI 10.1038/336392a0; SELANDER RK, 1980, SCIENCE, V210, P545, DOI 10.1126/science.6999623; SELANDER RK, 1987, ESCHERICHIA COLI SAL, P1625; SHARP PM, 1987, MOL BIOL EVOL, V4, P222; SMITH NH, 1990, J BACTERIOL, V172, P2209, DOI 10.1128/jb.172.5.2209-2216.1990; SPRATT BG, 1988, REV INFECT DIS, V10, P699; SPRATT BG, 1988, NATURE, V332, P173, DOI 10.1038/332173a0; SPRATT BG, 1989, P NATL ACAD SCI USA, V86, P8988, DOI 10.1073/pnas.86.22.8988; SPRATT BG, 1989, HDB EXPT PHARM, V91, P77; STEPHENS JC, 1985, MOL BIOL EVOL, V2, P539; STEWART GJ, 1986, ANNU REV MICROBIOL, V40, P211, DOI 10.1146/annurev.micro.40.1.211; STOLTZFUS A, 1988, GENETICS, V120, P345; WHITTAM TS, 1983, P NATL ACAD SCI-BIOL, V80, P1751, DOI 10.1073/pnas.80.6.1751; WOJCIECHOWSKI MF, 1989, GENETICS, V121, P411	38	288	299	0	9	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JAN 3	1991	349	6304					29	31		10.1038/349029a0	http://dx.doi.org/10.1038/349029a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EQ601	1985260				2022-12-24	WOS:A1991EQ60100040
J	BOLOS, AM; DEAN, M; LUCASDERSE, S; RAMSBURG, M; BROWN, GL; GOLDMAN, D				BOLOS, AM; DEAN, M; LUCASDERSE, S; RAMSBURG, M; BROWN, GL; GOLDMAN, D			POPULATION AND PEDIGREE STUDIES REVEAL A LACK OF ASSOCIATION BETWEEN THE DOPAMINE-D2 RECEPTOR GENE AND ALCOHOLISM	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									NIAAA,CLIN STUDIES LAB,GENET STUDIES LAB,9000 ROCKVILLE PIKE,BLDG 10,ROOM 3C-102,ROCKVILLE,MD 20852; PROGRAM RESOURCES INC,FREDERICK,MD; NIAAA,CLIN STUDIES LAB,FAMILY STUDIES UNIT,ROCKVILLE,MD 20852	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)			Dean, Michael/R-7501-2019; Goldman, David/F-9772-2010; Dean, Michael/G-8172-2012	Goldman, David/0000-0002-1724-5405; Dean, Michael/0000-0003-2234-0631	OFFICE OF THE DIRECTOR, NCI [N01CO074102] Funding Source: NIH RePORTER; NCI NIH HHS [N01-CO-74102] Funding Source: Medline	OFFICE OF THE DIRECTOR, NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ASTON CE, 1990, AM J HUM GENET, V46, P879; BLUM K, 1990, JAMA-J AM MED ASSOC, V263, P2055, DOI 10.1001/jama.263.15.2055; BOHMAN M, 1981, ARCH GEN PSYCHIAT, V38, P965; CLONINGER CR, 1981, ARCH GEN PSYCHIAT, V38, P861; DAUSSET J, 1990, GENOMICS, V6, P676; DEAN M, 1990, CELL, V61, P863, DOI 10.1016/0092-8674(90)90196-L; DEVOR EJ, 1989, ANNU REV GENET, V23, P19, DOI 10.1146/annurev.ge.23.120189.000315; ENDICOTT J, 1978, ARCH GEN PSYCHIAT, V35, P837; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GILLIGAN SB, 1987, GENET EPIDEMIOL, V4, P395, DOI 10.1002/gepi.1370040602; GOODWIN DW, 1973, ARCH GEN PSYCHIAT, V28, P238; GOODWIN DW, 1974, ARCH GEN PSYCHIAT, V31, P164; GRANDY DK, 1989, P NATL ACAD SCI USA, V86, P9762, DOI 10.1073/pnas.86.24.9762; GRANDY DK, 1989, AM J HUM GENET, V45, P778; KAIJ L, 1960, ALCOHOLISM TWINS; MAINIATIS T, 1982, MOL CLONING LABORATO, P280; ORITA M, 1989, GENOMICS, V5, P874, DOI 10.1016/0888-7543(89)90129-8; SCHUCKIT MA, 1986, AM J PSYCHIAT, V143, P140; SCHUCKIT MA, 1972, AM J PSYCHIAT, V128, P1132, DOI 10.1176/ajp.128.9.1132; SELZER ML, 1971, AM J PSYCHIAT, V127, P1653, DOI 10.1176/ajp.127.12.1653; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; SPITZER RL, 1978, ARCH GEN PSYCHIAT, V35, P773, DOI 10.1001/archpsyc.1978.01770300115013; STABENAU JR, 1984, AM J PSYCHIAT, V141, P1178; VONKNORRING AL, 1985, ACTA PSYCHIAT SCAND, V72, P51; WHITE MB, 1990, NATURE, V344, P665, DOI 10.1038/344665a0; WINOKUR G, 1971, BRIT J PSYCHIAT, V118, P525, DOI 10.1192/bjp.118.546.525; 1987, DIAGNOSTIC STATISTIC; 1990, ADM901656 US DEP HLT	28	225	233	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 26	1990	264	24					3156	3160						5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EN614	1979357				2022-12-24	WOS:A1990EN61400035
J	CARLSON, J; HELMBY, H; HILL, AVS; BREWSTER, D; GREENWOOD, BM; WAHLGREN, M				CARLSON, J; HELMBY, H; HILL, AVS; BREWSTER, D; GREENWOOD, BM; WAHLGREN, M			HUMAN CEREBRAL MALARIA - ASSOCIATION WITH ERYTHROCYTE ROSETTING AND LACK OF ANTI-ROSETTING ANTIBODIES	LANCET			English	Article									UNIV STOCKHOLM, DEPT IMMUNOL, S-10691 STOCKHOLM, SWEDEN; MRC LABS, FAJARA, SENEGAMBIA; UNIV UPPSALA, AKAD SJUKHUSET, DEPT INFECT DIS, S-75105 UPPSALA, SWEDEN; ROYAL VICTORIA HOSP BANJUL, DEPT PEDIAT, BANJUL, NSW, AUSTRALIA; KAROLINSKA INST, ROSLAGSTULLS SJUKHUS, DEPT INFECT DIS, S-10401 STOCKHOLM 60, SWEDEN; INST MOLEC MED, MOLEC IMMUNOL GRP, OXFORD, ENGLAND	Stockholm University; Uppsala University; Uppsala University Hospital; Karolinska Institutet; University of Oxford			HILL, Adrian V>S>/C-1306-2008; Helmby, Helena/ABE-1649-2020	Helmby, Helena/0000-0003-0761-7348; Carlson, Johan/0000-0002-6216-6132				BARNWELL JW, 1989, J CLIN INVEST, V84, P1; BERENDT AR, 1989, NATURE, V341, P57, DOI 10.1038/341057a0; CARLSON J, 1990, P NATL ACAD SCI USA, V87, P2511, DOI 10.1073/pnas.87.7.2511; DAVID PH, 1988, AM J TROP MED HYG, V38, P289, DOI 10.4269/ajtmh.1988.38.289; HANDUNNETTI SM, 1989, AM J TROP MED HYG, V40, P115, DOI 10.4269/ajtmh.1989.40.115; HOWARD RJ, 1988, PROG ALLERGY, V41, P98; Knisely M. H., 1941, Anatomical Record Philadelphia, V79, P90; MACPHERSON GG, 1985, AM J PATHOL, V119, P385; MARSH K, 1988, EXP PARASITOL, V65, P202, DOI 10.1016/0014-4894(88)90123-3; OCKENHOUSE CF, 1989, SCIENCE, V243, P1469, DOI 10.1126/science.2467377; ROBERTS DD, 1985, NATURE, V318, P64, DOI 10.1038/318064a0; TAYLOR DW, 1987, MOL BIOCHEM PARASIT, V25, P165, DOI 10.1016/0166-6851(87)90005-3; TAYLOR TE, 1988, NEW ENGL J MED, V319, P1040, DOI 10.1056/NEJM198810203191602; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; UDOMSANGPETCH R, 1989, J EXP MED, V169, P1835, DOI 10.1084/jem.169.5.1835; WAHLGREN M, 1990, VACCINES 90, P467; WAHLGREN M, 1990, AM J TROP MED HYG, V43, P333, DOI 10.4269/ajtmh.1990.43.333; WAHLGREN M, 1989, PARASITOL TODAY, V5, P183, DOI 10.1016/0169-4758(89)90141-5; WAHLGREN M, 1986, ANTIGENS ANTIBODIES, P1	19	380	385	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 15	1990	336	8729					1457	1460		10.1016/0140-6736(90)93174-N	http://dx.doi.org/10.1016/0140-6736(90)93174-N			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EN157	1979090				2022-12-24	WOS:A1990EN15700001
J	SOUTHERN, JP; SMITH, RMM; PALMER, SR				SOUTHERN, JP; SMITH, RMM; PALMER, SR			BIRD ATTACK ON MILK BOTTLES - POSSIBLE MODE OF TRANSMISSION OF CAMPYLOBACTER-JEJUNI TO MAN	LANCET			English	Article									CARDIFF ROYAL INFIRM, CTR COMMUNICABLE DIS SURVEILLANCE, PUBL HLTH LAB SERV, WELSH UNIT, CARDIFF CF2 1SZ, S GLAM, WALES	Cardiff Royal Infirmary								BLASER MJ, 1987, JAMA-J AM MED ASSOC, V257, P43, DOI 10.1001/jama.257.1.43; DEMING MS, 1987, AM J EPIDEMIOL, V126, P526, DOI 10.1093/oxfordjournals.aje.a114685; HARRIS NV, 1986, AM J PUBLIC HEALTH, V76, P407, DOI 10.2105/AJPH.76.4.407; HOPKINS RS, 1983, J INFECT DIS, V148, P770, DOI 10.1093/infdis/148.4.770; HUDSON SJ, 1990, LANCET, V335, P1160, DOI 10.1016/0140-6736(90)91162-4; KAPPERUD G, 1983, APPL ENVIRON MICROB, V45, P375, DOI 10.1128/AEM.45.2.375-380.1983; KORNBLATT AN, 1985, AM J EPIDEMIOL, V122, P884, DOI 10.1093/oxfordjournals.aje.a114171; OOSTEROM J, 1984, J HYG-CAMBRIDGE, V93, P325, DOI 10.1017/S002217240006486X; PALMER SR, 1989, J EPIDEMIOL COMMUN H, V43, P311, DOI 10.1136/jech.43.4.311; PALMER SR, 1983, LANCET, V1, P287, DOI 10.1016/S0140-6736(83)91698-7; PALMER SR, 1990, BRIT MED J, V300, P774, DOI 10.1136/bmj.300.6727.774; ROBINSON DA, 1981, BRIT MED J, V282, P1374, DOI 10.1136/bmj.282.6273.1374; SALFIELD NJ, 1987, BRIT MED J, V294, P21, DOI 10.1136/bmj.294.6563.21; Schlesselman JJ, 1982, CASE CONTROL STUDIES; 1990, MICROBIOLOGICAL SA 1, P126	15	40	41	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 8	1990	336	8728					1425	1427		10.1016/0140-6736(90)93114-5	http://dx.doi.org/10.1016/0140-6736(90)93114-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL851	1978882				2022-12-24	WOS:A1990EL85100016
J	PRUSINER, SB; SCOTT, M; FOSTER, D; PAN, KM; GROTH, D; MIRENDA, C; TORCHIA, M; YANG, SL; SERBAN, D; CARLSON, GA; HOPPE, PC; WESTAWAY, D; DEARMOND, SJ				PRUSINER, SB; SCOTT, M; FOSTER, D; PAN, KM; GROTH, D; MIRENDA, C; TORCHIA, M; YANG, SL; SERBAN, D; CARLSON, GA; HOPPE, PC; WESTAWAY, D; DEARMOND, SJ			TRANSGENETIC STUDIES IMPLICATE INTERACTIONS BETWEEN HOMOLOGOUS PRP ISOFORMS IN SCRAPIE PRION REPLICATION	CELL			English	Article									UNIV CALIF SAN FRANCISCO,DEPT BIOCHEM & BIOPHYS,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT PATHOL,SAN FRANCISCO,CA 94143; MCLAUGHLIN RES INST,GREAT FALLS,MT 59401; JACKSON LAB,BAR HARBOR,ME 04609	University of California System; University of California San Francisco; University of California System; University of California San Francisco; McLaughlin Research Institute for Biomedical Sciences, Inc.; Jackson Laboratory	PRUSINER, SB (corresponding author), UNIV CALIF SAN FRANCISCO,DEPT NEUROL,SAN FRANCISCO,CA 94143, USA.				NIA NIH HHS [AG02132] Funding Source: Medline; NINDS NIH HHS [NS22786, NS14069] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS014069, P01NS014069, P01NS022786] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG002132] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AIKEN JM, 1989, J VIROL, V63, P1686, DOI 10.1128/JVI.63.4.1686-1694.1989; AMBLER L, 1984, ANAL BIOCHEM, V137, P66, DOI 10.1016/0003-2697(84)90347-6; BARRY R A, 1987, P239; BARRY RA, 1986, J INFECT DIS, V154, P518, DOI 10.1093/infdis/154.3.518; BARRY RA, 1985, J IMMUNOL, V135, P603; BASLER K, 1986, CELL, V46, P417, DOI 10.1016/0092-8674(86)90662-8; BELLINGERKAWAHARA C, 1987, VIROLOGY, V160, P271, DOI 10.1016/0042-6822(87)90072-9; BELLINGERKAWAHARA C, 1987, J VIROL, V61, P159, DOI 10.1128/JVI.61.1.159-166.1987; BELLINGERKAWAHARA CG, 1988, VIROLOGY, V164, P537, DOI 10.1016/0042-6822(88)90569-7; BOCKMAN JM, 1987, ANN NEUROL, V21, P589, DOI 10.1002/ana.410210611; BORCHELT DR, 1990, J CELL BIOL, V110, P743, DOI 10.1083/jcb.110.3.743; BRAIG HR, 1985, EMBO J, V4, P2309, DOI 10.1002/j.1460-2075.1985.tb03931.x; BRUCE ME, 1985, J NEUROPATH EXP NEUR, V44, P285, DOI 10.1097/00005072-198505000-00006; BRUCE ME, 1976, NEUROPATH APPL NEURO, V2, P471, DOI 10.1111/j.1365-2990.1976.tb00521.x; BRUCE ME, 1987, J GEN VIROL, V68, P79, DOI 10.1099/0022-1317-68-1-79; BUTLER DA, 1988, J VIROL, V62, P1558, DOI 10.1128/JVI.62.5.1558-1564.1988; CARLSON GA, 1989, P NATL ACAD SCI USA, V86, P7475, DOI 10.1073/pnas.86.19.7475; CARLSON GA, 1986, CELL, V46, P503, DOI 10.1016/0092-8674(86)90875-5; CARLSON GA, 1988, MOL CELL BIOL, V8, P5528, DOI 10.1128/MCB.8.12.5528; CAUGHEY B, 1990, J VIROL, V64, P1093, DOI 10.1128/JVI.64.3.1093-1101.1990; CAUGHEY B, 1989, J VIROL, V63, P175, DOI 10.1128/JVI.63.1.175-181.1989; CHANDLER RL, 1961, LANCET, V1, P1378; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CREIGHTON TE, 1980, J MOL BIOL, V142, P43, DOI 10.1016/0022-2836(80)90205-3; CZUB M, 1988, J GEN VIROL, V69, P1753, DOI 10.1099/0022-1317-69-7-1753; DEARMOND S J, 1987, P387; DEARMOND SJ, 1985, CELL, V41, P221, DOI 10.1016/0092-8674(85)90076-5; DEARMOND SJ, 1987, NEUROLOGY, V37, P1271, DOI 10.1212/WNL.37.8.1271; DICKINSON AG, 1968, J COMP PATHOL, V78, P293, DOI 10.1016/0021-9975(68)90005-4; Dickinson AG., 1979, SLOW TRANSMISSIBLE D, P13; DUGUID JR, 1988, P NATL ACAD SCI USA, V85, P5738, DOI 10.1073/pnas.85.15.5738; EKLUND CM, 1967, J INFECT DIS, V117, P15, DOI 10.1093/infdis/117.1.15; ENDO T, 1989, BIOCHEMISTRY-US, V28, P8380, DOI 10.1021/bi00447a017; EVANS PA, 1987, NATURE, V329, P266, DOI 10.1038/329266a0; FOX RO, 1986, NATURE, V320, P192, DOI 10.1038/320192a0; FRASER H, 1989, ALZHEIMERS DISEASE R, P637; GABIZON R, 1990, BIOCHEM J, V266, P1; GABIZON R, 1988, P NATL ACAD SCI USA, V85, P6617, DOI 10.1073/pnas.85.18.6617; GABIZON R, 1987, P NATL ACAD SCI USA, V84, P4017, DOI 10.1073/pnas.84.12.4017; HAY B, 1987, BIOCHEMISTRY-US, V26, P8110, DOI 10.1021/bi00399a014; HAY B, 1987, MOL CELL BIOL, V7, P914, DOI 10.1128/MCB.7.2.914; HSIAO K, 1989, NATURE, V338, P342, DOI 10.1038/338342a0; HUNTER N, 1987, J GEN VIROL, V68, P2711, DOI 10.1099/0022-1317-68-10-2711; IJSSELMUIDEN OE, 1987, EUR J CLIN MICROBIOL, V6, P281, DOI 10.1007/BF02017613; IJSSELMUIDEN OE, 1989, J IMMUNOL METHODS, V119, P35, DOI 10.1016/0022-1759(89)90378-5; KIMBERLIN RH, 1977, J GEN VIROL, V34, P295, DOI 10.1099/0022-1317-34-2-295; KIMBERLIN RH, 1978, J COMP PATHOL, V88, P39, DOI 10.1016/0021-9975(78)90059-2; KIMBERLIN RH, 1989, J GEN VIROL, V70, P2017, DOI 10.1099/0022-1317-70-8-2017; KRIEG PA, 1984, NUCLEIC ACIDS RES, V12, P7057, DOI 10.1093/nar/12.18.7057; LANG K, 1987, NATURE, V329, P268, DOI 10.1038/329268a0; LEINIKKI PO, 1978, J CLIN MICROBIOL, V8, P419; LOPEZ CD, 1990, SCIENCE, V248, P226, DOI 10.1126/science.1970195; MANUELIDIS L, 1987, EMBO J, V6, P341, DOI 10.1002/j.1460-2075.1987.tb04760.x; MARSH RF, 1975, J INFECT DIS, V131, P104, DOI 10.1093/infdis/131.2.104; MCBRIDE PA, 1988, NEUROPATH APPL NEURO, V14, P325, DOI 10.1111/j.1365-2990.1988.tb00892.x; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; MEYER N, 1990, IN PRESS J GEN VIROL; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; MURDOCH GH, 1990, J VIROL, V64, P1477, DOI 10.1128/JVI.64.4.1477-1486.1990; OESCH B, 1990, BIOCHEMISTRY-US, V29, P5848, DOI 10.1021/bi00476a029; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; OSTERMANN J, 1989, NATURE, V341, P125, DOI 10.1038/341125a0; Pattison I. H., 1965, NINDB MONOGRAPH, V2, P249; PATTISON IH, 1968, RES VET SCI, V9, P408; PRUISNER SB, 1989, ANNU REV MICROBIOL, V43, P345; PRUSINER S B, 1987, P83; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; PRUSINER SB, 1982, BIOCHEMISTRY-US, V21, P6942, DOI 10.1021/bi00269a050; PRUSINER SB, 1982, ANN NEUROL, V11, P353, DOI 10.1002/ana.410110406; PRUSINER SB, 1977, P NATL ACAD SCI USA, V74, P4656, DOI 10.1073/pnas.74.10.4656; PUISSANT C, 1990, BIOTECHNIQUES, V8, P148; RACE RE, 1988, J VIROL, V62, P2845, DOI 10.1128/JVI.62.8.2845-2849.1988; RACE RE, 1990, J GEN VIROL, V71, P493, DOI 10.1099/0022-1317-71-2-493; ROBERTS GW, 1986, NEW ENGL J MED, V315, P1231; Rosen K., 1990, FOCUS, V12, P23; SCOTT M, 1989, CELL, V59, P847, DOI 10.1016/0092-8674(89)90608-9; SERBAN D, 1990, NEUROLOGY, V40, P110, DOI 10.1212/WNL.40.1.110; SINGH L, 1984, NUCLEIC ACIDS RES, V12, P5627, DOI 10.1093/nar/12.14.5627; SKLAVIADIS TK, 1989, J VIROL, V63, P1212, DOI 10.1128/JVI.63.3.1212-1222.1989; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; TARABOULOS A, 1990, IN PRESS P NATL ACAD; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; UHL J, 1988, J IMMUNOL METHODS, V110, P79, DOI 10.1016/0022-1759(88)90085-3; WEISSMANN C, 1989, NATURE, V338, P298, DOI 10.1038/338298a0; WEITGREFE S, 1985, SCIENCE, V230, P1177; WESTAWAY D, 1987, CELL, V51, P651, DOI 10.1016/0092-8674(87)90134-6; WOOD GS, 1981, J HISTOCHEM CYTOCHEM, V29, P1196, DOI 10.1177/29.10.7028859; YOST CS, 1990, NATURE, V343, P669, DOI 10.1038/343669a0	88	755	777	0	30	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	NOV 16	1990	63	4					673	686		10.1016/0092-8674(90)90134-Z	http://dx.doi.org/10.1016/0092-8674(90)90134-Z			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EJ590	1977523				2022-12-24	WOS:A1990EJ59000004
J	TZAKIS, AG; RICORDI, C; ALEJANDRO, R; ZENG, YJ; FUNG, JJ; TODO, S; DEMETRIS, AJ; MINTZ, DH; STARZL, TE				TZAKIS, AG; RICORDI, C; ALEJANDRO, R; ZENG, YJ; FUNG, JJ; TODO, S; DEMETRIS, AJ; MINTZ, DH; STARZL, TE			PANCREATIC-ISLET TRANSPLANTATION AFTER UPPER ABDOMINAL EXENTERATION AND LIVER REPLACEMENT	LANCET			English	Article									UNIV PITTSBURGH,UNIV HLTH CTR PITTSBURGH,DEPT MED,PITTSBURGH,PA 15213; UNIV PITTSBURGH,UNIV HLTH CTR PITTSBURGH,DEPT PATHOL,PITTSBURGH,PA 15213; UNIV MIAMI,SCH MED,DIABET RES INST,MIAMI,FL 33152; UNIV MILAN,INST H SAN RAFFAELE,DEPT SURG,I-20122 MILAN,ITALY	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Miami; University of Milan; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele	TZAKIS, AG (corresponding author), UNIV PITTSBURGH,UNIV HLTH CTR PITTSBURGH,DEPT SURG,3601 5TH AVE,PITTSBURGH,PA 15213, USA.		FUNG, John Julian/A-2679-2012; RICORDI, CAMILLO/AAA-4740-2019	FUNG, John Julian/0000-0002-3038-0441; Ricordi, Camillo/0000-0001-8092-7153	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK025802, R01DK029961] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01 DK025802, R01 DK029961-19, DK 25802] Funding Source: Medline; PHS HHS [DL 29961] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		ALDERSON D, 1987, TRANSPLANTATION, V43, P579, DOI 10.1097/00007890-198704000-00026; ALEJANDRO A, IN PRESS TRANSPLANTA; ALEJANDRO R, 1988, TRANSPLANTATION, V45, P1036, DOI 10.1097/00007890-198806000-00008; ALEJANDRO R, 1987, TRANSPLANT P, V19, P2359; BELZER FO, 1988, TRANSPLANTATION, V45, P673, DOI 10.1097/00007890-198804000-00001; BONNERWEIR S, 1983, J CLIN INVEST, V71, P1544, DOI 10.1172/JCI110910; GRAY DWR, 1987, TRANSPLANTATION, V43, P321, DOI 10.1097/00007890-198703000-00001; GRAY DWR, 1984, DIABETES, V33, P1055, DOI 10.2337/diabetes.33.11.1055; KANO Y, 1986, DIABETES, V35, P486, DOI 10.2337/diabetes.35.4.486; LAKE SP, 1989, DIABETES, V38, P143, DOI 10.2337/diab.38.1.S143; LATIF ZA, 1988, TRANSPLANTATION, V45, P827; MORRIS PJ, 1983, TRANSPLANTATION, V36, P230; REDDY S, 1986, DIABETOLOGIA, V29, P802, DOI 10.1007/BF00873220; RICORDI C, 1988, DIABETES, V37, P413, DOI 10.2337/diabetes.37.4.413; RICORDI C, 1990, SURGERY, V107, P688; RICORDI CC, IN PRESS ACTA DIABET; SCHARP DW, 1990, DIABETES, V39, P515, DOI 10.2337/diabetes.39.4.515; SHARP DW, 1989, TRANSPLANT P, V21, P2744; SRIKANTA S, 1983, NEW ENGL J MED, V308, P322, DOI 10.1056/NEJM198302103080607; STARZL TE, 1989, ANN SURG, V210, P374, DOI 10.1097/00000658-198909000-00013; STARZL TE, 1987, SURG GYNECOL OBSTET, V165, P343; STARZL TE, 1989, LANCET, V2, P1000; STARZL TE, 1990, JAMA-J AM MED ASSOC, V264, P63, DOI 10.1001/jama.264.1.63; TODO S, IN PRESS ANN SURG; TZAKIS AG, 1990, TRANSPLANT P, V22, P273; WARNOCK GL, 1989, LANCET, V2, P570; WARNOCK GL, 1988, TRANSPLANTATION, V45, P957, DOI 10.1097/00007890-198805000-00024	27	267	270	0	6	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	AUG 18	1990	336	8712					402	405		10.1016/0140-6736(90)91946-8	http://dx.doi.org/10.1016/0140-6736(90)91946-8			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV277	1974944	Green Accepted			2022-12-24	WOS:A1990DV27700005
J	IMMERGLUCK, K; LAWRENCE, PA; BIENZ, M				IMMERGLUCK, K; LAWRENCE, PA; BIENZ, M			INDUCTION ACROSS GERM LAYERS IN DROSOPHILA MEDIATED BY A GENETIC CASCADE	CELL			English	Article									MRC,MOLEC BIOL LAB,CAMBRIDGE CB2 2QH,ENGLAND	MRC Laboratory Molecular Biology	IMMERGLUCK, K (corresponding author), UNIV ZURICH,INST ZOOL,WINTERTHURERSTR 190,CH-8057 ZURICH,SWITZERLAND.			Lawrence, Peter/0000-0002-9554-8268				ABRAHAM I, 1978, P NATL ACAD SCI USA, V75, P4446, DOI 10.1073/pnas.75.9.4446; AKAM M, 1987, DEVELOPMENT, V101, P1; AKAM ME, 1985, EMBO J, V4, P155, DOI 10.1002/j.1460-2075.1985.tb02330.x; AKAM ME, 1985, EMBO J, V4, P1689, DOI 10.1002/j.1460-2075.1985.tb03838.x; BAKER NE, 1987, EMBO J, V6, P1765, DOI 10.1002/j.1460-2075.1987.tb02429.x; BENDER W, 1983, SCIENCE, V221, P23, DOI 10.1126/science.221.4605.23; BIENZ M, 1988, NATURE, V333, P576, DOI 10.1038/333576a0; BIENZ M, 1988, CELL, V53, P567, DOI 10.1016/0092-8674(88)90573-9; BOGAERT T, 1987, CELL, V51, P929, DOI 10.1016/0092-8674(87)90580-0; CABRERA CV, 1987, CELL, V50, P659, DOI 10.1016/0092-8674(87)90039-0; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; CARLSON JR, 1985, DEV BIOL, V108, P355, DOI 10.1016/0012-1606(85)90039-9; CASANOVA J, 1987, EMBO J, V6, P3103, DOI 10.1002/j.1460-2075.1987.tb02619.x; DIEDERICH RJ, 1989, GENE DEV, V3, P399, DOI 10.1101/gad.3.3.399; GURDON JB, 1987, DEVELOPMENT, V99, P285; HAFEN E, 1984, CELL, V37, P833, DOI 10.1016/0092-8674(84)90418-5; HARTENSTEIN V, 1985, Wilhelm Roux's Archives of Developmental Biology, V194, P213, DOI 10.1007/BF00848248; INGHAM PW, 1988, NATURE, V335, P25, DOI 10.1038/335025a0; IRISH VF, 1987, GENE DEV, V1, P544; KORNBERG T, 1985, CELL, V40, P45, DOI 10.1016/0092-8674(85)90307-1; KRASNOW MA, 1989, CELL, V57, P1031, DOI 10.1016/0092-8674(89)90341-3; LAUGHON A, 1984, NATURE, V310, P25, DOI 10.1038/310025a0; LAWRENCE PA, 1985, TRENDS NEUROSCI, V8, P267, DOI 10.1016/0166-2236(85)90100-6; LAWRENCE PA, 1987, NATURE, V328, P440, DOI 10.1038/328440a0; LAWRENCE PA, 1986, CELL, V45, P505, DOI 10.1016/0092-8674(86)90282-5; LEVINE M, 1988, CELL, V52, P785, DOI 10.1016/0092-8674(88)90418-7; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; MARTINEZARIAS A, 1985, NATURE, V313, P639, DOI 10.1038/313639a0; MARTINEZARIAS A, 1989, TRENDS GENET, V5, P262; MCGINNIS W, 1984, NATURE, V308, P428, DOI 10.1038/308428a0; MLODZIK M, 1988, EMBO J, V7, P2569, DOI 10.1002/j.1460-2075.1988.tb03106.x; NUSSLEINVOLHARD C, 1987, SCIENCE, V238, P1675, DOI 10.1126/science.3686007; PADGETT RW, 1987, NATURE, V325, P81, DOI 10.1038/325081a0; Poulson D. F., 1950, BIOL DROSOPHILA, P168; RIJSEWIJK F, 1987, CELL, V50, P649, DOI 10.1016/0092-8674(87)90038-9; SAMSON ML, 1989, CELL, V57, P1045, DOI 10.1016/0092-8674(89)90342-5; STJOHNSTON RD, 1987, EMBO J, V6, P2785, DOI 10.1002/j.1460-2075.1987.tb02574.x; STJOHNSTON RD, 1990, IN PRESS GENES DEV; TECHNAU GM, 1986, ROUX ARCH DEV BIOL, V195, P445, DOI 10.1007/BF00375748; THALI M, 1988, NATURE, V336, P598, DOI 10.1038/336598a0; TOMLINSON A, 1987, DEV BIOL, V120, P366, DOI 10.1016/0012-1606(87)90239-9; TREMML G, 1989, EMBO J, V8, P2677, DOI 10.1002/j.1460-2075.1989.tb08408.x; TREMML G, 1989, EMBO J, V8, P2687, DOI 10.1002/j.1460-2075.1989.tb08409.x; VANDENHEUVEL M, 1989, CELL, V59, P739, DOI 10.1016/0092-8674(89)90020-2; WHITE RAH, 1984, CELL, V39, P163, DOI 10.1016/0092-8674(84)90202-2; WILLIAMS GJA, 1980, J EMBRYOL EXP MORPH, V58, P35	46	324	324	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	JUL 27	1990	62	2					261	268		10.1016/0092-8674(90)90364-K	http://dx.doi.org/10.1016/0092-8674(90)90364-K			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DR202	1973634				2022-12-24	WOS:A1990DR20200007
J	LEE, T; LATHAM, J; KERR, RSC; KAAR, G; TEDDY, PJ; DOBSON, D; ANSLOW, P				LEE, T; LATHAM, J; KERR, RSC; KAAR, G; TEDDY, PJ; DOBSON, D; ANSLOW, P			EFFECT OF A NEW COMPUTED TOMOGRAPHIC IMAGE TRANSFER SYSTEM ON MANAGEMENT OF REFERRALS TO A REGIONAL NEUROSURGICAL SERVICE	LANCET			English	Article									RADCLIFFE INFIRM,DEPT NEUROSURG,OXFORD OX2 6HE,ENGLAND; RADCLIFFE INFIRM,DEPT NEURORADIOL,OXFORD OX2 6HE,ENGLAND	Radcliffe Infirmary; Radcliffe Infirmary								[Anonymous], 1986, REPORT WORKING PARTY; BARTLETT JR, 1979, INJURY, V11, P144, DOI 10.1016/S0020-1383(79)80012-1; BION JF, 1988, BRIT MED J, V296, P170, DOI 10.1136/bmj.296.6616.170; BRYDEN JS, 1983, BRIT MED J, V286, P1791, DOI 10.1136/bmj.286.6380.1791; Fleischer A S, 1976, Surg Neurol, V6, P31; GENTLEMAN D, 1990, LANCET, V335, P330, DOI 10.1016/0140-6736(90)90615-C; GENTLEMAN D, 1981, LANCET, V2, P853; HEWER RL, 1989, BRIT MED J, V298, P1219, DOI 10.1136/bmj.298.6682.1219; JENNETT B, 1981, BRIT MED J, V282, P903; Jennett B., 1981, MANAGEMENT HEAD INJU; MACDONALD RC, 1980, INJURY, V12, P225, DOI 10.1016/0020-1383(80)90012-1; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; MORSE TS, 1969, PEDIATR CLIN N AM, V16, P565; SEDZIMIR CB, 1981, BRIT MED J, V282, P903, DOI 10.1136/bmj.282.6267.903-d; TEASDALE G, 1982, BRIT MED J, V285, P1695, DOI 10.1136/bmj.285.6356.1695; WINYARD GP, 1981, BRIT MED J, V282, P498; WRIGHT IH, 1988, BRIT MED J, V296, P543, DOI 10.1136/bmj.296.6621.543	17	28	28	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JUL 14	1990	336	8707					101	103		10.1016/0140-6736(90)91607-C	http://dx.doi.org/10.1016/0140-6736(90)91607-C			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN793	1975285				2022-12-24	WOS:A1990DN79300013
J	WEBB, SR; SPRENT, J				WEBB, SR; SPRENT, J			INDUCTION OF NEONATAL TOLERANCE TO MLSA ANTIGENS BY CD8+ T-CELLS	SCIENCE			English	Article											WEBB, SR (corresponding author), SCRIPPS CLIN & RES FDN, RES INST, DEPT IMMUNOL, LA JOLLA, CA 92037 USA.				NCI NIH HHS [CA 25803, CA 41993, CA 38355] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA038355, P01CA025803, R01CA038355, R01CA041993] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ABE R, 1988, NATURE, V335, P827, DOI 10.1038/335827a0; ABE R, 1989, ANNU REV IMMUNOL, V7, P683, DOI 10.1146/annurev.iy.07.040189.003343; AHMED A, 1977, J IMMUNOGENET, V4, P201; BILLINGHAM RE, 1953, NATURE, V172, P603, DOI 10.1038/172603a0; BOEHMER HV, 1974, NATURE, V249, P363, DOI 10.1038/249363a0; BRUCE J, 1981, J IMMUNOL, V127, P2496; CEREDIG R, 1985, NATURE, V314, P98, DOI 10.1038/314098a0; DENNERT G, 1980, CELL IMMUNOL, V53, P350, DOI 10.1016/0008-8749(80)90335-4; FESTENSTEIN H, 1976, TRANSPLANT P, V8, P339; FINK PJ, 1988, ANNU REV IMMUNOL, V6, P115; FRY AM, 1988, NATURE, V335, P830, DOI 10.1038/335830a0; HUDSON L, 1976, J EXP MED, V143, P444, DOI 10.1084/jem.143.2.444; JANEWAY CA, 1985, J IMMUNOL, V134, P2057; KANAGAWA O, 1989, CELL IMMUNOL, V119, P412, DOI 10.1016/0008-8749(89)90255-4; KAPPLER JW, 1988, NATURE, V332, P35, DOI 10.1038/332035a0; KATZ ME, 1985, J IMMUNOL, V134, P2064; LUBAROFF DM, 1973, J IMMUNOL, V111, P65; MACDONALD HR, 1988, J EXP MED, V167, P2005, DOI 10.1084/jem.167.6.2005; MACDONALD HR, 1988, NATURE, V332, P40, DOI 10.1038/332040a0; MACPHAIL S, 1985, J IMMUNOL, V135, P2967; MELCHERS I, 1980, REGULATORY T LYMPHOC, P91; MOLINA IJ, 1989, J IMMUNOL, V143, P39; MORRISSEY PJ, 1985, TRANSPLANTATION, V40, P68, DOI 10.1097/00007890-198507000-00014; NAGY Z, 1976, J EXP MED, V143, P648, DOI 10.1084/jem.143.3.648; PULLEN AM, 1988, NATURE, V335, P796, DOI 10.1038/335796a0; PULLEN AM, 1989, IMMUNOL REV, V107, P125, DOI 10.1111/j.1600-065X.1989.tb00006.x; RAMSDELL F, 1989, SCIENCE, V246, P1038, DOI 10.1126/science.2511629; SARMIENTO M, 1980, J IMMUNOL, V125, P2665; SHIMONKEVITZ RP, 1988, J EXP MED, V168, P143, DOI 10.1084/jem.168.1.143; SPEISER DE, 1989, J EXP MED, V170, P595, DOI 10.1084/jem.170.2.595; SPRENT J, 1987, ADV IMMUNOL, V41, P39, DOI 10.1016/S0065-2776(08)60030-9; WAITE DJ, 1988, CELL IMMUNOL, V117, P70, DOI 10.1016/0008-8749(88)90077-9; WAITE DJ, 1988, CELL IMMUNOL, V117, P78, DOI 10.1016/0008-8749(88)90078-0; WEBB SR, 1989, IMMUNOL REV, V107, P141, DOI 10.1111/j.1600-065X.1989.tb00007.x; WEBB SR, 1985, EUR J IMMUNOL, V15, P92, DOI 10.1002/eji.1830150118; WEBB SR, 1989, J EXP MED, V169, P1, DOI 10.1084/jem.169.1.1; WEBB SR, UNPUB	37	118	118	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 29	1990	248	4963					1643	1646						4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL481	1973003				2022-12-24	WOS:A1990DL48100036
J	GEANEY, DP; SOPER, N; SHEPSTONE, BJ; COWEN, PJ				GEANEY, DP; SOPER, N; SHEPSTONE, BJ; COWEN, PJ			EFFECT OF CENTRAL CHOLINERGIC STIMULATION ON REGIONAL CEREBRAL BLOOD-FLOW IN ALZHEIMER-DISEASE	LANCET			English	Article									JOHN RADCLIFFE HOSP,NUCL MED UNIT,OXFORD OX3 9DU,ENGLAND; UNIV OXFORD,DEPT RADIOL,OXFORD,ENGLAND; LITTLEMORE HOSP,MRC,CLIN PHYSIOL UNIT,OXFORD,ENGLAND	University of Oxford; University of Oxford	GEANEY, DP (corresponding author), UNIV OXFORD,WARNEFORD HOSP,DEPT PSYCHIAT,OXFORD OX3 7JX,ENGLAND.			Cowen, Philip/0000-0001-5518-6138				BATTISTIN L, 1989, EUR NEUROL, V29, P261, DOI 10.1159/000116423; BURNS A, 1989, J NEUROL NEUROSUR PS, V52, P248, DOI 10.1136/jnnp.52.2.248; DUARA R, 1986, NEUROLOGY, V36, P879, DOI 10.1212/WNL.36.7.879; ESTRADA C, 1983, BRAIN RES, V266, P261, DOI 10.1016/0006-8993(83)90657-1; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FOSTER NL, 1984, ANN NEUROL, V16, P649, DOI 10.1002/ana.410160605; FRACKOWIAK RSJ, 1981, BRAIN, V104, P753, DOI 10.1093/brain/104.4.753; FRIEDLAND RP, 1983, J COMPUT ASSIST TOMO, V7, P590, DOI 10.1097/00004728-198308000-00003; GUSTAFSON L, 1987, PSYCHOPHARMACOLOGY, V93, P31, DOI 10.1007/BF02439583; HACHINSKI VC, 1975, ARCH NEUROL-CHICAGO, V32, P632, DOI 10.1001/archneur.1975.00490510088009; HOLLANDER E, 1986, BRIT MED BULL, V42, P97, DOI 10.1093/oxfordjournals.bmb.a072106; HUNTER R, 1989, PSYCHOL MED, V19, P847, DOI 10.1017/S0033291700005560; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; NAJLERAHIM A, 1988, BIOCHEM J, V251, P305, DOI 10.1042/bj2510305; NEARY D, 1987, J NEUROL NEUROSUR PS, V50, P1101, DOI 10.1136/jnnp.50.9.1101; NEIRINCKX RD, 1987, J NUCL MED, V28, P191; PERRY EK, 1978, BRIT MED J, V2, P1457, DOI 10.1136/bmj.2.6150.1457; ROTH M, 1986, BRIT J PSYCHIAT, V149, P698, DOI 10.1192/bjp.149.6.698; 1987, DIAGNOSTIC STATISTIC	19	121	122	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JUN 23	1990	335	8704					1484	1487		10.1016/0140-6736(90)93028-N	http://dx.doi.org/10.1016/0140-6736(90)93028-N			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK586	1972432				2022-12-24	WOS:A1990DK58600003
J	SANTIS, G; OSBORNE, L; KNIGHT, RA; HODSON, ME				SANTIS, G; OSBORNE, L; KNIGHT, RA; HODSON, ME			LINKED MARKER HAPLOTYPES AND THE DELTA-F508 MUTATION IN ADULTS WITH MILD PULMONARY-DISEASE AND CYSTIC-FIBROSIS	LANCET			English	Article											SANTIS, G (corresponding author), ROYAL BROMPTON & NATL HEART HOSP, NATL HEART & LUNG INST, DEPT CYST FIBROSIS, LONDON SW3 6HP, ENGLAND.							COREY M, 1989, J PEDIATR-US, V115, P274, DOI 10.1016/S0022-3476(89)80082-4; FEREC L, 1988, J GENET HUM, V36, P413; HODSON ME, 1983, BMJ-BRIT MED J, V286, P1381, DOI 10.1136/bmj.286.6375.1381; HUNT B, 1985, THORAX, V40, P23, DOI 10.1136/thx.40.1.23; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KNOWLES M, 1981, NEW ENGL J MED, V305, P1489, DOI 10.1056/NEJM198112173052502; LEMNA WK, 1990, NEW ENGL J MED, V322, P291, DOI 10.1056/NEJM199002013220503; MCCONKIEROSELL A, 1989, ANN INTERN MED, V111, P797, DOI 10.7326/0003-4819-111-10-797; MCINTOSH I, 1989, LANCET, V2, P1404; PENKETH ARL, 1987, THORAX, V42, P526, DOI 10.1136/thx.42.7.526; SANTAGNESE PAD, 1979, AM J MED, V66, P121, DOI 10.1016/0002-9343(79)90491-1; SANTIS G, 1990, LANCET, V335, P294, DOI 10.1016/0140-6736(90)90114-K; SAUTIS G, IN PRESS HUM GENET; SCHMIDTKE J, 1989, LANCET, V1, P393; SCHMIDTKE J, 1987, HUM GENET, V76, P337, DOI 10.1007/BF00272441; SHWACHMAN H, 1975, PEDIATR CLIN N AM, V22, P787; SHWACHMAN H, 1977, MEDICINE, V56, P129, DOI 10.1097/00005792-197703000-00004; WOOD RE, 1976, AM REV RESPIR DIS, V113, P833	18	51	51	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 16	1990	335	8703					1426	1429		10.1016/0140-6736(90)91448-J	http://dx.doi.org/10.1016/0140-6736(90)91448-J			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ234	1972211				2022-12-24	WOS:A1990DJ23400005
J	ROSE, PE; STRUTHERS, GS; ROBERTSON, M; KAVI, J; CHANT, I; TAYLOR, CM				ROSE, PE; STRUTHERS, GS; ROBERTSON, M; KAVI, J; CHANT, I; TAYLOR, CM			FACTOR-VIII VONWILLEBRAND PROTEIN IN HEMOLYTIC UREMIC SYNDROME AND SYSTEMIC VASCULITIDES	LANCET			English	Article									CHILDRENS HOSP,DEPT PAEDIAT NEPHROL,BIRMINGHAM B16 8ET,W MIDLANDS,ENGLAND; COVENTRY & WARWICKSHIRE HOSP,DEPT RHEUMATOL,COVENTRY CV1 4FH,W MIDLANDS,ENGLAND		ROSE, PE (corresponding author), WARWICK GEN HOSP,DEPT HAEMATOL & MICROBIOL,PATHOL LAB,LAKIN RD,WARWICK CV34 5BJ,ENGLAND.							BLOMBACK B, 1978, THROMB RES, V12, P1177, DOI 10.1016/0049-3848(78)90072-5; DRUMMOND KN, 1985, NEW ENGL J MED, V312, P116, DOI 10.1056/NEJM198501103120211; GASSER C, 1955, Schweiz Med Wochenschr, V85, P905; KAVI J, 1987, LANCET, V2, P1035; LEUNG DYM, 1988, LANCET, V2, P183; MOAKE JL, 1984, BLOOD, V64, P592; NUSINOW SR, 1984, ARTHRITIS RHEUM, V27, P1405, DOI 10.1002/art.1780271211; OBRIG TG, 1987, LANCET, V2, P687; ROSE PE, 1984, ARCH DIS CHILD, V59, P1135, DOI 10.1136/adc.59.12.1135; ROSE PE, 1989, BLOOD REV, V3, P136, DOI 10.1016/0268-960X(89)90009-X; SHORT PE, 1982, MED LAB SCI, V39, P351; 1988, LANCET, V1, P1203; 1987, LANCET, V2, P1437	13	19	19	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	MAR 3	1990	335	8688					500	502		10.1016/0140-6736(90)90736-O	http://dx.doi.org/10.1016/0140-6736(90)90736-O			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT015	1968528				2022-12-24	WOS:A1990CT01500004
J	WOODLAND, D; HAPP, MP; BILL, J; PALMER, E				WOODLAND, D; HAPP, MP; BILL, J; PALMER, E			REQUIREMENT FOR COTOLEROGENIC GENE-PRODUCTS IN THE CLONAL DELETION OF I-E REACTIVE T-CELLS	SCIENCE			English	Article									NATL JEWISH CTR IMMUNOL & RESP MED, DIV BASIC SCI, DENVER, CO 80206 USA; UNIV COLORADO, HLTH SCI CTR, DEPT MICROBIOL & IMMUNOL, DENVER, CO 80262 USA	National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI022295, R01AI022259] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR037070] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-22295, AI-22259] Funding Source: Medline; NIAMS NIH HHS [AR-37070] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ABE R, 1989, J EXP MED, V170, P1059, DOI 10.1084/jem.170.4.1059; BILL J, 1989, J EXP MED, V169, P1405, DOI 10.1084/jem.169.4.1405; BILL J, UNPUB; FESTENSTEIN H, 1976, TRANSPLANT P, V8, P339; FOWLKES BJ, 1989, ADV IMMUNOL, V44, P207; HAPP MP, 1989, P NATL ACAD SCI USA, V86, P6293, DOI 10.1073/pnas.86.16.6293; JONES B, 1982, IMMUNOGENETICS, V16, P243, DOI 10.1007/BF00343313; KANAGAWA O, 1989, CELL IMMUNOL, V119, P412, DOI 10.1016/0008-8749(89)90255-4; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; KAPPLER JW, 1987, CELL, V49, P263, DOI 10.1016/0092-8674(87)90567-8; KAPPLER JW, 1988, NATURE, V332, P35, DOI 10.1038/332035a0; KAPPLER JW, 1981, J EXP MED, V153, P1198, DOI 10.1084/jem.153.5.1198; LYNCH DH, 1985, J IMMUNOL, V134, P2071; MACDONALD HR, 1988, NATURE, V332, P40, DOI 10.1038/332040a0; MARRACK P, 1988, NATURE, V332, P840, DOI 10.1038/332840a0; MISHELL RI, 1967, J EXP MED, V126, P423, DOI 10.1084/jem.126.3.423; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; OKADA CY, 1989, J EXP MED, V169, P1703, DOI 10.1084/jem.169.5.1703; OZATO K, 1980, J IMMUNOL, V124, P533; PULLEN AM, 1989, J IMMUNOL, V142, P3033; PULLEN AM, 1988, NATURE, V335, P796, DOI 10.1038/335796a0; REICH EP, 1989, NATURE, V341, P326, DOI 10.1038/341326a0; TAYLOR BA, 1987, ORIGIN INBRED MICE, P423; TOMONARI K, 1988, IMMUNOGENETICS, V28, P445, DOI 10.1007/BF00355377; TRAINA VL, 1981, J VIROL, V40, P735, DOI 10.1128/JVI.40.3.735-744.1981; VIDOVIC D, 1988, NATURE, V336, P222, DOI 10.1038/336222a0; WOODLAND D, UNPUB	27	238	240	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 23	1990	247	4945					964	967		10.1126/science.1968289	http://dx.doi.org/10.1126/science.1968289			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP906	1968289				2022-12-24	WOS:A1990CP90600040
J	FAHEY, JL; TAYLOR, JMG; DETELS, R; HOFMANN, B; MELMED, R; NISHANIAN, P; GIORGI, JV				FAHEY, JL; TAYLOR, JMG; DETELS, R; HOFMANN, B; MELMED, R; NISHANIAN, P; GIORGI, JV			THE PROGNOSTIC VALUE OF CELLULAR AND SEROLOGIC MARKERS IN INFECTION WITH HUMAN IMMUNODEFICIENCY VIRUS TYPE-1	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									UNIV CALIF LOS ANGELES, SCH MED, JONSSON COMPREHENS CANC CTR, LOS ANGELES, CA 90024 USA; UNIV CALIF LOS ANGELES, SCH PUBL HLTH, LOS ANGELES, CA 90024 USA	UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles					NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P50AI015332, N01AI072631, U01AI023606] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-15332, AI-23606, AI-72631] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALLAIN JP, 1987, NEW ENGL J MED, V317, P1114, DOI 10.1056/NEJM198710293171804; CHMIEL JS, 1987, AM J EPIDEMIOL, V126, P568, DOI 10.1093/oxfordjournals.aje.a114696; COX DR, 1972, J R STAT SOC B, V34, P187; DETELS R, 1987, INT J EPIDEMIOL, V16, P271, DOI 10.1093/ije/16.2.271; DETELS R, 1988, J ACQ IMMUN DEF SYND, V1, P390; DEWOLF F, 1987, BMJ-BRIT MED J, V295, P569, DOI 10.1136/bmj.295.6598.569; FAHEY JL, 1984, AM J MED, V76, P95, DOI 10.1016/0002-9343(84)90756-3; FAHEY JL, 1987, ANN INST PASTEUR IMM, V138, P245, DOI 10.1016/S0769-2625(87)80075-2; FAUCI AS, 1984, ANN INTERN MED, V100, P92, DOI 10.7326/0003-4819-100-1-92; FUCHS D, 1988, IMMUNOL TODAY, V9, P150, DOI 10.1016/0167-5699(88)91203-0; GIORGI JV, 1987, J CLIN IMMUNOL, V7, P140, DOI 10.1007/BF00916008; GIORGI JV, 1987, J IMMUNOL, V138, P3725; GIORGI JV, IN PRESS CLIN IMMUNO; GOEDERT JJ, 1986, SCIENCE, V231, P992, DOI 10.1126/science.3003917; HOFMANN B, 1987, BRIT MED J, V295, P293, DOI 10.1136/bmj.295.6593.293; HOFMANN B, IN PRESS AIDS; HUBER C, 1984, J EXP MED, V160, P310, DOI 10.1084/jem.160.1.310; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KASLOW RA, 1987, AM J EPIDEMIOL, V126, P310, DOI 10.1093/aje/126.2.310; LACEY CJN, 1987, AIDS, V1, P123; LANE HC, 1983, NEW ENGL J MED, V309, P453, DOI 10.1056/NEJM198308253090803; LANE HC, 1985, NEW ENGL J MED, V313, P79, DOI 10.1056/NEJM198507113130204; LELIE PN, 1988, NEW ENGL J MED, V318, P1204, DOI 10.1056/NEJM198805053181814; MARTINEZMAZA O, 1987, J IMMUNOL, V138, P3720; MCDOUGAL JS, 1985, J IMMUNOL, V135, P3151; MELBYE M, 1986, ANN INTERN MED, V104, P496, DOI 10.7326/0003-4819-104-4-496; MELMED RN, 1989, J ACQ IMMUN DEF SYND, V2, P70; MOSS AR, 1988, BRIT MED J, V296, P745, DOI 10.1136/bmj.296.6624.745; MUNOZ A, 1988, J ACQ IMMUN DEF SYND, V1, P396; NAKAJIMA K, 1989, J IMMUNOL, V142, P531; NISHANIAN P, 1987, J CLIN MICROBIOL, V25, P395, DOI 10.1128/JCM.25.2.395-400.1987; POLK BF, 1987, NEW ENGL J MED, V316, P61, DOI 10.1056/NEJM198701083160201; PRINCE HE, 1988, J IMMUNOL, V140, P1139; PRINCE HE, 1984, J IMMUNOL, V133, P1313; SALAZARGONZALEZ JF, 1985, J IMMUNOL, V135, P1778; TAYLOR JMG, 1989, J ACQ IMMUN DEF SYND, V2, P114; WITTEK AE, 1987, ANN INTERN MED, V107, P286, DOI 10.7326/0003-4819-107-2-286; ZIEGLER I, 1986, EOS-RIV IMMUNOL, V6, P169	38	1079	1091	0	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 18	1990	322	3					166	172		10.1056/NEJM199001183220305	http://dx.doi.org/10.1056/NEJM199001183220305			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH840	1967191				2022-12-24	WOS:A1990CH84000005
J	RANGANATHAN, R; HARRIS, GL; STEVENS, CF; ZUKER, CS				RANGANATHAN, R; HARRIS, GL; STEVENS, CF; ZUKER, CS			A DROSOPHILA MUTANT DEFECTIVE IN EXTRACELLULAR CALCIUM-DEPENDENT PHOTORECEPTOR DEACTIVATION AND RAPID DESENSITIZATION	NATURE			English	Article								CALCIUM is involved in the adaptation of vertebrate photoreceptors to light 1,2 and may have a similar role in invertebrate phototransduction 3,4. But the molecular mechanisms mediating this stimulus-dependent regulation are not well understood in any G protein-coupled transduction system. We have developed a preparation of isolated Drosophila photoreceptors that has allowed us to carry out an electrophysiological characterization of the light-activated response in these sensory neurons using patch-clamp techniques. We report here that extracellular calcium entering through the light-activated conductance is a key regulator of both the activation and deactivation phases of the phototransduction cascade, and that inaC mutant photoreceptors 5 are specifically defective in the calcium-dependent deactivation mechanism. These data suggest that the light-dependent calcium influx inactivates this cascade through a biochemical pathway that requires the inaC gene product, and that this mechanism represents a molecular basis for stimulus-dependent regulation of visual transduction in Drosophila photoreceptors.	UNIV CALIF SAN DIEGO, HOWARD HUGHES MED INST, LA JOLLA, CA 92093 USA; UNIV CALIF SAN DIEGO, DEPT BIOL, LA JOLLA, CA 92093 USA; UNIV CALIF SAN DIEGO, DEPT NEUROSCI, LA JOLLA, CA 92093 USA; SALK INST BIOL STUDIES, LA JOLLA, CA 92093 USA; SAN DIEGO STATE UNIV, DEPT BIOL, SAN DIEGO, CA 92182 USA; SAN DIEGO STATE UNIV, INST MOLEC BIOL, SAN DIEGO, CA 92182 USA	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Salk Institute; California State University System; San Diego State University; California State University System; San Diego State University								BAINBRIDGE SP, 1981, J EMBRYOL EXP MORPH, V66, P57; BROWN JE, 1974, J GEN PHYSIOL, V64, P643, DOI 10.1085/jgp.64.6.643; DIZHOOR AM, 1991, SCIENCE, V251, P915, DOI 10.1126/science.1672047; FAIN GL, 1990, TRENDS NEUROSCI, V13, P378, DOI 10.1016/0166-2236(90)90023-4; FEIN A, 1975, SCIENCE, V187, P1094, DOI 10.1126/science.1114339; Fein A., 1989, P173; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARDIE RC, 1991, NEURON, V6, P477, DOI 10.1016/0896-6273(91)90255-X; HARDIE RC, 1983, PROGR SENSORY PHYSL, P1; HENGSTEN, 1967, KYBERNETIK, V3, P276; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; KAWAMURA S, 1991, NATURE, V349, P420, DOI 10.1038/349420a0; KOCH KW, 1988, NATURE, V334, P64, DOI 10.1038/334064a0; KOENIG JH, 1977, DROSOPHILA INFORMATI, V52, P50; LAMBRECHT HG, 1991, EMBO J, V10, P793, DOI 10.1002/j.1460-2075.1991.tb08011.x; LISMAN JE, 1972, J GEN PHYSIOL, V59, P701, DOI 10.1085/jgp.59.6.701; MATTHEWS HR, 1988, NATURE, V334, P67, DOI 10.1038/334067a0; NAKATANI K, 1988, NATURE, V334, P69, DOI 10.1038/334069a0; OTOUSA JE, 1985, CELL, V40, P839, DOI 10.1016/0092-8674(85)90343-5; Pak W.L., 1979, P67; PAK WL, 1975, HDB GENETICS, P703; PAYNE R, 1986, PHOTOBIOCH PHOTOBIOP, V13, P373; PAYNE R, 1986, J GEN PHYSIOL, V88, P127, DOI 10.1085/jgp.88.1.127; PUGH EN, 1990, VISION RES, V30, P1923, DOI 10.1016/0042-6989(90)90013-B; RUBIN LJ, 1985, BIOPHYS J, V47, P38; TOMLINSON A, 1988, DEVELOPMENT, V104, P183; TSIEN RY, 1980, BIOCHEMISTRY-US, V19, P2396, DOI 10.1021/bi00552a018; ZUKER CS, 1985, CELL, V40, P851, DOI 10.1016/0092-8674(85)90344-7	28	163	164	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 21	1991	354	6350					230	232		10.1038/354230a0	http://dx.doi.org/10.1038/354230a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ948	1961249				2022-12-24	WOS:A1991GQ94800049
J	BIRCH, LL; JOHNSON, SL; ANDRESEN, G; PETERS, JC; SCHULTE, MC				BIRCH, LL; JOHNSON, SL; ANDRESEN, G; PETERS, JC; SCHULTE, MC			THE VARIABILITY OF YOUNG CHILDRENS ENERGY-INTAKE	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							FOOD-INTAKE; CALORIC COMPENSATION; SELF-REGULATION	Background. Research conducted in the 1930s showed that, given nutritious choices, children can select an adequate diet without adult supervision. Paradoxically, children grew well and were healthy despite patterns of intake at individual meals that were unpredictable and highly variable. Methods. To investigate in more detail the energy intake of young children, we measured 24-hour food intake for 15 children, from two to five years of age, on six days. For each of the six days of the study, coefficients of variation were calculated for each child for each of the six meals and snacks (breakfast, lunch, dinner, and morning, afternoon, and evening snacks) and for total daily energy intake. Results. The children's intake at individual meals was highly variable, but total daily energy intake was relatively constant for each child. The mean coefficient of variation for each child's energy intake at individual meals was 33.6 percent; in contrast, the mean coefficient of variation for each child's total daily energy intake was 10.4 percent. In most cases, high energy intake at one meal was followed by low energy intake at the next meal, or vice versa. Conclusions. Although children's food consumption is highly variable from meal to meal, daily energy intake is relatively constant, because children adjust their energy intake at successive meals.	PROCTER & GAMBLE CO,MIAMI VALLEY LABS,CINCINNATI,OH 45247	Procter & Gamble	BIRCH, LL (corresponding author), UNIV ILLINOIS,SCH HUMAN RESOURCES & FAMILY STUDIES,CHILD DEV LAB,URBANA,IL 61801, USA.							BIRCH LL, 1980, CHILD DEV, V51, P856, DOI 10.2307/1129474; BIRCH LL, 1986, APPETITE, V7, P323, DOI 10.1016/S0195-6663(86)80001-0; BIRCH LL, 1985, LEARN MOTIV, V16, P341, DOI 10.1016/0023-9690(85)90020-7; BIRCH LL, 1989, PHYSIOL BEHAV, V45, P387, DOI 10.1016/0031-9384(89)90145-5; BIRCH LL, 1984, CHILD DEV, V55, P431, DOI 10.2307/1129954; Costanzo P. R., 1984, J SOC CLIN PSYCHOL, V2, P305; Davis CM, 1928, AM J DIS CHILD, V36, P651; Davis CM, 1939, CAN MED ASSOC J, V41, P257; FOLTIN RW, 1990, AM J CLIN NUTR, V52, P969, DOI 10.1093/ajcn/52.6.969; FOMON SJ, 1974, INFANT NUTRITION; HARRIES JM, 1962, P NUTR SOC, V21, P157, DOI 10.1079/PNS19620027; PELLETT PL, 1990, AM J CLIN NUTR, V51, P711, DOI 10.1093/ajcn/51.5.711	12	253	257	0	13	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 24	1991	324	4					232	235		10.1056/NEJM199101243240405	http://dx.doi.org/10.1056/NEJM199101243240405			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EU022	1985244				2022-12-24	WOS:A1991EU02200005
J	SACHS, GA; MILES, SH; LEVIN, RA				SACHS, GA; MILES, SH; LEVIN, RA			LIMITING RESUSCITATION - EMERGING POLICY IN THE EMERGENCY MEDICAL SYSTEM	ANNALS OF INTERNAL MEDICINE			English	Article							PROSPECTIVE PAYMENT SYSTEM	Patients, families, and physicians frequently decide that a hospitalized patient will forgo cardiopulmonary resuscitation and document this decision with a do-not-resuscitate (DNR) order. In community settings (home, nursing home, hospice), these orders may conflict with paramedics' standing orders to provide cardiopulmonary resuscitation whenever it is medically indicated. We did a nationwide telephone survey of state offices for coordination of emergency medical services (EMS) to see how the states deal with this potential conflict. We identified eight states that have specific policies enabling EMS personnel to accept DNR orders for patients being transported by ambulance. State officials identified administrative complexities and legal concerns as the primary barriers to enacting prehospitalization DNR policies. We also identified 21 local EMS systems that have developed policies for accepting orders to withhold life-sustaining treatment. Four types of policy models, characterized according to procedure for validating DNR orders and telephone accessing the EMS system, show that regulatory reform can address policy barriers in the absence of enabling legislation.	UNIV CHICAGO, PRITZKER SCH MED, CHICAGO, IL 60637 USA; UNIV MINNESOTA, HENNEPIN CTY MED CTR, MINNEAPOLIS, MN 55415 USA	University of Chicago; Hennepin County Medical Center; University of Minnesota System; University of Minnesota Twin Cities								CRIMMINS TJ, 1988, MINN MED, V71, P708; CRIMMINS TJ, 1990, PREHOSP DISASTER MED, V5, P47; FITZGERALD JF, 1988, NEW ENGL J MED, V319, P1392, DOI 10.1056/NEJM198811243192106; LEWIS MA, 1985, GERONTOLOGIST, V25, P382, DOI 10.1093/geront/25.4.382; MARSHALL L, 1985, J EMERG MED SERV, P24; MILES SH, 1985, JAMA-J AM MED ASSOC, V254, P525, DOI 10.1001/jama.254.4.525; MILES SH, 1987, J AM GERIATR SOC, V35, P74, DOI 10.1111/j.1532-5415.1987.tb01323.x; MILES SH, 1989, PROTOCOLS ELECTIVE U; President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research, 1983, DECIDING FOREGO LIFE; SAGER MA, 1989, NEW ENGL J MED, V320, P433, DOI 10.1056/NEJM198902163200705; WAGNER A, 1984, NEW ENGL J MED, V310, P1129, DOI 10.1056/NEJM198404263101732; 1986, JAMA-J AM MED ASSOC, V255, P2979; 1988, ANN EMERG MED, V17, P1106; 1988, LONG TERM CARE STAND, P27; 1987, ACEP NEWS, V6, P11; 1987, GUIDELINES TERMINATI; 1985, PHYSICIAN HOPELESSLY; 1988, ACCREDITATION MANUAL, P90	18	29	29	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 15	1991	114	2					151	154		10.7326/0003-4819-114-2-151	http://dx.doi.org/10.7326/0003-4819-114-2-151			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ER534	1984394				2022-12-24	WOS:A1991ER53400012
J	SELBY, R; STARZL, TE; YUNIS, E; BROWN, BI; KENDALL, RS; TZAKIS, A				SELBY, R; STARZL, TE; YUNIS, E; BROWN, BI; KENDALL, RS; TZAKIS, A			LIVER-TRANSPLANTATION FOR TYPE-IV GLYCOGEN-STORAGE-DISEASE	NEW ENGLAND JOURNAL OF MEDICINE			English	Note							BRANCHING ENZYME-ACTIVITY; PEPTIDYL-PROLYL ISOMERASE; IMMUNOSUPPRESSANT FK506; DEFICIENCY; VARIANT; LIGHT		UNIV PITTSBURGH,UNIV HLTH CTR PITTSBURGH,CHILDRENS HOSP,DEPT SURG,3601 5TH AVE,PITTSBURGH,PA 15213; UNIV PITTSBURGH,UNIV HLTH CTR PITTSBURGH,CHILDRENS HOSP,DEPT PATHOL,PITTSBURGH,PA 15213; MARY BRIDGE CHILDRENS HOSP,TACOMA,WA; WASHINGTON UNIV,SCH MED,DEPT BIOCHEM,ST LOUIS,MO 63110	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Washington University (WUSTL)					NIDDK NIH HHS [DK 29961, R01 DK029961-19] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK029961, R37DK029961] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ANDERSEN DH, 1952, CARBOHYD METABOL, P28; BANNAYAN GA, 1976, AM J CLIN PATHOL, V66, P702; BROWN BI, 1989, AM J HUM GENET, V44, P378; BROWN BI, 1966, P NATL ACAD SCI USA, V56, P725, DOI 10.1073/pnas.56.2.725; BROWN BI, 1986, MYOLOGY, P1653; BROWN DH, 1983, BIOCHEM BIOPH RES CO, V111, P636, DOI 10.1016/0006-291X(83)90354-6; FERGUSON IT, 1983, J NEUROL SCI, V60, P337, DOI 10.1016/0022-510X(83)90144-2; GREENE GM, 1987, ARCH PATHOL LAB MED, V111, P977; GREENE HL, 1988, HEPATOLOGY, V8, P302, DOI 10.1002/hep.1840080219; GUERRA AS, 1986, EUR J PEDIATR, V145, P179, DOI 10.1007/BF00446059; HARDING MW, 1989, NATURE, V341, P758, DOI 10.1038/341758a0; HERS HG, 1989, METABOLIC BASIS INHE, V1, P425; ILLINGWORTH B, 1952, J BIOL CHEM, V199, P653; ISHIHARA T, 1975, ACTA PATHOL JAPON, V25, P613; ISHIHARA T, 1987, ACTA PATHOL JAPON, V37, P1591; MAZZAFERRO V, 1990, SURGERY, V107, P533; MCMASTER KR, 1979, ARCH PATHOL LAB MED, V103, P105; REED GB, 1968, LAB INVEST, V19, P546; SCHOCHET SS, 1970, ARCH PATHOL, V90, P354; SERVIDEI S, 1987, J PEDIATR-US, V111, P51, DOI 10.1016/S0022-3476(87)80341-4; SIEKIERKA JJ, 1989, NATURE, V341, P755, DOI 10.1038/341755a0; STARZL TE, 1976, LANCET, V1, P821; STARZL TE, 1989, NEW ENGL J MED, V321, P1014, DOI 10.1056/NEJM198910123211505; STARZL TE, 1979, GASTROENTEROLOGY, V77, P375; STARZL TE, IN PRESS TRANSPLANTA; ZELLWEGE.H, 1972, J PEDIATR-US, V80, P842	26	49	49	0	0	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 3	1991	324	1					39	42		10.1056/NEJM199101033240107	http://dx.doi.org/10.1056/NEJM199101033240107			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EQ503	1984162	Green Accepted			2022-12-24	WOS:A1991EQ50300007
J	VANDENPOL, AN; WUARIN, JP; DUDEK, FE				VANDENPOL, AN; WUARIN, JP; DUDEK, FE			GLUTAMATE, THE DOMINANT EXCITATORY TRANSMITTER IN NEUROENDOCRINE REGULATION	SCIENCE			English	Article									UNIV CALIF LOS ANGELES,SCH MED,MENTAL RETARDAT RES CTR,LOS ANGELES,CA 90024	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	VANDENPOL, AN (corresponding author), YALE UNIV,SCH MED,NEUROSURG SECT,NEW HAVEN,CT 06510, USA.				NIDA NIH HHS [DA05711] Funding Source: Medline; NINDS NIH HHS [NS10174, NS16296] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS016296, P50NS010174] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA005711, F30DA005711] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		ANDREW RD, 1981, SCIENCE, V211, P1187, DOI 10.1126/science.7466393; BROADWELL RD, 1976, J COMP NEUROL, V166, P257, DOI 10.1002/cne.901660302; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; COBBETT P, 1986, BRAIN RES, V362, P7, DOI 10.1016/0006-8993(86)91392-2; CONNOR JA, 1988, SCIENCE, V240, P649, DOI 10.1126/science.2452481; CORNELLBELL AH, 1990, SCIENCE, V247, P470, DOI 10.1126/science.1967852; COTMAN CW, 1987, TRENDS NEUROSCI, V10, P273, DOI 10.1016/0166-2236(87)90172-X; DECAVEL C, 1989, Society for Neuroscience Abstracts, V15, P1086; DECAVEL C, UNPUB; DECAVEL C, IN PRESS J COMP NEUR; EVERITT BJ, 1984, NEUROENDOCRINOLOGY, V39, P189, DOI 10.1159/000123977; GANONG WF, 1990, FRONT NEUROENDOCRIN, V11, P1; GRIBKOFF VK, 1990, J NEUROPHYSIOL, V63, P60, DOI 10.1152/jn.1990.63.1.60; GRIBKOFF VK, 1988, BRAIN RES, V442, P152, DOI 10.1016/0006-8993(88)91443-6; HERMAN JP, 1986, BRAIN RES, V383, P367, DOI 10.1016/0006-8993(86)90042-9; HOFFMAN N W, 1989, Society for Neuroscience Abstracts, V15, P1088; HOKFELT T, 1989, ACTA PHYSL SCAND S, V583, P105; HONORE T, 1989, BIOCHEM PHARMACOL, V38, P3207, DOI 10.1016/0006-2952(89)90615-1; MEEKER RB, 1989, NEUROSCIENCE, V33, P157, DOI 10.1016/0306-4522(89)90318-7; MEISTER B, 1988, NEUROENDOCRINOLOGY, V48, P516, DOI 10.1159/000125058; MONAGHAN DT, 1982, BRAIN RES, V252, P91, DOI 10.1016/0006-8993(82)90981-7; OTTERSEN OP, 1989, J CHEM NEUROANAT, V2, P57; PETERSON GM, 1980, BRAIN RES, V202, P165, DOI 10.1016/0006-8993(80)90651-4; POULAIN DA, 1982, NEUROSCIENCE, V7, P773, DOI 10.1016/0306-4522(82)90044-6; POULAIN P, 1987, BRAIN RES BULL, V19, P453, DOI 10.1016/0361-9230(87)90149-3; RAINBOW TC, 1984, BRAIN RES, V309, P173, DOI 10.1016/0006-8993(84)91025-4; RANDLE JCR, 1987, J PHYSIOL-LONDON, V387, P629, DOI 10.1113/jphysiol.1987.sp016592; RENAUD LP, 1985, ELECTROPHYSIOLOGY SE, P165; Silverman A.J., 1983, CHEM NEUROANATOMY, P295; Sladek CD, 1987, VASOPRESSIN PRINCIPL, P275; SOMOGYI P, 1984, J NEUROSCI, V4, P2590; SOMOGYI P, 1986, NEUROSCIENCE, V19, P1045, DOI 10.1016/0306-4522(86)90121-1; STORMMATHISEN J, 1983, NATURE, V301, P517, DOI 10.1038/301517a0; SWANSON LW, 1983, ANNU REV NEUROSCI, V6, P269, DOI 10.1146/annurev.ne.06.030183.001413; SWANSON LW, 1987, HDB CHEM NEUROANATOM, P1; TAPPAZ ML, 1984, PSYCHONEUROENDOCRINO, V9, P85, DOI 10.1016/0306-4530(84)90028-3; TASKER JG, IN PRESS J PHYSL LON; VANDENPOL AN, 1986, J CELL BIOL, V102, P2281, DOI 10.1083/jcb.102.6.2281; VANDENPOL AN, 1982, J COMP NEUROL, V206, P317, DOI 10.1002/cne.902060402; VANDENPOL AN, 1982, J COMP NEUROL, V204, P65, DOI 10.1002/cne.902040108; VANDENPOL AN, 1985, SCIENCE, V228, P332, DOI 10.1126/science.2858916; VANDENPOL AN, 1989, J MICROSC-OXFORD, V155, P27, DOI 10.1111/j.1365-2818.1989.tb04297.x; VANDENPOL AN, 1985, J NEUROSCI, V5, P2940	43	527	539	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 30	1990	250	4985					1276	1278		10.1126/science.1978759	http://dx.doi.org/10.1126/science.1978759			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK723	1978759				2022-12-24	WOS:A1990EK72300043
J	ARTOLA, A; BROCHER, S; SINGER, W				ARTOLA, A; BROCHER, S; SINGER, W			DIFFERENT VOLTAGE-DEPENDENT THRESHOLDS FOR INDUCING LONG-TERM DEPRESSION AND LONG-TERM POTENTIATION IN SLICES OF RAT VISUAL-CORTEX	NATURE			English	Article											ARTOLA, A (corresponding author), MAX PLANCK INST BRAIN RES,DEUTSCHORDENSTR 46,W-6000 FRANKFURT 71,GERMANY.		Singer, Wolf/D-6874-2012	ARTOLA, Alain/0000-0003-4717-4297				ARTOLA A, 1990, EUR J NEUROSCI, V2, P254, DOI 10.1111/j.1460-9568.1990.tb00417.x; ARTOLA A, 1987, NATURE, V330, P649, DOI 10.1038/330649a0; BEAR MF, 1987, SCIENCE, V237, P42, DOI 10.1126/science.3037696; BEAR MF, 1990, J NEUROSCI, V10, P909; BIENENSTOCK EL, 1982, J NEUROSCI, V2, P32, DOI 10.1523/jneurosci.02-01-00032.1982; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; CHAGNACAMITAI Y, 1989, J NEUROPHYSIOL, V61, P747, DOI 10.1152/jn.1989.61.4.747; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; KIMURA F, 1989, J PHYSIOL-LONDON, V414, P125, DOI 10.1113/jphysiol.1989.sp017680; KOMATSU Y, 1981, NEUROSCI LETT, V26, P269, DOI 10.1016/0304-3940(81)90144-0; LARSON J, 1986, SCIENCE, V232, P985, DOI 10.1126/science.3704635; LEE KS, 1982, BRAIN RES, V239, P617, DOI 10.1016/0006-8993(82)90538-8; PERKINS AT, 1988, BRAIN RES, V439, P222; REITER HO, 1988, P NATL ACAD SCI USA, V85, P3623, DOI 10.1073/pnas.85.10.3623; STANTON PK, 1989, NATURE, V339, P215, DOI 10.1038/339215a0; STAUBLI U, 1988, NEUR ABSTR, V225, P16; SUTOR B, 1989, NEUROSCI LETT, V97, P111, DOI 10.1016/0304-3940(89)90148-1; WIGSTROM H, 1983, NATURE, V301, P603, DOI 10.1038/301603a0	18	667	668	0	33	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	SEP 6	1990	347	6288					69	72		10.1038/347069a0	http://dx.doi.org/10.1038/347069a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX402	1975639				2022-12-24	WOS:A1990DX40200060
J	GUGENHEIM, J; SAMUEL, D; REYNES, M; BISMUTH, H				GUGENHEIM, J; SAMUEL, D; REYNES, M; BISMUTH, H			LIVER-TRANSPLANTATION ACROSS ABO BLOOD-GROUP BARRIERS	LANCET			English	Article									HOP PAUL BROUSSE,S PARIS FAC MED,HEPATOBILIARY SURG & TRANSPLANTAT RES UNIT,F-94800 VILLEJUIF,FRANCE; HOP PAUL BROUSSE,S PARIS FAC MED,DEPT PATHOL,F-94800 VILLEJUIF,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Paul-Brousse - APHP								BERNUAU J, 1986, HEPATOLOGY, V6, P648, DOI 10.1002/hep.1840060417; Bismuth H, 1988, Clin Transpl, P35; BISMUTH H, 1987, ANN INTERN MED, V107, P337, DOI 10.7326/0003-4819-107-2-337; DEMETRIS AJ, 1988, AM J PATHOL, V132, P489; GORDON RD, 1986, SURGERY, V100, P342; GUGENHEIM J, 1987, TRANSPLANT P, V19, P3805; GUGENHEIM J, 1989, TRANSPLANT P, V21, P2223; IWATSUKI S, 1984, TRANSPLANT P, V16, P1427; KISSMEYE F, 1966, LANCET, V2, P662, DOI 10.1016/S0140-6736(66)92829-7; KNECHTLE SJ, 1987, TRANSPLANTATION, V43, P8, DOI 10.1097/00007890-198701000-00003; MARSH JW, 1988, ANN SURG, V207, P21; ROUGER P, 1986, TISSUE ANTIGENS, V27, P78; SAMUEL D, 1989, TRANSPLANT P, V21, P2225; STARZL TE, 1974, TRANSPLANT P, V6, P129; STARZL TE, 1968, NEW ENGL J MED, V278, P642, DOI 10.1056/NEJM196803212781202; VALDIVIA LA, 1987, TRANSPL P, V19, P1158; WEIL R, 1981, TRANSPLANTATION, V32, P71	17	249	264	0	3	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 1	1990	336	8714					519	523		10.1016/0140-6736(90)92082-S	http://dx.doi.org/10.1016/0140-6736(90)92082-S			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DW781	1975036				2022-12-24	WOS:A1990DW78100001
J	LESTER, RAJ; CLEMENTS, JD; WESTBROOK, GL; JAHR, CE				LESTER, RAJ; CLEMENTS, JD; WESTBROOK, GL; JAHR, CE			CHANNEL KINETICS DETERMINE THE TIME COURSE OF NMDA RECEPTOR-MEDIATED SYNAPTIC CURRENTS	NATURE			English	Article											LESTER, RAJ (corresponding author), OREGON HLTH SCI UNIV,VOLLUM INST,PORTLAND,OR 97201, USA.		yasin, raiesa/F-9500-2011					ANDREASEN M, 1989, J PHYSIOL-LONDON, V414, P317, DOI 10.1113/jphysiol.1989.sp017690; BEKKERS JM, 1989, NATURE, V341, P230, DOI 10.1038/341230a0; BLAKE JF, 1988, NEUROSCI LETT, V89, P182, DOI 10.1016/0304-3940(88)90378-3; COLLINGRIDGE GL, 1988, J PHYSIOL-LONDON, V399, P283; COLQUHOUN D, 1988, J PHYSIOL-LONDON, V395, P131, DOI 10.1113/jphysiol.1988.sp016912; COLQUHOUN D, 1977, J PHYSIOL-LONDON, V266, P361, DOI 10.1113/jphysiol.1977.sp011772; CULLCANDY SG, 1987, NATURE, V325, P525, DOI 10.1038/325525a0; DALE N, 1985, J PHYSIOL-LONDON, V363, P35, DOI 10.1113/jphysiol.1985.sp015694; FORSYTHE ID, 1988, J PHYSIOL-LONDON, V396, P515, DOI 10.1113/jphysiol.1988.sp016975; FORSYTHE ID, IN PRESS J PHYSL LON; HESTRIN S, 1990, J PHYSIOL-LONDON, V422, P203, DOI 10.1113/jphysiol.1990.sp017980; JAHR CE, 1987, NATURE, V325, P522, DOI 10.1038/325522a0; KAUER JA, 1988, NEURON, V1, P911, DOI 10.1016/0896-6273(88)90148-1; LESTER RAJ, 1989, MOL PHARMACOL, V35, P565; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; OLVERMAN HJ, 1984, NATURE, V307, P460, DOI 10.1038/307460a0; PATNEAU DK, IN PRESS J NEUROSCI; SERNAGOR E, 1989, NEURON, V2, P1221, DOI 10.1016/0896-6273(89)90306-1; TANG CM, 1989, SCIENCE, V243, P1474, DOI 10.1126/science.2467378; TRUSSELL LO, 1989, NEURON, V3, P209, DOI 10.1016/0896-6273(89)90034-2; WESTBROOK GL, 1989, SEMINARS NEUROSCIENC, V1, P103; WIGSTROM H, 1985, ACTA PHYSIOL SCAND, V124, P475, DOI 10.1111/j.1748-1716.1985.tb07685.x	23	442	449	0	14	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	AUG 9	1990	346	6284					565	567		10.1038/346565a0	http://dx.doi.org/10.1038/346565a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DT679	1974037				2022-12-24	WOS:A1990DT67900073
J	GOULDING, NJ; GODOLPHIN, JL; SHARLAND, PR; PEERS, SH; SAMPSON, M; MADDISON, PJ; FLOWER, RJ				GOULDING, NJ; GODOLPHIN, JL; SHARLAND, PR; PEERS, SH; SAMPSON, M; MADDISON, PJ; FLOWER, RJ			ANTIINFLAMMATORY LIPOCORTIN-1 PRODUCTION BY PERIPHERAL-BLOOD LEUKOCYTES IN RESPONSE TO HYDROCORTISONE	LANCET			English	Article									ROYAL UNITED HOSP,BATH,AVON,ENGLAND; ST BARTHOLOMEWS HOSP & MED COLL,DEPT BIOCHEM PHARMACOL,LONDON EC1A 7BE,ENGLAND	University of London; Queen Mary University London	GOULDING, NJ (corresponding author), UNIV BATH,BATH INST RHEUMAT DIS,TRIM BRIDGE,BATH BA1 1HD,ENGLAND.				Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BALLARD PL, 1974, ENDOCRINOLOGY, V94, P998, DOI 10.1210/endo-94-4-998; BIENKOWSKI MJ, 1989, J BIOL CHEM, V264, P6536; BROWNING JL, IN PRESS P SCLAVO IN; CIRINO G, 1987, PROSTAGLANDINS, V34, P59, DOI 10.1016/0090-6980(87)90262-0; CIRINO G, 1987, NATURE, V328, P270, DOI 10.1038/328270a0; ELLULMIC.R, 1974, CLIN SCI MOL MED, V47, P105, DOI 10.1042/cs0470105; ERRASFA M, 1989, BRIT J PHARMACOL, V97, P1051, DOI 10.1111/j.1476-5381.1989.tb12561.x; FERRANTE A, 1978, J IMMUNOL METHODS, V24, P389, DOI 10.1016/0022-1759(78)90143-6; FLOWER RJ, 1988, BRIT J PHARMACOL, V94, P987, DOI 10.1111/j.1476-5381.1988.tb11614.x; GOULDING N J, 1989, British Journal of Pharmacology, V97, p426P; GOULDING NJ, 1989, ANN RHEUM DIS, V48, P843, DOI 10.1136/ard.48.10.843; HULLIN F, 1989, J BIOL CHEM, V264, P3506; JOHNSON LK, 1979, J BIOL CHEM, V254, P7785; KNUDSEN PJ, 1987, J IMMUNOL, V139, P4129; MARINKOVIC S, 1989, J IMMUNOL, V142, P808; MERCIER L, 1983, ENDOCRINOLOGY, V112, P601, DOI 10.1210/endo-112-2-601; PEPINSKY RB, 1989, BIOCHEM J, V263, P97, DOI 10.1042/bj2630097; PEPINSKY RB, 1990, FEBS LETT, V261, P247, DOI 10.1016/0014-5793(90)80564-Y; PEPINSKY RB, 1986, J BIOL CHEM, V261, P4239; STEVENS TRJ, 1988, BRIT J PHARMACOL, V93, pP139; VIOLETTE SM, 1990, J CELL PHYSIOL, V142, P70, DOI 10.1002/jcp.1041420110; WALLNER BP, 1986, NATURE, V320, P77, DOI 10.1038/320077a0	22	179	182	0	3	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JUN 16	1990	335	8703					1416	1418		10.1016/0140-6736(90)91445-G	http://dx.doi.org/10.1016/0140-6736(90)91445-G			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ234	1972208				2022-12-24	WOS:A1990DJ23400002
J	ZENKE, M; MUNOZ, A; SAP, J; VENNSTROM, B; BEUG, H				ZENKE, M; MUNOZ, A; SAP, J; VENNSTROM, B; BEUG, H			V-ERBA ONCOGENE ACTIVATION ENTAILS THE LOSS OF HORMONE-DEPENDENT REGULATOR ACTIVITY OF C-ERBA	CELL			English	Article									INST INVEST BIOMED,E-28029 MADRID,SPAIN; WEIZMANN INST SCI,DEPT CHEM IMMUNOL,IL-76100 REHOVOT,ISRAEL; KAROLINSKA INST,DEPT MOLEC BIOL,S-10401 STOCKHOLM 60,SWEDEN	Weizmann Institute of Science; Karolinska Institutet	ZENKE, M (corresponding author), INST MOLEC PATHOL,DR BOHR GASSE 7,A-1030 VIENNA,AUSTRIA.		Munoz, Alberto/O-6393-2014	Munoz, Alberto/0000-0003-3890-4251				BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; BECKER PB, 1986, NATURE, V324, P686, DOI 10.1038/324686a0; BENBROOK D, 1987, SCIENCE, V238, P788, DOI 10.1126/science.3672126; BENBROOK D, 1988, NATURE, V333, P669, DOI 10.1038/333669a0; BERG JM, 1989, CELL, V57, P1065, DOI 10.1016/0092-8674(89)90042-1; BEUG H, 1982, CELL, V28, P907, DOI 10.1016/0092-8674(82)90070-8; BEUG H, 1986, J VIROL, V57, P1127, DOI 10.1128/JVI.57.3.1127-1138.1986; BEUG H, 1985, VIROLOGY, V145, P141, DOI 10.1016/0042-6822(85)90209-0; BEUG H, 1981, VIROLOGY, V111, P201, DOI 10.1016/0042-6822(81)90665-6; BEUG H, 1980, P NATL ACAD SCI-BIOL, V77, P6683, DOI 10.1073/pnas.77.11.6683; BEUG H, 1979, CELL, V18, P375, DOI 10.1016/0092-8674(79)90057-6; BEUG H, 1984, CELL, V36, P963, DOI 10.1016/0092-8674(84)90046-1; BEUG H, 1985, MODERN TRENDS HUMAN, V6, P290; BIGLER J, 1988, MOL CELL BIOL, V8, P4155, DOI 10.1128/MCB.8.10.4155; BOUCHER P, 1988, J VIROL, V62, P534, DOI 10.1128/JVI.62.2.534-544.1988; BRAND N, 1988, NATURE, V332, P850, DOI 10.1038/332850a0; CHOI OR, 1986, MOL CELL BIOL, V6, P1751, DOI 10.1128/MCB.6.5.1751; Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45; DAINIAK N, 1986, BLOOD, V68, P1289; DAINIAK N, 1978, NATURE, V272, P260, DOI 10.1038/272260a0; DAMM K, 1987, EMBO J, V6, P375, DOI 10.1002/j.1460-2075.1987.tb04765.x; DAMM K, 1989, NATURE, V339, P593, DOI 10.1038/339593a0; DANIELSEN M, 1989, CELL, V57, P1131, DOI 10.1016/0092-8674(89)90050-0; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; FEIN HG, 1975, MED CLIN N AM, V59, P1133, DOI 10.1016/S0025-7125(16)31963-0; FORMAN BM, 1989, MOL ENDOCRINOL, V3, P1610, DOI 10.1210/mend-3-10-1610; FRYKBERG L, 1983, CELL, V32, P227, DOI 10.1016/0092-8674(83)90513-5; FUHRMANN U, 1989, GENE DEV, V3, P2072, DOI 10.1101/gad.3.12b.2072; GANDRILLON O, 1989, CELL, V58, P115, DOI 10.1016/0092-8674(89)90408-X; GANDRILLON O, 1987, CELL, V49, P687, DOI 10.1016/0092-8674(87)90545-9; GARNIER J, 1978, J MOL BIOL, V120, P97, DOI 10.1016/0022-2836(78)90297-8; GIGUERE V, 1987, NATURE, V330, P624, DOI 10.1038/330624a0; GIGUERE V, 1989, NATURE, V337, P566, DOI 10.1038/337566a0; GLASS CK, 1989, CELL, V59, P697, DOI 10.1016/0092-8674(89)90016-0; GLISIN V, 1974, BIOCHEMISTRY-US, V13, P2633, DOI 10.1021/bi00709a025; GRAF T, 1978, BIOCHIM BIOPHYS ACTA, V516, P269, DOI 10.1016/0304-419X(78)90011-2; GRAF T, 1983, CELL, V34, P7, DOI 10.1016/0092-8674(83)90130-7; GRAUPNER G, 1989, NATURE, V340, P653, DOI 10.1038/340653a0; HAYMAN MJ, 1982, J CELL BIOCHEM, V18, P351, DOI 10.1002/jcb.1982.240180308; HENTZEN D, 1987, MOL CELL BIOL, V7, P2416, DOI 10.1128/MCB.7.7.2416; HORTON L, 1976, Q J MED, V45, P101; IZUMO S, 1988, NATURE, V334, P539, DOI 10.1038/334539a0; JANSSON M, 1987, ONCOGENE, V1, P167; KAHN P, 1984, P NATL ACAD SCI-BIOL, V81, P7122, DOI 10.1073/pnas.81.22.7122; KAHN P, 1986, CELL, V45, P349, DOI 10.1016/0092-8674(86)90320-X; KAHN P, 1986, S COMP RES LEUKEMIA, V12, P41; KNIGHT J, 1988, GENE DEV, V2, P247, DOI 10.1101/gad.2.2.247; KNIGHT J, 1988, ONCOGENE, V2, P317; KOENIG RJ, 1988, P NATL ACAD SCI USA, V85, P5031, DOI 10.1073/pnas.85.14.5031; KOWENZ E, 1987, MODERN TRENDS HUMAN, V7, P199; KRUST A, 1989, P NATL ACAD SCI USA, V86, P5310, DOI 10.1073/pnas.86.14.5310; MADER S, 1989, NATURE, V338, P271, DOI 10.1038/338271a0; Maniatis T., 1982, MOL CLONING; MULLER R, 1988, CELLULAR ONCOGENE AC, P1; MUNOZ A, 1988, EMBO J, V7, P155, DOI 10.1002/j.1460-2075.1988.tb02795.x; NARBAITZ R, 1984, ANN NY ACAD SCI, V429, P479, DOI 10.1111/j.1749-6632.1984.tb12374.x; PETKOVICH M, 1987, NATURE, V330, P444, DOI 10.1038/330444a0; PRIVALSKY ML, 1988, MOL CELL BIOL, V8, P4510, DOI 10.1128/MCB.8.10.4510; PTASHNE M, 1988, NATURE, V335, P683, DOI 10.1038/335683a0; RADKE K, 1982, CELL, V31, P643, DOI 10.1016/0092-8674(82)90320-8; RAGSDALE CW, 1989, NATURE, V341, P654, DOI 10.1038/341654a0; SAP J, 1989, NATURE, V340, P242, DOI 10.1038/340242a0; SAP J, 1986, NATURE, V324, P635, DOI 10.1038/324635a0; SCHMIDT JA, 1986, DIFFERENTIATION, V31, P166, DOI 10.1111/j.1432-0436.1986.tb00397.x; SCHMIDT JA, 1986, LEUKEMIA RES, V10, P257, DOI 10.1016/0145-2126(86)90023-8; SCHMIDT JA, 1986, CELL, V46, P41, DOI 10.1016/0092-8674(86)90858-5; SMITH DR, 1989, P NATL ACAD SCI USA, V86, P5291, DOI 10.1073/pnas.86.14.5291; THOMPSON CC, 1987, SCIENCE, V237, P1610, DOI 10.1126/science.3629259; UMESONO K, 1989, CELL, V57, P1139, DOI 10.1016/0092-8674(89)90051-2; VENNSTROM B, 1980, J VIROL, V36, P575; WEINBERGER C, 1986, NATURE, V324, P641, DOI 10.1038/324641a0; WOODS CM, 1986, J CELL BIOL, V103, P1789, DOI 10.1083/jcb.103.5.1789; ZELENT A, 1989, NATURE, V339, P714, DOI 10.1038/339714a0; ZENKE M, 1988, CELL, V52, P107, DOI 10.1016/0092-8674(88)90535-1	74	243	252	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	JUN 15	1990	61	6					1035	1049		10.1016/0092-8674(90)90068-P	http://dx.doi.org/10.1016/0092-8674(90)90068-P			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DK145	1972036				2022-12-24	WOS:A1990DK14500013
J	GONZALEZREYES, A; URQUIA, N; GEHRING, WJ; STRUHL, G; MORATA, G				GONZALEZREYES, A; URQUIA, N; GEHRING, WJ; STRUHL, G; MORATA, G			ARE CROSS-REGULATORY INTERACTIONS BETWEEN HOMEOTIC GENES FUNCTIONALLY SIGNIFICANT	NATURE			English	Article									UNIV BASEL,BIOCTR,CH-4056 BASEL,SWITZERLAND; COLUMBIA UNIV,HOWARD HUGHES MED INST,NEW YORK,NY 10032	University of Basel; Columbia University; Howard Hughes Medical Institute	GONZALEZREYES, A (corresponding author), UNIV AUTONOMA MADRID,CSIC,CTR BIOL MOLEC,CANTO BLANCO,E-28049 MADRID,SPAIN.		Gonzalez-Reyes, Acaimo/L-1993-2014	Gonzalez-Reyes, Acaimo/0000-0003-3048-0968; Morata, Gines/0000-0003-3274-5173				AKAM M, 1987, DEVELOPMENT, V101, P1; BEACHY PA, 1985, NATURE, V313, P545, DOI 10.1038/313545a0; BEACHY PA, 1988, CELL, V55, P1069, DOI 10.1016/0092-8674(88)90251-6; BIENZ M, 1988, NATURE, V333, P576, DOI 10.1038/333576a0; CARROLL SB, 1986, CELL, V47, P113, DOI 10.1016/0092-8674(86)90372-7; CHADWICK R, 1987, EMBO J, V6, P779, DOI 10.1002/j.1460-2075.1987.tb04820.x; GEHRING WJ, 1986, ANNU REV GENET, V20, P147, DOI 10.1146/annurev.ge.20.120186.001051; GIBSON G, 1988, DEVELOPMENT, V102, P657; HAFEN E, 1984, NATURE, V307, P287, DOI 10.1038/307287a0; KRASNOW MA, 1989, CELL, V57, P1031, DOI 10.1016/0092-8674(89)90341-3; KUZIORA MA, 1988, CELL, V55, P477, DOI 10.1016/0092-8674(88)90034-7; LEMOTTE PK, 1989, EMBO J, V8, P219, DOI 10.1002/j.1460-2075.1989.tb03367.x; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; MAHAFFEY JW, 1989, DEVELOPMENT, V105, P167; MARTINEZARIAS A, 1985, NATURE, V313, P639, DOI 10.1038/313639a0; MLODZIK M, 1988, EMBO J, V7, P2569, DOI 10.1002/j.1460-2075.1988.tb03106.x; MULLER M, 1988, EMBO J, V7, P4299, DOI 10.1002/j.1460-2075.1988.tb03328.x; PEIFER M, 1987, GENE DEV, V1, P891, DOI 10.1101/gad.1.9.891; REGULSKI M, 1987, EMBO J, V6, P767, DOI 10.1002/j.1460-2075.1987.tb04819.x; SANCHEZHERRERO E, 1985, NATURE, V313, P108, DOI 10.1038/313108a0; SCHNEUWLY S, 1987, NATURE, V325, P816, DOI 10.1038/325816a0; STRUHL G, 1983, J EMBRYOL EXP MORPH, V76, P297; STRUHL G, 1982, P NATL ACAD SCI-BIOL, V79, P7380, DOI 10.1073/pnas.79.23.7380; STRUHL G, 1981, NATURE, V293, P36, DOI 10.1038/293036a0; STRUHL G, 1989, NATURE, V338, P741, DOI 10.1038/338741a0; STRUHL G, 1985, CELL, V43, P507, DOI 10.1016/0092-8674(85)90180-1; WAKIMOTO BT, 1981, DEV BIOL, V81, P51, DOI 10.1016/0012-1606(81)90347-X; WIRZ J, 1986, EMBO J, V5, P3327, DOI 10.1002/j.1460-2075.1986.tb04647.x	28	123	124	0	5	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAR 1	1990	344	6261					78	80		10.1038/344078a0	http://dx.doi.org/10.1038/344078a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ972	1968232				2022-12-24	WOS:A1990CQ97200068
J	WHITEHEAD, MI; FRASER, D; SCHENKEL, L; CROOK, D; STEVENSON, JC				WHITEHEAD, MI; FRASER, D; SCHENKEL, L; CROOK, D; STEVENSON, JC			TRANSDERMAL ADMINISTRATION OF ESTROGEN PROGESTAGEN HORMONE REPLACEMENT THERAPY	LANCET			English	Article									WYNN INST METAB RES LONDON, LONDON, ENGLAND; CIBA GEIGY AG, CH-4002 BASEL, SWITZERLAND	Imperial College London; Novartis	WHITEHEAD, MI (corresponding author), KINGS COLL, SCH MED, ACAD DEPT OBSTET & GYNAECOL, MENOPAUSE CLIN, DENMARK HILL, LONDON SE5 8RX, ENGLAND.			Crook, David/0000-0002-9587-3730				BUSH TL, 1987, CIRCULATION, V75, P1102, DOI 10.1161/01.CIR.75.6.1102; CHETKOWSKI RJ, 1986, NEW ENGL J MED, V314, P1615, DOI 10.1056/NEJM198606193142505; FRASER D, 1989, BRIT J OBSTET GYNAEC, V96, P776, DOI 10.1111/j.1471-0528.1989.tb03315.x; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; GIDEZ LI, 1982, J LIPID RES, V23, P1206; JENSEN J, 1986, BRIT J OBSTET GYNAEC, V93, P613, DOI 10.1111/j.1471-0528.1986.tb08035.x; MOUNT JN, 1988, J CLIN PATHOL, V41, P471, DOI 10.1136/jcp.41.4.471; OTTOSSON UB, 1985, AM J OBSTET GYNECOL, V151, P746, DOI 10.1016/0002-9378(85)90509-5; PAGANINIHILL A, 1989, BRIT J CANCER, V59, P445, DOI 10.1038/bjc.1989.91; PERSSON I, 1989, BRIT MED J, V298, P147, DOI 10.1136/bmj.298.6667.147; PETERSON HB, 1986, MENOPAUSE PHYSL PHAR, P275; ROSS RK, 1986, MENOPAUSE PHYSL PHAR, P209; WARNICK GR, 1978, J LIPID RES, V19, P65; WHITEHEAD MI, 1987, OBSTET GYN CLIN N AM, V14, P299; WHITEHEAD MI, 1981, NEW ENGL J MED, V305, P1599, DOI 10.1056/NEJM198112313052701	15	76	77	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 10	1990	335	8685					310	312		10.1016/0140-6736(90)90605-5	http://dx.doi.org/10.1016/0140-6736(90)90605-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM846	1967769				2022-12-24	WOS:A1990CM84600003
J	BERNAUER, W; GRATWOHL, A; KELLER, A; DAICKER, B				BERNAUER, W; GRATWOHL, A; KELLER, A; DAICKER, B			MICROVASCULOPATHY IN THE OCULAR FUNDUS AFTER BONE-MARROW TRANSPLANTATION	ANNALS OF INTERNAL MEDICINE			English	Article							MALIGNANT ARTERIAL-HYPERTENSION; RADIATION RETINOPATHY; AUTOIMMUNE-DISEASES; CYCLOSPORIN-A; HOST DISEASE; MANIFESTATIONS; RECIPIENTS; GRAFT; IRRADIATION; LEUKEMIA	Objective: To determine the incidence and time course of retinal and optic-disk ischemia after bone marrow transplantation and to describe the clinical, fluorescein-angiographic, and histologic findings in patients with these ischemic fundus lesions. Design: Prospective cohort study; standardized clinical and ophthalmologic evaluation of all patients before bone marrow transplantation and 3, 6, and 12 months after transplantation (and when indicated). Setting: University hospitals in Basel, Switzerland. Patients: Consecutive patients (127) treated with allogeneic or autologous bone marrow grafts. Main Results: Thirteen of the 127 patients (10%; 95% Cl, 5% to 15%) had lesions of the ocular microcirculation. All patients had cotton-wool spots in the fundus of both eyes, and three patients also had bilateral optic-disk edema. Secondary changes included retinal hemorrhages and lipid deposits. The ischemic fundus lesions appeared during the first 6 months after transplantation and were reversible in 9 of the 13 patients. The lesions occurred only in patients who were treated with total body irradiation and were given cyclosporin A as prophylaxis for graft-versus-host disease. Conclusions: Ischemic fundus lesions area frequent complication after bone marrow transplantation. They were only observed in patients treated with total body irradiation and cyclosporin A. This combination of therapy appears to have an additive effect on the development of ocular and possibly generalized microvascular lesions.	KANTONSSPITAL, DEPT INNERE MED & FORSCH, HAEMATOL ABT, PETERSGRABEN 4, CH-4031 BASEL, SWITZERLAND; UNIV BASEL, HOSP EYE, CH-4051 BASEL, SWITZERLAND	Kantonsspital Aarau AG (KSA); University of Basel								BERNAUER W, 1991, KLIN MONATSBL AUGENH, V198, P447, DOI 10.1055/s-2008-1046007; BINAGHI M, 1983, J FR OPHTALMOL, V6, P881; BLOOM JN, 1988, ANN INTERN MED, V109, P963, DOI 10.7326/0003-4819-109-12-963; BROWN GC, 1982, OPHTHALMOLOGY, V89, P1494; COCCIA PF, 1988, BLOOD, V71, P888; COHEN DJ, 1984, ANN INTERN MED, V101, P667, DOI 10.7326/0003-4819-101-5-667; DAICKER B, 1988, OPHTHALMOLOGICA, V197, P169, DOI 10.1159/000309939; DIETERLE A, 1990, TRANSPLANTATION, V49, P1093, DOI 10.1097/00007890-199006000-00013; DUKEELDER S, 1972, SYSTEM OPHTHALMOLOGY, P981; DUKEELDER S, 1967, SYSTEM OPHTHALMOLOGY, V10, P23; FRANKLIN RM, 1983, OPHTHALMOLOGY, V90, P4; FREY FJ, 1990, SCHWEIZ MED WSCHR, V120, P772; GLOOR B, 1985, BRIT J OPHTHALMOL, V69, P320, DOI 10.1136/bjo.69.5.320; GRATWHOL AA, 1977, ANN INTERN MED, V87, P703, DOI 10.7326/0003-4819-87-6-703; GRATWOHL A, 1986, PROG ALLERGY, V38, P404; GRATWOHL A, 1983, NEW ENGL J MED, V308, P1101; HAMILTON DV, 1982, TRANSPLANT P, V14, P597; HAYREH SS, 1989, OPHTHALMOLOGICA, V198, P197, DOI 10.1159/000309999; HAYREH SS, 1989, OPHTHALMOLOGICA, V198, P216, DOI 10.1159/000310000; HAYREH SS, 1986, OPHTHALMOLOGY, V93, P74; HAYREH SS, 1989, OPHTHALMOLOGICA, V198, P230, DOI 10.1159/000310001; HAYREH SS, 1989, OPHTHALMOLOGICA, V198, P178, DOI 10.1159/000309998; HIRST LW, 1983, ARCH OPHTHALMOL-CHIC, V101, P580, DOI 10.1001/archopht.1983.01040010580010; JABS DA, 1983, ARCH OPHTHALMOL-CHIC, V101, P585, DOI 10.1001/archopht.1983.01040010585011; JACK MK, 1983, ARCH OPHTHALMOL-CHIC, V101, P1080; JOSS DV, 1982, LANCET, V1, P906; KINYOUN JL, 1984, ARCH OPHTHALMOL-CHIC, V102, P1473; KINYOUN JL, 1988, AM J OPHTHALMOL, V105, P470, DOI 10.1016/0002-9394(88)90237-1; LEISHMAN R, 1957, Br J Ophthalmol, V41, P641, DOI 10.1136/bjo.41.11.641; LIVESEY SJ, 1989, EYE, V3, P271, DOI 10.1038/eye.1989.37; Merriam GR., 1972, FRONT RAD THER ONCOL, P346; MIHATSCH MJ, 1988, KLIN WOCHENSCHR, V66, P43, DOI 10.1007/BF01713009; NOLL RB, 1984, ARCH NEUROL-CHICAGO, V41, P329, DOI 10.1001/archneur.1984.04050150111026; NUSSENBLATT RB, 1986, SURV OPHTHALMOL, V31, P159, DOI 10.1016/0039-6257(86)90035-4; OECHSLIN M, 1986, TRANSPLANTATION, V41, P60, DOI 10.1097/00007890-198601000-00012; PALESTINE AG, 1984, AM J MED, V77, P652, DOI 10.1016/0002-9343(84)90356-5; PEPOSE JS, 1985, OPHTHALMOLOGY, V92, P472; PILLUNAT LE, 1987, KLIN MONATSBL AUGENH, V190, P131, DOI 10.1055/s-2008-1050344; POMERANTZ RJ, 1987, NEW ENGL J MED, V317, P1643, DOI 10.1056/NEJM198712243172607; SPECK B, 1988, TRANSPLANT P, V20, P505; Speck B, 1989, Clin Transpl, P115; VOGLER WR, 1990, BONE MARROW TRANSPL, V6, P405; WOLFE JA, 1986, TRANSPLANTATION, V41, P541	43	58	59	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 15	1991	115	12					925	930		10.7326/0003-4819-115-12-925	http://dx.doi.org/10.7326/0003-4819-115-12-925			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU417	1952488				2022-12-24	WOS:A1991GU41700002
J	KWON, IC; BAE, YH; KIM, SW				KWON, IC; BAE, YH; KIM, SW			ELECTRICALLY ERODIBLE POLYMER GEL FOR CONTROLLED RELEASE OF DRUGS	NATURE			English	Article							INTERMACROMOLECULAR COMPLEXES; SENSITIVE POLYMERS; PHASE-TRANSITION; DELIVERY; MEMBRANE	NEW controlled drug-delivery systems are being explored to overcome the disadvantages of conventional dosage forms 1. For example, stimulated drug-delivery has been used to overcome the tolerance problems that occur with a constant delivery rate, to mimic the physiological pattern of hormonal concentration and to supply drugs on demand 1,2. Stimuli-sensitive polymers, which are potentially useful for pulsed drug delivery, experience changes in either their structure or their chemical properties in response to changes in environmental conditions 2. Environmental stimuli include temperature 3,4, pH 5,6, light (ultraviolet 7 or visible 8), electric field 9-12 or certain chemicals 13. Volume changes of stimuli-sensitive gel networks are particularly responsive to external stimuli, but swelling is slow to occur 14,15. As well as being useful in the controlled release of drugs, such systems also provide insight into intermolecular interactions 16. Here we report on a novel polymeric system, which rapidly changes from a solid state to solution in response to small electric currents, by disintegration of the solid polymer complex into two water-soluble polymers. We show that the modulated release of insulin, and by extension other macromolecules, can be achieved with this polymeric system.			KWON, IC (corresponding author), UNIV UTAH,CTR CONTROLLED CHEM DELIVERY,421 WAKARA WAY,SALT LAKE CITY,UT 84108, USA.		KWON, ICK CHAN/AAS-4776-2020	KWON, ICK CHAN/0000-0003-1272-7074				BAE YH, 1987, MAKROMOL CHEM-RAPID, V8, P481; CHEN FL, 1988, POLYMER, V29, P2285, DOI 10.1016/0032-3861(88)90123-1; EISENBERG SR, 1984, J MEMBRANE SCI, V19, P173, DOI 10.1016/S0376-7388(00)80207-0; HIROKAWA Y, 1984, J CHEM PHYS, V81, P6379, DOI 10.1063/1.447548; HOFFMAN A S, 1986, Journal of Controlled Release, V4, P213; HOPFENBERG HB, 1976, CONTROLLED RELEASE P, pCH3; ILMAIN F, 1991, NATURE, V349, P400, DOI 10.1038/349400a0; ISHIHARA K, 1984, J POLYM SCI POL CHEM, V22, P881, DOI 10.1002/pol.1984.170220341; ISHIHARA K, 1984, J APPL POLYM SCI, V29, P211, DOI 10.1002/app.1984.070290119; Kost J., 1990, PULSED SELF REGULATE; KUHN W, 1950, NATURE, V165, P514, DOI 10.1038/165514a0; KWON IC, 1990, MAKROMOL CHEM-M SYMP, V33, P265, DOI 10.1002/masy.19900330123; LANGER R, 1990, SCIENCE, V249, P1527, DOI 10.1126/science.2218494; LICHKUS AM, 1988, MACROMOLECULES, V21, P2636, DOI 10.1021/ma00186a054; OSADA Y, 1981, J POLYM SCI POL LETT, V19, P303, DOI 10.1002/pol.1981.130190605; SIEGEL RA, 1988, MACROMOLECULES, V21, P3254, DOI 10.1021/ma00189a021; SUZUKI A, 1990, NATURE, V346, P345, DOI 10.1038/346345a0; TANAKA T, 1982, SCIENCE, V218, P467, DOI 10.1126/science.218.4571.467; TSUCHIDA E, 1982, ADV POLYM SCI, V45, P1	19	607	683	1	113	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 28	1991	354	6351					291	293		10.1038/354291a0	http://dx.doi.org/10.1038/354291a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT204	1956379				2022-12-24	WOS:A1991GT20400042
J	KLAG, MJ; WHELTON, PK; CORESH, J; GRIM, CE; KULLER, LH				KLAG, MJ; WHELTON, PK; CORESH, J; GRIM, CE; KULLER, LH			THE ASSOCIATION OF SKIN COLOR WITH BLOOD-PRESSURE IN UNITED-STATES BLACKS WITH LOW SOCIOECONOMIC-STATUS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GEOGRAPHIC DIFFERENCES; STROKE MORTALITY; PUERTO-RICO; HYPERTENSION; POPULATION; WHITES; LIGHT; MEN	To determine the association of skin color, measured by a reflectometer, with blood pressure in US blacks, we studied a community sample of 457 blacks from three US cities. Persons taking antihypertensive medications were excluded. Both systolic and diastolic blood pressure were higher in darker persons and increased by 2 mm Hg for every 1-SD increase in skin darkness. However, the association was dependent on socioeconomic status, whether measured by education or an index consisting of education, occupation, and ethnicity, being present only in persons with lower levels of either indicator. Using multiple linear regression, both systolic and diastolic blood pressure remained significantly associated with darker skin color in the lower levels of socioeconomic status, independent of age, body mass index, and concentrations of blood glucose, serum urea nitrogen, serum uric acid, and urinary sodium and potassium. The association of skin color with blood pressure only in low socioeconomic strata may be due to the lesser ability of such groups to deal with the psychosocial stress associated with darker skin color. However, these findings also are consistent with an interaction between an environmental factor associated with low socioeconomic status and a susceptible gene that has a higher prevalence in persons with darker skin color.	JOHNS HOPKINS UNIV, SCH MED, DEPT MED, BALTIMORE, MD 21205 USA; JOHNS HOPKINS UNIV, SCH MED, DEPT EPIDEMIOL, BALTIMORE, MD 21205 USA; JOHNS HOPKINS UNIV, SCH MED, DEPT HLTH POLICY & MANAGEMENT, BALTIMORE, MD 21205 USA; JOHNS HOPKINS UNIV, SCH HYG & PUBL HLTH, DEPT EPIDEMIOL, BALTIMORE, MD 21218 USA; CHARLES R DREW UNIV, SCH MED, DEPT MED, LOS ANGELES, CA USA; UNIV PITTSBURGH, SCH PUBL HLTH, DEPT EPIDEMIOL, PITTSBURGH, PA 15260 USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Charles R. Drew University of Medicine & Science; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh					NCRR NIH HHS [5M01RR00722] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000722] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		BOYLE E, 1970, J AMER MED ASSOC, V213, P1637, DOI 10.1001/jama.213.10.1637; Cavalli-Sforza L.L., 1971, GENETICS HUMAN POPUL; COMSTOCK GW, 1957, AM J HYG, V65, P271, DOI 10.1093/oxfordjournals.aje.a119870; COSTAS R, 1981, AM J PUBLIC HEALTH, V71, P614, DOI 10.2105/AJPH.71.6.614; DRIZD R, 1986, VITAL HLTH STAT, V11, P31; GILLUM RF, 1979, HYPERTENSION, V1, P468, DOI 10.1161/01.HYP.1.5.468; GREEN LW, 1970, PUBLIC HEALTH REP, V85, P815, DOI 10.2307/4593972; GRIM CE, 1984, AUST NZ J MED, V14, P453, DOI 10.1111/j.1445-5994.1984.tb03614.x; HARBURG E, 1978, AM J PUBLIC HEALTH, V68, P1177, DOI 10.2105/AJPH.68.12.1177; HARBURG E, 1982, HUM BIOL, V54, P283; HYPERTENSION DETECTION FOLLOW-UP, 1977, AM J EPIDEMIOL, V106, P351; JAMES SA, 1987, AM J EPIDEMIOL, V126, P664, DOI 10.1093/oxfordjournals.aje.a114706; KEIL JE, 1981, AM J PUBLIC HEALTH, V71, P532, DOI 10.2105/AJPH.71.5.532; KEIL JE, 1977, AM J PUBLIC HEALTH, V67, P634, DOI 10.2105/AJPH.67.7.634; LUFT FC, 1977, J LAB CLIN MED, V90, P555; MACLEAN CJ, 1974, AM J HUM GENET, V26, P614; MILLER JM, 1985, AM J PUBLIC HEALTH, V75, P558, DOI 10.2105/AJPH.75.5.558; NEFZGER MD, 1977, STROKE, V8, P546, DOI 10.1161/01.STR.8.5.546; SORLIE PD, 1988, AM HEART J, V116, P777, DOI 10.1016/0002-8703(88)90337-7; STOLLEY PD, 1977, STROKE, V8, P551, DOI 10.1161/01.STR.8.5.551; TYROLER HA, 1978, AM J PUBLIC HEALTH, V68, P1170, DOI 10.2105/AJPH.68.12.1170; 1985, SAS USERS GUIDE BASI	22	131	133	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	1991	265	5					599	602		10.1001/jama.265.5.599	http://dx.doi.org/10.1001/jama.265.5.599			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EV718	1987409				2022-12-24	WOS:A1991EV71800015
J	SATO, K				SATO, K			HYPERHIDROSIS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter											SATO, K (corresponding author), UNIV IOWA,SCH MED,IOWA CITY,IA 52242, USA.							FEALEY RD, 1989, MAYO CLIN PROC, V64, P617, DOI 10.1016/S0025-6196(12)65338-5; GOBBI PG, 1990, CANCER, V65, P2074, DOI 10.1002/1097-0142(19900501)65:9<2074::AID-CNCR2820650931>3.0.CO;2-O; KENNEY MJ, 1986, CLIN EXP DERMATOL, V11, P543, DOI 10.1111/j.1365-2230.1986.tb00506.x; SANDEL ME, 1986, ARCH PHYS MED REHAB, V67, P469; SATO K, 1989, J AM ACAD DERMATOL, V20, P713, DOI 10.1016/S0190-9622(89)70081-5; SATO KT, 1988, AM J MED SCI, V295, P528, DOI 10.1097/00000441-198806000-00006	6	9	13	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	1991	265	5					651	651		10.1001/jama.265.5.651	http://dx.doi.org/10.1001/jama.265.5.651			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EV718	1987421				2022-12-24	WOS:A1991EV71800029
J	SARTORI, S; NIELSEN, I; INDELLI, M; TREVISANI, L; PAZZI, P; GRANDI, E				SARTORI, S; NIELSEN, I; INDELLI, M; TREVISANI, L; PAZZI, P; GRANDI, E			BARRETT-ESOPHAGUS AFTER CHEMOTHERAPY WITH CYCLOPHOSPHAMIDE, METHOTREXATE, AND 5-FLUOROURACIL (CMF) - AN IATROGENIC INJURY	ANNALS OF INTERNAL MEDICINE			English	Note							COLUMNAR-LINED ESOPHAGUS; AGENTS	Methotrexate and 5-fluorouracil can provoke oral mucosal erosions and ulceration that may extend throughout the esophagus. This study was conducted to determine whether prolonged chemotherapy-induced esophageal damage may cause the development of Barrett esophagus. Sixteen women who had breast cancer and had been selected to receive at least six breast cancer and had been selected to receive at least six courses of chemotherapy with cyclophosphamide, methotrexate, and 5-flourouracil were included in the study. They had esophagoscopy, and several biopsy specimens were taken from the lower esophagus (3, 6, and 9 cm above the lower esophageal sphincter) before chemotherapy was begun and 1 month after the sixth course of chemotherapy. All patients had a normal esophagus at the first examination. After finishing chemotherapy, 10 (63%) had developed Barrett esophagus. One patient had the junctional type, 2 patients had the fundic type, 4 patients had a combination of the junctional and fundic types, and 3 patients had the intestinal type. These results suggest that chemotherapy-induced esophageal injury may have been responsible for the development of Barrett esophagus in our patients.	UNIV FERRARA, SCH MED, I-44100 FERRARA, ITALY	University of Ferrara	SARTORI, S (corresponding author), ST ANNA GEN HOSP, CORSO GIOVECCA 230, I-44100 FERRARA, ITALY.		sartori, samantha/AAL-8884-2020					ADRIAN RM, 1980, CA-CANCER J CLIN, V30, P143, DOI 10.3322/canjclin.30.3.143; DAHMS BB, 1987, CANCER, V60, P2896, DOI 10.1002/1097-0142(19871215)60:12<2896::AID-CNCR2820601208>3.0.CO;2-P; LEWIS JH, 1986, AM J GASTROENTEROL, V81, P819; MCCLAVE SA, 1987, GASTROINTEST ENDOSC, V33, P413, DOI 10.1016/S0016-5107(87)71676-9; ROTHERY GA, 1986, GUT, V27, P1062, DOI 10.1136/gut.27.9.1062; SARTORI S, 1989, HEPATO-GASTROENTEROL, V36, P304; SAVARY M, 1985, ESOPHAGEAL DISORDERS, P101; SPECHLER SJ, 1986, NEW ENGL J MED, V315, P362, DOI 10.1056/NEJM198608073150605; TYTGAT GNJ, 1989, ENDOSCOPY, V21, P177, DOI 10.1055/s-2007-1012937	9	53	54	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 1	1991	114	3					210	211		10.7326/0003-4819-114-3-210	http://dx.doi.org/10.7326/0003-4819-114-3-210			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EV339	1984745				2022-12-24	WOS:A1991EV33900007
J	LACKRITZ, EM; LOBEL, HO; HOWELL, BJ; BLOLAND, P; CAMPBELL, CC				LACKRITZ, EM; LOBEL, HO; HOWELL, BJ; BLOLAND, P; CAMPBELL, CC			IMPORTED PLASMODIUM-FALCIPARUM MALARIA IN AMERICAN TRAVELERS TO AFRICA - IMPLICATIONS FOR PREVENTION STRATEGIES	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Note								Data from the US National Malaria Surveillance System were analyzed to assess characteristics of travelers who acquired Plasmodium falciparum infections in Africa and evaluate the impact of chloroquine resistance on the incidence of imported malaria. Although the number of cases acquired in East Africa has stabilized, the number of imported P falciparum infections acquired in West Africa increased threefold from 1985 to 1988, and the proportion of travelers who reported failure of chloroquine prophylaxis increased from 10% to 48%. Fifty-eight percent of patients who acquired malaria in West Africa had not used chemoprophylaxis. To curb the rising incidence of P falciparum infections in American travelers, the Centers for Disease Control revised malaria prophylaxis recommendations to include the use of mefloquine in areas of chloroquine resistance. Use of malaria protection measures by travelers to West Africa must also be improved.			LACKRITZ, EM (corresponding author), CTR DIS CONTROL,CTR INFECT DIS,DIV PARASIT DIS,MALARIA BRANCH,MAILSTOP F-12,1600 CLIFTON RD,ATLANTA,GA 30333, USA.			Lackritz, Eve/0000-0002-5397-7291				KEAN BH, 1979, JAMA-J AM MED ASSOC, V241, P395, DOI 10.1001/jama.241.4.395; LOBEL HO, 1990, B WORLD HEALTH ORGAN, V68, P209; LOBEL HO, 1991, JAMA-J AM MED ASSOC, V265, P361, DOI 10.1001/jama.265.3.361; LOBEL HO, 1985, J INFECT DIS, V152, P613, DOI 10.1093/infdis/152.3.613; LOBEL HO, 1988, TRAVEL MED, P81; MORAN JS, 1989, JAMA-J AM MED ASSOC, V262, P245, DOI 10.1001/jama.262.2.245; MORAN JS, 1987, AMA, V257, P2376; PHILLIPSHOWARD PA, 1990, LANCET, V335, P119, DOI 10.1016/0140-6736(90)90596-W; SANSONETTI PJ, 1985, LANCET, V1, P1154; 1988, MALARIA SURVEILLANCE; 1990, MMWR, V39, P630; 1988, EC SURVEY; 1990, CDC908280 US DEP HLT; 1990, MMWR, V39, P1	14	42	44	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 16	1991	265	3					383	385		10.1001/jama.265.3.383	http://dx.doi.org/10.1001/jama.265.3.383			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ER256	1984539				2022-12-24	WOS:A1991ER25600030
J	DJABALI, K; PORTIER, MM; GROS, F; BLOBEL, G; GEORGATOS, SD				DJABALI, K; PORTIER, MM; GROS, F; BLOBEL, G; GEORGATOS, SD			NETWORK ANTIBODIES IDENTIFY NUCLEAR LAMIN-B AS A PHYSIOLOGICAL ATTACHMENT SITE FOR PERIPHERIN INTERMEDIATE FILAMENTS	CELL			English	Article							ANTI-IDIOTYPIC ANTIBODIES; AMINO-ACID-SEQUENCE; PLASMA-MEMBRANE; AVIAN ERYTHROCYTES; MESSENGER-RNA; DESMIN DERIVATIVES; SIZED FILAMENTS; DYNAMIC ASPECTS; PROTEIN FAMILY; KERATIN CDNAS	We studied the molecular associations between peripherin (a neuronal, type III intermediate filament subunit) and nuclear lamins. We show here that isolated peripherin binds selectively to mammalian lamin B under in vitro conditions. We further demonstrate that a synthetic peptide, representing the proximal part of peripherin's tall domain (P(I)), also associates with mammalian lamin B in a saturable, cooperative, and specific fashion. Laboratory animals immunized with P(I) spontaneously develop idiotypic and antiidiotypic antibodies recognizing peripherin and lamin B, respectively. These data provide essentially in vivo evidence that lamin B represents a constitutive nuclear "receptor" site for the tail domains of peripherin intermediate filaments.	ROCKEFELLER UNIV,HOWARD HUGHES MED INST,CELL BIOL LAB,NEW YORK,NY 10021; EUROPEAN MOLEC BIOL LAB,PROGRAMME CELL BIOL,W-6900 HEIDELBERG,GERMANY	Howard Hughes Medical Institute; Rockefeller University; European Molecular Biology Laboratory (EMBL)	DJABALI, K (corresponding author), COLL FRANCE,11 PL MARCELIN BERTHELOT,F-75231 PARIS 05,FRANCE.			Georgatos, Spyros/0000-0002-2078-7467				AARONSON RP, 1975, P NATL ACAD SCI USA, V72, P1007, DOI 10.1073/pnas.72.3.1007; AEBI U, 1983, J CELL BIOL, V97, P1131, DOI 10.1083/jcb.97.4.1131; AEBI U, 1986, NATURE, V323, P560, DOI 10.1038/323560a0; ALBERS K, 1987, J CELL BIOL, V105, P791, DOI 10.1083/jcb.105.2.791; ALBERS K, 1989, J CELL BIOL, V108, P1477, DOI 10.1083/jcb.108.4.1477; ALETTA JM, 1989, J BIOL CHEM, V264, P4619; BLALOCK JE, 1984, BIOCHEM BIOPH RES CO, V121, P203, DOI 10.1016/0006-291X(84)90707-1; BOST KL, 1985, P NATL ACAD SCI USA, V82, P1372, DOI 10.1073/pnas.82.5.1372; BOST KL, 1989, METHOD ENZYMOL, V168, P16; CAPCO DG, 1982, CELL, V29, P847, DOI 10.1016/0092-8674(82)90446-9; CARMO-FONSECA M, 1987, European Journal of Cell Biology, V45, P282; CARMOFONSECA M, 1990, ELECTRON MICROSC REV, V3, P115, DOI 10.1016/0892-0354(90)90017-M; CARTAUD A, 1989, J CELL BIOL, V109, P1745, DOI 10.1083/jcb.109.4.1745; CARTAUD A, 1990, J CELL BIOL, V111, P581, DOI 10.1083/jcb.111.2.581; CHIN SSM, 1989, EUR J CELL BIOL, V50, P475; COULOMBE PA, 1990, J CELL BIOL, V111, P153, DOI 10.1083/jcb.111.1.153; CROIZAT B, 1979, CR ACAD SCI D NAT, V289, P1283; ESCURAT M, 1990, J NEUROSCI, V10, P764; FISHER DZ, 1986, P NATL ACAD SCI USA, V83, P6450, DOI 10.1073/pnas.83.17.6450; FRANKE WW, 1971, PROTOPLASMA, V73, P263, DOI 10.1007/BF01275600; FRANKE WW, 1987, CELL, V48, P3, DOI 10.1016/0092-8674(87)90345-X; GEISLER N, 1982, EMBO J, V1, P1649, DOI 10.1002/j.1460-2075.1982.tb01368.x; GEISLER N, 1982, CELL, V30, P277, DOI 10.1016/0092-8674(82)90033-2; GEISLER N, 1986, STRUCTURAL ASPECTS I; GEORGATOS SD, 1985, J CELL BIOL, V100, P1955, DOI 10.1083/jcb.100.6.1955; GEORGATOS SD, 1987, J CELL BIOL, V105, P117, DOI 10.1083/jcb.105.1.117; GEORGATOS SD, 1987, P NATL ACAD SCI USA, V84, P6780, DOI 10.1073/pnas.84.19.6780; GEORGATOS SD, 1985, J CELL BIOL, V100, P1962, DOI 10.1083/jcb.100.6.1962; GEORGATOS SD, 1987, J CELL BIOL, V105, P105, DOI 10.1083/jcb.105.1.105; GOLDMAN R, 1985, ANN NY ACAD SCI, V455, P1, DOI 10.1111/j.1749-6632.1985.tb50400.x; GRANGER BL, 1982, CELL, V30, P263, DOI 10.1016/0092-8674(82)90032-0; GUILLY MN, 1987, EUR J CELL BIOL, V43, P266; HANUKOGLU I, 1983, CELL, V33, P915, DOI 10.1016/0092-8674(83)90034-X; HARLOW E, 1968, ANTIBODIES LABORATOR; HOGER TH, 1990, CHROMOSOMA, V99, P379, DOI 10.1007/BF01726689; HOGER TH, 1988, EUR J CELL BIOL, V47, P283; JERNE NK, 1974, ANN INST PASTEUR IMM, VC125, P373; JERNE NK, 1985, EMBO J, V4, P847, DOI 10.1002/j.1460-2075.1985.tb03709.x; JONES JCR, 1982, CELL MOTIL CYTOSKEL, V2, P197, DOI 10.1002/cm.970020302; KAUFMANN E, 1985, J MOL BIOL, V185, P733, DOI 10.1016/0022-2836(85)90058-0; KAUFMANN S, 1989, J BIOL CHEM, V267, P13946; KROHNE G, 1987, EMBO J, V6, P3801, DOI 10.1002/j.1460-2075.1987.tb02716.x; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LANDON F, 1989, EMBO J, V8, P1719, DOI 10.1002/j.1460-2075.1989.tb03564.x; LANGLEY RC, 1985, J CELL BIOCHEM, V30, P101; LAZARIDES E, 1982, ANNU REV BIOCHEM, V51, P219, DOI 10.1146/annurev.bi.51.070182.001251; LAZARIDES E, 1980, NATURE, V283, P249, DOI 10.1038/283249a0; LEHNER CF, 1987, J CELL BIOL, V105, P577, DOI 10.1083/jcb.105.1.577; LEHNER CF, 1986, J BIOL CHEM, V261, P3293; LEHTO VP, 1978, NATURE, V272, P175, DOI 10.1038/272175a0; LEONARD DGB, 1988, J CELL BIOL, V106, P181, DOI 10.1083/jcb.106.1.181; LISCHWE MA, 1982, ANAL BIOCHEM, V127, P453, DOI 10.1016/0003-2697(82)90203-2; LU X, 1990, CELL, V62, P681, DOI 10.1016/0092-8674(90)90114-T; MCKEON FD, 1986, NATURE, V319, P463, DOI 10.1038/319463a0; MULCHAHEY JJ, 1986, P NATL ACAD SCI USA, V83, P9714, DOI 10.1073/pnas.83.24.9714; NGAI J, 1990, CELL, V60, P415, DOI 10.1016/0092-8674(90)90593-4; OAS TG, 1988, NATURE, V336, P42, DOI 10.1038/336042a0; PARYSEK LM, 1988, NEURON, V1, P395, DOI 10.1016/0896-6273(88)90189-4; PASCUAL DW, 1989, J IMMUNOL, V143, P3697; PETER M, 1989, J MOL BIOL, V208, P393, DOI 10.1016/0022-2836(89)90504-4; PORTIER MM, 1984, DEV NEUROSCI-BASEL, V6, P335, DOI 10.1159/000112360; QUAX W, 1985, CELL, V43, P327, DOI 10.1016/0092-8674(85)90038-8; QUAX W, 1983, CELL, V35, P215, DOI 10.1016/0092-8674(83)90224-6; QUINLAN RA, 1984, J MOL BIOL, V178, P365, DOI 10.1016/0022-2836(84)90149-9; RAMAEKERS FCS, 1982, P NATL ACAD SCI-BIOL, V79, P3208, DOI 10.1073/pnas.79.10.3208; RENNER W, 1981, J MOL BIOL, V149, P285, DOI 10.1016/0022-2836(81)90303-X; RIVAS CI, 1988, P NATL ACAD SCI USA, V85, P6092, DOI 10.1073/pnas.85.16.6092; SARRIA AJ, 1990, J CELL BIOL, V111, P553, DOI 10.1083/jcb.111.2.553; SCATCHARD G, 1949, ANN NY ACAD SCI, V51, P660, DOI 10.1111/j.1749-6632.1949.tb27297.x; SHECHTER Y, 1984, J BIOL CHEM, V259, P6411; SHECHTER Y, 1982, SCIENCE, V216, P542, DOI 10.1126/science.7041258; SMITH LR, 1987, J IMMUNOL, V138, P7; STEINERT PM, 1990, CELL, V60, P521, DOI 10.1016/0092-8674(90)90651-T; STEINERT PM, 1988, ANNU REV BIOCHEM, V57, P593, DOI 10.1146/annurev.bi.57.070188.003113; Stewart M, 1990, CURR OPIN CELL BIOL, V2, P91, DOI 10.1016/S0955-0674(05)80037-7; TOOZE J, 1989, EUR J CELL BIOL, V49, P259; VIKSTROM KL, 1989, P NATL ACAD SCI USA, V86, P549, DOI 10.1073/pnas.86.2.549; VORBURGER K, 1989, J MOL BIOL, V208, P405, DOI 10.1016/0022-2836(89)90505-6; WANG E, 1985, ANN NY ACAD SCI, V455, P32, DOI 10.1111/j.1749-6632.1985.tb50402.x; WELLING GW, 1985, FEBS LETT, V188, P215, DOI 10.1016/0014-5793(85)80374-4; WRIGHT PE, 1988, BIOCHEMISTRY-US, V27, P7167, DOI 10.1021/bi00419a001; ZACKROFF RV, 1979, P NATL ACAD SCI USA, V76, P6226, DOI 10.1073/pnas.76.12.6226; ZEHNER ZE, 1987, J BIOL CHEM, V262, P8112	83	107	107	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	JAN 11	1991	64	1					109	121		10.1016/0092-8674(91)90213-I	http://dx.doi.org/10.1016/0092-8674(91)90213-I			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ET175	1986862				2022-12-24	WOS:A1991ET17500013
J	BURGER, BJ; BURGER, JD; BOS, CFA; OBERMANN, WR; ROZING, PM; VANDENBROUCKE, JP				BURGER, BJ; BURGER, JD; BOS, CFA; OBERMANN, WR; ROZING, PM; VANDENBROUCKE, JP			NEONATAL SCREENING AND STAGGERED EARLY TREATMENT FOR CONGENITAL DISLOCATION OR DYSPLASIA OF THE HIP	LANCET			English	Article							AVASCULAR NECROSIS; NEWBORN	In 14 264 consecutive newborn babies the results of screening and early treatment for congenital dislocation and/or dysplasia of the hip (CDH) were evaluated in a prospective follow-up study. Barlow's test was done and the family history was recorded. Babies who were positive (n = 140) were immediately given abduction treatment. If the screening result was doubtful (133) or if the test was negative but the family history positive (685) the child was radiographed at 5 months and abduction treatment was started if any form of CDH was seen. Among Barlow-negative children with no family history (13 306), two reference groups were selected - at age 5 months (596) and at age 2 years (4365). Dislocation was missed at screening in 0.02%. Dysplasia was seen at 5 months in 15% of Barlow-negative children with a positive family history and in 2-3% of the reference group children. Crude estimates of the lower limits of validity indices for the screening test showed that the test is efficient in the identification of dislocation but probably has not value for dysplasia. Of the babies in whom treatment was started immediately 17% had relapse dysplasia after withdrawal of therapy, 3% had avascular necrosis, and 78% were normal at 2 years. When treatment was started at 5 months were found no relapse dysplasia, only 1% avascular necrosis, and 53-63% success at 2 years. In children with dislocatable hips were propose a wait-and-see treatment strategy, with early ultrasonography or radiography at 5 months.	UNIV HOSP LEIDEN, DEPT RADIOL, 2300 RC LEIDEN, NETHERLANDS; UNIV HOSP LEIDEN, DEPT CLIN EPIDEMIOL, 2300 RC LEIDEN, NETHERLANDS; ELIZABETH GASTHUIS, HAARLEM, NETHERLANDS	Leiden University; Leiden University Medical Center (LUMC); Leiden University; Leiden University Medical Center (LUMC)	BURGER, BJ (corresponding author), UNIV HOSP LEIDEN, DEPT ORTHOPAED SURG, 2300 RC LEIDEN, NETHERLANDS.		Vandenbroucke, Jan/AAM-3928-2020	Vandenbroucke, Jan/0000-0001-5668-6716				ANDREN L, 1961, ACTA ORTHOP SCAND, V30, P169; BARLOW TG, 1962, J BONE JOINT SURG BR, V44, P292, DOI 10.1302/0301-620X.44B2.292; BECKER F, 1979, Z ORTHOP, V106, P173; BJERKREIM I, 1987, ACTA ORTHOP SCAND, V58, P504, DOI 10.3109/17453678709146388; BRADLEY J, 1987, J BONE JOINT SURG BR, V69, P257, DOI 10.1302/0301-620X.69B2.3818757; CARDOSO AC, 1987, MONTHLY B HLTH STATI, V4, P22; DAVIES RW, 1970, J BONE JOINT SURG BR, V53, P704; DAVIES SJM, 1984, J BONE JOINT SURG BR, V66, P479, DOI 10.1302/0301-620X.66B4.6746677; DUNN PM, 1984, LANCET, V1, P846; DUNN PM, 1985, ARCH DIS CHILD, V60, P407, DOI 10.1136/adc.60.5.407; DUNN PM, 1976, CLIN ORTHOP RELAT R, V119, P11; HADLOW V, 1988, J BONE JOINT SURG BR, V70, P740, DOI 10.1302/0301-620X.70B5.3192572; JONES D, 1977, J BONE JOINT SURG BR, V59, P318, DOI 10.1302/0301-620X.59B3.893510; KALAMCHI A, 1980, J BONE JOINT SURG AM, V62, P876, DOI 10.2106/00004623-198062060-00002; KELLER MS, 1988, RADIOLOGY, V169, P733, DOI 10.1148/radiology.169.3.3055037; KLISIC PJ, 1989, J BONE JOINT SURG BR, V71, P136, DOI 10.1302/0301-620X.71B1.2914985; MacKenzie I G, 1972, J Bone Joint Surg Br, V54, P18; MITCHELL G P, 1972, Journal of Bone and Joint Surgery British Volume, V54, P4; ROBERTON NRC, 1984, LANCET, V1, P909; SAIES AD, 1988, J PEDIATR ORTHOPED, V8, P436, DOI 10.1097/01241398-198807000-00010; SERINGE R, 1982, REV CHIR ORTHOP, V68, P145; TONNIS D, 1976, CLIN ORTHOP RELAT R, P39; TONNIS D, 1984, CONGENITAL HIP DISLO; VONROSEN S, 1962, J BONE JOINT SURG BR, V44, P284, DOI 10.1302/0301-620X.44B2.284; WEINER DS, 1977, J BONE JOINT SURG AM, V59, P306, DOI 10.2106/00004623-197759030-00002; WILLIAMSON J, 1972, Journal of Bone and Joint Surgery British Volume, V54, P13	26	46	48	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 22	1990	336	8730					1549	1553		10.1016/0140-6736(90)93317-I	http://dx.doi.org/10.1016/0140-6736(90)93317-I			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP037	1979375				2022-12-24	WOS:A1990EP03700013
J	MCMURDO, MET; HUTCHISON, GL; LINDSAY, G				MCMURDO, MET; HUTCHISON, GL; LINDSAY, G			TASTE DISTURBANCE WITH ACETAZOLAMIDE	LANCET			English	Letter									UNIV DUNDEE,NINEWELLS HOSP & MED SCH,DEPT ANAESTHET,DUNDEE DD1 9SY,SCOTLAND; UNIV DUNDEE,NINEWELLS HOSP & MED SCH,DEPT PHARM,DUNDEE DD1 9SY,SCOTLAND	University of Dundee; University of Dundee	MCMURDO, MET (corresponding author), UNIV DUNDEE,NINEWELLS HOSP & MED SCH,DEPT MED,DUNDEE DD1 9SY,SCOTLAND.							GRABER M, 1988, AM J MED, V84, P979, DOI 10.1016/0002-9343(88)90091-5; Hansson HPJ, 1961, NORD MED, V65, P566	2	14	14	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 10	1990	336	8724					1190	1191		10.1016/0140-6736(90)92803-P	http://dx.doi.org/10.1016/0140-6736(90)92803-P			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG701	1978045				2022-12-24	WOS:A1990EG70100038
J	LIPUMA, JJ; DASEN, SE; NIELSON, DW; STERN, RC; STULL, TL				LIPUMA, JJ; DASEN, SE; NIELSON, DW; STERN, RC; STULL, TL			PERSON-TO-PERSON TRANSMISSION OF PSEUDOMONAS-CEPACIA BETWEEN PATIENTS WITH CYSTIC-FIBROSIS	LANCET			English	Article									MED COLL PENN,DEPT MICROBIOL IMMUNOL,PHILADELPHIA,PA 19129; UNIV UTAH,DEPT PEDIAT,SALT LAKE CITY,UT 84112; CASE WESTERN RESERVE UNIV,SCH MED,DEPT PEDIAT,CLEVELAND,OH 44106	Drexel University; Utah System of Higher Education; University of Utah; Case Western Reserve University	LIPUMA, JJ (corresponding author), MED COLL PENN,DEPT PEDIAT,3300 HENRY AVE,PHILADELPHIA,PA 19129, USA.							GILLIGAN PH, 1985, J CLIN MICROBIOL, V22, P5, DOI 10.1128/JCM.22.1.5-8.1985; GOLD R, 1983, J ANTIMICROB CHEMOTH, V12, P331, DOI 10.1093/jac/12.suppl_A.331; GOVAN JRW, 1985, J CLIN MICROBIOL, V22, P490, DOI 10.1128/JCM.22.4.490-494.1985; HARDY KA, 1986, J PEDIATR-US, V109, P51, DOI 10.1016/S0022-3476(86)80571-6; HEIDT A, 1983, J CLIN MICROBIOL, V18, P738, DOI 10.1128/JCM.18.3.738-740.1983; ISLES A, 1984, J PEDIATR-US, V104, P206, DOI 10.1016/S0022-3476(84)80993-2; KUIJPER EJ, 1989, J CLIN MICROBIOL, V27, P1280, DOI 10.1128/JCM.27.6.1280-1285.1989; LIPUMA JJ, 1988, J PEDIATR-US, V113, P859, DOI 10.1016/S0022-3476(88)80018-0; LIPUMA JJ, 1989, J INFECT DIS, V159, P526, DOI 10.1093/infdis/159.3.526; NAKAMURA Y, 1986, J CLIN MICROBIOL, V24, P152, DOI 10.1128/JCM.24.1.152-154.1986; PRINCE A, 1986, AM REV RESPIR DIS, V134, P644; PRINCE A, 1986, J PEDIATR-US, V108, P830, DOI 10.1016/S0022-3476(86)80753-3; RABKIN CS, 1989, REV INFECT DIS, V11, P600; RICHARD C, 1981, ANN BIOL CLIN-PARIS, V39, P9; ROSENSTEIN BJ, 1980, JOHNS HOPKINS MED J, V147, P188; SNIPES KP, 1989, J CLIN MICROBIOL, V27, P1847, DOI 10.1128/JCM.27.8.1847-1853.1989; STERN RC, 1989, J PEDIATR-US, V114, P31, DOI 10.1016/S0022-3476(89)80597-9; STULL TL, 1988, J INFECT DIS, V157, P280, DOI 10.1093/infdis/157.2.280; TABLAN OC, 1987, J CLIN MICROBIOL, V25, P485, DOI 10.1128/JCM.25.3.485-487.1987; TABLAN OC, 1987, CHEST, V91, P527, DOI 10.1378/chest.91.4.527; TABLAN OC, 1985, J PEDIATR-US, V107, P382, DOI 10.1016/S0022-3476(85)80511-4; TABLAN OC, 1989, PEDIATR PULM S, V4, P138; THOMASSEN MJ, 1985, AM REV RESPIR DIS, V131, P791; THOMASSEN MJ, 1986, AM REV RESPIR DIS, V134, P669	24	250	251	0	11	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 3	1990	336	8723					1094	1096		10.1016/0140-6736(90)92571-X	http://dx.doi.org/10.1016/0140-6736(90)92571-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF992	1977981				2022-12-24	WOS:A1990EF99200005
J	GRANDER, D; OBERG, K; LUNDQVIST, ML; JANSON, ET; ERIKSSON, B; EINHORN, S				GRANDER, D; OBERG, K; LUNDQVIST, ML; JANSON, ET; ERIKSSON, B; EINHORN, S			INTERFERON-INDUCED ENHANCEMENT OF 2',5'-OLIGOADENYLATE SYNTHETASE IN MIDGUT CARCINOID-TUMORS	LANCET			English	Article									KAROLINSKA HOSP, RADIUM HEMMET, DIV EXPTL ONCOL, S-10401 STOCKHOLM, SWEDEN; AKAD HOSP UPPSALA, LUDWIG INST CANC RES, UPPSALA, SWEDEN; AKAD HOSP UPPSALA, DEPT INTERNAL MED, UPPSALA, SWEDEN	Karolinska Institutet; Karolinska University Hospital; Ludwig Institute for Cancer Research			Oberg, Kjell/AAG-7118-2019					AFFABRIS E, 1983, VIROLOGY, V125, P508, DOI 10.1016/0042-6822(83)90224-6; BOGDEN AE, 1979, EXP CELL BIOL, V47, P281; EINHORN L, 1985, INTERVIROLOGY, V23, P140, DOI 10.1159/000149597; EINHORN S, 1987, EUR J CANCER CLIN ON, V23, P1607, DOI 10.1016/0277-5379(87)90438-X; EINHORN S, 1988, EUR J CANCER CLIN ON, V24, P1505, DOI 10.1016/0277-5379(88)90342-2; EINHORN S, 1978, HUMAN INTERFERON PRO, P159; EINHORN S, 1983, BIOL INTERFERON SYST, P347; FOGH J, 1977, NUDE MOUSE EXPT CLIN; GRESSER I, 1972, NATURE, V239, P167, DOI 10.1038/239167a0; HAMBURGER AW, 1977, SCIENCE, V197, P461, DOI 10.1126/science.560061; KERR IM, 1978, P NATL ACAD SCI USA, V75, P256, DOI 10.1073/pnas.75.1.256; KVOLS LK, 1986, NEW ENGL J MED, V315, P663, DOI 10.1056/NEJM198609113151102; LENGYEL P, 1981, INTERFERON, P78; MARTI J, 1981, J INTERFERON RES, V1, P287, DOI 10.1089/jir.1981.1.287; OBERG K, 1987, ACTA ONCOL, V26, P429; OBERG K, 1986, CANCER TREAT REP, V70, P1297; OBERG K, 1989, J NATL CANCER I, V81, P531, DOI 10.1093/jnci/81.7.531; OBERT HJ, 1982, UCLA S MOL CELLULAR, P426; OSTLUND L, 1986, CANCER RES, V46, P2160; OSTLUND L, 1986, BLOOD, V67, P152; PAUCKER K, 1962, VIROLOGY, V17, P324, DOI 10.1016/0042-6822(62)90123-X; Revel M, 1981, Methods Enzymol, V79, P149; SALZBERG S, 1983, MOL CELL BIOL, V3, P1759, DOI 10.1128/MCB.3.10.1759; SILVERMAN RH, 1983, BIOL INTERFERON SYST, P189; STRANDER H, 1986, ADV CANCER RES, V46, pR9; TOVEY MG, 1983, J GEN VIROL, V64, P2649, DOI 10.1099/0022-1317-64-12-2649; WEISENTHAL LM, 1983, CANCER RES, V43, P258	27	65	65	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 11	1990	336	8711					337	340		10.1016/0140-6736(90)91879-F	http://dx.doi.org/10.1016/0140-6736(90)91879-F			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU075	1975335				2022-12-24	WOS:A1990DU07500004
J	DANGELO, E; ROSSI, P; GARTHWAITE, J				DANGELO, E; ROSSI, P; GARTHWAITE, J			DUAL-COMPONENT NMDA RECEPTOR CURRENTS AT A SINGLE CENTRAL SYNAPSE	NATURE			English	Article									UNIV LIVERPOOL,DEPT PHYSIOL,BROWNLOW HILL,POB 147,LIVERPOOL L69 3BX,ENGLAND	University of Liverpool			D'Angelo, Egidio/AAC-3846-2022	D'Angelo, Egidio/0000-0002-6007-7187; ROSSI, Paola/0000-0002-1134-4111				ASCHER P, 1988, J PHYSIOL-LONDON, V399, P207; ASCHER P, 1987, TRENDS NEUROSCI, V10, P284, DOI 10.1016/0166-2236(87)90174-3; BEKKERS JM, 1989, NATURE, V341, P230, DOI 10.1038/341230a0; BIRCH PJ, 1988, EUR J PHARMACOL, V156, P177, DOI 10.1016/0014-2999(88)90163-X; COLLINGRIDGE GL, 1988, J PHYSIOL-LONDON, V399, P283; COLLINGRIDGE GL, 1987, TRENDS NEUROSCI, V10, P288, DOI 10.1016/0166-2236(87)90175-5; DALE N, 1985, J PHYSIOL-LONDON, V363, P35, DOI 10.1113/jphysiol.1985.sp015694; EDWARDS FA, 1989, PFLUG ARCH EUR J PHY, V414, P600, DOI 10.1007/BF00580998; GAGE PW, 1976, PHYSIOL REV, V56, P177, DOI 10.1152/physrev.1976.56.1.177; GARTHWAITE J, 1989, NEUROSCIENCE, V29, P401, DOI 10.1016/0306-4522(89)90067-5; GUSTAFSSON B, 1988, TRENDS NEUROSCI, V11, P156, DOI 10.1016/0166-2236(88)90142-7; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; HOWE JR, 1988, PROC R SOC SER B-BIO, V233, P407, DOI 10.1098/rspb.1988.0030; HUETTNER JE, 1989, SCIENCE, V243, P1611, DOI 10.1126/science.2467381; JOHNSON JW, 1987, NATURE, V325, P529, DOI 10.1038/325529a0; JONES KA, 1988, J NEUROSCI, V8, P3522; KATZ B, 1973, J PHYSIOL-LONDON, V231, P549, DOI 10.1113/jphysiol.1973.sp010248; KLECKNER NW, 1988, SCIENCE, V241, P835, DOI 10.1126/science.2841759; MAYER ML, 1987, J PHYSIOL-LONDON, V394, P501, DOI 10.1113/jphysiol.1987.sp016883; MAYER ML, 1987, PROG NEUROBIOL, V28, P197, DOI 10.1016/0301-0082(87)90011-6; OTTERSEN OP, 1988, BRAIN RES, V450, P342, DOI 10.1016/0006-8993(88)91573-9; Palay S. L., 1974, CEREBELLAR CORTEX CY; PALKOVIT.M, 1972, BRAIN RES, V45, P15, DOI 10.1016/0006-8993(72)90213-2; PAN ZZ, 1989, J NEUROPHYSIOL, V61, P719, DOI 10.1152/jn.1989.61.4.719; SAH P, 1989, SCIENCE, V246, P815, DOI 10.1126/science.2573153; THOMSON AM, 1986, J PHYSIOL-LONDON, V370, P531, DOI 10.1113/jphysiol.1986.sp015949; THOMSON AM, 1989, TRENDS NEUROSCI, V12, P349, DOI 10.1016/0166-2236(89)90042-8; WILKIN GP, 1981, BRAIN RES, V216, P11, DOI 10.1016/0006-8993(81)91275-0; WOOD PL, 1989, J NEUROCHEM, V53, P979, DOI 10.1111/j.1471-4159.1989.tb11803.x	29	85	85	0	2	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	AUG 2	1990	346	6283					467	470		10.1038/346467a0	http://dx.doi.org/10.1038/346467a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR713	1974034				2022-12-24	WOS:A1990DR71300057
J	WIKLUND, O; ANGELIN, B; OLOFSSON, SO; ERIKSSON, M; FAGER, G; BERGLUND, L; BONDJERS, G				WIKLUND, O; ANGELIN, B; OLOFSSON, SO; ERIKSSON, M; FAGER, G; BERGLUND, L; BONDJERS, G			APOLIPOPROTEIN(A) AND ISCHEMIC-HEART-DISEASE IN FAMILIAL HYPERCHOLESTEROLEMIA	LANCET			English	Article									GOTHENBURG UNIV,DEPT MED 1,WALLENBERG LAB,S-41124 GOTHENBURG,SWEDEN; HUDDINGE UNIV HOSP,KAROLINSKA INST,DEPT MED,METAB UNIT,S-14186 HUDDINGE,SWEDEN; HUDDINGE UNIV HOSP,KAROLINSKA INST,DEPT CLIN CHEM,S-14186 HUDDINGE,SWEDEN	University of Gothenburg; Karolinska Institutet; Karolinska Institutet				Berglund, Lars/0000-0001-6705-1791				ARMSTRONG VW, 1989, EUR J CLIN INVEST, V19, P235, DOI 10.1111/j.1365-2362.1989.tb00223.x; BEAUMONT V, 1976, ATHEROSCLEROSIS, V24, P441, DOI 10.1016/0021-9150(76)90136-2; BERG K, 1963, ACTA PATHOL MIC SC, V59, P369; BERG K, 1974, CLIN GENET, V6, P230; BOERWINKLE E, 1989, HUM GENET, V82, P73, DOI 10.1007/BF00288277; CARLSON LA, 1989, J INTERN MED, V226, P271, DOI 10.1111/j.1365-2796.1989.tb01393.x; DARNFORS C, 1989, ATHEROSCLEROSIS, V75, P183, DOI 10.1016/0021-9150(89)90175-5; FAGER G, 1981, ARTERIOSCLEROSIS, V1, P273, DOI 10.1161/01.ATV.1.4.273; GAGNE C, 1979, ATHEROSCLEROSIS, V34, P13, DOI 10.1016/0021-9150(79)90101-1; Goldstein J.L., 1989, METABOLIC BASIS INHE, P1215; GURAKAR A, 1985, ATHEROSCLEROSIS, V57, P293, DOI 10.1016/0021-9150(85)90041-3; GUYTON JR, 1985, ARTERIOSCLEROSIS, V5, P265, DOI 10.1161/01.ATV.5.3.265; HEIBERG A, 1977, BRIT MED J, V2, P493, DOI 10.1136/bmj.2.6085.493; HIROBE K, 1982, ATHEROSCLEROSIS, V44, P201, DOI 10.1016/0021-9150(82)90114-9; ILLINGWORTH RD, 1989, ARTERIOSCLEROSIS, V9; KEMPLER F, 1980, J CLIN INVEST, V65, P1483; MORRISETT JD, 1987, PLASMA LIPOPROTEINS, P129; NIKKILA EA, 1973, LANCET, V1, P954; RHOADS GG, 1986, JAMA-J AM MED ASSOC, V256, P2540, DOI 10.1001/jama.256.18.2540; RUSSEL DW, 1989, ARTERIOSCLEROSIS, V9; SHRIEWAR H, 1984, J CLIN CHEM CLIN BIO, V22, P591; STONE NJ, 1974, CIRCULATION, V49, P476, DOI 10.1161/01.CIR.49.3.476; STREJA D, 1978, METABOLISM, V35, P311; THIERY J, 1988, KLIN WOCHENSCHR, V66, P462, DOI 10.1007/BF01745519; THOMPSON GR, 1989, ARTERIOSCLEROSIS, V9; UTERMANN G, 1989, P NATL ACAD SCI USA, V86, P4171, DOI 10.1073/pnas.86.11.4171; UTERMANN G, 1987, J CLIN INVEST, V80, P458, DOI 10.1172/JCI113093; UTERMANN G, 1988, HUM GENET, V78, P41, DOI 10.1007/BF00291232; VESSBY B, 1982, ATHEROSCLEROSIS, V44, P61, DOI 10.1016/0021-9150(82)90053-3; WIKLUND O, 1980, ATHEROSCLEROSIS, V37, P47, DOI 10.1016/0021-9150(80)90092-1; WIKLUND O, IN PRESS J INTERN ME	31	204	205	0	6	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JUN 9	1990	335	8702					1360	1363		10.1016/0140-6736(90)91242-3	http://dx.doi.org/10.1016/0140-6736(90)91242-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH145	1971660				2022-12-24	WOS:A1990DH14500003
J	UMETSU, DT; MOSS, RB; KING, VV; LEWISTON, NJ				UMETSU, DT; MOSS, RB; KING, VV; LEWISTON, NJ			SINUS DISEASE IN PATIENTS WITH SEVERE CYSTIC-FIBROSIS - RELATION TO PULMONARY EXACERBATION	LANCET			English	Article									CHILDRENS HOSP STANFORD,DIV ALLERGY & PULM DIS,PALO ALTO,CA 94304; STANFORD UNIV,MED CTR,SCH MED,DEPT OTOLARYNGOL,STANFORD,CA 94305	Stanford University	UMETSU, DT (corresponding author), STANFORD UNIV,MED CTR,SCH MED,DEPT PEDIAT,RM S380,STANFORD,CA 94305, USA.		Moss, Richard B./S-9218-2019	Moss, Richard B./0000-0003-3611-4221				GHARIB R, 1964, AM J DIS CHILD, V108, P499, DOI 10.1001/archpedi.1964.02090010501009; KULCZYCKI LL, 1970, CLIN PEDIATR, V9, P390, DOI 10.1177/000992287000900707; LEDESMAMEDINA J, 1984, PEDIATR RADIOL, V9, P61; RACHELEFSKY GS, 1984, PEDIATRICS, V73, P526; SHAPIRO ED, 1982, J INFECT DIS, V146, P589, DOI 10.1093/infdis/146.5.589; SHAPIRO GG, 1985, PEDIATR INFECT DIS J, V4, pS55, DOI 10.1097/00006454-198511001-00003; SHWACHMAN H, 1962, PEDIATRICS, V30, P389; SLAVIN RG, 1980, J ALLERGY CLIN IMMUN, V66, P250, DOI 10.1016/0091-6749(80)90048-2; UMETSU DT, 1988, AM J ASTHMA ALLERGY, V1, P85; 1984, NIH DATA BOOK, P57; 1971, DIGEST HLTH STATISTI	11	61	64	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	MAY 5	1990	335	8697					1077	1078		10.1016/0140-6736(90)92642-U	http://dx.doi.org/10.1016/0140-6736(90)92642-U			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC568	1970379				2022-12-24	WOS:A1990DC56800012
J	WADE, AJ; MARBUT, MM; ROUND, JM				WADE, AJ; MARBUT, MM; ROUND, JM			MUSCLE-FIBER TYPE AND ETIOLOGY OF OBESITY	LANCET			English	Article									UNIV COLL & MIDDLESEX SCH MED,DEPT CHEM PATHOL,LONDON,ENGLAND	University of London; University College London	WADE, AJ (corresponding author), UNIV LONDON LONDON HOSP,COLL MED,DEPT PHYSIOL,TURNER ST,LONDON E1 2AD,ENGLAND.		Wade, Amy/GSO-1924-2022; Wade, Amy/GSN-9485-2022					BAILEY N, 1962, STATISTICAL METHODS; BERGH U, 1978, MED SCI SPORT EXER, V10, P151; BERGSTROM J, 1962, SCAND J CLIN INV S68, V14, P12; BROOKE MH, 1970, ARCH NEUROL-CHICAGO, V23, P369, DOI 10.1001/archneur.1970.00480280083010; FRIDEN J, 1984, EUR J APPL PHYSIOL O, V52, P266, DOI 10.1007/BF01015207; GOLLNICK PD, 1972, J APPL PHYSIOL, V33, P312, DOI 10.1152/jappl.1972.33.3.312; HOLLOSZY JO, 1984, J APPL PHYSIOL, V56, P831, DOI 10.1152/jappl.1984.56.4.831; JACKSON AS, 1985, PHYSICIAN SPORTSMED, V13, P76, DOI 10.1080/00913847.1985.11708790; NOBLE BJ, 1983, MED SCI SPORT EXER, V15, P523; ROUND JM, 1982, J CLIN PATHOL, V35, P620, DOI 10.1136/jcp.35.6.620; SIRI WE, 1961, NAT ACAD SCI NAT RES; STARON RS, 1984, J HISTOCHEM CYTOCHEM, V32, P146, DOI 10.1177/32.2.6229571; WADE AJ, 1986, J PHYSIOL-LONDON, V381, pP12	13	223	226	0	17	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	APR 7	1990	335	8693					805	808		10.1016/0140-6736(90)90933-V	http://dx.doi.org/10.1016/0140-6736(90)90933-V			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY371	1969558				2022-12-24	WOS:A1990CY37100001
J	MACDOUGALL, IC; LEWIS, NP; SAUNDERS, MJ; COCHLIN, DL; DAVIES, ME; HUTTON, RD; FOX, KAA; COLES, GA; WILLIAMS, JD				MACDOUGALL, IC; LEWIS, NP; SAUNDERS, MJ; COCHLIN, DL; DAVIES, ME; HUTTON, RD; FOX, KAA; COLES, GA; WILLIAMS, JD			LONG-TERM CARDIORESPIRATORY EFFECTS OF AMELIORATION OF RENAL ANEMIA BY ERYTHROPOIETIN	LANCET			English	Article									CARDIFF ROYAL INFIRM, DEPT HAEMATOL, CARDIFF CF2 1SZ, S GLAM, WALES; CARDIFF ROYAL INFIRM, DEPT RADIOL, CARDIFF CF2 1SZ, S GLAM, WALES; UNIV HOSP WALES, DEPT CARDIOL, CARDIFF, WALES; LLANDOUGH HOSP, DEPT RESP MED, PENARTH GP6 1XX, S GLAM, WALES	Cardiff Royal Infirmary; Cardiff Royal Infirmary; Cardiff University	MACDOUGALL, IC (corresponding author), CARDIFF ROYAL INFIRM, INST NEPHROL, CARDIFF CF2 1SZ, S GLAM, WALES.		Fox, keith A A/I-3742-2013	Fox, Keith/0000-0002-0140-2752				COTES JE, 1972, CLIN SCI, V42, P325, DOI 10.1042/cs0420325; DEGOULET P, 1982, NEPHRON, V31, P103, DOI 10.1159/000182627; DEVEREUX RB, 1977, CIRCULATION, V55, P613, DOI 10.1161/01.CIR.55.4.613; DEVEREUX RB, 1984, AM J CARDIOL, V54, P592, DOI 10.1016/0002-9149(84)90255-8; DUKE M, 1969, CIRCULATION, V39, P503, DOI 10.1161/01.CIR.39.4.503; HIMELMAN RB, 1988, J AM COLL CARDIOL, V12, P915, DOI 10.1016/0735-1097(88)90454-8; HUTING J, 1988, NEPHRON, V49, P284, DOI 10.1159/000185077; Kramer W, 1986, Contrib Nephrol, V52, P97; LIPKIN DP, 1987, BRIT HEART J, V58, P559; LONDON GM, 1989, KIDNEY INT, V36, P878, DOI 10.1038/ki.1989.274; LOW I, 1989, CLIN NEPHROL, V31, P26; LUNDIN AP, 1989, SEMIN NEPHROL, V9, P22; MACDOUGALL IC, 1989, NEPHROL DIAL TRANSPL, V4, P319; MATSUMURA N, 1983, CIRCULATION, V68, P360, DOI 10.1161/01.CIR.68.2.360; MAYER G, 1988, KIDNEY INT, V34, P525, DOI 10.1038/ki.1988.213; MAYER G, 1989, CLIN SCI, V76, P265, DOI 10.1042/cs0760265; MAYER G, 1989, KIDNEY INT, V35, P316; NEFF MS, 1971, CIRCULATION, V43, P876, DOI 10.1161/01.CIR.43.6.876; Nonnast-Daniel B, 1988, Contrib Nephrol, V66, P185; RAINE AEG, 1988, LANCET, V1, P97; RAINE AEG, 1984, KIDNEY TRANSPLANTATI, P469; RICHARDSON TQ, 1959, AM J PHYSIOL, V197, P1167, DOI 10.1152/ajplegacy.1959.197.6.1167; ROSTAND SG, 1979, KIDNEY INT, V16, P600, DOI 10.1038/ki.1979.170; SCHAEFER RM, 1988, AM J NEPHROL, V8, P449, DOI 10.1159/000167652; SILBERBERG JS, 1989, KIDNEY INT, V36, P286, DOI 10.1038/ki.1989.192; TAYLOR HL, 1955, J APPL PHYSIOL, V8, P73, DOI 10.1152/jappl.1955.8.1.73	26	227	229	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 3	1990	335	8688					489	493		10.1016/0140-6736(90)90733-L	http://dx.doi.org/10.1016/0140-6736(90)90733-L			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT015	1968526				2022-12-24	WOS:A1990CT01500001
J	DIMOPOULOS, MA; BARLOGIE, B; SMITH, TL; ALEXANIAN, R				DIMOPOULOS, MA; BARLOGIE, B; SMITH, TL; ALEXANIAN, R			HIGH SERUM LACTATE-DEHYDROGENASE LEVEL AS A MARKER FOR DRUG-RESISTANCE AND SHORT SURVIVAL IN MULTIPLE-MYELOMA	ANNALS OF INTERNAL MEDICINE			English	Article							PROGNOSTIC FACTORS; STAGING SYSTEM; BETA-2-MICROGLOBULIN; MICROGLOBULIN; LYMPHOMA	Objective: To evaluate serum lactate dehydrogenase (LDH) as a prognostic factor in previously untreated patients with multiple myeloma. Design: Study of 391 consecutive patients with uniformly treated multiple myeloma, followed until death in 63% of patients. Setting: Tertiary, referral cancer center. Patients: A total of 391 consecutive, previously untreated, symptomatic patients with various stages of multiple myeloma. Intervention: Various chemotherapy regimens that included doxorubicin or glucocorticoids, or both, with a consistent response rate (53%). Measurements: Outcomes included clinical response based on a 75% reduction of calculated tumor load and survival time from treatment. Univariate and multivariate analyses were used. Main Results: Eleven percent of patients showed a high serum LDH level of more than 5.0-mu-kat/L (300 U/L). An elevated LDH level was seen more frequently with a rise in the tumor load; an increased level was present in 26% of patients with high tumor mass. A high LDH level was associated with plasma cell leukemia or lymphoma-like clinical features (43%) and with plasma cell hypodiploidy (17%). Only 20% of patients with elevated LDH levels responded to chemotherapy compared with a response rate of 57% for patients with low levels of LDH. Using multivariate analysis, LDH was a significant independent predictor of response (P = 0.001), with an odds ratio of 0.25 (95% Cl, 0.11 to 0.57). A high LDH level was associated with a short median survival (9 months) and showed the highest relative risk (2.63; Cl, 1.75 to 3.95; P = 0.001). Conclusions: Elevation of the LDH level suggests the presence of occult extraosseous disease and high tumor mass. The LDH level is a predictor of a poor prognosis in selected patients who should be considered for early intensive treatment.	UNIV TEXAS, MD ANDERSON CANC CTR, BOX 1, 1515 HOLCOMBE BLVD, HOUSTON, TX 77030 USA	University of Texas System; UTMD Anderson Cancer Center			Dimopoulos, Meletios Athanasios/AAD-4130-2019	Dimopoulos, Meletios/0000-0001-8990-3254	NATIONAL CANCER INSTITUTE [R01CA037161, R01CA028771, P30CA016672] Funding Source: NIH RePORTER; NCI NIH HHS [CA-28771, CA-16672, CA-37161] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ALEXANIAN R, 1975, CANCER, V36, P1192, DOI 10.1002/1097-0142(197510)36:4<1192::AID-CNCR2820360403>3.0.CO;2-I; ALEXANIAN R, 1990, AM J HEMATOL, V33, P86, DOI 10.1002/ajh.2830330203; ALEXANIAN R, 1985, AM J HEMATOL, V20, P345, DOI 10.1002/ajh.2830200405; BARLOGIE B, 1989, ANN INTERN MED, V110, P521, DOI 10.7326/0003-4819-110-7-521; BARLOGIE B, 1985, BLOOD, V66, P338; BARLOGIE B, 1989, J CLIN ONCOL, V7, P1514, DOI 10.1200/JCO.1989.7.10.1514; Cox, 1970, ANAL BINARY DATA, P87; COX DR, 1972, J R STAT SOC B, V34, P187; DALTON WS, 1989, J CLIN ONCOL, V7, P415, DOI 10.1200/JCO.1989.7.4.415; DURIE BGM, 1990, BLOOD, V75, P823; DURIE BGM, 1975, CANCER, V36, P842, DOI 10.1002/1097-0142(197509)36:3<842::AID-CNCR2820360303>3.0.CO;2-U; GOLDIE JH, 1983, CANCER TREAT REP, V67, P923; GOULD J, 1988, BLOOD, V71, P453; GREIPP PR, 1988, BLOOD, V72, P219; JAGANNATH S, 1990, BLOOD, V76, P1860; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; SALMON SE, 1978, NEW ENGL J MED, V298, P1321, DOI 10.1056/NEJM197806152982401; SIMONSSON B, 1987, EUR J CLIN INVEST, V17, P336, DOI 10.1111/j.1365-2362.1987.tb02197.x; SWAN F, 1989, J CLIN ONCOL, V7, P1518, DOI 10.1200/JCO.1989.7.10.1518; [No title captured]	20	152	155	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 15	1991	115	12					931	935		10.7326/0003-4819-115-12-931	http://dx.doi.org/10.7326/0003-4819-115-12-931			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU417	1952489				2022-12-24	WOS:A1991GU41700003
J	MILLER, EK; LI, L; DESIMONE, R				MILLER, EK; LI, L; DESIMONE, R			A NEURAL MECHANISM FOR WORKING AND RECOGNITION MEMORY IN INFERIOR TEMPORAL CORTEX	SCIENCE			English	Article							STATE DEPENDENT ACTIVITY; MONKEY VISUAL-CORTEX; SHORT-TERM; RESPONSES; NEURONS; TASKS; V4	Inferior temporal (IT) cortex is critical for visual memory, but it is not known how IT neurons retain memories while new information is streaming into the visual system. Single neurons were therefore recorded from IT cortex of two rhesus monkeys performing tasks that required them to hold items in memory while concurrently viewing other items. The neuronal response to an incoming visual stimulus was attenuated if it matched a stimulus actively held in working memory, even when several other stimuli intervened. The neuronal response to novel stimuli declined as the stimuli became familiar to the animal. IT neurons appear to function as adaptive mnemonic "filters" that preferentially pass information about new, unexpected, or not recently seen stimuli.	NIMH,NEUROPSYCHOL LAB,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH)			Miller, Earl K./AAE-8187-2019; Desimone, Robert/G-1121-2018	Miller, Earl K./0000-0002-0582-6958; 				BAYLIS GC, 1987, EXP BRAIN RES, V65, P614; CARPENTER GA, 1990, NEURAL NETWORKS, V3, P129, DOI 10.1016/0893-6080(90)90085-Y; ESKANDAR EN, 1991, INVEST OPHTH VIS SCI, V32, P1036; FUSTER JM, 1982, J NEUROSCI, V2, P361; GAFFAN D, 1980, BRAIN RES, V196, P373, DOI 10.1016/0006-8993(80)90402-3; GROSS CG, 1972, J NEUROPHYSIOL, V35, P96, DOI 10.1152/jn.1972.35.1.96; HAENNY PE, 1988, EXP BRAIN RES, V69, P225, DOI 10.1007/BF00247569; HAENNY PE, 1988, EXP BRAIN RES, V69, P245, DOI 10.1007/BF00247570; HOREL JA, 1984, BEHAV NEUROSCI, V98, P310, DOI 10.1037/0735-7044.98.2.310; Hosmer D., 2000, APPL LOGISTIC REGRES, V2; Kohonen Teuvo, 1984, SELF ORG ASS MEMORY; MIKAMI A, 1980, BRAIN RES, V182, P65, DOI 10.1016/0006-8993(80)90830-6; MILLER EK, IN PRESS VIS NEUROSC; MISHKIN M, 1982, PHILOS T R SOC LONDO, V85, P95; MIYASHITA Y, 1988, NATURE, V331, P68, DOI 10.1038/331068a0; RICHES IP, 1991, J NEUROSCI, V11, P1763; ROLLS ET, 1989, EXP BRAIN RES, V76, P153; SQUIRE L, 1991, Society for Neuroscience Abstracts, V17, P4	18	507	514	1	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 29	1991	254	5036					1377	1379		10.1126/science.1962197	http://dx.doi.org/10.1126/science.1962197			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR777	1962197				2022-12-24	WOS:A1991GR77700056
J	BRENNAN, TA; LEAPE, LL; LAIRD, NM; HEBERT, L; LOCALIO, AR; LAWTHERS, AG; NEWHOUSE, JP; WEILER, PC; HIATT, HH				BRENNAN, TA; LEAPE, LL; LAIRD, NM; HEBERT, L; LOCALIO, AR; LAWTHERS, AG; NEWHOUSE, JP; WEILER, PC; HIATT, HH			INCIDENCE OF ADVERSE EVENTS AND NEGLIGENCE IN HOSPITALIZED-PATIENTS - RESULTS OF THE HARVARD MEDICAL-PRACTICE STUDY-I	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MALPRACTICE	Background. As part of an interdisciplinary study of medical injury and malpractice litigation, we estimated the incidence of adverse events, defined as injuries caused by medical management, and of the subgroup of such injuries that resulted from negligent or substandard care. Methods. We reviewed 30, 121 randomly selected records from 51 randomly selected acute care, nonpsychiatric hospitals in New York State in 1984. We then developed population estimates of injuries and computed rates according to the age and sex of the patients as well as the specialties of the physicians. Results. Adverse events occurred in 3.7 percent of the hospitalizations (95 percent confidence interval, 3.2 to 4.2), and 27.6 percent of the adverse events were due to negligence (95 percent confidence interval, 22.5 to 32.6). Although 70.5 percent of the adverse events gave rise to disability lasting less than six months, 2.6 percent caused permanently disabling injuries and 13.6 percent led to death. The percentage of adverse events attributable to negligence increased in the categories of more severe injuries (Wald test chi-2 = 21.04, P < 0.0001). Using weighted totals, we estimated that among the 2,671,863 patients discharged from New York hospitals in 1984 there were 98,609 adverse events and 27,179 adverse events involving negligence. Rates of adverse events rose with age (P < 0.0001). The percentage of adverse events due to negligence was markedly higher among the elderly (P < 0.01). There were significant differences in rates of adverse events among categories of clinical specialties (P < 0.0001), but no differences in the percentage due to negligence. Conclusions. There is a substantial amount of injury to patients from medical management, and many injuries are the result of substandard care.	HARVARD UNIV,SCH PUBL HLTH,DEPT HLTH POLICY & MANAGEMENT,BOSTON,MA 02115; HARVARD UNIV,SCH PUBL HLTH,DEPT BIOSTAT,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT HLTH CARE POLICY,BOSTON,MA 02115; HARVARD UNIV,JOHN F KENNEDY SCH GOVT,CAMBRIDGE,MA 02138; HARVARD UNIV,SCH LAW,CAMBRIDGE,MA 02138	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Harvard University; Harvard University	BRENNAN, TA (corresponding author), BRIGHAM & WOMENS HOSP,DIV GEN MED,75 FRANCIS ST,BOSTON,MA 02115, USA.		Newhouse, Joseph/AGJ-5632-2022					BRENNAN TA, 1990, ANN INTERN MED, V112, P221, DOI 10.7326/0003-4819-112-3-221; BRENNAN TA, 1989, MED CARE, V27, P1148, DOI 10.1097/00005650-198912000-00006; BRENNAN TA, IN PRESS JUST DOCTOR; COUCH NP, 1981, NEW ENGL J MED, V304, P634, DOI 10.1056/NEJM198103123041103; HIATT HH, 1989, NEW ENGL J MED, V321, P480, DOI 10.1056/NEJM198908173210725; NADER R, 1987, GONZAGA LAW REV, V22, P15; PEAR T, 1990, NY TIMES        0923, P1; PRIEST, 1987, VAL UL REV, V22, P1; ROBINSON GO, 1986, LAW CONTEMP PROBL, V49, P5, DOI 10.2307/1191413; SHAH BV, 1981, SESUDAAN STANDARD ER; SIEGEL DR, 1986, NEW YORK STATE J MED, V86, P377; STEEL K, 1981, NEW ENGL J MED, V304, P638, DOI 10.1056/NEJM198103123041104; 1986, GAO HRD86112 GEN ACC; 1985, STATEWIDE PLANNING R; 1987, DHHS19041270133 DEP; 1977, REPORT MED INSURANCE; 1986, GAO HRD8755 GEN ACC; 1987, PRELIMINARY FACT FIN; 1986, GAO HRD8721 GEN ACC; 1990, PATIENTS DOCTORS LAW	20	2979	3075	0	67	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 7	1991	324	6					370	376		10.1056/NEJM199102073240604	http://dx.doi.org/10.1056/NEJM199102073240604			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EW296	1987460				2022-12-24	WOS:A1991EW29600004
J	FINGERHUT, MA; HALPERIN, WE; MARLOW, DA; PIACITELLI, LA; HONCHAR, PA; SWEENEY, MH; GREIFE, AL; DILL, PA; STEENLAND, K; SURUDA, AJ				FINGERHUT, MA; HALPERIN, WE; MARLOW, DA; PIACITELLI, LA; HONCHAR, PA; SWEENEY, MH; GREIFE, AL; DILL, PA; STEENLAND, K; SURUDA, AJ			CANCER MORTALITY IN WORKERS EXPOSED TO 2,3,7,8-TETRACHLORODIBENZO-PARA-DIOXIN	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							SOFT-TISSUE SARCOMA; NON-HODGKINS LYMPHOMA; PHENOXYACETIC ACIDS; MALIGNANT-LYMPHOMA; ORGANIC-SOLVENTS; CHEMICAL WORKERS; COHORT MORTALITY; CASE-REFERENT; CHLOROPHENOLS; PROMOTION	Background. In both animal and epidemiologic studies, exposure to dioxin (2,3,7,8-tetrachlorodibenzo-p-dioxin, or TCDD) has been associated with an increased risk of cancer. Methods. We conducted a retrospective cohort study of mortality among the 5172 workers at 12 plants in the United States that produced chemicals contaminated with TCDD. Occupational exposure was documented by reviewing job descriptions and by measuring TCDD in serum from a sample of 253 workers. Causes of death were taken from death certificates. Results. Mortality from several cancers previously associated with TCDD (stomach, liver, and nasal cancers, Hodgkin's disease, and non-Hodgkin's lymphoma) was not significantly elevated in this cohort. Mortality from soft-tissue sarcoma was increased, but not significantly (4 deaths; standardized mortality ratio [SMR], 338; 95 percent confidence interval, 92 to 865). In the subcohort of 1520 workers with greater-than-or-equal-to 1 year of exposure and greater-than-or-equal-to 20 years of latency, however, mortality was significantly increased for soft-tissue sarcoma (3 deaths; SMR, 922;95 percent confidence interval, 190 to 2695) and for cancers of the respiratory system (SMR, 142; 95 percent confidence interval, 103 to 192). Mortality from all cancers combined was slightly but significantly elevated in the overall cohort (SMR, 115; 95 percent confidence interval, 102 to 130) and was higher in the subcohort with greater-than-or-equal-to 1 year of exposure and greater-than-or-equal-to 20 years of latency (SMR, 146; 95 percent confidence interval, 121 to 176). Conclusions. This study of mortality among workers with occupational exposure to TCDD does not confirm the high relative risks reported for many cancers in previous studies. Conclusions about an increase in the risk of soft-tissue sarcoma are limited by small numbers and misclassification on death certificates. Excess mortality from all cancers combined, cancers of the respiratory tract, and soft-tissue sarcoma may result from exposure to TCDD, although we cannot exclude the possible contribution of factors such as smoking and occupational exposure to other chemicals.			FINGERHUT, MA (corresponding author), CTR DIS CONTROL, DIV SURVEILLANCE HAZARD EVALUAT & FIELD STUDIES, IND WIDE STUDIES BRANCH, CINCINNATI, OH 45226 USA.							AXELSON O, 1978, SCAND J WORK ENV HEA, V4, P98, DOI 10.5271/sjweh.2720; AXELSON O, 1980, SCAND J WORK ENV HEA, V6, P73, DOI 10.5271/sjweh.2631; ERIKSSON M, 1981, BRIT J IND MED, V38, P27; ERIKSSON M, 1990, J NATL CANCER I, V82, P486, DOI 10.1093/jnci/82.6.486; ESPOSITO M, 1980, EPA600280197 PUBL; FINGERHUT M, 1990, PB91125971; FINGERHUT MA, 1984, SCAND J WORK ENV HEA, V10, P299, DOI 10.5271/sjweh.2325; FOX AJ, 1976, BRIT J PREV SOC MED, V30, P225; HARDELL L, 1979, BRIT J CANCER, V39, P711, DOI 10.1038/bjc.1979.125; HARDELL L, 1984, BRIT J CANCER, V50, P389, DOI 10.1038/bjc.1984.188; HARDELL L, 1981, BRIT J CANCER, V43, P169, DOI 10.1038/bjc.1981.25; HARDELL L, 1988, CANCER, V62, P652, DOI 10.1002/1097-0142(19880801)62:3<652::AID-CNCR2820620334>3.0.CO;2-4; HARDELL L, 1983, BRIT J CANCER, V48, P217, DOI 10.1038/bjc.1983.177; HARDELL L, 1982, American Journal of Industrial Medicine, V3, P247, DOI 10.1002/ajim.4700030304; KOCIBA RJ, 1978, TOXICOL APPL PHARM, V46, P279, DOI 10.1016/0041-008X(78)90075-3; MONSON RR, 1990, OCCUPATIONAL EPIDEMI, P100; OLSEN JH, 1984, LANCET, V2, P47; OTT MG, 1987, J OCCUP ENVIRON MED, V29, P422; PATTERSON DG, 1989, AM J IND MED, V16, P135, DOI 10.1002/ajim.4700160205; PEARCE NE, 1987, INT J CANCER, V39, P155, DOI 10.1002/ijc.2910390206; PERCY C, 1981, AM J PUBLIC HEALTH, V71, P242, DOI 10.2105/AJPH.71.3.242; PERSSON B, 1989, BRIT J IND MED, V46, P516; PITOT HC, 1980, CANCER RES, V40, P3616; POLAND A, 1982, NATURE, V300, P271, DOI 10.1038/300271a0; RAO MS, 1988, CARCINOGENESIS, V9, P1677, DOI 10.1093/carcin/9.9.1677; ROTHMAN KJ, 1979, DHEW NIH791649 PUBL, P30; ROTHMAN KJ, 1986, MODERN EPIDEMIOLOGY, P229; SIEMIATYCKI J, 1988, J OCCUP ENVIRON MED, V30, P617, DOI 10.1097/00043764-198808000-00004; SMITH AH, 1984, J NATL CANCER I, V73, P1111; STEENLAND K, 1990, J OCCUP ENVIRON MED, V32, P1091, DOI 10.1097/00043764-199011000-00008; STEENLAND K, 1984, SCAND J WORK ENV HEA, V10, P143, DOI 10.5271/sjweh.2349; SUIT HD, 1978, CA-CANCER J CLIN, V28, P284, DOI 10.3322/canjclin.28.5.284; SUSKIND RR, 1984, JAMA-J AM MED ASSOC, V251, P2372, DOI 10.1001/jama.251.18.2372; SWEENEY MH, 1989, CHEMOSPHERE, V19, P973, DOI 10.1016/0045-6535(89)90443-8; THIESS A M, 1982, American Journal of Industrial Medicine, V3, P179, DOI 10.1002/ajim.4700030209; WIKLUND K, 1987, BRIT J CANCER, V56, P505, DOI 10.1038/bjc.1987.234; WIKLUND K, 1986, J NATL CANCER I, V76, P229; WIKLUND K, 1984, BRIT J CANCER, V2, P47; WOODS JS, 1987, J NATL CANCER I, V78, P899; ZACK JA, 1980, J OCCUP ENVIRON MED, V22, P11, DOI 10.1097/00043764-198001000-00005; Zack Judith A., 1983, HUMAN ENV RISKS CHLO, P575; ZOBER A, 1990, INT ARCH OCC ENV HEA, V62, P139, DOI 10.1007/BF00383591; 1977, INT CLASSIFICATION D; 1982, DHHS NIH821765 PUBL	44	467	476	0	32	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 24	1991	324	4					212	218		10.1056/NEJM199101243240402	http://dx.doi.org/10.1056/NEJM199101243240402			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU022	1985242				2022-12-24	WOS:A1991EU02200002
J	MOSER, M; BLAUFOX, MD; FREIS, E; GIFFORD, RW; KIRKENDALL, W; LANGFORD, H; SHAPIRO, A; SHEPS, S				MOSER, M; BLAUFOX, MD; FREIS, E; GIFFORD, RW; KIRKENDALL, W; LANGFORD, H; SHAPIRO, A; SHEPS, S			WHO REALLY DETERMINES YOUR PATIENTS PRESCRIPTIONS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							FOLLOW-UP; HYPERTENSION; DIURETICS; GLUCOSE; LIPIDS; TRIAL		YALE UNIV,SCH MED,DEPT MED,NEW HAVEN,CT 06510; YESHIVA UNIV ALBERT EINSTEIN COLL MED,DEPT MED,BRONX,NY 10461; VET ADM,WASHINGTON,DC 20420; CLEVELAND CLIN EDUC FDN,CLEVELAND,OH 44106; UNIV TEXAS,HLTH SCI CTR,HOUSTON,TX 77225; UNIV MISSISSIPPI,MED CTR,SCH MED,JACKSON,MS 39216; UNIV PITTSBURGH,SCH MED,PITTSBURGH,PA 15261; MAYO CLIN & MAYO FDN,ROCHESTER,MN 55905	Yale University; Yeshiva University; Albert Einstein College of Medicine; Cleveland Clinic Foundation; University of Texas System; University of Texas Health Science Center Houston; University of Mississippi; University of Mississippi Medical Center; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Mayo Clinic			Blaufox, MDonald/AAF-6965-2020	Blaufox, MDonald/0000-0002-4148-6866				AMES RP, 1986, DRUGS, V32, P260, DOI 10.2165/00003495-198632030-00003; [Anonymous], 1981, LANCET, V2, P539; COLLINS R, 1990, LANCET, V335, P827, DOI 10.1016/0140-6736(90)90944-Z; CURB JD, 1986, PROG CARDIOVASC DIS, V29, P73; EDELSON JT, 1990, JAMA-J AM MED ASSOC, V263, P407, DOI 10.1001/jama.263.3.407; FREIS ED, 1989, ARCH INTERN MED, V149, P2649; GREENBERG G, 1984, AM J MED, V76, P45, DOI 10.1016/0002-9343(84)90956-2; MACMAHON S, 1989, HYPERTENSION S1, V13, P145; MOSER M, 1989, CARDIOVASC DRUG THER, V3, P743, DOI 10.1007/BF01857624; MOSER M, 1989, AM HEART J, V118, P1362, DOI 10.1016/0002-8703(89)90059-8; MOSER M, 1985, J HYPERTENS, V3, P437; MOSER M, 1989, AM FAM PHYSICIAN, V40, P213; MURPHY MB, 1982, LANCET, V2, P1293; PARVING HH, 1987, BRIT MED J, V294, P1443, DOI 10.1136/bmj.294.6585.1443; POLLARE T, 1989, NEW ENGL J MED, V321, P868, DOI 10.1056/NEJM198909283211305; SHAPIRO AP, 1961, NEW ENGL J MED, V265, P1028, DOI 10.1056/NEJM196111232652102; SHEKELLE RB, 1984, ATHER REV, V12, P113; 1980, LANCET, V1, P1261; 1985, AM J CARDIOL, V56, P913; 1979, JAMA-J AM MED ASSOC, V242, P2562; 1980, AM J MED, V69, P725; 1988, JAMA-J AM MED ASSOC, V259, P2113; 1990, CIRCULATION, V82, P1616; 1985, JAMA-J AM MED ASSOC, V291, P97; 1985, LANCET, V1, P1349; 1982, JAMA-J AM MED ASSOC, V248, P1996	26	30	30	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 23	1991	265	4					498	500		10.1001/jama.265.4.498	http://dx.doi.org/10.1001/jama.265.4.498			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ET377	1985236				2022-12-24	WOS:A1991ET37700031
J	RAUB, W				RAUB, W			TAMOXIFEN AND CHEMOTHERAPY MORE EFFECTIVE THAN TAMOXIFEN ALONE IN TREATING BREAST-CANCER	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material											RAUB, W (corresponding author), NIH, BLDG 31, ROOM 2B23, BETHESDA, MD 20892 USA.							1990, J CLIN ONCOL, V8, P1005	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	1991	265	1					19	19						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP555	1984118				2022-12-24	WOS:A1991EP55500007
J	BRAHAMS, D				BRAHAMS, D			DUTY OF CARE TO UNBORN CHILD	LANCET			English	Editorial Material																			0	2	2	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 22	1990	336	8730					1572	1572		10.1016/0140-6736(90)93335-M	http://dx.doi.org/10.1016/0140-6736(90)93335-M			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP037	1979383				2022-12-24	WOS:A1990EP03700021
J	MARSDEN, PD				MARSDEN, PD			LETTER FROM BRASILIA - YELLOW-FEVER	BRITISH MEDICAL JOURNAL			English	Editorial Material											MARSDEN, PD (corresponding author), UNIV BRASILIA,CP 153127,BR-70010 BRASILIA,DF,BRAZIL.							PORTERFIELD J, 1989, BR MED J, V299	1	0	0	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	DEC 15	1990	301	6765					1382	1383		10.1136/bmj.301.6765.1382	http://dx.doi.org/10.1136/bmj.301.6765.1382			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EN919	1980221	Bronze, Green Published			2022-12-24	WOS:A1990EN91900030
J	RES, PCM; TELGT, D; VANLAAR, JM; POOL, MO; BREEDVELD, FC; DEVRIES, RRP				RES, PCM; TELGT, D; VANLAAR, JM; POOL, MO; BREEDVELD, FC; DEVRIES, RRP			HIGH ANTIGEN REACTIVITY IN MONONUCLEAR-CELLS FROM SITES OF CHRONIC INFLAMMATION	LANCET			English	Article									STATE UNIV LEIDEN HOSP, DEPT RHEUMATOL, 2333 AA LEIDEN, NETHERLANDS; FREE UNIV AMSTERDAM HOSP, DEPT INTERNAL MED, AMSTERDAM, NETHERLANDS	Leiden University; Leiden University Medical Center (LUMC); Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	RES, PCM (corresponding author), UNIV HOSP LEIDEN, DEPT IMMUNOHAEMATOL & BLOOD BANK, BLDG 1 E3-Q, POSTBUS 9600, 2300 RC LEIDEN, NETHERLANDS.							DAUPHINEE MJ, 1989, J AUTOIMMUN, V2, P813, DOI 10.1016/0896-8411(89)90007-3; GASTON JSH, 1989, J IMMUNOL, V143, P2494; HARDING B, 1986, CLIN EXP IMMUNOL, V63, P594; HOLOSHITZ J, 1983, SCIENCE, V219, P56, DOI 10.1126/science.6336851; HOLOSHITZ J, 1986, LANCET, V2, P305; KLUINNELEMANS HC, 1984, J RHEUMATOL, V11, P272; KOSTER FT, 1971, J EXP MED, V133, P400, DOI 10.1084/jem.133.2.400; KOSTER FT, 1971, J EXP MED, V133, P864, DOI 10.1084/jem.133.4.864; LIFE PF, 1990, CLIN EXP IMMUNOL, V79, P189; PITZALIS C, 1988, EUR J IMMUNOL, V18, P1397, DOI 10.1002/eji.1830180915; RES PCM, 1988, LANCET, V2, P478, DOI 10.1016/S0140-6736(88)90123-7; ROSENSTREICH DL, 1971, J EXP MED, V134, P1170, DOI 10.1084/jem.134.5.1170; SANDERS ME, 1988, IMMUNOL TODAY, V9, P195, DOI 10.1016/0167-5699(88)91212-1; THOLE JER, 1987, INFECT IMMUN, V55, P1466, DOI 10.1128/IAI.55.6.1466-1475.1987; VANDEPUTTE LBA, 1976, ANN RHEUM DIS, V35, P451, DOI 10.1136/ard.35.5.451; VANEDEN W, 1985, P NATL ACAD SCI USA, V82, P5117; VANEDEN W, 1988, NATURE, V331, P171, DOI 10.1038/331171a0; WAALEN K, 1987, CLIN EXP IMMUNOL, V70, P1; WERNET D, 1975, J EXP MED, V141, P573, DOI 10.1084/jem.141.3.573	19	55	55	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 8	1990	336	8728					1406	1408		10.1016/0140-6736(90)93104-W	http://dx.doi.org/10.1016/0140-6736(90)93104-W			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL851	1978874				2022-12-24	WOS:A1990EL85100007
J	REGAN, L; OWEN, EJ; JACOBS, HS				REGAN, L; OWEN, EJ; JACOBS, HS			HYPERSECRETION OF LUTEINIZING-HORMONE, INFERTILITY, AND MISCARRIAGE	LANCET			English	Article									ROSIE MATERN HOSP, DEPT OBSTET & GYNAECOL, CAMBRIDGE, ENGLAND; UNIV COLL & MIDDLESEX SCH MED, MIDDLESEX HOSP, COBBOLD LABS, LONDON W1, ENGLAND; ADDENBROOKES HOSP, DEPT OBSTET & GYNAECOL, CAMBRIDGE CB2 2QQ, ENGLAND	University of London; University College London; Addenbrooke's Hospital; University of Cambridge			Jacobs, Howard/A-9845-2009					ARMAR NA, 1990, FERTIL STERIL, V53, P45; Austin C.R., 1982, P46; BAKKER TG, REPRODUCTION MAMMA 1, P17; CONWAY GS, 1989, CLIN ENDOCRINOL, V30, P459, DOI 10.1111/j.1365-2265.1989.tb00446.x; EDEN JA, 1989, CLIN ENDOCRINOL, V30, P77, DOI 10.1111/j.1365-2265.1989.tb03729.x; EDEN JA, 1989, BRIT J OBSTET GYNAEC, V96, P809, DOI 10.1111/j.1471-0528.1989.tb03320.x; GUERREROV R, 1975, NEW ENGL J MED, V293, P573; HOMBURG R, 1990, HUM REPROD, V5, P32, DOI 10.1093/oxfordjournals.humrep.a137035; HOMBURG R, 1988, BRIT MED J, V297, P1024, DOI 10.1136/bmj.297.6655.1024; HOMBURG R, 1989, FERTIL STERIL, V51, P196; HOMBURG R, 1989, BRIT MED J, V298, P809, DOI 10.1136/bmj.298.6676.809; HOWLES CM, 1986, LANCET, V2, P521; HUNTER RHF, 1976, NATURE, V260, P156, DOI 10.1038/260156a0; JACOBS HS, 1990, CLIN ENDOCRINOLOGY M, V4, P195; POLSON DW, 1988, LANCET, V1, P870; PUNNONEN R, 1988, FERTIL STERIL, V49, P479; REGAN L, 1989, BRIT MED J, V299, P541, DOI 10.1136/bmj.299.6698.541; REIJNDERS FJL, 1988, BRIT J OBSTET GYNAEC, V95, P462, DOI 10.1111/j.1471-0528.1988.tb12797.x; SAGLE M, 1988, BMJ-BRIT MED J, V297, P1027, DOI 10.1136/bmj.297.6655.1027; SETH J, 1989, LANCET, V1, P671; SETH J, 1989, CLIN CHIM ACTA, V186, P67, DOI 10.1016/0009-8981(89)90205-2; SHEARMAN RP, 1963, BRIT MED J, P292; STANGER JD, 1985, BRIT J OBSTET GYNAEC, V92, P385, DOI 10.1111/j.1471-0528.1985.tb01113.x; THOMAS A, 1989, BRIT J OBSTET GYNAEC, V96, P1328, DOI 10.1111/j.1471-0528.1989.tb03232.x; Tsafriri A., 1988, P527; WALKER EM, 1988, BRIT J OBSTET GYNAEC, V95, P659, DOI 10.1111/j.1471-0528.1988.tb06526.x; WHITTAKER PG, 1989, BRIT J OBSTET GYNAEC, V96, P1207, DOI 10.1111/j.1471-0528.1989.tb03198.x; WILCOX AJ, 1988, NEW ENGL J MED, V319, P189, DOI 10.1056/NEJM198807283190401; 1977, ACTA OBSTEG GYNAECOL, V56, P247	29	370	383	0	11	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 10	1990	336	8724					1141	1144		10.1016/0140-6736(90)92765-A	http://dx.doi.org/10.1016/0140-6736(90)92765-A			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG701	1978024				2022-12-24	WOS:A1990EG70100001
J	SULLIVAN, SN				SULLIVAN, SN			HYPOTHESIS REVISITED - TOOTHPASTE AND THE CAUSE OF CROHNS-DISEASE	LANCET			English	Article											SULLIVAN, SN (corresponding author), VICTORIA HOSP,GASTROINTESTINAL UNIT,LONDON N6A 4G5,ONTARIO,CANADA.							BAXTER PM, 1980, BRIT DENT J, V148, P125, DOI 10.1038/sj.bdj.4804398; CALKINS BM, 1989, DIGEST DIS SCI, V34, P1841, DOI 10.1007/BF01536701; CHESS S, 1950, SURGERY, V27, P221; COFFEY RJ, 1938, MAYO CLIN P, V13, P541; KIRSNER JB, 1982, NEW ENGL J MED, V306, P837, DOI 10.1056/NEJM198204083061404; KIRSNER JB, 1988, J CLIN GASTROENTEROL, V10, P286, DOI 10.1097/00004836-198806000-00012; KORELITZ BI, 1982, AM J GASTROENTEROL, V77, P929; KOWITZ G, 1973, Journal of Oral Medicine, V28, P105; LASHNER BA, 1986, GASTROENTEROLOGY, V91, P1396, DOI 10.1016/0016-5085(86)90193-9; MAYBERRY JF, 1989, INT J COLORECTAL DIS, V4, P59, DOI 10.1007/BF01648555; MAYBERRY JF, 1984, GUT, V25, P886, DOI 10.1136/gut.25.8.886; MILLARD LG, 1973, BRIT MED J, V1, P676, DOI 10.1136/bmj.1.5854.676; MILLER WA, 1976, J PERIODONTOL, V47, P101, DOI 10.1902/jop.1976.47.2.101; PINCHBECK BR, 1988, J CLIN GASTROENTEROL, V10, P505, DOI 10.1097/00004836-198810000-00007; REICHERT FL, 1936, ANN SURG, V104, P606; REIMANN HA, 1964, JAMA-J AM MED ASSOC, V189, P195; REIMANN HA, 1966, AM J CARDIOL, V17, P269, DOI 10.1016/0002-9149(66)90362-6; ROTH MP, 1989, GASTROENTEROLOGY, V97, P900, DOI 10.1016/0016-5085(89)91495-9; VANDERWOERD LA, 1962, ACTA PHYSIOL PHARM N, V11, P133; 1982, ACCEPTED DENTAL THER, P369	20	42	43	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 3	1990	336	8723					1096	1097		10.1016/0140-6736(90)92572-Y	http://dx.doi.org/10.1016/0140-6736(90)92572-Y			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF992	1977982				2022-12-24	WOS:A1990EF99200006
J	CHANT, A				CHANT, A			TISSUE PRESSURE, POSTURE, AND VENOUS ULCERATION	LANCET			English	Editorial Material											CHANT, A (corresponding author), ROYAL S HANS HOSP,DEPT VASC SURG,GRAHAM RD,SOUTHAMPTON SO9 4PE,HANTS,ENGLAND.							Allen AJ, 1988, PHLEBOLOGY, V3, P163; BROWSE NL, 1982, LANCET, V2, P243; CHANT ADB, 1970, BMJ-BRIT MED J, V2, P235, DOI 10.1136/bmj.2.5703.235-c; CHANT ADB, 1972, BRIT J SURG, V59, P552, DOI 10.1002/bjs.1800590713; CHANT ADB, 1970, THESIS U LONDON; CHRISTENSON JT, 1986, SCAND J CLIN LAB INV, V46, P137, DOI 10.3109/00365518609083649; HARGENS AR, 1987, NATURE, V329, P59, DOI 10.1038/329059a0; HENDRIKSEN O, 1977, ACTA PHYSL SCAND S, V450, P7; HENDRIKSEN O, 1983, ACTA PHYSL SCAND, V118, P271; LANSMAN JB, 1987, NATURE, V325, P811, DOI 10.1038/325811a0; LEVICK JR, 1978, J PHYSIOL-LONDON, V274, P97, DOI 10.1113/jphysiol.1978.sp012136; MELLANDER S, 1964, ACTA PHYSIOL SCAND, V61, P34, DOI 10.1111/j.1748-1716.1964.tb02940.x; RAYMAN G, 1986, BRIT MED J, V292, P87, DOI 10.1136/bmj.292.6513.87; SCOTT HJ, 1989, PHLEBOLOGY, V4, P217; SKAGEN S, 1982, CLIN SCI, V62, P605; Wilson E., 1989, HLTH THENDS, V21, P97	16	20	20	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 27	1990	336	8722					1050	1051		10.1016/0140-6736(90)92503-A	http://dx.doi.org/10.1016/0140-6736(90)92503-A			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF076	1977031				2022-12-24	WOS:A1990EF07600016
J	BOWES, C; LI, TS; DANCIGER, M; BAXTER, LC; APPLEBURY, ML; FARBER, DB				BOWES, C; LI, TS; DANCIGER, M; BAXTER, LC; APPLEBURY, ML; FARBER, DB			RETINAL DEGENERATION IN THE RD MOUSE IS CAUSED BY A DEFECT IN THE BETA-SUBUNIT OF ROD CGMP-PHOSPHODIESTERASE	NATURE			English	Article									UNIV CALIF LOS ANGELES,SCH MED,JULES STEIN EYE INST,LOS ANGELES,CA 90024; UNIV CHICAGO,EYE RES LABS,CHICAGO,IL 60637; LOYOLA MARYMOUNT UNIV,LOS ANGELES,CA 90045	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Chicago; Loyola Marymount University				Farber, Debora/0000-0002-3207-697X; Bowes Rickman, Catherine/0000-0002-8555-9596				BAEHR W, 1979, J BIOL CHEM, V254, P1669; BOWES C, 1987, EXP EYE RES, V45, P467, DOI 10.1016/S0014-4835(87)80058-1; BOWES C, 1989, P NATL ACAD SCI USA, V86, P9722, DOI 10.1073/pnas.86.24.9722; BOWES C, 1988, EXP EYE RES, V47, P369, DOI 10.1016/0014-4835(88)90049-8; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5924; DANCIGER M, 1989, EXP EYE RES, V48, P303, DOI 10.1016/S0014-4835(89)80079-X; DANCIGER M, 1990, INVEST OPHTH VIS SCI, V31, P1427; DANCIGER M, 1990, EXP EYE RES, V351, P185; DAVIS RC, 1987, DEV BIOL, V119, P164, DOI 10.1016/0012-1606(87)90218-1; DETERRE P, 1988, P NATL ACAD SCI USA, V85, P2424, DOI 10.1073/pnas.85.8.2424; DEVEREUX J, 1984, NUCLEIC ACIDS RES, V12, P387, DOI 10.1093/nar/12.1Part1.387; DRAGER UC, 1978, J COMP NEUROL, V180, P85, DOI 10.1002/cne.901800107; FARBER DB, 1976, J CYCLIC NUCL PROT, V2, P139; FARBER DB, 1974, SCIENCE, V186, P449, DOI 10.1126/science.186.4162.449; FARBER DB, 1988, EXPL EYE RES, V46, P3363; LAVAIL MM, 1974, ARCH OPHTHALMOL-CHIC, V91, P394; LI T, 1990, P NATL ACAD SCI USA, V87, P293, DOI 10.1073/pnas.87.1.293; LIPKIN VM, 1990, J BIOL CHEM, V265, P12955; Maniatis T., 1982, MOL CLONING; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SIDMAN RL, 1965, J HERED, V56, P23, DOI 10.1093/oxfordjournals.jhered.a107364; YAU KW, 1989, ANNU REV NEUROSCI, V12, P289, DOI 10.1146/annurev.ne.12.030189.001445	22	690	709	0	12	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	OCT 18	1990	347	6294					677	680		10.1038/347677a0	http://dx.doi.org/10.1038/347677a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED620	1977087				2022-12-24	WOS:A1990ED62000057
J	WILTON, AN; COOPER, DW; BRENNECKE, SP; BISHOP, SM; MARSHALL, P				WILTON, AN; COOPER, DW; BRENNECKE, SP; BISHOP, SM; MARSHALL, P			ABSENCE OF CLOSE LINKAGE BETWEEN MATERNAL GENES FOR SUSCEPTIBILITY TO PREECLAMPSIA ECLAMPSIA AND HLA DR-BETA	LANCET			English	Article									MACQUARIE UNIV,SCH BIOL SCI,N RYDE,NSW 2109,AUSTRALIA; MONASH UNIV,DEPT OBSTET & GYNAECOL,MONASH PERINATAL UNIT,CLAYTON,VIC 3168,AUSTRALIA	Macquarie University; Monash University			Brennecke, Shaun/AFV-3919-2022; Wilton, Alan N/C-2430-2011	Brennecke, Shaun/0000-0003-3070-6971; 				ADAMS EM, 1961, LANCET, V2, P1373; ADAMS EM, 1961, LANCET, V2, P1375; BIDWELL JL, 1988, TRANSPLANTATION, V45, P640, DOI 10.1097/00007890-198803000-00027; BOLIS PF, 1987, BIOL RES PREG PERIN, V8, P42; Chesley L, 1978, HYPERTENSIVE DISORDE; CHESLEY LC, 1986, BRIT J OBSTET GYNAEC, V93, P898, DOI 10.1111/j.1471-0528.1986.tb08006.x; CHESLEY LC, 1968, OBSTET GYNECOL, V32, P303; COOPER DW, 1979, J MED GENET, V16, P409, DOI 10.1136/jmg.16.6.409; COOPER DW, 1988, BRIT J OBSTET GYNAEC, V95, P644, DOI 10.1111/j.1471-0528.1988.tb06524.x; FISCHER KA, 1981, MEDICINE, V60, P267; GREEN A, 1982, TISSUE ANTIGENS, V19, P213, DOI 10.1111/j.1399-0039.1982.tb01442.x; HODGE S E, 1984, Genetic Epidemiology, V1, P109, DOI 10.1002/gepi.1370010203; JENKINS DM, 1978, BRIT MED J, V1, P542, DOI 10.1136/bmj.1.6112.542; JOHNSON N, 1989, BRIT J OBSTET GYNAEC, V96, P369, DOI 10.1111/j.1471-0528.1989.tb02400.x; JOHNSON N, 1988, BRIT J OBSTET GYNAEC, V95, P877, DOI 10.1111/j.1471-0528.1988.tb06572.x; KILPATRICK DC, 1989, LANCET, V2, P1063; KILPATRICK DC, 1987, TISSUE ANTIGENS, V29, P232; KOHONENCORISH MRJ, 1986, HUM IMMUNOL, V15, P263, DOI 10.1016/0198-8859(86)90002-9; KUNKEL LM, 1977, P NATL ACAD SCI USA, V74, P1245, DOI 10.1073/pnas.74.3.1245; LONG EO, 1982, P NATL ACAD SCI-BIOL, V79, P7465, DOI 10.1073/pnas.79.23.7465; MacGillivray I, 1983, PREECLAMPSIA HYPERTE; Maniatis T., 1982, MOL CLONING; NELSON TR, 1955, J OBSTET GYNAECOL, V62, P48; OTT J, 1977, CLIN GENET, V12, P119; OTT J, 1974, AM J HUM GENET, V26, P588; OTT J, 1985, ANAL HUMAN GENETIC L; REDMAN CWG, 1978, LANCET, V2, P397; RISCH N, 1988, AM J HUM GENET, V42, P353; ROBSON EB, 1984, CYTOGENET CELL GENET, V37, P47, DOI 10.1159/000132004; SIMON P, 1988, KIDNEY INT, V34, pS125; SUTHERLAND A, 1981, BRIT J OBSTET GYNAEC, V88, P785, DOI 10.1111/j.1471-0528.1981.tb01304.x; WEEKS DE, 1988, AM J HUM GENET, V42, P315; 1988, LANCET, V2, P778	33	54	55	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 15	1990	336	8716					653	657		10.1016/0140-6736(90)92149-C	http://dx.doi.org/10.1016/0140-6736(90)92149-C			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DY737	1975853				2022-12-24	WOS:A1990DY73700004
J	IKUTA, K; KINA, T; MACNEIL, I; UCHIDA, N; PEAULT, B; CHIEN, YH; WEISSMAN, IL				IKUTA, K; KINA, T; MACNEIL, I; UCHIDA, N; PEAULT, B; CHIEN, YH; WEISSMAN, IL			A DEVELOPMENTAL SWITCH IN THYMIC LYMPHOCYTE MATURATION POTENTIAL OCCURS AT THE LEVEL OF HEMATOPOIETIC STEM-CELLS	CELL			English	Article									STANFORD UNIV, MED CTR, SCH MED, DEPT PATHOL, STANFORD, CA 94305 USA; STANFORD UNIV, MED CTR, SCH MED, DEPT DEV BIOL, STANFORD, CA 94305 USA; STANFORD UNIV, MED CTR, SCH MED, DEPT MICROBIOL & IMMUNOL, STANFORD, CA 94305 USA; KYOTO UNIV, CHEST DIS RES INST, DEPT MOLEC PATHOL, KYOTO 606, JAPAN; DNAX RES INST MOLEC & CELLULAR BIOL INC, DEPT IMMUNOL, PALO ALTO, CA 94304 USA	Stanford University; Stanford University; Stanford University; Kyoto University; Merck & Company; Dnax Research Institute Of Molecular & Cellular Biology Inc.	IKUTA, K (corresponding author), STANFORD UNIV, MED CTR, SCH MED, HOWARD HUGHES MED INST, STANFORD, CA 94305 USA.			Ikuta, Koichi/0000-0003-1319-1021	NATIONAL CANCER INSTITUTE [R35CA042551] Funding Source: NIH RePORTER; NCI NIH HHS [CA42551] Funding Source: Medline; NIAID NIH HHS [AI09072] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ADKINS B, 1988, IMMUNOGENETICS, V27, P180, DOI 10.1007/BF00346584; ASARNOW DM, 1988, CELL, V55, P837, DOI 10.1016/0092-8674(88)90139-0; ASARNOW DM, 1989, NATURE, V341, P60, DOI 10.1038/341060a0; BOSMA GC, 1983, NATURE, V301, P527, DOI 10.1038/301527a0; CHIEN YH, 1987, NATURE, V330, P722, DOI 10.1038/330722a0; COFFMAN RL, 1981, NATURE, V289, P681, DOI 10.1038/289681a0; DIALYNAS DP, 1983, IMMUNOL REV, V74, P29, DOI 10.1111/j.1600-065X.1983.tb01083.x; ELLIOTT JF, 1988, NATURE, V331, P627; FANTONI A, 1967, SCIENCE, V157, P1327, DOI 10.1126/science.157.3794.1327; GARMAN RD, 1986, CELL, V45, P733, DOI 10.1016/0092-8674(86)90787-7; HARDY RR, 1986, IMMUNOL REV, V93, P53, DOI 10.1111/j.1600-065X.1986.tb01502.x; HARDY RR, 1986, HDB EXPT IMMUNOLOGY, V1, pCH31; HAVRAN WL, 1989, P NATL ACAD SCI USA, V86, P4185, DOI 10.1073/pnas.86.11.4185; HAVRAN WL, 1987, NATURE, V330, P170, DOI 10.1038/330170a0; HAVRAN WL, 1990, NATURE, V344, P68, DOI 10.1038/344068a0; HAVRAN WL, 1988, NATURE, V335, P443, DOI 10.1038/335443a0; HAYAKAWA K, 1985, J EXP MED, V161, P1554, DOI 10.1084/jem.161.6.1554; HEIMFELD S, 1989, COLD SPRING HARB SYM, V54, P75; HERZENBERG LA, 1986, IMMUNOL REV, V93, P81, DOI 10.1111/j.1600-065X.1986.tb01503.x; HODGSON GS, 1979, NATURE, V281, P381, DOI 10.1038/281381a0; HOLMES KL, 1986, J IMMUNOL, V137, P679; HOULDEN BA, 1990, IN PRESS COLD SPRING; ITO K, 1989, P NATL ACAD SCI USA, V86, P631, DOI 10.1073/pnas.86.2.631; JENKINSON EJ, 1982, EUR J IMMUNOL, V12, P583, DOI 10.1002/eji.1830120710; JORDAN CT, 1990, CELL, V61, P953, DOI 10.1016/0092-8674(90)90061-I; KINGSTON R, 1985, NATURE, V317, P811, DOI 10.1038/317811a0; LAFAILLE JJ, 1989, CELL, V59, P859, DOI 10.1016/0092-8674(89)90609-0; LEDBETTER JA, 1979, IMMUNOL REV, V47, P63, DOI 10.1111/j.1600-065X.1979.tb00289.x; LEO O, 1987, P NATL ACAD SCI USA, V84, P1374, DOI 10.1073/pnas.84.5.1374; LORD BI, 1986, LYMPHOKINE RES, V5, P59; LOSTROM ME, 1979, VIROLOGY, V98, P336, DOI 10.1016/0042-6822(79)90557-9; MCKEARN JP, 1985, P NATL ACAD SCI USA, V82, P7414, DOI 10.1073/pnas.82.21.7414; METCALF D, 1971, FRONT BIOL, V24, pCH4; MULLERSIEBURG CE, 1986, CELL, V44, P653, DOI 10.1016/0092-8674(86)90274-6; PARKS DR, 1984, METHOD ENZYMOL, V108, P197; PILLEMER E, 1984, P NATL ACAD SCI-BIOL, V81, P4434, DOI 10.1073/pnas.81.14.4434; PYKE KW, 1983, J IMMUNOL METHODS, V58, P243, DOI 10.1016/0022-1759(83)90279-X; ROMANI N, 1985, J EXP MED, V161, P1368, DOI 10.1084/jem.161.6.1368; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SCHULER W, 1986, CELL, V46, P963, DOI 10.1016/0092-8674(86)90695-1; SHERWOOD PJ, 1990, INT IMMUNOL, V2, P399, DOI 10.1093/intimm/2.5.399; SILINI G, 1967, J EMBRYOL EXP MORPH, V17, P303; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; SPRINGER T, 1979, EUR J IMMUNOL, V9, P301, DOI 10.1002/eji.1830090410; STINGL G, 1987, P NATL ACAD SCI USA, V84, P2430, DOI 10.1073/pnas.84.8.2430; TILL JE, 1961, RADIAT RES, V14, P213, DOI 10.2307/3570892; VISSER JWM, 1984, J EXP MED, V159, P1576, DOI 10.1084/jem.159.6.1576; WATANABE Y, 1989, THYMUS, V13, P57; Weissman I, 1978, DIFFERENTIATION NORM, V5, P33; WEISSMAN IL, 1976, COLD SPRING HARB SYM, V41, P9, DOI 10.1101/SQB.1977.041.01.005	50	555	568	0	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	SEP 7	1990	62	5					863	874		10.1016/0092-8674(90)90262-D	http://dx.doi.org/10.1016/0092-8674(90)90262-D			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DY100	1975515				2022-12-24	WOS:A1990DY10000006
J	HERRERA, VLM; RUIZOPAZO, N				HERRERA, VLM; RUIZOPAZO, N			ALTERATION OF ALPHA-1 NA+,K+-ATPASE RB-86+ INFLUX BY A SINGLE AMINO-ACID SUBSTITUTION	SCIENCE			English	Article											HERRERA, VLM (corresponding author), BOSTON UNIV,SCH MED,WHITAKER CARDIOVASC INST,MOLEC GENET SECT,L-411,BOSTON,MA 02118, USA.			Herrera, Victoria/0000-0001-8991-2134; Ruiz-Opazo, Nelson/0000-0001-8234-1332	NHLBI NIH HHS [HL 01967, HL 18318, HL 39267] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL018318, P60HL018318] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		CASTRO J, 1979, J BIOL CHEM, V254, P2221; Colman A., 1984, TRANSCRIPTION TRANSL; DAHL LK, 1962, NATURE, V194, P480, DOI 10.1038/194480b0; ENGLISH LH, 1985, J BIOL CHEM, V260, P1114; FAMBROUGH DM, 1987, KIDNEY INT, V32, pS97; FELSENFELD DP, 1988, J BIOL CHEM, V263, P10932; HERRERA VLM, 1987, J CELL BIOL, V105, P1855, DOI 10.1083/jcb.105.4.1855; HERRERA VLM, 1988, SCIENCE, V241, P221, DOI 10.1126/science.2838907; HERRERA VLM, UNPUB; HUYNH TV, 1985, DNA CLONING, V1; JORGENSE.PL, 1969, BIOCHEM BIOPH RES CO, V37, P39; JORGENSEN PL, 1974, BIOCHIM BIOPHYS ACTA, V356, P36, DOI 10.1016/0005-2736(74)90292-2; JORGENSEN PL, 1982, BIOCHIM BIOPHYS ACTA, V694, P27, DOI 10.1016/0304-4157(82)90013-2; JORGENSEN PL, 1980, PHYSIOL REV, V60, P864; JORGENSEN PL, 1975, BIOCHIM BIOPHYS ACTA, V401, P399, DOI 10.1016/0005-2736(75)90239-4; KYTE J, 1981, NATURE, V292, P201, DOI 10.1038/292201a0; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LECHENE C, 1988, NAT PLUS K PLUS PUMP; MARTINVASALLO P, 1989, J BIOL CHEM, V264, P4613; MERCER RW, 1986, MOL CELL BIOL, V6, P3884, DOI 10.1128/MCB.6.11.3884; MESSING J, 1981, NUCLEIC ACIDS RES, V9, P309, DOI 10.1093/nar/9.2.309; NOGUCHI S, 1987, FEBS LETT, V225, P27, DOI 10.1016/0014-5793(87)81125-0; NORBY JG, 1971, BIOCHIM BIOPHYS ACTA, V233, P104, DOI 10.1016/0005-2736(71)90362-2; RAPP JP, 1989, SCIENCE, V243, P542, DOI 10.1126/science.2563177; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SHULL GE, 1986, BIOCHEMISTRY-US, V25, P8125, DOI 10.1021/bi00373a001; SKOU JC, 1988, METHOD ENZYMOL, V156, P1; SKOU JC, 1975, Q REV BIOPHYS, V7, P401; SWEADNER KJ, 1980, NEW ENGL J MED, V302, P777, DOI 10.1056/NEJM198004033021404; YOUNG RM, 1987, BIOCHEM BIOPH RES CO, V145, P52, DOI 10.1016/0006-291X(87)91286-1; YOUNG RM, 1987, J BIOL CHEM, V262, P4905	31	80	83	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	AUG 31	1990	249	4972					1023	1026		10.1126/science.1975705	http://dx.doi.org/10.1126/science.1975705			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX004	1975705				2022-12-24	WOS:A1990DX00400040
J	BRAHAMS, D				BRAHAMS, D			COMPENSATION FOR HEAT-ILLNESS DEATH, USA	LANCET			English	Editorial Material																		BRAHAMS D, 1989, LANCET, V2, P1167; HOWE P, 1990, BOSTON GLOBE    0713	2	0	0	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	AUG 4	1990	336	8710					303	303		10.1016/0140-6736(90)91823-S	http://dx.doi.org/10.1016/0140-6736(90)91823-S			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT007	1973984				2022-12-24	WOS:A1990DT00700019
J	MENSAH, PPA; TOMKINS, AM; DRASAR, BS; HARRISON, TJ				MENSAH, PPA; TOMKINS, AM; DRASAR, BS; HARRISON, TJ			FERMENTATION OF CEREALS FOR REDUCTION OF BACTERIAL-CONTAMINATION OF WEANING FOODS IN GHANA	LANCET			English	Article									UNIV LONDON LONDON SCH HYG & TROP MED,DEPT CLIN SCI,KEPPEL ST,LONDON WC1E 7HT,ENGLAND; NOGUCHI MEM INST,LEGON,GHANA	University of London; London School of Hygiene & Tropical Medicine; University of Ghana								AKINRELE IA, 1970, J SCI FOOD AGR, V21, P619, DOI 10.1002/jsfa.2740211205; Andah A., 1973, Ghana Journal of Agricultural Science, V6, P103; BANIGO EOI, 1972, J SCI FOOD AGR, V23, P101, DOI 10.1002/jsfa.2740230113; BARRELL RAE, 1979, T ROY SOC TROP MED H, V73, P85, DOI 10.1016/0035-9203(79)90136-6; BLACK RE, 1982, T ROY SOC TROP MED H, V76, P259, DOI 10.1016/0035-9203(82)90292-9; BLACK RE, 1989, AM J EPIDEMIOL, V129, P785, DOI 10.1093/oxfordjournals.aje.a115193; CAPPARELLI E, 1975, APPL MICROBIOL, V29, P802, DOI 10.1177/0146167203029006012; DEWILDE M, 1981, MOL BIOL PATHOGENICI, P596; ELEGBE IA, 1984, CLIN PEDIATR, V23, P261, DOI 10.1177/000992288402300502; Esrey S, 1989, WHOCDD8930; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GENNARO ML, 1982, NUCLEIC ACIDS RES, V10, P4883, DOI 10.1093/nar/10.16.4883; GORDON JE, 1963, AM J MED SCI, V245, P345; GRUNSTEIN M, 1975, P NATL ACAD SCI USA, V72, P3961, DOI 10.1073/pnas.72.10.3961; JHARRIGAN WF, 1976, LABORATORY METHODS D; LATHE R, 1980, NATURE, V284, P473, DOI 10.1038/284473a0; Mason PJ, 1985, NUCLEIC ACID HYBRIDI, P113; MENSAH PPA, 1989, T R SOC TROP MED HYG, V82, P635; MOSELEY SL, 1980, J INFECT DIS, V142, P892, DOI 10.1093/infdis/142.6.892; Muller H. G., 1970, Ghana Journal of Agricultural Science, V3, P187; Nout M. J. R., 1988, [Publication] International Development Research Centre, P245; Nyaga P N, 1982, Bull Anim Health Prod Afr, V30, P19; ROWLAND M G M, 1978, Lancet, V1, P136; SAKOANE AL, 1988, P WORKSHOP NAIROBI, V3, P136; Thatcher F. S., 1968, MICROORGANISMS FOODS, V1; Tomkins A., 1988, [Publication] International Development Research Centre, P136	26	38	40	0	6	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JUL 21	1990	336	8708					140	143		10.1016/0140-6736(90)91660-3	http://dx.doi.org/10.1016/0140-6736(90)91660-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP866	1973473				2022-12-24	WOS:A1990DP86600004
J	PLAYFORD, RJ; DOMIN, J; BEACHAM, J; PARMAR, KB; TATEMOTO, K; BLOOM, SR; CALAM, J				PLAYFORD, RJ; DOMIN, J; BEACHAM, J; PARMAR, KB; TATEMOTO, K; BLOOM, SR; CALAM, J			PRELIMINARY-REPORT - ROLE OF PEPTIDE-YY IN DEFENSE AGAINST DIARRHEA	LANCET			English	Article									HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,GASTROENTEROL UNIT,DU CANE RD,LONDON W12 0NN,ENGLAND; HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,ENDOCRINOL UNIT,LONDON W12 0NN,ENGLAND; HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,DEPT MED,LONDON W12 0NN,ENGLAND; HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,DEPT CHEM PATHOL,LONDON W12 0NN,ENGLAND; STANFORD UNIV,MED CTR,SCH MED,STANFORD,CA 94305	Imperial College London; Imperial College London; Imperial College London; Imperial College London; Stanford University				Playford, Raymond/0000-0003-1235-8504				ADRIAN TE, 1986, GASTROENTEROLOGY, V90, P379, DOI 10.1016/0016-5085(86)90936-4; ADRIAN TE, 1985, GASTROENTEROLOGY, V89, P494, DOI 10.1016/0016-5085(85)90442-1; ADRIAN TE, 1985, GASTROENTEROLOGY, V89, P1070, DOI 10.1016/0016-5085(85)90211-2; BISHOP AE, 1980, GASTROENTEROLOGY, V79, P853; CALAM J, 1990, GASTROENTEROLOGY, V98, P505, DOI 10.1016/0016-5085(90)90847-T; CASSUTO J, 1981, GUT, V22, P958, DOI 10.1136/gut.22.11.958; DOCKRAY GJ, 1986, PHYSL GASTROINTESTIN, V1, P41; EKLUND S, 1985, NEUROSCIENCE, V14, P673, DOI 10.1016/0306-4522(85)90318-5; HILL GL, 1974, GUT, V15, P928; Hyden S., 1955, KUNGL LANTBRUKSHOGSK, V22, P139; ITOH Z, 1988, Biomedical Research (Tokyo), V9, P8; LONG RG, 1981, BRIT MED J, V282, P1767, DOI 10.1136/bmj.282.6278.1767; MEYER BM, 1989, LANCET, V2, P12, DOI 10.1016/S0140-6736(89)90255-9; MITCHELL SJ, 1978, GUT, V19, P1043, DOI 10.1136/gut.19.11.1043; SAVAGE AP, 1987, GUT, V28, P166, DOI 10.1136/gut.28.2.166; SERVIN AL, 1989, ENDOCRINOLOGY, V124, P692, DOI 10.1210/endo-124-2-692	16	61	69	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JUN 30	1990	335	8705					1555	1557		10.1016/0140-6736(90)91378-N	http://dx.doi.org/10.1016/0140-6736(90)91378-N			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL480	1972488				2022-12-24	WOS:A1990DL48000005
J	MCCORMICK, A; BRADY, H; THEILL, LE; KARIN, M				MCCORMICK, A; BRADY, H; THEILL, LE; KARIN, M			REGULATION OF THE PITUITARY-SPECIFIC HOMEOBOX GENE GHF1 BY CELL-AUTONOMOUS AND ENVIRONMENTAL CUES	NATURE			English	Article											MCCORMICK, A (corresponding author), UNIV CALIF SAN DIEGO,SCH MED,CTR MOLEC GENET,DEPT PHARMACOL,M036,LA JOLLA,CA 92093, USA.							AKAM M, 1987, DEVELOPMENT, V101, P1; ALTABA AR, 1989, NATURE, V341, P33; ANGEL P, 1988, NATURE, V332, P166, DOI 10.1038/332166a0; BARINAGA M, 1983, NATURE, V306, P84, DOI 10.1038/306084a0; BIENZ M, 1988, NATURE, V333, P576, DOI 10.1038/333576a0; BILEZIKJIAN LM, 1983, ENDOCRINOLOGY, V113, P1726, DOI 10.1210/endo-113-5-1726; BILLESTRUP N, 1986, P NATL ACAD SCI USA, V83, P6854, DOI 10.1073/pnas.83.18.6854; BODNER M, 1987, CELL, V50, P267, DOI 10.1016/0092-8674(87)90222-4; BODNER M, 1988, CELL, V55, P505, DOI 10.1016/0092-8674(88)90037-2; COPP RP, 1989, MOL ENDOCRINOL, V3, P790, DOI 10.1210/mend-3-5-790; DANA S, 1989, MOL ENDOCRINOL, V3, P815, DOI 10.1210/mend-3-5-815; DOLLE P, 1990, CELL, V60, P809, DOI 10.1016/0092-8674(90)90095-V; DOLLE P, 1989, NATURE, V342, P767, DOI 10.1038/342767a0; GEHRING WJ, 1987, SCIENCE, V236, P1245, DOI 10.1126/science.2884726; GONZALEZ GA, 1989, NATURE, V337, P749, DOI 10.1038/337749a0; HATTORI K, 1988, P NATL ACAD SCI USA, V85, P9148, DOI 10.1073/pnas.85.23.9148; HIROMI Y, 1987, CELL, V50, P963, DOI 10.1016/0092-8674(87)90523-X; HOOPER JE, 1989, CELL, V59, P751, DOI 10.1016/0092-8674(89)90021-4; HRSKOWITZ I, 1989, NATURE, V342, P749; INGRAHAM HA, 1988, CELL, V55, P519, DOI 10.1016/0092-8674(88)90038-4; KARIN M, 1990, TRENDS GENET, V6, P92, DOI 10.1016/0168-9525(90)90100-K; LEFEVRE C, 1987, EMBO J, V6, P971, DOI 10.1002/j.1460-2075.1987.tb04847.x; LEWIS J, 1989, NATURE, V342, P734, DOI 10.1038/342734a0; MCCORMICK A, 1988, CELL, V55, P379, DOI 10.1016/0092-8674(88)90061-X; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; NAKANO Y, 1989, NATURE, V341, P508, DOI 10.1038/341508a0; RIJSEWIJK F, 1987, CELL, V50, P649, DOI 10.1016/0092-8674(87)90038-9; RIVIER J, 1982, NATURE, V300, P276, DOI 10.1038/300276a0; ROBERTSON M, 1988, NATURE, V336, P522, DOI 10.1038/336522a0; ROSE FM, CELL, V57, P965; SARGENT TD, 1979, P NATL ACAD SCI USA, V76, P3256, DOI 10.1073/pnas.76.7.3256; SCOTT MP, 1989, BIOCHIM BIOPHYS ACTA, V989, P25, DOI 10.1016/0304-419X(89)90033-4; STUDIER FW, IN PRESS METH ENZYM; THEILL LE, 1989, NATURE, V342, P945, DOI 10.1038/342945a0	34	202	207	0	2	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUN 28	1990	345	6278					829	832		10.1038/345829a0	http://dx.doi.org/10.1038/345829a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL646	1972784				2022-12-24	WOS:A1990DL64600065
J	ZANETTA, JP; WARTER, JM; KUCHLER, S; MARSCHAL, P; RUMBACH, L; LEHMANN, S; TRANCHANT, C; REEBER, A; VINCENDON, G				ZANETTA, JP; WARTER, JM; KUCHLER, S; MARSCHAL, P; RUMBACH, L; LEHMANN, S; TRANCHANT, C; REEBER, A; VINCENDON, G			ANTIBODIES TO CEREBELLAR SOLUBLE LECTIN CSL IN MULTIPLE-SCLEROSIS	LANCET			English	Article									UNIV STRASBOURG 1,SERV NEUROL 2,F-67070 STRASBOURG,FRANCE	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	ZANETTA, JP (corresponding author), CNRS,CTR NEUROCHIM,5 RUE BLAISE PASCAL,F-67000 STRASBOURG,FRANCE.		Lehmann, Sylvain/P-1301-2017	Lehmann, Sylvain/0000-0001-6117-562X; Kuchler-Bopp, Sabine/0000-0002-7497-1200; tranchant, christine/0000-0002-2895-1292				ACHIRON A, 1989, ANN NEUROL, V26, P291, DOI 10.1002/ana.410260224; BACH JF, 1989, IMMUNOLOGIE; BENVENISTE EN, 1986, NATURE, V321, P610, DOI 10.1038/321610a0; BROMAN T, 1964, ACTA NEUROL SCAND, V40, P21, DOI 10.1111/j.1600-0404.1964.tb04718.x; DONTENWILL M, 1985, DEV BRAIN RES, V17, P245, DOI 10.1016/0165-3806(85)90148-8; FRESSINAUD C, 1988, CR ACAD SCI III-VIE, V307, P863; GILES PD, 1989, ANN CLIN BIOCHEM, V26, P317, DOI 10.1177/000456328902600403; HAFLER DA, 1985, NEW ENGL J MED, V312, P1405, DOI 10.1056/NEJM198505303122201; HAWKES R, 1982, ANAL BIOCHEM, V119, P142, DOI 10.1016/0003-2697(82)90677-7; KOOPMANS RA, 1989, NEUROLOGY, V39, P959, DOI 10.1212/WNL.39.7.959; KUCHLER S, 1988, DEV NEUROSCI-BASEL, V10, P199, DOI 10.1159/000111970; KUCHLER S, 1989, CELL MOL BIOL, V45, P33; KUCHLER S, 1989, GLIA, V2, P10; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAUER K, 1984, J NEUROL, V231, P130, DOI 10.1007/BF00313680; MARSCHAL P, 1989, BIOCHIMIE, V71, P645, DOI 10.1016/0300-9084(89)90159-4; MCDONALD WI, 1989, TRENDS NEUROSCI, V12, P376, DOI 10.1016/0166-2236(89)90075-1; MORGAN BP, 1984, LANCET, V2, P251, DOI 10.1016/S0140-6736(84)90298-8; PERRAUD F, 1988, J NEUROCYTOL, V17, P745, DOI 10.1007/BF01216703; PRINEAS JW, 1981, ANN NEUROL, V10, P149, DOI 10.1002/ana.410100205; SHARON N, 1984, BIOL CELL, V51, P239, DOI 10.1111/j.1768-322X.1984.tb00304.x; SHERBLOM AP, 1989, J IMMUNOL, V143, P939; SOLA P, 1989, ACTA NEUROL SCAND, V80, P394, DOI 10.1111/j.1600-0404.1989.tb03900.x; ZANETTA JP, 1987, CELL MOL BIOL, V33, P423; ZANETTA JP, 1985, DEV BRAIN RES, V17, P233, DOI 10.1016/0165-3806(85)90147-6; ZANETTA JP, 1987, J NEUROCHEM, V49, P1250, DOI 10.1111/j.1471-4159.1987.tb10017.x	26	21	22	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JUN 23	1990	335	8704					1482	1484		10.1016/0140-6736(90)93027-M	http://dx.doi.org/10.1016/0140-6736(90)93027-M			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK586	1972431				2022-12-24	WOS:A1990DK58600002
J	VANROOD, JJ; CLAAS, FHJ				VANROOD, JJ; CLAAS, FHJ			THE INFLUENCE OF ALLOGENEIC CELLS ON THE HUMAN T-CELL AND B-CELL REPERTOIRE	SCIENCE			English	Article									STATE UNIV LEIDEN HOSP,BLOOD BANK,2333 AA LEIDEN,NETHERLANDS	Leiden University; Leiden University Medical Center (LUMC)	VANROOD, JJ (corresponding author), STATE UNIV LEIDEN HOSP,DEPT IMMUNOHAEMATOL,2333 AA LEIDEN,NETHERLANDS.							ALBERT ED, 1981, TRANSPLANT P, V13, P175; BACH FH, 1976, NEW ENGL J MED, V295, P806, DOI 10.1056/NEJM197610072951504; BACH FH, 1976, NEW ENGL J MED, V295, P872, DOI 10.1056/NEJM197610142951606; BACH FH, 1976, NEW ENGL J MED, V295, P927, DOI 10.1056/NEJM197610212951705; BATCHELOR JR, 1989, IMMUNOL TODAY, V10, P37; BEAN MA, 1990, TRANSPLANTATION, V49, P382, DOI 10.1097/00007890-199002000-00031; BEATTY PG, 1985, NEW ENGL J MED, V313, P765, DOI 10.1056/NEJM198509263131301; BILLINGHAM RE, 1953, NATURE, V172, P603, DOI 10.1038/172603a0; BONNEVILLE M, 1988, J IMMUNOL, V141, P4187; BORLEFFS JCC, 1982, TRANSPLANTATION, V33, P285, DOI 10.1097/00007890-198203000-00015; BORLEFFS JCC, 1982, LANCET, V1, P1117; BORLEFFS JCC, 1982, CYCLOSPORIN A KIDNEY, P323; BURROWS L, 1982, TRANSPLANT P, V14, P272; Cecka J M, 1987, Clin Transpl, P423; CHAPMAN JR, 1985, TRANSPLANT P, V17, P1038; CHARDONNENS X, 1980, TISSUE ANTIGENS, V15, P401; CLAAS FHJ, 1988, SCIENCE, V241, P1815, DOI 10.1126/science.3051377; CLAAS FHJ, 1988, TRANSPLANT INT, V1, P53, DOI 10.1007/BF00353819; COCHRUM K, 1981, TRANSPLANT P, V13, P190; CORRY RJ, 1988, TRANSPLANT P, V20, P1079; COULMY E, 1989, TRANSPLANTATION, V48, P559; DALLMAN MJ, 1989, TRANSPLANT P, V21, P1165; Dausset Jean, 1954, VOX SANG BASEL, V4, P190; DEKOSTER HS, 1989, J EXP MED, V169, P1191, DOI 10.1084/jem.169.3.1191; DEWAAL LP, 1989, ABSTR NEWSL DUTCH SO; GOULMY E, 1988, TRANSPLANT P, V20, P183; HEEG K, IN PRESS J EXP MED; HERZOG WR, 1987, TRANSPLANTATION, V43, P384, DOI 10.1097/00007890-198703000-00013; HUME DM, 1955, J CLIN INVEST, V34, P327, DOI 10.1172/JCI103085; JONKER M, COMMUNICATIONJ; KALIA A, 1988, TRANSPLANTATION, V46, P70, DOI 10.1097/00007890-198807000-00012; KAMINSKI E, 1988, BONE MARROW TRANSPL, V3, P149; KISSMEYE F, 1966, LANCET, V2, P662, DOI 10.1016/S0140-6736(66)92829-7; LAGAAIJ EL, 1987, TRANSPLANTATION, V44, P788, DOI 10.1097/00007890-198712000-00013; LAGAAIJ EL, 1989, NEW ENGL J MED, V321, P701, DOI 10.1056/NEJM198909143211101; LAGAAIJ EL, 1989, 7TH INT C IMM BERL, P809; LAGAAIJ EL, 1990, THESIS STATE U LEIDE; LAZDA VA, IN PRESS TRANSPLANTA; LECHLER RI, 1990, IMMUNOL TODAY, V11, P83, DOI 10.1016/0167-5699(90)90033-6; LOMBARDI G, 1989, J IMMUNOL, V142, P573; MADSEN JC, 1988, NATURE, V332, P161, DOI 10.1038/332161a0; MARTIN DR, 1989, J EXP MED, V170, P679, DOI 10.1084/jem.170.3.679; Merrill John P, 1955, SURG FORUM, V6, P432; MORAHAN G, 1989, NATURE, V339, P622, DOI 10.1038/339622a0; MORRIS PJ, 1978, TRANSPLANTATION, V26, P276; MORRIS PJ, 1989, PROGR IMMUNOLOGY, V7, P1155; NOSSAL GJV, 1989, SCIENCE, V245, P147, DOI 10.1126/science.2526369; NUBE MJ, 1981, TISSUE ANTIGENS, V17, P449; OPELZ G, 1982, TRANSPLANTATION, V33, P87, DOI 10.1097/00007890-198201000-00017; OPELZ G, 1987, TRANSPLANT P, V19, P149; OPELZ G, 1973, TRANSPLANTATION, V16, P649, DOI 10.1097/00007890-197312000-00017; OPELZ G, 1987, TRANSPLANT P, V19, P641; OTTENHOFF THM, UNPUB; PATEL R, 1969, NEW ENGL J MED, V280, P735, DOI 10.1056/NEJM196904032801401; PEARSON TC, 1989, NOV BR TRANSPL SOC M, P19; PERSIJN GG, 1981, ANN CLIN RES, V13, P215; PERSIJN GG, 1979, TRANSPLANTATION, V28, P396, DOI 10.1097/00007890-197911000-00010; PERSIJN GG, 1982, NEW ENGL J MED, V307, P905, DOI 10.1056/NEJM198210073071501; POHANKA E, 1989, HUM IMMUNOL, V26, P92; QUIGLEY RL, 1989, TRANSPLANTATION, V47, P684, DOI 10.1097/00007890-198904000-00022; RAMMENSEE HG, 1989, NATURE, V339, P541, DOI 10.1038/339541a0; REED E, 1987, NEW ENGL J MED, V316, P1450, DOI 10.1056/NEJM198706043162305; Sachs DH, 1989, PROGR IMMUNOLOGY, VVII, P1171; SCHWARTZ R, 1960, J CLIN INVEST, V39, P952, DOI 10.1172/JCI104116; STAINES NJ, 1973, TRANSPLANTATION, V18, P192; STROBER S, 1989, NEW ENGL J MED, V321, P28, DOI 10.1056/NEJM198907063210106; TAKIFF H, 1988, TRANSPLANT P, V20, P39; Terasaki P I, 1988, Clin Transpl, P409; THOROGOOD J, COMMUNICATION; TING A, 1984, TISSUE ANTIGENS, V24, P256, DOI 10.1111/j.1399-0039.1984.tb02135.x; van Aken W G, 1989, Transfus Med Rev, V3, P243, DOI 10.1016/S0887-7963(89)70085-7; VANDEKERCKHOVE BAE, 1990, J IMMUNOL, V144, P1288; VANHOOFF JP, 1976, TRANSPLANTATION, V22, P306; VANROOD JJ, 1973, TRANSPL P, V5, P409; VANROOD JJ, 1989, IMMUNOL LETT, V21, P51, DOI 10.1016/0165-2478(89)90011-4; VANTWUYVER E, 1989, TRANSPLANTATION, V48, P844; Zhang L., UNPUB	77	95	96	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 15	1990	248	4961					1388	1393		10.1126/science.1972596	http://dx.doi.org/10.1126/science.1972596			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ501	1972596				2022-12-24	WOS:A1990DJ50100034
J	CONNELL, JA; PARRY, JV; MORTIMER, PP; DUNCAN, RJS; MCLEAN, KA; JOHNSON, AM; HAMBLING, MH; BARBARA, J; FARRINGTON, CP				CONNELL, JA; PARRY, JV; MORTIMER, PP; DUNCAN, RJS; MCLEAN, KA; JOHNSON, AM; HAMBLING, MH; BARBARA, J; FARRINGTON, CP			ACCURATE ASSAYS FOR ANTI-HIV IN URINE - PRELIMINARY-REPORT	LANCET			English	Article									PUBL HLTH LAB SERV,VIRUS REFERENCE LAB,COLINDALE AVE,LONDON NW9 5HT,ENGLAND; PUBL HLTH LAB SERV,CTR COMMUN DIS SURVEILLANCE,LONDON,ENGLAND; W LONDON HOSP,DEPT GENITOURINARY MED,LONDON,ENGLAND; WELLCOME FDN LTD,BECKENHAM,KENT,ENGLAND; UNIV COLL & MIDDLESEX SCH MED,DEPT GENITOURINARY MED,LONDON,ENGLAND; PUBL HLTH LAB,LEEDS,ENGLAND; N LONDON BLOOD TRANSFUS CTR,LONDON,ENGLAND	Public Health England; Public Health England; GlaxoSmithKline; University of London; University College London				Johnson, Anne/0000-0003-1330-7100; Farrington, Conor Patrick/0000-0002-7148-2612				CAO Y, 1989, AIDS RES HUM RETROV, V5, P311, DOI 10.1089/aid.1989.5.311; CAO YZ, 1988, LANCET, V1, P831; JOHNSON AM, 1988, AIDS, V2, P369, DOI 10.1097/00002030-198810000-00006; PARRY JV, 1987, LANCET, V2, P72, DOI 10.1016/S0140-6736(87)92737-1; PARRY JV, 1989, AIDS, V3, P173, DOI 10.1097/00002030-198903000-00008; REAGAN KJ, 1990, LANCET, V1, P358; Roitt I, 1983, IMMUNOLOGY ORAL DIS, P279; SELF CH, 1985, J IMMUNOL METHODS, V76, P389, DOI 10.1016/0022-1759(85)90316-3; 307149	9	73	75	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JUN 9	1990	335	8702					1366	1369		10.1016/0140-6736(90)91245-6	http://dx.doi.org/10.1016/0140-6736(90)91245-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH145	1971662				2022-12-24	WOS:A1990DH14500005
J	BLACKMAN, MA; BURGERT, HG; WOODLAND, DL; PALMER, E; KAPPLER, JW; MARRACK, P				BLACKMAN, MA; BURGERT, HG; WOODLAND, DL; PALMER, E; KAPPLER, JW; MARRACK, P			A ROLE FOR CLONAL INACTIVATION IN T-CELL TOLERANCE TO MLS-1A	NATURE			English	Article									NATL JEWISH CTR IMMUNOL & RESP MED, DEPT MED, DIV BASIC IMMUNOL, DENVER, CO 80206 USA; NATL JEWISH CTR IMMUNOL & RESP MED, DEPT PEDIAT, DIV BASIC SCI, DENVER, CO 80206 USA; UNIV COLORADO, HLTH SCI CTR, DEPT MICROBIOL IMMUNOL & MED, DENVER, CO 80206 USA; UNIV COLORADO, HLTH SCI CTR, DEPT BIOCHEM BIOPHYS & GENET, DENVER, CO 80206 USA	National Jewish Health; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	BLACKMAN, MA (corresponding author), HOWARD HUGHES MED INST, 1400 JACKSON ST, DENVER, CO 80206 USA.		Marrack, Philippa/AHE-6316-2022; Burgert, Hans-Gerhard/AAE-6668-2020	Burgert, Hans-Gerhard/0000-0002-1650-9878; Marrack, Philippa/0000-0003-1883-3687				BERG LJ, 1989, NATURE, V340, P559, DOI 10.1038/340559a0; BILL J, 1989, J EXP MED, V169, P1405, DOI 10.1084/jem.169.4.1405; BLACKMAN M, 1986, CELL, V47, P349, DOI 10.1016/0092-8674(86)90591-X; FESTENSTEIN H, 1973, TRANSPLANT REV-DENMA, V15, P62; FINKEL TH, 1989, CELL, V58, P1047, DOI 10.1016/0092-8674(89)90503-5; FOWLKES BJ, 1988, NATURE, V334, P620, DOI 10.1038/334620a0; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; HAPP MP, 1989, P NATL ACAD SCI USA, V86, P6293, DOI 10.1073/pnas.86.16.6293; HASKINS K, 1984, J EXP MED, V160, P452, DOI 10.1084/jem.160.2.452; JANEWAY CA, 1989, IMMUNOL REV, V15, P62; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; KAPPLER JW, 1987, CELL, V49, P263, DOI 10.1016/0092-8674(87)90567-8; KAPPLER JW, 1988, NATURE, V332, P35, DOI 10.1038/332035a0; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; KRIMPENFORT P, 1988, EMBO J, V7, P745, DOI 10.1002/j.1460-2075.1988.tb02871.x; KUBO RT, 1989, J IMMUNOL, V142, P2736; LEO O, 1987, P NATL ACAD SCI USA, V83, P767; LO D, 1989, J EXP MED, V170, P87, DOI 10.1084/jem.170.1.87; LO D, 1988, CELL, V53, P159, DOI 10.1016/0092-8674(88)90497-7; MACDONALD HR, 1988, J EXP MED, V167, P2005, DOI 10.1084/jem.167.6.2005; MACDONALD HR, 1988, NATURE, V332, P40, DOI 10.1038/332040a0; MARRACK P, 1987, SCIENCE, V238, P1073, DOI 10.1126/science.3317824; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; PIRCHER H, 1989, EMBO J, V8, P719, DOI 10.1002/j.1460-2075.1989.tb03431.x; PULLEN AM, 1988, NATURE, V335, P796, DOI 10.1038/335796a0; QIN SX, 1989, J EXP MED, V169, P779, DOI 10.1084/jem.169.3.779; RAMMENSEE HG, 1989, NATURE, V339, P541, DOI 10.1038/339541a0; RAMSDELL F, 1989, SCIENCE, V246, P1038, DOI 10.1126/science.2511629; SHA WC, 1988, NATURE, V336, P73, DOI 10.1038/336073a0; STAERZ UD, 1985, J IMMUNOL, V134, P3994; WHITE J, 1989, CELL, V56, P27, DOI 10.1016/0092-8674(89)90980-X	31	204	207	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JUN 7	1990	345	6275					540	542		10.1038/345540a0	http://dx.doi.org/10.1038/345540a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DH143	1971916				2022-12-24	WOS:A1990DH14300065
J	EIDSON, M; PHILEN, RM; SEWELL, CM; VOORHEES, R; KILBOURNE, EM				EIDSON, M; PHILEN, RM; SEWELL, CM; VOORHEES, R; KILBOURNE, EM			L-TRYPTOPHAN AND EOSINOPHILIA-MYALGIA SYNDROME IN NEW-MEXICO	LANCET			English	Article									CTR DIS CONTROL,CTR ENVIRONM HLTH & INJURY CONTROL,ATLANTA,GA 30333; CTR DIS CONTROL,CTR ENVIRONM HLTH & INJURY CONTROL,ATLANTA,GA 30333	Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	EIDSON, M (corresponding author), NEW MEXICO HLTH & ENVIRONM DEPT,OFF EPIDEMIOL,1190 ST FRANCIS DR,SANTA FE,NM 87503, USA.							CAMPOS N, 1989, AM J EPIDEMIOL, V129, P439, DOI 10.1093/oxfordjournals.aje.a115148; KILBOURNE EM, 1983, NEW ENGL J MED, V309, P1408, DOI 10.1056/NEJM198312083092302; KILBOURNE EM, 1990, ANN INTERN MED, V112, P85, DOI 10.7326/0003-4819-112-2-85; KILBOURNE EM, 1988, AM J EPIDEMIOL, V127, P1210, DOI 10.1093/oxfordjournals.aje.a114914; SCHRIER SL, 1989, SCI AM MED, V5, P12; 1990, MMWR, V39, P14; 1989, MMWR, V38, P785; 1989, MMWR, V38, P765	8	121	121	0	3	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	MAR 17	1990	335	8690					645	648		10.1016/0140-6736(90)90421-Z	http://dx.doi.org/10.1016/0140-6736(90)90421-Z			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU314	1969024				2022-12-24	WOS:A1990CU31400013
J	SURTEES, R; HYLAND, K; SMITH, I				SURTEES, R; HYLAND, K; SMITH, I			CENTRAL-NERVOUS-SYSTEM METHYL-GROUP METABOLISM IN CHILDREN WITH NEUROLOGICAL COMPLICATIONS OF HIV-INFECTION	LANCET			English	Article											SURTEES, R (corresponding author), INST CHILD HLTH,DEPT CHILD HLTH,30 GUILFORD ST,LONDON WC1N 1EH,ENGLAND.				Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BARTHOLOMEW DW, 1988, J PEDIATR-US, V112, P32, DOI 10.1016/S0022-3476(88)80114-8; Beckman D R, 1987, Birth Defects Orig Artic Ser, V23, P47; BELMAN AL, 1986, NEUROLOGY, V36, P1192, DOI 10.1212/WNL.36.9.1192; BELMAN AL, 1988, AM J DIS CHILD, V142, P29, DOI 10.1001/archpedi.1988.02150010039017; BUDKA H, 1986, ACTA NEUROPATHOL, V69, P253, DOI 10.1007/BF00688301; CLAYTON PT, 1986, J NEUROL NEUROSUR PS, V49, P920, DOI 10.1136/jnnp.49.8.920; DEVIVO DC, 1984, NEUROLOGY, V27, P609; DICKSON DW, 1989, NEUROLOGY, V39, P227, DOI 10.1212/WNL.39.2.227; EPSTEIN LG, 1988, ANN NEUROL, V23, pS19, DOI 10.1002/ana.410230709; GRAY F, 1988, BRAIN, V111, P245, DOI 10.1093/brain/111.2.245; HABIBI P, 1989, EUR J PEDIATR, V148, P315, DOI 10.1007/BF00444122; HIRATA F, 1980, SCIENCE, V209, P1082, DOI 10.1126/science.6157192; HOWELLS DW, 1986, J CHROMATOGR, V381, P285, DOI 10.1016/S0378-4347(00)83594-X; HYLAND K, 1988, NEUROLOGY, V38, P459, DOI 10.1212/WNL.38.3.459; KOENIG S, 1986, SCIENCE, V233, P1089, DOI 10.1126/science.3016903; LUND E, 1984, NEURORADIOLOGY, V26, P351, DOI 10.1007/BF00327486; Nathan C F, 1986, Interferon, V7, P125; PETITO CK, 1985, NEW ENGL J MED, V312, P874, DOI 10.1056/NEJM198504043121402; PRICE RW, 1988, SCIENCE, V239, P586, DOI 10.1126/science.3277272; RICHTER C, 1987, CHEM PHYS LIPIDS, V44, P175, DOI 10.1016/0009-3084(87)90049-1; SCOTT JM, 1981, LANCET, V2, P334; SMITH I, 1985, J INHERIT METAB DIS, V8, P39, DOI 10.1007/BF01800658; SMITH I, 1987, LANCET, V2, P215; SURTEEDS R, IN PRESS J NEUROL NE; SURTEES R, 1989, ANAL BIOCHEM, V181, P331, DOI 10.1016/0003-2697(89)90252-2; WALKER DG, 1989, J NEUROL NEUROSUR PS, V52, P583, DOI 10.1136/jnnp.52.5.583; WEIR DG, 1988, J NEUROCHEM, V51, P1949, DOI 10.1111/j.1471-4159.1988.tb01184.x; ZAPPIA V, 1979, BIOCH PHARM ROLES AD, P2	28	63	65	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	MAR 17	1990	335	8690					619	621		10.1016/0140-6736(90)90409-X	http://dx.doi.org/10.1016/0140-6736(90)90409-X			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU314	1969014				2022-12-24	WOS:A1990CU31400002
J	ROSENLOF, K; FYHRQUIST, F; TENHUNEN, R				ROSENLOF, K; FYHRQUIST, F; TENHUNEN, R			ERYTHROPOIETIN, ALUMINUM, AND ANEMIA IN PATIENTS ON HEMODIALYSIS	LANCET			English	Article									UNIV HELSINKI, CENT HOSP, DEPT CLIN CHEM, SF-00170 HELSINKI 17, FINLAND	University of Helsinki; Helsinki University Central Hospital	ROSENLOF, K (corresponding author), UNIV HELSINKI, CENT HOSP, DEPT MED 4, UNIONINKATU 38, SF-00170 HELSINKI 17, FINLAND.							ALTMANN P, 1988, LANCET, V1, P1012; BEAUMONT C, 1984, EXP CELL RES, V154, P474, DOI 10.1016/0014-4827(84)90171-X; BROWN S, 1984, CLIN CHEM, V30, P1216; COCHRAN M, 1984, FEBS LETT, V176, P129, DOI 10.1016/0014-5793(84)80926-6; ESCHBACH JW, 1987, NEW ENGL J MED, V316, P73, DOI 10.1056/NEJM198701083160203; GRONHAGENRISKA C, 1989, ALUMINIUM AND IRON OVERLOAD IN HAEMODIALYSIS, P56; JACOBS K, 1985, NATURE, V313, P806, DOI 10.1038/313806a0; MCGONIGLE RJS, 1985, NEPHRON, V39, P1, DOI 10.1159/000183328; MLADENOVIC J, 1988, J CLIN INVEST, V81, P1661, DOI 10.1172/JCI113502; MOREB J, 1983, NEPHRON, V35, P196, DOI 10.1159/000183074; PASANEN AVO, 1980, INT J BIOCHEM, V12, P969; PASANEN AVO, 1985, SCAND J HAEMATOL, V34, P235; PASANEN AVO, 1982, ANN CLIN RES, V14, P61; ROSENLOF K, 1989, J INTERN MED, V226, P311, DOI 10.1111/j.1365-2796.1989.tb01401.x; RUTHERFORD T, 1979, P NATL ACAD SCI USA, V76, P833, DOI 10.1073/pnas.76.2.833; SANO S, 1961, J BIOL CHEM, V236, P1173; SASSA S, 1979, P NATL ACAD SCI USA, V76, P5321, DOI 10.1073/pnas.76.10.5321; TRAPP GA, 1983, LIFE SCI, V33, P311, DOI 10.1016/S0024-3205(83)80002-2; Van de Vyver F L, 1987, Contrib Nephrol, V55, P198; WINEARLS CG, 1986, LANCET, V2, P1175, DOI 10.1016/S0140-6736(86)92192-6	20	92	93	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 3	1990	335	8684					247	249						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL815	1967718				2022-12-24	WOS:A1990CL81500002
J	JALIHAL, S; MORRIS, GK				JALIHAL, S; MORRIS, GK			ANTISTREPTOKINASE TITERS AFTER INTRAVENOUS STREPTOKINASE	LANCET			English	Article									CITY HOSP NOTTINGHAM,NOTTINGHAM NG5 1PB,ENGLAND; UNIV NOTTINGHAM HOSP,QUEENS MED CTR,DEPT CARDIOL,NOTTINGHAM NG7 2UH,ENGLAND	Nottingham University Hospital NHS Trust; Nottingham City Hospital; University of Nottingham	JALIHAL, S (corresponding author), UNIV NOTTINGHAM HOSP,QUEENS MED CTR,DEPT HAEMATOL,NOTTINGHAM NG7 2UH,ENGLAND.							ARGENT N, 1990, LANCET, P106; CALLAN MFC, 1990, LANCET, P106; DYKEWICZ M S, 1986, Archives of Internal Medicine, V146, P305, DOI 10.1001/archinte.146.2.305; MCGRATH KG, 1984, JAMA-J AM MED ASSOC, V252, P1314, DOI 10.1001/jama.252.10.1314; PAYNE ST, 1989, LANCET, V2, P1398	5	84	86	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JAN 27	1990	335	8683					184	185		10.1016/0140-6736(90)90276-B	http://dx.doi.org/10.1016/0140-6736(90)90276-B			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL185	1967665				2022-12-24	WOS:A1990CL18500002
J	DAVIS, I; ISHHOROWICZ, D				DAVIS, I; ISHHOROWICZ, D			APICAL LOCALIZATION OF PAIR-RULE TRANSCRIPTS REQUIRES 3' SEQUENCES AND LIMITS PROTEIN DIFFUSION IN THE DROSOPHILA BLASTODERM EMBRYO	CELL			English	Article							MATERNAL MESSENGER-RNA; SEGMENT-POLARITY GENE; FUSHI-TARAZU; PATTERN-FORMATION; INSITU HYBRIDIZATION; XENOPUS OOCYTES; BICOID PROTEIN; EXPRESSION; HUNCHBACK; ENCODES	The peripheral cytoplasm (periplasm) of the Drosophila blastoderm embryo is subdivided into apical and basal compartments by a layer of nuclei. We have demonstrated three classes of periplasmic transcript localization: apical, basal, and unlocalized (apical and basal), each of which depends on 3' sequences. We define 3' apical localization signals within the even-skipped, fushi tarazu, and hairy pair-rule segmentation genes and the alpha-1-tubulin and bicoid genes. 3' human alpha-globin sequences direct transcripts basally. Transcript destination depends on transcript structure, not on transcript stability or chromosomal location. Apical transcripts direct apical compartmentalization of cytoplasmic protein. We propose that apical localization of pair-rule transcripts restricts lateral protein diffusion, thereby allowing pair-rule proteins to define sharp boundaries and precise spatial domains.			DAVIS, I (corresponding author), IMPERIAL CANC RES FUND, DEV BIOL UNIT, DEPT ZOOL, OXFORD OX1 3PS, ENGLAND.		Davis, Ilan/F-4975-2010	Ish-Horowicz, David/0000-0001-5684-7129; Davis, Ilan/0000-0002-5385-3053				AKAM ME, 1985, EMBO J, V4, P1689, DOI 10.1002/j.1460-2075.1985.tb03838.x; Alberts B., 2017, MOL BIOL CELL; ARIAS AM, 1988, DEVELOPMENT, V103, P157; BAKER NE, 1988, DEV BIOL, V125, P96, DOI 10.1016/0012-1606(88)90062-0; BANERJEE U, 1987, CELL, V49, P281, DOI 10.1016/0092-8674(87)90569-1; BANERJEE U, 1987, CELL, V51, P151, DOI 10.1016/0092-8674(87)90020-1; BAUMGARTNER S, 1987, GENE DEV, V1, P1247, DOI 10.1101/gad.1.10.1247; BERLETH T, 1988, EMBO J, V7, P1749, DOI 10.1002/j.1460-2075.1988.tb03004.x; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; DAVIS I, 1990, CELL BIOL INT REP, V14, pS9; DAVIS I, 1990, THESIS OXFORD U OXFO; DAVIS L, 1987, NATURE, V330, P477, DOI 10.1038/330477a0; DINARDO S, 1987, GENE DEV, V1, P1212, DOI 10.1101/gad.1.10.1212; DOE CQ, 1988, SCIENCE, V239, P170, DOI 10.1126/science.2892267; DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; EDGAR BA, 1987, GENE DEV, V1, P1226, DOI 10.1101/gad.1.10.1226; EDGAR BA, 1989, DEV GENET, V10, P124, DOI 10.1002/dvg.1020100303; EDGAR BA, 1986, CELL, V47, P747, DOI 10.1016/0092-8674(86)90517-9; Erlich H.A., 1989, PCR TECHNOLOGY; FONTAINE B, 1988, EMBO J, V7, P603, DOI 10.1002/j.1460-2075.1988.tb02853.x; GARNER CC, 1988, NATURE, V336, P674, DOI 10.1038/336674a0; GAUL U, 1989, DEVELOPMENT, V107, P651; Gottlieb E, 1990, CURR OPIN CELL BIOL, V2, P1080, DOI 10.1016/0955-0674(90)90159-C; HAENLIN M, 1990, DEVELOPMENT, V110, P905; HARTLEY DA, 1987, EMBO J, V6, P3407, DOI 10.1002/j.1460-2075.1987.tb02664.x; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; HIROMI Y, 1985, CELL, V43, P603, DOI 10.1016/0092-8674(85)90232-6; HOOPER JE, 1989, CELL, V59, P751, DOI 10.1016/0092-8674(89)90021-4; Howard K, 1990, Semin Cell Biol, V1, P161; HULSKAMP M, 1990, NATURE, V346, P577, DOI 10.1038/346577a0; INGHAM P, 1988, DEVELOPMENT, V104, P51; INGHAM PW, 1988, NATURE, V331, P73, DOI 10.1038/331073a0; INGHAM PW, 1988, NATURE, V335, P25, DOI 10.1038/335025a0; INGHAM PW, 1985, NATURE, V318, P439, DOI 10.1038/318439a0; ISHHOROWICZ D, 1987, CELL, V51, P405, DOI 10.1016/0092-8674(87)90636-2; JAEGER JA, 1989, P NATL ACAD SCI USA, V86, P7706, DOI 10.1073/pnas.86.20.7706; KALDERON D, 1984, CELL, V39, P499, DOI 10.1016/0092-8674(84)90457-4; KELLERMAN KA, 1990, GENE DEV, V4, P1936, DOI 10.1101/gad.4.11.1936; KOPCZYNSKI CC, 1989, DEVELOPMENT, V107, P623; LAUGHON A, 1984, NATURE, V310, P25, DOI 10.1038/310025a0; LAWRENCE JB, 1986, CELL, V45, P407, DOI 10.1016/0092-8674(86)90326-0; LAWRENCE PA, 1987, NATURE, V328, P440, DOI 10.1038/328440a0; LAWRENCE PA, 1989, DEVELOPMENT, V105, P761; LEHMANN R, 1991, DEVELOPMENT, V112, P679; MACDONALD PM, 1988, NATURE, V336, P595, DOI 10.1038/336595a0; MACDONALD PM, 1986, CELL, V47, P721, DOI 10.1016/0092-8674(86)90515-5; Mattaj IW, 1990, CURR OPIN CELL BIOL, V2, P528, DOI 10.1016/0955-0674(90)90138-5; MELTON DA, 1987, NATURE, V328, P80, DOI 10.1038/328080a0; MITCHISON TJ, 1983, DEV BIOL, V99, P261, DOI 10.1016/0012-1606(83)90275-0; NAKANO Y, 1989, NATURE, V341, P508, DOI 10.1038/341508a0; OFARRELL PH, 1989, SCIENCE, V246, P635, DOI 10.1126/science.2683080; PANKRATZ MJ, 1990, CELL, V61, P309, DOI 10.1016/0092-8674(90)90811-R; POLLOCK JA, 1990, GENE DEV, V4, P806, DOI 10.1101/gad.4.5.806; RAFF JW, 1990, DEVELOPMENT, V110, P1249; RALSTON E, 1989, SCIENCE, V244, P1066, DOI 10.1126/science.2543074; RIDDIHOUGH G, 1991, IN PRESS GENES DEV; ROTHBERG JM, 1990, GENE DEV, V4, P2169, DOI 10.1101/gad.4.12a.2169; RUSHLOW CA, 1989, EMBO J, V8, P3095, DOI 10.1002/j.1460-2075.1989.tb08461.x; Sambrook J., 1989, MOL CLONING LAB MANU; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHWEISGUTH F, 1990, GENE DEV, V4, P922, DOI 10.1101/gad.4.6.922; SILVER PA, 1991, CELL, V64, P489, DOI 10.1016/0092-8674(91)90233-O; SIMONS K, 1990, CELL, V62, P207, DOI 10.1016/0092-8674(90)90357-K; Spradling AC, 1986, DROSOPHILA PRACTICAL, P175; STELLER H, 1985, EMBO J, V4, P167, DOI 10.1002/j.1460-2075.1985.tb02332.x; STJOHNSTON D, 1989, DEVELOPMENT, V107, P13; STRUHL G, 1989, CELL, V57, P1259, DOI 10.1016/0092-8674(89)90062-7; STRUHL G, 1985, NATURE, V318, P677, DOI 10.1038/318677a0; TAUTZ D, 1987, NATURE, V327, P383, DOI 10.1038/327383a0; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; TRAPP BD, 1987, P NATL ACAD SCI USA, V84, P7773, DOI 10.1073/pnas.84.21.7773; WEINER AJ, 1984, CELL, V37, P843, DOI 10.1016/0092-8674(84)90419-7; WEIR MP, 1985, NATURE, V318, P433, DOI 10.1038/318433a0; Wieschaus E., 1986, P199; YISRAELI JK, 1988, NATURE, V336, P592, DOI 10.1038/336592a0	77	134	135	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 29	1991	67	5					927	940		10.1016/0092-8674(91)90366-7	http://dx.doi.org/10.1016/0092-8674(91)90366-7			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GT755	1959136				2022-12-24	WOS:A1991GT75500012
J	RUSSELL, DM; DEMBIC, Z; MORAHAN, G; MILLER, JFAP; BURKI, K; NEMAZEE, D				RUSSELL, DM; DEMBIC, Z; MORAHAN, G; MILLER, JFAP; BURKI, K; NEMAZEE, D			PERIPHERAL DELETION OF SELF-REACTIVE B-CELLS	NATURE			English	Article							IMMUNOGLOBULIN-M; TRANSGENIC MICE; CLONAL DELETION; LYMPHOCYTES-B; T-CELL; TOLERANCE; SUSCEPTIBILITY; SUPPRESSION; EXPRESSION; ANTIGENS	B LYMPHOCYTES are key participants in the immune response because of their specificity, their ability to take up and present antigens to T cells, and their capacity to differentiate into antibody-secreting cells. To limit reactivity to self antigens, autospecific B cells can be functionally inactivated or deleted 1-4. Developing B cells that react with membrane antigens expressed in the bone, marrow are deleted from the peripheral lymphocyte pool 4-6. It is important to ascertain the fate of B cells that recognize membrane autoantigens expressed exclusively on peripheral tissues because B cells in the peripheral lymphoid organs are phenotypically and functionally distinct from bone-marrow B cells 7-9. Here we show that in immunoglobulin-transgenic mice, B cells specific for major histocompatibility complex class I antigen can be deleted if they encounter membrane-bound antigen at a post-bone-marrow stage of development. This deletion may be necessary to prevent organ-specific autoimmunity.	NATL JEWISH CTR IMMUNOL & RESP MED,DEPT PEDIAT,DIV BASIC SCI,1400 JACKSON ST,DENVER,CO 80206; HOFFMANN LA ROCHE AG,DEPT MOLEC BIOL,CH-4005 BASEL,SWITZERLAND; ROYAL MELBOURNE HOSP,WALTER & ELIZA HALL INST MED RES,PARKVILLE,VIC 3050,AUSTRALIA; ROYAL MELBOURNE HOSP,PARKVILLE,VIC 3050,AUSTRALIA; SANDOZ LTD,DEPT BIOTECHNOL,CH-4002 BASEL,SWITZERLAND; UNIV COLORADO,HLTH SCI CTR,DEPT MICROBIOL & IMMUNOL,DENVER,CO 80262	National Jewish Health; Roche Holding; Royal Melbourne Hospital; Walter & Eliza Hall Institute; Royal Melbourne Hospital; Novartis; Sandoz; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver			Morahan, Grant/T-7501-2019; Dembic, Zlatko/A-1833-2008	Dembic, Zlatko/0000-0002-9970-6497	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM044809] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM044809] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALESMARTINEZ JE, 1988, P NATL ACAD SCI USA, V85, P6919, DOI 10.1073/pnas.85.18.6919; CHESTNUT RW, 1981, J IMMUNOL, V115, P1075; COFFMAN RL, 1981, NATURE, V289, P681, DOI 10.1038/289681a0; DEMBIC Z, 1986, NATURE, V320, P232, DOI 10.1038/320232a0; ERIKSON J, 1991, NATURE, V349, P331, DOI 10.1038/349331a0; GOODNOW CC, 1988, NATURE, V334, P676, DOI 10.1038/334676a0; GROSVELD FG, 1982, NUCLEIC ACIDS RES, V10, P67145; GU H, 1991, J EXP MED, V173, P1357, DOI 10.1084/jem.173.6.1357; Hardy R. R., 1986, HDB EXPT IMMUNOLOGY; JONES DT, 1987, J BIOL CHEM, V262, P13241; LEPTIN M, 1984, EUR J IMMUNOL, V14, P534, DOI 10.1002/eji.1830140610; MORAHAN G, 1989, P NATL ACAD SCI USA, V86, P3782, DOI 10.1073/pnas.86.10.3782; NAKAMURA RM, 1986, HDB EXPT IMMUNOLOGY; NEMAZEE D, 1991, IMMUNOL REV, V122, P117, DOI 10.1111/j.1600-065X.1991.tb00600.x; NEMAZEE D, 1989, P NATL ACAD SCI USA, V86, P8039, DOI 10.1073/pnas.86.20.8039; NEMAZEE DA, 1989, NATURE, V337, P562, DOI 10.1038/337562a0; NEMAZEE DA, 1987, P EMBO WORKSHOP TOLE, V2, P52; NOSSAL GJV, 1989, SCIENCE, V245, P147, DOI 10.1126/science.2526369; OZATO K, 1980, J IMMUNOL, V124, P533; RAFF MC, 1975, J EXP MED, V142, P1052, DOI 10.1084/jem.142.5.1052; RAMMENSEE HG, 1985, IMMUNOL TODAY, V6, P41, DOI 10.1016/0167-5699(85)90044-1; RON Y, 1987, J IMMUNOL, V138, P2848; SCOTT DW, 1977, J EXP MED, V146, P1473, DOI 10.1084/jem.146.6.1473; SIDMAN CL, 1975, NATURE, V257, P149, DOI 10.1038/257149a0; SIECKMAN D, 1987, FED PROC, V43, P488; STALL AM, 1984, J IMMUNOL, V132, P187; STEINMETZ M, 1981, CELL, V24, P125, DOI 10.1016/0092-8674(81)90508-0; TISCH R, 1988, P NATL ACAD SCI USA, V85, P6914, DOI 10.1073/pnas.85.18.6914; VITETTA ES, 1977, J EXP MED, V146, P1804, DOI 10.1084/jem.146.6.1804	29	325	328	0	3	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 28	1991	354	6351					308	311		10.1038/354308a0	http://dx.doi.org/10.1038/354308a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT204	1956380	Green Accepted			2022-12-24	WOS:A1991GT20400048
J	BLACK, ME; SCHEUER, MA; VICTOR, C; BENZEVAL, M; GILL, M; JUDGE, K				BLACK, ME; SCHEUER, MA; VICTOR, C; BENZEVAL, M; GILL, M; JUDGE, K			UTILIZATION BY HOMELESS PEOPLE OF ACUTE HOSPITAL SERVICES IN LONDON	BRITISH MEDICAL JOURNAL			English	Article								Objectives - To estimate the numbers and distribution of homeless people in London; to quantify the utilisation of acute inpatient services by homeless people in two health authorities; and to predict the total numbers of admissions in homeless people in district health authorities across London. Design - Data were collected from various sources on the distribution of homeless people across London boroughs. All unplanned acute inpatient admissions during November 1990 to relevant hospitals were identified. Setting - Bloomsbury and Paddington and North Kensington, two former inner London district health authorities. Subjects - Homeless people in London residing in bed and breakfast and private sector leased accommodation, residing in hostels, and of no fixed abode. Main outcome measures - Number and cost of acute unplanned admissions in homeless people in two health authorities in November 1990; predicted number of such admissions each year in district health authorities in London. Results - There were at least 60000 homeless people in London in March 1990. The majority were housed in temporary accommodation (55 412). There were at least 3295 hostel dwellers and 651 people sleeping rough. Homeless people accounted for 105 (8%) of the 1256 acute unbooked admissions in residents of Bloomsbury and Paddington and North Kensington health authorities in November 1990. Considerable variations in the pattern of acute unplanned admissions in homeless people were observed in the two districts with respect to housing status and specialty of admission. The total number of acute unplanned admissions in homeless people across London each year was estimated at 7598, ranging from 38 in Bexley to 1515 in Parkside. Conclusions - The results have fundamental implications for resource allocation across London. Allocation must take better account of the heterogeneity, uneven distribution, and extra health needs of homeless people.	KINGS FUND INST,LONDON NW1 7NF,ENGLAND; BLOOMSBURY & ISLINGTON HLTH AUTHOR,DEPT PUBL HLTH MED,LONDON WC1E 6DB,ENGLAND; PARKSIDE HLTH AUTHOR,DEPT PUBL HLTH MED,LONDON W2 1PF,ENGLAND				Benzeval, Michaela/J-3163-2015	Benzeval, Michaela/0000-0002-0372-2098; Victor, Christina/0000-0002-4213-3974				BARRY A, 1991, 84 U YORK CTR HLTH E; BRAMLEY G, 1987, HOMELESSNESS LONDON; CANTER D, 1990, FACES HOMELESSNESS L; CONNELLY J, 1990, PUBLIC HEALTH, V104, P109, DOI 10.1016/S0033-3506(05)80361-0; CONWAY J, 1988, PRESCRIPTION POOR HL; EVANS A, 1989, RESPONDING HOMELESSN; NEWMAN R, 1989, LONDON HOSTELS DIREC; PRIEST RG, 1976, J PSYCHIATRY, V128, P130; SCHEUER MA, 1991, 4 KINGS FUND I OCC P; SHANKS NJ, 1988, J EPIDEMIOL COMMUN H, V42, P183, DOI 10.1136/jech.42.2.183; STERN R, 1988, MARGINS MAINSTREAM C; THOMAS A, 1989, LIVING TEMPORARY ACC; VICTOR CR, 1989, BRIT MED J, V229, P725; 1991, 1991 CENSUS PRELIMIN; 1991, HOUSING HOMELESSNESS; 1989, WORKING PATIENTS; 1990, EL90MB22 DEP HLTH; 1989, HOMELESS FAMILIES TH; 1990, ACTIONS LOCAL AUTHOR; 1990, LOCATION HOMELESS HO; 1988, HOMELESSNESS USE TEM	21	13	13	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 19	1991	303	6808					958	961		10.1136/bmj.303.6808.958	http://dx.doi.org/10.1136/bmj.303.6808.958			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GL127	1954419	Green Published, Bronze			2022-12-24	WOS:A1991GL12700021
J	PEVNY, L; SIMON, MC; ROBERTSON, E; KLEIN, WH; TSAI, SF; DAGATI, V; ORKIN, SH; COSTANTINI, F				PEVNY, L; SIMON, MC; ROBERTSON, E; KLEIN, WH; TSAI, SF; DAGATI, V; ORKIN, SH; COSTANTINI, F			ERYTHROID-DIFFERENTIATION IN CHIMERIC MICE BLOCKED BY A TARGETED MUTATION IN THE GENE FOR TRANSCRIPTION FACTOR GATA-1	NATURE			English	Article							DNA-BINDING FACTOR; STEM-CELLS; EXPRESSION; PROTEIN	THE zinc-finger transcription factor GATA-1 (previously known as GF-1, NF-E1 or Eryf 1 (refs 1-5)) binds to GATA consensus elements in regulatory regions of the alpha- and beta-globin gene clusters 2-6 and other erythroid cell-specific genes 7-9. Analysis of the effects of mutations in GATA-bindig sites in cell culture and in binding assays in vitro 2,5,10,11, as well as transactivation studies with GATA-1 expression vectors in heterologous cells 12, have provided indirect evidence that this factor is involved in the activation of globin and other genes during erythroid cell maturation. GATA-1 is also expressed in megakaryocyte 13,14 and mast cells, but not in other blood cell lineages or in non-haemopoietic cells. To investigate the role of this factor in haematopoiesis in vivo, we disrupted the X-linked GATA-1 gene by homologous recombination in a male (XY) murine embryonic stem cell line and tested the GATA-1-deficient cells for their ability to contribute to different tissues in chimaeric mice. The mutant embryonic stem cells contributed to all non-haemopoietic tissues tested and to a white blood cell fraction, but failed to give rise to mature red blood cells. This demonstrates that GATA-1 is required for the normal differentiation of erythroid cells, and that other GATA-binding proteins 15,16 cannot compensate for its absence.	COLUMBIA UNIV COLL PHYS & SURG,DEPT GENET & DEV,701 W 168TH ST,NEW YORK,NY 10032; COLUMBIA UNIV COLL PHYS & SURG,DEPT PATHOL,NEW YORK,NY 10032; HARVARD UNIV,CHILDRENS HOSP,SCH MED,DEPT PEDIAT,DIV HEMATOL ONCOL,BOSTON,MA 02115; HOWARD HUGHES MED INST,BOSTON,MA 02115	Columbia University; Columbia University; Harvard University; Boston Children's Hospital; Harvard Medical School; Howard Hughes Medical Institute			Tsai, Shih-Feng/E-3997-2010; Simon, Celeste/AAG-3941-2021					BRADY HJM, 1989, FEBS LETT, V257, P451, DOI 10.1016/0014-5793(89)81594-7; DICHIARA TM, 1990, NATURE, V344, P78; EVANS T, 1988, P NATL ACAD SCI USA, V85, P5976, DOI 10.1073/pnas.85.16.5976; EVANS T, 1989, CELL, V58, P877, DOI 10.1016/0092-8674(89)90940-9; FLEISCHMAN RA, 1982, CELL, V30, P351, DOI 10.1016/0092-8674(82)90233-1; FRAMPTON J, 1990, MOL CELL BIOL, V10, P3838, DOI 10.1128/MCB.10.7.3838; KOLLER BH, 1990, SCIENCE, V248, P1227, DOI 10.1126/science.2112266; MANSOUR SL, 1988, NATURE, V236, P438; MARTIN DIK, 1990, GENE DEV, V4, P1886, DOI 10.1101/gad.4.11.1886; MARTIN DIK, 1989, NATURE, V338, P435, DOI 10.1038/338435a0; MARTIN DIK, 1990, NATURE, V344, P444, DOI 10.1038/344444a0; MCCULLOCH EA, 1964, SCIENCE, V144, P844, DOI 10.1126/science.144.3620.844; MCLAREN A, 1981, GENET RES CAMB, V37, P305; MIGNOTTE V, 1989, NUCLEIC ACIDS RES, V17, P37, DOI 10.1093/nar/17.1.37; ORKIN SH, 1990, CELL, V63, P665, DOI 10.1016/0092-8674(90)90133-Y; REITMAN M, 1988, P NATL ACAD SCI USA, V85, P6267, DOI 10.1073/pnas.85.17.6267; ROBERTSON E, 1986, NATURE, V323, P445, DOI 10.1038/323445a0; Robertson EJ, 1987, TERATOCARCINOMAS EMB, P71; ROMEO PH, 1990, NATURE, V344, P447, DOI 10.1038/344447a0; RUSSELL ES, 1974, ANN NY ACAD SCI, V241, P25, DOI 10.1111/j.1749-6632.1974.tb21864.x; SCHOLER HR, 1989, EMBO J, V8, P2543, DOI 10.1002/j.1460-2075.1989.tb08392.x; THOMAS KR, 1987, CELL, V51, P503, DOI 10.1016/0092-8674(87)90646-5; TSAI SF, 1989, NATURE, V339, P446, DOI 10.1038/339446a0; WALL L, 1988, GENE DEV, V2, P1089, DOI 10.1101/gad.2.9.1089; WHITNEY JB, 1978, BIOCHEM GENET, V16, P667, DOI 10.1007/BF00484723; WILSON DB, 1990, MOL CELL BIOL, V10, P4854, DOI 10.1128/MCB.10.9.4854; YAMAMOTO M, IN PRESS GENES DEV; YOUSSOUFIAN H, 1990, MOL CELL BIOL, V10, P3675, DOI 10.1128/MCB.10.7.3675; ZIJLSTRA M, 1990, NATURE, V344, P742, DOI 10.1038/344742a0; ZON LI, 1990, P NATL ACAD SCI USA, V87, P668, DOI 10.1073/pnas.87.2.668	30	1112	1139	0	20	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JAN 17	1991	349	6306					257	260		10.1038/349257a0	http://dx.doi.org/10.1038/349257a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET519	1987478				2022-12-24	WOS:A1991ET51900062
J	GOODWIN, JS				GOODWIN, JS			MERCY KILLING - MERCY FOR WHOM	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	13	13	1	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 16	1991	265	3					326	326		10.1001/jama.265.3.326	http://dx.doi.org/10.1001/jama.265.3.326			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ER256	1984530				2022-12-24	WOS:A1991ER25600009
J	LIN, HF; WOLFNER, MF				LIN, HF; WOLFNER, MF			THE DROSOPHILA MATERNAL-EFFECT GENE FS(1)YA ENCODES A CELL-CYCLE DEPENDENT NUCLEAR-ENVELOPE COMPONENT REQUIRED FOR EMBRYONIC MITOSIS	CELL			English	Article							FEMALE-STERILE MUTANTS; DNA-BINDING PROTEINS; MONOCLONAL-ANTIBODIES; DEVELOPMENTAL REGULATION; MITOTIC CONTROL; POLE CELLS; HEAT-SHOCK; MELANOGASTER; EMBRYOGENESIS; DIVISION	The maternal-effect gene fs(1)Ya is specifically required for embryonic mitosis in Drosophila. fs(1)Ya is involved in the initiation of the first embryonic mitosis and may also be necessary for subsequent embryonic mitotic divisions. fs(1)Ya encodes a 91.3 kd hydrophilic protein containing two putative MPF phosphorylation target sites and two potential nuclear localization signals. This protein is synthesized during postoogenic maturation from its maternal RNA and persists throughout embryogenesis. In early embryos, the fs(1)Ya protein is localized to the nuclear envelope from interphase to metaphase. During anaphase and telophase, it is dispersed in the nucleoplasm and cytoplasm, a behavior that is different from that of both the nuclear envelope and lamins. These results suggest that the fs(1)Ya protein is a cell cycle-dependent component of the nuclear envelope that specifically functions in embryonic mitosis.	CORNELL UNIV, GENET & DEV SECT, ITHACA, NY 14853 USA	Cornell University								ALLIS CD, 1977, DEV BIOL, V56, P372, DOI 10.1016/0012-1606(77)90277-9; BAKER BS, 1975, GENETICS, V80, P267; BERLETH T, 1988, EMBO J, V7, P1749, DOI 10.1002/j.1460-2075.1988.tb03004.x; BLOW J, 1989, TRENDS GENET, V5, P166, DOI 10.1016/0168-9525(89)90067-X; Blumenthal AB, 1974, COLD SPRING HARB SYM, V38, P205, DOI 10.1101/sqb.1974.038.01.024; BREEDEN L, 1987, CELL, V48, P389, DOI 10.1016/0092-8674(87)90190-5; BREEUWER JAJ, 1990, NATURE, V346, P558, DOI 10.1038/346558a0; BROWN NH, 1988, J MOL BIOL, V203, P425, DOI 10.1016/0022-2836(88)90010-1; CAVENER DR, 1987, NUCLEIC ACIDS RES, V15, P1353, DOI 10.1093/nar/15.4.1353; CHURCHILL MEA, 1989, EMBO J, V8, P4189, DOI 10.1002/j.1460-2075.1989.tb08604.x; COUREY AJ, 1988, CELL, V55, P887, DOI 10.1016/0092-8674(88)90144-4; CYERT MS, 1989, CELL, V57, P891, DOI 10.1016/0092-8674(89)90325-5; DIBENEDETTO AJ, 1990, DEV BIOL, V139, P134, DOI 10.1016/0012-1606(90)90284-P; DINGWALL C, 1986, ANNU REV CELL BIOL, V2, P367, DOI 10.1146/annurev.cellbio.2.1.367; DOOLITTLE FR, 1986, URFS ORFS PRIMER ANA; DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; DUNPHY WG, 1988, CELL, V55, P925, DOI 10.1016/0092-8674(88)90234-6; EDGAR BA, 1986, CELL, V44, P871, DOI 10.1016/0092-8674(86)90009-7; EDGAR BA, 1986, CELL, V44, P365, DOI 10.1016/0092-8674(86)90771-3; EDGAR BA, 1989, CELL, V57, P177, DOI 10.1016/0092-8674(89)90183-9; ELKINS T, 1990, CELL, V60, P565, DOI 10.1016/0092-8674(90)90660-7; EVANS RM, 1988, CELL, V52, P1, DOI 10.1016/0092-8674(88)90522-3; FINNEY M, 1988, CELL, V55, P757, DOI 10.1016/0092-8674(88)90132-8; FOE VE, 1983, J CELL SCI, V61, P31; FOE VE, 1989, DEVELOPMENT, V107, P1; FOX CA, 1989, GENE DEV, V3, P2151, DOI 10.1101/gad.3.12b.2151; FOX VE, 1983, J CELL SCI, V61, P31; FRASCH M, 1988, J CELL SCI, V90, P247; FREEMAN M, 1986, CELL, V46, P457, DOI 10.1016/0092-8674(86)90666-5; FREEMAN M, 1987, GENE DEV, V1, P924, DOI 10.1101/gad.1.9.924; FUCHS JP, 1983, J CELL SCI, V64, P331; FUYAMA Y, 1984, JPN J GENET, V59, P91, DOI 10.1266/jjg.59.91; FUYAMA Y, 1986, GENETICS, V112, P237; GANS M, 1975, GENETICS, V81, P683; GERACE L, 1986, TRENDS BIOCHEM SCI, V11, P443, DOI 10.1016/0968-0004(86)90243-4; GILBERT SF, 1988, DEV BIOL, P785; GLOVER DM, 1989, J CELL SCI, V92, P137; GLOVER DM, 1990, NATURE, V348, P117, DOI 10.1038/348117a0; GOEBL M, 1988, CELL, V54, P739; GUO LH, 1984, GENE, V29, P251, DOI 10.1016/0378-1119(84)90186-0; HARLOW E, 1988, ANTIBODIES LABORATOR; HARTWELL LH, 1989, SCIENCE, V246, P629, DOI 10.1126/science.2683079; HEALD R, 1990, CELL, V61, P579, DOI 10.1016/0092-8674(90)90470-Y; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; JUDD BH, 1972, GENETICS, V71, P139; JUDD BH, 1973, COLD SPRING HARB SYM, V38, P573, DOI 10.1101/SQB.1974.038.01.061; KARR TL, 1986, J CELL BIOL, V102, P1494, DOI 10.1083/jcb.102.4.1494; KLEMENZ R, 1987, NUCLEIC ACIDS RES, V15, P3947, DOI 10.1093/nar/15.10.3947; KOMALSKI D, 1976, BIOCHEMISTRY-US, V15, P4463; KROHNE G, 1986, EXP CELL RES, V162, P1, DOI 10.1016/0014-4827(86)90421-0; KROHNE G, 1989, J CELL BIOL, V109, P2003, DOI 10.1083/jcb.109.5.2003; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; LASKO PF, 1988, NATURE, V335, P611, DOI 10.1038/335611a0; LAUGHON A, 1984, NATURE, V310, P25, DOI 10.1038/310025a0; LEHNER CF, 1989, CELL, V56, P957, DOI 10.1016/0092-8674(89)90629-6; LEHNER CF, 1990, CELL, V61, P535, DOI 10.1016/0092-8674(90)90535-M; LEWIN B, 1990, CELL, V61, P743, DOI 10.1016/0092-8674(90)90181-D; LIN H, 1989, MOL GEN GENET, V215, P257, DOI 10.1007/BF00339726; LOHKA MJ, 1989, J CELL SCI, V92, P131; Mahowald A.P., 1980, Genetics and Biology of Drosophila, V2d, P141; Maniatis T., 1982, MOL CLONING; MASUI Y, 1971, J EXP ZOOL, V177, P129, DOI 10.1002/jez.1401770202; MCGINNIS W, 1984, NATURE, V308, P428, DOI 10.1038/308428a0; MERRILL PT, 1988, DEVELOPMENT, V104, P495; MOHLER JD, 1977, GENETICS, V85, P259; MONSMA SA, 1988, GENE DEV, V2, P1063, DOI 10.1101/gad.2.9.1063; MURRAY AW, 1989, NATURE, V339, P275, DOI 10.1038/339275a0; NEWPORT J, 1987, CELL, V48, P205, DOI 10.1016/0092-8674(87)90424-7; NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0; OFARRELL PH, 1989, SCIENCE, V246, P635, DOI 10.1126/science.2683080; PERRIMON N, 1986, GENETICS, V113, P695; PETER M, 1990, CELL, V61, P591, DOI 10.1016/0092-8674(90)90471-P; PETER M, 1990, CELL, V60, P791, DOI 10.1016/0092-8674(90)90093-T; POOLE SJ, 1985, CELL, V40, P37, DOI 10.1016/0092-8674(85)90306-X; PTASHNE M, 1988, NATURE, V335, P683, DOI 10.1038/335683a0; QUERY CC, 1989, CELL, V57, P89, DOI 10.1016/0092-8674(89)90175-X; RAFF JW, 1989, CELL, V57, P611, DOI 10.1016/0092-8674(89)90130-X; RESTIFO LL, 1986, DEV BIOL, V115, P507, DOI 10.1016/0012-1606(86)90271-X; RISAU W, 1981, EXP CELL RES, V133, P47, DOI 10.1016/0014-4827(81)90355-4; ROBERTSON HM, 1988, GENETICS, V118, P461; SANTAMARIA P, 1980, NATURE, V287, P143, DOI 10.1038/287143a0; SAUMWEBER H, 1980, CHROMOSOMA, V80, P253, DOI 10.1007/BF00292684; SCHUPBACH T, 1989, GENETICS, V121, P101; SMITH DE, 1984, J CELL BIOL, V99, P20, DOI 10.1083/jcb.99.1.20; SMITH LD, 1971, DEV BIOL, V25, P232, DOI 10.1016/0012-1606(71)90029-7; SOLOMON M, 1988, CELL, V54, P738, DOI 10.1016/S0092-8674(88)90933-6; Sonnenblick B., 1950, BIOL DROSOPHILA, P62; STAFSTROM JP, 1984, EUR J CELL BIOL, V34, P179; STRUHL G, 1989, CELL, V57, P1259, DOI 10.1016/0092-8674(89)90062-7; SUZUKI M, 1989, EMBO J, V8, P797, DOI 10.1002/j.1460-2075.1989.tb03440.x; THEILL LE, 1989, NATURE, V342, P945, DOI 10.1038/342945a0; VASSALLI JD, 1989, GENE DEV, V3, P2163, DOI 10.1101/gad.3.12b.2163; WARD GE, 1990, CELL, V61, P561, DOI 10.1016/0092-8674(90)90469-U; WHARTON KA, 1985, CELL, V40, P55, DOI 10.1016/0092-8674(85)90308-3; WHITFIELD WGF, 1988, J CELL SCI, V89, P467; WHITFIELD WGF, 1989, NATURE, V338, P337, DOI 10.1038/338337a0; WIESCHAUS E, 1988, DEVELOPMENT, V104, P483; WOLSTENHOLME DR, 1965, GENETICS, V52, P949; XIAO H, 1989, MOL CELL BIOL, V9, P1746, DOI 10.1128/MCB.9.4.1746; YOUNG MW, 1978, GENETICS, V88, P723; ZALOKAR M, 1976, DEV BIOL, V49, P425, DOI 10.1016/0012-1606(76)90185-8; ZALOKAR M, 1976, J MICROSC BIOL CELL, V25, P97; ZALOKAR M, 1975, DEV BIOL, V47, P419, DOI 10.1016/0012-1606(75)90295-X	103	67	68	0	1	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 11	1991	64	1					49	62		10.1016/0092-8674(91)90208-G	http://dx.doi.org/10.1016/0092-8674(91)90208-G			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ET175	1986869				2022-12-24	WOS:A1991ET17500008
J	TAMIMI, TM; WOSORNU, L; ALKHOZAIM, A; ABDULGHANI, A				TAMIMI, TM; WOSORNU, L; ALKHOZAIM, A; ABDULGHANI, A			INCREASED CHOLECYSTECTOMY RATES IN SAUDI-ARABIA	LANCET			English	Article									KING FAISAL UNIV,KING FAHD HOSP,DEPT SURG,AL KHOBAR,SAUDI ARABIA; KING FAISAL UNIV,KING FAHD HOSP,DEPT HAEMATOL,AL KHOBAR,SAUDI ARABIA	Imam Abdulrahman Bin Faisal University; King Faisal University; Imam Abdulrahman Bin Faisal University; King Faisal University								ACALOVSCHI M, 1987, DIGEST DIS SCI, V32, P354, DOI 10.1007/BF01296287; BATES T, 1990, J ROY SOC MED, V83, P176, DOI 10.1177/014107689008300316; BENNION LJ, 1978, NEW ENGL J MED, V299, P1221, DOI 10.1056/NEJM197811302992205; BENNION LJ, 1978, NEW ENGL J MED, V299, P1161, DOI 10.1056/NEJM197811232992104; BIANTON D, 1976, NEW ENGL J MED, V294, P1147; BOUCHIER IA, 1969, GUT, V10, P705, DOI 10.1136/gut.10.9.705; BRETT M, 1976, INT J EPIDEMIOL, V5, P335, DOI 10.1093/ije/5.4.335; BURKITT DP, 1973, BMJ-BRIT MED J, V1, P274, DOI 10.1136/bmj.1.5848.274; BURKITT DP, 1975, J TROP MED HYG, V78, P140; CRANSTON D, 1988, BRIT J SURG, V75, P508, DOI 10.1002/bjs.1800750604; DIEHL AK, 1987, LANCET, V2, P683; HEATON KW, 1975, REFINED CARBOHYDRATE, P173; KALSER MH, 1985, GASTROENTEROLOGY, V6, P3619; LOEFLER IJP, 1988, LANCET, V2, P683; LOWENFELS AB, 1988, LANCET, V1, P1385; MOFTI AB, 1987, ANN SAUDI MED, V7, P107, DOI 10.5144/0256-4947.1987.107; NASSR HAR, 1987, SAUDI MED J, V8, P396; NORRBY S, 1986, SCAND J GASTROENTERO, V21, P158, DOI 10.3109/00365528609034641; PHILIPP R, 1987, LANCET, V1, P170; PIXLEY F, 1985, BRIT MED J, V291, P11, DOI 10.1136/bmj.291.6487.11; SAMPLINER RE, 1970, NEW ENGL J MED, V283, P1358, DOI 10.1056/NEJM197012172832502; SCRAGG RKR, 1984, BRIT MED J, V288, P1113, DOI 10.1136/bmj.288.6424.1113; 1988, FOOD BALANCE SHEETS; 1984, AM J EPIDEMIOL, V119, P796	24	24	24	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 17	1990	336	8725					1235	1237		10.1016/0140-6736(90)92845-9	http://dx.doi.org/10.1016/0140-6736(90)92845-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ064	1978082				2022-12-24	WOS:A1990EJ06400015
J	GRIMM, G; ODER, W; PRAYER, L; FERENCI, P; MADL, C				GRIMM, G; ODER, W; PRAYER, L; FERENCI, P; MADL, C			EVOKED-POTENTIALS IN ASSESSMENT AND FOLLOW-UP OF PATIENTS WITH WILSONS-DISEASE	LANCET			English	Article									UNIV VIENNA,DEPT MED,A-1090 VIENNA,AUSTRIA; UNIV VIENNA,DEPT NEUROL,A-1090 VIENNA,AUSTRIA; UNIV VIENNA,DEPT RADIOL,A-1090 VIENNA,AUSTRIA; UNIV VIENNA,DEPT GASTROENTEROL & HEPATOL,A-1090 VIENNA,AUSTRIA	University of Vienna; University of Vienna; University of Vienna; University of Vienna								ANDERSON DC, 1984, ARCH NEUROL-CHICAGO, V41, P369, DOI 10.1001/archneur.1984.04050160031011; CANT BR, 1986, EVOKED POTENTIAL, P58; CHIAPPA KH, 1988, NEUROL CLIN, V6, P161; CHU NS, 1986, BRAIN, V109, P491, DOI 10.1093/brain/109.3.491; FUJITA M, 1981, ANN NEUROL, V9, P42, DOI 10.1002/ana.410090108; GRIMM G, IN PRESS NEUROLOGY; HOROUPIAN DS, 1988, CLIN NEUROPATHOL, V7, P62; ROACH ES, 1985, J NEUROL, V232, P20, DOI 10.1007/BF00314035; STAROSTARUBINSTEIN S, 1987, ARCH NEUROL-CHICAGO, V44, P365, DOI 10.1001/archneur.1987.00520160007005; STOCKARD JJ, 1977, MAYO CLIN PROC, V52, P761; WALSHE JM, 1988, LANCET, V2, P435; [No title captured]	12	48	49	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 20	1990	336	8721					963	964		10.1016/0140-6736(90)92419-I	http://dx.doi.org/10.1016/0140-6736(90)92419-I			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ED601	1977004				2022-12-24	WOS:A1990ED60100003
J	BRAHAMS, D				BRAHAMS, D			CONFIDENTIAL DOCUMENTS IN HIV HEMOPHILIA LITIGATION	LANCET			English	Editorial Material																		BRAHAMS D, 1990, LANCET, V336, P238, DOI 10.1016/0140-6736(90)91753-W; BRAHAMS D, 1990, LANCET, V335, P528, DOI 10.1016/0140-6736(90)90751-P; BRAHAMS D, 1984, LANCET, V2, P1224	3	0	0	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 29	1990	336	8718					805	805		10.1016/0140-6736(90)93260-V	http://dx.doi.org/10.1016/0140-6736(90)93260-V			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB077	1976159				2022-12-24	WOS:A1990EB07700021
J	BERTORELLO, AM; HOPFIELD, JF; APERIA, A; GREENGARD, P				BERTORELLO, AM; HOPFIELD, JF; APERIA, A; GREENGARD, P			INHIBITION BY DOPAMINE OF (NA++K+)ATPASE ACTIVITY IN NEOSTRIATAL NEURONS THROUGH D1 AND D2 DOPAMINE RECEPTOR SYNERGISM	NATURE			English	Article									ROCKEFELLER UNIV,MOLEC & CELLULAR NEUROSCI LAB,NEW YORK,NY 10021; KAROLINSKA INST,ST GORANS CHILDRENS HOSP,DEPT PEDIAT,S-11281 STOCKHOLM,SWEDEN	Rockefeller University; Karolinska Institutet								APERIA A, 1987, AM J PHYSIOL, V252, pF39, DOI 10.1152/ajprenal.1987.252.1.F39; BERTORELLO A, 1987, ACTA PHYSIOL SCAND, V130, P571, DOI 10.1111/j.1748-1716.1987.tb08178.x; BERTORELLO A, 1989, AM J PHYSIOL, V256, pF57, DOI 10.1152/ajprenal.1989.256.1.F57; BERTORELLO A, 1988, ACTA PHYSIOL SCAND, V132, P441, DOI 10.1111/j.1748-1716.1988.tb08350.x; BERTORELLO A, 1989, AM J PHYSIOL, V256, pG370; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARLSSON A, 1988, NEUROPSYCHOPHARMACOL, V1, P179, DOI 10.1016/0893-133X(88)90012-7; CLARK D, 1987, SYNAPSE, V1, P347, DOI 10.1002/syn.890010408; DAPRADA M, 1984, EXPERIENTIA, V40, P1165; FREEDMAN JE, 1988, P NATL ACAD SCI USA, V85, P3618, DOI 10.1073/pnas.85.10.3618; GADSBY DC, 1983, NATURE, V306, P691, DOI 10.1038/306691a0; GERFEN CR, 1988, J ELECTRON MICR TECH, V10, P265, DOI 10.1002/jemt.1060100305; Glynn I. M., 1985, ENZYMES BIOL MEMBR, P35; HEMMINGS HC, 1987, RECEPTOR BIOCH METHO, V9, P115; KAY AR, 1986, J NEUROSCI METH, V16, P227, DOI 10.1016/0165-0270(86)90040-3; KEBABIAN JW, 1972, P NATL ACAD SCI USA, V69, P2145, DOI 10.1073/pnas.69.8.2145; LAFFERTY P, 1985, BIOCHEM PHARMACOL, V34, P3591, DOI 10.1016/0006-2952(85)90738-5; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MERCURI N, 1985, BRAIN RES, V358, P110, DOI 10.1016/0006-8993(85)90954-0; PHILLIS JW, 1981, PROG NEUROBIOL, V17, P141, DOI 10.1016/0301-0082(81)90012-5; RICHFIELD EK, 1989, NEUROSCIENCE, V30, P767, DOI 10.1016/0306-4522(89)90168-1; SHARP T, 1986, J NEUROCHEM, V47, P113; SKOU JC, 1965, PHYSIOL REV, V45, P596, DOI 10.1152/physrev.1965.45.3.596; SMITH PA, 1986, NEUROSCI LETT, V71, P72, DOI 10.1016/0304-3940(86)90259-4; SMITH PA, 1984, TRENDS PHARMACOL SCI, P422; STOOF JC, 1984, LIFE SCI, V35, P2281, DOI 10.1016/0024-3205(84)90519-8; VANDERKROGT JA, 1980, BIOCHEM PHARMACOL, V29, P857, DOI 10.1016/0006-2952(80)90215-4; WANG RY, 1987, DOPAMINE RECEPTORS, P153	28	280	282	1	10	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	SEP 27	1990	347	6291					386	388		10.1038/347386a0	http://dx.doi.org/10.1038/347386a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EA564	1977083				2022-12-24	WOS:A1990EA56400064
J	DUPUY, JM; FREIDEL, L				DUPUY, JM; FREIDEL, L			LAG BETWEEN DISCOVERY AND PRODUCTION OF NEW VACCINES FOR THE DEVELOPING-WORLD	LANCET			English	Editorial Material											DUPUY, JM (corresponding author), PASTEUR MERIEUX SERUMS & VACCINS,58 AVE LECLERC,F-69007 LYONS,FRANCE.							GIBBONS A, 1990, SCIENCE, V249, P678; HINMAN AR, 1990, LANCET, P707; HINMAN AR, 1989, REV INFECT DIS S3, V11, P663; ROBBINS A, 1988, SCI AM, V259, P126, DOI 10.1038/scientificamerican1188-126; ROBBINS A, 1990, LANCET, P1436	5	7	8	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 22	1990	336	8717					733	734		10.1016/0140-6736(90)92216-5	http://dx.doi.org/10.1016/0140-6736(90)92216-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DZ624	1975902				2022-12-24	WOS:A1990DZ62400014
J	KINLEN, LJ; CLARKE, K; HUDSON, C				KINLEN, LJ; CLARKE, K; HUDSON, C			EVIDENCE FROM POPULATION MIXING IN BRITISH NEW TOWNS 1946-85 OF AN INFECTIVE BASIS FOR CHILDHOOD LEUKEMIA	LANCET			English	Article									UNIV OXFORD,CANC RES CTR,CANC EPIDEMIOL RES GRP,OXFORD,ENGLAND	University of Oxford	KINLEN, LJ (corresponding author), UNIV EDINBURGH,CANC RES CTR,CANC EPIDEMIOL UNIT,15 GEORGE SQ,EDINBURGH EH8 9J2,SCOTLAND.							AABY P, 1989, DAN MED BULL, V36, P93; Acheson F, 1952, BR J SOC MED, V6, P68; Anderson R.M., 1982, POPULATION DYNAMICS; ANDERSON RM, 1979, NATURE, V280, P361, DOI 10.1038/280361a0; ANDERSON RM, 1982, SCIENCE, V215, P1053, DOI 10.1126/science.7063839; COOKMOZAFFARI P, 1987, STUDIES MED POPULATI, V51; FOX JP, 1971, AM J EPIDEMIOL, V94, P179, DOI 10.1093/oxfordjournals.aje.a121310; FRANCIS DP, 1980, AM J EPIDEMIOL, V111, P337, DOI 10.1093/oxfordjournals.aje.a112905; GREAVES MF, 1986, BRIT J HAEMATOL, V64, P1, DOI 10.1111/j.1365-2141.1986.tb07568.x; GREAVES MF, 1988, LEUKEMIA, V2, P120; HEATH CW, 1963, AM J MED, V34, P796, DOI 10.1016/0002-9343(63)90088-3; Hewitt D, 1951, BR J SOC MED, V5, P209; HOOVER EA, 1976, J NATL CANCER I, V57, P365, DOI 10.1093/jnci/57.2.365; KINLEN L, 1988, LANCET, V2, P1323; KINLEN LJ, 1989, MED RESPONSE EFFECTS, P272; Lowe CR, 1954, BRIT J PREV SOC MED, V8, P24; MILES A, 1983, PRINCIPLES BACTERIOL, V1, P413; NEWTON MP, 1951, STUDIES MED POPULATI, V5; ONIONS DE, 1987, CANCER SURV, V6, P161; OSBORNE FJ, 1977, NEW TOWNS THEIR ORIG; Pocock, 1960, SCOTTISH GEOGRAPHICA, V76, P169, DOI DOI 10.1080/00369226008735804; SMITH PG, 1982, CANCER EPIDEMIOLOGY; SORDILLO PP, 1982, JNCI-J NATL CANCER I, V69, P333; 1951, REPORTS CUMBERNAULD	24	169	169	0	4	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 8	1990	336	8715					577	582		10.1016/0140-6736(90)93389-7	http://dx.doi.org/10.1016/0140-6736(90)93389-7			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DX401	1975376				2022-12-24	WOS:A1990DX40100001
J	POLKEY, CE				POLKEY, CE			SURGICAL-TREATMENT OF EPILEPSY	LANCET			English	Note											POLKEY, CE (corresponding author), MAUDSLEY HOSP & INST PSYCHIAT,NEUROSURG UNIT,LONDON SE5 8AZ,ENGLAND.							ADAMS CBT, 1983, J NEUROL NEUROSUR PS, V46, P617, DOI 10.1136/jnnp.46.7.617; Anonymous, 1988, LANCET, V2, P1115; Beardsworth E D, 1988, Br J Neurosurg, V2, P73, DOI 10.3109/02688698808999662; DREIFUSS FE, 1987, SURGICAL TREATMENT E, P31; Engel Jr J., 1987, SURG TREATMENT EPILE, P553; Engel Jr J, 1987, SURG TREATMENT EPILE, P465; FISH D, 1989, CHRONIC EPILEPSY ITS, P59; GOLDRING S, 1984, J NEUROSURG, V60, P457, DOI 10.3171/jns.1984.60.3.0457; HAHN JF, 1987, SURGICAL TREATMENT E, P621; Horsely V., 1886, BMJ-BRIT MED J, V2, P670; JENSEN I, 1975, ACTA NEUROL SCAND, V52, P354, DOI 10.1111/j.1600-0404.1975.tb05831.x; JENSEN I, 1979, J NEUROL NEUROSUR PS, V42, P256, DOI 10.1136/jnnp.42.3.256; MORRELL F, 1989, J NEUROSURG, V70, P231, DOI 10.3171/jns.1989.70.2.0231; MORRELL F, 1987, SURGICAL TREATMENT E, P701; OJEMANN GA, 1975, NEUROSURGICAL MANAGE, P241; OUNSTEAD C, 1987, TEMPORAL LOBE EPILEP, P70; Polkey C, 1988, Br J Neurosurg, V2, P143, DOI 10.3109/02688698808992663; RASMUSSEN T, 1987, PRESURGICAL EVALUATI, P344; RAYPORT M, 1983, APPL NEUROPHYSIOL, V46, P47; SCHORNER W, 1987, AM J ROENTGENOL, V149, P1231, DOI 10.2214/ajr.149.6.1231; SPENCER DD, 1987, SURGICAL TREATMENT E, P477; TALAIRACH J, 1974, NEUROCHIRURGIE S, V2; TAYLOR DC, 1987, SURG TREATMENT EPILE, P485; VAERNET K, 1972, CONFIN NEUROL, V34, P176, DOI 10.1159/000103055; VANBUREN JM, 1975, NEUROSURGICAL MANAGE, V8, P155; WIESER HG, 1985, ELECTROEN CLIN NEURO, V61, P314, DOI 10.1016/0013-4694(85)91098-3; Williamson PD, 1985, EPILEPSY CORPUS CALL, P243; [No title captured]	28	7	7	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 1	1990	336	8714					553	555		10.1016/0140-6736(90)92099-4	http://dx.doi.org/10.1016/0140-6736(90)92099-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DW781	1975049				2022-12-24	WOS:A1990DW78100015
J	SWANK, RL; DUGAN, BB				SWANK, RL; DUGAN, BB			EFFECT OF LOW SATURATED FAT DIET IN EARLY AND LATE CASES OF MULTIPLE-SCLEROSIS	LANCET			English	Editorial Material											SWANK, RL (corresponding author), OREGON HLTH SCI UNIV,DEPT NEUROL,PORTLAND,OR 97201, USA.							ALTER M, 1974, ARCH NEUROL-CHICAGO, V31, P267, DOI 10.1001/archneur.1974.00490400081010; BATES D, 1978, BMJ-BRIT MED J, V2, P1390, DOI 10.1136/bmj.2.6149.1390; DWORKIN RH, 1984, NEUROLOGY, V34, P1441, DOI 10.1212/WNL.34.11.1441; FITZGERALD G, 1987, HUM NUTR-APPL NUTR, V41A, P297; GOLDBERG P, 1986, MED HYPOTHESES, V21, P193, DOI 10.1016/0306-9877(86)90010-1; KURTZKE JF, 1983, NEUROLOGY, V33, P1444, DOI 10.1212/WNL.33.11.1444; LEHOCZKY T, 1963, PRESSE MED, V71, P2294; MACKAY RP, 1967, ARCH NEUROL-CHICAGO, V17, P588, DOI 10.1001/archneur.1967.00470300030007; MILLAR JHD, 1973, BMJ-BRIT MED J, V1, P765, DOI 10.1136/bmj.1.5856.765; PATY DW, 1978, ACTA NEUROL SCAND, V58, P53; Swank R.L., 1987, MULTIPLE SCLEROSIS D; SWANK RL, 1950, AM J MED SCI, V220, P421, DOI 10.1097/00000441-195022040-00011; SWANK RL, 1952, NEW ENGL J MED, V246, P721, DOI 10.1056/NEJM195205082461901; SWANK RL, 1960, J NERV MENT DIS, V131, P468, DOI 10.1097/00005053-196012000-00002; SWANK RL, 1953, AMA ARCH NEUROL PSY, V69, P91, DOI 10.1001/archneurpsyc.1953.02320250097011; SWANK RL, 1970, ARCH NEUROL-CHICAGO, V23, P460, DOI 10.1001/archneur.1970.00480290080009; SWANK RL, 1988, AM J CLIN NUTR, V48, P1387, DOI 10.1093/ajcn/48.6.1387	17	126	128	1	25	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JUL 7	1990	336	8706					37	39		10.1016/0140-6736(90)91533-G	http://dx.doi.org/10.1016/0140-6736(90)91533-G			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM385	1973220				2022-12-24	WOS:A1990DM38500015
J	WADA, T; QIAN, XL; GREENE, MI				WADA, T; QIAN, XL; GREENE, MI			INTERMOLECULAR ASSOCIATION OF THE P185NEU PROTEIN AND EGF RECEPTOR MODULATES EGF RECEPTOR FUNCTION	CELL			English	Article											WADA, T (corresponding author), UNIV PENN,SCH MED,DEPT PATHOL & LAB MED,PHILADELPHIA,PA 19104, USA.							AKIYAMA T, 1988, MOL CELL BIOL, V8, P1019, DOI 10.1128/MCB.8.3.1019; BARGMANN CI, 1988, P NATL ACAD SCI USA, V85, P5394, DOI 10.1073/pnas.85.15.5394; BARGMANN CI, 1986, NATURE, V319, P226, DOI 10.1038/319226a0; BARGMANN CI, 1986, CELL, V45, P649, DOI 10.1016/0092-8674(86)90779-8; BONISCHNETZLER M, 1987, P NATL ACAD SCI USA, V84, P7832, DOI 10.1073/pnas.84.22.7832; CARPENTER G, 1987, ANNU REV BIOCHEM, V56, P881, DOI 10.1146/annurev.biochem.56.1.881; COCHET C, 1988, J BIOL CHEM, V263, P3290; COHEN JA, 1989, ONCOGENE, V4, P81; DAVIS RJ, 1988, J BIOL CHEM, V263, P9462; DEFIZE LHK, 1989, J CELL BIOL, V109, P2495, DOI 10.1083/jcb.109.5.2495; DEFIZE LHK, 1989, J CELL BIOL, V107, P939; DOBASHI K, 1989, DNA-J MOLEC CELL BIO, V8, P723, DOI 10.1089/dna.1989.8.723; DREBIN JA, 1985, CELL, V41, P695, DOI 10.1016/S0092-8674(85)80050-7; DREBIN JA, 1986, P NATL ACAD SCI USA, V83, P9129, DOI 10.1073/pnas.83.23.9129; DREBIN JA, 1988, ONCOGENE, V2, P273; FEIZI T, 1985, TRENDS BIOCHEM SCI, V10, P24, DOI 10.1016/0968-0004(85)90012-X; GLENNEY JR, 1988, CELL, V52, P675, DOI 10.1016/0092-8674(88)90405-9; HAIGLER HT, 1980, J BIOL CHEM, V255, P1239; HUNG MC, 1986, P NATL ACAD SCI USA, V83, P261, DOI 10.1073/pnas.83.2.261; HUNTER T, 1985, ANNU REV BIOCHEM, V54, P897, DOI 10.1146/annurev.biochem.54.1.897; KAWAMOTO T, 1983, P NATL ACAD SCI-BIOL, V80, P1337, DOI 10.1073/pnas.80.5.1337; KING AC, 1982, J BIOL CHEM, V257, P3053; KING CR, 1988, EMBO J, V7, P1647, DOI 10.1002/j.1460-2075.1988.tb02991.x; KOKAI Y, 1989, CELL, V58, P287, DOI 10.1016/0092-8674(89)90843-X; KOKAI Y, 1987, P NATL ACAD SCI USA, V84, P8498, DOI 10.1073/pnas.84.23.8498; KOKAI Y, 1988, P NATL ACAD SCI USA, V85, P5389, DOI 10.1073/pnas.85.15.5389; LIN CR, 1986, CELL, V44, P839, DOI 10.1016/0092-8674(86)90006-1; LOWENTHAL JW, 1987, J EXP MED, V166, P1156, DOI 10.1084/jem.166.4.1156; PODSKALNY J, 1984, BIOCHEM BIOPH RES CO, V125, P70, DOI 10.1016/S0006-291X(84)80335-6; ROBB RJ, 1987, J EXP MED, V165, P1201, DOI 10.1084/jem.165.4.1201; SCHECHTER AL, 1984, NATURE, V312, P513, DOI 10.1038/312513a0; SCHECHTER AL, 1985, SCIENCE, V229, P976, DOI 10.1126/science.2992090; SHECHTER Y, 1978, P NATL ACAD SCI USA, V75, P5788, DOI 10.1073/pnas.75.12.5788; SHOYAB M, 1979, NATURE, V279, P387, DOI 10.1038/279387a0; STERN DF, 1986, MOL CELL BIOL, V6, P1729, DOI 10.1128/MCB.6.5.1729; STERN DF, 1988, EMBO J, V7, P995, DOI 10.1002/j.1460-2075.1988.tb02906.x; STERN DF, 1988, MOL CELL BIOL, V8, P3969, DOI 10.1128/MCB.8.9.3969; TESHIGAWARA K, 1987, J EXP MED, V165, P223, DOI 10.1084/jem.165.1.223; TSUDO M, 1986, P NATL ACAD SCI USA, V83, P9694, DOI 10.1073/pnas.83.24.9694; WADA T, 1990, ONCOGENE, V5, P489; WANG HM, 1987, J EXP MED, V166, P1055, DOI 10.1084/jem.166.4.1055; WEINER DB, 1989, ONCOGENE, V4, P1175; WEINER DB, 1989, NATURE, V339, P230, DOI 10.1038/339230a0; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1443, DOI 10.1021/bi00379a035; YARDEN Y, 1987, BIOCHEMISTRY-US, V26, P1434, DOI 10.1021/bi00379a034	45	381	408	1	6	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	JUN 29	1990	61	7					1339	1347		10.1016/0092-8674(90)90697-D	http://dx.doi.org/10.1016/0092-8674(90)90697-D			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DM156	1973074				2022-12-24	WOS:A1990DM15600021
J	LOFT, DE; MARSH, MN; CROWE, PT				LOFT, DE; MARSH, MN; CROWE, PT			RECTAL GLUTEN CHALLENGE AND DIAGNOSIS OF CELIAC-DISEASE	LANCET			English	Article									UNIV MANCHESTER,HOPE HOSP,SCH MED,DEPT MED,SALFORD M6 8HD,LANCS,ENGLAND	University of Manchester								ARRANZ E, 1986, J CLIN NUTR GASTROEN, V1, P291; BENSON JA, 1957, NEW ENGL J MED, V256, P335, DOI 10.1056/NEJM195702212560802; COOKE WT, 1968, PROGR GASTROENTEROLO, P299; DHESI I, 1984, VIRCHOWS ARCH A, V403, P173, DOI 10.1007/BF00695233; DORMANDY KM, 1963, LANCET, V1, P632; FINLAY JM, 1958, ANN INTERN MED, V49, P1332, DOI 10.7326/0003-4819-49-6-1332; FRAZER AC, 1959, LANCET, V2, P252; FRIIS SU, 1986, SCAND J GASTROENTERO, V21, P1058, DOI 10.3109/00365528608996420; GIGER H, 1970, BIOMETR Z, V12, P156; HALLERT C, 1981, SCAND J GASTROENTERO, V16, P263, DOI 10.3109/00365528109181966; HALLSTROM O, 1989, GUT, V30, P1225, DOI 10.1136/gut.30.9.1225; HOFFBRAND AV, 1974, CLIN GASTROENTEROL, V3, P71; KELLY J, 1987, ARCH DIS CHILD, V62, P469, DOI 10.1136/adc.62.5.469; KRAWITT EL, 1975, AM J CLIN PATHOL, V63, P261; KUMAR V, 1986, J PEDIATR GASTR NUTR, V5, P730, DOI 10.1097/00005176-198609000-00011; LABROOY JT, 1986, CLIN EXP IMMUNOL, V66, P661; LOFT DE, 1989, GASTROENTEROLOGY, V97, P29, DOI 10.1016/0016-5085(89)91411-X; MANN JG, 1970, AM J MED, V48, P357, DOI 10.1016/0002-9343(70)90066-5; MARSH MN, 1983, AM J PATHOL, V112, P302; MARSH MN, 1986, VIRCHOWS ARCH A, V409, P11, DOI 10.1007/BF00705403; NIAZI NM, 1984, VIRCHOWS ARCH A, V404, P49, DOI 10.1007/BF00704250; RUBIN CE, 1960, GASTROENTEROLOGY, V38, P28; SHMERLING DH, 1974, COELIAC DISEASE, P339; Sladen G E, 1973, Br Med J, V3, P223; STAHLBERG MR, 1986, J PEDIATR GASTR NUTR, V5, P726, DOI 10.1097/00005176-198609000-00010	26	50	51	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JUN 2	1990	335	8701					1293	1295		10.1016/0140-6736(90)91183-B	http://dx.doi.org/10.1016/0140-6736(90)91183-B			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG095	1971374				2022-12-24	WOS:A1990DG09500001
J	[Anonymous]				[Anonymous]			LATE CONSEQUENCES OF SPRAINED ANKLE	LANCET			English	Editorial Material																		BASSETT FH, 1990, J BONE JOINT SURG AM, V72A, P55, DOI 10.2106/00004623-199072010-00009; Blazina M E, 1965, Clin Orthop Relat Res, V42, P73; BOARDMAN KP, 1979, INJURY, V11, P43, DOI 10.1016/S0020-1383(79)80124-2; BROOKS SC, 1981, BMJ-BRIT MED J, V282, P606, DOI 10.1136/bmj.282.6264.606; HAWKINS RB, 1988, FOOT ANKLE, V9, P87, DOI 10.1177/107110078800900205; JOHNSON EE, 1983, J BONE JOINT SURG AM, V65, P81, DOI 10.2106/00004623-198365010-00011; KLEIGER B, 1982, FOOT ANKLE, V3, P69, DOI 10.1177/107110078200300203; MCCULLOCH PG, 1985, BRIT J CLIN PRACT, V39, P69; MCGUIRE MR, 1988, CLIN ORTHOP RELAT R, P174; MCMURRAY TP, 1950, J BONE JOINT SURG BR, V32, P68, DOI 10.1302/0301-620X.32B1.68; Morris LH., 1943, J BONE JOINT SURG, V25, P220; NICHOLAS JA, 1974, ORTHOP CLIN N AM, V5, P153; ODONOGHUE DH, 1957, J BONE JOINT SURG AM, V39, P835, DOI 10.2106/00004623-195739040-00007; PARKES JC, 1980, J TRAUMA, V20, P895, DOI 10.1097/00005373-198010000-00015	14	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 2	1990	335	8701					1313	1314						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG095	1971381				2022-12-24	WOS:A1990DG09500008
J	BERGER, HM; LINDEMAN, JHN; VANZOERENGROBBEN, D; HOUDKAMP, E; SCHRIJVER, J; KANHAI, HH				BERGER, HM; LINDEMAN, JHN; VANZOERENGROBBEN, D; HOUDKAMP, E; SCHRIJVER, J; KANHAI, HH			IRON OVERLOAD, FREE-RADICAL DAMAGE, AND RHESUS HEMOLYTIC-DISEASE	LANCET			English	Article									UNIV HOSP LEIDEN,DEPT OBSTET,2300 RC LEIDEN,NETHERLANDS; TNO,CIVO,INST TOXICOL & NUTR,ZEIST,NETHERLANDS	Leiden University; Leiden University Medical Center (LUMC); Netherlands Organization Applied Science Research	BERGER, HM (corresponding author), UNIV HOSP LEIDEN,DEPT PEDIAT,NEONATAL UNIT,POSTBOX 9600,2300 RC LEIDEN,NETHERLANDS.							ASAKAWA T, 1980, LIPIDS, V15, P137, DOI 10.1007/BF02540959; BIEMOND P, 1988, FREE RADICAL BIO MED, V4, P185, DOI 10.1016/0891-5849(88)90026-3; BOTHWELL TH, 1979, IRON METABOLISM MAN, P163; BOYER RF, 1987, FREE RADICAL BIO MED, V3, P389, DOI 10.1016/0891-5849(87)90017-7; BROUWERS HAA, 1988, LANCET, V2, P641; CHIU D, 1989, SEMIN HEMATOL, V26, P257; CLARK IA, 1987, FREE RADICALS OXIDAN, P237; FREI B, 1988, P NATL ACAD SCI USA, V85, P9748, DOI 10.1073/pnas.85.24.9748; GOLDEN MHN, 1987, P NUTR SOC, V46, P53, DOI 10.1079/PNS19870008; GUTTERIDGE JMC, 1989, CLIN HAEMATOL, V2, P195; HALLIWELL B, 1989, BRIT J EXP PATHOL, V70, P737; Halliwell B, 1989, FREE RADICALS BIOL M, VUK; HERSHKO C, 1989, SEMIN HEMATOL, V26, P277; JAIN SK, 1985, CLIN CHIM ACTA, V149, P257, DOI 10.1016/0009-8981(85)90339-0; LINDEMAN JHN, 1989, PEDIATR RES, V26, P20, DOI 10.1203/00006450-198907000-00008; LUNDH B, 1970, ACTA PAEDIATR SCAND, V59, P121, DOI 10.1111/j.1651-2227.1970.tb08975.x; MCCORD JM, 1985, NEW ENGL J MED, V312, P159; Otani H, 1989, MED BIOCH CHEM ASPEC, P1181; RODECK CH, 1989, BRIT J OBSTET GYNAEC, V96, P759, DOI 10.1111/j.1471-0528.1989.tb03312.x; SAMOKYSZYN VM, 1989, J BIOL CHEM, V264, P21; SCOTT PH, 1975, ARCH DIS CHILD, V50, P796, DOI 10.1136/adc.50.10.796; STOCKER R, 1987, P NATL ACAD SCI USA, V84, P5918, DOI 10.1073/pnas.84.16.5918; SULLIVAN JL, 1988, AM J DIS CHILD, V142, P1341, DOI 10.1001/archpedi.1988.02150120095048; Thurnham DI, 1988, FREE RADICALS CHEM P, P161; WANG WC, 1986, J PEDIATR-US, V108, P552, DOI 10.1016/S0022-3476(86)80832-0; WAYNER DDM, 1987, BIOCHIM BIOPHYS ACTA, V924, P408, DOI 10.1016/0304-4165(87)90155-3; 1989, LANCET, V2, P1016	27	62	62	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	APR 21	1990	335	8695					933	936		10.1016/0140-6736(90)90997-J	http://dx.doi.org/10.1016/0140-6736(90)90997-J			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DA350	1970026				2022-12-24	WOS:A1990DA35000003
J	PIRO, LD; CARRERA, CJ; CARSON, DA; BEUTLER, E				PIRO, LD; CARRERA, CJ; CARSON, DA; BEUTLER, E			LASTING REMISSIONS IN HAIRY-CELL LEUKEMIA INDUCED BY A SINGLE INFUSION OF 2-CHLORODEOXYADENOSINE	NEW ENGLAND JOURNAL OF MEDICINE			English	Article											PIRO, LD (corresponding author), SCRIPPS CLIN & RES FDN,RES INST,DEPT MOLEC & EXPTL MED,10666 N TORREY PINES RD,LA JOLLA,CA 92037, USA.				NCRR NIH HHS [MO1 RR00833] Funding Source: Medline; NIGMS NIH HHS [GM23200] Funding Source: Medline; FDA HHS [FD-R-000280] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM023200] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); FDA HHS; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BOURONCLE BA, 1958, BLOOD, V13, P609, DOI 10.1182/blood.V13.7.609.609; CARSON DA, 1984, P NATL ACAD SCI-BIOL, V81, P2232, DOI 10.1073/pnas.81.7.2232; CASTAIGNE S, 1986, CANCER, V57, P1681, DOI 10.1002/1097-0142(19860415)57:8+<1681::AID-CNCR2820571309>3.0.CO;2-N; DALY JW, 1982, J MED CHEM, V25, P197, DOI 10.1021/jm00345a001; DELAHABA G, 1986, BIOCHEMISTRY-US, V25, P8337, DOI 10.1021/bi00373a031; KIM IY, 1985, BIOCHIM BIOPHYS ACTA, V829, P150, DOI 10.1016/0167-4838(85)90183-9; KRAUT EH, 1986, BLOOD, V68, P1119; MAJOR PP, 1981, CANCER CHEMOTH PHARM, V5, P193, DOI 10.1007/BF00258479; MAJOR PP, 1981, BLOOD, V58, P91; MITCHELL BS, 1980, BLOOD, V56, P556; OKEN MM, 1982, AM J CLIN ONCOL-CANC, V5, P649, DOI 10.1097/00000421-198212000-00014; PIRO LD, 1988, BLOOD, V72, P1069; QUESADA JR, 1986, CANCER, V57, P1678, DOI 10.1002/1097-0142(19860415)57:8+<1678::AID-CNCR2820571308>3.0.CO;2-6; RATAIN MJ, 1985, BLOOD, V65, P644; RIEBER EP, 1979, BRIT J HAEMATOL, V42, P175, DOI 10.1111/j.1365-2141.1979.tb01122.x; SETO S, 1985, J CLIN INVEST, V75, P377, DOI 10.1172/JCI111710; URBA WJ, 1989, BLOOD, V73, P38; VENNER PM, 1981, CANCER RES, V41, P4508	18	483	490	0	4	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 19	1990	322	16					1117	1121		10.1056/NEJM199004193221605	http://dx.doi.org/10.1056/NEJM199004193221605			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ486	1969613	Bronze			2022-12-24	WOS:A1990CZ48600005
J	DENT, AL; MATIS, LA; HOOSHMAND, F; WIDACKI, SM; BLUESTONE, JA; HEDRICK, SM				DENT, AL; MATIS, LA; HOOSHMAND, F; WIDACKI, SM; BLUESTONE, JA; HEDRICK, SM			SELF-REACTIVE GAMMA-DELTA T-CELLS ARE ELIMINATED IN THE THYMUS	NATURE			English	Article									UNIV CALIF SAN DIEGO, CTR CANC, LA JOLLA, CA 92093 USA; US FDA, CTR BIOL EVALUAT & RES, DIV CYTOKINE BIOL, BETHESDA, MD 20892 USA; UNIV CHICAGO, BEN MAY LAB CANC RES, CHICAGO, IL 60637 USA	University of California System; University of California San Diego; US Food & Drug Administration (FDA); University of Chicago	DENT, AL (corresponding author), UNIV CALIF SAN DIEGO, DEPT BIOL, LA JOLLA, CA 92093 USA.		Hedrick, Stephen M/E-9171-2010	Hedrick, Stephen/0000-0002-6345-8751				AUGUSTIN A, 1989, NATURE, V340, P239, DOI 10.1038/340239a0; BLUESTONE JA, 1987, NATURE, V326, P82, DOI 10.1038/326082a0; BLUESTONE JA, 1988, J EXP MED, V168, P1899, DOI 10.1084/jem.168.5.1899; BRENNER MB, 1986, NATURE, V322, P145, DOI 10.1038/322145a0; CHIEN YH, 1987, NATURE, V327, P677, DOI 10.1038/327677a0; CRISPE IN, 1987, NATURE, V329, P336, DOI 10.1038/329336a0; CRON RQ, 1988, J IMMUNOL, V141, P1074; DEVILLARTAY JP, 1988, NATURE, V335, P170, DOI 10.1038/335170a0; ELLIOTT JF, 1988, NATURE, V331, P627; EVANS GA, 1989, GENE, V79, P9, DOI 10.1016/0378-1119(89)90088-7; FOWLKES BJ, 1989, ADV IMMUNOL, V44, P207, DOI 10.1016/S0065-2776(08)60643-4; FOWLKES BJ, 1987, NATURE, V329, P251, DOI 10.1038/329251a0; GARMAN RD, 1986, CELL, V45, P733, DOI 10.1016/0092-8674(86)90787-7; GOODMAN T, 1988, NATURE, V333, P855, DOI 10.1038/333855a0; HAMMERLING GJ, 1982, P NATL ACAD SCI-BIOL, V79, P4737, DOI 10.1073/pnas.79.15.4737; HATA S, 1988, SCIENCE, V240, P1541, DOI 10.1126/science.3259726; Hogan B., 1986, MANIPULATING MOUSE E; HOULDEN BA, IN PRESS COLD SPRING, V54; ITOHARA S, 1989, P NATL ACAD SCI USA, V86, P5094, DOI 10.1073/pnas.86.13.5094; IWASHIMA M, 1988, P NATL ACAD SCI USA, V85, P8161, DOI 10.1073/pnas.85.21.8161; KAYE J, 1989, NATURE, V341, P746, DOI 10.1038/341746a0; KISIELOW P, 1984, J IMMUNOL, V133, P1117; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; KUBO RT, 1989, J IMMUNOL, V142, P2736; LANIER LL, 1987, J EXP MED, V165, P1076, DOI 10.1084/jem.165.4.1076; LEO O, 1987, P NATL ACAD SCI USA, V84, P1374, DOI 10.1073/pnas.84.5.1374; LEW AM, 1986, SCIENCE, V234, P1401, DOI 10.1126/science.3787252; Maniatis T., 1982, MOL CLONING; MIESCHER GC, 1988, J IMMUNOL, V140, P1779; PARDOLL DM, 1987, NATURE, V326, P79, DOI 10.1038/326079a0; PARDOLL DM, 1988, J IMMUNOL, V140, P4091; PARNES JR, 1989, ADV IMMUNOL, V44, P265, DOI 10.1016/S0065-2776(08)60644-6; RAULET DH, 1989, ANNU REV IMMUNOL, V7, P175, DOI 10.1146/annurev.iy.07.040189.001135; SHA WC, 1988, NATURE, V336, P73, DOI 10.1038/336073a0; SORGER SB, 1987, J EXP MED, V165, P279, DOI 10.1084/jem.165.2.279; SOWDER JT, 1988, J EXP MED, V167, P315, DOI 10.1084/jem.167.2.315; STINGL G, 1987, P NATL ACAD SCI USA, V84, P4586, DOI 10.1073/pnas.84.13.4586; TEH HS, 1988, NATURE, V335, P229, DOI 10.1038/335229a0; VONBOEHMER H, 1988, ANNU REV IMMUNOL, V6, P309, DOI 10.1146/annurev.iy.06.040188.001521; WEISS A, 1986, P NATL ACAD SCI USA, V83, P6998, DOI 10.1073/pnas.83.18.6998; WINOTO A, 1989, NATURE, V338, P430, DOI 10.1038/338430a0	41	216	217	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 22	1990	343	6260					714	719		10.1038/343714a0	http://dx.doi.org/10.1038/343714a0			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CP807	1968227				2022-12-24	WOS:A1990CP80700048
J	STRASSER, A; HARRIS, AW; CORY, S				STRASSER, A; HARRIS, AW; CORY, S			BCL-2 TRANSGENE INHIBITS T-CELL DEATH AND PERTURBS THYMIC SELF-CENSORSHIP	CELL			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; MONOCLONAL-ANTIBODY; DNA FRAGMENTATION; MEMBRANE PROTEIN; BETA-CHAIN; B-CELLS; RECEPTOR; EXPRESSION; ANTIGEN; TRANSLOCATION	Early death is the fate of most developing T lymphocytes. Because bcl-2 can promote cell survival, we tested its impact in mice expressing an E-mu-bcl-2 transgene within the T lymphoid compartment. The T cells showed remarkably sustained viability and some spontaneous differentiation in vitro. They also resisted killing by lymphotoxic agents. Although total T cell numbers and the rate of thymic involution were unaltered, the response to immunization was enhanced, consistent with reduced death of activated T cells. No T cells reactive with self-superantigens appeared in the lymph nodes, but an excess was found in the thymus. These observations, together with previous findings on B cells, suggest that modulated bcl-2 expression is a determinant of life and death in normal lymphocytes.			STRASSER, A (corresponding author), ROYAL MELBOURNE HOSP,WALTER & ELIZA HALL INST MED RES,PARKVILLE,VIC 3050,AUSTRALIA.		Strasser, Andreas/C-7581-2013; Cory, Suzanne/E-1642-2013	Strasser, Andreas/0000-0002-5020-4891; Cory, Suzanne/0000-0002-6818-3451	NATIONAL CANCER INSTITUTE [R01CA043540] Funding Source: NIH RePORTER; NCI NIH HHS [CA43540] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ACHAORBEA H, 1985, EUR J IMMUNOL, V15, P31, DOI 10.1002/eji.1830150107; ACHAORBEA H, 1991, NATURE, V350, P207, DOI 10.1038/350207a0; BAKHSHI A, 1985, CELL, V41, P899, DOI 10.1016/S0092-8674(85)80070-2; BEHLKE MA, 1986, P NATL ACAD SCI USA, V83, P767, DOI 10.1073/pnas.83.3.767; BLACKMAN M, 1990, SCIENCE, V248, P1335, DOI 10.1126/science.1972592; CHENLEVY Z, 1989, MOL CELL BIOL, V9, P701, DOI 10.1128/MCB.9.2.701; CHOI YW, 1991, NATURE, V350, P203, DOI 10.1038/350203a0; CLEARY ML, 1986, CELL, V47, P19, DOI 10.1016/0092-8674(86)90362-4; DAVIS MM, 1990, ANNU REV BIOCHEM, V59, P475, DOI 10.1146/annurev.biochem.59.1.475; DELLABONA P, 1990, CELL, V62, P1115, DOI 10.1016/0092-8674(90)90388-U; DIALYNAS DP, 1983, IMMUNOL REV, V74, P29, DOI 10.1111/j.1600-065X.1983.tb01083.x; DUVALL E, 1986, IMMUNOL TODAY, V7, P115, DOI 10.1016/0167-5699(86)90152-0; EGERTON M, 1990, P NATL ACAD SCI USA, V87, P2579, DOI 10.1073/pnas.87.7.2579; GOODMAN T, 1989, J EXP MED, V170, P1569, DOI 10.1084/jem.170.5.1569; HASKINS K, 1984, J EXP MED, V160, P452, DOI 10.1084/jem.160.2.452; HENDERSON S, 1991, CELL, V65, P1107, DOI 10.1016/0092-8674(91)90007-L; HENGARTNER H, 1988, NATURE, V336, P388, DOI 10.1038/336388a0; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; HOCKENBERY DM, 1991, P NATL ACAD SCI USA, V88, P6961, DOI 10.1073/pnas.88.16.6961; HOUSTON LL, 1980, J IMMUNOL, V125, P837; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; KAPPLER JW, 1988, NATURE, V332, P35, DOI 10.1038/332035a0; KARASUYAMA H, 1988, EUR J IMMUNOL, V18, P97, DOI 10.1002/eji.1830180115; KAWABE Y, 1991, NATURE, V349, P245, DOI 10.1038/349245a0; KIZAKI H, 1989, J IMMUNOL, V143, P1790; KUBO RT, 1989, J IMMUNOL, V142, P2736; LEDBETTER JA, 1979, IMMUNOL REV, V47, P63, DOI 10.1111/j.1600-065X.1979.tb00289.x; LEO O, 1987, P NATL ACAD SCI USA, V84, P1374, DOI 10.1073/pnas.84.5.1374; LIU YJ, 1991, EUR J IMMUNOL, V21, P1905, DOI 10.1002/eji.1830210819; MACDONALD HR, 1990, NATURE, V343, P642, DOI 10.1038/343642a0; MACDONALD HR, 1988, NATURE, V332, P40, DOI 10.1038/332040a0; MACDONALD HR, 1991, EUR J IMMUNOL, V21, P1963, DOI 10.1002/eji.1830210827; MARRACK P, 1987, SCIENCE, V238, P1073, DOI 10.1126/science.3317824; MCDONNELL TJ, 1990, MOL CELL BIOL, V10, P1901, DOI 10.1128/MCB.10.5.1901; MCDONNELL TJ, 1991, NATURE, V349, P254, DOI 10.1038/349254a0; MCDONNELL TJ, 1989, CELL, V57, P79, DOI 10.1016/0092-8674(89)90174-8; NUNEZ G, 1990, J IMMUNOL, V144, P3602; OHASHI PS, 1990, NATURE, V346, P861, DOI 10.1038/346861a0; PETRIE HT, 1990, J EXP MED, V172, P1583, DOI 10.1084/jem.172.6.1583; PEZZELLA F, 1990, AM J PATHOL, V137, P225; PULLEN AM, 1990, CELL, V61, P1365, DOI 10.1016/0092-8674(90)90700-O; PULLEN AM, 1988, NATURE, V335, P796, DOI 10.1038/335796a0; SCOLLAY R, 1984, IMMUNOL REV, V82, P79, DOI 10.1111/j.1600-065X.1984.tb01118.x; SHI YF, 1990, J IMMUNOL, V144, P3326; SHI YF, 1991, J IMMUNOL, V146, P3340; SMITH CA, 1989, NATURE, V337, P181, DOI 10.1038/337181a0; STAERZ UD, 1985, J IMMUNOL, V134, P3994; STRASSER A, 1990, CURR TOP MICROBIOL, V166, P175; STRASSER A, 1991, P NATL ACAD SCI USA, V88, P8661, DOI 10.1073/pnas.88.19.8661; STRASSER A, 1990, NATURE, V348, P331, DOI 10.1038/348331a0; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; TSUJIMOTO Y, 1987, ONCOGENE, V2, P3; TSUJIMOTO Y, 1984, SCIENCE, V226, P1097, DOI 10.1126/science.6093263; TSUJIMOTO Y, 1989, ONCOGENE, V4, P1331; UNKELESS JC, 1979, J EXP MED, V150, P580, DOI 10.1084/jem.150.3.580; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; VONBOEHMER H, 1990, SCIENCE, V248, P1369, DOI 10.1126/science.1972594; WEBB S, 1990, CELL, V63, P1249, DOI 10.1016/0092-8674(90)90420-J; WHITE J, 1989, CELL, V56, P27, DOI 10.1016/0092-8674(89)90980-X; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0	60	1076	1121	0	13	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	NOV 29	1991	67	5					889	899		10.1016/0092-8674(91)90362-3	http://dx.doi.org/10.1016/0092-8674(91)90362-3			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GT755	1959134				2022-12-24	WOS:A1991GT75500008
J	GILKS, C				GILKS, C			AIDS, MONKEYS AND MALARIA	NATURE			English	Editorial Material							LENTIVIRUSES		KENYA GOVT MED RES CTR, NAIROBI, KENYA	Kenya Medical Research Institute	GILKS, C (corresponding author), JOHN RADCLIFFE HOSP, NUFFIELD DEPT CLIN MED, OXFORD OX3 9DU, ENGLAND.		Gilks, Charles/B-4184-2012	Gilks, Charles/0000-0002-8953-3123				Blacklock B., 1922, Annals of Tropical Medicine and Parasitology, V16, P99; COATNEY GR, 1968, AM J TROP MED HYG, V17, P145; Coatney GR, 1971, PRIMATE MALARIAS; CONTACOS PG, 1970, AM J TROP MED HYG, V19, P190, DOI 10.4269/ajtmh.1970.19.190; DESROSIERS RC, 1989, AIDS RES HUM RETROV, V5, P465, DOI 10.1089/aid.1989.5.465; Garnham P.C.C., 1966, MALARIA PARASITES OT; HIRSCH VM, 1989, NATURE, V339, P389, DOI 10.1038/339389a0; KARPAS A, 1990, NATURE, V348, P578, DOI 10.1038/348578a0; MCLURE M, 1990, NEW SCI         0730, P54; OWUSU SK, 1991, NATURE, V350, P184, DOI 10.1038/350184a0; PEETERS M, 1989, AIDS, V3, P625, DOI 10.1097/00002030-198910000-00001; Rodhain J., 1939, Annales de la Societe Belge de Medecine Tropicale, V19, P563; Rodhain J., 1943, Annales de la Societe Belge de Medecine Tropicale, V23; Rodhain J., 1955, Annales de la Societe Belge de Medecine Tropicale, V35, P757; Rodhain J., 1936, Annales de la Societe Belge de Medecine Tropicale, V16, P521; SCHNEIDER J, 1988, AIDS, V2, P1, DOI 10.1097/00002030-198802000-00001	16	15	15	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 28	1991	354	6351					262	262		10.1038/354262a0	http://dx.doi.org/10.1038/354262a0			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT204	1956378	Bronze			2022-12-24	WOS:A1991GT20400021
J	ROY, AL; MEISTERERNST, M; POGNONEC, P; ROEDER, RG				ROY, AL; MEISTERERNST, M; POGNONEC, P; ROEDER, RG			COOPERATIVE INTERACTION OF AN INITIATOR-BINDING TRANSCRIPTION INITIATION-FACTOR AND THE HELIX LOOP HELIX ACTIVATOR USF	NATURE			English	Article							RNA POLYMERASE-II; MAJOR LATE PROMOTER; GENETIC SPECIFICITY; UPSTREAM ELEMENT; DNA-BINDING; TATA; PROTEINS; IDENTIFICATION; PURIFICATION; EXPRESSION	TRANSCRIPTION initiation by mammalian RNA polymerase II is effected by multiple common factors 1,2 interacting through minimal promoter elements and regulated by gene-specific factors 3 interacting with distal control elements. Minimal promoter elements that can function independently or together, depending on the specific promoter, include the upstream TATA box 4,5 and a pyrimidine-rich initiator 6-8 (Inr) overlapping the transcription start site. The binding of TFIID to the TATA element 4,9 promotes the assembly of other factors into a preinitiation complex 10-12 but factors which function at the Inr have not been defined. We show here that a novel factor (TFII-I) binds specifically to Inr elements, supports basal transcription from the adenovirus major late promoter and is immunologically related to the helix-loop-helix activator USF (ref. 13). We further show that TFII-I also binds to the upstream high-affinity USF site (E box), that USF also binds to the Inr, and that TFII-I and USF interact cooperatively at both Inr and E box sites. Thus, TFII-I represents a novel type of transcription initiation factor whose interactions at multiple promoter elements may aid novel communication mechanisms between upstream regulatory factors and the general transcriptional machinery.			ROY, AL (corresponding author), ROCKEFELLER UNIV,BIOCHEM & MOLEC BIOL LAB,NEW YORK,NY 10021, USA.							BLACKWOOD EM, 1991, SCIENCE, V251, P1149; BREATHNACH R, 1981, ANNU REV BIOCHEM, V50, P349, DOI 10.1146/annurev.bi.50.070181.002025; BURATOWSKI S, 1989, CELL, V56, P549, DOI 10.1016/0092-8674(89)90578-3; CARTHEW RW, 1985, CELL, V43, P439, DOI 10.1016/0092-8674(85)90174-6; DAVIS RL, 1990, CELL, V60, P733, DOI 10.1016/0092-8674(90)90088-V; GREGOR PD, 1990, GENE DEV, V4, P1730, DOI 10.1101/gad.4.10.1730; GROSSCHEDL R, 1980, P NATL ACAD SCI-BIOL, V77, P1432, DOI 10.1073/pnas.77.3.1432; HOFFMANN A, 1990, NATURE, V346, P387, DOI 10.1038/346387a0; MALDONADO E, 1990, MOL CELL BIOL, V10, P6335, DOI 10.1128/MCB.10.12.6335; MANIATIS T, 1987, SCIENCE, V236, P1237, DOI 10.1126/science.3296191; MATSUI T, 1980, J BIOL CHEM, V255, P1992; MEISTERENST M, 1991, CELL, V66, P1; MIYAMOTO NG, 1985, EMBO J, V4, P3563, DOI 10.1002/j.1460-2075.1985.tb04118.x; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; NAKAJIMA N, 1988, MOL CELL BIOL, V8, P4028, DOI 10.1128/MCB.8.10.4028; NAKATANI Y, 1990, NATURE, V348, P86, DOI 10.1038/348086a0; POGNONEC P, 1991, MOL CELL BIOL, V11, P5125, DOI 10.1128/MCB.11.10.5125; PRENDERGAST GC, 1991, CELL, V65, P395, DOI 10.1016/0092-8674(91)90457-A; SAWADOGO M, 1985, CELL, V43, P165, DOI 10.1016/0092-8674(85)90021-2; SMALE ST, 1989, CELL, V57, P103, DOI 10.1016/0092-8674(89)90176-1; SMALE ST, 1990, P NATL ACAD SCI USA, V87, P4509, DOI 10.1073/pnas.87.12.4509; SUMIMOTO H, 1990, P NATL ACAD SCI USA, V87, P9158, DOI 10.1073/pnas.87.23.9158; VANDYKE MW, 1988, SCIENCE, V241, P1335, DOI 10.1126/science.3413495	24	439	444	0	6	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 21	1991	354	6350					245	248		10.1038/354245a0	http://dx.doi.org/10.1038/354245a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ948	1961251				2022-12-24	WOS:A1991GQ94800054
J	LEON, DA				LEON, DA			INFLUENCE OF BIRTH-WEIGHT ON DIFFERENCES IN INFANT-MORTALITY BY SOCIAL-CLASS AND LEGITIMACY	BRITISH MEDICAL JOURNAL			English	Article								Objective - To investigate the influence of birth weight on the pronounced social class differences in infant mortality in Britain. Design - Analysis of routine data on births and infant deaths. Setting - England and Wales. Subjects - All live births and infant deaths, 1983-5. Main outcome measure - Mortality in infants by social class, birth weight, and legitimacy according to birth and death certificates. Results - Neonatal and postneonatal mortality (deaths/1000 births) increased with social class. Neonatal and postneonatal mortality was 4.2/1000 and 2.3/1000 respectively for social class I and 6.8/1000 and 5.6/1000 respectively for social class V. Mortality was lower among births registered within marriage (postneonatal 3.5/1000; neonatal 5.2/1000) than among those jointly registered outside marriage (5.1/1000; 6.4/1000); mortality was highest in those solely registered outside marriage (7-2/1000; 7.0/1000). For neonatal mortality the effect of social class varied with birth weight. Social class had little effect on neonatal mortality in low birthweight babies and increasing effect in heavier babies. For postneonatal mortality the effect of social class was similar for all birth weights and was almost as steep as for all birth weights combined. Conclusion - Birth weight mediates little of the effect of social class on postneonatal mortality.			LEON, DA (corresponding author), UNIV LONDON LONDON SCH HYG & TROP MED,DEPT EPIDEMIOL & POPULAT SCI,LONDON WC1E 7HT,ENGLAND.		Leon, David A/G-2195-2010	Leon, David A/0000-0001-9747-1762				ACHESON ED, 1990, LANCET, V336, P1482; ADELSTEIN AM, 1980, 41 STUD MED POP SUBJ; AITKIN M, 1989, STATISTICAL MODELLIN; [Anonymous], 1980, INEQUALITIES HLTH RE; [Anonymous], 1980, CLASSIFICATION OCCUP; BAKER RJ, 1978, GLIM SYSTEM; BROOKE OG, 1989, BRIT MED J, V298, P795, DOI 10.1136/bmj.298.6676.795; MACFARLANE A, 1988, BRIT MED J, V296, P230, DOI 10.1136/bmj.296.6617.230; MALLOY MH, 1988, AM J EPIDEMIOL, V128, P46, DOI 10.1093/oxfordjournals.aje.a114957; McCullagh P., 1983, GEN LINEAR MODELS, DOI [10.1007/978-1-4899-3244-0, DOI 10.1007/978-1-4899-3244-0]; MORRIS JN, 1955, LANCET, V1, P554; Pharoah P O, 1979, Epidemiol Rev, V1, P170; RODRIGUES L, 1989, OPCS POPULATION TREN, V55, P7; WILCOX AJ, 1986, INT J EPIDEMIOL, V15, P188, DOI 10.1093/ije/15.2.188; 1978, OFFICE POPULATION DS, V1; 1990, DH321 OFF POP CENS S; 1988, OFFICE POPULATION DS, V8	17	24	25	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 19	1991	303	6808					964	967		10.1136/bmj.303.6808.964	http://dx.doi.org/10.1136/bmj.303.6808.964			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GL127	1954421	Green Published, Bronze			2022-12-24	WOS:A1991GL12700023
J	BIX, M; LIAO, NS; ZIJLSTRA, M; LORING, J; JAENISCH, R; RAULET, D				BIX, M; LIAO, NS; ZIJLSTRA, M; LORING, J; JAENISCH, R; RAULET, D			REJECTION OF CLASS-I MHC-DEFICIENT HEMATOPOIETIC-CELLS BY IRRADIATED MHC-MATCHED MICE	NATURE			English	Article							BONE-MARROW ALLOGRAFTS; NATURAL-KILLER CELLS; EMBRYONIC STEM-CELLS; GRAFT-REJECTION; T-CELLS; HISTOCOMPATIBILITY ANTIGENS; HOMOLOGOUS RECOMBINATION; EXPRESSION; SUSCEPTIBILITY; DIFFERENTIATION	IRRADIATED MHC-heterozygous mice often reject bone marrow cells transplanted from one of the homozygous parental strains, a phenomenon ('hybrid resistance') that appears to violate the laws of transplantation 1,2. Rejection of parental and allogeneic marrow cells also differs from conventional T cell-mediated rejection mechanisms as it is effected by NK1.1+ cells 3-5. To account for the unusual specificity of bone marrow rejection, it has been proposed that NK1.1+ cells destroy marrow cells that fail to express the full complement of self MHC class I (MHC-I) molecules 5. We show here that NK1.1+ cells in normal mice reject haemopoietic transplants from mice that are deficient for normal cell-surface MHC-I expression because of a targeted mutation in the beta-2-microglobulin gene 6-9. These findings demonstrate that deficient expression of MHC-I molecules renders marrow cells susceptible to rejection.	MIT,CTR CANC RES,CAMBRIDGE,MA 02139; MIT,DEPT BIOL,CAMBRIDGE,MA 02139; MIT,DEPT BIOL,CAMBRIDGE,MA 02142; WHITEHEAD INST BIOMED RES,CAMBRIDGE,MA 02142	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute			Liao, Nan-Shih/ABE-7580-2020; Loring, Jeanne F/A-1620-2011	Liao, Nan-Shih/0000-0003-3707-4145; Loring, Jeanne F/0000-0001-6226-9767; Bix, Mark/0000-0003-4617-0497; Raulet, David/0000-0002-1257-8649				CUDKOWICZ G, 1964, NATURE, V204, P450, DOI 10.1038/204450a0; CUDKOWICZ G, 1971, J EXP MED, V134, P1513, DOI 10.1084/jem.134.6.1513; CUDKOWICZ G, 1973, TRANSPLANT P, V4, P1399; DENNERT G, 1990, IMMUNOGENETICS, V31, P161; FOWLKES BJ, 1985, J EXP MED, V162, P802, DOI 10.1084/jem.162.3.802; HARELBELLAN A, 1986, P NATL ACAD SCI USA, V83, P5688, DOI 10.1073/pnas.83.15.5688; HERBERMAN RB, 1981, SCIENCE, V214, P24, DOI 10.1126/science.7025208; HOGLUND P, 1988, J EXP MED, V168, P1469, DOI 10.1084/jem.168.4.1469; KARRE K, 1986, NATURE, V319, P675, DOI 10.1038/319675a0; KIESSLING R, 1977, EUR J IMMUNOL, V7, P655, DOI 10.1002/eji.1830070915; KLEIN J, 1978, IMMUNOGENETICS, V6, P489, DOI 10.1007/BF01563941; KOLLER BH, 1989, P NATL ACAD SCI USA, V86, P8932, DOI 10.1073/pnas.86.22.8932; KOLLER BH, 1990, SCIENCE, V248, P1227, DOI 10.1126/science.2112266; KOO GC, 1986, J IMMUNOL, V137, P3742; LIAO NS, 1989, J EXP MED, V170, P135, DOI 10.1084/jem.170.1.135; MURPHY WJ, 1987, J EXP MED, V166, P1499, DOI 10.1084/jem.166.5.1499; MURPHY WJ, 1987, J EXP MED, V165, P1212, DOI 10.1084/jem.165.4.1212; OHLEN C, 1989, SCIENCE, V246, P666, DOI 10.1126/science.2814488; REMBECKI RM, 1987, J IMMUNOL, V138, P2734; SCHRIER PI, 1983, NATURE, V305, P771, DOI 10.1038/305771a0; SHIMIZU Y, 1989, EUR J IMMUNOL, V19, P447, DOI 10.1002/eji.1830190306; STALLCUP KC, 1981, J IMMUNOL, V127, P923; STORKUS WJ, 1987, J IMMUNOL, V138, P1657; STUMHOFEL K, 1990, EUR J IMMUNOL, V20, P171; YANKELEVICH B, 1989, J IMMUNOL, V142, P3423; ZIJLSTRA M, 1989, NATURE, V342, P435, DOI 10.1038/342435a0; ZIJLSTRA M, 1990, NATURE, V344, P742, DOI 10.1038/344742a0	27	359	384	0	3	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JAN 24	1991	349	6307					329	331		10.1038/349329a0	http://dx.doi.org/10.1038/349329a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU501	1987491				2022-12-24	WOS:A1991EU50100052
J	BATES, DW; GOLDMAN, L; LEE, TH				BATES, DW; GOLDMAN, L; LEE, TH			CONTAMINANT BLOOD CULTURES AND RESOURCE UTILIZATION - THE TRUE CONSEQUENCES OF FALSE-POSITIVE RESULTS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							COSTS	To determine whether contaminant blood cultures increase resource utilization, we studied charge and length of stay data for episodes in which blood cultures were obtained from hospitalized adults. Compared with 1097 negative episodes, 94 false-positive episodes were associated with increased subsequent length of stay (median, 12.5 vs 8 days) and subsequent total charges (median, $13 116 vs $8731), pharmacy charges (median, $1456 vs $798), and laboratory charges (median, $2057 vs $1426). In multivariate analyses, contaminants were independently correlated with 20% and 39% increases in total subsequent laboratory charges and intravenous antibiotic charges, respectively. Thus, the true costs of contaminants may greatly exceed those of the test itself. Identifying patients at very low risk of bacteremia and attention to sterile technique may reduce costs by decreasing the frequency of contaminants.	BRIGHAM & WOMENS HOSP,DEPT MED,DIV CLIN EPIDEMIOL,75 FRANCIS ST,BOSTON,MA 02115; BRIGHAM & WOMENS HOSP,DEPT MED,DIV GEN MED,BOSTON,MA 02115; HARVARD UNIV,SCH MED,BOSTON,MA 02115	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School					AHRQ HHS [1 F32 HS00040-01] Funding Source: Medline	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)		ARONSON MD, 1987, ANN INTERN MED, V106, P246, DOI 10.7326/0003-4819-106-2-246; BATES DW, 1990, ANN INTERN MED, V113, P495, DOI 10.7326/0003-4819-113-7-495; BOR DH, 1988, J GEN INTERN MED, V3, P119, DOI 10.1007/BF02596115; BRANNEN AL, 1989, ARCH INTERN MED, V149, P1083, DOI 10.1001/archinte.149.5.1083; BUSHICK JB, 1989, J GEN INTERN MED, V4, P493, DOI 10.1007/BF02599547; DUNAGAN WC, 1989, AM J MED, V87, P253; EISENBERG JM, 1987, ANN INTERN MED, V107, P900, DOI 10.7326/0003-4819-107-6-900; FINKLER SA, 1982, ANN INTERN MED, V96, P102, DOI 10.7326/0003-4819-96-1-102; MACGREGOR RR, 1972, ARCH INTERN MED, V130, P84, DOI 10.1001/archinte.130.1.84; MCCABE WR, 1962, ARCH INTERN MED, V110, P845; RATNER HB, 1985, J CLIN MICROBIOL, V21, P995, DOI 10.1128/JCM.21.6.995-996.1985; WAKEFIELD DS, 1987, MED CARE, V25, P481, DOI 10.1097/00005650-198706000-00003; WEINSTEIN MP, 1983, REV INFECT DIS, V5, P35, DOI 10.1093/clinids/5.1.35	13	402	406	0	12	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 16	1991	265	3					365	369		10.1001/jama.265.3.365	http://dx.doi.org/10.1001/jama.265.3.365			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ER256	1984535				2022-12-24	WOS:A1991ER25600026
J	SULLIVAN, TJ				SULLIVAN, TJ			CROSS-REACTIONS AMONG FUROSEMIDE, HYDROCHLOROTHIAZIDE, AND SULFONAMIDES	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							SUSCEPTIBILITY; SENSITIVITY				SULLIVAN, TJ (corresponding author), UNIV TEXAS,HLTH SCI CTR,DALLAS,TX 75235, USA.							ANDREWS AW, 1984, MUTAT RES, V135, P105, DOI 10.1016/0165-1218(84)90162-9; BARNHART ER, 1990, PHYSICIANS DESK REFE, P1046; BARNHART ER, 1989, PHYSICIANS DESK REFE, P1024; CARRINGTON DM, 1987, J ALLERGY CLIN IMMUN, V79, P442, DOI 10.1016/0091-6749(87)90361-7; GRUCHALLA R S, 1990, Journal of Allergy and Clinical Immunology, V85, P157; HANSBROUGH JR, 1987, J ALLERGY CLIN IMMUN, V80, P538, DOI 10.1016/0091-6749(87)90004-2; MITCHELL JR, 1976, J PHARMACOL EXP THER, V199, P41; MOSS C, 1985, CLIN EXP IMMUNOL, V61, P232; RIEDER MJ, 1988, J PHARMACOL EXP THER, V244, P724; ROUJEAU JC, 1987, ARCH DERMATOL, V123, P1171, DOI 10.1001/archderm.123.9.1171; SCHNEIWEISS F, 1983, CLIN PHARMACY, V2, P510; SULLIVAN TJ, 1989, J ALLERGY CLIN IMMUN, V83, P270; SULLIVAN TJ, 1988, ALLERGY PRINCIPLES P, P1523	13	17	18	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	1991	265	1					120	121		10.1001/jama.265.1.120	http://dx.doi.org/10.1001/jama.265.1.120			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP555	1984112				2022-12-24	WOS:A1991EP55500045
J	STOTT, EJ; CHAN, WL; MILLS, KHG; PAGE, M; TAFFS, F; CRANAGE, M; GREENAWAY, P; KITCHIN, P				STOTT, EJ; CHAN, WL; MILLS, KHG; PAGE, M; TAFFS, F; CRANAGE, M; GREENAWAY, P; KITCHIN, P			PRELIMINARY-REPORT - PROTECTION OF CYNOMOLGUS MACAQUES AGAINST SIMIAN IMMUNODEFICIENCY VIRUS BY FIXED INFECTED-CELL VACCINE	LANCET			English	Article							ANIMAL-MODELS; AIDS	Cynomolgus macaques were vaccinated with inactivated simian immunodeficiency virus-infected cells and 'Quil-A' as adjuvant at 0,4,8, and 36 weeks or at 0,4,8, and 16 weeks. 2 weeks later these animals, together with a similar unvaccinated group, were challenged with 10 MID50 (50% monkey infectious doses) of a pool of SIVmac251 previously titrated in vivo. Virus was repeatedly isolated from unvaccinated animals on at least five separate occasions and proviral DNA was detected in circulating lymphocytes by polymerase chain reaction amplification. By contrast, virus and proviral DNA were not found in any of the vaccinated animals. However, the same vaccination regimen used after live virus challenge did not eliminate virus from previously infected macaques.	NATL INST BIOL STAND & CONTROLS,DIV IMMUNOBIOL,POTTERS BAR EN6 3QG,HERTS,ENGLAND; CTR APPL MICROBIOL & RES,SALISBURY,WILTS,ENGLAND	National Institute for Biological Standards & Control	STOTT, EJ (corresponding author), NATL INST BIOL STAND & CONTROLS,CTR AIDS COLLABORATING,BLANCHE LANE,ROTTERS BAR EN6 3QG,HERTS,ENGLAND.		Mills, Kingston H/F-5684-2013	Mills, Kingston H/0000-0003-3646-8222				ALMOND N, 1990, J VIROL METHODS, V28, P305, DOI 10.1016/0166-0934(90)90124-X; BERMAN PW, 1990, NATURE, V345, P622, DOI 10.1038/345622a0; CARLSON JR, IN PRESS AIDS RES HU; CRANAGE MP, IN PRESS P INT M ANI; DANIEL MD, 1989, AIDS, V3, pS31; DESROSIERS RC, 1987, REV INFECT DIS, V9, P438; DESROSIERS RC, 1989, AIDS RES HUM RETROV, V5, P465, DOI 10.1089/aid.1989.5.465; DESROSIERS RC, 1989, P NATL ACAD SCI USA, V86, P6353, DOI 10.1073/pnas.86.16.6353; GARDNER MB, 1989, J MED PRIMATOL, V18, P321; GARDNER MB, 1989, FASEB J, V3, P2593, DOI 10.1096/fasebj.3.14.2556312; GNANN JW, 1987, SCIENCE, V237, P1346, DOI 10.1126/science.2888192; KITCHIN PA, 1990, J VIROL METHODS, V28, P85, DOI 10.1016/0166-0934(90)90090-3; KITCHIN PA, IN PRESS P INT M ANI; LEVINE A, 1990, JUN SAN FRANC AIDS M; MILLS KHG, 1990, J IMMUNOL, V144, P1677; MONTEFIORI DC, 1990, J VIROL, V64, P113, DOI 10.1128/JVI.64.1.113-119.1990; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; MURPHEYCORB M, 1989, SCIENCE, V246, P1293, DOI 10.1126/science.2555923; PICARD O, 1990, LANCET, V336, P179, DOI 10.1016/0140-6736(90)91699-B; ROBINSON WE, 1990, JUN SAN FRANC AIDS M; SALK J, 1987, NATURE, V327, P473, DOI 10.1038/327473a0; SODROSKI JG, 1984, SCIENCE, V225, P381, DOI 10.1126/science.6330891; STOTT EJ, 1984, J HYG-CAMBRIDGE, V93, P251, DOI 10.1017/S0022172400064779; SUTJIPTO S, 1990, J VIROL, V64, P2290, DOI 10.1128/JVI.64.5.2290-2297.1990	24	159	166	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 22	1990	336	8730					1538	1541		10.1016/0140-6736(90)93310-L	http://dx.doi.org/10.1016/0140-6736(90)93310-L			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP037	1979369				2022-12-24	WOS:A1990EP03700007
J	MYBURGH, KH; HUTCHINS, J; FATAAR, AB; HOUGH, SF; NOAKES, TD				MYBURGH, KH; HUTCHINS, J; FATAAR, AB; HOUGH, SF; NOAKES, TD			LOW BONE-DENSITY IS AN ETIOLOGIC FACTOR FOR STRESS-FRACTURES IN ATHLETES	ANNALS OF INTERNAL MEDICINE			English	Article									UNIV CAPE TOWN, SCH MED, DEPT PHYSIOL, MRC, BIOENERGET RES UNIT, CAPE TOWN 7925, SOUTH AFRICA; GROOTE SCHUUR HOSP, DEPT NUCL MED, CAPE TOWN 7925, SOUTH AFRICA; TYGERBERG HOSP, ENDOCRINE UNIT, TYGERBERG 7505, SOUTH AFRICA	University of Cape Town; University of Cape Town; Tygerberg Hospital			Noakes, Tim/AAD-3162-2020	Noakes, Tim/0000-0001-7244-2375; Myburgh, Kathryn/0000-0003-4501-2120				BARROW GW, 1988, AM J SPORT MED, V16, P209, DOI 10.1177/036354658801600302; BERNING J, 1985, MED SCI SPORT EXER, V17, P242, DOI 10.1249/00005768-198504000-00270; BILANIN JE, 1989, MED SCI SPORT EXER, V21, P66, DOI 10.1249/00005768-198902000-00012; CUMMINGS SR, 1985, EPIDEMIOL REV, V7, P178, DOI 10.1093/oxfordjournals.epirev.a036281; DESMET AA, 1985, AM J ROENTGENOL, V145, P601, DOI 10.2214/ajr.145.3.601; DRINKWATER BL, 1984, NEW ENGL J MED, V311, P277, DOI 10.1056/NEJM198408023110501; DRINKWATER BL, 1986, JAMA-J AM MED ASSOC, V256, P380, DOI 10.1001/jama.256.3.380; HOUGH FS, 1988, S AFRICAN J CONTINUI, V6, P39; JONES HH, 1977, J BONE JOINT SURG AM, V59, P204, DOI 10.2106/00004623-197759020-00012; LANGENHOVEN L, 1986, NRIND FOOD QUANTITIE; LINDBERG JS, 1984, ANN INTERN MED, V101, P647, DOI 10.7326/0003-4819-101-5-647; LINDBERG JS, 1987, WESTERN J MED, V146, P39; LLOYD T, 1986, MED SCI SPORT EXER, V18, P374; MARCUS R, 1985, ANN INTERN MED, V102, P158, DOI 10.7326/0003-4819-102-2-158; MATKOVIC V, 1979, AM J CLIN NUTR, V32, P540, DOI 10.1093/ajcn/32.3.540; MAZESS RB, 1983, OSTEOPOROTIC SYNDROM, P85; MESSIER SP, 1988, MED SCI SPORT EXER, V20, P501; MORRIS JM, 1967, FATIGUE FRACTURES CL; MYBURGH KH, 1988, PHYSICIAN SPORTSMED, V16, P129, DOI 10.1080/00913847.1988.11709486; NOAKES TD, 1985, LORE RUNNING, P354; ORAVA S, 1978, ACTA ORTHOP SCAND, V49, P19, DOI 10.3109/17453677809005718; POUILLES JM, 1989, BONE, V10, P105, DOI 10.1016/8756-3282(89)90006-9; RIGGS BL, 1967, J BONE JOINT SURG AM, VA 49, P915, DOI 10.2106/00004623-196749050-00008; RIGOTTI NA, 1984, NEW ENGL J MED, V311, P1601, DOI 10.1056/NEJM198412203112503; SIEGEL S, 1956, NONPARAMETRIC STAT, P63; SMITH EL, 1986, ACTA MED SCAND, P149; SNEDECOR GW, 1946, STATISTICAL METHODS, P85; STEVENSON JC, 1982, BRIT MED J, V285, P585, DOI 10.1136/bmj.285.6342.585; WAHNER HH, 1982, NONINVASIVE BONE MEA, P191; 1979, J AM DIET ASSOC, P623	30	283	286	2	43	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	NOV 15	1990	113	10					754	759		10.7326/0003-4819-113-10-754	http://dx.doi.org/10.7326/0003-4819-113-10-754			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EH363	1978620				2022-12-24	WOS:A1990EH36300006
J	SANTIS, G; OSBORNE, L; KNIGHT, RA; HODSON, ME				SANTIS, G; OSBORNE, L; KNIGHT, RA; HODSON, ME			INDEPENDENT GENETIC-DETERMINANTS OF PANCREATIC AND PULMONARY STATUS IN CYSTIC-FIBROSIS	LANCET			English	Article											SANTIS, G (corresponding author), ROYAL BROMPTON & NATL HEART HOSP,NATL HEART & LUNG INST,DEPT CYST FIBROSIS,MANRESA RD,LONDON SW3 6LR,ENGLAND.							BORGO G, 1990, LANCET, V1, P1601; COREY M, 1989, J PEDIATR-US, V115, P274, DOI 10.1016/S0022-3476(89)80082-4; CUTTING GR, 1990, NATURE, V346, P366, DOI 10.1038/346366a0; DEAN M, 1990, CELL, V61, P863, DOI 10.1016/0092-8674(90)90196-L; DEVOTO M, 1989, GENOMICS, V5, P894, DOI 10.1016/0888-7543(89)90131-6; GASKIN K, 1982, J PEDIATR-US, V100, P857, DOI 10.1016/S0022-3476(82)80501-5; HODSON ME, 1983, BMJ-BRIT MED J, V286, P1381, DOI 10.1136/bmj.286.6375.1381; KEREM BS, 1989, SCIENCE, V245, P1073, DOI 10.1126/science.2570460; KEREM BS, 1989, AM J HUM GENET, V44, P827; KEREM E, 1990, J PEDIATR-US, V116, P714, DOI 10.1016/S0022-3476(05)82653-8; KNOWLES M, 1981, NEW ENGL J MED, V305, P1489, DOI 10.1056/NEJM198112173052502; KOPELMAN H, 1990, LANCET, V1, P1601; PENKETH ARL, 1987, THORAX, V42, P526, DOI 10.1136/thx.42.7.526; ROMMENS J, 1990, AM J HUM GENET, V46, P395; SANTIS G, 1990, LANCET, V1, P1426; SHWACHMAN H, 1975, PEDIATR CLIN N AM, V22, P787; SHWACHMAN H, 1965, AM J DIS CHILD, V92, P347; STUHRMANN M, 1990, LANCET, V1, P738; WATERS DL, 1990, NEW ENGL J MED, V322, P303, DOI 10.1056/NEJM199002013220505	19	129	131	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 3	1990	336	8723					1081	1084		10.1016/0140-6736(90)92566-Z	http://dx.doi.org/10.1016/0140-6736(90)92566-Z			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF992	1977977				2022-12-24	WOS:A1990EF99200001
J	SLATTERY, RM; KJERNIELSEN, L; ALLISON, J; CHARLTON, B; MANDEL, TE; MILLER, JFAP				SLATTERY, RM; KJERNIELSEN, L; ALLISON, J; CHARLTON, B; MANDEL, TE; MILLER, JFAP			PREVENTION OF DIABETES IN NONOBESE DIABETIC I-AK TRANSGENIC MICE	NATURE			English	Article									MONASH UNIV,SCH MED,DEPT PATHOL & IMMUNOL,PRAHRAN,VIC 3181,AUSTRALIA	Monash University	SLATTERY, RM (corresponding author), ROYAL MELBOURNE HOSP,WALTER & ELIZA HALL INST MED RES,PARKVILLE,VIC 3050,AUSTRALIA.		Slattery, Robyn/D-5832-2011					BACELJ A, 1989, DIABETES, V38, P1492, DOI 10.2337/diabetes.38.11.1492; BOITARD C, 1989, J EXP MED, V169, P1669, DOI 10.1084/jem.169.5.1669; CHANDY KG, 1984, J CLIN IMMUNOL, V4, P424, DOI 10.1007/BF00916571; CHOI E, 1983, SCIENCE, V221, P283, DOI 10.1126/science.6407114; ESTESS P, 1986, P NATL ACAD SCI USA, V83, P3594, DOI 10.1073/pnas.83.11.3594; GAMMON G, 1989, NATURE, V342, P183, DOI 10.1038/342183a0; GEPTS W, 1984, IMMUNOLOGY DIABETES, P21; HARLTON B, 1989, DIABETES, V38, P441; HATTORI M, 1986, SCIENCE, V231, P733, DOI 10.1126/science.3003909; JOHNSON NA, 1989, J IMMUNOL, V142, P3298; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; KOIKE T, 1987, DIABETES, V36, P539, DOI 10.2337/diabetes.36.4.539; LEMEUR M, 1989, J IMMUNOL, V142, P323; MACDONALD HR, 1988, NATURE, V332, P40, DOI 10.1038/332040a0; MCCLUSKEY J, 1988, J IMMUNOL, V140, P2081; MILLER BJ, 1988, J IMMUNOL, V140, P52; NISHIMOTO H, 1987, NATURE, V328, P432, DOI 10.1038/328432a0; PIERRES M, 1981, IMMUNOGENETICS, V14, P481, DOI 10.1007/BF00350120; PROCHAZKA M, 1987, SCIENCE, V237, P286, DOI 10.1126/science.2885918; REICH EP, 1989, NATURE, V341, P326, DOI 10.1038/341326a0; TEH HS, 1988, NATURE, V335, P229, DOI 10.1038/335229a0; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0; Uehira M, 1989, Int Immunol, V1, P209, DOI 10.1093/intimm/1.2.209; WICKER LS, 1987, J EXP MED, V165, P1639, DOI 10.1084/jem.165.6.1639; ZINKERNA.RM, 1974, NATURE, V248, P701, DOI 10.1038/248701a0	25	203	206	0	0	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUN 21	1990	345	6277					724	726		10.1038/345724a0	http://dx.doi.org/10.1038/345724a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK399	1972779				2022-12-24	WOS:A1990DK39900069
J	WEDEL, A; WEISS, DS; POPHAM, D; DROGE, P; KUSTU, S				WEDEL, A; WEISS, DS; POPHAM, D; DROGE, P; KUSTU, S			A BACTERIAL ENHANCER FUNCTIONS TO TETHER A TRANSCRIPTIONAL ACTIVATOR NEAR A PROMOTER	SCIENCE			English	Article									UNIV CALIF BERKELEY,DEPT MOLEC & CELLULAR BIOL,BERKELEY,CA 94720	University of California System; University of California Berkeley	WEDEL, A (corresponding author), UNIV CALIF BERKELEY,DEPT PLANT PATHOL,BERKELEY,CA 94720, USA.		Droge, Peter/A-2203-2011; Popham, David L/F-8066-2015	Popham, David L/0000-0002-2614-143X; Droge, Peter/0000-0001-5447-738X; Weiss, David/0000-0003-2217-0070	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038361, R37GM038361] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 38361] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ADHYA S, 1989, ANNU REV GENET, V23, P207; Ausubel F, 1989, MOL REPROD DEV, V1, P146; BENJAMIN HW, IN PRESS J BIOL CHEM; BRENT R, 1985, CELL, V43, P729, DOI 10.1016/0092-8674(85)90246-6; BUCK M, 1986, NATURE, V320, P374, DOI 10.1038/320374a0; BUCK M, 1987, MOL MICROBIOL, V1, P243, DOI 10.1111/j.1365-2958.1987.tb00518.x; CONTRERAS A, 1988, NUCLEIC ACIDS RES, V16, P4025, DOI 10.1093/nar/16.9.4025; COUREY AJ, 1986, CELL, V45, P567, DOI 10.1016/0092-8674(86)90288-6; CRAIGIE R, 1986, CELL, V45, P793, DOI 10.1016/0092-8674(86)90554-4; DRUMMOND M, 1983, NATURE, V301, P302, DOI 10.1038/301302a0; DUNAWAY M, 1989, NATURE, V341, P657, DOI 10.1038/341657a0; ELLIOTT T, 1984, CELL, V36, P211, DOI 10.1016/0092-8674(84)90091-6; GUARENTE L, 1988, CELL, V52, P303, DOI 10.1016/S0092-8674(88)80020-5; HERENDEEN DR, 1989, SCIENCE, V245, P952, DOI 10.1126/science.2672335; JEANG KT, 1988, BIOESSAYS, V8, P104, DOI 10.1002/bies.950080404; KRASNOW MA, 1983, CELL, V32, P1313, DOI 10.1016/0092-8674(83)90312-4; MINCHIN SD, 1989, EMBO J, V8, P3491, DOI 10.1002/j.1460-2075.1989.tb08514.x; MOSSING MC, 1986, SCIENCE, V233, P889, DOI 10.1126/science.3090685; MULLER HP, 1989, CELL, V58, P767, DOI 10.1016/0092-8674(89)90110-4; MULLER MM, 1988, EUR J BIOCHEM, V176, P485, DOI 10.1111/j.1432-1033.1988.tb14306.x; PLON SE, 1986, CELL, V45, P575, DOI 10.1016/0092-8674(86)90289-8; POPHAM DL, 1989, SCIENCE, V243, P629, DOI 10.1126/science.2563595; PORTER S, UNPUB; PTASHNE M, 1986, NATURE, V322, P697, DOI 10.1038/322697a0; PTASHNE M, 1988, NATURE, V335, P683, DOI 10.1038/335683a0; REED RR, 1981, CELL, V25, P721, DOI 10.1016/0092-8674(81)90179-3; REED RR, 1981, CELL, V25, P713, DOI 10.1016/0092-8674(81)90178-1; REITZER LJ, 1989, J BACTERIOL, V171, P5512, DOI 10.1128/jb.171.10.5512-5522.1989; REITZER LJ, 1986, CELL, V45, P785, DOI 10.1016/0092-8674(86)90553-2; SASSEDWIGHT S, 1988, P NATL ACAD SCI USA, V85, P8934, DOI 10.1073/pnas.85.23.8934; SASSONECORSI P, 1984, P NATL ACAD SCI-BIOL, V81, P308, DOI 10.1073/pnas.81.2.308; SCHLEIF R, 1988, SCIENCE, V240, P127, DOI 10.1126/science.3353710; SU W, UNPUB; WANG JC, 1988, SCIENCE, V240, P300, DOI 10.1126/science.3281259; WASSERMAN SA, 1988, NATURE, V334, P448, DOI 10.1038/334448a0; WEDEL A, UNPUB; WONG PK, 1987, J BACTERIOL, V169, P2876, DOI 10.1128/jb.169.6.2876-2880.1987	37	178	178	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	APR 27	1990	248	4954					486	490		10.1126/science.1970441	http://dx.doi.org/10.1126/science.1970441			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DA756	1970441				2022-12-24	WOS:A1990DA75600045
J	MCMANAWAY, ME; NECKERS, LM; LOKE, SL; ALNASSER, AA; REDNER, RL; SHIRAMIZU, BT; GOLDSCHMIDTS, WL; HUBER, BE; BHATIA, K; MAGRATH, IT				MCMANAWAY, ME; NECKERS, LM; LOKE, SL; ALNASSER, AA; REDNER, RL; SHIRAMIZU, BT; GOLDSCHMIDTS, WL; HUBER, BE; BHATIA, K; MAGRATH, IT			TUMOR-SPECIFIC INHIBITION OF LYMPHOMA GROWTH BY AN ANTISENSE OLIGODEOXYNUCLEOTIDE	LANCET			English	Article									NCI, PEDIAT BRANCH, BLDG 10, ROOM 13N240, BETHESDA, MD 20892 USA; NCI, MED BRANCH, BETHESDA, MD 20205 USA; NHLBI, CLIN HEMATOL BRANCH, BETHESDA, MD 20205 USA; BURROUGHS WELLCOME CO, RALEIGH, NC USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Burroughs Wellcome Fund								ARRUSHDI A, 1983, SCIENCE, V222, P390, DOI 10.1126/science.6414084; CROCE CM, 1985, BLOOD, V65, P1; DALLAFAVERA R, 1983, SCIENCE, V219, P963, DOI 10.1126/science.6401867; DALLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P7824, DOI 10.1073/pnas.79.24.7824; DENNY CT, 1985, MOL CELL BIOL, V5, P3199, DOI 10.1128/MCB.5.11.3199; EVAN GI, 1985, CELL, V43, P253, DOI 10.1016/0092-8674(85)90030-3; GELMANN EP, 1983, NATURE, V306, P799, DOI 10.1038/306799a0; HARELBELLAN A, 1988, J IMMUNOL, V140, P2431; HEIKKILA R, 1987, NATURE, V328, P445, DOI 10.1038/328445a0; HOLT JT, 1988, MOL CELL BIOL, V8, P963, DOI 10.1128/MCB.8.2.963; HUBER BE, 1987, CANCER RES, V47, P3414; KLEIN G, 1985, IMMUNOL TODAY, V6, P208, DOI 10.1016/0167-5699(85)90036-2; LEDER P, 1983, SCIENCE, V222, P765, DOI 10.1126/science.6356357; LOKE SL, 1988, CURR TOP MICROBIOL, V141, P282; MAGRATH IT, 1985, PEDIATRIC HEMATOLOGY, P1; MURPHY W, 1986, P NATL ACAD SCI USA, V83, P2939, DOI 10.1073/pnas.83.9.2939; PELICCI PG, 1986, P NATL ACAD SCI USA, V83, P2984, DOI 10.1073/pnas.83.9.2984; STEIN CA, 1988, CANCER RES, V48, P2659; TAUB R, 1982, P NATL ACAD SCI-BIOL, V79, P7837, DOI 10.1073/pnas.79.24.7837; WICKSTROM E, 1986, J BIOCHEM BIOPH METH, V13, P97, DOI 10.1016/0165-022X(86)90021-7; ZAMECNIK PC, 1986, P NATL ACAD SCI USA, V83, P4143, DOI 10.1073/pnas.83.12.4143	21	153	156	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 7	1990	335	8693					808	811		10.1016/0140-6736(90)90934-W	http://dx.doi.org/10.1016/0140-6736(90)90934-W			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY371	1969559				2022-12-24	WOS:A1990CY37100002
J	COPPA, GV; GABRIELLI, O; GIORGI, P; CATASSI, C; MONTANARI, MP; VARALDO, PE; NICHOLS, BL				COPPA, GV; GABRIELLI, O; GIORGI, P; CATASSI, C; MONTANARI, MP; VARALDO, PE; NICHOLS, BL			PRELIMINARY-STUDY OF BREASTFEEDING AND BACTERIAL ADHESION TO UROEPITHELIAL CELLS	LANCET			English	Article									BAYLOR UNIV,USDA ARS,CHILDRENS NUTR RES CTR,HOUSTON,TX 77030; UNIV ANCONA,SCH MED,INST MICROBIOL,I-60123 ANCONA,ITALY	Baylor University; United States Department of Agriculture (USDA); Marche Polytechnic University	COPPA, GV (corresponding author), UNIV ANCONA,SCH MED,DEPT PAEDIAT,VIA CORRIDONI 11,I-60123 ANCONA,ITALY.			Orazio, Gabrielli/0000-0003-1037-6899; VARALDO, Pietro/0000-0002-4131-487X				ANDERSSON B, 1986, J INFECT DIS, V153, P232, DOI 10.1093/infdis/153.2.232; ASHKENAZI S, 1987, PEDIATR RES, V22, P130, DOI 10.1203/00006450-198708000-00004; COPPA GV, 1988, ITAL J PEDIATR, V14, P182; CUNNINGHAM AS, 1979, J PEDIATR-US, V95, P685, DOI 10.1016/S0022-3476(79)80711-8; DATE JW, 1964, SCAND J CLIN LAB INV, V16, P597, DOI 10.3109/00365516409055222; DOLAN SA, 1986, J INFECT DIS, V154, P722, DOI 10.1093/infdis/154.4.722; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; EDEN CS, 1977, INFECT IMMUN, V18, P767, DOI 10.1128/IAI.18.3.767-774.1977; Ehrlich P., 1892, HYG LNFEKT KRANKH, V2, P183, DOI [10.1007/BF02284236, DOI 10.1007/BF02284236]; FEIZI T, 1985, NATURE, V314, P53, DOI 10.1038/314053a0; HALLGREN P, 1977, J BIOL CHEM, V252, P1034; HANSON LA, 1988, BIOL HUMAN MILK, P141; HOLMGREN J, 1983, INFECT IMMUN, V39, P147, DOI 10.1128/IAI.39.1.147-154.1983; JASON JM, 1984, PEDIATRICS, V74, P702; KALLENIUS G, 1979, FEMS MICROBIOL LETT, V5, P295; KARLSSON KA, 1986, CHEM PHYS LIPIDS, V42, P153, DOI 10.1016/0009-3084(86)90050-2; KOBATA A, 1972, METHOD ENZYMOL, V28, P262; KOVAR MG, 1984, PEDIATRICS, V74, P615; LARSEN SA, 1978, J PEDIATR-US, V92, P417, DOI 10.1016/S0022-3476(78)80430-2; MONTREUIL J, 1960, B SOC CHIM BIOL, V42, P365; NARAYANAN I, 1981, J PEDIATR-US, V99, P496, DOI 10.1016/S0022-3476(81)80360-5; ROSENSTEIN IJ, 1988, LANCET, V2, P1327; STRECKER G, 1977, EUR J BIOCHEM, V75, P391, DOI 10.1111/j.1432-1033.1977.tb11540.x; VIVERGE D, 1985, ANN NUTR METAB, V29, P1, DOI 10.1159/000176947; WARREN L, 1959, J BIOL CHEM, V234, P1971; WINBERG J, 1971, LANCET, V1, P1091; WRIGHT JA, 1987, PEDIATRIC NUTRITION, P293; YAMASHITA K, 1982, METHOD ENZYMOL, V83, P105; 1981, LANCET, V2, P508	29	111	114	0	10	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	MAR 10	1990	335	8689					569	571		10.1016/0140-6736(90)90350-E	http://dx.doi.org/10.1016/0140-6736(90)90350-E			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT653	1968576				2022-12-24	WOS:A1990CT65300005
J	NITTA, T; SATO, K; YAGITA, H; OKUMURA, K; ISHII, S				NITTA, T; SATO, K; YAGITA, H; OKUMURA, K; ISHII, S			PRELIMINARY TRIAL OF SPECIFIC TARGETING THERAPY AGAINST MALIGNANT GLIOMA	LANCET			English	Article									JUNTENDO UNIV,SCH MED,DEPT IMMUNOL,2-1-1 HONGO,BUNKYO KU,TOKYO 113,JAPAN; JUNTENDO UNIV,SCH MED,DEPT NEUROL SURG,TOKYO 113,JAPAN	Juntendo University; Juntendo University								BURGER PC, 1987, CANCER, V59, P1617, DOI 10.1002/1097-0142(19870501)59:9<1617::AID-CNCR2820590916>3.0.CO;2-X; ETTINGHAUSEN SE, 1988, JNCI-J NATL CANCER I, V80, P177, DOI 10.1093/jnci/80.3.177; GRIMM EA, 1982, J EXP MED, V155, P1823, DOI 10.1084/jem.155.6.1823; GRIMM EA, 1983, J EXP MED, V157, P884, DOI 10.1084/jem.157.3.884; ITOH K, 1988, J EXP MED, V168, P1419, DOI 10.1084/jem.168.4.1419; JACOBS SK, 1986, CANCER RES, V46, P2101; JOHNSON GD, 1978, HDB EXPT IMMUNOLOGY, V3, P1; JUNG G, 1988, IMMUNOL TODAY, V9, P257, DOI 10.1016/0167-5699(88)91304-7; LOTZE MT, 1986, CANCER, V58, P2764, DOI 10.1002/1097-0142(19861215)58:12<2764::AID-CNCR2820581235>3.0.CO;2-Z; MERCHANT RE, 1988, NEUROSURGERY, V23, P725, DOI 10.1227/00006123-198812000-00007; NITTA T, 1989, EUR J IMMUNOL, V19, P1437, DOI 10.1002/eji.1830190814; PEREZ P, 1986, J EXP MED, V163, P166, DOI 10.1084/jem.163.1.166; PEREZ P, 1986, J IMMUNOL, V137, P2069; ROSENBERG SA, 1987, NEW ENGL J MED, V316, P889, DOI 10.1056/NEJM198704093161501; ROSENBERG SA, 1985, NEW ENGL J MED, V313, P1485, DOI 10.1056/NEJM198512053132327; ROSENBERG SA, 1986, SCIENCE, V233, P1318, DOI 10.1126/science.3489291; ROSENSTEIN M, 1986, J IMMUNOL, V137, P1735; STAERZ UD, 1985, NATURE, V314, P628, DOI 10.1038/314628a0; TITUS JA, 1987, J IMMUNOL, V138, P4018; UEDA R, 1988, LUNG CANCER, V4, P96; WEST WH, 1987, NEW ENGL J MED, V316, P898, DOI 10.1056/NEJM198704093161502; 1979, HISTOLOGICAL TYPING	22	236	277	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	FEB 17	1990	335	8686					368	371		10.1016/0140-6736(90)90205-J	http://dx.doi.org/10.1016/0140-6736(90)90205-J			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN988	1968115				2022-12-24	WOS:A1990CN98800002
J	JEFFREYS, AJ; MACLEOD, A; TAMAKI, K; NEIL, DL; MONCKTON, DG				JEFFREYS, AJ; MACLEOD, A; TAMAKI, K; NEIL, DL; MONCKTON, DG			MINISATELLITE REPEAT CODING AS A DIGITAL APPROACH TO DNA TYPING	NATURE			English	Article								Most DNA typing systems used in forensic and legal medicine assay allelic length variation at tandem repetitive DNA regions such as minisatellites. A simple alternative approach that displays patterns of variant repeat units along minisatellite alleles is described here. This produces DNA profiles as extraordinarily variable digital sequences appropriate for forensic investigations, including computer databasing, and for analysing allele diversity and the role of recombination in minisatellite instability.			JEFFREYS, AJ (corresponding author), UNIV LEICESTER, DEPT GENET, UNIV RD, LEICESTER LE1 7RH, ENGLAND.		; Monckton, Darren/B-4943-2013	Neil, David/0000-0002-9994-9536; Monckton, Darren/0000-0002-8298-8264				ARMOUR JAL, 1989, GENOMICS, V4, P328, DOI 10.1016/0888-7543(89)90338-8; BAIRD M, 1986, AM J HUM GENET, V39, P489; BALAZS I, 1989, AM J HUM GENET, V44, P182; BOERWINKLE E, 1989, P NATL ACAD SCI USA, V86, P212, DOI 10.1073/pnas.86.1.212; BUDOWLE B, 1991, AM J HUM GENET, V48, P841; CHAKRABORTY R, 1991, EXPER SUPPL, V58, P127; CHANDLEY AC, 1988, CYTOGENET CELL GENET, V48, P152, DOI 10.1159/000132613; DEVLIN B, 1990, SCIENCE, V249, P1416, DOI 10.1126/science.2205919; GRAY IC, 1991, P ROY SOC B-BIOL SCI, V243, P241, DOI 10.1098/rspb.1991.0038; HAGELBERG E, 1991, NATURE, V352, P427, DOI 10.1038/352427a0; JARMAN AP, 1986, EMBO J, V5, P1857, DOI 10.1002/j.1460-2075.1986.tb04437.x; JEFFREYS AJ, 1988, NUCLEIC ACIDS RES, V16, P10953, DOI 10.1093/nar/16.23.10953; JEFFREYS AJ, 1991, EXPER SUPPL, V58, P1; JEFFREYS AJ, 1985, NATURE, V317, P818, DOI 10.1038/317818a0; JEFFREYS AJ, 1990, CELL, V60, P473, DOI 10.1016/0092-8674(90)90598-9; JEFFREYS AJ, 1985, NATURE, V316, P76, DOI 10.1038/316076a0; JEFFREYS AJ, 1991, AM J HUM GENET, V48, P824; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; LANDER ES, 1989, NATURE, V339, P501, DOI 10.1038/339501a0; LITT M, 1989, AM J HUM GENET, V44, P397; NAKAMURA Y, 1987, NUCLEIC ACIDS RES, V15, P2537, DOI 10.1093/nar/15.6.2537; NAKAMURA Y, 1987, SCIENCE, V235, P1616, DOI 10.1126/science.3029872; ODELBERG SJ, 1989, GENOMICS, V5, P915, DOI 10.1016/0888-7543(89)90134-1; OWERBACH D, 1984, GENE, V32, P475, DOI 10.1016/0378-1119(84)90021-0; PAGE D C, 1987, Genomics, V1, P243, DOI 10.1016/0888-7543(87)90051-6; ROYLE NJ, 1988, GENOMICS, V3, P352, DOI 10.1016/0888-7543(88)90127-9; SIMMLER MC, 1987, EMBO J, V6, P963, DOI 10.1002/j.1460-2075.1987.tb04846.x; SMITH JC, 1990, J FORENSIC SCI SOC, V30, P19, DOI 10.1016/S0015-7368(90)73298-7; TAUTZ D, 1989, NUCLEIC ACIDS RES, V17, P6463, DOI 10.1093/nar/17.16.6463; WEBER JL, 1989, AM J HUM GENET, V44, P388; WOLFF RK, 1989, GENOMICS, V5, P382, DOI 10.1016/0888-7543(89)90076-1; WOLFF RK, 1988, GENOMICS, V3, P347, DOI 10.1016/0888-7543(88)90126-7; WONG Z, 1986, NUCLEIC ACIDS RES, V14, P4605, DOI 10.1093/nar/14.11.4605; WONG Z, 1987, ANN HUM GENET, V51, P269, DOI 10.1111/j.1469-1809.1987.tb01062.x	34	364	390	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	NOV 21	1991	354	6350					204	209		10.1038/354204a0	http://dx.doi.org/10.1038/354204a0			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ948	1961248				2022-12-24	WOS:A1991GQ94800040
J	FIRLIK, AD				FIRLIK, AD			MARGO LOGO	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material																			0	41	41	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	1991	265	2					201	201		10.1001/jama.265.2.201	http://dx.doi.org/10.1001/jama.265.2.201			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EQ602	1984141				2022-12-24	WOS:A1991EQ60200013
J	BUNKER, CB; TERENGHI, G; SPRINGALL, DR; POLAK, JM; DOWD, PM				BUNKER, CB; TERENGHI, G; SPRINGALL, DR; POLAK, JM; DOWD, PM			DEFICIENCY OF CALCITONIN GENE-RELATED PEPTIDE IN RAYNAUDS-PHENOMENON	LANCET			English	Article							HUMAN-SKIN	Skin biopsy samples from the fingers of nine patients with primary Raynaud's phenomenon, nine with the disorder associated with systemic sclerosis, and eleven healthy controls were examined by immunocytochemistry. There were no differences between the groups in the distribution of PGP 9.5 (a pan-neuronal marker) immunoreactivity, but there was a significant reduction in the number of calcitonin gene-related peptide (CGRP) immunoreactive neurons in the skin of patients with primary Raynaud's phenomenon and those with systemic sclerosis. These finding implicate dysfunction of the CGRP neurovascular axis in the pathophysiology of Raynaud's phenomenon.	UNIV COLL & MIDDLESEX SCH MED,MIDDLESEX HOSP,DEPT DERMATOL,MORTIMER ST,LONDON W1N 8AA,ENGLAND; HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,DEPT HISTOCHEM,LONDON W12 0HS,ENGLAND	University of London; University College London; Imperial College London				Bunker, Christopher/0000-0002-6693-7483				Allen EV, 1932, AM J MED SCI, V183, P187, DOI 10.1097/00000441-193202000-00004; BUNKER C B, 1990, British Journal of Rheumatology, V29, P1; BUNKER CB, 1990, LANCET, V335, P239, DOI 10.1016/0140-6736(90)90343-4; BUNKER CB, 1988, BRIT J DERMATOL, V119, P771, DOI 10.1111/j.1365-2133.1988.tb03502.x; BUNKER CB, 1989, BR J DERMATOL S34, V121, P43; BUNKER CB, IN PRESS J INVEST DE; Coffman JD., 1989, RAYNAUDS PHENOMENON; DALSGAARD CJ, 1989, HISTOCHEMISTRY, V91, P35, DOI 10.1007/BF00501907; DALSGAARD CJ, 1989, HISTOCHEMISTRY, V92, P385, DOI 10.1007/BF00492495; DOWD PM, 1990, LANCET, V336, P1014, DOI 10.1016/0140-6736(90)92481-V; GIBBINS IL, 1987, BRAIN RES, V414, P143, DOI 10.1016/0006-8993(87)91335-7; HOWDEN CW, 1988, CLIN SCI, V74, P413, DOI 10.1042/cs0740413; Lewis T, 1929, HEART-J STUD CIRC, V15, P7; Lewis T., 1927, BLOOD VESSELS HUMAN; LEWIS T, 1933, CLIN SCI, V1, P327; MARSHALL I, 1986, NEUROENDOCRINE MOL B, P1; PIOTROWSKI W, 1986, BRIT J DERMATOL, V114, P37, DOI 10.1111/j.1365-2133.1986.tb02777.x; RAYNAUD M, 1888, SELECTED MONOGRAPHS, V121; SHAWKET S, 1989, LANCET, V2, P1354; STRUTHERS AD, 1986, CLIN SCI, V70, P389, DOI 10.1042/cs0700389; WALLENGREN J, 1987, ACTA DERM-VENEREOL, V67, P185; ZAMORA MR, 1990, LANCET, V336, P1144, DOI 10.1016/0140-6736(90)92766-B; 1980, ARCH RHEUM, V23, P581	23	96	98	1	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 22	1990	336	8730					1530	1533		10.1016/0140-6736(90)93307-B	http://dx.doi.org/10.1016/0140-6736(90)93307-B			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP037	1979366				2022-12-24	WOS:A1990EP03700004
J	KWIATKOWSKI, D; HILL, AVS; SAMBOU, I; TWUMASI, P; CASTRACANE, J; MANOGUE, KR; CERAMI, A; BREWSTER, DR; GREENWOOD, BM				KWIATKOWSKI, D; HILL, AVS; SAMBOU, I; TWUMASI, P; CASTRACANE, J; MANOGUE, KR; CERAMI, A; BREWSTER, DR; GREENWOOD, BM			TNF CONCENTRATION IN FATAL CEREBRAL, NONFATAL CEREBRAL, AND UNCOMPLICATED PLASMODIUM-FALCIPARUM MALARIA	LANCET			English	Article									MRC LABS,FAJARA,SENEGAMBIA; ENDOGEN CORP,BOSTON,MA; UNIV OXFORD,INST MOLEC MED,OXFORD,ENGLAND; ROCKEFELLER UNIV,NEW YORK,NY 10021; ROYAL VICTORIA HOSP,BANJUL,SENEGAMBIA	University of Oxford; Rockefeller University			HILL, Adrian V>S>/C-1306-2008	Kwiatkowski, Dominic/0000-0002-5023-0176				BERENDT AR, 1989, NATURE, V341, P57, DOI 10.1038/341057a0; BEUTLER BA, 1985, J IMMUNOL, V135, P3972; BREWSTER DR, 1990, LANCET, V336, P1039, DOI 10.1016/0140-6736(90)92498-7; CLARK IA, 1978, LANCET, V2, P75; CLARK IA, 1987, PARASITOL TODAY, V3, P300, DOI 10.1016/0169-4758(87)90187-6; CLARK IA, IN PRESS TUMOR NECRO; ENGELMANN H, 1990, J BIOL CHEM, V265, P1531; GRAU GE, 1989, NEW ENGL J MED, V320, P1586, DOI 10.1056/NEJM198906153202404; GRAU GE, 1987, SCIENCE, V237, P1210, DOI 10.1126/science.3306918; GREENWOOD BM, 1987, T ROY SOC TROP MED H, V81, P478, DOI 10.1016/0035-9203(87)90170-2; KERN P, 1989, AM J MED, V87, P139, DOI 10.1016/S0002-9343(89)80688-6; KWIATKOWSKI D, 1989, PARASITOL TODAY, V5, P264, DOI 10.1016/0169-4758(89)90261-5; KWIATKOWSKI D, 1989, CLIN EXP IMMUNOL, V77, P361; KWIATKOWSKI D, 1989, J EXP MED, V169, P357, DOI 10.1084/jem.169.1.357; LE JM, 1987, LAB INVEST, V56, P234; MOLYNEUX ME, 1989, Q J MED, V71, P441; PHILLIPS R E, 1986, Parasitology Today, V2, P271, DOI 10.1016/0169-4758(86)90136-5; SCHALL TJ, 1990, CELL, V61, P361, DOI 10.1016/0092-8674(90)90816-W; SHENTON FC, 1988, T ROY SOC TROP MED H, V82, P216, DOI 10.1016/0035-9203(88)90415-4; TAVERNE J, 1989, CLIN EXP IMMUNOL, V67, P1; TRACEY KJ, 1989, LANCET, V1, P1122; WHITE NJ, 1985, LANCET, V1, P776	22	761	772	0	19	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 17	1990	336	8725					1201	1204		10.1016/0140-6736(90)92827-5	http://dx.doi.org/10.1016/0140-6736(90)92827-5			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ064	1978068				2022-12-24	WOS:A1990EJ06400001
J	LAVECCHIA, C; NEGRI, E; DAVANZO, B; FRANCESCHI, S				LAVECCHIA, C; NEGRI, E; DAVANZO, B; FRANCESCHI, S			HISTAMINE-2-RECEPTOR ANTAGONISTS AND GASTRIC-CANCER RISK	LANCET			English	Article									UNIV LAUSANNE,INST SOCIAL & PREVENT MED,CH-1000 LAUSANNE 17,SWITZERLAND; AVIANO CANC CTR,AVIANO,ITALY	University of Lausanne	LAVECCHIA, C (corresponding author), MARIO NEGRI INST PHARMACOL RES,VIA ERITREA 62,I-20157 MILAN,ITALY.		Negri, Eva Vanna Lorenza/AAC-5698-2019; franceschi, silvia/M-2452-2014; Negri, Eva/B-7244-2013; D'Avanzo, Barbara/AAA-7654-2020	Negri, Eva Vanna Lorenza/0000-0001-9712-8526; franceschi, silvia/0000-0003-4181-8071; Negri, Eva/0000-0001-9712-8526; D'Avanzo, Barbara/0000-0002-0361-7263; La Vecchia, Carlo/0000-0003-1441-897X				ARMITAGE JO, 1979, LANCET, V1, P882; Breslow NE., 1980, IARC SCI PUBL, V32, P5; COLINJONES DG, 1985, BMJ-BRIT MED J, V291, P1084, DOI 10.1136/bmj.291.6502.1084; COLINJONES DG, 1983, BMJ-BRIT MED J, V286, P1713, DOI 10.1136/bmj.286.6379.1713; COLINJONES DG, 1982, BRIT MED J, V285, P1311, DOI 10.1136/bmj.285.6351.1311; ELDER JB, 1979, LANCET, V1, P1005, DOI 10.1016/S0140-6736(79)92757-0; FLODGREN P, 1983, INT J CANCER, V32, P657, DOI 10.1002/ijc.2910320603; HAWKER PC, 1980, LANCET, V1, P709; HILL MJ, 1979, LANCET, V1, P1235; LANGMAN MJS, 1985, BRIT MED J, V290, P1850, DOI 10.1136/bmj.290.6485.1850; LAVECCHIA C, 1987, INT J CANCER, V40, P484, DOI 10.1002/ijc.2910400409; MARSHALL ME, 1987, J CLIN ONCOL, V5, P862, DOI 10.1200/JCO.1987.5.6.862; OSBAND ME, 1981, LANCET, V1, P636; REED PI, 1979, LANCET, V1, P1234; RUDDELL WSJ, 1979, LANCET, V1, P1234; SCHOTCHER S, 1981, LANCET, V2, P630; TAYLOR TV, 1979, LANCET, V1, P1235; TONNESEN H, 1988, LANCET, V2, P990	18	32	32	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	AUG 11	1990	336	8711					355	357		10.1016/0140-6736(90)91888-H	http://dx.doi.org/10.1016/0140-6736(90)91888-H			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU075	1975342				2022-12-24	WOS:A1990DU07500011
J	COULDEN, RA; BRITTON, PD; FARMAN, P; NOBLEJAMIESON, G; WIGHT, DGD				COULDEN, RA; BRITTON, PD; FARMAN, P; NOBLEJAMIESON, G; WIGHT, DGD			PRELIMINARY-REPORT - HEPATIC VEIN DOPPLER IN THE EARLY DIAGNOSIS OF ACUTE LIVER-TRANSPLANT REJECTION	LANCET			English	Article									ADDENBROOKES HOSP,DEPT RADIOL,CAMBRIDGE CB2 2QQ,ENGLAND; ADDENBROOKES HOSP,DEPT PAEDIAT,CAMBRIDGE CB2 2QQ,ENGLAND; ADDENBROOKES HOSP,DEPT PATHOL,CAMBRIDGE CB2 2QQ,ENGLAND	Addenbrooke's Hospital; University of Cambridge; Addenbrooke's Hospital; University of Cambridge; Addenbrooke's Hospital; University of Cambridge								APPLETON CP, 1987, J AM COLL CARDIOL, V10, P1032, DOI 10.1016/S0735-1097(87)80343-1; BISMUTH H, 1985, TRANSPLANT P, V17, P279; COULDEN RA, 1989, SEP P ROYAL COLL RAD; DEMETRIS AJ, 1985, AM J PATHOL, V118, P151; DOMINGUEZ R, 1986, GASTROINTEST RADIOL, V11, P326, DOI 10.1007/BF02035101; FLINT EW, 1988, AM J ROENTGENOL, V151, P481, DOI 10.2214/ajr.151.3.481; LONGLEY DG, 1988, RADIOLOGY, V169, P417, DOI 10.1148/radiology.169.2.3051117; RABY N, 1988, CLIN RADIOL, V39, P507, DOI 10.1016/S0009-9260(88)80215-0; REES JIS, 1989, 21ST P M BRIT MED UL; SNOVER DC, 1986, TRANSPLANT P, V18, P123; TAYLOR KJW, 1986, RADIOLOGY, V159, P357, DOI 10.1148/radiology.159.2.3515417; WECHSLER RJ, 1987, RADIOLOGY, V165, P67; WHITE RM, 1987, AM J ROENTGENOL, V148, P1095, DOI 10.2214/ajr.148.6.1095	13	33	33	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	AUG 4	1990	336	8710					273	275		10.1016/0140-6736(90)91804-J	http://dx.doi.org/10.1016/0140-6736(90)91804-J			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT007	1973972				2022-12-24	WOS:A1990DT00700005
J	LUNDE, I; ORTMANN, J				LUNDE, I; ORTMANN, J			PREVALENCE AND SEQUELAE OF SEXUAL TORTURE	LANCET			English	Article											LUNDE, I (corresponding author), ETICA TREATMENT CTR,BORGERGADE 40,DK-1300 COPENHAGEN,DENMARK.							AGGER I, 1988, NORD SEXOL, V6, P31; AGGER I, 1986, NORDISK SEXOLOGI, V4, P147; ALLODI F, 1982, CAN J PSYCHIAT, V27, P98, DOI 10.1177/070674378202700203; DOMOVITCH E, 1984, CAN FAM PHYSICIAN, V30, P827; Hosmer D., 2000, APPL LOGISTIC REGRES, V2; LUNDE I, 1981, ARCH SEX BEHAV, V10, P25, DOI 10.1007/BF01542672; LUNDE I, 1985, UGESKRIFT LAEGER, V147, P2407; LUNDE I, 1987, HLTH HAZARDS ORGANIZ; LUNDE I, 1981, 20TH C FRENCH CRIM L; RASMUSSEN OV, 1980, DAN MED BULL, V27, P241; THORVALDSEN P, 1986, THESIS LAEGEFORENINE; 1986, TORTURE EL SALVADOR; 1977, EVIDENCE TORTURE STU; 1978, REPORT AMNESTY INT M	14	36	36	0	3	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	AUG 4	1990	336	8710					289	291		10.1016/0140-6736(90)91814-Q	http://dx.doi.org/10.1016/0140-6736(90)91814-Q			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DT007	1973980				2022-12-24	WOS:A1990DT00700013
J	EDWARDS, IR; LINDQUIST, M; WIHOLM, BE; NAPKE, E				EDWARDS, IR; LINDQUIST, M; WIHOLM, BE; NAPKE, E			QUALITY CRITERIA FOR EARLY SIGNALS OF POSSIBLE ADVERSE DRUG-REACTIONS	LANCET			English	Article									HLTH PROTECT BRANCH,OTTAWA,ONTARIO,CANADA; NATL BOARD HLTH WELF,DEPT DRUGS,DRUG EPIDEMIOL & INFORMAT BRANCH,UPPSALA,SWEDEN	National Board of Health & Welfare	EDWARDS, IR (corresponding author), UNIV OTAGO,SCH MED,NATL TOXICOL GRP,DUNEDIN,NEW ZEALAND.							Enfors B, 1965, Nord Med, V74, P1286; STRICKER BHC, 1988, BRIT MED J, V297, P1434, DOI 10.1136/bmj.297.6661.1434; STRICKER BHC, 1986, BRIT MED J, V293, P536, DOI 10.1136/bmj.293.6546.536; STRICKER BHC, 1987, BRIT MED J, V295, P1313, DOI 10.1136/bmj.295.6609.1313; VENNING GR, 1983, BRIT MED J, V286, P199, DOI 10.1136/bmj.286.6360.199; VENNING GR, 1983, BRIT MED J, V286, P289, DOI 10.1136/bmj.286.6361.289; VENNING GR, 1982, BRIT MED J, V282, P249; WIHOLM BE, 1986, 3RD WORLD C CLIN PHA; 1986, JAMA-J AM MED ASSOC, V256, P1749; 1974, TENALIDIN KALCIUMGLU, V21, P4; 1958, J MAINE MED ASSOC, V49, P335; 1973, LAKARTIDNINGEN, V70, P1258; 1958, JAMA-J AM MED ASSOC, V3, P112	13	87	91	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JUL 21	1990	336	8708					156	158		10.1016/0140-6736(90)91669-2	http://dx.doi.org/10.1016/0140-6736(90)91669-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP866	1973481				2022-12-24	WOS:A1990DP86600012
J	ATKINSON, MA; MACLAREN, NK; SCHARP, DW; LACY, PE; RILEY, WJ				ATKINSON, MA; MACLAREN, NK; SCHARP, DW; LACY, PE; RILEY, WJ			64000 MR AUTOANTIBODIES AS PREDICTORS OF INSULIN-DEPENDENT DIABETES	LANCET			English	Article									UNIV FLORIDA,COLL MED,DEPT PATHOL & LAB MED,GAINESVILLE,FL 32610; WASHINGTON UNIV,SCH MED,DEPT SURG,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT PATHOL,ST LOUIS,MO 63110	State University System of Florida; University of Florida; Washington University (WUSTL); Washington University (WUSTL)								ATKINSON MA, 1988, DIABETES, V37, P1587, DOI 10.2337/diabetes.37.11.1587; ATKINSON MA, 1986, DIABETES, V35, P894, DOI 10.2337/diabetes.35.8.894; ATKINSON MA, 1988, DIABETES S1, V37, pA98; ATKINSON MA, IN PRESS AUTOIMMUNIT; BAEKKESKOV S, 1984, SCIENCE, V224, P1348, DOI 10.1126/science.6374896; BAEKKESKOV S, 1982, NATURE, V298, P167, DOI 10.1038/298167a0; BAEKKESKOV S, 1987, J CLIN INVEST, V79, P926, DOI 10.1172/JCI112903; BONIFACIO E, 1990, LANCET, V335, P147, DOI 10.1016/0140-6736(90)90013-U; BOTTAZZO GF, 1980, LANCET, V1, P668; CHRISTIE M, 1988, DIABETOLOGIA, V31, P597, DOI 10.1007/BF00264766; CHRISTIE MR, 1990, J BIOL CHEM, V265, P376; COLMAN PG, 1987, DIABETES, V36, P1432, DOI 10.2337/diabetes.36.12.1432; GEPTS W, 1981, AM J MED, V70, P105, DOI 10.1016/0002-9343(81)90417-4; GLEICHMANN H, 1987, DIABETES, V36, P578, DOI 10.2337/diabetes.36.5.578; GORSUCH AN, 1981, LANCET, V2, P1363; HOLMES LA, 1990, DIABETES S1, V39, pA70; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LERNMARK A, 1978, NEW ENGL J MED, V299, P375, DOI 10.1056/NEJM197808242990802; MACLAREN NK, 1988, DIABETES, V37, P1591, DOI 10.2337/diabetes.37.12.1591; MACLAREN NK, 1975, LANCET, V1, P997; MACLAREN NK, 1988, DIABETES, V38, P534; NEUFELD M, 1980, DIABETES, V29, P589, DOI 10.2337/diabetes.29.8.589; PALMER JP, 1983, SCIENCE, V222, P1337, DOI 10.1126/science.6362005; RICORDI C, 1988, DIABETES, V37, P413, DOI 10.2337/diabetes.37.4.413; Riley W J, 1988, Adv Pediatr, V35, P167; RILEY WJ, 1988, J PEDIATR-US, V112, P314, DOI 10.1016/S0022-3476(88)80078-7; RILEY WJ, 1989, PREDIABETES, P45; SERREZE DV, 1988, DIABETES, V37, P351, DOI 10.2337/diabetes.37.3.351; SILVERSTEIN J, 1988, NEW ENGL J MED, V319, P599, DOI 10.1056/NEJM198809083191002; SNEDECOR T, 1967, STATISTICAL METHODS; SRIKANTA S, 1986, DIABETES, V35, P139, DOI 10.2337/diabetes.35.2.139; VARDI P, 1987, DIABETES, V36, P1286, DOI 10.2337/diabetes.36.11.1286; WILKIN T, 1985, LANCET, V1, P480; 1979, DIABETES, V28, P1039	34	238	251	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JUN 9	1990	335	8702					1357	1360		10.1016/0140-6736(90)91241-2	http://dx.doi.org/10.1016/0140-6736(90)91241-2			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH145	1971659				2022-12-24	WOS:A1990DH14500002
J	REUSZ, GS; LATTA, K; HOYER, PF; BYRD, DJ; EHRICH, JHH; BRODEHL, J				REUSZ, GS; LATTA, K; HOYER, PF; BYRD, DJ; EHRICH, JHH; BRODEHL, J			EVIDENCE SUGGESTING HYPEROXALURIA AS A CAUSE OF NEPHROCALCINOSIS IN PHOSPHATE-TREATED HYPOPHOSPHATEMIC RICKETS	LANCET			English	Article									MED SCH HANOVER,CHILDRENS HOSP,DEPT PEDIAT NEPHROL & METAB DIS,KONSTANTY GUTSCHOW STR 8,W-3000 HANOVER 61,GERMANY; SEMMELWEIS UNIV MED,SCH MED,DEPT PEDIAT 1,H-1085 BUDAPEST 8,HUNGARY	Semmelweis University			Reusz, George S/N-7918-2017	Reusz, George S/0000-0003-0396-043X				ALON U, 1983, PEDIATRICS, V71, P970; BRODEHL J, 1982, CLIN NEPHROL, V17, P163; CHESNEY RW, 1980, AM J DIS CHILD, V134, P135, DOI 10.1001/archpedi.1980.02130140009004; De Santo N G, 1987, Contrib Nephrol, V58, P8; DELVIN EE, 1981, CALCIFIED TISSUE INT, V33, P173, DOI 10.1007/BF02409431; EARNEST DL, 1974, GASTROENTEROLOGY, V66, P1114; FARRINGTON CJ, 1979, CLIN CHEM, V25, P1993; FRASER D, 1976, AM J CLIN NUTR, V29, P1315, DOI 10.1093/ajcn/29.11.1315; GLORIEUX FH, 1973, CLIN ASPECTS METABOL, P421; GOODYER PR, 1987, J PEDIATR-US, V111, P700, DOI 10.1016/S0022-3476(87)80245-7; ISOGNA KL, 1983, J CLIN INVEST, V71, P1562; KRUSE K, 1984, EUR J PEDIATR, V143, P25, DOI 10.1007/BF00442743; LEUMANN EP, 1985, INT J PED NEPHROL, V6, P13; LYLES KW, 1982, CALCIFIED TISSUE INT, V34, P125, DOI 10.1007/BF02411222; MALBERTI F, 1988, KIDNEY INT S, V33, pS184; MCENERY PT, 1972, J PEDIATR-US, V80, P763, DOI 10.1016/S0022-3476(72)80128-8; PARVIAINEN MT, 1981, CLIN CHIM ACTA, V114, P233, DOI 10.1016/0009-8981(81)90396-X; ROBERTSON WG, 1969, CLIN CHIM ACTA, V24, P149, DOI 10.1016/0009-8981(69)90152-1; SCHARLA S, 1984, CLIN CHIM ACTA, V142, P325, DOI 10.1016/0009-8981(84)90270-5; STICKLER GB, 1970, MAYO CLIN PROC, V45, P197; WADMAN SK, 1971, PHENYLKETONURIA, P65; Williams HE, 1983, METABOLIC BASIS INHE, P204	23	33	33	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	MAY 26	1990	335	8700					1240	1243		10.1016/0140-6736(90)91304-S	http://dx.doi.org/10.1016/0140-6736(90)91304-S			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF451	1971321				2022-12-24	WOS:A1990DF45100004
J	IGGO, R; GATTER, K; BARTEK, J; LANE, D; HARRIS, AL				IGGO, R; GATTER, K; BARTEK, J; LANE, D; HARRIS, AL			INCREASED EXPRESSION OF MUTANT FORMS OF P53 ONCOGENE IN PRIMARY LUNG-CANCER	LANCET			English	Article									JOHN RADCLIFFE HOSP, INST MOLEC MED,IMPERIAL CANC RES FUND,ONCOL UNIT, MOLEC ONCOL LAB, OXFORD OX3 9DU, ENGLAND; IMPERIAL CANC RES FUND, MOLEC IMMUNOCHEM LAB, POTTERS BAR, HERTS, ENGLAND; RES INST CLIN & EXPTL ONCOL, BRNO, CZECHOSLOVAKIA; UNIV OXFORD, DEPT PATHOL, OXFORD, ENGLAND	University of Oxford; University of Oxford			Iggo, Richard/G-3546-2014; Bartek, Jiri/G-5870-2014; Lane, David P/C-4920-2008; Harris, Adrian L/ABA-3343-2020	Harris, Adrian L/0000-0003-1376-8409; Lane, David/0000-0003-0551-3545				Ausubel FM., 1988, CURRENT PROTOCOLS MO; BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; BERGER MS, 1987, J PATHOL, V152, P297, DOI 10.1002/path.1711520408; CATTORETTI G, 1988, INT J CANCER, V41, P178, DOI 10.1002/ijc.2910410204; CORDELL JL, 1984, J HISTOCHEM CYTOCHEM, V32, P219, DOI 10.1177/32.2.6198355; DUNNILL MS, 1986, HISTOPATHOLOGY, V10, P461, DOI 10.1111/j.1365-2559.1986.tb02498.x; FINLAY CA, 1988, MOL CELL BIOL, V8, P531, DOI 10.1128/MCB.8.2.531; FINLAY CA, 1989, CELL, V57, P1083, DOI 10.1016/0092-8674(89)90045-7; GERDES J, 1983, INT J CANCER, V31, P13, DOI 10.1002/ijc.2910310104; GYLLENSTEN UB, 1988, P NATL ACAD SCI USA, V85, P7652, DOI 10.1073/pnas.85.20.7652; HARLOW E, 1985, MOL CELL BIOL, V5, P1601, DOI 10.1128/MCB.5.7.1601; HINDS P, 1989, J VIROL, V63, P739, DOI 10.1128/JVI.63.2.739-746.1989; JOHN P, 1988, P NATL ACAD SCI USA, V85, P3499; LAMB P, 1986, MOL CELL BIOL, V6, P1379, DOI 10.1128/MCB.6.5.1379; LANE DP, 1979, NATURE, V278, P261, DOI 10.1038/278261a0; LAVIGUEUR A, 1989, MOL CELL BIOL, V9, P3982, DOI 10.1128/MCB.9.9.3982; MASON DY, 1989, J CLIN PATHOL, V42, P1194, DOI 10.1136/jcp.42.11.1194; MAZUR M, 1988, SOMAT CELL MOLEC GEN, V14, P393, DOI 10.1007/BF01534647; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; OREN M, 1981, MOL CELL BIOL, V1, P101, DOI 10.1128/MCB.1.2.101; RODENHUIS S, 1988, CANCER RES, V48, P5738; SAKSELA K, 1989, INT J CANCER, V44, P182, DOI 10.1002/ijc.2910440132; SOUSSI T, 1987, ONCOGENE, V1, P71; STURZBECHER HW, 1987, ONCOGENE, V1, P201; TAKAHASHI T, 1989, SCIENCE, V246, P491, DOI 10.1126/science.2554494; VEALE D, 1989, CANCER RES, V49, P1313; WANG EH, 1989, CELL, V57, P379, DOI 10.1016/0092-8674(89)90913-6; WILLIAMS JG, 1985, NUCLEIC ACID HYBRIDI, P17; WOOD WI, 1985, P NATL ACAD SCI USA, V82, P1585, DOI 10.1073/pnas.82.6.1585; ZANTEMA A, 1985, VIROLOGY, V142, P44, DOI 10.1016/0042-6822(85)90421-0	30	1177	1195	0	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 24	1990	335	8691					675	679		10.1016/0140-6736(90)90801-B	http://dx.doi.org/10.1016/0140-6736(90)90801-B			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV305	1969059				2022-12-24	WOS:A1990CV30500001
J	NUCHTERN, JG; BIDDISON, WE; KLAUSNER, RD				NUCHTERN, JG; BIDDISON, WE; KLAUSNER, RD			CLASS-II MHC MOLECULES CAN USE THE ENDOGENOUS PATHWAY OF ANTIGEN PRESENTATION	NATURE			English	Article									NINCDS,NEUROIMMUNOL BRANCH,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	NUCHTERN, JG (corresponding author), NICHHD,CELL BIOL & METAB BRANCH,BETHESDA,MD 20892, USA.							BLUM JS, 1988, P NATL ACAD SCI USA, V85, P3975, DOI 10.1073/pnas.85.11.3975; COWAN EP, 1987, P NATL ACAD SCI USA, V84, P5014, DOI 10.1073/pnas.84.14.5014; FLEISCHER B, 1985, J IMMUNOL, V135, P2800; FRAZER KB, 1978, MEASLES VIRUS ITS BI, P74; GERMAIN RN, 1986, NATURE, V322, P687, DOI 10.1038/322687a0; GOTCH F, 1987, NATURE, V326, P881, DOI 10.1038/326881a0; HELENIUS A, 1982, J GEN VIROL, V58, P47, DOI 10.1099/0022-1317-58-1-47; HELENIUS A, 1980, J CELL BIOL, V84, P404, DOI 10.1083/jcb.84.2.404; HOGAN KT, 1988, J EXP MED, V168, P725, DOI 10.1084/jem.168.2.725; JACOBSON S, 1989, J VIROL, V63, P1756, DOI 10.1128/JVI.63.4.1756-1762.1989; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; LONG EO, 1989, IMMUNOL TODAY, V10, P45, DOI 10.1016/0167-5699(89)90303-4; MALISSEN B, 1984, CELL, V36, P319, DOI 10.1016/0092-8674(84)90225-3; MATLIN KS, 1981, J CELL BIOL, V91, P601, DOI 10.1083/jcb.91.3.601; MISUMI Y, 1986, J BIOL CHEM, V261, P1398; MOORE MW, 1988, CELL, V54, P777, DOI 10.1016/S0092-8674(88)91043-4; MORRISON LA, 1986, J EXP MED, V163, P903, DOI 10.1084/jem.163.4.903; NUCHTERN JG, 1989, NATURE, V339, P223, DOI 10.1038/339223a0; ROTHBARD JB, 1988, CELL, V52, P515, DOI 10.1016/0092-8674(88)90464-3; SEKALY RP, 1988, P NATL ACAD SCI USA, V85, P1209, DOI 10.1073/pnas.85.4.1209; SHIMOJO N, 1989, J IMMUNOL, V143, P2939; STOCKINGER B, 1989, CELL, V56, P683, DOI 10.1016/0092-8674(89)90590-4; SWEETSER MT, 1989, NATURE, V342, P180, DOI 10.1038/342180a0; TAKATSUKI A, 1985, AGR BIOL CHEM TOKYO, V49, P899, DOI 10.1080/00021369.1985.10866826; TOWNSEND A, 1988, J EXP MED, V168, P1211, DOI 10.1084/jem.168.4.1211; TOWNSEND A, 1989, NATURE, V340, P443, DOI 10.1038/340443a0; TOWNSEND ARM, 1986, NATURE, V324, P575, DOI 10.1038/324575a0; TOWNSEND ARM, 1985, CELL, V42, P457, DOI 10.1016/0092-8674(85)90103-5; WHITE J, 1980, J CELL BIOL, V87, P264, DOI 10.1083/jcb.87.1.264; WHITE J, 1981, J CELL BIOL, V89, P674, DOI 10.1083/jcb.89.3.674; YEWDELL JW, 1989, SCIENCE, V244, P1072, DOI 10.1126/science.2471266; YEWDELL JW, 1988, SCIENCE, V239, P637, DOI 10.1126/science.3257585	32	291	294	0	2	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JAN 4	1990	343	6253					74	76		10.1038/343074a0	http://dx.doi.org/10.1038/343074a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG614	1967486				2022-12-24	WOS:A1990CG61400058
J	BRAVEMAN, PA; EGERTER, S; BENNETT, T; SHOWSTACK, J				BRAVEMAN, PA; EGERTER, S; BENNETT, T; SHOWSTACK, J			DIFFERENCES IN HOSPITAL RESOURCE-ALLOCATION AMONG SICK NEWBORNS ACCORDING TO INSURANCE-COVERAGE	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article								Objective. - To assess whether newborns insurance coverage was associated with differences in the allocation of hospital services. Design. - Retrospective analysis of computerized hospital discharge data, comparing resource allocation among newborns according to insurance status, controlling for race/ethnicity, diagnoses, hospital characteristics (ownership, teaching status, nursery level), and disposition. Setting. - All California civilian acute-care hospitals. Patients. - Population-based sample, excluding out-of-hospital and military hospital births. Resource allocation was studied among all newborns discharged in 1987 with evidence of serious problems (N = 29 751). Main Outcome Measures. - Length of stay, total charges, and charges per day. Results. - Sick newborns without insurance received fewer inpatient services than comparable privately insured newborns with either indemnity or prepaid coverage. This pattern was observed across all hospital ownership types. Mean stay was 15.7 days for all privately insured newborns (15.6 days for those with indemnity and 15.7 days for those with prepaid coverage), 14.8 days for Medicaid-covered newborns, and 13.2 days for uninsured newborns (P < .001). Length of stay, total charges, and charges per day were 16%, 28%, and 10% less, respectively, for the uninsured than for all privately insured newborns (P < .001). Resources for newborns covered by Medicaid were generally greater than for the uninsured and less than for the privately insured. Both uninsured and Medicaid-covered newborns were found to have more severe medical problems than the privately insured. Conclusions. - The findings cannot be explained by differences in medical need or by differences in non-medically indicated services; they constitute prima facie evidence of inequities that need to be addressed by policy changes.	UNIV CALIF SAN FRANCISCO, SCH MED, INST HLTH POLICY STUDIES, SAN FRANCISCO, CA 94143 USA	University of California System; University of California San Francisco	BRAVEMAN, PA (corresponding author), UNIV CALIF SAN FRANCISCO, SCH MED, DEPT FAMILY & COMMUNITY MED, BOX 0900, SAN FRANCISCO, CA 94143 USA.		Showstack, Jonathan/L-6556-2013	Showstack, Jonathan/0000-0002-1367-419X				ADAY LA, 1978, HEALTH SERV RES, V13, P369; ADAY LA, 1984, AM J PUBLIC HEALTH, V74, P1331, DOI 10.2105/AJPH.74.12.1331; Amler RW, 1987, CLOSING GAP BURDEN U; BAZZOLI GJ, 1986, HEALTH SERV RES, V21, P353; Becker E R, 1983, Inquiry, V20, P248; BRAVEMAN P, 1989, NEW ENGL J MED, V321, P508, DOI 10.1056/NEJM198908243210805; BROWN ER, 1988, CHANGES HLTH INSURAN; CAPER P, 1988, NEW ENGL J MED, V318, P1535, DOI 10.1056/NEJM198806093182310; COHODES DR, 1986, INQUIRY-J HEALTH CAR, V23, P227; DAVIS K, 1983, MILBANK FUND Q, V61, P149, DOI 10.2307/3349903; DAVIS K, 1981, ANNU REV PUBL HEALTH, V2, P159, DOI 10.1146/annurev.pu.02.050181.001111; DOWD BE, 1986, MED CARE, V24, P694, DOI 10.1097/00005650-198608000-00005; EPSTEIN AM, 1990, NEW ENGL J MED, V322, P1122, DOI 10.1056/NEJM199004193221606; FUCHS VR, 1987, NEW ENGL J MED, V316, P1154, DOI 10.1056/NEJM198704303161812; GORDON T, 1986, PEDIATRICS, V77, P29; HADLEY J, 1991, JAMA-J AM MED ASSOC, V265, P374, DOI 10.1001/jama.265.3.374; JOHNSON AN, 1989, INQUIRY-J HEALTH CAR, V26, P388; LINCOLN R, 1987, BLESSED EVENTS BOTTO; MARMOT MG, 1978, J EPIDEMIOL COMMUN H, V32, P244, DOI 10.1136/jech.32.4.244; MURRAY JL, 1988, NEW ENGL J MED, V319, P1385, DOI 10.1056/NEJM198811243192105; NUTTER DO, 1987, NEW ENGL J MED, V316, P1156, DOI 10.1056/NEJM198704303161813; SHOWSTACK JA, 1984, AM J PUBLIC HEALTH, V74, P1003, DOI 10.2105/AJPH.74.9.1003; STARFIELD B, 1985, HEALTH SERV RES, V19, P817; STERN RS, 1989, ARCH INTERN MED, V149, P1185, DOI 10.1001/archinte.149.5.1185; WEISFELD VD, 1987, 2 R WOOD JOHNS F SPE; WEISSMAN J, 1989, JAMA-J AM MED ASSOC, V261, P3572, DOI 10.1001/jama.261.24.3572; WENNEKER MB, 1990, JAMA-J AM MED ASSOC, V264, P1255, DOI 10.1001/jama.264.10.1255; WISE PH, 1985, NEW ENGL J MED, V313, P360, DOI 10.1056/NEJM198508083130605; 1980, PHS801260 US DEP HLT, P1; 1985, SAS USERS GUIDE STAT; 1987, AM HOSPITAL ASS GUID; [No title captured]	32	80	80	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 18	1991	266	23					3300	3308		10.1001/jama.266.23.3300	http://dx.doi.org/10.1001/jama.266.23.3300			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GU964	1960830				2022-12-24	WOS:A1991GU96400029
J	PEREZMESA, C				PEREZMESA, C			PATHOLOGY EVALUATION OF LUMPECTOMY SPECIMEN	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							BREAST-CANCER; MASTECTOMY				PEREZMESA, C (corresponding author), ELLIS FISCHEL STATE CANC CTR,COLUMBIA,MO 65203, USA.							FERGUSON DJ, 1989, NEW ENGL J MED, V321, P689; FISHER B, 1985, WORLD J SURG, V9, P692, DOI 10.1007/BF01655182; FISHER ER, 1986, CANCER-AM CANCER SOC, V57, P1717, DOI 10.1002/1097-0142(19860501)57:9<1717::AID-CNCR2820570902>3.0.CO;2-H; LAGIOS MD, 1983, CANCER, V52, P2173, DOI 10.1002/1097-0142(19831201)52:11<2173::AID-CNCR2820521133>3.0.CO;2-0; ROSEN PP, 1975, CANCER, V35, P739, DOI 10.1002/1097-0142(197503)35:3<739::AID-CNCR2820350329>3.0.CO;2-5	5	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 16	1991	265	3					412	412		10.1001/jama.265.3.412	http://dx.doi.org/10.1001/jama.265.3.412			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ER256	1984544				2022-12-24	WOS:A1991ER25600039
J	SASAHARA, M; FRIES, JWU; RAINES, EW; GOWN, AM; WESTRUM, LE; FROSCH, MP; BONTHRON, DT; ROSS, R; COLLINS, T				SASAHARA, M; FRIES, JWU; RAINES, EW; GOWN, AM; WESTRUM, LE; FROSCH, MP; BONTHRON, DT; ROSS, R; COLLINS, T			PDGF B-CHAIN IN NEURONS OF THE CENTRAL-NERVOUS-SYSTEM, POSTERIOR PITUITARY, AND IN A TRANSGENIC MODEL	CELL			English	Article							EPIDERMAL GROWTH-FACTOR; FACTOR-A-CHAIN; FACTOR RECEPTORS; MESSENGER-RNA; HUMAN-FIBROBLASTS; CELL-MEMBRANES; FACTOR-BINDING; FACTOR-ALPHA; RAT-BRAIN; C-SIS	Platelet-derived growth factors (PDGFs) are growth-regulatory molecules that stimulate chemotaxis, proliferation, and increased metabolism of primarily connective tissue cells. In a survey of normal tissues, we found specific immunostaining for PDGF B-chain in neurons, principal dendrites, some axons, and probable terminals throughout the brain, in the dorsal horn of the spinal cord, and in the posterior pituitary of the nonhuman primate (Macaca nemestrina). PDGF activity was extracted from brain cortex and posterior pituitary, and ubiquitous expression of transcripts for the two chains of PDGF and both PDGF receptors was detected throughout the brain and posterior pituitary. A transgenic model was also evaluated in which the chloramphenicol acetyltransferase gene was placed under transcriptional control of the PDGF B-chain promoter. The transgene was preferentially expressed within neural cell bodies in the cortex, hippocampus, and cerebellum. PDGF may act as a neuronal regulatory agent. Neuronal release of PDGF could contribute to nerve regeneration and to glial proliferation that leads to gliosis and scarring.	UNIV WASHINGTON,DEPT NEUROL SURG & BIOL STRUCT,SEATTLE,WA 98195; BRIGHAM & WOMENS HOSP,DEPT PATHOL,BOSTON,MA 02115; UNIV EDINBURGH,WESTERN GEN HOSP,HUMAN GENET UNIT,EDINBURGH EH8 9YL,MIDLOTHIAN,SCOTLAND	University of Washington; University of Washington Seattle; Harvard University; Brigham & Women's Hospital; University of Edinburgh	SASAHARA, M (corresponding author), UNIV WASHINGTON,DEPT PATHOL,SEATTLE,WA 98195, USA.		Frosch, Matthew P/ABD-7456-2021; Fries, Jochen/AAM-5999-2020	Frosch, Matthew P/0000-0002-3940-9861; Fries, Jochen/0000-0003-2054-6345; Bonthron, David/0000-0001-8132-8179	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL018645, R01HL029873] Funding Source: NIH RePORTER; NCI NIH HHS [CA-36250] Funding Source: Medline; NHLBI NIH HHS [HL-29873, HL-18645] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BARRETT TB, 1988, P NATL ACAD SCI USA, V85, P2810, DOI 10.1073/pnas.85.8.2810; BETSHOLTZ C, 1986, NATURE, V320, P695, DOI 10.1038/320695a0; BETSHOLTZ C, 1989, MOL CHEM NEUROPATHOL, V10, P27, DOI 10.1007/BF02969484; BONTHRON DT, 1988, P NATL ACAD SCI USA, V85, P1492, DOI 10.1073/pnas.85.5.1492; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRESSLER JP, 1985, BRAIN RES, V344, P249, DOI 10.1016/0006-8993(85)90802-9; BRODAL A, 1981, NEUROLOGICAL RELATIO, P734; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; COOPER JA, 1982, CELL, V31, P263, DOI 10.1016/0092-8674(82)90426-3; DAVIS JB, 1990, J CELL BIOL, V110, P1353, DOI 10.1083/jcb.110.4.1353; EK B, 1984, J BIOL CHEM, V259, P1145; Emoto N, 1989, GROWTH FACTORS, V2, P21, DOI 10.3109/08977198909069078; Fallon JH, 1990, GROWTH FACTORS, V2, P241, DOI 10.3109/08977199009071510; FALLON JH, 1984, SCIENCE, V224, P1107, DOI 10.1126/science.6144184; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; GARCIA RL, 1989, AM J PATHOL, V134, P733; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GRONWALD RGK, 1988, P NATL ACAD SCI USA, V85, P3435, DOI 10.1073/pnas.85.10.3435; HANAI K, 1987, J CELL BIOL, V104, P1675, DOI 10.1083/jcb.104.6.1675; HARLOW E, 1988, ANTIBODIES LABORATOR, P594; HART CE, 1988, SCIENCE, V240, P1529, DOI 10.1126/science.2836952; HART CE, 1990, BIOCHEMISTRY-US, V29, P166, DOI 10.1021/bi00453a022; HARVEY AK, 1987, INVEST OPHTH VIS SCI, V28, P1092; HELDIN CH, 1988, EMBO J, V7, P1387, DOI 10.1002/j.1460-2075.1988.tb02955.x; HELDIN CH, 1990, CELL REGUL, V1, P555, DOI 10.1091/mbc.1.8.555; HELDIN CH, 1989, J BIOL CHEM, V264, P8905; HEMMINGS HC, 1989, FASEB J, V3, P1583, DOI 10.1096/fasebj.3.5.2493406; Hogan B., 1986, MANIPULATING MOUSE E; KENNEDY MB, 1989, CELL, V59, P777, DOI 10.1016/0092-8674(89)90601-6; KUDLOW JE, 1989, J BIOL CHEM, V264, P3880; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MALDONADO PE, 1988, J MEMBRANE BIOL, V106, P203, DOI 10.1007/BF01872158; MARCH SC, 1974, ANAL BIOCHEM, V60, P149, DOI 10.1016/0003-2697(74)90139-0; MATSUI T, 1989, SCIENCE, V243, P800, DOI 10.1126/science.2536956; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MERCOLA M, 1990, DEV BIOL, V138, P114, DOI 10.1016/0012-1606(90)90181-H; MERCOLA M, 1985, SCIENCE, V227, P266, DOI 10.1126/science.3917575; MORRISON RS, 1987, SCIENCE, V238, P72, DOI 10.1126/science.3498986; NISHIMURA J, 1982, P NATL ACAD SCI-BIOL, V79, P4303, DOI 10.1073/pnas.79.14.4303; NISTER M, 1988, CANCER RES, V48, P3910; NOBLE M, 1988, NATURE, V333, P560, DOI 10.1038/333560a0; OVERBEEK PA, 1986, SCIENCE, V231, P1574, DOI 10.1126/science.3006249; OWEN AJ, 1982, P NATL ACAD SCI-BIOL, V79, P3203, DOI 10.1073/pnas.79.10.3203; PECH M, 1989, MOL CELL BIOL, V9, P396, DOI 10.1128/MCB.9.2.396; PIKE LJ, 1983, J BIOL CHEM, V258, P9383; PLATASALAMAN CR, 1988, NEUROSCI LETT, V94, P161, DOI 10.1016/0304-3940(88)90288-1; PRENCE EM, 1990, J CELL BIOL, V110, P319, DOI 10.1083/jcb.110.2.319; Raines E. W., 1990, HDB EXPT PHARM PEPTI, V951, P173; RAINES EW, 1987, METHOD ENZYMOL, V147, P48; RAINES EW, 1985, METHOD ENZYMOL, V109, P749; RAINES EW, 1989, SCIENCE, V243, P393, DOI 10.1126/science.2783498; RAIVICH G, 1987, J NEUROCYTOL, V16, P701, DOI 10.1007/BF01637661; RATNER L, 1987, NUCLEIC ACIDS RES, V15, P6017, DOI 10.1093/nar/15.15.6017; RICHARDSON WD, 1988, CELL, V53, P309, DOI 10.1016/0092-8674(88)90392-3; Roberts AB, 1990, HDB EXPT PHARM, V95, P419; RORSMAN F, 1988, MOL CELL BIOL, V8, P571, DOI 10.1128/MCB.8.2.571; ROSS R, 1986, NEW ENGL J MED, V314, P488, DOI 10.1056/NEJM198602203140806; ROSS R, 1990, SCIENCE, V248, P1009, DOI 10.1126/science.2343305; SEIFERT RA, 1989, J BIOL CHEM, V264, P8771; Shaw W V, 1975, Methods Enzymol, V43, P737; SHAW WV, 1991, IN PRESS ANN REV BIO; SHIMOKADO K, 1985, CELL, V43, P277, DOI 10.1016/0092-8674(85)90033-9; SHIRAISHI T, 1989, CLIN CHIM ACTA, V184, P65, DOI 10.1016/0009-8981(89)90257-X; Smits A, 1989, GROWTH FACTORS, V2, P1, DOI 10.3109/08977198909069076; VANZOELEN EJJ, 1985, MOL CELL BIOL, V5, P2289, DOI 10.1128/MCB.5.9.2289; WALICKE P, 1986, P NATL ACAD SCI USA, V83, P3012, DOI 10.1073/pnas.83.9.3012; WALICKE PA, 1988, DEV BRAIN RES, V40, P71, DOI 10.1016/0165-3806(88)90009-0; YOSHIZAWA T, 1990, SCIENCE, V247, P462, DOI 10.1126/science.2405487; YOUNG G, 1990, IN PRESS MOL CELL BI	69	383	405	0	7	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	JAN 11	1991	64	1					217	227		10.1016/0092-8674(91)90223-L	http://dx.doi.org/10.1016/0092-8674(91)90223-L			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ET175	1986868				2022-12-24	WOS:A1991ET17500023
J	KOSTREWA, D; GRANZIN, J; KOCH, C; CHOE, HW; RAGHUNATHAN, S; WOLF, W; LABAHN, J; KAHMANN, R; SAENGER, W				KOSTREWA, D; GRANZIN, J; KOCH, C; CHOE, HW; RAGHUNATHAN, S; WOLF, W; LABAHN, J; KAHMANN, R; SAENGER, W			3-DIMENSIONAL STRUCTURE OF THE ESCHERICHIA-COLI DNA-BINDING PROTEIN FIS	NATURE			English	Article							SITE-SPECIFIC RECOMBINATION; HOST FACTOR; RESOLUTION; INVERSION; ENHANCER; LAMBDA; PHASE; REFINEMENT; REPRESSOR; GROWTH	The factor for inversion stimulation, FIS, is involved in several cellular processes, including site-specific recombination and transcriptional activation 1-4. In the reactions catalysed by the DNA invertases Gin, Hin and Cin, FIS stimulates recombination by binding to an enhancer sequence 1. Within the enhancer, two FIS dimers (each 2 x 98 amino acids) 5-7 bind to two 15-base-pair consensus sequences 8,9 (Fig. 1) and induce bending of DNA 10,11. Current models propose that the enhancer-FIS complex organizes a specific synapse, either through direct interactions with Gin, or by modelling the substrate into a configuration suitable for recombination 1,9,12. Using X-ray analysis at 2.0 angstrom resolution, we now show that FIS is composed of four alpha-helices tightly intertwined to form a globular dimer with two protruding helix-turn-helix motifs. The 24 N-terminal amino acids are so poorly defined in the electron density map as to make interpretation doubtful, indicating that they might act as 'feelers' suitable for DNA or protein (invertase) recognition. We infer from model building that DNA has to bend for tight binding to FIS.	INST GENBIOL FORSCH BERLIN GMBH,W-1000 BERLIN 33,GERMANY		KOSTREWA, D (corresponding author), FREE UNIV BERLIN,INST KRISTALLOG,TAKUSTR 6,W-1000 BERLIN 33,GERMANY.		Granzin, Joachim/G-8937-2013; Koch, Christian/W-5731-2019; Labahn, Jörg/G-9593-2013; Koch, Christian/J-5716-2013	Granzin, Joachim/0000-0001-6604-950X; Koch, Christian/0000-0001-8407-4952; Labahn, Jörg/0000-0002-0648-8145; Wolf, Wojciech/0000-0002-9162-9933				ANDERSON WF, 1981, NATURE, V290, P754, DOI 10.1038/290754a0; BETERMIER M, 1989, MOL MICROBIOL, V3, P459, DOI 10.1111/j.1365-2958.1989.tb00192.x; BREG JN, 1990, NATURE, V346, P586, DOI 10.1038/346586a0; BRENNAN RG, 1989, J BIOL CHEM, V264, P1903; BRUIST MF, 1987, GENE DEV, V1, P762, DOI 10.1101/gad.1.8.762; CHOE HW, 1989, J MOL BIOL, V208, P209, DOI 10.1016/0022-2836(89)90098-3; HUBNER P, 1989, J MOL BIOL, V205, P493, DOI 10.1016/0022-2836(89)90220-9; HUNER P, 1989, EMBO J, V8, P577; JOHNSON RC, 1988, P NATL ACAD SCI USA, V85, P3484, DOI 10.1073/pnas.85.10.3484; JOHNSON RC, 1987, TRENDS GENET, V3, P262, DOI 10.1016/0168-9525(87)90261-7; KANAAR R, 1988, P NATL ACAD SCI USA, V85, P752, DOI 10.1073/pnas.85.3.752; KOCH C, 1986, J BIOL CHEM, V261, P5673; KOCH C, 1988, P NATL ACAD SCI USA, V85, P4237, DOI 10.1073/pnas.85.12.4237; KOCH C, 1988, THESIS FREIE U BERLI; NILSSON L, 1990, EMBO J, V9, P727, DOI 10.1002/j.1460-2075.1990.tb08166.x; PABO CO, 1990, SCIENCE, V247, P1210, DOI 10.1126/science.2315694; PABO CO, 1982, NATURE, V298, P443, DOI 10.1038/298443a0; PRAFFERTYJB, 1989, NATURE, V341, P705; RICE DW, 1981, ACTA CRYSTALLOGR A, V37, P491, DOI 10.1107/S0567739481001186; RICHMOND TJ, 1984, NATURE, V311, P532, DOI 10.1038/311532a0; STEITZ TA, 1990, Q REV BIOPHYS, V23, P205, DOI 10.1017/S0033583500005552; TANAKA I, 1984, NATURE, V310, P376, DOI 10.1038/310376a0; THOMPSON JF, 1987, CELL, V50, P901, DOI 10.1016/0092-8674(87)90516-2; THOMPSON JF, 1988, NUCLEIC ACIDS RES, V16, P9687, DOI 10.1093/nar/16.20.9687; TRONRUD DE, 1987, ACTA CRYSTALLOGR A, V43, P489, DOI 10.1107/S0108767387099124; WANG BC, 1985, METHOD ENZYMOL, V115, P90; WILMOT CM, 1988, J MOL BIOL, V203, P221, DOI 10.1016/0022-2836(88)90103-9; 1986, CCP4 COOPERATIVE COM	28	141	143	0	6	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JAN 10	1991	349	6305					178	180		10.1038/349178a0	http://dx.doi.org/10.1038/349178a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER418	1986310				2022-12-24	WOS:A1991ER41800066
J	HAROOTUNIAN, AT; KAO, JPY; PARANJAPE, S; TSIEN, RY				HAROOTUNIAN, AT; KAO, JPY; PARANJAPE, S; TSIEN, RY			GENERATION OF CALCIUM OSCILLATIONS IN FIBROBLASTS BY POSITIVE FEEDBACK BETWEEN CALCIUM AND IP3	SCIENCE			English	Article							DEPENDENT PROTEIN-KINASE; INOSITOL 1,4,5-TRISPHOSPHATE; SARCOPLASMIC-RETICULUM; INTRACELLULAR CA-2+; PHOSPHOLIPASE-C; INDUCED RELEASE; PHOSPHATES; HEPARIN; MUSCLE; POTENT	A wide variety of nonexcitable cells generate repetitive transient increases in cytosolic calcium ion concentration ([Ca2+]i) when stimulated with agonists that engage the phosphoinositide signalling pathway. Current theories regarding the mechanisms of oscillation disagree on whether Ca2+ inhibits or stimulates its own release from internal stores and whether inositol 1,4,5-trisphosphate (IP3) and diacylglycerol (DG) also undergo oscillations linked to the Ca2+ spikes. In this study, Ca2+ was found to stimulate its own release in REF52 fibroblasts primed by mitogens plus depolarization. However, unlike Ca2+ release in muscle and nerve cells, this amplification was insensitive to caffeine or ryanodine and required hormone receptor occupancy and functional IP3 receptors. Oscillations in [Ca2+]i were accompanied by oscillations in IP3 concentration but did not require functional protein kinase C. Therefore, the dominant feedback mechanism in this cell type appears to be Ca2+ stimulation of phospholipase C once this enzyme has been activated by hormone receptors.	UNIV CALIF SAN DIEGO,HOWARD HUGHES MED INST M047,LA JOLLA,CA 92093	University of California System; University of California San Diego				Kao, Joseph/0000-0002-8875-2180	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS027177, R37NS027177] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 31004] Funding Source: Medline; NINDS NIH HHS [NS 27177] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADAMS SR, 1988, J AM CHEM SOC, V110, P3212, DOI 10.1021/ja00218a034; AMBLER SK, 1987, MOL PHARMACOL, V32, P376; BERRIDGE MJ, 1988, PHILOS T ROY SOC B, V320, P325, DOI 10.1098/rstb.1988.0080; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BERRIDGE MJ, 1990, J BIOL CHEM, V265, P9583; DEAN NM, 1989, ANAL BIOCHEM, V183, P199, DOI 10.1016/0003-2697(89)90468-5; EBERHARD DA, 1988, TRENDS NEUROSCI, V11, P517, DOI 10.1016/0166-2236(88)90174-9; ENDO M, 1970, NATURE, V228, P34, DOI 10.1038/228034a0; FABIATO A, 1983, AM J PHYSIOL, V245, pC1; GHOSH TK, 1988, J BIOL CHEM, V263, P11075; GOLDBETER A, 1990, P NATL ACAD SCI USA, V87, P1461, DOI 10.1073/pnas.87.4.1461; HANNUN YA, 1989, SCIENCE, V243, P500, DOI 10.1126/science.2643164; HAROOTUNIAN A, UNPUB; HAROOTUNIAN A T, 1989, Journal of Cell Biology, V109, p99A; HAROOTUNIAN AT, 1988, COLD SPRING HARB SYM, V53, P945; JACOB R, 1990, BIOCHIM BIOPHYS ACTA, V1052, P427, DOI 10.1016/0167-4889(90)90152-4; KAO JPY, 1989, J BIOL CHEM, V264, P8179; KAPLAN JH, 1990, ANNU REV PHYSIOL, V52, P897; KIKKAWA U, 1982, J BIOL CHEM, V257, P13341; KOBAYASHI S, 1989, J BIOL CHEM, V264, P17997; KUBA K, 1980, J PHYSL, V298, P547; LIPSCOMBE D, 1988, NEURON, V1, P335; MALGAROLI A, 1990, J BIOL CHEM, V265, P3005; MEYER T, 1988, P NATL ACAD SCI USA, V85, P5051, DOI 10.1073/pnas.85.14.5051; MICHEL MC, 1989, J BIOL CHEM, V264, P4986; MOCHLYROSEN D, 1987, J BIOL CHEM, V262, P2291; PALADE P, 1989, MOL PHARMACOL, V36, P673; PARKER I, 1990, P NATL ACAD SCI USA, V87, P260, DOI 10.1073/pnas.87.1.260; PAYNE R, 1990, NEURON, V4, P547, DOI 10.1016/0896-6273(90)90112-S; RENARD D, 1987, BIOCHEM J, V243, P319; RHEE SG, 1989, SCIENCE, V244, P546, DOI 10.1126/science.2541501; Rink TJ, 1990, CURR OPIN CELL BIOL, V2, P198, DOI 10.1016/0955-0674(90)90007-2; RODRIGUEZPENA A, 1984, BIOCHEM BIOPH RES CO, V120, P1053, DOI 10.1016/S0006-291X(84)80213-2; ROONEY TA, 1989, J BIOL CHEM, V264, P17131; RUEGG UT, 1989, TRENDS PHARMACOL SCI, V10, P218, DOI 10.1016/0165-6147(89)90263-0; SEISHIMA M, 1988, BIOCHEM BIOPH RES CO, V156, P1077, DOI 10.1016/S0006-291X(88)80742-3; TSIEN RW, 1990, ANNU REV CELL BIOL, V6, P715, DOI 10.1146/annurev.cb.06.110190.003435; VALDEOLMILLOS M, 1989, PFLUG ARCH EUR J PHY, V413, P676, DOI 10.1007/BF00581820; WAKUI M, 1989, NATURE, V339, P317, DOI 10.1038/339317a0; WOODS NM, 1987, CELL CALCIUM, V8, P79, DOI 10.1016/0143-4160(87)90038-8	40	302	304	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JAN 4	1991	251	4989					75	78		10.1126/science.1986413	http://dx.doi.org/10.1126/science.1986413			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EQ603	1986413				2022-12-24	WOS:A1991EQ60300030
J	LI, S; CRENSHAW, EB; RAWSON, EJ; SIMMONS, DM; SWANSON, LW; ROSENFELD, MG				LI, S; CRENSHAW, EB; RAWSON, EJ; SIMMONS, DM; SWANSON, LW; ROSENFELD, MG			DWARF LOCUS MUTANTS LACKING 3 PITUITARY CELL-TYPES RESULT FROM MUTATIONS IN THE POU-DOMAIN GENE PIT-1	NATURE			English	Article									UNIV CALIF SAN DIEGO, DEPT CHEM, LA JOLLA, CA 92093 USA; UNIV CALIF SAN DIEGO, SCH MED, HOWARD HUGHES MED INST, LA JOLLA, CA 92093 USA; SALK INST BIOL STUDIES, NEURAL SYST LAB, LA JOLLA, CA 92037 USA	University of California System; University of California San Diego; Howard Hughes Medical Institute; University of California System; University of California San Diego; Salk Institute	LI, S (corresponding author), UNIV CALIF SAN DIEGO, EUKARYOT REGULATORY BIOL PROGRAM, M-013, LA JOLLA, CA 92093 USA.							BALLING R, 1988, CELL, V55, P531, DOI 10.1016/0092-8674(88)90039-6; BEHRINGER RR, 1988, GENE DEV, V2, P453, DOI 10.1101/gad.2.4.453; BODNER M, 1988, CELL, V55, P505, DOI 10.1016/0092-8674(88)90037-2; BORRELLI HR, 1989, NATURE, V339, P267; CAO ZD, 1987, MOL CELL BIOL, V7, P3402, DOI 10.1128/MCB.7.10.3402; CARSNER RL, 1960, SCIENCE, V131, P829, DOI 10.1126/science.131.3403.829-a; CASTRILLO JL, 1989, SCIENCE, V243, P814, DOI 10.1126/science.2563596; CHALFIE M, 1981, CELL, V24, P59, DOI 10.1016/0092-8674(81)90501-8; CHENG TC, 1983, ENDOCRINOLOGY, V113, P1669, DOI 10.1210/endo-113-5-1669; CRENSHAW EB, 1989, GENE DEV, V3, P959, DOI 10.1101/gad.3.7.959; DOLLE P, 1990, CELL, V60, P809, DOI 10.1016/0092-8674(90)90095-V; EICHER EM, 1980, J HERED, V71, P187, DOI 10.1093/oxfordjournals.jhered.a109344; FINNEY M, 1988, CELL, V55, P757, DOI 10.1016/0092-8674(88)90132-8; FOX SR, 1990, MOL ENDOCRINOL, V4, P1069, DOI 10.1210/mend-4-7-1069; GEHRING WJ, 1987, SCIENCE, V236, P1245, DOI 10.1126/science.2884726; HERR W, 1988, GENE DEV, V2, P1513, DOI 10.1101/gad.2.12a.1513; HERSKOWITZ I, 1989, NATURE, V342, P749, DOI 10.1038/342749a0; HOEFFLER JP, 1985, ENDOCRINOLOGY, V117, P187, DOI 10.1210/endo-117-1-187; INGHAM PW, 1988, NATURE, V335, P25, DOI 10.1038/335025a0; INGRAHAM HA, 1988, CELL, V55, P519, DOI 10.1016/0092-8674(88)90038-4; INGRAHAM HA, 1990, REV PHYSL, V52, P773; KEMLER I, 1990, FASEB J, V4, P1444, DOI 10.1096/fasebj.4.5.2407588; LARKIN S, IN PRESS EUR J BIOCH; LUFKIN T, 1987, SCIENCE, V237, P283, DOI 10.1126/science.3474782; MANGALAM HJ, 1989, GENE DEV, V3, P946, DOI 10.1101/gad.3.7.946; NELSON C, 1988, SCIENCE, V239, P1400, DOI 10.1126/science.2831625; NELSON C, 1986, NATURE, V322, P557, DOI 10.1038/322557a0; ROUX M, 1982, CELL TISSUE RES, V223, P415, DOI 10.1007/BF01258498; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; Schaible R., 1961, Genetics, V46, P896; SCHUSTER WA, 1988, EMBO J, V7, P1721, DOI 10.1002/j.1460-2075.1988.tb03001.x; Schwind JL, 1928, AM J ANAT, V41, P295, DOI 10.1002/aja.1000410206; SCOTT MP, 1989, BIOCHIM BIOPHYS ACTA, V989, P25, DOI 10.1016/0304-419X(89)90033-4; SIMMONS DM, 1990, GENE DEV, V4, P695, DOI 10.1101/gad.4.5.695; Smith PE, 1930, ANAT RECORD, V46, P249, DOI 10.1002/ar.1090460305; Smith PE, 1931, ANAT REC, V50, P85, DOI 10.1002/ar.1090500108; Snell GD, 1929, P NATL ACAD SCI USA, V15, P274, DOI 10.1073/pnas.15.3.274; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STURM RA, 1988, NATURE, V336, P601, DOI 10.1038/336601a0; VANBUULOFFERS S, 1983, ACTA ENDOCR-COP    S, V258, P7; WAHL GM, 1987, P NATL ACAD SCI USA, V84, P2160, DOI 10.1073/pnas.84.8.2160; WATANABE YG, 1979, DEV BIOL, V68, P557, DOI 10.1016/0012-1606(79)90226-4; WEST BL, 1987, MOL CELL BIOL, V7, P1193, DOI 10.1128/MCB.7.3.1193; WILSON DB, 1986, ANAT REC, V215, P282, DOI 10.1002/ar.1092150311; WILSON DB, 1986, ANAT EMBRYOL, V174, P277, DOI 10.1007/BF00824343; XI H, 1989, NATURE, V340, P35, DOI 10.1038/340035a0; YASHIRO T, 1988, CELL TISSUE RES, V251, P249, DOI 10.1007/BF00215832; YE ZS, 1987, J BIOL CHEM, V262, P6313; 1982, MOUSE NEWS LETT, V66, P4	50	1063	1092	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	OCT 11	1990	347	6293					528	533		10.1038/347528a0	http://dx.doi.org/10.1038/347528a0			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC454	1977085				2022-12-24	WOS:A1990EC45400043
J	Wijmenga, C; Frants, RR; Browwer, OF; Moerer, P; Weber, JL; Padberg, GW				Wijmenga, C; Frants, RR; Browwer, OF; Moerer, P; Weber, JL; Padberg, GW			Location of Facioscapulohumeral muscular dystrophy gene on chromosome 4	LANCET			English	Article									Leiden Univ, Dept Neurol, Leiden, NETHERLANDS; Leiden Univ, Dept Human Genet, Leiden, NETHERLANDS; Marshfield Med Res Fdn, Marshfield, WI USA	Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University - Excl LUMC	Padberg, GW (corresponding author), Univ Leiden Hosp, Dept Neurol, PO Box 9600, NL-2300 RC Leiden, NETHERLANDS.		Wijmenga, Cisca/D-2173-2009; Padberg, G.W.A.M./H-8079-2014; Wijmenga, Cisca/AAE-7719-2019	Wijmenga, Cisca/0000-0002-5635-1614				BIGGIN MD, 1983, P NATL ACAD SCI-BIOL, V80, P3963, DOI 10.1073/pnas.80.13.3963; BLAKE D M, 1989, Neurology, V39, P404; BRZUSTOWICZ LM, 1990, NATURE, V344, P540, DOI 10.1038/344540a0; FITZSIMONS RB, 1987, BRAIN, V110, P631, DOI 10.1093/brain/110.3.631; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LOVE DR, 1989, NATURE, V339, P55, DOI 10.1038/339055a0; LUNT PW, 1989, J MED GENET, V26, P535, DOI 10.1136/jmg.26.8.535; LUNT PW, 1989, J MED GENET, V26, P755, DOI 10.1136/jmg.26.12.755; MUNSAT TL, 1986, FACIOSCAPULOHYMERAL, P1251; PADBERG GW, 1988, MUSCLE NERVE, V11, P833, DOI 10.1002/mus.880110806; PADBERG GW, 1982, THESIS LEIDEN U; SARFARAZI M, 1989, J MED GENET, V26, P481, DOI 10.1136/jmg.26.8.481; VOIT T, 1986, EUR J PEDIATR, V145, P280, DOI 10.1007/BF00439401; WEBER JL, 1989, AM J HUM GENET, V44, P388; WEBER JL, 1990, NUCLEIC ACIDS RES, V18, P2202; WIJMENGA C, 1990, J NEUROL SCI, V95, P225, DOI 10.1016/0022-510X(90)90245-I	16	259	270	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	SEP 15	1990	336	8716					651	653		10.1016/0140-6736(90)92148-B	http://dx.doi.org/10.1016/0140-6736(90)92148-B			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DY737	1975852				2022-12-24	WOS:A1990DY73700057
J	PLUDA, JM; YARCHOAN, R; JAFFE, ES; FEUERSTEIN, IM; SOLOMON, D; STEINBERG, SM; WYVILL, KM; RAUBITSCHEK, A; KATZ, D; BRODER, S				PLUDA, JM; YARCHOAN, R; JAFFE, ES; FEUERSTEIN, IM; SOLOMON, D; STEINBERG, SM; WYVILL, KM; RAUBITSCHEK, A; KATZ, D; BRODER, S			DEVELOPMENT OF NON-HODGKIN LYMPHOMA IN A COHORT OF PATIENTS WITH SEVERE HUMAN-IMMUNODEFICIENCY-VIRUS (HIV) INFECTION ON LONG-TERM ANTIRETROVIRAL THERAPY	ANNALS OF INTERNAL MEDICINE			English	Article									NCI, BETHESDA, MD 20205 USA; NINCDS, BETHESDA, MD 20205 USA; GEORGETOWN UNIV, WASHINGTON, DC 20057 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Georgetown University	PLUDA, JM (corresponding author), NIH, BLDG 10, ROOM 13N248, BETHESDA, MD 20892 USA.		Jaffe, Elaine S/G-8984-2014	Jaffe, Elaine S/0000-0003-4632-0301				ALLEGRA CJ, 1987, NEW ENGL J MED, V317, P978, DOI 10.1056/NEJM198710153171602; AYERS KM, 1988, AM J MED, V85, P186; BACCHETTI P, 1989, NATURE, V338, P251, DOI 10.1038/338251a0; BERMUDEZ MA, 1989, AM J MED, V86, P71, DOI 10.1016/0002-9343(89)90232-5; BERNSTEIN L, 1989, CANCER RES, V49, P466; BIRX DL, 1986, NEW ENGL J MED, V314, P874, DOI 10.1056/NEJM198604033141403; BROWNLEE KA, 1965, STAT THEORY METHODOL, P148; CHAGANTI RSK, 1983, BLOOD, V61, P1265; COTELINGAM JD, 1985, CANCER INVEST, V3, P515, DOI 10.3109/07357908509039813; DOLL DC, 1982, LANCET, V1, P1026; EGERTER DA, 1988, ARCH PATHOL LAB MED, V112, P602; FILIPOVICH AH, 1987, AM J PEDIAT HEMATOL, V9, P183; FISCHL MA, 1990, ANN INTERN MED, V112, P727, DOI 10.7326/0003-4819-112-10-727; FISCHL MA, 1987, NEW ENGL J MED, V317, P185, DOI 10.1056/NEJM198707233170401; GATTI RA, 1971, CANCER-AM CANCER SOC, V28, P89, DOI 10.1002/1097-0142(197107)28:1<89::AID-CNCR2820280117>3.0.CO;2-Q; GILL PS, 1989, ANN INTERN MED, V110, P937, DOI 10.7326/0003-4819-110-11-937; GIRARD PM, 1989, LANCET, V1, P1348; GOLDEN JA, 1989, LANCET, V1, P654; GOTTLIEB MS, 1981, NEW ENGL J MED, V305, P1425, DOI 10.1056/NEJM198112103052401; HARNLY ME, 1988, AM J EPIDEMIOL, V128, P261, DOI 10.1093/oxfordjournals.aje.a114966; HYMES KB, 1981, LANCET, V2, P598; JAFFE ES, 1988, J VIROL METHODS, V21, P265, DOI 10.1016/0166-0934(88)90072-9; JAFFE ES, 1990, SEMIN ONCOL, V17, P11; JAFFE ES, 1986, MANUAL CLIN LABORATO, P779; KALTER SP, 1985, BLOOD, V66, P655; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KAPLAN LD, 1989, JAMA-J AM MED ASSOC, V261, P719; KERSEY JH, 1973, INT J CANCER, V12, P333, DOI 10.1002/ijc.2910120204; KNOWLES DM, 1988, ANN INTERN MED, V108, P744, DOI 10.7326/0003-4819-108-5-744; KOVACS JA, 1988, NEW ENGL J MED, V318, P589, DOI 10.1056/NEJM198803103181001; LEMP GF, 1990, JAMA-J AM MED ASSOC, V263, P402, DOI 10.1001/jama.263.3.402; LEVINE AM, 1984, ANN INTERN MED, V100, P7, DOI 10.7326/0003-4819-100-1-7; LEVINE AM, 1985, JAMA-J AM MED ASSOC, V254, P1921, DOI 10.1001/jama.254.14.1921; LIPPMAN SM, 1988, ARCH PATHOL LAB MED, V112, P128; LISKERMELMAN M, 1989, AM J GASTROENTEROL, V84, P1445; LOWENTHAL DA, 1988, CANCER, V61, P2325, DOI 10.1002/1097-0142(19880601)61:11<2325::AID-CNCR2820611130>3.0.CO;2-0; MASUR H, 1981, NEW ENGL J MED, V305, P1431, DOI 10.1056/NEJM198112103052402; MONTGOMERY AB, 1989, AM REV RESPIR DIS, V139, P1548, DOI 10.1164/ajrccm/139.6.1548; PAHWA S, 1985, P NATL ACAD SCI USA, V82, P8198, DOI 10.1073/pnas.82.23.8198; PELICCI PG, 1986, J EXP MED, V164, P2049, DOI 10.1084/jem.164.6.2049; Penn I, 1978, Adv Cancer Res, V28, P31, DOI 10.1016/S0065-230X(08)60645-4; PENN I, 1988, ANNU REV MED, V39, P63, DOI 10.1146/annurev.me.39.020188.000431; PENN I, 1981, CLIN EXP IMMUNOL, V46, P459; PERRY GS, 1980, J PEDIATR-US, V97, P72, DOI 10.1016/S0022-3476(80)80133-8; PETERSON RD, 1964, LANCET, V1, P1189; PIZZO PA, 1988, NEW ENGL J MED, V319, P889, DOI 10.1056/NEJM198810063191401; REAL FX, 1986, AM J MED, V80, P119, DOI 10.1016/0002-9343(86)90060-4; ROTHMAN KJ, 1978, J CHRON DIS, V31, P557, DOI 10.1016/0021-9681(78)90043-7; SCHNITTMAN SM, 1986, SCIENCE, V233, P1084, DOI 10.1126/science.3016902; SCHULHAFER EP, 1987, AM J MED, V82, P313, DOI 10.1016/0002-9343(87)90076-3; SIEGAL FP, 1981, NEW ENGL J MED, V305, P1439, DOI 10.1056/NEJM198112103052403; SURBONE A, 1988, ANN INTERN MED, V108, P534, DOI 10.7326/0003-4819-108-4-534; VOLBERDING PA, 1990, NEW ENGL J MED, V322, P941, DOI 10.1056/NEJM199004053221401; WALDMANN TA, 1983, ANN INTERN MED, V99, P367, DOI 10.7326/0003-4819-99-3-367; WHANGPENG J, 1984, BLOOD, V63, P818; YARCHOAN R, 1988, CLIN RES, V36, pA450; YARCHOAN R, 1986, J CLIN INVEST, V78, P439, DOI 10.1172/JCI112595; YARCHOAN R, 1986, LANCET, V1, P575; YARCHOAN R, 1987, LANCET, V1, P132, DOI 10.1016/S0140-6736(87)91968-4; YARCHOAN R, 1987, PRELIMINARY RESULTS, P214; ZAMAN MK, 1988, ANN INTERN MED, V109, P7, DOI 10.7326/0003-4819-109-1-7; ZIEGLER JL, 1984, NEW ENGL J MED, V311, P565, DOI 10.1056/NEJM198408303110904; ZIEGLER JL, 1982, LANCET, V2, P631; 1989, COMPREHENSIVE INFORM, P48; 1987, MMWR S, V36, pS1; 1990, CANCER STATISTICS RE, P4; 1990, HIV AIDS SURVEILLANC, P1; 1985, MMWR, V34, P373	68	311	315	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 15	1990	113	4					276	282		10.7326/0003-4819-113-4-276	http://dx.doi.org/10.7326/0003-4819-113-4-276			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU081	1973886				2022-12-24	WOS:A1990DU08100005
J	MELKI, J; SHETH, P; ABDELHAK, S; BURLET, P; BACHELOT, MF; LATHROP, MG; FREZAL, J; MUNNICH, A				MELKI, J; SHETH, P; ABDELHAK, S; BURLET, P; BACHELOT, MF; LATHROP, MG; FREZAL, J; MUNNICH, A			MAPPING OF ACUTE (TYPE-I) SPINAL MUSCULAR-ATROPHY TO CHROMOSOME 5Q12-Q14	LANCET			English	Article									HOP NECKER ENFANTS MALAD,INSERM,U12,149 RUE SEVIES,F-75743 PARIS 15,FRANCE; HOP NECKER ENFANTS MALAD,CTR ETUD POLYMORPHISMES HUMAINS,F-75743 PARIS 15,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite			Abdelhak, Sonia/L-2831-2013	Abdelhak, Sonia/0000-0001-8466-5525				BRZUSTOWICZ LM, 1990, NATURE, V344, P540, DOI 10.1038/344540a0; DUBOWITZ V, 1964, BRAIN, V87, P707, DOI 10.1093/brain/87.4.707; EMERY AEH, 1971, J MED GENET, V8, P481, DOI 10.1136/jmg.8.4.481; EMERY AEH, 1976, J NEUROL SCI, V30, P375, DOI 10.1016/0022-510X(76)90141-6; ENGEL WK, 1970, ARCH NEUROL-CHICAGO, V22, P97, DOI 10.1001/archneur.1970.00480200003001; HAUSMANOWAPETRUSEWICZ I, 1985, J MED GENET, V22, P350, DOI 10.1136/jmg.22.5.350; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; KUGELBERG E, 1956, ARCH NEURO PSYCHIATR, V75, P500, DOI 10.1001/archneurpsyc.1956.02330230050005; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEPPERT M, 1987, CYTOGENET CELL GENET, V46, P649; LYONNET S, 1988, LANCET, V2, P507; MELKI J, 1990, NATURE, V344, P767, DOI 10.1038/344767a0; Monaco AP, 1988, GENOMICS, V2, P90, DOI 10.1016/0888-7543(88)90113-9; MOOSA A, 1976, ARCH DIS CHILD, V51, P974, DOI 10.1136/adc.51.12.974; MORTON NE, 1956, AM J HUM GENET, V8, P80; PEARN J, 1980, LANCET, V1, P919; RIORDAN JR, 1989, SCIENCE, V245, P1066; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; Wohlfart G, 1955, ACTA PSYCH NEUROL, V30, P395	19	236	238	0	6	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	AUG 4	1990	336	8710					271	273		10.1016/0140-6736(90)91803-I	http://dx.doi.org/10.1016/0140-6736(90)91803-I			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT007	1973971				2022-12-24	WOS:A1990DT00700004
J	MULHOLLAND, EK; OLINSKY, A; SHANN, FA				MULHOLLAND, EK; OLINSKY, A; SHANN, FA			CLINICAL FINDINGS AND SEVERITY OF ACUTE BRONCHIOLITIS	LANCET			English	Article									ROYAL CHILDRENS HOSP, DEPT MICROBIOL, PARKVILLE, VIC 3052, AUSTRALIA; ROYAL CHILDRENS HOSP, DEPT THORAC MED, PARKVILLE, VIC 3052, AUSTRALIA; ROYAL CHILDRENS HOSP, DEPT INTENS CARE, PARKVILLE, VIC 3052, AUSTRALIA	Royal Children's Hospital Melbourne; Royal Children's Hospital Melbourne; Royal Children's Hospital Melbourne			Shann, Frank/C-9510-2011					CHERIAN T, 1988, LANCET, V2, P125; KENDIG E, 1983, DISORDERS RESPIRATOR, P284; NUNN JF, 1987, APPLIED RESPIRATORY, P229; REYNOLDS EO, 1963, BMJ-BRIT MED J, P1192, DOI 10.1136/bmj.1.5339.1192; SIMPSON H, 1974, BMJ-BRIT MED J, V2, P629, DOI 10.1136/bmj.2.5920.629; SIMPSON H, 1967, LANCET, V1, P7; 1989, WHOARI893; 1985, WHORSD8515	8	86	88	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 26	1990	335	8700					1259	1261		10.1016/0140-6736(90)91314-Z	http://dx.doi.org/10.1016/0140-6736(90)91314-Z			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF451	1971330				2022-12-24	WOS:A1990DF45100013
J	FEEST, TG; RIAD, HN; COLLINS, CH; GOLBY, MGS; NICHOLLS, AJ; HAMAD, SN				FEEST, TG; RIAD, HN; COLLINS, CH; GOLBY, MGS; NICHOLLS, AJ; HAMAD, SN			PROTOCOL FOR INCREASING ORGAN DONATION AFTER CEREBROVASCULAR DEATHS IN A DISTRICT GENERAL-HOSPITAL	LANCET			English	Article									ROYAL DEVON & EXETER HOSP, INTENS CARE UNIT, EXETER EX2 5DW, DEVON, ENGLAND; ROYAL DEVON & EXETER HOSP, RENAL UNIT, EXETER EX2 5DW, DEVON, ENGLAND	University of Exeter; University of Exeter			Sano, Michael/E-1715-2011					[Anonymous], 1976, BMJ-BRIT MED J, V2, P1187; BODENHAM A, 1989, BRIT MED J, V299, P1009, DOI 10.1136/bmj.299.6706.1009; GORE SM, 1989, BRIT MED J, V299, P1193, DOI 10.1136/bmj.299.6709.1193; JENNETT B, 1981, BRIT J ANAESTH, V53, P1111, DOI 10.1093/bja/53.11.1111; SEARLE J, 1980, LANCET, V1, P641; 1989 UK TRANSPL SERV; 1987 UK TRANSPL SERV; 1987, WORKING PARTY SUPPLY; 1989, INTENSIVE CARE SERVI	9	91	91	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAY 12	1990	335	8698					1133	1135		10.1016/0140-6736(90)91134-V	http://dx.doi.org/10.1016/0140-6736(90)91134-V			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC929	1971871				2022-12-24	WOS:A1990DC92900011
J	POIKOLAINEN, K; REUNALA, T; KARVONEN, J; LAUHARANTA, J; KARKKAINEN, P				POIKOLAINEN, K; REUNALA, T; KARVONEN, J; LAUHARANTA, J; KARKKAINEN, P			ALCOHOL INTAKE - A RISK FACTOR FOR PSORIASIS IN YOUNG AND MIDDLE-AGED MEN	BRITISH MEDICAL JOURNAL			English	Article									TAMPERE UNIV,CENT HOSP,DEPT DERMATOL,SF-33520 TAMPERE,FINLAND; OULU UNIV,CENT HOSP,DEPT DERMATOL,SF-90220 OULU,FINLAND; UNIV HELSINKI,CENT HOSP,DEPT DERMATOL,SF-00170 HELSINKI 17,FINLAND; UNIV HELSINKI,ALCOHOL DIS RES UNIT,SF-00290 HELSINKI 29,FINLAND	Tampere University; Tampere University Hospital; University of Oulu; University of Helsinki; Helsinki University Central Hospital; University of Helsinki	POIKOLAINEN, K (corresponding author), NATL PUBL HLTH INST,MANNERHEIMINTIE 166,SF-00300 HELSINKI,FINLAND.							BAKER RJ, 1978, GLIM SYSTEM; BAUGHMAN RD, 1982, PSORIASIS, P323; BRAATHEN LR, 1989, ACTA DERM-VENEREOL S, V142, P9; Carmichael M M, 1984, Health Bull (Edinb), V42, P258; CHAPUT JC, 1985, BRIT MED J, V291, P25, DOI 10.1136/bmj.291.6487.25; CHRISTOPHERS E, 1987, DERMATOLOGY GENERAL, P461; DELANEY TJ, 1974, ACTA DERM-VENEREOL, V54, P237; GREAVES MW, 1983, BRIT J DERMATOL, V109, P115, DOI 10.1111/j.1365-2133.1983.tb04001.x; GRUNNET E, 1974, DERMATOLOGICA, V149, P136, DOI 10.1159/000251513; KAVLI G, 1985, BRIT MED J, V291, P999, DOI 10.1136/bmj.291.6501.999; Levvy G.A., 1966, METHODS ENZYMOLOGY, P571, DOI 10.1016/0076-6879(66) 08104-7; LINDEGARD B, 1986, DERMATOLOGICA, V172, P298, DOI 10.1159/000249365; MONK BE, 1986, DERMATOLOGICA, V173, P57, DOI 10.1159/000249219; MORSE RM, 1985, ALCOHOL CLIN EXP RES, V9, P396, DOI 10.1111/j.1530-0277.1985.tb05570.x; PITKANEN E, 1980, DIABETOLOGIA, V18, P275; POIKOLAINEN K, 1985, J STUD ALCOHOL, V46, P219, DOI 10.15288/jsa.1985.46.219; RAMSAY B, 1988, BRIT J DERMATOL, V118, P195, DOI 10.1111/j.1365-2133.1988.tb01774.x; ROSSET M, 1971, Q J STUD ALCOHOL, V32, P1017; SIMPURA J, 1983, J STUD ALCOHOL, V44, P911, DOI 10.15288/jsa.1983.44.911; Simpura J, 1987, FINNISH DRINKING HAB, V35; SOBELL LC, 1988, J STUD ALCOHOL, V49, P225, DOI 10.15288/jsa.1988.49.225; SONNEX TS, 1988, BRIT J DERMATOL, V119, P653, DOI 10.1111/j.1365-2133.1988.tb03479.x; 1971, AAKKOSELLINEN AMMATT	23	150	153	0	5	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	MAR 24	1990	300	6727					780	783		10.1136/bmj.300.6727.780	http://dx.doi.org/10.1136/bmj.300.6727.780			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CW227	1969757	Green Published, Bronze			2022-12-24	WOS:A1990CW22700018
J	HAVRAN, WL; ALLISON, JP				HAVRAN, WL; ALLISON, JP			ORIGIN OF THY-1+ DENDRITIC EPIDERMAL-CELLS OF ADULT MICE FROM FETAL THYMIC PRECURSORS	NATURE			English	Article									UNIV CALIF BERKELEY, DEPT MOLEC & CELL BIOL, DIV IMMUNOL, BERKELEY, CA 94720 USA	University of California System; University of California Berkeley	HAVRAN, WL (corresponding author), UNIV CALIF BERKELEY, CANC RES LAB, BERKELEY, CA 94720 USA.			Allison, James/0000-0001-8980-5697				ASARNOW DM, 1988, CELL, V55, P837, DOI 10.1016/0092-8674(88)90139-0; ASARNOW DM, 1989, NATURE, V341, P60, DOI 10.1038/341060a0; BERGSTRESSER PR, 1985, J INVEST DERMATOL, V85, pS85, DOI 10.1111/1523-1747.ep12275516; BERGSTRESSER PR, 1984, J INVEST DERMATOL, V83, P83, DOI 10.1111/1523-1747.ep12262587; BONYHADI M, 1987, NATURE, V330, P574, DOI 10.1038/330574a0; CHIEN YH, 1987, NATURE, V330, P722, DOI 10.1038/330722a0; DIALYNAS DP, 1983, J IMMUNOL, V131, P2445; ELLIOTT JF, 1988, NATURE, V331, P627; FOWLKES BJ, 1989, ADV IMMUNOL, V44, P207; GARMAN RD, 1986, CELL, V45, P733, DOI 10.1016/0092-8674(86)90787-7; HAVRAN WL, 1989, P NATL ACAD SCI USA, V86, P4185, DOI 10.1073/pnas.86.11.4185; HAVRAN WL, 1989, J IMMUNOL, V142, P1422; HAVRAN WL, 1987, NATURE, V330, P170, DOI 10.1038/330170a0; HAVRAN WL, 1988, NATURE, V335, P443, DOI 10.1038/335443a0; ITO K, 1989, P NATL ACAD SCI USA, V86, P631, DOI 10.1073/pnas.86.2.631; KONING F, 1987, SCIENCE, V236, P834, DOI 10.1126/science.2883729; KUZIEL WA, 1987, NATURE, V328, P263, DOI 10.1038/328263a0; LANCKI DW, 1984, IMMUNOL REV, V81, P65, DOI 10.1111/j.1600-065X.1984.tb01105.x; NIXONFULTON JL, 1988, J IMMUNOL, V141, P1897; STINGL G, 1987, P NATL ACAD SCI USA, V84, P2430, DOI 10.1073/pnas.84.8.2430; SULLIVAN S, 1985, J INVEST DERMATOL, V84, P491, DOI 10.1111/1523-1747.ep12273454; TOMOOKA S, 1987, J IMMUNOL, V139, P3986; TSCHACHLER E, 1983, J INVEST DERMATOL, V81, P282, DOI 10.1111/1523-1747.ep12518326; YOKOYAMA WM, 1987, J EXP MED, V165, P1725, DOI 10.1084/jem.165.6.1725	24	282	291	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 1	1990	344	6261					68	70		10.1038/344068a0	http://dx.doi.org/10.1038/344068a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ972	1968230				2022-12-24	WOS:A1990CQ97200064
J	STEWART, PM; BEASTALL, GH; SHACKLETON, CHL; EDWARDS, CRW				STEWART, PM; BEASTALL, GH; SHACKLETON, CHL; EDWARDS, CRW			5-ALPHA-REDUCTASE ACTIVITY IN POLYCYSTIC OVARY SYNDROME	LANCET			English	Article									WESTERN GEN HOSP, DEPT MED, EDINBURGH EH4 2XU, MIDLOTHIAN, SCOTLAND; CHILDRENS HOSP MED CTR NO CALIF, OAKLAND, CA 94609 USA; GLASGOW ROYAL INFIRM, GLASGOW G4 0SF, SCOTLAND	University of Edinburgh; University of Glasgow								ABRAHAM GE, 1981, OBSTET GYNECOL, V57, P158; BIRNBAUM MD, 1984, OBSTET GYNECOL, V63, P445; DIJKSTRA AC, 1987, J INVEST DERMATOL, V89, P87, DOI 10.1111/1523-1747.ep12580432; FISHER LK, 1978, J CLIN ENDOCR METAB, V47, P653, DOI 10.1210/jcem-47-3-653; GIVENS JR, 1975, J CLIN ENDOCR METAB, V40, P988, DOI 10.1210/jcem-40-6-988; GLASS AR, 1981, METABOLISM, V30, P89, DOI 10.1016/0026-0495(81)90224-9; IMPERATOMCGINLEY J, 1986, J CLIN ENDOCR METAB, V63, P1313, DOI 10.1210/jcem-63-6-1313; KANDEEL FR, 1980, CLIN ENDOCRINOL, V13, P601, DOI 10.1111/j.1365-2265.1980.tb03429.x; LACHELIN GCL, 1979, J CLIN ENDOCR METAB, V49, P892, DOI 10.1210/jcem-49-6-892; LOUGHLIN T, 1986, J CLIN ENDOCR METAB, V62, P142, DOI 10.1210/jcem-62-1-142; MAUVAISJARVIS P, 1986, CLIN ENDOCRINOL META, V15, P307, DOI 10.1016/S0300-595X(86)80027-5; MCKENNA TJ, 1988, NEW ENGL J MED, V318, P558, DOI 10.1056/NEJM198803033180906; MIGEON CJ, 1963, METABOLISM, V12, P718; MOORE A, 1983, CLIN ENDOCRINOL, V18, P391, DOI 10.1111/j.1365-2265.1983.tb00584.x; PHILLIPOU G, 1985, J STEROID BIOCHEM, V22, P435, DOI 10.1016/0022-4731(85)90451-0; POLSON DW, 1988, LANCET, V1, P870; SERAFINI P, 1985, J CLIN ENDOCR METAB, V60, P349, DOI 10.1210/jcem-60-2-349; STEWART PM, 1988, J CLIN INVEST, V82, P340, DOI 10.1172/JCI113592; STEWART PM, 1987, LANCET, V2, P821; TAYLOR NF, 1984, J ENDOCRINOLOGY S, V102, P90, DOI DOI 10.1677/JOE.0.102S00NP; WERK EE, 1964, J CLIN INVEST, V43, P1824, DOI 10.1172/JCI105056; WILSON EA, 1979, AM J OBSTET GYNECOL, V134, P56, DOI 10.1016/0002-9378(79)90796-8; ZUMOFF B, 1983, J STEROID BIOCHEM, V18, P437, DOI 10.1016/0022-4731(83)90062-6; ZUMOFF B, 1974, J CLIN ENDOCR METAB, V38, P169, DOI 10.1210/jcem-38-2-169	24	164	167	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 24	1990	335	8687					431	433		10.1016/0140-6736(90)90664-Q	http://dx.doi.org/10.1016/0140-6736(90)90664-Q			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP907	1968168				2022-12-24	WOS:A1990CP90700002
J	WEINER, AJ; KUO, G; BRADLEY, DW; BONINO, F; SARACCO, G; LEE, C; ROSENBLATT, J; CHOO, QL; HOUGHTON, M				WEINER, AJ; KUO, G; BRADLEY, DW; BONINO, F; SARACCO, G; LEE, C; ROSENBLATT, J; CHOO, QL; HOUGHTON, M			DETECTION OF HEPATITIS-C VIRAL SEQUENCES IN NON-A-HEPATITIS NON-B-HEPATITIS	LANCET			English	Article									CTR DIS CONTROL,HEPATITIS BRANCH,ATLANTA,GA 30333; SAN GIOVANNI BATTISTA MOLINETTE HOSP,TURIN,ITALY	Centers for Disease Control & Prevention - USA; A.O.U. Citta della Salute e della Scienza di Torino; AOU San Giovanni Battista-Molinette	WEINER, AJ (corresponding author), CHIRON CORP,4560 HORTON ST,EMERYVILLE,CA 94608, USA.		Rosenblatt, Jody/AAD-4260-2019; Bonino, Ferruccio/C-6036-2018; Bonino, Ferruccio/B-7522-2013	Rosenblatt, Jody/0000-0001-9460-5868; Bonino, Ferruccio/0000-0001-9942-0328; Saracco, Giorgio Maria/0000-0001-5310-4143				ALTER HJ, 1978, LANCET, V1, P459; ALTER HJ, 1975, LANCET, V2, P838, DOI 10.1016/S0140-6736(75)90234-2; ALTER HJ, 1985, INFECTION IMMUNITY B, P47; BRADLEY DW, 1985, J VIROL METHODS, V10, P307, DOI 10.1016/0166-0934(85)90047-3; BRADLEY DW, 1979, J MED VIROL, V3, P253, DOI 10.1002/jmv.1890030403; BRADLEY DW, 1986, SEMIN LIVER DIS, V6, P56, DOI 10.1055/s-2008-1040794; BRADLEY DW, 1981, VIRAL HEPATITIS, P319; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; DIENSTAG JL, 1986, SEMIN LIVER DIS, V6, P67, DOI 10.1055/s-2008-1040795; ESTEBAN JI, 1989, LANCET, V2, P294; FEINSTONE SM, 1981, J INFECT DIS, V144, P588, DOI 10.1093/infdis/144.6.588; FEINSTONE SM, 1975, NEW ENGL J MED, V292, P767, DOI 10.1056/NEJM197504102921502; KNODELL RG, 1975, GASTROENTEROLOGY, V69, P1278; KUHNL P, 1989, LANCET, V2, P324; KUO G, 1989, SCIENCE, V244, P362, DOI 10.1126/science.2496467; ROGGENDORF M, 1989, LANCET, V2, P324; ROSENBERG S, 1984, NATURE, V312, P77, DOI 10.1038/312077a0; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; VANDERPOEL CL, 1989, LANCET, V2, P297	19	663	690	0	13	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JAN 6	1990	335	8680					1	3		10.1016/0140-6736(90)90134-Q	http://dx.doi.org/10.1016/0140-6736(90)90134-Q			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG766	1967327				2022-12-24	WOS:A1990CG76600001
J	ROCHE, PA; MARKS, MS; CRESSWELL, P				ROCHE, PA; MARKS, MS; CRESSWELL, P			FORMATION OF A NINE-SUBUNIT COMPLEX BY HLA CLASS-II GLYCOPROTEINS AND THE INVARIANT CHAIN	NATURE			English	Article							LYMPHOBLASTOID CELL; BETA-CHAIN; ANTIGENS; PROTEINS; BINDING; GLYCOSYLATION; ASSOCIATION; PEPTIDE	HLA CLASS II molecules are heterodimeric transmembrane glycoproteins that bind and present processed antigenic peptides to CD4-positive T lymphocytes. Intracellularly, class II molecules associate with a third subunit termed the invariant (1) chain. Here we describe the physical characteristics of the intracellular class II alpha-beta-I complex. Chemical crosslinking, size exclusion chromatography and sedimentation velocity studies demonstrate that the alpha-beta-I complex is a nine-subunit transmembrane protein that contains three alpha-beta-dimers associated with an I chain trimer. The organization of class II alpha- and beta-subunits in such a multimer may have a role in the documented ability of the I chain to inhibit peptide binding to class II molecules 1-3. In addition, the formation of the nine-chain complex may induce the structural changes necessary to overcome the cytoplasmic retention signal responsible for the localization of free I chain in the endoplasmic reticulum, releasing class II-I chain complexes for transport to endosomes 4-6.	DUKE UNIV,MED CTR,DEPT MICROBIOL & IMMUNOL,DURHAM,NC 27710	Duke University			Marks, Michael S/Q-7223-2019	Marks, Michael S/0000-0001-7435-7262; Roche, Paul/0000-0002-8949-9172				BAKKE O, 1990, CELL, V63, P707, DOI 10.1016/0092-8674(90)90137-4; DEKRETSER TA, 1982, EUR J IMMUNOL, V12, P214, DOI 10.1002/eji.1830120309; GUY K, 1982, EUR J IMMUNOL, V12, P942, DOI 10.1002/eji.1830121109; HELENIUS A, 1972, J BIOL CHEM, V247, P3656; KELNER DN, 1986, J IMMUNOL, V137, P2632; LAMB CA, 1991, P NATL ACAD SCI USA, V88, P5998, DOI 10.1073/pnas.88.14.5998; LOTTEAU V, 1990, NATURE, V348, P600, DOI 10.1038/348600a0; MACHAMER CE, 1984, P NATL ACAD SCI-BIOL, V81, P1287, DOI 10.1073/pnas.81.5.1287; MACHAMER CE, 1982, J IMMUNOL, V129, P2564; MARKS MS, 1990, J CELL BIOL, V111, P839, DOI 10.1083/jcb.111.3.839; MARKS MS, 1989, THESIS DUKE U; MARTIN RG, 1961, J BIOL CHEM, V236, P1372; POLLET RJ, 1981, J BIOL CHEM, V256, P2118; ROCHE PA, 1990, J IMMUNOL, V144, P1849; ROCHE PA, 1990, NATURE, V345, P615, DOI 10.1038/345615a0; ROCHE PA, 1991, P NATL ACAD SCI USA, V88, P3150, DOI 10.1073/pnas.88.8.3150; SANT AJ, 1983, J EXP MED, V158, P1979, DOI 10.1084/jem.158.6.1979; SANT AJ, 1985, J EXP MED, V162, P1916, DOI 10.1084/jem.162.6.1916; SOBERS HA, 1968, HDB BIOCH, pJ248; STRUBIN M, 1986, EMBO J, V5, P3483, DOI 10.1002/j.1460-2075.1986.tb04673.x; TANFORD C, 1974, BIOCHEMISTRY-US, V13, P2369, DOI 10.1021/bi00708a021; TEYTON L, 1990, NATURE, V348, P39, DOI 10.1038/348039a0	22	311	315	0	7	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	DEC 5	1991	354	6352					392	394		10.1038/354392a0	http://dx.doi.org/10.1038/354392a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT761	1956401				2022-12-24	WOS:A1991GT76100051
J	HARRIS, R				HARRIS, R			MEDICAL GENETICS	BRITISH MEDICAL JOURNAL			English	Article											HARRIS, R (corresponding author), ST MARYS HOSP,DEPT MED GENET,MANCHESTER M13 0JH,LANCS,ENGLAND.							BULOW S, 1987, DAN MED BULL, V34, P1; MCKUSICK VA, 1991, NATURE, V352, P279, DOI 10.1038/352279a0; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; OWEN DJ, 1991, ANTENATAL DIAGNOSIS, P353; PECKHAM M, 1991, LANCET, V338, P367, DOI 10.1016/0140-6736(91)90494-A; RONA RJ, 1989, J MED GENET, V26, P226, DOI 10.1136/jmg.26.4.226; WALD N, 1991, ANTENATAL DIAGNOSIS, P45; YU S, 1991, SCIENCE, V252, P1179, DOI 10.1126/science.252.5009.1179; 1991, PURCHASERS GUIDELINE; 1991, CMMD1523; 1990, TEACHING GENETICS ME; 1991, CLIN GENETICS 1990; 1989, PRENATAL DIAGNOSIS G	13	5	5	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 19	1991	303	6808					977	979		10.1136/bmj.303.6808.977	http://dx.doi.org/10.1136/bmj.303.6808.977			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GL127	1954427	Green Published, Bronze			2022-12-24	WOS:A1991GL12700031
J	NOSSENT, HC; SWAAK, TJG; BERDEN, JHM				NOSSENT, HC; SWAAK, TJG; BERDEN, JHM			SYSTEMIC LUPUS-ERYTHEMATOSUS AFTER RENAL-TRANSPLANTATION - PATIENT AND GRAFT-SURVIVAL AND DISEASE-ACTIVITY	ANNALS OF INTERNAL MEDICINE			English	Article							KIDNEY-TRANSPLANTS; CLINICAL COURSE; EXPERIENCE; RATES	Objective: To determine the outcome of renal transplantation in patients with systemic lupus erythematosus and end-stage renal failure and to compare disease activity after transplantation with disease activity before transplantation. Design: Retrospective case finding using data for an 8-year period from the central registry for renal replacement therapy in The Netherlands. Setting: Tertiary care hospitals with facilities for renal transplantation in The Netherlands. Patients: Twenty-eight patients who fulfilled at least four of the American Rheumatology Association's criteria for the classification of systemic lupus erythematosus and who received a renal transplant. Measurements: Acturial survival rates for grafts and patients after transplantation, maximal nonrenal scores on the Systemic Lupus Erythematosus Disease Activity Index, and time-adjusted disease exacerbation rates in all patients before and after transplantation. Results: The actuarial graft survival rate at 1 year and 5 years was 68% (95% CI, 47% to 82%) and 54% (CI, 25% to 77%), respectively, whereas the acturial patient survival rate was 87% (CI, 69% to 96%) at 1 and 5 years. High disease activity was not found to affect graft survival adversely before the start of renal replacement therapy or during dialysis. After transplantation, disease activity per patient and the overall incidence of disease exacerbations decreased. One case of recurrent lupus nephritis was seen. Conclusions: Patients with systemic lupus erythematosus and end-stage renal failure are excellent candidates for renal transplantation; disease activity after transplantation is sporadic and low, and the recurrence of lupus nephritis is rare.	DR DANIEL DENHOED CLIN, POB 5201, 3008 AE ROTTERDAM, NETHERLANDS; UNIV HOSP NIJMEGEN, NIJMEGEN, NETHERLANDS	Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; Radboud University Nijmegen			Berden, J.H.M./H-8009-2014	Nossent, Johannes/0000-0002-2833-7997				AMEND WJC, 1981, ANN INTERN MED, V94, P444, DOI 10.7326/0003-4819-94-4-444; CAMERON JS, 1982, TRANSPLANTATION, V34, P237; CANTAROVICH M, 1988, ANN INTERN MED, V109, P254, DOI 10.7326/0003-4819-109-3-254; CATS S, 1984, TRANSPLANTATION, V37, P575, DOI 10.1097/00007890-198406000-00010; CHANG C, 1986, ARTHRITIS RHEUM, V29, P593; COPLON NS, 1983, NEW ENGL J MED, V308, P186, DOI 10.1056/NEJM198301273080403; DUBOIS EL, 1952, JAMA-J AM MED ASSOC, V149, P995, DOI 10.1001/jama.1952.02930280017006; GOLDBLUM SE, 1980, ANN INTERN MED, V93, P597, DOI 10.7326/0003-4819-93-4-597; HELLERSTEDT WL, 1984, MAYO CLIN PROC, V59, P776, DOI 10.1016/S0025-6196(12)65589-X; JARRETT MP, 1983, ARCH INTERN MED, V143, P1353, DOI 10.1001/archinte.143.7.1353; Klemperer P, 1941, ARCH PATHOL, V32, P569; KUMANO K, 1987, CLIN NEPHROL, V27, P94; LIANG MH, 1989, ARTHRITIS RHEUM, V32, P1107, DOI 10.1002/anr.1780320909; LIANG MH, 1989, 2ND P INT C SYST LUP, P64; MEJIA G, 1983, ARCH INTERN MED, V143, P2089, DOI 10.1001/archinte.143.11.2089; MIETTINEN O, 1985, STAT MED, V4, P213, DOI 10.1002/sim.4780040211; MOARTY AV, 1989, ARTHRITIS RHEUM, V31, P464; OPELZ G, 1973, TRANSPLANT P, V5, P253; POLLAK VE, 1961, J LAB CLIN MED, V57, P495; ROTH D, 1987, AM J NEPHROL, V7, P367, DOI 10.1159/000167615; ROTHFIELD NF, 1963, NEW ENGL J MED, V269, P537, DOI 10.1056/NEJM196309122691101; SINGH YN, 1989, 2ND P INT C SYST LUP, P59; SOHMIYA S, 1986, JPN J TRANSPLANT, V21, P18; SWAAK AJG, 1989, ANN RHEUM DIS, V48, P455, DOI 10.1136/ard.48.6.455; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; YAKUB YN, 1981, NEPHRON, V27, P197; ZWEIMAN B, 1968, ANN INTERN MED, V69, P441, DOI 10.7326/0003-4819-69-3-441; 1975, JAMA-J AM MED ASSOC, V232, P148	28	80	82	1	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 1	1991	114	3					183	188		10.7326/0003-4819-114-3-183	http://dx.doi.org/10.7326/0003-4819-114-3-183			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EV339	1984742				2022-12-24	WOS:A1991EV33900002
J	SZTUL, E; KAPLIN, A; SAUCAN, L; PALADE, G				SZTUL, E; KAPLIN, A; SAUCAN, L; PALADE, G			PROTEIN TRAFFIC BETWEEN DISTINCT PLASMA-MEMBRANE DOMAINS - ISOLATION AND CHARACTERIZATION OF VESICULAR CARRIERS INVOLVED IN TRANSCYTOSIS	CELL			English	Article							POLYMERIC IGA RECEPTOR; TRANS-CELLULAR TRANSPORT; INTESTINAL VILLUS CELLS; RAT HEPATOCYTES; COATED VESICLES; GOLGI-COMPLEX; MORPHOLOGICAL CHARACTERIZATION; IMMUNOGLOBULIN RECEPTOR; MONOCLONAL-ANTIBODIES; MICROVILLUS MEMBRANES	We have isolated a population of vesicular carriers involved in the transport (transcytosis) of proteins from the basolateral to the apical plasma membrane of hepatocytes. The obtained fraction was enriched in compartments containing known transcytosed proteins and depleted in elements of the secretory pathway, Golgi elements, basolateral plasma membrane, as well as early endosomal components. The fraction was analyzed by biochemical and immunological procedures. Antibodies raised against the proteins in the fraction recognized a single 108K antigen. Based on its subcellular distribution, the 108K antigen may represent a novel marker for transcytotic vesicular carriers.	JOHNS HOPKINS UNIV,BALTIMORE,MD 21205; UNIV CALIF SAN DIEGO,SCH MED,LA JOLLA,CA 92093	Johns Hopkins University; University of California System; University of California San Diego	SZTUL, E (corresponding author), PRINCETON UNIV,DEPT MOLEC BIOL,PRINCETON,NJ 08544, USA.				NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034989] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM027303] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK 34989] Funding Source: Medline; NIGMS NIH HHS [GM 27303] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ABRAHAMSON DR, 1981, J CELL BIOL, V91, P270, DOI 10.1083/jcb.91.1.270; BARTLES JR, 1988, TRENDS BIOCHEM SCI, V13, P181, DOI 10.1016/0968-0004(88)90147-8; BARTLES JR, 1987, J CELL BIOL, V105, P1241, DOI 10.1083/jcb.105.3.1241; Boyer J.L., 1986, PHYSL MEMBRANE DISOR, P609; CAMERON RS, 1986, J CELL BIOL, V103, P1299, DOI 10.1083/jcb.103.4.1299; CHAO YS, 1981, P NATL ACAD SCI-BIOL, V78, P597, DOI 10.1073/pnas.78.1.597; DANIELSEN EM, 1985, EUR J BIOCHEM, V152, P493, DOI 10.1111/j.1432-1033.1985.tb09223.x; DECURTIS I, 1989, CELL, V58, P719, DOI 10.1016/0092-8674(89)90106-2; DEVANEY E, 1985, EMBO J, V4, P3123, DOI 10.1002/j.1460-2075.1985.tb04054.x; DUNN WA, 1986, J CELL BIOL, V102, P24, DOI 10.1083/jcb.102.1.24; EHRENREICH JH, 1973, J CELL BIOL, V59, P45, DOI 10.1083/jcb.59.1.45; GEUZE HJ, 1984, CELL, V37, P195, DOI 10.1016/0092-8674(84)90315-5; GRIFFITHS G, 1986, SCIENCE, V234, P438, DOI 10.1126/science.2945253; GRUENBERG J, 1985, EUR J CELL BIOL, V38, P312; HAURI HP, 1985, J CELL BIOL, V101, P838, DOI 10.1083/jcb.101.3.838; HOPPE CA, 1985, J CELL BIOL, V101, P2113, DOI 10.1083/jcb.101.6.2113; HOWELL KE, 1982, J CELL BIOL, V92, P822, DOI 10.1083/jcb.92.3.822; HUBBARD AL, 1985, J CELL BIOL, V100, P1115, DOI 10.1083/jcb.100.4.1115; KORNFELD S, 1986, J CLIN INVEST, V77, P1, DOI 10.1172/JCI112262; KUHN LC, 1983, ANN NY ACAD SCI, V409, P751, DOI 10.1111/j.1749-6632.1983.tb26914.x; LARKIN JM, 1986, P NATL ACAD SCI USA, V83, P4759, DOI 10.1073/pnas.83.13.4759; LEBIVIC A, 1989, P NATL ACAD SCI USA, V86, P9313; LISANTI MP, 1989, J CELL BIOL, V109, P2117, DOI 10.1083/jcb.109.5.2117; MAHAFFEY DT, 1989, J CELL BIOL, V108, P1615, DOI 10.1083/jcb.108.5.1615; MALHOTRA V, 1989, CELL, V58, P329, DOI 10.1016/0092-8674(89)90847-7; MASSEY D, 1987, J MEMBRANE BIOL, V96, P19, DOI 10.1007/BF01869331; MEIER PJ, 1984, J CELL BIOL, V98, P991, DOI 10.1083/jcb.98.3.991; MERISKO EM, 1982, J CELL BIOL, V92, P846, DOI 10.1083/jcb.92.3.846; MOSTOV KE, 1986, CELL, V46, P613, DOI 10.1016/0092-8674(86)90887-1; PEARSE BMF, 1987, ANNU REV BIOPHYS BIO, V16, P49, DOI 10.1146/annurev.bb.16.060187.000405; QUARONI A, 1979, BIOCHEM J, V182, P213, DOI 10.1042/bj1820213; QUARONI A, 1979, BIOCHEM J, V182, P203, DOI 10.1042/bj1820203; RINDLER MJ, 1984, J CELL BIOL, V98, P1301; RODEWALD R, 1984, J CELL BIOL, V99, P595; ROTH J, 1982, J CELL BIOL, V93, P223, DOI 10.1083/jcb.93.1.223; SARASTE J, 1986, P NATL ACAD SCI USA, V83, P6425, DOI 10.1073/pnas.83.17.6425; SCHIFF JM, 1984, J CELL BIOL, V98, P79, DOI 10.1083/jcb.98.1.79; SCHMID SL, 1988, CELL, V52, P73, DOI 10.1016/0092-8674(88)90532-6; SIMONS K, 1985, ANNU REV CELL BIOL, V1, P243, DOI 10.1146/annurev.cb.01.110185.001331; SOLARI R, 1985, J BIOL CHEM, V260, P1141; STOORVOGEL W, 1987, J CELL BIOL, V104, P1261, DOI 10.1083/jcb.104.5.1261; SZTUL ES, 1985, J CELL BIOL, V100, P1248, DOI 10.1083/jcb.100.4.1248; SZTUL ES, 1985, J CELL BIOL, V100, P1255, DOI 10.1083/jcb.100.4.1255; SZTUL ES, 1983, J CELL BIOL, V97, P1582, DOI 10.1083/jcb.97.5.1582; TAKAHASHI I, 1982, J IMMUNOL, V128, P1181; VONFIGURA K, 1986, ANNU REV BIOCHEM, V55, P167, DOI 10.1146/annurev.biochem.55.1.167; WALL DA, 1985, J CELL BIOL, V101, P2104, DOI 10.1083/jcb.101.6.2104	47	85	86	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	JAN 11	1991	64	1					81	89		10.1016/0092-8674(91)90210-P	http://dx.doi.org/10.1016/0092-8674(91)90210-P			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ET175	1986870				2022-12-24	WOS:A1991ET17500010
J	NIGHTINGALE, SL				NIGHTINGALE, SL			GUIDELINE FOR THE STUDY OF DRUGS IN THE ELDERLY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material											NIGHTINGALE, SL (corresponding author), US FDA,OFF HLTH AFFAIRS,PARKLAWN BLDG,5600 FISHERS LN,ROCKVILLE,MD 20857, USA.								0	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	1991	265	2					182	182						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EQ602	1984138				2022-12-24	WOS:A1991EQ60200009
J	LILFORD, RJ				LILFORD, RJ			TRADE-OFF BETWEEN GESTATIONAL-AGE AND MISCARRIAGE RISK OF PRENATAL TESTING - DOES IT VARY ACCORDING TO GENETIC RISK	LANCET			English	Editorial Material											LILFORD, RJ (corresponding author), UNIV LEEDS,ST JAMES UNIV HOSP,DEPT OBSTET & GYNAECOL,LEEDS LS9 7TF,W YORKSHIRE,ENGLAND.							Canadian Collaborative CVS-Amniocentesis Clinical Trial Group, 1989, LANCET, V1, P1; ELSTEIN AS, 1977, PROFESSIONAL JUDGEME, P109; LILFORD RJ, 1986, CLIN OBSTET GYNAECOL, V13, P611; PAUKER SP, 1977, YALE J BIOL MED, V50, P275; Weinstein MC, 1980, CLIN DECISION ANAL	5	9	9	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 24	1990	336	8726					1303	1305		10.1016/0140-6736(90)92977-P	http://dx.doi.org/10.1016/0140-6736(90)92977-P			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ943	1978126				2022-12-24	WOS:A1990EJ94300015
J	GOULD, AP; BROOKMAN, JJ; STRUTT, DI; WHITE, RAH				GOULD, AP; BROOKMAN, JJ; STRUTT, DI; WHITE, RAH			TARGETS OF HOMEOTIC GENE-CONTROL IN DROSOPHILA	NATURE			English	Article											GOULD, AP (corresponding author), UNIV CAMBRIDGE, DEPT ANAT, DOWNING ST, CAMBRIDGE CB2 3DY, ENGLAND.		Gould, Alex/A-7479-2010; White, Rob A H/G-4835-2012; Gould, Alex/M-5353-2019; Strutt, David/E-6196-2010	Gould, Alex/0000-0002-6875-6985; Gould, Alex/0000-0002-6875-6985; Strutt, David/0000-0001-8185-4515	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		AKAM ME, 1985, EMBO J, V4, P1689, DOI 10.1002/j.1460-2075.1985.tb03838.x; ALMER A, 1986, EMBO J, V5, P2689, DOI 10.1002/j.1460-2075.1986.tb04552.x; BEACHY PA, 1988, CELL, V55, P1069, DOI 10.1016/0092-8674(88)90251-6; BIEDENKAPP H, 1988, NATURE, V335, P835, DOI 10.1038/335835a0; BIENZ M, 1988, NATURE, V333, P576, DOI 10.1038/333576a0; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; CARROLL SB, 1986, CELL, V47, P113, DOI 10.1016/0092-8674(86)90372-7; CASANOVA J, 1986, CELL, V47, P627, DOI 10.1016/0092-8674(86)90627-6; CELNIKER SE, 1989, GENE DEV, V3, P1424, DOI 10.1101/gad.3.9.1424; DELORENZI M, 1988, EMBO J, V7, P3223, DOI 10.1002/j.1460-2075.1988.tb03189.x; DESPLAN C, 1988, CELL, V54, P1081, DOI 10.1016/0092-8674(88)90123-7; DESPLAN C, 1985, NATURE, V318, P630, DOI 10.1038/318630a0; Garcia-Bellido A, 1975, Ciba Found Symp, V0, P161; GEHRING WJ, 1987, SCIENCE, V236, P1245, DOI 10.1126/science.2884726; GIBSON G, 1988, DEVELOPMENT, V102, P657; GOULD AP, 1990, THESIS U CAMBRIDGE U; GOUTTE C, 1988, CELL, V52, P875, DOI 10.1016/0092-8674(88)90429-1; GRUSS C, 1988, VIROLOGY, V167, P349, DOI 10.1016/S0042-6822(88)90095-5; HAFEN E, 1984, NATURE, V307, P287, DOI 10.1038/307287a0; HARDING K, 1985, SCIENCE, V229, P1236, DOI 10.1126/science.3898362; HAYES PH, 1984, P NATL ACAD SCI-BIOL, V81, P545, DOI 10.1073/pnas.81.2.545; JOHNSON FB, 1990, GENE DEV, V4, P1044, DOI 10.1101/gad.4.6.1044; KELEHER CA, 1988, CELL, V53, P927, DOI 10.1016/S0092-8674(88)90449-7; KRASNOW MA, 1989, CELL, V57, P1031, DOI 10.1016/0092-8674(89)90341-3; KUZIORA MA, 1988, CELL, V55, P477, DOI 10.1016/0092-8674(88)90034-7; LANE DP, 1985, PROC R SOC SER B-BIO, V226, P25, DOI 10.1098/rspb.1985.0077; LANGERSAFER PR, 1982, P NATL ACAD SCI-BIOL, V79, P4381, DOI 10.1073/pnas.79.14.4381; LAUGHON A, 1988, DEVELOPMENT, V104, P75; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; LEWIS EB, 1963, AM ZOOL, V3, P33; MARTINEZARIAS A, 1985, NATURE, V313, P639, DOI 10.1038/313639a0; MORATA G, 1981, NATURE, V290, P778, DOI 10.1038/290778a0; MULLER M, 1988, EMBO J, V7, P4299, DOI 10.1002/j.1460-2075.1988.tb03328.x; NOLL M, 1975, SCIENCE, V187, P1203, DOI 10.1126/science.187.4182.1203; PINA B, 1990, CELL, V60, P719, DOI 10.1016/0092-8674(90)90087-U; Sambrook J., 1989, MOL CLONING LAB MANU; SAMSON ML, 1989, CELL, V57, P1045, DOI 10.1016/0092-8674(89)90342-5; SANCHEZHERRERO E, 1985, NATURE, V313, P108, DOI 10.1038/313108a0; SCOTT MP, 1989, BIOCHIM BIOPHYS ACTA, V989, P25, DOI 10.1016/0304-419X(89)90033-4; SOMPAYRAC L, 1990, P NATL ACAD SCI USA, V87, P3274, DOI 10.1073/pnas.87.9.3274; STADEN R, 1984, NUCLEIC ACIDS RES, V12, P505, DOI 10.1093/nar/12.1Part2.505; STRUHL G, 1984, NATURE, V308, P454, DOI 10.1038/308454a0; STRUHL G, 1985, CELL, V43, P507, DOI 10.1016/0092-8674(85)90180-1; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; THALI M, 1988, NATURE, V336, P598, DOI 10.1038/336598a0; THOMAS GH, 1988, EMBO J, V7, P2191, DOI 10.1002/j.1460-2075.1988.tb03058.x; VINCENT JP, 1990, EMBO J, V9, P2573, DOI 10.1002/j.1460-2075.1990.tb07438.x; WHITE RAH, 1984, CELL, V39, P163, DOI 10.1016/0092-8674(84)90202-2; WHITE RAH, 1985, EMBO J, V4, P2035, DOI 10.1002/j.1460-2075.1985.tb03889.x; WINSLOW GM, 1989, CELL, V57, P1017, DOI 10.1016/0092-8674(89)90340-1; WU C, 1984, NATURE, V309, P229, DOI 10.1038/309229a0	51	152	156	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 22	1990	348	6299					308	312		10.1038/348308a0	http://dx.doi.org/10.1038/348308a0			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EJ955	1979146				2022-12-24	WOS:A1990EJ95500051
J	ZARLING, JM; MORAN, PA; HAFFAR, O; SIAS, J; RICHMAN, DD; SPINA, CA; MYERS, DE; KUEBELBECK, V; LEDBETTER, JA; UCKUN, FM				ZARLING, JM; MORAN, PA; HAFFAR, O; SIAS, J; RICHMAN, DD; SPINA, CA; MYERS, DE; KUEBELBECK, V; LEDBETTER, JA; UCKUN, FM			INHIBITION OF HIV REPLICATION BY POKEWEED ANTIVIRAL PROTEIN TARGETED TO CD4+ CELLS BY MONOCLONAL-ANTIBODIES	NATURE			English	Article									VET ADM MED CTR,SAN DIEGO,CA 92161; UNIV CALIF SAN DIEGO,LA JOLLA,CA 92093; UNIV MINNESOTA,DEPT THERAPEUT RADIOL,TUMOR IMMUNOL LAB,MINNEAPOLIS,MN 55455	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Diego; University of Minnesota System; University of Minnesota Twin Cities	ZARLING, JM (corresponding author), ONCOGEN CORP,3005 1ST AVE,SEATTLE,WA 98121, USA.			Uckun, Fatih M./0000-0001-9334-183X				ARON GM, 1980, ANTIMICROB AGENTS CH, V17, P1032, DOI 10.1128/AAC.17.6.1032; CHAUDHARY VK, 1988, NATURE, V335, P369, DOI 10.1038/335369a0; DAGLEISH AG, 1984, NATURE, V312, P763; DUGGAR B. M., 1925, Ann. Mo. Bot. Gdn., V12, P359, DOI 10.2307/2394061; FISCHL MA, 1987, NEW ENGL J MED, V317, P185, DOI 10.1056/NEJM198707233170401; GARRY RF, 1988, BIOSCIENCE REP, V8, P35, DOI 10.1007/BF01128970; HAFFAR OK, 1988, J CELL BIOL, V107, P1677, DOI 10.1083/jcb.107.5.1677; HARPER ME, 1986, P NATL ACAD SCI USA, V83, P772, DOI 10.1073/pnas.83.3.772; HOXIE JA, 1986, SCIENCE, V234, P1123, DOI 10.1126/science.3095925; IRVIN JD, 1983, PHARMACOL THERAPEUT, V21, P371, DOI 10.1016/0163-7258(83)90061-X; LEDBETTER JA, 1988, EUR J IMMUNOL, V18, P525, DOI 10.1002/eji.1830180406; LEDBETTER JA, 1987, MOL IMMUNOL, V24, P1255, DOI 10.1016/0161-5890(87)90119-2; LINSLEY PS, 1988, J VIROL, V62, P3695, DOI 10.1128/JVI.62.10.3695-3702.1988; LITTMAN DR, 1987, ANNU REV IMMUNOL, V5, P561, DOI 10.1146/annurev.iy.05.040187.003021; MCDOUGAL JS, 1985, J IMMUNOL, V135, P361; MYERS DE, 1989, J IMMUNOL METHODS, V121, P129, DOI 10.1016/0022-1759(89)90428-6; OBRIG TG, 1973, ARCH BIOCHEM BIOPHYS, V155, P278, DOI 10.1016/0003-9861(73)90116-1; PINCUS SH, 1989, J IMMUNOL, V142, P3070; POLI G, 1989, SCIENCE, V244, P575, DOI 10.1126/science.2470148; PSALLIDOPOULOS MC, 1989, J VIROL, V63, P4626, DOI 10.1128/JVI.63.11.4626-4631.1989; RAMAKRISHNAN S, 1985, CANCER RES, V45, P2031; ROYSTON I, 1980, J IMMUNOL, V125, P725; SCHNITTMAN SM, 1989, SCIENCE, V245, P305, DOI 10.1126/science.2665081; STARCICH BR, 1986, CELL, V45, P637, DOI 10.1016/0092-8674(86)90778-6; TELTOW GJ, 1983, ANTIMICROB AGENTS CH, V23, P390, DOI 10.1128/AAC.23.3.390; TILL MA, 1988, SCIENCE, V242, P1166, DOI 10.1126/science.2847316; TILL MA, IN PRESS P NATN ACAD; TOMLINSON JA, 1974, J GEN VIROL, V22, P225, DOI 10.1099/0022-1317-22-2-225; UCKUN FM, 1986, J EXP MED, V163, P347, DOI 10.1084/jem.163.2.347; UCKUN FM, 1985, J IMMUNOL, V135, P3817; UCKUN FM, 1985, J IMMUNOL, V140, P2103; UCKUN FM, 1988, CANCER RES, V45, P69; UCKUN FM, 1989, AUTOLOGOUS BONE MARR, P171; UCKUN FM, 1987, UCLA S MOL CELL BIOL, V45, P243; UCKUN FM, 1988, ANTIBODY IMMUNOCONJ, V1, P247; USSERY MA, 1977, ANN NY ACAD SCI, V284, P431, DOI 10.1111/j.1749-6632.1977.tb21979.x; WEISS RA, 1986, NATURE, V324, P572, DOI 10.1038/324572a0; WYATT SD, 1969, PHYTOPATHOLOGY, V59, P1787; YARCHOAN R, 1987, LANCET, V1, P132, DOI 10.1016/S0140-6736(87)91968-4	39	198	237	0	13	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	SEP 6	1990	347	6288					92	95		10.1038/347092a0	http://dx.doi.org/10.1038/347092a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX402	1975641				2022-12-24	WOS:A1990DX40200067
J	SAVALGI, RS; CORBISHLEY, CM; CAYGILL, C; HILL, M; COOK, MG; KIRKHAM, JS; NORTHFIELD, TC				SAVALGI, RS; CORBISHLEY, CM; CAYGILL, C; HILL, M; COOK, MG; KIRKHAM, JS; NORTHFIELD, TC			RELATION BETWEEN SEVERITY AND EXTENT OF PRECANCEROUS LESIONS IN THE POSTOPERATIVE STOMACH	LANCET			English	Article									ST GEORGE HOSP,SCH MED,DIV BIOCHEM MED,LONDON SW17 0RE,ENGLAND; ST GEORGE HOSP,SCH MED,NORMAN TANNER GASTROENTEROL UNIT,LONDON SW17 0RE,ENGLAND; ST GEORGE HOSP,SCH MED,DEPT PATHOL,LONDON SW17 0RE,ENGLAND; PUBL HLTH LAB SERV,CTR APPL MICROBIOL & RES,DIV PATHOL,PORTON DOWN,WILTS,ENGLAND; PUBL HLTH LAB SERV,CTR COMMUNICABLE DIS SURVEILLANCE,LONDON,ENGLAND	St Georges University London; St Georges University London; St Georges University London; Public Health England								BENEDETTI G, 1982, INT J TISSUE REACT, V4, P247; BERNARDINIS GD, 1983, TUMORI, V69, P231; BOGOMOLETZ WV, 1984, AM J SURG PATHOL, V8, P381, DOI 10.1097/00000478-198405000-00007; CAYGILL CPJ, 1986, LANCET, V2, P923; CLARK CG, 1983, WORLD J SURG, V7, P236, DOI 10.1007/BF01656150; CLEMENCON G, 1976, DEUT MED WOCHENSCHR, V101, P1015, DOI 10.1055/s-0028-1104207; CORREA P, 1975, LANCET, V2, P58; CORREA P, 1983, PRECANCEROUS LESIONS, P145; DOMELLOF L, 1977, AM J SURG, V134, P581, DOI 10.1016/0002-9610(77)90439-1; DOUGHERTY SH, 1982, ARCH SURG-CHICAGO, V117, P294; EBERLEIN TJ, 1978, ANN SURG, V187, P251, DOI 10.1097/00000658-197803000-00007; GRUNDMANN E, 1978, PATHOL RES PRACT, V162, P347, DOI 10.1016/S0344-0338(78)80067-3; JASS JR, 1983, HISTOPATHOLOGY, V7, P181, DOI 10.1111/j.1365-2559.1983.tb02234.x; LOSCOS JM, 1986, GASTROINTEST ENDOSC, V32, P75; LYGIDAKIS NJ, 1986, ACTA CHIR SCAND, V152, P139; MORSON BC, 1980, J CLIN PATHOL, V33, P711, DOI 10.1136/jcp.33.8.711; NOGUCHI Y, 1985, WORLD J SURG, V9, P786, DOI 10.1007/BF01655194; ORLANDO R, 1981, AM J SURG, V141, P487, DOI 10.1016/0002-9610(81)90145-8; OVASKA JT, 1986, ACTA CHIR SCAND, V152, P199; OVASKA JT, 1986, ACTA CHIR SCAND, V152, P289; PEREZ D, 1984, AM SURGEON, V50, P538; PICKFORD IR, 1984, GUT, V25, P393, DOI 10.1136/gut.25.4.393; SAEGESSER F, 1972, CANCER-AM CANCER SOC, V29, P1150, DOI 10.1002/1097-0142(197205)29:5<1150::AID-CNCR2820290505>3.0.CO;2-5; SAVALGI RS, 1989, GUT, V30, pA1487; SCHNAPKA G, 1984, ENDOSCOPY, V16, P171, DOI 10.1055/s-2007-1018572; SCHRUMPF E, 1977, LANCET, V2, P467; SCHUMAN BM, 1986, GASTROINTEST ENDOSC, V32, P117, DOI 10.1016/S0016-5107(86)71773-2; STALSBERG H, 1971, LANCET, V2, P1175; SZENTIRMAY Z, 1982, CANCER DETECT PREV, V5, P185; WU C, 1983, J FORMOSAN MED ASSOC, V83, P1252	30	10	10	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	AUG 18	1990	336	8712					413	416		10.1016/0140-6736(90)91954-9	http://dx.doi.org/10.1016/0140-6736(90)91954-9			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV277	1974951				2022-12-24	WOS:A1990DV27700012
J	COHEN, SM; JURGENS, G				COHEN, SM; JURGENS, G			MEDIATION OF DROSOPHILA HEAD DEVELOPMENT BY GAP-LIKE SEGMENTATION GENES	NATURE			English	Article									BAYLOR UNIV,DEPT CELL BIOL,HOUSTON,TX 77030; UNIV MUNICH,INST GENET & MIKROBIOL,W-8000 MUNICH 19,GERMANY	Baylor University; University of Munich	COHEN, SM (corresponding author), BAYLOR UNIV,HOWARD HUGHES MED INST,HOUSTON,TX 77030, USA.		Cohen, Stephen M/G-9930-2011	Cohen, Stephen M/0000-0003-2858-9163				AKAM M, 1987, DEVELOPMENT, V101, P1; BAKER NE, 1988, DEVELOPMENT, V103, P289; BENDER M, 1987, DEV BIOL, V119, P418, DOI 10.1016/0012-1606(87)90046-7; BERLETH T, 1988, EMBO J, V7, P1749, DOI 10.1002/j.1460-2075.1988.tb03004.x; COHEN SM, 1989, EMBO J, V8, P2045, DOI 10.1002/j.1460-2075.1989.tb03613.x; COHEN SM, 1990, NATURE, V343, P173, DOI 10.1038/343173a0; DALTON D, 1989, GENE DEV, V3, P1940, DOI 10.1101/gad.3.12a.1940; DRIEVER W, 1989, NATURE, V340, P363, DOI 10.1038/340363a0; DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; DRIEVER W, 1989, NATURE, V337, P138, DOI 10.1038/337138a0; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; FINKELSTEIN R, 1990, NATURE, V346, P485, DOI 10.1038/346485a0; FRIGERIO G, 1986, CELL, V47, P735, DOI 10.1016/0092-8674(86)90516-7; FROHNHOFER HG, 1986, NATURE, V324, P120, DOI 10.1038/324120a0; INGHAM PW, 1988, NATURE, V335, P25, DOI 10.1038/335025a0; JURGENS G, 1986, ROUX ARCH DEV BIOL, V195, P359, DOI 10.1007/BF00402870; JURGENS G, 1984, ROUX ARCH DEV BIOL, V193, P283, DOI 10.1007/BF00848157; LAWRENCE PA, 1987, NATURE, V328, P440, DOI 10.1038/328440a0; LAWRENCE PA, 1989, DEVELOPMENT, V105, P761; LEHMANN R, 1987, DEV BIOL, V119, P404; MAHAFFEY JW, 1989, DEVELOPMENT, V105, P167; NUSSLEINVOLHARD C, 1987, SCIENCE, V238, P1675, DOI 10.1126/science.3686007; PANKRATZ MJ, 1990, CELL, V61, P309, DOI 10.1016/0092-8674(90)90811-R; SCHRODER C, 1988, EMBO J, V7, P2881, DOI 10.1002/j.1460-2075.1988.tb03145.x; STANOJEVIC D, 1989, NATURE, V341, P331, DOI 10.1038/341331a0; STRUHL G, 1989, CELL, V57, P1259, DOI 10.1016/0092-8674(89)90062-7; STRUHL G, 1981, DEV BIOL, V84, P386, DOI 10.1016/0012-1606(81)90407-3; SUNKEL CE, 1987, ROUX ARCH DEV BIOL, V196, P124, DOI 10.1007/BF00402034; TAUTZ D, 1987, NATURE, V327, P383, DOI 10.1038/327383a0; TAUTZ D, 1988, NATURE, V332, P281, DOI 10.1038/332281a0; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; WIESCHAUS E, 1984, ROUX ARCH DEV BIOL, V193, P296, DOI 10.1007/BF00848158	32	238	243	0	6	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	AUG 2	1990	346	6283					482	484		10.1038/346482a0	http://dx.doi.org/10.1038/346482a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR713	1974035				2022-12-24	WOS:A1990DR71300063
J	GUTIERREZRAMOS, JC; ANDREU, JL; REVILLA, Y; VINUELA, E; MARTINEZ, C				GUTIERREZRAMOS, JC; ANDREU, JL; REVILLA, Y; VINUELA, E; MARTINEZ, C			RECOVERY FROM AUTOIMMUNITY OF MRL LPR MICE AFTER INFECTION WITH AN INTERLEUKIN-2 VACCINIA RECOMBINANT VIRUS	NATURE			English	Article									UNIV AUTONOMA MADRID,CSIC,CTR BIOL MOLEC,CAMPUS CANTOBLANCO,E-28049 MADRID,SPAIN	Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC)			Andreu, José Luis/E-5115-2012	Andreu, José Luis/0000-0002-6002-1239; Yolanda, Revilla/0000-0001-6555-6331				ALTMAN A, 1981, J EXP MED, V154, P791, DOI 10.1084/jem.154.3.791; BUDD RC, 1985, J IMMUNOL, V135, P3704; CHAKRABARTI S, 1985, MOL CELL BIOL, V5, P3403, DOI 10.1128/MCB.5.12.3403; CLARK SC, 1984, P NATL ACAD SCI-BIOL, V81, P2543, DOI 10.1073/pnas.81.8.2543; COHEN PL, 1986, CLIN IMMUNOL IMMUNOP, V40, P485, DOI 10.1016/0090-1229(86)90193-5; DIXON FJ, 1981, IMMUNOL TODAY, V2, P145, DOI 10.1016/0167-5699(81)90083-9; FLEXNER C, 1987, NATURE, V330, P259, DOI 10.1038/330259a0; KATAGIRI T, 1988, J EXP MED, V167, P741, DOI 10.1084/jem.167.3.741; LEO O, 1987, P NATL ACAD SCI USA, V84, P1374, DOI 10.1073/pnas.84.5.1374; LINKERISRAELI M, 1983, J IMMUNOL, V130, P2651; MARCOS MR, 1987, SCAND J IMMUNOL, V25, P321, DOI 10.1111/j.1365-3083.1987.tb02197.x; MIESCHER GC, 1987, J IMMUNOL, V138, P1959; MOLLER G, 1981, IMMUNOL REV, V63, P1; MOUNTZ JD, 1988, J IMMUNOL, V140, P2943; NEMAZEE DA, 1985, EUR J IMMUNOL, V15, P760, DOI 10.1002/eji.1830150804; RAMSHAW IA, 1987, NATURE, V329, P545, DOI 10.1038/329545a0; SAKAGUCHI S, 1985, J EXP MED, V161, P72, DOI 10.1084/jem.161.1.72; SINGER PA, 1986, P NATL ACAD SCI USA, V83, P7018, DOI 10.1073/pnas.83.18.7018; THEOFILOPOULOS AN, 1985, ADV IMMUNOL, V37, P269, DOI 10.1016/S0065-2776(08)60342-9; TORIBIO ML, 1989, NATURE, V342, P82, DOI 10.1038/342082a0; WADSWORTH S, 1989, P NATL ACAD SCI USA, V86, P1018, DOI 10.1073/pnas.86.3.1018; WESTON KM, 1988, J IMMUNOL, V131, P734	22	121	125	0	4	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUL 19	1990	346	6281					271	274		10.1038/346271a0	http://dx.doi.org/10.1038/346271a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP456	1973822				2022-12-24	WOS:A1990DP45600066
J	JOHNSON, S; CLABOTS, CR; LINN, FV; OLSON, MM; PETERSON, LR; GERDING, DN				JOHNSON, S; CLABOTS, CR; LINN, FV; OLSON, MM; PETERSON, LR; GERDING, DN			NOSOCOMIAL CLOSTRIDIUM-DIFFICILE COLONIZATION AND DISEASE	LANCET			English	Article									UNIV MINNESOTA,SCH MED,MINNEAPOLIS,MN 55455	University of Minnesota System; University of Minnesota Twin Cities	JOHNSON, S (corresponding author), VET ADM MED CTR,DEPT MED,INFECT DIS SECT 111F,1 VET DR,MINNEAPOLIS,MN 55417, USA.			Johnson, Stuart/0000-0001-9548-229X				BACON AE, 1988, J INFECT DIS, V158, P349, DOI 10.1093/infdis/158.2.349; BARTLETT JG, 1978, NEW ENGL J MED, V298, P531, DOI 10.1056/NEJM197803092981003; BENDER BS, 1986, LANCET, V2, P11, DOI 10.1016/S0140-6736(86)92559-6; BURDON DW, 1982, INFECTION, V10, P203, DOI 10.1007/BF01666909; CLEARY PP, 1988, J INFECT DIS, V158, P1317, DOI 10.1093/infdis/158.6.1317; DELMEE M, 1987, EUR J CLIN MICROBIOL, V6, P623, DOI 10.1007/BF02013056; DEVLIN HR, 1987, J CLIN MICROBIOL, V25, P2168, DOI 10.1128/JCM.25.11.2168-2172.1987; DEVLIN HR, 1988, 28TH INT C ANT AG CH; FEKETY R, 1981, AM J MED, V70, P906, DOI 10.1016/0002-9343(81)90553-2; FLEISS JL, 1973, STATISTICAL METHODS, P23; GEORGE WL, 1979, J CLIN MICROBIOL, V9, P214; GERDING DN, 1986, ARCH INTERN MED, V146, P95, DOI 10.1001/archinte.146.1.95; JOHNSON S, 1990, AM J MED, V88, P137, DOI 10.1016/0002-9343(90)90462-M; JOHNSON S, 1989, J INFECT DIS, V159, P340, DOI 10.1093/infdis/159.2.340; JOHNSON S, 1988, 88TH ANN M AM SOC MI; KUIJPER EJ, 1987, J CLIN MICROBIOL, V25, P751, DOI 10.1128/JCM.25.4.751-753.1987; LARSON HE, 1978, LANCET, V1, P1063; MCFARLAND LV, 1987, J CLIN MICROBIOL, V25, P2241, DOI 10.1128/JCM.25.11.2241-2242.1987; MCFARLAND LV, 1989, NEW ENGL J MED, V320, P204, DOI 10.1056/NEJM198901263200402; MCFARLAND LV, 1986, AM J INFECT CONTROL, V14, P99, DOI 10.1016/0196-6553(86)90018-0; PEERBOOMS PGH, 1987, J CLIN PATHOL, V40, P771, DOI 10.1136/jcp.40.7.771; PHILLIPS KD, 1981, J CLIN PATHOL, V34, P642, DOI 10.1136/jcp.34.6.642; PIERCE PF, 1982, J INFECT DIS, V145, P269, DOI 10.1093/infdis/145.2.269; SCHERER S, 1987, J CLIN MICROBIOL, V25, P675, DOI 10.1128/JCM.25.4.675-679.1987; SHANHOLTZER CJ, 1983, J CLIN MICROBIOL, V17, P906, DOI 10.1128/JCM.17.5.906-908.1983; TEDESCO FJ, 1974, ANN INTERN MED, V81, P429, DOI 10.7326/0003-4819-81-4-429; VISCIDI R, 1981, GASTROENTEROLOGY, V81, P5; WALTERS BAJ, 1982, AUST NZ J MED, V12, P255, DOI 10.1111/j.1445-5994.1982.tb02471.x; WREN BW, 1987, J CLIN MICROBIOL, V25, P2402, DOI 10.1128/JCM.25.12.2402-2404.1987	29	280	289	0	11	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JUL 14	1990	336	8707					97	100		10.1016/0140-6736(90)91605-A	http://dx.doi.org/10.1016/0140-6736(90)91605-A			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN793	1975332				2022-12-24	WOS:A1990DN79300012
J	ATZPODIEN, J; KORFER, A; FRANKS, CR; POLIWODA, H; KIRCHNER, H				ATZPODIEN, J; KORFER, A; FRANKS, CR; POLIWODA, H; KIRCHNER, H			HOME THERAPY WITH RECOMBINANT INTERLEUKIN-2 AND INTERFERON-ALPHA-2B IN ADVANCED HUMAN MALIGNANCIES	LANCET			English	Article									MED HSCH HANOVER,MED CTR,DEPT HAEMATOL & ONCOL,W-3000 HANOVER 61,GERMANY; EUROCETUS BV,AMSTERDAM,NETHERLANDS									ATZPODIEN J, 1990, Molecular Biotherapy, V2, P18; ATZPODIEN J, 1988, LEUKAMIEN LYMPHOME, P211; ENGVALL E, 1971, IMMUNOCHEMISTRY, V8, P871, DOI 10.1016/0019-2791(71)90454-X; FISHER RI, 1988, ANN INTERN MED, V108, P518, DOI 10.7326/0003-4819-108-4-518; GILLIS S, 1978, J IMMUNOL, V120, P2027; HUBERMAN M, 1988, P AM SOC CLIN ONCOL, V7, P653; KOLITZ JE, 1988, J BIOL RESP MODIF, V7, P457; LEE KH, 1989, J CLIN ONCOL, V7, P1726, DOI 10.1200/JCO.1989.7.11.1726; LEE RE, 1989, J CLIN ONCOL, V7, P7, DOI 10.1200/JCO.1989.7.1.7; LEGHA SS, 1986, CANCER, V57, P1675, DOI 10.1002/1097-0142(19860415)57:8+<1675::AID-CNCR2820571307>3.0.CO;2-I; MUSS HB, 1987, SEMIN ONCOL, V14, P36; NEGRIER S, 1989, EUR J CANCER CLIN S3, V25, P21; ROSENBERG SA, 1989, J CLIN ONCOL, V7, P1863, DOI 10.1200/JCO.1989.7.12.1863; ROSENBERG SA, 1988, NEW ENGL J MED, V319, P1676, DOI 10.1056/NEJM198812223192527; ROSENBERG SA, 1988, ANN INTERN MED, V108, P853, DOI 10.7326/0003-4819-108-6-853; ROSENBERG SA, 1987, NEW ENGL J MED, V316, P880; ROSENSTEIN M, 1986, J IMMUNOL, V137, P1735; WEST WH, 1987, NEW ENGL J MED, V316, P898, DOI 10.1056/NEJM198704093161502	18	324	326	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JUN 23	1990	335	8704					1509	1512		10.1016/0140-6736(90)93039-R	http://dx.doi.org/10.1016/0140-6736(90)93039-R			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK586	1972442				2022-12-24	WOS:A1990DK58600013
J	HODGE, B; THOMPSON, JF				HODGE, B; THOMPSON, JF			NOISE-POLLUTION IN THE OPERATING-THEATER	LANCET			English	Article									ROYAL PRINCE ALFRED HOSP, SYDNEY, AUSTRALIA	University of Sydney			Thompson, John/F-9075-2013	Thompson, John/0000-0002-2816-2496				AITKEN RJ, 1982, ARCH ENVIRON HEALTH, V37, P361, DOI 10.1080/00039896.1982.10667592; BAUM A, 1985, SOCIAL PSYCHOL; Beranek LL, 1971, NOISE VIBRATION CONT, P554; CROMER AH, 1974, PHYSICS LIFE SCI; Davies JM, 1989, ANAESTHESIA INTENSIV, V17, P98; FALK SA, 1973, NEW ENGL J MED, V289, P774, DOI 10.1056/NEJM197310112891504; FISHER J, 1984, ENV PSYCHOL; Glass DC., 1972, URBAN STRESS EXPT NO; Hockney GR, 1978, HDB NOISE ASSESSMENT, P335; Holahan C. J., 1982, ENV PSYCHOL; KESTIN IG, 1988, ANESTHESIOLOGY, V69, P106, DOI 10.1097/00000542-198807000-00018; Kryter K. D., 1970, EFFECTS NOISE MAN; Mori H, 1979, JAP J ANAESTHESIOL, V10, P1102; OSZEWSKI DA, 1976, M MID W PSYCHOL ASS; SHAPIRO RA, 1972, NEW ENGL J MED, V287, P1236, DOI 10.1056/NEJM197212142872407; WALKER JG, 1975, HDB NOISE ASSESSMENT, V7, P185; 1977, ACOUSTICS METHODS AS; 1977, AMBIENT SOUND LEVELS	18	135	137	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 14	1990	335	8694					891	894		10.1016/0140-6736(90)90486-O	http://dx.doi.org/10.1016/0140-6736(90)90486-O			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ135	1969991				2022-12-24	WOS:A1990CZ13500012
J	CASHMAN, NR; LOERTSCHER, R; NALBANTOGLU, J; SHAW, I; KASCSAK, RJ; BOLTON, DC; BENDHEIM, PE				CASHMAN, NR; LOERTSCHER, R; NALBANTOGLU, J; SHAW, I; KASCSAK, RJ; BOLTON, DC; BENDHEIM, PE			CELLULAR ISOFORM OF THE SCRAPIE AGENT PROTEIN PARTICIPATES IN LYMPHOCYTE-ACTIVATION	CELL			English	Article									MCGILL UNIV,DEPT MED,MONTREAL H3A 2B4,QUEBEC,CANADA; INST NATL RES SCI SANTE,POINTE CLAIRE H9R 1G6,QUEBEC,CANADA; NEW YORK STATE INST BASIC RES DEV DISABILITIES,DEPT VIROL,STATEN ISL,NY 10314; NEW YORK STATE INST BASIC RES DEV DISABILITIES,DEPT MOLEC BIOL,STATEN ISL,NY 10314	McGill University; University of Quebec; Institute for Basic Research in Developmental Disabilities; Institute for Basic Research in Developmental Disabilities	CASHMAN, NR (corresponding author), MONTREAL NEUROL HOSP & INST,DEPT NEUROL & NEUROSURG,MONTREAL H3A 2B4,QUEBEC,CANADA.				NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS021349, R01NS023948, R29NS024720] Funding Source: NIH RePORTER; NINDS NIH HHS [NS24720, NS21349, NS23948] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BASLER K, 1986, CELL, V46, P417, DOI 10.1016/0092-8674(86)90662-8; BENDHEIM PE, 1984, NATURE, V310, P418, DOI 10.1038/310418a0; BENDHEIM PE, 1988, J INFECT DIS, V158, P1198, DOI 10.1093/infdis/158.6.1198; BOLTON DC, 1987, ARCH BIOCHEM BIOPHYS, V258, P579, DOI 10.1016/0003-9861(87)90380-8; BOLTON DC, 1982, SCIENCE, V218, P1309, DOI 10.1126/science.6815801; BOLTON DC, 1988, CIBA F SYMP, V135, P164; BOLTON DC, 1984, BIOCHEMISTRY-US, V23, P5893; BROWN HR, 1990, IN PRESS ACTA NEUROP; CAMERINI D, 1989, NATURE, V342, P78, DOI 10.1038/342078a0; CARP R I, 1989, Alzheimer Disease and Associated Disorders, V3, P79, DOI 10.1097/00002093-198903010-00008; CAUGHEY B, 1988, J GEN VIROL, V69, P711, DOI 10.1099/0022-1317-69-3-711; CAUGHEY B, 1989, J VIROL, V63, P175, DOI 10.1128/JVI.63.1.175-181.1989; CHESEBRO B, 1985, NATURE, V315, P331, DOI 10.1038/315331a0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CZUB M, 1986, ARCH VIROL, V91, P83; DAVIS LS, 1988, J IMMUNOL, V141, P2246; DEARMOND SJ, 1987, NEUROLOGY, V37, P1271, DOI 10.1212/WNL.37.8.1271; DEARMOND SJ, 1988, ALZ DIS ASSOC DIS, V2, P304; DICKINSON AG, 1978, NATURE, V272, P54, DOI 10.1038/272054a0; DOI S, 1988, J GEN VIROL, V69, P955, DOI 10.1099/0022-1317-69-4-955; ENDO T, 1989, BIOCHEMISTRY-US, V28, P8380, DOI 10.1021/bi00447a017; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FRASER H, 1970, NATURE, V226, P462, DOI 10.1038/226462a0; Fraser H., 1976, Slow virus diseases of animals and man,, P267; FRASER H, 1987, VET MICROBIOL, V13, P211, DOI 10.1016/0378-1135(87)90084-8; FREIMUTH WW, 1979, J IMMUNOL, V123, P201; GABIZON R, 1988, P NATL ACAD SCI USA, V85, P6617, DOI 10.1073/pnas.85.18.6617; GAJDUSEK DC, 1986, VIROLOGY, P1516; GRIFFITH JS, 1967, NATURE, V215, P1043, DOI 10.1038/2151043a0; HAZIOT A, 1988, J IMMUNOL, V141, P547; HOLLANDER N, 1988, J IMMUNOL, V141, P4283; HOPE J, 1986, EMBO J, V5, P2591, DOI 10.1002/j.1460-2075.1986.tb04539.x; HUIZINGA TWJ, 1988, NATURE, V333, P67; KANOF ME, 1987, J IMMUNOL, V139, P49; KASCSAK RJ, 1987, J VIROL, V61, P3688, DOI 10.1128/JVI.61.12.3688-3693.1987; KRETZSCHMAR HA, 1986, AM J PATHOL, V122, P1; KROCZEK RA, 1986, J IMMUNOL, V136, P4379; KURODA Y, 1983, INFECT IMMUN, V41, P154, DOI 10.1128/IAI.41.1.154-161.1983; LAVELLE GC, 1972, INFECT IMMUN, V5, P319, DOI 10.1128/IAI.5.3.319-323.1972; LE P, 1990, IN PRESS J IMMUNOL; LEHRACH H, 1977, BIOCHEMISTRY-US, V16, P4743, DOI 10.1021/bi00640a033; LETARTE M, 1980, J IMMUNOL, V125, P370; LOCHT C, 1986, P NATL ACAD SCI USA, V83, P6372, DOI 10.1073/pnas.83.17.6372; LOW MG, 1988, SCIENCE, V239, P268, DOI 10.1126/science.3276003; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; OKAYAMA H, 1982, MOL CELL BIOL, V2, P161, DOI 10.1128/MCB.2.2.161; OLESZAK EL, 1988, J VIROL, V62, P3103, DOI 10.1128/JVI.62.9.3103-3108.1988; PIERRES M, 1988, T CELL RECEPTOR, P293; PRUSINER SB, 1987, NEW ENGL J MED, V317, P1571, DOI 10.1056/NEJM198712173172505; PRUSINER SB, 1984, CELL, V38, P127, DOI 10.1016/0092-8674(84)90533-6; ROBAKIS NK, 1986, P NATL ACAD SCI USA, V83, P6377, DOI 10.1073/pnas.83.17.6377; ROBINSON PJ, 1987, P NATL ACAD SCI USA, V84, P527, DOI 10.1073/pnas.84.2.527; ROBINSON PJ, 1989, NATURE, V342, P85, DOI 10.1038/342085a0; ROCK KL, 1986, J EXP MED, V163, P315, DOI 10.1084/jem.163.2.315; RUBENSTEIN R, 1986, J GEN VIROL, V67, P671, DOI 10.1099/0022-1317-67-4-671; SANDERS ME, 1988, J IMMUNOL, V140, P1401; SHINAGAWA M, 1986, J GEN VIROL, V67, P1745, DOI 10.1099/0022-1317-67-8-1745; SOLOSKI MJ, 1986, P NATL ACAD SCI USA, V83, P2949, DOI 10.1073/pnas.83.9.2949; SPRINGER TA, 1987, ANNU REV IMMUNOL, V5, P223, DOI 10.1146/annurev.immunol.5.1.223; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; STIERNBERG J, 1987, J IMMUNOL, V138, P3877; THORLEYLAWSON DA, 1982, CELL, V30, P415, DOI 10.1016/0092-8674(82)90239-2; WEISS A, 1987, ADV IMMUNOL, V41, P1, DOI 10.1016/S0065-2776(08)60029-2; WONIGEIT K, 1987, TRANSPLANT P, V19, P296; YEH ETH, 1988, CELL, V52, P665, DOI 10.1016/0092-8674(88)90404-7	66	282	289	0	4	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	APR 6	1990	61	1					185	192		10.1016/0092-8674(90)90225-4	http://dx.doi.org/10.1016/0092-8674(90)90225-4			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CY382	1969332				2022-12-24	WOS:A1990CY38200020
J	GOOSSENS, H; VLAES, L; DEBOECK, M; POT, B; KERSTERS, K; LEVY, J; DEMOL, P; BUTZLER, JP; VANDAMME, P				GOOSSENS, H; VLAES, L; DEBOECK, M; POT, B; KERSTERS, K; LEVY, J; DEMOL, P; BUTZLER, JP; VANDAMME, P			IS CAMPYLOBACTER-UPSALIENSIS AN UNRECOGNIZED CAUSE OF HUMAN DIARRHEA	LANCET			English	Article									ST PIETERS HOSP,WHO,COLLABORATING CTR ENTER CAMPYLOBACTER,BRUSSELS,BELGIUM; STATE UNIV GHENT,MICROBIOL & MICROBIAL GENET LAB,B-9000 GHENT,BELGIUM	World Health Organization; Ghent University			Vandamme, Peter AR/B-7967-2009; Vandamme, Peter/ABG-3431-2021; Pot, Bruno DF/I-6645-2012	Vandamme, Peter AR/0000-0002-5581-7937; Vandamme, Peter/0000-0002-5581-7937; 				BOLTON FJ, 1984, J CLIN MICROBIOL, V19, P169, DOI 10.1128/JCM.19.2.169-171.1984; BRASSEUR D, 1986, EUR J PEDIATR, V144, P517, DOI 10.1007/BF00441757; GOOSSENS H, 1989, J CLIN MICROBIOL, V27, P2143, DOI 10.1128/JCM.27.9.2143-2144.1989; GOOSSENS H, 1983, EUR J CLIN MICROBIOL, V2, P389, DOI 10.1007/BF02019476; GOOSSENS H, 1986, J CLIN MICROBIOL, V24, P840, DOI 10.1128/JCM.24.5.840-843.1986; GOOSSENS H, 1989, J CLIN MICROBIOL, V27, P1077, DOI 10.1128/JCM.27.5.1077-1080.1989; GOOSSENS H, IN PRESS J CLIN MICR; KASPER G, 1985, LANCET, V1, P111; LASTOVICA AJ, 1989, J CLIN MICROBIOL, V27, P657, DOI 10.1128/JCM.27.4.657-659.1989; LIOR H, 1984, J CLIN MICROBIOL, V20, P636, DOI 10.1128/JCM.20.4.636-640.1984; MEGRAUD F, 1986, J INFECTION, V12, P275, DOI 10.1016/S0163-4453(86)94398-7; PATTON CM, 1989, J CLIN MICROBIOL, V27, P66, DOI 10.1128/JCM.27.1.66-73.1989; SANDSTEDT K, 1983, CURR MICROBIOL, V8, P209, DOI 10.1007/BF01579548; SANDSTEDT K, 1986, 14 INT C MICR MANCH, P37; STEELE TW, 1985, J CLIN MICROBIOL, V22, P71, DOI 10.1128/JCM.22.1.71-74.1985; STEELE TW, 1984, PATHOLOGY, V16, P263, DOI 10.3109/00313028409068535; TAYLOR DE, 1989, J CLIN MICROBIOL, V27, P2042, DOI 10.1128/JCM.27.9.2042-2045.1989; WALMSLEY SL, 1989, J CLIN MICROBIOL, V27, P688	18	81	81	0	5	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	MAR 10	1990	335	8689					584	586		10.1016/0140-6736(90)90359-D	http://dx.doi.org/10.1016/0140-6736(90)90359-D			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT653	1968583				2022-12-24	WOS:A1990CT65300013
J	YOST, CS; LOPEZ, CD; PRUSINER, SB; MYERS, RM; LINGAPPA, VR				YOST, CS; LOPEZ, CD; PRUSINER, SB; MYERS, RM; LINGAPPA, VR			NONHYDROPHOBIC EXTRACYTOPLASMIC DETERMINANT OF STOP TRANSFER IN THE PRION PROTEIN	NATURE			English	Article									UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT NEUROL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT BIOCHEM & BIOPHYS,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	YOST, CS (corresponding author), UNIV CALIF SAN FRANCISCO,DEPT ANESTHESIA,SAN FRANCISCO,CA 94143, USA.			Lingappa, Vishwanath R./0000-0003-0962-6571				ADAMS GA, 1985, CELL, V41, P1007, DOI 10.1016/S0092-8674(85)80081-7; BASLER K, 1986, CELL, V46, P417, DOI 10.1016/0092-8674(86)90662-8; BLOBEL G, 1980, P NATL ACAD SCI-BIOL, V77, P1496, DOI 10.1073/pnas.77.3.1496; BOEKE JD, 1982, P NATL ACAD SCI-BIOL, V79, P5200, DOI 10.1073/pnas.79.17.5200; CARLSON GA, 1986, CELL, V46, P503, DOI 10.1016/0092-8674(86)90875-5; CUTLER DF, 1986, J CELL BIOL, V102, P902, DOI 10.1083/jcb.102.3.902; DAVIS GL, 1987, J CELL BIOL, V105, P1191, DOI 10.1083/jcb.105.3.1191; DAVIS NG, 1985, CELL, V41, P607, DOI 10.1016/S0092-8674(85)80033-7; DOYLE C, 1986, J CELL BIOL, V103, P1193, DOI 10.1083/jcb.103.4.1193; EISENBERG D, 1984, ANNU REV BIOCHEM, V53, P595, DOI 10.1146/annurev.bi.53.070184.003115; GETHING MJ, 1982, NATURE, V300, P598, DOI 10.1038/300598a0; GILMORE R, 1985, CELL, V42, P497, DOI 10.1016/0092-8674(85)90107-2; HANSEN W, 1986, CELL, V45, P397, DOI 10.1016/0092-8674(86)90325-9; HAY B, 1987, BIOCHEMISTRY-US, V26, P8110, DOI 10.1021/bi00399a014; HAY B, 1987, MOL CELL BIOL, V7, P914, DOI 10.1128/MCB.7.2.914; HSIAO K, 1989, NATURE, V338, P342, DOI 10.1038/338342a0; LINGAPPA VR, 1989, J CLIN INVEST, V83, P739, DOI 10.1172/JCI113952; LINGAPPA VR, 1984, P NATL ACAD SCI-BIOL, V81, P456, DOI 10.1073/pnas.81.2.456; LIPP J, 1988, J CELL BIOL, V106, P1813, DOI 10.1083/jcb.106.6.1813; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MEYER RK, 1986, P NATL ACAD SCI USA, V83, P2310, DOI 10.1073/pnas.83.8.2310; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; PERARA E, 1985, J CELL BIOL, V101, P2292, DOI 10.1083/jcb.101.6.2292; PERARA E, 1989, PROTEIN TRANSFER ORG, P3; PRUSINER SB, 1987, NEW ENGL J MED, V317, P1571, DOI 10.1056/NEJM198712173172505; ROSE JK, 1982, CELL, V30, P753, DOI 10.1016/0092-8674(82)90280-X; ROTHMAN RE, 1988, J BIOL CHEM, V263, P10470; SIEGEL V, 1988, CELL, V52, P39, DOI 10.1016/0092-8674(88)90529-6; SIVASUBRAMANIAN N, 1987, P NATL ACAD SCI USA, V84, P1, DOI 10.1073/pnas.84.1.1; STAHL N, 1988, FASEB J, V2, pA989; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; SZCZESNASKORUPA E, 1988, P NATL ACAD SCI USA, V85, P738, DOI 10.1073/pnas.85.3.738; WESTAWAY D, 1987, CELL, V51, P651, DOI 10.1016/0092-8674(87)90134-6; WIDEMANN M, 1987, NATURE, V328, P830; YOST CS, 1983, CELL, V34, P759; ZERIAL M, 1987, CELL, V48, P147, DOI 10.1016/0092-8674(87)90365-5	36	116	118	0	4	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	FEB 15	1990	343	6259					669	672		10.1038/343669a0	http://dx.doi.org/10.1038/343669a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CN989	1968226				2022-12-24	WOS:A1990CN98900073
J	MELLINS, E; SMITH, L; ARP, B; COTNER, T; CELIS, E; PIOUS, D				MELLINS, E; SMITH, L; ARP, B; COTNER, T; CELIS, E; PIOUS, D			DEFECTIVE PROCESSING AND PRESENTATION OF EXOGENOUS ANTIGENS IN MUTANTS WITH NORMAL HLA CLASS-II GENES	NATURE			English	Article									UNIV WASHINGTON,DEPT GENET,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT IMMUNOL,SEATTLE,WA 98195; T CELL SCI,CAMBRIDGE,MA 02139	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	MELLINS, E (corresponding author), UNIV WASHINGTON,DEPT PEDIAT,SEATTLE,WA 98195, USA.							BABBITT BP, 1985, NATURE, V317, P359, DOI 10.1038/317359a0; BILLING RJ, 1976, J IMMUNOL, V117, P1589; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; BUUS S, 1988, SCIENCE, V242, P1045, DOI 10.1126/science.3194755; CELLS E, 1988, J IMMUNOL, V140, P1808; CLARK EA, 1984, LEUCOCYTE TYPING; COTNER T, 1988, J BIOL CHEM, V264, P11107; CRESSWELL P, 1977, EUR J IMMUNOL, V7, P636, DOI 10.1002/eji.1830070911; DEMOTZ S, 1989, J IMMUNOL, V142, P394; DORKEN B, IN PRESS LEUCOCYTE T, V4; GLADSTONE P, 1982, P NATL ACAD SCI-BIOL, V79, P1235, DOI 10.1073/pnas.79.4.1235; GLADSTONE P, 1978, NATURE, V271, P459, DOI 10.1038/271459a0; GLADSTONE P, 1980, SOMAT CELL GENET, V6, P285, DOI 10.1007/BF01538802; GUY K, 1982, EUR J IMMUNOL, V12, P942, DOI 10.1002/eji.1830121109; JOHNSON JP, 1982, J EXP MED, V156, P104, DOI 10.1084/jem.156.1.104; JONES PP, 1979, MOL IMMUNOL, V16, P51, DOI 10.1016/0161-5890(79)90027-0; KONING F, 1984, HUM IMMUNOL, V9, P221, DOI 10.1016/0198-8859(84)90027-2; LANE R, 1986, METHOD ENZYMOL, V121, P174; LANZAVECCHIA A, 1985, NATURE, V314, P537, DOI 10.1038/314537a0; LEVINE F, 1985, P NATL ACAD SCI USA, V82, P3741, DOI 10.1073/pnas.82.11.3741; MELLINS E, 1988, J EXP MED, V168, P1531, DOI 10.1084/jem.168.5.1531; MELLINS E, 1987, HUM IMMUNOL, V18, P211, DOI 10.1016/0198-8859(87)90086-3; MILLER AD, 1986, MOL CELL BIOL, V6, P2895, DOI 10.1128/MCB.6.8.2895; NOWELL J, 1985, J EXP MED, V162, P1371, DOI 10.1084/jem.162.4.1371; PIOUS D, 1985, J EXP MED, V162, P1193, DOI 10.1084/jem.162.4.1193; PIOUS D, 1983, BANBURY REP COLD SPR, V14, P61; SACHS JA, 1986, TISSUE ANTIGENS, V28, P199; SAITO T, 1987, NATURE, V325, P125, DOI 10.1038/325125a0; SHIMONKEVITZ R, 1983, J EXP MED, V158, P303, DOI 10.1084/jem.158.2.303; WATSON AJ, 1983, NATURE, V304, P358, DOI 10.1038/304358a0; ZIEGLER HK, 1982, P NATL ACAD SCI-BIOL, V79, P175, DOI 10.1073/pnas.79.1.175; ZIEGLER K, 1981, P NATL ACAD SCI USA, V79, P1869	32	251	253	0	6	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JAN 4	1990	343	6253					71	74		10.1038/343071a0	http://dx.doi.org/10.1038/343071a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG614	1967485				2022-12-24	WOS:A1990CG61400057
J	VAITKEVICIUS, PV; ESSERWEIN, DM; MAYNARD, AK; OCONNOR, FC; FLEG, JL				VAITKEVICIUS, PV; ESSERWEIN, DM; MAYNARD, AK; OCONNOR, FC; FLEG, JL			FREQUENCY AND IMPORTANCE OF POSTPRANDIAL BLOOD-PRESSURE REDUCTION IN ELDERLY NURSING-HOME PATIENTS	ANNALS OF INTERNAL MEDICINE			English	Article						FRAIL ELDERLY; NURSING HOMES; HYPOTENSION; POSTPRANDIAL PERIOD; SYNCOPE	ORTHOSTATIC HYPOTENSION; HEMODYNAMIC-CHANGES; RESPONSES; INGESTION	Objective: To determine the frequency and importance of postprandial reductions in systolic blood pressure in debilitated, elderly patients receiving nursing home care. Design: Cohort study. Setting: Community-based, university-affiliated, teaching nursing home. Patients: A total of 113 volunteer nursing-home residents with a mean (+/- SD) age of 78 +/- 9 years; seven residents who refused the test meal served as controls. Intervention: Participants had sequential blood pressure measurements for 90 minutes after the administration of a standardized meal. Measurements and Main Results: Of 113 patients, 109 (96%) showed a postprandial reduction in systolic blood pressure (mean reduction, 17.9 +/- 15.5 mm Hg) within 75 minutes; 41 patients (36%) had a reduction in systolic blood pressure of more than 20 mm Hg. Twelve patients (11%) had a reduction in systolic blood pressure to less than 100 mm Hg (mean systolic blood pressure, 88 +/- 6.4 mm Hg); two of these patients became acutely symptomatic. Multiple regression analysis showed that higher premeal systolic blood pressure, a history of syncope, treatment with vasodilators, and dependent posture of the lower extremities during the postprandial period were all associated with a more severe postprandial decline in systolic blood pressure. Systolic blood pressure in noneating control subjects did not change during the same observation period. No significant differences in the mean systolic blood pressure nadir were found between the 14 patients who died during the follow-up period (mean follow-up, 6.1 +/- 3.8 months) and those who survived. Conclusion: Postprandial reductions in systolic blood pressure among elderly nursing-home patients are common, often large, and potentially symptomatic, but they do not generally presage subsequent intermediate-term mortality.	NIA, FRANCIS SCOTT KEY MED CTR, GERONTOL RES CTR, CARDIOVASC SCI LAB, BALTIMORE, MD 21224 USA; JOHNS HOPKINS UNIV, SCH MED, DIV GERIATR MED, BALTIMORE, MD 21205 USA; FRANCIS SCOTT KEY MED CTR, BALTIMORE, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Johns Hopkins University					NIA NIH HHS [5T32AG00120-03] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [T32AG000120] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		FAGAN TC, 1986, AM J CARDIOL, V58, P636, DOI 10.1016/0002-9149(86)90291-2; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Heberden W., 1772, MED T COLL PHYSICIAN, V2, P59; JANSEN RWMM, 1987, AM J CARDIOL, V60, P1087, DOI 10.1016/0002-9149(87)90358-4; JONSSON PV, 1990, ARCH INTERN MED, V150, P1518, DOI 10.1001/archinte.150.7.1518; KANNEL WB, 1985, HDB BIOL AGING, P859; KELBAEK H, 1989, ARCH INTERN MED, V149, P363, DOI 10.1001/archinte.149.2.363; KELBAEK H, 1987, J APPL PHYSIOL, V63, P1862, DOI 10.1152/jappl.1987.63.5.1862; LAKATTA EG, 1987, CIRCULATION, V75, P69; LIPSITZ LA, 1986, J AM GERIATR SOC, V34, P267, DOI 10.1111/j.1532-5415.1986.tb04222.x; LIPSITZ LA, 1983, NEW ENGL J MED, V309, P81, DOI 10.1056/NEJM198307143090205; LIPSITZ LA, 1986, J CHRON DIS, V39, P619, DOI 10.1016/0021-9681(86)90187-6; LIPSITZ LA, 1989, NEW ENGL J MED, V321, P952; LIU K, 1983, GERONTOLOGIST, V23, P92, DOI 10.1093/geront/23.1.92; LIU K, 1984, GERONTOLOGIST, V24, P70, DOI 10.1093/geront/24.1.70; MICIELI G, 1987, NEUROLOGY, V37, P386, DOI 10.1212/WNL.37.3.386; PEITZMAN SJ, 1989, ARCH INTERN MED, V149, P286, DOI 10.1001/archinte.149.2.286; ROBERTSON D, 1981, AM J CARDIOL, V48, P1048, DOI 10.1016/0002-9149(81)90319-2; ROBINSON BJ, 1985, AGE AGEING, V14, P168, DOI 10.1093/ageing/14.3.168; SHERMAN RA, 1988, AM J KIDNEY DIS, V12, P37, DOI 10.1016/S0272-6386(88)80069-6	20	90	90	1	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 1	1991	115	11					865	870		10.7326/0003-4819-115-11-865	http://dx.doi.org/10.7326/0003-4819-115-11-865			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR171	1952473				2022-12-24	WOS:A1991GR17100005
J	HART, MJ; EVA, A; EVANS, T; AARONSON, SA; CERIONE, RA				HART, MJ; EVA, A; EVANS, T; AARONSON, SA; CERIONE, RA			CATALYSIS OF GUANINE-NUCLEOTIDE EXCHANGE ON THE CDC42HS PROTEIN BY THE DBL ONCOGENE PRODUCT	NATURE			English	Article							GTP-BINDING PROTEINS; SACCHAROMYCES-CEREVISIAE; MOLECULAR-CLONING; CELL POLARITY; HUMAN HOMOLOG; GENE; PURIFICATION; CYCLE; G25K; IDENTIFICATION	THE superfamily of low molecular mass GTP-binding proteins, for which the ras proteins are prototypes, has been implicated in the regulation of diverse biological activities including protein trafficking, secretion, and cell growth and differentiation 1-3. One member of this family, CDC42Hs (originally referred to as Gp or G25K) 4-5, seems to be the human homologue of the Saccharomyces cerevisiae cell-division-cycle protein, CDC42Sc (refs 6-9). A second S. cerevisiae protein, CDC24 (ref. 10), which is known from complementation studies to act with CDC42Sc to regulate the development of normal cell shape and the selection of nonrandom budding sites in yeast, contains a region with sequence similarity to the dbl oncogene product 11-14. Here we show that dbl specifically catalyses the dissociation of GDP from CDC42Hs and thereby qualifies as a highly selective guanine nucleotide exchange factor for the GTP-binding protein. Although guanine nucleotide exchange activities have been previously described for other members of the Ras-related GTP-binding protein family 15-17, this is the first demonstration, to our knowledge, of the involvement of a human oncogenic protein in catalysing exchange activity.	CORNELL UNIV,DEPT PHARMACOL,ITHACA,NY 14853; NCI,CELLULAR & MOLEC BIOL LAB,BETHESDA,MD 20892; GENENTECH INC,DEPT CELL BIOL,S SAN FRANCISCO,CA 94080	Cornell University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Roche Holding; Genentech	HART, MJ (corresponding author), CORNELL UNIV,DEPT BIOCHEM CELLULAR & MOLEC BIOL,ITHACA,NY 14853, USA.		Eva, Alessandra/J-8268-2016	Eva, Alessandra/0000-0003-2949-078X; Hart, Matthew/0000-0002-2683-480X				ADAMS AEM, 1990, J CELL BIOL, V111, P131, DOI 10.1083/jcb.111.1.131; BOURNE HR, 1990, NATURE, V348, P125, DOI 10.1038/348125a0; EVA A, 1985, NATURE, V316, P273, DOI 10.1038/316273a0; EVA A, 1988, P NATL ACAD SCI USA, V85, P2061, DOI 10.1073/pnas.85.7.2061; EVANS T, 1986, J BIOL CHEM, V261, P7052; Evans T, 1991, CURR OPIN CELL BIOL, V3, P185, DOI 10.1016/0955-0674(91)90137-N; GRAZIANI G, 1989, ONCOGENE, V4, P823; GRAZIANI G, IN PRESS ONCOGENE; HALL A, 1990, SCIENCE, V249, P635, DOI 10.1126/science.2116664; HART MJ, 1990, J BIOL CHEM, V265, P5990; HART MJ, IN PRESS J BIOL CHEM; HUANG YK, 1990, P NATL ACAD SCI USA, V87, P8008, DOI 10.1073/pnas.87.20.8008; JOHNSON DI, 1990, J CELL BIOL, V111, P143, DOI 10.1083/jcb.111.1.143; MUNEMITSU S, 1990, MOL CELL BIOL, V10, P5977, DOI 10.1128/MCB.10.11.5977; POLAKIS PG, 1989, BIOCHEM BIOPH RES CO, V160, P25, DOI 10.1016/0006-291X(89)91615-X; POLAKIS PG, 1989, J BIOL CHEM, V264, P16378; RON D, 1988, EMBO J, V7, P2465, DOI 10.1002/j.1460-2075.1988.tb03093.x; RON D, 1991, NEW BIOL, V3, P372; SHINJO K, 1990, P NATL ACAD SCI USA, V87, P9853, DOI 10.1073/pnas.87.24.9853; SLOAT BF, 1981, J CELL BIOL, V89, P395, DOI 10.1083/jcb.89.3.395; WOLFMAN A, 1990, SCIENCE, V248, P67, DOI 10.1126/science.2181667; YAMAMOTO T, 1990, J BIOL CHEM, V265, P16626	22	389	400	0	5	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 28	1991	354	6351					311	314		10.1038/354311a0	http://dx.doi.org/10.1038/354311a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT204	1956381				2022-12-24	WOS:A1991GT20400049
J	WHITLEY, R; ARVIN, A; PROBER, C; COREY, L; BURCHETT, S; PLOTKIN, S; STARR, S; JACOBS, R; POWELL, D; NAHMIAS, A; SUMAYA, C; EDWARDS, K; ALFORD, C; CADDELL, G; SOONG, SJ				WHITLEY, R; ARVIN, A; PROBER, C; COREY, L; BURCHETT, S; PLOTKIN, S; STARR, S; JACOBS, R; POWELL, D; NAHMIAS, A; SUMAYA, C; EDWARDS, K; ALFORD, C; CADDELL, G; SOONG, SJ			PREDICTORS OF MORBIDITY AND MORTALITY IN NEONATES WITH HERPES-SIMPLEX VIRUS-INFECTIONS	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RECURRENT GENITAL HERPES; VIDARABINE THERAPY; ENCEPHALITIS; HISTORY; MOTHERS	Background. In a controlled trial comparing acyclovir with vidarabine in the treatment of neonatal herpes simplex virus (HSV) infection, we found no significant difference between the treatments in adjusted mortality and morbidity. Hence, we sought to define for the entire cohort (n = 202) the clinical characteristics that best predicted the eventual outcome in these neonates. Methods. Data were gathered prospectively at 27 centers between 1981 and 1988 in infants less than one months of age who had virologically confirmed HSV infection. We examined the outcomes by multivariate analyses of 24 variables. Disease was classified in one of three categories based on the extent of the involvement at entry into the trial: infection confined to skin, eyes, or mouth; encephalitis; or disseminated infection. Results and Conclusions. There were no deaths among the 85 infants with localized HSV infection. The mortality rate was significantly higher in the 46 neonates with disseminated infection (57 percent) than in the 71 with encephalitis (15 percent). In addition, the risk of death was increased in neonates who were in or near coma at entry (relative risk, 5.2), had disseminated intravascular coagulopathy (relative risk, 3.8), or were premature (relative risk, 3.7). In babies with disseminated disease, HSV pneumonitis was also associated with greater mortality (relative risk, 3.6). In the survivors, morbidity was most frequent in infants with encephalitis (relative risk, 4.4), disseminated infection (relative risk, 2.1), seizures (relative risk, 3.0), or infection with HSV type 2 (relative risk, 4.9). With HSV infection limited to the skin, eyes, or mouth, the presence of three or more recurrences of vesicles was associated with an increased risk of neurologic impairment as compared with two or fewer recurrences.	UNIV ALABAMA,DEPT MICROBIOL,BIRMINGHAM,AL 35294; UNIV ALABAMA,DEPT MED,BIRMINGHAM,AL 35294; UNIV ALABAMA,DEPT BIOSTAT,BIRMINGHAM,AL 35294; STANFORD UNIV,DEPT PEDIAT,STANFORD,CA 94305; UNIV WASHINGTON,DEPT MED,SEATTLE,WA 98195; JOSEPH STOKES JR RES INST,DEPT PEDIAT,PHILADELPHIA,PA; UNIV ARKANSAS,DEPT PEDIAT,LITTLE ROCK,AR 72204; OHIO STATE UNIV,DEPT PEDIAT,COLUMBUS,OH 43210; EMORY UNIV,DEPT PEDIAT,ATLANTA,GA 30322; UNIV TEXAS,DEPT PEDIAT,SAN ANTONIO,TX 78285; VANDERBILT UNIV,DEPT PEDIAT,NASHVILLE,TN 37240	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Stanford University; University of Washington; University of Washington Seattle; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Arkansas System; University of Arkansas Fayetteville; University of Arkansas Little Rock; University System of Ohio; Ohio State University; Emory University; University of Texas System; Vanderbilt University	WHITLEY, R (corresponding author), UNIV ALABAMA,DEPT PEDIAT,BIRMINGHAM,AL 35294, USA.		Corey, Lawrence/AAE-1796-2020	Corey, Lawrence/0000-0002-2179-2436	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [N01AI062554] Funding Source: NIH RePORTER; NCRR NIH HHS [RR-032] Funding Source: Medline; NIAID NIH HHS [N01-AI-62554] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		COREY L, 1988, LANCET, V1, P1; JOHNSON RE, 1989, NEW ENGL J MED, V321, P7, DOI 10.1056/NEJM198907063210102; KALBFLEISCH JD, 1980, STATISTICAL ANAL FAI; LEE FK, 1985, J CLIN MICROBIOL, V22, P641, DOI 10.1128/JCM.22.4.641-644.1985; PROBER CG, 1987, NEW ENGL J MED, V316, P240, DOI 10.1056/NEJM198701293160503; STONE KM, 1989, SEX TRANSM DIS, V16, P152, DOI 10.1097/00007435-198907000-00007; STRAUS SE, 1989, SEX TRANSM DIS, V16, P107; SULLIVANBOLYAI J, 1983, JAMA-J AM MED ASSOC, V250, P3059, DOI 10.1001/jama.250.22.3059; SULLIVANBOLYAI JZ, 1986, PEDIATR INFECT DIS J, V5, P309, DOI 10.1097/00006454-198605000-00007; WHITLEY R, 1991, NEW ENGL J MED, V324, P444, DOI 10.1056/NEJM199102143240703; WHITLEY RJ, 1980, PEDIATRICS, V66, P489; WHITLEY RJ, 1977, NEW ENGL J MED, V297, P289, DOI 10.1056/NEJM197708112970601; WHITLEY RJ, 1988, J INFECT DIS, V158, P109, DOI 10.1093/infdis/158.1.109; WHITLEY RJ, 1986, NEW ENGL J MED, V314, P144, DOI 10.1056/NEJM198601163140303; WHITLEY RJ, 1981, NEW ENGL J MED, V304, P313, DOI 10.1056/NEJM198102053040602; WHITLEY RJ, 1983, PEDIATRICS, V72, P778; WHITLEY RJ, 1980, PEDIATRICS, V66, P495; YEAGER AS, 1984, PEDIATRICS, V73, P188; [No title captured]; 1985, NEW VACCINE DEV ESTA, V1, P280	20	270	273	0	2	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 14	1991	324	7					450	454		10.1056/NEJM199102143240704	http://dx.doi.org/10.1056/NEJM199102143240704			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX363	1988830				2022-12-24	WOS:A1991EX36300004
J	OHOLLAREN, MT; YUNGINGER, JW; OFFORD, KP; SOMERS, MJ; OCONNELL, EJ; BALLARD, DJ; SACHS, MI				OHOLLAREN, MT; YUNGINGER, JW; OFFORD, KP; SOMERS, MJ; OCONNELL, EJ; BALLARD, DJ; SACHS, MI			EXPOSURE TO AN AEROALLERGEN AS A POSSIBLE PRECIPITATING FACTOR IN RESPIRATORY ARREST IN YOUNG-PATIENTS WITH ASTHMA	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NEW-ZEALAND; ALTERNARIA ALLERGENS; FATAL ASTHMA; ALT-I; MORTALITY; DEATHS; IMMUNOTHERAPY; PATHOGENESIS; INCREASES; RESPONSES	Background. Exposure to airborne spores of the common mold Alternaria alternata has been implicated in asthma attacks. Such exposure is particularly frequent in the Midwest during the summer and fall months. To determine the role of A. alternata in triggering severe asthma attacks, we investigated the cases of 11 patients with asthma who had sudden respiratory arrest and determined the frequency of sensitivity to this allergen in these patients. Methods. The 11 patients (age range, 11 to 25 years) with initial episodes of respiratory arrest, which was fatal in 2 patients, were identified in the course of their care in our pediatric and adult clinical allergy practice and by a retrospective review of all Mayo Clinic records of patients with severe asthma cared for between 1980 and 1989. Skin-test reactivity to A. alternata and levels of IgE antibody against this mold in the 11 patients were compared with those in 99 matched controls with asthma who had no history of respiratory arrest. Results. All the patients came from the upper Mid-West, and the episodes of respiratory arrest occurred in the summer or early fall. Ten of the 11 patients with asthma who had respiratory arrest (91 percent) had positive skin-puncture tests for sensitivity to alternaria, as compared with 31 percent of the controls (P < 0.001), and the serum levels of IgE antibodies to alternaria were elevated in all 9 patients tested. Among the covariates we examined (age, sex, and distance from the Mayo Clinic), only age was a significant confounder. After adjustment for age, alternaria skin-test reactivity was found to be associated with an increase of approximately 200-fold in the risk of respiratory arrest (adjusted odd ratio, 189.5; 95 percent confidence interval, 6.5 to 5535.8). Conclusions. Exposure to the aeroallergen A. alternata is a risk factor for respiratory arrest in children and young adults with asthma.	MAYO CLIN & MAYO FDN,DIV ALLERG DIS & INTERNAL MED,200 1ST ST SW,ROCHESTER,MN 55905; MAYO CLIN & MAYO FDN,DEPT HLTH SCI RES,ROCHESTER,MN 55905; MAYO CLIN & MAYO FDN,GEN PEDIAT & PEDIAT ALLERGY & IMMUNOL SECT,ROCHESTER,MN 55905	Mayo Clinic; Mayo Clinic; Mayo Clinic			Ballard, David J/H-1062-2018					AGARWAL MK, 1983, J ALLERGY CLIN IMMUN, V72, P40, DOI 10.1016/0091-6749(83)90050-7; BENATAR SR, 1986, NEW ENGL J MED, V314, P423, DOI 10.1056/NEJM198602133140706; BURNEY PGJ, 1986, LANCET, V2, P323; BURNEY PGJ, 1987, J ALLERGY CLIN IMMUN, V80, P379, DOI 10.1016/0091-6749(87)90054-6; COCKCROFT DW, 1977, CLIN ALLERGY, V7, P503, DOI 10.1111/j.1365-2222.1977.tb01481.x; DRAZEN JM, 1987, J ALLERGY CLIN IMMUN, V80, P428, DOI 10.1016/0091-6749(87)90069-8; EVANS R, 1987, J ALLERGY CLIN IMMUN, V80, P377, DOI 10.1016/0091-6749(87)90053-4; HOGG JC, 1987, J ALLERGY CLIN IMMUN, V80, P417, DOI 10.1016/0091-6749(87)90065-0; JACKSON RT, 1982, BRIT MED J, V285, P771, DOI 10.1136/bmj.285.6344.771; KRAVIS LP, 1985, AM J DIS CHILD, V139, P558, DOI 10.1001/archpedi.1985.02140080028026; LICORISH K, 1985, J ALLERGY CLIN IMMUN, V76, P819, DOI 10.1016/0091-6749(85)90755-9; MARKHAM D, 1986, J ALLERGY CLIN IMMUN, V77, P161; METZGER WJ, 1983, J ALLERGY CLIN IMMUN, V71, P119, DOI 10.1016/0091-6749(83)90245-2; MILES RM, 1983, J ALLERGY CLIN IMMUN, V71, P36, DOI 10.1016/0091-6749(83)90544-4; NYHOLM L, 1983, J ALLERGY CLIN IMMUN, V71, P461, DOI 10.1016/0091-6749(83)90462-1; OBYRNE PM, 1987, AM REV RESPIR DIS, V136, P740, DOI 10.1164/ajrccm/136.3.740; OGDEN EC, 1967, J ALLERGY, V40, P1, DOI 10.1016/0021-8707(67)90053-6; PICCOLO MC, 1988, ANN ALLERGY, V60, P107; PLATTSMILLS TAE, 1982, LANCET, V2, P675; POLLART SM, 1989, J ALLERGY CLIN IMMUN, V83, P875, DOI 10.1016/0091-6749(89)90100-0; REA HH, 1986, THORAX, V41, P833, DOI 10.1136/thx.41.11.833; REID MJ, 1986, J ALLERGY CLIN IMMUN, V78, P590, DOI 10.1016/0091-6749(86)90076-X; Richerson H B, 1986, Iowa Med, V76, P212; RICHERSON HB, 1986, ASTHMA CLIN PHARM TH, P23; RUBINSTEIN S, 1984, ANN ALLERGY, V53, P311; SALVAGGI.J, 1970, J ALLERGY, V45, P257, DOI 10.1016/0021-8707(70)90032-8; SEARS MR, 1987, J ALLERGY CLIN IMMUN, V80, P477, DOI 10.1016/0091-6749(87)90079-0; SEARS MR, 1988, J ALLERGY CLIN IMMUN, V82, P957, DOI 10.1016/0091-6749(88)90130-3; SEARS MR, 1985, NEW ZEAL MED J, V98, P271; SEARS MR, 1987, J ALLERGY CLIN IMMUN, V80, P383, DOI 10.1016/0091-6749(87)90055-8; SIEGEL SC, 1987, J ALLERGY CLIN IMMUN, V80, P458, DOI 10.1016/0091-6749(87)90075-3; SLY RM, 1984, ANN ALLERGY, V53, P20; SLY RM, 1986, ANN ALLERGY, V56, P207; SLY RM, 1988, J ALLERGY CLIN IMMUN, V82, P705, DOI 10.1016/0091-6749(88)90069-3; SOLOMON WR, 1988, ALLERGY PRINCIPLES P, V1, P312; STRUNK RC, 1985, JAMA-J AM MED ASSOC, V254, P1193; STRUNK RC, 1989, J ALLERGY CLIN IMMUN, V83, P477, DOI 10.1016/0091-6749(89)90137-1; WEISS KB, 1990, JAMA-J AM MED ASSOC, V263, P2323; WOOLCOCK AJ, 1986, CHEST, V90, pS40, DOI 10.1378/chest.90.5_Supplement.40S; YAN K, 1983, THORAX, V38, P760, DOI 10.1136/thx.38.10.760; YUNGINGER JW, 1980, J ALLERGY CLIN IMMUN, V66, P138, DOI 10.1016/0091-6749(80)90061-5; CAUSES DEATH AUSTR 1; 1982, BMJ, V285, P1251	43	500	508	0	18	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 7	1991	324	6					359	363		10.1056/NEJM199102073240602	http://dx.doi.org/10.1056/NEJM199102073240602			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EW296	1987459				2022-12-24	WOS:A1991EW29600002
J	SPOOR, TC				SPOOR, TC			SUDDEN VISUAL-LOSS FOLLOWING CATARACT REMOVAL	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter											SPOOR, TC (corresponding author), WAYNE STATE UNIV,SCH MED,KRESGE EYE INST,DETROIT,MI 48201, USA.								0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	1991	265	5					650	651						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EV718	1987420				2022-12-24	WOS:A1991EV71800028
J	WAGNER, DD; SAFFARIPOUR, S; BONFANTI, R; SADLER, JE; CRAMER, EM; CHAPMAN, B; MAYADAS, TN				WAGNER, DD; SAFFARIPOUR, S; BONFANTI, R; SADLER, JE; CRAMER, EM; CHAPMAN, B; MAYADAS, TN			INDUCTION OF SPECIFIC STORAGE ORGANELLES BY VON-WILLEBRAND FACTOR PROPOLYPEPTIDE	CELL			English	Article							HUMAN-ENDOTHELIAL CELLS; VONWILLEBRAND ANTIGEN-II; WEIBEL-PALADE BODIES; VIII-RELATED ANTIGEN; GRANULE MEMBRANE-PROTEIN; INTRACELLULAR-LOCALIZATION; PLASMINOGEN-ACTIVATOR; FUNCTIONAL DOMAINS; MULTIMER FORMATION; SECRETION	Endothelial cells store the multimeric adhesive glycoprotein von Willebrand factor (vWf), which promotes the formation of a platelet plug at the site of vessel injury. To investigate the packaging of vWf into the granules called Weibel-Palade bodies, we expresed pro-vWf cDNA and cDNA lacking the prosequence in a variety of cell lines. Storage granules formed only in cells that contain a regulated pathway of secretion. Furthermore, packaging required the prosequence. Pro-vWf, lacking the C-terminal region involved in interchain disulfide bonding, formed granules. We conclude that the signal for storage is universal in that an adhesive glycoprotein can be stored by a hormone-secreting cell; the storage of vWf is independent of its covalent multimeric structure; the unusual rod shape of Weibel-Palade bodies is due to vWf; and the vWf propolypeptide is necessary for the formation of vWf storage granules.	TUFTS UNIV, DEPT MED, BOSTON, MA 02111 USA; TUFTS UNIV, DEPT ANAT, BOSTON, MA 02111 USA; TUFTS UNIV, DEPT CELLULAR BIOL, BOSTON, MA 02111 USA; WASHINGTON UNIV, SCH MED, HOWARD HUGHES MED INST, ST LOUIS, MO 63110 USA; HOP LARIBOISIERE, INST VAISSEAUX & SANG, F-75475 PARIS 10, FRANCE; HOP LARIBOISIERE, INSERM, U150, F-75475 PARIS 10, FRANCE; CHIRON CORP, EMERYVILLE, CA 94608 USA	Tufts University; Tufts University; Howard Hughes Medical Institute; Washington University (WUSTL); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Novartis	WAGNER, DD (corresponding author), NEW ENGLAND MED CTR HOSP, BOSTON, MA 02111 USA.		Sadler, Evan/D-8556-2011	Cramer Borde, Elisabeth/0000-0001-7595-0885; Sadler, J. Evan/0000-0001-5705-469X	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL041002] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL41002] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BONFANTI R, 1989, BLOOD, V73, P1109; BURGESS TL, 1987, ANNU REV CELL BIOL, V3, P243, DOI 10.1146/annurev.cellbio.3.1.243; BURKE RL, 1986, J BIOL CHEM, V261, P2574; CHUNG KN, 1989, SCIENCE, V243, P192, DOI 10.1126/science.2911732; CRAMER EM, 1985, BLOOD, V66, P710; EWENSTEIN BM, 1987, J CELL BIOL, V104, P1423, DOI 10.1083/jcb.104.5.1423; FAY PJ, 1986, SCIENCE, V232, P995, DOI 10.1126/science.3486471; FRETTO LJ, 1986, J BIOL CHEM, V261, P5679; FUMAGALLI G, 1985, J CELL BIOL, V100, P2019, DOI 10.1083/jcb.100.6.2019; GIDDINGS JC, 1982, BRIT J HAEMATOL, V52, P79, DOI 10.1111/j.1365-2141.1982.tb03863.x; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; HAIGWOOD NL, 1989, PROTEIN ENG, V2, P611, DOI 10.1093/protein/2.8.611; HAMBURGER SA, 1990, BLOOD, V75, P550; HAMILTON KK, 1987, J CLIN INVEST, V79, P600, DOI 10.1172/JCI112853; HANSS M, 1987, J LAB CLIN MED, V109, P97; HATTORI R, 1989, J BIOL CHEM, V264, P9053; HORMIA M, 1984, EUR J CELL BIOL, V33, P217; IKAUFMAN RJ, 1989, MOL CELL BIOL, V9, P1233; JAFFE EA, 1973, J CLIN INVEST, V52, P2757, DOI 10.1172/JCI107471; KELLY RB, 1985, SCIENCE, V230, P25, DOI 10.1126/science.2994224; KEMMLER W, 1973, J BIOL CHEM, V248, P4544; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LARSEN E, 1989, CELL, V59, P305, DOI 10.1016/0092-8674(89)90292-4; LEVINE JD, 1982, BLOOD, V60, P531; LOESBERG C, 1983, BIOCHIM BIOPHYS ACTA, V763, P160, DOI 10.1016/0167-4889(83)90039-3; LYNCH DC, 1983, P NATL ACAD SCI-BIOL, V80, P2738, DOI 10.1073/pnas.80.9.2738; MARTI T, 1987, BIOCHEMISTRY-US, V26, P8099, DOI 10.1021/bi00399a013; MATSUDA H, 1970, INVEST OPHTH VISUAL, V9, P919; MAYADAS TN, 1989, J BIOL CHEM, V264, P13497; MCCARROLL DR, 1985, J CLIN INVEST, V75, P1089, DOI 10.1172/JCI111802; MCEVER RP, 1989, J CLIN INVEST, V84, P92, DOI 10.1172/JCI114175; NACHMAN R, 1977, J CLIN INVEST, V60, P914, DOI 10.1172/JCI108846; POWELL SK, 1988, J CELL BIOL, V106, P1843, DOI 10.1083/jcb.106.6.1843; REINDERS JH, 1985, BIOCHIM BIOPHYS ACTA, V844, P306, DOI 10.1016/0167-4889(85)90131-4; REINDERS JH, 1988, HAEMOSTASIS, V18, P246; RIBES JA, 1987, J CLIN INVEST, V79, P117, DOI 10.1172/JCI112771; RUGGERI ZM, 1980, J CLIN INVEST, V65, P1318, DOI 10.1172/JCI109795; RUGGERI ZM, 1987, BLOOD, V70, P895; SADLER JE, 1985, P NATL ACAD SCI USA, V82, P6394, DOI 10.1073/pnas.82.19.6394; SENGEL A, 1970, J CELL BIOL, V44, P223, DOI 10.1083/jcb.44.1.223; SEVARINO KA, 1987, J BIOL CHEM, V262, P4987; SEVARINO KA, 1989, CELL, V57, P11, DOI 10.1016/0092-8674(89)90167-0; SHELTONINLOES BB, 1987, BIOCHEM BIOPH RES CO, V144, P657, DOI 10.1016/S0006-291X(87)80016-5; SOSSIN WS, 1990, J CELL BIOL, V110, P1, DOI 10.1083/jcb.110.1.1; SPORN LA, 1986, CELL, V46, P185, DOI 10.1016/0092-8674(86)90735-X; STEINER DF, 1974, FED PROC, V33, P2105; STOLLER TJ, 1989, J CELL BIOL, V108, P1647, DOI 10.1083/jcb.108.5.1647; Tarentino A L, 1978, Methods Enzymol, V50, P574; TOOZE J, 1986, J CELL BIOL, V103, P839, DOI 10.1083/jcb.103.3.839; VERWEIJ CL, 1987, EMBO J, V6, P2885, DOI 10.1002/j.1460-2075.1987.tb02591.x; VERWEIJ CL, 1988, J BIOL CHEM, V263, P7921; VOORBERG J, 1990, EMBO J, V9, P797, DOI 10.1002/j.1460-2075.1990.tb08176.x; WAGNER DD, 1987, P NATL ACAD SCI USA, V84, P1955, DOI 10.1073/pnas.84.7.1955; WAGNER DD, 1986, J CELL BIOL, V102, P1320, DOI 10.1083/jcb.102.4.1320; WAGNER DD, 1987, BLOOD, V69, P27; WAGNER DD, 1982, J CELL BIOL, V95, P355, DOI 10.1083/jcb.95.1.355; WAGNER DD, 1984, J CELL BIOL, V99, P2123, DOI 10.1083/jcb.99.6.2123; WAGNER DD, 1990, ANNU REV CELL BIOL, V6, P217, DOI 10.1146/annurev.cellbio.6.1.217; WAGNER DD, 1983, J BIOL CHEM, V258, P2065; WAGNER DD, 1989, COAGULATION BLEEDING, P161; WEIBEL ER, 1964, J CELL BIOL, V23, P101, DOI 10.1083/jcb.23.1.101; WENCELDRAKE JD, 1984, AM J PATHOL, V115, P156; WHITE JG, 1968, BLOOD, V32, P148, DOI 10.1182/blood.V32.1.148.148; WIGLER M, 1978, CELL, V14, P725, DOI 10.1016/0092-8674(78)90254-4; WISE RJ, 1988, CELL, V52, P229, DOI 10.1016/0092-8674(88)90511-9; ZIMMERMAN TS, 1983, PROG HEMATOL, V13, P279; ZOLLER MJ, 1983, METHOD ENZYMOL, V100, P468	67	233	237	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	1991	64	2					403	413		10.1016/0092-8674(91)90648-I	http://dx.doi.org/10.1016/0092-8674(91)90648-I			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EV336	1988154				2022-12-24	WOS:A1991EV33600016
J	TUOMANEN, E; LINDQUIST, S; SANDE, S; GALLENI, M; LIGHT, K; GAGE, D; NORMARK, S				TUOMANEN, E; LINDQUIST, S; SANDE, S; GALLENI, M; LIGHT, K; GAGE, D; NORMARK, S			COORDINATE REGULATION OF BETA-LACTAMASE INDUCTION AND PEPTIDOGLYCAN COMPOSITION BY THE AMP OPERON	SCIENCE			English	Article							PENICILLIN-BINDING PROTEINS; ESCHERICHIA-COLI; MUREIN; DELETION; GENE	The amp operon, which is located on the Escherichia coli chromosome, modulates the induction of plasmid-borne beta-lactamase genes by extracellular beta-lactam antibiotics. This suggests that the gene products AmpD and AmpE may function in the transduction of external signals. Beta-Lactam antibiotics are analogs of cell wall components that can be released during cell wall morphogenesis of enterobacteria. The amp operon was studied to determine its importance in signal transduction during cell wall morphogenesis. The peptidoglycan compositions of amp mutants were determined by high-performance liquid chromotography and fast atom bombardment mass spectrometry. When a chromosomal or plasmid-borne copy of ampD was present, the amount of pentapeptide-containing muropeptides in the cell wall increased upon addition of the cell wall constituent diaminopimelic acid to the growth medium. These results suggest that beta-lactamase induction and modulation of the composition of the cell wall share elements of a regulatory circuit that involves AmpD. Escherichia coli requires AmpD to respond to extracellular signaling amino acids, such as diaminopimelic acid, and this signal transduction system may regulate peptidoglycan composition in response to cell wall turnover products.	UMEA UNIV,DEPT MICROBIOL,S-90187 UMEA,SWEDEN; WASHINGTON UNIV,DEPT MOLEC MICROBIOL,ST LOUIS,MO 63110; MICHIGAN STATE UNIV,NIH,MASS SPECT FACIL,DEPT BIOCHEM,E LANSING,MI 48824	Umea University; Washington University (WUSTL); Michigan State University; National Institutes of Health (NIH) - USA	TUOMANEN, E (corresponding author), ROCKEFELLER UNIV,MICROBIOL LAB,NEW YORK,NY 10021, USA.		Tuomanen, Elaine I/N-3081-2018	Tuomanen, Elaine I/0000-0003-0349-8716	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI023459, R01AI027913] Funding Source: NIH RePORTER; NCRR NIH HHS [DRR00480] Funding Source: Medline; NIAID NIH HHS [AI23459, AI27913] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		BROOMESMITH JK, 1982, J BACTERIOL, V152, P904; CHANG ACY, 1978, J BACTERIOL, V134, P1141, DOI 10.1128/JB.134.3.1141-1156.1978; GALLENI M, 1990, 90TH ANN M AM SOC MI, P187; GALLENI M, UNPUB; GLAUNER B, 1988, ANAL BIOCHEM, V172, P451, DOI 10.1016/0003-2697(88)90468-X; GOODELL EW, 1983, J BACTERIOL, V156, P136, DOI 10.1128/JB.156.1.136-140.1983; LANGLEY D, 1977, J GEN MICROBIOL, V99, P263, DOI 10.1099/00221287-99-2-263; LINDBERG F, 1987, J BACTERIOL, V169, P1923, DOI 10.1128/jb.169.5.1923-1928.1987; LINDBERG F, 1985, P NATL ACAD SCI USA, V82, P4620, DOI 10.1073/pnas.82.14.4620; LINDQUIST S, 1989, MOL MICROBIOL, V3, P1091, DOI 10.1111/j.1365-2958.1989.tb00259.x; MARKIEWICZ Z, 1985, ACTA MICROBIOL POL, V34, P121; METT H, 1980, J BACTERIOL, V144, P45, DOI 10.1128/JB.144.1.45-52.1980; SPRATT BG, 1977, EUR J BIOCHEM, V72, P341, DOI 10.1111/j.1432-1033.1977.tb11258.x; TIPPER D, 1956, P NATL ACAD SCI USA, V54, P1133; TOMASZ A, 1975, P NATL ACAD SCI USA, V72, P4162, DOI 10.1073/pnas.72.10.4162; TUOMANEN E, 1987, J BACTERIOL, V169, P5308, DOI 10.1128/jb.169.11.5308-5310.1987; TUOMANEN E, 1989, J BIOL CHEM, V264, P11093	17	41	49	1	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JAN 11	1991	251	4990					201	204		10.1126/science.1987637	http://dx.doi.org/10.1126/science.1987637			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET173	1987637				2022-12-24	WOS:A1991ET17300042
J	SMALL, DM; OLIVA, C; TERCYAK, A				SMALL, DM; OLIVA, C; TERCYAK, A			CHEMISTRY IN THE KITCHEN - MAKING GROUND MEAT MORE HEALTHFUL	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY	Background. The National Cholesterol Education Program recommends a diet containing less than 30 percent of calories in the form of fat, less than 10 percent in the form of saturated fat, and less than 300 mg of cholesterol per day. Since American's diets generally exceed these recommendations, we wished to find an easy kitchen method to reduce substantially saturated fat and cholesterol in ground meat. Methods. Raw ground meat was hated in vegetable oil and rinsed with boiling water to extract fat and cholesterol. The fat-free broth was recombined with the meat to restore flavor. The amounts of total fat, saturated fat, and cholesterol in the meat after extraction were compared with the amounts in meat cooked as patties and in stir-fried, rinsed meat. Results. When raw ground beef containing 9.6 to 20.8 percent fat was cooked as patties and the fat poured off, 6 to 17 percent of the fat and 1.3 to 4.3 percent of the cholesterol were lost. In stir-fried, rinsed ground beef, 23 to 59 percent of the fat and 9.0 to 18.8 percent of the cholesterol were lost. When vegetable oil was use to extract fat and cholesterol from beef containing 20.7 percent fat, a mean (+/- SD) of 67.7 +/- 1.6 percent of the fat and 39.2 +/- 5.1 percent of the cholesterol were lost. The differences between conventionally cooked meat and meat prepared by the extraction of fat were significant (P < 0.001). An average of 43 percent (range, 38 to 49) of cholesterol was extracted from a wide variety of ground meats. Although conventional cooking produced no change in fatty-acid composition as compared with raw meat, our extraction process greatly increased the ratio of unsaturated to saturated fat, from 1.32 in conventionally cooked meat to 2.92 to 4.56 in meat after extraction. Extraction resulted in the loss of 72 to 87 percent of saturated fat. Conclusions. This method produces a tasty meat product that is much lower in saturated fat and cholesterol than conventionally cooked meat, and that can be used in sauces, soups, and solid meat products.			SMALL, DM (corresponding author), BOSTON UNIV, SCH MED, HOUSMAN MED RES CTR, DEPT BIOPHYS, 80 E CONCORD ST, BOSTON, MA 02118 USA.			Small, Donald/0000-0002-3072-243X				BARTLETT GR, 1959, J BIOL CHEM, V234, P466; BLANKENHORN DH, 1987, JAMA-J AM MED ASSOC, V257, P3233, DOI 10.1001/jama.257.23.3233; DOWNING DT, 1968, J CHROMATOGR, V38, P91, DOI 10.1016/0021-9673(68)85011-3; FOLCH J, 1957, J BIOL CHEM, V226, P497; FRICK MH, 1987, NEW ENGL J MED, V317, P1237, DOI 10.1056/NEJM198711123172001; GURR MI, 1989, FATS FUTURE, P41; KATZ S S, 1976, Journal of Clinical Investigation, V58, P200; Keys A., 1980, SCIENCE, DOI DOI 10.1126/SCIENCE.208.4448.1138; MORRISON WR, 1964, J LIPID RES, V5, P600; RIFKIND BM, 1984, JAMA-J AM MED ASSOC, V251, P351; SMALL DM, 1979, NEW ENGL J MED, V300, P801, DOI 10.1056/NEJM197904053001421; SMALL DM, 1986, HDB LIPID RES, V64; 1980, 17 SUP CHROM SUPPL C, P25; 1988, ARCH INTERN MED, V48, P36	14	16	16	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 10	1991	324	2					73	77		10.1056/NEJM199101103240201	http://dx.doi.org/10.1056/NEJM199101103240201			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EQ977	1984186				2022-12-24	WOS:A1991EQ97700001
J	HANSOTIA, P; BROSTE, SK				HANSOTIA, P; BROSTE, SK			THE EFFECT OF EPILEPSY OR DIABETES-MELLITUS ON THE RISK OF AUTOMOBILE ACCIDENTS	NEW ENGLAND JOURNAL OF MEDICINE			English	Article								Background. Previous studies of possible associations between chronic medical conditions and traffic safety have been inconsistent and subject to bias because of the incomplete identification of affected persons. Recent advances in the diagnosis and management of epilepsy and diabetes mellitus have improved the control of these disorders and suggest a need to reexamine the risk of traffic mishaps among patients with these conditions. Methods. We conducted a population-based retrospective cohort study of 30,420 subjects 16 to 90 years of age, with and without epilepsy or diabetes mellitus. Subjects included all the licensed drivers in seven contiguous ZIP Code areas in which the Marshfield Clinic and St. Joseph's Hospital, Marshfield, Wisconsin, are the primary sources of medical care. Standardized rates of moving violations and accidents over a four-year period (1985 through 1988) were compared in affected and unaffected cohorts. Results. Standardized mishap ratios for subjects with diabetes were 1.14 for all moving violations (P = 0.23) and 1.32 for accidents (P = 0.01); for subjects with epilepsy the ratios were 1.13 for moving violations (P = 0.26) and 1.33 for accidents (P = 0.04). Conclusions. We conclude that drivers with epilepsy or diabetes mellitus have slightly increased risks of traffic accidents as compared with unaffected persons. The increases in risk observed in our study were generally smaller than those in previous studies, and we believe they are not great enough to warrant further restrictions on driving privileges.	MARSHFIELD MED RES FDN, DEPT EPIDEMIOL & BIOSTAT, MARSHFIELD, WI USA		HANSOTIA, P (corresponding author), MARSHFIELD CLIN FDN MED RES & EDUC, DEPT NEUROL, 1000 N OAK AVE, MARSHFIELD, WI 54449 USA.							Checkoway H., 1989, RES METHODS OCCUPATI; CRANCER A, 1968, J AMER MED ASSOC, V205, P272, DOI 10.1001/jama.1968.03140310030006; DCCT Res Grp, 1987, DIABETES CARE, V10, P1; GASTAUT H, 1987, NEUROLOGY, V37, P1613, DOI 10.1212/WNL.37.10.1613; HORMIA A, 1961, ACTA PSYCHIATR SCA S, V150, P210; KLEINBAUM DG, 1987, APPLIED REGRESSION A; ROTHMAN KJ, 1979, NIH791649 DEP HLTH P; SONGER TJ, 1988, DIABETES CARE, V11, P701, DOI 10.2337/diacare.11.9.701; Waller J.A, 1973, MED IMPAIRMENT DRIVI; WALLER JA, 1965, NEW ENGL J MED, V273, P1413, DOI 10.1056/NEJM196512232732605; YSANDER L, 1966, BRIT J IND MED, V23, P28; 1985, DHHS PHS861232 NAT C; 1980, DHHS PHS801260 DEP H	13	200	202	1	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 3	1991	324	1					22	26		10.1056/NEJM199101033240105	http://dx.doi.org/10.1056/NEJM199101033240105			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EQ503	1984160	Bronze			2022-12-24	WOS:A1991EQ50300005
J	RAUB, W				RAUB, W			NEW REPORT ON HYPERTENSION IN PREGNANCY PUBLISHED	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material											RAUB, W (corresponding author), NIH, BLDG 31, ROOM 2B23, BETHESDA, MD 20892 USA.							1990, AM J OBSTET GYNECOL, V63, P1689	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	1991	265	1					19	19						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP555	1984118				2022-12-24	WOS:A1991EP55500009
J	ROBERTS, RG; BENTLEY, DR; BARBY, TFM; MANNERS, E; BOBROW, M				ROBERTS, RG; BENTLEY, DR; BARBY, TFM; MANNERS, E; BOBROW, M			DIRECT DIAGNOSIS OF CARRIERS OF DUCHENNE AND BECKER MUSCULAR-DYSTROPHY BY AMPLIFICATION OF LYMPHOCYTE RNA	LANCET			English	Article							PRENATAL-DIAGNOSIS; DNA AMPLIFICATION; DMD CDNA; DELETION; GENE; PROBES	Rapid detection of deletion and duplication mutations that cause Duchenne and Becker muscular dystrophy was achieved in patients and carriers after amplification of small amounts of mRNA from peripheral blood lymphocytes. The entire coding region of the dystrophin mRNA was amplified in 10 sections by reverse transcription and nested polymerase chain reaction, and the products were directly visualised on acrylamide minigels with ethidium staining. Major structural gene mutations were identified by the appearance of a band of different size to that of the wild type. The altered band was readily detected in all patients and heterozygous relatives. This non-radioactive test of venous blood samples can be used for unambiguous and rapid identification of virtually all carriers of deletions or insertions within the dystrophin gene.			ROBERTS, RG (corresponding author), UNITED MED & DENT SCH GUYS & ST THOMAS HOSP, GUYS HOSP, DIV MED & MOLEC GENET, PAEDIAT RES UNIT, LONDON SE1 9RT, ENGLAND.		Roberts, Roland G/C-3596-2009	Roberts, Roland/0000-0001-6636-1579				BAKKER E, 1987, NATURE, V329, P554, DOI 10.1038/329554a0; CHAMBERLAIN JS, 1988, NUCLEIC ACIDS RES, V16, P11141, DOI 10.1093/nar/16.23.11141; CHELLY J, 1988, NATURE, V333, P858, DOI 10.1038/333858a0; CHEN JD, 1988, AM J HUM GENET, V42, P777; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DENDUNNEN JT, 1989, AM J HUM GENET, V45, P835; GILLARD EF, 1989, AM J HUM GENET, V45, P507; GREENPM, 1989, EMBO J, V8, P1067; HODGSON S, 1989, J MED GENET, V26, P682, DOI 10.1136/jmg.26.11.682; HODGSON SV, 1989, BRIT MED BULL, V45, P719, DOI 10.1093/oxfordjournals.bmb.a072354; HOLDING C, 1989, LANCET, V2, P532; KAARIAINEN H, 1990, CLIN GENET, V37, P179; KOENIG M, 1989, AM J HUM GENET, V45, P498; KOENIG M, 1988, CELL, V53, P219, DOI 10.1016/0092-8674(88)90383-2; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; MAO YP, 1989, HUM GENET, V81, P193, DOI 10.1007/BF00293903; Monaco AP, 1988, GENOMICS, V2, P90, DOI 10.1016/0888-7543(88)90113-9; NORMAN AM, 1990, J MED GENET, V27, P236, DOI 10.1136/jmg.27.4.236; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SIBERT JR, 1979, ARCH DIS CHILD, V54, P534, DOI 10.1136/adc.54.7.534; SPEER A, 1989, J MED GENET, V26, P1, DOI 10.1136/jmg.26.1.1; VOGELSTEIN B, 1987, CANCER RES, V47, P4806; ZATZ M, 1977, LANCET, V1, P759	23	83	101	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 22	1990	336	8730					1523	1526		10.1016/0140-6736(90)93305-9	http://dx.doi.org/10.1016/0140-6736(90)93305-9			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP037	1979364				2022-12-24	WOS:A1990EP03700002
J	CHIN, J				CHIN, J			CURRENT AND FUTURE DIMENSIONS OF THE HIV AIDS PANDEMIC IN WOMEN AND CHILDREN	LANCET			English	Article											CHIN, J (corresponding author), WHO,GLOBAL PROGRAMME AIDS,CH-1211 GENEVA 27,SWITZERLAND.							CHIN J, 1988, AIDS, V2, pS247, DOI 10.1097/00002030-198800001-00038; CHIN J, 1989, B WORLD HEALTH ORGAN, V67, P1; CHIN J, 1989, MATERNAL CHILD CARE; MANN JM, 1988, SCI AM, V259, P82, DOI 10.1038/scientificamerican1088-82; MOSS AR, 1989, AIDS, V3, P55, DOI 10.1097/00002030-198902000-00001; SATO PA, 1989, AIDS, V3, pS301, DOI 10.1097/00002030-198901001-00043; 1989, LANCET, V1, P941	7	232	236	0	6	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JUL 28	1990	336	8709					221	224		10.1016/0140-6736(90)91743-T	http://dx.doi.org/10.1016/0140-6736(90)91743-T			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ701	1973779				2022-12-24	WOS:A1990DQ70100012
J	PAGE, DC; FISHER, EMC; MCGILLIVRAY, B; BROWN, LG				PAGE, DC; FISHER, EMC; MCGILLIVRAY, B; BROWN, LG			ADDITIONAL DELETION IN SEX-DETERMINING REGION OF HUMAN Y-CHROMOSOME RESOLVES PARADOX OF X,T(Y-22) FEMALE	NATURE			English	Article									MIT,CAMBRIDGE,MA 02139; UNIV BRITISH COLUMBIA,CLIN GENET UNIT,VANCOUVER V6H 3N1,BC,CANADA	Massachusetts Institute of Technology (MIT); University of British Columbia	PAGE, DC (corresponding author), WHITEHEAD INST BIOMED RES,9 CAMBRIDGE CTR,CAMBRIDGE,MA 02142, USA.		Fisher, Elizabeth MC/C-2168-2008	Fisher, Elizabeth MC/0000-0003-2850-9936				BROWN WRA, 1988, EMBO J, V7, P2377, DOI 10.1002/j.1460-2075.1988.tb03082.x; BURGOYNE PS, 1989, NATURE, V342, P860, DOI 10.1038/342860a0; COOKE HJ, 1985, NATURE, V317, P687, DOI 10.1038/317687a0; DELACHAPELLE A, 1981, HUM GENET, V58, P105, DOI 10.1007/BF00284157; DELACHAPELLE A, 1984, ASPECTS HUMAN GENETI, P125; ELLIS NA, 1989, NATURE, V337, P81, DOI 10.1038/337081a0; FERGUSON-SMITH M A, 1965, J Med Genet, V2, P142, DOI 10.1136/jmg.2.2.142; FISHER EMC, 1990, GENOMICS, V7, P625, DOI 10.1016/0888-7543(90)90209-D; FORD CE, 1959, LANCET, V1, P711; GOODFELLOW PJ, 1986, SCIENCE, V234, P740, DOI 10.1126/science.2877492; JACOBS PA, 1959, NATURE, V183, P302, DOI 10.1038/183302a0; LEVILLIERS J, 1989, P NATL ACAD SCI USA, V86, P2296, DOI 10.1073/pnas.86.7.2296; LITT M, 1985, P NATL ACAD SCI USA, V82, P6206, DOI 10.1073/pnas.82.18.6206; PAGE D C, 1987, Genomics, V1, P243, DOI 10.1016/0888-7543(87)90051-6; PAGE DC, 1987, CELL, V51, P1091, DOI 10.1016/0092-8674(87)90595-2; PAGE DC, 1987, NATURE, V328, P437, DOI 10.1038/328437a0; PALMER MS, 1989, NATURE, V342, P937, DOI 10.1038/342937a0; PETIT C, 1988, EMBO J, V7, P2369, DOI 10.1002/j.1460-2075.1988.tb03081.x; ROUYER F, 1986, NATURE, V319, P291, DOI 10.1038/319291a0; SCHNEIDERGADICKE A, 1989, CELL, V57, P1247, DOI 10.1016/0092-8674(89)90061-5; SIMMLER MC, 1985, NATURE, V317, P692, DOI 10.1038/317692a0; Turner HH, 1938, ENDOCRINOLOGY, V23, P566, DOI 10.1210/endo-23-5-566	22	79	81	0	3	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUL 19	1990	346	6281					279	287		10.1038/346279a0	http://dx.doi.org/10.1038/346279a0			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DP456	1973823				2022-12-24	WOS:A1990DP45600069
J	GOUGH, NM; GEARING, DP; NICOLA, NA; BAKER, E; PRITCHARD, M; CALLEN, DF; SUTHERLAND, GR				GOUGH, NM; GEARING, DP; NICOLA, NA; BAKER, E; PRITCHARD, M; CALLEN, DF; SUTHERLAND, GR			LOCALIZATION OF THE HUMAN GM-CSF RECEPTOR GENE TO THE X-Y PSEUDOAUTOSOMAL REGION	NATURE			English	Editorial Material									ADELAIDE CHILDRENS HOSP INC,DEPT CYTOGENET & MOLEC GENET,ADELAIDE,SA 5006,AUSTRALIA		GOUGH, NM (corresponding author), ROYAL MELBOURNE HOSP,WALTER & ELIZA HALL INST MED RES,PO ROYAL MELBOURNE HOSP,PARKVILLE,VIC 3050,AUSTRALIA.		Sutherland, Grant Robert/D-2606-2012; Callen, David F/G-1975-2012; Nicola, Nicos/D-2989-2011	Nicola, Nicos/0000-0003-1054-7889; Callen, David/0000-0002-6189-9991				BEGLEY CG, 1987, LEUKEMIA, V1, P1; BROWN WRA, 1988, EMBO J, V7, P2377, DOI 10.1002/j.1460-2075.1988.tb03082.x; BUDEL LM, 1989, BLOOD, V74, P565; BURGOYNE PS, 1982, HUM GENET, V61, P85, DOI 10.1007/BF00274192; CALLEN D F, 1988, Genomics, V2, P144, DOI 10.1016/0888-7543(88)90096-1; CALLEN DF, 1986, ANN GENET-PARIS, V29, P235; CALLEN DF, 1989, GENOMICS, V4, P348, DOI 10.1016/0888-7543(89)90341-8; COOKE HJ, 1985, NATURE, V317, P687, DOI 10.1038/317687a0; CROW TJ, 1988, LANCET, V153, P675; DARLING SM, 1986, COLD SPRING HARB SYM, V51, P205, DOI 10.1101/SQB.1986.051.01.025; ELLIS N, 1989, TRENDS GENET, V5, P406, DOI 10.1016/0168-9525(89)90199-6; FERGUSON-SMITH M A, 1969, Birth Defects Original Article Series, V5, P3; FERGUSON-SMITH M A, 1965, J Med Genet, V2, P142, DOI 10.1136/jmg.2.2.142; GEARING DP, 1989, EMBO J, V8, P3667, DOI 10.1002/j.1460-2075.1989.tb08541.x; GELIN C, 1989, EMBO J, V8, P3253, DOI 10.1002/j.1460-2075.1989.tb08485.x; GOODFELLOW PJ, 1986, SCIENCE, V234, P740, DOI 10.1126/science.2877492; GOODFELLOW PJ, 1987, ANN HUM GENET, V51, P161, DOI 10.1111/j.1469-1809.1987.tb01058.x; GOUGH NM, 1989, COLONY STIMULATING F, P111; Haldane JBS, 1936, ANN EUGENIC, V7, P28, DOI 10.1111/j.1469-1809.1936.tb02127.x; Koller PC, 1934, J GENET, V29, P159, DOI 10.1007/BF02982193; MITELMAN F, 1988, CATALOG CHROMOSOME A; NUSSBAUM RL, 1983, HUM GENET, V64, P148, DOI 10.1007/BF00327113; ONETTOPOTHIER N, 1990, BLOOD, V75, P59; PETIT C, 1988, EMBO J, V7, P2369, DOI 10.1002/j.1460-2075.1988.tb03081.x; PONDER B, 1988, NATURE, V335, P400, DOI 10.1038/335400a0; PRITCHARD CA, 1987, NATURE, V328, P273, DOI 10.1038/328273a0; ROUYER F, 1986, COLD SPRING HARB SYM, V51, P221, DOI 10.1101/SQB.1986.051.01.027; ROUYER F, 1986, NATURE, V319, P291, DOI 10.1038/319291a0; SIMMLER MC, 1985, NATURE, V317, P692, DOI 10.1038/317692a0; SUTHERLAND GR, 1988, AM J HUM GENET, V43, P331; SUTHERLAND GR, 1989, CYTOGENET CELL GENET, V50, P149, DOI 10.1159/000132746; SUTHERS GK, 1989, SCIENCE, V246, P1298, DOI 10.1126/science.2573953; VELLENGA E, 1987, EXP HEMATOL, V15, P652; VELLENGA E, 1987, BLOOD, V69, P1771; 1989, NIGMS NIH892011 HUM	35	117	120	0	2	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUN 21	1990	345	6277					734	736		10.1038/345734a0	http://dx.doi.org/10.1038/345734a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK399	1972780				2022-12-24	WOS:A1990DK39900073
J	CLARKE, A				CLARKE, A			GENETICS, ETHICS, AND AUDIT	LANCET			English	Editorial Material											CLARKE, A (corresponding author), INST MED GENET WALES,CARDIFF CF4 4XW,WALES.							CHAPPLE JC, 1987, LANCET, V1, P1189; MODELL B, 1989, CLIN GENET, V36, P286; 1989, PRENATAL DIAGNOSIS G	3	40	40	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	MAY 12	1990	335	8698					1145	1147		10.1016/0140-6736(90)91139-2	http://dx.doi.org/10.1016/0140-6736(90)91139-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DC929	1971875				2022-12-24	WOS:A1990DC92900015
J	SUTER, B; STEWARD, R				SUTER, B; STEWARD, R			REQUIREMENT FOR PHOSPHORYLATION AND LOCALIZATION OF THE BICAUDAL-D PROTEIN IN DROSOPHILA OOCYTE DIFFERENTIATION	CELL			English	Article							GENE; MELANOGASTER; OOGENESIS; EMBRYOS; SEGMENTATION; POLYMERASE; POLARITY; SEQUENCE; ELEGANS; REGION	In the Drosophila female the product of the germline stem cell, the cystoblast, gives rise to 16 interconnected cystocytes. One of them differentiates into the oocyte, while the 15 others become polyploid nurse cells. Bk-D is required for the differentiation of an oocyte and hence for fertility. Recessive mutations in Bic-D block the oocyte-specific accumulation of its own and other RNAs. Based on its properties and distribution, the Bic-D protein appears to be a component of a cytoskeletal transport or anchoring system. Additional results suggest that the phosphorylation of the Bic-D protein is essential for its accumulation in the pro-oocyte and that this process leads to the gradual localization to the pro-oocyte of factors required for oocyte differentiation.			SUTER, B (corresponding author), PRINCETON UNIV,DEPT MOLEC BIOL,MOFFETT LAB A13,PRINCETON,NJ 08544, USA.							BOPP D, 1991, GENE DEV, V5, P403, DOI 10.1101/gad.5.3.403; BROWN EH, 1964, GROWTH, V28, P41; CARPENTER ATC, 1975, CHROMOSOMA, V1, P157; DAVIDSON EH, 1990, DEVELOPMENT, V108, P365; EPHRUSSI A, 1991, CELL, V66, P37, DOI 10.1016/0092-8674(91)90137-N; GUTZEIT HO, 1982, J EMBRYOL EXP MORPH, V67, P101; HAENLIN M, 1987, EMBO J, V6, P801, DOI 10.1002/j.1460-2075.1987.tb04822.x; HIGUCHI RG, 1989, NUCLEIC ACIDS RES, V17, P5865, DOI 10.1093/nar/17.14.5865; JACKSON SP, 1990, CELL, V63, P155, DOI 10.1016/0092-8674(90)90296-Q; KIMHA J, 1991, CELL, V66, P23, DOI 10.1016/0092-8674(91)90136-M; King R. C., 1970, OVARIAN DEV DROSOPHI; KOCH EA, 1967, J MORPHOL, V121, P55, DOI 10.1002/jmor.1051210106; KOCH EA, 1966, J MORPHOL, V119, P283, DOI 10.1002/jmor.1051190303; KOCH EA, 1983, CELL TISSUE RES, V228, P21; KOCH EA, 1969, Z ZELLFORSCH MIK ANA, V102, P129, DOI 10.1007/BF00336421; LEHMANN R, 1986, CELL, V47, P141, DOI 10.1016/0092-8674(86)90375-2; Mahowald A.P., 1980, Genetics and Biology of Drosophila, V2d, P141; MAHOWALD AP, 1980, J CELL BIOL, V45, P306; MCKEARIN DM, 1990, GENE DEV, V4, P2242, DOI 10.1101/gad.4.12b.2242; MEYER GF, 1961, Z ZELLFORSCH MIK ANA, V54, P238, DOI 10.1007/BF00338705; MOHLER J, 1986, GENETICS, V112, P803; SCHRIEFER LA, 1989, J MOL BIOL, V207, P451, DOI 10.1016/0022-2836(89)90267-2; SCHUPBACH T, 1991, IN PRESS GENETICS; SEYDOUX G, 1989, CELL, V57, P1237, DOI 10.1016/0092-8674(89)90060-3; SPRADLING A, 1992, IN PRESS DROSOPHILA; STEINHAUER WR, 1989, MOL CELL BIOL, V9, P5726, DOI 10.1128/MCB.9.12.5726; STEWARD R, 1986, GENETICS, V113, P665; Steward R., 1987, UCLA (University of California Los Angeles) Symposia on Molecular and Cellular Biology New Series, V51, P39; STORTO PD, 1989, DEV GENET, V10, P70, DOI 10.1002/dvg.1020100203; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; SUTER B, 1989, GENE DEV, V3, P1957, DOI 10.1101/gad.3.12a.1957; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; Telfer W. H., 1975, Advances Insect Physiol, V11, P223, DOI 10.1016/S0065-2806(08)60164-2; WHARTON RP, 1989, CELL, V59, P881, DOI 10.1016/0092-8674(89)90611-9; WIESCHAUS E, 1979, DEV BIOL, V68, P29, DOI 10.1016/0012-1606(79)90241-0; YISRAELI JK, 1990, DEVELOPMENT, V108, P289; ZOLLER MJ, 1984, DNA-J MOLEC CELL BIO, V3, P479, DOI 10.1089/dna.1.1984.3.479	37	207	207	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	NOV 29	1991	67	5					917	926		10.1016/0092-8674(91)90365-6	http://dx.doi.org/10.1016/0092-8674(91)90365-6			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GT755	1959135				2022-12-24	WOS:A1991GT75500011
J	CHOWRIRA, BM; BERZALHERRANZ, A; BURKE, JM				CHOWRIRA, BM; BERZALHERRANZ, A; BURKE, JM			NOVEL GUANOSINE REQUIREMENT FOR CATALYSIS BY THE HAIRPIN RIBOZYME	NATURE			English	Article							TOBACCO RINGSPOT VIRUS; T7 RNA-POLYMERASE; SATELLITE RNA; SEQUENCE; CLEAVAGE	THERE is much interest in the development of 'designer ribozymes' to target destruction of RNAs in vitro and in vivo 1. Engineering of ribozymes with novel specificities requires detailed knowledge of the ribozyme-substrate interaction, and a rigorous evaluation of sequence specificity. The hairpin ribozyme catalyses an efficient and reversible site-specific cleavage reaction 2-4. We have used mutagenesis and in vitro selection strategies to show that RNA cleavage and ligation has an absolute requirement for guanosine immediately 3' to the cleavage-ligation site. This G is not required for efficient substrate binding, rather, its 2-amino group is an essential component of the active site required for catalysis.	UNIV VERMONT, MARKEY CTR MOLEC GENET, DEPT MICROBIOL & MOLEC GENET, BURLINGTON, VT 05405 USA	University of Vermont			, John/AAB-5945-2021; Berzal-Herranz, Alfredo/K-8614-2014	Berzal-Herranz, Alfredo/0000-0003-3722-7973				BURKARD U, 1988, J BIOL CHEM, V263, P2447; CARTER BJ, 1990, J BIOL CHEM, V265, P7100; CECH TR, 1990, ANNU REV BIOCHEM, V59, P543, DOI 10.1146/annurev.bi.59.070190.002551; CECH TR, 1988, JAMA-J AM MED ASSOC, V260, P3030; CHOWRIRA BM, 1991, BIOCHEMISTRY-US, V30, P8518, DOI 10.1021/bi00099a003; DOUDNA JA, 1990, J ORG CHEM, V55, P5547, DOI 10.1021/jo00308a003; FEDOR MJ, 1990, P NATL ACAD SCI USA, V87, P1668, DOI 10.1073/pnas.87.5.1668; FELDSTEIN PA, 1989, GENE, V82, P53, DOI 10.1016/0378-1119(89)90029-2; GREEN CJ, 1988, J BIOL CHEM, V263, P652; HAMPEL A, 1990, NUCLEIC ACIDS RES, V18, P299, DOI 10.1093/nar/18.2.299; HAMPEL A, 1989, BIOCHEMISTRY-US, V28, P4929, DOI 10.1021/bi00438a002; HASELOFF J, 1989, GENE, V82, P43, DOI 10.1016/0378-1119(89)90028-0; KOIZUMI M, 1991, BIOCHEMISTRY-US, V30, P5145, DOI 10.1021/bi00235a005; MILLIGAN JF, 1989, METHOD ENZYMOL, V180, P51; PYLE AM, 1990, P NATL ACAD SCI USA, V87, P8187, DOI 10.1073/pnas.87.21.8187; RUBINO L, 1990, J GEN VIROL, V71, P1897, DOI 10.1099/0022-1317-71-9-1897; RUFFNER DE, 1990, BIOCHEMISTRY-US, V29, P10695, DOI 10.1021/bi00499a018; VANTOL H, 1990, NUCLEIC ACIDS RES, V18, P1971, DOI 10.1093/nar/18.8.1971	18	143	163	1	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 28	1991	354	6351					320	322		10.1038/354320a0	http://dx.doi.org/10.1038/354320a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT204	1956383				2022-12-24	WOS:A1991GT20400052
J	BROWN, CJ; BALLABIO, A; RUPERT, JL; LAFRENIERE, RG; GROMPE, M; TONLORENZI, R; WILLARD, HF				BROWN, CJ; BALLABIO, A; RUPERT, JL; LAFRENIERE, RG; GROMPE, M; TONLORENZI, R; WILLARD, HF			A GENE FROM THE REGION OF THE HUMAN X-INACTIVATION CENTER IS EXPRESSED EXCLUSIVELY FROM THE INACTIVE X-CHROMOSOME	NATURE			English	Article							CONTROLLING ELEMENTS; LINKED GENE; MOUSE; DNA; LOCUS; HYPOTHESIS; DELETIONS; MUTATIONS; CELLS; CDNA	X-chromosome inactivation results in the cis-limited dosage compensation of genes on one of the pair of X chromosomes in mammalian females. Although most X-linked genes are believed to be subject to inactivation, several are known to be expressed from both active and inactive X chromosomes. Here we describe an X-linked gene with a novel expression pattern-transcript are detected only from the inactive X chromosome (X(i)) and not from the active X chromosome (X(a)). This gene, called XIST (for X(i)-specific transcripts), is a candidate for a gene either involved in or uniquely influenced by the process of X inactivation.	STANFORD UNIV,MED CTR,SCH MED,DEPT GENET,STANFORD,CA 94305; BAYLOR UNIV,INST MOLEC GENET,HOUSTON,TX 77030	Stanford University; Baylor College of Medicine; Baylor University			BALLABIO, Andrea/AAL-2672-2020; Tonlorenzi, Rossana/AAN-2241-2020; Brown, Carolyn J/A-5159-2014	BALLABIO, Andrea/0000-0003-1381-4604; Brown, Carolyn J/0000-0002-8959-0101; Tonlorenzi, Rossana/0000-0002-6060-8208; Grompe, Markus/0000-0002-6616-4345				BALLABIO A, 1987, P NATL ACAD SCI USA, V84, P4519, DOI 10.1073/pnas.84.13.4519; BROWN CJ, 1991, NATURE, V349, P82, DOI 10.1038/349082a0; BROWN CJ, 1989, AM J HUM GENET, V45, P592; BROWN CJ, 1989, J HUM GENET, V45, pA178; BROWN SW, 1973, P NATL ACAD SCI USA, V70, P195, DOI 10.1073/pnas.70.1.195; BROWNCJ, 1990, NUCLEIC ACIDS RES, V18, P4191; BRWN CJ, 1990, J HUM GENET, V46, P273; CATTANACH BM, 1975, ANNU REV GENET, V9, P1, DOI 10.1146/annurev.ge.09.120175.000245; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DAVIDSON RG, 1963, P NATL ACAD SCI USA, V50, P481, DOI 10.1073/pnas.50.3.481; FICKETT JW, 1982, NUCLEIC ACIDS RES, V10, P5303, DOI 10.1093/nar/10.17.5303; FISHER EMC, 1990, CELL, V63, P1205, DOI 10.1016/0092-8674(90)90416-C; FLEJTER WL, 1984, AM J HUM GENET, V36, P218; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GARTLER SM, 1983, ANNU REV GENET, V17, P155, DOI 10.1146/annurev.ge.17.120183.001103; GIBBS RA, 1989, P NATL ACAD SCI USA, V86, P1919, DOI 10.1073/pnas.86.6.1919; GOODFELLOW P, 1984, AM J HUM GENET, V36, P777; GRAVES JAM, 1986, SOMAT CELL MOLEC GEN, V12, P275, DOI 10.1007/BF01570786; GROMPE M, 1989, P NATL ACAD SCI USA, V86, P5888, DOI 10.1073/pnas.86.15.5888; JOHNSTON PG, 1981, GENET RES, V37, P151, DOI 10.1017/S0016672300020127; KEER JT, 1990, GENOMICS, V7, P566, DOI 10.1016/0888-7543(90)90200-E; KORNELUK RG, 1985, GENE, V40, P317, DOI 10.1016/0378-1119(85)90055-1; LYON MF, 1972, BIOL REV, V47, P1; LYON MF, 1961, NATURE, V190, P372, DOI 10.1038/190372a0; LYON MF, 1986, J EMBRYOL EXP MORPH, V97, P75; MATTEI MG, 1981, HUM GENET, V56, P401, DOI 10.1007/BF00274702; MEYER WJ, 1975, P NATL ACAD SCI USA, V72, P1469, DOI 10.1073/pnas.72.4.1469; MIGEON BR, 1979, CELL, V18, P637, DOI 10.1016/0092-8674(79)90118-1; MIGEON BR, 1968, SCIENCE, V160, P425, DOI 10.1126/science.160.3826.425; NADON N, 1988, SOMAT CELL MOLEC GEN, V14, P541, DOI 10.1007/BF01535309; RASTAN S, 1982, GENET RES, V40, P139, DOI 10.1017/S0016672300019017; RASTAN S, 1983, J EMBRYOL EXP MORPH, V78, P1; RASTAN S, 1985, J EMBRYOL EXP MORPH, V90, P379; RIGGS AD, 1990, AUST J ZOOL, V37, P419, DOI 10.1071/ZO9890419; RUSSELL LB, 1963, SCIENCE, V140, P976, DOI 10.1126/science.140.3570.976; SCHNEIDERGADICKE A, 1989, CELL, V57, P1247, DOI 10.1016/0092-8674(89)90061-5; SHAPIRO LJ, 1979, SCIENCE, V204, P1224, DOI 10.1126/science.156396; SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155; Summitt R L, 1978, Birth Defects Orig Artic Ser, V14, P219; THERMAN E, 1974, CHROMOSOMA, V44, P361; WILLARD HF, 1980, SOMAT CELL GENET, V6, P187, DOI 10.1007/BF01538795	41	1227	1274	4	96	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JAN 3	1991	349	6304					38	44		10.1038/349038a0	http://dx.doi.org/10.1038/349038a0			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EQ601	1985261				2022-12-24	WOS:A1991EQ60100042
J	MILLS, JL; KLEBANOFF, MA; GRAUBARD, BI; CAREY, JC; BERENDES, HW				MILLS, JL; KLEBANOFF, MA; GRAUBARD, BI; CAREY, JC; BERENDES, HW			BARRIER CONTRACEPTIVE METHODS AND PREECLAMPSIA	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PRE-ECLAMPSIA	Recent investigations have suggested that women who use barrier methods of contraception may be at increased risk for preeclampsia. We used data from two prospective pregnancy studies to examine the relationship between contraceptive use before conception and preeclampsia. The preeclampsia rates among women using barrier contraceptives were not significantly higher than the rates in women using nonbarrier contraceptives or the rates in women using no contraceptives in either study. The odds ratios for preeclampsia in barrier contraceptive users in the two studies were 0.89 (95% confidence interval [Cl], 0.71 to 1.12) and 0.85 (95% Cl, 0.49 to 1.45) compared with nonbarrier contraceptive users and 0.91 (95% Cl, 0.71 to 1.16) and 0.81 (95% Cl, 0.48 to 1.35) compared with women using no contraceptives. After adjusting for other risk factors, we found no association between preeclampsia and barrier contraceptive use. Additional studies are needed to resolve this issues; however, we would recommend that women not be advised to avoid barrier contraceptives unless more data linking their use to preeclampsia appear.	NCI,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	MILLS, JL (corresponding author), NICHHD,PREVENT RES PROGRAM,EPN BLDG,ROOM 640,BETHESDA,MD 20892, USA.			Mills, James/0000-0003-4496-332X				ARMITAGE P, 1955, BIOMETRICS, V11, P375, DOI 10.2307/3001775; BEER AE, 1978, SEMIN PERINATOL, V2, P39; CHESLEY LC, 1984, CLIN OBSTET GYNECOL, V27, P801, DOI 10.1097/00003081-198412000-00004; Feeney JG, 1980, P 1 C INT SOC STUD H, P41; KONOFFCOHEN HS, 1989, JAMA-J AM MED ASSOC, V262, P3143; MARTI JJ, 1977, AM J OBSTET GYNECOL, V128, P489, DOI 10.1016/0002-9378(77)90030-8; Mosher W. D., 1990, ADV DATA, V182, P1; SCOTT JR, 1976, AM J OBSTET GYNECOL, V125, P418, DOI 10.1016/0002-9378(76)90579-2; SERHAL PF, 1987, LANCET, V2, P744; WOOLF B, 1956, ANN HUM GENET, V20, P309; 1983, BMDP BIOMEDICAL CO P; 1985, SAS USERS GUIDE STAT	12	25	25	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	1991	265	1					70	73		10.1001/jama.265.1.70	http://dx.doi.org/10.1001/jama.265.1.70			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP555	1984127				2022-12-24	WOS:A1991EP55500030
J	RAUB, W				RAUB, W			GENETIC MUTATION IN FAMILIAL AORTIC-ANEURYSMS IDENTIFIED	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material											RAUB, W (corresponding author), NIH, BLDG 31, ROOM 2B23, BETHESDA, MD 20892 USA.							1990, J CLIN INVEST, V86, P1465	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	1991	265	1					19	19						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP555	1984118				2022-12-24	WOS:A1991EP55500006
J	DEVERSON, EV; GOW, IR; COADWELL, WJ; MONACO, JJ; BUTCHER, GW; HOWARD, JC				DEVERSON, EV; GOW, IR; COADWELL, WJ; MONACO, JJ; BUTCHER, GW; HOWARD, JC			MHC CLASS-II REGION ENCODING PROTEINS RELATED TO THE MULTIDRUG RESISTANCE FAMILY OF TRANSMEMBRANE TRANSPORTERS	NATURE			English	Article									VIRGINIA COMMONWEALTH UNIV,DEPT MICROBIOL & IMMUNOL,RICHMOND,VA 23298	Virginia Commonwealth University	DEVERSON, EV (corresponding author), INST ANIM PHYSIOL & GENET,DEPT IMMUNOL,CAMBRIDGE RES STN,BABRAHAM HALL,BABRAHAM,CAMBRIDGE CB2 4AT,ENGLAND.			Howard, Jonathan/0000-0003-2756-5143				AMES GFL, 1986, ANNU REV BIOCHEM, V55, P397, DOI 10.1146/annurev.biochem.55.1.397; BLIGHT MA, 1990, MOL MICROBIOL, V4, P873, DOI 10.1111/j.1365-2958.1990.tb00660.x; BUTCHER GW, 1986, HDB EXPT IMMUNOLOGY; CARTER C, IN PRESS IMMUNOGENET; CERUNDOLO V, 1990, NATURE, V345, P449, DOI 10.1038/345449a0; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; DIAMOND AG, 1989, J IMMUNOL, V142, P3268; DOOLITTLE RF, 1986, NATURE, V323, P451, DOI 10.1038/323451a0; EISENBERG D, 1984, ANNU REV BIOCHEM, V53, P595, DOI 10.1146/annurev.bi.53.070184.003115; ENDICOTT JA, 1989, REV BIOCH, V58, P137; FELMLEE T, 1985, J BACTERIOL, V163, P94, DOI 10.1128/JB.163.1.94-105.1985; GERMAIN RN, 1986, NATURE, V322, P687, DOI 10.1038/322687a0; GLASER P, 1988, EMBO J, V7, P3997, DOI 10.1002/j.1460-2075.1988.tb03288.x; GROS P, 1986, CELL, V47, P371, DOI 10.1016/0092-8674(86)90594-5; HIGGINS CF, 1986, NATURE, V323, P448, DOI 10.1038/323448a0; HIGGINS CF, 1990, PHILOS T R SOC B, V326, P353, DOI 10.1098/rstb.1990.0017; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; HYDE SC, 1990, NATURE, V346, P362, DOI 10.1038/346362a0; JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x; KLEIN J, 1990, IMMUNOGENETICS, V32, P147, DOI 10.1007/BF02114967; LIVINGSTONE AM, 1989, J EXP MED, V170, P777, DOI 10.1084/jem.170.3.777; MCGRATH JP, 1989, NATURE, V340; MONACO JJ, IN PRESS SCIENCE; MOORE MW, 1988, CELL, V54, P777, DOI 10.1016/S0092-8674(88)91043-4; MORRISON LA, 1986, J EXP MED, V163, P903, DOI 10.1084/jem.163.4.903; MUESCH A, 1990, TRENDS BIOCHEM SCI, V15, P86, DOI 10.1016/0968-0004(90)90186-F; NICKERSON CL, 1990, J EXP MED, V172, P1255, DOI 10.1084/jem.172.4.1255; RADA C, 1990, P NATL ACAD SCI USA, V87, P2167, DOI 10.1073/pnas.87.6.2167; RIORDAN JR, 1989, SCIENCE, V245, P1066; SALTER RD, 1985, IMMUNOGENETICS, V21, P235, DOI 10.1007/BF00375376; STEINMETZ M, 1986, CELL, V44, P895, DOI 10.1016/0092-8674(86)90012-7; TOWNSEND A, 1989, NATURE, V340, P443, DOI 10.1038/340443a0; TOWNSEND A, 1989, REV IMMUNOL, V7, P601; TOWNSEND ARM, 1985, CELL, V42, P457, DOI 10.1016/0092-8674(85)90103-5; VANDERBLIEK AM, 1987, EMBO J, V6, P3325, DOI 10.1002/j.1460-2075.1987.tb02653.x; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; WANG R, IN PRESS J MOL BIOL; WATSON MEE, 1984, NUCLEIC ACIDS RES, V12, P5145, DOI 10.1093/nar/12.13.5145; WATTERS JWF, 1987, IMMUNOGENETICS, V26, P220, DOI 10.1007/BF00346516; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9	40	443	446	0	3	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	DEC 20	1990	348	6303					738	741		10.1038/348738a0	http://dx.doi.org/10.1038/348738a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EP049	1979660				2022-12-24	WOS:A1990EP04900062
J	HSIAO, KK; SCOTT, M; FOSTER, D; GROTH, DF; DEARMOND, SJ; PRUSINER, SB				HSIAO, KK; SCOTT, M; FOSTER, D; GROTH, DF; DEARMOND, SJ; PRUSINER, SB			SPONTANEOUS NEURODEGENERATION IN TRANSGENIC MICE WITH MUTANT PRION PROTEIN	SCIENCE			English	Article									UNIV CALIF SAN FRANCISCO,DEPT PATHOL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT BIOCHEM,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco	HSIAO, KK (corresponding author), UNIV CALIF SAN FRANCISCO,DEPT NEUROL,SAN FRANCISCO,CA 94143, USA.				NIA NIH HHS [AG02132] Funding Source: Medline; NINDS NIH HHS [NS22786, NS14069] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS014069, P01NS014069, P01NS022786] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG002132] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ALLEN ND, 1990, CELL, V61, P853, DOI 10.1016/0092-8674(90)90195-K; BAKER HF, 1985, BRIT MED J, V291, P299, DOI 10.1136/bmj.291.6491.299; BASLER K, 1986, CELL, V46, P417, DOI 10.1016/0092-8674(86)90662-8; BOLTON DC, 1982, SCIENCE, V218, P1309, DOI 10.1126/science.6815801; BORCHELT DR, 1990, J CELL BIOL, V110, P743, DOI 10.1083/jcb.110.3.743; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRINSTER RL, 1988, P NATL ACAD SCI USA, V85, P836, DOI 10.1073/pnas.85.3.836; CARLSON GA, 1986, CELL, V46, P503, DOI 10.1016/0092-8674(86)90875-5; CARLSON GA, 1988, MOL CELL BIOL, V8, P5528, DOI 10.1128/MCB.8.12.5528; CHANDLER RL, 1961, LANCET, V1, P1378; COLLINGE J, 1989, LANCET, V2, P15, DOI 10.1016/S0140-6736(89)90256-0; DICKINSON AG, 1969, GENET RES, V13, P213, DOI 10.1017/S0016672300002895; DOHURA K, 1989, BIOCHEM BIOPH RES CO, V163, P974, DOI 10.1016/0006-291X(89)92317-6; GABIZON R, 1990, BIOCHEM J, V266, P1; GABIZON R, IN PRESS NEUROLOGY; Gerstmann J., 1936, Z NEUROL, V154, P736, DOI [10.1007/BF02865827, DOI 10.1007/BF02865827]; GOLDFARB L, 1990, LANCET, P637; GOLDFARB LG, 1990, LANCET, P514; GOLDGABER D, 1989, EXP NEUROL, V106, P204, DOI 10.1016/0014-4886(89)90095-2; Haldane JBS, 1941, J GENET, V41, P149, DOI 10.1007/BF02983018; HISAO K, 1989, NATURE, V338, P342; HSIAO K, 1989, ANN NEUROL, V26, P137; HSIAO K, UNPUB; HSIAO K K, 1988, American Journal of Human Genetics, V43, pA87; HSIAO KK, IN PRESS NEUROLOGY; HUNTER N, 1987, J GEN VIROL, V68, P2711, DOI 10.1099/0022-1317-68-10-2711; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAIRD CD, 1990, TRENDS GENET, V6, P242, DOI 10.1016/0168-9525(90)90206-L; LIAO YCJ, 1986, SCIENCE, V233, P364, DOI 10.1126/science.3014653; MASTERS CL, 1981, BRAIN, V104, P559, DOI 10.1093/brain/104.3.559; MCKINLEY MP, 1983, CELL, V35, P57, DOI 10.1016/0092-8674(83)90207-6; MEYER RK, 1986, P NATL ACAD SCI USA, V83, P2310, DOI 10.1073/pnas.83.8.2310; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; OWEN F, 1989, LANCET, V1, P51; Pattison I. H., 1965, NINDB MONOGRAPH, V2, P249; PRUSINER SB, 1989, ANNU REV MICROBIOL, V43, P345, DOI 10.1146/annurev.mi.43.100189.002021; PRUSINER SB, 1982, BIOCHEMISTRY-US, V21, P6942, DOI 10.1021/bi00269a050; PRUSINER SB, 1990, CELL, V63, P673, DOI 10.1016/0092-8674(90)90134-Z; RACE RE, 1990, CELL, V71, P493; RIDLEY RM, 1988, J MED GENET, V25, P589, DOI 10.1136/jmg.25.9.589; ROBAKIS NK, 1986, BIOCHEM BIOPH RES CO, V140, P758, DOI 10.1016/0006-291X(86)90796-5; SCOTT M, 1989, CELL, V59, P847, DOI 10.1016/0092-8674(89)90608-9; SERBAN D, 1990, NEUROLOGY, V40, P110, DOI 10.1212/WNL.40.1.110; SPARKES RS, 1986, P NATL ACAD SCI USA, V83, P7358, DOI 10.1073/pnas.83.19.7358; TATEISHI J, 1979, ANN NEUROL, V5, P581, DOI 10.1002/ana.410050616; WEISSMANN C, 1989, NATURE, V338, P298, DOI 10.1038/338298a0; WESTAWAY D, 1987, CELL, V51, P651, DOI 10.1016/0092-8674(87)90134-6; WESTAWAY D, 1990, 8TH INT C VIR BERL, P59	48	496	501	0	16	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	DEC 14	1990	250	4987					1587	1590		10.1126/science.1980379	http://dx.doi.org/10.1126/science.1980379			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EM931	1980379				2022-12-24	WOS:A1990EM93100045
J	FINKELSTEIN, R; PERRIMON, N				FINKELSTEIN, R; PERRIMON, N			THE ORTHODENTICLE GENE IS REGULATED BY BICOID AND TORSO AND SPECIFIES DROSOPHILA HEAD DEVELOPMENT	NATURE			English	Article									HARVARD UNIV,SCH MED,HOWARD HUGHES MED INST,BOSTON,MA 02115	Harvard University; Harvard Medical School; Howard Hughes Medical Institute	FINKELSTEIN, R (corresponding author), HARVARD UNIV,SCH MED,DEPT GENET,25 SHATTUCK ST,BOSTON,MA 02115, USA.			Perrimon, Norbert/0000-0001-7542-472X				AKAM M, 1987, DEVELOPMENT, V101, P1; BAKER NE, 1988, DEVELOPMENT, V103, P289; BERLETH T, 1988, EMBO J, V7, P1749, DOI 10.1002/j.1460-2075.1988.tb03004.x; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; DALTON D, 1989, GENE DEV, V3, P1940, DOI 10.1101/gad.3.12a.1940; DINARDO S, 1985, CELL, V43, P59, DOI 10.1016/0092-8674(85)90012-1; DRIEVER W, 1989, NATURE, V340, P363, DOI 10.1038/340363a0; DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1; DRIEVER W, 1989, NATURE, V337, P138, DOI 10.1038/337138a0; DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3; FINKELSTEIN R, IN PRESS GENES DEV; FRIGERIO G, 1986, CELL, V47, P735, DOI 10.1016/0092-8674(86)90516-7; FROHNHOFER HG, 1986, NATURE, V324, P120, DOI 10.1038/324120a0; HANES SD, 1989, CELL, V57, P1275, DOI 10.1016/0092-8674(89)90063-9; INGHAM PW, 1988, NATURE, V335, P25, DOI 10.1038/335025a0; JURGENS G, 1986, ROUX ARCH DEV BIOL, V195, P359, DOI 10.1007/BF00402870; JURGENS G, 1984, ROUX ARCH DEV BIOL, V193, P283, DOI 10.1007/BF00848157; KLINGENSMITH J, 1989, DEV BIOL, V134, P130, DOI 10.1016/0012-1606(89)90084-5; LEHMANN R, 1987, DEV BIOL, V119, P412; MANSEAU LJ, 1989, TRENDS GENET, V5, P400, DOI 10.1016/0168-9525(89)90198-4; NAUBER U, 1988, NATURE, V336, P489, DOI 10.1038/336489a0; NUSSLEINVOLHARD C, 1987, SCIENCE, V238, P1675, DOI 10.1126/science.3686007; ROSENBERG UB, 1986, NATURE, V319, P336, DOI 10.1038/319336a0; STRUHL G, 1989, CELL, V57, P1259, DOI 10.1016/0092-8674(89)90062-7; TAUTZ D, 1987, NATURE, V327, P383, DOI 10.1038/327383a0; TAUTZ D, 1989, CHROMOSOMA, V98, P81, DOI 10.1007/BF00291041; TREISMAN J, 1989, CELL, V59, P553; Van der Meer JM., 1977, DROS INFORM SERV, V52, P160; VANDENHEUVEL M, 1989, CELL, V59, P739, DOI 10.1016/0092-8674(89)90020-2; WIESCHAUS E, 1984, WILHELM ROUXS ARCH D, V193, P286	30	231	233	0	3	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	AUG 2	1990	346	6283					485	488		10.1038/346485a0	http://dx.doi.org/10.1038/346485a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR713	1974036				2022-12-24	WOS:A1990DR71300064
J	SCHWEITZER, P; MADAMBA, S; SIGGINS, GR				SCHWEITZER, P; MADAMBA, S; SIGGINS, GR			ARACHIDONIC-ACID METABOLITES AS MEDIATORS OF SOMATOSTATIN-INDUCED INCREASE OF NEURONAL M-CURRENT	NATURE			English	Article									SCRIPPS CLIN & RES FDN, RES INST, DEPT NEUROPHARMACOL, 10666 N TORREY PINES RD, LA JOLLA, CA 92037 USA	Scripps Research Institute								ADAMS PR, 1982, J PHYSIOL-LONDON, V332, P263, DOI 10.1113/jphysiol.1982.sp014412; AXELROD J, 1988, TRENDS NEUROSCI, V11, P117, DOI 10.1016/0166-2236(88)90157-9; BERLARDETTI F, 1988, TRENDS NEUROSCI, V11, P232; BERRIDGE MJ, 1987, WENNERGREN CTR INT S, V48, P145; BLACKWELL GJ, 1983, BRIT MED BULL, V39, P260, DOI 10.1093/oxfordjournals.bmb.a071830; BROWN D, 1988, TRENDS NEUROSCI, V11, P294, DOI 10.1016/0166-2236(88)90089-6; BROWN DA, 1989, J PHYSIOL-LONDON, V413, P469, DOI 10.1113/jphysiol.1989.sp017664; BROWN DA, 1980, NATURE, V283, P673, DOI 10.1038/283673a0; DUTAR P, 1988, J NEUROSCI, V8, P4214; EGAN RW, 1984, PROSTAGLANDINS LEUKO, P593; HALLIWELL JV, 1982, BRAIN RES, V250, P71, DOI 10.1016/0006-8993(82)90954-4; HIGGS GA, 1983, BRIT MED BULL, V39, P265, DOI 10.1093/oxfordjournals.bmb.a071831; IRVINE RF, 1982, BIOCHEM J, V204, P3, DOI 10.1042/bj2040003; KIM D, 1989, NATURE, V337, P557, DOI 10.1038/337557a0; KURACHI Y, 1989, NATURE, V337, P555, DOI 10.1038/337555a0; LINDGREN JA, 1984, P NATL ACAD SCI-BIOL, V81, P6212, DOI 10.1073/pnas.81.19.6212; MARTIN JL, 1989, J NEUROSCI, V9, P2536; MOORE SD, 1988, SCIENCE, V239, P278, DOI 10.1126/science.2892268; PALMER MR, 1981, J PHARMACOL EXP THER, V219, P91; PIOMELLI D, 1987, NATURE, V328, P38, DOI 10.1038/328038a0; PIOMELLI D, 1987, J NEUROSCI, V7, P3675; PIOMELLI D, 1989, P NATL ACAD SCI USA, V86, P1721, DOI 10.1073/pnas.86.5.1721; SCHAAD NC, 1987, NATURE, V328, P637, DOI 10.1038/328637a0; SCHALLING M, 1986, EUR J PHARMACOL, V122, P251, DOI 10.1016/0014-2999(86)90110-X; SCHWEITZER P, 1989, Society for Neuroscience Abstracts, V15, P526; SIMS SM, 1988, SCIENCE, V239, P190, DOI 10.1126/science.2827305	26	170	170	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	AUG 2	1990	346	6283					464	467		10.1038/346464a0	http://dx.doi.org/10.1038/346464a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DR713	1974033				2022-12-24	WOS:A1990DR71300056
J	POYARTSALMERON, C; CARLIER, C; TRIEUCUOT, P; COURTIEU, AL; COURVALIN, P				POYARTSALMERON, C; CARLIER, C; TRIEUCUOT, P; COURTIEU, AL; COURVALIN, P			TRANSFERABLE PLASMID-MEDIATED ANTIBIOTIC-RESISTANCE IN LISTERIA-MONOCYTOGENES	LANCET			English	Article									HOP HOTEL DIEU NANTES,CTR NATL REFERENCE LISTERIA,BACTERIOL LAB,NANTES,FRANCE; INST PASTEUR,UNITE AGENTS ANTIBACTERIENS,F-75724 PARIS 15,FRANCE	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris			POYART, Claire/P-4225-2017	POYART, Claire/0000-0003-2158-6293; TRIEU-CUOT, Patrick/0000-0002-2768-9587				BISMUTH R, IN PRESS ANTIMICROB; BOISIVON A, 1990, EUR J CLIN MICROBIOL, V9, P206, DOI 10.1007/BF01963839; BURDETT V, 1982, J BACTERIOL, V149, P995, DOI 10.1128/JB.149.3.995-1004.1982; BUUHOI A, 1984, ANTIMICROB AGENTS CH, V25, P289, DOI 10.1128/AAC.25.2.289; CAILLAUD F, 1987, PLASMID, V17, P58, DOI 10.1016/0147-619X(87)90009-6; CLEWELL DB, 1974, J BACTERIOL, V117, P283, DOI 10.1128/JB.117.1.283-289.1974; COURVALIN P, 1986, MOL GEN GENET, V205, P291, DOI 10.1007/BF00430441; COURVALIN PM, 1978, ANTIMICROB AGENTS CH, V13, P716, DOI 10.1128/AAC.13.5.716; ENGEL HWB, 1980, J BACTERIOL, V142, P407, DOI 10.1128/JB.142.2.407-413.1980; EVANS RP, 1983, J BACTERIOL, V154, P1347, DOI 10.1128/JB.154.3.1347-1355.1983; FLAMM RK, 1984, INFECT IMMUN, V44, P157, DOI 10.1128/IAI.44.1.157-161.1984; GELLIN BG, 1989, JAMA-J AM MED ASSOC, V261, P1313, DOI 10.1001/jama.261.9.1313; HORINOUCHI S, 1982, J BACTERIOL, V150, P815, DOI 10.1128/JB.150.2.815-825.1982; HORODNICEANU T, 1982, PLASMID, V8, P199, DOI 10.1016/0147-619X(82)90057-9; HORODNICEANU T, 1979, PLASMID, V2, P197, DOI 10.1016/0147-619X(79)90038-6; HOSHINO T, 1985, GENE, V37, P131; JACOB AE, 1974, J BACTERIOL, V117, P360, DOI 10.1128/JB.117.2.360-372.1974; JENSSEN WD, 1987, ANTIMICROB AGENTS CH, V31, P883, DOI 10.1128/AAC.31.6.883; KHAN SA, 1983, PLASMID, V10, P251, DOI 10.1016/0147-619X(83)90039-2; LARSSON S, 1985, ANTIMICROB AGENTS CH, V28, P12, DOI 10.1128/AAC.28.1.12; LECLERCQ R, 1989, ANTIMICROB AGENTS CH, V33, P10, DOI 10.1128/AAC.33.1.10; Maniatis T., 1982, MOL CLONING; MARTIN P, 1986, NUCLEIC ACIDS RES, V14, P7047, DOI 10.1093/nar/14.17.7047; MOELLERI.RC, 1972, ANTIMICROB AGENTS CH, V1, P30, DOI 10.1128/AAC.1.1.30; NIEMAN RE, 1980, REV INFECT DIUS, V2, P202; NUNEZPOULSEN P, 1988, APMIS, V96, P223, DOI 10.1111/j.1699-0463.1988.tb05295.x; OUNISSI H, 1987, STREPTOCOCCAL GENETI, P275; PEPPER K, 1986, PLASMID, V16, P195, DOI 10.1016/0147-619X(86)90057-0; PEREZDIAZ JC, 1982, PLASMID, V8, P112, DOI 10.1016/0147-619X(82)90049-X; SHAW WV, 1985, FEBS LETT, V179, P101, DOI 10.1016/0014-5793(85)80200-3; SOUGAKOFF W, 1987, FEMS MICROBIOL LETT, V44, P153, DOI 10.1016/0378-1097(87)90218-7; STEERS EDWARD, 1959, ANTIBIOT AND CHEMOTHER, V9, P307; VICENTE MF, 1988, J ANTIMICROB CHEMOTH, V21, P309, DOI 10.1093/jac/21.3.309; ZILHAO R, 1988, ANTIMICROB AGENTS CH, V32, P1793, DOI 10.1128/AAC.32.12.1793	34	205	213	0	11	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JUN 16	1990	335	8703					1422	1426		10.1016/0140-6736(90)91447-I	http://dx.doi.org/10.1016/0140-6736(90)91447-I			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ234	1972210				2022-12-24	WOS:A1990DJ23400004
J	WILSON, JM; PING, AJ; KRAUSS, JC; MAYOBOND, L; ROGERS, CE; ANDERSON, DC; TODD, RF				WILSON, JM; PING, AJ; KRAUSS, JC; MAYOBOND, L; ROGERS, CE; ANDERSON, DC; TODD, RF			CORRECTION OF CD18-DEFICIENT LYMPHOCYTES BY RETROVIRUS-MEDIATED GENE-TRANSFER	SCIENCE			English	Article									TEXAS CHILDRENS HOSP,SPEROS P MARTEL LEUKOCYTE BIOL LAB,HOUSTON,TX 77030; UNIV MICHIGAN,SCH MED,DEPT BIOL CHEM,ANN ARBOR,MI 48109; UNIV MICHIGAN,SCH MED,PROGRAM CELLULAR & MOLEC BIOL,ANN ARBOR,MI 48109; BAYLOR UNIV,DEPT PEDIAT,HOUSTON,TX 77030; BAYLOR UNIV,DEPT CELL BIOL,HOUSTON,TX 77030	Baylor College of Medicine; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Baylor University; Baylor University	WILSON, JM (corresponding author), UNIV MICHIGAN,SCH MED,DEPT INTERNAL MED,HOWARD HUGHES MED INST,ANN ARBOR,MI 48109, USA.		Wilson, James M/F-9220-2011; Todd, Robert/GWM-4486-2022	Wilson, James M/0000-0002-9630-3131; 	NATIONAL CANCER INSTITUTE [R01CA039064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI023521, R01AI019031] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA39064] Funding Source: Medline; NIAID NIH HHS [R01 AI23521, R01 AI19031] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ANDERSON DC, 1985, J INFECT DIS, V152, P668, DOI 10.1093/infdis/152.4.668; ANDERSON DC, 1987, ANNU REV MED, V38, P175, DOI 10.1146/annurev.med.38.1.175; ARNAOUT MA, 1984, J CLIN INVEST, V74, P1291, DOI 10.1172/JCI111539; BARKLIS E, 1986, CELL, V47, P391, DOI 10.1016/0092-8674(86)90596-9; BODINE DM, 1989, P NATL ACAD SCI USA, V86, P8897, DOI 10.1073/pnas.86.22.8897; DANA N, 1987, J CLIN INVEST, V79, P1010, DOI 10.1172/JCI112868; DANA N, 1984, J CLIN INVEST, V73, P153, DOI 10.1172/JCI111186; DANOS O, 1988, P NATL ACAD SCI USA, V85, P6460, DOI 10.1073/pnas.85.17.6460; DUSTIN ML, 1989, NATURE, V341, P619, DOI 10.1038/341619a0; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FRIEDMANN T, 1989, SCIENCE, V244, P1275, DOI 10.1126/science.2660259; GIGER U, 1987, BLOOD, V69, P1622; HICKSTEIN DD, 1988, J BIOL CHEM, V263, P13863; KAMELREID S, 1988, SCIENCE, V242, P1706, DOI 10.1126/science.2904703; KISHIMOTO TK, 1989, J BIOL CHEM, V264, P3588; KISHIMOTO TK, 1987, CELL, V48, P681, DOI 10.1016/0092-8674(87)90246-7; KISHIMOTO TK, 1987, CELL, V50, P193, DOI 10.1016/0092-8674(87)90215-7; KRAUSS JH, UNPUB; LEDEIST F, 1989, BLOOD, V74, P512; LIM B, 1989, P NATL ACAD SCI USA, V86, P8892, DOI 10.1073/pnas.86.22.8892; MARLIN SD, 1986, J EXP MED, V164, P855, DOI 10.1084/jem.164.3.855; MCCUNE JM, 1988, SCIENCE, V241, P1632, DOI 10.1126/science.2971269; METCALF D, 1989, NATURE, V339, P27, DOI 10.1038/339027a0; MIEDEMA F, 1984, EUR J IMMUNOL, V14, P518, DOI 10.1002/eji.1830140607; MILLER LJ, 1987, J CLIN INVEST, V80, P535, DOI 10.1172/JCI113102; MILLER LJ, 1986, J IMMUNOL, V137, P2891; ROTHLEIN R, 1986, J EXP MED, V163, P1132, DOI 10.1084/jem.163.5.1132; SCHMIDT RE, 1985, NATURE, V318, P289, DOI 10.1038/318289a0; SPRINGER TA, 1984, J EXP MED, V160, P1901, DOI 10.1084/jem.160.6.1901; SZILVASSY SJ, 1989, P NATL ACAD SCI USA, V86, P8798, DOI 10.1073/pnas.86.22.8798; TODD RF, 1983, CLIN IMMUNOL IMMUNOP, V26, P118, DOI 10.1016/0090-1229(83)90180-0; TODD RF, 1988, HEMATOL ONCOL CLIN N, V2, P13; VANBEVEREN C, 1985, RNA TUMOR VIRUSES, P766; WILSON JM, 1990, P NATL ACAD SCI USA, V87, P439, DOI 10.1073/pnas.87.1.439; WILSON JM, 1989, SCIENCE, V244, P1344, DOI 10.1126/science.2734614; WILSON JM, 1988, P NATL ACAD SCI USA, V85, P4421, DOI 10.1073/pnas.85.12.4421	36	63	76	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JUN 15	1990	248	4961					1413	1416		10.1126/science.1972597	http://dx.doi.org/10.1126/science.1972597			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ501	1972597				2022-12-24	WOS:A1990DJ50100041
J	WELLEMS, TE; PANTON, LJ; GLUZMAN, IY; DOROSARIO, VE; GWADZ, RW; WALKERJONAH, A; KROGSTAD, DJ				WELLEMS, TE; PANTON, LJ; GLUZMAN, IY; DOROSARIO, VE; GWADZ, RW; WALKERJONAH, A; KROGSTAD, DJ			CHLOROQUINE RESISTANCE NOT LINKED TO MDR-LIKE GENES IN A PLASMODIUM-FALCIPARUM CROSS	NATURE			English	Article									WASHINGTON UNIV,SCH MED,DEPT MED,ST LOUIS,MO 63110; WASHINGTON UNIV,SCH MED,DEPT PATHOL,ST LOUIS,MO 63110	Washington University (WUSTL); Washington University (WUSTL)	WELLEMS, TE (corresponding author), NIAID,PARASIT DIS LAB,BETHESDA,MD 20892, USA.							BHASIN VK, 1984, AM J TROP MED HYG, V33, P534, DOI 10.4269/ajtmh.1984.33.534; Clyde D. F., 1987, Medicina Tropicale nella Cooperazione allo Sviluppo, V3, P41; Clyde D. F., 1987, Medicina Tropicale nella Cooperazione allo Sviluppo, V3, P3; COWMAN AF, 1988, P NATL ACAD SCI USA, V85, P9109, DOI 10.1073/pnas.85.23.9109; FOOTE SJ, 1990, NATURE, V345, P255, DOI 10.1038/345255a0; FOOTE SJ, 1990, P NATL ACAD SCI USA, V87, P3014, DOI 10.1073/pnas.87.8.3014; FOOTE SJ, 1989, CELL, V57, P921, DOI 10.1016/0092-8674(89)90330-9; GROS P, 1986, CELL, V47, P371, DOI 10.1016/0092-8674(86)90594-5; HIGGINS C, 1989, NATURE, V341, P103, DOI 10.1038/341103a0; HIGGINS C, 1989, NATURE, V340, P342, DOI 10.1038/340342a0; Ifediba T, 1981, NATURE, V294, P364, DOI 10.1038/294364a0; KILEJIAN A, 1986, P NATL ACAD SCI USA, V83, P7938, DOI 10.1073/pnas.83.20.7938; KROGSTAD DJ, 1985, J CELL BIOL, V101, P2302, DOI 10.1083/jcb.101.6.2302; KROGSTAD DJ, 1987, SCIENCE, V238, P1283, DOI 10.1126/science.3317830; KROGSTAD DJ, 1987, NEW ENGL J MED, V317, P542, DOI 10.1056/NEJM198708273170905; MARTIN SK, 1987, SCIENCE, V235, P899, DOI 10.1126/science.3544220; ODUOLA AMJ, 1988, EXP PARASITOL, V67, P354, DOI 10.1016/0014-4894(88)90082-3; PETERSON DS, 1988, P NATL ACAD SCI USA, V85, P9114, DOI 10.1073/pnas.85.23.9114; PETERSON DS, 1990, P NATL ACAD SCI USA, V87, P3018, DOI 10.1073/pnas.87.8.3018; POLOGE LG, 1986, NATURE, V322, P474, DOI 10.1038/322474a0; PONNUDURAI T, 1982, T ROY SOC TROP MED H, V76, P242, DOI 10.1016/0035-9203(82)90289-9; RAVETCH JV, 1985, SCIENCE, V227, P1593, DOI 10.1126/science.3883491; Reese R T, 1979, Bull World Health Organ, V57 Suppl 1, P53; ROSARIO V, 1981, SCIENCE, V212, P1037, DOI 10.1126/science.7015505; VANDERBERG JP, 1980, MALARIA, V2, P154; WALLIKER D, 1987, SCIENCE, V236, P1661, DOI 10.1126/science.3299700; WEBER JL, 1987, GENE, V52, P103, DOI 10.1016/0378-1119(87)90399-4; WELLEMS TE, 1987, CELL, V49, P633, DOI 10.1016/0092-8674(87)90539-3; WELLEMS TE, 1988, REV BRAS GENET, V11, P813; WILSON CM, 1989, SCIENCE, V244, P1184, DOI 10.1126/science.2658061; YANON A, 1984, EMBO J, V3, P2695; YAYON A, 1985, P NATL ACAD SCI USA, V82, P2784, DOI 10.1073/pnas.82.9.2784	32	457	466	0	7	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAY 17	1990	345	6272					253	255		10.1038/345253a0	http://dx.doi.org/10.1038/345253a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DD973	1970614				2022-12-24	WOS:A1990DD97300061
J	HAGEGE, AA; DESNOS, M; CHACHQUES, JC; CARPENTIER, A; FERNANDEZ, F; FONTALIRAN, F; GUEROT, C				HAGEGE, AA; DESNOS, M; CHACHQUES, JC; CARPENTIER, A; FERNANDEZ, F; FONTALIRAN, F; GUEROT, C			PRELIMINARY-REPORT - FOLLOW-UP AFTER DYNAMIC CARDIOMYOPLASTY	LANCET			English	Article									HOP BROUSSAIS,DEPT CARDIOVASC SURG,F-75674 PARIS 14,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite	HAGEGE, AA (corresponding author), HOP BOUCICAULT,DEPT CARDIOL,78 RUE CONVENT,F-75730 PARIS 15,FRANCE.			HAGEGE, Albert/0000-0003-4685-6077				CARPENTIER A, 1985, CR ACAD SCI III-VIE, V301, P581; CARPENTIER A, 1985, LANCET, V1, P1267; CARPENTIER A, 1988, 68TH P M AM ASS THOR, P64; CHACHQUES JC, 1988, CIRCULATION, V78, P203; MAGOVERN GJ, 1988, ANN THORAC SURG, V45, P614, DOI 10.1016/S0003-4975(10)64761-3; MOLTENI L, 1989, Journal of Thoracic and Cardiovascular Surgery, V97, P439	6	40	43	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	MAY 12	1990	335	8698					1122	1124		10.1016/0140-6736(90)91126-U	http://dx.doi.org/10.1016/0140-6736(90)91126-U			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC929	1971865				2022-12-24	WOS:A1990DC92900005
J	KESSEL, M; BALLING, R; GRUSS, P				KESSEL, M; BALLING, R; GRUSS, P			VARIATIONS OF CERVICAL-VERTEBRAE AFTER EXPRESSION OF A HOX-1.1 TRANSGENE IN MICE	CELL			English	Article											KESSEL, M (corresponding author), MAX PLANCK INST BIOPHYS CHEM, DEPT MOLEC CELL BIOL, W-3400 GOTTINGEN, GERMANY.			Balling, Rudi/0000-0003-2902-5650				AKAM M, 1988, DEVELOPMENT, V104, P123; BALLING R, 1988, CELL, V55, P531, DOI 10.1016/0092-8674(88)90039-6; BALLING R, 1989, CELL, V58, P337, DOI 10.1016/0092-8674(89)90848-9; Bateson W., 1894, MAT STUDY VARIATION, DOI [10.5962/bhl.title.1348, DOI 10.5962/BHL.TITLE.1348]; BAUR R, 1969, ACTA ANAT, V72, P321; CURRY GA, 1959, J EMBRYOL EXP MORPH, V7, P39; DAWES B, 1930, PHILOS T ROY SOC B, V218, P155; DEROBERTIS EM, 1989, CELL, V57, P189, DOI 10.1016/0092-8674(89)90954-9; DEUTSCH U, 1988, CELL, V53, P617, DOI 10.1016/0092-8674(88)90577-6; EVANS FRANCIS GAYNOR, 1939, ANN NEW YORK ACAD SCI, V39, P29, DOI 10.1111/j.1749-6632.1939.tb55370.x; FEATHERSTONE MS, 1988, P NATL ACAD SCI USA, V85, P4760, DOI 10.1073/pnas.85.13.4760; GARCIABELLIDO A, 1977, AM ZOOL, V17, P613; GAUNT SJ, 1988, DEVELOPMENT, V103, P135; GIBSON G, 1988, DEVELOPMENT, V102, P657; GRUNEBERG H, 1950, J GENET, V50, P142, DOI 10.1007/BF02986800; GRUNEBERG H, 1952, GENETICS MOUSE; GRUNEBERG H, 1960, PATHOLOGY DEV; HAYEK H, 1924, ANATOMIE, V53, P137; Hayek H., 1922, SITZUNGSBERICHTE AKA, V31, P25; Hayek H, 1927, JB MORPHOLOGIE MIKRO, V53, P269; HILL RE, 1989, GENE DEV, V3, P26, DOI 10.1101/gad.3.1.26; HUNTER RH, 1923, J ANAT, V58, P140; JENKINS FA, 1969, ANAT REC, V164, P173, DOI 10.1002/ar.1091640205; KUZIORA MA, 1988, CELL, V55, P477, DOI 10.1016/0092-8674(88)90034-7; KUZIORA MA, 1989, CELL, V59, P563, DOI 10.1016/0092-8674(89)90039-1; Le Douarin N.M., 1982, NEURAL CREST; LEISSING C, 1987, THESIS U ZURICH; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; MAHON KA, 1988, DEVELOPMENT, V104, P187; MCGINNIS W, 1984, CELL, V37, P403, DOI 10.1016/0092-8674(84)90370-2; MOCK BA, 1987, GENETICS, V116, P607; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; OUWENEEL WJ, 1976, ADV GENET, V18, P179, DOI 10.1016/S0065-2660(08)60439-3; PEIFER M, 1987, GENE DEV, V1, P891, DOI 10.1101/gad.1.9.891; Raff R.A., 1983, EMBRYOS GENES EVOLUT; Reiter A., 1944, Z ANAT ENTWICKLUNGS, V113, P66; ROBERT B, 1989, EMBO J, V8, P91, DOI 10.1002/j.1460-2075.1989.tb03352.x; Schmidt H., 1960, OKZIPITALE DYSPLASIE, P40; SCHNEUWLY S, 1987, NATURE, V325, P816, DOI 10.1038/325816a0; SCOTT MP, 1989, BIOCHIM BIOPHYS ACTA, V989, P25, DOI 10.1016/0304-419X(89)90033-4; Starck D., 1979, VERGLEICHENDE ANATOM; STERN CD, 1986, NATO ASI SER, V118, P147; THEILER K, 1988, ADV ANAT EMBRYOL CEL, V112, P1; Torklus Dv, 1975, OBERE HALSWIRBELSAUL; VERBOUT AJ, 1985, ADV ANAT EMBRYOL CEL, V90, P1; WRIGHT CVE, 1989, CELL, V59, P81, DOI 10.1016/0092-8674(89)90871-4; ZIMMER A, 1989, NATURE, V338, P150, DOI 10.1038/338150a0	47	337	341	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	APR 20	1990	61	2					301	308		10.1016/0092-8674(90)90810-2	http://dx.doi.org/10.1016/0092-8674(90)90810-2			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DA752	1970515	Green Published			2022-12-24	WOS:A1990DA75200012
J	MCFARLANE, IG; SMITH, HM; JOHNSON, PJ; BRAY, GP; VERGANI, D; WILLIAMS, R				MCFARLANE, IG; SMITH, HM; JOHNSON, PJ; BRAY, GP; VERGANI, D; WILLIAMS, R			HEPATITIS-C VIRUS-ANTIBODIES IN CHRONIC ACTIVE HEPATITIS - PATHOGENETIC FACTOR OR FALSE-POSITIVE RESULT	LANCET			English	Article									UNIV LONDON,LONDON,ENGLAND; UNIV LONDON KINGS COLL HOSP,DEPT IMMUNOL,LONDON SE5 9RS,ENGLAND	University of London; King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London	MCFARLANE, IG (corresponding author), UNIV LONDON KINGS COLL HOSP,LIVER UNIT,DENMARK HILL,LONDON SE5 9RS,ENGLAND.		Vergani, Diego/H-7610-2019	opoku, anita/0000-0001-7243-8157				BURMAN P, 1986, J CLIN ENDOCR METAB, V63, P1086, DOI 10.1210/jcem-63-5-1086; Choo G.L, 1989, SCIENCE, V244, P359; ESTEBAN JI, 1989, LANCET, V2, P294; KUO G, 1989, SCIENCE, V244, P362, DOI 10.1126/science.2496467; LENZI M, 1990, LANCET, V1, P258; MACKAY IR, 1985, CLIN EXP IMMUNOL, V61, P39; MCFARLANE BM, 1986, J HEPATOL, V3, P196, DOI 10.1016/S0168-8278(86)80026-5; MCFARLANE IG, 1985, J HEPATOL, V1, P313, DOI 10.1016/S0168-8278(85)80058-1; MCFARLANE IG, 1983, J IMMUNOL METHODS, V64, P215, DOI 10.1016/0022-1759(83)90400-3; MCFARLANE IG, 1989, IMMUNOLOGY IMMUNOPAT, P281; ROBERTSON DAF, 1987, LANCET, V2, P9; SCHULTZ M, 1989, LANCET, V1, P1452; STELLON AJ, 1988, HEPATOLOGY, V8, P781, DOI 10.1002/hep.1840080414; VENTO S, 1988, J CLIN LAB IMMUNOL, V25, P1; VENTO S, 1989, LANCET, V2, P926; 1989, LANCET, V2, P307; 1976, FOGARTY INT CTR P, V22, P9	17	444	446	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	MAR 31	1990	335	8692					754	757		10.1016/0140-6736(90)90870-B	http://dx.doi.org/10.1016/0140-6736(90)90870-B			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CW994	1969512				2022-12-24	WOS:A1990CW99400005
J	SHAM, JST; WEI, WI; ZONG, YS; CHOY, D; GUO, YQ; LUO, Y; LIN, ZX; NG, MH				SHAM, JST; WEI, WI; ZONG, YS; CHOY, D; GUO, YQ; LUO, Y; LIN, ZX; NG, MH			DETECTION OF SUBCLINICAL NASOPHARYNGEAL CARCINOMA BY FIBEROPTIC ENDOSCOPY AND MULTIPLE BIOPSY	LANCET			English	Article									SHANTOU UNIV,COLL MED,DEPT PATHOL & ONCOL,SHANTOU,PEOPLES R CHINA; UNIV HONG KONG,QUEEN MARY HOSP,DEPT SURG,HONG KONG,HONG KONG; UNIV HONG KONG,QUEEN MARY HOSP,DEPT MICROBIOL,HONG KONG,HONG KONG; ZHONGSHAN PEOPLES HOSP,ZHONGSHAN,PEOPLES R CHINA; GUANGDONG PROV PEOPLES HOSP,GUANGZHOU,PEOPLES R CHINA	Shantou University; University of Hong Kong; University of Hong Kong; Guangdong Academy of Medical Sciences & Guangdong General Hospital	SHAM, JST (corresponding author), UNIV HONG KONG,QUEEN MARY HOSP,DEPT RADIOTHERAPY & ONCOL,HONG KONG,HONG KONG.			wei, william/0000-0002-6281-7126				BOON ME, 1987, CANCER-AM CANCER SOC, V59, P862, DOI 10.1002/1097-0142(19870215)59:4<862::AID-CNCR2820590434>3.0.CO;2-P; BOYES DA, 1981, GYNECOL ONCOL, V12, pS143, DOI 10.1016/0090-8258(81)90070-6; CHEN JY, 1989, J MED VIROL, V27, P269, DOI 10.1002/jmv.1890270403; CHOA G, 1974, J LARYNGOL OTOL, V88, P145, DOI 10.1017/S0022215100078488; DETHE G, 1985, EPSTEIN BARR VIRUS R, P237; HENLE G, 1976, INT J CANCER, V17, P1, DOI 10.1002/ijc.2910170102; HENLE G, 1985, ADV VIRAL ONCOL, P201; HO HC, 1978, LANCET, V1, P436; HO HC, 1976, BRIT J CANCER, V34, P655, DOI 10.1038/bjc.1976.228; Ho HC, 1972, IARC SCI PUBL, V2, P357; LANIER AP, 1980, INT J CANCER, V26, P133, DOI 10.1002/ijc.2910260203; LAU WH, 1983, NASOPHARYNGEAL CARCI, P125; LEVINE PH, 1980, INT J CANCER, V26, P741, DOI 10.1002/ijc.2910260607; Prasad U, 1979, Med J Malaysia, V33, P222; SHAM JST, 1989, CANCER, V64, P1838, DOI 10.1002/1097-0142(19891101)64:9<1838::AID-CNCR2820640914>3.0.CO;2-C; SHAM JST, IN PRESS BR J RADIOL; SHAPIRO S, 1989, WORLD J SURG, V13, P9, DOI 10.1007/BF01671148; SHAPIRO S, 1971, J AMER MED ASSOC, V215, P1777; TABAR L, 1985, LANCET, V1, P829, DOI 10.1016/S0140-6736(85)92204-4; YU MC, 1989, INT J CANCER, V43, P1077, DOI 10.1002/ijc.2910430621; ZENG Y, 1984, CHINESE MED J-PEKING, V97, P155; ZENG Y, 1985, INT J CANCER, V36, P545, DOI 10.1002/ijc.2910360505; ZENG Y, 1982, INT J CANCER, V29, P139, DOI 10.1002/ijc.2910290204	23	90	107	0	5	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	FEB 17	1990	335	8686					371	374		10.1016/0140-6736(90)90206-K	http://dx.doi.org/10.1016/0140-6736(90)90206-K			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN988	1968116				2022-12-24	WOS:A1990CN98800003
J	MACLENNAN, DH; DUFF, C; ZORZATO, F; FUJII, J; PHILLIPS, M; KORNELUK, RG; FRODIS, W; BRITT, BA; WORTON, RG				MACLENNAN, DH; DUFF, C; ZORZATO, F; FUJII, J; PHILLIPS, M; KORNELUK, RG; FRODIS, W; BRITT, BA; WORTON, RG			RYANODINE RECEPTOR GENE IS A CANDIDATE FOR PREDISPOSITION TO MALIGNANT HYPERTHERMIA	NATURE			English	Article									CHILDRENS HOSP EASTERN ONTARIO,DIV GENET,OTTAWA K1H 8L1,ONTARIO,CANADA; UNIV TORONTO,DEPT MED GENET,TORONTO M5G 1X8,ONTARIO,CANADA; UNIV TORONTO,TORONTO GEN HOSP,DEPT ANAESTHESIA,TORONTO M5G 2C4,ONTARIO,CANADA; UNIV TORONTO,TORONTO GEN HOSP,DEPT PHARMACOL,TORONTO M5G 2C4,ONTARIO,CANADA; HOSP SICK CHILDREN,DEPT GENET,TORONTO M5G 1X8,ONTARIO,CANADA	University of Ottawa; Children's Hospital of Eastern Ontario; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	MACLENNAN, DH (corresponding author), UNIV TORONTO,CHARLES H BEST INST,BANTING & BEST DEPT MED RES,112 COLL ST,TORONTO M5G 1L6,ONTARIO,CANADA.							BRITT BA, 1989, MALIGNANT HYPERTHERM, P53; BRITT BA, 1987, MALIGNANT HYPERTHERM, P11; DAVIES W, 1988, ANIM GENET, V19, P203, DOI 10.1111/j.1365-2052.1988.tb00809.x; ENDO M, 1983, BIOMED RES-TOKYO, V4, P83, DOI 10.2220/biomedres.4.83; HULSEBOS T, 1986, NUCLEIC ACIDS RES, V14, P7137, DOI 10.1093/nar/14.17.7137; Humphries S E, 1983, Mol Biol Med, V1, P463; IAIZZO PA, 1988, PFLUG ARCH EUR J PHY, V411, P648, DOI 10.1007/BF00580861; KALOW W, 1970, LANCET, V2, P895, DOI 10.1016/S0140-6736(70)92069-6; KALOW W, 1987, MALIGNANT HYPERTHERM, P155; KIM DH, 1984, BIOCHIM BIOPHYS ACTA, V775, P320, DOI 10.1016/0005-2736(84)90187-1; MACKENZIE AE, UNPUB AM J HUM GENET; MCCARTHY TV, 1990, NATURE, V343, P562, DOI 10.1038/343562a0; MICKELSON JR, 1988, J BIOL CHEM, V263, P9310; NELSON TE, 1983, J CLIN INVEST, V72, P862, DOI 10.1172/JCI111057; OBRIEN PJ, 1986, CAN J VET RES, V50, P318; OHNISHI ST, 1983, FEBS LETT, V161, P103; SCHEPENS J, 1987, NUCLEIC ACIDS RES, V15, P3193, DOI 10.1093/nar/15.7.3193; SCHEPENS J, 1987, NUCLEIC ACIDS RES, V15, P3192, DOI 10.1093/nar/15.7.3192; SCHONK D, 1989, GENOMICS, V4, P384, DOI 10.1016/0888-7543(89)90346-7; SMEETS H, 1989, NUCLEIC ACIDS RES, V17, P3325, DOI 10.1093/nar/17.8.3325; SMEETS H, 1989, NUCLEIC ACIDS RES, V17, P3324, DOI 10.1093/nar/17.8.3324; SMEETS H, 1987, NUCLEIC ACIDS RES, V15, P8120, DOI 10.1093/nar/15.19.8120; ZORZATO F, 1990, J BIOL CHEM, V265, P2244; [No title captured]	24	481	489	0	27	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	FEB 8	1990	343	6258					559	561		10.1038/343559a0	http://dx.doi.org/10.1038/343559a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CM830	1967823				2022-12-24	WOS:A1990CM83000066
J	EDDE, B; ROSSIER, J; LECAER, JP; DESBRUYERES, E; GROS, F; DENOULET, P				EDDE, B; ROSSIER, J; LECAER, JP; DESBRUYERES, E; GROS, F; DENOULET, P			POSTTRANSLATIONAL GLUTAMYLATION OF ALPHA-TUBULIN	SCIENCE			English	Article									CNRS,PHYSIOL NERVEUSE LAB,F-91198 GIF SUR YVETTE,FRANCE	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	EDDE, B (corresponding author), COLL FRANCE,BIOCHIM CELLULAIRE LAB,F-75231 PARIS 05,FRANCE.							BERWALDNETTER Y, 1981, P NATL ACAD SCI-BIOL, V78, P1245, DOI 10.1073/pnas.78.2.1245; BIDLINGMEYER BA, 1984, J CHROMATOGR, V336, P93, DOI 10.1016/S0378-4347(00)85133-6; COWAN NJ, 1987, CYTOSKELETON CELL DI, P157; DENOULET P, 1988, STRUCTURE FUNCTIONS, P231; EDDE B, 1989, BIOL CELL, V65, P109; EDDE B, 1987, DEV BIOL, V123, P549, DOI 10.1016/0012-1606(87)90413-1; EDDE B, UNPUB; FIELD DJ, 1988, ELECTROPHORESIS, V9, P555, DOI 10.1002/elps.1150090915; GARD DL, 1985, J CELL BIOL, V100, P764, DOI 10.1083/jcb.100.3.764; GREER K, 1989, CELL MOVEMENT, V2, P47; LECAER JP, 1988, ANAL BIOCHEM, V169, P246, DOI 10.1016/0003-2697(88)90281-3; LEDIZET M, 1987, P NATL ACAD SCI USA, V84, P572; LHERNAULT SW, 1985, BIOCHEMISTRY-US, V24, P473, DOI 10.1021/bi00323a034; LITTAUER UZ, 1986, P NATL ACAD SCI USA, V83, P7162, DOI 10.1073/pnas.83.19.7162; MACCIONI RB, 1988, EMBO J, V7, P1957, DOI 10.1002/j.1460-2075.1988.tb03033.x; MATSUBARA H, 1970, METHOD ENZYMOL, V19, P642; RAYBIN D, 1977, J CELL BIOL, V73, P492, DOI 10.1083/jcb.73.2.492; SERRANO L, 1986, J BIOL CHEM, V261, P7076; VALLEE RB, 1982, J CELL BIOL, V92, P435, DOI 10.1083/jcb.92.2.435; VILLASANTE A, 1986, MOL CELL BIOL, V6, P2409, DOI 10.1128/MCB.6.7.2409; WOLFF A, 1982, NEUROSCI LETT, V31, P323, DOI 10.1016/0304-3940(82)90041-6	21	446	456	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JAN 5	1990	247	4938					83	85		10.1126/science.1967194	http://dx.doi.org/10.1126/science.1967194			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CG620	1967194				2022-12-24	WOS:A1990CG62000042
J	TANG, WJ; GILMAN, AG				TANG, WJ; GILMAN, AG			TYPE-SPECIFIC REGULATION OF ADENYLYL CYCLASE BY G-PROTEIN BETA-GAMMA-SUBUNITS	SCIENCE			English	Article							PIG CEREBRAL-CORTEX; GTP-BINDING PROTEINS; ADENOSINE-3',5'-MONOPHOSPHATE METABOLISM; ALPHA-SUBUNITS; ADENOSINE; PURIFICATION; RESPONSES; HISTAMINE; ONTOGENY; NOREPINEPHRINE	Heterotrimeric guanine nucleotide-binding regulatory proteins (G proteins) dissociate into guanosine triphosphate (GTP)bound alpha-subunits and a complex of beta and gamma-subunits after interaction with receptors. The GTP-alpha subunit complex activates appropriate effectors, such as adenylyl cyclase, retinal phosphodiesterase, phospholipase C, and ion channels. G protein beta-gamma-subunits have been found to have regulatory effects on certain types of adenylyl cyclase. In the presence of G(s-alpha), the alpha-subunit of the G protein that activates adenylyl cyclase, one form of adenylyl cyclase was inhibited by beta-gamma, some forms were activated by beta-gamma and some forms were not affected by beta-gamma. These interactions suggest mechanisms for communication between distinct signal-transducing pathways.	UNIV TEXAS,SW MED CTR,DEPT PHARMACOL,DALLAS,TX 75235	University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas				Tang, Wei-Jen/0000-0002-8267-8995	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034497, R37GM034497] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM34497] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BAKALYAR HA, 1990, SCIENCE, V250, P1403, DOI 10.1126/science.2255909; BLUMER KJ, 1991, ANNU REV PHYSIOL, V53, P37; BROWN AM, 1990, ANNU REV PHYSIOL, V52, P197, DOI 10.1146/annurev.ph.52.030190.001213; CASEY PJ, 1989, BIOCHEMISTRY-US, V28, P611, DOI 10.1021/bi00428a029; FEINSTEIN P, IN PRESS P NATL ACAD; GAO B, IN PRESS P NATL ACAD; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; GILMAN AG, 1984, CELL, V36, P577, DOI 10.1016/0092-8674(84)90336-2; GRAZIANO MP, 1989, J BIOL CHEM, V264, P409; GROEBE DR, 1990, NUCLEIC ACIDS RES, V18, P4033, DOI 10.1093/nar/18.13.4033; ITOH H, 1991, J BIOL CHEM, V266, P16226; KATADA T, 1987, J BIOL CHEM, V262, P11897; KATADA T, 1984, J BIOL CHEM, V259, P3586; KITTS PA, 1990, NUCLEIC ACIDS RES, V18, P5667, DOI 10.1093/nar/18.19.5667; KRUPINSKI J, 1989, SCIENCE, V244, P1558, DOI 10.1126/science.2472670; KRUPINSKI J, COMMUNICATION; LOGOTHETIS DE, 1987, NATURE, V325, P321, DOI 10.1038/325321a0; PANG IH, 1989, P NATL ACAD SCI USA, V86, P7814, DOI 10.1073/pnas.86.20.7814; POSSEE RD, 1987, NUCLEIC ACIDS RES, V15, P10233, DOI 10.1093/nar/15.24.10233; RALL TW, 1987, MOL CELL BIOCHEM, V73, P157; SATTIN A, 1975, J PHARMACOL EXP THER, V192, P22; SHONK RF, 1987, MOL CELL BIOCHEM, V73, P141; SHONK RF, 1987, MOL CELL BIOCHEM, V73, P169; SIMON MI, 1991, SCIENCE, V252, P802, DOI 10.1126/science.1902986; SMIGEL MD, 1986, J BIOL CHEM, V261, P1976; STERNWEIS PC, 1981, J BIOL CHEM, V256, P1517; TANG WJ, 1991, J BIOL CHEM, V266, P8595	27	847	858	0	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	DEC 6	1991	254	5037					1500	1503		10.1126/science.1962211	http://dx.doi.org/10.1126/science.1962211			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT903	1962211				2022-12-24	WOS:A1991GT90300038
J	FAN, CM; MANIATIS, T				FAN, CM; MANIATIS, T			GENERATION OF P50 SUBUNIT OF NF-KAPPA-B BY PROCESSING OF P105 THROUGH AN ATP-DEPENDENT PATHWAY	NATURE			English	Article							INTERFERON GENE-REGULATION; ENHANCER-BINDING-PROTEIN; REL; PURIFICATION; MEDIATOR	THE transcription factor NF-kappa-B is a heterodimer consisting of two proteins encoded by different members of the rel gene family (p50 and p65) 1-7. The p50 subunit is unusual among DNA-binding proteins in that its functional form is encoded in an open reading frame of relative molecular mass 105,000 (p105; ref. 4). The N-terminal region of this open reading frame encodes p50, whereas the remaining C terminus contains ankyrin repeats. Although p50 binds to DNA, full-length p105 translated in vitro does not 4,5. The mechanism by which p50 is generated in vivo, and the fate of the C-terminal region of p105 have not been established. Here we show that functional p50 is produced by ATP-dependent proteolysis of p105. Moreover, we find that the C-terminal half of p 105 is not required for processing in vivo, and is rapidly degraded on processing. We propose that the C-terminal region of p105 is involved in the cytoplasmic assembly of the complex between the p50/p65 heterodimer and the inhibitor I-kappa-B.			FAN, CM (corresponding author), HARVARD UNIV,DEPT BIOCHEM & MOLEC BIOL,7 DIVIN AVE,CAMBRIDGE,MA 02138, USA.							BAEUERLE PA, 1989, GENE DEV, V3, P1689, DOI 10.1101/gad.3.11.1689; BALLARD DW, 1990, CELL, V63, P803, DOI 10.1016/0092-8674(90)90146-6; FAN CM, 1989, EMBO J, V8, P101, DOI 10.1002/j.1460-2075.1989.tb03353.x; FIELD J, 1988, MOL CELL BIOL, V8, P2159, DOI 10.1128/MCB.8.5.2159; GHOSH S, 1990, CELL, V62, P1019, DOI 10.1016/0092-8674(90)90276-K; HARLOW E, 1988, ANTIBODIES LABORATOR; HASKILL S, 1991, CELL, V65, P1281, DOI 10.1016/0092-8674(91)90022-Q; HERSHKO A, 1988, J BIOL CHEM, V263, P15237; INOUE J, 1991, P NATL ACAD SCI USA, V88, P3715, DOI 10.1073/pnas.88.9.3715; KAWAKAMI K, 1988, P NATL ACAD SCI USA, V85, P4700, DOI 10.1073/pnas.85.13.4700; KIERAN M, 1990, CELL, V62, P1007, DOI 10.1016/0092-8674(90)90275-J; LENARDO MJ, 1989, CELL, V57, P287, DOI 10.1016/0092-8674(89)90966-5; LENARDO MJ, 1989, CELL, V58, P227, DOI 10.1016/0092-8674(89)90833-7; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; NOLAN GP, 1991, CELL, V64, P961, DOI 10.1016/0092-8674(91)90320-X; RECHSTEINER M, 1991, CELL, V66, P615, DOI 10.1016/0092-8674(91)90104-7; RIVIERE Y, 1991, NATURE, V350, P625, DOI 10.1038/350625a0; RUBEN SM, 1991, SCIENCE, V251, P1490, DOI 10.1126/science.2006423; TANAKA M, 1990, CELL, V60, P375, DOI 10.1016/0092-8674(90)90589-7	19	282	292	0	12	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	DEC 5	1991	354	6352					395	398		10.1038/354395a0	http://dx.doi.org/10.1038/354395a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT761	1956402				2022-12-24	WOS:A1991GT76100052
J	CHASE, HP; GARG, SK; MARSHALL, G; BERG, CL; HARRIS, S; JACKSON, WE; HAMMAN, RE				CHASE, HP; GARG, SK; MARSHALL, G; BERG, CL; HARRIS, S; JACKSON, WE; HAMMAN, RE			CIGARETTE-SMOKING INCREASES THE RISK OF ALBUMINURIA AMONG SUBJECTS WITH TYPE-I DIABETES	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RETINOPATHY; NEPHROPATHY; MELLITUS	The effect of cigarette smoking on diabetic renal and retinal complications was evaluated in 359 young subjects with insulin-dependent diabetes mellitus. The prevalence of increased albumin excretion rates was 2.8 times higher in smokers than nonsmokers. Mean glycohemoglobin levels and duration of diabetes were also significant factors in the development of diabetic nephropathy and retinopathy in a logistic regression model. Smoking remained a significant factor in the logistic regression model for albuminuria (but not retinopathy) when controlled for glycohemoglobin level, duration of diabetes, age, gender, and blood pressure. The progression of albuminuria and of retinopathy was also greater in smokers. Albuminuria improved significantly when subjects ceased smoking. It is concluded that cigarette smoking is an independent risk factor and is associated with the development and progression of early diabetic renal damage (albuminuria) and with the worsening of retinal disease in young subjects with diabetes.	UNIV COLORADO,HLTH SCI CTR,DEPT PREVENT MED & BIOMETR,DENVER,CO 80262; UNIV COLORADO,HLTH SCI CTR,DEPT OPHTHALMOL,DENVER,CO 80262	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	CHASE, HP (corresponding author), UNIV COLORADO,HLTH SCI CTR,DEPT PEDIAT,BARBARA DAVIS CTR CHILDHOOD DIABET,4200 E 9TH AVE,DENVER,CO 80262, USA.		Marshall, Guillermo/F-2302-2011		NCRR NIH HHS [RR69] Funding Source: Medline	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		AGRESTI A, 1990, CATEGORICAL DATA ANA, P306; BORCHJOHNSEN K, 1985, DIABETOLOGIA, V28, P590, DOI 10.1007/BF00281993; CHASE HP, 1990, OPHTHALMOLOGY, V97, P155; CHASE HP, 1990, ARCH INTERN MED, V150, P639, DOI 10.1001/archinte.150.3.639; CHASE HP, 1989, JAMA-J AM MED ASSOC, V261, P1155, DOI 10.1001/jama.261.8.1155; KLEIN BEK, 1984, OPHTHALMOLOGY, V91, P10; KLEIN R, 1983, AM J EPIDEMIOL, V118, P228, DOI 10.1093/oxfordjournals.aje.a113630; LUNDMAN BM, 1990, J INTERN MED, V227, P101, DOI 10.1111/j.1365-2796.1990.tb00126.x; MCCANCE DR, 1989, LANCET, V2, P824; MOGENSEN CE, 1985, HYPERTENSION, V7, P64; MUHLHAUSER I, 1986, DIABETOLOGIA, V29, P500, DOI 10.1007/BF00453501; NORDEN G, 1984, ACTA MED SCAND, V215, P257; ORCHARD TJ, 1990, DIABETES CARE, V13, P741, DOI 10.2337/diacare.13.7.741; OSBERG I, 1990, CLIN CHEM, V36, P1428; ROSE GA, 1968, CARDIOVASCULAR SURVE, P160; RUDEHILL A, 1989, CLIN PHYSIOL, V9, P243, DOI 10.1111/j.1475-097X.1989.tb00976.x; VIBERTI GC, 1982, LANCET, V1, P1430; VOORS AW, 1976, CIRCULATION, V54, P319, DOI 10.1161/01.CIR.54.2.319; 1987, SAS STAT GUIDE PERSO; 1989, MMWR, V38, P543; 1981, INVEST OPHTHALMOL VI, V21, P210	21	215	222	0	18	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	1991	265	5					614	617		10.1001/jama.265.5.614	http://dx.doi.org/10.1001/jama.265.5.614			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EV718	1987411				2022-12-24	WOS:A1991EV71800018
J	HIRANO, S; FUSE, S; SOHAL, GS				HIRANO, S; FUSE, S; SOHAL, GS			THE EFFECT OF THE FLOOR PLATE ON PATTERN AND POLARITY IN THE DEVELOPING CENTRAL-NERVOUS-SYSTEM	SCIENCE			English	Article							ACID-BINDING-PROTEIN; RETINOIC ACID; CHICK-EMBRYO; NEURAL-TUBE; LOCAL APPLICATION; MOUSE; LIMB; EXPRESSION; ORIGIN; CELLS	The effect of floor plate on cellular differentiation in the neural tube of quail embryos was examined. In the developing neural tube the floor plate, which consists of specialized neuroepithelial cells, is located in the ventral midline of the neural tube. When Hensen's node was extirpated the floor plate and notochord did not develop, and the normal differentiation of the ventral horn motor neurons and dorsal and ventral roots did not occur. When one side of the neural tube was deprived of notochord, the ventro-dorsal differentiation took place on both sides. However, when one side of the neural tube was deprived of the floor plate, the ventral horn motor neurons and dorsal and ventral roots did not develop on that side. These observations suggest that the floor plate influences motor neuron differentiation and acts as an intrinsic organizer to establish pattern and polarity in the developing nervous system.	MED COLL GEORGIA, DEPT ANAT, AUGUSTA, GA 30912 USA; NIIGATA UNIV, SCH MED, DEPT ANAT, NIIGATA 951, JAPAN	University System of Georgia; Augusta University; Niigata University					NICHD NIH HHS [HD 18280, HD 17800] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD017800, R01HD018280] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BARRON DH, 1946, J COMP NEUROL, V85, P149, DOI 10.1002/cne.900850202; BOVOLENTA P, 1990, DEVELOPMENT, V109, P435; CAJAL SRR, 1929, STUDIES VERTEBRATE N; EICHELE G, 1985, J CELL BIOL, V101, P1913, DOI 10.1083/jcb.101.5.1913; FUJITA S, 1964, J COMP NEUROL, V122, P311, DOI 10.1002/cne.901220303; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HOLLYDAY M, 1977, BRAIN RES, V132, P197, DOI 10.1016/0006-8993(77)90416-4; Jacobson M., 2013, DEV NEUROBIOL; JESSELL TM, 1989, CIBA F SYMP, V144, P255; MADEN M, 1990, DEVELOPMENT, V109, P75; MADEN M, 1989, DEV BIOL, V135, P124, DOI 10.1016/0012-1606(89)90163-2; MADEN M, 1989, DEVELOPMENT S, V109; MOMOI M, 1990, DEV BRAIN RES, V54, P161, DOI 10.1016/0165-3806(90)90138-O; NICOLET G, 1970, Journal of Embryology and Experimental Morphology, V23, P79; PEREZCASTRO AV, 1989, P NATL ACAD SCI USA, V86, P8813, DOI 10.1073/pnas.86.22.8813; ROSENQUIST GLENN C., 1966, CARNEGIE INST WASH PUBL, V38, P71; SCHOENWOLF GC, 1989, J EXP ZOOL, V249, P271, DOI 10.1002/jez.1402490305; SMITH JL, 1989, J EXP ZOOL, V250, P49, DOI 10.1002/jez.1402500107; SPRATT NT, 1952, J EXP ZOOL, V120, P109, DOI 10.1002/jez.1401200105; SUMMERBELL D, 1983, J EMBRYOL EXP MORPH, V78, P269; TESSIERLAVIGNE M, 1988, NATURE, V336, P775, DOI 10.1038/336775a0; TICKLE C, 1982, NATURE, V296, P564, DOI 10.1038/296564a0; VAESSEN MJ, 1989, DIFFERENTIATION, V40, P99, DOI 10.1111/j.1432-0436.1989.tb00819.x; VANSTRAATEN HWM, 1988, ANAT EMBRYOL, V177, P317; WAGNER M, 1990, NATURE, V345, P819, DOI 10.1038/345819a0; WENTWORTH LE, 1978, J COMP NEUROL, V177, P611, DOI 10.1002/cne.901770406	26	75	77	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 18	1991	251	4991					310	313		10.1126/science.1987648	http://dx.doi.org/10.1126/science.1987648			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET678	1987648				2022-12-24	WOS:A1991ET67800033
J	DUBACH, UC; ROSNER, B; STURMER, T				DUBACH, UC; ROSNER, B; STURMER, T			AN EPIDEMIOLOGIC-STUDY OF ABUSE OF ANALGESIC DRUGS - EFFECTS OF PHENACETIN AND SALICYLATE ON MORTALITY AND CARDIOVASCULAR MORBIDITY (1968 TO 1987)	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							WORKING FEMALE POPULATION; RENAL-DISEASE; URORENAL DISORDERS; HEART-DISEASE; NEPHROPATHY; PROSTACYCLIN; SWITZERLAND; ASPIRIN	Background. Phenacetin abuse is known to produce kidney disease; salicylate use is supposed to prevent cardiovascular disease. We conducted a prospective, longitudinal epidemiologic study to examine the effects of these drugs on cause-specific mortality and on cardiovascular morbidity. Methods. In 1968 we evaluated a study group of 623 healthy women 30 to 49 years old who had evidence of a regular intake of phenacetin, as measured by urinary excretion of its metabolites, and a matched control group of 621 women. Salicylate excretion was also measured. All subjects were examined over a period of 20 years. Results. Life-table analyses of mortality during the 20 years, with adjustment for the year of birth, cigarette smoking, and length of follow-up, revealed significant differences between the groups in overall mortality (study group vs. control group, 74 vs. 27 deaths; relative risk, 2.2; 95 percent confidence interval, 1.5 to 3.3), deaths due to urologic or renal disease (relative risk, 16.1; 95 percent confidence interval, 3.9 to 66.1), deaths due to cancer (relative risk, 1.9; 95 percent confidence interval, 1.1 to 3.3), and deaths due to cardiovascular disease (relative risk, 2.9; 95 percent confidence interval, 1.5 to 5.5). The relative risk of cardiovascular disease (fatal or nonfatal myocardial infarction, heart failure, or stroke) was 1.8, and the 95 percent confidence interval 1.3 to 2.6. The odds ratio for the incidence of hypertension was 1.6, and the 95 percent confidence interval 1.2 to 2.1. The effects of phenacetin on morbidity and mortality, with adjustment for base-line salicylate excretion, were similar. In contrast, salicylate use had no effect on either mortality or morbidity. Conclusions. Regular use of analgesic drugs containing phenacetin is associated with an increased risk of hypertension and mortality and morbidity due to cardiovascular disease, as well as an increased risk of mortality due to cancer and urologic or renal disease. The use of salicylates carries no such risk.	HARVARD UNIV,SCH MED,CHANNING LAB,BOSTON,MA 02115	Harvard University; Harvard Medical School	DUBACH, UC (corresponding author), UNIV BASEL,KANTONSSPITAL,MED POLIKLIN,DEPT INTERNAL MED,PETERSGRABEN 4,CH-4031 BASEL,SWITZERLAND.		Stürmer, Til/AAB-5459-2022					ARMITAGE P, 1971, STATISTICAL METHODS; Bengtsson U, 2017, SCAND J UROL, V51, P213, DOI 10.3109/00365596809135358; BRODIE BB, 1948, J PHARMACOL EXP THER, V94, P22; BUCKALEW VM, 1986, MEDICINE, V65, P291, DOI 10.1097/00005792-198609000-00002; CIABATTONI G, 1984, NEW ENGL J MED, V310, P279, DOI 10.1056/NEJM198402023100502; CLIVE DM, 1984, NEW ENGL J MED, V310, P563, DOI 10.1056/NEJM198403013100905; COVESMIT.JR, 1973, LANCET, V2, P70; DUBACH UC, 1983, NEW ENGL J MED, V308, P357, DOI 10.1056/NEJM198302173080703; DUBACH UC, 1968, HELV MED ACTA, V34, P297; DUBACH UC, 1971, AM J EPIDEMIOL, V93, P425, DOI 10.1093/oxfordjournals.aje.a121276; DUBACH UC, 1975, LANCET, V1, P539; DUBACH UC, 1967, GER MED MON, V12, P380; FITZGERALD GA, 1983, J CLIN INVEST, V71, P676, DOI 10.1172/JCI110814; GLOOR F, 1982, PATHOLOGE, V3, P132; KALADELFOS G, 1976, NEPHRON, V16, P388, DOI 10.1159/000180624; KINCAIDSMITH P, 1978, KIDNEY INT, V13, P1, DOI 10.1038/ki.1978.1; KLEINBAUM DG, 1982, EPIDEMIOLOGIC RES; KRISHNAS.S, 1974, AUST NZ J MED, V4, P426; MCGIFF JC, 1980, CLIN SCI, V59, pS105, DOI 10.1042/cs059105s; Moncada S., 1980, GOODMAN GILMANS PHAR, V6th., P668; MURRAY TG, 1983, ARCH INTERN MED, V143, P1687, DOI 10.1001/archinte.143.9.1687; NANRA RS, 1978, KIDNEY INT, V13, P79, DOI 10.1038/ki.1978.11; PETO R, 1977, BRIT J CANCER, V35, P1, DOI 10.1038/bjc.1977.1; PRESCOTT LF, 1982, DRUGS, V23, P75, DOI 10.2165/00003495-198223010-00004; SANDLER DP, 1989, NEW ENGL J MED, V320, P1238, DOI 10.1056/NEJM198905113201903; SPUHLER O, 1953, Z KLIN MED, V151, P1; VANE JR, 1978, AGENTS ACTIONS, V8, P430, DOI 10.1007/BF01968671	27	86	86	1	5	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 17	1991	324	3					155	160		10.1056/NEJM199101173240304	http://dx.doi.org/10.1056/NEJM199101173240304			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ER471	1984193				2022-12-24	WOS:A1991ER47100004
J	SCHAPIRA, DV; URBAN, N				SCHAPIRA, DV; URBAN, N			A MINIMALIST POLICY FOR BREAST-CANCER SURVEILLANCE	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ROUTINE FOLLOW-UP; BONE SCANS; CARCINOMA; METASTASES		FRED HUTCHINSON CANC RES CTR,SEATTLE,WA 98104	Fred Hutchinson Cancer Center	SCHAPIRA, DV (corresponding author), UNIV S FLORIDA,COLL MED,H LEE MOFFITT CANC CTR & RES INST,CANC PREVENT SECT,TAMPA,FL 33612, USA.							BAKER RR, 1977, ANN SURG, V186, P363, DOI 10.1097/00000658-197709000-00014; BLUMENSCHEIN GR, 1983, 3RD EUR ONC RES TREA; BROYN T, 1982, ACTA CHIR SCAND, V148, P401; BURKETT FE, 1979, SURG GYNECOL OBSTET, V149, P523; CANTWELL B, 1982, IRISH J MED SCI, V151, P1, DOI 10.1007/BF02940131; CORCORAN RJ, 1976, RADIOLOGY, V121, P663, DOI 10.1148/121.3.663; HARTUNIAN NS, 1980, AM J PUBLIC HEALTH, V70, P1249, DOI 10.2105/AJPH.70.12.1249; HODGSON TA, 1982, MILBANK FUND Q, V60, P429, DOI 10.2307/3349801; HOLLAND JF, 1983, J CLIN ONCOL, V1, P74; KHANDEKAR JD, 1978, P AM ASSOC CANC RES, V19, P379; LEGHA SS, 1979, ANN INTERN MED, V91, P847, DOI 10.7326/0003-4819-91-6-847; LIPPMAN ME, 1988, DIAGNOSIS MANAGEMENT, P375; MCNEIL BJ, 1978, SURG GYNECOL OBSTET, V147, P745; OCONNELL MJ, 1978, MAYO CLIN PROC, V53, P221; PANDYA KJ, 1985, CANCER, V55, P202, DOI 10.1002/1097-0142(19850101)55:1<202::AID-CNCR2820550132>3.0.CO;2-X; PEDRAZZINI A, 1986, J CLIN ONCOL, V4, P389, DOI 10.1200/JCO.1986.4.3.389; PEREZ DJ, 1983, LANCET, V2, P613; ROSSING N, 1982, EUR J CANCER CLIN ON, V18, P629, DOI 10.1016/0277-5379(82)90208-5; RUSSELL L, 1986, IS PREVENTION BETTER, P116; SCANLON EF, 1980, CANCER, V46, P977, DOI 10.1002/1097-0142(19800815)46:4+<977::AID-CNCR2820461320>3.0.CO;2-0; TABAR L, 1989, J EPIDEMIOL COMMUN H, V43, P107, DOI 10.1136/jech.43.2.107; WARNER KE, 1982, COST BENEFIT COST EF, P93; WICKERHAM L, 1983, BREAST CANCER RES TR, V1, P24; WINCHESTER DP, 1979, CANCER, V43, P956, DOI 10.1002/1097-0142(197903)43:3<956::AID-CNCR2820430326>3.0.CO;2-L; ZWAVELING A, 1987, J SURG ONCOL, V34, P194, DOI 10.1002/jso.2930340314; 1989, STATISTICAL ABSTRACT, P17; 1990, CANCER FACTS FIGURES, P6	27	100	102	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 16	1991	265	3					380	382		10.1001/jama.265.3.380	http://dx.doi.org/10.1001/jama.265.3.380			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ER256	1984538				2022-12-24	WOS:A1991ER25600029
J	DEGASPERI, R; THOMAS, LJ; SUGIYAMA, E; CHANG, HM; BECK, PJ; ORLEAN, P; ALBRIGHT, C; WANECK, G; SAMBROOK, JF; WARREN, CD; YEH, ETH				DEGASPERI, R; THOMAS, LJ; SUGIYAMA, E; CHANG, HM; BECK, PJ; ORLEAN, P; ALBRIGHT, C; WANECK, G; SAMBROOK, JF; WARREN, CD; YEH, ETH			CORRECTION OF A DEFECT IN MAMMALIAN GPI ANCHOR BIOSYNTHESIS BY A TRANSFECTED YEAST GENE	SCIENCE			English	Article									HARVARD UNIV,MASSACHUSETTS GEN HOSP,SCH MED,DEPT MED,ARTHRIT UNIT,BOSTON,MA 02114; UNIV TEXAS,SW MED CTR,DEPT BIOCHEM,DALLAS,TX 75235; HARVARD UNIV,MASSACHUSETTS GEN HOSP,SCH MED,DEPT BIOL CHEM & MOLEC PHARMACOL,BOSTON,MA 02114; HARVARD UNIV,MASSACHUSETTS GEN HOSP,SCH MED,DEPT ANESTHESIA,BOSTON,MA 02114; HARVARD UNIV,MASSACHUSETTS GEN HOSP,SCH MED,DEPT SURG,BOSTON,MA 02114; MIT,CTR CANC RES,CAMBRIDGE,MA 02139	Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT)				Chang, Hui-Ming/0000-0002-5856-3397	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD016942, R01HD021087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P01AR003564] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR-03564] Funding Source: Medline; NICHD NIH HHS [HD-16942, HD-21087] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		BECK PJ, 1990, MOL CELL BIOL, V10, P4612, DOI 10.1128/MCB.10.9.4612; CARAS IW, 1987, SCIENCE, V238, P1280, DOI 10.1126/science.2446389; CHANG H, UNPUB; CHAPMAN A, 1980, J BIOL CHEM, V255, P4441; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CONZELMANN A, 1986, EMBO J, V5, P3291, DOI 10.1002/j.1460-2075.1986.tb04642.x; DEGASPERI R, UNPUB; DOERING TL, 1990, J BIOL CHEM, V265, P611; FATEMI SH, 1986, CELL, V46, P653, DOI 10.1016/0092-8674(86)90340-5; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; FERGUSON MAJ, 1986, J BIOL CHEM, V261, P356; FERGUSON MAJ, 1988, SCIENCE, V239, P753, DOI 10.1126/science.3340856; FERGUSON MAJ, 1988, ANNU REV BIOCHEM, V57, P285; GUPTA D, 1988, SCIENCE, V242, P1446, DOI 10.1126/science.2904699; HOMANS SW, 1988, NATURE, V333, P269, DOI 10.1038/333269a0; HUBBARD SC, 1981, ANNU REV BIOCHEM, V50, P555, DOI 10.1146/annurev.bi.50.070181.003011; LOW MG, 1989, FASEB J, V3, P1600, DOI 10.1096/fasebj.3.5.2522071; MASTERSON WJ, 1989, CELL, V56, P793, DOI 10.1016/0092-8674(89)90684-3; MENON AK, 1988, J BIOL CHEM, V263, P1970; ORLEAN P, 1988, J BIOL CHEM, V263, P17499; ROBERTS WL, 1988, J BIOL CHEM, V263, P18766; SCHWARTZ RT, 1989, J CELL BIOCH SA, V13, P143; THOMAS L, UNPUB; TROWBRIDGE IS, 1979, CELL, V17, P503, DOI 10.1016/0092-8674(79)90258-7; WANECK GL, 1988, SCIENCE, V241, P697, DOI 10.1126/science.3399901; WARREN CD, 1989, SWAINSONINE AND RELATED GLYCOSIDASE INHIBITORS, P304; WARREN CD, 1975, J BIOL CHEM, V250, P8069; WARREN CD, 1983, CARBOHYD RES, V116, P171, DOI 10.1016/0008-6215(83)88107-5; WARREN CD, 1981, CARBOHYD RES, V82, P71; YEH ETH, 1988, CELL, V52, P665, DOI 10.1016/0092-8674(88)90404-7; YEH ETH, 1987, J IMMUNOL, V138, P91	32	90	90	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 16	1990	250	4983					988	991		10.1126/science.1978413	http://dx.doi.org/10.1126/science.1978413			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EH793	1978413				2022-12-24	WOS:A1990EH79300043
J	[Anonymous]				[Anonymous]			WHO ON LOW-DOSE ORAL INTERFERON-ALPHA FOR AIDS	LANCET			English	Editorial Material																		1990, E AFRICAN MED J S2, V67, pSS64	1	0	0	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 13	1990	336	8720					935	935						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EC456	1976944				2022-12-24	WOS:A1990EC45600026
J	BRUNO, P; HASSELL, LH; BROWN, J; TANNER, W; LAU, A				BRUNO, P; HASSELL, LH; BROWN, J; TANNER, W; LAU, A			THE PROTEAN MANIFESTATIONS OF HEMORRHAGIC-FEVER WITH RENAL SYNDROME - A RETROSPECTIVE REVIEW OF 26 CASES FROM KOREA	ANNALS OF INTERNAL MEDICINE			English	Review									USA, 121ST EVACUAT HOSP, YONGSON, SOUTH KOREA; USAF, 13TH MED CTR, CLARK AFB, PHILIPPINES	United States Department of Defense; United States Air Force	BRUNO, P (corresponding author), TRIPLER ARMY MED CTR, INFECT DIS SERV, HONOLULU, HI 96859 USA.							ANTONIADIS A, 1989, REV INFECT DIS, V11, pS891; BRUMMERKORVENKONTIO M, 1980, J INFECT DIS, V141, P131, DOI 10.1093/infdis/141.2.131; BUTKUS DE, 1983, ARCH INTERN MED, V143, P2299, DOI 10.1001/archinte.143.12.2299; CHUN PKC, 1984, AM HEART J, V108, P410, DOI 10.1016/0002-8703(84)90634-3; DESMYTER J, 1983, LANCET, V2, P1445; FORTHAL DN, 1987, AM J EPIDEMIOL, V126, P1210, DOI 10.1093/oxfordjournals.aje.a114760; HULLINGHORST RL, 1953, ANN INTERN MED, V38, P77, DOI 10.7326/0003-4819-38-1-77; LEDUC JW, 1984, AM J TROP MED HYG, V33, P992, DOI 10.4269/ajtmh.1984.33.992; LEE HW, 1984, CAN J MICROBIOL, V30, P1137, DOI 10.1139/m84-178; LEE HW, 1982, J INFECT DIS, V146, P645, DOI 10.1093/infdis/146.5.645; LEE HW, 1981, AM J TROP MED HYG, V30, P1106, DOI 10.4269/ajtmh.1981.30.1106; LEE HW, 1982, J INFECT DIS, V146, P638, DOI 10.1093/infdis/146.5.638; LEE HW, 1978, J INFECT DIS, V137, P298, DOI 10.1093/infdis/137.3.298; LEE HW, 1989, REV INFECT DIS, V11, pS864; Lee HW., 1976, KOREAN J INTERN MED, V19, P371; LEE MH, 1989, REV INFECT DIS, V11, pS877; LEE PW, 1982, LANCET, V2, P1405; LEONCINI F, 1989, Giornale di Malattie Infettive e Parassitarie, V41, P68; LLOYD G, 1984, LANCET, V1, P1175; MCKEE KT, 1985, MIL MED, V150, P640, DOI 10.1093/milmed/150.12.640; MEAKINS JL, 1980, SURG CLIN N AM, V60, P117; Meegan J. M., 1989, MANUAL HEMORRHAGIC F, P83; MELIN JP, 1984, PRESSE MED, V13, P2741; POWELL GM, 1954, MEDICINE, V33, P97, DOI 10.1097/00005792-195405000-00002; SCHMALJOHN CS, 1983, VIROLOGY, V131, P482, DOI 10.1016/0042-6822(83)90514-7; SCHMALJOHN CS, 1985, SCIENCE, V227, P1041, DOI 10.1126/science.2858126; SHEEDY JA, 1954, AM J MED, V16, P619, DOI 10.1016/0002-9343(54)90268-5; TSAI TF, 1987, LAB ANIM SCI, V37, P428; WALKER E, 1984, LANCET, V2, P982; YANAGIHARA R, 1984, NEW ENGL J MED, V310, P1325, DOI 10.1056/NEJM198405173102013; ZHAO CL, 1983, CHINESE J INTERNAL M, V22, P775; ZHEN DH, 1983, CHINESE J INTERNAL M, V22, P774; 1988, MMWR, V37, P95; 1983, B WORLD HEALTH ORGAN, V61, P269; 1988, MMWR, V37, P87	35	55	55	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	SEP 1	1990	113	5					385	391		10.7326/0003-4819-113-5-385	http://dx.doi.org/10.7326/0003-4819-113-5-385			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV651	1974404				2022-12-24	WOS:A1990DV65100010
J	PARRYBILLINGS, M; EVANS, J; CALDER, PC; NEWSHOLME, EA				PARRYBILLINGS, M; EVANS, J; CALDER, PC; NEWSHOLME, EA			DOES GLUTAMINE CONTRIBUTE TO IMMUNOSUPPRESSION AFTER MAJOR BURNS	LANCET			English	Article									DERRIFORD HOSP,SUBREG PLAST SURG & BURNS UNIT,PLYMOUTH,ENGLAND	Derriford Hospital	PARRYBILLINGS, M (corresponding author), UNIV OXFORD,DEPT BIOCHEM,CELLULAR NUTR RES GRP,OXFORD OX1 3QU,ENGLAND.		Calder, Philip C/E-9739-2013	Calder, Philip C/0000-0002-6038-710X				ARDAWI MSM, 1988, CLIN SCI, V74, P165, DOI 10.1042/cs0740165; ARDAWI MSM, 1983, BIOCHEM J, V212, P835, DOI 10.1042/bj2120835; ARDAWI MSM, 1988, METABOLISM, V37, P99, DOI 10.1016/0026-0495(88)90036-4; ASKANAZI J, 1980, ANN SURG, V192, P78, DOI 10.1097/00000658-198007000-00014; BADWEY JA, 1980, J CELL PHYSIOL, V105, P541, DOI 10.1002/jcp.1041050319; BAKER CC, 1980, AM J SURG, V140, P144, DOI 10.1016/0002-9610(80)90431-6; CALDER PC, 1990, BIOCHEM J, V269, P807, DOI 10.1042/bj2690807; CHIANG XJ, 1983, BURNS, V10, P109; GREEN DR, 1988, IMMUNOL TODAY, V9, P253, DOI 10.1016/0167-5699(88)91300-X; GROVES AC, 1978, SURGERY, V83, P138; KNIGHT SC, 1987, LYMPHOCYTES PRACTICA, P189; LUND J, 1986, CLIN SCI, V71, P487, DOI 10.1042/cs0710487; MOSS N M, 1986, Surgical Forum (Chicago), V37, P93; NEWSHOLME EA, 1985, Q J EXP PHYSIOL CMS, V70, P473, DOI 10.1113/expphysiol.1985.sp002935; NEWSHOLME P, 1987, BIOCHEM J, V242, P631, DOI 10.1042/bj2420631; PARRYBILLINGS M, 1989, INT J BIOCHEM, V21, P419, DOI 10.1016/0020-711X(89)90366-2; ROTH E, 1988, CLIN SCI, V75, P641, DOI 10.1042/cs0750641; STINNETT JD, 1982, ANN SURG, V195, P75, DOI 10.1097/00000658-198201001-00012; SZONDY Z, 1989, BIOCHEM J, V261, P979, DOI 10.1042/bj2610979; ZIEGLER F, 1989, CLIN NUTR S, V8, P104	20	289	295	0	9	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 1	1990	336	8714					523	525		10.1016/0140-6736(90)92083-T	http://dx.doi.org/10.1016/0140-6736(90)92083-T			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DW781	1975037				2022-12-24	WOS:A1990DW78100002
J	LICHTIGER, S; PRESENT, DH				LICHTIGER, S; PRESENT, DH			PRELIMINARY-REPORT - CYCLOSPORINE IN TREATMENT OF SEVERE ACTIVE ULCERATIVE-COLITIS	LANCET			English	Article									CUNY MT SINAI SCH MED, NEW YORK, NY 10029 USA	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai								ALLISON M C, 1987, Alimentary Pharmacology and Therapeutics, V1, P39; ATKINSON K, 1983, TRANSPLANT P, V15, P2446; BAKER K, 1989, ALIMENT PHARM THERAP, V3, P143; BOREL JF, 1976, AGENTS ACTIONS, V6, P468, DOI 10.1007/BF01973261; BOREL JF, 1986, ANN NY ACAD SCI, V475, P307, DOI 10.1111/j.1749-6632.1986.tb20879.x; BRYNSKOV J, 1989, NEW ENGL J MED, V321, P845, DOI 10.1056/NEJM198909283211301; COCKBURN I, 1987, TRANSPLANT P, V19, P1804; COHEN DJ, 1984, ANN INTERN MED, V101, P667, DOI 10.7326/0003-4819-101-5-667; DICKINSON RJ, 1980, GASTROENTEROLOGY, V79, P1199; GUPTA S, 1984, LANCET, V2, P1277, DOI 10.1016/S0140-6736(84)92826-5; JARNEROT G, 1985, GASTROENTEROLOGY, V89, P1005; JEWELL DP, 1985, SCAND J GASTROENTERO, V20, P119, DOI 10.3109/00365528509093772; KIRK AP, 1982, BRIT MED J, V284, P1291, DOI 10.1136/bmj.284.6325.1291; KOZAREK RA, 1989, ANN INTERN MED, V110, P353, DOI 10.7326/0003-4819-110-5-353; LARSSON EL, 1980, J IMMUNOL, V124, P2828; LICHTIGER S, 1988, AM J GASTROENTEROL, V83, P1051; MASUDA K, 1989, LANCET, V1, P1093; MEYERS S, 1983, GASTROENTEROLOGY, V85, P351; MEYERS S, 1987, J CLIN GASTROENTEROL, V9, P50, DOI 10.1097/00004836-198702000-00013; MIHATSCH MJ, 1988, KLIN WOCHENSCHR, V66, P43, DOI 10.1007/BF01713009; MYERS BD, 1986, KIDNEY INT, V30, P964, DOI 10.1038/ki.1986.280; NUSSENBLATT RB, 1983, LANCET, V2, P235; PARROTT NR, 1988, BRIT J SURG, V75, P1185, DOI 10.1002/bjs.1800751213; PRESENT DH, 1988, GASTROENTEROLOGY, V94, pA359; PRESENT DH, 1989, ANN INTERN MED, V111, P641, DOI 10.7326/0003-4819-111-8-641; PTACHCINSKI RJ, 1986, CLIN PHARMACOKINET, V11, P107, DOI 10.2165/00003088-198611020-00002; SAVIDGE RS, 1969, POSTGRAD MED J, VS, P101; STARZL TE, 1984, LANCET, V1, P583; TRUELOVE SC, 1974, LANCET, V1, P1067; TRUELOVE SC, 1959, BRIT MED J, V1, P386, DOI 10.1136/bmj.1.5119.387	30	272	279	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 7	1990	336	8706					16	19		10.1016/0140-6736(90)91521-B	http://dx.doi.org/10.1016/0140-6736(90)91521-B			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM385	1973211				2022-12-24	WOS:A1990DM38500005
J	CHEVALIER, JY; DURANDY, Y; BATISSE, A; MATHE, JC; COSTIL, J				CHEVALIER, JY; DURANDY, Y; BATISSE, A; MATHE, JC; COSTIL, J			EXTRACORPOREAL LUNG SUPPORT FOR NEONATAL ACUTE RESPIRATORY-FAILURE - PRELIMINARY-REPORT	LANCET			English	Article									CTR MEDICOCHIRURG PORTE DE CHOISY,DEPT CARDIAC SURG,PARIS,FRANCE		CHEVALIER, JY (corresponding author), HOP TROUSSEAU,PEDIAT INTENS CARE UNIT,F-75571 PARIS 12,FRANCE.							BARTLETT RH, 1986, ANN SURG, V204, P236, DOI 10.1097/00000658-198609000-00003; DORRINGTON KL, 1989, INTENS CARE MED, V15, P184, DOI 10.1007/BF01058571; DURANDY Y, 1990, J THORAC CARDIOV SUR, V99, P404; GATTINONI L, 1980, LANCET, V2, P292; HANNERMAN C, 1989, CLIN PERINATOL, V16, P137; KOLOBOW T, 1987, AM REV RESPIR DIS, V135, P312; MORONT MG, 1989, J THORAC CARDIOV SUR, V97, P706; TRENTO A, 1986, ANN THORAC SURG, V42, P56, DOI 10.1016/S0003-4975(10)61836-X	8	39	39	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JUN 9	1990	335	8702					1364	1366		10.1016/0140-6736(90)91244-5	http://dx.doi.org/10.1016/0140-6736(90)91244-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH145	1971661				2022-12-24	WOS:A1990DH14500004
J	BAGSHAWE, KD; LAWLER, SD; PARADINAS, FJ; DENT, J; BROWN, P; BOXER, GM				BAGSHAWE, KD; LAWLER, SD; PARADINAS, FJ; DENT, J; BROWN, P; BOXER, GM			GESTATIONAL TROPHOBLASTIC TUMORS FOLLOWING INITIAL DIAGNOSIS OF PARTIAL HYDATIDIFORM MOLE	LANCET			English	Article									CHARING CROSS & WESTMINSTER MED SCH,CANC RES CAMPAIGN LAB,LONDON,ENGLAND; CHARING CROSS & WESTMINSTER MED SCH,DEPT HISTOPATHOL,LONDON,ENGLAND; CHARING CROSS & WESTMINSTER MED SCH,DEPT MED ONCOL,LONDON,ENGLAND	Imperial College London; Imperial College London; Imperial College London								ALANEN KA, 1989, CYTOMETRY, V10, P417, DOI 10.1002/cyto.990100409; Bagshawe K.D., 1982, CANC EPIDEMIOLOGY PR, P909; BAGSHAWE KD, 1976, CANCER, V38, P1373, DOI 10.1002/1097-0142(197609)38:3<1373::AID-CNCR2820380342>3.0.CO;2-E; BAGSHAWE KD, 1986, LANCET, V2, P673; BEISCHER NA, 1968, AM J OBSTET GYNECOL, V100, P276, DOI 10.1016/S0002-9378(15)33733-9; FISHER RA, 1987, PLACENTA, V8, P249, DOI 10.1016/0143-4004(87)90048-8; FISHER RA, 1982, BMJ-BRIT MED J, V284, P1218, DOI 10.1136/bmj.284.6324.1218; FISHER RA, 1988, BRIT J CANCER, V58, P788, DOI 10.1038/bjc.1988.310; HEDLEY DW, 1989, CYTOMETRY, V10, P229, DOI 10.1002/cyto.990100302; HEDLEY DW, 1983, J HISTOCHEM CYTOCHEM, V31, P1333, DOI 10.1177/31.11.6619538; HEMMING JD, 1987, J CLIN PATHOL, V40, P615, DOI 10.1136/jcp.40.6.615; JACOBS PA, 1982, ANN HUM GENET, V46, P223, DOI 10.1111/j.1469-1809.1982.tb00714.x; KAJII T, 1977, NATURE, V268, P633, DOI 10.1038/268633a0; LAWLER SD, 1976, BRIT J OBSTET GYNAEC, V83, P651, DOI 10.1111/j.1471-0528.1976.tb00905.x; LAWLER SD, 1982, CANCER GENET CYTOGEN, V5, P309, DOI 10.1016/0165-4608(82)90096-6; LAWLER SD, 1987, PLACENTA, V8, P77, DOI 10.1016/0143-4004(87)90041-5; Ohama K., 1981, NATURE, V29, P551; STONE M, 1976, LANCET, V1, P535; SZULMAN AE, 1985, AM J OBSTET GYNECOL, V152, P1107, DOI 10.1016/0002-9378(85)90572-1; SZULMAN AE, 1978, AM J OBSTET GYNECOL, V131, P665, DOI 10.1016/0002-9378(78)90829-3; 1983, TECHNICAL REPORT SER, V692	21	112	115	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	MAY 5	1990	335	8697					1074	1076		10.1016/0140-6736(90)92641-T	http://dx.doi.org/10.1016/0140-6736(90)92641-T			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC568	1970378				2022-12-24	WOS:A1990DC56800011
J	NELSON, KE; VLAHOV, D; MARGOLICK, J; BERNAL, M; TAYLOR, E				NELSON, KE; VLAHOV, D; MARGOLICK, J; BERNAL, M; TAYLOR, E			BLOOD AND PLASMA DONATIONS AMONG A COHORT OF INTRAVENOUS-DRUG-USERS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									JOHNS HOPKINS UNIV,SCH HYG & PUBL HLTH,DEPT ENVIRONM HLTH SCI,BALTIMORE,MD 21205	Johns Hopkins University	NELSON, KE (corresponding author), JOHNS HOPKINS UNIV,SCH HYG & PUBL HLTH,DEPT EPIDEMIOL,INFECT DIS PROGRAM,ROOM 884,BALTIMORE,MD 21205, USA.				NIDA NIH HHS [DA 04334] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R37DA004334, R01DA004334] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		COHEN ND, 1989, NEW ENGL J MED, V320, P1172, DOI 10.1056/NEJM198905043201803; CUMMING PD, 1989, NEW ENGL J MED, V321, P941, DOI 10.1056/NEJM198910053211405; GIORGI JV, IN PRESS CLIN IMMUNO; HOFFMAN RA, 1980, P NATL ACAD SCI-BIOL, V77, P4914, DOI 10.1073/pnas.77.8.4914; MENITOVE JE, 1989, NEW ENGL J MED, V321, P966, DOI 10.1056/NEJM198910053211409; NESS PM, 1989, NEW ENGL J MED, V321, P615; PRINCE AM, 1986, NEW ENGL J MED, V314, P386; SCHIMPF K, 1989, NEW ENGL J MED, V321, P1148, DOI 10.1056/NEJM198910263211702; STRAMER SL, 1989, JAMA-J AM MED ASSOC, V262, P64, DOI 10.1001/jama.262.1.64; VANDENBERG W, 1986, LANCET, V1, P803; VLAHOV D, IN PRESS LONGITUDINA; WARD JW, 1988, NEW ENGL J MED, V318, P473, DOI 10.1056/NEJM198802253180803; WARD JW, 1989, NEW ENGL J MED, V321, P947, DOI 10.1056/NEJM198910053211406; WHITE GC, 1986, LANCET, V1, P611; 1985, MMWR, V34, P1; 1987, MMWR, V36, P121	16	15	15	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 25	1990	263	16					2194	2197		10.1001/jama.263.16.2194	http://dx.doi.org/10.1001/jama.263.16.2194			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CZ676	1969502				2022-12-24	WOS:A1990CZ67600033
J	POL, S; DEBURE, A; DEGOTT, C; CARNOT, F; LEGENDRE, C; BRECHOT, C; KREIS, H				POL, S; DEBURE, A; DEGOTT, C; CARNOT, F; LEGENDRE, C; BRECHOT, C; KREIS, H			CHRONIC HEPATITIS IN KIDNEY ALLOGRAFT RECIPIENTS	LANCET			English	Article									HOP LAENNEC, UNITE HEPATOL, PARIS, FRANCE; HOP NECKER ENFANTS MALAD, DEPT NEPHROL ADULTE, SERV TRANSPLANTAT, F-75743 PARIS 15, FRANCE; HOP BEAUJON, SERV ANAT PATHOL, CLICHY, FRANCE; HOP LAENNEC, SERV ANAT PATHOL, PARIS, FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Beaujon - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP								Debure A, 1988, Adv Nephrol Necker Hosp, V17, P375; DEGOS F, 1980, TRANSPLANTATION, V29, P100, DOI 10.1097/00007890-198002000-00003; DEGOTT C, 1983, LIVER, V3, P377; DEGROOTE J, 1968, LANCET, V2, P626; DUSHEIKO G, 1983, HEPATOLOGY, V3, P330; HILLIS WD, 1979, JAMA-J AM MED ASSOC, V242, P329, DOI 10.1001/jama.242.4.329; HOOFNAGLE JH, 1982, ANN INTERN MED, V96, P447, DOI 10.7326/0003-4819-96-4-447; KIRKMAN RL, 1982, TRANSPLANTATION, V34, P347, DOI 10.1097/00007890-198212000-00007; LAM KC, 1981, NEW ENGL J MED, V304, P380, DOI 10.1056/NEJM198102123040702; LAQUAGLIA MP, 1981, TRANSPLANTATION, V32, P504, DOI 10.1097/00007890-198112000-00011; PARFREY PS, 1985, TRANSPLANTATION, V39, P610, DOI 10.1097/00007890-198506000-00007; PARFREY PS, 1984, TRANSPLANTATION, V37, P461, DOI 10.1097/00007890-198405000-00008; SAGNELLI E, 1983, HEPATOLOGY, V3, P690; VILLA E, 1982, LANCET, V2, P1243; WEIR MR, 1985, KIDNEY INT, V28, P839, DOI 10.1038/ki.1985.206; WELLER IVD, 1982, GUT, V23, P650, DOI 10.1136/gut.23.8.650	16	119	119	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	APR 14	1990	335	8694					878	880		10.1016/0140-6736(90)90477-M	http://dx.doi.org/10.1016/0140-6736(90)90477-M			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ135	1969984				2022-12-24	WOS:A1990CZ13500004
J	LAURSEN, LS; NAESDAL, J; BUKHAVE, K; LAURITSEN, K; RASKMADSEN, J				LAURSEN, LS; NAESDAL, J; BUKHAVE, K; LAURITSEN, K; RASKMADSEN, J			SELECTIVE 5-LIPOXYGENASE INHIBITION IN ULCERATIVE-COLITIS	LANCET			English	Article									UNIV COPENHAGEN,BISPEBJERG HOSP,DEPT GASTROENTEROL,BISPEBJERG BAKKE,DK-2400 COPENHAGEN,DENMARK; HERLEV UNIV HOSP,DEPT MED GASTROENTEROL,HERLEV,DENMARK; ODENSE UNIV,DEPT MED GASTROENTEROL,DK-5230 ODENSE M,DENMARK; TECH UNIV DENMARK,DEPT BIOCHEM & NUTR,COPENHAGEN,DENMARK	University of Copenhagen; Bispebjerg Hospital; University of Copenhagen; Herlev & Gentofte Hospital; University of Southern Denmark; Technical University of Denmark								BLACKWELL GJ, 1980, NATURE, V287, P147, DOI 10.1038/287147a0; BOKOCH GM, 1981, J BIOL CHEM, V256, P5317; BUKHAVE K, 1983, BIOMED MASS SPECTROM, V10, P265, DOI 10.1002/bms.1200100406; DAVIES P, 1984, ANNU REV IMMUNOL, V2, P335, DOI 10.1146/annurev.immunol.2.1.335; FORDHUTCHINSON AW, 1980, NATURE, V286, P264, DOI 10.1038/286264a0; GOETZL EJ, 1980, J IMMUNOL, V125, P1789; LAURITSEN K, 1987, GUT, V28, P1095, DOI 10.1136/gut.28.9.1095; LAURITSEN K, 1986, GASTROENTEROLOGY, V91, P837, DOI 10.1016/0016-5085(86)90684-0; LAURITSEN K, 1988, GASTROENTEROLOGY, V95, P11, DOI 10.1016/0016-5085(88)90284-3; LAURITSEN K, 1989, INT J COLORECTAL DIS, V4, P75, DOI 10.1007/BF01646865; LEWIS RA, 1980, P NATL ACAD SCI-BIOL, V77, P3710, DOI 10.1073/pnas.77.6.3710; LEWIS RA, 1980, BIOCHEM BIOPH RES CO, V96, P271, DOI 10.1016/0006-291X(80)91210-3; MARCUS AJ, 1985, AM J MED, V78, P805, DOI 10.1016/0002-9343(85)90287-6; NIELSEN OH, 1987, DIGEST DIS SCI, V32, P577, DOI 10.1007/BF01296156; PESKAR BM, 1986, AGENTS ACTIONS, V18, P381, DOI 10.1007/BF01965001; SAMUELSSON B, 1979, PROSTAGLANDINS, V17, P785, DOI 10.1016/0090-6980(79)90052-2; SHARON P, 1984, GASTROENTEROLOGY, V86, P453; SIRCAR JC, 1983, BIOCHEM PHARMACOL, V32, P170, DOI 10.1016/0006-2952(83)90673-1; SMITH MJH, 1980, J PHARM PHARMACOL, V32, P517, DOI 10.1111/j.2042-7158.1980.tb12985.x; STENSON WF, 1982, J CLIN INVEST, V69, P494, DOI 10.1172/JCI110474; WALLACE JL, 1989, GASTROENTEROLOGY, V96, P29, DOI 10.1016/0016-5085(89)90760-9	21	110	114	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	MAR 24	1990	335	8691					683	685						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV305	1969061				2022-12-24	WOS:A1990CV30500003
J	HECKMATT, JZ; LOH, L; DUBOWITZ, V				HECKMATT, JZ; LOH, L; DUBOWITZ, V			NIGHT-TIME NASAL VENTILATION IN NEUROMUSCULAR DISEASE	LANCET			English	Article									RADCLIFFE INFIRM,DEPT ANAESTHET,OXFORD OX2 6HE,ENGLAND	Radcliffe Infirmary	HECKMATT, JZ (corresponding author), HAMMERSMITH HOSP,DEPT PAEDIAT,LONDON W12 0NN,ENGLAND.							BACH J, 1981, ARCH PHYS MED REHAB, V62, P328; BACH JR, 1987, CHEST, V92, P169; CARROLL N, 1988, THORAX, V43, P349, DOI 10.1136/thx.43.5.349; DAVIS JN, 1976, Q J MED, V45, P87; ELLIS ER, 1987, AM REV RESPIR DIS, V136, P188, DOI 10.1164/ajrccm/136.1.188; ELLIS ER, 1987, AM REV RESPIR DIS, V135, P148; GODFREY S, 1970, British Journal of Diseases of the Chest, V64, P15, DOI 10.1016/S0007-0971(70)80045-6; HECKMATT JZ, 1987, BRIT MED J, V295, P1014, DOI 10.1136/bmj.295.6605.1014; HECKMATT JZ, 1989, PEDIATRICS, V83, P250; KERBY GR, 1987, AM REV RESPIR DIS, V135, P738; MILLER JR, 1988, DEV MED CHILD NEUROL, V30, P200; NOBLEJAMIESON CM, 1986, ARCH DIS CHILD, V61, P178, DOI 10.1136/adc.61.2.178; Rideau Y, 1983, Acta Neurol (Napoli), V5, P118; SEGALL D, 1988, CHEST, V93, P1299	14	80	80	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	MAR 10	1990	335	8689					579	582		10.1016/0140-6736(90)90357-B	http://dx.doi.org/10.1016/0140-6736(90)90357-B			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT653	1968582				2022-12-24	WOS:A1990CT65300011
J	JAHRLING, PB; GEISBERT, TW; DALGARD, DW; JOHNSON, ED; KSIAZEK, TG; HALL, WC; PETERS, CJ				JAHRLING, PB; GEISBERT, TW; DALGARD, DW; JOHNSON, ED; KSIAZEK, TG; HALL, WC; PETERS, CJ			PRELIMINARY-REPORT - ISOLATION OF EBOLA VIRUS FROM MONKEYS IMPORTED TO USA	LANCET			English	Article									HAZLETON RES PROD,RESTON,VA; PATHOL ASSOCIATES INC,FREDERICK,MD		JAHRLING, PB (corresponding author), USA,MED RES INST INFECT DIS,DIV DIS ASSESSMENT,FREDERICK,MD 21701, USA.							[Anonymous], 1978, Bull World Health Organ, V56, P271; [Anonymous], 1978, Bull World Health Organ, V56, P247; ARBORIO M, 1989, RES VIROLOGY, V140, P165, DOI 10.1016/S0923-2516(89)80094-9; JAHRLING PB, 1989, DIAGNOSTIC PROCEDURE, P857; LONDON WT, 1977, NATURE, V268, P344, DOI 10.1038/268344a0; MEEGAN J, 1989, RES VIROLOGY, V140, P59, DOI 10.1016/S0923-2516(89)80085-8; RICHMAN DD, 1983, J INFECT DIS, V147, P268, DOI 10.1093/infdis/147.2.268; 1990, MMWR, V39, P22	8	287	311	1	60	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	MAR 3	1990	335	8688					502	505		10.1016/0140-6736(90)90737-P	http://dx.doi.org/10.1016/0140-6736(90)90737-P			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT015	1968529				2022-12-24	WOS:A1990CT01500005
J	PHIPPS, JH; LEWIS, BV; ROBERTS, T; PRIOR, MV; HAND, JW; ELDER, M; FIELD, SB				PHIPPS, JH; LEWIS, BV; ROBERTS, T; PRIOR, MV; HAND, JW; ELDER, M; FIELD, SB			TREATMENT OF FUNCTIONAL MENORRHAGIA BY RADIOFREQUENCY-INDUCED THERMAL ENDOMETRIAL ABLATION	LANCET			English	Article									HAMMERSMITH HOSP,MRC,CYCLOTRON UNIT,HYPERTHERMIA SECT,LONDON W12 0HS,ENGLAND; ROYAL POSTGRAD MED SCH,INST OBSTET & GYNAECOL,LONDON W12 0HS,ENGLAND	Imperial College London; Imperial College London	PHIPPS, JH (corresponding author), WATFORD DIST GEN HOSP,DEPT OBSTET & GYNAECOL,VICARAGE RD,WATFORD WD1 8HB,HERTS,ENGLAND.		Hand, Jeff/AAF-1503-2020	Hand, Jeffrey/0000-0002-4898-9511				ASHERMAN JG, 1948, J OBSTET GYN BRIT EM, V55, P23; ASTRAHAN MA, 1989, INT J HYPERTHER, V5, P383; COAKLEY WT, 1979, J THERM BIOL, V4, P85, DOI 10.1016/0306-4565(79)90051-2; DAVIS J, 1987, BAILLIERE CLIN OB GY, V1, P331, DOI 10.1016/S0950-3552(87)80058-5; DECHERNEY A, 1983, OBSTET GYNECOL, V61, P392; DROEGEMUELLER W, 1971, OBSTET GYNECOL, V38, P256; GOLDRATH MH, 1987, GYNAECOLOGICAL LASER, P253; LOMANO JM, 1988, AM J OBSTET GYNECOL, V159, P152, DOI 10.1016/0002-9378(88)90512-1; SUGAHARA T, 1989, HYPERTHERMIC ONCOLOG	9	77	86	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	FEB 17	1990	335	8686					374	376		10.1016/0140-6736(90)90207-L	http://dx.doi.org/10.1016/0140-6736(90)90207-L			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN988	1968117				2022-12-24	WOS:A1990CN98800004
J	WAPNER, RJ; DAVIS, GH; JOHNSON, A; WEINBLATT, VJ; FISCHER, RL; JACKSON, LG; CHERVENAK, FA; MCCULLOUGH, LB				WAPNER, RJ; DAVIS, GH; JOHNSON, A; WEINBLATT, VJ; FISCHER, RL; JACKSON, LG; CHERVENAK, FA; MCCULLOUGH, LB			SELECTIVE REDUCTION OF MULTIFETAL PREGNANCIES	LANCET			English	Article									CORNELL UNIV, MED CTR, NEW YORK HOSP, DEPT OBSTET & GYNECOL, NEW YORK, NY 10021 USA; BAYLOR UNIV, CTR ETH MED & PUBL ISSUES, HOUSTON, TX 77030 USA; THOMAS JEFFERSON UNIV, DEPT OBSTET & GYNECOL, DIV MATERNAL FETAL MED, PHILADELPHIA, PA 19107 USA; THOMAS JEFFERSON UNIV, DEPT MED, DIV GENET & FETAL MED, PHILADELPHIA, PA 19107 USA	Cornell University; NewYork-Presbyterian Hospital; Baylor University; Jefferson University; Jefferson University			Chervenak, Frank/P-3555-2017; Sampiev, Abdulmutalip/O-9577-2017	Chervenak, Frank/0000-0002-4600-0853; Sampiev, Abdulmutalip/0000-0002-5100-2239; Wapner, Ronald/0000-0003-0727-1244				ABERG A, 1978, LANCET, V2, P990; ANNAS G, 1984, NEW ENGL J MED, V316, P1213; ANTSAKLIS A, 1984, PRENATAL DIAG, V4, P289, DOI 10.1002/pd.1970040408; BECK L, 1980, GEBURTSH FRAUENHEILK, V40, P397, DOI 10.1055/s-2008-1037329; BENIRSCHKE K, 1961, NY J MED, V61, P1499; BERKOWITZ RL, 1988, NEW ENGL J MED, V318, P1043, DOI 10.1056/NEJM198804213181607; Dumez Y, 1986, Contrib Gynecol Obstet, V15, P50; EVANS MI, 1988, OBSTET GYNECOL, V71, P289; FARQUHARSON DF, 1988, AM J OBSTET GYNECOL, V158, P413, DOI 10.1016/0002-9378(88)90167-6; FINK IJ, 1982, J ULTRAS MED, V1, P337, DOI 10.7863/jum.1982.1.8.337; GOLBUS MS, 1988, AM J MED GENET, V31, P339, DOI 10.1002/ajmg.1320310211; ITSKOVITZ J, 1989, AM J OBSTET GYNECOL, V160, P215, DOI 10.1016/0002-9378(89)90125-7; JACKSON L, 1987, AM J HUM GENET, V3, P826; KERENYI TD, 1981, NEW ENGL J MED, V304, P1525, DOI 10.1056/NEJM198106183042505; KORANYI G, 1975, ACTA PAEDIATR HUNG, V16, P119; LANDY HJ, 1986, AM J OBSTET GYNECOL, V155, P14, DOI 10.1016/0002-9378(86)90068-2; LUBCHENCO LO, 1963, PEDIATRICS, V32, P793; MELNICK M, 1977, LANCET, V2, P1287; MOORE CM, 1969, J PEDIATR, V74, P523, DOI 10.1016/S0022-3476(69)80034-X; NEWMAN RB, 1989, AM J OBSTET GYNECOL, V161, P547, DOI 10.1016/0002-9378(89)90354-2; PETRES RE, 1981, NEW ENGL J MED, V305, P1218; REDWINE FO, 1984, ACTA GENET MED GEMEL, V33, P35, DOI 10.1017/S0001566000007467; REISMAN LE, 1966, AM J DIS CHILD, V111, P541, DOI 10.1001/archpedi.1966.02090080119011; RODECK CH, 1984, ACTA GENET MED GEMEL, V33, P57, DOI 10.1017/S0001566000007509; RODECK CH, 1982, PRENATAL DIAG, V2, P189, DOI 10.1002/pd.1970020308; ROMERO R, 1984, NEW ENGL J MED, V310, P772, DOI 10.1056/NEJM198403223101207; SKELLY H, 1982, AM J OBSTET GYNECOL, V142, P595, DOI 10.1016/0002-9378(82)90769-4; TIETZE C, 1986, INDUCED ABORTION WOR, P11	28	117	118	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 13	1990	335	8681					90	93		10.1016/0140-6736(90)90550-O	http://dx.doi.org/10.1016/0140-6736(90)90550-O			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CH516	1967427				2022-12-24	WOS:A1990CH51600013
J	GASTON, RS; JULIAN, BA; DIETHELM, AG; CURTIS, JJ				GASTON, RS; JULIAN, BA; DIETHELM, AG; CURTIS, JJ			EFFECTS OF ENALAPRIL ON ERYTHROCYTOSIS AFTER RENAL-TRANSPLANTATION	ANNALS OF INTERNAL MEDICINE			English	Note							ERYTHROPOIETIN; HYPERTENSION; RENIN		UNIV ALABAMA, DEPT SURG, BIRMINGHAM, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	GASTON, RS (corresponding author), UNIV ALABAMA, MED CTR, DIV NEPHROL, UAB STN, BIRMINGHAM, AL 35294 USA.		Gaston, Robert/AAR-2932-2020					AEBERHARD JM, 1990, TRANSPLANTATION, V50, P613, DOI 10.1097/00007890-199010000-00017; BAKRIS GL, 1990, NEW ENGL J MED, V323, P86, DOI 10.1056/NEJM199007123230203; FRIMAN S, 1990, NEPHROL DIAL TRANSPL, V5, P969, DOI 10.1093/ndt/5.11.969; GOULD AB, 1980, J LAB CLIN MED, V96, P523; ISLAM MS, 1990, TRANSPLANT INT, V3, P222, DOI 10.1111/j.1432-2277.1990.tb01928.x; JACKSON B, 1990, J LAB CLIN MED, V115, P21; MURRAY BM, 1990, AM J KIDNEY DIS, V16, P66, DOI 10.1016/S0272-6386(12)80787-6; THOMAS DJ, 1977, LANCET, V2, P941, DOI 10.1016/S0140-6736(77)90885-6; VLAHAKOS DV, 1991, AM J KIDNEY DIS, V17, P199, DOI 10.1016/S0272-6386(12)81129-2; WICKRE CG, 1983, KIDNEY INT, V23, P731, DOI 10.1038/ki.1983.86; WILLIAMS GH, 1988, NEW ENGL J MED, V319, P1517	11	66	67	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 15	1991	115	12					954	955		10.7326/0003-4819-115-12-954	http://dx.doi.org/10.7326/0003-4819-115-12-954			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU417	1952492				2022-12-24	WOS:A1991GU41700008
J	FEIGHERY, E; ALTMAN, DG; SHAFFER, G				FEIGHERY, E; ALTMAN, DG; SHAFFER, G			THE EFFECTS OF COMBINING EDUCATION AND ENFORCEMENT TO REDUCE TOBACCO SALES TO MINORS - A STUDY OF 4 NORTHERN CALIFORNIA COMMUNITIES	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							YOUNG ADULTHOOD; DRUG-USE; PROGRESSION; ADOLESCENCE; CIGARETTES; PATTERNS; CHILDREN	Objective. - To examine the effects of a community education and law enforcement intervention on illegal tobacco sales to minors. Design. - A 2-year, before and after trial with retail stores as the unit of analysis. Setting. - Implementation occurred in four suburban California communities with populations of 25000 to 100000. Participants. - All the retail stores in one intervention community and half the retail stores, randomly selected, in the other three intervention communities (n = 169) were visited by minors aged 14 to 16 years with the intent to purchase tobacco. Intervention. - Ongoing community and merchant education and four law enforcement operations were conducted. Main Outcome Measures. - Over-the-counter and vending machine sales of tobacco to minors were the primary outcomes. Results. - Among a cohort of stores visited by minors at the pretest (n = 104) in June 1988, 71% sold tobacco over the counter and 92% sold tobacco through vending machines. At posttest 2 in May 1990, 24% sold tobacco over the counter and 93% sold tobacco through vending machines. Of the 31 stores issued citations, 16 were followed into the courts where the fines were dismissed or reduced. Conclusions. - Education alone had a limited effect on reducing illegal tobacco sales to minors. It did promote community support for more aggressive enforcement strategies. Education plus enforcement decreased significantly over-the-counter sales; vending machine sales were unaffected by these interventions. The lack of support at the judicial level may temper the effectiveness of enforcement. Legislative remedies addressing judicial obstacles and vending machine sales are needed.	N BAY HLTH RESOURCES CTR,PETALUMA,CA		FEIGHERY, E (corresponding author), STANFORD UNIV,MED CTR,SCH MED,CTR RES DIS PREVENT,1000 WELCH RD,STANFORD,CA 94305, USA.							ALTMAN DG, 1991, AM J PUBLIC HEALTH, V81, P891, DOI 10.2105/AJPH.81.7.891; ALTMAN DG, 1989, JAMA-J AM MED ASSOC, V261, P80, DOI 10.1001/jama.261.1.80; ASHLEY MJ, 1988, ANNU REV PUBL HEALTH, V9, P233; DIFRANZA JR, 1987, JAMA-J AM MED ASSOC, V257, P3387, DOI 10.1001/jama.257.24.3387; DIFRANZA JR, 1990, JAMA-J AM MED ASSOC, V263, P2784, DOI 10.1001/jama.263.20.2784; FLEMING R, 1989, ADDICT BEHAV, V14, P261, DOI 10.1016/0306-4603(89)90057-9; GREYDANUS DE, 1989, JAMA-J AM MED ASSOC, V261, P99, DOI 10.1001/jama.261.1.99; HOLDER HD, 1988, JAN I MED PAN OPP RE; HOLDER HD, 1987, ADV SUBST ABUSE S1, V1, P405; KIRN TF, 1987, JAMA-J AM MED ASSOC, V257, P3323; MILGRAM GG, 1986, HDB PREVENTION, P243; YAMAGUCHI K, 1984, AM J PUBLIC HEALTH, V74, P668, DOI 10.2105/AJPH.74.7.668; YAMAGUCHI K, 1984, AM J PUBLIC HEALTH, V74, P673, DOI 10.2105/AJPH.74.7.673; 1989, SURGEON GENERALS WOR; 1990, YOUTH ACCESS CIGARET; 1988, 888406 DEP HLTH HUM; 1990, TOBACCO USE CALIFORN	17	83	83	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 11	1991	266	22					3168	3171						4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GT654	1956106				2022-12-24	WOS:A1991GT65400027
J	WANG, J; BEDZYK, MJ; PENNER, TL; CAFFREY, M				WANG, J; BEDZYK, MJ; PENNER, TL; CAFFREY, M			STRUCTURAL STUDIES OF MEMBRANES AND SURFACE-LAYERS UP TO 1,000 A THICK USING X-RAY STANDING WAVES	NATURE			English	Article							BRAGG-DIFFRACTION; INTERFACE; REFLECTION; FIELDS	THE X-ray standing wave (XSW) method, developed in the 1960s, was used originally to determine heavy atom positions in and on silicon and germanium single crystals 1-7. An X-ray standing wave generated by the interference of coherent incident and reflected beams excites X-ray fluorescence from the heavy atom, the intensity of which as a function of incident angle provides an indication of the atom's distance from the X-ray reflecting surface. The availability of X-ray mirrors and the ability to prepare layered synthetic microstructures has made possible the study of biologically relevant structures using the XSW technique on length scales of typically tens to hundreds of angstroms 8-12, allowing heavy atoms in such structures to be located with angstrom or subangstrom resolution. Many model biological systems (such as Langmuir-Blodgett films, which mimic membranes) require access to still larger scales, but it is not obvious that an XSW will remain coherent over such length scales. Here we report studies of a lipid multilayer system using the XSW method, in which we have been able to locate the metal atoms in a zinc arachidate bilayer with angstrom resolution at a distance of almost 1,000 angstrom above the surface of a gold mirror. Our results indicate that the XSW technique should be useful for structural studies of supramolecular aggregates, receptor-ligand interactions and multi-membrane stacks, in which length scales of this order are encountered.	CORNELL UNIV,CORNELL HIGH ENERGY SYNCHROTRON SOURCE,ITHACA,NY 14853; EASTMAN DENT CTR,CORP RES LABS,ROCHESTER,NY 14620	Cornell University; Eastman Chemical Company; University of Rochester	WANG, J (corresponding author), OHIO STATE UNIV,DEPT CHEM,COLUMBUS,OH 43210, USA.		Bedzyk, Michael J/B-7503-2009; Bedzyk, Michael J/K-6903-2013					ANDERSEN SK, 1976, PHYS REV LETT, V37, P1141, DOI 10.1103/PhysRevLett.37.1141; BATTERMAN BW, 1969, PHYS REV LETT, V22, P703, DOI 10.1103/PhysRevLett.22.703; BATTERMAN BW, 1964, PHYS REV A, V133, P759; BECKER RS, 1983, PHYS REV LETT, V50, P153, DOI 10.1103/PhysRevLett.50.153; BEDZYK MJ, 1985, PHYS REV B, V31, P4110, DOI 10.1103/PhysRevB.31.4110; BEDZYK MJ, 1990, SCIENCE, V248, P52, DOI 10.1126/science.2321026; BEDZYK MJ, 1989, PHYS REV LETT, V62, P1376, DOI 10.1103/PhysRevLett.62.1376; BEDZYK MJ, 1988, SCIENCE, V241, P1788, DOI 10.1126/science.3175619; BLOCH JM, 1985, PHYS REV LETT, V54, P1039, DOI 10.1103/PhysRevLett.54.1039; COWAN PL, 1980, PHYS REV LETT, V44, P1680, DOI 10.1103/PhysRevLett.44.1680; DEBOER DKG, 1991, PHYS REV B, V44, P498, DOI 10.1103/PhysRevB.44.498; GOLOVCHENKO JA, 1982, PHYS REV LETT, V49, P560, DOI 10.1103/PhysRevLett.49.560; GOLOVCHENKO JA, 1974, PHYS REV B, V10, P4239, DOI 10.1103/PhysRevB.10.4239; IIDA A, 1985, JPN J APPL PHYS 2, V24, pL675, DOI 10.1143/JJAP.24.L675; MARRA WC, 1979, J APPL PHYS, V50, P6927, DOI 10.1063/1.325845; PARRATT LG, 1954, PHYS REV, V95, P359, DOI 10.1103/PhysRev.95.359; ZHELUDEVA SI, 1990, THIN SOLID FILMS, V193, P395, DOI 10.1016/S0040-6090(05)80049-5	17	62	64	1	15	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	DEC 5	1991	354	6352					377	380		10.1038/354377a0	http://dx.doi.org/10.1038/354377a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT761	1956399				2022-12-24	WOS:A1991GT76100045
J	BARR, GS; COATESWORTH, AP				BARR, GS; COATESWORTH, AP			PASSIVE SMOKING AND OTITIS-MEDIA WITH EFFUSION	BRITISH MEDICAL JOURNAL			English	Article							CHILDREN		QUEEN ELIZABETH HOSP,DEPT OTOLARYNGOL,BIRMINGHAM B15 2TH,W MIDLANDS,ENGLAND	University of Birmingham								HINTON AE, 1989, J LARYNGOL OTOL, V103, P559, DOI 10.1017/S0022215100109326; MAW AR, 1987, SCOTT BROWNS OTOLARY, V6, P159; RICHARDSON K, 1976, BRIT J AUDIOL, V10, P117; ROBINSON GC, 1967, CAN MED ASSOC J, V97, P1199; STRACHAN DP, 1989, BRIT MED J, V298, P1549, DOI 10.1136/bmj.298.6687.1549	5	17	18	0	2	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 26	1991	303	6809					1032	1033		10.1136/bmj.303.6809.1032	http://dx.doi.org/10.1136/bmj.303.6809.1032			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GM478	1954455	Green Published, Bronze			2022-12-24	WOS:A1991GM47800021
J	BRENOWITZ, EA				BRENOWITZ, EA			ALTERED PERCEPTION OF SPECIES-SPECIFIC SONG BY FEMALE BIRDS AFTER LESIONS OF A FOREBRAIN NUCLEUS	SCIENCE			English	Article							WHITE-CROWNED SPARROW; AUDITORY RESPONSES; SEXUAL DIMORPHISM; ZEBRA FINCHES; CANARY; RECOGNITION; NEURONS; SYSTEM; BRAIN	Female birds that do not normally sing possess brain nuclei associated with song production in males. To determine whether one song nucleus, the caudal nucleus of the ventral hyperstriatum (HVc), acts in conspecific song perception, courtship responses of female canaries to canary and white-crowned sparrow songs were compared before and after HVc lesions. Bilateral lesions of a portion of the HVc resulted in copulation solicitations to heterospecific song as well as conspecific song. Control females continued to respond only to conspecific song. This suggests that the HVc is critical for conspecific song perception in females. Because female canaries do not normally sing, neurons in female HVc must develop response selectivity by a mechanism different from that proposed for male birds in the motor theory of song perception.	UNIV WASHINGTON, DEPT ZOOL, SEATTLE, WA 98195 USA	University of Washington; University of Washington Seattle	BRENOWITZ, EA (corresponding author), UNIV WASHINGTON, DEPT PSYCHOL, SEATTLE, WA 98195 USA.		Galantucci, Bruno/E-5770-2010		NIDCD NIH HHS [DC 00487] Funding Source: Medline; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R29DC000487] Funding Source: NIH RePORTER	NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		BAKER MC, 1981, SCIENCE, V214, P819, DOI 10.1126/science.214.4522.819; BAKER MC, 1984, BRAIN RES, V295, P85, DOI 10.1016/0006-8993(84)90818-7; Baptista L. F., 1975, U CALIF PUBL ZOOL, V105; BRENOWITZ E A, 1986, Society for Neuroscience Abstracts, V12, P314; Ingle, 1983, ADV VERTEBRATE NEURO; KATZ LC, 1981, BRAIN RES, V221, P192, DOI 10.1016/0006-8993(81)91073-8; KELLEY DB, 1979, J COMP NEUROL, V183, P455, DOI 10.1002/cne.901830302; KING AP, 1977, SCIENCE, V195, P1002, DOI 10.1126/science.841321; LIBERMAN AM, 1982, AM PSYCHOL, V37, P148, DOI 10.1037/0003-066X.37.2.148; MARGOLIASH D, 1986, J NEUROSCI, V6, P1643; MILLER DB, 1979, NATURE, V280, P389, DOI 10.1038/280389a0; MILLER DB, 1979, ANIM BEHAV, V27, P376, DOI 10.1016/0003-3472(79)90172-6; NOTTEBOHM F, 1978, Z TIERPSYCHOL, V46, P298; NOTTEBOHM F, 1976, SCIENCE, V194, P211, DOI 10.1126/science.959852; NOTTEBOHM F, 1982, J COMP NEUROL, V207, P344, DOI 10.1002/cne.902070406; NOTTEBOHM F, 1987, HDB PHYSL 1, P85; NOTTEBOHM F, 1984, BIOL PERSPECTIVES LA, P65; PESCH A, 1985, J ORNITHOL, V126, P108, DOI 10.1007/BF01640450; SEARCY WA, 1984, Z TIERPSYCHOL, V66, P128; SEARCY WA, 1988, NATURE, V332, P152, DOI 10.1038/332152a0; VOLMAN S F, 1987, Society for Neuroscience Abstracts, V13, P870; WILLIAMS H, 1985, SCIENCE, V229, P279, DOI 10.1126/science.4012321	22	209	212	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 18	1991	251	4991					303	305		10.1126/science.1987645	http://dx.doi.org/10.1126/science.1987645			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET678	1987645				2022-12-24	WOS:A1991ET67800030
J	SPEISER, PW; AGDERE, L; UESHIBA, H; WHITE, PC; NEW, MI				SPEISER, PW; AGDERE, L; UESHIBA, H; WHITE, PC; NEW, MI			ALDOSTERONE SYNTHESIS IN SALT-WASTING CONGENITAL ADRENAL-HYPERPLASIA WITH COMPLETE ABSENCE OF ADRENAL 21-HYDROXYLASE	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PLASMA DEOXYCORTICOSTERONE; STEROID 21-HYDROXYLATION; DEFICIENCY; GENE; PROGESTERONE; WOMEN; CYTOCHROME-P-450-1; RADIOIMMUNOASSAY; REARRANGEMENTS; FASCICULATA	Background: Congenital adrenal hyperplasia due to 21-hydroxylase deficiency is a disorder of cortisol and aldosterone biosynthesis that results from mutations in the CYP21 gene encoding the adrenal 21-hydroxylase P-450c21. It can cause severe salt wasting in newborns that requires long-term treatment with glucocorticoids and mineralocorticoids. We describe a spontaneous partial recovery from this disorder in a 19-year-old woman who had discontinued treatment. Methods. We measured plasma and urinary levels of adrenal hormones, plasma renin activity, and sodium balance longitudinally in the patient and four other patients in whom adrenal hyperplasia had been diagnosed in infancy and in whom DNA analysis had predicted a complete absence of functional P-450c21. The ratio of plasma renin activity to urinary aldosterone was used as a measure of the response of the adrenal zona glomerulosa. Two patients underwent intravenous infusion of [H-3]progesterone for the measurement of extraadrenal production of 21-hydroxylated precursors of aldosterone. Results. The patient who had discontinued her medication excreted a normal amount of aldosterone (20.0 nmol per square meter of body-surface area per day) while following a diet low in sodium. Her ratio of plasma renin activity to urinary aldosterone-18-glucuronide excretion was 1.7 after three days of sodium restriction, as compared with a ratio of 4.7 at the age of nine years (normal range, 0.03 to 0.1). The percentage of extraadrenal conversion of progesterone to deoxycorticosterone was low. The four other patients had variable responses to sodium restriction after the neonatal period (range for plasma renin activity:urinary aldosterone-18-glucuronide, 1.9 to 19.4). Conclusions. Although patients with salt-wasting 21-hydroxylase deficiency have functionally equivalent mutations in their CYP21 genes, they may vary from one another and over time in their ability to produce mineralocorticoids. This variation may be attributable to another adrenal enzyme with 21-hydroxylase activity.			SPEISER, PW (corresponding author), CORNELL UNIV,MED CTR,NEW YORK HOSP,DEPT PEDIAT,525 E 68TH ST,NEW YORK,NY 10021, USA.				EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD000072, R01HD000072] Funding Source: NIH RePORTER; NCRR NIH HHS [RR-47, RR-06020-01] Funding Source: Medline; NICHD NIH HHS [HD-00072] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		AMOR M, 1988, P NATL ACAD SCI USA, V85, P1600, DOI 10.1073/pnas.85.5.1600; ANTONIPILLAI I, 1983, J CLIN ENDOCR METAB, V56, P93, DOI 10.1210/jcem-56-1-93; ANTONIPILLAI I, 1983, J CLIN ENDOCR METAB, V57, P580, DOI 10.1210/jcem-57-3-580; CHAKMAKJIAN ZH, 1974, ANAL LETT, V7, P97; CHIOU SH, 1990, J BIOL CHEM, V265, P3549; DIETER HH, 1982, BIOCHEM BIOPH RES CO, V105, P515, DOI 10.1016/0006-291X(82)91465-6; DUPONT B, 1984, HISTOCOMPATIBILITY T, P660; GLOBERMAN H, 1988, J CLIN INVEST, V82, P139, DOI 10.1172/JCI113562; HIGASHI Y, 1986, P NATL ACAD SCI USA, V83, P2841, DOI 10.1073/pnas.83.9.2841; HORNER JM, 1979, J CLIN ENDOCR METAB, V48, P776, DOI 10.1210/jcem-48-5-776; JOHNSON EF, 1989, ARCH BIOCHEM BIOPHYS, V273, P273, DOI 10.1016/0003-9861(89)90484-0; KORTHSCHUTZ S, 1978, J CLIN ENDOCR METAB, V46, P452, DOI 10.1210/jcem-46-3-452; KUHNLE U, 1981, J CLIN ENDOCR METAB, V52, P534, DOI 10.1210/jcem-52-3-534; LUETSCHER JA, 1962, T ASSOC AM PHYSICIAN, V75, P293; MACDONALD PC, 1982, J CLIN INVEST, V69, P469, DOI 10.1172/JCI110471; MELLON SH, 1989, J CLIN INVEST, V84, P1497, DOI 10.1172/JCI114325; MOREL Y, 1989, J CLIN INVEST, V83, P527, DOI 10.1172/JCI113914; MOREL Y, 1989, J CLIN ENDOCR METAB, V68, P592, DOI 10.1210/jcem-68-3-592; NEW MI, 1970, J CLIN ENDOCR METAB, V30, P361, DOI 10.1210/jcem-30-3-361; NEW MI, 1966, J CLIN INVEST, V45, P412, DOI 10.1172/JCI105356; OKINO ST, 1987, J BIOL CHEM, V262, P16072; OKINO ST, 1988, J BIOL CHEM, V263, P2576; PANG S, 1977, J CLIN ENDOCR METAB, V45, P1003, DOI 10.1210/jcem-45-5-1003; PRADER A, 1958, Helv Paediatr Acta, V13, P5; PREIBISZ JJ, 1982, CARDIOVASC REV REP, V3, P787; RAUH W, 1978, KLIN WOCHENSCHR, V56, P161, DOI 10.1007/BF01477468; ROSENBLOOM AL, 1966, PEDIATRICS, V38, P215; SINNOTT PJ, 1989, J MED GENET, V26, P10, DOI 10.1136/jmg.26.1.10; STONER E, 1986, CLIN ENDOCRINOL, V24, P9, DOI 10.1111/j.1365-2265.1986.tb03249.x; STRACHAN T, 1990, CLIN ENDOCRINOL, V32, P373, DOI 10.1111/j.1365-2265.1990.tb00878.x; TUKEY RH, 1985, J BIOL CHEM, V260, P3347; TUSIELUNA MT, 1990, J BIOL CHEM, V265, P20916; WHITE PC, 1989, ENDOCR RES, V15, P239, DOI 10.1080/07435808909039099; WHITE PC, 1984, P NATL ACAD SCI-BIOL, V81, P7505, DOI 10.1073/pnas.81.23.7505; WHITE PC, 1987, NEW ENGL J MED, V316, P1580, DOI 10.1056/NEJM198706183162506; WHITE PC, 1988, P NATL ACAD SCI USA, V85, P4436, DOI 10.1073/pnas.85.12.4436; WHITE PC, 1986, P NATL ACAD SCI USA, V83, P5111, DOI 10.1073/pnas.83.14.5111; WHITE PC, 1987, NEW ENGL J MED, V316, P1519, DOI 10.1056/NEJM198706113162406; WINKEL CA, 1980, J CLIN INVEST, V66, P803, DOI 10.1172/JCI109918; WINKEL CA, 1983, J CLIN ENDOCR METAB, V56, P104, DOI 10.1210/jcem-56-1-104	40	63	65	0	2	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 17	1991	324	3					145	149		10.1056/NEJM199101173240302	http://dx.doi.org/10.1056/NEJM199101173240302			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ER471	1984191				2022-12-24	WOS:A1991ER47100002
J	STROUPBENHAM, CA; TREVINO, FM				STROUPBENHAM, CA; TREVINO, FM			REPRODUCTIVE CHARACTERISTICS OF MEXICAN-AMERICAN, MAINLAND PUERTO-RICAN, AND CUBAN-AMERICAN WOMEN - DATA FROM THE HISPANIC HEALTH AND NUTRITION EXAMINATION SURVEY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LOW-BIRTH-WEIGHT; UNITED-STATES; CONTRACEPTIVE USE; SOCIOECONOMIC-STATUS; DEPRESSIVE SYMPTOMS; NATIONAL SURVEY; FAMILY GROWTH; PREVALENCE; CANCER; FERTILITY	Data from the Hispanic Health and Nutrition Examination Survey were used to investigate reproductive characteristics of Hispanic females aged 15 to 45 years. Mexican-American and Puerto Rican women reported approximately 1.9 and 1.7 live births each, respectively, whereas Cuban-American women reported 1.1. Mexican-American women were more likely to be using oral contraceptives and were more likely to have had a hysterectomy or an oophorectomy than were Cubans and Puerto Ricans. The largest percentage fo tubal ligations were found among Puerto Rican women. Mexican women who had been pregnant in the previous 12 months were more likely than their Puerto Rican and Cuban-American counterparts to be breastfeeding. Further research is needed to investigate the decision processes and/or cultural variations that may be responsible for these differences in reproductive traits across national origin groups.			STROUPBENHAM, CA (corresponding author), UNIV TEXAS, MED BRANCH, CTR CROSS CULTURAL RES, OFF EDUC DEV, 144 GAIL BORDEN BLDG F-64, GALVESTON, TX 77550 USA.							BACHRACH CA, 1984, FAM PLANN PERSPECT, V16, P253, DOI 10.2307/2134914; BACHRACH CA, 1984, PHS851250 US DEP HLT; BLOOM B, 1981, PHS821250 US DEP HLT; BRYANT CA, 1982, SOC SCI MED, V16, P1757, DOI 10.1016/0277-9536(82)90269-6; DELEON CFM, 1988, AM J EPIDEMIOL, V127, P150; Diehl A K, 1989, Adv Intern Med, V34, P73; EHLING MB, 1981, CULTURE CHILDREARING, P192; FOMON SJ, 1971, ACTA PAEDIATR SC   S, V223, P3; FRERICHS RR, 1981, AM J EPIDEMIOL, V113, P691, DOI 10.1093/oxfordjournals.aje.a113149; HAMMAN RF, 1989, AM J EPIDEMIOL, V129, P295, DOI 10.1093/oxfordjournals.aje.a115134; HANIS CL, 1983, AM J EPIDEMIOL, V118, P659, DOI 10.1093/oxfordjournals.aje.a113677; HAZUDA HP, 1988, AM J EPIDEMIOL, V128, P1289, DOI 10.1093/oxfordjournals.aje.a115082; Herold J M, 1986, Fam Plann Perspect, V18, P185, DOI 10.2307/2947984; HIRSCHMAN C, 1979, VITAL HLTH STAT, V23; HOWE HL, 1984, AM J PUBLIC HEALTH, V74, P560, DOI 10.2105/AJPH.74.6.560; HUMBLE CG, 1985, AM J PUBLIC HEALTH, V75, P145, DOI 10.2105/AJPH.75.2.145; HUNT IF, 1984, AM J CLIN NUTR, V40, P508, DOI 10.1093/ajcn/40.3.508; KLEINMAN JC, 1985, AM J EPIDEMIOL, V121, P843, DOI 10.1093/oxfordjournals.aje.a114055; KOVAR MG, 1985, VITAL HLTH STAT, V1, pCH11; LACROIX AZ, 1989, AM J EPIDEMIOL, V129, P669, DOI 10.1093/oxfordjournals.aje.a115183; MOHRER J, 1979, MED ANTHROPOL, V39, P125; MOSHER WD, 1987, STUD FAMILY PLANN, V18, P83, DOI 10.2307/1966699; MOSHER WD, 1988, FAM PLANN PERSPECT, V20, P207, DOI 10.2307/2135622; MOSHER WD, 1981, VITA HLTH STAT, V23; NEWACHECK PW, 1989, PEDIATRICS, V84, P1056; POKRAS R, 1988, AM J PUBLIC HEALTH, V78, P852, DOI 10.2105/AJPH.78.7.852; PRAGER K, 1984, PUBLIC HEALTH REP, V99, P117; PRATT WF, 1984, POPUL BULL, V39, P3; PRESSER HB, 1980, INT FAM PLAN PERSPEC, V6, P20; RASSIN DK, 1984, PEDIATRICS, V73, P132; RICHARDSON JL, 1987, PREV MED, V16, P761, DOI 10.1016/0091-7435(87)90016-8; RUSSELLBRIEFEL R, 1985, AM J PUBLIC HEALTH, V75, P1173, DOI 10.2105/AJPH.75.10.1173; SAMUELS SE, 1985, AM J CLIN NUTR, V42, P504, DOI 10.1093/ajcn/42.3.504; SCRIBNER R, 1989, AM J PUBLIC HEALTH, V79, P1263, DOI 10.2105/AJPH.79.9.1263; SHAI D, 1986, PUBLIC HEALTH REP, V101, P547; SMITH JC, 1982, AM J PUBLIC HEALTH, V72, P59, DOI 10.2105/AJPH.72.1.59; SMITH PB, 1986, J DEV BEHAV PEDIATR, V7, P346; VEGA W, 1984, AM J EPIDEMIOL, V120, P592, DOI 10.1093/oxfordjournals.aje.a113921; VENTURA SJ, 1984, 33 DEP HLGH HUM SERV; WESTOFF CF, 1986, SCIENCE, V234, P554, DOI 10.1126/science.3532324; WRIGHT AL, 1988, PEDIATRICS, V82, P496; 1989, 1987 DEMOGRAPHIC YB, P698; 1989, STATISTIAL ABSTRACT; 1988, CURRENT POPULATI P20, V427; 1988, CURRENT POPULATI P60, V161; 1983, 1980 CENSUS POPULATI, V1	46	29	29	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	1991	265	2					222	226		10.1001/jama.265.2.222	http://dx.doi.org/10.1001/jama.265.2.222			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EQ602	1984151				2022-12-24	WOS:A1991EQ60200029
J	SIMMONDS, P; ZHANG, LQ; WATSON, HG; REBUS, S; FERGUSON, ED; BALFE, P; LEADBETTER, GH; YAP, PL; PEUTHERER, JF; LUDLAM, CA				SIMMONDS, P; ZHANG, LQ; WATSON, HG; REBUS, S; FERGUSON, ED; BALFE, P; LEADBETTER, GH; YAP, PL; PEUTHERER, JF; LUDLAM, CA			HEPATITIS-C QUANTIFICATION AND SEQUENCING IN BLOOD PRODUCTS, HEMOPHILIACS, AND DRUG-USERS	LANCET			English	Article									ROYAL INFIRM, DEPT HAEMATOL, LAURISTON PL, EDINBURGH EH3 9YW, MIDLOTHIAN, SCOTLAND; EDINBURGH & SE SCOTLAND REG BLOOD TRANSFUS SERV, EDINBURGH, SCOTLAND; UNIV EDINBURGH, DEPT MED MICROBIOL, EDINBURGH EH8 9YL, MIDLOTHIAN, SCOTLAND; UNIV EDINBURGH, DEPT GENET, EDINBURGH EH8 9YL, MIDLOTHIAN, SCOTLAND	Royal Infirmary of Edinburgh; University of Edinburgh; University of Edinburgh				Balfe, Peter/0000-0002-6246-0876; Simmonds, Peter/0000-0002-7964-4700				ALIZON M, 1986, CELL, V46, P63, DOI 10.1016/0092-8674(86)90860-3; ALSHAWI R, 1988, MOL CELL BIOL, V8, P4821, DOI 10.1128/MCB.8.11.4821; ALTER HJ, 1989, NEW ENGL J MED, V321, P1494, DOI 10.1056/NEJM198911303212202; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; FELSENSTEIN J, 1988, ANNU REV GENET, V22, P521, DOI 10.1146/annurev.ge.22.120188.002513; GARSON JA, 1990, LANCET, V335, P1419, DOI 10.1016/0140-6736(90)91446-H; GARSON JA, 1990, LANCET, P1473; HOUGHTON M, 318216 PUBL; HOUGHTON M, Patent No. 883109925; LI WH, 1985, MOL BIOL EVOL, V2, P150; MACFARLANE IG, 1990, LANCET, P754; MILLER RH, 1990, P NATL ACAD SCI USA, V87, P2057, DOI 10.1073/pnas.87.6.2057; SIMMONDS P, 1990, J VIROL, V64, P864, DOI 10.1128/JVI.64.2.864-872.1990; SIMMONDS P, 1990, J VIROL, V64, P5840, DOI 10.1128/JVI.64.12.5840-5850.1990; SKIDMORE S, 1990, LANCET, P1346; STARCICH BR, 1986, CELL, V45, P637, DOI 10.1016/0092-8674(86)90778-6; WEINER AJ, 1990, LANCET, P1	18	208	217	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 15	1990	336	8729					1469	1472		10.1016/0140-6736(90)93179-S	http://dx.doi.org/10.1016/0140-6736(90)93179-S			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EN157	1979093				2022-12-24	WOS:A1990EN15700004
J	CHENG, MY; HARTL, FU; HORWICH, AL				CHENG, MY; HARTL, FU; HORWICH, AL			THE MITOCHONDRIAL CHAPERONIN HSP60 IS REQUIRED FOR ITS OWN ASSEMBLY	NATURE			English	Article									YALE UNIV,SCH MED,DEPT HUMAN GENET,NEW HAVEN,CT 06510; UNIV MUNICH,INST PHYSIOL CHEM,W-8000 MUNICH 2,GERMANY	Yale University; University of Munich	CHENG, MY (corresponding author), YALE UNIV,SCH MED,HOWARD HUGHES MED INST,333 CEDAR ST,NEW HAVEN,CT 06510, USA.		Hartl, F. Ulrich/Y-8206-2019					BAHR GF, 1962, J CELL BIOL, V15, P489, DOI 10.1083/jcb.15.3.489; BARRACLOUGH R, 1980, BIOCHIM BIOPHYS ACTA, V608, P19, DOI 10.1016/0005-2787(80)90129-X; CHENG MY, 1989, NATURE, V337, P620, DOI 10.1038/337620a0; CHENG MY, 1990, THESIS YALE U; ELLIS RJ, 1989, TRENDS BIOCHEM SCI, V14, P339, DOI 10.1016/0968-0004(89)90168-0; GOLOUBINOFF P, 1989, NATURE, V342, P884, DOI 10.1038/342884a0; HARTL FU, 1990, SCIENCE, V247, P930, DOI 10.1126/science.2406905; HEMMINGSEN SM, 1988, NATURE, V333, P330, DOI 10.1038/333330a0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LASKEY RA, 1978, NATURE, V275, P416, DOI 10.1038/275416a0; LISSIN NM, 1990, NATURE, V348, P339, DOI 10.1038/348339a0; LUCK DJL, 1965, J CELL BIOL, V24, P461, DOI 10.1083/jcb.24.3.461; MCMULLIN TW, 1988, MOL CELL BIOL, V8, P371, DOI 10.1128/MCB.8.1.371; MUSGROVE JE, 1987, EUR J BIOCHEM, V163, P529, DOI 10.1111/j.1432-1033.1987.tb10900.x; OSTERMANN J, 1989, NATURE, V341, P125, DOI 10.1038/341125a0; PELHAM HRB, 1976, EUR J BIOCHEM, V67, P247, DOI 10.1111/j.1432-1033.1976.tb10656.x; READING DS, 1989, NATURE, V337, P655, DOI 10.1038/337655a0; ROTHMAN JE, 1989, CELL, V59, P591, DOI 10.1016/0092-8674(89)90005-6; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350	19	164	166	0	10	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 29	1990	348	6300					455	458		10.1038/348455a0	http://dx.doi.org/10.1038/348455a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK697	1978929				2022-12-24	WOS:A1990EK69700067
J	LIN, HJ; LAI, CL; LAU, JYN; CHUNG, HT; LAUDER, IJ; FONG, MW				LIN, HJ; LAI, CL; LAU, JYN; CHUNG, HT; LAUDER, IJ; FONG, MW			EVIDENCE FOR INTRAFAMILIAL TRANSMISSION OF HEPATITIS-B VIRUS FROM SEQUENCE-ANALYSIS OF MUTANT HBV DNAS IN 2 CHINESE FAMILIES	LANCET			English	Article									UNIV HONG KONG, DEPT MED, HONG KONG, HONG KONG; UNIV HONG KONG, DEPT STAT, HONG KONG, HONG KONG; UNIV HONG KONG, ADV STUDIES UNIT, HONG KONG, HONG KONG	University of Hong Kong; University of Hong Kong; University of Hong Kong			Lai, Ching Lung/C-4298-2009	Lai, Ching-Lung/0000-0002-5927-2436				BENPORATH E, 1985, J CLIN INVEST, V76, P1338, DOI 10.1172/JCI112108; BICHKO V, 1985, FEBS LETT, V185, P208, DOI 10.1016/0014-5793(85)80771-7; BURRELL CJ, 1979, NATURE, V279, P43, DOI 10.1038/279043a0; CHAN V, 1988, BLOOD, V72, P1420; CHARNAY P, 1979, P NATL ACAD SCI USA, V76, P2222, DOI 10.1073/pnas.76.5.2222; COUROUCEPAUTY AM, 1979, J INFECT DIS, V140, P975, DOI 10.1093/infdis/140.6.975; ESTACIO RC, 1988, J GASTROEN HEPATOL, V3, P215, DOI 10.1111/j.1440-1746.1988.tb00241.x; FRANKS AL, 1989, NEW ENGL J MED, V321, P1301, DOI 10.1056/NEJM198911093211905; GAN RB, 1987, SCI CHINA SER B, V30, P507; HOOFNAGLE JH, 1977, GASTROENTEROLOGY, V72, P290; Iswari S. R., 1985, ICMR Annals, V5, P39; KANEKO S, 1989, J INFECT DIS, V160, P903, DOI 10.1093/infdis/160.5.903; KOBAYASHI M, 1984, GENE, V30, P227; LAI CL, 1989, ASIA PACIFIC C SERIE, V91, P34; LEE SD, 1986, HEPATOLOGY, V6, P369, DOI 10.1002/hep.1840060306; Lin H J, 1989, Adv Clin Chem, V27, P143, DOI 10.1016/S0065-2423(08)60183-3; LIN HJ, 1987, J VIROL METHODS, V15, P139, DOI 10.1016/0166-0934(87)90057-7; LIN HJ, 1986, J INFECT DIS, V154, P983, DOI 10.1093/infdis/154.6.983; LIN TM, 1989, ANTICANCER RES, V9, P737; LOK ASF, 1987, AM J EPIDEMIOL, V126, P492, DOI 10.1093/oxfordjournals.aje.a114681; OKAMOTO H, 1987, JPN J EXP MED, V57, P217; OKAMOTO H, 1986, J GEN VIROL, V67, P2305, DOI 10.1099/0022-1317-67-11-2305; OKAMOTO H, 1987, JPN J EXP MED, V57, P231; ONO Y, 1983, NUCLEIC ACIDS RES, V11, P1747, DOI 10.1093/nar/11.6.1747; PASEK M, 1979, NATURE, V282, P575, DOI 10.1038/282575a0; PUGH JC, 1986, J MED VIROL, V20, P229, DOI 10.1002/jmv.1890200305; RHO HM, 1989, NUCLEIC ACIDS RES, V17, P2124, DOI 10.1093/nar/17.5.2124; SHAFRITZ DA, 1981, HEPATOLOGY, V1, P1, DOI 10.1002/hep.1840010102; SOULIER JP, 1973, VOX SANG, V25, P212, DOI 10.1111/j.1423-0410.1973.tb04366.x; STEVENS CE, 1975, NEW ENGL J MED, V292, P771, DOI 10.1056/NEJM197504102921503; TAKAHASHI T, 1976, J IMMUNOL, V117, P1392	31	34	35	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JUL 28	1990	336	8709					208	212		10.1016/0140-6736(90)91735-S	http://dx.doi.org/10.1016/0140-6736(90)91735-S			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DQ701	1973772				2022-12-24	WOS:A1990DQ70100005
J	STCLAIR, D; BLACKWOOD, D; MUIR, W; CAROTHERS, A; WALKER, M; SPOWART, G; GOSDEN, C; EVANS, HJ				STCLAIR, D; BLACKWOOD, D; MUIR, W; CAROTHERS, A; WALKER, M; SPOWART, G; GOSDEN, C; EVANS, HJ			ASSOCIATION WITHIN A FAMILY OF A BALANCED AUTOSOMAL TRANSLOCATION WITH MAJOR MENTAL-ILLNESS	LANCET			English	Article									UNIV EDINBURGH,ROYAL EDINBURGH HOSP,DEPT PSYCHIAT,EDINBURGH EH8 9YL,MIDLOTHIAN,SCOTLAND	Royal Infirmary of Edinburgh; University of Edinburgh	STCLAIR, D (corresponding author), WESTERN GEN HOSP,MRC,HUMAN GENET UNIT,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND.		St Clair, David/AAN-2412-2021		Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		BARON M, 1976, AM J PSYCHIAT, V133, P1070; BARTON D E, 1988, Genomics, V3, P17, DOI 10.1016/0888-7543(88)90153-X; ENDICOTT J, 1978, ARCH GEN PSYCHIAT, V35, P837; GERSHON ES, 1986, ARCH GEN PSYCHIAT, V143, P1098; GRANDY DK, 1989, AM J HUM GENET, V45, P778; GUZE SB, 1983, ARCH GEN PSYCHIAT, V40, P1273; JACOBS PA, 1970, ANN HUM GENET, V33, P325, DOI 10.1111/j.1469-1809.1970.tb01658.x; KARLSSON JL, 1988, BRIT J PSYCHIAT, V152, P324, DOI 10.1192/bjp.152.3.324; KENDLER KS, 1982, ARCH GEN PSYCHIAT, V39, P1257; KENDLER KS, 1986, AM J PSYCHIAT, V143, P1098; LATHROP GM, 1984, AM J HUM GENET, V36, P460; ROBERTSON M, 1989, NATURE, V342, P222, DOI 10.1038/342222a0; RUTTER M, 1984, AUST NZ J PSYCHIAT, V18, P225, DOI 10.3109/00048678409161295; SEEMAN P, 1989, P NATL ACAD SCI USA, V86, P10156, DOI 10.1073/pnas.86.24.10156; SEEMAN P, 1984, SCIENCE, V225, P728, DOI 10.1126/science.6147018; SHERRINGTON R, 1988, NATURE, V336, P164, DOI 10.1038/336164a0; SMITH M, 1989, American Journal of Human Genetics, V45, pA220; SPITZER RL, 1987, RES DIAGNOSTIC CRITE; TSUANG MT, 1980, BRIT J PSYCHIAT, V137, P497, DOI 10.1192/bjp.137.6.497; WEINTRAUB S, 1987, SCHIZOPHRENIA BULL, V13, P439, DOI 10.1093/schbul/13.3.439; ZEITLIN J, 1986, MAUDSLEY MONOGRAPHS, V29; 1987, DIAGNOSTIC STATISTIC	22	580	596	1	27	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JUL 7	1990	336	8706					13	16		10.1016/0140-6736(90)91520-K	http://dx.doi.org/10.1016/0140-6736(90)91520-K			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DM385	1973210				2022-12-24	WOS:A1990DM38500004
J	KHUROO, MS; ZARGAR, SA; MAHAJAN, R				KHUROO, MS; ZARGAR, SA; MAHAJAN, R			HEPATOBILIARY AND PANCREATIC ASCARIASIS IN INDIA	LANCET			English	Article											KHUROO, MS (corresponding author), SHERIKASHMIR INST MED SCI,DEPT GASTROENTEROL,POB 27,SRINAGAR,KASHMIR 190011,INDIA.		Khuroo, Mohammad Sultan/N-3571-2014	Khuroo, Mohammad Sultan/0000-0003-2823-8814				CERRI GG, 1983, RADIOLOGY, V146, P753, DOI 10.1148/radiology.146.3.6828691; CHUGH T D, 1970, Indian Journal of Pathology and Bacteriology, V13, P38; Crompton DWT, 1985, ASCARIASIS ITS PUBLI; Crompton DWT, 1989, ASCARIASIS ITS PREVE; HLAING T, 1987, J TROP MED HYG, V90, P165; KAMATH PS, 1986, GASTROENTEROLOGY, V91, P730, DOI 10.1016/0016-5085(86)90646-3; KHUROO MS, 1989, GUT, V30, P201, DOI 10.1136/gut.30.2.201; KHUROO MS, 1985, GASTROENTEROLOGY, V88, P418, DOI 10.1016/0016-5085(85)90501-3; KHUROO MS, 1987, GASTROENTEROLOGY, V93, P267, DOI 10.1016/0016-5085(87)91013-4; LLOYD DA, 1981, BRIT J SURG, V8, P468; MAKI T, 1966, ANN SURG, V164, P90, DOI 10.1097/00000658-196607000-00010; MANIALAWI MS, 1986, ENDOSCOPY, V18, P204, DOI 10.1055/s-2007-1018375; MUIR JBG, 1982, BMJ-BRIT MED J, V11, P1077; NOVIS IMS, 1923, BRIT J SURG, V10, P421; OSBORNE DH, 1981, BRIT J SURG, V68, P758, DOI 10.1002/bjs.1800681103; RANEY R, 1970, ANN INTERN MED, V72, P405, DOI 10.7326/0003-4819-72-3-405; ROBINSON KP, 1966, BRIT J SURG, V53, P430, DOI 10.1002/bjs.1800530512; SCHULMAN A, 1982, AM J ROENTGENOL, V139, P485, DOI 10.2214/ajr.139.3.485; SCHULMAN A, 1977, AM J GASTROENTEROL, V68, P167; WRIGHT RM, 1963, ARCH SURG-CHICAGO, V86, P72; YANG SCH, 1946, ANN SURG, V123, P299, DOI 10.1097/00000658-194602000-00009; 1989, LANCET, V1, P997	22	167	175	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JUN 23	1990	335	8704					1503	1506		10.1016/0140-6736(90)93037-P	http://dx.doi.org/10.1016/0140-6736(90)93037-P			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK586	1972440				2022-12-24	WOS:A1990DK58600011
J	MAL, F; MEYRIER, A; CALLARD, P; ALTMAN, JJ; KLEINKNECHT, D; BEAUGRAND, M; FERRIER, JP				MAL, F; MEYRIER, A; CALLARD, P; ALTMAN, JJ; KLEINKNECHT, D; BEAUGRAND, M; FERRIER, JP			TRANSJUGULAR RENAL BIOPSY	LANCET			English	Article									HOP AVICENNE,SERV NEPHROL,BOBIGNY,FRANCE; CTR HOSP MONTREUIL,SERV NEPHROL,MONTREUIL,FRANCE; HOP JEAN VERDIER,SERV ANAT PATHOL,F-93140 BONDY,FRANCE; CTR PASTEUR VALLERY RADOT,PARIS,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Jean-Verdier - APHP	MAL, F (corresponding author), HOP JEAN VERDIER,SERV HEPATOGASTROENTEROL,F-93140 BONDY,FRANCE.		Meyrier, Alain/GWQ-3527-2022					ALMKUIST RD, 1979, UROL CLIN N AM, V6, P503; BOLTON WK, 1977, J UROLOGY, V117, P696, DOI 10.1016/S0022-5347(17)58590-0; CHODAK GW, 1983, KIDNEY INT, V24, P804, DOI 10.1038/ki.1983.232; COHEN AH, 1989, AM J NEPHROL, V9, P309, DOI 10.1159/000167986; Diaz-Buxo J A, 1975, Clin Nephrol, V4, P223; GILL WB, 1973, J UROLOGY, V109, P538, DOI 10.1016/S0022-5347(17)60473-7; GONICK P, 1978, Urology, V11, P568, DOI 10.1016/0090-4295(78)90004-3; KARK RM, 1958, ARCH INTERN MED, V101, P439, DOI 10.1001/archinte.1958.00260140271038; LEBREC D, 1982, GASTROENTEROLOGY, V83, P338; MUTH RG, 1965, J UROLOGY, V94, P1; NOMOTO Y, 1987, NEPHRON, V45, P224, DOI 10.1159/000184122; SAITOH M, 1984, UROL RADIOL, V6, P30, DOI 10.1007/BF02923695; WICKRE CG, 1982, AM J NEPHROL, V2, P173, DOI 10.1159/000166640	13	44	44	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JUN 23	1990	335	8704					1512	1513		10.1016/0140-6736(90)93040-V	http://dx.doi.org/10.1016/0140-6736(90)93040-V			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK586	1972443				2022-12-24	WOS:A1990DK58600014
J	BLACKMAN, M; KAPPLER, J; MARRACK, P				BLACKMAN, M; KAPPLER, J; MARRACK, P			THE ROLE OF THE T-CELL RECEPTOR IN POSITIVE AND NEGATIVE SELECTION OF DEVELOPING T-CELLS	SCIENCE			English	Article									UNIV COLORADO, HLTH SCI CTR, DEPT MICROBIOL & IMMUNOL, DENVER, CO 80206 USA; UNIV COLORADO, HLTH SCI CTR, DEPT MED, DENVER, CO 80206 USA; UNIV COLORADO, HLTH SCI CTR, DEPT BIOCHEM, DENVER, CO 80206 USA; UNIV COLORADO, HLTH SCI CTR, DEPT BIOPHYS & GENET, DENVER, CO 80206 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	BLACKMAN, M (corresponding author), NATL JEWISH CTR IMMUNOL & RESP MED, DEPT MED, HOWARD HUGHES INST, DENVER, CO 80206 USA.		Marrack, Philippa/AHE-6316-2022	Marrack, Philippa/0000-0003-1883-3687	NIAID NIH HHS [AI 17134, AI 18785, AI 22295] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI017134, R56AI017134, R56AI018785, R37AI018785, R37AI017134, R01AI018785, P01AI022295] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ARDEN B, 1985, NATURE, V316, P783, DOI 10.1038/316783a0; BABBITT BP, 1985, NATURE, V317, P359, DOI 10.1038/317359a0; BANK I, 1985, J EXP MED, V162, P1294, DOI 10.1084/jem.162.4.1294; BENOIST C, 1989, CELL, V58, P1027, DOI 10.1016/0092-8674(89)90501-1; BERG LJ, 1989, NATURE, V340, P559, DOI 10.1038/340559a0; BERG LJ, 1989, CELL, V58, P1035, DOI 10.1016/0092-8674(89)90502-3; BERG LJ, 1990, CELL, V60, P1043, DOI 10.1016/0092-8674(90)90352-F; BEVAN MJ, 1978, IMMUNOL REV, V42, P3, DOI 10.1111/j.1600-065X.1978.tb00256.x; BIDDISON WE, 1984, J EXP MED, V159, P783, DOI 10.1084/jem.159.3.783; BILL J, 1988, P NATL ACAD SCI USA, V85, P9184, DOI 10.1073/pnas.85.23.9184; BILL J, 1989, NATURE, V341, P649, DOI 10.1038/341649a0; BILL J, 1989, J EXP MED, V169, P1405, DOI 10.1084/jem.169.4.1405; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; BJORKMAN PJ, 1987, NATURE, V329, P512, DOI 10.1038/329512a0; BLACKMAN M, IN PRESS NATURE; BLACKMAN M, UNPUB; BLACKMAN MA, 1988, IMMUNOL REV, V101, P5, DOI 10.1111/j.1600-065X.1988.tb00730.x; BLACKMAN MA, 1989, SCIENCE, V244, P214, DOI 10.1126/science.2784868; BORN W, 1987, J IMMUNOL, V138, P999; BROWN JH, 1988, NATURE, V332, P845, DOI 10.1038/332845a0; BURGERT HG, 1989, J EXP MED, V170, P1887, DOI 10.1084/jem.170.6.1887; BURKLY LC, 1989, NATURE, V342, P564, DOI 10.1038/342564a0; BUUS S, 1986, CELL, V47, P1071, DOI 10.1016/0092-8674(86)90822-6; COWING C, 1985, IMMUNOL TODAY, V6, P72, DOI 10.1016/0167-5699(85)90018-0; DAVIS M, 1986, ANNU REV IMMUNOL, V4, P529; FINK PJ, 1986, NATURE, V321, P219, DOI 10.1038/321219a0; FINKEL TH, 1989, CELL, V58, P1047, DOI 10.1016/0092-8674(89)90503-5; FOWLKES BJ, 1988, NATURE, V334, P620, DOI 10.1038/334620a0; FOWLKES BJ, 1989, ADV IMMUNOL, V44, P207; FRY AM, 1989, SCIENCE, V246, P1044, DOI 10.1126/science.2511630; FRY AM, 1989, J IMMUNOL, V143, P2723; HAPP MP, 1989, P NATL ACAD SCI USA, V86, P6293, DOI 10.1073/pnas.86.16.6293; HODES RJ, 1989, SCIENCE, V246, P1041, DOI 10.1126/science.2587987; JENKINSON EJ, 1982, EUR J IMMUNOL, V12, P583, DOI 10.1002/eji.1830120710; KANAGAWA O, 1989, CELL IMMUNOL, V119, P412, DOI 10.1016/0008-8749(89)90255-4; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; KAPPLER JW, 1987, CELL, V49, P263, DOI 10.1016/0092-8674(87)90567-8; KAPPLER JW, 1988, NATURE, V332, P35, DOI 10.1038/332035a0; KAPPLER JW, 1989, J EXP MED, V169, P1533, DOI 10.1084/jem.169.5.1533; KISIELOW P, 1988, NATURE, V335, P730, DOI 10.1038/335730a0; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; KYEWSKI BA, 1984, NATURE, V308, P196, DOI 10.1038/308196a0; LO D, 1986, NATURE, V319, P672, DOI 10.1038/319672a0; LORENZ RG, 1989, NATURE, V340, P557, DOI 10.1038/340557a0; LORENZ RG, 1989, NATURE, V337, P560, DOI 10.1038/337560a0; MACDONALD HR, 1988, J EXP MED, V167, P2005, DOI 10.1084/jem.167.6.2005; MACDONALD HR, 1988, NATURE, V336, P471, DOI 10.1038/336471a0; MACDONALD HR, 1988, NATURE, V332, P40, DOI 10.1038/332040a0; MACDONALD HR, 1988, NATURE, V335, P174, DOI 10.1038/335174a0; MARKMANN J, 1988, NATURE, V336, P476, DOI 10.1038/336476a0; MARRACK P, 1989, COLD SPRING HARB SYM, V54, P105; MARRACK P, 1988, J IMMUNOL, V140, P2508; MARRACK P, 1989, NATURE, V338, P503, DOI 10.1038/338503a0; MARRACK P, 1987, SCIENCE, V238, P1073, DOI 10.1126/science.3317824; MARRACK P, 1988, NATURE, V332, P840, DOI 10.1038/332840a0; MARRACK P, UNPUB; MARUSICGALESIC S, 1988, NATURE, V333, P180, DOI 10.1038/333180a0; MCDUFFIE M, 1986, P NATL ACAD SCI USA, V83, P8728, DOI 10.1073/pnas.83.22.8728; MCDUFFIE M, 1988, J IMMUNOL, V141, P1840; MOORE MW, 1988, CELL, V54, P777, DOI 10.1016/S0092-8674(88)91043-4; MORRISON LA, 1986, J EXP MED, V163, P903, DOI 10.1084/jem.163.4.903; MUELLER DL, 1989, ANNU REV IMMUNOL, V7, P445, DOI 10.1146/annurev.iy.07.040189.002305; MURPHY DB, 1989, NATURE, V338, P765, DOI 10.1038/338765a0; NIKOLICZUGIC J, 1990, NATURE, V344, P65, DOI 10.1038/344065a0; PIRCHER H, 1989, EMBO J, V8, P719, DOI 10.1002/j.1460-2075.1989.tb03431.x; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; PULLEN AM, 1988, NATURE, V335, P796, DOI 10.1038/335796a0; QIN SX, 1989, J EXP MED, V169, P779, DOI 10.1084/jem.169.3.779; RAMMENSEE HG, 1989, NATURE, V339, P541, DOI 10.1038/339541a0; RAMSDELL F, 1989, SCIENCE, V246, P1038, DOI 10.1126/science.2511629; RAMSDELL F, 1990, SCIENCE, V248, P1342, DOI 10.1126/science.1972593; READY AR, 1984, NATURE, V310, P231, DOI 10.1038/310231a0; ROEHM N, 1984, CELL, V38, P577, DOI 10.1016/0092-8674(84)90512-9; SCHWARTZ RH, 1990, SCIENCE, V248, P1349, DOI 10.1126/science.2113314; SCOLLAY R, 1984, IMMUNOL TODAY, V5, P168; SHA WC, 1988, NATURE, V336, P73, DOI 10.1038/336073a0; SMITH CA, 1989, NATURE, V337, P181, DOI 10.1038/337181a0; SMITH H, 1989, SCIENCE, V245, P749, DOI 10.1126/science.2788921; SPRENT J, 1987, ADV IMMUNOL, V41, P39, DOI 10.1016/S0065-2776(08)60030-9; SWAIN SL, 1983, IMMUNOL REV, V74, P129, DOI 10.1111/j.1600-065X.1983.tb01087.x; TITE JP, 1986, J MOL CELL IMMUNOL, V2, P179; VONBOEHMER H, 1984, EUR J IMMUNOL, V14, P1048, DOI 10.1002/eji.1830141116; WEISS A, 1986, ANNU REV IMMUNOL, V4, P593, DOI 10.1146/annurev.iy.04.040186.003113; WHITE J, 1989, CELL, V56, P27, DOI 10.1016/0092-8674(89)90980-X; WOODLAND D, 1990, SCIENCE, V247, P964, DOI 10.1126/science.1968289; YAGI J, 1990, INT IMMUNOL, V2, P83, DOI 10.1093/intimm/2.1.83; ZINKERNA.RM, 1974, NATURE, V251, P547, DOI 10.1038/251547a0; ZINKERNAGEL RM, 1978, J EXP MED, V147, P882, DOI 10.1084/jem.147.3.882	88	607	621	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 15	1990	248	4961					1335	1341		10.1126/science.1972592	http://dx.doi.org/10.1126/science.1972592			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ501	1972592				2022-12-24	WOS:A1990DJ50100026
J	RAMSDELL, F; FOWLKES, BJ				RAMSDELL, F; FOWLKES, BJ			CLONAL DELETION VERSUS CLONAL ANERGY - THE ROLE OF THE THYMUS IN INDUCING SELF TOLERANCE	SCIENCE			English	Article									NIAID, CELLULAR & MOLEC IMMUNOL LAB, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)								ABE R, 1988, NATURE, V335, P827, DOI 10.1038/335827a0; ABE R, 1989, ANNU REV IMMUNOL, V7, P683, DOI 10.1146/annurev.iy.07.040189.003343; ADKINS B, 1987, ANNU REV IMMUNOL, V5, P325, DOI 10.1146/annurev.iy.05.040187.001545; ALLISON J, 1988, NATURE, V333, P529, DOI 10.1038/333529a0; BARCLAY AN, 1981, J EXP MED, V153, P1666, DOI 10.1084/jem.153.6.1666; BERG LJ, 1989, NATURE, V340, P559, DOI 10.1038/340559a0; BERG LJ, 1989, CELL, V58, P1035, DOI 10.1016/0092-8674(89)90502-3; BILL J, 1989, J EXP MED, V169, P1405, DOI 10.1084/jem.169.4.1405; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; BJORKMAN PJ, 1987, NATURE, V329, P512, DOI 10.1038/329512a0; BLACKMAN M, 1990, SCIENCE, V248, P1335, DOI 10.1126/science.1972592; BRETSCHER P, 1970, SCIENCE, V169, P1042, DOI 10.1126/science.169.3950.1042; BURKLY LC, 1989, NATURE, V342, P564, DOI 10.1038/342564a0; Burnet F., 1959, CLONAL SELECTION THE, DOI DOI 10.5962/BHL.TITLE.8281; DEMBIC Z, 1987, NATURE, V326, P510, DOI 10.1038/326510a0; DORN A, 1988, MOL CELL BIOL, V8, P3975, DOI 10.1128/MCB.8.10.3975; DOSREIS GA, 1983, J EXP MED, V157, P1287, DOI 10.1084/jem.157.4.1287; DOYLE C, 1987, NATURE, V330, P256, DOI 10.1038/330256a0; EGERTON M, 1990, INT IMMUNOL, V2, P157, DOI 10.1093/intimm/2.2.157; FESTENSTEIN H, 1989, IMMUNOL REV, V107, P29, DOI 10.1111/j.1600-065X.1989.tb00002.x; FLAJNIK MF, 1985, EUR J IMMUNOL, V15, P540, DOI 10.1002/eji.1830150603; FLEISCHER B, 1988, J EXP MED, V167, P1697, DOI 10.1084/jem.167.5.1697; FOWLKES BJ, 1988, NATURE, V334, P620, DOI 10.1038/334620a0; FOWLKES BJ, 1989, ADV IMMUNOL, V44, P207; FRASER JD, 1989, NATURE, V339, P221, DOI 10.1038/339221a0; FRY AM, 1989, SCIENCE, V246, P1044, DOI 10.1126/science.2511630; FRY AM, 1988, NATURE, V335, P830, DOI 10.1038/335830a0; GABERT J, 1987, CELL, V50, P545, DOI 10.1016/0092-8674(87)90027-4; GAO EK, 1989, J EXP MED, V170, P1947, DOI 10.1084/jem.170.6.1947; GORDON RD, 1976, J EXP MED, V144, P810, DOI 10.1084/jem.144.3.810; GROVES ES, 1983, J EXP MED, V158, P1483, DOI 10.1084/jem.158.5.1483; GUERDER S, IN PRESS QUANTITATIV; GUNTHER J, 1982, EUR J IMMUNOL, V12, P247, DOI 10.1002/eji.1830120315; HODES RJ, 1989, SCIENCE, V246, P1041, DOI 10.1126/science.2587987; JANEWAY CA, 1988, IMMUNOL TODAY, V9, P125, DOI 10.1016/0167-5699(88)91189-9; JANEWAY CA, 1989, NATURE, V341, P482, DOI 10.1038/341482a0; JANEWAY CA, 1989, IMMUNOL REV, V107, P61, DOI 10.1111/j.1600-065X.1989.tb00003.x; JENKINS MK, 1987, P NATL ACAD SCI USA, V84, P5409, DOI 10.1073/pnas.84.15.5409; JENKINSON EJ, 1981, J EXP MED, V153, P280, DOI 10.1084/jem.153.2.280; JENKINSON EJ, 1982, EUR J IMMUNOL, V12, P583, DOI 10.1002/eji.1830120710; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; KAPPLER JW, 1988, NATURE, V332, P35, DOI 10.1038/332035a0; KISIELOW P, 1988, NATURE, V335, P730, DOI 10.1038/335730a0; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; KORNGOLD R, 1980, J EXP MED, V151, P314, DOI 10.1084/jem.151.2.314; LEDERBERG J, 1959, SCIENCE, V129, P1649, DOI 10.1126/science.129.3364.1649; Lo D, 1989, Semin Immunol, V1, P147; LO D, 1986, NATURE, V319, P672, DOI 10.1038/319672a0; LO D, 1989, J EXP MED, V170, P87, DOI 10.1084/jem.170.1.87; LORENZ RG, 1989, NATURE, V340, P557, DOI 10.1038/340557a0; MACDONALD HR, 1988, NATURE, V332, P40, DOI 10.1038/332040a0; MACDONALD HR, 1988, NATURE, V335, P174, DOI 10.1038/335174a0; MARRACK P, 1988, CELL, V53, P627, DOI 10.1016/0092-8674(88)90578-8; MARRACK P, 1987, SCIENCE, V238, P1073, DOI 10.1126/science.3317824; MARTH JD, 1985, CELL, V43, P393, DOI 10.1016/0092-8674(85)90169-2; MATZINGER P, 1984, NATURE, V308, P738, DOI 10.1038/308738a0; MATZINGER P, 1989, NATURE, V338, P74, DOI 10.1038/338074a0; MATZINGER P, 1977, CELL IMMUNOL, V33, P92, DOI 10.1016/0008-8749(77)90137-X; MUELLER DL, 1989, ANNU REV IMMUNOL, V7, P445, DOI 10.1146/annurev.iy.07.040189.002305; NORMENT AM, 1988, NATURE, V336, P79, DOI 10.1038/336079a0; OHKI H, 1987, SCIENCE, V237, P1032, DOI 10.1126/science.3616623; OTTEN G, COMMUNICATION; PARDOLL DM, UNPUB; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; PULLEN A, COMMUNICATION; PULLEN AM, 1988, NATURE, V335, P796, DOI 10.1038/335796a0; QIN SX, 1989, J EXP MED, V169, P779, DOI 10.1084/jem.169.3.779; RAMMENSEE HG, 1984, NATURE, V308, P741, DOI 10.1038/308741a0; RAMMENSEE HG, 1989, NATURE, V339, P541, DOI 10.1038/339541a0; RAMSDELL F, 1989, SCIENCE, V246, P1038, DOI 10.1126/science.2511629; RAMSDELL F, UNPUB; RAULET DH, 1989, ANNU REV IMMUNOL, V7, P175, DOI 10.1146/annurev.iy.07.040189.001135; READY AR, 1984, NATURE, V310, P231, DOI 10.1038/310231a0; REES MA, 1990, P NATL ACAD SCI USA, V87, P2765, DOI 10.1073/pnas.87.7.2765; ROBERTS JL, 1990, J EXP MED, V171, P935, DOI 10.1084/jem.171.3.935; ROBEY E, IN PRESS SEMIN IMMUN; SCHWARTZ RH, 1990, SCIENCE, V248, P1349, DOI 10.1126/science.2113314; SHA WC, 1988, NATURE, V336, P73, DOI 10.1038/336073a0; SPEISER DE, 1989, J EXP MED, V170, P595, DOI 10.1084/jem.170.2.595; SPEISER DE, 1989, J EXP MED, V170, P2165, DOI 10.1084/jem.170.6.2165; SPRENT J, 1975, J EXP MED, V142, P321, DOI 10.1084/jem.142.2.321; SPRENT J, 1988, IMMUNOL REV, V101, P173, DOI 10.1111/j.1600-065X.1988.tb00737.x; TEH HS, 1989, J EXP MED, V169, P795, DOI 10.1084/jem.169.3.795; UNANUE ER, 1987, SCIENCE, V236, P551, DOI 10.1126/science.2437650; VANEWIJK W, 1988, CELL, V53, P357, DOI 10.1016/0092-8674(88)90156-0; VANVLIET E, 1985, EUR J IMMUNOL, V15, P675, DOI 10.1002/eji.1830150707; VEILLETTE A, 1989, NATURE, V338, P257, DOI 10.1038/338257a0; VEILLETTE A, 1988, CELL, V55, P301, DOI 10.1016/0092-8674(88)90053-0; VONBOEHMER H, 1986, NATURE, V320, P626, DOI 10.1038/320626a0; VONBOEHMER H, 1984, EUR J IMMUNOL, V14, P1048, DOI 10.1002/eji.1830141116; VONBOEHMER H, 1990, SCIENCE, V248, P1369, DOI 10.1126/science.1972594; WEBB SR, 1988, J IMMUNOL, V141, P1828; WEISS A, 1986, ANNU REV IMMUNOL, V4, P593, DOI 10.1146/annurev.iy.04.040186.003113; WHITE J, 1989, CELL, V56, P27, DOI 10.1016/0092-8674(89)90980-X; WIDERA G, 1987, CELL, V51, P175, DOI 10.1016/0092-8674(87)90145-0; WILSON DB, 1989, IMMUNOL REV, V107, P159, DOI 10.1111/j.1600-065X.1989.tb00008.x; YOSHIKAI Y, 1989, EUR J IMMUNOL, V19, P1009, DOI 10.1002/eji.1830190609; YUUKI H, 1990, J IMMUNOL, V144, P474	98	401	402	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 15	1990	248	4961					1342	1348		10.1126/science.1972593	http://dx.doi.org/10.1126/science.1972593			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ501	1972593				2022-12-24	WOS:A1990DJ50100027
J	VIPOND, MN; WHAWELL, SA; THOMPSON, JN; DUDLEY, HAF				VIPOND, MN; WHAWELL, SA; THOMPSON, JN; DUDLEY, HAF			PERITONEAL FIBRINOLYTIC-ACTIVITY AND INTRAABDOMINAL ADHESIONS	LANCET			English	Article									HAMMERSMITH HOSP,DEPT SURG,LONDON W12 0HS,ENGLAND	Imperial College London	VIPOND, MN (corresponding author), ST MARYS HOSP,ACAD SURG UNIT,LONDON W2 1NY,ENGLAND.							ALCHALABI HA, 1987, INT J FERTIL, V32, P332; BEVAN PG, 1984, ANN ROY COLL SURG, V66, P164; DOODY KJ, 1989, FERTIL STERIL, V51, P509; ELLIS H, 1965, BRIT J SURG, V52, P471, DOI 10.1002/bjs.1800520616; HANSS M, 1987, J LAB CLIN MED, V109, P97; HAU T, 1979, SURG GYNECOL OBSTET, V148, P415; MENZIES D, 1989, J ROY SOC MED, V82, P534, DOI 10.1177/014107688908200909; MYHREJENSEN O, 1969, ARCH PATHOL, V88, P623; RAFTERY AT, 1979, J ANAT, V129, P659; RANBY M, 1988, ENZYME, V40, P130; RIVKIND AI, 1985, EUR SURG RES, V17, P254, DOI 10.1159/000128475; THOMPSON JN, 1989, BRIT J SURG, V76, P382, DOI 10.1002/bjs.1800760422	12	192	198	1	5	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	MAY 12	1990	335	8698					1120	1122		10.1016/0140-6736(90)91125-T	http://dx.doi.org/10.1016/0140-6736(90)91125-T			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC929	1971864				2022-12-24	WOS:A1990DC92900004
J	BYRN, RA; MORDENTI, J; LUCAS, C; SMITH, D; MARSTERS, SA; JOHNSON, JS; COSSUM, P; CHAMOW, SM; WURM, FM; GREGORY, T; GROOPMAN, JE; CAPON, DJ				BYRN, RA; MORDENTI, J; LUCAS, C; SMITH, D; MARSTERS, SA; JOHNSON, JS; COSSUM, P; CHAMOW, SM; WURM, FM; GREGORY, T; GROOPMAN, JE; CAPON, DJ			BIOLOGICAL PROPERTIES OF A CD4 IMMUNOADHESIN	NATURE			English	Article									HARVARD UNIV,NEW ENGLAND DEACONESS HOSP,SCH MED,DIV HEMATOL ONCOL,BOSTON,MA 02215	Harvard University; Harvard Medical School	BYRN, RA (corresponding author), GENENTECH INC,460 POINT SAN BRUNO BLVD,S SAN FRANCISCO,CA 94080, USA.		Wurm, Florian M./D-7224-2013	wurm, florian maria/0000-0003-1114-4520				CAPON DJ, 1989, NATURE, V337, P525, DOI 10.1038/337525a0; CHAUDHARY VK, 1988, NATURE, V335, P369, DOI 10.1038/335369a0; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; DANCIS J, 1961, AM J OBSTET GYNECOL, V82, P167, DOI 10.1016/S0002-9378(16)36111-7; GITLIN D, 1964, J CLIN INVEST, V43, P1938, DOI 10.1172/JCI105068; HOWELL DN, 1985, J IMMUNOL, V134, P971; JOHNSON PM, 1981, PLACENTA, V2, P355, DOI 10.1016/S0143-4004(81)80031-8; Kabat E. A., 1987, SEQUENCES PROTEINS I, DOI 10.1016/0003-2697(84)90805-4; KATZ SL, 1989, NEW ENGL J MED, V320, P1687, DOI 10.1056/NEJM198906223202509; KLATZMANN D, 1984, NATURE, V312, P767, DOI 10.1038/312767a0; LASKY LA, 1986, SCIENCE, V233, P209, DOI 10.1126/science.3014647; LYERLY HK, 1987, P NATL ACAD SCI USA, V84, P4601, DOI 10.1073/pnas.84.13.4601; MADDON PJ, 1986, CELL, V47, P333, DOI 10.1016/0092-8674(86)90590-8; MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030; MCDOUGAL JS, 1986, SCIENCE, V231, P382, DOI 10.1126/science.3001934; NAKANE PK, 1967, J CELL BIOL, V33, P307, DOI 10.1083/jcb.33.2.307; SMITH DH, 1987, SCIENCE, V238, P1704, DOI 10.1126/science.3500514; TILL MA, 1988, SCIENCE, V242, P1166, DOI 10.1126/science.2847316; TRAUNECKER A, 1989, NATURE, V339, P68, DOI 10.1038/339068a0; ZOLLER MJ, 1982, NUCLEIC ACIDS RES, V10, P6487, DOI 10.1093/nar/10.20.6487	20	155	254	0	8	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	APR 12	1990	344	6267					667	670		10.1038/344667a0	http://dx.doi.org/10.1038/344667a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY719	1970124				2022-12-24	WOS:A1990CY71900089
J	PINTER, GG; ATKINS, JL				PINTER, GG; ATKINS, JL			WHAT CAUSES DIABETIC RENAL-FAILURE	LANCET			English	Editorial Material									WALTER REED ARMY MED CTR,DEPT NEPHROL,WASHINGTON,DC 20307; UNIV LONDON KINGS COLL,DEPT PHYSIOL,DIV BIOMED SCI,LONDON WC2R 2LS,ENGLAND	United States Department of Defense; United States Army; Walter Reed National Military Medical Center; University of London; King's College London	PINTER, GG (corresponding author), UNIV MARYLAND,SCH MED,DEPT PHYSIOL,BALTIMORE,MD 21201, USA.		Atkins, James L./B-3577-2011					BADER R, 1980, PATHOL RES PRACT, V167, P204, DOI 10.1016/S0344-0338(80)80051-3; BELL DR, 1978, J PHYSIOL-LONDON, V279, P621, DOI 10.1113/jphysiol.1978.sp012365; Berlilner RW., 1973, HDB PHYSL, P185; PINTER GG, 1989, J PHYSIOL-LONDON, V417, pP47; PINTER GG, 1983, CLIN SCI, V65, P393, DOI 10.1042/cs0650393; THOMSEN OF, 1984, DIABETOLOGIA, V26, P361; 1988, LANCET, V1, P1433; 1972, LANCET, V2, P1403	8	10	10	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	MAR 10	1990	335	8689					590	591		10.1016/0140-6736(90)90361-8	http://dx.doi.org/10.1016/0140-6736(90)90361-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT653	1968584				2022-12-24	WOS:A1990CT65300015
J	DEKROM, MCTFM; KNIPSCHILD, PG; KESTER, ADM; SPAANS, F				DEKROM, MCTFM; KNIPSCHILD, PG; KESTER, ADM; SPAANS, F			EFFICACY OF PROVOCATIVE TESTS FOR DIAGNOSIS OF CARPAL-TUNNEL SYNDROME	LANCET			English	Article									STATE UNIV LIMBURG HOSP,DEPT EPIDEMIOL & HLTH CARE RES,MAASTRICHT,NETHERLANDS; STATE UNIV LIMBURG HOSP,DEPT CLIN NEUROPHYSIOL,MAASTRICHT,NETHERLANDS; STATE UNIV LIMBURG,DEPT MED INFORMAT & STAT,6200 MD MAASTRICHT,NETHERLANDS	Maastricht University; Maastricht University; Maastricht University	DEKROM, MCTFM (corresponding author), STATE UNIV LIMBURG HOSP,DEPT NEUROL,POB 1918,6201 BX MAASTRICHT,NETHERLANDS.							AEBIOCHSNER C, 1979, FORTSCHR NEUROL PSYC, V47, P307; BENINI A, 1975, KARPAL TUNNEL SYNDRO; BOWLES AP, 1983, ANN NEUROL, V13, P689, DOI 10.1002/ana.410130627; BRENNINKMEYER R, 1979, ACTA NEUROL SCAND, V60, P119; BUCHTHAL F, 1974, J NEUROL NEUROSUR PS, V37, P340, DOI 10.1136/jnnp.37.3.340; DUENSING F, 1974, Z NEUROL, V206, P267, DOI 10.1007/BF00316540; GELLMAN H, 1986, J BONE JOINT SURG AM, V68A, P735, DOI 10.2106/00004623-198668050-00015; GELMERS HJ, 1979, ACTA NEUROCHIR, V49, P255, DOI 10.1007/BF01808965; GILLIATT RW, 1953, LANCET, V2, P595; GOLDING DN, 1986, BRIT J RHEUMATOL, V25, P388; HELLER L, 1986, EUR NEUROL, V25, P40, DOI 10.1159/000115985; HEYWOOD PL, 1987, BRIT MED J, V294, P660, DOI 10.1136/bmj.294.6573.660-a; JOHNSON EW, 1981, ARCH PHYS MED REHAB, V62, P206; KENDALL D, 1960, BRIT MED J, V2, P1633, DOI 10.1136/bmj.2.5213.1633; KNIPSCHILD P, 1988, BRIT MED J, V297, P1578, DOI 10.1136/bmj.297.6663.1578; LUTHY F, 1962, SCHWEIZ MED WSCHR, V92, P1573; MOSSMAN SS, 1987, BRIT MED J, V294, P680, DOI 10.1136/bmj.294.6573.680; MUMENTHALER M, 1987, LASIONEN PERIPHERER, P243; MUMENTHALER M, 1982, SCHULTER ARM SCHMERZ, P93; PHALEN GS, 1970, J AMER MED ASSOC, V212, P1365, DOI 10.1001/jama.212.8.1365; PHALEN GS, 1957, JAMA-J AM MED ASSOC, V164, P524, DOI 10.1001/jama.1957.02980050014005; PRYSEPHILLIPS WEM, 1984, J NEUROL NEUROSUR PS, V47, P870, DOI 10.1136/jnnp.47.8.870; REDMOND MD, 1988, MUSCLE NERVE, V11, P511, DOI 10.1002/mus.880110515; SPAANS F, 1984, CURRENT PRACTICE CLI, P233; STEVENS JC, 1987, MUSCLE NERVE, V10, P99, DOI 10.1002/mus.880100202; STEWART JD, 1978, BRIT MED J, V2, P1125, DOI 10.1136/bmj.2.6145.1125-a; SZABO RM, 1984, J BONE JOINT SURG AM, V66A, P60, DOI 10.2106/00004623-198466010-00009; TINEL J, 1915, PRESSE MED, V23, P388; WALTON J, 1985, BRAINS DISEASES NERV, P505; [No title captured]; [No title captured]	31	129	131	0	4	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	FEB 17	1990	335	8686					393	395		10.1016/0140-6736(90)90218-T	http://dx.doi.org/10.1016/0140-6736(90)90218-T			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN988	1968125	Bronze			2022-12-24	WOS:A1990CN98800013
J	CEGIELSKI, JP; RAMAIYA, K; LALLINGER, GJ; MTULIA, IA; MBAGA, IM				CEGIELSKI, JP; RAMAIYA, K; LALLINGER, GJ; MTULIA, IA; MBAGA, IM			PERICARDIAL DISEASE AND HUMAN-IMMUNODEFICIENCY-VIRUS IN DAR-ES-SALAAM, TANZANIA	LANCET			English	Article									DUKE UNIV,MED CTR,DIV INFECT DIS & INT HLTH,DURHAM,NC 27710; UNIV DAR ES SALAAM,MUHIMBILI MED CTR,DEPT MED,DAR ES SALAAM,TANZANIA	Duke University; University of Dar es Salaam								ANDERSON DW, 1988, 3RD INT C AIDS WASH, P9; BLASER MJ, 1986, REV INFECT DIS, V8, P21; CAMMAROSANO C, 1985, J AM COLL CARDIOL, V5, P703, DOI 10.1016/S0735-1097(85)80397-1; CHAISSON RE, 1987, AM REV RESPIR DIS, V136, P570, DOI 10.1164/ajrccm/136.3.570; COLEBUNDERS R, 1987, LANCET, V1, P492; CORALLO S, 1988, EUR HEART J, V9, P887, DOI 10.1093/oxfordjournals.eurheartj.a062583; DALLI E, 1987, AM HEART J, V114, P905, DOI 10.1016/0002-8703(87)90807-6; DCRUZ IA, 1986, AM HEART J, V112, P1100, DOI 10.1016/0002-8703(86)90331-5; FINK L, 1984, AM J CARDIOL, V54, P1161, DOI 10.1016/S0002-9149(84)80178-2; FREEDBERG RS, 1987, NEW YORK STATE J MED, V87, P304; GILL PS, 1987, J CLIN ONCOL, V5, P216, DOI 10.1200/JCO.1987.5.2.216; HANDWERGER S, 1987, CHEST, V91, P176, DOI 10.1378/chest.91.2.176; HIMELMAN RB, 1989, J AM COLL CARDIOL, V13, P1030, DOI 10.1016/0735-1097(89)90256-8; LANGER E, 1988, DEUT MED WOCHENSCHR, V113, P1187, DOI 10.1055/s-2008-1067791; LEVY WS, 1988, 4TH INT C AIDS STOCK, V1, P401; LORELL BH, 1988, HEART DISEASE, P1484; MALU K, 1988, ARCH MAL COEUR VAISS, V81, P207; NIEDT GW, 1988, KAPOSIS SARCOMA TEXT, P271; PALLANGYO PK, 1989, 25TH MED ASS TANZ AN; PITCHENIK AE, 1984, ANN INTERN MED, V101, P641, DOI 10.7326/0003-4819-101-5-641; PITCHENIK AE, 1987, AM REV RESPIR DIS, V135, P875, DOI 10.1164/arrd.1987.135.4.875; QUINN TC, 1986, SCIENCE, V234, P955, DOI 10.1126/science.3022379; REILLY JM, 1988, AM J CARDIOL, V62, P789, DOI 10.1016/0002-9149(88)91223-4; SUNDERAM G, 1986, JAMA-J AM MED ASSOC, V256, P362, DOI 10.1001/jama.256.3.362; URASSA W, 1989, 4TH INT C AIDS ASS C; VERCAUTEREN G, 1987, EUR J CLIN MICROBIOL, V6, P132, DOI 10.1007/BF02018193; ZUGER A, 1986, ANN INTERN MED, V104, P234, DOI 10.7326/0003-4819-104-2-234; 1988, JAMA-J AM MED ASSOC, V259, P338	28	80	81	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JAN 27	1990	335	8683					209	212		10.1016/0140-6736(90)90288-G	http://dx.doi.org/10.1016/0140-6736(90)90288-G			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL185	1967676				2022-12-24	WOS:A1990CL18500013
J	KATKOV, WN; FRIEDMAN, LS; CODY, H; EVANS, A; KUO, G; CHOO, QL; HOUGHTON, M; DIENSTAG, JL				KATKOV, WN; FRIEDMAN, LS; CODY, H; EVANS, A; KUO, G; CHOO, QL; HOUGHTON, M; DIENSTAG, JL			ELEVATED SERUM ALANINE AMINOTRANSFERASE LEVELS IN BLOOD-DONORS - THE CONTRIBUTION OF HEPATITIS-C VIRUS	ANNALS OF INTERNAL MEDICINE			English	Note						BLOOD DONORS; HEPATITIS, VIRAL, NON-A, NON-B; HEPATITIS-C VIRUS; ALANINE AMINOTRANSFERASE; HEPATITIS ANTIBODIES	NON-B-HEPATITIS; TRANSFUSION-TRANSMITTED VIRUSES; NON-A; RECIPIENTS; ANTIBODY; RISK	In 1983, anticipating the introduction of alanine aminotransferase (ALT) screening to limit the frequency of transfusion-associated non-A, non-B hepatitis, we evaluated 100 consecutive blood donors with elevated ALT levels. To assess the role of hepatitis C virus (HCV) in blood donors with ALT elevations, we tested donor sera for antibody to HCV (anti-HCV). Antibody was detected and "confirmed" by a second-generation recombinant immunoblot assay (RIBA-2) in 17% of donors. Aminotransferase levels were higher in donors with anti-HCV. Antibody to HCV was more frequent in donors with persistent ALT elevations and in those who used intravenous drugs; anti-HCV was less frequent in donors who were overweight, who drank alcohol regularly, and who had no alternative explanation for an elevated ALT level. We conclude that asymptomatic ALT elevations are infrequently associated with HCV infection, unless the elevation is substantial, persistent, or associated with intravenous drug use. Hepatitis C virus infection is an unlikely cause of asymptomatic ALT elevations in persons who drink alcohol regularly or who are obese; however, HCV infection is a more likely cause of ALT elevations in thin persons who do not drink alcohol regularly.	HARVARD UNIV, MASSACHUSETTS GEN HOSP, SCH MED, GASTROINTESTINAL UNIT, BOSTON, MA 02114 USA; HARVARD UNIV, SCH PUBL HLTH, BOSTON, MA 02115 USA; THOMAS JEFFERSON UNIV, JEFFERSON MED COLL, PHILADELPHIA, PA 19107 USA; CHIRON CORP, EMERYVILLE, CA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Jefferson University; Novartis				Dienstag, Jules/0000-0001-7024-0980; Houghton, Michael/0000-0003-3762-6771	NIDDK NIH HHS [T32-DK07191] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007191] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		AACH RD, 1981, NEW ENGL J MED, V304, P989, DOI 10.1056/NEJM198104233041701; ALTER HJ, 1981, JAMA-J AM MED ASSOC, V246, P630, DOI 10.1001/jama.246.6.630; FRIEDMAN LS, 1987, ANN INTERN MED, V107, P137, DOI 10.7326/0003-4819-107-2-137; KOZIOL DE, 1986, ANN INTERN MED, V104, P488, DOI 10.7326/0003-4819-104-4-488; KUO G, 1989, SCIENCE, V244, P362, DOI 10.1126/science.2496467; MACFARLANE DG, 1990, LANCET, V335, P727, DOI 10.1016/0140-6736(90)90843-T; PALMER M, 1990, GASTROENTEROLOGY, V99, P1408, DOI 10.1016/0016-5085(90)91169-7; SHERMAN KE, 1982, J INFECT DIS, V145, P383, DOI 10.1093/infdis/145.3.383; STEVENS CE, 1984, ANN INTERN MED, V101, P733, DOI 10.7326/0003-4819-101-6-733; VANDERPOEL CL, 1991, LANCET, V337, P317, DOI 10.1016/0140-6736(91)90942-I	10	39	39	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 1	1991	115	11					882	884		10.7326/0003-4819-115-11-882	http://dx.doi.org/10.7326/0003-4819-115-11-882			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR171	1952477				2022-12-24	WOS:A1991GR17100009
J	FELGNER, PL; RHODES, G				FELGNER, PL; RHODES, G			GENE THERAPEUTICS	NATURE			English	Article							FOREIGN GENE; EXPRESSION; INVIVO; DNA; DELIVERY; TRANSFECTION; VIRUS; LIVER; MICE				FELGNER, PL (corresponding author), VICAL INC,DIV GENE THERAPEUT,9373 TOWNE CTR DR,SAN DIEGO,CA 92121, USA.							BENVENISTY N, 1986, P NATL ACAD SCI USA, V83, P9551, DOI 10.1073/pnas.83.24.9551; BEVIN MJ, 1987, NATURE, V325, P192; BOUCHARD L, 1984, VIROLOGY, V135, P53, DOI 10.1016/0042-6822(84)90116-8; BRIGHAM KL, 1989, AM J MED SCI, V298, P278, DOI 10.1097/00000441-198910000-00013; DUBENSKY TW, 1984, P NATL ACAD SCI-BIOL, V81, P7529, DOI 10.1073/pnas.81.23.7529; FELGNER P L, 1990, Advanced Drug Delivery Reviews, V5, P163, DOI 10.1016/0169-409X(90)90015-K; FUNG YKT, 1983, P NATL ACAD SCI-BIOL, V80, P353, DOI 10.1073/pnas.80.2.353; GERMAIN RN, 1986, NATURE, V322, P687, DOI 10.1038/322687a0; HOLT CE, 1990, NEURON, V4, P203, DOI 10.1016/0896-6273(90)90095-W; ISRAEL MA, 1979, J VIROL, V29, P990, DOI 10.1128/JVI.29.3.990-996.1979; JOHNSTON SA, 1990, NATURE, V346, P776, DOI 10.1038/346776a0; KANEDA Y, 1989, SCIENCE, V243, P375, DOI 10.1126/science.2911748; LIN H, 1990, CIRCULATION, V82, P2217, DOI 10.1161/01.CIR.82.6.2217; MALONE RW, 1989, FOCUS, V11, P4; NABEL EG, 1990, SCIENCE, V249, P1285, DOI 10.1126/science.2119055; NICOLAU C, 1983, P NATL ACAD SCI-BIOL, V80, P1068, DOI 10.1073/pnas.80.4.1068; ONO T, 1990, NEUROSCI LETT, V117, P259, DOI 10.1016/0304-3940(90)90673-W; SEEGER C, 1984, P NATL ACAD SCI-BIOL, V81, P5849, DOI 10.1073/pnas.81.18.5849; TOWNSEND A, 1989, ANNU REV IMMUNOL, V7, P601, DOI 10.1146/annurev.iy.07.040189.003125; WANG CY, 1987, P NATL ACAD SCI USA, V84, P7851, DOI 10.1073/pnas.84.22.7851; WOLFF JA, 1990, SCIENCE, V247, P1465, DOI 10.1126/science.1690918; WU CH, 1989, J BIOL CHEM, V264, P16985; WU GY, 1988, J BIOL CHEM, V263, P14621; YANG NS, 1990, P NATL ACAD SCI USA, V87, P9568, DOI 10.1073/pnas.87.24.9568	24	201	241	2	8	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JAN 24	1991	349	6307					351	352		10.1038/349351a0	http://dx.doi.org/10.1038/349351a0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EU501	1987492				2022-12-24	WOS:A1991EU50100060
J	LOWRY, PW; BLANKENSHIP, RJ; GRIDLEY, W; TROUP, NJ; TOMPKINS, LS				LOWRY, PW; BLANKENSHIP, RJ; GRIDLEY, W; TROUP, NJ; TOMPKINS, LS			A CLUSTER OF LEGIONELLA-STERNAL WOUND INFECTIONS DUE TO POSTOPERATIVE TOPICAL EXPOSURE TO CONTAMINATED TAP WATER	NEW ENGLAND JOURNAL OF MEDICINE			English	Note							NOSOCOMIAL LEGIONNAIRES-DISEASE; PNEUMOPHILA; EPIDEMIC; PATIENT; OUTBREAK; SYSTEMS		STANFORD UNIV,MED CTR,SCH MED,DEPT MED,DIV INFECT DIS,RM H1537J,STANFORD,CA 94305; STANFORD UNIV HOSP,DEPT CARE REVIEW RISK MANAGEMENT,INFECT CONTROL PROGRAM,STANFORD,CA 94305; STANFORD UNIV,MED CTR,CLIN MICROBIOL LAB,STANFORD,CA 94305	Stanford University; Stanford University; Stanford University								AMPEL NM, 1985, ANN INTERN MED, V102, P630, DOI 10.7326/0003-4819-102-5-630; ARNOW PM, 1982, J INFECT DIS, V146, P460, DOI 10.1093/infdis/146.4.460; ARNOW PM, 1985, J INFECT DIS, V152, P145, DOI 10.1093/infdis/152.1.145; ARNOW PM, 1983, ANN INTERN MED, V98, P184, DOI 10.7326/0003-4819-98-2-184; BOPP CA, 1981, J CLIN MICROBIOL, V13, P714, DOI 10.1128/JCM.13.4.714-719.1981; BRABENDER W, 1983, JAMA-J AM MED ASSOC, V250, P3091, DOI 10.1001/jama.250.22.3091; BROOME CV, 1979, ANN INTERN MED, V90, P573, DOI 10.7326/0003-4819-90-4-573; CORDES LG, 1981, ANN INTERN MED, V94, P195, DOI 10.7326/0003-4819-94-2-195; DONDERO TJ, 1980, NEW ENGL J MED, V302, P365, DOI 10.1056/NEJM198002143020703; DORMAN SA, 1980, ANN INTERN MED, V93, P835, DOI 10.7326/0003-4819-93-6-835; DOURNON E, 1982, LANCET, V1, P1363; EDELSTEIN PH, 1985, MANUAL CLIN MICROBIO, P373; FISHERHOCH SP, 1981, LANCET, V1, P932; FRASER DW, 1977, NEW ENGL J MED, V297, P1189, DOI 10.1056/NEJM197712012972201; GROSS D, 1981, CHEST, V79, P232, DOI 10.1378/chest.79.2.232; HALEY CE, 1979, ANN INTERN MED, V90, P583, DOI 10.7326/0003-4819-90-4-583; HARRIS LF, 1981, ARCH INTERN MED, V141, P1385, DOI 10.1001/archinte.1981.00340100141031; KALWEIT WH, 1982, ANN INTERN MED, V96, P173, DOI 10.7326/0003-4819-96-2-173; LANDES BW, 1982, ARCH INTERN MED, V142, P1234, DOI 10.1001/archinte.142.6.1234; ROSNER BA, 1982, FUNDAMENTALS BIOSTAT, P417; SCHLANGER G, 1984, AM J MED, V77, P957, DOI 10.1016/0002-9343(84)90551-5; SIEGEL S, 1956, NONPARAMETRIC STAT, P184; STOUT J, 1982, NEW ENGL J MED, V306, P466, DOI 10.1056/NEJM198202253060807; TOBIN JOH, 1980, LANCET, V2, P118; TOMPKINS LS, 1987, J CLIN MICROBIOL, V25, P1875, DOI 10.1128/JCM.25.10.1875-1880.1987; TOMPKINS LS, 1988, NEW ENGL J MED, V318, P530, DOI 10.1056/NEJM198803033180902; WADOWSKY RM, 1982, APPL ENVIRON MICROB, V43, P1104, DOI 10.1128/AEM.43.5.1104-1110.1982	27	87	90	0	3	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 10	1991	324	2					109	113		10.1056/NEJM199101103240207	http://dx.doi.org/10.1056/NEJM199101103240207			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EQ977	1984176				2022-12-24	WOS:A1991EQ97700007
J	COLEBATCH, JG; FINDLEY, LJ; FRACKOWIAK, RSJ; MARSDEN, CD; BROOKS, DJ				COLEBATCH, JG; FINDLEY, LJ; FRACKOWIAK, RSJ; MARSDEN, CD; BROOKS, DJ			PRELIMINARY-REPORT - ACTIVATION OF THE CEREBELLUM IN ESSENTIAL TREMOR	LANCET			English	Article									NATL HOSP,INST NEUROL,MRC,HUMAN MOVEMENT & BALANCE UNIT,LONDON WC1N 3BG,ENGLAND	University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust			Frackowiak, Richard/H-4383-2011; Frackowiak, Richard S/I-1809-2013	Frackowiak, Richard/0000-0002-3151-822X; Brooks, David/0000-0003-2602-2518; Colebatch, James/0000-0002-2099-4976	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		DUPUIS MJM, 1989, MOVEMENT DISORD, V4, P183, DOI 10.1002/mds.870040210; FRISTON KJ, 1990, J CEREBR BLOOD F MET, V10, P458, DOI 10.1038/jcbfm.1990.88; FRISTON KJ, 1989, J CEREBR BLOOD F MET, V9, P690, DOI 10.1038/jcbfm.1989.97; HERSKOVI.E, 1969, J NEUROL NEUROSUR PS, V32, P509, DOI 10.1136/jnnp.32.6.509; HIRAI T, 1983, BRAIN, V106, P1001, DOI 10.1093/brain/106.4.1001; LAMARRE Y, 1984, MOVEMENT DISORDERS T, P183; LAMMERTSMA AA, 1990, J CEREBR BLOOD F MET, V10, P675, DOI 10.1038/jcbfm.1990.121; Marsden C. D., 1983, CURRENT CONCEPTS PAR, P31; MARSDEN CD, 1986, TRENDS NEUROSCI, V9, P512, DOI 10.1016/0166-2236(86)90162-1; Raichle M. E., 1987, HDB PHYSL NERVOUS SY, V1, P643; Talairach J., 1988, COPLANAR STEREOTAXIC; YOUNG RR, 1986, HDB CLIN NEUROLOGY, V49, P565	12	158	160	0	4	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 27	1990	336	8722					1028	1030		10.1016/0140-6736(90)92489-5	http://dx.doi.org/10.1016/0140-6736(90)92489-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF076	1977019				2022-12-24	WOS:A1990EF07600004
J	CUTHBERT, RJG; LUDLAM, CA; TUCKER, J; STEEL, CM; BEATSON, D; REBUS, S; PEUTHERER, JF				CUTHBERT, RJG; LUDLAM, CA; TUCKER, J; STEEL, CM; BEATSON, D; REBUS, S; PEUTHERER, JF			5-YEAR PROSPECTIVE-STUDY OF HIV-INFECTION IN THE EDINBURGH HEMOPHILIAC COHORT	BMJ-BRITISH MEDICAL JOURNAL			English	Article									ROYAL INFIRM, DEPT HAEMATOL, EDINBURGH EH3 9YW, MIDLOTHIAN, SCOTLAND; WESTERN GEN HOSP, MRC, HUMAN GENET UNIT, EDINBURGH EH4 2XU, MIDLOTHIAN, SCOTLAND; UNIV EDINBURGH, DEPT BACTERIOL, EDINBURGH EH8 9YL, MIDLOTHIAN, SCOTLAND	Royal Infirmary of Edinburgh; University of Edinburgh; University of Edinburgh								BRETTLER DB, 1986, AM J MED, V81, P607, DOI 10.1016/0002-9343(86)90545-0; CARR R, 1984, LANCET, V1, P1431; CUTHBERT RJG, 1989, BRIT J HAEMATOL, V72, P387, DOI 10.1111/j.1365-2141.1989.tb07720.x; EYSTER ME, 1987, ANN INTERN MED, V107, P1, DOI 10.7326/0003-4819-107-1-1; FUCHS D, 1988, IMMUNOL TODAY, V9, P150, DOI 10.1016/0167-5699(88)91203-0; JIN ZW, 1989, J ALLERGY CLIN IMMUN, V83, P165, DOI 10.1016/0091-6749(89)90492-2; KASLOW RA, 1990, LANCET, V335, P927, DOI 10.1016/0140-6736(90)90995-H; LEE CA, 1989, BRIT J HAEMATOL, V73, P228, DOI 10.1111/j.1365-2141.1989.tb00257.x; LEFRERE JJ, 1989, AIDS, V3, P603, DOI 10.1097/00002030-198909000-00008; LUDLAM CA, 1985, LANCET, V2, P233; MALLAL S, 1990, LANCET, V335, P1591, DOI 10.1016/0140-6736(90)91418-A; MILDVAN D, 1987, CURRENT TOPICS AIDS, V1, P31; MOSS AR, 1988, BRIT MED J, V296, P745, DOI 10.1136/bmj.296.6624.745; MOSS AR, 1988, BRIT MED J, V297, P1067, DOI 10.1136/bmj.297.6656.1067; MUNOZ A, 1988, J ACQ IMMUN DEF SYND, V1, P396; PEDERSEN C, 1989, J INTERN MED, V225, P403, DOI 10.1111/j.1365-2796.1989.tb00103.x; POLK BF, 1987, NEW ENGL J MED, V316, P61, DOI 10.1056/NEJM198701083160201; SEARS SD, 1987, CLIN IMMUNOL IMMUNOP, V45, P177, DOI 10.1016/0090-1229(87)90032-8; SIMMONDS P, 1988, BRIT MED J, V296, P593, DOI 10.1136/bmj.296.6622.593; STEEL CM, 1988, LANCET, V1, P1185; 1989, LANCET, V2, P483	21	37	37	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 27	1990	301	6758					956	961		10.1136/bmj.301.6758.956	http://dx.doi.org/10.1136/bmj.301.6758.956			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF075	1979015	Bronze, Green Published			2022-12-24	WOS:A1990EF07500017
J	BISACCIA, E; BERGER, C; KLAINER, AS				BISACCIA, E; BERGER, C; KLAINER, AS			EXTRACORPOREAL PHOTOPHERESIS IN THE TREATMENT OF AIDS-RELATED COMPLEX - A PILOT-STUDY	ANNALS OF INTERNAL MEDICINE			English	Article									COLUMBIA UNIV COLL PHYS & SURG, NEW YORK, NY 10032 USA	Columbia University	BISACCIA, E (corresponding author), MORRISTOWN MEM HOSP, PHOTOPHERESIS UNIT, 100 MADISON AVE, MORRISTOWN, NJ 07962 USA.							AMMANN AJ, 1984, JAMA-J AM MED ASSOC, V251, P1447, DOI 10.1001/jama.251.11.1447; ANDREWS CA, 1987, J PEDIATR-US, V111, P672, DOI 10.1016/S0022-3476(87)80241-X; COHEN IR, 1984, ADV INTERNAL MED, V29, P147; COOMBS RW, 1989, NEW ENGL J MED, V321, P1626, DOI 10.1056/NEJM198912143212402; EDELSON R, 1987, NEW ENGL J MED, V316, P297, DOI 10.1056/NEJM198702053160603; EDELSON RL, 1988, SCI AM, V259, P68, DOI 10.1038/scientificamerican0888-68; FAHEY JL, 1990, NEW ENGL J MED, V322, P166, DOI 10.1056/NEJM199001183220305; GALLO RC, 1988, J ACQ IMMUN DEF SYND, V1, P521; JACKSON GG, 1988, ANN INTERN MED, V108, P175, DOI 10.7326/0003-4819-108-2-175; KHAVARI PA, 1988, CLIN RES, V36, pA662; KUNG PC, 1981, BLOOD, V57, P261; LACEY CJN, 1987, AIDS, V1, P123; LEVY JA, 1985, J INFECT DIS, V152, P734, DOI 10.1093/infdis/152.4.734; MASUR H, 1989, ANN INTERN MED, V111, P223, DOI 10.7326/0003-4819-111-3-223; MCDOUGAL JS, 1987, J CLIN INVEST, V80, P316, DOI 10.1172/JCI113075; MURRAY HW, 1989, AM J MED, V86, P533, DOI 10.1016/0002-9343(89)90380-X; MUSAJO L, 1965, EXPERIENTIA, V21, P22, DOI 10.1007/BF02136362; NAKASHIMA K, 1978, J BIOL CHEM, V253, P8680; NG VL, 1989, J CLIN MICROBIOL, V27, P977, DOI 10.1128/JCM.27.5.977-982.1989; QUINNAN GV, 1986, TRANSFUSION, V26, P481, DOI 10.1046/j.1537-2995.1986.26587020131.x; REDFIELD DC, 1981, INFECT IMMUN, V32, P1216, DOI 10.1128/IAI.32.3.1216-1226.1981; REDFIELD RR, 1986, NEW ENGL J MED, V314, P131, DOI 10.1056/NEJM198601093140232; ROTHENBERG R, 1987, NEW ENGL J MED, V317, P1297, DOI 10.1056/NEJM198711193172101; VELLECA WN, 1986, TRAINING MANUAL CTR, V3	24	57	66	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	AUG 15	1990	113	4					270	275		10.7326/0003-4819-113-4-270	http://dx.doi.org/10.7326/0003-4819-113-4-270			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU081	1973885				2022-12-24	WOS:A1990DU08100004
J	REGEHR, WG; TANK, DW				REGEHR, WG; TANK, DW			POSTSYNAPTIC NMDA RECEPTOR-MEDIATED CALCIUM ACCUMULATION IN HIPPOCAMPAL CA1 PYRAMIDAL CELL DENDRITES	NATURE			English	Article									AT&T BELL LABS, BIOPHYS RES DEPT, MURRAY HILL, NJ 07974 USA	AT&T; Nokia Corporation; Nokia Bell Labs								ANDERSEN P, 1980, J PHYSIOL-LONDON, V307, P273, DOI 10.1113/jphysiol.1980.sp013435; ASCHER P, 1988, J PHYSIOL-LONDON, V399, P247; BLISS T V P, 1988, P3; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BROWN TH, 1988, SCIENCE, V242, P724, DOI 10.1126/science.2903551; COLLINGRIDGE GL, 1989, NMDA RECEPTOR, P123; COLLINGRIDGE GL, 1988, J PHYSIOL-LONDON, V399, P301; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P19, DOI 10.1113/jphysiol.1983.sp014477; DUNWIDDIE T, 1978, J PHYSIOL-LONDON, V276, P353, DOI 10.1113/jphysiol.1978.sp012239; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; HOLMES WR, IN PRESS J NEUROPHYS; JAHR CE, 1987, NATURE, V325, P522, DOI 10.1038/325522a0; LEVY WB, 1983, NEUROSCIENCE, V8, P791, DOI 10.1016/0306-4522(83)90010-6; LISMAN J, 1989, P NATL ACAD SCI USA, V86, P9574, DOI 10.1073/pnas.86.23.9574; LYNCH G, 1983, NATURE, V305, P719, DOI 10.1038/305719a0; LYNCH GS, 1977, NATURE, V266, P737, DOI 10.1038/266737a0; MACDERMOTT AB, 1986, NATURE, V321, P519, DOI 10.1038/321519a0; MALENKA RC, 1988, SCIENCE, V242, P81, DOI 10.1126/science.2845577; MALENKA RC, 1989, NATURE, V340, P554, DOI 10.1038/340554a0; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; MAYER ML, 1987, J PHYSIOL-LONDON, V394, P501, DOI 10.1113/jphysiol.1987.sp016883; MAYER ML, 1984, NATURE, V309, P261, DOI 10.1038/309261a0; NICOLL RA, 1988, NEURON, V1, P97, DOI 10.1016/0896-6273(88)90193-6; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; RALL W, 1973, BIOPHYS J, V13, P648, DOI 10.1016/S0006-3495(73)86014-X; Rall W, 1988, COMPUTER SIMULATION, P26; REGEHR WG, 1989, NATURE, V341, P533, DOI 10.1038/341533a0; SCHWARTZKROIN PA, 1975, BRAIN RES, V85, P423, DOI 10.1016/0006-8993(75)90817-3; STANTON PK, 1989, NATURE, V339, P215, DOI 10.1038/339215a0; TANK DW, 1988, SCIENCE, V242, P773, DOI 10.1126/science.2847315; WIGSTROM H, 1988, P73	31	184	188	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JUN 28	1990	345	6278					807	810		10.1038/345807a0	http://dx.doi.org/10.1038/345807a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL646	1972782				2022-12-24	WOS:A1990DL64600058
J	OMAHONY, S; VESTEY, JP; FERGUSON, A				OMAHONY, S; VESTEY, JP; FERGUSON, A			SIMILARITIES IN INTESTINAL HUMORAL IMMUNITY IN DERMATITIS-HERPETIFORMIS WITHOUT ENTEROPATHY AND IN CELIAC-DISEASE	LANCET			English	Article									ROYAL INFIRM,DEPT DERMATOL,EDINBURGH EH3 9HB,MIDLOTHIAN,SCOTLAND	Royal Infirmary of Edinburgh	OMAHONY, S (corresponding author), UNIV EDINBURGH,WESTERN GEN HOSP,GASTROINTESTINAL LAB,GASTROINTESTINAL UNIT,EDINBURGH EH4 2XU,SCOTLAND.							ANDERSSON H, 1984, HUM NUTR-CLIN NUTR, V38C, P279; BROW JR, 1971, GASTROENTEROLOGY, V60, P355; CHORZELSKI TP, 1987, IMMUNOPATHOLOGY SKIN, P407; COOPER BT, 1980, GASTROENTEROLOGY, V79, P801; DOHERTY M, 1981, LANCET, V1, P517; FERGUSON A, 1977, J CLIN PATHOL, V30, P1068, DOI 10.1136/jcp.30.11.1068; FERGUSON A, 1971, GUT, V12, P988, DOI 10.1136/gut.12.12.988; FERGUSON A, 1987, SCAND J GASTROENTERO, V22, P543, DOI 10.3109/00365528708991895; FRY L, 1967, LANCET, V2, P729; GAWKRODGER DJ, 1984, GUT, V25, P151, DOI 10.1136/gut.25.2.151; GAWKRODGER DJ, IN PRESS GUT; GAWKRODGR DJ, 1989, BR J DERMATOL S34, V121, P49; LAURENT J, 1987, AM J NEPHROL, V7, P178, DOI 10.1159/000167460; Leonard JN, 1987, IMMUNOPATHOLOGY SKIN, P421; LOGAN RFA, 1986, GASTROENTEROLOGY, V90, P334, DOI 10.1016/0016-5085(86)90929-7; MARSH MN, 1990, GUT, V31, P32, DOI 10.1136/gut.31.1.32; MARSH MN, 1988, SCANNING MICROSCOPY, V2, P1663; MEEUWISSE GW, 1970, ACTA PAEDIATR SCAND, V59, P461; OFARRELLY C, 1988, LANCET, V2, P819; OMAHONY S, IN PRESS GUT; REUNALA T, 1977, BRIT J DERMATOL, V97, P473, DOI 10.1111/j.1365-2133.1977.tb14122.x; STROBEL S, 1984, GUT, V25, P1241, DOI 10.1136/gut.25.11.1241; STROBER W, 1978, PERSPECTIVES COELIAC, P169; TRONCONE R, 1988, P INT COELIAC S, P14; WEINSTEIN WM, 1974, GASTROENTEROLOGY, V66, P489; WRAY D, 1981, DIGEST DIS SCI, V26, P737, DOI 10.1007/BF01316864	26	69	69	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JUN 23	1990	335	8704					1487	1490		10.1016/0140-6736(90)93029-O	http://dx.doi.org/10.1016/0140-6736(90)93029-O			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DK586	1972433				2022-12-24	WOS:A1990DK58600004
J	OKADA, Y; TSUJI, T				OKADA, Y; TSUJI, T			NEOEXPRESSION OF SIALYL OLIGOMERIC LEWIS-X BY KUPFFER CELLS IN CHRONIC HEPATITIS	LANCET			English	Article									OKAYAMA UNIV,SCH MED,DEPT INTERNAL MED 1,OKAYAMA 700,JAPAN	Okayama University	OKADA, Y (corresponding author), OKAYAMA PREFECTURAL JR COLL,DEPT FOOD & NUTR,OKAYAMA 700,JAPAN.							ADAMS TE, 1983, IMMUNOLOGY, V50, P613; ALBERTI A, 1977, GUT, V18, P1004, DOI 10.1136/gut.18.12.1004; ALLEN PM, 1988, HEPATOLOGY, V8, P677, DOI 10.1002/hep.1840080340; BELLAMY A, 1986, J NEUROIMMUNOL, V12, P107, DOI 10.1016/0165-5728(86)90024-X; BOTTAZZO GF, 1983, LANCET, V2, P1115; BOYER JL, 1976, GASTROENTEROLOGY, V70, P1161; CHU CM, 1987, HEPATOLOGY, V7, P1311, DOI 10.1002/hep.1840070622; FEIJI T, 1985, NATURE, V314, P53; FERRARI C, 1988, J HEPATOL, V7, P21, DOI 10.1016/S0168-8278(88)80503-8; FRANCO A, 1988, HEPATOLOGY, V8, P449, DOI 10.1002/hep.1840080302; FUKASATO T, 1986, AM J PATHOL, V123, P364; FUKUDA M, 1985, Biochimica et Biophysica Acta, V780, P119; FUKUSHI Y, 1985, CANCER RES, V45, P3711; FUKUSHI Y, 1984, J BIOL CHEM, V259, P511; GUDAT F, 1975, LAB INVEST, V32, P1; HAKOMORI S, 1983, JNCI-J NATL CANCER I, V71, P231; HANAFUSA T, 1983, LANCET, V2, P1111; HENNINGSSON CM, 1987, CANCER IMMUNOL IMMUN, V25, P231; HSU SM, 1981, J HISTOCHEM CYTOCHEM, V29, P577, DOI 10.1177/29.4.6166661; KANNAGI R, 1986, CANCER RES, V46, P2619; LONDEI M, 1985, SCIENCE, V228, P85, DOI 10.1126/science.3871967; LONDEI M, 1984, NATURE, V312, P639, DOI 10.1038/312639a0; LORENZ RG, 1988, IMMUNOL REV, V106, P115, DOI 10.1111/j.1600-065X.1988.tb00776.x; MOKOENA T, 1985, J CLIN INVEST, V75, P624, DOI 10.1172/JCI111740; MONDELLI M, 1982, J IMMUNOL, V129, P2773; MONTANO L, 1982, HEPATOLOGY, V2, P557; NADLER PI, 1980, J IMMUNOL, V125, P2521; OKADA Y, 1988, J HEPATOL, V6, P63, DOI 10.1016/S0168-8278(88)80463-X; OKADA Y, 1988, AM J PATHOL, V130, P384; OKADA Y, 1988, J IMMUNOL METHODS, V112, P243, DOI 10.1016/0022-1759(88)90364-X; OKADA Y, 1990, J HEPATOL, V1, P1; PETERS M, 1986, PROG LIVER DIS, V8, P453; PILLER F, 1988, J BIOL CHEM, V263, P15146; RAY MB, 1976, GASTROENTEROLOGY, V71, P462; RICHMAN LK, 1979, J IMMUNOL, V123, P6002; ROGOFF TM, 1980, J IMMUNOL, V124, P1740; RUBINSTEIN D, 1986, J IMMUNOL, V137, P1803; SPENGLER U, 1988, HEPATOLOGY, V8, P459, DOI 10.1002/hep.1840080304; THOMAS H C, 1986, P179; 1977, LANCET, V2, P914	40	6	8	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JUN 2	1990	335	8701					1302	1306		10.1016/0140-6736(90)91187-F	http://dx.doi.org/10.1016/0140-6736(90)91187-F			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG095	1971377				2022-12-24	WOS:A1990DG09500004
J	PETER, M; SIPPELL, WG; LORENZEN, F; WILLIG, RP; WESTPHAL, E; GROSSEWILDE, H				PETER, M; SIPPELL, WG; LORENZEN, F; WILLIG, RP; WESTPHAL, E; GROSSEWILDE, H			IMPROVED TEST TO IDENTIFY HETEROZYGOTES FOR CONGENITAL ADRENAL-HYPERPLASIA WITHOUT INDEX CASE EXAMINATION	LANCET			English	Article									UNIV HAMBURG, HOSP EPPENDORF, DEPT PAEDIAT, W-2000 HAMBURG 13, GERMANY; UNIV ESSEN GESAMTHSCH, INST IMMUNOGENET, W-4300 ESSEN 1, GERMANY; UNIV KIEL, DEPT PAEDIAT, PAEDIAT ENDOCRINOL SECT, W-2300 KIEL 1, GERMANY; UNIV KIEL, DEPT IMMUNOL, W-2300 KIEL 1, GERMANY	University of Hamburg; University of Duisburg Essen; University of Kiel; University of Kiel								BERCOVICI JP, 1981, J STEROID BIOCHEM, V14, P1049, DOI 10.1016/0022-4731(81)90215-6; CARROLL MC, 1985, P NATL ACAD SCI USA, V82, P521, DOI 10.1073/pnas.82.2.521; CHILD DF, 1979, CLIN ENDOCRINOL, V11, P391, DOI 10.1111/j.1365-2265.1979.tb03091.x; CHILDS B, 1956, J CLIN INVEST, V35, P213, DOI 10.1172/JCI103266; DUPONT B, 1977, LANCET, V2, P1309; GROSSEWILDE H, 1979, IMMUNOGENETICS, V8, P41, DOI 10.1007/BF01561412; GUTAI JP, 1979, J PEDIATR-US, V94, P770, DOI 10.1016/S0022-3476(79)80152-3; GUTAI JP, 1977, J PEDIATR-US, V90, P924, DOI 10.1016/S0022-3476(77)80560-X; HOLLER W, 1985, J CLIN ENDOCR METAB, V60, P757; KNORR D, 1978, PEDIATR RES, V12, P1100, DOI 10.1203/00006450-197811000-00113; KNORR D, 1975, PEDIATR RES, V9, P681, DOI 10.1203/00006450-197508000-00084; KNORR D, 1983, J STEROID BIOCHEM, V19, P645, DOI 10.1016/0022-4731(83)90231-5; KRENSKY AM, 1977, J PEDIATR-US, V90, P930, DOI 10.1016/S0022-3476(77)80561-1; LEE PA, 1975, J CLIN ENDOCR METAB, V41, P415, DOI 10.1210/jcem-41-2-415; LEJEUNELENAIN C, 1980, CLIN ENDOCRINOL, V12, P525, DOI 10.1111/j.1365-2265.1980.tb01372.x; LORENZEN F, 1980, J CLIN ENDOCR METAB, V50, P572, DOI 10.1210/jcem-50-3-572; MAUSETH RS, 1980, J PEDIATR-US, V97, P749, DOI 10.1016/S0022-3476(80)80257-5; MAUTHE I, 1977, KLIN PADIATR, V189, P172; MILLER WL, 1987, J PEDIATR-US, V111, P1, DOI 10.1016/S0022-3476(87)80334-7; MOREL Y, 1989, J CLIN ENDOCR METAB, V68, P592, DOI 10.1210/jcem-68-3-592; NELSON EB, 1975, J CLIN ENDOCR METAB, V41, P7, DOI 10.1210/jcem-41-1-7; PARDINI DP, 1983, J CLIN ENDOCR METAB, V57, P1061, DOI 10.1210/jcem-57-5-1061; PRADER A, 1958, Helv Paediatr Acta, V13, P426; SIPPELL WG, 1975, J CHROMATOGR, V108, P305, DOI 10.1016/S0021-9673(00)84673-7; SIPPELL WG, 1978, J STEROID BIOCHEM, V9, P63, DOI 10.1016/0022-4731(78)90104-8; TERASAKI PI, 1964, NATURE, V204, P998, DOI 10.1038/204998b0; VONSCHNAKENBURG K, 1980, EUR J PEDIATR, V111, P259; WEIL J, 1979, ACTA ENDOCRINOL-COP, V91, P109, DOI 10.1530/acta.0.0910109; WHITE PC, 1984, P NATL ACAD SCI-BIOL, V81, P7505, DOI 10.1073/pnas.81.23.7505	29	35	36	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 2	1990	335	8701					1296	1299		10.1016/0140-6736(90)91185-D	http://dx.doi.org/10.1016/0140-6736(90)91185-D			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG095	1971375				2022-12-24	WOS:A1990DG09500002
J	SCHRAVEN, B; SAMSTAG, Y; ALTEVOGT, P; MEUER, SC				SCHRAVEN, B; SAMSTAG, Y; ALTEVOGT, P; MEUER, SC			ASSOCIATION OF CD2 AND CD45 ON HUMAN LYMPHOCYTES-T	NATURE			English	Article									DEUTSCH KREBSFORSCHUNGSZENTRUM,INST IMMUNOL & GENET,ZELLULARE IMMUNOL ABT,W-6900 HEIDELBERG,GERMANY	Helmholtz Association; German Cancer Research Center (DKFZ)	SCHRAVEN, B (corresponding author), DEUTSCH KREBSFORSCHUNGSZENTRUM,INST RADIOL & PATHOPHYSIOL,ANGEW IMMUNOL ABT,NEUENHEIMER FELD 280,D-6900 HEIDELBERG,FED REP GER.							ALCOVER A, 1988, EMBO J, V7, P1973, DOI 10.1002/j.1460-2075.1988.tb03035.x; ALTEVOGT P, IN PRESS INT IMMUNOL; BERNARD A, 1982, J EXP MED, V155, P1317, DOI 10.1084/jem.155.5.1317; BREITMEYER JB, 1987, J IMMUNOL, V139, P2899; CANTRELL DA, 1988, EUR J IMMUNOL, V18, P1391, DOI 10.1002/eji.1830180914; CHARBONNEAU H, 1988, P NATL ACAD SCI USA, V85, P7182, DOI 10.1073/pnas.85.19.7182; CLEVELAND DW, 1977, J BIOL CHEM, V252, P1102; EYE PL, 1978, IMMUNOCHEMISTRY, V15, P429; FAURE F, 1988, J IMMUNOL, V140, P2128; HOLTER W, 1986, J EXP MED, V163, P654, DOI 10.1084/jem.163.3.654; LEDBETTER JA, 1988, P NATL ACAD SCI USA, V85, P8628, DOI 10.1073/pnas.85.22.8628; MEUER SC, 1984, CELL, V36, P897, DOI 10.1016/0092-8674(84)90039-4; MEUER SC, 1983, J EXP MED, V157, P705, DOI 10.1084/jem.157.2.705; MEUER SC, 1983, J EXP MED, V158, P988, DOI 10.1084/jem.158.3.988; MORIMOTO C, 1985, J IMMUNOL, V134, P1508; SCHRAVEN B, 1989, EUR J IMMUNOL, V19, P397, DOI 10.1002/eji.1830190226; SCHRAVEN B, 1989, LEUKOCYTE TYPING, V4, P640; SILICIANO RF, 1985, NATURE, V317, P428, DOI 10.1038/317428a0; STREULI M, 1988, J IMMUNOL, V141, P3910; THOMPSON CB, 1989, P NATL ACAD SCI USA, V86, P1333, DOI 10.1073/pnas.86.4.1333; TONKS N K, 1988, Biochemistry, V27, P8695, DOI 10.1021/bi00424a001; TONKS NK, 1988, J BIOL CHEM, V263, P6731; TURCO MC, 1988, J IMMUNOL, V141, P2275; YOUNG SY, 1986, J IMMUNOL, V137, P1097	24	182	182	0	1	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAY 3	1990	345	6270					71	74		10.1038/345071a0	http://dx.doi.org/10.1038/345071a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DB957	1970422				2022-12-24	WOS:A1990DB95700060
J	VANCE, ML; LIPPER, M; KLIBANSKI, A; BILLER, BMK; SAMAAN, NA; MOLITCH, ME				VANCE, ML; LIPPER, M; KLIBANSKI, A; BILLER, BMK; SAMAAN, NA; MOLITCH, ME			TREATMENT OF PROLACTIN-SECRETING PITUITARY MACROADENOMAS WITH THE LONG-ACTING NONERGOT DOPAMINE AGONIST CV-205-502	ANNALS OF INTERNAL MEDICINE			English	Article									MASSACHUSETTS GEN HOSP, BOSTON, MA 02114 USA; UNIV TEXAS, MD ANDERSON HOSP & TUMOR INST, CTR CANC, HOUSTON, TX 77030 USA; NORTHWESTERN UNIV, SCH MED, CHICAGO, IL 60611 USA	Harvard University; Massachusetts General Hospital; University of Texas System; UTMD Anderson Cancer Center; Northwestern University	VANCE, ML (corresponding author), UNIV VIRGINIA, HLTH SCI CTR, BOX 511, CHARLOTTESVILLE, VA 22908 USA.				NCRR NIH HHS [RR-00847] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000847] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		AMBROSI B, 1982, ACTA ENDOCRINOL-COP, V100, P10, DOI 10.1530/acta.0.1000010; CHIODINI P, 1981, J CLIN ENDOCR METAB, V53, P737, DOI 10.1210/jcem-53-4-737; GAILLARD RC, 1989, J CLIN ENDOCR METAB, V68, P329, DOI 10.1210/jcem-68-2-329; KENDALLTAYLOR P, 1982, BRIT MED J, V285, P465, DOI 10.1136/bmj.285.6340.465; KLEINBERG DL, 1983, NEW ENGL J MED, V309, P704, DOI 10.1056/NEJM198309223091205; LIUZZI A, 1985, NEW ENGL J MED, V313, P656, DOI 10.1056/NEJM198509123131103; MOLITCH ME, 1985, J CLIN ENDOCR METAB, V60, P698, DOI 10.1210/jcem-60-4-698; PELLEGRINI I, 1989, J CLIN ENDOCR METAB, V69, P500, DOI 10.1210/jcem-69-3-500; THORNER MO, 1980, J CLIN ENDOCR METAB, V50, P1026, DOI 10.1210/jcem-50-6-1026; THORNER MO, 1980, J CLIN ENDOCR METAB, V51, P438, DOI 10.1210/jcem-51-3-438; VANCE ML, 1989, J CLIN ENDOCR METAB, V68, P336, DOI 10.1210/jcem-68-2-336; VANCE ML, 1984, ANN INTERN MED, V100, P78, DOI 10.7326/0003-4819-100-1-78	12	59	59	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 1	1990	112	9					668	673		10.7326/0003-4819-112-9-668	http://dx.doi.org/10.7326/0003-4819-112-9-668			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DB070	1970714				2022-12-24	WOS:A1990DB07000005
J	AVIGAD, S; COHEN, BE; BAUER, S; SCHWARTZ, G; FRYDMAN, M; WOO, SLC; NINY, Y; SHILOH, Y				AVIGAD, S; COHEN, BE; BAUER, S; SCHWARTZ, G; FRYDMAN, M; WOO, SLC; NINY, Y; SHILOH, Y			A SINGLE ORIGIN OF PHENYLKETONURIA IN YEMENITE JEWS	NATURE			English	Article									TEL AVIV UNIV,SACKLER SCH MED,DEPT HUMAN GENET,IL-69978 TEL AVIV,ISRAEL; TEL AVIV UNIV,DEPT JEWISH HIST,IL-69978 TEL AVIV,ISRAEL; CHAIM SHEBA MED CTR,INST CHILD DEV,IL-52621 TEL HASHOMER,ISRAEL; HASHARON HOSP,DEPT PEDIAT,PETAH TIQWA,ISRAEL; BAYLOR UNIV,HOWARD HUGHES MED INST,DEPT CELL BIOL,HOUSTON,TX 77030	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Chaim Sheba Medical Center; Rabin Medical Center; Baylor University; Howard Hughes Medical Institute								ABADIE V, 1989, GENOMICS, V5, P936, DOI 10.1016/0888-7543(89)90137-7; BODMER J, 1972, HISTOCOMPATIBILITY T, P125; Cavalli-Sforza L.L., 1971, GENETICS HUMAN POPUL; Cohen B E, 1978, Monogr Hum Genet, V9, P95; COHEN BE, 1963, PEDIATRICS, V32, P1069; COHEN BE, 1961, LANCET, V1, P344; DAIGER SP, 1989, AM J HUM GENET, V45, P319; DAIGER SP, 1989, AM J HUM GENET, V45, P310; DILELLA AG, 1986, BIOCHEMISTRY-US, V25, P743, DOI 10.1021/bi00352a001; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; KARLIN S, 1979, AM J HUM GENET, V31, P341; LIDSKY AS, 1985, AM J HUM GENET, V37, P619; LITT M, 1985, P NATL ACAD SCI USA, V82, P6206, DOI 10.1073/pnas.82.18.6206; OKANOY, IN PRESS AM J HUM GE; SCRIVER CR, 1988, ANNU REV GENET, V22, P301; SHILOH Y, 1986, CANCER RES, V46, P5297; WOO SLC, 1989, BIOCHEMISTRY-US, V28, P1, DOI 10.1021/bi00427a001; Woolf L I, 1978, J Inherit Metab Dis, V1, P101, DOI 10.1007/BF01805682; WOOLF LI, 1986, AM J HUM GENET, V38, P773; WOOLF LI, 1975, ANN HUM GENET, V38, P461, DOI 10.1111/j.1469-1809.1975.tb00635.x; WOOLF LI, 1976, J IRISH MED ASSOC, V69, P398; [No title captured]	22	67	68	0	5	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAR 8	1990	344	6262					168	170		10.1038/344168a0	http://dx.doi.org/10.1038/344168a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CT095	1968617				2022-12-24	WOS:A1990CT09500075
J	KLAUSER, AG; SCHINDLBECK, NE; MULLERLISSNER, SA				KLAUSER, AG; SCHINDLBECK, NE; MULLERLISSNER, SA			SYMPTOMS IN GASTROESOPHAGEAL REFLUX DISEASE	LANCET			English	Article									UNIV MUNICH, MED & CHIRURG KLIN INNENSTADT, DEPT GASTROENTEROL, W-8000 MUNICH 2, GERMANY	University of Munich								BENZ LJ, 1972, GASTROENTEROLOGY, V62, P1; BOUCHIER IAD, 1982, CLIN SKILLS, P1; DAVIES HA, 1985, J CLIN GASTROENTEROL, V7, P477, DOI 10.1097/00004836-198512000-00007; DEMEESTER TR, 1980, J THORAC CARDIOV SUR, V79, P656; FITZGERALD JM, 1989, CAN MED ASSOC J, V140, P520; FLEMING PR, 1985, FRENCHS INDEX DIFFER, P378; FUCHS KH, 1987, SURGERY, V102, P575; GROSS R, 1989, DTSH ARZTEBLATT, V38, P2643; HEWSON EG, 1989, GUT, V30, P305, DOI 10.1136/gut.30.3.305; HOGAN WJ, 1989, GASTROINTESTINAL DIS, P594; HOPE RA, 1989, OXFORD HDB CLIN MED, P22; HORROCKS JC, 1978, GUT, V19, P19, DOI 10.1136/gut.19.1.19; HORROCKS JC, 1975, BRIT MED J, V3, P421, DOI 10.1136/bmj.3.5980.421; JOHNSSON F, 1988, GUT, V29, P886, DOI 10.1136/gut.29.7.886; JOHNSSON F, 1987, SCAND J GASTROENTERO, V22, P714, DOI 10.3109/00365528709011148; KLAUSER AG, 1989, AM J GASTROENTEROL, V84, P362; LACHENBRUCH PA, 1975, DISCRIMINANT ANAL; PAUKER SG, 1988, CECIL TXB MED, P74; RICHTER JE, 1982, ANN INTERN MED, V97, P93, DOI 10.7326/0003-4819-97-1-93; ROKKAS TH, 1987, ITAL J GASTROENTEROL, V19, P176; SCHINDLBECK NE, 1987, GASTROENTEROLOGY, V93, P85, DOI 10.1016/0016-5085(87)90318-0; SCHOFIELD PM, 1989, DIGESTION, V42, P70, DOI 10.1159/000199828; SMITH JL, 1989, GASTROENTEROLOGY, V96, P683; WAHL PW, 1977, BIOMETRICS, V33, P479, DOI 10.2307/2529362; WIENER GJ, 1988, AM J GASTROENTEROL, V83, P358; WIENER GJ, 1988, DIGEST DIS SCI, V33, P1127, DOI 10.1007/BF01535789	26	613	635	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 27	1990	335	8683					205	208		10.1016/0140-6736(90)90287-F	http://dx.doi.org/10.1016/0140-6736(90)90287-F			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL185	1967675				2022-12-24	WOS:A1990CL18500012
J	CORNELLBELL, AH; FINKBEINER, SM; COOPER, MS; SMITH, SJ				CORNELLBELL, AH; FINKBEINER, SM; COOPER, MS; SMITH, SJ			GLUTAMATE INDUCES CALCIUM WAVES IN CULTURED ASTROCYTES - LONG-RANGE GLIAL SIGNALING	SCIENCE			English	Article									YALE UNIV, SCH MED, NEW HAVEN, CT 06510 USA	Yale University	CORNELLBELL, AH (corresponding author), YALE UNIV, HOWARD HUGHES MED INST, MOLEC NEUROBIOL SECT, NEW HAVEN, CT 06510 USA.				NIGMS NIH HHS [GM 07205] Funding Source: Medline; NINDS NIH HHS [NS-12961-14, NS16671-09] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007205] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS012961, R01NS016671] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BARRES BA, 1989, NEURON, V2, P1375, DOI 10.1016/0896-6273(89)90076-7; BARRES BA, 1989, J NEUROSCI, V9, P3169; BERRIDGE MJ, 1989, NATURE, V341, P197, DOI 10.1038/341197a0; BOWMAN CL, 1984, NATURE, V311, P656, DOI 10.1038/311656a0; BREHM P, 1989, NEURON, V3, P191, DOI 10.1016/0896-6273(89)90032-9; BUCHANAN JW, UNPUB; CSERR HF, 1986, ANN NY ACAD SCI, V481, P1, DOI 10.1111/j.1749-6632.1986.tb27134.x; FINKBEINER S, 1988, P NATL ACAD SCI USA, V85, P4071, DOI 10.1073/pnas.85.11.4071; FINKBEINER SM, UNPUB; FORSCHER P, 1987, J NEUROSCI, V7, P3600; GRAF P, 1987, BIOCHEM J, V241, P933, DOI 10.1042/bj2410933; HONORE T, 1988, SCIENCE, V241, P701, DOI 10.1126/science.2899909; JACOB R, 1988, NATURE, V335, P40, DOI 10.1038/335040a0; JENSEN AM, IN PRESS J NEUROSCI; KAO JPY, 1989, J BIOL CHEM, V264, P8179; KETTENMANN H, 1985, J NEUROSCI, V5, P3295; MACVICAR BA, 1987, NATURE, V329, P242, DOI 10.1038/329242a0; MACVICAR BA, 1984, SCIENCE, V226, P1345, DOI 10.1126/science.6095454; MARRERO H, 1989, NATURE, V339, P378, DOI 10.1038/339378a0; PEARCE B, 1986, NEUROSCI LETT, V72, P335, DOI 10.1016/0304-3940(86)90537-9; PENNER R, 1988, NATURE, V334, P499, DOI 10.1038/334499a0; PETERS A, 1962, J ANAT, V96, P237; PIN JP, 1984, FEBS LETT, V175, P31, DOI 10.1016/0014-5793(84)80563-3; RAFF MC, 1983, J NEUROSCI, V3, P1289; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RINK TJ, 1989, TRENDS NEUROSCI, V12, P43, DOI 10.1016/0166-2236(89)90133-1; SAEZ JC, 1989, P NATL ACAD SCI USA, V86, P2708, DOI 10.1073/pnas.86.8.2708; SCHOEPP DD, 1988, J NEUROCHEM, V50, P1605, DOI 10.1111/j.1471-4159.1988.tb03050.x; Shank RP, 1988, GLUTAMINE GLUTAMATE, VII, P3; SLADECZEK F, 1988, TRENDS NEUROSCI, V11, P545, DOI 10.1016/0166-2236(88)90183-X; SUGIYAMA H, 1987, NATURE, V325, P531, DOI 10.1038/325531a0; SUGIYAMA H, 1989, NEURON, V3, P129, DOI 10.1016/0896-6273(89)90121-9; USOWICZ MM, 1989, NATURE, V339, P380, DOI 10.1038/339380a0; VILVEN J, 1988, NATURE, V336, P587, DOI 10.1038/336587a0; WOODS NM, 1986, NATURE, V319, P600, DOI 10.1038/319600a0; YAMADA KA, 1989, J NEUROSCI, V9, P3230	36	1455	1478	1	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 26	1990	247	4941					470	473		10.1126/science.1967852	http://dx.doi.org/10.1126/science.1967852			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK705	1967852				2022-12-24	WOS:A1990CK70500044
J	VANDERGOOT, FG; GONZALEZMANAS, JM; LAKEY, JH; PATTUS, F				VANDERGOOT, FG; GONZALEZMANAS, JM; LAKEY, JH; PATTUS, F			A MOLTEN-GLOBULE MEMBRANE-INSERTION INTERMEDIATE OF THE PORE-FORMING DOMAIN OF COLICIN-A	NATURE			English	Article							PHOSPHOLIPID MONOLAYERS; LIPID BILAYERS; PROTEINS; CHANNEL; STATE; PEPTIDE; TRANSLOCATION; MECHANISM; LIPOSOMES; FRAGMENT	THE 'molten' globular conformation of a protein is compact with a native secondary structure but a poorly defined tertiary structure 1,2. Molten globular states are intermediates in protein folding and unfolding 3-5 and they may be involved in the translocation or insertion of proteins into membranes 6. Here we investigate the membrane insertion of the pore-forming domain of colicin A, a bacteriocin that depolarizes the cytoplasmic membrane of sensitive cells 7-9. We find that this pore-forming domain, the insertion of which depends on pH (refs 10, 11), undergoes a native to molten globule transition at acidic pH. The variation of the kinetic constant of membrane insertion of the protein into negatively charged lipid vesicles as a function of the interfacial pH correlates with the appearance of the acidic molten globular state, indicating that this state could be an intermediate formed during the insertion of colicin A into membranes.			VANDERGOOT, FG (corresponding author), EUROPEAN MOLEC BIOL LAB,MEYERHOFSTR 1,W-6900 HEIDELBERG,GERMANY.		van der Goot, Gisou G/B-2279-2012	van der Goot, Gisou G/0000-0002-8522-274X				BRUNDEN KR, 1984, J BIOL CHEM, V259, P7682; BYCHKOVA VE, 1988, FEBS LETT, V238, P231, DOI 10.1016/0014-5793(88)80485-X; CRAMER WA, 1990, MOL MICROBIOL, V4, P519, DOI 10.1111/j.1365-2958.1990.tb00619.x; DOLGIKH DA, 1981, FEBS LETT, V136, P311, DOI 10.1016/0014-5793(81)80642-4; EAST JM, 1982, BIOCHEMISTRY-US, V21, P4144, DOI 10.1021/bi00260a035; EISENBERG M, 1979, BIOCHEMISTRY-US, V18, P5213, DOI 10.1021/bi00590a028; EWBANK JJ, 1991, NATURE, V350, P518, DOI 10.1038/350518a0; FINK AL, 1990, CURRENT RES PROTEIN, P417; FRENETTE M, 1989, BIOCHEMISTRY-US, V28, P2509, DOI 10.1021/bi00432a024; GOTO Y, 1990, BIOCHEMISTRY-US, V29, P3480, DOI 10.1021/bi00466a009; GOTO Y, 1990, P NATL ACAD SCI USA, V87, P573, DOI 10.1073/pnas.87.2.573; JIANG JX, 1991, BIOCHEMISTRY-US, V30, P3857, DOI 10.1021/bi00230a008; LAKEY JH, 1991, EUR J BIOCHEM, V196, P599, DOI 10.1111/j.1432-1033.1991.tb15855.x; LAKEY JH, 1991, J MOL BIOL, V219, P639; LOHNER K, 1991, BIOCHEMISTRY-US, V30, P6620, DOI 10.1021/bi00240a035; MENESTRINA G, 1989, BIOPHYS J, V55, P393, DOI 10.1016/S0006-3495(89)82833-4; MERRILL AR, 1990, BIOCHEMISTRY-US, V29, P5829, DOI 10.1021/bi00476a026; OHGUSHI M, 1983, FEBS LETT, V164, P21, DOI 10.1016/0014-5793(83)80010-6; OLNES S, 1988, TRENDS BIOCHEM SCI, V13, P348; PARKER MW, 1990, TRENDS BIOCHEM SCI, V15, P126, DOI 10.1016/0968-0004(90)90205-P; PARKER MW, 1989, NATURE, V337, P93, DOI 10.1038/337093a0; PARKER MW, IN PRESS J MOL BIOL; PATTUS F, 1985, EUR J BIOCHEM, V152, P681, DOI 10.1111/j.1432-1033.1985.tb09248.x; PATTUS F, 1990, EXPERIENTIA, V46, P180; PATTUS F, 1983, BIOCHEMISTRY-US, V22, P5698, DOI 10.1021/bi00294a003; PTITSYN OB, 1990, FEBS LETT, V262, P20, DOI 10.1016/0014-5793(90)80143-7; RAMSAY G, 1990, BIOCHEMISTRY-US, V29, P8677, DOI 10.1021/bi00489a024; SCHWARZ G, 1987, BIOPHYS J, V52, P685, DOI 10.1016/S0006-3495(87)83263-0; SLATIN SL, 1988, INT J BIOCHEM, V20, P737, DOI 10.1016/0020-711X(88)90058-4; SONG HY, 1991, J BACTERIOL, V173, P2927, DOI 10.1128/JB.173.9.2927-2934.1991; WINISKI AP, 1986, BIOCHEMISTRY-US, V25, P8206, DOI 10.1021/bi00373a013	31	405	411	0	13	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	DEC 5	1991	354	6352					408	410		10.1038/354408a0	http://dx.doi.org/10.1038/354408a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT761	1956406				2022-12-24	WOS:A1991GT76100056
J	MALKIN, D; LI, FP; STRONG, LC; FRAUMENI, JF; NELSON, CE; KIM, DH; KASSEL, J; GRYKA, MA; BISCHOFF, FZ; TAINSKY, MA; FRIEND, SH				MALKIN, D; LI, FP; STRONG, LC; FRAUMENI, JF; NELSON, CE; KIM, DH; KASSEL, J; GRYKA, MA; BISCHOFF, FZ; TAINSKY, MA; FRIEND, SH			GERM LINE P53 MUTATIONS IN A FAMILIAL SYNDROME OF BREAST-CANCER, SARCOMAS, AND OTHER NEOPLASMS	SCIENCE			English	Article									MASSACHUSETTS GEN HOSP,CTR CANC,DIV MOLEC GENET,MGH E,BOSTON,MA 02129; UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DEPT TUMOR BIOL,HOUSTON,TX 77030; HARVARD UNIV,CHILDRENS HOSP,SCH MED,DANA FARBER CANC INST,DEPT PEDIAT,DIV HEMATOL ONCOL,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DANA FARBER CANC INST,DIV BIOSTAT & EPIDEMIOL,BOSTON,MA 02115; UNIV TEXAS,MD ANDERSON HOSP & TUMOR INST,CTR CANC,DIV PEDIAT,HOUSTON,TX 77030; NCI,DIV CANC ETIOL,CLIN EPIDEMIOL BRANCH,BETHESDA,MD 20892; NCI,DIV CANC ETIOL,EPIDEMIOL & BIOSTAT PROGRAM,BETHESDA,MD 20892	Harvard University; Massachusetts General Hospital; University of Texas System; UTMD Anderson Cancer Center; Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Texas System; UTMD Anderson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)			Malkin, David/AAW-8715-2021; Pinheiro, Maísa/E-7424-2012	Tainsky, Michael/0000-0002-0261-831X	NCI NIH HHS [5-T32-CA09299] Funding Source: Medline; PHS HHS [34936] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009299] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AHUJA H, 1989, P NATL ACAD SCI USA, V86, P6783, DOI 10.1073/pnas.86.17.6783; BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; BARTEK J, 1990, ONCOGENE, V5, P893; BIRCH JM, 1990, J CLIN ONCOL, V8, P583, DOI 10.1200/JCO.1990.8.4.583; BIRCH JM, 1984, BRIT J CANCER, V49, P325, DOI 10.1038/bjc.1984.51; BUCHMAN VL, 1988, GENE, V70, P245, DOI 10.1016/0378-1119(88)90196-5; DILLER L, 1990, MOL CELL BIOL, V10, P5772, DOI 10.1128/MCB.10.11.5772; ELIYAHU D, 1989, P NATL ACAD SCI USA, V86, P8763, DOI 10.1073/pnas.86.22.8763; FINLAY CA, 1988, MOL CELL BIOL, V8, P531, DOI 10.1128/MCB.8.2.531; FINLAY CA, 1989, CELL, V57, P1083, DOI 10.1016/0092-8674(89)90045-7; FRANCKE U, 1979, CYTOGENET CELL GENET, V24, P185, DOI 10.1159/000131375; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; FRIEND SH, UNPUB; GARBER JE, 1990, P AM ASSOC CANC RES, V31, P210; HINDS P, 1989, J VIROL, V63, P739, DOI 10.1128/JVI.63.2.739-746.1989; HINDS PW, 1987, MOL CELL BIOL, V7, P2863, DOI 10.1128/MCB.7.8.2863; HINDS PW, IN PRESS CELL GROWTH; IGGO R, 1990, LANCET, V335, P675, DOI 10.1016/0140-6736(90)90801-B; ISOBE M, 1986, NATURE, V320, P84, DOI 10.1038/320084a0; LAVIGUEUR A, 1989, MOL CELL BIOL, V9, P3982, DOI 10.1128/MCB.9.9.3982; LEVINE AJ, UNPUB; LI FP, 1982, JAMA-J AM MED ASSOC, V247, P2692, DOI 10.1001/jama.247.19.2692; LI FP, 1988, CANCER RES, V48, P5358; LI FP, 1969, ANN INTERN MED, V71, P747, DOI 10.7326/0003-4819-71-4-747; MASHARANI U, 1988, NUCLEIC ACIDS RES, V16, P7757, DOI 10.1093/nar/16.15.7757; MENON AG, 1990, P NATL ACAD SCI USA, V87, P5435, DOI 10.1073/pnas.87.14.5435; MULLIGAN LM, 1990, P NATL ACAD SCI USA, P5863; NAKAMURA Y, 1988, NUCLEIC ACIDS RES, V16, P5707, DOI 10.1093/nar/16.12.5707; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; RICARDI VM, 1978, PEDIATRICS, V61, P604; ROMANO JW, 1989, ONCOGENE, V4, P1483; Sambrook J., 1989, MOL CLONING LAB MANU; SEIZINGER B, UNPUB; SOUSSI T, 1990, ONCOGENE, V5, P945; STRONG LC, 1987, JNCI-J NATL CANCER I, V79, P1213; STURZBECHER HW, 1987, ONCOGENE, V1, P201; TAKAHASHI T, 1989, SCIENCE, V246, P491, DOI 10.1126/science.2554494; VOGELSTEIN B, UNPUB; WIGGS J, 1988, NEW ENGL J MED, V318, P151, DOI 10.1056/NEJM198801213180305; WILLIAMS WR, 1985, FAM CANCER, P151; YOUNG JL, 1981, NCI MONOGRAPH, V57	41	3043	3149	3	81	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 30	1990	250	4985					1233	1238		10.1126/science.1978757	http://dx.doi.org/10.1126/science.1978757			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK723	1978757				2022-12-24	WOS:A1990EK72300030
J	HEMMATIBRIVANLOU, A; STEWART, RM; HARLAND, RM				HEMMATIBRIVANLOU, A; STEWART, RM; HARLAND, RM			REGION-SPECIFIC NEURAL INDUCTION OF AN ENGRAILED PROTEIN BY ANTERIOR NOTOCHORD IN XENOPUS	SCIENCE			English	Article									UNIV CALIF BERKELEY,DEPT MOLEC & CELLULAR BIOL,DIV BIOCHEM & MOLEC BIOL,BERKELEY,CA 94720; UNIV CALIF BERKELEY,DEPT MOLEC & CELLULAR BIOL,DIV CELL & DEV BIOL,BERKELEY,CA 94720	University of California System; University of California Berkeley; University of California System; University of California Berkeley					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM042341, R01GM019363, R37GM019363] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 19363, GM 42341] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AKAM M, 1987, DEVELOPMENT, V101, P1; CARROLL SB, 1990, CELL, V60, P9, DOI 10.1016/0092-8674(90)90711-M; DIXON JE, 1989, DEVELOPMENT, V106, P749; GERHART J, 1989, DEVELOPMENT, V107, P37; GIMLICH RL, 1983, NATURE, V306, P471, DOI 10.1038/306471a0; GRANT P, 1972, DEV BIOL, V28, P454, DOI 10.1016/0012-1606(72)90029-2; HEMMATIBRIVANLO.A, 1989, DEVELOPMENT, V106, P611; HEMMATIBRIVANLO.A, UNPUB; JONES EA, 1989, DEVELOPMENT, V107, P785; KELLER RE, 1976, DEV BIOL, V51, P118, DOI 10.1016/0012-1606(76)90127-5; KELLER RE, 1975, DEV BIOL, V42, P222, DOI 10.1016/0012-1606(75)90331-0; KINTNER CR, 1987, DEVELOPMENT, V99, P311; Mangold O, 1933, NATURWISSENSCHAFTEN, V21, P761, DOI 10.1007/BF01503740; Nieuwkoop P.D., 1967, NORMAL TABLE XENOPUS; NIEUWKOOP PD, 1985, J EMBRYOL EXP MORPH, V89, P333; NIEUWKOOP PD, 1952, J EXP ZOOL, V120, P1, DOI 10.1002/jez.1401200102; PATEL NH, 1989, CELL, V58, P955, DOI 10.1016/0092-8674(89)90947-1; RECANZONE G, 1985, Wilhelm Roux's Archives of Developmental Biology, V194, P344, DOI 10.1007/BF00877372; SAVAGE R, 1989, DEV BIOL, V133, P157, DOI 10.1016/0012-1606(89)90307-2; SCHARF SR, 1980, DEV BIOL, V79, P181, DOI 10.1016/0012-1606(80)90082-2; SHARPE CR, 1987, CELL, V50, P749, DOI 10.1016/0092-8674(87)90333-3; SIVE HL, 1989, CELL, V58, P171, DOI 10.1016/0092-8674(89)90413-3; SMITH JC, 1983, J EMBRYOL EXP MORPH, V78, P299; Spemann H., 1924, FDN EXPT EMBRYOLOGY, P144; Spemann H., 1938, EMBRYONIC DEV INDUCT; STEWART RM, 1990, DEVELOPMENT, V109, P363	26	138	140	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 9	1990	250	4982					800	802		10.1126/science.1978411	http://dx.doi.org/10.1126/science.1978411			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG883	1978411				2022-12-24	WOS:A1990EG88300033
J	MARUYAMA, K; TERAKADO, K; USAMI, M; YOSHIKAWA, K				MARUYAMA, K; TERAKADO, K; USAMI, M; YOSHIKAWA, K			FORMATION OF AMYLOID-LIKE FIBRILS IN COS CELLS OVEREXPRESSING PART OF THE ALZHEIMER AMYLOID PROTEIN-PRECURSOR	NATURE			English	Article									PSYCHIAT RES INST TOKYO,DEPT MOLEC BIOL,SETAGAYA KU,TOKYO 156,JAPAN; SAITAMA UNIV,FAC SCI,DEPT REGULAT BIOL,URAWA,SAITAMA 338,JAPAN	Tokyo Institute of Psychiatry; Saitama University								BRANDL CJ, 1987, J BIOL CHEM, V262, P3768; DYRKS T, 1988, EMBO J, V7, P949, DOI 10.1002/j.1460-2075.1988.tb02900.x; ESCH FS, 1990, SCIENCE, V248, P1122, DOI 10.1126/science.2111583; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V122, P1131, DOI 10.1016/0006-291X(84)91209-9; ISHII T, 1989, NEUROPATH APPL NEURO, V15, P135, DOI 10.1111/j.1365-2990.1989.tb01216.x; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; KIDD M, 1964, BRAIN, V87, P307, DOI 10.1093/brain/87.2.307; KIRSCHNER DA, 1987, P NATL ACAD SCI USA, V84, P6953, DOI 10.1073/pnas.84.19.6953; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; MAROTTA CA, 1989, P NATL ACAD SCI USA, V86, P337, DOI 10.1073/pnas.86.1.337; MARUYAMA K, 1988, P NATL ACAD SCI USA, V85, P3314, DOI 10.1073/pnas.85.10.3314; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; MERZ PA, 1983, ACTA NEUROPATHOL, V60, P113, DOI 10.1007/BF00685355; MIYAKAWA T, 1986, VIRCHOWS ARCH B, V52, P99, DOI 10.1007/BF02889954; MIYAKAWA T, 1986, ACTA NEUROPATHOL, V70, P202, DOI 10.1007/BF00686073; ROBAKIS NK, 1987, P NATL ACAD SCI USA, V84, P4190, DOI 10.1073/pnas.84.12.4190; SAITOH T, 1989, CELL, V58, P615, DOI 10.1016/0092-8674(89)90096-2; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SELKOE DJ, 1988, P NATL ACAD SCI USA, V85, P7341, DOI 10.1073/pnas.85.19.7341; SISODIA SS, 1990, SCIENCE, V248, P492, DOI 10.1126/science.1691865; SOMPAYRAC LM, 1981, P NATL ACAD SCI-BIOL, V78, P7575, DOI 10.1073/pnas.78.12.7575; SPRINGER TA, 1981, J BIOL CHEM, V256, P3833; TERRY RD, 1964, AM J PATHOL, V44, P269; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; WOLF D, 1990, EMBO J, V9, P2079, DOI 10.1002/j.1460-2075.1990.tb07375.x; WONG GG, 1985, SCIENCE, V228, P810, DOI 10.1126/science.3923623; YANKNER BA, 1989, SCIENCE, V245, P417, DOI 10.1126/science.2474201; YOSHIKAWA K, 1984, J BIOL CHEM, V259, P4301	29	121	127	0	4	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	OCT 11	1990	347	6293					566	569		10.1038/347566a0	http://dx.doi.org/10.1038/347566a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EC454	1977086				2022-12-24	WOS:A1990EC45400057
J	OLD, JM; VARAWALLA, NY; WEATHERALL, DJ				OLD, JM; VARAWALLA, NY; WEATHERALL, DJ			RAPID DETECTION AND PRENATAL-DIAGNOSIS OF BETA-THALASSEMIA - STUDIES IN INDIAN AND CYPRIOT POPULATIONS IN THE UK	LANCET			English	Article									JOHN RADCLIFFE HOSP,INST MOLEC MED,NATL HAEMOGLOBINOPATHY REFERENCE LAB,OXFORD OX3 9DU,ENGLAND	University of Oxford								CHEHAB FF, 1989, P NATL ACAD SCI USA, V86, P9178, DOI 10.1073/pnas.86.23.9178; KRETZ KA, 1989, NUCLEIC ACIDS RES, V17, P5864, DOI 10.1093/nar/17.14.5864; KULOZIK AE, 1988, BRIT J HAEMATOL, V70, P455, DOI 10.1111/j.1365-2141.1988.tb02516.x; NEWTON CR, 1989, LANCET, V2, P1481; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; Old JM., 1983, METHODS HEMATOLOGY T, V6, P74; SAIKI RK, 1986, NATURE, V324, P163, DOI 10.1038/324163a0; SAIKI RK, 1988, NEW ENGL J MED, V319, P537, DOI 10.1056/NEJM198809013190903; SEMENZA GL, 1989, NUCLEIC ACIDS RES, V17, P2376, DOI 10.1093/nar/17.6.2376; THEIN SL, 1989, BLOOD, V73, P924; THEIN SL, 1988, BRIT J HAEMATOL, V70, P225, DOI 10.1111/j.1365-2141.1988.tb02468.x	11	281	287	0	3	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 6	1990	336	8719					834	837		10.1016/0140-6736(90)92338-I	http://dx.doi.org/10.1016/0140-6736(90)92338-I			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB901	1976877				2022-12-24	WOS:A1990EB90100003
J	EKBOM, A; HELMICK, C; ZACK, M; ADAMI, HO				EKBOM, A; HELMICK, C; ZACK, M; ADAMI, HO			INCREASED RISK OF LARGE-BOWEL CANCER IN CROHNS-DISEASE WITH COLONIC INVOLVEMENT	LANCET			English	Article									CTR DIS CONTROL,ATLANTA,GA 30333	Centers for Disease Control & Prevention - USA	EKBOM, A (corresponding author), UNIV HOSP UPPSALA,DEPT SURG,S-75185 UPPSALA,SWEDEN.							BINDER V, 1985, GUT, V26, P146, DOI 10.1136/gut.26.2.146; FIREMAN Z, 1989, SCAND J GASTROENTERO, V24, P346, DOI 10.3109/00365528909093058; GARLAND CF, 1981, GASTROENTEROLOGY, V81, P1115; GLOTZER DJ, 1985, GASTROENTEROLOGY, V89, P438, DOI 10.1016/0016-5085(85)90350-6; GOLLOP JH, 1988, GUT, V29, P49, DOI 10.1136/gut.29.1.49; GREENSTEIN AJ, 1981, CANCER, V48, P2742, DOI 10.1002/1097-0142(19811215)48:12<2742::AID-CNCR2820481231>3.0.CO;2-P; GYDE SN, 1980, GUT, V21, P1024, DOI 10.1136/gut.21.12.1024; HAMILTON SR, 1985, GASTROENTEROLOGY, V89, P398, DOI 10.1016/0016-5085(85)90343-9; JONES JH, 1969, GUT, V10, P651, DOI 10.1136/gut.10.8.651; KVIST N, 1986, SCAND J GASTROENTERO, V21, P82, DOI 10.3109/00365528609034627; WEEDON DD, 1973, NEW ENGL J MED, V289, P1099, DOI 10.1056/NEJM197311222892101	11	543	548	0	9	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	AUG 11	1990	336	8711					357	359		10.1016/0140-6736(90)91889-I	http://dx.doi.org/10.1016/0140-6736(90)91889-I			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU075	1975343	Green Submitted			2022-12-24	WOS:A1990DU07500012
J	HUNG, J; WHITFORD, EG; PARSONS, RW; HILLMAN, DR				HUNG, J; WHITFORD, EG; PARSONS, RW; HILLMAN, DR			ASSOCIATION OF SLEEP-APNEA WITH MYOCARDIAL-INFARCTION IN MEN	LANCET			English	Article									UNIV WESTERN AUSTRALIA, DIV PUBL HLTH, NEDLANDS, WA 6009, AUSTRALIA	University of Western Australia	HUNG, J (corresponding author), SIR CHARLES GAIRDNER HOSP, DEPT CARDIOVASC MED, NEDLANDS, WA 6009, AUSTRALIA.			Hillman, David/0000-0001-9987-539X				BERRY DTR, 1984, CHEST, V86, P529, DOI 10.1378/chest.86.4.529; BLOCK AJ, 1982, NEW ENGL J MED, V306, P166, DOI 10.1056/NEJM198201213060308; BURACK B, 1984, AM HEART J, V107, P543, DOI 10.1016/0002-8703(84)90098-X; DEOLAZABAL JR, 1982, CHEST, V82, P548, DOI 10.1378/chest.82.5.548; DIAMOND GA, 1979, NEW ENGL J MED, V300, P1350, DOI 10.1056/NEJM197906143002402; FLETCHER EC, 1985, ANN INTERN MED, V103, P190, DOI 10.7326/0003-4819-103-2-190; FRANCESCHI M, 1982, SLEEP, V5, P239, DOI 10.1093/sleep/5.3.239; GAINER JL, 1987, ATHEROSCLEROSIS, V68, P263, DOI 10.1016/0021-9150(87)90206-1; GILASON T, 1988, J CLIN EPIDEMIOL, V41, P571; GOULD GA, 1988, AM REV RESPIR DIS, V137, P895, DOI 10.1164/ajrccm/137.4.895; Guilleminault C., 1978, SLEEP APNEAS SYNDROM, V1, P1; KADER GA, 1983, SLEEP, V6, P67, DOI 10.1093/sleep/6.1.67; KOSKENVUO M, 1985, LANCET, V1, P893; KOSVENVUO M, 1987, BRIT MED J, V294, P16; LAVIE P, 1984, AM HEART J, V108, P373, DOI 10.1016/0002-8703(84)90628-8; LAVIE P, 1983, SLEEP, V6, P312, DOI 10.1093/sleep/6.4.312; MARTIN RJ, 1985, SLEEP, V8, P371, DOI 10.1093/sleep/8.4.371; MARTIN RJ, 1984, CARDIORESPIRATORY DI, P41; MCGINTY D, 1988, CHEST, V94, P305, DOI 10.1378/chest.94.2.305; MULLER JE, 1985, NEW ENGL J MED, V313, P1315, DOI 10.1056/NEJM198511213132103; NORTON PG, 1985, BRIT MED J, V291, P630, DOI 10.1136/bmj.291.6496.630; PARTINEN M, 1982, ACTA MED SCAND, P69; SANDERS MH, 1984, CHEST, V86, P839, DOI 10.1378/chest.86.6.839; SCHARF SM, 1984, SLEEP BREATHING LUNG, V21, P221; Shiomi T, 1986, Kokyu To Junkan, V34, P333; STROHL KP, 1986, AM REV RESPIR DIS, V134, P791; STROHL KP, 1984, LUNG BIOL HLTH DISEA, V21, P365; SULLIVAN CE, 1981, LANCET, V1, P862; THAWLEY SE, 1985, MED CLIN N AM, V69, P1337, DOI 10.1016/S0025-7125(16)30990-7; WALLER PC, 1989, LANCET, V1, P143; WILLIAMS AJ, 1985, AM J CARDIOL, V55, P1019, DOI 10.1016/0002-9149(85)90738-6	31	698	734	0	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 4	1990	336	8710					261	264		10.1016/0140-6736(90)91799-G	http://dx.doi.org/10.1016/0140-6736(90)91799-G			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DT007	1973968				2022-12-24	WOS:A1990DT00700001
J	MULLEN, KD; SZAUTER, KM; KAMINSKYRUSS, K				MULLEN, KD; SZAUTER, KM; KAMINSKYRUSS, K			ENDOGENOUS BENZODIAZEPINE ACTIVITY IN BODY-FLUIDS OF PATIENTS WITH HEPATIC-ENCEPHALOPATHY	LANCET			English	Article											MULLEN, KD (corresponding author), CASE WESTERN RESERVE UNIV,METROHEALTH MED CTR,DEPT MED,DIV GASTROENTEROL,ROOM W619,CLEVELAND,OH 44109, USA.				NCRR NIH HHS [RR-05410-26] Funding Source: Medline; NIDDK NIH HHS [R01-DK-39527-01] Funding Source: Medline; NIMH NIH HHS [R29 MH43524-01A1] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK039527] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R29MH043524] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		BASILE AS, 1989, J NEUROCHEM, V53, P1057, DOI 10.1111/j.1471-4159.1989.tb07395.x; BASSETT ML, 1987, GASTROENTEROLOGY, V93, P1069, DOI 10.1016/0016-5085(87)90571-3; Conn HO, 1978, HEPATIC COMA SYNDROM; DEBLAS AL, 1987, BRAIN RES, V413, P275, DOI 10.1016/0006-8993(87)91018-3; JONES EA, 1990, PHARMACOL THERAPEUT, V45, P331; KLOTZ U, 1977, CLIN PHARMACOL THER, V21, P430; MEDINA JH, 1988, BIOCHEM BIOPH RES CO, V152, P534, DOI 10.1016/S0006-291X(88)80070-6; MULLEN KD, 1989, METAB BRAIN DIS, V4, P253, DOI 10.1007/BF00999771; MULLEN KD, 1988, LANCET, V1, P457; MULLEN KD, 1988, ADV AMMONIA METABOLI, P333; MULLEN KD, 1989, HEPATIC ENCEPHALOPAT, P287; MULLEN KD, 1989, ANN INTERN MED, V110, P541; OLASMAA M, 1989, LANCET, V1, P481; PEDERSEN C, 1987, CLIN CHEM, V33, P973; SANGAMESWARAN L, 1986, P NATL ACAD SCI USA, V83, P9236, DOI 10.1073/pnas.83.23.9236; SKOLNICK P, 1979, ARCH GEN PSYCHIAT, V36, P78; UNSELD E, 1989, BIOCHEM PHARMACOL, V38, P2473, DOI 10.1016/0006-2952(89)90091-9; VANDERRIJT CCD, 1989, HEPATOLOGY, V10, P590; WILDMANN J, 1987, J NEURAL TRANSM, V70, P383, DOI 10.1007/BF01253613; WILDMANN J, 1988, BIOCHEM PHARMACOL, V37, P3549, DOI 10.1016/0006-2952(88)90384-X; WILDMANN J, 1988, BIOCHEM BIOPH RES CO, V157, P1436, DOI 10.1016/S0006-291X(88)81036-2; WILDMANN J, 1988, LIFE SCI, V43, P1257, DOI 10.1016/0024-3205(88)90216-0	22	108	109	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JUL 14	1990	336	8707					81	83		10.1016/0140-6736(90)91594-Z	http://dx.doi.org/10.1016/0140-6736(90)91594-Z			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DN793	1975325				2022-12-24	WOS:A1990DN79300005
J	ANAND, IS; MALHOTRA, RM; CHANDRASHEKHAR, Y; BALI, HK; CHAUHAN, SS; JINDAL, SK; BHANDARI, RK; WAHI, PL				ANAND, IS; MALHOTRA, RM; CHANDRASHEKHAR, Y; BALI, HK; CHAUHAN, SS; JINDAL, SK; BHANDARI, RK; WAHI, PL			ADULT SUBACUTE MOUNTAIN-SICKNESS - A SYNDROME OF CONGESTIVE HEART-FAILURE IN MAN AT VERY HIGH-ALTITUDE	LANCET			English	Article									COMMAND HOSP,CHANDIGARH,INDIA; POSTGRAD INST MED EDUC & RES,DEPT PULM MED,CHANDIGARH 160012,INDIA	Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh	ANAND, IS (corresponding author), POSTGRAD INST MED EDUC & RES,DEPT CARDIOL,CHANDIGARH 160012,INDIA.							ANAND IS, 1989, CIRCULATION, V80, P299, DOI 10.1161/01.CIR.80.2.299; ARIASSTELLA J, 1963, CIRCULATION, V28, P915, DOI 10.1161/01.CIR.28.5.915; BARER GR, 1983, J PHYSIOL-LONDON, V336, P27, DOI 10.1113/jphysiol.1983.sp014563; CERRETELLI P, 1976, J APPL PHYSIOL, V40, P658, DOI 10.1152/jappl.1976.40.5.658; DICKINSON J, 1983, THORAX, V38, P646, DOI 10.1136/thx.38.9.646; FISHMAN AP, 1976, CIRC RES, V38, P221, DOI 10.1161/01.RES.38.4.221; HACKETT P, 1977, LANCET, V1, P491; HARTLEY LH, 1967, J APPL PHYSIOL, V23, P839, DOI 10.1152/jappl.1967.23.6.839; HERGET J, 1978, THORAX, V33, P468, DOI 10.1136/thx.33.4.468; HULTGREN HN, 1965, J APPL PHYSIOL, V20, P239, DOI 10.1152/jappl.1965.20.2.239; MEYRICK B, 1979, AM J PATHOL, V96, P51; Monge Carlos, 1943, PHYSIOL REV, V23, P166; PEI SX, 1989, Q J MED, V71, P555; PENALOZA D, 1971, AM J MED, V50, P728, DOI 10.1016/0002-9343(71)90181-1; PUGH L G, 1962, Br Med J, V2, P621; Puri D S, 1986, J Assoc Physicians India, V34, P477; REEVES JT, 1987, J APPL PHYSIOL, V63, P531, DOI 10.1152/jappl.1987.63.2.531; ROTTA A, 1956, J APPL PHYSIOL, V9, P328, DOI 10.1152/jappl.1956.9.3.328; SIME F, 1971, BRIT HEART J, V33, P647; SINGH I, 1965, LANCET, V1, P229; SMITH P, 1974, J PATHOL, V112, P11, DOI 10.1002/path.1711120104; STENMARK KR, 1987, J APPL PHYSIOL, V62, P821, DOI 10.1152/jappl.1987.62.2.821; SUI GJ, 1988, J PATHOL, V155, P161, DOI 10.1002/path.1711550213; TUCKER CE, 1976, J APPL PHYSIOL, V41, P356, DOI 10.1152/jappl.1976.41.3.356; WEST JB, 1984, HIGH ALTITUDE MAN, P5; WILL DH, 1978, J APPL PHYSIOL, V45, P469, DOI 10.1152/jappl.1978.45.3.469; WILLIAMS ES, 1979, CLIN SCI, V56, P305, DOI 10.1042/cs0560305	27	59	60	0	3	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	MAR 10	1990	335	8689					561	565		10.1016/0140-6736(90)90348-9	http://dx.doi.org/10.1016/0140-6736(90)90348-9			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT653	1968575				2022-12-24	WOS:A1990CT65300003
J	CHEHAB, FF; KAN, YW				CHEHAB, FF; KAN, YW			DETECTION OF SICKLE-CELL-ANEMIA MUTATION BY COLOR DNA AMPLIFICATION	LANCET			English	Article									APPL BIOSYST INC, FOSTER CITY, CA USA; UNIV CALIF SAN FRANCISCO, DEPT MED, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, DEPT LAB MED, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, HOWARD HUGHES MED INST, SAN FRANCISCO, CA 94143 USA	Thermo Fisher Scientific; Applied Biosystems; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK016666, R37DK016666] Funding Source: NIH RePORTER; NIDDK NIH HHS [DK-16666] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		CHANG JC, 1982, NEW ENGL J MED, V307, P30, DOI 10.1056/NEJM198207013070105; CHEHAB FF, 1989, MODERN PATHOL, V2, P75; CHEHAB FF, 1987, NATURE, V329, P293, DOI 10.1038/329293b0; CHEHAB FF, 1989, P NATL ACAD SCI USA, V86, P9178, DOI 10.1073/pnas.86.23.9178; CONNER BJ, 1983, P NATL ACAD SCI-BIOL, V80, P278, DOI 10.1073/pnas.80.1.278; COTTON RGH, 1988, P NATL ACAD SCI USA, V85, P4397, DOI 10.1073/pnas.85.12.4397; KAN YW, 1978, LANCET, V2, P910; KAN YW, 1976, NEW ENGL J MED, V294, P1039, DOI 10.1056/NEJM197605062941905; KAZAZIAN HH, 1988, BLOOD, V72, P1107; MYERS RM, 1985, SCIENCE, V12, P42; ORKIN SH, 1982, NEW ENGL J MED, V307, P32, DOI 10.1056/NEJM198207013070106; RUBIN EM, 1989, HUM GENET, V82, P134, DOI 10.1007/BF00284045; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SAIKI RK, 1986, NATURE, V324, P163, DOI 10.1038/324163a0; SHEFFIELD VC, 1989, P NATL ACAD SCI USA, V86, P232, DOI 10.1073/pnas.86.1.232; SMITH LM, 1986, NATURE, V321, P674, DOI 10.1038/321674a0	16	39	54	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 6	1990	335	8680					15	17		10.1016/0140-6736(90)90138-U	http://dx.doi.org/10.1016/0140-6736(90)90138-U			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CG766	1967329				2022-12-24	WOS:A1990CG76600005
J	BARR, E; LEIDEN, JM				BARR, E; LEIDEN, JM			SYSTEMIC DELIVERY OF RECOMBINANT PROTEINS BY GENETICALLY MODIFIED MYOBLASTS	SCIENCE			English	Article							MEDIATED GENE-TRANSFER; HUMAN ADENOSINE-DEAMINASE; TROPONIN-C GENE; HUMAN FACTOR-IX; HEMOPHILIA-B; BONE-MARROW; STEM-CELLS; EXPRESSION; MUSCLE; TRANSPLANTATION	The ability to stably deliver recombinant proteins to the systemic circulation would facilitate the treatment of a variety of acquired and inherited diseases. To explore the feasibility of the use of genetically engineered myoblasts as a recombinant protein delivery system, stable transfectants of the murine C2C12 myoblast cell line were produced that synthesize and secrete high levels of human growth hormone (hGH) in vitro. Mice injected with hGH-transfected myoblasts had significant levels of hGH in both muscle and serum that were stable for at least 3 weeks after injection. Histological examination of muscles injected with beta-galactosidase-expressing C2C12 myoblasts demonstrated that many of the injected cells had fused to form multinucleated myotubes. Thus, genetically engineered myoblasts can bc used for the stable delivery of recombinant proteins into the circulation.	UNIV MICHIGAN,MED CTR,HOWARD HUGHES MED INST,ANN ARBOR,MI 48109; UNIV MICHIGAN,MED CTR,DEPT INTERNAL MED,ANN ARBOR,MI 48109	Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan					NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P01DK042718] Funding Source: NIH RePORTER; NIDDK NIH HHS [1 P01 DK42718-01] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		ARMENTANO D, 1990, P NATL ACAD SCI USA, V87, P6141, DOI 10.1073/pnas.87.16.6141; BARR E, UNPUB; BLAU HM, 1981, P NATL ACAD SCI-BIOL, V78, P5623, DOI 10.1073/pnas.78.9.5623; BLAU HM, 1985, SCIENCE, V230, P758, DOI 10.1126/science.2414846; CULVER K, 1991, P NATL ACAD SCI USA, V88, P3155, DOI 10.1073/pnas.88.8.3155; DZIERZAK EA, 1988, NATURE, V331, P35, DOI 10.1038/331035a0; EVANS WS, 1987, AM J PHYSIOL, V252, pE549, DOI 10.1152/ajpendo.1987.252.4.E549; FAVIA A, 1989, J CLIN ENDOCR METAB, V68, P535; FLOWERS MED, 1990, P NATL ACAD SCI USA, V87, P2349, DOI 10.1073/pnas.87.6.2349; HOLL RW, 1991, J CLIN ENDOCR METAB, V72, P854, DOI 10.1210/jcem-72-4-854; HUGHES SM, 1990, NATURE, V345, P350, DOI 10.1038/345350a0; KALEKO M, 1990, BLOOD, V75, P1733; KARPATI G, 1989, AM J PATHOL, V135, P27; LAW PK, 1988, MUSCLE NERVE, V11, P525, DOI 10.1002/mus.880110602; LIN H, 1990, CIRCULATION, V82, P2217, DOI 10.1161/01.CIR.82.6.2217; Mammen E F, 1983, Semin Thromb Hemost, V9, P1, DOI 10.1055/s-2007-1004999; MILLER DG, 1990, MOL CELL BIOL, V10, P4239, DOI 10.1128/MCB.10.8.4239; NABEL EG, 1990, SCIENCE, V249, P1285, DOI 10.1126/science.2119055; PALMER TD, 1989, BLOOD, V73, P438; PARMACEK MS, 1990, J BIOL CHEM, V265, P15970; PARMACEK MS, 1989, J BIOL CHEM, V264, P13217; PARTRIDGE TA, 1989, NATURE, V337, P176, DOI 10.1038/337176a0; PONDER KP, 1991, P NATL ACAD SCI USA, V88, P1217, DOI 10.1073/pnas.88.4.1217; PRICE J, 1987, P NATL ACAD SCI USA, V84, P156, DOI 10.1073/pnas.84.1.156; RUDMAN D, 1981, NEW ENGL J MED, V305, P123, DOI 10.1056/NEJM198107163050302; SCHARFMANN R, 1991, P NATL ACAD SCI USA, V88, P4626, DOI 10.1073/pnas.88.11.4626; SCHIFFRIN A, 1982, DIABETES, V31, P255, DOI 10.2337/diabetes.31.3.255; WILSON JM, 1990, P NATL ACAD SCI USA, V87, P439, DOI 10.1073/pnas.87.1.439; YAFFE D, 1977, NATURE, V270, P725, DOI 10.1038/270725a0	29	272	324	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	DEC 6	1991	254	5037					1507	1509		10.1126/science.1962212	http://dx.doi.org/10.1126/science.1962212			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT903	1962212				2022-12-24	WOS:A1991GT90300040
J	DHAWAN, J; PAN, LC; PAVLATH, GK; TRAVIS, MA; LANCTOT, AM; BLAU, HM				DHAWAN, J; PAN, LC; PAVLATH, GK; TRAVIS, MA; LANCTOT, AM; BLAU, HM			SYSTEMIC DELIVERY OF HUMAN GROWTH-HORMONE BY INJECTION OF GENETICALLY ENGINEERED MYOBLASTS	SCIENCE			English	Article							DIRECT GENE-TRANSFER; THERAPY; EXPRESSION; INVIVO; CELLS; MICE; DNA; IMPLANTATION; DYSTROPHIN; PROGRESS	A recombinant gene encoding human growth hormone (hGH) was stably introduced into cultured myoblasts with a retroviral vector. After injection of genetically engineered myoblasts into mouse muscle, hGH could be detected in serum for 3 months. The fate of injected myoblasts was assessed by coinfecting the cells with two retroviral vectors, one encoding hGH and the other encoding beta-galactosidase from Escherichia coli. These results provide evidence that myoblasts, which can fuse into preexisting multinucleated myofibers that are vascularized and innervated, may be advantageous as vehicles for systemic delivery of recombinant proteins.	STANFORD UNIV, MED CTR, SCH MED, DEPT PHARMACOL, STANFORD, CA 94305 USA	Stanford University					NIA NIH HHS [AG-09521] Funding Source: Medline; NICHD NIH HHS [HD-18179] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD018179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG009521, R37AG009521] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ACSADI G, 1991, NATURE, V352, P815, DOI 10.1038/352815a0; ALFORD FP, 1973, J CLIN ENDOCR METAB, V37, P515, DOI 10.1210/jcem-37-4-515; AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; BLAU HM, 1981, P NATL ACAD SCI-BIOL, V78, P5623, DOI 10.1073/pnas.78.9.5623; BLAU HM, 1985, SCIENCE, V230, P758, DOI 10.1126/science.2414846; DANOS O, 1988, P NATL ACAD SCI USA, V85, P6460, DOI 10.1073/pnas.85.17.6460; FAUSTMAN D, 1991, SCIENCE, V252, P1700, DOI 10.1126/science.1710828; FEINBERG AP, 1983, ANAL BIOCHEM, V132, P6, DOI 10.1016/0003-2697(83)90418-9; FRIEDMANN T, 1989, SCIENCE, V244, P1275, DOI 10.1126/science.2660259; GARVER RI, 1987, SCIENCE, V237, P762, DOI 10.1126/science.3497452; GUSSONI E, UNPUB; Hughes S., UNPUB; HUGHES SM, 1990, NATURE, V345, P350, DOI 10.1038/345350a0; KAPLAN SL, 1986, LANCET, V1, P697; KARPATI G, 1989, AM J PATHOL, V135, P27; KOLLER BH, 1989, P NATL ACAD SCI USA, V86, P8932, DOI 10.1073/pnas.86.22.8932; LIN H, 1990, CIRCULATION, V82, P2217, DOI 10.1161/01.CIR.82.6.2217; LINDAHL A, 1990, INT CONGR SER, V925, P383; MILLER AD, 1990, BLOOD, V76, P271; MILLER SC, 1988, GENE DEV, V2, P330, DOI 10.1101/gad.2.3.330; MORGAN JE, 1990, J CELL BIOL, V111, P2437, DOI 10.1083/jcb.111.6.2437; MORGAN JR, 1987, SCIENCE, V237, P1476; NABEL EG, 1990, SCIENCE, V249, P1285, DOI 10.1126/science.2119055; PALMER TD, 1991, P NATL ACAD SCI USA, V88, P1330, DOI 10.1073/pnas.88.4.1330; PAN L, UNPUB; PARTRIDGE TA, 1991, NATURE, V352, P757, DOI 10.1038/352757a0; PARTRIDGE TA, 1989, NATURE, V337, P176, DOI 10.1038/337176a0; PARTRIDGE TA, 1988, J CELL BIOCHEM     S, V12, P331; PAVLATH GK, UNPUB; PEETERS S, 1977, ENDOCRINOLOGY, V101, P1164, DOI 10.1210/endo-101-4-1164; PETERSON CA, 1990, CELL, V62, P493, DOI 10.1016/0092-8674(90)90014-6; ROEDERER M, 1991, Methods (Orlando), V2, P248, DOI 10.1016/S1046-2023(05)80067-2; RUDMAN D, 1990, NEW ENGL J MED, V323, P1, DOI 10.1056/NEJM199007053230101; SALOMON F, 1989, NEW ENGL J MED, V321, P1797, DOI 10.1056/NEJM198912283212605; SCHARFMANN R, 1991, P NATL ACAD SCI USA, V88, P4626, DOI 10.1073/pnas.88.11.4626; SELDEN RF, 1987, SCIENCE, V236, P714, DOI 10.1126/science.3472348; SHIZURU JA, 1987, SCIENCE, V237, P278, DOI 10.1126/science.2955518; STLOUIS D, 1988, P NATL ACAD SCI USA, V85, P3150; TASSIN AM, 1985, J CELL BIOL, V101, P630, DOI 10.1083/jcb.101.2.630; TEUMER J, 1990, FASEB J, V4, P3245, DOI 10.1096/fasebj.4.14.2227214; WEBSTER C, 1988, EXP CELL RES, V174, P252, DOI 10.1016/0014-4827(88)90159-0; WEBSTER C, 1990, SOMAT CELL MOLEC GEN, V16, P557, DOI 10.1007/BF01233096; WOLFF JA, 1990, SCIENCE, V247, P1465, DOI 10.1126/science.1690918; ZIJLSTRA M, 1989, NATURE, V342, P435, DOI 10.1038/342435a0	44	328	382	0	11	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 6	1991	254	5037					1509	1512		10.1126/science.1962213	http://dx.doi.org/10.1126/science.1962213			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT903	1962213				2022-12-24	WOS:A1991GT90300041
J	FERRIN, LJ; CAMERINIOTERO, RD				FERRIN, LJ; CAMERINIOTERO, RD			SELECTIVE CLEAVAGE OF HUMAN DNA - RECA-ASSISTED RESTRICTION ENDONUCLEASE (RARE) CLEAVAGE	SCIENCE			English	Article							TRIPLE-HELIX FORMATION; SITE-SPECIFIC CLEAVAGE; CYSTIC-FIBROSIS GENE; ESCHERICHIA-COLI; PROTEIN; SEQUENCES; IDENTIFICATION; PURIFICATION; CHROMOSOME; DUPLEX	Current methods for sequence-specific cleavage of large segments of DNA are severely limited because of the paucity of possible cleavage sites. A method is described whereby any Eco RI site can be targeted for specific cleavage. The technique is based on the ability of RecA protein from Escherichia coli to pair an oligonucleotide to its homologous sequence in duplex DNA and to form a three-stranded complex. This complex is protected from Eco RI methylase; after methylation and RecA protein removal, Eco RI restriction enzyme cleavage was limited to the site previously protected from methylation. When pairs of oligonucleotides are used, a specific fragment can be cleaved out of genomes. The method was tested on lambda-phage, Escherichia coli, and human DNA. Fragments exceeding 500 kilobases in length and yields exceeding 80 percent could be obtained.	NIDDKD,GENET & BIOCHEM BRANCH,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)								BEAL PA, 1991, SCIENCE, V251, P1360, DOI 10.1126/science.2003222; COX MM, 1981, J BIOL CHEM, V256, P4676; CRAIG NL, 1981, J BIOL CHEM, V256, P8039; DANIELS DL, 1983, LAMBDA, V2, P519; FERRIN LJ, UNPUB; GRIFFITH J, 1985, BIOCHEMISTRY-US, V24, P158, DOI 10.1021/bi00322a022; HSIEH P, 1990, GENE DEV, V4, P1951, DOI 10.1101/gad.4.11.1951; HSIEH P, 1989, J BIOL CHEM, V264, P5089; HSIEH PL, UNPUB; KOHARA Y, 1987, CELL, V50, P495, DOI 10.1016/0092-8674(87)90503-4; KOOB M, 1990, SCIENCE, V250, P271, DOI 10.1126/science.2218529; KOWALCZYKOWSKI SC, UNPUB; MCCLELLAND M, 1987, METHOD ENZYMOL, V155, P22; MOSER HE, 1987, SCIENCE, V238, P645, DOI 10.1126/science.3118463; PEI DH, 1990, P NATL ACAD SCI USA, V87, P9858, DOI 10.1073/pnas.87.24.9858; RAO BJ, 1991, P NATL ACAD SCI USA, V88, P2984, DOI 10.1073/pnas.88.8.2984; RIORDAN JR, 1989, SCIENCE, V245, P1066; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; RUDD KE, 1990, NUCLEIC ACIDS RES, V18, P313, DOI 10.1093/nar/18.2.313; STROBEL SA, 1991, NATURE, V350, P172, DOI 10.1038/350172a0; UHLIN BE, 1981, J BACTERIOL, V148, P386, DOI 10.1128/JB.148.1.386-390.1981; WILSON WW, 1990, ANAL BIOCHEM, V191, P370, DOI 10.1016/0003-2697(90)90234-Z; ZIELENSKI J, 1991, GENOMICS, V10, P214, DOI 10.1016/0888-7543(91)90503-7	23	199	232	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	DEC 6	1991	254	5037					1494	1497		10.1126/science.1962209	http://dx.doi.org/10.1126/science.1962209			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT903	1962209				2022-12-24	WOS:A1991GT90300036
J	NIELSEN, PE; EGHOLM, M; BERG, RH; BUCHARDT, O				NIELSEN, PE; EGHOLM, M; BERG, RH; BUCHARDT, O			SEQUENCE-SELECTIVE RECOGNITION OF DNA BY STRAND DISPLACEMENT WITH A THYMINE-SUBSTITUTED POLYAMIDE	SCIENCE			English	Article							TRIPLE-HELIX FORMATION; SITE-SPECIFIC CLEAVAGE; DUPLEX DNA; INTERCALATING AGENTS; MAJOR GROOVE; BINDING; PROTEIN; MOTIF; INHIBITION; COMPLEX	A polyamide nucleic acid (PNA) was designed by detaching the deoxyribose phosphate backbone of DNA in a computer model and replacing it with an achiral polyamide backbone. On the basis of this model, oligomers consisting of thymine-linked aminoethylglycyl units were prepared. These oligomers recognize their complementary target in double-stranded DNA by strand displacement The displacement is made possible by the extraordinarily high stability of the PNA-DNA hybrids. The results show that the backbone of DNA can be replaced by a polyamide, with the resulting oligomer retaining base-specific hybridization.	HC ORSTED INST,DEPT ORGAN CHEM,DK-2100 COPENHAGEN 0,DENMARK; RISO NATL LAB,DEPT MAT,POLYMER GRP,DK-4000 ROSKILDE,DENMARK	University of Copenhagen; Technical University of Denmark	NIELSEN, PE (corresponding author), PANUM INST,DEPT BIOCHEM B,MED BIOTECHNOL RES CTR,BLEGDAMSVEJ 3C,DK-2200 COPENHAGEN N,DENMARK.		Berg, Rolf H/C-6339-2009	/0000-0001-8771-330X				BEAL PA, 1991, SCIENCE, V251, P1360, DOI 10.1126/science.2003222; BIRG F, 1990, NUCLEIC ACIDS RES, V18, P2901, DOI 10.1093/nar/18.10.2901; BRENNAN RG, 1989, J BIOL CHEM, V264, P1903; DERVAN PB, 1986, SCIENCE, V232, P464, DOI 10.1126/science.2421408; DREW HR, 1984, J MOL BIOL, V176, P535, DOI 10.1016/0022-2836(84)90176-1; EBRIGHT RH, 1990, P NATL ACAD SCI USA, V87, P2882, DOI 10.1073/pnas.87.8.2882; FEDOROVA OS, 1988, FEBS LETT, V228, P273, DOI 10.1016/0014-5793(88)80014-0; FRANCOIS JC, 1988, NUCLEIC ACIDS RES, V16, P11431, DOI 10.1093/nar/16.24.11431; GRIFFIN LC, 1989, SCIENCE, V245, P967, DOI 10.1126/science.2549639; GUERON M, 1987, NATURE, V328, P89, DOI 10.1038/328089a0; HELENE C, 1990, BIOCHIM BIOPHYS ACTA, V1049, P99, DOI 10.1016/0167-4781(90)90031-V; HORNE DA, 1990, J AM CHEM SOC, V112, P2435, DOI 10.1021/ja00162a063; JEPPESEN C, 1989, EUR J BIOCHEM, V182, P437, DOI 10.1111/j.1432-1033.1989.tb14850.x; JEPPESEN C, 1989, NUCLEIC ACIDS RES, V17, P4947, DOI 10.1093/nar/17.13.4947; MACK DP, 1990, J AM CHEM SOC, V112, P4604, DOI 10.1021/ja00167a102; MACK DP, 1988, J AM CHEM SOC, V110, P7572, DOI 10.1021/ja00230a067; MAHER LJ, 1989, SCIENCE, V245, P725, DOI 10.1126/science.2549631; MOSER HE, 1987, SCIENCE, V238, P645, DOI 10.1126/science.3118463; NIELSEN PE, 1991, BIOCONJUGATE CHEM, V2, P1, DOI 10.1021/bc00007a001; NIELSEN PE, 1989, BIOCHEMISTRY-US, V27, P6338; OLLIS DL, 1987, CHEM REV, V87, P981, DOI 10.1021/cr00081a006; PEI D, 1990, J AM CHEM SOC, V112, P4579, DOI 10.1021/ja00167a085; SAUER RT, 1990, NATURE, V347, P514, DOI 10.1038/347514b0; SCHLEIF R, 1988, SCIENCE, V241, P1182, DOI 10.1126/science.2842864; SLUKA JP, 1987, SCIENCE, V238, P1129, DOI 10.1126/science.3120311; STROBEL SA, 1990, SCIENCE, V249, P73, DOI 10.1126/science.2195655; SUN JS, 1989, P NATL ACAD SCI USA, V86, P9198, DOI 10.1073/pnas.86.23.9198; WAKELIN LPG, 1990, J MED CHEM, V33, P2039, DOI 10.1021/jm00169a039; [No title captured]	29	2714	3852	16	382	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	DEC 6	1991	254	5037					1497	1500		10.1126/science.1962210	http://dx.doi.org/10.1126/science.1962210			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT903	1962210				2022-12-24	WOS:A1991GT90300037
J	NASRIN, N; BUGGS, C; KONG, XF; CARNAZZA, J; GOEBL, M; ALEXANDERBRIDGES, M				NASRIN, N; BUGGS, C; KONG, XF; CARNAZZA, J; GOEBL, M; ALEXANDERBRIDGES, M			DNA-BINDING PROPERTIES OF THE PRODUCT OF THE TESTIS-DETERMINING GENE AND A RELATED PROTEIN	NATURE			English	Article							SEX-DETERMINING REGION; MOTIF; EXPRESSION; HOMOLOGY; CLONING; CELLS; SRY	THE upstream region of the human glyceraldehyde-3-phosphate dehydrogenase gene contains an insulin-response element (IRE-A) responsible for insulin-dependent transcription of the gene (ref. 1). The open reading frame of a rat complementary DNA encoding a protein (IRE-ABP) that binds to this sequence contains an HMG box motif 2 that is 67% identical to the mouse candidate gene for the testis-determining factor SRY, and 98% identical to the mouse SRY-like gene, alpha-4(refs 3, 4). Here we report that IRE-ABP and SRY bind to IRE-A DNA with comparable specificity in a DNase-I footprinting assay. Two females with sex reversal were found to have a single amino-acid substitution in the HMG box domain of SRY at position 3 and 7, respectively 5,6. SRY derivatives containing corresponding mutations do not make contact with IRE-A DNA. These results are direct evidence that mouse SRY-like proteins are sequence-specific DNA-binding proteins and identify two amino acids critical to this interaction. Moreover, IRE-A is a candidate SRY-response element.	HARVARD UNIV,MASSACHUSETTS GEN HOSP,SCH MED,HOWARD HUGHES MED INST,DIABET UNIT,50 BLOSSOM ST,BOSTON,MA 02114; HARVARD UNIV,MASSACHUSETTS GEN HOSP,SCH MED,MED SERV,BOSTON,MA 02114	Harvard University; Harvard Medical School; Massachusetts General Hospital; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Massachusetts General Hospital								BERTA P, 1990, NATURE, V348, P448, DOI 10.1038/348448A0; GUBBAY J, 1990, NATURE, V346, P245, DOI 10.1038/346245a0; JAGER RJ, 1990, NATURE, V348, P452, DOI 10.1038/348452a0; JANTZEN HM, 1990, NATURE, V344, P830, DOI 10.1038/344830a0; JUTTE NHPM, 1982, J REPROD FERTIL, V65, P431, DOI 10.1530/jrf.0.0650431; KOOPMAN P, 1990, NATURE, V348, P450, DOI 10.1038/348450a0; LABRIE F, 1984, ENDOCRINOLOGY, P615; NASRIN N, 1990, P NATL ACAD SCI USA, V87, P5273, DOI 10.1073/pnas.87.14.5273; ROBINSON R, 1981, BIOL REPROD, V24, P1032, DOI 10.1095/biolreprod24.5.1032; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; SINGH H, 1988, CELL, V52, P415, DOI 10.1016/S0092-8674(88)80034-5; SKINNER MK, 1991, ENDOCR REV, V12, P45, DOI 10.1210/edrv-12-1-45; STAUDT LM, 1988, SCIENCE, V241, P577, DOI 10.1126/science.3399892; TRAVIS A, 1991, GENE DEV, V5, P880, DOI 10.1101/gad.5.5.880; VANDEWETERING M, 1991, EMBO J, V10, P123, DOI 10.1002/j.1460-2075.1991.tb07928.x; WATERMAN M L, 1990, New Biologist, V2, P621; WATERMAN ML, 1991, GENE DEV, V5, P656, DOI 10.1101/gad.5.4.656	17	172	175	0	0	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 28	1991	354	6351					317	320		10.1038/354317a0	http://dx.doi.org/10.1038/354317a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT204	1956382				2022-12-24	WOS:A1991GT20400051
J	CEBRATHOMAS, JA; DECKER, CL; SNYDER, LC; PILDER, SH; SILVER, LM				CEBRATHOMAS, JA; DECKER, CL; SNYDER, LC; PILDER, SH; SILVER, LM			ALLELE-SPECIFIC AND HAPLOID-SPECIFIC PRODUCT GENERATED BY ALTERNATIVE SPLICING FROM A MOUSE T-COMPLEX-RESPONDER LOCUS CANDIDATE	NATURE			English	Article							DISTORTER GENES; HAPLOTYPES; FAMILY; DNA	MOUSE t haplotypes represent a variant form of chromosome 17 that has evolved the ability to propagate through natural populations by the phenomenon of 'transmission ratio distortion' (TRD), in which heterozygous +/t males transmit their t-carrying chromosome to 95% or more of their offspring 1,2. Although multiple t-associated loci have a role in expression of this phenotype, only one-the t complex responder (Tcr) locus-is responsible for determining which of the two homologues of chromosome 17 will be transmitted at a high ratio 3. A candiate gene (Tcp-10b) for Tcr that is expressed in both meiotic and post-meiotic male germ cells has been cloned 4. But for this candiate gene to function as the haploid effector of TRD, the t-allele of this gene (Tcp-10b(t)) must express a unique product in a haploid-specific manner. Here we show that a change in the splicing pattern of Tcp-10b(t) transcripts occurs during sperm differentiation. This change results in a unique allele-specific and haploid-specific transcript which could encode a variant polypeptide that would fulfil the conditions required of the Tcr effector of TRD.	PRINCETON UNIV,DEPT MOLEC BIOL,PRINCETON,NJ 08544	Princeton University								Ausubel FM., 1987, CURRENT PROTOCOLS MO, DOI 10.1002/mrd.1080010210; BULLARD DC, 1990, GENETICS, V124, P957; Klein J., 1986, NATURAL HIST MAJOR H; LYON MF, 1986, CELL, V44, P357, DOI 10.1016/0092-8674(86)90770-1; LYON MF, 1984, CELL, V37, P621, DOI 10.1016/0092-8674(84)90393-3; ROSEN LL, 1990, GENOMICS, V8, P134, DOI 10.1016/0888-7543(90)90235-M; SCHIMENTI J, 1987, J MOL BIOL, V194, P583, DOI 10.1016/0022-2836(87)90235-X; SCHIMENTI J, 1988, CELL, V55, P71, DOI 10.1016/0092-8674(88)90010-4; SILVER LM, 1985, ANNU REV GENET, V19, P179, DOI 10.1146/annurev.ge.19.120185.001143; WOLGEMUTH DJ, 1985, GAMETE RES, V12, P1, DOI 10.1002/mrd.1120120102	10	45	46	0	1	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JAN 17	1991	349	6306					239	241		10.1038/349239a0	http://dx.doi.org/10.1038/349239a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET519	1987476				2022-12-24	WOS:A1991ET51900055
J	HULL, RD; RASKOB, GE				HULL, RD; RASKOB, GE			LOW-PROBABILITY LUNG-SCAN FINDINGS - A NEED FOR CHANGE	ANNALS OF INTERNAL MEDICINE			English	Note							SUSPECTED PULMONARY-EMBOLISM; VENTILATION-PERFUSION; ANGIOGRAPHY; DIAGNOSIS				HULL, RD (corresponding author), UNIV CALGARY, FOOTHILLS HOSP, DEPT MED, 3330 HOSP DR NW, CALGARY T2N 4N1, ALBERTA, CANADA.							ALDERSON PO, 1976, RADIOLOGY, V120, P633, DOI 10.1148/120.3.633; BIELLO DR, 1979, AM J ROENTGENOL, V133, P1033, DOI 10.2214/ajr.133.6.1033; CHEELY R, 1981, AM J MED, V70, P17, DOI 10.1016/0002-9343(81)90406-X; HULL RD, 1985, CHEST, V88, P819, DOI 10.1378/chest.88.6.819; HULL RD, 1990, CHEST, V97, P23, DOI 10.1378/chest.97.1.23; HULL RD, 1983, ANN INTERN MED, V98, P891, DOI 10.7326/0003-4819-98-6-891; MCNEIL BJ, 1980, J NUCL MED, V21, P319; MOSER KM, 1990, AM REV RESPIR DIS, V141, P235, DOI 10.1164/ajrccm/141.1.235; VREIM CE, 1990, JAMA-J AM MED ASSOC, V263, P2753	9	82	83	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 15	1991	114	2					142	143		10.7326/0003-4819-114-2-142	http://dx.doi.org/10.7326/0003-4819-114-2-142			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ER534	1984390				2022-12-24	WOS:A1991ER53400008
J	PARDO, JV; FOX, PT; RAICHLE, ME				PARDO, JV; FOX, PT; RAICHLE, ME			LOCALIZATION OF A HUMAN SYSTEM FOR SUSTAINED ATTENTION BY POSITRON EMISSION TOMOGRAPHY	NATURE			English	Article							INTRAVENOUS (H2O)-O-15; HUMAN-BRAIN; PET IMAGES; CORTEX	POSITRON emission tomographic (PET) studies of human attention have begun to dissect isolable components of this complex higher brain function, including a midline attentional system in a region of the anterior cingulate cortex1-3. The right hemisphere may play a special part in human attention4; neglect, an important phenomenon associated with damage to attentional systems, is more severe, extensive and long-lasting after lesions to the right hemisphere. Here we use PET measurements of brain flood flow in healthy subjects to identify changes in regional brain activity during simple visual and somatosensory tasks of sustained attention or vigilance. We find localized increases in blood flow in the prefrontal and superior parietal cortex primarily in the right hemisphere, regardless of the modality or laterality of sensory input. The anterior cingulate was not activated during either task. These data localize the vigilance aspects of normal human attention to sensory stimuli, thereby clarifying the biology underlying asymmetries of attention to such stimuli that have been reported in clinical lesions.	WASHINGTON UNIV,MED CTR,DEPT NEUROL & NEUROL SURG,ST LOUIS,MO 63110; WASHINGTON UNIV,MED CTR,DEPT PSYCHIAT,ST LOUIS,MO 63110; WASHINGTON UNIV,MED CTR,MALLINCKRODT INST RADIOL,ST LOUIS,MO 63110; WASHINGTON UNIV,MED CTR,MCDONNELL CTR STUDIES HIGHER BRAIN FUNCT,ST LOUIS,MO 63110	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)			Fox, Peter/B-4725-2010	Fox, Peter/0000-0002-0465-2028				CAVADA C, 1989, J COMP NEUROL, V287, P393, DOI 10.1002/cne.902870402; CORBETTA M, 1990, SCIENCE, V248, P1556, DOI 10.1126/science.2360050; FOX PT, 1989, J NUCL MED, V30, P141; FOX PT, 1988, J CEREBR BLOOD F MET, V8, P642, DOI 10.1038/jcbfm.1988.111; FOX PT, 1987, J NEUROSURG, V67, P34, DOI 10.3171/jns.1987.67.1.0034; FOX PT, 1987, J NEUROSCI, V7, P913; Fuster J.M., 1989, PREFRONTAL CORTEX; Goldman-Rakic P. S., 1987, COMPR PHYSIOL, P373, DOI DOI 10.1002/CPHY.CP010509; HEILMAN KM, 1987, HDB PHYSL 1, V5, P461; HERSCOVITCH P, 1983, J NUCL MED, V24, P782; MINTUN MA, 1989, J CEREBR BLOOD F MET, V9, P96, DOI 10.1038/jcbfm.1989.13; PARDO JV, 1990, P NATL ACAD SCI USA, V87, P256, DOI 10.1073/pnas.87.1.256; POSNER MI, 1988, SCIENCE, V240, P1627, DOI 10.1126/science.3289116; RAICHLE ME, 1983, J NUCL MED, V24, P790; Talairach J, 1967, ATLAS ANATOMIE STERE; YAMAMOTO M, 1982, IEEE T NUCL SCI, V29, P529, DOI 10.1109/TNS.1982.4335901	16	1056	1068	0	47	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JAN 3	1991	349	6304					61	64		10.1038/349061a0	http://dx.doi.org/10.1038/349061a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EQ601	1985266				2022-12-24	WOS:A1991EQ60100050
J	BOUCHER, CAB; TERSMETTE, M; LANGE, JMA; KELLAM, P; DEGOEDE, REY; MULDER, JW; DARBY, G; GOUDSMIT, J; LARDER, BA				BOUCHER, CAB; TERSMETTE, M; LANGE, JMA; KELLAM, P; DEGOEDE, REY; MULDER, JW; DARBY, G; GOUDSMIT, J; LARDER, BA			ZIDOVUDINE SENSITIVITY OF HUMAN IMMUNODEFICIENCY VIRUSES FROM HIGH-RISK, SYMPTOM-FREE INDIVIDUALS DURING THERAPY	LANCET			English	Article									UNIV AMSTERDAM, ACAD MED CTR, HUMAN RETROVIRUS LAB, 1105 AZ AMSTERDAM, NETHERLANDS; UNIV AMSTERDAM, ACAD MED CTR, DEPT INTERNAL MED, 1105 AZ AMSTERDAM, NETHERLANDS; UNIV AMSTERDAM, NETHERLANDS RED CROSS, BLOOD TRANSFUS SERV, CENT LAB, AMSTERDAM, NETHERLANDS; MUNICIPAL HLTH SERV, DEPT INFECT DIS, AMSTERDAM, NETHERLANDS; WELLCOME RES LABS, BECKENHAM BR3 3BS, KENT, ENGLAND	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; GlaxoSmithKline; Wellcome Research Laboratories			Larder, Brendan/AAB-3106-2020	Kellam, Paul/0000-0003-3166-4734				CHESEBRO B, 1988, J VIROL, V62, P3779, DOI 10.1128/JVI.62.10.3779-3788.1988; CREAGHKIRK T, 1988, JAMA-J AM MED ASSOC, V260, P3009, DOI 10.1001/jama.260.20.3009; DEWOLF F, 1988, J INFECT DIS, V158, P615, DOI 10.1093/infdis/158.3.615; DEWOLF F, 1988, LANCET, V1, P373; DOURNON E, 1988, LANCET, V2, P1297; FISCHL M, 1989, Journal of the American Medical Association, V262, P2405, DOI 10.1001/jama.262.17.2405; FISCHL MA, 1987, NEW ENGL J MED, V317, P185, DOI 10.1056/NEJM198707233170401; HO DD, 1989, NEW ENGL J MED, V321, P1621, DOI 10.1056/NEJM198912143212401; LANGE JMA, 1986, BRIT MED J, V293, P1459, DOI 10.1136/bmj.293.6560.1459; LARDER BA, 1989, SCIENCE, V243, P1731, DOI 10.1126/science.2467383; LARDER BA, 1990, ANTIMICROB AGENTS CH, V34, P436, DOI 10.1128/AAC.34.3.436; LARDER BA, 1989, SCIENCE, V246, P1155, DOI 10.1126/science.2479983; MULDER JW, 1990, ANTIVIR RES, V13, P127, DOI 10.1016/0166-3542(90)90028-6; PARKS WP, 1988, J ACQ IMMUN DEF SYND, V1, P125; RICHMAN DD, 1988, AM J MED, V85, P208; STAMBUK D, 1989, Q J MED, V70, P161; STEINBERG JP, 1989, J ACQ IMMUN DEF SYND, V2, P229; TERSMETTE M, 1988, J VIROL, V62, P2026, DOI 10.1128/JVI.62.6.2026-2032.1988; [No title captured]; [No title captured]; 1989, LANCET, V2, P483	21	192	195	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 8	1990	336	8715					585	590		10.1016/0140-6736(90)93391-2	http://dx.doi.org/10.1016/0140-6736(90)93391-2			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DX401	1975378				2022-12-24	WOS:A1990DX40100003
J	OHASHI, PS; PIRCHER, H; BURKI, K; ZINKERNAGEL, RM; HENGARTNER, H				OHASHI, PS; PIRCHER, H; BURKI, K; ZINKERNAGEL, RM; HENGARTNER, H			DISTINCT SEQUENCE OF NEGATIVE OR POSITIVE SELECTION IMPLIED BY THYMOCYTE T-CELL RECEPTOR DENSITIES	NATURE			English	Article									SANDOZ PHARMA LTD,PRECLIN RES,CH-4002 BASEL,SWITZERLAND	Novartis; Sandoz	OHASHI, PS (corresponding author), UNIV HOSP ZURICH,INST PATHOL,DEPT EXPTL PATHOL,CH-8091 ZURICH,SWITZERLAND.			Ohashi, Pamela S./0000-0003-2915-9317				BENOIST C, 1989, CELL, V58, P1027, DOI 10.1016/0092-8674(89)90501-1; BLUE ML, 1987, J IMMUNOL, V139, P1065; HASKINS K, 1984, J EXP MED, V160, P452, DOI 10.1084/jem.160.2.452; HAVRAN WL, 1987, NATURE, V330, P170, DOI 10.1038/330170a0; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; KAPPLER JW, 1988, NATURE, V332, P35, DOI 10.1038/332035a0; KISIELOW P, 1988, NATURE, V333, P742, DOI 10.1038/333742a0; MACDONALD HR, 1988, NATURE, V332, P40, DOI 10.1038/332040a0; MARRACK P, 1988, IMMUNOL TODAY, V9, P308, DOI 10.1016/0167-5699(88)91324-2; MCCARTHY SA, 1988, NATURE, V336, P76, DOI 10.1038/336076a0; Ohashi P S, 1989, Semin Immunol, V1, P95; PFLUCKER JCZ, 1989, NATURE, V338, P76; PFLUCKER JCZ, 1989, J EXP MED, V169, P2085; PIRCHER H, 1989, EMBO J, V8, P719, DOI 10.1002/j.1460-2075.1989.tb03431.x; PIRCHER H, 1989, NATURE, V342, P559, DOI 10.1038/342559a0; ROEHM N, 1984, CELL, V38, P577, DOI 10.1016/0092-8674(84)90512-9; ROTHENBERG EV, 1990, IMMUNOL TODAY, V11, P116, DOI 10.1016/0167-5699(90)90047-D; SCHWARTZ RH, 1989, CELL, V57, P1073, DOI 10.1016/0092-8674(89)90044-5; SHA WC, 1988, NATURE, V336, P73, DOI 10.1038/336073a0; TEH HS, 1988, NATURE, V335, P229, DOI 10.1038/335229a0; TOMONARI K, 1988, IMMUNOGENETICS, V28, P455, DOI 10.1007/BF00355379; WHITE J, 1989, CELL, V56, P27, DOI 10.1016/0092-8674(89)90980-X; ZEPP F, 1988, NATURE, V336, P473, DOI 10.1038/336473a0	23	151	151	0	1	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	AUG 30	1990	346	6287					861	863		10.1038/346861a0	http://dx.doi.org/10.1038/346861a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW488	1975427				2022-12-24	WOS:A1990DW48800061
J	OKSENBERG, JR; STUART, S; BEGOVICH, AB; BELL, RB; ERLICH, HA; STEINMAN, L; BERNARD, CCA				OKSENBERG, JR; STUART, S; BEGOVICH, AB; BELL, RB; ERLICH, HA; STEINMAN, L; BERNARD, CCA			LIMITED HETEROGENEITY OF REARRANGED T-CELL RECEPTOR V-ALPHA TRANSCRIPTS IN BRAINS OF MULTIPLE-SCLEROSIS PATIENTS	NATURE			English	Article									STANFORD UNIV,DEPT NEUROL,STANFORD,CA 94305; STANFORD UNIV,DEPT GENET & PEDIAT,STANFORD,CA 94305; LA TROBE UNIV,NEUROIMMUNOL LAB,BUNDOORA,VIC 3083,AUSTRALIA; CETUS CORP,DEPT HUMAN GENET,EMERYVILLE,CA 94608	Stanford University; Stanford University; La Trobe University				Steinman, Lawrence/0000-0002-2437-2250				ACHAORBEA H, 1988, CELL, V54, P263, DOI 10.1016/0092-8674(88)90558-2; BEALL SS, 1989, J NEUROIMMUNOL, V21, P59, DOI 10.1016/0165-5728(89)90159-8; BENNUN A, 1981, NATURE, V292, P60, DOI 10.1038/292060a0; HAFLER DA, 1988, J EXP MED, V167, P1313, DOI 10.1084/jem.167.4.1313; HAFLER DA, 1987, ANN NEUROL, V22, P89, DOI 10.1002/ana.410220121; HAFLER DA, 1987, IMMUNOL REV, V100, P307, DOI 10.1111/j.1600-065X.1987.tb00537.x; Hoffman F. M., 1989, J EXP MED, V170, P607; HOFFMAN FM, 1986, J IMMUNOL, V136, P3239; HOWELL MD, 1989, SCIENCE, V246, P668, DOI 10.1126/science.2814489; KATZ EH, 1989, IMMUNOL TODAY, V10, P164; KLEIN MH, 1987, P NATL ACAD SCI USA, V84, P6884, DOI 10.1073/pnas.84.19.6884; LOH EY, 1989, SCIENCE, V243, P217, DOI 10.1126/science.2463672; MCFARLIN DE, 1982, NEW ENGL J MED, V307, P1183, DOI 10.1056/NEJM198211043071905; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; OKSENBERG JR, 1989, P NATL ACAD SCI USA, V86, P988, DOI 10.1073/pnas.86.3.988; PRINEAS JW, 1978, LAB INVEST, V38, P409; Prineas JW., 1985, HDB CLIN NEUROLOGY, V3, P213; RAINE CS, 1984, IMMUNOREGULATORY PRO, P151; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SAKAI K, 1988, P NATL ACAD SCI USA, V85, P8608, DOI 10.1073/pnas.85.22.8608; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SEBOUN E, 1989, CELL, V57, P1095, DOI 10.1016/0092-8674(89)90046-9; SIM GK, 1984, NATURE, V312, P771; SOBEL RA, 1988, J IMMUNOL, V140, P2210; TRAUGOTT U, 1983, J NEUROIMMUNOL, V4, P201, DOI 10.1016/0165-5728(83)90036-X; URBAN JL, 1988, CELL, V54, P577, DOI 10.1016/0092-8674(88)90079-7; VANDENBARK AA, 1989, NATURE, V341, P541, DOI 10.1038/341541a0; WINOTO A, 1989, EMBO J, V8, P729, DOI 10.1002/j.1460-2075.1989.tb03432.x; WOODROOFE MN, 1986, J NEUROL SCI, V74, P135, DOI 10.1016/0022-510X(86)90100-0; YOSHIKAI Y, 1986, J EXP MED, V164, P90, DOI 10.1084/jem.164.1.90	30	413	438	0	0	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAY 24	1990	345	6273					344	346		10.1038/345344a0	http://dx.doi.org/10.1038/345344a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF149	1971424				2022-12-24	WOS:A1990DF14900065
J	LEACH, RM; MCBRIEN, DJ				LEACH, RM; MCBRIEN, DJ			BRACHIORADIAL DELAY - A NEW CLINICAL INDICATOR OF THE SEVERITY OF AORTIC-STENOSIS	LANCET			English	Article									WORTHING DIST HOSP,DEPT MED,WORTHING,ENGLAND									Bramwell JC, 1922, P R SOC LOND B-CONTA, V93, P298, DOI 10.1098/rspb.1922.0022; BURCH GE, 1963, AM HEART J, V66, P439, DOI 10.1016/0002-8703(63)90374-0; COPELAND JG, 1977, J THORAC CARDIOV SUR, V74, P875; EPSTEIN EJ, 1964, BRIT HEART J, V26, P84; FRANK S, 1973, BRIT HEART J, V35, P41; HANCOCK EW, 1957, CIRCULATION, V16, P572, DOI 10.1161/01.CIR.16.4.572; Hickson S K, 1924, J Physiol, V59, P217; LEWES D, 1951, BRIT MED J, V1, P211, DOI 10.1136/bmj.1.4700.211; Mcdonald DA, 1974, BLOOD FLOW ARTERIES; MORGAN DJR, 1979, BRIT MED J, V1, P784, DOI 10.1136/bmj.1.6166.784; ORAM S, CLIN HEART DISEASE, P236; OROURKE MF, 1970, CARDIOVASC RES, V4, P291, DOI 10.1093/cvr/4.3.291; ROBERTS WC, 1971, AM J CARDIOL, V27, P497, DOI 10.1016/0002-9149(71)90412-7; WIGGER CJ, 1928, PRESSURE PULSES CARD; WOOD P, 1958, AM J CARDIOL, V1, P553, DOI 10.1016/0002-9149(58)90138-3; WREN C, 1983, J ROY COLL PHYS LOND, V17, P192; WRIGHT JL, 1956, STAFF M MAYO CLIN, V31, P121	17	3	3	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	MAY 19	1990	335	8699					1199	1201		10.1016/0140-6736(90)92709-Q	http://dx.doi.org/10.1016/0140-6736(90)92709-Q			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE448	1971044				2022-12-24	WOS:A1990DE44800012
J	HAPPLE, R; KOOPMAN, R; MIER, PD				HAPPLE, R; KOOPMAN, R; MIER, PD			HYPOTHESIS - VASCULAR TWIN NEVI AND SOMATIC RECOMBINATION IN MAN	LANCET			English	Article											HAPPLE, R (corresponding author), CATHOLIC UNIV NIJMEGEN,DEPT DERMATOL,POB 9101,6500 HB NIJMEGEN,NETHERLANDS.							GERMAN J, 1973, J INVEST DERMATOL, V60, P427; GERMAN J, 1964, SCIENCE, V144, P298, DOI 10.1126/science.144.3616.298; GRAF U, 1984, ENVIRON MUTAGEN, V6, P153, DOI 10.1002/em.2860060206; HAMM H, 1986, HAUTARZT, V37, P388; HARRISON BJ, 1977, HEREDITY, V38, P169, DOI 10.1038/hdy.1977.22; KAFER E, 1988, MUTAT RES, V201, P385, DOI 10.1016/0027-5107(88)90026-7; Metz CW, 1916, J EXP ZOOL, V21, P213, DOI 10.1002/jez.1400210204; PATTERSON JT, 1929, P NATL ACAD SCI USA, V16, P109; RAFF M, 1981, WIEN KLIN WOCHENSCHR, V93, P3; SHAW MW, 1965, GENETICS, V51, P181; Stern C, 1936, GENETICS, V21, P625; VIG BK, 1982, MUTAT RES, V99, P339, DOI 10.1016/0165-1110(82)90050-1; VOGEL F, 1974, HUMANGENETIK, V25, P265, DOI 10.1007/BF00336904	13	44	44	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	FEB 17	1990	335	8686					376	378		10.1016/0140-6736(90)90209-N	http://dx.doi.org/10.1016/0140-6736(90)90209-N			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN988	1968118				2022-12-24	WOS:A1990CN98800005
J	WEGNER, CD; GUNDEL, RH; REILLY, P; HAYNES, N; LETTS, LG; ROTHLEIN, R				WEGNER, CD; GUNDEL, RH; REILLY, P; HAYNES, N; LETTS, LG; ROTHLEIN, R			INTERCELLULAR-ADHESION MOLECULE-1 (ICAM-1) IN THE PATHOGENESIS OF ASTHMA	SCIENCE			English	Article									BOEHRINGER INGELHEIM PHARMACEUT INC,DEPT IMMUNOL,RIDGEFIELD,CT 06877	Boehringer Ingelheim	WEGNER, CD (corresponding author), BOEHRINGER INGELHEIM PHARMACEUT INC,DEPT PHARMACOL,RIDGEFIELD,CT 06877, USA.							ANDERSON DC, 1985, J INFECT DIS, V152, P668, DOI 10.1093/infdis/152.4.668; ANDERSON DC, 1987, ANNU REV MED, V38, P175, DOI 10.1146/annurev.med.38.1.175; BARTON RW, 1989, J IMMUNOL, V143, P1278; BOULET LP, 1983, J ALLERGY CLIN IMMUN, V71, P399, DOI 10.1016/0091-6749(83)90069-6; BOUSHEY HA, 1980, AM REV RESPIR DIS, V121, P389; CHANYEUNG M, 1982, AM J MED, V72, P411, DOI 10.1016/0002-9343(82)90497-1; DEMONCHY JGR, 1985, AM REV RESPIR DIS, V131, P373; DURHAM SR, 1985, CLIN ALLERGY, V15, P411, DOI 10.1111/j.1365-2222.1985.tb02290.x; DUSTIN ML, 1988, J EXP MED, V167, P1323, DOI 10.1084/jem.167.4.1323; DUSTIN ML, 1986, J IMMUNOL, V137, P245; EMPEY DW, 1976, AM REV RESPIR DIS, V113, P131; FRIGAS E, 1986, J ALLERGY CLIN IMMUN, V77, P527, DOI 10.1016/0091-6749(86)90341-6; GUENTER CA, 1981, AM REV RESPIR DIS, V123, P79; GUNDEL RH, 1989, AM REV RESPIR DIS, V140, P629, DOI 10.1164/ajrccm/140.3.629; HARGREAVE FE, 1981, J ALLERGY CLIN IMMUN, V68, P347, DOI 10.1016/0091-6749(81)90132-9; HUNNINGHAKE GW, 1981, AM REV RESPIR DIS, V123, P407; HUNNINGHAKE GW, 1979, AM J PATHOL, V97, P149; JUNIPER EF, 1981, THORAX, V36, P575, DOI 10.1136/thx.36.8.575; KOHL S, 1984, J IMMUNOL, V133, P2972; LAITINEN LA, 1985, AM REV RESPIR DIS, V131, P599, DOI 10.1164/arrd.1985.131.4.599; LAM S, 1979, J ALLERGY CLIN IMMUN, V63, P28, DOI 10.1016/0091-6749(79)90158-1; LAM S, 1983, J ALLERGY CLIN IMMUN, V72, P134, DOI 10.1016/0091-6749(83)90520-1; LEIFERMAN KM, 1985, NEW ENGL J MED, V313, P282, DOI 10.1056/NEJM198508013130502; MARLIN SD, 1987, CELL, V51, P813, DOI 10.1016/0092-8674(87)90104-8; MARTZ E, 1985, MECHANISMS CELL MEDI, V2, P1; MULLARKEY MF, 1980, J ALLERGY CLIN IMMUN, V65, P122, DOI 10.1016/0091-6749(80)90196-7; MYGIND N, 1979, ALLERGY, V34, P195, DOI 10.1111/j.1398-9995.1979.tb01699.x; PETERS MS, 1983, J INVEST DERMATOL, V81, P39, DOI 10.1111/1523-1747.ep12538380; RIDING GA, 1981, J IMMUNOL METHODS, V46, P113, DOI 10.1016/0022-1759(81)90338-0; ROSSI GA, 1984, AM REV RESPIR DIS, V129, P850, DOI 10.1164/arrd.1984.129.5.850; ROTHLEIN R, 1986, J IMMUNOL, V137, P1270; ROTHLEIN R, 1988, J IMMUNOL, V141, P1665; RYAN G, 1982, THORAX, V37, P423, DOI 10.1136/thx.37.6.423; SHERTER CB, 1981, CLIN CHEST MED, V2, P67; SMITH CW, 1988, J CLIN INVEST, V82, P1746, DOI 10.1172/JCI113788; SMITH CW, 1989, STRUCTURE FUNCTION M; SOTOMAYOR H, 1984, AM REV RESPIR DIS, V130, P56; SPRY CJF, 1985, INT ARCH ALLER A IMM, V77, P252, DOI 10.1159/000233803; STRATH M, 1985, J IMMUNOL METHODS, V83, P209, DOI 10.1016/0022-1759(85)90242-X; TODD RF, 1988, HEMATOL ONCOL CLIN N, V2, P13; WANTZIN GL, 1989, J AM ACAD DERMATOL, V20, P782; WARDLAW AJ, 1988, AM REV RESPIR DIS, V137, P62, DOI 10.1164/ajrccm/137.1.62; WEGNER C, UNPUB; WEGNER C D, 1989, American Review of Respiratory Disease, V139, pA324	44	879	925	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JAN 26	1990	247	4941					456	459		10.1126/science.1967851	http://dx.doi.org/10.1126/science.1967851			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CK705	1967851				2022-12-24	WOS:A1990CK70500039
J	CLEM, RJ; FECHHEIMER, M; MILLER, LK				CLEM, RJ; FECHHEIMER, M; MILLER, LK			PREVENTION OF APOPTOSIS BY A BACULOVIRUS GENE DURING INFECTION OF INSECT CELLS	SCIENCE			English	Article							NUCLEAR POLYHEDROSIS-VIRUS; HOMOLOGOUS DNA; DEATH; EXPRESSION; GENOME; VECTORS; INVITRO; PROTEIN; REGION	Programmed cell death is an active process of self destruction that is important in both the development and maintenance of multicellular animals. The molecular mechanisms controlling activation or suppression of programmed cell death are largely unknown. Apoptosis, a morphologically and biochemically defined type of programmed cell death commonly seen in vertebrates, was found to be initiated during baculovirus replication in insect cells. A specific viral gene product, p35, was identified as being responsible for blocking the apoptotic response. Identification of the function of this gene will allow further definition of the molecular pathways involved in the regulation of programmed cell death and may identify the role of apoptosis in invertebrate viral defense systems.	UNIV GEORGIA, DEPT GENET, ATHENS, GA 30602 USA; UNIV GEORGIA, DEPT ENTOMOL, ATHENS, GA 30602 USA; UNIV GEORGIA, DEPT ZOOL, ATHENS, GA 30602 USA	University System of Georgia; University of Georgia; University System of Georgia; University of Georgia; University System of Georgia; University of Georgia			GUO, Zhaoyu/AAS-5699-2020	Clem, Rollie/0000-0002-2368-720X	NIAID NIH HHS [AI23719] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI023719, R01AI023719] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		CASADABAN MJ, 1980, J BACTERIOL, V143, P971, DOI 10.1128/JB.143.2.971-980.1980; CHEN LB, 1989, METHOD CELL BIOL, V29, P103; CLEM RJ, UNPUB; CLOUSTON WM, 1985, MED HYPOTHESES, V18, P399, DOI 10.1016/0306-9877(85)90107-0; COCHRAN MA, 1983, J VIROL, V45, P961, DOI 10.1128/JVI.45.3.961-970.1983; DICKSON JA, 1991, J VIROL, V65, P4006, DOI 10.1128/JVI.65.8.4006-4016.1991; FRIESEN PD, 1987, J VIROL, V61, P2264, DOI 10.1128/JVI.61.7.2264-2272.1987; GIORGI F, 1976, J EMBRYOL EXP MORPH, V35, P521; GUARINO LA, 1986, J VIROL, V60, P215, DOI 10.1128/JVI.60.1.215-223.1986; HENDERSON S, 1991, CELL, V65, P1107, DOI 10.1016/0092-8674(91)90007-L; HINK WF, 1970, NATURE, V226, P466, DOI 10.1038/226466b0; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; Kerr J.F.R., 1987, P93; KERR JFR, 1972, BRIT J CANCER, V26, P239, DOI 10.1038/bjc.1972.33; LEE HH, 1978, J VIROL, V27, P754, DOI 10.1128/JVI.27.3.754-767.1978; LIU AF, 1986, J GEN VIROL, V67, P2565, DOI 10.1099/0022-1317-67-11-2565; LOCKSHIN RA, 1985, COMPREHENSIVE INSECT, V2, P301; MARTZ E, 1989, IMMUNOL TODAY, V10, P79, DOI 10.1016/0167-5699(89)90231-4; MILLER LK, 1988, ANNU REV MICROBIOL, V42, P177, DOI 10.1146/annurev.micro.42.1.177; NISSEN MS, 1989, J VIROL, V63, P493, DOI 10.1128/JVI.63.2.493-503.1989; OREILLY DR, 1988, J VIROL, V62, P3109, DOI 10.1128/JVI.62.9.3109-3119.1988; PIPAN N, 1980, ZOOMORPHOLOGIE, V94, P217, DOI 10.1007/BF01081936; SMITH WA, 1982, TISSUE CELL, V14, P243, DOI 10.1016/0040-8166(82)90022-2; VAUGHN JL, 1977, IN VITRO CELL DEV B, V13, P213; VOLKMAN LE, 1982, APPL ENVIRON MICROB, V44, P227, DOI 10.1128/AEM.44.1.227-233.1982; Walker N I, 1988, Methods Achiev Exp Pathol, V13, P18; WILSON ME, 1986, VIROLOGY, V151, P315, DOI 10.1016/0042-6822(86)90052-8; Wyllie A H, 1980, Int Rev Cytol, V68, P251; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; YONISHROUACH E, 1991, NATURE, V352, P345, DOI 10.1038/352345a0	30	687	767	3	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 29	1991	254	5036					1388	1390		10.1126/science.1962198	http://dx.doi.org/10.1126/science.1962198			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR777	1962198				2022-12-24	WOS:A1991GR77700060
J	DROUFFE, JM; MAGGS, AC; LEIBLER, S				DROUFFE, JM; MAGGS, AC; LEIBLER, S			COMPUTER-SIMULATIONS OF SELF-ASSEMBLED MEMBRANES	SCIENCE			English	Article							THERMAL FLUCTUATIONS; STATISTICAL-MECHANICS; MOLECULAR-DYNAMICS; BENDING ELASTICITY; FLUID MEMBRANES; HEXATIC ORDER; IONIC GEL; VESICLES; UNDULATIONS; CURVATURE	Molecular dynamics simulations in three dimensions of particles that self-assemble to form two-dimensional, membrane-like objects are presented. Anisotropic, multibody forces, chosen so as to mimic real interactions between amphiphilic molecules, generate a finite rigidity and compressibility of the assembled membranes, as well as a finite line tension at their free edges. This model and its generalizations can be used to study a large class of phenomena taking place in fluctuating membranes. For instance, both fluid and solid-like phases, separated by a phase transition, are obtained and some of the large-scale properties of these membranes studied. In particular, thermal undulations of quasi-spherical fluid vesicles are analyzed, in a manner similar to recent experiments in lipid systems.	SERV PHYS THEOR SACLAY,F-91191 GIF SUR YVETTE,FRANCE; ECOLE SUPER PHYS & CHIM IND,PHYSICOCHIM THEOR LAB,F-75231 PARIS 05,FRANCE	UDICE-French Research Universities; PSL Research University Paris; Ecole Superieure de Physique et de Chimie Industrielles de la Ville de Paris (ESPCI)								ABRAHAM FF, 1990, SCIENCE, V249, P393, DOI 10.1126/science.249.4967.393; ABRAHAM FF, 1989, PHYS REV LETT, V62, P1757, DOI 10.1103/PhysRevLett.62.1757; Alberts B., 2017, MOL BIOL CELL; BAILLIE CF, 1990, NUCL PHYS B, V335, P469, DOI 10.1016/0550-3213(90)90504-7; BEYSENS D, IN PRESS DYNAMICAL P; BIVAS I, 1987, J PHYS-PARIS, V48, P855, DOI 10.1051/jphys:01987004805085500; CATTERALL SM, 1989, PHYS LETT B, V220, P207, DOI 10.1016/0370-2693(89)90038-5; CICOTTI G, 1987, MOL DYNAMICS MONTE C; DAVID F, 1987, J PHYS-PARIS, V48, P2059, DOI 10.1051/jphys:0198700480120205900; ENGELHARDT H, 1985, J PHYS LETT-PARIS, V46, pL395, DOI 10.1051/jphyslet:01985004608039500; EVANS DJ, 1977, MOL PHYS, V34, P327, DOI 10.1080/00268977700101761; FAUCON JF, 1989, J PHYS-PARIS, V50, P2389, DOI 10.1051/jphys:0198900500170238900; HELFRICH W, 1988, PHYS REV A, V38, P3065, DOI 10.1103/PhysRevA.38.3065; HELFRICH W, 1985, J PHYS-PARIS, V46, P1263, DOI 10.1051/jphys:019850046070126300; HELFRICH W, 1973, Z NATURFORSCH C, VC 28, P693, DOI 10.1515/znc-1973-11-1209; HO JS, 1990, EUROPHYS LETT, V12, P295, DOI 10.1209/0295-5075/12/4/002; HO JS, 1990, PHYS REV A, V41, P5745; HUSE DA, 1988, J PHYS-PARIS, V49, P605, DOI 10.1051/jphys:01988004904060500; Israelachvili JN, 1985, INTERMOLECULAR SURFA; KANTOR Y, 1986, PHYS REV LETT, V57, P791, DOI 10.1103/PhysRevLett.57.791; KANTOR Y, 1987, PHYS REV A, V38, P4020; LEIBLER S, 1990, NATURE, V348, P586, DOI 10.1038/348586a0; LEIBLER S, 1989, PHYS REP, V184, P265, DOI 10.1016/0370-1573(89)90044-6; LIPOWSKY R, 1990, PHYS REV LETT, V65, P2893, DOI 10.1103/PhysRevLett.65.2893; LIPOWSKY R, 1991, NATURE, V349, P475, DOI 10.1038/349475a0; MEUNIER J, 1987, PHYSICS AMPHIPHILIC; MILNER ST, 1987, PHYS REV A, V36, P4371, DOI 10.1103/PhysRevA.36.4371; Nelson D., 1988, Random Fluctuations and Pattern Growth: Experiments and Models. Proceedings of the NATO Advanced Study Institute, P193; NELSON DR, 1987, J PHYS-PARIS, V48, P1085, DOI 10.1051/jphys:019870048070108500; NELSON DR, 1989, STATISTICAL MECHANIC; PELITI L, 1985, PHYS REV LETT, V54, P1690, DOI 10.1103/PhysRevLett.54.1690; RENKEN RL, 1991, NUCL PHYS B, V354, P328, DOI 10.1016/0550-3213(91)90358-5; SCHNEIDER MB, 1984, J PHYS-PARIS, V45, P1457, DOI 10.1051/jphys:019840045090145700; SMIT B, 1990, NATURE, V348, P624, DOI 10.1038/348624a0; STOKKE BT, 1986, EUR BIOPHYS J BIOPHY, V13, P219, DOI 10.1007/BF00260369; STOKKE BT, 1986, EUR BIOPHYS J BIOPHY, V13, P203, DOI 10.1007/BF00260368	36	146	148	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 29	1991	254	5036					1353	1356		10.1126/science.1962193	http://dx.doi.org/10.1126/science.1962193			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GR777	1962193				2022-12-24	WOS:A1991GR77700048
J	HANSEN, MA; OVERGAARD, K; RIIS, BJ; CHRISTIANSEN, C				HANSEN, MA; OVERGAARD, K; RIIS, BJ; CHRISTIANSEN, C			ROLE OF PEAK BONE MASS AND BONE LOSS IN POSTMENOPAUSAL OSTEOPOROSIS - 12 YEAR STUDY	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PHOTON-ABSORPTIOMETRY; VERTEBRAL FRACTURES; SINGLE-PHOTON; WOMEN	Objective - To examine the role of peak bone mass and subsequent postmenopausal bone loss in the development of osteoporosis and the reliability of identifying women at risk from one bone mass measurement and one biochemical assessment of the future bone loss. Design - Population based study. Setting - Outpatient clinic for research into osteoporosis. Subjects - 178 healthy early postmenopausal women who had participated in a two year study in 1977. 154 of the women underwent follow up examination in 1989, of whom 33 were excluded because of diseases or taking drugs known to affect calcium metabolism. Main outcome measures - Bone mineral content of the forearm and values of biochemical markers of bone turnover. Results - The average reduction in bone mineral content during 1977-89 was 20%, but the fast losers had lost 10.0% more than had the slow loser group (mean loss 26.6% in fast losers and 16.6% in slow losers; p < 0.001). Prediction of future bone mineral content using baseline bone mineral content and estimated rate of loss gave results almost identical with the actual bone mineral content measured in 1989. Seven women had had a Colles; fracture and 20 a spinal compression fracture. The group with Colles' fracture had low baseline bone mineral content (34.7 (95% confidence interval 31.3 to 38.1) units-upsilon 39.4 (38.1 to 40.8) units in women with no fracture) whereas the group with spinal fracture had a normal baseline bone mineral content (38.1 (35.0 to 41.1) units) but an increased rate of loss (-2.4 (-3.5 to -1.3)%/year v -1.8 (-2.1 to -1.5)%/year in women with no fracture). Conclusions - One baseline measurement of bone mass combined with a single estimation of the rate of bone loss can reliably identify the women at menopause who are at highest risk of developing osteoporosis later in life. The rate of loss may have an independent role in likelihood of vertebral fracture.			HANSEN, MA (corresponding author), UNIV COPENHAGEN, GLOSTRUP HOSP, DEPT CLIN CHEM, DK-2600 GLOSTRUP, DENMARK.							BROWN JP, 1984, LANCET, V1, P1091; Christiansen C, 1990, Osteoporos Int, V1, P35, DOI 10.1007/BF01880414; CHRISTIANSEN C, 1987, LANCET, V1, P1106; CUMMINGS SR, 1990, JAMA-J AM MED ASSOC, V263, P665, DOI 10.1001/jama.263.5.665; GEUSENS P, 1986, J NUCL MED, V27, P1540; Hansen M A, 1991, Osteoporos Int, V1, P95; HASSAGER C, 1991, OSTEOPOROSIS INT, V1, P226; HUI SL, 1989, ANN INTERN MED, V111, P355, DOI 10.7326/0003-4819-111-5-355; MELTON LJ, 1989, AM J EPIDEMIOL, V129, P1000, DOI 10.1093/oxfordjournals.aje.a115204; MELTON LJ, 1988, OSTEOPOROSIS ETIOLOG, P111; NILAS L, 1987, J NUCL MED, V28, P960; NILAS L, 1985, J NUCL MED, V26, P1257; OTT SM, 1987, J BONE MINER RES, V2, P201; RIGGS BL, 1990, NEW ENGL J MED, V322, P802, DOI 10.1056/NEJM199003223221203; RIIS BJ, 1989, THESIS HANDELSTRYKKE, P16; ROSS PD, 1988, J BONE MINER RES, V3, P1; 1989, FRACTURED NECK FEMUR	17	438	450	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 19	1991	303	6808					961	964		10.1136/bmj.303.6808.961	http://dx.doi.org/10.1136/bmj.303.6808.961			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GL127	1954420	Green Published			2022-12-24	WOS:A1991GL12700022
J	CARLSON, LM; OETTINGER, MA; SCHATZ, DG; MASTELLER, EL; HURLEY, EA; MCCORMACK, WT; BALTIMORE, D; THOMPSON, CB				CARLSON, LM; OETTINGER, MA; SCHATZ, DG; MASTELLER, EL; HURLEY, EA; MCCORMACK, WT; BALTIMORE, D; THOMPSON, CB			SELECTIVE EXPRESSION OF RAG-2 IN CHICKEN B-CELLS UNDERGOING IMMUNOGLOBULIN GENE CONVERSION	CELL			English	Article							LIGHT CHAIN GENE; TRANSGENIC MICE; REARRANGEMENT; FABRICIUS; BURSA; RECOMBINATION; MECHANISM; SEGMENTS; OCCURS; REGION	Chickens create their immunoglobulin (Ig) repertoires during B cell development in the bursa of Fabricius by intrachromasomal gene conversion. Recent evidence has suggested that Ig gene conversion may involve cis-acting DNA elements related to those involved in V(D)J recombination. Therefore, we have examined the potential role of the V(D)J recombination activating genes, RAG-1 and RAG-2, in regulating chicken Ig gene conversion. In contrast to the coexpression of RAG-1 and RAG-2 observed in mammalian B cells that undergo V(D)J recombination, chicken B cells isolated from the bursa of Fabricius express high levels of the RAG-2 mRNA but do not express RAG-1 mRNA. The developmental and phenotypic characteristics of the bursal lymphocytes and chicken B cell lines that express RAG-2 mRNA demonstrate that selective RAG-2 expression occurs specifically in B cells undergoing Ig diversification by gene conversion. These data suggest that RAG-2 plays a fundamental role in Ig-specific gene conversion.	UNIV MICHIGAN, MED CTR, DEPT INTERNAL MED, ANN ARBOR, MI 48109 USA; UNIV MICHIGAN, MED CTR, DEPT MICROBIOL & IMMUNOL, ANN ARBOR, MI 48109 USA; WHITEHEAD INST BIOMED RES, CAMBRIDGE, MA 02142 USA; MIT, DEPT BIOL, CAMBRIDGE, MA 02139 USA; ROCKEFELLER UNIV, NEW YORK, NY 10021 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Rockefeller University	CARLSON, LM (corresponding author), UNIV MICHIGAN, MED CTR, HOWARD HUGHES MED INST, ANN ARBOR, MI 48109 USA.		Schatz, David/A-6748-2013	Schatz, David/0000-0002-5669-1176; McCormack, Wayne/0000-0002-2117-8727	NCI NIH HHS [CA51466, CA48023] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R37CA048023, R01CA048023] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AGUILERA A, 1988, GENETICS, V119, P779; AGUILERA A, 1990, MOL CELL BIOL, V10, P1439, DOI 10.1128/MCB.10.4.1439; ALT FW, 1986, IMMUNOL REV, V89, P5, DOI 10.1111/j.1600-065X.1986.tb01470.x; BECKER RS, 1990, CELL, V63, P987, DOI 10.1016/0092-8674(90)90502-6; BUCCHINI D, 1987, NATURE, V326, P409, DOI 10.1038/326409a0; BUERSTEDDE JM, 1990, EMBO J, V9, P921, DOI 10.1002/j.1460-2075.1990.tb08190.x; CARLSON LM, 1990, GENE DEV, V4, P536, DOI 10.1101/gad.4.4.536; CHAN MM, 1988, J IMMUNOL, V140, P2133; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHUN JJM, 1991, CELL, V64, P189, DOI 10.1016/0092-8674(91)90220-S; CLEVELAND DW, 1980, CELL, V20, P95, DOI 10.1016/0092-8674(80)90238-X; COLTEY M, 1989, J EXP MED, V170, P543, DOI 10.1084/jem.170.2.543; FULOP GM, 1990, NATURE, V347, P479, DOI 10.1038/347479a0; GOODHARDT M, 1987, P NATL ACAD SCI USA, V84, P4229, DOI 10.1073/pnas.84.12.4229; HUNKAPILLER T, 1989, ADV IMMUNOL, V44, P1; KIM S, 1990, MOL CELL BIOL, V10, P3224, DOI 10.1128/MCB.10.6.3224; KLEINFIELD R, 1986, NATURE, V322, P843, DOI 10.1038/322843a0; LEWIS S, 1989, CELL, V59, P585, DOI 10.1016/0092-8674(89)90002-0; LIEBER MR, 1987, GENE DEV, V1, P751, DOI 10.1101/gad.1.8.751; McCormack W T, 1990, Adv Immunol, V48, P41, DOI 10.1016/S0065-2776(08)60751-8; McCormack W T, 1989, Int Immunol, V1, P332, DOI 10.1093/intimm/1.4.332; MCCORMACK WT, 1989, CELL, V56, P785, DOI 10.1016/0092-8674(89)90683-1; MCCORMACK WT, 1989, GENE DEV, V3, P838, DOI 10.1101/gad.3.6.838; MCCORMACK WT, 1990, GENE DEV, V4, P548, DOI 10.1101/gad.4.4.548; OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047; PINK JRL, 1986, IMMUNOL REV, V91, P115, DOI 10.1111/j.1600-065X.1986.tb01486.x; PRATT LF, 1988, EMBO J, V7, P931, DOI 10.1002/j.1460-2075.1988.tb02898.x; RATCLIFFE MJH, 1985, IMMUNOL TODAY, V6, P223, DOI 10.1016/0167-5699(85)90039-8; RETH M, 1986, NATURE, V322, P840, DOI 10.1038/322840a0; REYNAUD CA, 1989, CELL, V59, P171, DOI 10.1016/0092-8674(89)90879-9; REYNAUD CA, 1987, CELL, V48, P379, DOI 10.1016/0092-8674(87)90189-9; ROUX KH, 1991, IN PRESS J IMMUNOL; SCHATZ DG, 1989, CELL, V59, P1035, DOI 10.1016/0092-8674(89)90760-5; THOMPSON CB, 1987, CELL, V48, P369, DOI 10.1016/0092-8674(87)90188-7; THOMPSON CB, 1985, NATURE, V314, P363, DOI 10.1038/314363a0; THOMPSON CB, 1987, CELL, V51, P371, DOI 10.1016/0092-8674(87)90633-7; THOMPSON CB, 1989, MECHANISMS B CELL NE, P46; TJOELKER LW, 1990, P NATL ACAD SCI USA, V87, P7856, DOI 10.1073/pnas.87.20.7856; TONEGAWA S, 1983, SCIENCE, V241, P577; WANG JC, 1990, CELL, V62, P403, DOI 10.1016/0092-8674(90)90002-V; WEILL JC, 1986, P NATL ACAD SCI USA, V83, P3336, DOI 10.1073/pnas.83.10.3336; YANCOPOULOS GD, 1986, CELL, V44, P251, DOI 10.1016/0092-8674(86)90759-2	42	121	126	1	9	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 11	1991	64	1					201	208		10.1016/0092-8674(91)90221-J	http://dx.doi.org/10.1016/0092-8674(91)90221-J			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ET175	1986866	Green Published			2022-12-24	WOS:A1991ET17500021
J	RAUB, W				RAUB, W			RESEARCH ON EOSINOPHILIA-MYALGIA-SYNDROME	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material											RAUB, W (corresponding author), NIH, BLDG 31, ROOM 2B23, BETHESDA, MD 20892 USA.							1990, P NATL ACAD SCI USA, V87, P8647	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	1991	265	1					19	19						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP555	1984118				2022-12-24	WOS:A1991EP55500008
J	SCHULTZ, PN; SOBOL, WM				SCHULTZ, PN; SOBOL, WM			ANGIOID STREAKS AND PSEUDOXANTHOMA ELASTICUM	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									UNIV IOWA HOSP & CLIN,DEPT OPHTHALMOL,RETINA SERV,IOWA CITY,IA 52242	University of Iowa								CLARKSON JG, 1982, SURV OPHTHALMOL, V26, P235, DOI 10.1016/0039-6257(82)90158-8; CONNOR PJ, 1961, AM J MED, V30, P537, DOI 10.1016/0002-9343(61)90078-X; ESTES JW, 1968, ANN INTERN MED, V68, P1237, DOI 10.7326/0003-4819-68-6-1237; LEBWOHL M, 1987, NEW ENGL J MED, V317, P347, DOI 10.1056/NEJM198708063170604; LEBWOHL MG, 1982, NEW ENGL J MED, V307, P228, DOI 10.1056/NEJM198207223070406; MCDONALD HR, 1988, OPHTHALMOLOGY, V95, P306; POPE FM, 1974, J MED GENET, V11, P152, DOI 10.1136/jmg.11.2.152; Scholz R, 1941, ARCH OPHTHALMOL-CHIC, V26, P677; SHIELDS JA, 1975, BRIT J OPHTHALMOL, V59, P257, DOI 10.1136/bjo.59.5.257; Singerman L J, 1981, Retina, V1, P75	10	4	4	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	1991	265	1					45	45						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP555	1984125				2022-12-24	WOS:A1991EP55500027
J	WILKINS, EGL; IVANYI, J				WILKINS, EGL; IVANYI, J			POTENTIAL VALUE OF SEROLOGY FOR DIAGNOSIS OF EXTRAPULMONARY TUBERCULOSIS	LANCET			English	Article									HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,MRC,TB & RELATED INFECT UNIT,LONDON W12 0HS,ENGLAND	Imperial College London	WILKINS, EGL (corresponding author), NORTHWICK PK HOSP & CLIN RES CTR,DEPT INFECT DIS,LISTER UNIT,WATFORD RD,HARROW HA1 3UJ,MIDDX,ENGLAND.		Ivanyi, Juraj/ABB-3326-2021					BOTHAMLEY G, 1988, EUR J CLIN MICROBIOL, V7, P639, DOI 10.1007/BF01964242; BRONNER WS, 1988, DESIGNING CLIN RES, P89; CASABONA NM, 1989, ACTA LEPROL S1, V7, P89; CHAWLA TC, 1986, TUBERCLE, V67, P55, DOI 10.1016/0041-3879(86)90032-2; Daniel T. M., 1989, REV INFECT DIS S2, V11, pS471; GANDHI BM, 1986, TUBERCLE, V67, P219, DOI 10.1016/S0041-3879(86)80028-9; HEWITT J, 1982, J IMMUNOL METHODS, V55, P205, DOI 10.1016/0022-1759(82)90032-1; IVANYI J, 1983, CLIN EXP IMMUNOL, V54, P337; IVANYI J, 1988, BRIT MED BULL, V44, P635, DOI 10.1093/oxfordjournals.bmb.a072273; JACKETT PS, 1988, J CLIN MICROBIOL, V26, P2313, DOI 10.1128/JCM.26.11.2313-2318.1988; KRAMBOVITIS E, 1986, J CLIN PATHOL, V39, P779, DOI 10.1136/jcp.39.7.779; KRAMBOVITIS E, 1986, J MED MICROBIOL, V21, P257, DOI 10.1099/00222615-21-3-257; SRIVASTAVA VK, 1987, EUR J RESPIR DIS, V71, P292; STROEBEL AB, 1982, J INFECT DIS, V146, P280, DOI 10.1093/infdis/146.2.280; STYBLO K, 1981, Bulletin of the International Union Against Tuberculosis, V56, P118; THONGKRAJAI P, 1989, J MED MICROBIOL, V30, P101, DOI 10.1099/00222615-30-2-101	16	73	75	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 15	1990	336	8716					641	644		10.1016/0140-6736(90)92144-7	http://dx.doi.org/10.1016/0140-6736(90)92144-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DY737	1975849				2022-12-24	WOS:A1990DY73700001
J	WILKIE, AOM; LAMB, J; HARRIS, PC; FINNEY, RD; HIGGS, DR				WILKIE, AOM; LAMB, J; HARRIS, PC; FINNEY, RD; HIGGS, DR			A TRUNCATED HUMAN CHROMOSOME-16 ASSOCIATED WITH ALPHA-THALASSEMIA IS STABILIZED BY ADDITION OF TELOMERIC REPEAT (TTAGGG)N	NATURE			English	Article									N TEES GEN HOSP,DEPT HAEMATOL,STOCKTON ON TEES TS19 8PE,CLEVELAND,ENGLAND	University Hospital of North Tees	WILKIE, AOM (corresponding author), JOHN RADCLIFFE HOSP,INST MOLEC MED,MRC,MOLEC HAEMATOL UNIT,OXFORD OX3 9DU,ENGLAND.		Wilkie, Andrew/AAC-3820-2020	Wilkie, Andrew/0000-0002-2972-5481; Lamb, Janette/0000-0002-8926-0516	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ALLSHIRE RC, 1989, NUCLEIC ACIDS RES, V17, P4611, DOI 10.1093/nar/17.12.4611; BAROIN A, 1987, NUCLEIC ACIDS RES, V15, P1717, DOI 10.1093/nar/15.4.1717; BIESSMANN H, 1990, P NATL ACAD SCI USA, V87, P1758, DOI 10.1073/pnas.87.5.1758; BIESSMANN H, 1990, CELL, V61, P663, DOI 10.1016/0092-8674(90)90478-W; CAPPAI R, 1989, MOL CELL BIOL, V9, P3584, DOI 10.1128/MCB.9.8.3584; CHEN EY, 1985, DNA-J MOLEC CELL BIO, V4, P165, DOI 10.1089/dna.1985.4.165; CHENG JF, 1989, NUCLEIC ACIDS RES, V17, P6109, DOI 10.1093/nar/17.15.6109; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; CORCORAN LM, 1988, CELL, V53, P807, DOI 10.1016/0092-8674(88)90097-9; DELANGE T, 1990, MOL CELL BIOL, V10, P518, DOI 10.1128/MCB.10.2.518; FORNEY JD, 1988, MOL CELL BIOL, V8, P251, DOI 10.1128/MCB.8.1.251; GALANELLO R, 1984, ACTA HAEMATOL-BASEL, V72, P34, DOI 10.1159/000206353; GROSVELD F, 1987, CELL, V51, P975, DOI 10.1016/0092-8674(87)90584-8; GUSELLA JF, 1985, NATURE, V318, P75, DOI 10.1038/318075a0; HARRIS PC, 1990, GENOMICS, V7, P195, DOI 10.1016/0888-7543(90)90541-2; HATTON CSR, 1990, BLOOD, V76, P221; HIGGS DR, 1989, BLOOD, V73, P1081; HIGGS DR, IN PRESS GENES DEV; JARMAN AP, 1988, AM J HUM GENET, V43, P249; LEDBETTER DH, 1989, P NATL ACAD SCI USA, V86, P5136, DOI 10.1073/pnas.86.13.5136; LEVIS RW, 1989, CELL, V58, P791, DOI 10.1016/0092-8674(89)90112-8; MORIN GB, 1989, CELL, V59, P521, DOI 10.1016/0092-8674(89)90035-4; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; MULLER H, 1938, J COLLECT NET, V13, P182; MURRAY AW, 1988, MOL CELL BIOL, V8, P4642, DOI 10.1128/MCB.8.11.4642; NICHOLLS RD, 1987, CELL, V49, P369, DOI 10.1016/0092-8674(87)90289-3; POLOGE LG, 1989, CELL, V9, P3584; Sambrook J., 1989, MOL CLONING; SEALEY PG, 1985, NUCLEIC ACIDS RES, V13, P1905, DOI 10.1093/nar/13.6.1905; SPANGLER EA, 1988, NUCLEIC ACIDS RES, V16, P5569, DOI 10.1093/nar/16.12.5569; WANG SS, 1990, NATURE, V345, P456, DOI 10.1038/345456a0; WATSON JD, 1972, NATURE-NEW BIOL, V239, P197, DOI 10.1038/newbio239197a0; WILKIE AOM, 1990, AM J HUM GENET, V46, P1112; YAO MC, 1981, P NATL ACAD SCI-BIOL, V78, P7436, DOI 10.1073/pnas.78.12.7436; YU GL, 1990, NATURE, V344, P126, DOI 10.1038/344126a0; ZAKIAN VA, 1989, ANNU REV GENET, V23, P579, DOI 10.1146/annurev.genet.23.1.579	36	255	259	0	5	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	AUG 30	1990	346	6287					868	871		10.1038/346868a0	http://dx.doi.org/10.1038/346868a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DW488	1975428				2022-12-24	WOS:A1990DW48800064
J	ROBERTS, MJD; YOUNG, IS; TROUTON, TG; TRIMBLE, ER; KHAN, MM; WEBB, SW; WILSON, CM; PATTERSON, GC; ADGEY, AAJ				ROBERTS, MJD; YOUNG, IS; TROUTON, TG; TRIMBLE, ER; KHAN, MM; WEBB, SW; WILSON, CM; PATTERSON, GC; ADGEY, AAJ			TRANSIENT RELEASE OF LIPID PEROXIDES AFTER CORONARY-ARTERY BALLOON ANGIOPLASTY	LANCET			English	Article									ROYAL VICTORIA HOSP,REG MED CARDIOL CTR,BELFAST BT12 6BA,NORTH IRELAND; QUEENS UNIV BELFAST,DEPT CHEM PATHOL,BELFAST BT7 1NN,ANTRIM,NORTH IRELAND	Queens University Belfast				Young, Ian/0000-0003-3890-3152				AMBROSIO G, 1986, CIRCULATION, V74, P1424, DOI 10.1161/01.CIR.74.6.1424; BIRD RP, 1984, METHOD ENZYMOL, V105, P299; BOLLI R, 1988, J CLIN INVEST, V82, P476, DOI 10.1172/JCI113621; BOLLI R, 1989, CIRC RES, V65, P607, DOI 10.1161/01.RES.65.3.607; DART RC, 1988, ANN EMERG MED, V17, P53, DOI 10.1016/S0196-0644(88)80504-3; DAVIES S W, 1989, European Heart Journal, V10, P274; EVENSEN SA, 1983, ATHEROSCLEROSIS, V49, P23, DOI 10.1016/0021-9150(83)90004-7; FOGELMAN AM, 1980, P NATL ACAD SCI-BIOL, V77, P2214, DOI 10.1073/pnas.77.4.2214; GUARNIERI C, 1980, J MOL CELL CARDIOL, V12, P797, DOI 10.1016/0022-2828(80)90081-4; KNIGHT JA, 1988, CLIN CHEM, V34, P2433; LEDWOZYW A, 1986, CLIN CHIM ACTA, V155, P275, DOI 10.1016/0009-8981(86)90247-0; MYERS ML, 1985, CIRCULATION, V72, P915, DOI 10.1161/01.CIR.72.4.915; OPIE LH, 1989, CIRCULATION, V80, P1049, DOI 10.1161/01.CIR.80.4.1049; SATO Y, 1979, BIOCHEM MED METAB B, V21, P104, DOI 10.1016/0006-2944(79)90061-9; SLATER TF, 1984, METHOD ENZYMOL, V105, P2873; WADE CR, 1987, CLIN CHIM ACTA, V164, P245, DOI 10.1016/0009-8981(87)90298-1; WONG SHY, 1987, CLIN CHEM, V33, P214; WOODWARD B, 1985, J MOL CELL CARDIOL, V17, P485, DOI 10.1016/S0022-2828(85)80053-5; YAGI K, 1984, METHOD ENZYMOL, V105, P328	19	104	108	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JUL 21	1990	336	8708					143	145		10.1016/0140-6736(90)91661-S	http://dx.doi.org/10.1016/0140-6736(90)91661-S			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP866	1973474				2022-12-24	WOS:A1990DP86600005
J	BERG, W; TRANEROTH, C; GUNNARSSON, A; LOSSING, C				BERG, W; TRANEROTH, C; GUNNARSSON, A; LOSSING, C			A METHOD FOR MEASURING PRESSURE SORES	LANCET			English	Article									GOTHENBURG UNIV, SAHLGRENS HOSP, DEPT PLAST SURG, S-41345 GOTHENBURG, SWEDEN	Sahlgrenska University Hospital; University of Gothenburg	BERG, W (corresponding author), VASA HOSP, DEPT GERIATR MED, GERIATR CLIN, S-41133 GOTHENBURG, SWEDEN.							BARBENEL JC, 1977, LANCET, V2, P548; KNIGHT AL, 1988, J FAM PRACTICE, V27, P95; PARISH LC, 1980, INT J DERMATOL, V19, P517, DOI 10.1111/j.1365-4362.1980.tb00379.x; RESCH CS, 1988, J AM GERIATR SOC, V36, P444, DOI 10.1111/j.1532-5415.1988.tb02385.x	4	35	35	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JUN 16	1990	335	8703					1445	1446		10.1016/0140-6736(90)91459-N	http://dx.doi.org/10.1016/0140-6736(90)91459-N			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ234	1972219				2022-12-24	WOS:A1990DJ23400014
J	MELKI, J; ABDELHAK, S; SHETH, P; BACHELOT, MF; BURLET, P; MARCADET, A; AICARDI, J; BAROIS, A; CARRIERE, JP; FARDEAU, M; FONTAN, D; PONSOT, G; BILLETTE, T; ANGELINI, C; BARBOSA, C; FERRIERE, G; LANZI, G; OTTOLINI, A; BABRON, MC; COHEN, D; HANAUER, A; CLERGETDARPOUX, F; LATHROP, M; MUNNICH, A; FREZAL, J				MELKI, J; ABDELHAK, S; SHETH, P; BACHELOT, MF; BURLET, P; MARCADET, A; AICARDI, J; BAROIS, A; CARRIERE, JP; FARDEAU, M; FONTAN, D; PONSOT, G; BILLETTE, T; ANGELINI, C; BARBOSA, C; FERRIERE, G; LANZI, G; OTTOLINI, A; BABRON, MC; COHEN, D; HANAUER, A; CLERGETDARPOUX, F; LATHROP, M; MUNNICH, A; FREZAL, J			GENE FOR CHRONIC PROXIMAL SPINAL MUSCULAR ATROPHIES MAPS TO CHROMOSOME-5Q	NATURE			English	Article									HOP NECKER ENFANTS MALAD,DEPT PEDIAT,F-75743 PARIS 15,FRANCE; CTR ETUD POLYMORPHISMES HUMAINS,F-75010 PARIS,FRANCE; HOP RAY POINCARE,F-92380 GARCHES,FRANCE; HOP PURPAN,F-31052 TOULOUSE,FRANCE; HOP LA PITIE SALPETRIERE,F-75651 PARIS 13,FRANCE; HOP ENFANTS,F-33000 BORDEAUX,FRANCE; HOP ST VINCENT DE PAUL,F-75674 PARIS 14,FRANCE; HOP TROUSSEAU,F-75571 PARIS 12,FRANCE; INST CLIN MALATTIE NERVOSE & MENTALI,I-35128 PADUA,ITALY; HOSP CRIANCAS MARIA PIA,P-4000 PORTS,PORTUGAL; HOP ST LUC,B-1200 BRUSSELS,BELGIUM; UNIV PAVIA,I-27100 PAVIA,ITALY; INSERM,U155,F-75016 PARIS,FRANCE; INST CHIM BIOL,F-67085 STRASBOURG,FRANCE	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; CHU de Toulouse; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; CHU Bordeaux; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Pavia; Institut National de la Sante et de la Recherche Medicale (Inserm)	MELKI, J (corresponding author), HOP NECKER ENFANTS MALAD,INSERM,U12,UNITE RECH HANDICAPS GENET ENFANT,149 RUE SEVRES,F-75743 PARIS 15,FRANCE.		Angelini, Corrado I/J-3655-2019; Abdelhak, Sonia/L-2831-2013	Angelini, Corrado I/0000-0002-9554-8794; Abdelhak, Sonia/0000-0001-8466-5525				DUBOWITZ V, 1964, BRAIN, V87, P707, DOI 10.1093/brain/87.4.707; DUCHEN LW, 1966, J PHYSIOL-LONDON, V183, P53; EMERY AEH, 1971, J MED GENET, V8, P481, DOI 10.1136/jmg.8.4.481; HAUSMANOWAPETRUSEWICZ I, 1985, J MED GENET, V22, P350, DOI 10.1136/jmg.22.5.350; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEPPERT M, 1987, CYTOGENET CELL GENET, V46, P649; MORTON NE, 1955, AM J HUM GENET, V7, P277; MURAKAMI T, 1981, MUSCLE NERVE, V4, P407, DOI 10.1002/mus.880040509	8	381	384	0	11	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	APR 19	1990	344	6268					767	768		10.1038/344767a0	http://dx.doi.org/10.1038/344767a0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CZ678	1970420				2022-12-24	WOS:A1990CZ67800055
J	ILLES, P; REGENOLD, JT				ILLES, P; REGENOLD, JT			INTERACTION BETWEEN NEUROPEPTIDE-Y AND NORADRENALINE ON CENTRAL CATECHOLAMINE NEURONS	NATURE			English	Article											ILLES, P (corresponding author), UNIV FREIBURG,DEPT PHARMACOL,HERMANN HERDER STR 5,W-7800 FREIBURG,GERMANY.							AGHAJANIAN GK, 1982, SCIENCE, V215, P1394, DOI 10.1126/science.6278591; AGHAJANIAN GK, 1987, NEUROPHARMACOLOGY, V26, P793, DOI 10.1016/0028-3908(87)90054-2; CHERUBINI E, 1988, J PHYSIOL-LONDON, V406, P431, DOI 10.1113/jphysiol.1988.sp017389; DUNLAP K, 1987, TRENDS NEUROSCI, V10, P241, DOI 10.1016/0166-2236(87)90166-4; EVERITT BJ, 1984, NEUROSCIENCE, V11, P443, DOI 10.1016/0306-4522(84)90036-8; FUXE K, 1989, NEUROSCI LETT, V101, P337, DOI 10.1016/0304-3940(89)90556-9; HOLETS VR, 1988, NEUROSCIENCE, V24, P893, DOI 10.1016/0306-4522(88)90076-0; REGENOLD JT, 1988, NEUROSCI LETT, V92, P347, DOI 10.1016/0304-3940(88)90615-5; Starke K, 1981, Rev Physiol Biochem Pharmacol, V88, P199, DOI 10.1007/BFb0034538; TIMMERMANS PBMWM, 1982, J MED CHEM, V25, P1389, DOI 10.1021/jm00354a001; WARDROUTLEDGE C, 1988, TRENDS PHARMACOL SCI, V9, P209, DOI 10.1016/0165-6147(88)90087-9; WILLIAMS JT, 1985, NEUROSCIENCE, V14, P95, DOI 10.1016/0306-4522(85)90166-6; WILLIAMS JT, 1984, MOL PHARMACOL, V26, P489; WILLIAMS JT, 1982, NATURE, V299, P74, DOI 10.1038/299074a0	14	78	78	0	1	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAR 1	1990	344	6261					62	63		10.1038/344062a0	http://dx.doi.org/10.1038/344062a0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ972	1968229				2022-12-24	WOS:A1990CQ97200061
J	CUEVAS, P; CARCELLER, F; ORTEGA, S; ZAZO, M; NIETO, I; GIMENEZGALLEGO, G				CUEVAS, P; CARCELLER, F; ORTEGA, S; ZAZO, M; NIETO, I; GIMENEZGALLEGO, G			HYPOTENSIVE ACTIVITY OF FIBROBLAST GROWTH-FACTOR	SCIENCE			English	Article							PLASMINOGEN-ACTIVATOR PRODUCTION; CAPILLARY ENDOTHELIAL-CELLS; DNA-SYNTHESIS; BLOOD-PRESSURE; NITRIC-OXIDE; K+ CHANNELS; L-ARGININE; BINDING; HEPARIN; GENE	Acidic and basic fibroblast growth factors (FGFs) are members of a family of proteins that are broad-spectrum mitogens, have diverse hormone-like activities, and function in tumorigenesis. FGF's ability to raise the concentration of intracellular calcium ion suggests that FGF could induce the synthesis of endothelium-derived relaxing factor (EDRF) and consequently vasodilation. Systemic administration of FGF decreased arterial blood pressure. This effect was mediated by EDRF and by adenosine triphosphate-sensitive potassium ion channels. The hypotensive effect of FGF was segregated from its mitogenic activity by protein engineering. These results extend the range of FGF autocrine activities and potential therapeutic applications, emphasize the role of endothelium as an arterial blood pressure-regulating organ, and provide insight on the structural basis of FGF functions.	CSIC, CTR INVEST BIOL, VELAZQUEZ 144, E-28006 MADRID, SPAIN; HOSP UNIV RAMON Y CAJAL, E-28034 MADRID, SPAIN	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); Consiglio Nazionale delle Ricerche (CNR); Hospital Universitario Ramon y Cajal								AISAKA K, 1989, BIOCHEM BIOPH RES CO, V160, P881, DOI 10.1016/0006-291X(89)92517-5; BAIRD A, 1985, P NATL ACAD SCI USA, V82, P5545, DOI 10.1073/pnas.82.16.5545; BAIRD A, 1986, REGUL PEPTIDES, V16, P243, DOI 10.1016/0167-0115(86)90023-6; BURGESS WH, 1989, ANNU REV BIOCHEM, V58, P575, DOI 10.1146/annurev.bi.58.070189.003043; CUEVAS P, UNPUB; FINCH PW, 1989, SCIENCE, V245, P752, DOI 10.1126/science.2475908; FLAUMENHAFT R, 1990, J CELL BIOL, V111, P1651, DOI 10.1083/jcb.111.4.1651; FUKUTO JM, 1990, BIOCHEM BIOPH RES CO, V168, P458, DOI 10.1016/0006-291X(90)92343-X; GIMENEZGALLEGO G, 1985, SCIENCE, V230, P1385, DOI 10.1126/science.4071057; GIMENEZGALLEGO G, UNPUB; IMAMURA T, 1990, SCIENCE, V249, P1567, DOI 10.1126/science.1699274; KAN M, 1989, P NATL ACAD SCI USA, V86, P7432, DOI 10.1073/pnas.86.19.7432; LINEMEYER DL, 1987, BIO-TECHNOL, V5, P960, DOI 10.1038/nbt0987-960; MAYER B, 1989, BIOCHEM BIOPH RES CO, V164, P678, DOI 10.1016/0006-291X(89)91513-1; MCNEIL PL, 1989, J CELL BIOL, V109, P811, DOI 10.1083/jcb.109.2.811; MOSCATELLI D, 1988, J CELL BIOL, V107, P753, DOI 10.1083/jcb.107.2.753; MOSCATELLI D, 1987, J CELL PHYSIOL, V131, P123, DOI 10.1002/jcp.1041310118; MOSCATELLI D, 1991, ANN NY ACAD SCI, V638, P177, DOI 10.1111/j.1749-6632.1991.tb49028.x; MOSCATELLI D, 1986, P NATL ACAD SCI USA, V83, P2091, DOI 10.1073/pnas.83.7.2091; NELSON MT, 1990, NATURE, V344, P770, DOI 10.1038/344770a0; PANDIELLA A, 1989, BIOCHEM BIOPH RES CO, V163, P1325, DOI 10.1016/0006-291X(89)91123-6; PRESTA M, 1986, MOL CELL BIOL, V6, P4060, DOI 10.1128/MCB.6.11.4060; QUAST U, 1989, TRENDS PHARMACOL SCI, V10, P431, DOI 10.1016/S0165-6147(89)80003-3; REES DD, 1989, P NATL ACAD SCI USA, V86, P3375, DOI 10.1073/pnas.86.9.3375; ROSENGART TK, 1989, CIRC RES, V64, P227, DOI 10.1161/01.RES.64.2.227; SAKSELA O, 1990, J CELL BIOL, V110, P767, DOI 10.1083/jcb.110.3.767; SAKSELA O, 1988, J CELL BIOL, V107, P743, DOI 10.1083/jcb.107.2.743; SANCHEZPUELLES JM, 1990, GENE, V89, P69, DOI 10.1016/0378-1119(90)90207-8; SANZ MJM, 1990, FEBS LETT, V232, P308; SATO Y, 1988, J CELL BIOL, V107, P1199, DOI 10.1083/jcb.107.3.1199; THOMAS KA, 1986, TRENDS BIOCHEM SCI, V11, P1; VANE J, 1990, NATURE, V348, P673, DOI 10.1038/348673a0	32	226	242	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 22	1991	254	5035					1208	1210		10.1126/science.1957172	http://dx.doi.org/10.1126/science.1957172			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ834	1957172				2022-12-24	WOS:A1991GQ83400049
J	DESIMONE, G; DEVEREUX, RB; ROMAN, MJ; SCHLUSSEL, Y; ALDERMAN, MH; LARAGH, JH				DESIMONE, G; DEVEREUX, RB; ROMAN, MJ; SCHLUSSEL, Y; ALDERMAN, MH; LARAGH, JH			ECHOCARDIOGRAPHIC LEFT-VENTRICULAR MASS AND ELECTROLYTE INTAKE PREDICT ARTERIAL-HYPERTENSION	ANNALS OF INTERNAL MEDICINE			English	Article							BLOOD-PRESSURE; CARDIAC SIZE; HYPERTROPHY; POTASSIUM; SALT; RECOMMENDATIONS; POPULATION; RESPONSES; STRESS; TWINS	Objective: To identify predictors of arterial hypertension. Patients: One hundred thirty-two normotensive adults from a large employed population. Methods: Echocardiography, standard blood tests, and 24-hour urine collection, at baseline and after an interval of 3 to 6 years (mean, 4.7 +/- 0.8 years). Results: At follow-up, 15 subjects (11%; 7 men, 8 women) had a systolic blood pressure greater than 140 mm Hg or a diastolic blood pressure greater than 90 mm Hg or both (mean, 143 +/- 7 and 87 +/- 6 mm Hg, respectively). At baseline, subjects who developed hypertension had a greater left ventricular mass index than those who did not (92 +/- 25 compared with 77 +/- 19 g/m2 body surface area; P < 0.005) and higher 24-hour urinary sodium/potassium excretion ratio (3.6 +/- 1.7 compared with 2.6 +/- 1.4; P < 0.04); there were no differences in race, initial age, systolic or diastolic blood pressure, coronary risk factors, or plasma renin activity. The likelihood of developing hypertension rose from 3% in the lowest quartile of sex-adjusted left ventricular mass index to 24% in the highest quartile (P < 0.005); a parallel trend was less regular for quartiles of the sodium/potassium excretion ratio (P < 0.04). In multivariate analyses, follow-up systolic pressures in all subjects and in the 117 who remained normotensive were predicted by initial age, systolic blood pressure, black race, and sex-adjusted left ventricular mass index; final diastolic blood pressure was predicted by its initial value, plasma triglyceride levels, urinary sodium/potassium ratio, low renin activity, black race, and plasma glucose level. Conclusions: Echocardiographic left ventricular mass in normotensive adults is directly related to the risk for developing subsequent hypertension. Left ventricular mass improves prediction of future systolic pressure, whereas diastolic pressure is more related to initial metabolic status. Black race is also an independent determinant of higher subsequent blood pressure.	CORNELL UNIV, MED CTR,NEW YORK HOSP,DIV CARDIOL,BOX 222, 525 E 68TH ST, NEW YORK, NY 10021 USA	Cornell University; NewYork-Presbyterian Hospital			de Simone, Giovanni/D-1767-2011	de Simone, Giovanni/0000-0001-8567-9881	NHLBI NIH HHS [HL 18323] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL018323] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABERNATHY JR, 1988, AM J CARDIOL, V61, P1071, DOI 10.1016/0002-9149(88)90128-2; ADAMS TD, 1985, CIRCULATION, V71, P39, DOI 10.1161/01.CIR.71.1.39; BLAUSTEIN MP, 1977, AM J PHYSIOL, V232, pC165, DOI 10.1152/ajpcell.1977.232.5.C165; CASALE PN, 1986, ANN INTERN MED, V105, P173, DOI 10.7326/0003-4819-105-2-173; CELENTANO A, 1988, J HYPERTENS, V6, pS107, DOI 10.1097/00004872-198812040-00030; CHIANG BN, 1969, CIRCULATION, V39, P403, DOI 10.1161/01.CIR.39.3.403; CHIEN S, 1965, P SOC EXP BIOL MED, V119, P1155; DAHL LK, 1972, AM J CLIN NUTR, V25, P231; DELEONARDIS V, 1988, AM J HYPERTENS, V1, P305, DOI 10.1093/ajh/1.3.305; DESIMONE G, 1990, CIRCULATION, V81, P107, DOI 10.1161/01.CIR.81.1.107; DESIMONE G, 1988, AM J NONINVAS CARD, V2, P217; DEVEREUX RB, 1989, AM J HYPERTENS, V2, pS186, DOI 10.1093/ajh/2.6.186S; DEVEREUX RB, 1987, HYPERTENSION, V9, P97; DEVEREUX RB, 1977, CIRCULATION, V55, P613, DOI 10.1161/01.CIR.55.4.613; DEVEREUX RB, 1983, CIRCULATION, V68, P470, DOI 10.1161/01.CIR.68.3.470; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; DEVEREUX RB, 1984, J AM COLL CARDIOL, V4, P1222, DOI 10.1016/S0735-1097(84)80141-2; DEVEREUX RB, 1988, AM HEART J, V116, P1124, DOI 10.1016/0002-8703(88)90176-7; DITTO B, 1989, HYPERTENSION, V13, P181, DOI 10.1161/01.HYP.13.2.181; FAGARD R, 1987, AM J CARDIOL, V60, P1362, DOI 10.1016/0002-9149(87)90620-5; GANAU A, 1989, J AM COLL CARDIOL, V14, P715, DOI 10.1016/0735-1097(89)90116-2; GANAU A, 1990, CIRCULATION, V81, P25, DOI 10.1161/01.CIR.81.1.25; GOSSE P, 1986, J HYPERTENS, V4, pS297; GOTTDIENER JS, 1990, ANN INTERN MED, V112, P161, DOI 10.7326/0003-4819-112-3-161; GUDMUNDSSON O, 1984, ACTA MED SCAND, V688, P31; HAMMOND IW, 1988, J AM COLL CARDIOL, V12, P996, DOI 10.1016/0735-1097(88)90467-6; HAMMOND IW, 1986, J AM COLL CARDIOL, V7, P639, DOI 10.1016/S0735-1097(86)80476-4; HARSHFIELD GA, 1990, AM J HYPERTENS, V3, P538, DOI 10.1093/ajh/3.7.538; KESTELOOT H, 1984, ANN CLIN RES, V16, P72; KOREN MJ, 1991, IN PRESS ANN INTERN; KRISHNA GG, 1987, J LAB CLIN MED, V109, P724; LEVY D, 1989, ANN INTERN MED, V110, P101, DOI 10.7326/0003-4819-110-2-101; LIU K, 1979, AM J EPIDEMIOL, V110, P219, DOI 10.1093/oxfordjournals.aje.a112806; MACGREGOR GA, 1985, HYPERTENSION, V7, P628, DOI 10.1161/01.HYP.7.4.628; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; MAHONEY LT, 1988, HYPERTENSION, V12, P206, DOI 10.1161/01.HYP.12.2.206; NATHWANI D, 1985, AM HEART J, V109, P386, DOI 10.1016/0002-8703(85)90622-2; Nielsen J R, 1985, Acta Med Scand Suppl, V693, P61; Pickering G, 1968, HIGH BLOOD PRESSURE, P236; RADICE M, 1986, AM HEART J, V111, P115, DOI 10.1016/0002-8703(86)90562-4; RAVOGLI A, 1990, IN PRESS HYPERTENSIO; SAHN DJ, 1978, CIRCULATION, V58, P1072, DOI 10.1161/01.CIR.58.6.1072; SEALEY JE, 1977, CARDIOVASC MED, V2, P1079; SEALEY JE, 1970, J CLIN INVEST, V49, P2119, DOI 10.1172/JCI106429; STAESSEN J, 1981, J EPIDEMIOL COMMUN H, V35, P256, DOI 10.1136/jech.35.4.256; TANNEN RL, 1983, ANN INTERN MED, V98, P773, DOI 10.7326/0003-4819-98-5-773; WALLERSON DC, 1987, HYPERTENSION, V9, P6; WEDER AB, 1985, PSYCHOSOM MED, V47, P406, DOI 10.1097/00006842-198509000-00001; WOOD DL, 1984, HYPERTENSION, V6, P301, DOI 10.1161/01.HYP.6.3.301; YOUNG DB, 1976, CIRC RES, V38, P84, DOI 10.1161/01.RES.38.6.84; ZAR JH, 1984, BIOSTAT ANAL, P346	51	105	105	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 1	1991	114	3					202	209		10.7326/0003-4819-114-3-202	http://dx.doi.org/10.7326/0003-4819-114-3-202			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EV339	1984744				2022-12-24	WOS:A1991EV33900006
J	HILLIS, DM; MORITZ, C; PORTER, CA; BAKER, RJ				HILLIS, DM; MORITZ, C; PORTER, CA; BAKER, RJ			EVIDENCE FOR BIASED GENE CONVERSION IN CONCERTED EVOLUTION OF RIBOSOMAL DNA	SCIENCE			English	Article							HETERONOTIA-BINOEI GEKKONIDAE; NON-HOMOLOGOUS CHROMOSOMES; MULTIGENE FAMILIES; MOLECULAR DRIVE; LINKAGE DISEQUILIBRIUM; IMMUNOGLOBULIN GENES; PARTHENOGENESIS; SEQUENCES; VARIANTS; REGIONS	Concerted evolution is the production and maintenance of homogeneity within repeated families of DNA. Two mechanisms-unequal crossing over and biased gene conversion-have been the principal explanation of concerted evolution. Concerted evolution of ribosomal DNA (rDNA) arrays is thought to be largely the result of unequal crossing over. However, concerted evolution of rDNA in parthenogenetic lizards of hybrid origin is strongly biased toward one of two parental sequences, which is consistent with biased gene conversion as the operative mechanism. The apparent gene conversions are independent of initial genome dosage and result in homogenization of rDNA arrays across all nucleolar organizer regions.	UNIV QUEENSLAND, DEPT ZOOL, ST LUCIA, QLD 4067, AUSTRALIA; TEXAS TECH UNIV, DEPT BIOL SCI, LUBBOCK, TX 79409 USA	University of Queensland; Texas Tech University System; Texas Tech University	HILLIS, DM (corresponding author), UNIV TEXAS, DEPT ZOOL, AUSTIN, TX 78712 USA.		Moritz, Craig/A-7755-2012; Hillis, David/L-5421-2019; Hillis, David M/B-4278-2008	Moritz, Craig/0000-0001-5313-7279; 				ARNHEIM N, 1980, P NATL ACAD SCI-BIOL, V77, P7323, DOI 10.1073/pnas.77.12.7323; Arnheim N., 1983, P38; ARNHEIM N, 1979, GENE, V7, P83, DOI 10.1016/0378-1119(79)90025-8; ARNOLD ML, 1988, CHROMOSOMA, V96, P368, DOI 10.1007/BF00330703; BALTIMORE D, 1981, CELL, V24, P592, DOI 10.1016/0092-8674(81)90082-9; CIMINO MC, 1972, SCIENCE, V175, P1484, DOI 10.1126/science.175.4029.1484; COEN ES, 1982, NATURE, V295, P564, DOI 10.1038/295564a0; COEN ES, 1982, J MOL BIOL, V153, P841; DAWLEY RM, 1989, BIOL UNISEXUAL VERTE, P1; DOVER G, 1982, NATURE, V299, P111, DOI 10.1038/299111a0; DOVER G, 1982, BIOSCIENCE, V32, P526, DOI 10.2307/1308904; DOVER GA, 1986, TRENDS GENET, V2, P159, DOI 10.1016/0168-9525(86)90211-8; DOVER GA, 1989, GENETICS, V122, P249; GOODMAN M, 1987, COLD SPRING HARB SYM, V52, P875, DOI 10.1101/SQB.1987.052.01.096; GOODPASTURE C, 1975, CHROMOSOMA, V53, P37, DOI 10.1007/BF00329389; HILLIS DM, 1989, INT CONGR SER, V824, P355; HILLIS DM, 1986, EVOLUTION, V40, P1275, DOI 10.1111/j.1558-5646.1986.tb05751.x; HILLIS DM, 1987, MOL BIOL EVOL, V4, P117; KRYSTAL M, 1981, P NATL ACAD SCI-BIOL, V78, P5744, DOI 10.1073/pnas.78.9.5744; LONG EO, 1980, ANNU REV BIOCHEM, V49, P727, DOI 10.1146/annurev.bi.49.070180.003455; MORITZ C, 1989, EVOLUTION, V43, P994, DOI 10.1111/j.1558-5646.1989.tb02545.x; MORITZ C, 1984, CHROMOSOMA, V89, P151, DOI 10.1007/BF00292899; MORITZ C, 1983, SCIENCE, V220, P735, DOI 10.1126/science.220.4598.735; MORITZ C, 1990, COPEIA, P333, DOI 10.2307/1446339; Moritz C., 1989, BIOL UNISEXUAL VERTE, P87; MOYZIS RK, 1987, CHROMOSOMA, V95, P375, DOI 10.1007/BF00333988; NAGYLAKI T, 1982, GENETICS, V100, P315; NAGYLAKI T, 1988, GENETICS, V120, P291; OHTA T, 1980, GENET RES, V36, P181, DOI 10.1017/S0016672300019790; OHTA T, 1981, GENETICS, V99, P555; OHTA T, 1983, P NATL ACAD SCI-BIOL, V80, P4079, DOI 10.1073/pnas.80.13.4079; RASCH EM, 1982, HISTOCHEMISTRY, V73, P515, DOI 10.1007/BF00493366; SCHERER S, 1980, SCIENCE, V209, P1380, DOI 10.1126/science.6251545; SEPERACK P, 1988, GENETICS, V119, P943; SLATKIN M, 1986, GENETICS, V112, P681; SMITH GP, 1973, COLD SPRING HARB SYM, V38, P507, DOI 10.1101/SQB.1974.038.01.055; TARTOF KD, 1973, COLD SPRING HARB SYM, V38, P491, DOI 10.1101/SQB.1974.038.01.053; UZZELL T, 1970, AM NAT, V104, P433, DOI 10.1086/282678	38	337	353	1	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 18	1991	251	4991					308	310		10.1126/science.1987647	http://dx.doi.org/10.1126/science.1987647			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET678	1987647				2022-12-24	WOS:A1991ET67800032
J	MENKE, A; JOCKUSCH, H				MENKE, A; JOCKUSCH, H			DECREASED OSMOTIC STABILITY OF DYSTROPHIN-LESS MUSCLE-CELLS FROM THE MDX MOUSE	NATURE			English	Article							DUCHENNE MUSCULAR-DYSTROPHY; GENE	HUMAN X-linked Duchenne and Becker muscular dystrophies are due to defects in dystrophin, the product of an exceptionally large gene1,2. Although dystrophin has been characterized as a spectrin-like3 submembranous4 cytoskeletal protein, there is no experimental evidence for its function in the structural maintenance of muscle5. Current hypotheses attribute necrosis of hystrophin-less fibres in situ to mechanical weakening of the outer membrane6, to an excessive influx of Ca2+ ions7,8, or to a combination of these two mechanisms, possibly mediated by stretch-sensitive ion channels9. Using hypo-osmotic shock to determine stress resistance10 and a mouse model (mdx)11,12 for the human disease, we show that functional dystrophin contributes to the stability of both cultured myotubes and isolated mature muscle fibres.			MENKE, A (corresponding author), UNIV BIELEFELD,DEV BIOL UNIT,W-4800 BIELEFELD 1,GERMANY.							BLAU HM, 1981, P NATL ACAD SCI-BIOL, V78, P5623, DOI 10.1073/pnas.78.9.5623; BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189; CARNWATH JW, 1987, J NEUROL SCI, V80, P39, DOI 10.1016/0022-510X(87)90219-X; COOPER BJ, 1989, SOC NEUR ABSTR, V15, P412; CULLEN MJ, 1990, PROC R SOC SER B-BIO, V240, P197, DOI 10.1098/rspb.1990.0034; DUNCAN CJ, 1989, EXPERIENTIA, V45, P175, DOI 10.1007/BF01954866; ERVASTI JM, 1990, NATURE, V345, P315, DOI 10.1038/345315a0; FOSTER AH, 1980, ANESTH ANALG, V58, P727; FRANCO A, 1990, NATURE, V344, P670, DOI 10.1038/344670a0; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; JOCKUSCH H, 1990, MUSCLE NERVE, V13, P551, DOI 10.1002/mus.880130613; JOCKUSCH H, 1990, DYNAMIC STATE OF MUSCLE FIBERS, P429; KARPATI G, 1986, AM J MED GENET, V25, P653, DOI 10.1002/ajmg.1320250407; KOELTGEN D, IN PRESS MUSCLE NERV; KOENIG M, 1990, J BIOL CHEM, V265, P4560; KOENIG M, 1987, CELL, V50, P509, DOI 10.1016/0092-8674(87)90504-6; MENKE A, 1990, J NEUROL SCI S, V98, P124; PARTRIDGE TA, 1989, NATURE, V337, P176, DOI 10.1038/337176a0; SICINSKI P, 1989, SCIENCE, V244, P1578, DOI 10.1126/science.2662404; Slater CR, 1989, CURR OPIN CELL BIOL, V1, P110, DOI 10.1016/S0955-0674(89)80046-8; TURNER PR, 1988, NATURE, V335, P735, DOI 10.1038/335735a0; WATKINS SC, 1989, MUSCLE NERVE, V12, P861, DOI 10.1002/mus.880121013	22	296	300	0	7	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JAN 3	1991	349	6304					69	71		10.1038/349069a0	http://dx.doi.org/10.1038/349069a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EQ601	1985268				2022-12-24	WOS:A1991EQ60100053
J	VANDERLINDEN, PWG; HACK, CE; KERCKHAERT, JAM; STRUYVENBERG, A; VANDERZWAN, JC				VANDERLINDEN, PWG; HACK, CE; KERCKHAERT, JAM; STRUYVENBERG, A; VANDERZWAN, JC			PRELIMINARY-REPORT - COMPLEMENT ACTIVATION IN WASP-STING ANAPHYLAXIS	LANCET			English	Article									NETHERLANDS RED CROSS, BLOOD TRANSFUS SERV, CENT LAB, AMSTERDAM, NETHERLANDS; STATE UNIV UTRECHT HOSP, DEPT MED, 3511 GV UTRECHT, NETHERLANDS	Utrecht University; Utrecht University Medical Center	VANDERLINDEN, PWG (corresponding author), EEMLAND HOSP, DEPT INTERNAL MED, UTRECHTSWEG 160, 3818 ES AMERSFOORT, NETHERLANDS.		Levi, Marcel/AAZ-8559-2020					BLAAUW PJ, 1985, J ALLERGY CLIN IMMUN, V75, P556, DOI 10.1016/0091-6749(85)90029-6; DELBALZO U, 1988, J PHARMACOL EXP THER, V246, P911; Friedberger E, 1910, Z IMMUNITATSFORSCH, V4, P636; GOLDEN DBK, 1989, JAMA-J AM MED ASSOC, V262, P240, DOI 10.1001/jama.262.2.240; HACK CE, 1989, AM J MED, V86, P20, DOI 10.1016/0002-9343(89)90224-6; HAKIM RM, 1984, NEW ENGL J MED, V311, P878, DOI 10.1056/NEJM198410043111403; HUGLI TE, 1981, INT ARCH ALLER A IMM, V66, P113, DOI 10.1159/000232882; JOHNSON AR, 1975, IMMUNOLOGY, V28, P1067; KAMPELMACHER MJ, 1987, CLIN ALLERGY, V17, P317, DOI 10.1111/j.1365-2222.1987.tb02021.x; LEVI R, 1988, CLIN IMMUNOLOGY, V1, P93; LICHTENSTEIN LM, 1979, J ALLERGY CLIN IMMUN, V64, P5, DOI 10.1016/0091-6749(79)90075-7; LOMNITZER R, 1988, CLIN ALLERGY, V18, P39, DOI 10.1111/j.1365-2222.1988.tb02841.x; Mueller H L, 1966, J Asthma Res, V3, P331; NAGATA S, 1987, J ALLERGY CLIN IMMUN, V80, P24, DOI 10.1016/S0091-6749(87)80186-0; POITIER P, 1902, CR SOC BIOL, V54, P170; REISMAN RE, 1975, J ALLERGY CLIN IMMUN, V56, P443, DOI 10.1016/0091-6749(75)90062-7; REISMAN RE, 1987, ANN ALLERGY, V59, P429; SCHWARTZ LB, 1987, NEW ENGL J MED, V316, P1622, DOI 10.1056/NEJM198706253162603; SCHWARTZ LB, 1983, J IMMUNOL, V130, P1891; SCHWARTZ LB, 1989, J CLIN INVEST, V83, P1551, DOI 10.1172/JCI114051; SERAFIN WE, 1987, NEW ENGL J MED, V317, P30, DOI 10.1056/NEJM198707023170106; SETTIPANE GA, 1979, CLIN ALLERGY, V9, P385, DOI 10.1111/j.1365-2222.1979.tb02497.x; SMITH PL, 1980, J CLIN INVEST, V66, P1072, DOI 10.1172/JCI109936; VOGT W, 1986, Complement, V3, P177; WESTABY S, 1985, CARDIOVASC RES, V19, P85, DOI 10.1093/cvr/19.2.85	25	49	49	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 13	1990	336	8720					904	906		10.1016/0140-6736(90)92272-J	http://dx.doi.org/10.1016/0140-6736(90)92272-J			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EC456	1976931				2022-12-24	WOS:A1990EC45600005
J	EASTWOOD, JB; LEVIN, GE; PAZIANAS, M; TAYLOR, AP; DENTON, J; FREEMONT, AJ				EASTWOOD, JB; LEVIN, GE; PAZIANAS, M; TAYLOR, AP; DENTON, J; FREEMONT, AJ			ALUMINUM DEPOSITION IN BONE AFTER CONTAMINATION OF DRINKING-WATER SUPPLY	LANCET			English	Article									UNIV SURREY,ROBENS INST,GUILDFORD GU2 5XH,SURREY,ENGLAND; UNIV MANCHESTER,DEPT RHEUMATOL,PATHOL LABS,MANCHESTER M13 9PT,LANCS,ENGLAND	University of Surrey; University of Manchester	EASTWOOD, JB (corresponding author), ST GEORGE HOSP,SCH MED,DEPT CELLULAR & MOLEC BIOL,CRANMER TERRACE,LONDON SW17 0RE,ENGLAND.		Pazianas, Michael/ABE-4572-2020; Freemont, Tony J/A-9000-2015	Pazianas, Michael/0000-0002-4670-0016; Freemont, Tony J/0000-0002-9780-208X				ALFREY AC, 1976, NEW ENGL J MED, V294, P184, DOI 10.1056/NEJM197601222940402; [Anonymous], 1980, OFF J EUR COMM L, V229, P11; BERLYNE GM, 1972, LANCET, V1, P564; CAM JM, 1976, CLIN SCI MOL MED, V51, P407, DOI 10.1042/cs0510407; CAMPISTOL JM, 1989, NEPHRON, V51, P103, DOI 10.1159/000185252; CLARKSON EM, 1972, CLIN SCI, V43, P519, DOI 10.1042/cs0430519; DENTON J, 1984, J CLIN PATHOL, V37, P136, DOI 10.1136/jcp.37.2.136; ELLIS HA, 1988, J CLIN PATHOL, V41, P1171, DOI 10.1136/jcp.41.11.1171; GREGER JL, 1983, FOOD CHEM TOXICOL, V21, P473, DOI 10.1016/0278-6915(83)90105-9; NATHAN E, 1980, ACTA PAEDIATR SCAND, V69, P793, DOI 10.1111/j.1651-2227.1980.tb07155.x; SLANINA P, 1984, FOOD CHEM TOXICOL, V22, P391, DOI 10.1016/0278-6915(84)90369-7; SMITH DB, 1980, JAMA-J AM MED ASSOC, V244, P365, DOI 10.1001/jama.244.4.365; 1989, WATER POLLUTION LOWE; 1988, LANCET, V2, P465	14	39	39	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	AUG 25	1990	336	8713					462	464		10.1016/0140-6736(90)92012-7	http://dx.doi.org/10.1016/0140-6736(90)92012-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV754	1974990				2022-12-24	WOS:A1990DV75400004
J	BRODIE, MJ				BRODIE, MJ			MANAGEMENT OF EPILEPSY DURING PREGNANCY AND LACTATION	LANCET			English	Article											BRODIE, MJ (corresponding author), WESTERN INFIRM & ASSOCIATED HOSP,DEPT MED & THERAPEUT,EPILEPSY RES UNIT,GLASGOW G11 6NT,SCOTLAND.							BRODIE MJ, 1987, EPILEPSY YOUNG PEOPL, P81; DALESSIO DJ, 1985, NEW ENGL J MED, V312, P559, DOI 10.1056/NEJM198502283120906; HOPKINS A, 1987, BRIT MED J, V294, P497, DOI 10.1136/bmj.294.6570.497; JONES KL, 1989, NEW ENGL J MED, V320, P1661, DOI 10.1056/NEJM198906223202505; NAKANE Y, 1980, EPILEPSIA, V21, P663, DOI 10.1111/j.1528-1157.1980.tb04320.x; NAU H, 1982, CLIN PHARMACOKINET, V7, P508, DOI 10.2165/00003088-198207060-00003; PERUCCA E, 1983, CLIN PHARM OBSTETRIC, P264; PHILBERT A, 1982, EPILEPSIA, V23, P85, DOI 10.1111/j.1528-1157.1982.tb05055.x; YERBY MS, 1988, RECENT ADV EPILEPSY, V4, P93; 1988, LANCET, V2, P1404	10	20	20	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	AUG 18	1990	336	8712					426	427		10.1016/0140-6736(90)91960-I	http://dx.doi.org/10.1016/0140-6736(90)91960-I			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV277	1974956				2022-12-24	WOS:A1990DV27700017
J	PUI, CH; HANCOCK, ML; RAIMONDI, SC; HEAD, DR; THOMPSON, E; WILIMAS, J; KUN, LE; BOWMAN, LC; CRIST, WM; PRATT, CB				PUI, CH; HANCOCK, ML; RAIMONDI, SC; HEAD, DR; THOMPSON, E; WILIMAS, J; KUN, LE; BOWMAN, LC; CRIST, WM; PRATT, CB			MYELOID NEOPLASIA IN CHILDREN TREATED FOR SOLID TUMORS	LANCET			English	Article									ST JUDE CHILDRENS RES HOSP, DEPT PATHOL & LAB MED, MEMPHIS, TN 38101 USA; ST JUDE CHILDRENS RES HOSP, DEPT RADIAT ONCOL, MEMPHIS, TN 38101 USA; ST JUDE CHILDRENS RES HOSP, DEPT BIOSTAT & INFORMAT SYST, MEMPHIS, TN 38101 USA; UNIV TENNESSEE, CTR HLTH SCI,COLL MED,DEPT PEDIAT, DIV HEMATOL & ONCOL, MEMPHIS, TN 38163 USA	St Jude Children's Research Hospital; St Jude Children's Research Hospital; St Jude Children's Research Hospital; University of Tennessee System; University of Tennessee Health Science Center	PUI, CH (corresponding author), ST JUDE CHILDRENS RES HOSP, DEPT HEMATOL ONCOL, POB 318, MEMPHIS, TN 38101 USA.		Raimondi, Susana C/N-8166-2018; Pui, Ching-Hon/N-8076-2018	Pui, Ching-Hon/0000-0003-0303-5658	NATIONAL CANCER INSTITUTE [P30CA021765, P01CA020180, P01CA023099] Funding Source: NIH RePORTER; NCI NIH HHS [CA-20180, CA-21765, CA-23099] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BRESLOW NE, 1988, JNCI-J NATL CANCER I, V80, P592, DOI 10.1093/jnci/80.8.592; CUZICK J, 1987, BRIT J CANCER, V55, P523, DOI 10.1038/bjc.1987.107; DAVIES SV, 1988, CANCER GENET CYTOGEN, V31, P271, DOI 10.1016/0165-4608(88)90227-0; DEVATHAIRE F, 1989, BRIT J CANCER, V59, P792, DOI 10.1038/bjc.1989.165; DUANE SF, 1985, MED PEDIATR ONCOL, V13, P207, DOI 10.1002/mpo.2950130410; FENAUX P, 1989, CANCER, V63, P2505, DOI 10.1002/1097-0142(19890615)63:12<2505::AID-CNCR2820631224>3.0.CO;2-Z; FOUCAR K, 1979, CANCER, V43, P1285, DOI 10.1002/1097-0142(197904)43:4<1285::AID-CNCR2820430416>3.0.CO;2-J; GELLER RB, 1988, J CLIN ONCOL, V6, P1558, DOI 10.1200/JCO.1988.6.10.1558; GUINAN EC, 1989, BLOOD, V73, P619; Harnden DG, 1985, INT SYSTEM HUMAN CYT; Harnden DG, 1985, BIRTH DEFECTS ORIGIN, V21; HAWKINS MM, 1987, BRIT J CANCER, V56, P339, DOI 10.1038/bjc.1987.200; INGRAM L, 1987, BRIT J CANCER, V55, P463, DOI 10.1038/bjc.1987.91; KALBFLEISCH JD, 1980, STATISTICAL ANAL FAI; KALDOR JM, 1990, NEW ENGL J MED, V322, P1, DOI 10.1056/NEJM199001043220101; KALDOR JM, 1990, NEW ENGL J MED, V322, P7, DOI 10.1056/NEJM199001043220102; KANTARJIAN HM, 1986, CANCER, V58, P924, DOI 10.1002/1097-0142(19860815)58:4<924::AID-CNCR2820580420>3.0.CO;2-Y; KANTARJIAN HM, 1986, J CLIN ONCOL, V4, P1748, DOI 10.1200/JCO.1986.4.12.1748; KAPLAN HS, 1980, HODGKINS DISEASE, P236; KINGSTON JE, 1987, BRIT J CANCER, V56, P331, DOI 10.1038/bjc.1987.199; LARSON RA, 1988, BLOOD, V72, P1333; LEBEAU MM, 1986, J CLIN ONCOL, V4, P325, DOI 10.1200/JCO.1986.4.3.325; MANTEL N, 1974, J AM STAT ASSOC, V69, P81, DOI 10.2307/2285503; MEADOWS AT, 1989, MED PEDIATR ONCOL, V17, P477; MEADOWS AT, 1985, J CLIN ONCOL, V3, P532, DOI 10.1200/JCO.1985.3.4.532; MIKE V, 1982, LANCET, V2, P1326; ODONNELL MR, 1987, J CLIN ONCOL, V5, P1822, DOI 10.1200/JCO.1987.5.11.1822; PEDERSENBJERGAARD J, 1987, LANCET, V2, P83, DOI 10.1016/S0140-6736(87)92744-9; PEDERSENBJERGAARD J, 1985, ANN INTERN MED, V103, P195, DOI 10.7326/0003-4819-103-2-195; PEDERSENBJERGAARD J, 1988, J CLIN ONCOL, V6, P395, DOI 10.1200/JCO.1988.6.2.395; PREISLER HD, 1983, NEW ENGL J MED, V308, P21, DOI 10.1056/NEJM198301063080105; PUI CH, 1989, BLOOD, V73, P209; PUI CH, 1989, NEW ENGL J MED, V321, P136, DOI 10.1056/NEJM198907203210302; RATAIN MJ, 1987, BLOOD, V70, P1412; TUCKER MA, 1988, NEW ENGL J MED, V318, P76, DOI 10.1056/NEJM198801143180203; TUCKER MA, 1987, J NATL CANCER I, V78, P459, DOI 10.1093/jnci/78.3.459; VANLEEUWEN FE, 1989, J CLIN ONCOL, V7, P1046, DOI 10.1200/JCO.1989.7.8.1046; WEH HJ, 1986, J CLIN ONCOL, V4, P1518, DOI 10.1200/JCO.1986.4.10.1518; WHANGPENG J, 1988, BLOOD, V71, P403; WILLIAMS DL, 1984, CANCER GENET CYTOGEN, V13, P239, DOI 10.1016/0165-4608(84)90046-3; 1988, CANCER GENET CYTOGEN, V32, P1	41	109	110	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	AUG 18	1990	336	8712					417	421		10.1016/0140-6736(90)91956-B	http://dx.doi.org/10.1016/0140-6736(90)91956-B			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV277	1974952				2022-12-24	WOS:A1990DV27700013
J	GRAY, D; HAMPTON, JR; BERNSTEIN, SJ; KOSECOFF, J; BROOK, RH				GRAY, D; HAMPTON, JR; BERNSTEIN, SJ; KOSECOFF, J; BROOK, RH			AUDIT OF CORONARY ANGIOGRAPHY AND BYPASS-SURGERY	LANCET			English	Article									UNIV CALIF LOS ANGELES,DEPT MED & PUBL HLTH,LOS ANGELES,CA 90024; RAND CORP,SANTA MONICA,CA 90406	University of California System; University of California Los Angeles; RAND Corporation	GRAY, D (corresponding author), UNIV NOTTINGHAM HOSP,DEPT MED,NOTTINGHAM NG7 2UH,ENGLAND.			Bernstein, Steven/0000-0003-3359-7168				BROOK RH, 1988, LANCET, V1, P750; FINK A, 1984, AM J PUBLIC HEALTH, V74, P979, DOI 10.2105/AJPH.74.9.979; PETCH MC, 1986, J ROY COLL PHYS LOND, V20, P21; Sackman H, 1975, DELPHI CRITIQUE; 1984, BRIT MED J, V289, P1527	5	88	88	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JUN 2	1990	335	8701					1317	1320		10.1016/0140-6736(90)91196-H	http://dx.doi.org/10.1016/0140-6736(90)91196-H			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG095	1971385				2022-12-24	WOS:A1990DG09500012
J	FLANAGAN, RJ; MEREDITH, TJ; RUPRAH, M; ONYON, LJ; LIDDLE, A				FLANAGAN, RJ; MEREDITH, TJ; RUPRAH, M; ONYON, LJ; LIDDLE, A			ALKALINE DIURESIS FOR ACUTE-POISONING WITH CHLOROPHENOXY HERBICIDES AND IOXYNIL	LANCET			English	Article											FLANAGAN, RJ (corresponding author), GUYS & ST THOMAS HOSP,POISONS UNIT,ST THOMAS ST,LONDON SE1 9RT,ENGLAND.							ABIKHALIL F, 1988, 24TH INT ASS FOR TOX, P512; AKERBLOM M, 1983, J CHROMATOGR, V258, P302, DOI 10.1016/S0021-9673(00)96431-8; ARNOLD EK, 1989, VET HUM TOXICOL, V31, P121; BRODY TM, 1952, P SOC EXP BIOL MED, V80, P533; CONSO F, 1977, ARCH MAL PROF MED, V38, P674; DICKEY W, 1988, POSTGRAD MED J, V64, P681, DOI 10.1136/pgmj.64.755.681; DONE AK, 1971, MOD TREAT, V8, P528; FLANAGAN RJ, 1989, CLIN CHEM, V35, P1342; FRASER AD, 1984, J FORENSIC SCI, V29, P1237; HILL JB, 1973, NEW ENGL J MED, V288, P1110, DOI 10.1056/NEJM197305242882107; KANCIR CB, 1988, J TOXICOL-CLIN TOXIC, V26, P257, DOI 10.3109/15563658809000352; MATTHEW H, 1979, TREATMENT COMMON ACU; MEULENBELT J, 1988, HUM TOXICOL, V7, P289, DOI 10.1177/096032718800700312; MOFFAT AC, 1986, CLARKES ISOLATION ID, P965; OREILLY JF, 1984, POSTGRAD MED J, V60, P76, DOI 10.1136/pgmj.60.699.76; OSTERLOH J, 1983, J ANAL TOXICOL, V7, P125, DOI 10.1093/jat/7.3.125; PRESCOTT LF, 1979, BRIT J CLIN PHARMACO, V7, P111, DOI 10.1111/j.1365-2125.1979.tb00906.x; PRESCOTT LF, 1982, BRIT MED J, V285, P1383, DOI 10.1136/bmj.285.6352.1383; SMYSL B, 1977, ARCH TOXICOL, V37, P241, DOI 10.1007/BF00355494; VESEY CJ, 1985, CLIN CHEM, V31, P270; WELLS WDE, 1981, CLIN TOXICOL, V18, P273	21	28	30	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	FEB 24	1990	335	8687					454	458		10.1016/0140-6736(90)90677-W	http://dx.doi.org/10.1016/0140-6736(90)90677-W			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP907	1968179				2022-12-24	WOS:A1990CP90700013
J	GAUTIER, J; MINSHULL, J; LOHKA, M; GLOTZER, M; HUNT, T; MALLER, JL				GAUTIER, J; MINSHULL, J; LOHKA, M; GLOTZER, M; HUNT, T; MALLER, JL			CYCLIN IS A COMPONENT OF MATURATION-PROMOTING FACTOR FROM XENOPUS	CELL			English	Article									UNIV COLORADO,SCH MED,DEPT PHARMACOL,DENVER,CO 80262; UNIV COLORADO,SCH MED,DEPT CELLULAR & STRUCT BIOL,DENVER,CO 80262; UNIV CAMBRIDGE,DEPT BIOCHEM,CAMBRIDGE CB2 1QW,ENGLAND	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; University of Cambridge	GAUTIER, J (corresponding author), UNIV CALIF SAN FRANCISCO,DEPT BIOCHEM & BIOPHYS,SAN FRANCISCO,CA 94143, USA.		Gautier, jean/A-2774-2008; Hunt, Tim/O-8544-2019	Hunt, Tim/0000-0001-5174-6038				ADLAKHA RC, 1988, J CELL BIOL, V106, P1445, DOI 10.1083/jcb.106.5.1445; ANDERSON CW, 1973, J VIROL, V12, P241, DOI 10.1128/JVI.12.2.241-252.1973; ARION D, 1988, CELL, V55, P371, DOI 10.1016/0092-8674(88)90060-8; BLAKE MS, 1984, ANAL BIOCHEM, V136, P175, DOI 10.1016/0003-2697(84)90320-8; BOOHER R, 1988, EMBO J, V7, P2321, DOI 10.1002/j.1460-2075.1988.tb03075.x; BRIZUELA L, 1987, EMBO J, V6, P3507, DOI 10.1002/j.1460-2075.1987.tb02676.x; CYERT MS, 1988, CELL, V53, P185, DOI 10.1016/0092-8674(88)90380-7; CYERT MS, 1988, DEV BIOL, V129, P209, DOI 10.1016/0012-1606(88)90175-3; DRAETTA G, 1988, CELL, V54, P17, DOI 10.1016/0092-8674(88)90175-4; DRAETTA G, 1989, CELL, V56, P829, DOI 10.1016/0092-8674(89)90687-9; DUNPHY WG, 1988, CELL, V54, P423, DOI 10.1016/0092-8674(88)90205-X; DUNPHY WG, 1989, CELL, V58, P181, DOI 10.1016/0092-8674(89)90414-5; ERIKSON E, 1989, J BIOL CHEM, V264, P19577; EVANS T, 1983, CELL, V33, P389, DOI 10.1016/0092-8674(83)90420-8; GAUTIER J, 1989, NATURE, V339, P626, DOI 10.1038/339626a0; GAUTIER J, 1988, CELL, V54, P433, DOI 10.1016/0092-8674(88)90206-1; GERHART J, 1984, J CELL BIOL, V98, P1247, DOI 10.1083/jcb.98.4.1247; GOEBL M, 1988, CELL, V54, P739; GOULD KL, 1989, NATURE, V342, P39, DOI 10.1038/342039a0; HAGAN I, 1988, J CELL SCI, V91, P587; HARLOW E, 1988, ANTIBODIES LABORATOR; HASHIMOTO N, 1988, DEV BIOL, V126, P242, DOI 10.1016/0012-1606(88)90135-2; Johnson R A, 1979, Adv Cyclic Nucleotide Res, V10, P135; KISHIMOTO T, 1982, EXP CELL RES, V137, P121, DOI 10.1016/0014-4827(82)90014-3; KISHIMOTO T, 1976, NATURE, V260, P321, DOI 10.1038/260321a0; LABBE JC, 1989, EMBO J, V8, P3053, DOI 10.1002/j.1460-2075.1989.tb08456.x; LABBE JC, 1989, CELL, V57, P253, DOI 10.1016/0092-8674(89)90963-X; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEHNER CF, 1989, CELL, V56, P957, DOI 10.1016/0092-8674(89)90629-6; LOHKA MJ, 1983, SCIENCE, V220, P719, DOI 10.1126/science.6601299; LOHKA MJ, 1985, J CELL BIOL, V101, P518, DOI 10.1083/jcb.101.2.518; LOHKA MJ, 1988, P NATL ACAD SCI USA, V85, P3009, DOI 10.1073/pnas.85.9.3009; MALLER J, 1977, DEV BIOL, V58, P295, DOI 10.1016/0012-1606(77)90093-8; Maniatis T., 1982, MOL CLONING; MASUI Y, 1971, J EXP ZOOL, V177, P129, DOI 10.1002/jez.1401770202; Masui Y., 1987, MOL REGULATION NUCLE, P1; MEIJER L, 1989, EMBO J, V8, P2275, DOI 10.1002/j.1460-2075.1989.tb08353.x; MEIJER L, 1984, INT REV CYTOL, V86, P129, DOI 10.1016/S0074-7696(08)60179-5; MIAKELYE R, 1985, CELL, V41, P165, DOI 10.1016/0092-8674(85)90071-6; MINSHULL J, 1989, CELL, V56, P947, DOI 10.1016/0092-8674(89)90628-4; MORLA AO, 1989, CELL, V58, P193, DOI 10.1016/0092-8674(89)90415-7; MURRAY AW, 1988, NATURE, V335, P207, DOI 10.1038/335207a0; MURRAY AW, 1989, NATURE, V339, P280, DOI 10.1038/339280a0; MURRAY AW, 1989, NATURE, V339, P275, DOI 10.1038/339275a0; PINES J, 1987, EMBO J, V6, P2987, DOI 10.1002/j.1460-2075.1987.tb02604.x; PINES J, 1989, CELL, V58, P833, DOI 10.1016/0092-8674(89)90936-7; REMAUT E, 1983, NUCLEIC ACIDS RES, V11, P4677, DOI 10.1093/nar/11.14.4677; SAGATA N, 1989, NATURE, V342, P512, DOI 10.1038/342512a0; SCZAKIEL G, 1987, NUCLEIC ACIDS RES, V15, P1878, DOI 10.1093/nar/15.4.1878; SMITH LD, 1971, DEV BIOL, V25, P232, DOI 10.1016/0012-1606(71)90029-7; SOLOMON M, 1988, CELL, V54, P738, DOI 10.1016/S0092-8674(88)90933-6; STANDART N, 1987, DEV BIOL, V124, P248, DOI 10.1016/0012-1606(87)90476-3; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; STUDIER FW, 1990, IN PRESS METH ENZYMO; SWENSON KI, 1986, CELL, V47, P861, DOI 10.1016/0092-8674(86)90801-9; WASSERMAN WJ, 1975, EXP CELL RES, V91, P381, DOI 10.1016/0014-4827(75)90118-4; WEINTRAUB H, 1982, CR ACAD SCI III-VIE, V295, P787; WHITFIELD WGF, 1989, NATURE, V338, P337, DOI 10.1038/338337a0; WITTENBERG C, 1988, CELL, V54, P1061, DOI 10.1016/0092-8674(88)90121-3; [No title captured]	60	585	594	1	27	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	FEB 9	1990	60	3					487	494		10.1016/0092-8674(90)90599-A	http://dx.doi.org/10.1016/0092-8674(90)90599-A			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	CP237	1967981				2022-12-24	WOS:A1990CP23700015
J	NIDORF, SM; PARSONS, RW; THOMPSON, PL; JAMROZIK, KD; HOBBS, MST				NIDORF, SM; PARSONS, RW; THOMPSON, PL; JAMROZIK, KD; HOBBS, MST			REDUCED RISK OF DEATH AT 28 DAYS IN PATIENTS TAKING A BETA-BLOCKER BEFORE ADMISSION TO HOSPITAL WITH MYOCARDIAL-INFARCTION	BRITISH MEDICAL JOURNAL			English	Article									QUEEN ELIZABETH II MED CTR,DIV PUBL HLTH,NEDLANDS,WA 6009,AUSTRALIA	University of Western Australia	NIDORF, SM (corresponding author), QUEEN ELIZABETH II MED CTR,DEPT CARDIOVASC MED,NEDLANDS,WA 6009,AUSTRALIA.		Thompson, Peter L/P-1071-2014					[Anonymous], 1986, Lancet, V2, P57; GOLDBERG R, 1979, JOHNS HOPKINS MED J, V144, P73; GOLDSTEIN S, 1983, CIRCULATION, V67, P53; GOMEZMARIN O, 1987, NEW ENGL J MED, V316, P1353, DOI 10.1056/NEJM198705283162201; JURGENSEN HJ, 1981, BRIT HEART J, V45, P583; MARTIN CA, 1988, ACTA MED SCAND S, V728, P40; NORRIS RM, 1980, BRIT HEART J, V43, P617; PEDERSEN TR, 1983, CIRCULATION, V67, P49; PETER T, 1978, CIRCULATION, V57, P1091, DOI 10.1161/01.CIR.57.6.1091; Prineas R., 1982, MINNESOTA CODE MANUA; THOMPSON PL, 1988, AUST NZ J MED, V18, P327, DOI 10.1111/j.1445-5994.1988.tb02045.x; TUNSTALL-PEDOE H, 1988, Journal of Clinical Epidemiology, V41, P105; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7; YUSUF S, 1983, CIRCULATION, V67, P32; 1983, CIRCULATION S1, V67, P26; 1985, EUR HEART J, V6, P199; 1985, MONICA57 MEM; 1987, EPIC EPIDEMIOLOGICAL	18	38	38	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JAN 13	1990	300	6717					71	74		10.1136/bmj.300.6717.71	http://dx.doi.org/10.1136/bmj.300.6717.71			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ080	1967956	Green Published, Bronze			2022-12-24	WOS:A1990CJ08000011
J	HALES, CN; BARKER, DJP; CLARK, PMS; COX, LJ; FALL, C; OSMOND, C; WINTER, PD				HALES, CN; BARKER, DJP; CLARK, PMS; COX, LJ; FALL, C; OSMOND, C; WINTER, PD			FETAL AND INFANT GROWTH AND IMPAIRED GLUCOSE-TOLERANCE AT AGE 64	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DIABETES-MELLITUS; HEART-DISEASE; INSULIN; HYPERTENSION; PREVALENCE; RISK; LIFE	Objective - To discover whether reduced fetal and infant growth is associated with non-insulin dependent diabetes and impaired glucose tolerance in adult life. Design - Follow up study of men born during 1920-30 whose birth weights and weights at 1 year were known. Setting - Hertfordshire, England. Subjects - 468 men born in east Hertfordshire and still living there. Main outcome measures-Fasting plasma glucose, insulin, proinsulin, and 32-33 split proinsulin concentrations and plasma glucose and insulin concentrations 30 and 120 minutes after a 75 g glucose drink. Results - 93 men had impaired glucose tolerance or hitherto undiagnosed diabetes. They had had a lower mean birth weight and a lower weight at 1 year. The proportion of men with impaired glucose tolerance fell progressively from 26% (6/23) among those who had weighed 18 lb (8-16 kg) or less at 1 year to 13% (3/24) among those who had weighed 27 lb (12.25 kg) or more. Corresponding figures for diabetes were 17% (4/23) and nil (0/24). Plasma glucose concentrations at 30 and 120 minutes fell with increasing birth weight and weight at 1 year. Plasma 32-33 split proinsulin concentration fell with increasing weight at 1 year. All these trends were significant and independent of current body mass. Blood pressure was inversely related to birth weight and strongly related to plasma glucose and 32-33 split proinsulin concentrations. Conclusions - Reduced growth in early life is strongly linked with impaired glucose tolerance and non-insulin dependent diabetes. Reduced early growth is also related to a raised plasma concentration of 32-33 split proinsulin, which is interpreted as a sign of beta-cell dysfunction. Reduced intrauterine growth is linked with high blood pressure, which may explain the association between hypertension and impaired glucose tolerance.	SOUTHAMPTON GEN HOSP, MRC, ENVIRONM EPIDEMIOL UNIT, SOUTHAMPTON SO9 4XY, HANTS, ENGLAND	University of Southampton	HALES, CN (corresponding author), UNIV CAMBRIDGE, ADDENBROOKES HOSP, DEPT CLIN BIOCHEM, CAMBRIDGE CB2 2QR, ENGLAND.			Osmond, Clive/0000-0002-9054-4655				[Anonymous], 1989, LANCET, V2, P839; [Anonymous], 1980, CLASSIFICATION OCCUP; BARKER DJP, 1989, LANCET, V2, P577; BARKER DJP, 1991, J ROY COLL PHYS LOND, V25, P129; BARKER DJP, 1990, BRIT MED J, V301, P259, DOI 10.1136/bmj.301.6746.259; COHEN MP, 1988, DIABETES, V37, P824, DOI 10.2337/diabetes.37.6.824; FREINKEL N, 1980, DIABETES, V29, P1023, DOI 10.2337/diabetes.29.12.1023; FULLER JH, 1980, LANCET, V1, P1373; HARRIS MI, 1987, DIABETES, V36, P523, DOI 10.2337/diabetes.36.4.523; Hellerstrom C, 1988, PATHOLOGY ENDOCRINE, P141; JOHANNSSON A, 1985, CLIN CHIM ACTA, V148, P119, DOI 10.1016/0009-8981(85)90221-9; KLOPPEL G, 1985, SURV SYN PATHOL RES, V4, P110; Kunst A., 1984, METHOD ENZYMAT AN, VVI, P163; MODAN M, 1985, J CLIN INVEST, V75, P809, DOI 10.1172/JCI111776; NEWMAN B, 1987, DIABETOLOGIA, V30, P763; REAVEN GM, 1988, DIABETES, V37, P1595, DOI 10.2337/diabetes.37.12.1595; SOBEY WJ, 1989, BIOCHEM J, V260, P535, DOI 10.1042/bj2600535; STAMLER J, 1975, J CHRON DIS, V28, P527, DOI 10.1016/0021-9681(75)90060-0; SWENNE I, 1987, DIABETES, V36, P454, DOI 10.2337/diabetes.36.4.454; TEMPLE RC, 1989, LANCET, V1, P293, DOI 10.1016/S0140-6736(89)91306-8; van Assche F A, 1979, Contrib Gynecol Obstet, V5, P44	21	2015	2073	2	73	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 26	1991	303	6809					1019	1022		10.1136/bmj.303.6809.1019	http://dx.doi.org/10.1136/bmj.303.6809.1019			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GM478	1954451	Green Published, Bronze			2022-12-24	WOS:A1991GM47800017
J	PRENDERGAST, GC; ZIFF, EB				PRENDERGAST, GC; ZIFF, EB			METHYLATION-SENSITIVE SEQUENCE-SPECIFIC DNA-BINDING BY THE C-MYC BASIC REGION	SCIENCE			English	Article							MAJOR LATE PROMOTER; TRANSCRIPTION FACTOR; UPSTREAM ELEMENT; ONCOGENE; FOS; DIFFERENTIATION; EXPRESSION; CELLS; JUN; COMMITMENT	The function of the c-Myc oncoprotein and its role in cell growth control is unclear. A basic region of c-Myc is structurally related to the basic motifs of helix-loop-helix (HLH) and leucine zipper proteins, which provide sequence-specific DNA binding function. The c-Myc basic region was tested for its ability to bind DNA by attaching it to the HLH dimerization interface of the E12 enhancer binding factor. Dimers of the chimeric protein, termed E6, specifically bound an E box element (GGCCACGT-GACC) recognized by other HLH proteins in a manner dependent on the integrity of the c-Myc basic motif. Methylation of the core CpG in the E box recognition site specifically inhibited binding by E6, but not by two other HLH proteins. Expression of E6 (but not an E6 DNA binding mutant) suppressed the ability of c-myc to cooperate with H-ras in a rat embryo fibroblast transformation assay, suggesting that the DNA recognition specificity of E6 is related to that of c-Myc in vivo.	NYU,SCH MED,KAPLAN CANC CTR,NEW YORK,NY 10016	New York University	PRENDERGAST, GC (corresponding author), NYU,SCH MED,DEPT BIOCHEM,HOWARD HUGHES MED INST,NEW YORK,NY 10016, USA.			Ziff, Edward/0000-0001-7389-8649				BECKMANN H, 1990, GENE DEV, V4, P167, DOI 10.1101/gad.4.2.167; BESTOR TH, 1990, PHILOS T ROY SOC B, V326, P179, DOI 10.1098/rstb.1990.0002; BLACKWELL TK, COMMUNICATION; CARTHEW RW, 1985, CELL, V43, P439, DOI 10.1016/0092-8674(85)90174-6; CEDAR H, 1988, CELL, V53, P3, DOI 10.1016/0092-8674(88)90479-5; CHEN C, 1987, MOL CELL BIOL, V7, P2745, DOI 10.1128/MCB.7.8.2745; COPPOLA JA, 1986, NATURE, V320, P760, DOI 10.1038/320760a0; DANG C, 1989, NATURE, V339, P664; DAVIS RL, 1990, CELL, V60, P733, DOI 10.1016/0092-8674(90)90088-V; DMITROVSKY E, 1986, NATURE, V322, P748, DOI 10.1038/322748a0; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; GREGOR PD, 1990, GENE DEV, V4, P1730, DOI 10.1101/gad.4.10.1730; HANN SR, 1988, CELL, V52, P185, DOI 10.1016/0092-8674(88)90507-7; INGHIRAMI G, 1990, SCIENCE, V250, P682, DOI 10.1126/science.2237417; JONES PA, 1986, CANCER RES, V46, P461; KELEKAR A, 1986, MOL CELL BIOL, V6, P7, DOI 10.1128/MCB.6.1.7; KOUZARIDES T, 1988, NATURE, V336, P646, DOI 10.1038/336646a0; KOUZARIDES T, 1989, NATURE, V340, P568, DOI 10.1038/340568a0; LACHMAN HM, 1986, P NATL ACAD SCI USA, V83, P6480, DOI 10.1073/pnas.83.17.6480; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; MARUYAMA K, 1987, ONCOGENE, V1, P361; MIYAMOTO NG, 1985, EMBO J, V4, P3563, DOI 10.1002/j.1460-2075.1985.tb04118.x; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; NAKABEPPU Y, 1989, EMBO J, V8, P3833, DOI 10.1002/j.1460-2075.1989.tb08561.x; NEUBERG M, 1989, NATURE, V338, P589, DOI 10.1038/338589a0; PRENDERGAST GC, 1989, MOL CELL BIOL, V9, P124, DOI 10.1128/MCB.9.1.124; PRENDERGAST GC, 1989, NATURE, V341, P392, DOI 10.1038/341392a0; PRENDERGAST GC, UNPUB; RULEY HE, 1983, NATURE, V304, P602, DOI 10.1038/304602a0; SAWADOGO M, 1985, CELL, V43, P165, DOI 10.1016/0092-8674(85)90021-2; TURNER R, 1989, SCIENCE, V243, P1689, DOI 10.1126/science.2494701	31	491	504	0	8	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JAN 11	1991	251	4990					186	189		10.1126/science.1987636	http://dx.doi.org/10.1126/science.1987636			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET173	1987636				2022-12-24	WOS:A1991ET17300037
J	ORHOLM, M; MUNKHOLM, P; LANGHOLZ, E; NIELSEN, OH; SORENSEN, TIA; BINDER, V				ORHOLM, M; MUNKHOLM, P; LANGHOLZ, E; NIELSEN, OH; SORENSEN, TIA; BINDER, V			FAMILIAL OCCURRENCE OF INFLAMMATORY BOWEL-DISEASE	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							REGIONAL PATIENT GROUP; CROHNS-DISEASE; ULCERATIVE-COLITIS; PREVALENCE; COPENHAGEN; RELATIVES; COUNTY; RISK; PROGNOSIS	Background and Methods. We assessed the familial occurrence in inflammatory bowel disease in Copenhagen County, where there has been a long-term interest in the epidemiology of such disorders. In 1987 we interviewed 662 patients in whom inflammatory bowel disease had been diagnosed before 1979, asking whether their first- and second-degree relatives had this disorder. Ninety-six percent of the patients (504 with ulcerative colitis and 133 with Crohn's disease) provided adequate information. Results. As compared with the general population, the first-degree relatives of the 637 patients with ulcerative colitis or Crohn's disease had a 10-fold increase in the risk of having the same disease as the patients, after standardization for age and sex. The risk of having the other of the two diseases was also increased, but less so, and the increase in the risk of having Crohn's disease was not significant in the relatives of patients with ulcerative colitis. The risk of ulcerative colitis in first-degree relatives of patients with ulcerative colitis appeared to be virtually independent of the generation to which the first-degree relative belonged and of the sex of the patient and the relative. The risk of ulcerative colitis in first-degree relatives tended to be higher if the disease had been diagnosed in the patient before the age of 50, but the risk seemed to be independent of the current age of the relatives. The prevalence of the same disease as that of the patient (either ulcerative colitis or Crohn's disease) among second-degree relatives was increased; the prevalence of the other disease was not increased. Conclusions. The 10-fold increase in the familial risk of ulcerative colitis and Crohn's disease strongly suggests that these disorders have a genetic cause.	UNIV COPENHAGEN,HERLEV HOSP,DEPT MED GASTROENTEROL C,DK-2730 HERLEV,DENMARK	University of Copenhagen; Herlev & Gentofte Hospital			Munkholm, Pia/ABD-2432-2021; Nielsen, Ole Haagen/AAK-2482-2021	Nielsen, Ole Haagen/0000-0003-4612-8635				BINDER V, 1966, Scandinavian Journal of Gastroenterology, V1, P49; BINDER V, 1985, GUT, V26, P146, DOI 10.1136/gut.26.2.146; BINDER V, 1982, GASTROENTEROLOGY, V83, P563; BOTH H, 1983, SCAND J GASTROENTERO, V18, P987, DOI 10.3109/00365528309182127; ELSON CO, 1988, INFLAMM BOWEL DIS, P97; FARMER RG, 1980, CLIN GASTROENTEROL, V9, P271; HAMMER B, 1968, GUT, V9, P17, DOI 10.1136/gut.9.1.17; HENDRIKSEN C, 1985, GUT, V26, P158, DOI 10.1136/gut.26.2.158; KHOURY MJ, 1988, AM J EPIDEMIOL, V127, P674, DOI 10.1093/oxfordjournals.aje.a114842; KIRSNER JB, 1963, ANN INTERN MED, V59, P133, DOI 10.7326/0003-4819-59-2-133; KORELITZ BI, 1981, RECENT ADV CROHNS DI, P208; LANGHOLZ E, 1989, SCAND J GASTROENTE S, V158, P66; LARSEN PM, 1989, SCAND J GASTROENTE S, V158, P67; LASHNER BA, 1986, GASTROENTEROLOGY, V91, P1396, DOI 10.1016/0016-5085(86)90193-9; LEWKONIA RM, 1976, GUT, V17, P235, DOI 10.1136/gut.17.3.235; MAYBERRY JF, 1980, BMJ-BRIT MED J, V1, P84; MCCONNELL RB, 1986, GENETICS EPIDEMIOLOG, V11, P1; MCCONNELL RB, 1980, DEV DIGESTIVE DISEAS, P129; MONSEN U, 1987, SCAND J GASTROENTERO, V22, P214, DOI 10.3109/00365528708991882; ROTH MP, 1989, GASTROENTEROLOGY, V96, P1016, DOI 10.1016/0016-5085(89)91618-1; SHERLOCK P, 1963, GASTROENTEROLOGY, V45, P413; SINGER HC, 1971, GASTROENTEROLOGY, V61, P423; TYSK C, 1988, GUT, V29, P990, DOI 10.1136/gut.29.7.990; WEISS KM, 1982, J CHRON DIS, V35, P539, DOI 10.1016/0021-9681(82)90073-X; WETERMAN IT, 1984, GASTROENTEROLOGY, V86, P449	25	506	529	0	12	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 10	1991	324	2					84	88		10.1056/NEJM199101103240203	http://dx.doi.org/10.1056/NEJM199101103240203			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EQ977	1984188				2022-12-24	WOS:A1991EQ97700003
J	SHIODA, T; LEVY, JA; CHENGMAYER, C				SHIODA, T; LEVY, JA; CHENGMAYER, C			MACROPHAGE AND T-CELL LINE TROPISMS OF HIV-1 ARE DETERMINED BY SPECIFIC REGIONS OF THE ENVELOPE GP120 GENE	NATURE			English	Article							HUMAN IMMUNODEFICIENCY VIRUS; AIDS-ASSOCIATED RETROVIRUS; VARIANTS; TYPE-1; EXPRESSION; SEQUENCES; CAPACITY	Strains of human immunodeficiency virus type 1 (HIV-1) display a high degree of biological heterogeneity which may be linked to certain clinical manifestations of AIDS. They vary in their ability to infect different cell types 1-3, to replicate rapidly and to high titre in culture 4-6, to down-modulate the CD4 receptor 7,8, and to cause cytopathic changes in infected cells 7,9-11. Some of these in vitro properties correlate with pathogenicity of the virus in vivo 11,12. To map the viral determinants of the cellular host range of HIV-1, recombinant viruses were generated between biologically active molecular clones of HIV-1 isolates showing differences in infection of primary peripheral blood macrophages and established T-cell lines. We report here at a specific region of the envelope gp120 gene representing 159 amino-acid residues of glycoprotein gp 120 seems to determine macrophage tropism, whereas an overlapping region representing 321 amino-acid residues determines T cell-line tropism. These studies provide a basis for relating functional domains of the HIV-1 env gene to pathogenic potential.			SHIODA, T (corresponding author), UNIV CALIF SAN FRANCISCO,DEPT MED,CANC RES INST,SAN FRANCISCO,CA 94143, USA.							ASJO B, 1986, LANCET, V2, P660; BERMAN PW, 1988, J VIROL, V62, P3135, DOI 10.1128/JVI.62.9.3135-3142.1988; CASTRO BA, 1988, AIDS, V2, pS17, DOI 10.1097/00002030-198800001-00004; CHENGMAYER C, 1990, J VIROL, V64, P4390, DOI 10.1128/JVI.64.9.4390-4398.1990; CHENGMAYER C, 1988, SCIENCE, V240, P80, DOI 10.1126/science.2832945; CHENGMAYER C, 1987, P NATL ACAD SCI USA, V84, P3526, DOI 10.1073/pnas.84.10.3526; CHENGMAYER C, 1989, P NATL ACAD SCI USA, V86, P8575, DOI 10.1073/pnas.86.21.8575; EMERMAN M, 1989, CELL, V57, P1155, DOI 10.1016/0092-8674(89)90053-6; EVANS LA, 1987, J IMMUNOL, V138, P3415; EVANS LA, 1988, SCIENCE, V240, P1522, DOI 10.1126/science.2836951; FENYO EM, 1988, J VIROL, V62, P4414; FISHER AG, 1988, NATURE, V334, P444, DOI 10.1038/334444a0; GALLAHER WR, 1987, CELL, V50, P327, DOI 10.1016/0092-8674(87)90485-5; HOFFMAN AD, 1985, VIROLOGY, V147, P326, DOI 10.1016/0042-6822(85)90135-7; LASKY LA, 1987, CELL, V50, P975, DOI 10.1016/0092-8674(87)90524-1; LEVY JA, 1984, SCIENCE, V225, P840, DOI 10.1126/science.6206563; LEVY JA, 1986, ANN I PASTEUR, V138, P101; LUCIW PA, 1984, NATURE, V312, P760, DOI 10.1038/312760a0; MODROW S, 1987, J VIROL, V61, P570, DOI 10.1128/JVI.61.2.570-578.1987; ROSEN CA, 1988, P NATL ACAD SCI USA, V85, P2071, DOI 10.1073/pnas.85.7.2071; SANCHEZPESADOR R, 1986, SCIENCE, V227, P484; TATENO M, 1988, VIROLOGY, V167, P299, DOI 10.1016/0042-6822(88)90084-0; TERSMETTE M, 1988, J VIROL, V62, P2026, DOI 10.1128/JVI.62.6.2026-2032.1988; TERSMETTE M, 1989, J VIROL, V63, P2118, DOI 10.1128/JVI.63.5.2118-2125.1989; YORKHIGGINS D, 1990, J VIROL, V64, P4016, DOI 10.1128/JVI.64.8.4016-4020.1990; YOURNO J, 1989, AIDS RES HUM RETROV, V5, P565, DOI 10.1089/aid.1989.5.565	26	521	524	0	5	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JAN 10	1991	349	6305					167	169		10.1038/349167a0	http://dx.doi.org/10.1038/349167a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ER418	1986308				2022-12-24	WOS:A1991ER41800062
J	GAFNI, RI				GAFNI, RI			MOTHERHOOD IN MEDICAL-SCHOOL	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article											GAFNI, RI (corresponding author), TEMPLE UNIV,HLTH SCI CTR,SCH MED,PHILADELPHIA,PA 19140, USA.								0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 2	1991	265	1					116	116		10.1001/jama.265.1.116	http://dx.doi.org/10.1001/jama.265.1.116			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EP555	1984109				2022-12-24	WOS:A1991EP55500042
J	TROUWBORST, A; VANWOERKENS, ECSM; VANDAELE, M; TENBRINCK, R				TROUWBORST, A; VANWOERKENS, ECSM; VANDAELE, M; TENBRINCK, R			ACUTE HYPERVOLEMIC HEMODILUTION TO AVOID BLOOD-TRANSFUSION DURING MAJOR SURGERY	LANCET			English	Article									ERASMUS UNIV,UNIV HOSP DIJKZIGT,DEPT CARDIOL,3015 GD ROTTERDAM,NETHERLANDS	Erasmus University Rotterdam; Erasmus MC	TROUWBORST, A (corresponding author), ERASMUS UNIV,UNIV HOSP DIJKZIGT,DEPT ANAESTHESIOL,DR MOLEWATERPLEIN 40,3015 GD ROTTERDAM,NETHERLANDS.							BAY J, 1968, BRIT J ANAESTH, V40, P398, DOI 10.1093/bja/40.6.398; CUTLER BS, 1984, SURGERY, V95, P717; DIXON JL, 1981, JAMA-J AM MED ASSOC, V246, P2471, DOI 10.1001/jama.246.21.2471; HEILMANN L, 1983, INFUS KLIN ERN, V10, P311; MESSMER K, 1986, EUR SURG RES, V18, P254, DOI 10.1159/000128533; NADLER SB, 1962, SURGERY, V51, P224; SINGH SK, 1987, EUR J CANCER CLIN ON, V23, P1537, DOI 10.1016/0277-5379(87)90097-6; TOY PTCY, 1987, NEW ENGL J MED, V316, P517, DOI 10.1056/NEJM198702263160906; TROUWBORST A, 1990, BRIT J ANAESTH, V64, P646, DOI 10.1093/bja/64.5.646; TROUWBORST A, 1990, ANESTH ANALG, V70, P523; WOOD JH, 1982, JAMA-J AM MED ASSOC, V248, P299; ZETTERSTROM H, 1986, ACTA ANAESTH SCAND, V30, P300, DOI 10.1111/j.1399-6576.1986.tb02418.x	12	49	68	0	3	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 24	1990	336	8726					1295	1297		10.1016/0140-6736(90)92973-L	http://dx.doi.org/10.1016/0140-6736(90)92973-L			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ943	1978123	Green Submitted			2022-12-24	WOS:A1990EJ94300012
J	RIFAT, SL; EASTWOOD, MR; MCLACHLAN, DRC; COREY, PN				RIFAT, SL; EASTWOOD, MR; MCLACHLAN, DRC; COREY, PN			EFFECT OF EXPOSURE OF MINERS TO ALUMINUM POWDER	LANCET			English	Article									UNIV TORONTO, DEPT PSYCHIAT, TORONTO M5S 1A1, ONTARIO, CANADA; UNIV TORONTO, DEPT PREVENT MED & BIOSTAT, TORONTO M5S 1A1, ONTARIO, CANADA; UNIV TORONTO, CTR RES NEURODEGENERAT DIS, TORONTO M5S 1A1, ONTARIO, CANADA	University of Toronto; University of Toronto; University of Toronto								ALFREY AC, 1976, NEW ENGL J MED, V294, P184, DOI 10.1056/NEJM197601222940402; ALFREY AC, 1989, ALUMINUM HLTH CRITIC, P101; BOEGMAN RJ, 1984, CAN J PHYSIOL PHARM, V62, P1010, DOI 10.1139/y84-170; CANDY JM, 1986, LANCET, V1, P354; CRAPPER DR, 1973, PHYSIOL BEHAV, V10, P925, DOI 10.1016/0031-9384(73)90063-2; Denny JJ, 1939, CAN MED ASSOC J, V40, P213; Dix WB., 1975, BRIEF ROYAL COMMISSI; FLATEN TP, 1986, THESIS U TRONDHEIM T; FOLSTEIN M, 1985, J AM GERIATR SOC, V33, P228, DOI 10.1111/j.1532-5415.1985.tb07109.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; GANROT PO, 1986, ENVIRON HEALTH PERSP, V65, P363, DOI 10.2307/3430204; Gent M., 1980, REPORT SCI TASK FORC; LONGSTRETH WT, 1985, ARCH INTERN MED, V145, P1972, DOI 10.1001/archinte.145.11.1972; MARTYN CN, 1989, LANCET, V1, P59; MCLACHLAN DRC, 1986, NEUROBIOL AGING, V7, P525; MCLAUGHLIN AIG, 1962, BRIT J IND MED, V19, P253; MICHEL P, 1990, 2ND INT C ALZH DIS R; Muller J., 1983, STUDY MORTALITY ON 1; Muller J., 1986, STUDY MORTALITY ON 2; Newkirk TE, 1972, STANDARD PRACTICES P; NEWKIRK TE, 1956, PHYSICAL CHEM CHARAC; PERL DP, 1980, SCIENCE, V208, P297, DOI 10.1126/science.7367858; PERL DP, 1987, LANCET, V1, P1028; PFEFFER RI, 1984, AM J EPIDEMIOL, V120, P922, DOI 10.1093/oxfordjournals.aje.a113963; RAVEN JC, 1986, MANUAL RAVENS COLOUR; Smith A., 1982, SYMBOL DIGIT MODALIT; SOLOMON PR, 1988, NEUROTOXICOLOGY, V9, P443; WISNIEWSKI HM, 1989, ALUMINUM HLTH CRITIC, P125	28	192	197	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	NOV 10	1990	336	8724					1162	1165		10.1016/0140-6736(90)92775-D	http://dx.doi.org/10.1016/0140-6736(90)92775-D			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG701	1978033				2022-12-24	WOS:A1990EG70100010
J	AUTIER, P; FERIR, MC; HAIRAPETIEN, A; ALEXANIAN, A; AGOUDJIAN, V; SCHMETS, G; DALLEMAGNE, G; LEVA, MN; PINEL, J				AUTIER, P; FERIR, MC; HAIRAPETIEN, A; ALEXANIAN, A; AGOUDJIAN, V; SCHMETS, G; DALLEMAGNE, G; LEVA, MN; PINEL, J			DRUG SUPPLY IN THE AFTERMATH OF THE 1988 ARMENIAN EARTHQUAKE	LANCET			English	Editorial Material									MED SANS FRONTIERES BRUSSELS,26 DESCHAMPHELEER ST,B-1080 BRUSSELS,BELGIUM; MINIST HLTH ARSSR,YEREVAN,ARMENIA,USSR				Autier, Philippe/A-4402-2014	Autier, Philippe/0000-0003-1538-5321				DEGOYET CD, 1977, EMERG PLANN DIGE JAN, P2; DEGOYET CD, 1976, TROPICAL DOCTOR, V6, P168; DEGOYET D, 1976, B PAN AM HLTH ORG, V10, P95; LECHAT MF, 1976, P ROY SOC MED, V69, P421, DOI 10.1177/003591577606900612; Reynolds J.E.F., 1989, MARTINDALE EXTRA PHA, V29th; ZEBALLOS JL, 1986, DISASTERS, V10, P141, DOI 10.1111/j.1467-7717.1986.tb00579.x; 1989, OFFICE UN DISASTER R; 1989, ESSENTIAL DRUGS POLI; 1983, SCI PUBLICATION PAN, V438	9	37	44	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JUN 9	1990	335	8702					1388	1390						3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH145	1971672				2022-12-24	WOS:A1990DH14500015
J	VAN BROECKHOVEN, C; HAAN, J; BAKKER, E; HARDY, JA; VANHUL, W; WEHNERT, A; VEGTERVANDERVLIS, M; ROOS, RAC				VAN BROECKHOVEN, C; HAAN, J; BAKKER, E; HARDY, JA; VANHUL, W; WEHNERT, A; VEGTERVANDERVLIS, M; ROOS, RAC			AMYLOID-BETA PROTEIN-PRECURSOR GENE AND HEREDITARY CEREBRAL-HEMORRHAGE WITH AMYLOIDOSIS (DUTCH)	SCIENCE			English	Article									UNIV HOSP LEIDEN, DEPT NEUROL, 2300 RC LEIDEN, NETHERLANDS; UNIV LONDON, ST MARYS HOSP, SCH MED, DEPT BIOCHEM, LONDON W2 1PG, ENGLAND; INNOGENET INC, B-9710 GHENT, BELGIUM; LEIDEN STATE UNIV, SYLVIUS LAB, DEPT HUMAN GENET, 2333 AL LEIDEN, NETHERLANDS; STATE UNIV LEIDEN HOSP, CTR CLIN GENET, 2333 AA LEIDEN, NETHERLANDS; AMYLOID RES GRP, LEIDEN, NETHERLANDS	Leiden University; Leiden University Medical Center (LUMC); Imperial College London; University of London; Innogenetics NV; Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC)	VAN BROECKHOVEN, C (corresponding author), UNIV INSTELLING ANTWERP, DEPT BIOCHEM, BORN BUNGE FDN, NEUROGENET LAB, UNIV PLEIN 1, B-2610 Antwerp, BELGIUM.		Bakker, Egbert/D-3525-2009; Hardy, John/C-2451-2009; Van Broeckhoven, Christine/G-8362-2017; Van Broeckhoven, Christine/M-7853-2019	Bakker, Egbert/0000-0002-2843-7357; Hardy, John/0000-0002-3122-0423; Van Broeckhoven, Christine/0000-0003-0183-7665; Van Broeckhoven, Christine/0000-0003-0183-7665; Van Hul, Wim/0000-0002-5065-7858				BENSON MD, 1989, TRENDS NEUROSCI, V12, P88, DOI 10.1016/0166-2236(89)90162-8; BLONDAL H, 1988, ALZ DIS ASSOC DIS, V2, P170; CASTANO EM, 1988, LAB INVEST, V58, P122; COHEN DH, 1983, J EXP MED, V158, P623, DOI 10.1084/jem.158.2.623; CORIA F, 1988, BRAIN RES, V463, P187, DOI 10.1016/0006-8993(88)90545-8; CORIA F, 1987, AM J PATHOL, V129, P422; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V122, P1131, DOI 10.1016/0006-291X(84)91209-9; GOATE AM, 1989, LANCET, V1, P352; GUDMUNDSSON G, 1972, BRAIN, V95, P387, DOI 10.1093/brain/95.2.387; HAAN J, 1989, CLIN NEUROL NEUROSUR, V91, P285, DOI 10.1016/0303-8467(89)90003-6; HSIAO K, 1989, NATURE, V338, P342, DOI 10.1038/338342a0; JOACHIM CL, 1989, NATURE, V341, P226, DOI 10.1038/341226a0; KANG J, 1987, NATURE, V325, P733, DOI 10.1038/325733a0; LATHROP GM, 1984, AM J HUM GENET, V36, P460; LATHROP GM, 1985, AM J HUM GENET, V37, P482; LUYENDIJK W, 1988, J NEUROL SCI, V85, P267, DOI 10.1016/0022-510X(88)90186-4; MASTERS C, 1988, AGING BRAIN, P183; PALSDOTTIR A, 1988, LANCET, V2, P603; PRELLI F, 1988, BIOCHEM BIOPH RES CO, V151, P1150, DOI 10.1016/S0006-291X(88)80486-8; RUMBLE B, 1989, NEW ENGL J MED, V320, P1446, DOI 10.1056/NEJM198906013202203; SELKOE DJ, 1989, ANNU REV NEUROSCI, V12, P463, DOI 10.1146/annurev.ne.12.030189.002335; STGEORGEHYSLOP PH, 1987, SCIENCE, V235, P885, DOI 10.1126/science.2880399; TAGLIAVINI F, 1988, NEUROSCI LETT, V93, P191, DOI 10.1016/0304-3940(88)90080-8; TANZI R E, 1988, Genomics, V3, P129, DOI 10.1016/0888-7543(88)90143-7; TANZI RE, 1987, NATURE, V329, P156, DOI 10.1038/329156a0; TANZI RE, 1987, SCIENCE, V235, P880, DOI 10.1126/science.2949367; VAN BROECKHOVEN C, 1987, NATURE, V329, P153; VANBROECKHOVEN C, 1988, GENETICS ALZHEIMERS, P124; VANDUINEN SG, 1987, P NATL ACAD SCI USA, V84, P5991; VINTERS HV, 1987, STROKE, V18, P311, DOI 10.1161/01.STR.18.2.311; WARREN AC, 1989, GENOMICS, V4, P579, DOI 10.1016/0888-7543(89)90282-6; WATTENDORFF AR, 1982, J NEUROL SCI, V55, P121, DOI 10.1016/0022-510X(82)90094-6; YAMAGUCHI H, 1988, ACTA NEUROPATHOL, V76, P541, DOI 10.1007/BF00689591; YE W, 1988, NUCLEIC ACIDS RES, V16, P1647, DOI 10.1093/nar/16.4.1647	35	379	410	0	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 1	1990	248	4959					1120	1122		10.1126/science.1971458	http://dx.doi.org/10.1126/science.1971458			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DF975	1971458				2022-12-24	WOS:A1990DF97500040
J	WERNERMAN, J; HAMMARQVIST, F; VINNARS, E				WERNERMAN, J; HAMMARQVIST, F; VINNARS, E			ALPHA-KETOGLUTARATE AND POSTOPERATIVE MUSCLE CATABOLISM	LANCET			English	Article									KAROLINSKA INST,ST GORANS CHILDRENS HOSP,DEPT SURG,S-11281 STOCKHOLM,SWEDEN; KAROLINSKA INST,ST GORANS CHILDRENS HOSP,METAB RES LAB,S-11281 STOCKHOLM,SWEDEN	Karolinska Institutet; Karolinska Institutet	WERNERMAN, J (corresponding author), KAROLINSKA INST,ST GORANS CHILDRENS HOSP,DEPT ANAESTHESIA & INTENS CARE,S-11281 STOCKHOLM,SWEDEN.							ALBERS S, 1988, CLIN SCI, V75, P463, DOI 10.1042/cs0750463; ALBERS S, 1989, CLIN SCI, V76, P643, DOI 10.1042/cs0760643; ASKANAZI J, 1980, ANN SURG, V192, P78, DOI 10.1097/00000658-198007000-00014; BERGSTROM J, 1974, J APPL PHYSIOL, V36, P693, DOI 10.1152/jappl.1974.36.6.693; CLOWES GHA, 1980, JPEN-PARENTER ENTER, V4, P195, DOI 10.1177/0148607180004002195; ESSEN P, 1988, CLIN NUTR S, V7, P67; HAMMARQVIST F, 1989, ANN SURG, V209, P455, DOI 10.1097/00000658-198904000-00011; HAMMARQVIST F, 1988, CLIN NUTR, V7, P171, DOI 10.1016/0261-5614(88)90021-0; HAMMARQVIST F, 1990, BRIT J SURG, V77, P214, DOI 10.1002/bjs.1800770227; HAMMARQVIST F, IN PRESS SURGERY; HAMMARQVIST F, 1989, CLIN NUTR S, V8, P57; IQBAL K, 1970, BIOCHEM J, V119, P145, DOI 10.1042/bj1190145; JEPSON MM, 1988, AM J PHYSIOL, V255, pE166, DOI 10.1152/ajpendo.1988.255.2.E166; LEANDER U, 1985, CLIN NUTR, V4, P43, DOI 10.1016/0261-5614(85)90037-8; MACLENNAN PA, 1987, FEBS LETT, V215, P187, DOI 10.1016/0014-5793(87)80139-4; NEWSHOLME EA, 1985, Q J EXP PHYSIOL CMS, V70, P473, DOI 10.1113/expphysiol.1985.sp002935; PETERSSON B, 1989, CLIN NUTR S, V8, P103; SOUBA WW, 1985, JPEN-PARENTER ENTER, V9, P608, DOI 10.1177/0148607185009005608; STEHLE P, 1989, LANCET, V1, P231; VESTERBERG K, 1987, CLIN NUTR, V6, P213, DOI 10.1016/0261-5614(87)90035-5; VINNARS E, 1975, ANN SURG, V182, P665, DOI 10.1097/00000658-197512000-00001; Vinnars E, 1983, Clin Nutr, V2, P3, DOI 10.1016/0261-5614(83)90023-7; WERNERMAN J, 1986, JPEN-PARENTER ENTER, V10, P578, DOI 10.1177/0148607186010006578; WERNERMAN J, 1985, METABOLISM, V34, P665, DOI 10.1016/0026-0495(85)90095-2; WERNERMAN J, 1987, ANN SURG, V206, P674	25	96	98	0	3	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	MAR 24	1990	335	8691					701	703		10.1016/0140-6736(90)90811-I	http://dx.doi.org/10.1016/0140-6736(90)90811-I			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CV305	1969067				2022-12-24	WOS:A1990CV30500010
J	STURM, AW; MOSTERT, R; ROUING, PJE; VANKLINGEREN, B; VANALPHEN, L				STURM, AW; MOSTERT, R; ROUING, PJE; VANKLINGEREN, B; VANALPHEN, L			OUTBREAK OF MULTIRESISTANT NON-ENCAPSULATED HEMOPHILUS-INFLUENZAE INFECTIONS IN A PULMONARY REHABILITATION CENTER	LANCET			English	Article									PULM REHABIL CTR HORNERHEIDE,HORN,NETHERLANDS; NATL INST PUBL HLTH & ENVIRONM PROTECT,BILTHOVEN,NETHERLANDS; UNIV AMSTERDAM,DEPT MED MICROBIOL,AMSTERDAM,NETHERLANDS	Netherlands National Institute for Public Health & the Environment; University of Amsterdam	STURM, AW (corresponding author), ST LAURENTIUS HOSP,DEPT MED MICROBIOL,POB 920,6040 AX ROERMOND,NETHERLANDS.							ALPHEN LV, 1983, J BACTERIOL, V155, P878; CAMPOS J, 1984, ANTIMICROB AGENTS CH, V25, P706, DOI 10.1128/AAC.25.6.706; FERNANDEZROBLAS R, 1988, J ANTIMICROB CHEMOTH, V22, P867, DOI 10.1093/jac/22.6.867; GLODE MP, 1976, J PEDIATR-US, V88, P36, DOI 10.1016/S0022-3476(76)80723-8; GROENEVELD K, 1988, J INFECT DIS, V158, P360, DOI 10.1093/infdis/158.2.360; KADO CI, 1981, J BACTERIOL, V145, P1365, DOI 10.1128/JB.145.3.1365-1373.1981; KILIAN M, 1976, J GEN MICROBIOL, V93, P9, DOI 10.1099/00221287-93-1-9; MURPHY TF, 1987, REV INFECT DIS, V9, P1; MURPHY TF, 1987, J INFECT DIS, V156, P723, DOI 10.1093/infdis/156.5.723; PATTERSON JE, 1988, J INFECT DIS, V157, P1002, DOI 10.1093/infdis/157.5.1002; STEERS EDWARD, 1959, ANTIBIOT AND CHEMOTHER, V9, P307; STURM AW, 1986, J MED MICROBIOL, V21, P349, DOI 10.1099/00222615-21-4-349; TURK DC, 1984, J MED MICROBIOL, V18, P1, DOI 10.1099/00222615-18-1-1; VANALPHEN L, 1988, EUR J CLIN MICROBIOL, V7, P309; VANALPHEN L, 1983, J INFECT DIS, V148, P75, DOI 10.1093/infdis/148.1.75; WARD JI, 1978, J PEDIATR-US, V92, P713, DOI 10.1016/S0022-3476(78)80134-6; WARD JI, 1979, NEW ENGL J MED, V301, P122, DOI 10.1056/NEJM197907193010302	17	28	28	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JAN 27	1990	335	8683					214	216		10.1016/0140-6736(90)90291-C	http://dx.doi.org/10.1016/0140-6736(90)90291-C			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL185	1967678				2022-12-24	WOS:A1990CL18500015
J	DIRCKX, JH				DIRCKX, JH			SUMMARIZING THE OBSTETRIC HISTORY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter																		CUNNINGHAM FG, 1989, WILLIAMS OBSTETRICS, P258; DANFORTH DN, 1986, OBSTET GYNECOL, P647; HACKER NF, 1986, ESSENTIALS OBSTETRIC, P22; WYNN RM, 1988, OBSTET GYNECOL, P4	4	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 18	1991	266	23					3344	3344		10.1001/jama.266.23.3344	http://dx.doi.org/10.1001/jama.266.23.3344			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GU964	1960839				2022-12-24	WOS:A1991GU96400040
J	MCFALLNGAI, MJ; RUBY, EG				MCFALLNGAI, MJ; RUBY, EG			SYMBIONT RECOGNITION AND SUBSEQUENT MORPHOGENESIS AS EARLY EVENTS IN AN ANIMAL-BACTERIAL MUTUALISM	SCIENCE			English	Article							EUPRYMNA-SCOLOPES; SQUID	Bacterial colonization of the developing tight organ of the squid Euprymna scolopes is shown to be highly specific, with the establishment of a successful association resulting only when the juvenile host is exposed to seawater containing one of a subset of Vibrio fischeri strains. Before a symbiotic infection the organ has elaborate epithelial structures covered with cilia and microvilli that are involved in the transfer of bacteria to the incipient symbiotic tissue. These structures regressed within days following infection; however, they were retained in uninfected animals, suggesting that the initiation of symbiosis influences, and is perhaps a prerequisite for, the normal developmental program of the juvenile host.			MCFALLNGAI, MJ (corresponding author), UNIV SO CALIF,DEPT BIOL SCI,LOS ANGELES,CA 90089, USA.							ARNOLD J M, 1972, Veliger, V14, P361; BLAKE PA, 1980, ANNU REV MICROBIOL, V34, P341, DOI 10.1146/annurev.mi.34.100180.002013; BOETTCHER KJ, 1990, J BACTERIOL, V172, P3701, DOI 10.1128/jb.172.7.3701-3706.1990; FINLAY BB, 1989, MICROBIOL REV, V53, P210, DOI 10.1128/MMBR.53.2.210-230.1989; FUKASAWA S, 1986, AGR BIOL CHEM TOKYO, V50, P1645, DOI 10.1080/00021369.1986.10867623; GILTURNES MS, 1989, SCIENCE, V246, P116, DOI 10.1126/science.2781297; GORDON HA, 1971, BACTERIOL REV, V35, P390, DOI 10.1128/MMBR.35.4.390-429.1971; HACKETT KJ, 1986, SCIENCE, V232, P1253, DOI 10.1126/science.232.4755.1253; HALVERSON LJ, 1986, MICROBIOL REV, V50, P193, DOI 10.1128/MMBR.50.2.193-225.1986; HASTINGS JW, 1987, SYMBIOSIS, V4, P3; ISBERG RR, 1991, SCIENCE, V252, P934, DOI 10.1126/science.1674624; LEE K-H, 1991, Abstracts of the General Meeting of the American Society for Microbiology, V91, P194; LONG SR, 1989, CELL, V56, P203, DOI 10.1016/0092-8674(89)90893-3; MCFALLNGAI M, 1990, BIOL BULL, V179, P332, DOI 10.2307/1542325; MCFALLNGAI MJ, 1990, ENDOCYTOBIOLOGY, V4, P319; MCFALLNGAI MJ, UNPUB; MEIGHEN EA, 1991, MICROBIOL REV, V55, P123, DOI 10.1128/MMBR.55.1.123-142.1991; Nealson KH, 1978, METHOD ENZYMOL, V57, P153; NESIS KN, 1982, CEPHALOPODS WORLD, P70; REICHELT JL, 1977, ARCH MICROBIOL, V112, P157, DOI 10.1007/BF00429329; ROLFE BG, 1988, ANNU REV PLANT PHYS, V39, P297, DOI 10.1146/annurev.pp.39.060188.001501; SAKAZAKI R, 1981, PROKARYOTES, V2, pCH103; WEI SL, 1989, MAR BIOL, V103, P541, DOI 10.1007/BF00399586	23	249	254	1	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	DEC 6	1991	254	5037					1491	1493		10.1126/science.1962208	http://dx.doi.org/10.1126/science.1962208			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT903	1962208				2022-12-24	WOS:A1991GT90300035
J	MAYOU, R; SEAGROATT, V; GOLDACRE, M				MAYOU, R; SEAGROATT, V; GOLDACRE, M			USE OF PSYCHIATRIC-SERVICES BY PATIENTS IN A GENERAL-HOSPITAL	BRITISH MEDICAL JOURNAL			English	Article							SUBSTANCE USE; DISORDERS; CONSULTATIONS; ANXIETY; PAIN	Objective - To identify physical disorders associated with increased rate of use of psychiatric services. Design - Retrospective analysis of routine s of general hospital inpatient records linked with those of psychiatric care, for inpatients with physical disorders with possible psychiatric associations and for controls. Setting - Oxfordshire health district. Subjects - Inpatients aged 15-64 years discharged from general hospitals during 1975-85 with a diagnosis among 14 selected diagnostic groups (including potentially life threatening conditions, chronic disabling diseases, and non-specific symptomatic conditions) and control inpatients with acute conditions. Main outcome measures - Observed and expected numbers of patients receiving psychiatric care. Results - Observed use of psychiatric services before and after index admission was close to that expected for controls. For most other diagnoses the observed use was significantly increased in the year preceding and that subsequent to the admission. For four diagnostic groups it was significantly greater in the year after admission than in that before (acute myocardial infarction (ratio before to after 2.17, 95% confidence interval 1.5 to 3.3), cancer (2.05, 1.7 to 2.5), diabetes mellitus (1.89, 1.4 to 2.9), and chest pain (1.78, 1.3 to 2.4)). During four years after the admission the use of psychiatric services was significantly higher than in the general population for nonsPecific symptomatic conditions (observed/expected: abdominal pain 1.7, chest pain 2.0, and headache 4.2), cirrhosis of the liver (10.4), and fractures in road accidents and other fractures (1.3, 1.6). Conclusions - More patients with certain physical conditions used psychiatric services. Alternative methods of service delivery may be needed, especially for disabling chronic physical illness, alcohol related disorders, and non-specific symptomatic conditions.	UNIV OXFORD,DEPT PUBL HLTH & PRIMARY CARE,CLIN EPIDEMIOL UNIT,OXFORD OX3 7LF,ENGLAND	University of Oxford	MAYOU, R (corresponding author), UNIV OXFORD,WARNEFORD HOSP,DEPT PSYCHIAT,OXFORD OX3 7JX,ENGLAND.							ACHESON ED, 1967, MEDICAL RECORD LINKA; BARSKY AJ, 1986, MED CARE, V24, P548, DOI 10.1097/00005650-198606000-00009; BERKSON J, 1946, BIOMETRICS BULL, V2, P47, DOI 10.2307/3002000; BRESLOW NE, 1987, STAT METHODS CANC RE, V2, P68; COLMAN M, 1986, INT J EPIDEMIOL, V15, P134; Devis T, 1984, POPULATION TRENDS, V36, P18; EASTWOOD MR, 1972, PSYCHOL MED, V2, P363, DOI 10.1017/S0033291700045177; FITZPATRICK RM, 1987, J NEUROL NEUROSUR PS, V44, P1061; FULOP G, 1989, HOSP COMMUNITY PSYCH, V40, P80; GILL LE, 1987, TXB MED RECORD LINKA, V3, P39; Goldberg DP, 1980, MENTAL ILLNESS COMMU; HANKIN JR, 1982, ARCH GEN PSYCHIAT, V39, P225; HENGEVELD MW, 1984, GEN HOSP PSYCHIAT, V6, P271, DOI 10.1016/0163-8343(84)90021-5; KESSLER LG, 1987, AM J PUBLIC HEALTH, V77, P18, DOI 10.2105/AJPH.77.1.18; MAYOU R, 1988, J PSYCHOSOM RES, V32, P541, DOI 10.1016/0022-3999(88)90038-4; MAYOU R, 1986, BRIT J PSYCHIAT, V149, P172, DOI 10.1192/bjp.149.2.172; MAYOU R, 1989, J PSYCHOSOM RES, V33, P393, DOI 10.1016/0022-3999(89)90001-9; RANG EH, 1970, BRIT J PREV SOC MED, V24, P47; REGIER DA, 1978, ARCH GEN PSYCHIAT, V35, P685; STEWART AL, 1989, JAMA-J AM MED ASSOC, V262, P907, DOI 10.1001/jama.262.7.907; WALLEN J, 1987, ARCH GEN PSYCHIAT, V44, P163; WELLS KB, 1989, AM J PSYCHIAT, V146, P1440; WELLS KB, 1989, GEN HOSP PSYCHIAT, V11, P320, DOI 10.1016/0163-8343(89)90119-9	23	11	11	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 26	1991	303	6809					1029	1032		10.1136/bmj.303.6809.1029	http://dx.doi.org/10.1136/bmj.303.6809.1029			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GM478	1954454	Green Published, Bronze			2022-12-24	WOS:A1991GM47800020
J	NEEQUAYE, JE; BYRNE, J; LEVINE, PH				NEEQUAYE, JE; BYRNE, J; LEVINE, PH			MENARCHE AND REPRODUCTION AFTER TREATMENT FOR AFRICAN BURKITTS-LYMPHOMA	BRITISH MEDICAL JOURNAL			English	Article							GONADAL DAMAGE		NCI,EPIDEMIOL & BIOSTAT PROGRAM,EPN 400,BETHESDA,MD 20892; UNIV GHANA,SCH MED,DEPT CHILD HLTH,BURKITTS TUMOR PROJECT,ACCRA,GHANA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Ghana					DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS [N01CP051009] Funding Source: NIH RePORTER; NCI NIH HHS [N01-CP-51009] Funding Source: Medline	DIVISION OF CANCER EPIDEMIOLOGY AND GENETICS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)NIH National Cancer Institute- Division of Cancer Epidemiology & Genetics); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BURKITT D, 1967, CANCER, V20, P756, DOI 10.1002/1097-0142(1967)20:5<756::AID-CNCR2820200530>3.0.CO;2-P; KOYAMA H, 1977, CANCER, V36, P1401; QUIGLEY C, 1989, NEW ENGL J MED, V321, P143, DOI 10.1056/NEJM198907203210303; RIVKEES SA, 1988, JAMA-J AM MED ASSOC, V259, P2123; WATSON AR, 1986, FERTIL STERIL, V46, P331	5	3	3	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 26	1991	303	6809					1033	1033		10.1136/bmj.303.6809.1033	http://dx.doi.org/10.1136/bmj.303.6809.1033			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GM478	1954456	Green Published, Bronze			2022-12-24	WOS:A1991GM47800022
J	STRINGER, MD; CAPPS, SNJ				STRINGER, MD; CAPPS, SNJ			RATIONALIZING THE MANAGEMENT OF SWALLOWED COINS IN CHILDREN	BRITISH MEDICAL JOURNAL			English	Article							FOREIGN-BODIES	Objective - To assess the management of swallowed coins in children and identify aspects that could be improved. Design - Study of records of three hospital departments for 1986-90. Setting - Accident and emergency, radiology, and operating theatre departments in a children's hospital. Subjects - 50 children reported to have ingested coins. Main outcome measures - Radiological investigations performed, position of coin, symptoms of child, and surgical intervention. Results - 50 children were recorded to have swallowed coins during 1986-90. Five children had only chest radiography, five only abdominal radiography, and 40 had both. A coin was detected in the oesophagus in 15 children, six of whom had symptoms, and below the cardia in 26, none of whom had symptoms; no coin was seen in nine children. Eleven children had further abdominal radiographs despite the absence of gastrointestinal symptoms; one child had a coin removed from the stomach. Conclusions - Children are being unnecessarily exposed to radiation and surgical intervention, and a consensus on management of swallowed coins is needed. Most children require only a single chest and neck radiograph.			STRINGER, MD (corresponding author), QUEEN MARYS HOSP CHILDREN,DEPT PAEDIAT SURG,CARSHALTON SM5 4NR,SURREY,ENGLAND.							BROWN WM, 1971, BMJ-BRIT MED J, V4, P620, DOI 10.1136/bmj.4.5787.620-a; Groff D. B., 1986, PEDIATR SURG, P907; JONES PG, 1963, MED J AUSTRALIA, V50, P236; MANDELL GA, 1977, PEDIATRICS, V60, P460; SPITZ L, 1971, BMJ-BRIT MED J, V4, P469, DOI 10.1136/bmj.4.5785.469; 1989, LANCET, V2, P659	6	30	30	0	0	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	JUN 1	1991	302	6788					1321	1322		10.1136/bmj.302.6788.1321	http://dx.doi.org/10.1136/bmj.302.6788.1321			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FQ444	1953854	Green Published, Bronze			2022-12-24	WOS:A1991FQ44400023
J	WELLS, V; MALLUCCI, L				WELLS, V; MALLUCCI, L			IDENTIFICATION OF AN AUTOCRINE NEGATIVE GROWTH-FACTOR - MOUSE BETA-GALACTOSIDE-BINDING PROTEIN IS A CYTOSTATIC FACTOR AND CELL-GROWTH REGULATOR	CELL			English	Article							EMBRYO FIBROBLASTS; CONCANAVALIN-A; MESSENGER-RNA; INTERFERON; LECTINS; SYNTHETASE; CYCLE; PURIFICATION; LYMPHOCYTES; EXPRESSION	Murine beta-galactoside-binding protein, a protein classified as a soluble lectin, is shown to be a cell growth-regulatory molecule and a cytostatic factor. The growth-inhibitory effect is not related to lectin properties, and competition assays indicate that the protein binds to specific cell surface receptors with high affinity. It exerts control in G0 and at G2, both as a regulator of cell replication and as a cytostatic factor.			WELLS, V (corresponding author), UNITED MED & DENT SCH GUYS & ST THOMASS HOSP,SCH MED,DIV MICROBIOL,CELLULAR & MOLEC BIOL LAB,LONDON SE1 9RT,ENGLAND.							ABBOTT WM, 1989, BIOCHEM J, V259, P291, DOI 10.1042/bj2590291; BARONDES SH, 1984, SCIENCE, V223, P1259, DOI 10.1126/science.6367039; BENNETT HPJ, 1980, J LIQ CHROMATOGR, V3, P1353, DOI 10.1080/01483918008062781; BOHMER FD, 1987, J BIOL CHEM, V262, P1537; CERRA RF, 1985, J BIOL CHEM, V260, P10474; CHILDS RA, 1979, BIOCHEM J, V183, P755, DOI 10.1042/bj1830755; CIERCH LB, 1988, BIOCHEMISTRY-US, V27, P692; COURAUD PO, 1989, J BIOL CHEM, V264, P1310; CREASEY AA, 1983, MOL CELL BIOL, V3, P780, DOI 10.1128/MCB.3.5.780; DEWAARD A, 1976, J BIOL CHEM, V251, P7581; FROCKLICK CA, 1983, P NATL ACAD SCI USA, V80, P3676; GITT MA, 1986, P NATL ACAD SCI USA, V83, P7603, DOI 10.1073/pnas.83.20.7603; HUNKAPILLER M, 1985, APPLIED BIOSYSTEMS P, V14; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; LIN SL, 1986, SCIENCE, V233, P356, DOI 10.1126/science.3726533; MACKLER BF, 1972, J NATL CANCER I, V49, P935; MALLUCCI L, 1983, J INTERFERON RES, V3, P181, DOI 10.1089/jir.1983.3.181; MASSAGUE J, 1985, TRENDS BIOCHEM SCI, V10, P237, DOI 10.1016/0968-0004(85)90141-0; MCCLAIN DA, 1976, J EXP MED, V144, P1494, DOI 10.1084/jem.144.6.1494; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; OHYAMA Y, 1986, BIOCHEM BIOPH RES CO, V134, P51, DOI 10.1016/0006-291X(86)90525-5; POWELL JT, 1980, BIOCHEM J, V187, P123, DOI 10.1042/bj1870123; RALPH P, 1973, J NATL CANCER I, V51, P883, DOI 10.1093/jnci/51.3.883; RAZ A, 1988, CANCER RES, V48, P645; REVEL M, 1982, TEX REP BIOL MED, V41, P452; ROBERTS AB, 1983, BIOCHEMISTRY-US, V22, P5692, DOI 10.1021/bi00294a002; ROBERTS AB, 1985, P NATL ACAD SCI USA, V82, P119, DOI 10.1073/pnas.82.1.119; ROFF CF, 1983, BIOCHEM J, V211, P625, DOI 10.1042/bj2110625; SEED B, 1987, NATURE, V329, P840, DOI 10.1038/329840a0; TROWBRIDGE IS, 1974, NATURE, V250, P304, DOI 10.1038/250304a0; TUCKER RF, 1984, SCIENCE, V226, P705, DOI 10.1126/science.6093254; WANG LJ, 1987, CONCANAVALIN A TOOL, P194; WATERFIELD MD, 1981, BIOL BIOMEDICAL APPL, V18, P135; WATERFIELD MD, 1985, PRACTICAL PROTEIN BI, P181; WELLS V, 1985, EXP CELL RES, V159, P27, DOI 10.1016/S0014-4827(85)80034-3; WELLS V, 1983, J CELL PHYSIOL, V117, P148, DOI 10.1002/jcp.1041170203; WELLS V, 1988, J INTERFERON RES, V8, P793, DOI 10.1089/jir.1988.8.793	37	259	268	0	3	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	JAN 11	1991	64	1					91	97		10.1016/0092-8674(91)90211-G	http://dx.doi.org/10.1016/0092-8674(91)90211-G			7	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ET175	1986871				2022-12-24	WOS:A1991ET17500011
J	NIGHTINGALE, SL				NIGHTINGALE, SL			GERIATRIC USE SUBSECTION PROPOSED ON DRUG LABELING	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material											NIGHTINGALE, SL (corresponding author), US FDA,OFF HLTH AFFAIRS,PARKLAWN BLDG,5600 FISHERS LN,ROCKVILLE,MD 20857, USA.								0	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	1991	265	2					182	182						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EQ602	1984138				2022-12-24	WOS:A1991EQ60200008
J	HUDSON, CP				HUDSON, CP			HOW AIDS FORCES REAPPRAISAL OF HEPATITIS-B VIRUS CONTROL IN SUB-SAHARAN AFRICA	LANCET			English	Editorial Material											HUDSON, CP (corresponding author), UNIV LONDON LONDON SCH HYG & TROP MED,DEPT EPIDEMIOL & POPULAT SCI,KEPPEL ST,LONDON WC1E 7HT,ENGLAND.							ALTER MJ, 1986, JAMA-J AM MED ASSOC, V256, P1307, DOI 10.1001/jama.256.10.1307; Barin F, 1981, Prog Med Virol, V27, P148; BEASLEY RP, 1977, AM J EPIDEMIOL, V105, P94, DOI 10.1093/oxfordjournals.aje.a112370; BEASLEY RP, 1981, LANCET, V2, P1129; BYROM NA, 1973, J INFECT DIS, V128, P259, DOI 10.1093/infdis/128.2.259; COURSAGET P, 1987, J MED VIROL, V22, P1, DOI 10.1002/jmv.1890220102; FOSTER O, 1984, LANCET, V1, P576; HSU HY, 1986, J MED VIROL, V18, P301, DOI 10.1002/jmv.1890180402; HUDSON CP, 1988, AIDS, V2, P255, DOI 10.1097/00002030-198808000-00003; JUPP PG, 1983, S AFR MED J, V63, P77; KARIM SA, 1988, INT J EPIDEMIOL, V17, P168; KARIM SSA, 1989, AM J PUBLIC HEALTH, V79, P893, DOI 10.2105/AJPH.79.7.893; MARINIER E, 1985, J PEDIATR-US, V106, P843, DOI 10.1016/S0022-3476(85)80371-1; MCCARTHY MC, 1989, AIDS, V3, P725, DOI 10.1097/00002030-198911000-00006; MERTENS T, 1989, INFECTION, V17, P4, DOI 10.1007/BF01643488; NASIDI A, 1986, INT J EPIDEMIOL, V15, P274, DOI 10.1093/ije/15.2.274; OGSTON CW, 1981, J MED ENTOMOL, V18, P107, DOI 10.1093/jmedent/18.2.107; PARKIN DM, 1988, INT J CANCER, V41, P184, DOI 10.1002/ijc.2910410205; PRINCE AM, 1984, IARC SCI PUBL, V63, P337; RUSTGI VK, 1987, GASTROENTEROL CLIN N, V16, P545; SMITH PG, 1988, T ROY SOC TROP MED H, V82, P753, DOI 10.1016/0035-9203(88)90226-X; SOBESLAVSKY O, 1980, B WORLD HEALTH ORGAN, V58, P621; TABOR E, 1985, J MED VIROL, V15, P113, DOI 10.1002/jmv.1890150203; TERMEULEN J, 1989, EUR J EPIDEMIOL, V5, P158, DOI 10.1007/BF00156822; TSEGA E, 1986, AM J EPIDEMIOL, V123, P344, DOI 10.1093/oxfordjournals.aje.a114243; Van de Perre P, 1987, Eur J Epidemiol, V3, P14, DOI 10.1007/BF00145066; WHITTLE HC, 1983, LANCET, V1, P1203; 1987, CANCER RES, V47, P5782; 1989, LANCET, V1, P1057	29	11	11	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 1	1990	336	8727					1364	1367		10.1016/0140-6736(90)92906-X	http://dx.doi.org/10.1016/0140-6736(90)92906-X			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL365	1978174				2022-12-24	WOS:A1990EL36500014
J	LISSIN, NM; VENYAMINOV, SY; GIRSHOVICH, AS				LISSIN, NM; VENYAMINOV, SY; GIRSHOVICH, AS			(MG-ATP)-DEPENDENT SELF-ASSEMBLY OF MOLECULAR CHAPERONE GROEL	NATURE			English	Article									ACAD SCI USSR, INST PROT RES, PUSHCHINO 142292, USSR	Russian Academy of Sciences								BOCHKAREVA ES, 1988, NATURE, V336, P254, DOI 10.1038/336254a0; CHANDRASEKHAR GN, 1986, J BIOL CHEM, V261, P2414; ELLIS J, 1987, NATURE, V328, P378, DOI 10.1038/328378a0; ELLIS RJ, 1989, TRENDS BIOCHEM SCI, V14, P339, DOI 10.1016/0968-0004(89)90168-0; FRIEDMAN DI, 1984, MICROBIOL REV, V48, P299, DOI 10.1128/MMBR.48.4.299-325.1984; GOLOUBINOFF P, 1989, NATURE, V342, P884, DOI 10.1038/342884a0; GOLOUBINOFF P, 1989, NATURE, V337, P44, DOI 10.1038/337044a0; HEMMINGSEN SM, 1988, NATURE, V333, P330, DOI 10.1038/333330a0; HENDRIX RW, 1979, J MOL BIOL, V129, P375, DOI 10.1016/0022-2836(79)90502-3; HOHN T, 1979, J MOL BIOL, V129, P359, DOI 10.1016/0022-2836(79)90501-1; ISHIHAMA A, 1976, J BIOCHEM-TOKYO, V79, P927, DOI 10.1093/oxfordjournals.jbchem.a131160; JAENICKE L, 1974, ANAL BIOCHEM, V61, P623, DOI 10.1016/0003-2697(74)90429-1; KASSENBROCK CK, 1989, EMBO J, V8, P1461, DOI 10.1002/j.1460-2075.1989.tb03529.x; LAMINET AA, 1990, EMBO J, V9, P2315, DOI 10.1002/j.1460-2075.1990.tb07403.x; LECKER S, 1989, EMBO J, V8, P2703, DOI 10.1002/j.1460-2075.1989.tb08411.x; MCLELLAN T, 1982, ANAL BIOCHEM, V126, P94, DOI 10.1016/0003-2697(82)90113-0; OROTHMAN JE, 1989, CELL, V59, P591; PELHAM HRB, 1986, CELL, V46, P959, DOI 10.1016/0092-8674(86)90693-8; PRIVALOV PL, 1988, ADV PROTEIN CHEM, V39, P191; PRIVALOV PL, 1989, ANNU REV BIOPHYS BIO, V18, P47, DOI 10.1146/annurev.biophys.18.1.47; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; VANDYK TK, 1989, NATURE, V342, P451, DOI 10.1038/342451a0	22	122	126	0	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 22	1990	348	6299					339	342		10.1038/348339a0	http://dx.doi.org/10.1038/348339a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EJ955	1979147				2022-12-24	WOS:A1990EJ95500062
J	SARREL, PM; LINDSAY, DC; POOLEWILSON, PA; COLLINS, P				SARREL, PM; LINDSAY, DC; POOLEWILSON, PA; COLLINS, P			HYPOTHESIS - INHIBITION OF ENDOTHELIUM-DERIVED RELAXING FACTOR BY HEMOGLOBIN IN THE PATHOGENESIS OF PREECLAMPSIA	LANCET			English	Article									NATL HEART & LUNG INST,DEPT CARDIAC MED,LONDON SW3 6LY,ENGLAND	Imperial College London	SARREL, PM (corresponding author), YALE UNIV,SCH MED,333 CEDAR ST,NEW HAVEN,CT 06510, USA.							ALTCHEK A, 1964, CIRCULATION S2, V29, P43; BELLAR FK, 1973, THROMB DIATH HAEMO, V29, P263; CAMPBELL DM, 1983, CLIN EXP HYPERTENS B, V2, P163, DOI 10.3109/10641958309023468; CUNNINGHAM FG, 1985, AM J OBSTET GYNECOL, V153, P358, DOI 10.1016/0002-9378(85)90071-7; DEVENUTO F, 1969, BIOCHIM BIOPHYS ACTA, V193, P36, DOI 10.1016/0005-2736(69)90056-X; DUKES PP, 1961, ENDOCRINOLOGY, V69, P21, DOI 10.1210/endo-69-1-21; EDWARDS DH, 1986, CARDIOVASC RES, V20, P549, DOI 10.1093/cvr/20.8.549; GARN SM, 1988, NEW ENGL J MED, V318, P783; GRIFFITH TM, 1988, J AM COLL CARDIOL, V12, P797, DOI 10.1016/0735-1097(88)90324-5; KITZMILL.JL, 1974, AM J OBSTET GYNECOL, V118, P362, DOI 10.1016/S0002-9378(16)33794-2; KNOTTNERUS JA, 1986, LANCET, V2, P282; MAGNESS RR, 1989, AM J PHYSIOL, V256, pE536, DOI 10.1152/ajpendo.1989.256.4.E536; MATTHEWS JD, 1975, LANCET, V2, P409; MYERS PR, 1990, NATURE, V345, P161, DOI 10.1038/345161a0; PRITCHARD JA, 1954, NEW ENGL J MED, V250, P89, DOI 10.1056/NEJM195401212500301; RAFFERTY TD, 1980, AM J OBSTET GYNECOL, V138, P263, DOI 10.1016/0002-9378(80)90246-X; ROBERTS JM, 1989, AM J OBSTET GYNECOL, V161, P1200, DOI 10.1016/0002-9378(89)90665-0; SCHIFF E, 1989, NEW ENGL J MED, V321, P351, DOI 10.1056/NEJM198908103210603; SCHNEIDER CL, 1951, J OBSTET GYN BRIT EM, V58, P538; SKAJAA KR, 1929, ACTA OBSTETR ET GYNECOL SCANDINAVICA, V8, P371; TODA N, 1990, AM J PHYSIOL, V258, pH57, DOI 10.1152/ajpheart.1990.258.1.H57; VALLANCE P, 1989, LANCET, V2, P997; WEINSTEIN L, 1982, AM J OBSTET GYNECOL, V142, P159, DOI 10.1016/S0002-9378(16)32330-4	23	53	53	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 27	1990	336	8722					1030	1032		10.1016/0140-6736(90)92490-9	http://dx.doi.org/10.1016/0140-6736(90)92490-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF076	1977020				2022-12-24	WOS:A1990EF07600005
J	COLES, C; THOMPSON, AM; ELDER, PA; COHEN, BB; MACKENZIE, IM; CRANSTON, G; CHETTY, U; MACKAY, J; MACDONALD, M; NAKAMURA, Y; HOYHEIM, B; STEEL, CM				COLES, C; THOMPSON, AM; ELDER, PA; COHEN, BB; MACKENZIE, IM; CRANSTON, G; CHETTY, U; MACKAY, J; MACDONALD, M; NAKAMURA, Y; HOYHEIM, B; STEEL, CM			EVIDENCE IMPLICATING AT LEAST 2 GENES ON CHROMOSOME-17P IN BREAST CARCINOGENESIS	LANCET			English	Article									WESTERN GEN HOSP,MRC,HUMAN GENET UNIT,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND; ROYAL INFIRM,DEPT SURG,EDINBURGH EH3 9HB,MIDLOTHIAN,SCOTLAND; INST CANC RES,DEPT BIOCHEM,TOKYO,JAPAN; UNIV UTAH,MED CTR,HOWARD HUGHES MED INST,SALT LAKE CITY,UT 84112	University of Edinburgh; Royal Infirmary of Edinburgh; Japanese Foundation for Cancer Research; Howard Hughes Medical Institute; Utah System of Higher Education; University of Utah								ALI IU, 1987, SCIENCE, V238, P185, DOI 10.1126/science.3659909; ASHTONRICKARDT PG, 1989, ONCOGENE, V4, P1169; BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; DEVILEE P, 1990, CYTOGENET CELL GENET, V53, P52, DOI 10.1159/000132893; DEVILEE P, 1989, GENOMICS, V5, P554, DOI 10.1016/0888-7543(89)90023-2; ECCLES DM, 1990, ONCOGENE, V5, P1599; HOYHEIM B, 1989, NUCLEIC ACIDS RES, V17, P88; IGGO R, 1990, LANCET, V335, P675, DOI 10.1016/0140-6736(90)90801-B; KNUDSON AG, 1985, CANCER RES, V45, P1437; LEE JH, 1989, CANCER GENET CYTOGEN, V41, P243; LYNCH HT, 1976, CANCER GENETICS; MACKAY J, 1988, LANCET, V2, P1384; Nakamura Y, 1988, GENOMICS, V2, P302, DOI 10.1016/0888-7543(88)90018-3; NIGRO JM, 1989, NATURE, V342, P705, DOI 10.1038/342705a0; PROSSER J, 1990, ONCOGENE, V5, P1573; TAKAHASHI T, 1989, SCIENCE, V246, P491, DOI 10.1126/science.2554494; THOMPSON AM, 1990, BRIT J CANCER, V61, P74, DOI 10.1038/bjc.1990.17; TOGUCHIDA J, 1989, CANCER RES, V49, P6247	18	225	225	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 29	1990	336	8718					761	763		10.1016/0140-6736(90)93236-I	http://dx.doi.org/10.1016/0140-6736(90)93236-I			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB077	1976143				2022-12-24	WOS:A1990EB07700001
J	WEIJMER, MC; NEERING, H; WELTEN, C				WEIJMER, MC; NEERING, H; WELTEN, C			PRELIMINARY-REPORT - FURUNCULOSIS AND HYPOFERREMIA	LANCET			English	Article									ST ELIZABETH GROOTE GASTHUIS,DEPT DERMATOL,HAARLEM,NETHERLANDS; ST ELIZABETH GROOTE GASTHUIS,DEPT INTERNAL MED,HAARLEM,NETHERLANDS; ROYAL NETHERLANDS NAVY HOSP,DEPT DERMATOL,OVERVEEN,NETHERLANDS		WEIJMER, MC (corresponding author), SOPHIA HOSP,DEPT INTERNAL MED,POB 10400,8000 GK ZWOLLE,NETHERLANDS.							ANDELMAN MB, 1966, AM J DIS CHILD, V111, P45, DOI 10.1001/archpedi.1966.02090040081007; BAGGS RB, 1973, J NUTR, V103, P1554, DOI 10.1093/jn/103.11.1554; BONDESTAM M, 1985, ACTA PAEDIATR SCAND, V74, P515, DOI 10.1111/j.1651-2227.1985.tb11020.x; BUCKLEY RH, 1975, J PEDIATR-US, V86, P993, DOI 10.1016/S0022-3476(75)80282-4; BULLEN JJ, 1981, REV INFECT DIS, V3, P1127; CHANDRA RK, 1973, ARCH DIS CHILD, V48, P864, DOI 10.1136/adc.48.11.864; CHANDRA RK, 1975, J PEDIATR-US, V86, P899, DOI 10.1016/S0022-3476(75)80221-6; DAHL MV, 1987, SOUTHERN MED J, V80, P352, DOI 10.1097/00007611-198703000-00020; EHRHARDT P, 1986, BMJ-BRIT MED J, V292, P90, DOI 10.1136/bmj.292.6513.90; GRIFFITHS E, 1983, MED MICROBIOLOGY, V0003, P00153; HIGASHI O, 1967, TOHOKU J EXP MED, V93, P105, DOI 10.1620/tjem.93.105; KADURUGAMUWA JL, 1987, J CLIN MICROBIOL, V25, P849, DOI 10.1128/JCM.25.5.849-855.1987; KATSUSHIMA N, 1963, TOHOKU J EXP MED, V79, P250, DOI 10.1620/tjem.79.250; KLEBANOFF SJ, 1970, SCIENCE, V169, P1095, DOI 10.1126/science.169.3950.1095; LAFORCE FM, 1986, J INFECT DIS, V154, P959, DOI 10.1093/infdis/154.6.959; LIKEHITE V, 1976, BRIT J HAEMATOL, V34, P251; LUKENS JN, 1975, AM J DIS CHILD, V129, P160, DOI 10.1001/archpedi.1975.02120390004002; MACDOUGALL LG, 1975, J PEDIATR-US, V86, P833, DOI 10.1016/S0022-3476(75)80211-3; MARCELIS JH, 1978, A VAN LEEUW J MICROB, V44, P257, DOI 10.1007/BF00394304; MASKELL JP, 1980, A VAN LEEUW J MICROB, V46, P343, DOI 10.1007/BF00421981; PRASAD JS, 1979, AM J CLIN NUTR, V32, P550, DOI 10.1093/ajcn/32.3.550; WEINBERG ED, 1978, MICROBIOL REV, V42, P45, DOI 10.1128/MMBR.42.1.45-66.1978; ZUROVSKY Y, 1987, CAN J PHYSIOL PHARM, V65, P1402, DOI 10.1139/y87-220; 1985, LANCET, V2, P81	24	15	15	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	AUG 25	1990	336	8713					464	466		10.1016/0140-6736(90)92013-8	http://dx.doi.org/10.1016/0140-6736(90)92013-8			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV754	1974991				2022-12-24	WOS:A1990DV75400005
J	ANTEQUERA, F; BOYES, J; BIRD, A				ANTEQUERA, F; BOYES, J; BIRD, A			HIGH-LEVELS OF DENOVO METHYLATION AND ALTERED CHROMATIN STRUCTURE AT CPG ISLANDS IN CELL-LINES	CELL			English	Article											ANTEQUERA, F (corresponding author), RES INST MOLEC PATHOL,DR BOHR GASSE 7,A-1030 VIENNA,AUSTRIA.		Fong, Kwun M/G-6369-2010; Antequera, Francisco/B-1115-2017	Antequera, Francisco/0000-0003-2623-4131; Boyes, Joan/0000-0002-8705-9827; Bird, Adrian/0000-0002-8600-0372				ANDRULIS IL, 1989, MOL CELL BIOL, V9, P2922, DOI 10.1128/MCB.9.7.2922; ANTEQUERA F, 1989, CELL, V58, P509, DOI 10.1016/0092-8674(89)90431-5; BESTOR T, 1988, J MOL BIOL, V203, P971, DOI 10.1016/0022-2836(88)90122-2; BIRD A, 1985, CELL, V40, P91, DOI 10.1016/0092-8674(85)90312-5; BIRD AP, 1987, EMBO J, V6, P999, DOI 10.1002/j.1460-2075.1987.tb04851.x; BIRD AP, 1984, NATURE, V307, P503, DOI 10.1038/307503a0; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; BROWN JR, 1985, MOL CELL BIOL, V5, P1694, DOI 10.1128/MCB.5.7.1694; BURCH JBE, 1983, CELL, V33, P65, DOI 10.1016/0092-8674(83)90335-5; BUSSLINGER M, 1983, GLOBIN GENE EXPRESSI, P193; CAROTTI D, 1989, NUCLEIC ACIDS RES, V17, P9219, DOI 10.1093/nar/17.22.9219; COOPER DN, 1983, NUCLEIC ACIDS RES, V11, P647, DOI 10.1093/nar/11.3.647; COTTEN M, 1989, MOL CELL BIOL, V9, P4479, DOI 10.1128/MCB.9.10.4479; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; DOERFLER W, 1983, ANNU REV BIOCHEM, V52, P93, DOI 10.1146/annurev.bi.52.070183.000521; DONOFRIO C, 1985, EMBO J, V4, P1981, DOI 10.1002/j.1460-2075.1985.tb03881.x; FEINBERG AP, 1984, ANAL BIOCHEM, V137, P266; GERBERHUBER S, 1983, CELL, V33, P43, DOI 10.1016/0092-8674(83)90333-1; GILMAN M, 1987, CURRENT PROTOCOLS MO; GOUNARI F, 1987, GENE DEV, V1, P899, DOI 10.1101/gad.1.9.899; HANSEN RS, 1988, MOL CELL BIOL, V8, P4692, DOI 10.1128/MCB.8.11.4692; HARRIS M, 1984, SOMAT CELL MOLEC GEN, V10, P615, DOI 10.1007/BF01535227; HARRIS M, 1984, SOMAT CELL MOLEC GEN, V10, P275, DOI 10.1007/BF01535249; HARRIS M, 1982, CELL, V29, P483, DOI 10.1016/0092-8674(82)90165-9; HOLLIDAY R, 1987, SCIENCE, V238, P163, DOI 10.1126/science.3310230; Jahner D., 1984, DNA METHYLATION BIOC, P189; JONES PA, 1980, CELL, V20, P85, DOI 10.1016/0092-8674(80)90237-8; JONES PA, 1990, PHILOS T R SOC B, V326, P277, DOI 10.1098/rstb.1990.0011; KASLOW DC, 1987, P NATL ACAD SCI USA, V84, P6210, DOI 10.1073/pnas.84.17.6210; KEENEY JB, 1989, P NATL ACAD SCI USA, V86, P6288, DOI 10.1073/pnas.86.16.6288; KELLEY DE, 1988, MOL CELL BIOL, V8, P930, DOI 10.1128/MCB.8.2.930; KESHET I, 1986, CELL, V44, P535, DOI 10.1016/0092-8674(86)90263-1; KESHET I, 1985, P NATL ACAD SCI USA, V82, P2560, DOI 10.1073/pnas.82.9.2560; KOLSTO AB, 1986, NUCLEIC ACIDS RES, V14, P9667; KRATZER PG, 1983, CELL, V33, P37, DOI 10.1016/0092-8674(83)90332-X; LAVIA P, 1987, EMBO J, V6, P2773, DOI 10.1002/j.1460-2075.1987.tb02572.x; LEVYWILSON B, 1989, J BIOL CHEM, V264, P9891; LLOYD J, 1987, GENE DEV, V1, P594, DOI 10.1101/gad.1.6.594; LOCK LF, 1987, CELL, V48, P39, DOI 10.1016/0092-8674(87)90353-9; MCKEON C, 1982, CELL, V29, P203, DOI 10.1016/0092-8674(82)90104-0; MEEHAN RR, 1989, CELL, V58, P499, DOI 10.1016/0092-8674(89)90430-3; Mellor A L, 1986, Oxf Surv Eukaryot Genes, V3, P95; MIGEON BR, 1988, NATURE, V335, P93, DOI 10.1038/335093a0; MOHANDAS T, 1981, SCIENCE, V211, P393, DOI 10.1126/science.6164095; OLIVA R, 1989, J BIOL CHEM, V264, P12472; OSHIMA RG, 1988, GENE DEV, V2, P505, DOI 10.1101/gad.2.5.505; SHIMADA T, 1985, J BIOL CHEM, V260, P2468; SNELLER MC, 1987, J IMMUNOL, V138, P3505; SPANOPOULOU E, 1988, MOL CELL BIOL, V8, P3847, DOI 10.1128/MCB.8.9.3847; STEGLICH C, 1985, SOMAT CELL MOLEC GEN, V11, P11, DOI 10.1007/BF01534730; SULLIVAN CH, 1989, MOL CELL BIOL, V9, P3132, DOI 10.1128/MCB.9.7.3132; TANAKA K, 1988, ANNU REV IMMUNOL, V6, P359; TAZI J, 1990, CELL, V60, P909, DOI 10.1016/0092-8674(90)90339-G; TYKOCINSKI ML, 1984, NUCLEIC ACIDS RES, V12, P4385, DOI 10.1093/nar/12.10.4385; VENOLIA L, 1982, P NATL ACAD SCI-BIOL, V79, P2352, DOI 10.1073/pnas.79.7.2352; WOLF SF, 1985, NATURE, V314, P467, DOI 10.1038/314467a0	56	656	679	0	17	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	AUG 10	1990	62	3					503	514		10.1016/0092-8674(90)90015-7	http://dx.doi.org/10.1016/0092-8674(90)90015-7			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DU445	1974172				2022-12-24	WOS:A1990DU44500012
J	GALLI, M; COMFURIUS, P; MAASSEN, C; HEMKER, HC; DEBAETS, MH; VANBREDAVRIESMAN, PJC; BARBUI, T; ZWAAL, RFA; BEVERS, EM				GALLI, M; COMFURIUS, P; MAASSEN, C; HEMKER, HC; DEBAETS, MH; VANBREDAVRIESMAN, PJC; BARBUI, T; ZWAAL, RFA; BEVERS, EM			ANTICARDIOLIPIN ANTIBODIES (ACA) DIRECTED NOT TO CARDIOLIPIN BUT TO A PLASMA-PROTEIN COFACTOR	LANCET			English	Article									STATE UNIV LIMBURG,CARDIOVASC RES INST,DEPT BIOCHEM,POB 616,6200 MD MAASTRICHT,NETHERLANDS; OSPED RIUNITI BERGAMO,DEPT HAEMATOL,I-24100 BERGAMO,ITALY; STATE UNIV LIMBURG,DEPT IMMUNOL,6200 MD MAASTRICHT,NETHERLANDS	Maastricht University; Ospedali Riuniti di Bergamo; Maastricht University				Hemker, Coen/0000-0003-1669-2358				GREEN D, 1983, THROMB HAEMOSTASIS, V49, P144; HARRIS EN, 1983, LANCET, V2, P1211; LECHNER K, 1987, THROMB DIATH HAEMO, P525; LOELIGER A, 1959, THROMB DIATH HAEMOST, V3, P237; LOIZOU S, 1985, CLIN EXP IMMUNOL, V62, P738; MCNEIL HP, 1989, BRIT J HAEMATOL, V73, P506, DOI 10.1111/j.1365-2141.1989.tb00289.x; NIMPF J, 1986, BIOCHIM BIOPHYS ACTA, V884, P142, DOI 10.1016/0304-4165(86)90237-0; PENGO V, 1987, BLOOD, V70, P69; RIVARD GE, 1974, THROMB DIATH HAEMOST, V32, P554, DOI 10.1055/s-0038-1647724; SEDMAK JJ, 1977, ANAL BIOCHEM, V79, P544, DOI 10.1016/0003-2697(77)90428-6; SHAPIRO SS, 1982, PROG HEMOST THROMB, V6, P263; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; YIN ET, 1965, THROMB DIATH HAEMOST, V14, P88	13	1297	1336	1	16	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JUN 30	1990	335	8705					1544	1547		10.1016/0140-6736(90)91374-J	http://dx.doi.org/10.1016/0140-6736(90)91374-J			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL480	1972485	Green Submitted			2022-12-24	WOS:A1990DL48000002
J	GILLIAM, TC; BRZUSTOWICZ, LM; CASTILLA, LH; LEHNER, T; PENCHASZADEH, GK; DANIELS, RJ; BYTH, BC; KNOWLES, J; HISLOP, JE; SHAPIRA, Y; DUBOWITZ, V; MUNSAT, TL; OTT, J; DAVIES, KE				GILLIAM, TC; BRZUSTOWICZ, LM; CASTILLA, LH; LEHNER, T; PENCHASZADEH, GK; DANIELS, RJ; BYTH, BC; KNOWLES, J; HISLOP, JE; SHAPIRA, Y; DUBOWITZ, V; MUNSAT, TL; OTT, J; DAVIES, KE			GENETIC HOMOGENEITY BETWEEN ACUTE AND CHRONIC FORMS OF SPINAL MUSCULAR-ATROPHY	NATURE			English	Article									COLUMBIA UNIV,DEPT NEUROL,NEW YORK,NY 10032; COLUMBIA UNIV,DEPT PSYCHIAT GENET & DEV,NEW YORK,NY 10032; NEW YORK STATE PSYCHIAT INST & HOSP,NEW YORK,NY 10032; JOHN RADCLIFFE HOSP,INST MOLEC MED,OXFORD OX3 9DU,ENGLAND; HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,DEPT PAEDIAT,LONDON W12 0HS,ENGLAND; HADASSA HOSP,IL-91240 JERUSALEM,ISRAEL; TUFTS UNIV,NEW ENGLAND MED CTR,DEPT NEUROL,BOSTON,MA 02111	Columbia University; Columbia University; New York State Psychiatry Institute; University of Oxford; Imperial College London; Tufts Medical Center; Tufts University	GILLIAM, TC (corresponding author), COLUMBIA UNIV,DEPT PSYCHIAT,NEW YORK,NY 10032, USA.							Brooke MH, 1985, CLIN VIEW NEUROMUSCU, P36; BRZUSTOWICZ LM, 1990, NATURE, V344, P540, DOI 10.1038/344540a0; Dubowitz V., 1978, MUSCLE DISORDERS CHI, P146; DUBOWITZ V, 1989, COLOUR ATLAS MUSCLE; EMERY AEH, 1976, J NEUROL SCI, V30, P375, DOI 10.1016/0022-510X(76)90141-6; GILLIAM TC, 1989, GENOMICS, V5, P940, DOI 10.1016/0888-7543(89)90138-9; KEATS B, 1989, CYTOGENET CELL GENET, V51, P459, DOI 10.1159/000132805; LANDER ES, 1987, SCIENCE, V236, P1567, DOI 10.1126/science.2884728; LATHROP GM, 1984, P NATL ACAD SCI-BIOL, V81, P3443, DOI 10.1073/pnas.81.11.3443; LEPPERT M, 1987, SCIENCE, V238, P1411, DOI 10.1126/science.3479843; MUNSAT TL, 1969, BRAIN, V92, P9, DOI 10.1093/brain/92.1.9; OTT J, 1985, ANAL HUMAN GENETIC L; PEARN J, 1978, J MED GENET, V15, P409, DOI 10.1136/jmg.15.6.409; Pearn J H, 1982, Adv Neurol, V36, P121; PEARN JH, 1973, J MED GENET, V10, P260, DOI 10.1136/jmg.10.3.260; SMITH CAB, 1953, J R STAT SOC B, V15, P153; WINSOR EJ, 1971, J MED GENET, V8, P143, DOI 10.1136/jmg.8.2.143	17	313	316	0	6	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUN 28	1990	345	6278					823	825		10.1038/345823a0	http://dx.doi.org/10.1038/345823a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DL646	1972783				2022-12-24	WOS:A1990DL64600063
J	HARMER, AW; RIGDEN, SPA; KOFFMAN, CG; WELSH, KI				HARMER, AW; RIGDEN, SPA; KOFFMAN, CG; WELSH, KI			PRELIMINARY-REPORT - DRAMATIC RISE IN RENAL-ALLOGRAFT FAILURE RATE	LANCET			English	Article									GUYS & ST THOMAS HOSP,DEPT MOLEC IMMUNOGENET,LONDON SE1 9RT,ENGLAND; GUYS & ST THOMAS HOSP,PAEDIAT RENAL UNIT,LONDON SE1 9RT,ENGLAND	Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust								CERILLI J, 1985, TRANSPLANTATION, V39, P286, DOI 10.1097/00007890-198503000-00016; CLARK AGB, 1989, TRANSPLANT P, V21, P1685; HAISCH C, 1985, TRANSPLANT P, V18, P128; HARMER AW, IN PRESS TRANSPLANT; KALIL J, 1989, TRANSPLANT P, V21, P711; KOFFMAN CG, 1989, TRANSPLANT P, V21, P2001; TAUBE D, 1989, TRANSPLANT P, V21, P694	7	4	4	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	MAY 19	1990	335	8699					1184	1185		10.1016/0140-6736(90)92698-H	http://dx.doi.org/10.1016/0140-6736(90)92698-H			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE448	1971037				2022-12-24	WOS:A1990DE44800005
J	MAKRIS, M; PRESTON, FE; TRIGER, DR; UNDERWOOD, JCE; CHOO, QL; KUO, G; HOUGHTON, M				MAKRIS, M; PRESTON, FE; TRIGER, DR; UNDERWOOD, JCE; CHOO, QL; KUO, G; HOUGHTON, M			HEPATITIS-C ANTIBODY AND CHRONIC LIVER-DISEASE IN HEMOPHILIA	LANCET			English	Article									ROYAL HALLAMSHIRE HOSP,DEPT HAEMATOL,SHEFFIELD S10 2JF,S YORKSHIRE,ENGLAND; CHIRON CORP,EMERYVILLE,CA; ROYAL HALLAMSHIRE HOSP,DEPT MED,SHEFFIELD S10 2JF,S YORKSHIRE,ENGLAND; ROYAL HALLAMSHIRE HOSP,DEPT PATHOL,SHEFFIELD S10 2JF,S YORKSHIRE,ENGLAND	University of Sheffield; Novartis; University of Sheffield; University of Sheffield			Makris, Mike/A-2772-2011	Makris, Mike/0000-0001-7622-7939; Houghton, Michael/0000-0003-3762-6771				BAMBER M, 1981, GUT, V22, P854, DOI 10.1136/gut.22.10.854; BAMBER MAY, 1981, J CLIN PATHOL, V34, P1175, DOI 10.1136/jcp.34.10.1175; CEDERBAUM AI, 1982, ARCH INTERN MED, V142, P481, DOI 10.1001/archinte.142.3.481; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; COLOMBO M, 1985, LANCET, V2, P1; CONTRERAS M, 1989, LANCET, V2, P505; DIENES HP, 1982, HEPATOLOGY, V2, P562; ESTEBAN JI, 1989, LANCET, V2, P294; EYSTER ME, 1985, BLOOD, V66, P1317; FLETCHER ML, 1983, BRIT MED J, V287, P1754, DOI 10.1136/bmj.287.6407.1754; HAY CRM, 1985, LANCET, V1, P1495; KERNOFF PBA, 1987, BRIT J HAEMATOL, V67, P207, DOI 10.1111/j.1365-2141.1987.tb02328.x; KUO G, 1989, SCIENCE, V244, P362, DOI 10.1126/science.2496467; MARTIN P, 1989, Gastroenterology, V96, pA627; MORTIMER PP, 1989, LANCET, V2, P798; NOEL L, 1989, LANCET, V2, P560; PRESTON FE, 1985, LANCET, V2, P213; ROGGENDORF M, 1989, LANCET, V2, P324; SCHMID M, 1982, Liver, V2, P61	19	189	190	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	MAY 12	1990	335	8698					1117	1119		10.1016/0140-6736(90)91124-S	http://dx.doi.org/10.1016/0140-6736(90)91124-S			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DC929	1971863				2022-12-24	WOS:A1990DC92900003
J	BUCHMEIER, NA; HEFFRON, F				BUCHMEIER, NA; HEFFRON, F			INDUCTION OF SALMONELLA STRESS PROTEINS UPON INFECTION OF MACROPHAGES	SCIENCE			English	Article											BUCHMEIER, NA (corresponding author), SCRIPPS CLIN & RES FDN,RES INST,DEPT MOLEC BIOL,LA JOLLA,CA 92037, USA.							ALIABADI Z, 1988, J BACTERIOL, V170, P842, DOI 10.1128/jb.170.2.842-851.1988; BUCHMEIER N, UNPUB; BUCHMEIER NA, 1989, INFECT IMMUN, V57, P1; CHRISTMAN MF, 1985, CELL, V41, P753, DOI 10.1016/S0092-8674(85)80056-8; FAYET O, 1989, J BACTERIOL, V171, P1379, DOI 10.1128/JB.171.3.1379-1385.1989; FIELDS PI, 1989, SCIENCE, V243, P1059, DOI 10.1126/science.2646710; FIELDS PI, 1986, P NATL ACAD SCI USA, V83, P5189, DOI 10.1073/pnas.83.14.5189; GARRELS JI, 1983, METHOD ENZYMOL, V100, P411; GERMANIER R, 1972, INFECT IMMUN, V5, P792, DOI 10.1128/IAI.5.5.792-797.1972; GROISMAN EA, 1989, P NATL ACAD SCI USA, V86, P7077, DOI 10.1073/pnas.86.18.7077; HARDING CV, 1989, J IMMUNOL, V142, P12; HARLOW E, 1988, ANTIBODIES LABORATOR, P490; HEDSTROM R, 1987, J EXP MED, V165, P1430, DOI 10.1084/jem.165.5.1430; HEMMINGSEN SM, 1988, NATURE, V333, P330, DOI 10.1038/333330a0; HOFFMAN PS, 1989, INFECT IMMUN, V57, P1731, DOI 10.1128/IAI.57.6.1731-1739.1989; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; LISSNER CR, 1983, J IMMUNOL, V131, P3006; MILLER JF, 1989, SCIENCE, V243, P916, DOI 10.1126/science.2537530; MILLER SI, 1989, P NATL ACAD SCI USA, V86, P5054, DOI 10.1073/pnas.86.13.5054; MORGAN RW, 1986, P NATL ACAD SCI USA, V83, P8059, DOI 10.1073/pnas.83.21.8059; NATHAN CF, 1983, T ROY SOC TROP MED H, V77, P620, DOI 10.1016/0035-9203(83)90190-6; SHINNICK TM, 1988, INFECT IMMUN, V56, P446, DOI 10.1128/IAI.56.2.446-451.1988; VODKIN MH, 1988, J BACTERIOL, V170, P1227, DOI 10.1128/jb.170.3.1227-1234.1988; YOUNG D, 1988, P NATL ACAD SCI USA, V85, P4267, DOI 10.1073/pnas.85.12.4267	24	399	412	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	MAY 11	1990	248	4956					730	732		10.1126/science.1970672	http://dx.doi.org/10.1126/science.1970672			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC926	1970672				2022-12-24	WOS:A1990DC92600033
J	LOPEZ, CD; YOST, CS; PRUSINER, SB; MYERS, RM; LINGAPPA, VR				LOPEZ, CD; YOST, CS; PRUSINER, SB; MYERS, RM; LINGAPPA, VR			UNUSUAL TOPOGENIC SEQUENCE DIRECTS PRION PROTEIN BIOGENESIS	SCIENCE			English	Article									UNIV CALIF SAN FRANCISCO,DEPT ANESTHESIA,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT NEUROL,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT BIOCHEM & BIOPHYS,SAN FRANCISCO,CA 94143; UNIV CALIF SAN FRANCISCO,DEPT MED,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	LOPEZ, CD (corresponding author), UNIV CALIF SAN FRANCISCO,DEPT PHYSIOL,SAN FRANCISCO,CA 94143, USA.			Lingappa, Vishwanath R./0000-0003-0962-6571	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS014069, P50NS014069] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG002132] Funding Source: NIH RePORTER; NIA NIH HHS [AG02132] Funding Source: Medline; NINDS NIH HHS [NS14069] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ADAMS GA, 1985, CELL, V41, P1007, DOI 10.1016/S0092-8674(85)80081-7; BASLER K, 1986, CELL, V46, P417, DOI 10.1016/0092-8674(86)90662-8; BLOBEL G, 1980, P NATL ACAD SCI-BIOL, V77, P1496, DOI 10.1073/pnas.77.3.1496; BORCHELT D, IN PRESS J CELL BIOL; CHIRICO WJ, 1988, NATURE, V332, P805, DOI 10.1038/332805a0; CONNOLLY T, 1989, CELL, V57, P599, DOI 10.1016/0092-8674(89)90129-3; DESHAIES RJ, 1988, NATURE, V332, P800, DOI 10.1038/332800a0; EISENBERG D, 1984, ANNU REV BIOCHEM, V53, P595, DOI 10.1146/annurev.bi.53.070184.003115; ERICKSON AH, 1983, METHOD ENZYMOL, V96, P38; HAY B, 1987, BIOCHEMISTRY-US, V26, P8110, DOI 10.1021/bi00399a014; HAY B, 1987, MOL CELL BIOL, V7, P914, DOI 10.1128/MCB.7.2.914; KATZ FN, 1977, P NATL ACAD SCI USA, V74, P3278, DOI 10.1073/pnas.74.8.3278; KATZ FN, 1979, J CELL BIOL, V80, P416, DOI 10.1083/jcb.80.2.416; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LINGAPPA VR, 1978, J BIOL CHEM, V253, P8667; LINGAPPA VR, 1978, P NATL ACAD SCI USA, V75, P2338, DOI 10.1073/pnas.75.5.2338; LOPEZ C, UNPUB; MCKINLEY MP, 1987, DEV BIOL, V121, P105, DOI 10.1016/0012-1606(87)90143-6; MERRICK WC, 1983, METHOD ENZYMOL, V101, P606; MIZE NK, 1986, CELL, V47, P711, DOI 10.1016/0092-8674(86)90514-3; OESCH B, 1985, CELL, V40, P735, DOI 10.1016/0092-8674(85)90333-2; PERARA E, 1986, SCIENCE, V232, P348, DOI 10.1126/science.3961485; PERARA E, 1988, PROTEIN TRANSFER ORG, P3; PRUSINER SB, 1989, ANNU REV MICROBIOL, V43, P345, DOI 10.1146/annurev.mi.43.100189.002021; ROSE JK, 1982, CELL, V30, P753, DOI 10.1016/0092-8674(82)90280-X; ROTHMAN RE, 1988, J BIOL CHEM, V263, P10470; SCECZESNASKORUP.E, 1988, P NATL ACAD SCI USA, V85, P738; SCOTT M, 1989, CELL, V59, P847, DOI 10.1016/0092-8674(89)90608-9; SIEGEL V, 1988, CELL, V52, P39, DOI 10.1016/0092-8674(88)90529-6; STAHL N, 1987, CELL, V51, P229, DOI 10.1016/0092-8674(87)90150-4; STAHL N, 1988, FASEB J A, V2, P989; WEIDMANN M, 1987, NATURE, V328, P830; YOST CS, 1990, NATURE, V343, P669, DOI 10.1038/343669a0; YOST CS, 1983, CELL, V34, P759	34	120	123	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	APR 13	1990	248	4952					226	229		10.1126/science.1970195	http://dx.doi.org/10.1126/science.1970195			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CY827	1970195				2022-12-24	WOS:A1990CY82700039
J	MARLIN, SD; STAUNTON, DE; SPRINGER, TA; STRATOWA, C; SOMMERGRUBER, W; MERLUZZI, VJ				MARLIN, SD; STAUNTON, DE; SPRINGER, TA; STRATOWA, C; SOMMERGRUBER, W; MERLUZZI, VJ			A SOLUBLE FORM OF INTERCELLULAR-ADHESION MOLECULE-1 INHIBITS RHINOVIRUS INFECTION	NATURE			English	Article									CTR BLOOD RES, BOSTON, MA 02115 USA; ERNST BOEHRINGER INST ARZNEIMITTELFORSCH, A-1120 VIENNA, AUSTRIA	Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM)	MARLIN, SD (corresponding author), BOEHRINGER INGELHEIM PHARMACEUT INC, DEPT IMMUNOL, 90 E RIDGE, RIDGEFIELD, CT 06877 USA.							ABRAHAM G, 1984, J VIROL, V51, P340, DOI 10.1128/JVI.51.2.340-345.1984; COLONNO RJ, 1987, POSITIVE STRAND RNA, P92; DUSTIN ML, 1988, IMMUNOL TODAY, V9, P213, DOI 10.1016/0167-5699(88)91216-9; GRAHAM FL, 1973, VIROLOGY, V52, P456, DOI 10.1016/0042-6822(73)90341-3; GREVE JM, 1989, CELL, V56, P839, DOI 10.1016/0092-8674(89)90688-0; KISHIMOTO TK, 1989, ADV IMMUNOL, V46, P149, DOI 10.1016/S0065-2776(08)60653-7; KUNKEL TA, 1985, P NATL ACAD SCI USA, V82, P488, DOI 10.1073/pnas.82.2.488; MARLIN SD, 1987, CELL, V51, P813, DOI 10.1016/0092-8674(87)90104-8; MITCHELL PJ, 1986, MOL CELL BIOL, V6, P425, DOI 10.1128/MCB.6.2.425; MULLIGAN RC, 1981, P NATL ACAD SCI-BIOL, V78, P2072, DOI 10.1073/pnas.78.4.2072; PETERSON A, 1988, CELL, V54, P65, DOI 10.1016/0092-8674(88)90180-8; ROSSMANN MG, 1989, J BIOL CHEM, V264, P14587; ROTHLEIN R, 1986, J IMMUNOL, V137, P1270; ROTHLEIN R, 1988, J IMMUNOL, V141, P1665; SPERBER SJ, 1988, ANTIMICROB AGENTS CH, V32, P409, DOI 10.1128/AAC.32.4.409; SPRINGER TA, 1987, ANNU REV IMMUNOL, V5, P223, DOI 10.1146/annurev.immunol.5.1.223; STAUNTON DE, 1989, CELL, V56, P849, DOI 10.1016/0092-8674(89)90689-2; STAUNTON DE, 1988, CELL, V52, P925, DOI 10.1016/0092-8674(88)90434-5; TOMASSINI JE, 1989, P NATL ACAD SCI USA, V86, P4907, DOI 10.1073/pnas.86.13.4907; WAWRYK SO, 1989, IMMUNOL REV, V108, P135, DOI 10.1111/j.1600-065X.1989.tb00016.x	20	265	302	1	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 1	1990	344	6261					70	72		10.1038/344070a0	http://dx.doi.org/10.1038/344070a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CQ972	1968231				2022-12-24	WOS:A1990CQ97200065
J	PIERCE, JP; GILPIN, E; BURNS, DM; WHALEN, E; ROSBROOK, B; SHOPLAND, D; JOHNSON, M				PIERCE, JP; GILPIN, E; BURNS, DM; WHALEN, E; ROSBROOK, B; SHOPLAND, D; JOHNSON, M			DOES TOBACCO ADVERTISING TARGET YOUNG-PEOPLE TO START SMOKING - EVIDENCE FROM CALIFORNIA	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES; CIGARETTE-SMOKING; TRENDS	Objective. - To evaluate whether tobacco advertising encourages teenagers younger than 18 years to start smoking. Design. - Comparison of 1990 California telephone survey data with data from a 1986 national telephone survey (both used a random-digit dialing system); 95% confidence intervals were calculated. To test our hypothesis, we considered whether the perception of advertising was related to age, whether the pattern of market share across age and sex groups followed the pattern of perceived advertising, and whether changes in market share paralleled changes in advertising as perceived by the youngest age group. Participants. - There were 24296 adults and 5040 teenagers. Results. - The most advertised brands of cigarettes were Marlboro, according to 33.6% of adults and 41.8% of teenagers, and Camel, according to 13.7% of adults and 28.5% of teenagers-named most often by 12- to 13-year-olds (34.2%). The brands that were purchased most often were Marlboro and Camel. Together these were the brands of choice of 79.9% of males and 85% of females aged 12 through 17 years. Marlboro's market share increased in youths and young adults up to age 24 years and then decreased gradually with age; Camel's market share decreased abruptly with age: it was the brand of choice of 24.5% +/- 5.8% of males aged 12 through 17 years but was chosen by only 12.7% +/- 3.6% of males aged 18 through 24 years; for females, 21.7% +/- 13.7% aged 12 through 17 years chose Camels, while only 5.5% +/- 3.2% aged 18 through 24 years preferred this brand. Both Marlboro and Camel brands had a higher market share in California in 1990 compared with that for the United States in 1986. Of interest is that the market share for Camel increased among the younger smokers but was more evenly distributed for Marlboro. Conclusions. - Perception of advertising is higher among young smokers; market-share patterns across age and sex groups follow the perceived advertising patterns; and changes in market share resulting from advertising occur mainly in younger smokers. Cigarette advertising encourages youth to smoke and should be banned.	CALIF DEPT HLTH SERV,TOBACCO CONTROL SECT,SACRAMENTO,CA; NCI,BETHESDA,MD 20892	California Department of Health Care Services; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	PIERCE, JP (corresponding author), UNIV CALIF SAN DIEGO,POPULAT STUDIES CANC PREVENT,2251 SAN DIEGO AVE,SUITE B-111,SAN DIEGO,CA 92110, USA.			Pierce, John/0000-0002-0075-7471				BIRD L, 1991, ADWEEKS MARKETI 0520, P20; BLUM A, 1991, NEW ENGL J MED, V324, P913, DOI 10.1056/NEJM199103283241310; CHAPMAN S, 1989, BRIT J ADDICT, V84, P1267; CHAPMAN S, 1982, AM J PUBLIC HEALTH, V72, P491, DOI 10.2105/AJPH.72.5.491; DAVIS RM, 1987, NEW ENGL J MED, V316, P725, DOI 10.1056/NEJM198703193161206; DOOLITTLE DE, 1991, TOBACCO REP      FEB, P14; Efron Bradley, 1982, JACKKNIFE BOOTSTRAP; FIORE MC, 1989, JAMA-J AM MED ASSOC, V261, P49, DOI 10.1001/jama.261.1.49; GOAD GP, 1991, WALL ST J       0729; GRISOM TE, 1991, WASHINGTON POST 0601, P21; HATZIANDREU EJ, 1990, J NATL CANCER I, V82, P1402, DOI 10.1093/jnci/82.17.1402; KLINTZNER M, 1991, BR J ADDICT, V86, P287; PIERCE JP, 1991, J NATL CANCER I, V83, P1009, DOI 10.1093/jnci/83.14.1009; PIERCE JP, 1990, MED J AUSTRALIA, V152, P113, DOI 10.5694/j.1326-5377.1990.tb125114.x; PIERCE JP, 1989, JAMA-J AM MED ASSOC, V261, P56, DOI 10.1001/jama.261.1.56; PIERCE JP, 1990, SMOKING CESSATION OR; RAFTERY J, 1989, BRIT J ADDICT, V84, P1241; Tye J B, 1987, J Public Health Policy, V8, P492, DOI 10.2307/3342275; WAKSBERG J, 1978, J AM STAT ASSOC, V73, P40, DOI 10.2307/2286513; WARNER KE, 1989, AM J PUBLIC HEALTH, V79, P144, DOI 10.2105/AJPH.79.2.144; WATERSON MJ, 1982, ADVERTISING CIGARETT; 1986, TOBACCO USE 1986 MET; 1988, CDC888406 DEP HLTH H; 1989, CDC898411 DEP HLTH H; 1986, NIH862687 DEP HLTH H; 1990, MMWR, V39, P261	26	197	200	0	14	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 11	1991	266	22					3154	3158		10.1001/jama.266.22.3154	http://dx.doi.org/10.1001/jama.266.22.3154			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GT654	1956103				2022-12-24	WOS:A1991GT65400024
J	BAXT, WG				BAXT, WG			USE OF AN ARTIFICIAL NEURAL NETWORK FOR THE DIAGNOSIS OF MYOCARDIAL-INFARCTION	ANNALS OF INTERNAL MEDICINE			English	Article						MYOCARDIAL INFARCTION; ARTIFICIAL INTELLIGENCE; EMERGENCY MEDICINE; MODELS, THEORETICAL; DIAGNOSIS, COMPUTER-AIDED	RECOGNITION; EMERGENCY; PROTOCOL	Objective: To validate prospectively the use of an artificial neural network to identify myocardial infarction in patients presenting to an emergency department with anterior chest pain. Design: Prospective, blinded testing. Setting: Tertiary university teaching center. Patients: A total of 331 consecutive adult patients presenting with anterior chest pain. Measurements: Diagnostic sensitivity and specificity with regard to the diagnosis of acute myocardial infarction. Main Results: An artificial neural network was trained on clinical pattern sets retrospectively derived from the cases of 351 patients hospitalized with a high likelihood of having myocardial infarction. It was prospectively tested on 331 consecutive patients presenting to an emergency department with anterior chest pain. The ability of the network to distinguish patients with from those without acute myocardial infarction was compared with that of physicians caring for the same patients. The physicians had a diagnostic sensitivity of 77.7% (95% CI, 77.0% to 82.9%) and a diagnostic specificity of 84.7% (CI, 84.0% to 86.4%). The artificial neural network had a sensitivity of 97.2% (CI, 97.2% to 97.5%; P = 0.033) and a specificity of 96.2% (CI, 96.2% to 96.4%; P < 0.001). Conclusion: An artificial neural network trained to identify myocardial infarction in adult patients presenting to an emergency department may be a valuable aid to the clinical diagnosis of myocardial infarction; however, this possibility must be confirmed through prospective testing on a larger patient sample.			BAXT, WG (corresponding author), UNIV CALIF SAN DIEGO, MED CTR, DEPT EMERGENCY MED, 225 DICKINSON ST, 8676, SAN DIEGO, CA 92103 USA.							BAILEY BJR, 1980, TECHNOMETRICS, V22, P583, DOI 10.2307/1268196; BAXT WG, 1991, NEURAL COMPUT, V2, P480; BOUNDS DG, 1990, NEURAL NETWORKS, V3, P583, DOI 10.1016/0893-6080(90)90008-9; CIOS KJ, 1990, IEEE ENG MED BIOL, V9, P58, DOI 10.1109/51.59215; EBERHART RC, 1991, 4TH P ANN IEEE S COM, P298; GALLANT SI, 1988, COMMUN ACM, V31, P152, DOI 10.1145/42372.42377; GOLDMAN L, 1988, NEW ENGL J MED, V318, P797, DOI 10.1056/NEJM198803313181301; HARRISON RF, 1991, P INT JOINT C NEURAL, V1, P1; HIRAIWA A, 1990, IEEE ENG MED BIOL, V9, P39, DOI 10.1109/51.59211; HUDSON DL, 1988, 12TH S COMP APPL MED, V12, P251; KAUFMAN JJ, 1990, IEEE ENG MED BIOL, V9, P23, DOI 10.1109/51.59209; MARCONI L, 1989, P INT JOINT C NEURAL, V2, P577; McClelland J. L., 1988, EXPLORATIONS PARALLE, P121; MCDONALD CJ, 1976, NEW ENGL J MED, V295, P1351, DOI 10.1056/NEJM197612092952405; MULSANT GH, 1988, 12TH S COMP APPL MED, V12, P245; POZEN MW, 1984, NEW ENGL J MED, V310, P1273, DOI 10.1056/NEJM198405173102001; REGGIA JA, 1985, COMPUTERS MED, V2; Rumelhart D. E., 1986, PARALLEL DISTRIBUTED, P318, DOI DOI 10.1016/B978-1-4832-1446-7.50035-2; RUSNAK RA, 1989, ANN EMERG MED, V18, P1029, DOI 10.1016/S0196-0644(89)80924-2; SAITO K, 1988, P IEEE INT C NEURAL, V1, P255; SMITH JW, 1988, 12TH S COMP APPL MED, V12, P261; SZOLOVITS P, 1988, ANN INTERN MED, V108, P80, DOI 10.7326/0003-4819-108-1-80; WEIGEND AS, 1990, PREDICTING FUTURE CO; Widrow G, 1960, CONVENTION RECORD 4, P96; Yoon Y. O., 1989, J NEURAL NETWORK SUM, P43	25	337	346	0	59	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 1	1991	115	11					843	848		10.7326/0003-4819-115-11-843	http://dx.doi.org/10.7326/0003-4819-115-11-843			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR171	1952470				2022-12-24	WOS:A1991GR17100002
J	GRUBB, BP; GERARD, G; ROUSH, K; TEMESYARMOS, P; ELLIOTT, L; HAHN, H; SPANN, C				GRUBB, BP; GERARD, G; ROUSH, K; TEMESYARMOS, P; ELLIOTT, L; HAHN, H; SPANN, C			DIFFERENTIATION OF CONVULSIVE SYNCOPE AND EPILEPSY WITH HEAD-UP TILT TESTING	ANNALS OF INTERNAL MEDICINE			English	Article						SYNCOPE; EPILEPSY; HEAD-UP TILT TABLE; CONVULSIONS; ISOPROTERENOL	NEURALLY MEDIATED HYPOTENSION; UNKNOWN ORIGIN; UNEXPLAINED SYNCOPE; HEALTHY-SUBJECTS; BRADYCARDIA; ISOPROTERENOL; DISOPYRAMIDE; PREVENTION; RECURRENT; RESPONSES	Objective: To evaluate the usefulness of head-upright tilt table testing in the differential diagnosis of convulsive syncope from epileptic seizures in patients with recurrent idiopathic seizure-like episodes. Design: Prospective, nonrandomized study. Setting: Electrophysiology laboratory of a university hospital. Patients: Fifteen patients (8 men and 7 women patients; mean age, 29 +/- 20 years) with recurrent unexplained seizure-like episodes, unresponsive to anti-seizure medication. Measurements: Head-upright tilt table testing with or without isoproterenol infusion. Five patients who were initially tilt positive had a second tilt test with continuous electroencephalographic (EEG) recording. Main Results: Syncope associated with tonic-clonic seizure-like activity occurred in six patients (40%) during the baseline tilt and in four patients (27%) during isoproterenol infusion (total positive tests, 67%). The EEG showed diffuse brain wave slowing (not typical of epileptic seizures) in five of five patients during the convulsive episode. All patients who had positive test results eventually become tilt table negative after therapy, and over a mean follow-up period of 21 +/- 2 months, no further seizure-like episodes have occurred. Conclusion: Upright tilt table testing combined with isoproterenol infusion may be useful to distinguish convulsive syncope from epileptic seizures.			GRUBB, BP (corresponding author), MED COLL OHIO, DIV CARDIOL, 3000 ARLINGTON AVE, POB 10008, TOLEDO, OH 43699 USA.							ABISAMRA F, 1988, PACE, V11, P1202, DOI 10.1111/j.1540-8159.1988.tb03973.x; ALMQUIST A, 1989, NEW ENGL J MED, V320, P346, DOI 10.1056/NEJM198902093200603; BRAHAM J, 1981, ANN NEUROL, V10, P277, DOI 10.1002/ana.410100318; CASTAUT H, 1958, ELECTROECEPHALOGR CL, V10, P607; CHEN MY, 1988, CIRCULATION, V78, P239; CHOSY JJ, 1965, J PSYCHOSOM RES, V9, P189, DOI 10.1016/0022-3999(65)90032-2; DEVINSKY O, 1990, SEMIN NEUROL, V10, P321, DOI 10.1055/s-2008-1063976; DUVOISIN RC, 1962, ARCH NEUROL-CHICAGO, V7, P219, DOI 10.1001/archneur.1962.04210030057008; ENGEL J, 1989, SEIZURES EPILEPSY, P340; EPSTEIN SE, 1968, CIRCULATION, V37, P524, DOI 10.1161/01.CIR.37.4.524; FERGUSON DW, 1983, CIRCULATION, V67, P802, DOI 10.1161/01.CIR.67.4.802; GAMACHE C, 1991, PACE, V14, P663; GASTAUT H, 1957, LANCET, V2, P1018; GASTAUT H, 1974, EPILEPSIES, P815; GLICK G, 1963, AM J MED, V34, P42, DOI 10.1016/0002-9343(63)90037-8; GOLDENBERG IF, 1987, CIRCULATION, V76, P133; GROSSI D, 1987, FUNCT NEUROL, V11, P457; GRUBB BP, 1991, AM J MED, V90, P6, DOI 10.1016/0002-9343(91)90499-N; GRUBB BP, 1991, CIRCULATION, V84, P1157, DOI 10.1161/01.CIR.84.3.1157; GURVITCH AM, 1966, ELECTROEN CLIN NEURO, V21, P355, DOI 10.1016/0013-4694(66)90041-1; HAINSWORTH R, 1988, CLIN SCI, V74, P17, DOI 10.1042/cs0740017; HAUSER WA, 1975, EPILEPSIA, V16, P1, DOI 10.1111/j.1528-1157.1975.tb04721.x; HAUSER WA, 1990, EPILEPSY FREQUENCY C, P21; JAEGER FJ, 1987, CLIN RES, V35, pA832; KLEIN LJ, 1964, AM J MED, V37, P263, DOI 10.1016/0002-9343(64)90010-5; LATHERS CM, 1990, EPILEPSY SUDDEN DEAT, P485; LIN JTY, 1982, ANN NEUROL, V11, P525, DOI 10.1002/ana.410110513; LLOYDSMITH DL, 1958, ELECTROEN CLIN NEURO, V10, P153, DOI 10.1016/0013-4694(58)90111-1; MALONEY JD, 1988, CLEV CLIN J MED, V55, P542, DOI 10.3949/ccjm.55.6.542; MARK AL, 1983, J AM COLL CARDIOL, V1, P90, DOI 10.1016/S0735-1097(83)80014-X; MCLARAN CJ, 1986, BRIT HEART J, V55, P53; MILSTEIN S, 1989, J AM COLL CARDIOL, V14, P1626, DOI 10.1016/0735-1097(89)90006-5; MILSTEIN S, 1989, PACE, V12, P117, DOI 10.1111/pace.1989.12.p1.117; MILSTEIN S, 1990, AM J CARDIOL, V65, P1339, DOI 10.1016/0002-9149(90)91324-Y; MORADY F, 1982, ANN INTERN MED, V96, P337, DOI 10.7326/0003-4819-96-3-337; PEDLEY TA, 1983, EPILEPSIA, V24, pS31, DOI 10.1111/j.1528-1157.1983.tb04641.x; RAVIELE A, 1990, AM J CARDIOL, V65, P1322, DOI 10.1016/0002-9149(90)91321-V; REA RF, 1989, J AM COLL CARDIOL, V14, P1633, DOI 10.1016/0735-1097(89)90007-7; SAPIRE DW, 1983, AM HEART J, V106, P1406; SCHEUER ML, 1990, NEW ENGL J MED, V323, P1468; SHELDON RS, 1991, PACE, V14, P662; SHVARTZ E, 1968, AEROSPACE MED, V39, P1094; SHVARTZ E, 1970, AEROSPACE MED, V41, P253; STRASBERG B, 1989, AM HEART J, V118, P923, DOI 10.1016/0002-8703(89)90225-1; Thoren P, 1979, Rev Physiol Biochem Pharmacol, V86, P1, DOI 10.1007/BFb0031531; VARGAS E, 1984, GERONTOLOGY, V30, P253, DOI 10.1159/000212640; VOGT FB, 1967, AEROSPACE MED, V38, P564; WAXMAN MB, 1989, AM J CARDIOL, V63, P58, DOI 10.1016/0002-9149(89)91076-X	48	142	144	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 1	1991	115	11					871	876		10.7326/0003-4819-115-11-871	http://dx.doi.org/10.7326/0003-4819-115-11-871			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GR171	1952474				2022-12-24	WOS:A1991GR17100006
J	YOUNG, B; HERSCHLAG, D; CECH, TR				YOUNG, B; HERSCHLAG, D; CECH, TR			MUTATIONS IN A NONCONSERVED SEQUENCE OF THE TETRAHYMENA RIBOZYME INCREASE ACTIVITY AND SPECIFICITY	CELL			English	Article							GROUP-I INTRON; SELF-SPLICING RNA; CIRCULARIZED INTERVENING SEQUENCE; THERMOPHILA RIBOZYME; KINETIC DESCRIPTION; RIBONUCLEASE-P; BINDING-SITE; CLEAVAGE; SUBSTRATE; CATALYSIS	The RNA substrate-binding site of the Tetrahymena ribozyme is connected to the catalytic core by the joining region J1/2. Although J1/2 is not conserved among group I introns, small insertions or deletions in this sequence have dramatic effects, enhancing the turnover number and sequence specificity of ribozyme-catalyzed RNA cleavage. Measurements of rate constants for individual steps in the reaction have revealed the basis of these improvements. Ironically, the higher turnover and specificity both result from decreased affinity for RNA, rather than better cleavage. These results provide evidence that the nonconserved J1/2 sequence positions the RNA substrate to optimize tertiary interactions and ensure cleavage at the position corresponding to the 5' splice site. The wild-type RNA is well adapted to its biological function, and its limitations in multiple turnover can be corrected by mutation.	UNIV COLORADO, HOWARD HUGHES MED INST, DEPT MOLEC CELLULAR & DEV, BOULDER, CO 80309 USA; UNIV COLORADO, HOWARD HUGHES MED INST, DEPT CHEM & BIOCHEM, BOULDER, CO 80309 USA	Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder								ALBERY WJ, 1976, BIOCHEMISTRY-US, V15, P5631, DOI 10.1021/bi00670a032; ALTMAN S, 1989, ADV ENZYMOL RAMB, V62, P1; BARFOD ET, 1989, MOL CELL BIOL, V9, P3657, DOI 10.1128/MCB.9.9.3657; BEAUDRY AA, 1990, BIOCHEMISTRY-US, V29, P6534, DOI 10.1021/bi00479a027; BEEN MD, 1991, SCIENCE, V252, P434, DOI 10.1126/science.2017681; BEEN MD, 1986, CELL, V47, P207, DOI 10.1016/0092-8674(86)90443-5; BEEN MD, 1987, COLD SPRING HARB SYM, V52, P147, DOI 10.1101/SQB.1987.052.01.019; BONNEAU PR, 1991, J AM CHEM SOC, V113, P1026, DOI 10.1021/ja00003a043; CECH TR, 1990, ANNU REV BIOCHEM, V59, P543, DOI 10.1146/annurev.bi.59.070190.002551; CECH TR, 1987, SCIENCE, V236, P1532, DOI 10.1126/science.2438771; COUTURE S, 1990, J MOL BIOL, V215, P345, DOI 10.1016/S0022-2836(05)80356-0; DANENBERG PV, 1989, BIOCHEMISTRY-US, V28, P6779, DOI 10.1021/bi00442a035; DOUDNA JA, 1989, P NATL ACAD SCI USA, V86, P7402, DOI 10.1073/pnas.86.19.7402; DOUDNA JA, 1989, NATURE, V339, P519, DOI 10.1038/339519a0; DOWNS WD, 1990, BIOCHEMISTRY-US, V29, P5605, DOI 10.1021/bi00475a027; Fersht A., 1985, ENZYME STRUCTURE MEC; FERSHT AR, 1974, PROC R SOC SER B-BIO, V187, P397, DOI 10.1098/rspb.1974.0084; FREIER SM, 1986, P NATL ACAD SCI USA, V83, P9373, DOI 10.1073/pnas.83.24.9373; GOOD NE, 1966, BIOCHEMISTRY-US, V5, P467, DOI 10.1021/bi00866a011; HERSCHLAG D, 1991, BIOCHEMISTRY-US, V30, P4844, DOI 10.1021/bi00234a003; HERSCHLAG D, 1990, BIOCHEMISTRY-US, V29, P10172, DOI 10.1021/bi00496a004; HERSCHLAG D, 1990, BIOCHEMISTRY-US, V29, P10159, DOI 10.1021/bi00496a003; HERSCHLAG D, 1991, P NATL ACAD SCI USA, V88, P6921, DOI 10.1073/pnas.88.16.6921; HERSCHLAG D, 1990, NATURE, V344, P405, DOI 10.1038/344405a0; JACQUIER A, 1987, CELL, V50, P17, DOI 10.1016/0092-8674(87)90658-1; JENCKS WP, 1975, ADV ENZYMOL RAMB, V43, P219; KUNKEL TA, 1987, METHOD ENZYMOL, V154, P367; MCSWIGGEN JA, 1989, SCIENCE, V244, P679, DOI 10.1126/science.2470150; MICHEL F, 1990, NATURE, V347, P578, DOI 10.1038/347578a0; MICHEL F, 1989, NATURE, V342, P391, DOI 10.1038/342391a0; MICHEL F, 1990, J MOL BIOL, V216, P585, DOI 10.1016/0022-2836(90)90386-Z; MILLIGAN JF, 1987, NUCLEIC ACIDS RES, V15, P8783, DOI 10.1093/nar/15.21.8783; MURPHY FL, 1989, P NATL ACAD SCI USA, V86, P9218, DOI 10.1073/pnas.86.23.9218; PACE NR, 1990, J BIOL CHEM, V265, P3587; PRICE JV, 1985, NUCLEIC ACIDS RES, V13, P1871, DOI 10.1093/nar/13.6.1871; PYLE AM, 1990, P NATL ACAD SCI USA, V87, P8187, DOI 10.1073/pnas.87.21.8187; PYLE AM, 1991, NATURE, V350, P628, DOI 10.1038/350628a0; RUFFNER DE, 1990, BIOCHEMISTRY-US, V29, P10695, DOI 10.1021/bi00499a018; SOLOMON BM, 1990, BIOCHEMISTRY-US, V29, P7303, DOI 10.1021/bi00483a021; SUGIMOTO N, 1989, CHEM LETT, P2223, DOI 10.1246/cl.1989.2223; SUGIMOTO N, 1989, NUCLEIC ACIDS RES, V17, P355, DOI 10.1093/nar/17.1.355; SUGIMOTO N, 1988, BIOCHEMISTRY-US, V27, P6384, DOI 10.1021/bi00417a029; WARING RB, 1986, NATURE, V321, P133, DOI 10.1038/321133a0; WAUGH DS, 1989, SCIENCE, V244, P1569, DOI 10.1126/science.2472671; YOUNG B, 1990, THESIS U COLORADO BO; ZAUG AJ, 1986, NATURE, V324, P429, DOI 10.1038/324429a0; ZAUG AJ, 1988, BIOCHEMISTRY-US, V27, P8924, DOI 10.1021/bi00425a008; ZAUG AJ, 1984, SCIENCE, V224, P574, DOI 10.1126/science.6200938	48	77	80	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	NOV 29	1991	67	5					1007	1019		10.1016/0092-8674(91)90373-7	http://dx.doi.org/10.1016/0092-8674(91)90373-7			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	GT755	1959129				2022-12-24	WOS:A1991GT75500019
J	HABER, HL; LEAVY, JA; KESSLER, PD; KUKIN, ML; GOTTLIEB, SS; PACKER, M				HABER, HL; LEAVY, JA; KESSLER, PD; KUKIN, ML; GOTTLIEB, SS; PACKER, M			THE ERYTHROCYTE SEDIMENTATION-RATE IN CONGESTIVE-HEART-FAILURE	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CORONARY-ARTERY DISEASE; CLINICAL-RESPONSE; BLOOD-VISCOSITY; SURVIVAL; SYSTEM; PLASMA	Background and Methods. Physicians have long believed that the erythrocyte sedimentation rate is low in patients with congestive heart failure, but this concept is based on a misinterpretation of the results in a single report published in 1936. To reevaluate this concept in the modern era, we measured the sedimentation rate in 242 patients who were referred for treatment of chronic heart failure. Results. The sedimentation rate was low (less than 5 mm per hour) in only 24 patients (10 percent) but was increased (above 25 mm per hour) in 50 percent. Patients with low or normal sedimentation rates (less-than-or-equal-to 25 mm per hour) had more severe hemodynamic abnormalities than patients with elevated rates: lower cardiac index (mean +/- SEM, 1.7 +/- 0.1 vs. 2.0 +/- 0.1 liters per minute per square meter of body-surface area) and higher mean right atrial pressure (mean +/- SEM, 12 +/- 1 vs. 9 +/- 1 mm Hg)(both P < 0.0001). New York Heart Association functional class IV symptoms were present in 66 percent of the patients with a low or normal sedimentation rate, as compared with 42 percent of those with elevated rates (P < 0.0001). After one to three months of therapy, patients whose sedimentation rates decreased showed little hemodynamic or clinical response to treatment, whereas both cardiac performance and functional status improved in patients whose rates increased (P < 0.02 for the comparison between groups). The sedimentation rate was correlated with the plasma fibrinogen level (r = 0.64, P = 0.0025), and changes in the sedimentation rate during treatment were correlated inversely with changes in mean right atrial pressure (r = -0.57, P = 0.0002). During long-term follow-up, patients with low or normal sedimentation rates had a worse one-year survival than patients with elevated rates (41 vs. 66 percent, P = 0.01). Conclusions. These data indicate that the erythrocyte sedimentation rate is correlated with the severity of illness in patients with chronic heart failure. Because of its lack of discriminatory power, however, the test is of limited value in the clinical management of this disorder.	CUNY MT SINAI SCH MED,DIV CARDIOL,1 GUSTAVE LEVY PL,NEW YORK,NY 10029; CUNY MT SINAI SCH MED,DEPT MED,DIV CARDIOL,CTR HEART FAILURE RES,NEW YORK,NY 10029	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai					NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL025055, K04HL001229, T32HL007347] Funding Source: NIH RePORTER; NHLBI NIH HHS [K04-HL-01229, R01-HL-25055, T32-HL-07347] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		BEDELL SE, 1985, AM J MED, V78, P1001, DOI 10.1016/0002-9343(85)90224-4; BOTTIGER LE, 1967, BRIT MED J, V2, P85, DOI 10.1136/bmj.2.5544.85; BRESLOW N, 1974, BIOMETRICS, V30, P89, DOI 10.2307/2529620; Coburn AF, 1936, J CLIN INVEST, V15, P715, DOI 10.1172/JCI100825; CREAGER MA, 1982, AM HEART J, V104, P1147, DOI 10.1016/0002-8703(82)90043-6; EISENBERG S, 1964, CIRCULATION, V30, P686, DOI 10.1161/01.CIR.30.5.686; ELSTER SK, 1956, AM HEART J, V51, P533, DOI 10.1016/0002-8703(56)90099-0; FABRY TL, 1987, BLOOD, V70, P1572; FLINT FJ, 1954, BRIT MED J, V2, P1018, DOI 10.1136/bmj.2.4895.1018; GAMBINO S R, 1965, Tech Bull Regist Med Technol, V35, P1; Gilligan DR, 1934, AM J MED SCI, V187, P552, DOI 10.1097/00000441-193404000-00012; GOLDSMITH RL, 1988, CIRCULATION S2, V78, P56; GRIFFITHS RA, 1984, BRIT MED J, V289, P724, DOI 10.1136/bmj.289.6447.724; Ham TH, 1938, MEDICINE, V17, P447, DOI 10.1097/00005792-193812000-00003; HAMILTON PJ, 1974, J CLIN PATHOL, V27, P326, DOI 10.1136/jcp.27.4.326; HENRY DP, 1975, LIFE SCI, V16, P375, DOI 10.1016/0024-3205(75)90258-1; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Kugel MA, 1933, ARCH INTERN MED, V52, P16, DOI 10.1001/archinte.1933.00160010023002; LEE WH, 1985, J AM COLL CARDIOL, V5, P461; LEE WH, 1986, CIRCULATION, V73, P257, DOI 10.1161/01.CIR.73.2.257; LOWE GD, 1986, DIABETES RES CLIN EX, V3, P67; LOWE GDO, 1980, BRIT MED J, V280, P673, DOI 10.1136/bmj.280.6215.673; MCGINNIS AE, 1953, AM J MED SCI, V225, P599, DOI 10.1097/00000441-195306000-00002; MEADE TW, 1979, BMJ-BRIT MED J, V1, P153, DOI 10.1136/bmj.1.6157.153; PACKER M, 1985, CIRCULATION, V71, P761, DOI 10.1161/01.CIR.71.4.761; PARRY EH, 1961, ACTA MED SCAND, V169, P79; RAINER C, 1987, CIRCULATION, V76, P15, DOI 10.1161/01.CIR.76.1.15; SANGHVI L M, 1960, Postgrad Med J, V36, P620; SANGHVI LM, 1963, GERIATRICS, V18, P382; SANGHVI LM, 1962, BRIT HEART J, V24, P180; SEALEY JE, 1972, KIDNEY INT, V1, P240, DOI 10.1038/ki.1972.34; WOOD P, 1936, Q J MED, V5, P1; ZANNAD F, 1988, J HYPERTENS, V6, P293	33	54	56	0	2	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 7	1991	324	6					353	358		10.1056/NEJM199102073240601	http://dx.doi.org/10.1056/NEJM199102073240601			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EW296	1987458	Bronze			2022-12-24	WOS:A1991EW29600001
J	MOLFINO, NA; NANNINI, LJ; MARTELLI, AN; SLUTSKY, AS				MOLFINO, NA; NANNINI, LJ; MARTELLI, AN; SLUTSKY, AS			RESPIRATORY ARREST IN NEAR-FATAL ASTHMA	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BETA-ADRENERGIC AGONISTS; ORAL THEOPHYLLINE; MORTALITY; DEATH; FENOTEROL; VENTILATION; EXPERIENCE; ZEALAND; RATES	Background and Methods. The majority of asthma-related deaths occur outside the hospital, and therefore the exact factors leading to the terminal event are difficult to ascertain. To examine the mechanisms by which patients might die during acute exacerbations of asthma, we studied 10 such patients who arrived at the hospital in respiratory arrest or in whom it developed soon (within 20 minutes) after admission. Results. The characteristics of the group were similar to those associated in the literature with a high risk of death from asthma, including a long history of the disease in young to middle-aged patients, previous life-threatening attacks or hospitalizations, delay in obtaining medical aid, and sudden onset of a rapidly progressive crisis. Extreme hypercapnia (mean [+/- SD] partial pressure of arterial carbon dioxide, 97.1 +/- 31.1 mm Hg) and acidosis (mean [+/- SD] pH, 7.01 +/- 0.11) were found before mechanical ventilation was begun, and four patients had hypokalemia on admission. Despite the severe respiratory acidosis, no patient had a serious cardiac arrhythmia during the resuscitation maneuvers or during hospitalization. We observed systemic hypertension and sinus tachycardia in eight patients, atrial fibrillation in one, and sinus bradycardia in another. In both patients with arrhythmia the heart reverted to sinus rhythm immediately after manual ventilation with 100 percent oxygen was begun. The median duration of mechanical ventilation was 12 hours, and all patients had normocapnia on discharge from the hospital. Conclusions. We conclude that at least in this group of patients, the near-fatal nature of the exacerbations was the result of severe asphyxia rather than cardiac arrhythmias. These results suggest that undertreatment rather than overtreatment may contribute to an increase in mortality from asthma.	HOSP NACL MARIA FERRER,BUENOS AIRES,ARGENTINA; UNIV TORONTO,MT SINAI HOSP,DEPT MED,DIV RESP,TORONTO M5G 1X5,ONTARIO,CANADA	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute			Slutsky, Arthur S/A-6013-2008; Slutsky, Arthur/M-3325-2019	Slutsky, Arthur S/0000-0002-6063-3876; 				[Anonymous], 1984, Thorax, V39, P505; BARGER LW, 1988, ANN ALLERGY, V60, P31; BARRIOT P, 1987, CHEST, V92, P460, DOI 10.1378/chest.92.3.460; BATEMAN JRM, 1979, THORAX, V34, P40, DOI 10.1136/thx.34.1.40; BENATAR SR, 1986, NEW ENGL J MED, V314, P423, DOI 10.1056/NEJM198602133140706; BUIST AS, 1988, CHEST, V93, P449, DOI 10.1378/chest.93.3.449; COCHRANE GM, 1975, THORAX, V30, P300, DOI 10.1136/thx.30.3.300; COLEMAN JJ, 1986, CHEST, V90, P45, DOI 10.1378/chest.90.1.45; CRANE J, 1989, LANCET, V1, P917; CROMPTON G, 1987, BRIT J DIS CHEST, V81, P321, DOI 10.1016/0007-0971(87)90179-3; DARIOLI R, 1984, AM REV RESPIR DIS, V129, P385; DRISLANE FW, 1987, AM REV RESPIR DIS, V135, P498; FLATT A, 1989, CHEST, V96, P1317, DOI 10.1378/chest.96.6.1317; HAALBOOM JRE, 1985, LANCET, V1, P1125; Huber HL, 1922, ARCH INTERN MED, V30, P689, DOI 10.1001/archinte.1922.00110120002001; JOHNSON AJ, 1984, BRIT MED J, V288, P1870, DOI 10.1136/bmj.288.6434.1870; Joseph X, 1981, Fundam Appl Toxicol, V1, P443, DOI 10.1016/S0272-0590(81)80025-5; KEMP JP, 1984, J ALLERGY CLIN IMMUN, V73, P32, DOI 10.1016/0091-6749(84)90481-0; KNOCHEL JP, 1982, AM J MED, V72, P521, DOI 10.1016/0002-9343(82)90522-8; LUKSZA AR, 1986, THORAX, V41, P459, DOI 10.1136/thx.41.6.459; MACDONALD JB, 1976, BRIT MED J, V1, P1493, DOI 10.1136/bmj.1.6024.1493; MANNING P, 1987, IRISH MED J, V80, P406; MAO Y, 1987, CAN MED ASSOC J, V137, P620; MORRIS JF, 1971, AM REV RESPIR DIS, V103, P57; MUSK AW, 1987, MED J AUSTRALIA, V147, P423, DOI 10.5694/j.1326-5377.1987.tb133582.x; NICKLAS RA, 1984, J ALLERGY CLIN IMMUN, V73, P20, DOI 10.1016/0091-6749(84)90479-2; NICKLAS RA, 1982, NEW ENGL J MED, V307, P557; REA HH, 1986, THORAX, V41, P833, DOI 10.1136/thx.41.11.833; REBUCK AS, 1971, AM J MED, V51, P788, DOI 10.1016/0002-9343(71)90307-X; ROBIN ED, 1988, CHEST, V93, P614, DOI 10.1378/chest.93.3.614; ROTHWELL RPG, 1987, NEW ZEAL MED J, V100, P199; SEARS MR, 1986, BRIT MED J, V293, P1342, DOI 10.1136/bmj.293.6558.1342; SHEFFER AL, 1987, J ALLERGY CLIN IMMUN, V80, P361, DOI 10.1016/0091-6749(87)90047-9; SIEGEL SC, 1987, J ALLERGY CLIN IMMUN, V80, P458, DOI 10.1016/0091-6749(87)90075-3; SLY RM, 1988, ANN ALLERGY, V60, P433; SWENSON E R, 1985, American Review of Respiratory Disease, V131, pA99; WESTERMAN DE, 1979, AM J MED, V66, P565, DOI 10.1016/0002-9343(79)91165-3; WILSON JD, 1981, LANCET, V1, P1235; WOOLCOCK AJ, 1986, CHEST, V90, pS40, DOI 10.1378/chest.90.5_Supplement.40S; 1987, AM REV RESPIR DIS, V136, P225; 1987, BR J DIS CHEST, V81, P30; 1982, BMJ, V285, P1251	42	173	175	0	3	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 31	1991	324	5					285	288		10.1056/NEJM199101313240502	http://dx.doi.org/10.1056/NEJM199101313240502			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EU922	1986288				2022-12-24	WOS:A1991EU92200002
J	HAYWARD, RA; SHAPIRO, MF				HAYWARD, RA; SHAPIRO, MF			A NATIONAL STUDY OF AIDS AND RESIDENCY TRAINING - EXPERIENCES, CONCERNS, AND CONSEQUENCES	ANNALS OF INTERNAL MEDICINE			English	Article							ACQUIRED IMMUNODEFICIENCY SYNDROME; NEEDLESTICK INJURIES; PHYSICIAN ATTITUDES; CARE; HOMOSEXUALITY; EPIDEMIC; MEDICINE; IMPACT	Objective: To examine residents' experiences in the care of patients with the acquired immunodeficiency syndrome (AIDS), and to examine factors that my influence their attitudes about such care. Design: Cross-sectional, self-administered questionnaire survey conducted in 1989. Participants: All senior internal medicine and family medicine residents in ten geographically representative states who were identified through the 1986 National Residency Matching Program. Measurements and Main Results: Seventy-four percent of residents reported that patients with AIDS accounted for 5% or more of general medicine admissions, and 50% of residents reported that they were currently following one or more human immunodeficiency virus (HIV)-infected patients in their continuity clinics. Among residents who had provided ambulatory care to patients with AIDS, 77% felt that it was an excellent educational experience, and among those who planned to do general primary care in their future practices, 74% planned on providing primary care to patients with AIDS. However, 61% expressed concerns about the adequacy of their training in AIDS ambulatory care. A greater amount of contact with outpatients who had AIDS, but not with inpatients who had AIDS, was associated with residents' intending to provide AIDS primary care in their future practices. Among all residents, 23% reported that, if given a choice, they would not provide care to any patients with AIDS, and 23% reported that they would not work in an area with a high prevalence of AIDS because of concern about contracting the syndrome. Nine percent of residents reported that they had been exposed to a blood-contaminated needlestick from an HIV-seropositive patient. Conclusions: Although most residents have substantial contact with inpatients and outpatients with AIDS, most still find their education in AIDS ambulatory care to be deficient. A minority of residents would prefer not to care for patients with AIDS. Residency curricula should include training and experience in ambulatory AIDS care, explicitly address negative attitudes toward caring for patients with AIDS, and include programs to reduce needlestick exposures.	UNIV MICHIGAN, SCH MED, ANN ARBOR, MI 48109 USA; UNIV MICHIGAN, SCH PUBL HLTH, ANN ARBOR, MI 48109 USA; UNIV CALIF LOS ANGELES, SCH MED, LOS ANGELES, CA 90024 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA								AOUN H, 1989, NEW ENGL J MED, V321, P693, DOI 10.1056/NEJM198909073211020; COHEN PT, AIDS KNOWLEDGE BASE; COONEY TG, 1986, J GEN INTERN MED, V1, P339, DOI 10.1007/BF02596215; CROWLEY AE, 1988, 1988 1989 DIRECTORY; DONDERO TJ, 1989, 5TH INT C AIDS MONTR, P45; DOUGLAS CJ, 1985, HOSP COMMUNITY PSYCH, V36, P1309; EDMOND M, 1988, INFECT CONT HOSP EP, V9, P114, DOI 10.1086/645806; FREEMAN G, AIDS ALERT; GERBERDING JL, 1987, J INFECT DIS, V156, P861, DOI 10.1093/infdis/156.6.861; GOLDWATER PN, 1989, INFECT CONT HOSP EP, V10, P21, DOI 10.1086/645910; GOTTLIEB MS, AIDS CLIN DIGEST; HAYWARD RA, 1991, IN PRESS J GEN INTER, V6; HENDERSON DK, 1990, AIDS UPDATES, V3, P1; JAMES JS, AIDS TREATMENT NEWS; KELLY JA, 1987, J MED EDUC, V62, P549; KELLY JA, 1987, AM J PUBLIC HEALTH, V77, P789, DOI 10.2105/AJPH.77.7.789; KENNEDY DA, 1988, J HOSP INFECT, V12, P315, DOI 10.1016/0195-6701(88)90074-6; LIEU TA, 1989, ACAD MED, V64, P622, DOI 10.1097/00001888-198910000-00015; LINK RN, 1988, AM J PUBLIC HEALTH, V78, P455, DOI 10.2105/AJPH.78.4.455; LINN LS, 1989, ACAD MED, V64, P408, DOI 10.1097/00001888-198907000-00016; MATHEWS WC, 1986, WESTERN J MED, V144, P106; MCKUSICK L, 1986, W J MED, V144, P750; MELZER SM, 1989, PEDIATRICS, V84, P211; MIZES JS, 1984, PUBLIC OPIN QUART, V48, P794, DOI 10.1086/268885; MORGAN DR, 1988, J HOSP INFECT, V12, P301, DOI 10.1016/0195-6701(88)90072-2; NESS R, 1989, ACAD MED, V64, P588, DOI 10.1097/00001888-198910000-00009; NORTHFELT DW, 1988, ANN INTERN MED, V109, P773, DOI 10.7326/0003-4819-109-10-773; PRICHARD JG, 1988, J FAM PRACTICE, V27, P637; RICHARDSON JL, 1987, MED CARE, V25, P675, DOI 10.1097/00005650-198708000-00001; ROSNER F, 1989, AM J MED, V87, P601, DOI 10.1016/S0002-9343(89)80630-8; SADOVSKY R, 1989, AM FAM PHYSICIAN, V40, P121; WACHTER RM, 1986, NEW ENGL J MED, V314, P177, DOI 10.1056/NEJM198601163140310; WHITE LJ, 1988, ANN INTERN MED, V108, P460, DOI 10.7326/0003-4819-108-3-460; WORMSER GP, 1989, POSTGRAD MED, V86, P174; 1989, HIV AIDS SURVEILLANC, P1; 1990, AIDS UPDATE, V3, P3; 1987, MED WORLD NEWS, V28, P12; 1989, AIDS PRIMARY CARE PR; 1986, PUB HLTH REP, V101, P341; 1990, MMWR, V39, P1	40	67	67	0	2	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 1	1991	114	1					23	32		10.7326/0003-4819-114-1-23	http://dx.doi.org/10.7326/0003-4819-114-1-23			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EQ040	1983928				2022-12-24	WOS:A1991EQ04000004
J	WEN, L; PEAKMAN, M; LOBOYEO, A; MCFARLANE, BM; MOWAT, AP; MIELIVERGANI, G; VERGANI, D				WEN, L; PEAKMAN, M; LOBOYEO, A; MCFARLANE, BM; MOWAT, AP; MIELIVERGANI, G; VERGANI, D			T-CELL-DIRECTED HEPATOCYTE DAMAGE IN AUTOIMMUNE CHRONIC ACTIVE HEPATITIS	LANCET			English	Article							MEMBRANE LIPOPROTEIN; AUTOANTIBODIES; ANTIBODIES	To investigate the function of activated T lymphocytes in atuoimmune chronic active hepatitis, 7 or 15 T-cell clones from the peripheral blood of 8 patients were studied. These clones showed specificity for liver-membrane antigen with proliferation when stimulated by rabbit liver cell membranes. 6 of these clones reacted with liver-specific lipoprotein complex, and 1 clone (and 3 subclones) responded to the asialoglycoprotein receptor (ASGPR), both known targets of immune attack in autoimmune chronic active hepatitis. 2 of these clones stimulated autologous B lymphocytes to produce liver-membrane-specific autoantibodies and antibody to the ASGPR. These results suggest that liver-membrane-specific activated T lymphocytes in peripheral blood may be important in the autoimmune attack of chronic active hepatitis.	KINGS COLL,SCH MED & DENT,DEPT IMMUNOL,BESSEMER RD,LONDON SE5 9PJ,ENGLAND; UNIV LONDON KINGS COLL,SCH MED & DENT,DEPT CHILD HLTH,LONDON WC2R 2LS,ENGLAND; UNIV LONDON KINGS COLL,SCH MED & DENT,LIVER UNIT,LONDON WC2R 2LS,ENGLAND	University of London; King's College London; University of London; King's College London; University of London; King's College London			Mieli-Vergani, Giorgina/G-5616-2011; Vergani, Diego/H-7610-2019	Mieli-Vergani, Giorgina/0000-0002-8215-4489; Wen, Li/0000-0002-8805-2934	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		ACHAORBEA H, 1988, CELL, V54, P263, DOI 10.1016/0092-8674(88)90558-2; BLUE ML, 1986, J IMMUNOL, V137, P1202; EDDLESTON ALW, 1974, LANCET, V2, P1543; Fiske CH, 1925, J BIOL CHEM, V66, P375; JENSEN DM, 1978, NEW ENGL J MED, V299, P1, DOI 10.1056/NEJM197807062990101; LOBOYEO A, 1987, CLIN EXP IMMUNOL, V67, P95; LONDEI M, 1985, SCIENCE, V228, P85, DOI 10.1126/science.3871967; MCFARLANE BM, 1986, J HEPATOL, V3, P196, DOI 10.1016/S0168-8278(86)80026-5; MCFARLANE IG, 1977, CLIN EXP IMMUNOL, V27, P381; MCFARLANE IG, 1984, LANCET, V2, P954; MIELI VERGANI G., 1979, Clinical and Experimental Immunology, V38, P16; NABHOLZ M, 1982, ISOLATION CHARACTERI, P163; Pertoft H., 1977, METHODS CELL, P25; SHERLOCK S, 1989, DISEASES LIVER BILIA, P348; SWANSON NR, 1989, CLIN IMMUNOL IMMUNOP, V52, P291, DOI 10.1016/0090-1229(89)90180-3; TASWELL C, 1981, J IMMUNOL, V126, P1614; VINCENT R, 1983, ANAL BIOCHEM, V135, P255	17	74	77	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 22	1990	336	8730					1527	1530		10.1016/0140-6736(90)93306-A	http://dx.doi.org/10.1016/0140-6736(90)93306-A			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP037	1979365				2022-12-24	WOS:A1990EP03700003
J	PRIVALSKY, ML; SHARIF, M; YAMAMOTO, KR				PRIVALSKY, ML; SHARIF, M; YAMAMOTO, KR			THE VIRAL ERBA ONCOGENE PROTEIN, A CONSTITUTIVE REPRESSOR IN ANIMAL-CELLS, IS A HORMONE-REGULATED ACTIVATOR IN YEAST	CELL			English	Article							AVIAN ERYTHROBLASTOSIS VIRUS; HEAT-SHOCK PROTEIN; THYROID-HORMONE; GLUCOCORTICOID RECEPTOR; V-ERBA; TRANS-ACTIVATION; RESPONSE ELEMENT; BINDING DOMAIN; RETINOIC-ACID; GENE	The v-erbA oncogene is a retrovirus-transduced and altered copy of a cellular gene for a thyroid hormone receptor. In animal cells, the v-erbA protein fails to respond to hormone and acts as a dominant negative allele, inhibiting gene activation normally conferred by the wild-type thyroid hormone receptor. We report here that, unexpectedly, the v-erbA protein acts as a hormone-regulated transcriptional activator in S. cerevisiae. We suggest that the ability of v-erbA protein to function as a transcriptional repressor or an activator is determined by interaction with, or modification by, other cellular factors, and that this phenomenon may be relevant to understanding ligand regulation of the normal thyroid and steroid hormone receptors.	UNIV CALIF SAN FRANCISCO,DEPT BIOCHEM & BIOPHYS,SAN FRANCISCO,CA 94143	University of California System; University of California San Francisco	PRIVALSKY, ML (corresponding author), UNIV CALIF DAVIS,DEPT MICROBIOL,DAVIS,CA 95616, USA.							AKERBLOM IE, 1988, SCIENCE, V241, P350, DOI 10.1126/science.2838908; BEATO M, 1989, CELL, V56, P335, DOI 10.1016/0092-8674(89)90237-7; BECKER DM, 1989, MOL CELL BIOL, V9, P3878, DOI 10.1128/MCB.9.9.3878; BONDE BG, 1990, J VIROL, V64, P1314, DOI 10.1128/JVI.64.3.1314-1320.1990; BOUCHER P, 1990, ONCOGENE, V5, P1303; BRESNICK EH, 1989, J BIOL CHEM, V264, P4992; DALMAN FC, 1990, J BIOL CHEM, V265, P3615; DAMM K, 1989, NATURE, V339, P593, DOI 10.1038/339593a0; DENIS M, 1989, CANCER RES, V49, pS2275; DIAMOND MI, 1990, SCIENCE, V249, P1266, DOI 10.1126/science.2119054; EILERS M, 1989, NATURE, V340, P66, DOI 10.1038/340066a0; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; GLASS CK, 1988, CELL, V54, P313, DOI 10.1016/0092-8674(88)90194-8; GLASS CK, 1987, NATURE, V329, P738, DOI 10.1038/329738a0; GOLDBERG Y, 1988, EMBO J, V7, P2425, DOI 10.1002/j.1460-2075.1988.tb03088.x; GRAF T, 1983, CELL, V34, P7, DOI 10.1016/0092-8674(83)90130-7; GRAUPNER G, 1989, NATURE, V340, P653, DOI 10.1038/340653a0; GRAVES BJ, 1986, CELL, V44, P565, DOI 10.1016/0092-8674(86)90266-7; GREEN S, 1988, TRENDS GENET, V4, P309, DOI 10.1016/0168-9525(88)90108-4; HOLLENBERG SM, 1988, CELL, V55, P899, DOI 10.1016/0092-8674(88)90145-6; INOUE A, 1983, ANAL BIOCHEM, V134, P176, DOI 10.1016/0003-2697(83)90280-4; JONAT G, 1990, CELL, V62, P1189; JONES KA, 1985, CELL, V42, P559, DOI 10.1016/0092-8674(85)90113-8; KLEINHITPASS L, 1990, CELL, V60, P247, DOI 10.1016/0092-8674(90)90740-6; KOENIG RJ, 1989, NATURE, V337, P659, DOI 10.1038/337659a0; MA J, 1987, CELL, V51, P113, DOI 10.1016/0092-8674(87)90015-8; MENDEL DB, 1990, PROG CLIN BIOL RES, V322, P97; METZGER D, 1988, NATURE, V334, P31, DOI 10.1038/334031a0; MUNOZ A, 1988, EMBO J, V7, P155, DOI 10.1002/j.1460-2075.1988.tb02795.x; NORDEEN SK, 1987, DNA-J MOLEC CELL BIO, V6, P173, DOI 10.1089/dna.1987.6.173; PICARD D, 1988, CELL, V54, P1073, DOI 10.1016/0092-8674(88)90122-5; PICARD D, 1990, IN PRESS NATURE; PRIVALSKY ML, 1988, MOL CELL BIOL, V8, P4510, DOI 10.1128/MCB.8.10.4510; PRIVALSKY ML, 1991, IN PRESS J BIOL CHEM; SAKAI DD, 1988, GENE DEV, V2, P1144, DOI 10.1101/gad.2.9.1144; SAP J, 1989, NATURE, V340, P242, DOI 10.1038/340242a0; SAP J, 1986, NATURE, V324, P635, DOI 10.1038/324635a0; SCHENA M, 1989, GENE DEV, V3, P1590, DOI 10.1101/gad.3.10.1590; SCHENA M, 1988, SCIENCE, V241, P965, DOI 10.1126/science.3043665; SCHENA M, 1990, IN PRESS METH ENZYMO; SCHULE R, 1990, CELL, V62, P1217, DOI 10.1016/0092-8674(90)90397-W; SHERIDAN PL, 1989, J BIOL CHEM, V264, P6520; SULLIVAN WP, 1988, J BIOL CHEM, V263, P14717; UMESONO K, 1988, NATURE, V336, P262, DOI 10.1038/336262a0; WEINBERGER C, 1986, NATURE, V324, P641, DOI 10.1038/324641a0; YANGYEN HF, 1990, CELL, V62, P1205, DOI 10.1016/0092-8674(90)90396-V; ZENKE M, 1988, CELL, V52, P107, DOI 10.1016/0092-8674(88)90535-1; ZENKE M, 1990, CELL, V61, P1035, DOI 10.1016/0092-8674(90)90068-P	48	86	90	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	DEC 21	1990	63	6					1277	1286		10.1016/0092-8674(90)90423-C	http://dx.doi.org/10.1016/0092-8674(90)90423-C			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN923	1979758				2022-12-24	WOS:A1990EN92300018
J	SUNAHARA, RK; NIZNIK, HB; WEINER, DM; STORMANN, TM; BRANN, MR; KENNEDY, JL; GELERNTER, JE; ROZMAHEL, R; YANG, Y; ISRAEL, Y; SEEMAN, P; ODOWD, BF				SUNAHARA, RK; NIZNIK, HB; WEINER, DM; STORMANN, TM; BRANN, MR; KENNEDY, JL; GELERNTER, JE; ROZMAHEL, R; YANG, Y; ISRAEL, Y; SEEMAN, P; ODOWD, BF			HUMAN DOPAMINE-D1 RECEPTOR ENCODED BY AN INTRONLESS GENE ON CHROMOSOME-5	NATURE			English	Article									UNIV TORONTO,DEPT PHARMACOL,TORONTO M5S 1A8,ONTARIO,CANADA; UNIV TORONTO,DEPT PSYCHIAT,TORONTO M5S 1A8,ONTARIO,CANADA; NINCDS,MOLEC BIOL LAB,BETHESDA,MD 20892; YALE UNIV,SCH MED,DEPT HUMAN GENET & PSYCHIAT,NEW HAVEN,CT 06511; HOSP SICK CHILDREN,RES INST,DEPT GENET,TORONTO M5G 1X8,ONTARIO,CANADA; ADDICT RES FDN,TORONTO M5S 2S1,ONTARIO,CANADA	University of Toronto; University of Toronto; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS); Yale University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Centre for Addiction & Mental Health - Canada			Sunahara, Roger/AAJ-8667-2020	Israel, Yedy/0000-0003-3468-7966; Gelernter, Joel/0000-0002-4067-1859				Bjorklund A., 1984, HDB CHEM NEUROANAT 1, V2, P55; BLUM K, 1990, JAMA-J AM MED ASSOC, V263, P2055, DOI 10.1001/jama.263.15.2055; BUNZOW JR, 1988, NATURE, V336, P783, DOI 10.1038/336783a0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; CLARK D, 1987, SYNAPSE, V1, P347, DOI 10.1002/syn.890010408; CULLEN BR, 1987, METHOD ENZYMOL, V152, P684; FREISSMUTH M, 1989, FASEB J, V3, P2125, DOI 10.1096/fasebj.3.10.2546847; GUIFFRA LA, 1988, CYTOGENET CELL GENET, V49, P313; HEMMINGS HC, 1987, TRENDS NEUROSCI, V10, P77; JARVIE KR, 1989, MOL PHARMACOL, V34, P566; KEBABIAN JW, 1979, NATURE, V277, P93, DOI 10.1038/277093a0; LANKFORD KL, 1988, P NATL ACAD SCI USA, V85, P2839, DOI 10.1073/pnas.85.8.2839; LATHROP GM, 1985, AM J HUM GENET, V37, P482; NIZNIK HB, 1988, MOL PHARMACOL, V34, P29; NIZNIK HB, 1987, MOL CELL ENDOCRINOL, V54, P1, DOI 10.1016/0303-7207(87)90134-1; ODOWD BF, 1985, P NATL ACAD SCI USA, V82, P1184, DOI 10.1073/pnas.82.4.1184; ODOWD BF, 1990, FEBS LETT, V262, P8, DOI 10.1016/0014-5793(90)80140-E; ODOWD BF, 1989, J BIOL CHEM, V264, P7564; ODOWD BF, 1988, J BIOL CHEM, V263, P15985; ODOWD BF, 1989, REV NEUROSCI, V12, P67; SAVASTA M, 1986, BRAIN RES, V375, P291, DOI 10.1016/0006-8993(86)90749-3; SEEMAN P, 1989, P NATL ACAD SCI USA, V86, P10156, DOI 10.1073/pnas.86.24.10156; SEEMAN P, 1980, PHARMACOL REV, V32, P229; SEEMAN P, 1987, NEUROPSYCHOPHARMACOL, V1, P5, DOI 10.1016/0893-133X(87)90004-2; SEEMAN P, 1987, SYNAPSE, V1, P333; WEINER DM, 1989, FEBS LETT, V253, P207, DOI 10.1016/0014-5793(89)80960-3; YANGFENG TL, 1990, P NATL ACAD SCI USA, V87, P1516, DOI 10.1073/pnas.87.4.1516	27	468	489	0	6	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	SEP 6	1990	347	6288					80	83		10.1038/347080a0	http://dx.doi.org/10.1038/347080a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DX402	1975640				2022-12-24	WOS:A1990DX40200063
J	SARAVIA, NG; WEIGLE, K; SEGURA, I; GIANNINI, SH; PACHECO, R; LABRADA, LA; GONCALVES, A				SARAVIA, NG; WEIGLE, K; SEGURA, I; GIANNINI, SH; PACHECO, R; LABRADA, LA; GONCALVES, A			RECURRENT LESIONS IN HUMAN LEISHMANIA-BRAZILIENSIS INFECTION - REACTIVATION OR REINFECTION	LANCET			English	Article									FDN OSWALDO CRUZ, RIO DE JANEIRO, BRAZIL; UNIV N CAROLINA, DEPT EPIDEMIOL, CHAPEL HILL, NC 27514 USA; UNIV MARYLAND, SCH MED, CTR VACCINE DEV, BALTIMORE, MD 21201 USA	Fundacao Oswaldo Cruz; University of North Carolina; University of North Carolina Chapel Hill; University System of Maryland; University of Maryland Baltimore	SARAVIA, NG (corresponding author), CTR INT INVEST MED, AVE 1, NORTE 3-03, CALI, COLOMBIA.				NIAID NIH HHS [AI16315] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI016315] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALGINDAN Y, 1984, INT J DERMATOL, V23, P194; BADARO R, 1986, LANCET, V1, P647; CHANCE ML, 1982, BIOCH CHARACTERISATI, P275; EVANS DA, 1984, T ROY SOC TROP MED H, V78, P35, DOI 10.1016/0035-9203(84)90168-8; FERNANDEZGUERRERO ML, 1987, AM J MED, V83, P1098, DOI 10.1016/0002-9343(87)90948-X; GIANNINI SH, 1990, MOL BIOCHEM PARASIT, V39, P9, DOI 10.1016/0166-6851(90)90003-5; GODFREY DG, 1976, T ROY SOC TROP MED H, V70, P219, DOI 10.1016/0035-9203(76)90043-2; Goncalves A. M., 1984, Genes and antigens of parasites. A laboratory manual. Proceedings of a course held 14 November-17 December 1983, Oswaldo Cruz Institute, FIOCRUZ, Rio de Janeiro, Brazil., P95; GUIRGES SY, 1971, ANN TROP MED PARASIT, V65, P197, DOI 10.1080/00034983.1971.11686746; KEPPEL AD, 1980, J PARASITOL, V66, P349; KILLICKKENDRICK R, 1985, T ROY SOC TROP MED H, V79, P363, DOI 10.1016/0035-9203(85)90381-5; LANHAM SM, 1981, T ROY SOC TROP MED H, V75, P742, DOI 10.1016/0035-9203(81)90169-3; LEBLANCO SM, 1986, T ROY SOC TROP MED H, V80, P113, DOI 10.1016/0035-9203(86)90208-7; Llanos-Cuentas E. A., 1984, Revista da Sociedade Brasileira de Medicina Tropical, V17, P169, DOI 10.1590/S0037-86821984000400003; LOPES UG, 1984, J PARASITOL, V70, P89, DOI 10.2307/3281930; Marsden P. D., 1984, Revista da Sociedade Brasileira de Medicina Tropical, V17, P179, DOI 10.1590/S0037-86821984000400004; MARSDEN PD, 1984, REV INFECT DIS, V6, P736; MARSDEN PD, 1986, T ROY SOC TROP MED H, V80, P859, DOI 10.1016/0035-9203(86)90243-9; MILES MA, 1980, T ROY SOC TROP MED H, V74, P244; MONTALBAN C, 1987, J INFECTION, V15, P247, DOI 10.1016/S0163-4453(87)92728-9; NETTO EM, 1986, LANCET, V2, P501; Pacheco RS, 1986, LEISHMANIA TAXONOMIE, P57; PRATT DM, 1981, NATURE, V291, P581, DOI 10.1038/291581a0; SARAVIA NG, 1985, AM J TROP MED HYG, V34, P714, DOI 10.4269/ajtmh.1985.34.714; SEBAI ZA, 1976, J TROP MED HYG, V79, P89; SPITHILL TW, 1984, MOL BIOCHEM PARASIT, V12, P217, DOI 10.1016/0166-6851(84)90137-3; WALTON BC, 1973, AM J TROP MED HYG, V22, P696, DOI 10.4269/ajtmh.1973.22.696; WEIGLE KA, 1987, AM J TROP MED HYG, V36, P489, DOI 10.4269/ajtmh.1987.36.489; WEIGLE KA, 1986, AM J TROP MED HYG, V35, P722, DOI 10.4269/ajtmh.1986.35.722; WEIGLE KA, 1985, LANCET, V2, P557	30	120	122	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	AUG 18	1990	336	8712					398	402		10.1016/0140-6736(90)91945-7	http://dx.doi.org/10.1016/0140-6736(90)91945-7			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV277	1974943				2022-12-24	WOS:A1990DV27700004
J	GONZALEZREYES, A; MORATA, G				GONZALEZREYES, A; MORATA, G			THE DEVELOPMENTAL EFFECT OF OVEREXPRESSING A UBX PRODUCT IN DROSOPHILA EMBRYOS IS DEPENDENT ON ITS INTERACTIONS WITH OTHER HOMEOTIC PRODUCTS	CELL			English	Article											GONZALEZREYES, A (corresponding author), UNIV AUTONOMA MADRID, CSIC, CTR BIOL MOLEC, CANTO BLANCO, E-28049 MADRID, SPAIN.		Gonzalez-Reyes, Acaimo/L-1993-2014	Gonzalez-Reyes, Acaimo/0000-0003-3048-0968; Morata, Gines/0000-0003-3274-5173				AKAM M, 1987, DEVELOPMENT, V101, P1; AKAM ME, 1985, EMBO J, V4, P1689, DOI 10.1002/j.1460-2075.1985.tb03838.x; BEACHY PA, 1985, NATURE, V313, P545, DOI 10.1038/313545a0; BEACHY PA, 1988, CELL, V55, P1069, DOI 10.1016/0092-8674(88)90251-6; BIENZ M, 1988, NATURE, V333, P576, DOI 10.1038/333576a0; BUSTURIA A, 1988, DEVELOPMENT, V104, P713; CABRERA CV, 1985, NATURE, V318, P569, DOI 10.1038/318569a0; Campos-Ortega J.A., 2013, EMBRYONIC DEV DROSOP; CARROLL SB, 1986, CELL, V47, P113, DOI 10.1016/0092-8674(86)90372-7; CASANOVA J, 1987, EMBO J, V6, P3103, DOI 10.1002/j.1460-2075.1987.tb02619.x; CASANOVA J, 1985, CELL, V42, P663, DOI 10.1016/0092-8674(85)90123-0; CASANOVA J, 1986, CELL, V47, P627, DOI 10.1016/0092-8674(86)90627-6; CELNIKER SE, 1989, GENE DEV, V3, P1424, DOI 10.1101/gad.3.9.1424; DELORENZI M, 1988, EMBO J, V7, P3223, DOI 10.1002/j.1460-2075.1988.tb03189.x; GIBSON G, 1988, DEVELOPMENT, V102, P657; GONZALEZREYES A, 1990, NATURE, V344, P78, DOI 10.1038/344078a0; HAFEN E, 1984, NATURE, V307, P287, DOI 10.1038/307287a0; INGHAM PW, 1988, NATURE, V335, P25, DOI 10.1038/335025a0; INGHAM PW, 1985, TRENDS GENET, V4, P112; JACK T, 1988, GENE DEV, V2, P635, DOI 10.1101/gad.2.6.635; JURGENS G, 1986, ROUX ARCH DEV BIOL, V195, P359, DOI 10.1007/BF00402870; JURGENS G, 1988, EMBO J, V7, P189, DOI 10.1002/j.1460-2075.1988.tb02799.x; JURGENS G, 1988, ROUX ARCH DEV BIOL, V197, P345, DOI 10.1007/BF00375954; KORNFELD K, 1989, GENE DEV, V3, P243, DOI 10.1101/gad.3.2.243; KRASNOW MA, 1989, CELL, V57, P1031, DOI 10.1016/0092-8674(89)90341-3; KUZIORA MA, 1988, CELL, V55, P477, DOI 10.1016/0092-8674(88)90034-7; KUZIORA MA, 1988, EMBO J, V7, P3233, DOI 10.1002/j.1460-2075.1988.tb03190.x; LAWRENCE PA, 1987, NATURE, V328, P440, DOI 10.1038/328440a0; LEMOTTE PK, 1989, EMBO J, V8, P219, DOI 10.1002/j.1460-2075.1989.tb03367.x; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; MAHAFFEY JW, 1989, DEVELOPMENT, V105, P167; MAHAFFEY JW, 1988, DEV GENETICS HIGHER, P329; MARTINEZARIAS A, 1985, NATURE, V313, P639, DOI 10.1038/313639a0; MORATA G, 1983, J EMBRYOL EXP MORPH, V78, P319; PEIFER M, 1987, GENE DEV, V1, P891, DOI 10.1101/gad.1.9.891; REGULSKI M, 1987, EMBO J, V6, P767, DOI 10.1002/j.1460-2075.1987.tb04819.x; SANCHEZHERRERO E, 1985, NATURE, V313, P108, DOI 10.1038/313108a0; SANCHEZHERRERO E, 1988, EMBO J, V7, P2163, DOI 10.1002/j.1460-2075.1988.tb03055.x; SCHNEUWLY S, 1987, NATURE, V325, P816, DOI 10.1038/325816a0; STRUHL G, 1983, J EMBRYOL EXP MORPH, V76, P297; STRUHL G, 1985, CELL, V43, P507, DOI 10.1016/0092-8674(85)90180-1; STRUHL G, 1985, NATURE, V318, P677, DOI 10.1038/318677a0; Van der Meer JM., 1977, DROS INFORM SERV, V52, P160; WHITE RAH, 1985, NATURE, V318, P563, DOI 10.1038/318563a0; WHITE RAH, 1984, CELL, V39, P163, DOI 10.1016/0092-8674(84)90202-2; WHITE RAH, 1985, EMBO J, V4, P2035, DOI 10.1002/j.1460-2075.1985.tb03889.x; Wieschaus E., 1986, P199; WIRZ J, 1986, EMBO J, V5, P3327, DOI 10.1002/j.1460-2075.1986.tb04647.x; ZINK B, 1989, NATURE, V337, P468, DOI 10.1038/337468a0	49	158	159	0	5	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	MAY 4	1990	61	3					515	522		10.1016/0092-8674(90)90533-K	http://dx.doi.org/10.1016/0092-8674(90)90533-K			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DC934	1970762				2022-12-24	WOS:A1990DC93400015
J	BOWIE, C				BOWIE, C			LESSONS FROM THE PERTUSSIS-VACCINE COURT TRIAL	LANCET			English	Editorial Material											BOWIE, C (corresponding author), SOMERSET HLTH AUTHOR,WELLSPRINGS RD,TAUNTON TA2 7PQ,SOMERSET,ENGLAND.			Bowie, Cam/0000-0002-6956-3691				DYER C, 1988, BRIT MED J, V296, P1189, DOI 10.1136/bmj.296.6630.1189; GRIFFITH AH, 1989, VACCINE, V7, P199, DOI 10.1016/0264-410X(89)90229-6; 1981, WHOOPING COUGH REPOR; 1989, CANADIAN IMMUNIZATIO; 1988, IMMUNISATION INFECTI	5	14	14	0	3	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	FEB 17	1990	335	8686					397	399		10.1016/0140-6736(90)90220-Y	http://dx.doi.org/10.1016/0140-6736(90)90220-Y			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	CN988	1968127				2022-12-24	WOS:A1990CN98800015
J	BRAHAMS, D				BRAHAMS, D			BRAIN BANKS	LANCET			English	Editorial Material																		BRAHAMS D, 1988, LANCET, V2, P1151; MASON JK, 1987, BUTTERWORTHS MED LEG, P274	2	3	3	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	FEB 3	1990	335	8684					282	283		10.1016/0140-6736(90)90089-N	http://dx.doi.org/10.1016/0140-6736(90)90089-N			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CL815	1967735				2022-12-24	WOS:A1990CL81500019
J	HARABUCHI, Y; YAMANAKA, N; KATAURA, A; IMAI, S; KINOSHITA, T; MIZUNO, F; OSATO, T				HARABUCHI, Y; YAMANAKA, N; KATAURA, A; IMAI, S; KINOSHITA, T; MIZUNO, F; OSATO, T			EPSTEIN-BARR VIRUS IN NASAL T-CELL LYMPHOMAS IN PATIENTS WITH LETHAL MIDLINE GRANULOMA	LANCET			English	Article									HOKKAIDO UNIV,SCH MED,INST CANC,DEPT VIROL,SAPPORO,HOKKAIDO 060,JAPAN; SAPPORO MED COLL,DEPT OTOLARYNGOL,SAPPORO,HOKKAIDO 060,JAPAN	Hokkaido University; Sapporo Medical University								ABO W, 1982, LANCET, V1, P1272; EPSTEIN MA, 1979, EPSTEINBARR VIRUS, P1; HARABUCHI Y, 1985, ARCH OTO-RHINO-LARYN, V242, P89, DOI 10.1007/BF00464413; HENLE G, 1976, INT J CANCER, V17, P1, DOI 10.1002/ijc.2910170102; HENLE W, 1970, SCIENCE, V169, P188, DOI 10.1126/science.169.3941.188; JONES JF, 1988, NEW ENGL J MED, V318, P733, DOI 10.1056/NEJM198803243181203; KIKUTA H, 1988, NATURE, V333, P455, DOI 10.1038/333455a0; LIPPMAN SM, 1987, CANCER, V59, P936, DOI 10.1002/1097-0142(19870301)59:5<936::AID-CNCR2820590514>3.0.CO;2-F; OKANO M, 1984, LANCET, V2, P933; OSATO T, 1986, HUMAN ONCOGENIC VIRU, P185; REEDMAN BM, 1973, INT J CANCER, V11, P499, DOI 10.1002/ijc.2910110302; SCHMITZ H, 1972, ARCH GES VIRUSFORSCH, V37, P332, DOI 10.1007/BF01241456; TEO CG, 1987, P NATL ACAD SCI USA, V84, P8473, DOI 10.1073/pnas.84.23.8473; VILDE JL, 1985, NEW ENGL J MED, V313, P1161; WANG D, 1985, CELL, V43, P831, DOI 10.1016/0092-8674(85)90256-9; WANG F, 1987, P NATL ACAD SCI USA, V84, P3452, DOI 10.1073/pnas.84.10.3452; YAMANAKA N, 1985, ANN OTO RHINOL LARYN, V94, P207, DOI 10.1177/000348948509400223; YOUNG L, 1989, NEW ENGL J MED, V321, P1080, DOI 10.1056/NEJM198910193211604	18	478	487	0	3	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JAN 20	1990	335	8682					128	130		10.1016/0140-6736(90)90002-M	http://dx.doi.org/10.1016/0140-6736(90)90002-M			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CJ979	1967431				2022-12-24	WOS:A1990CJ97900002
J	SMITH, DP; RANGANATHAN, R; HARDY, RW; MARX, J; TSUCHIDA, T; ZUKER, CS				SMITH, DP; RANGANATHAN, R; HARDY, RW; MARX, J; TSUCHIDA, T; ZUKER, CS			PHOTORECEPTOR DEACTIVATION AND RETINAL DEGENERATION MEDIATED BY A PHOTORECEPTOR-SPECIFIC PROTEIN-KINASE-C	SCIENCE			English	Article							LIMULUS VENTRAL PHOTORECEPTORS; DROSOPHILA-MELANOGASTER; LIGHT ADAPTATION; PHOSPHOLIPASE-C; PHORBOL ESTERS; PHOSPHOINOSITIDE HYDROLYSIS; MOLECULAR HETEROGENEITY; CALCIUM-CONCENTRATION; CYTOPLASMIC CALCIUM; CELLS	The protein kinase C (PKC) family of serine-threonine kinases has been implicated in the regulation of a variety of signaling cascades. One member of this family, eye-PKC, is expressed exclusively in the Drosophila visual system. The inaC (inactivation-no-afterpotential C) locus was shown to be the structural gene for eye-PKC. Analysis of the light response from inaC mutants showed that this kinase is required for the deactivation and rapid desensitization of the visual cascade. Light adaptation was also defective in inaC mutant flies. In flies carrying the retinal degeneration mutation rdgB, absence of eye-PKC suppressed photoreceptor cell degeneration. These results indicate that eye-PKC functions in the light-dependent regulation of the phototransduction cascade in Drosophila.	UNIV CALIF SAN DIEGO,HOWARD HUGHES MED INST,LA JOLLA,CA 92093; UNIV CALIF SAN DIEGO,DEPT BIOL,LA JOLLA,CA 92093; UNIV CALIF SAN DIEGO,DEPT NEUROSCI,LA JOLLA,CA 92093	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego				Smith, Dean/0000-0002-4271-0436				BACIGALUPO J, 1991, P NATL ACAD SCI USA, V88, P7938, DOI 10.1073/pnas.88.18.7938; BACILUPO J, 1990, TRANSDUCTION BIOL SY; BAYLOR DA, 1979, J PHYSIOL-LONDON, V288, P613; BLOOMQUIST BT, 1988, CELL, V54, P723, DOI 10.1016/S0092-8674(88)80017-5; BROWN JE, 1984, NATURE, V311, P160, DOI 10.1038/311160a0; COLLEY NJ, 1990, J CELL SCI, V95, P11; DECOUET HG, 1987, EUR J CELL BIOL, V44, P50; DIZHOOR AM, 1991, SCIENCE, V251, P915, DOI 10.1126/science.1672047; FAIN GL, 1989, J PHYSIOL-LONDON, V416, P215, DOI 10.1113/jphysiol.1989.sp017757; FEIN A, 1984, NATURE, V311, P157, DOI 10.1038/311157a0; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; HARRIS WA, 1977, J GEN PHYSIOL, V69, P261, DOI 10.1085/jgp.69.3.261; HILMAN P, 1983, PHYSIOL REV, V63, P668; HORN R, 1988, J GEN PHYSIOL, V92, P145, DOI 10.1085/jgp.92.2.145; HOUSE C, 1987, SCIENCE, V238, P1726, DOI 10.1126/science.3686012; KARESS RE, 1984, CELL, V38, P135, DOI 10.1016/0092-8674(84)90534-8; KIKKAWA U, 1988, COLD SPRING HARB SYM, V53, P97, DOI 10.1101/SQB.1988.053.01.015; KIKUCHI A, 1986, CANCER RES, V46, P3401; KOCH KW, 1988, NATURE, V334, P64, DOI 10.1038/334064a0; KORENBROT JI, 1989, VISION RES, V29, P939, DOI 10.1016/0042-6989(89)90108-9; KUHN H, 1987, J RECEPTOR RES, V7, P283, DOI 10.3109/10799898709054990; LABARCA R, 1984, BIOCHEM BIOPH RES CO, V123, P703, DOI 10.1016/0006-291X(84)90286-9; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LEVINE H, 1990, MECH DEVELOP, V33, P19, DOI 10.1016/0925-4773(90)90131-5; LIDSLEY DL, 1990, DROSOPH INFO SER, V68, P125; LISMAN JE, 1972, J GEN PHYSIOL, V59, P701, DOI 10.1085/jgp.59.6.701; MATTHEWS HR, 1988, NATURE, V334, P67, DOI 10.1038/334067a0; MCMILLAN M, 1986, BIOCHEM BIOPH RES CO, V134, P970, DOI 10.1016/S0006-291X(86)80515-0; MINKE B, 1975, J COMP PHYSIOL, V98, P345, DOI 10.1007/BF00709805; MINKE B, 1990, P NATL ACAD SCI USA, V87, P113, DOI 10.1073/pnas.87.1.113; MINKE B, 1986, MOL MECHANISM PHOTOR, P241; NAKATANI K, 1988, NATURE, V334, P69, DOI 10.1038/334069a0; NISHIZUKA Y, 1984, NATURE, V308, P693, DOI 10.1038/308693a0; NISHIZUKA Y, 1988, NATURE, V334, P661, DOI 10.1038/334661a0; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; OREVI N, UNPUB; Pak W.L., 1979, P67; PAYNE R, 1986, J GEN PHYSIOL, V88, P127, DOI 10.1085/jgp.88.1.127; RANGANATHAN R, IN PRESS NATURE; ROSENTHAL A, 1987, EMBO J, V6, P433, DOI 10.1002/j.1460-2075.1987.tb04773.x; RYU SH, 1990, J BIOL CHEM, V265, P17941; Saibil H., 1990, Seminars in the Neurosciences, V2, P15; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SCHAEFFER E, 1989, CELL, V57, P403, DOI 10.1016/0092-8674(89)90915-X; SHEARMAN MS, 1989, PHARMACOL REV, V41, P211; Smith D, UNPUB; SMITH DP, 1991, ANNU REV CELL BIOL, V7, P161; STAMNES MA, 1991, CELL, V65, P219, DOI 10.1016/0092-8674(91)90156-S; STARK WS, 1985, INT J INSECT MORPHOL, V14, P243, DOI 10.1016/0020-7322(85)90057-1; STRYER L, 1986, ANNU REV NEUROSCI, V9, P87, DOI 10.1146/annurev.ne.09.030186.000511; SUH PG, 1988, CELL, V54, P161, DOI 10.1016/0092-8674(88)90548-X; SVED J, 1986, DROSOPH INFO SERV, V73, P169; YAMADA T, 1990, SCIENCE, V248, P483, DOI 10.1126/science.2158671; YAMAGATA K, 1990, NEURON, V2, P469; YOKOHAMA H, 1988, BIOCHEM J, V255, P957, DOI 10.1042/bj2550957; YOSHIOKA T, 1983, BIOCHEM BIOPH RES CO, V111, P567, DOI 10.1016/0006-291X(83)90344-3; ZICK Y, 1986, P NATL ACAD SCI USA, V83, P9294, DOI 10.1073/pnas.83.24.9294	57	212	213	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	DEC 6	1991	254	5037					1478	1484		10.1126/science.1962207	http://dx.doi.org/10.1126/science.1962207			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT903	1962207				2022-12-24	WOS:A1991GT90300031
J	SPRINGER, TA				SPRINGER, TA			THE NEXT CLUSTER OF DIFFERENTIATION (CD) WORKSHOP	NATURE			English	Article											SPRINGER, TA (corresponding author), HARVARD UNIV,SCH MED,CTR BLOOD RES,800 HUNTINGTON AVE,BOSTON,MA 02115, USA.							Bernard A., 1984, LEUCOCYTE TYPING; GILKS WR, 1988, LEUKOCYTE TYPING DIS, V3; GILKS WR, 1990, LEUKOCYTE TYPING DAT, V4; KNAPPD W, 1989, LEUKOCYTE TYPING, V4; MCMICHAEL AJ, 1987, LEUKOCYTE TYPING, V3; REINHERZ EL, 1986, LEUKOCYTE TYPING 2, V2	6	0	1	0	2	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	DEC 5	1991	354	6352					415	416		10.1038/354415a0	http://dx.doi.org/10.1038/354415a0			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT761	1956408				2022-12-24	WOS:A1991GT76100058
J	KERPPOLA, TK; CURRAN, T				KERPPOLA, TK; CURRAN, T			DNA BENDING BY FOS AND JUN - THE FLEXIBLE HINGE MODEL	SCIENCE			English	Article							TRANSCRIPTION FACTOR AP-1; INTEGRATION HOST FACTOR; LEUCINE ZIPPER; BINDING DOMAIN; PROTEIN COMPLEXES; BASIC REGION; PRODUCT; RECOGNITION; ACTIVATION; ONCOGENE	DNA bending is essential for the assembly of multiprotein complexes that contact several DNA sequence elements. An approach based on phasing analysis was developed that allows determination of both the directed DNA bend angle and the orientation of DNA bending. This technique has been applied to the analysis of DNA bending by the transcription regulatory proteins Fos and Jun. Complexes that contained different combinations of full-length and truncated Fos and Jun induced DNA bends of different magnitudes and orientations. The DNA bends induced by the individual proteins were determined on the basis of a quantitative model for DNA bending by dimeric complexes. This information was used to visualize the consequences of DNA bending by Fos and Jun for the structures of Fos-Jun-DNA and Jun-DNA complexes.	ROCHE INST MOLEC BIOL,DEPT MOLEC ONCOL & VIROL,NUTLEY,NJ 07110				Kerppola, Tom/AFK-6155-2022; Kerppola, Tom/AAG-4457-2022; Curran, Tom/D-7515-2011; Curran, Tom/F-5234-2018; Curran, Thomas/AAE-7631-2019; Curran, Tom/C-1164-2008	Kerppola, Tom/0000-0002-0611-9446; Kerppola, Tom/0000-0002-0611-9446; Curran, Tom/0000-0003-1444-7551; Curran, Thomas/0000-0003-1444-7551; Curran, Tom/0000-0003-1444-7551				ABATE C, 1991, MOL CELL BIOL, V11, P3624, DOI 10.1128/MCB.11.7.3624; ABATE C, 1990, P NATL ACAD SCI USA, V87, P1032, DOI 10.1073/pnas.87.3.1032; BOHMANN D, 1987, SCIENCE, V238, P1386, DOI 10.1126/science.2825349; COHEN DR, 1989, GENE DEV, V3, P173, DOI 10.1101/gad.3.2.173; COHEN DR, 1990, ONCOGENE, V5, P929; CURRAN T, 1988, CELL, V55, P305; GARTENBERG MR, 1990, P NATL ACAD SCI USA, V87, P6034, DOI 10.1073/pnas.87.16.6034; GENTZ R, 1989, SCIENCE, V243, P1695, DOI 10.1126/science.2494702; GOBER JW, 1990, GENE DEV, V4, P1494, DOI 10.1101/gad.4.9.1494; HAGERMAN PJ, 1985, BIOCHEMISTRY-US, V24, P7033, DOI 10.1021/bi00346a001; HAI T, 1991, P NATL ACAD SCI USA, V88, P3720, DOI 10.1073/pnas.88.9.3720; HOOVER TR, 1990, CELL, V63, P11, DOI 10.1016/0092-8674(90)90284-L; KERPPOLA TK, 1991, CELL, V66, P317, DOI 10.1016/0092-8674(91)90621-5; KOO HS, 1986, NATURE, V320, P501, DOI 10.1038/320501a0; KOUZARIDES T, 1988, NATURE, V336, P646, DOI 10.1038/336646a0; LANDSCHULZ WH, 1989, SCIENCE, V243, P1681, DOI 10.1126/science.2494700; LANDSCHULZ WH, 1988, SCIENCE, V240, P1759, DOI 10.1126/science.3289117; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; MORGAN JI, 1991, ANNU REV NEUROSCI, V14, P421, DOI 10.1146/annurev.ne.14.030191.002225; NAKABEPPU Y, 1988, CELL, V55, P907, DOI 10.1016/0092-8674(88)90146-8; NAKABEPPU Y, 1989, EMBO J, V8, P3833, DOI 10.1002/j.1460-2075.1989.tb08561.x; NYE JA, 1990, P NATL ACAD SCI USA, V87, P3992, DOI 10.1073/pnas.87.10.3992; OAKLEY MG, 1990, SCIENCE, V248, P847, DOI 10.1126/science.2111578; ONEIL KT, 1990, SCIENCE, V249, P774, DOI 10.1126/science.2389143; PATEL L, 1990, NATURE, V347, P572, DOI 10.1038/347572a0; RAUSCHER FJ, 1988, SCIENCE, V240, P1010, DOI 10.1126/science.3130660; RICHARDSON JS, 1988, SCIENCE, V240, P1648, DOI 10.1126/science.3381086; RISSE G, 1989, EMBO J, V8, P3825, DOI 10.1002/j.1460-2075.1989.tb08560.x; ROJO F, 1990, J MOL BIOL, V211, P713, DOI 10.1016/0022-2836(90)90072-T; TALANIAN RV, 1990, SCIENCE, V249, P769, DOI 10.1126/science.2389142; THOMPSON JF, 1988, NUCLEIC ACIDS RES, V16, P9687, DOI 10.1093/nar/16.20.9687; TURNER R, 1989, SCIENCE, V243, P1689, DOI 10.1126/science.2494701; VINSON CR, 1989, SCIENCE, V246, P911, DOI 10.1126/science.2683088; WEISS MA, 1990, NATURE, V347, P575, DOI 10.1038/347575a0; WU HM, 1984, NATURE, V308, P509, DOI 10.1038/308509a0; ZERIAL M, 1989, EMBO J, V8, P805, DOI 10.1002/j.1460-2075.1989.tb03441.x; ZINKEL SS, 1987, NATURE, V328, P178, DOI 10.1038/328178a0; ZINKEL SS, 1991, J MOL BIOL, V219, P201, DOI 10.1016/0022-2836(91)90562-K	38	186	188	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 22	1991	254	5035					1210	1214		10.1126/science.1957173	http://dx.doi.org/10.1126/science.1957173			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ834	1957173				2022-12-24	WOS:A1991GQ83400050
J	STRANG, J				STRANG, J			THE HEALTH OF THE NATION - RESPONSES - INJECTING DRUG MISUSE	BMJ-BRITISH MEDICAL JOURNAL			English	Article							USERS; NOTIFICATION; ENGLAND; SYSTEM; AIDS				STRANG, J (corresponding author), BETHLEM ROYAL & MAUDSLEY HOSP, DRUG DEPENDENCE CLIN RES & TREATMENT UNIT, BECKENHAM BR3 3BX, ENGLAND.		Strang, John/H-5460-2011	Strang, John/0000-0002-5413-2725				BALL JC, 1988, J HEALTH SOC BEHAV, V29, P214, DOI 10.2307/2137033; BLACK D, 1988, J ROY SOC HEALTH, V108, P83, DOI 10.1177/146642408810800304; BRETTLE RP, 1987, BRIT MED J, V295, P421, DOI 10.1136/bmj.295.6595.421; Buning E., 1990, AIDS DRUG MISUSE CHA, P153; CARBALLO M, 1990, AIDS DRUG MISUSE, P16; DAWE S, 1991, BRIT J ADDICT, V86, P977; De Alarcon R, 1972, Psychol Med, V2, P293; DONMALL M, 1990, DRUGLINK, V5, P10; EDWARDS G, 1981, B WORLD HEALTH ORGAN, V59, P225; EDWARDS G, 1981, DRUG PROBLEMS BRITAI, P25; FARRELL M, 1990, BRIT J ADDICT, V85, P1657; GHODSE AH, 1977, BRIT MED J, V1, P1381, DOI 10.1136/bmj.1.6073.1381; GLANZ A, 1986, BRIT MED J, V293, P427, DOI 10.1136/bmj.293.6544.427; GLANZ A, 1989, BRIT MED J, V299, P1076, DOI 10.1136/bmj.299.6707.1076; GOSSOP M, 1988, BRIT J ADDICT, V83, P1159; JAMESON A, 1984, DEALING DRUG MISUSE; JOHNSON AM, 1991, BRIT MED J, V303, P573, DOI 10.1136/bmj.303.6802.573; LOVE J, 1985, BRIT J ADDICT, V80, P435; MacGregor S., 1990, DRUG SERVICES ENGLAN; MADEN A, 1991, BRIT MED J, V302, P880, DOI 10.1136/bmj.302.6781.880; MCGLOTHLIN WH, 1981, ARCH GEN PSYCHIAT, V38, P1055; OPPENHEIMER E, 1988, BRIT J ADDICT, V83, P635; PARKER H, 1987, BRIT J ADDICT, V82, P147; ROBERTSON R, 1990, AIDS DRUG MISUSE CHA; SMART RG, 1974, BRIT J ADDICT, V69, P225; STIMSON GV, 1988, BRIT MED J, V296, P1717, DOI 10.1136/bmj.296.6638.1717; Strang J., 1987, Health Trends, V19, P16; STRANG J, 1985, BRIT J PSYCHIAT, V147, P195, DOI 10.1192/bjp.147.2.195; STRANG J, 1990, LANCET, V335, P740, DOI 10.1016/0140-6736(90)90865-3; STRANG J, 1990, AIDS DRUG MISUSE CHA; STRANG J, 1989, DRUGS BRIT SOC RESPO; 1988, HLTH ALL AUSTR, P45; 1985, 5TH HOUS COMM INT RE; 1989, REPORT AIDS DRUG M 2; 1984, REPORT PREVENTION; 1984, GUIDELINES GOOD CLIN; 1990, WHO20 Q REP; 1986, MCCLELLAND REPORT; 1991, STATISTICS MISUSE DR; 1982, REPORT TREATMENT REH; 1988, REPORT AIDS DRUG M 1; 1985, DRUG MISUSE PREVALEN; 1991, CM1523; 1988, WATKINS REPORT; 1990, HLTH PEOPLE 2000; 1988, IMMUNISATION INFECTI; 1986, TACKLING DRUG MISUSE	47	5	5	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	OCT 26	1991	303	6809					1043	1046		10.1136/bmj.303.6809.1043	http://dx.doi.org/10.1136/bmj.303.6809.1043			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GM478	1954460	Bronze, Green Published			2022-12-24	WOS:A1991GM47800027
J	MIRKIN, G				MIRKIN, G			EXERCISE-ASSOCIATED URTICARIA	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							INDUCED ANAPHYLAXIS; CHOLINERGIC URTICARIA				MIRKIN, G (corresponding author), GEORGETOWN UNIV,SCH MED,WASHINGTON,DC 20057, USA.							BLACK AK, 1988, ACTA DERM-VENEREOL, V68, P541; CASALE TB, 1986, JAMA-J AM MED ASSOC, V255, P2049, DOI 10.1001/jama.255.15.2049; HARRIES MG, 1979, CLIN ALLERGY, V9, P437, DOI 10.1111/j.1365-2222.1979.tb02506.x; HATTY S, 1983, POSTGRAD MED J, V59, P586, DOI 10.1136/pgmj.59.695.586; KAPLAN AP, 1981, J ALLERGY CLIN IMMUN, V68, P319, DOI 10.1016/0091-6749(81)90158-5; KIVITY S, 1988, J ALLERGY CLIN IMMUN, V81, P1155, DOI 10.1016/0091-6749(88)90884-6; KUSHIMOTO H, 1985, ARCH DERMATOL, V121, P355, DOI 10.1001/archderm.121.3.355; MCCLEAN SP, 1989, J ALLERGY CLIN IMMUN, V83, P738, DOI 10.1016/0091-6749(89)90008-0; SHEFFER AL, 1984, J ALLERGY CLIN IMMUN, V73, P699, DOI 10.1016/0091-6749(84)90309-9; SHEFFER AL, 1980, J ALLERGY CLIN IMMUN, V66, P106, DOI 10.1016/0091-6749(80)90056-1; SHEFFER AL, 1988, NEW ENGL REG ALLERGY, V9, P215	11	1	1	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 6	1991	265	5					650	650						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EV718	1987418				2022-12-24	WOS:A1991EV71800026
J	MEYTES, D; SCHOCHAT, B; LEE, H; NADEL, G; SIDI, Y; CERNEY, M; SWANSON, P; SHAKLAI, M; KILIM, Y; ELGAT, M; CHIN, E; DANON, Y; ROSENBLATT, JD				MEYTES, D; SCHOCHAT, B; LEE, H; NADEL, G; SIDI, Y; CERNEY, M; SWANSON, P; SHAKLAI, M; KILIM, Y; ELGAT, M; CHIN, E; DANON, Y; ROSENBLATT, JD			SEROLOGICAL AND MOLECULAR SURVEY FOR HTLV-I INFECTION IN A HIGH-RISK MIDDLE-EASTERN GROUP	LANCET			English	Article							CELL LEUKEMIA-VIRUS; DRUG-ABUSERS; ANTIBODIES; LYMPHOMA; INDIVIDUALS; PREVALENCE; FALASHAS; ISRAEL	To define the extent of human T-cell leukaemia virus (HTLV-1) infection among a group of Jewish immigrants to Israel with an increased frequency of adult T-cell leukaemia, various serological and molecular screening methods, including enzyme-linked immunosorbent assay (ELISA) for anti-HTLV-1, ELISA for antibody to recombinant HTLV-1 p40tax protein, and molecular detection of infection by polymerase chain reaction (PCR) amplification of HTLV-1 proviral DNA from peripheral blood mononuclear cell DNA, were used. By HTLV-1 ELISA overall rate of infection was 12% (24 of 208) among immigrants from Khurusan, northeastern Iran; no HTLV-1 carriers were detected among 111 unselected Jewish immigrants from other parts of Iran. There was unexplained clustering of HTLV-1 infection within a cohort of 32 elderly women of similar geographic origin in a home for old people - 14 were seropositive by ELISA and 19 of 29 were positive by PCR. The findings in this newly identified high-risk population suggest that in addition to ELISA, other screening techniques may be required to detect all carriers in high-risk populations.	EDITH WOLFSON MED CTR,HOLON,ISRAEL; TEL AVIV UNIV,SACKLER SCH MED,HOLON,ISRAEL; BEILINSON MED CTR,IL-49100 PETAH TIQWA,ISRAEL; MINIST HLTH,TEL AVIV,ISRAEL; ABBOTT LABS,DIV DIAGNOST,N CHICAGO,IL 60064; UNIV CALIF LOS ANGELES,SCH MED,DEPT MED,DIV HEMATOL ONCOL,LOS ANGELES,CA 90024	Tel Aviv University; Sackler Faculty of Medicine; Rabin Medical Center; Abbott Laboratories; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA				sidi, yechezkel/0000-0001-7781-6153	NCI NIH HHS [CA52410-01, CA01314] Funding Source: Medline; NATIONAL CANCER INSTITUTE [K11CA001314, R01CA052410] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BENISHAI Z, 1985, NATURE, V315, P665, DOI 10.1038/315665a0; BIGGAR RJ, 1985, LANCET, V2, P520; BLATTNER WA, 1983, LANCET, V2, P61; BUNN PA, 1983, NEW ENGL J MED, V309, P257, DOI 10.1056/NEJM198308043090501; EHRLICH GD, 1989, BLOOD, V74, P1658; EHRLICH GD, 1989, BLOOD, V74, P1066; HINUMA Y, 1982, INT J CANCER, V29, P631, DOI 10.1002/ijc.2910290606; HINUMA Y, 1986, AIDS RES, V2, P517; KAMIHIRA S, 1989, JPN J CANCER RES, V80, P1066, DOI 10.1111/j.1349-7006.1989.tb02260.x; KARPAS A, 1986, NATURE, V319, P794, DOI 10.1038/319794a0; LEE H, 1989, SCIENCE, V244, P471, DOI 10.1126/science.2655084; LEOR J, 1988, ISRAEL J MED SCI, V24, P397; ROBERTGUROFF M, 1986, JAMA-J AM MED ASSOC, V255, P3133, DOI 10.1001/jama.255.22.3133; SIDI Y, 1990, CANCER, V65, P590, DOI 10.1002/1097-0142(19900201)65:3<590::AID-CNCR2820650334>3.0.CO;2-2; YOKATA T, 1989, INT J CANCER, V43, P970; 1972, ENCY JUDAICA, V11, P1399	16	77	78	0	3	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 22	1990	336	8730					1533	1535		10.1016/0140-6736(90)93308-C	http://dx.doi.org/10.1016/0140-6736(90)93308-C			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EP037	1979367				2022-12-24	WOS:A1990EP03700005
J	AROIAN, RV; KOGA, M; MENDEL, JE; OHSHIMA, Y; STERNBERG, PW				AROIAN, RV; KOGA, M; MENDEL, JE; OHSHIMA, Y; STERNBERG, PW			THE LET-23 GENE NECESSARY FOR CAENORHABDITIS-ELEGANS VULVAR INDUCTION ENCODES A TYROSINE KINASE OF THE EGF RECEPTOR SUBFAMILY	NATURE			English	Article									KYUSHU UNIV,FAC SCI,DEPT BIOL,HIGASHI KU,FUKUOKA 812,JAPAN	Kyushu University	AROIAN, RV (corresponding author), CALTECH,ARTHUR AMOS NOYES LAB CHEM PHYS,HOWARD HUGHES MED INST,DIV BIOL,PASADENA,CA 91125, USA.			Sternberg, Paul/0000-0002-7699-0173				ANDERSON SK, 1985, MOL CELL BIOL, V5, P1122, DOI 10.1128/MCB.5.5.1122; BARSTEAD RJ, 1989, J BIOL CHEM, V264, P10177; BIETEL GJ, 1990, NATURE, V348, P503; CARPENTER G, 1979, ANNU REV BIOCHEM, V48, P193, DOI 10.1146/annurev.bi.48.070179.001205; COTTON RGH, 1988, P NATL ACAD SCI USA, V85, P4397, DOI 10.1073/pnas.85.12.4397; COULSON A, 1988, NATURE, V335, P184, DOI 10.1038/335184a0; ELLIS C, 1990, NATURE, V343, P377, DOI 10.1038/343377a0; FERGUSON EL, 1989, GENETICS, V123, P109; FERGUSON EL, 1987, NATURE, V326, P259, DOI 10.1038/326259a0; FERGUSON EL, 1985, GENETICS, V110, P17; GIBBS JB, 1988, P NATL ACAD SCI USA, V85, P5026, DOI 10.1073/pnas.85.14.5026; GREENWALD IS, 1983, CELL, V34, P435, DOI 10.1016/0092-8674(83)90377-X; HAN M, 1990, GENETICS, V126, P899; HAN M, 1990, CELL, V63, P921, DOI 10.1016/0092-8674(90)90495-Z; HANKS SK, 1988, SCIENCE, V241, P42, DOI 10.1126/science.3291115; HENIKOFF S, 1984, GENE, V28, P351, DOI 10.1016/0378-1119(84)90153-7; HERMAN RK, 1978, GENETICS, V88, P49; HERMAN RK, 1990, NATURE, V348, P169, DOI 10.1038/348169a0; HORVITZ HR, 1980, GENETICS, V96, P435; HUNTER T, 1986, ENZYMES, V17; KAMPS MP, 1986, MOL CELL BIOL, V6, P751, DOI 10.1128/MCB.6.3.751; KAPLAN DR, 1990, CELL, V61, P125, DOI 10.1016/0092-8674(90)90220-9; KAZLAUSKAS A, 1990, SCIENCE, V247, P1578, DOI 10.1126/science.2157284; KIM SK, 1990, GENE DEV, V4, P357, DOI 10.1101/gad.4.3.357; KIMBLE J, 1981, DEV BIOL, V87, P286, DOI 10.1016/0012-1606(81)90152-4; KRAMER JM, 1990, J MOL CELL BIOL, V10, P2081; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LIVNEH E, 1985, CELL, V40, P599, DOI 10.1016/0092-8674(85)90208-9; Maniatis T., 1982, MOL CLONING; MULCAHY LS, 1985, NATURE, V313, P241, DOI 10.1038/313241a0; NECKAMEYER WS, 1985, J VIROL, V53, P879, DOI 10.1128/JVI.53.3.879-884.1985; PARSONS JT, 1990, TRENDS GENET, V6, P169; RUVKUN G, 1989, GENETICS, V121, P501; SCHEJTER ED, 1986, CELL, V46, P1091, DOI 10.1016/0092-8674(86)90709-9; SCHLESSINGER J, 1983, CRC CR REV BIOCH MOL, V14, P93, DOI 10.3109/10409238309102791; SCHWARTZ DC, 1984, CELL, V37, P67, DOI 10.1016/0092-8674(84)90301-5; SEYDOUX G, 1989, CELL, V57, P1237, DOI 10.1016/0092-8674(89)90060-3; SHTIVELMAN E, 1986, CELL, V47, P277, DOI 10.1016/0092-8674(86)90450-2; SIGURDSON DC, 1984, GENETICS, V108, P331; STERNBERG PW, 1986, CELL, V44, P761, DOI 10.1016/0092-8674(86)90842-1; STERNBERG PW, 1989, CELL, V58, P679, DOI 10.1016/0092-8674(89)90103-7; STERNBERG PW, 1988, NATURE, V335, P551, DOI 10.1038/335551a0; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1981, DEV BIOL, V82, P41, DOI 10.1016/0012-1606(81)90427-9; SULSTON JE, 1980, DEV BIOL, V78, P577, DOI 10.1016/0012-1606(80)90353-X; Sulston JHJ, 1988, NEMATODE CAENORHABDI; THOMAS JH, 1990, CELL, V62, P1041, DOI 10.1016/0092-8674(90)90382-O; TRAHEY M, 1987, SCIENCE, V238, P542, DOI 10.1126/science.2821624; ULLRICH A, 1984, NATURE, V309, P418, DOI 10.1038/309418a0; ULLRICH A, 1985, NATURE, V313, P576; WATSON MEE, 1984, NUCLEIC ACIDS RES, V12, P5145, DOI 10.1093/nar/12.13.5145; WEISSMAN BE, 1983, CELL, V32, P599, DOI 10.1016/0092-8674(83)90479-8; WITTBRODT J, 1989, NATURE, V341, P415, DOI 10.1038/341415a0; YARDEN Y, 1986, NATURE, V323, P226, DOI 10.1038/323226a0; YOCHEM J, 1988, NATURE, V335, P547, DOI 10.1038/335547a0	56	371	382	0	13	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	DEC 20	1990	348	6303					693	699		10.1038/348693a0	http://dx.doi.org/10.1038/348693a0			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EP049	1979659				2022-12-24	WOS:A1990EP04900046
J	MERIGAN, TC				MERIGAN, TC			YOU CAN TEACH AN OLD DOG NEW TRICKS - HOW AIDS TRIALS ARE PIONEERING NEW STRATEGIES	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material											MERIGAN, TC (corresponding author), STANFORD UNIV,CTR AIDS RES,STANFORD,CA 94305, USA.		Merigan, Thomas/AGQ-7464-2022					FISCHL MA, 1987, NEW ENGL J MED, V317, P185, DOI 10.1056/NEJM198707233170401; FISCHL MA, 1990, NEW ENGL J MED, V323, P1009, DOI 10.1056/NEJM199010113231501; FISCHL MA, 1990, SURROGATE ENDPOINTS, P4; LARDER BA, 1989, SCIENCE, V243, P1731, DOI 10.1126/science.2467383; LEMP GF, 1990, JAMA-J AM MED ASSOC, V263, P1497, DOI 10.1001/jama.263.11.1497; LIFSON AR, 1989, 5 INT C AIDS MONTR; MERIGAN TC, 1984, NEW ENGL J MED, V311, P1311, DOI 10.1056/NEJM198411153112009; MERIGAN TC, 1989, J INFECT DIS, V159, P390, DOI 10.1093/infdis/159.3.390; PIZZO PA, 1990, J INFECT DIS, V161, P316, DOI 10.1093/infdis/161.2.316; VOLBERDING PA, 1990, NEW ENGL J MED, V322, P941, DOI 10.1056/NEJM199004053221401	10	27	27	0	2	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	NOV 8	1990	323	19					1341	1343		10.1056/NEJM199011083231911	http://dx.doi.org/10.1056/NEJM199011083231911			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG588	1977082				2022-12-24	WOS:A1990EG58800011
J	MONUKI, ES; KUHN, R; WEINMASTER, G; TRAPP, BD; LEMKE, G				MONUKI, ES; KUHN, R; WEINMASTER, G; TRAPP, BD; LEMKE, G			EXPRESSION AND ACTIVITY OF THE POU TRANSCRIPTION FACTOR SCIP	SCIENCE			English	Article									SALK INST BIOL STUDIES, MOLEC NEUROBIOL LAB, LA JOLLA, CA 92037 USA; UNIV CALIF SAN DIEGO, DEPT NEUROSCI, LA JOLLA, CA 92093 USA; JOHNS HOPKINS UNIV, DEPT NEUROL, BALTIMORE, MD 21205 USA	Salk Institute; University of California System; University of California San Diego; Johns Hopkins University				Monuki, Edwin/0000-0001-5130-781X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS023896] Funding Source: NIH RePORTER; NINDS NIH HHS [NS 23896] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ABERCROMBIE M, 1957, J CELL COMPAR PHYSL, V50, P429, DOI 10.1002/jcp.1030500308; AGUAYO AJ, 1977, NATURE, V268, P753, DOI 10.1038/268753a0; BODNER M, 1988, CELL, V55, P505, DOI 10.1016/0092-8674(88)90037-2; BRADLEY W G, 1970, Experimental Neurology, V26, P275, DOI 10.1016/0014-4886(70)90125-1; BRAY GM, 1981, ANNU REV NEUROSCI, V4, P127, DOI 10.1146/annurev.ne.04.030181.001015; BROWN MJ, 1981, EXP NEUROL, V74, P170, DOI 10.1016/0014-4886(81)90157-6; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; ELLIS L, 1986, CELL, V45, P721, DOI 10.1016/0092-8674(86)90786-5; FINNEY M, 1988, CELL, V55, P757, DOI 10.1016/0092-8674(88)90132-8; GORMAN CM, 1982, P NATL ACAD SCI-BIOL, V79, P6777, DOI 10.1073/pnas.79.22.6777; HERR W, 1988, GENE DEV, V2, P1513, DOI 10.1101/gad.2.12a.1513; HEUMANN R, 1987, J CELL BIOL, V104, P1623, DOI 10.1083/jcb.104.6.1623; INGRAHAM HA, 1988, CELL, V55, P519, DOI 10.1016/0092-8674(88)90038-4; JESSEN KR, 1990, DEVELOPMENT, V109, P91; LAMPH WW, 1990, P NATL ACAD SCI USA, V87, P4320, DOI 10.1073/pnas.87.11.4320; LEMKE G, 1988, NEURON, V1, P73, DOI 10.1016/0896-6273(88)90211-5; LEMKE G, 1988, NEURON, V1, P535, DOI 10.1016/0896-6273(88)90103-1; LEMKE G, 1988, DEVELOPMENT, V102, P499; LEMKE G, 1985, CELL, V40, P501, DOI 10.1016/0092-8674(85)90198-9; LENARDO MJ, 1989, SCIENCE, V243, P544, DOI 10.1126/science.2536195; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; MERMOD N, 1989, CELL, V58, P741, DOI 10.1016/0092-8674(89)90108-6; MONUKI ES, 1989, NEURON, V3, P783, DOI 10.1016/0896-6273(89)90247-X; MULLER MM, 1988, NATURE, V336, P544, DOI 10.1038/336544a0; OKAMOTO K, 1990, CELL, V60, P461, DOI 10.1016/0092-8674(90)90597-8; RAFF MC, 1978, CELL, V15, P813, DOI 10.1016/0092-8674(78)90266-0; ROSNER MH, 1990, NATURE, V345, P686, DOI 10.1038/345686a0; SCHEIDEREIT C, 1988, NATURE, V336, P551, DOI 10.1038/336551a0; SCHOLERHR, 1990, NATURE, V344, P435; SEHGAL A, 1988, MOL CELL BIOL, V8, P3160, DOI 10.1128/MCB.8.8.3160; STURM RA, 1988, GENE DEV, V2, P1582, DOI 10.1101/gad.2.12a.1582; TANAKA M, 1990, CELL, V60, P375, DOI 10.1016/0092-8674(90)90589-7; TRAPP BD, 1988, J NEUROSCI, V8, P3515; VERRIJZER CP, 1990, EMBO J, V9, P1883, DOI 10.1002/j.1460-2075.1990.tb08314.x; WEBSTER HD, 1984, PERIPHERAL NEUROPATH, P329; XI H, 1989, NATURE, V340, P35, DOI 10.1038/340035a0; YAN Q, 1988, J NEUROSCI, V8, P3481	37	234	237	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	SEP 14	1990	249	4974					1300	1303		10.1126/science.1975954	http://dx.doi.org/10.1126/science.1975954			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DY351	1975954				2022-12-24	WOS:A1990DY35100040
J	BENIGNI, A; RIZZONI, G; ANTOLINI, A; PICCINELLI, A; REMUZZI, G				BENIGNI, A; RIZZONI, G; ANTOLINI, A; PICCINELLI, A; REMUZZI, G			PRELIMINARY-REPORT - RENAL THROMBOXANE-A2 SYNTHESIS IN CHILDREN WITH FREQUENT RELAPSING NEPHROTIC SYNDROME	LANCET			English	Article									OSPED RIUNITI BERGAMO, MARIO NEGRI INST PHARMACOL RES, I-24100 BERGAMO, ITALY; OSPED PEDIAT BAMBINO GESU, INST SCI RES, DIV NEPHROL, ROME, ITALY; OSPED RIUNITI BERGAMO, DIV NEPHROL, I-24100 BERGAMO, ITALY	Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Ospedali Riuniti di Bergamo; IRCCS Bambino Gesu; Ospedali Riuniti di Bergamo			Ariela, Benigni/ABH-3492-2020; Remuzzi, Giuseppe/V-9766-2017	Ariela, Benigni/0000-0002-4721-5485; Remuzzi, Giuseppe/0000-0002-6194-3446				[Anonymous], 1974, LANCET, V2, P423; COLLINS DM, 1990, KIDNEY INT, V37, P501; CRAVEN PA, 1990, KIDNEY INT, V37, P347; CYBULSKY AV, 1987, AM J PATHOL, V128, P45; DUNN MJ, 1983, GLOMERULAR INJURY 30, P75; FITZGERALD GA, 1983, CIRCULATION, V67, P1174, DOI 10.1161/01.CIR.67.6.1174; GOTO T, 1987, 10TH INT C NEPHR LON, P227; LIANOS EA, 1983, J CLIN INVEST, V72, P1439, DOI 10.1172/JCI111100; LOWRY OH, 1951, J BIOL CHEM, V193, P265; MACCONI D, 1989, J LAB CLIN MED, V113, P549; NIWA T, 1988, CLIN NEPHROL, V30, P276; PATRONO C, 1983, ADV PROSTAGLANDIN TH, P493; PERICO N, 1986, AM J PHYSIOL, V251, pF581, DOI 10.1152/ajprenal.1986.251.4.F581; PURKERSON ML, 1985, P NATL ACAD SCI USA, V82, P193, DOI 10.1073/pnas.82.1.193; RAHMAN MA, 1987, KIDNEY INT, V31, P1317, DOI 10.1038/ki.1987.145; REMUZZI G, 1985, J CLIN INVEST, V75, P94, DOI 10.1172/JCI111703; STAHL RAK, 1987, RENAL PHYSIOL BIOCH, V10, P1	17	9	9	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	SEP 1	1990	336	8714					533	534		10.1016/0140-6736(90)92088-Y	http://dx.doi.org/10.1016/0140-6736(90)92088-Y			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DW781	1975040				2022-12-24	WOS:A1990DW78100005
J	YANOFSKY, MF; MA, H; BOWMAN, JL; DREWS, GN; FELDMANN, KA; MEYEROWITZ, EM				YANOFSKY, MF; MA, H; BOWMAN, JL; DREWS, GN; FELDMANN, KA; MEYEROWITZ, EM			THE PROTEIN ENCODED BY THE ARABIDOPSIS HOMEOTIC GENE AGAMOUS RESEMBLES TRANSCRIPTION FACTORS	NATURE			English	Article									CALTECH,DIV BIOL 15629,PASADENA,CA 91125; DUPONT CO INC,WILMINGTON,DE 19880	California Institute of Technology; DuPont			Ma, Hong/W-5251-2018; Meyerowitz, Elliot M/A-7118-2009	Ma, Hong/0000-0001-8717-4422; Bowman, John/0000-0001-7347-3691				BARKER SJ, 1988, P NATL ACAD SCI USA, V85, P458, DOI 10.1073/pnas.85.2.458; BOWMAN JL, 1989, PLANT CELL, V1, P37, DOI 10.1105/tpc.1.1.37; BRAUN A, 1873, GESELL NATURFORSCH F, P75; CHANG C, 1988, P NATL ACAD SCI USA, V85, P6856, DOI 10.1073/pnas.85.18.6856; CONRAD D, 1971, Biologisches Zentralblatt, V90, P137; CRAWFORD NM, 1986, P NATL ACAD SCI USA, V83, P8073, DOI 10.1073/pnas.83.21.8073; DUBOIS E, 1987, MOL GEN GENET, V207, P142, DOI 10.1007/BF00331501; FELDMANN KA, 1989, SCIENCE, V243, P1351, DOI 10.1126/science.243.4896.1351; FELDMANN KA, 1987, MOL GEN GENET, V208, P1, DOI 10.1007/BF00330414; FRALEY RT, 1985, BIO-TECHNOL, V3, P629, DOI 10.1038/nbt0785-629; HAYES TE, 1987, P NATL ACAD SCI USA, V84, P1272, DOI 10.1073/pnas.84.5.1272; HERSKOWITZ I, 1989, NATURE, V342, P749, DOI 10.1038/342749a0; INGHAM PW, 1988, NATURE, V335, P25, DOI 10.1038/335025a0; KOMAKI MK, 1988, DEVELOPMENT, V104, P195; Koornneef J, 1980, ARABIDOPSIS INFORMAT, V17, P11; KOORNNEEF M, 1987, GENETIC MAPS 1987 CO, P742; KUNST L, 1989, PLANT CELL, V1, P1131; LIPMAN DJ, 1985, SCIENCE, V227, P1435, DOI 10.1126/science.2983426; LLOYD AM, 1986, SCIENCE, V234, P464, DOI 10.1126/science.234.4775.464; MA H, 1990, P NATL ACAD SCI USA, V87, P3821, DOI 10.1073/pnas.87.10.3821; MEYEROWITZ EM, 1989, CELL, V56, P263, DOI 10.1016/0092-8674(89)90900-8; MEYEROWITZ EM, 1989, DEVELOPMENT, V106, P209; MEYEROWITZ EM, 1987, ANNU REV GENET, V21, P93, DOI 10.1146/annurev.genet.21.1.93; MURRE C, 1989, CELL, V58, P537, DOI 10.1016/0092-8674(89)90434-0; NORMAN C, 1988, CELL, V55, P989, DOI 10.1016/0092-8674(88)90244-9; PASSMORE S, 1988, J MOL BIOL, V204, P593, DOI 10.1016/0022-2836(88)90358-0; PRUITT RE, 1987, 45TH S SOC DEV BIOL, P327; SCHROTER H, 1990, EMBO J, V9, P1123, DOI 10.1002/j.1460-2075.1990.tb08218.x; SMYTH DR, IN PRESS PLANT CELL, V2; SOMMER H, 1990, EMBO J, V9, P605, DOI 10.1002/j.1460-2075.1990.tb08152.x; VELTEN J, 1985, NUCLEIC ACIDS RES, V13, P6981, DOI 10.1093/nar/13.19.6981	31	1216	1347	11	167	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUL 5	1990	346	6279					35	39		10.1038/346035a0	http://dx.doi.org/10.1038/346035a0			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DM396	1973265				2022-12-24	WOS:A1990DM39600050
J	KHAMASHTA, MA; CERVERA, R; ASHERSON, RA; FONT, J; GIL, A; COLTART, DJ; VAZQUEZ, JJ; PARE, C; INGELMO, M; OLIVER, J; HUGHES, GRV				KHAMASHTA, MA; CERVERA, R; ASHERSON, RA; FONT, J; GIL, A; COLTART, DJ; VAZQUEZ, JJ; PARE, C; INGELMO, M; OLIVER, J; HUGHES, GRV			ASSOCIATION OF ANTIBODIES AGAINST PHOSPHOLIPIDS WITH HEART-VALVE DISEASE IN SYSTEMIC LUPUS-ERYTHEMATOSUS	LANCET			English	Article									HOSP LA PAZ,DEPT INTERNAL MED,MADRID,SPAIN; HOSP LA PAZ,DEPT CARDIOL,MADRID,SPAIN; HOSP CLIN BARCELONA,DEPT INTERNAL MED,BARCELONA,SPAIN; HOSP CLIN BARCELONA,DEPT CARDIOL,BARCELONA,SPAIN; ST THOMAS HOSP,DEPT CARDIOL,LONDON SE1 7EH,ENGLAND	Hospital Universitario La Paz; Hospital Universitario La Paz; University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; Guy's & St Thomas' NHS Foundation Trust	KHAMASHTA, MA (corresponding author), ST THOMAS HOSP,RAYNE INST,LUPUS ARTHRITIS RES UNIT,LONDON SE1 7EH,ENGLAND.							ALARCONSEGOVIA D, 1989, MEDICINE, V68, P353, DOI 10.1097/00005792-198911000-00003; ASHERSON RA, 1989, MEDICINE, V68, P366, DOI 10.1097/00005792-198911000-00004; ASHERSON RA, 1988, J RHEUMATOL, V15, P539; BENOTTI JR, 1984, CHEST, V86, P140, DOI 10.1378/chest.86.1.140; BULKLEY BH, 1975, AM J MED, V58, P243, DOI 10.1016/0002-9343(75)90575-6; CERVERA R, 1990, ANN RHEUM DIS, V49, P109, DOI 10.1136/ard.49.2.109; CHAMBERS JB, 1988, BMJ-BRIT MED J, V297, P1071, DOI 10.1136/bmj.297.6656.1071; CHARTASH EK, 1989, AM J MED, V86, P407, DOI 10.1016/0002-9343(89)90337-9; CROZIER I, 1989, NEW ENGL J MED, V320, P739; DOHERTY NE, 1985, AM HEART J, V110, P1257, DOI 10.1016/0002-8703(85)90023-7; DOHERTY NE, 1988, AM J CARDIOL, V61, P1144, DOI 10.1016/0002-9149(88)90150-6; ELKAYAM U, 1977, ANN RHEUM DIS, V36, P349, DOI 10.1136/ard.36.4.349; EXNER T, 1975, PATHOLOGY, V7, P319, DOI 10.3109/00313027509081688; FONT J, 1989, CLIN RHEUMATOL, V8, P475, DOI 10.1007/BF02032099; FORD PM, 1988, J RHEUMATOL, V15, P597; GALVE E, 1988, NEW ENGL J MED, V319, P817, DOI 10.1056/NEJM198809293191302; GHARAVI AE, 1987, ANN RHEUM DIS, V46, P1, DOI 10.1136/ard.46.1.1; HARRIS EN, 1987, CLIN EXP IMMUNOL, V68, P215; HARRIS EN, 1986, ARCH INTERN MED, V146, P2153, DOI 10.1001/archinte.146.11.2153; HUGHES GRV, 1983, BRIT MED J, V287, P1088, DOI 10.1136/bmj.287.6399.1088; KHAMASHTA MA, 1989, AM J MED, V86, P633, DOI 10.1016/0002-9343(89)90414-2; KLINKHOFF AV, 1985, JAMA-J AM MED ASSOC, V253, P3273, DOI 10.1001/jama.253.22.3273; Libman E, 1924, ARCH INTERN MED, V33, P701, DOI 10.1001/archinte.1924.00110300044002; LOCKSHIN MD, 1985, NEW ENGL J MED, V313, P152, DOI 10.1056/NEJM198507183130304; MANDELL BF, 1987, SEMIN ARTHRITIS RHEU, V17, P126, DOI 10.1016/0049-0172(87)90035-7; PAGET SA, 1975, AM J MED, V59, P134, DOI 10.1016/0002-9343(75)90331-9; SHAPIRO RF, 1977, ANN RHEUM DIS, V36, P508, DOI 10.1136/ard.36.6.508; STRAATON KV, 1988, AM J MED, V85, P645; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; 1986, ARTHRITIS RHEUM, V29, P93	30	265	275	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JUN 30	1990	335	8705					1541	1544		10.1016/0140-6736(90)91373-I	http://dx.doi.org/10.1016/0140-6736(90)91373-I			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL480	1972484				2022-12-24	WOS:A1990DL48000001
J	ROSNER, MH; VIGANO, MA; OZATO, K; TIMMONS, PM; POIRIER, F; RIGBY, PWJ; STAUDT, LM				ROSNER, MH; VIGANO, MA; OZATO, K; TIMMONS, PM; POIRIER, F; RIGBY, PWJ; STAUDT, LM			A POU-DOMAIN TRANSCRIPTION FACTOR IN EARLY STEM-CELLS AND GERM-CELLS OF THE MAMMALIAN EMBRYO	NATURE			English	Article									HOWARD HUGHES MED INST,BETHESDA,MD 20892; GEORGETOWN UNIV,SCH MED,DEPT PATHOL,WASHINGTON,DC 20057; NICHHD,DEV & MOLEC IMMUN LAB,BETHESDA,MD 20892; NATL INST MED RES,EUKARYOT MOLEC GENET LAB,LONDON NW7 1AA,ENGLAND	Howard Hughes Medical Institute; Georgetown University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); MRC National Institute for Medical Research	ROSNER, MH (corresponding author), NCI,METAB BRANCH,BETHESDA,MD 20892, USA.		Staudt, Louis/AAC-5324-2019	vigano, maria alessandra/0000-0003-2009-0384				ANDREWS PW, 1984, LAB INVEST, V50, P147; Ausubel FM., 1988, CURRENT PROTOCOLS MO; BOHMANN D, 1987, NATURE, V325, P268, DOI 10.1038/325268a0; CLERC RG, 1988, GENE DEV, V2, P1570, DOI 10.1101/gad.2.12a.1570; DUVOVAN PJ, 1986, CELL, V44, P831; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; EVANS MJ, 1983, CANCER SURV, V2, P185; FLETCHER C, 1987, CELL, V51, P773, DOI 10.1016/0092-8674(87)90100-0; GABE M, 1975, HIST TECHNIQUES, P602; GARDNER RL, 1979, J EMBRYOL EXP MORPH, V52, P141; GERSTER T, 1987, EMBO J, V6, P1323, DOI 10.1002/j.1460-2075.1987.tb02371.x; GUBLER U, 1983, GENE, V25, P263, DOI 10.1016/0378-1119(83)90230-5; GUNNING P, 1983, MOL CELL BIOL, V3, P787, DOI 10.1128/MCB.3.5.787; HAGER DA, 1980, ANAL BIOCHEM, V109, P76, DOI 10.1016/0003-2697(80)90013-5; HERR W, 1988, GENE DEV, V2, P1513, DOI 10.1101/gad.2.12a.1513; HOLLAND PWH, 1988, GENE DEV, V2, P773, DOI 10.1101/gad.2.7.773; HUARTE J, 1987, GENE DEV, V1, P1201, DOI 10.1101/gad.1.10.1201; KO HS, 1988, CELL, V55, P135, DOI 10.1016/0092-8674(88)90016-5; LANDOLFI NF, 1986, NATURE, V323, P548, DOI 10.1038/323548a0; LEBOWITZ JH, 1988, GENE DEV, V2, P1227, DOI 10.1101/gad.2.10.1227; LENARDO MJ, 1989, SCIENCE, V243, P544, DOI 10.1126/science.2536195; Maniatis T., 1982, MOL CLONING; MARTIN GR, 1975, CELL, V5, P229, DOI 10.1016/0092-8674(75)90098-7; MARTIN GR, 1981, P NATL ACAD SCI-BIOL, V78, P7634, DOI 10.1073/pnas.78.12.7634; MCBURNEY MW, 1982, NATURE, V299, P165, DOI 10.1038/299165a0; MERMOD N, 1989, CELL, V58, P741, DOI 10.1016/0092-8674(89)90108-6; MLODZIK M, 1987, CELL, V48, P465, DOI 10.1016/0092-8674(87)90197-8; MULLER MM, 1988, NATURE, V336, P544, DOI 10.1038/336544a0; OKAMOTO K, 1990, CELL, V60, P461, DOI 10.1016/0092-8674(90)90597-8; ROBERTSON E, 1986, NATURE, V323, P445, DOI 10.1038/323445a0; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHEIDEREIT C, 1988, NATURE, V336, P551, DOI 10.1038/336551a0; SCHEIDEREIT C, 1987, CELL, V51, P783, DOI 10.1016/0092-8674(87)90101-2; SCHOLER HR, 1989, EMBO J, V8, P2543, DOI 10.1002/j.1460-2075.1989.tb08392.x; SCHOLER HR, 1990, NATURE, V344, P435, DOI 10.1038/344435a0; SCHOLER HR, 1989, EMBO J, V8, P2551, DOI 10.1002/j.1460-2075.1989.tb08393.x; SEVERNE Y, 1988, EMBO J, V7, P2503, DOI 10.1002/j.1460-2075.1988.tb03097.x; SINGH H, 1986, NATURE, V319, P154, DOI 10.1038/319154a0; SIVE HL, 1986, P NATL ACAD SCI USA, V83, P6382, DOI 10.1073/pnas.83.17.6382; STAUDT LM, 1986, NATURE, V323, P640, DOI 10.1038/323640a0; STAUDT LM, 1988, SCIENCE, V241, P577, DOI 10.1126/science.3399892; STEVENS LC, 1967, J NATL CANCER I, V38, P549; STEVENS LC, 1974, DEV BIOL, V37, P369, DOI 10.1016/0012-1606(74)90155-9; STRICKLAND S, 1978, CELL, V15, P393, DOI 10.1016/0092-8674(78)90008-9; STURM R, 1987, GENE DEV, V1, P1147, DOI 10.1101/gad.1.10.1147; STURM RA, 1988, GENE DEV, V2, P1582, DOI 10.1101/gad.2.12a.1582; WILKINSON DG, 1987, CELL, V50, P79, DOI 10.1016/0092-8674(87)90664-7; ZIMARINO V, 1987, NATURE, V327, P727, DOI 10.1038/327727a0	48	766	797	0	24	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUN 21	1990	345	6277					686	692		10.1038/345686a0	http://dx.doi.org/10.1038/345686a0			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DK399	1972777				2022-12-24	WOS:A1990DK39900055
J	[Anonymous]				[Anonymous]			GROWTH AND NUTRITION IN CHILDREN WITH CEREBRAL-PALSY	LANCET			English	Editorial Material																		DRVARIC DM, 1987, J PEDIATR ORTHOPED, V7, P187, DOI 10.1097/01241398-198703000-00015; FINNIE N, 1974, HANDLING YOUNG CEREB, P120; FISHERBRANDIES H, 1987, EUROPEAN J ORTHODONT, V9, P139; GISEL EG, 1988, LANCET, V1, P283; GRIGGS CA, 1989, DEV MED CHILD NEUROL, V31, P303; HULME JB, 1987, AM J OCCUP THER, V41, P81, DOI 10.5014/ajot.41.2.81; ILLINWORTH RS, 1987, DEV INFANT YOUNG CHI, P324; MOFFAT V, 1984, PHYSICALLY HANDICAPP, P133; Morris S. E., 1987, PREFEEDING SKILLS; Mulcahy C, 1988, PHYSIOTHERAPY, V74, P531; OTTENBACHER K, 1983, PHYS OCCUP THER PEDI, V3, P1; PATRICK J, 1986, DEV MED CHILD NEUROL, V28, P734; POLNAY L, 1985, COMMUNITY PEDIATRICS, P230; PRYOR HB, 1967, CLIN PEDIATR, V6, P501, DOI 10.1177/000992286700600819; REMPEL GR, 1988, PEDIATRICS, V82, P857; ROCKEY J, 1984, PHYSICALLY HANDICAPP, P350; TANNER JM, 1984, FOETUS MAN, P140; TOPPING MJ, 1989, P CAMBRIDGE WORKSHOP, P73	18	1	1	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	MAY 26	1990	335	8700					1253	1254						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF451	1971327				2022-12-24	WOS:A1990DF45100010
J	COLLINS, RA; SAVILLE, BJ				COLLINS, RA; SAVILLE, BJ			INDEPENDENT TRANSFER OF MITOCHONDRIAL CHROMOSOMES AND PLASMIDS DURING UNSTABLE VEGETATIVE FUSION IN NEUROSPORA	NATURE			English	Article									UNIV TORONTO,CTR PLANT BIOTECHNOL,TORONTO M5S 3B2,ONTARIO,CANADA	University of Toronto	COLLINS, RA (corresponding author), UNIV TORONTO,DEPT BOT,TORONTO M5S 3B2,ONTARIO,CANADA.							AKINS RA, 1988, J MOL BIOL, V204, P1, DOI 10.1016/0022-2836(88)90594-3; BELFORT M, 1989, TRENDS GENET, V5, P209, DOI 10.1016/0168-9525(89)90083-8; COLLINS RA, 1981, CELL, V24, P443, DOI 10.1016/0092-8674(81)90335-4; COLLINS RA, 1983, PLASMID, V9, P53, DOI 10.1016/0147-619X(83)90031-8; Davis R.H., 1970, 789 METHODS ENZYMOLO, VVolume 17, P79, DOI DOI 10.1016/0076-6879(71)17168-6; DUJON B, 1989, GENE, V82, P91, DOI 10.1016/0378-1119(89)90034-6; GARRIGA G, 1984, CELL, V36, P623, DOI 10.1016/0092-8674(84)90342-8; HEINEMANN JA, 1989, NATURE, V340, P205, DOI 10.1038/340205a0; KEMBLE RJ, 1988, MOL GEN GENET, V213, P202, DOI 10.1007/BF00339582; Lambowitz A M, 1979, Methods Enzymol, V59, P421; LAMBOWITZ AM, 1989, CELL, V56, P323, DOI 10.1016/0092-8674(89)90232-8; LANG BF, 1984, EMBO J, V3, P2129, DOI 10.1002/j.1460-2075.1984.tb02102.x; Maniatis T., 1982, MOL CLONING; MANNELLA CA, 1979, J BACTERIOL, V137, P1449, DOI 10.1128/JB.137.3.1449-1451.1979; MAY G, 1989, NATURE, V339, P320, DOI 10.1038/339320a0; MICHEL F, 1985, NATURE, V316, P641, DOI 10.1038/316641a0; MITCHELL MB, 1952, P NATL ACAD SCI USA, V38, P442, DOI 10.1073/pnas.38.5.442; MYLYK OM, 1976, GENETICS, V83, P275; NARGANG FE, 1984, CELL, V38, P441, DOI 10.1016/0092-8674(84)90499-9; NATVIG DO, 1984, J BACTERIOL, V159, P288, DOI 10.1128/JB.159.1.288-293.1984; PERKINS DD, 1988, EXP MYCOL, V12, P91, DOI 10.1016/0147-5975(88)90001-1; SAVILLE BJ, IN PRESS CELL; SOUTHERN EM, 1975, J MOL BIOL, V98, P503, DOI 10.1016/S0022-2836(75)80083-0; STACHEL SE, 1989, NATURE, V340, P190, DOI 10.1038/340190a0; SYVANEN M, 1986, TRENDS GENET, V2, P63, DOI 10.1016/0168-9525(86)90180-0; TAYLOR JW, 1985, MOL GEN GENET, V201, P161, DOI 10.1007/BF00425654	26	99	101	0	6	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	MAY 10	1990	345	6271					177	179		10.1038/345177a0	http://dx.doi.org/10.1038/345177a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DC833	1970854				2022-12-24	WOS:A1990DC83300073
J	PIPELEERSMARICHAL, M; SOMERS, G; WILLEMS, G; FOULIS, A; IMRIE, C; BISHOP, AE; POLAK, JM; HACKI, WH; STAMM, B; HEITZ, PU; KLOPPEL, G				PIPELEERSMARICHAL, M; SOMERS, G; WILLEMS, G; FOULIS, A; IMRIE, C; BISHOP, AE; POLAK, JM; HACKI, WH; STAMM, B; HEITZ, PU; KLOPPEL, G			GASTRINOMAS IN THE DUODENUMS OF PATIENTS WITH MULTIPLE ENDOCRINE NEOPLASIA TYPE-1 AND THE ZOLLINGER-ELLISON SYNDROME	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									VRIJE UNIV BRUSSELS,ACAD HOSP,DEPT MED,B-1090 BRUSSELS,BELGIUM; VRIJE UNIV BRUSSELS,ACAD HOSP,DEPT SURG,B-1090 BRUSSELS,BELGIUM; GLASGOW ROYAL INFIRM,DEPT PATHOL,GLASGOW G4 0SF,SCOTLAND; GLASGOW ROYAL INFIRM,DEPT SURG,GLASGOW G4 0SF,SCOTLAND; HAMMERSMITH HOSP,ROYAL POSTGRAD MED SCH,DEPT HISTOCHEM,LONDON W12 0HS,ENGLAND; UNIV ZURICH,DEPT INTERNAL MED,CH-8006 ZURICH,SWITZERLAND; UNIV ZURICH,INST PATHOL,CH-8006 ZURICH,SWITZERLAND	Vrije Universiteit Brussel; Vrije Universiteit Brussel; University of Glasgow; University of Glasgow; Imperial College London; University of Zurich; University of Zurich	PIPELEERSMARICHAL, M (corresponding author), VRIJE UNIV BRUSSELS,ACAD HOSP,DEPT PATHOL,LAARBEEKLAAN 101,B-1090 BRUSSELS,BELGIUM.			Imrie, Clem/0000-0002-1190-7084				BALLARD HS, 1964, MEDICINE, V43, P481, DOI 10.1097/00005792-196407000-00003; BONFILS S, 1981, ANN SURG, V194, P692, DOI 10.1097/00000658-198112000-00005; BORDI C, 1987, AM J CLIN PATHOL, V88, P153, DOI 10.1093/ajcp/88.2.153; BRANDI ML, 1987, ENDOCR REV, V8, P391, DOI 10.1210/edrv-8-4-391; CREUTZFELDT W, 1975, HUM PATHOL, V6, P47, DOI 10.1016/S0046-8177(75)80109-2; DELCORE R, 1988, ANN SURG, V208, P291, DOI 10.1097/00000658-198809000-00006; DEVENEY CW, 1983, ANN SURG, V198, P546, DOI 10.1097/00000658-198310000-00015; FRIESEN SR, 1980, AM J SURG, V139, P61, DOI 10.1016/0002-9610(80)90231-7; FRIESEN SR, 1982, AM J SURG, V143, P331, DOI 10.1016/0002-9610(82)90102-7; ISENBERG JI, 1973, GASTROENTEROLOGY, V65, P140, DOI 10.1016/s0016-5085(19)33157-9; KLOPPEL G, 1986, CANCER, V57, P1824, DOI 10.1002/1097-0142(19860501)57:9<1824::AID-CNCR2820570920>3.0.CO;2-Q; LAMERS CB, 1978, AM J MED, V64, P607, DOI 10.1016/0002-9343(78)90580-6; MALAGELADA JR, 1983, GASTROENTEROLOGY, V84, P1524; OBERG K, 1982, AM J MED, V73, P619, DOI 10.1016/0002-9343(82)90401-6; PILATO FP, 1988, CANCER, V61, P1815, DOI 10.1002/1097-0142(19880501)61:9<1815::AID-CNCR2820610916>3.0.CO;2-L; Ptak T, 1970, Adv Intern Med, V16, P213; Schimke R N, 1976, Adv Intern Med, V21, P249; STAMM B, 1986, VIRCHOWS ARCH A, V408, P475, DOI 10.1007/BF00705301; THOMPSON NW, 1984, WORLD J SURG, V8, P561, DOI 10.1007/BF01654938; THOMPSON NW, 1989, ANN SURG, V209, P396, DOI 10.1097/00000658-198904000-00002; WEICHERT RF, 1971, AM J SURG, V121, P195, DOI 10.1016/0002-9610(71)90098-5; WOLFE MM, 1987, NEW ENGL J MED, V317, P1200, DOI 10.1056/NEJM198711053171907; ZOLLINGER RM, 1987, SEMIN ONCOL, V14, P247	23	282	285	0	1	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 15	1990	322	11					723	727		10.1056/NEJM199003153221103	http://dx.doi.org/10.1056/NEJM199003153221103			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT652	1968616				2022-12-24	WOS:A1990CT65200003
J	SUMIMOTO, H; OHKUMA, Y; SINN, E; KATO, H; SHIMASAKI, S; HORIKOSHI, M; ROEDER, RG				SUMIMOTO, H; OHKUMA, Y; SINN, E; KATO, H; SHIMASAKI, S; HORIKOSHI, M; ROEDER, RG			CONSERVED SEQUENCE MOTIFS IN THE SMALL SUBUNIT OF HUMAN GENERAL TRANSCRIPTION FACTOR TFIIE	NATURE			English	Article							RNA POLYMERASE-II; SIGMA-FACTORS; INITIATION; PROTEINS; PURIFICATION; SPECIFICITY; EXPRESSION; BINDING; MYOD	A GENERAL initiation factor, TFIIE, is essential for transcription initiation by RNA polymerase II in conjunction with other general factors 1,2 . TFIIE is a heterotetramer containing two subunits of relative molecular mass 57,000 (TFIIE-alpha) and two of 34,000 (TFIIE-beta) 3,4. TFIIE-beta is required in conjunction with TFIIE-alpha for transcription initiation. Here we report the cloning and expression of a complementary DNA encoding a functional human TFIIE-beta. Recombinant TFIIE-beta could replace the natural TFIIE-beta for transcription in conjunction with TFIIE-alpha. Amino-acid sequence comparisons reveal regions with sequence similarities to: subregion 3 of bacterial or factors 6; a region of RAP30 (the small subunit of TFIIF) with sequence similarity to a sigma-factor subregion implicated in binding to RNA polymerase 7; and a portion of the basic region-helix-loop-helix motif found in several enhancer-binding proteins 8-10. These potential homologies have implications for the role of TFIIE in preinitiation complex assembly and function.	WHITTIER INST DIABET & ENDOCRINOL,DEPT MOLEC ENDOCRINOL,LA JOLLA,CA 92037		SUMIMOTO, H (corresponding author), ROCKEFELLER UNIV,BIOCHEM & MOLEC BIOL LAB,NEW YORK,NY 10021, USA.							CAI MJ, 1990, CELL, V61, P437, DOI 10.1016/0092-8674(90)90525-J; CONAWAY JW, 1991, J BIOL CHEM, V266, P7804; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; FLORES O, 1989, J BIOL CHEM, V264, P8913; GORBALENYA AE, 1989, NUCLEIC ACIDS RES, V17, P8413, DOI 10.1093/nar/17.21.8413; GRIBSKOV M, 1986, NUCLEIC ACIDS RES, V14, P6745, DOI 10.1093/nar/14.16.6745; HELMANN JD, 1988, ANNU REV BIOCHEM, V57, P839, DOI 10.1146/annurev.bi.57.070188.004203; HOFFMANN A, 1990, NATURE, V346, P387, DOI 10.1038/346387a0; HORIKOSHI M, 1989, NATURE, V341, P299, DOI 10.1038/341299a0; HU YF, 1990, GENE DEV, V4, P1741, DOI 10.1101/gad.4.10.1741; INOSTROZA J, 1991, J BIOL CHEM, V266, P9304; JOHNSON PF, 1989, ANNU REV BIOCHEM, V58, P799, DOI 10.1146/annurev.biochem.58.1.799; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; LESZCZYNSKI JF, 1986, SCIENCE, V234, P849, DOI 10.1126/science.3775366; LUSCHER B, 1990, GENE DEV, V4, P2235, DOI 10.1101/gad.4.12b.2235; MALIK S, IN PRESS P NATN ACAD; MATSUI T, 1980, J BIOL CHEM, V255, P1992; MCCRACKEN S, 1991, SCIENCE, V253, P900, DOI 10.1126/science.1652156; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; OHKUMA Y, 1990, P NATL ACAD SCI USA, V87, P9163, DOI 10.1073/pnas.87.23.9163; OHKUMA Y, 1991, NATURE, V354, P398, DOI 10.1038/354398a0; OLSON EN, 1990, GENE DEV, V4, P1454, DOI 10.1101/gad.4.9.1454; REINBERG D, 1987, J BIOL CHEM, V262, P3310; ROSENBERG AH, 1987, GENE, V56, P125, DOI 10.1016/0378-1119(87)90165-X; SALTZMAN AG, 1989, FASEB J, V3, P1723, DOI 10.1096/fasebj.3.6.2649403; SAWADOGO M, 1990, ANNU REV BIOCHEM, V59, P711, DOI 10.1146/annurev.bi.59.070190.003431; SAWADOGO M, 1985, P NATL ACAD SCI USA, V82, P4394, DOI 10.1073/pnas.82.13.4394; SAWADOGO M, 1984, J BIOL CHEM, V259, P5321; SCHEIDEREIT C, 1988, NATURE, V336, P551, DOI 10.1038/336551a0; SUMIMOTO H, 1990, P NATL ACAD SCI USA, V87, P9158, DOI 10.1073/pnas.87.23.9158	30	79	80	0	2	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	DEC 5	1991	354	6352					401	404		10.1038/354401a0	http://dx.doi.org/10.1038/354401a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT761	1956404				2022-12-24	WOS:A1991GT76100054
J	ALTIERI, DC; ETINGIN, OR; FAIR, DS; BRUNCK, TK; GELTOSKY, JE; HAJJAR, DP; EDGINGTON, TS				ALTIERI, DC; ETINGIN, OR; FAIR, DS; BRUNCK, TK; GELTOSKY, JE; HAJJAR, DP; EDGINGTON, TS			STRUCTURALLY HOMOLOGOUS LIGAND-BINDING OF INTEGRIN MAC-1 AND VIRAL GLYCOPROTEIN-C RECEPTORS	SCIENCE			English	Article							COAGULATION FACTOR-X; ENDOTHELIAL-CELLS; BLOOD COAGULATION; ALPHA-CHYMOTRYPSIN; FACTOR-VA; ACTIVATION; THROMBIN; CLONING; SUBUNIT; SITE	Three spatially distant surface loops were found to mediate the interaction of the coagulation protein factor X with the leukocyte integrin Mac-1. This interacting region, which by computational modeling defines a three-dimensional macromotif in the catalytic domain, was also recognized by glycoprotein C (gC), a factor X receptor expressed on herpes simplex virus (HSV)-infected endothelial cells. Peptidyl mimicry of each loop inhibited factor X binding to Mac-1 and gC, blocked monocyte generation of thrombin, and prevented monocyte adhesion to HSV-infected endothelium. These data link the ligand recognition of Mac-1 to established mechanisms of receptor-mediated vascular injury.	UNIV TEXAS, CTR HLTH, DEPT BIOCHEM, TYLER, TX 75710 USA; CORVAS INT INC, SAN DIEGO, CA 92121 USA; RW JOHNSON PHARMACEUT RES INST, SAN DIEGO, CA 92121 USA; CORNELL UNIV, MED CTR, COLL MED, DEPT BIOCHEM, NEW YORK, NY 10021 USA; CORNELL UNIV, MED CTR, COLL MED, DEPT PATHOL, NEW YORK, NY 10021 USA	University of Texas System; University of Texas at Tyler; University of Texas-Health Sciences Center at Tyler (UTHSCT); Johnson & Johnson; Johnson & Johnson USA; Cornell University; Cornell University	ALTIERI, DC (corresponding author), SCRIPPS RES INST, DEPT IMMUNOL, LA JOLLA, CA 92037 USA.				NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL016411, R01HL043773] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL 43773, HL 46408, P01 HL 16411] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ALTIERI DC, 1988, J BIOL CHEM, V263, P7007; ALTIERI DC, 1988, P NATL ACAD SCI USA, V85, P7462, DOI 10.1073/pnas.85.20.7462; ARNAOUT MA, 1990, BLOOD, V75, P1037; ARNAOUT MA, 1988, P NATL ACAD SCI USA, V85, P2776, DOI 10.1073/pnas.85.8.2776; BARSHAVIT R, 1983, SCIENCE, V220, P728, DOI 10.1126/science.6836310; BENDITT EP, 1983, P NATL ACAD SCI-BIOL, V80, P6386, DOI 10.1073/pnas.80.20.6386; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; BLEVINS RA, 1985, J BIOL CHEM, V260, P4264; BODE W, 1983, J MOL BIOL, V164, P237, DOI 10.1016/0022-2836(83)90077-3; BROZE GJ, 1982, J CLIN INVEST, V70, P526, DOI 10.1172/JCI110644; BRUNCK TK, COMMUNICATION; CHATTOPADHYAY A, 1989, J BIOL CHEM, V264, P11035; CORBI AL, 1988, J BIOL CHEM, V263, P12403; ETINGIN OR, 1990, CELL, V61, P657, DOI 10.1016/0092-8674(90)90477-V; FRIEDMAN HM, 1984, NATURE, V309, P633, DOI 10.1038/309633a0; FRINK RJ, 1983, J VIROL, V45, P634, DOI 10.1128/JVI.45.2.634-647.1983; FUNG MR, 1985, P NATL ACAD SCI USA, V82, P3591, DOI 10.1073/pnas.82.11.3591; GLENN KC, 1979, NATURE, V278, P711, DOI 10.1038/278711a0; GREER J, 1990, PROTEINS, V7, P317, DOI 10.1002/prot.340070404; HAJJAR DP, 1987, J CLIN INVEST, V80, P1317, DOI 10.1172/JCI113208; HANSON SR, 1988, P NATL ACAD SCI USA, V85, P3184, DOI 10.1073/pnas.85.9.3184; KISHIMOTO TK, 1987, CELL, V48, P681, DOI 10.1016/0092-8674(87)90246-7; LAM SCT, 1987, J BIOL CHEM, V262, P947; MARQUART M, 1983, ACTA CRYSTALLOGR B, V39, P480, DOI 10.1107/S010876818300275X; MARUYAMA I, 1984, J CLIN INVEST, V74, P224, DOI 10.1172/JCI111405; NIEMETZ J, 1971, NATURE-NEW BIOL, V232, P247, DOI 10.1038/newbio232247a0; RUOSLAHTI E, 1991, J CLIN INVEST, V87, P1, DOI 10.1172/JCI114957; SANTORO SA, 1987, CELL, V48, P867, DOI 10.1016/0092-8674(87)90083-3; SAWYER L, 1978, J MOL BIOL, V118, P137, DOI 10.1016/0022-2836(78)90412-6; SPRINGER TA, 1990, NATURE, V346, P425, DOI 10.1038/346425a0; STERN DM, 1985, J BIOL CHEM, V260, P6717; TRACY PB, 1979, J BIOL CHEM, V254, P354; VISSER MR, 1988, P NATL ACAD SCI USA, V85, P8227, DOI 10.1073/pnas.85.21.8227; ZIMMERMAN GA, 1985, J CLIN INVEST, V76, P2235, DOI 10.1172/JCI112232; [No title captured]	35	50	50	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 22	1991	254	5035					1200	1202		10.1126/science.1957171	http://dx.doi.org/10.1126/science.1957171			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ834	1957171				2022-12-24	WOS:A1991GQ83400046
J	HUA, QX; SHOELSON, SE; KOCHOYAN, M; WEISS, MA				HUA, QX; SHOELSON, SE; KOCHOYAN, M; WEISS, MA			RECEPTOR-BINDING REDEFINED BY A STRUCTURAL SWITCH IN A MUTANT HUMAN INSULIN	NATURE			English	Article								CRYSTAL Structures of insulin have been determined in various distinct forms 1-5, the relevance of which to receptor recognition has long been the subject of speculation 2,6,7. Recently the crystal structure of an inactive insulin analogue has been determined and, surprisingly, found to have a conformation identical to native insulin 8,9. On this basis Dodson and colleagues have suggested that the known insulin crystal structures reflect an inactive conformation, and that a change in conformation is required for activity-specifically, the carboxy terminal residues of the B-chain are proposed to separate from the amino terminal residues of the A-chain 8. Here we report the solution structure of an active insulin mutant 7,10, determined by two-dimensional NMR, which supports this hypothesis. In the mutant, the carboxy terminal beta-turn and beta-strand of the B-chain are destabilized and do not pack across the rest of the molecule. We suggest that analogous detachment of the carboxy terminal region of the B-chain occurs in native insulin on binding to its receptor. Our finding that partial unfolding of the B-chain exposes an alternative protein surface rationalizes the receptor-binding properties of a series of anomalous insulin analogues 7,11-13, including a mutant insulin associated with diabetes mellitus in man 14,15.	MASSACHUSETTS GEN HOSP, DEPT MED, BOSTON, MA 02114 USA; CHINESE ACAD SCI, INST BIOPHYS, BEIJING, PEOPLES R CHINA; BRIGHAM & WOMENS HOSP, JOSLIN DIABET CTR, BOSTON, MA 02115 USA; BRIGHAM & WOMENS HOSP, DEPT MED, BOSTON, MA 02115 USA; HARVARD UNIV, SCH MED, DEPT MED, BOSTON, MA 02115 USA; CNRS, UA 32, F-91128 PALAISEAU, FRANCE	Harvard University; Massachusetts General Hospital; Chinese Academy of Sciences; Institute of Biophysics, CAS; Harvard University; Brigham & Women's Hospital; Joslin Diabetes Center, Inc.; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Centre National de la Recherche Scientifique (CNRS)								BADGER J, 1991, ACTA CRYSTALLOGR B, V47, P127, DOI 10.1107/S0108768190009570; BAKER EN, 1988, PHILOS T R SOC LON B, V319, P389; BENTLEY G, 1976, NATURE, V261, P166, DOI 10.1038/261166a0; BI RC, 1984, BIOPOLYMERS, V23, P391, DOI DOI 10.1002/BIP.360230302; BOELENS R, 1990, EUR J BIOCHEM, V191, P147, DOI 10.1111/j.1432-1033.1990.tb19104.x; BRANGE J, 1988, NATURE, V333, P679, DOI 10.1038/333679a0; BROWN H, 1955, BIOCHEM J, V60, P556, DOI 10.1042/bj0600556; CASARETTO M, 1987, BIOL CHEM H-S, V368, P709, DOI 10.1515/bchm3.1987.368.1.709; CHOTHIA C, 1983, NATURE, V302, P500, DOI 10.1038/302500a0; CLORE GM, 1989, CRIT REV BIOCHEM MOL, V24, P479, DOI 10.3109/10409238909086962; DAI JB, 1987, SCI CHINA SER B, V30, P55; DEREWENDA U, 1989, NATURE, V338, P594, DOI 10.1038/338594a0; DEREWENDA U, 1991, J MOL BIOL, V220, P425, DOI 10.1016/0022-2836(91)90022-X; DODSON EJ, 1983, BIOPOLYMERS, V22, P281, DOI 10.1002/bip.360220137; HUA QX, 1991, BIOCHEMISTRY-US, V30, P5505, DOI 10.1021/bi00236a025; HUA QX, UNPUB J MOL BIOL; KLINE AD, 1990, BIOCHEMISTRY-US, V29, P2906, DOI 10.1021/bi00464a003; KOBAYASHI M, 1982, BIOCHEM BIOPH RES CO, V107, P329, DOI 10.1016/0006-291X(82)91708-9; KRISTENSEN SM, 1991, J MOL BIOL, V218, P221, DOI 10.1016/0022-2836(91)90886-B; MARKUSSEN J, 1985, INT J PEPT PROT RES, V26, P70; MIRMIRA RG, 1989, J BIOL CHEM, V264, P6349; NAKAGAWA SH, 1986, J BIOL CHEM, V261, P7332; NANJO K, 1986, J CLIN INVEST, V77, P514, DOI 10.1172/JCI112331; PULLEN RA, 1976, NATURE, V259, P369, DOI 10.1038/259369a0; SHOELSON S, 1983, NATURE, V302, P540, DOI 10.1038/302540a0; SHOELSON SE, UNPUB BIOCHEMISTRY; Steiner D. F., 1990, ENDOCRINOLOGY, P1263; WANG SH, 1991, J PROTEIN CHEM, V10, P313, DOI 10.1007/BF01025630; WEISS MA, 1991, BIOCHEMISTRY-US, V30, P7373, DOI 10.1021/bi00244a004; WUTHRICH K, 1989, METHOD ENZYMOL, V177, P125	30	234	249	0	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	NOV 21	1991	354	6350					238	241		10.1038/354238a0	http://dx.doi.org/10.1038/354238a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ948	1961250				2022-12-24	WOS:A1991GQ94800052
J	FELSON, DT; SLOUTSKIS, D; ANDERSON, JJ; ANTHONY, JM; KIEL, DP				FELSON, DT; SLOUTSKIS, D; ANDERSON, JJ; ANTHONY, JM; KIEL, DP			THIAZIDE DIURETICS AND THE RISK OF HIP FRACTURE - RESULTS FROM THE FRAMINGHAM-STUDY	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POSTMENOPAUSAL WOMEN; MINERAL-CONTENT; BONE LOSS; CALCIUM	Thiazide diuretics may preserve bone mass and prevent elderly women's osteopenic fractures, but studies have not distinquished between thiazide preparations or examined former users. We performed a case-control study looking at thiazide use and subsequent hip fracture in postmenopausal female members of the Framingham Study cohort. Cases who had experienced a first hip fracture (n = 176) were compared with age-matched controls (n = 672). Results showed a modest protective effect of any recent thiazide use (not significant). However, recent pure thiazide users experienced significant protection against fracture (adjusted odds ratio, 0.31; 95% confidence interval, 0.11 to 0.88), whereas recent users of combination drugs containing thaizides experienced no protection (adjusted odds ratio, 1.16; 95% confidence interval, 0.44 to 3.05). Combination drugs generally contained only 25 mg of hydrochlorothiazide, suggesting that the small amount of thiazide was insufficient to preserve bone mass. Former thiazide users were not protected against fracture. In sum, recent pure thiazide use in women protects against hip fracture.	BOSTON CITY HOSP,DEPT MED,BOSTON,MA 02118; UNIV HOSP BOSTON,DEPT MED,BOSTON,MA 02118; BROWN UNIV,DIV GEN INTERNAL MED,PROGRAM MED,PROVIDENCE,RI 02912; RHODE ISL HOSP,PROVIDENCE,RI 02902	Boston Medical Center; Brown University; Lifespan Health Rhode Island; Rhode Island Hospital	FELSON, DT (corresponding author), BOSTON UNIV,SCH MED,CTR ARTHRITIS,A-203,80 E CONCORD ST,BOSTON,MA 02118, USA.			Felson, David/0000-0002-2668-2447; Kiel, Douglas/0000-0001-8474-0310	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P60AR020613] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR-20613] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		ADLANDDAVENPORT P, 1985, AM J OBSTET GYNECOL, V152, P630, DOI 10.1016/S0002-9378(85)80035-1; FELSON DT, 1988, AM J EPIDEMIOL, V128, P1102; FELSON DT, 1989, J AM GERIATR SOC, V37, P495, DOI 10.1111/j.1532-5415.1989.tb05678.x; HASTINGS RP, 1986, SUGI SUPPLEMENTAL LI; HEANEY RP, 1982, AM J CLIN NUTR, V36, P986, DOI 10.1093/ajcn/36.5.986; KIEL DP, 1990, AM J EPIDEMIOL, V132, P675, DOI 10.1093/oxfordjournals.aje.a115709; KIEL DP, 1987, NEW ENGL J MED, V317, P1169, DOI 10.1056/NEJM198711053171901; LACROIX AZ, 1990, NEW ENGL J MED, V322, P286, DOI 10.1056/NEJM199002013220502; LJUNGHALL S, 1981, SCAND J UROL NEPHROL, V15, P257, DOI 10.3109/00365598109179613; RAY WA, 1989, LANCET, V1, P687; RIGGS BL, 1987, J CLIN INVEST, V80, P979, DOI 10.1172/JCI113191; TRANSBOL I, 1982, METABOLISM, V31, P383, DOI 10.1016/0026-0495(82)90115-9; WASNICH RD, 1983, NEW ENGL J MED, V309, P344, DOI 10.1056/NEJM198308113090605	13	123	130	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 16	1991	265	3					370	373		10.1001/jama.265.3.370	http://dx.doi.org/10.1001/jama.265.3.370			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ER256	1984536				2022-12-24	WOS:A1991ER25600027
J	KISSINGER, CR; LIU, BS; MARTINBLANCO, E; KORNBERG, TB; PABO, CO				KISSINGER, CR; LIU, BS; MARTINBLANCO, E; KORNBERG, TB; PABO, CO			CRYSTAL-STRUCTURE OF AN ENGRAILED HOMEODOMAIN-DNA COMPLEX AT 2.8-A RESOLUTION - A FRAMEWORK FOR UNDERSTANDING HOMEODOMAIN-DNA INTERACTIONS	CELL			English	Article									JOHNS HOPKINS UNIV,SCH MED,HOWARD HUGHES MED INST,BALTIMORE,MD 21205; UNIV CALIF SAN FRANCISCO,DEPT BIOCHEM & BIOPHYS,SAN FRANCISCO,CA 94143	Howard Hughes Medical Institute; Johns Hopkins University; University of California System; University of California San Francisco	KISSINGER, CR (corresponding author), JOHNS HOPKINS UNIV,SCH MED,DEPT MOLEC BIOL & GENET,BALTIMORE,MD 21205, USA.		Martin-Blanco, Enrique/ABH-1280-2020	Martin-Blanco, Enrique/0000-0002-6926-910X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM031471] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM24635, GM31471] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		AFFOLTER M, 1990, P NATL ACAD SCI USA, V87, P4093, DOI 10.1073/pnas.87.11.4093; AGGARWAL AK, 1988, SCIENCE, V242, P899, DOI 10.1126/science.3187531; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; BRUNGER AT, 1990, XPLOR V21 MANUAL; BURLEY SK, 1985, SCIENCE, V229, P23, DOI 10.1126/science.3892686; DICKERSON RE, 1981, J MOL BIOL, V149, P761, DOI 10.1016/0022-2836(81)90357-0; HANES SD, 1989, CELL, V57, P1275, DOI 10.1016/0092-8674(89)90063-9; HERR W, 1988, GENE DEV, V2, P1513, DOI 10.1101/gad.2.12a.1513; INGRAHAM HA, 1990, CELL, V61, P1021, DOI 10.1016/0092-8674(90)90067-O; JOHNSON AD, 1980, THESIS HARVARD U CAM; JORDAN SR, 1988, SCIENCE, V242, P893, DOI 10.1126/science.3187530; JORDAN SR, 1985, SCIENCE, V230, P1383; KORNBERG T, 1981, P NATL ACAD SCI-BIOL, V78, P1095, DOI 10.1073/pnas.78.2.1095; LAUGHON A, 1984, NATURE, V310, P25, DOI 10.1038/310025a0; LIU BS, 1990, BIOCHEM BIOPH RES CO, V171, P257, DOI 10.1016/0006-291X(90)91385-6; OTWINOWSKI Z, 1988, NATURE, V335, P321, DOI 10.1038/335321a0; PABO CO, 1990, SCIENCE, V247, P1210, DOI 10.1126/science.2315694; PABO CO, 1984, ANNU REV BIOCHEM, V53, P293, DOI 10.1146/annurev.bi.53.070184.001453; POOLE SJ, 1985, CELL, V40, P37, DOI 10.1016/0092-8674(85)90306-X; QIAN YQ, 1989, CELL, V59, P573, DOI 10.1016/0092-8674(89)90040-8; ROSSMANN MG, 1980, ACTA CRYSTALLOGR B, V36, P819, DOI 10.1107/S056774088000461X; ROULD MA, 1989, SCIENCE, V246, P1135, DOI 10.1126/science.2479982; SCOTT MP, 1989, BIOCHIM BIOPHYS ACTA, V989, P25, DOI 10.1016/0304-419X(89)90033-4; SEEMAN NC, 1976, P NATL ACAD SCI USA, V73, P804, DOI 10.1073/pnas.73.3.804; SHEPHERD JCW, 1984, NATURE, V310, P70, DOI 10.1038/310070a0; SLUKA JP, 1990, BIOCHEMISTRY-US, V29, P6551, DOI 10.1021/bi00480a002; STAACKE D, 1990, EMBO J, V9, P1963, DOI 10.1002/j.1460-2075.1990.tb08324.x; TREISMAN J, 1989, CELL, V59, P553; WANG BC, 1985, METHOD ENZYMOL, V115, P90; WANG JC, 1979, P NATL ACAD SCI USA, V76, P200, DOI 10.1073/pnas.76.1.200	30	956	966	4	23	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	NOV 2	1990	63	3					579	590		10.1016/0092-8674(90)90453-L	http://dx.doi.org/10.1016/0092-8674(90)90453-L			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EG687	1977522				2022-12-24	WOS:A1990EG68700015
J	GARSON, JA; TUKE, PW; MAKRIS, M; BRIGGS, M; MACHIN, SJ; PRESTON, FE; TEDDER, RS				GARSON, JA; TUKE, PW; MAKRIS, M; BRIGGS, M; MACHIN, SJ; PRESTON, FE; TEDDER, RS			DEMONSTRATION OF VIREMIA PATTERNS IN HEMOPHILIACS TREATED WITH HEPATITIS-C-VIRUS-CONTAMINATED FACTOR-VIII CONCENTRATES	LANCET			English	Article									UNIV COLL & MIDDLESEX SCH MED,DEPT HAEMATOL,LONDON,ENGLAND; ROYAL HALLAMSHIRE HOSP,DEPT HAEMATOL,SHEFFIELD S10 2JF,S YORKSHIRE,ENGLAND	University of London; University College London; University of Sheffield	GARSON, JA (corresponding author), UNIV COLL & MIDDLESEX SCH MED,SCH PATHOL,DEPT MED MICROBIOL,VIROL SECT,67 RIDINGHOUSE ST,LONDON W1P 7PN,ENGLAND.		Garson, Jeremy A/C-5357-2008; Makris, Mike/A-2772-2011	Makris, Mike/0000-0001-7622-7939; Tedder, Richard/0000-0002-9672-5721; Garson, Jeremy/0000-0003-0553-0126				ALTER HJ, 1989, NEW ENGL J MED, V321, P1494, DOI 10.1056/NEJM198911303212202; BRETTLER DB, 1989, BLOOD, V73, P2067; CHEINSONGPOPOV R, 1986, BRIT MED J, V293, P168, DOI 10.1136/bmj.293.6540.168; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; COLOMBO M, 1985, LANCET, V2, P1; DAVIS GL, 1989, NEW ENGL J MED, V321, P1501, DOI 10.1056/NEJM198911303212203; FLETCHER ML, 1983, BRIT MED J, V287, P1754, DOI 10.1136/bmj.287.6407.1754; GARSON JA, 1990, LANCET, V335, P1473, DOI 10.1016/0140-6736(90)91510-H; GARSON JA, 1990, LANCET, V335, P1419, DOI 10.1016/0140-6736(90)91446-H; GARSON JA, 1990, LANCET, V336, P878, DOI 10.1016/0140-6736(90)92384-T; HAY CRM, 1985, LANCET, V1, P1495; IKKALA E, 1982, BRIT J HAEMATOL, V52, P7, DOI 10.1111/j.1365-2141.1982.tb03856.x; KASPER CK, 1972, J AMER MED ASSOC, V221, P510, DOI 10.1001/jama.1972.03200180052024; KERNOFF PBA, 1987, BRIT J HAEMATOL, V67, P207, DOI 10.1111/j.1365-2141.1987.tb02328.x; KOO G, 1989, SCIENCE, V244, P362; KWOK S, 1989, NATURE, V339, P237, DOI 10.1038/339237a0; LUDLAM CA, 1989, LANCET, V2, P560; MAKRIS, 1990, LANCET, V335, P1117; PRESTON FE, 1985, LANCET, V2, P213; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; TRIGER DR, 1990, BRIT J HAEMATOL, V74, P241, DOI 10.1111/j.1365-2141.1990.tb02577.x; VANDERPOEL CL, 1990, LANCET, V335, P558, DOI 10.1016/0140-6736(90)90347-8; WAITE J, 1988, AIDS, V2, P443, DOI 10.1097/00002030-198812000-00006; WEINER AJ, 1990, LANCET, V335, P1, DOI 10.1016/0140-6736(90)90134-Q	24	214	217	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 27	1990	336	8722					1022	1025		10.1016/0140-6736(90)92487-3	http://dx.doi.org/10.1016/0140-6736(90)92487-3			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EF076	1977017				2022-12-24	WOS:A1990EF07600002
J	GOUGH, AC; MILES, JS; SPURR, NK; MOSS, JE; GAEDIGK, A; EICHELBAUM, M; WOLF, CR				GOUGH, AC; MILES, JS; SPURR, NK; MOSS, JE; GAEDIGK, A; EICHELBAUM, M; WOLF, CR			IDENTIFICATION OF THE PRIMARY GENE DEFECT AT THE CYTOCHROME-P450 CYP2D LOCUS	NATURE			English	Article									UNIV EDINBURGH,DEPT BIOCHEM,IMPERIAL CANC RES FUND,MOLEC PHARMACOL GRP,HUGH ROBSON BLDG,EDINBURGH EH8 9XD,SCOTLAND; IMPERIAL CANC RES FUND,HUMAN GENET RESOURCES,CLARE HALL LABS,POTTERS BAR EN6 3LD,ENGLAND; DR MARGARETE FISCHER BOSCH INST CLIN PHARMACOL,W-7000 STUTTGART 50,GERMANY	University of Edinburgh; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital								AYESH R, 1984, NATURE, V312, P169, DOI 10.1038/312169a0; BIGGIN MD, 1983, P NATL ACAD SCI-BIOL, V80, P3963, DOI 10.1073/pnas.80.13.3963; CUPORASO N, 1989, CANCER RES, V49, P3675; CUPORASO N, 1988, P SOC CLIN ONCOL, V8; EICHELBAUM M, 1988, ISI ATLAS-PHARMACOL, V2, P243; EICHELBAUM M, 1979, EUR J CLIN PHARMACOL, V16, P183, DOI 10.1007/BF00562059; FEINBERG AP, 1983, ANAL BIOCHEM, V136, P6; FORRESTER LM, 1990, METABOLIC MOL BASIS, P3; GAEDIGK A, 1990, Naunyn-Schmiedeberg's Archives of Pharmacology, V341, pR109; GONZALEZ FJ, 1988, NATURE, V331, P442, DOI 10.1038/331442a0; GONZALEZ FJ, 1989, PHARMACOL REV, V40, P243; GUENGERICH FP, 1987, CYTOCHROME P450, V2; GUENGERICH FP, 1987, CYTOCHROME P450, V1; KAISARY A, 1987, CANCER RES, V47, P5488; KIMURA S, 1989, AM J HUM GENET, V45, P889; KRONBACH T, 1987, ANAL BIOCHEM, V162, P24, DOI 10.1016/0003-2697(87)90006-6; KWOK SCM, 1985, BIOCHEMISTRY-US, V24, P556, DOI 10.1021/bi00324a002; MAHGOUB A, 1977, LANCET, V2, P584, DOI 10.1016/S0140-6736(77)91430-1; MEYER UA, 1986, XENOBIOTICA, V16, P449, DOI 10.3109/00498258609050251; NEBERT DW, 1989, DNA-J MOLEC CELL BIO, V8, P1, DOI 10.1089/dna.1.1989.8.1; NEBERT DW, 1988, PHENOTYPIC VARIATION; ROOTS I, 1988, KLIN WOCHENSCHR, V66, P87; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SANGER F, 1980, J MOL BIOL, V143, P161, DOI 10.1016/0022-2836(80)90196-5; SKODA RC, 1988, P NATL ACAD SCI USA, V85, P5240, DOI 10.1073/pnas.85.14.5240; SPIERS CJ, 1989, BR J CLIN PHARM, V29, P101; STADEN R, 1986, NUCLEIC ACIDS RES, V14, P217, DOI 10.1093/nar/14.1.217; TUCKER GT, 1977, LANCET, V2, P718; WOLF CR, 1986, TRENDS GENET, V2, P209, DOI 10.1016/0168-9525(86)90232-5	29	317	330	0	6	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	OCT 25	1990	347	6295					773	776		10.1038/347773a0	http://dx.doi.org/10.1038/347773a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EE659	1978251				2022-12-24	WOS:A1990EE65900066
J	YARCHOAN, R; PLUDA, JM; THOMAS, RV; MITSUYA, H; BROUWERS, P; WYVILL, KM; HARTMAN, N; JOHNS, DG; BRODER, S				YARCHOAN, R; PLUDA, JM; THOMAS, RV; MITSUYA, H; BROUWERS, P; WYVILL, KM; HARTMAN, N; JOHNS, DG; BRODER, S			LONG-TERM TOXICITY ACTIVITY PROFILE OF 2',3'-DIDEOXYINOSINE IN AIDS OR AIDS-RELATED COMPLEX	LANCET			English	Article									NCI,DEV THERAPEUT PROGRAM,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	YARCHOAN, R (corresponding author), NCI,CLIN ONCOL PROGRAM,BLDG 10,RM 13N248,BETHESDA,MD 20892, USA.							AHLUWALIA G, 1987, BIOCHEM PHARMACOL, V36, P3797, DOI 10.1016/0006-2952(87)90440-0; AHLUWALIA G, 1988, 1988 P AM ASS CANC R, P349; BUTLER K, 1989, 29TH INT C ANT AG CH, P106; CLAS D, 1989, CAN MED ASSOC J, V140, P823; COOLEY TP, 1990, NEW ENGL J MED, V322, P1430; DU DL, 1989, EXP HEMATOL, V17, P519; FAUCI AS, 1990, NEW ENGL J MED, V322, P1386, DOI 10.1056/NEJM199005103221909; FULLER GN, 1989, LANCET, V2, P937; GRUNFELD C, 1989, AM J MED, V86, P27, DOI 10.1016/0002-9343(89)90225-8; HARTMAN NR, 1990, CLIN PHARMACOL THER, V47, P647, DOI 10.1038/clpt.1990.86; HERER B, 1989, BRIT MED J, V298, P605, DOI 10.1136/bmj.298.6673.605-a; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; LAMBERT JS, 1990, NEW ENGL J MED, V322, P1333, DOI 10.1056/NEJM199005103221901; MALLORY A, 1980, GASTROENTEROLOGY, V78, P813, DOI 10.1016/0016-5085(80)90689-7; MITSUYA H, 1987, P NATL ACAD SCI USA, V84, P2033, DOI 10.1073/pnas.84.7.2033; MITSUYA H, 1986, P NATL ACAD SCI USA, V83, P1911, DOI 10.1073/pnas.83.6.1911; MOLINA JM, 1989, NEW ENGL J MED, V321, P1478; PERNO CF, 1989, J EXP MED, V169, P933, DOI 10.1084/jem.169.3.933; PRESENT DH, 1989, ANN INTERN MED, V111, P641, DOI 10.7326/0003-4819-111-8-641; RICHMAN DD, 1987, NEW ENGL J MED, V317, P192, DOI 10.1056/NEJM198707233170402; SCHWARTZ MS, 1989, AM J GASTROENTEROL, V84, P459; YARCHOAN R, 1989, SCIENCE, V245, P412, DOI 10.1126/science.2502840; YARCHOAN R, 1990, REV INFECT DIS, V12, pS522; YARCHOAN R, 1989, J CELL BIOCHEM, V13, P313	24	230	244	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 1	1990	336	8714					526	529		10.1016/0140-6736(90)92085-V	http://dx.doi.org/10.1016/0140-6736(90)92085-V			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DW781	1975038				2022-12-24	WOS:A1990DW78100003
J	PSATY, BM; KOEPSELL, TD; WAGNER, EH; LOGERFO, JP; INUI, TS				PSATY, BM; KOEPSELL, TD; WAGNER, EH; LOGERFO, JP; INUI, TS			THE RELATIVE RISK OF INCIDENT CORONARY HEART-DISEASE ASSOCIATED WITH RECENTLY STOPPING THE USE OF BETA-BLOCKERS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									UNIV WASHINGTON,DEPT MED,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT EPIDEMIOL,SEATTLE,WA 98195; UNIV WASHINGTON,DEPT HLTH SERV,SEATTLE,WA 98195; GRP HLTH COOPERAT PUGET SOUND,CTR HLTH STUDIES,SEATTLE,WA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative								BOLLI P, 1981, CIRCULATION, V64, P1130, DOI 10.1161/01.CIR.64.6.1130; EGSTRUP K, 1988, AM J CARDIOL, V61, P1219, DOI 10.1016/0002-9149(88)91158-7; FRISHMAN WH, 1987, AM J CARDIOL, V59, pF26, DOI 10.1016/0002-9149(87)90038-5; HART GR, 1981, ARCH INTERN MED, V141, P1125, DOI 10.1001/archinte.141.9.1125; HELD PH, 1989, BMJ-BRIT MED J, V299, P1187, DOI 10.1136/bmj.299.6709.1187; HOUSTON MC, 1988, AM HEART J, V116, P515, DOI 10.1016/0002-8703(88)90627-8; JICK H, 1979, NEW ENGL J MED, V300, P218, DOI 10.1056/NEJM197902013000502; McCullagh P., 1983, GEN LINEAR MODELS, DOI [10.1007/978-1-4899-3244-0, DOI 10.1007/978-1-4899-3244-0]; MULCAHY D, 1988, LANCET, V2, P755; OLSSON G, 1988, EUR HEART J, V9, P365, DOI 10.1093/oxfordjournals.eurheartj.a062512; PSATY BM, 1987, J GEN INTERN MED, V2, P381, DOI 10.1007/BF02596362; PSATY BM, 1989, JAMA-J AM MED ASSOC, V261, P2087, DOI 10.1001/jama.261.14.2087; REITHMANN C, 1987, KLIN WOCHENSCHR, V65, P308, DOI 10.1007/BF01745384; Schlesselman JJ, 1982, CASE CONTROL STUDIES; SHEPARD DS, 1977, AM J PUBLIC HEALTH, V67, P743, DOI 10.2105/AJPH.67.8.743; WALDEN RJ, 1982, AM HEART J, V104, P515, DOI 10.1016/0002-8703(82)90149-1; WIKSTRAND J, 1987, J CLIN PHARM THER, V12, P347, DOI 10.1111/j.1365-2710.1987.tb00548.x; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7; 1981, EUR HEART J, V2, P389; 1984, EUR HEART J, V5, P189	20	215	219	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 23	1990	263	12					1653	1657		10.1001/jama.263.12.1653	http://dx.doi.org/10.1001/jama.263.12.1653			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT964	1968518				2022-12-24	WOS:A1990CT96400029
J	LOISANCE, D; DUBOISRANDE, JL; DELEUZE, P; OKUDE, J; ROSENVAL, O; GESCHWIND, H				LOISANCE, D; DUBOISRANDE, JL; DELEUZE, P; OKUDE, J; ROSENVAL, O; GESCHWIND, H			PROPHYLACTIC INTRAVENTRICULAR PUMPING IN HIGH-RISK CORONARY ANGIOPLASTY	LANCET			English	Article									FAC MED CRETEIL,DEPT SURG RES,CNRS,UNITE 591,F-94010 CRETEIL,FRANCE	Centre National de la Recherche Scientifique (CNRS); Universite Gustave-Eiffel; Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	LOISANCE, D (corresponding author), FAC MED CRETEIL,DEPT CARDIAC SURG,CNRS,UNITE 591,8 RUE GEN SARRAIL,F-94010 CRETEIL,FRANCE.							FRAZIER OH, IN PRESS T AM SOC IN; HINGLAIS J., 1965, COEUR MED INTERN, V4, P85; LAKS H, 1986, CIRCULATION S3, V74, P15; LOISANCE D, 1989, LANCET, V1, P561; Wampler R K, 1988, ASAIO Trans, V34, P450	5	31	33	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	FEB 24	1990	335	8687					438	440		10.1016/0140-6736(90)90666-S	http://dx.doi.org/10.1016/0140-6736(90)90666-S			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP907	1968170				2022-12-24	WOS:A1990CP90700004
J	PREMACHANDRA, DJ; WOODWARD, BM; MILTON, CM; SERGEANT, RJ; FABRE, JW				PREMACHANDRA, DJ; WOODWARD, BM; MILTON, CM; SERGEANT, RJ; FABRE, JW			TREATMENT OF POSTOPERATIVE OTORRHEA BY GRAFTING OF MASTOID CAVITIES WITH CULTURED AUTOLOGOUS EPIDERMAL-CELLS	LANCET			English	Article									QUEEN VICTORIA HOSP, BLOND MCINDOE CTR MED RES, E GRINSTEAD RH19 3DZ, W SUSSEX, ENGLAND; KENT & SUSSEX HOSP, DEPT EAR NOSE & THROAT SURG, TUNBRIDGE WELLS, ENGLAND; QUEEN VICTORIA HOSP, REG PLAST SURG UNIT, E GRINSTEAD RH19 3DZ, W SUSSEX, ENGLAND									AUBOCK J, 1988, TRANSPLANTATION, V45, P730, DOI 10.1097/00007890-198804000-00013; BRAIN A, 1989, BRIT MED J, V298, P917, DOI 10.1136/bmj.298.6678.917; BURT AM, 1989, BRIT MED J, V298, P915, DOI 10.1136/bmj.298.6678.915; FABRE JW, 1989, TRANSPLANTATION, V48, P306, DOI 10.1097/00007890-198908000-00024; GACEK RR, 1976, ANN OTO RHINOL LARYN, V85, P305, DOI 10.1177/000348947608500301; GALLICO GG, 1984, NEW ENGL J MED, V311, P448, DOI 10.1056/NEJM198408163110706; GREEN H, 1979, P NATL ACAD SCI USA, V76, P5665, DOI 10.1073/pnas.76.11.5665; HEFTON JM, 1983, LANCET, V2, P428; LEIGH IM, 1986, CLIN EXP DERMATOL, V11, P650, DOI 10.1111/j.1365-2230.1986.tb00526.x; Milstein S, 1980, Am J Otol, V1, P174; OCONNOR NE, 1981, LANCET, V1, P75; PALVA T, 1970, ARCHIV OTOLARYNGOL, V92, P366; PALVA T, 1960, ACTA OTO-LARYNGOL, V51, P175; RAMBO J H T, 1958, Laryngoscope, V68, P1216; SOLOMONS NB, 1988, J LARYNGOL OTOL, V102, P783, DOI 10.1017/S0022215100106437; THIVOLET J, 1986, TRANSPLANTATION, V42, P274, DOI 10.1097/00007890-198609000-00010	16	30	30	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 17	1990	335	8686					365	367		10.1016/0140-6736(90)90204-I	http://dx.doi.org/10.1016/0140-6736(90)90204-I			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CN988	1968114				2022-12-24	WOS:A1990CN98800001
J	DONALDSON, JG; KAHN, RA; LIPPINCOTTSCHWARTZ, J; KLAUSNER, RD				DONALDSON, JG; KAHN, RA; LIPPINCOTTSCHWARTZ, J; KLAUSNER, RD			BINDING OF ARF AND BETA-COP TO GOLGI MEMBRANES - POSSIBLE REGULATION BY A TRIMERIC G-PROTEIN	SCIENCE			English	Article							ADENYLATE-CYCLASE; ADP-RIBOSYLATION; CHOLERA-TOXIN; BREFELDIN-A; TRANSPORT; SECRETION; COMPONENT; PURIFICATION; APPARATUS; SUGGESTS	The binding of cytosolic coat proteins to organelles may regulate membrane structure and traffic. Evidence is presented that a small guanosine triphosphate (GTP)-binding protein, the adenosine diphosphate ribosylation factor (ARF), reversibly associates with the Golgi apparatus in an energy, GTP, and fungal metabolite brefeldin A (BFA)-sensitive manner similar to, but distinguishable from, the 110-kilodalton cytosolic coat protein beta-COP. Addition of beta-gamma-subunits of G proteins inhibited the association of both ARF and beta-COP with Golgi membranes that occurred upon incubation with guanosine 5'-O-(3-thiotriphosphate) (GTP-gamma-S). Thus, heterotrimeric G proteins may function to regulate the assembly of coat proteins onto the Golgi membrane.	NCI, DIV CANC TREATMENT, BIOL CHEM LAB, BETHESDA, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	DONALDSON, JG (corresponding author), NICHHD, CELL BIOL & METAB BRANCH, BETHESDA, MD 20892 USA.		Kahn, Richard/ABD-2666-2020	Kahn, Richard/0000-0002-0259-0601				ALLAN VJ, 1986, J CELL BIOL, V103, P2229, DOI 10.1083/jcb.103.6.2229; BALCH WE, 1984, CELL, V39, P405, DOI 10.1016/0092-8674(84)90019-9; BOURNE HR, 1988, CELL, V53, P669, DOI 10.1016/0092-8674(88)90081-5; COREY EJ, 1976, TETRAHEDRON LETT, P4701; DONALDSON JG, 1990, J CELL BIOL, V111, P2295, DOI 10.1083/jcb.111.6.2295; DONALDSON JG, 1991, J CELL BIOL, V112, P579, DOI 10.1083/jcb.112.4.579; DONALDSON JG, UNPUB; DUDEN R, 1991, CELL, V64, P649, DOI 10.1016/0092-8674(91)90248-W; ERCOLANI L, 1990, P NATL ACAD SCI USA, V87, P4635, DOI 10.1073/pnas.87.12.4635; GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151; HIGASHIJIMA T, 1991, J BIOL CHEM, V266, P3396; KAHN RA, 1984, J BIOL CHEM, V259, P6228; KAHN RA, 1991, J BIOL CHEM, V266, P15595; KAHN RA, 1986, J BIOL CHEM, V261, P7906; KAHN RA, UNPUB; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W; LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5; MALHOTRA V, 1989, CELL, V58, P329, DOI 10.1016/0092-8674(89)90847-7; MELANCON P, 1987, CELL, V51, P1053, DOI 10.1016/0092-8674(87)90591-5; NAKANO A, 1989, J CELL BIOL, V109, P2677, DOI 10.1083/jcb.109.6.2677; NORTHUP JK, 1983, J BIOL CHEM, V258, P1369; OKABE K, 1990, J BIOL CHEM, V265, P12854; ORCI L, 1991, CELL, V64, P1183; SALMINEN A, 1987, CELL, V49, P527, DOI 10.1016/0092-8674(87)90455-7; SCHMITT HD, 1988, CELL, V53, P635, DOI 10.1016/0092-8674(88)90579-X; SEGEV N, 1988, CELL, V52, P915, DOI 10.1016/0092-8674(88)90433-3; SERAFINI T, 1991, NATURE, V349, P214, DOI 10.1038/349215a0; STEARNS T, 1990, P NATL ACAD SCI USA, V87, P1238, DOI 10.1073/pnas.87.3.1238; STERNWEIS PC, 1982, P NATL ACAD SCI-BIOL, V79, P4888, DOI 10.1073/pnas.79.16.4888; STERNWEIS PC, 1984, J BIOL CHEM, V259, P3806; WATERS MG, 1991, NATURE, V349, P248, DOI 10.1038/349248a0; ZAHROUI A, 1989, J BIOL CHEM, V264	33	325	328	1	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 22	1991	254	5035					1197	1199		10.1126/science.1957170	http://dx.doi.org/10.1126/science.1957170			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GQ834	1957170				2022-12-24	WOS:A1991GQ83400045
J	GOBER, JW; CHAMPER, R; REUTER, S; SHAPIRO, L				GOBER, JW; CHAMPER, R; REUTER, S; SHAPIRO, L			EXPRESSION OF POSITIONAL INFORMATION DURING CELL-DIFFERENTIATION IN CAULOBACTER	CELL			English	Article							GRAM-NEGATIVE BACTERIA; GENE-EXPRESSION; FLAGELLAR GENE; BACILLUS-SUBTILIS; MESSENGER-RNA; TRANSCRIPTIONAL REGULATION; PROTOPLAST FUSION; ESCHERICHIA-COLI; SPATIAL CONTROL; CRESCENTUS	The asymmetric targeting of proteins to the Caulobacter predivisional cell poles yields dissimilar progeny. We show that the products of transcriptional reporter gene fusions to a flagellin gene and to the flagellar hook operon are segregated to the progeny swarmer cell. This segregation does not depend on sequences within the mRNA, but on the upstream regulatory region. The subset of developmentally regulated flagellar genes that exhibit mRNA segregation has the same upstream cis-acting elements: an activator-binding site known as the ftr sequence and an IHF-binding site. We propose that these genes are preferentially transcribed from the chromosome in the incipient swarmer cell pole of the predivisional cell.			GOBER, JW (corresponding author), STANFORD UNIV, MED CTR, SCH MED, DEPT DEV BIOL, STANFORD, CA 94305 USA.				NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM032506, R01GM032506] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM32506] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BELLOFATTO V, 1984, P NATL ACAD SCI-BIOL, V81, P1035, DOI 10.1073/pnas.81.4.1035; BROYLES SS, 1986, J MOL BIOL, V187, P47, DOI 10.1016/0022-2836(86)90405-5; CHAMPER R, 1985, COLD SPRING HARB SYM, V50, P831, DOI 10.1101/SQB.1985.050.01.101; CHAMPER R, 1987, J MOL BIOL, V194, P71, DOI 10.1016/0022-2836(87)90716-9; CHEN LS, 1986, P NATL ACAD SCI USA, V83, P2860, DOI 10.1073/pnas.83.9.2860; CONTRERAS I, 1978, J BACTERIOL, V135, P1130, DOI 10.1128/JB.135.3.1130-1136.1978; COOK WR, 1986, J BACTERIOL, V168, P1430, DOI 10.1128/jb.168.3.1430-1438.1986; DINGWALL A, 1990, J BACTERIOL, V172, P6066, DOI 10.1128/jb.172.10.6066-6076.1990; DITTA G, 1980, P NATL ACAD SCI-BIOL, V77, P7347, DOI 10.1073/pnas.77.12.7347; EVINGER M, 1979, P NATL ACAD SCI USA, V76, P175, DOI 10.1073/pnas.76.1.175; EVINGER M, 1977, J BACTERIOL, V132, P294, DOI 10.1128/JB.132.1.294-301.1977; FUJITA Y, 1977, J BACTERIOL, V132, P282, DOI 10.1128/JB.132.1.282-293.1977; GOBER JW, 1990, GENE DEV, V4, P1494, DOI 10.1101/gad.4.9.1494; GOBER JW, 1990, IN PRESS J MOL BIOL; GOMES SL, 1990, J BACTERIOL, V172, P3051, DOI 10.1128/jb.172.6.3051-3059.1990; GOMES SL, 1984, J MOL BIOL, V178, P551, DOI 10.1016/0022-2836(84)90238-9; GUILLEN N, 1982, MOL GEN GENET, V185, P69, DOI 10.1007/BF00333792; HIROOKA T, 1987, J BACTERIOL, V169, P1529, DOI 10.1128/jb.169.4.1529-1536.1987; HOTCHKISS RD, 1980, P NATL ACAD SCI-BIOL, V77, P3553, DOI 10.1073/pnas.77.6.3553; KAPLAN JB, 1989, J MOL BIOL, V205, P71, DOI 10.1016/0022-2836(89)90365-3; KARMAZYNCAMPELLI C, 1989, GENE DEV, V3, P150, DOI 10.1101/gad.3.2.150; KROOS L, 1989, SCIENCE, V243, P526, DOI 10.1126/science.2492118; KUNKEL B, 1990, GENE DEV, V4, P525, DOI 10.1101/gad.4.4.525; KUNKEL B, 1988, J BACTERIOL, V170, P3513, DOI 10.1128/jb.170.8.3513-3522.1988; KUNKEL B, 1989, GENE DEV, V3, P1735, DOI 10.1101/gad.3.11.1735; LEHEGARAT E, 1978, SPORES, V7, P193; LOEWY ZG, 1987, GENE DEV, V1, P626, DOI 10.1101/gad.1.6.626; MACALISTER TJ, 1983, P NATL ACAD SCI-BIOL, V80, P1372, DOI 10.1073/pnas.80.5.1372; MACDONALD PM, 1988, NATURE, V336, P595, DOI 10.1038/336595a0; Maniatis T., 1982, MOL CLONING; MARCZYNSKI GT, 1990, J MOL BIOL, V212, P709, DOI 10.1016/0022-2836(90)90232-B; MARSH JL, 1984, GENE, V32, P481, DOI 10.1016/0378-1119(84)90022-2; MELTON DA, 1987, NATURE, V328, P80, DOI 10.1038/328080a0; MILHAUSEN M, 1983, NATURE, V302, P630, DOI 10.1038/302630a0; MINNICH SA, 1987, P NATL ACAD SCI USA, V84, P1142, DOI 10.1073/pnas.84.5.1142; MULLIN D, 1987, J MOL BIOL, V195, P939, DOI 10.1016/0022-2836(87)90497-9; MULLIN DA, 1989, J BACTERIOL, V171, P3218, DOI 10.1128/jb.171.6.3218-3227.1989; NATHAN P, 1986, J MOL BIOL, V191, P433, DOI 10.1016/0022-2836(86)90138-5; NICHOLSON WL, 1990, J BACTERIOL, V172, P7, DOI 10.1128/JB.172.1.7-14.1990; OHTA N, 1985, J MOL BIOL, V186, P107, DOI 10.1016/0022-2836(85)90261-X; POINDEXTER JS, 1964, BACTERIOL REV, V28, P231, DOI 10.1128/MMBR.28.3.231-295.1964; RATHER PN, 1988, J BACTERIOL, V170, P5086, DOI 10.1128/jb.170.11.5086-5092.1988; REUTER SH, 1987, J MOL BIOL, V194, P653, DOI 10.1016/0022-2836(87)90242-7; SHAPIRO L, 1982, J MOL BIOL, V159, P303, DOI 10.1016/0022-2836(82)90497-1; SHAPIRO L, 1989, J CELL SCI, P85; SHEFFERY M, 1981, CELL, V24, P49, DOI 10.1016/0092-8674(81)90500-6; SUN DX, 1989, GENE DEV, V3, P141, DOI 10.1101/gad.3.2.141; SWOBODA UK, 1982, J GEN MICROBIOL, V128, P291; WADA M, 1988, J MOL BIOL, V204, P581, DOI 10.1016/0022-2836(88)90357-9; XU H, 1989, P NATL ACAD SCI USA, V86, P6656, DOI 10.1073/pnas.86.17.6656	50	63	63	0	0	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 25	1991	64	2					381	391		10.1016/0092-8674(91)90646-G	http://dx.doi.org/10.1016/0092-8674(91)90646-G			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EV336	1988153				2022-12-24	WOS:A1991EV33600014
J	FISCH, P; MALKOVSKY, M; KOVATS, S; STURM, E; BRAAKMAN, E; KLEIN, BS; VOSS, SD; MORRISSEY, LW; DEMARS, R; WELCH, WJ; BOLHUIS, RLH; SONDEL, PM				FISCH, P; MALKOVSKY, M; KOVATS, S; STURM, E; BRAAKMAN, E; KLEIN, BS; VOSS, SD; MORRISSEY, LW; DEMARS, R; WELCH, WJ; BOLHUIS, RLH; SONDEL, PM			RECOGNITION BY HUMAN V-GAMMA-9/V-DELTA-2 T-CELLS OF A GROEL HOMOLOG ON DAUDI-BURKITT LYMPHOMA-CELLS	SCIENCE			English	Article									UNIV WISCONSIN, DEPT HUMAN ONCOL, MADISON, WI 53792 USA; UNIV WISCONSIN, DEPT MED MICROBIOL & IMMUNOL, MADISON, WI 53706 USA; UNIV WISCONSIN, WISCONSIN REG PRIMATE RES CTR, MADISON, WI 53706 USA; UNIV WISCONSIN, GENET LAB, MADISON, WI 53706 USA; UNIV WISCONSIN, DEPT PEDIAT, MADISON, WI 53792 USA; UNIV WISCONSIN, DEPT MED, MADISON, WI 53792 USA; DR DANIEL DENHOED CANC CTR, 3075 EA ROTTERDAM, NETHERLANDS; UNIV CALIF SAN FRANCISCO, DEPT MED, SAN FRANCISCO, CA 94143 USA; UNIV CALIF SAN FRANCISCO, DEPT PHYSIOL, SAN FRANCISCO, CA 94143 USA; UNIV WISCONSIN, DEPT GENET, MADISON, WI 53792 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Erasmus University Rotterdam; Erasmus MC; Erasmus MC Cancer Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of Wisconsin System; University of Wisconsin Madison				Malkovsky, Miroslav/0000-0002-5056-5224; Kovats, Susan/0000-0001-5479-9952				ALLEN H, 1986, P NATL ACAD SCI USA, V83, P7447, DOI 10.1073/pnas.83.19.7447; ASARNOW DM, 1988, CELL, V55, P837, DOI 10.1016/0092-8674(88)90139-0; AUGUSTIN A, 1989, NATURE, V340, P239, DOI 10.1038/340239a0; BJORKMAN PJ, 1987, NATURE, V329, P512, DOI 10.1038/329512a0; BORN W, 1990, IMMUNOL TODAY, V11, P40; BORN W, 1990, SCIENCE, V249, P67, DOI 10.1126/science.1695022; BORST J, 1987, NATURE, V325, P683, DOI 10.1038/325683a0; BORST J, 1988, J EXP MED, V167, P1625, DOI 10.1084/jem.167.5.1625; BOTTINO C, 1988, J EXP MED, V168, P491, DOI 10.1084/jem.168.2.491; BRENNER MB, 1987, NATURE, V325, P689, DOI 10.1038/325689a0; CASORATI G, 1989, J EXP MED, V170, P1521, DOI 10.1084/jem.170.5.1521; CASTEN LA, 1988, J IMMUNOL, V140, P404; CHIEN YH, 1987, NATURE, V327, P677, DOI 10.1038/327677a0; CICCONE E, 1988, J EXP MED, V168, P1, DOI 10.1084/jem.168.1.1; DANIEL TM, 1975, AM REV RESPIR DIS, V112, P639; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; DEMARS R, 1984, HUM IMMUNOL, V11, P77, DOI 10.1016/0198-8859(84)90047-8; DEMOTZ S, 1990, SCIENCE, V249, P1028, DOI 10.1126/science.2118680; ELIAS D, 1990, P NATL ACAD SCI USA, V87, P1576, DOI 10.1073/pnas.87.4.1576; FERRINI S, 1989, EUR J IMMUNOL, V19, P57, DOI 10.1002/eji.1830190110; FISCH P, 1990, J EXP MED, V171, P1567, DOI 10.1084/jem.171.5.1567; FISCH P, UNPUB; HAPP MP, 1989, NATURE, V342, P696, DOI 10.1038/342696a0; HARDING CV, 1990, NATURE, V346, P574, DOI 10.1038/346574a0; HAREGEWOIN A, 1989, NATURE, V340, P309, DOI 10.1038/340309a0; HATA S, 1988, SCIENCE, V240, P1541, DOI 10.1126/science.3259726; HATA S, 1989, J EXP MED, V169, P41, DOI 10.1084/jem.169.1.41; HAYDAY AC, 1985, CELL, V40, P259, DOI 10.1016/0092-8674(85)90140-0; HOLOSHITZ J, 1989, NATURE, V339, P226, DOI 10.1038/339226a0; JANEWAY CA, 1988, IMMUNOL TODAY, V9, P73, DOI 10.1016/0167-5699(88)91267-4; JANIS EM, 1989, SCIENCE, V244, P713, DOI 10.1126/science.2524098; JINDAL S, 1989, MOL CELL BIOL, V9, P2279, DOI 10.1128/MCB.9.5.2279; KABELITZ D, 1990, J EXP MED, V171, P667, DOI 10.1084/jem.171.3.667; KAUFMANN SHE, 1990, IMMUNOL TODAY, V11, P129, DOI 10.1016/0167-5699(90)90050-J; KAUFMANN SHE, 1989, IMMUNOL TODAY, V59, P5; KAVATHAS P, 1980, P NATL ACAD SCI-BIOL, V77, P4251, DOI 10.1073/pnas.77.7.4251; KOGA T, 1989, SCIENCE, V245, P1112, DOI 10.1126/science.2788923; KOLLER BH, 1990, SCIENCE, V248, P1227, DOI 10.1126/science.2112266; KOVATS S, 1990, SCIENCE, V248, P220, DOI 10.1126/science.2326636; LAKEY EK, 1987, P NATL ACAD SCI USA, V84, P1659, DOI 10.1073/pnas.84.6.1659; LANIER LL, 1988, EUR J IMMUNOL, V18, P1985, DOI 10.1002/eji.1830181218; LEFRANC MP, 1986, CELL, V45, P237, DOI 10.1016/0092-8674(86)90388-0; LINDQUIST S, 1988, ANNU REV GENET, V22, P631, DOI 10.1146/annurev.ge.22.120188.003215; LJUNGGREN HG, 1990, NATURE, V346, P476, DOI 10.1038/346476a0; MALKOVSKY M, UNPUB; MAMICHOUAIB F, 1989, EUR J IMMUNOL, V19, P1545, DOI 10.1002/eji.1830190905; MARKWELL MAK, 1978, BIOCHEMISTRY-US, V17, P4807, DOI 10.1021/bi00615a031; MARRACK P, 1990, SCIENCE, V248, P705, DOI 10.1126/science.2185544; MATIS LA, 1987, NATURE, V330, P262, DOI 10.1038/330262a0; MIOSSEC C, 1990, J EXP MED, V171, P1171, DOI 10.1084/jem.171.4.1171; MIZZEN LA, 1989, J BIOL CHEM, V264, P20664; MIZZEN LA, UNPUB; MODLIN RL, 1989, NATURE, V339, P544, DOI 10.1038/339544a0; OBRIEN RL, 1989, CELL, V57, P667, DOI 10.1016/0092-8674(89)90135-9; OTTENHOFF THM, 1988, J EXP MED, V168, P1947, DOI 10.1084/jem.168.5.1947; PARKER CM, 1990, J EXP MED, V171, P1597, DOI 10.1084/jem.171.5.1597; PORCELLI S, 1989, NATURE, V341, P447, DOI 10.1038/341447a0; QUARANTA V, 1981, IMMUNOGENETICS, V13, P285, DOI 10.1007/BF00364494; QUERTERMOUS T, 1986, SCIENCE, V231, P252, DOI 10.1126/science.3079918; QUERTERMOUS T, 1986, NATURE, V322, P184, DOI 10.1038/322184a0; RAULET DH, 1989, NATURE, V339, P342, DOI 10.1038/339342a0; RES PCM, 1988, LANCET, V2, P478, DOI 10.1016/S0140-6736(88)90123-7; ROSA F, 1983, EMBO J, V2, P239, DOI 10.1002/j.1460-2075.1983.tb01412.x; ROTHMAN JE, 1989, IMMUNOL TODAY, V59, P591; SAITO H, 1984, NATURE, V309, P757, DOI 10.1038/309757a0; SANCHEZMADRID F, 1983, J EXP MED, V158, P1785, DOI 10.1084/jem.158.6.1785; SCHNABL E, 1990, J EXP MED, V171, P1431, DOI 10.1084/jem.171.5.1431; SCHUMACHER TNM, 1990, CELL, V62, P563, DOI 10.1016/0092-8674(90)90020-F; SEONG RH, 1988, J EXP MED, V167, P288, DOI 10.1084/jem.167.2.288; SHIMIZU Y, 1989, J IMMUNOL, V142, P3320; SHINNICK TM, 1988, INFECT IMMUN, V56, P446, DOI 10.1128/IAI.56.2.446-451.1988; STROMINGER JL, 1989, CELL, V57, P895, DOI 10.1016/0092-8674(89)90326-7; STROMINGER JL, 1989, SCIENCE, V244, P943, DOI 10.1126/science.2658058; STURM E, 1989, EUR J IMMUNOL, V19, P1261, DOI 10.1002/eji.1830190717; STURM E, IN PRESS J IMMUNOL; TAKIHARA Y, 1989, J EXP MED, V169, P393, DOI 10.1084/jem.169.2.393; TRIEBEL F, 1988, J EXP MED, V167, P694, DOI 10.1084/jem.167.2.694; VANBUSKIRK A, 1989, J EXP MED, V170, P1799, DOI 10.1084/jem.170.6.1799; VANNOESEL C, 1988, NATURE, V333, P850, DOI 10.1038/333850a0; VIDOVIC D, 1989, NATURE, V340, P646, DOI 10.1038/340646a0; Welch WJ, 1990, STRESS PROTEINS BIOL, P223; WHITE J, 1989, CELL, V56, P27, DOI 10.1016/0092-8674(89)90980-X; WINFIELD JB, 1989, ARTHRITIS RHEUM, V32, P1497, DOI 10.1002/anr.1780321202; YOUNG D, 1988, P NATL ACAD SCI USA, V85, P4267, DOI 10.1073/pnas.85.12.4267; YOUNG DB, 1987, IMMUNOL TODAY, V8, P215, DOI 10.1016/0167-5699(87)90168-X; YOUNG RA, 1990, ANNU REV IMMUNOL, V8, P401, DOI 10.1146/annurev.immunol.8.1.401; ZIJLSTRA M, 1990, NATURE, V344, P742, DOI 10.1038/344742a0	87	383	386	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	NOV 30	1990	250	4985					1269	1273		10.1126/science.1978758	http://dx.doi.org/10.1126/science.1978758			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EK723	1978758				2022-12-24	WOS:A1990EK72300041
J	DRANGINIS, AM				DRANGINIS, AM			BINDING OF YEAST A1 AND ALPHA-2 AS A HETERODIMER TO THE OPERATOR DNA OF A HAPLOID-SPECIFIC GENE	NATURE			English	Article											DRANGINIS, AM (corresponding author), NIDDKD,CELLULAR & DEV BIOL LAB,BLDG 6,ROOM B1-10,BETHESDA,MD 20892, USA.							ASTELL CR, 1981, CELL, V27, P15, DOI 10.1016/0092-8674(81)90356-1; AUSUBEL FM, 1989, CURRENTS PROTOCOLS M; DRANGINIS AM, 1989, MOL CELL BIOL, V9, P3992, DOI 10.1128/MCB.9.9.3992; GEHRING WJ, 1986, ANNU REV GENET, V20, P147, DOI 10.1146/annurev.ge.20.120186.001051; GOUTTE C, 1988, CELL, V52, P875, DOI 10.1016/0092-8674(88)90429-1; HALL MN, 1987, SCIENCE, V237, P1007, DOI 10.1126/science.2887035; HERSKOWITZ I, 1989, NATURE, V342, P749, DOI 10.1038/342749a0; HOPE IA, 1985, CELL, V43, P177, DOI 10.1016/0092-8674(85)90022-4; HOPE IA, 1987, EMBO J, V6, P2781, DOI 10.1002/j.1460-2075.1987.tb02573.x; JARVIS EE, 1988, MOL CELL BIOL, V8, P309, DOI 10.1128/MCB.8.1.309; JOHNSON AD, 1985, CELL, V42, P237, DOI 10.1016/S0092-8674(85)80119-7; JONES N, 1990, CELL, V61, P9, DOI 10.1016/0092-8674(90)90207-U; KELEHER CA, 1988, CELL, V53, P927, DOI 10.1016/S0092-8674(88)90449-7; KELEHER CA, 1989, MOL CELL BIOL, V9, P5228, DOI 10.1128/MCB.9.11.5228; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MILLER AM, 1984, EMBO J, V3, P1061, DOI 10.1002/j.1460-2075.1984.tb01927.x; MILLER AM, 1985, NATURE, V314, P598, DOI 10.1038/314598a0; MULLER M, 1988, EMBO J, V7, P4299, DOI 10.1002/j.1460-2075.1988.tb03328.x; NER SS, 1989, MOL CELL BIOL, V9, P4613, DOI 10.1128/MCB.9.11.4613; PABO CO, 1984, ANNU REV BIOCHEM, V53, P293, DOI 10.1146/annurev.bi.53.070184.001453; PASSMORE S, 1989, GENE DEV, V3, P921, DOI 10.1101/gad.3.7.921; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; Sambrook J., 1989, MOL CLONING LAB MANU; SAUER RT, 1988, GENE DEV, V2, P807, DOI 10.1101/gad.2.7.807; SCHULZ B, 1990, CELL, V60, P295, DOI 10.1016/0092-8674(90)90744-Y; SHEPHERD JCW, 1984, NATURE, V310, P70, DOI 10.1038/310070a0; SILICIANO PG, 1986, P NATL ACAD SCI USA, V83, P2320, DOI 10.1073/pnas.83.8.2320; SMITH DR, 1984, CELL, V37, P645, DOI 10.1016/0092-8674(84)90396-9; STRATHERN J, 1981, J MOL BIOL, V147, P357, DOI 10.1016/0022-2836(81)90488-5; TATCHELL K, 1981, CELL, V27, P25, DOI 10.1016/0092-8674(81)90357-3; TRAVERS AA, 1989, ANNU REV BIOCHEM, V58, P427, DOI 10.1146/annurev.biochem.58.1.427	31	105	108	0	3	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	OCT 18	1990	347	6294					682	685		10.1038/347682a0	http://dx.doi.org/10.1038/347682a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ED620	1977088				2022-12-24	WOS:A1990ED62000059
J	KORALNIK, IJ; BEAUMANOIR, A; HAUSLER, R; KOHLER, A; SAFRAN, AB; DELACOUX, R; VIBERT, D; MAYER, E; BURKHARD, P; NAHORY, A; MAGISTRIS, MR; SANCHES, J; MYERS, P; PACCOLAT, F; QUOEX, F; GABRIEL, V; PERRIN, L; MERMILLOD, B; GAUTHIER, G; WALDVOGEL, FA; HIRSCHEL, B				KORALNIK, IJ; BEAUMANOIR, A; HAUSLER, R; KOHLER, A; SAFRAN, AB; DELACOUX, R; VIBERT, D; MAYER, E; BURKHARD, P; NAHORY, A; MAGISTRIS, MR; SANCHES, J; MYERS, P; PACCOLAT, F; QUOEX, F; GABRIEL, V; PERRIN, L; MERMILLOD, B; GAUTHIER, G; WALDVOGEL, FA; HIRSCHEL, B			A CONTROLLED-STUDY OF EARLY NEUROLOGIC ABNORMALITIES IN MEN WITH ASYMPTOMATIC HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									UNIV GENEVA, HOP CANTONAL, DEPT INTERNAL MED, CH-1211 GENEVA 4, SWITZERLAND; UNIV GENEVA, HOP CANTONAL, DEPT NEUROL, CH-1211 GENEVA 4, SWITZERLAND; UNIV GENEVA, HOP CANTONAL, DEPT EAR NOSE & THROAT, CH-1211 GENEVA 4, SWITZERLAND; UNIV GENEVA, HOP CANTONAL, DEPT OPHTHALMOL, CH-1211 GENEVA 4, SWITZERLAND; UNIV GENEVA, HOP CANTONAL, DEPT RADIOL, CH-1211 GENEVA 4, SWITZERLAND; UNIV GENEVA, HOP CANTONAL, DIV INFECT DIS, CH-1211 GENEVA 4, SWITZERLAND; UNIV GENEVA, HOP CANTONAL, DIV STAT & COMP SCI, CH-1211 GENEVA 4, SWITZERLAND	University of Geneva; University of Geneva; University of Geneva; University of Geneva; University of Geneva; University of Geneva; University of Geneva								BEAUMANOIR A, 1988, Neurophysiologie Clinique, V18, P313, DOI 10.1016/S0987-7053(88)80088-1; BONNARDEL R, 1977, TEST INTELLIGENCE VE; BONNARDEL R, 1977, BATTERIE FACTORIELLE; BRICKENKAMP R, 1966, TEST D2; BUKDA H, 1989, ACTA NEUROPATHOL BER, V77, P225; Chiappa K.H., 1983, EVOKED POTENTIALS CL; COMI G, 1987, EVOKED POTENTIAL, V3, P408; DELAMONTE SM, 1987, NEUROLOGY, V37, P562, DOI 10.1212/WNL.37.4.562; ELOVAARA I, 1987, J NEUROL SCI, V78, P331, DOI 10.1016/0022-510X(87)90046-3; GABUZDA DH, 1988, CLIN ELECTROENCEPHAL, V19, P1; GASSER T, 1982, ELECTROEN CLIN NEURO, V53, P119, DOI 10.1016/0013-4694(82)90112-2; GRANT I, 1987, ANN INTERN MED, V107, P828, DOI 10.7326/0003-4819-107-6-828; HAUSLER R, 1983, ACTA OTO-LARYNGOL, P1; HAUSLER R, 1985, EXPLORATIONS ELECTRO; HELWEGLARSEN S, 1988, ACTA NEUROL SCAND, V77, P64, DOI 10.1111/j.1600-0404.1988.tb06976.x; HO DD, 1989, ANN INTERN MED, V111, P400, DOI 10.7326/0003-4819-111-5-400; HOLLANDER H, 1987, ANN INTERN MED, V106, P692, DOI 10.7326/0003-4819-106-5-692; JAKOBSEN J, 1989, BRIT MED J, V299, P225, DOI 10.1136/bmj.299.6693.225; JANSSEN RS, 1988, ANN NEUROL, V23, P49, DOI 10.1002/ana.410230109; JANSSEN RS, 1989, ANN NEUROL, V26, P592, DOI 10.1002/ana.410260503; LEGUEN R, 1980, CARTOGRAPHIE EEG MET, P19; LEVY RM, 1985, J NEUROSURG, V62, P475, DOI 10.3171/jns.1985.62.4.0475; MARSHALL DW, 1988, ARCH NEUROL-CHICAGO, V45, P954, DOI 10.1001/archneur.1988.00520330032007; MCALLISTER RH, 1989, 5TH P INT C AIDS MON, P287; MCARTHUR JC, 1990, J ACQ IMMUN DEF SYND, V3, P252; MCARTHUR JC, 1988, ANN NEUROL, V23, pS34, DOI 10.1002/ana.410230712; MILLER EN, 1990, NEUROLOGY, V40, P197, DOI 10.1212/WNL.40.2.197; NAVIA BA, 1987, ARCH NEUROL-CHICAGO, V44, P65, DOI 10.1001/archneur.1987.00520130051017; NAVIA BA, 1986, ANN NEUROL, V19, P517, DOI 10.1002/ana.410190602; PARISI A, 1988, AIDS, V2, P482, DOI 10.1097/00002030-198812000-00013; PARISI A, 1989, CLIN ELECTROENCEPHAL, V20, P1; PARISI A, 1989, AIDS, V3, P209, DOI 10.1097/00002030-198904000-00003; PERRIN LH, 1990, BLOOD, V76, P641; ROSENHALL U, 1989, ACTA NEUROL SCAND, V79, P140, DOI 10.1111/j.1600-0404.1989.tb03726.x; SELNES OA, 1990, NEUROLOGY, V40, P204, DOI 10.1212/WNL.40.2.204; SMITH T, 1988, ANN NEUROL, V23, P295, DOI 10.1002/ana.410230313; SOMMAMAUVAIS H, 1990, REV NEUROL, V146, P196; TOURTELLOTTE WW, 1989, JUN SAT C NEUR NEUR; VAZEUX R, 1987, AM J PATHOL, V126, P403; VOLBERDING PA, 1990, NEW ENGL J MED, V322, P941, DOI 10.1056/NEJM199004053221401; WHIMBEY A, 1980, INTELLIGENCE CAN TAU, P345; WILEY CA, 1986, P NATL ACAD SCI USA, V83, P7089, DOI 10.1073/pnas.83.18.7089	42	144	148	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	SEP 27	1990	323	13					864	870		10.1056/NEJM199009273231303	http://dx.doi.org/10.1056/NEJM199009273231303			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EA113	1975637				2022-12-24	WOS:A1990EA11300003
J	COLLIS, GG; COLE, CH; LESOUEF, PN				COLLIS, GG; COLE, CH; LESOUEF, PN			DILUTION OF NEBULIZED AEROSOLS BY AIR ENTRAINMENT IN CHILDREN	LANCET			English	Article									PRINCESS MARGARET HOSP,DEPT RESP MED,PERTH,WA 6001,AUSTRALIA				Le Souef, Peter N/H-5256-2014	Le Souef, Peter/0000-0003-0930-1654				BRAIN JD, 1979, AM REV RESPIR DIS, V120, P1325; CANNY GJ, 1988, ANN ALLERGY, V60, P11; COCKCROFT DW, 1982, CHEST, V82, P572, DOI 10.1378/chest.82.5.572; COCKCROFT DW, 1977, CLIN ALLERGY, V7, P235, DOI 10.1111/j.1365-2222.1977.tb01448.x; HARGREAVE FE, 1986, RESPIRATION, V50, P72, DOI 10.1159/000195103; LESOUEF PN, 1989, AM REV RESPIR DIS, V139, P62, DOI 10.1164/ajrccm/139.1.62; PERERA B J C, 1987, Ceylon Medical Journal, V32, P105; PHELAN PD, 1982, RESPIRATORY ILLNESS; RITCHIE D, 1979, NZ MED J, V89, P332; RYAN G, 1981, J ALLERGY CLIN IMMUN, V67, P156, DOI 10.1016/0091-6749(81)90012-9; TEPPER RS, 1987, J APPL PHYSIOL, V62, P1155, DOI 10.1152/jappl.1987.62.3.1155; 1989, ROYAL CHILDRENS HOSP, P115	12	109	111	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	AUG 11	1990	336	8711					341	343		10.1016/0140-6736(90)91880-J	http://dx.doi.org/10.1016/0140-6736(90)91880-J			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DU075	1975336				2022-12-24	WOS:A1990DU07500005
J	BETTS, T				BETTS, T			PSEUDOSEIZURES - SEIZURES THAT ARE NOT EPILEPSY	LANCET			English	Article									UNIV ASTON,NEUROPSYCHIAT CLIN,BIRMINGHAM B4 7ET,W MIDLANDS,ENGLAND	Aston University	BETTS, T (corresponding author), UNIV BIRMINGHAM,DEPT PSYCHIAT,BIRMINGHAM B15 2TT,W MIDLANDS,ENGLAND.							FENTON GW, 1986, BRIT J PSYCHIAT, V149, P28, DOI 10.1192/bjp.149.1.28; LESSER RP, 1985, RECENT ADV EPILEPSY, V2, P273; Ramani V., 1986, ADV NEUROL, V46, P203; RAO ML, 1989, NEUROENDOCRINOLOGY, V49, P33, DOI 10.1159/000125088; ROY A, 1977, PSYCHOL MED, V7, P271, DOI 10.1017/S0033291700029366; SAVARD G, 1988, NEUROLOGY, V38, P1628, DOI 10.1212/WNL.38.10.1628; TRIMBLE M, 1983, BRIT J HOSP MED, V29, P326	7	39	39	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JUL 21	1990	336	8708					163	164		10.1016/0140-6736(90)91673-X	http://dx.doi.org/10.1016/0140-6736(90)91673-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP866	1973484				2022-12-24	WOS:A1990DP86600015
J	GOUGH, J; KRAAK, WAG; ANDERSON, EC; NICHOLS, WW; SLACK, MPE; MCGHIE, D				GOUGH, J; KRAAK, WAG; ANDERSON, EC; NICHOLS, WW; SLACK, MPE; MCGHIE, D			CROSS-INFECTION BY NONENCAPSULATED HAEMOPHILUS-INFLUENZAE	LANCET			English	Article									BIRCH HILL HOSP,DEPT MICROBIOL,ROCHDALE,ENGLAND; JOHN RADCLIFFE HOSP,REG PUBL HLTH LAB,OXFORD OX3 9DU,ENGLAND	University of Oxford								BARENKAMP SJ, 1982, INFECT IMMUN, V36, P535, DOI 10.1128/IAI.36.2.535-540.1982; BARENKAMP SJ, 1984, J PEDIATR-US, V105, P533, DOI 10.1016/S0022-3476(84)80415-1; COVERDALE CH, 1989, J CLIN PATHOL, V42, P409, DOI 10.1136/jcp.42.4.409; GROENEVELD K, 1988, J INFECT DIS, V158, P360, DOI 10.1093/infdis/158.2.360; HENEY C, 1990, EUR J CLIN MICROBIOL, V9, P24, DOI 10.1007/BF01969528; KILIAN M, 1976, J GEN MICROBIOL, V93, P9, DOI 10.1099/00221287-93-1-9; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LOEB MR, 1980, INFECT IMMUN, V30, P709; MALMVALL BE, 1978, SCAND J INFECT DIS, V10, P53, DOI 10.3109/inf.1978.10.issue-1.12; Mehtar S, 1980, J Hosp Infect, V1, P357, DOI 10.1016/0195-6701(80)90014-6; MURPHY TF, 1983, J INFECT DIS, V147, P838, DOI 10.1093/infdis/147.5.838; MUSSER JM, 1986, INFECT IMMUN, V52, P183, DOI 10.1128/IAI.52.1.183-191.1986; PORRAS O, 1986, INFECT IMMUN, V53, P79, DOI 10.1128/IAI.53.1.79-89.1986; SPINOLA SM, 1986, J INFECT DIS, V154, P100, DOI 10.1093/infdis/154.1.100; STURM AW, 1990, LANCET, V335, P214, DOI 10.1016/0140-6736(90)90291-C; VANALPHEN L, 1987, ANAL BIOCHEM, V166, P36, DOI 10.1016/0003-2697(87)90542-2; VANALPHEN L, 1987, J INFECTION, V15, P95, DOI 10.1016/S0163-4453(87)91626-4; VANALPHEN L, 1983, J BACTERIOL, V155, P878, DOI 10.1128/JB.155.2.878-885.1983; VANALPHEN L, 1988, INT C S SERIES, V128, P17	19	24	25	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JUL 21	1990	336	8708					159	160		10.1016/0140-6736(90)91670-6	http://dx.doi.org/10.1016/0140-6736(90)91670-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DP866	1973482				2022-12-24	WOS:A1990DP86600013
J	GARSON, JA; TEDDER, RS; BRIGGS, M; TUKE, P; GLAZEBROOK, JA; TRUTE, A; PARKER, D; BARBARA, JAJ; CONTRERAS, M; ALOYSIUS, S				GARSON, JA; TEDDER, RS; BRIGGS, M; TUKE, P; GLAZEBROOK, JA; TRUTE, A; PARKER, D; BARBARA, JAJ; CONTRERAS, M; ALOYSIUS, S			DETECTION OF HEPATITIS-C VIRAL SEQUENCES IN BLOOD DONATIONS BY NESTED POLYMERASE CHAIN-REACTION AND PREDICTION OF INFECTIVITY	LANCET			English	Article									WELLCOME FDN LTD,BECKENHAM,KENT,ENGLAND; N LONDON BLOOD TRANSFUS CTR,LONDON,ENGLAND	GlaxoSmithKline	GARSON, JA (corresponding author), UNIV COLL & MIDDLESEX SCH MED,SCH PATHOL,DEPT MED MICROBIOL,VIROL SECT,67 RIDINGHOUSE ST,LONDON W1P 7PN,ENGLAND.		Garson, Jeremy A/C-5357-2008	Garson, Jeremy/0000-0003-0553-0126; Tedder, Richard/0000-0002-9672-5721				AACH RD, 1981, NEW ENGL J MED, V304, P989, DOI 10.1056/NEJM198104233041701; ALTER HJ, 1989, NEW ENGL J MED, V321, P1494, DOI 10.1056/NEJM198911303212202; BARBARA JAJ, 1983, VOX SANG, V45, P87, DOI 10.1111/j.1423-0410.1983.tb04128.x; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; DAVIS GL, 1989, NEW ENGL J MED, V321, P1501, DOI 10.1056/NEJM198911303212203; FEINSTONE SM, 1975, NEW ENGL J MED, V292, P767, DOI 10.1056/NEJM197504102921502; KEMP DJ, 1989, P NATL ACAD SCI USA, V86, P2423, DOI 10.1073/pnas.86.7.2423; KUHNL P, 1989, LANCET, V2, P324; KUO G, 1989, SCIENCE, V244, P362, DOI 10.1126/science.2496467; KWOK S, 1989, NATURE, V339, P237, DOI 10.1038/339237a0; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; VANDERPOEL CL, 1990, LANCET, V335, P558, DOI 10.1016/0140-6736(90)90347-8; WEINER AJ, 1990, LANCET, V335, P1, DOI 10.1016/0140-6736(90)90134-Q	14	554	561	0	11	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JUN 16	1990	335	8703					1419	1422		10.1016/0140-6736(90)91446-H	http://dx.doi.org/10.1016/0140-6736(90)91446-H			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ234	1972209				2022-12-24	WOS:A1990DJ23400003
J	ROWLEY, AH; WHITLEY, RJ; LAKEMAN, FD; WOLINSKY, SM				ROWLEY, AH; WHITLEY, RJ; LAKEMAN, FD; WOLINSKY, SM			RAPID DETECTION OF HERPES-SIMPLEX-VIRUS DNA IN CEREBROSPINAL-FLUID OF PATIENTS WITH HERPES-SIMPLEX ENCEPHALITIS	LANCET			English	Article									NORTHWESTERN UNIV,DEPT PEDIAT,CHICAGO,IL 60611; NORTHWESTERN UNIV,DEPT MED,CHICAGO,IL 60611; UNIV ALABAMA,DEPT PEDIAT,BIRMINGHAM,AL; UNIV ALABAMA,DEPT CLIN VIROL,BIRMINGHAM,AL	Northwestern University; Northwestern University; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham			Wolinsky, Steven/B-2893-2012	Rowley, Anne/0000-0003-4695-6676; Wolinsky, Steven/0000-0002-9625-6697				JOHNSON RT, 1968, ARCH NEUROL-CHICAGO, V18, P260, DOI 10.1001/archneur.1968.00470330050004; KAHLON J, 1987, J INFECT DIS, V155, P38, DOI 10.1093/infdis/155.1.38; KWOK S, 1988, BLOOD, V72, P1117; KWOK S, 1987, J VIROL, V61, P1690, DOI 10.1128/JVI.61.5.1690-1694.1987; LAKEMAN FD, 1987, J INFECT DIS, V155, P1172, DOI 10.1093/infdis/155.6.1172; MANOS MM, 1989, CANCER CEL, V7, P209; NAHMIAS AJ, 1982, J INFECT DIS, V145, P829, DOI 10.1093/infdis/145.6.829; ROWLEY AH, 1989, PEDIATR RES, V25, pA189; SAIKI RK, 1985, SCIENCE, V230, P1350, DOI 10.1126/science.2999980; SKOLDENBERG B, 1984, LANCET, V2, P707; WHITLEY RJ, 1988, AM J MED, V85, P61; WHITLEY RJ, 1977, NEW ENGL J MED, V297, P289, DOI 10.1056/NEJM197708112970601; WHITLEY RJ, 1989, JAMA-J AM MED ASSOC, V262, P234, DOI 10.1001/jama.262.2.234	13	222	233	0	5	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	FEB 24	1990	335	8687					440	441		10.1016/0140-6736(90)90667-T	http://dx.doi.org/10.1016/0140-6736(90)90667-T			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CP907	1968171				2022-12-24	WOS:A1990CP90700005
J	SIMARD, C; JOLICOEUR, P				SIMARD, C; JOLICOEUR, P			THE EFFECT OF ANTINEOPLASTIC DRUGS ON MURINE ACQUIRED-IMMUNODEFICIENCY-SYNDROME	SCIENCE			English	Article							C57BL/6 MICE; LEUKEMIA-VIRUS; RETROVIRUS; INDUCTION; LYMPHOMAS; DISEASE; MOUSE	The murine acquired immunodeficiency syndrome (MAIDS) is associated with proliferation of target cells that have been infected by a defective retrovirus. To control the growth of this primary neoplasia, virus-inoculated mice were treated with antineoplastic drugs. Paradoxically, cyclophosphamide, which is also immunosuppressive, was very effective in preventing the appearance and progression of the disease, in restoring a normal T cell function, and in depleting the number of infected target cells. This result suggests that the proliferating infected target cells were responsible for the immunodeficiency.	UNIV MONTREAL,DEPT MICROBIOL & IMMUNOL,MONTREAL H3C 3J7,QUEBEC,CANADA; CLIN RES INST MONTREAL,MOLEC BIOL LAB,MONTREAL H2W 1R7,QUEBEC,CANADA	Universite de Montreal; Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal								AZIZ DC, 1989, NATURE, V338, P505, DOI 10.1038/338505a0; BULLER RML, 1987, J VIROL, V61, P383, DOI 10.1128/JVI.61.2.383-387.1987; CHATTOPADHYAY SK, 1989, P NATL ACAD SCI USA, V86, P3862, DOI 10.1073/pnas.86.10.3862; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; DEWHURST S, 1990, NATURE, V345, P636, DOI 10.1038/345636a0; DUPLAN JF, 1970, B CANCER, V57, P23; FAUCI AS, 1988, SCIENCE, V239, P617, DOI 10.1126/science.3277274; FAUCI AS, 1990, J ALLERGY CLIN IMMUN, V66, P5; FREI E, 1974, CANCER RES, V34, P184; HARTLEY JW, 1989, J VIROL, V63, P1223, DOI 10.1128/JVI.63.3.1223-1231.1989; HUANG M, 1989, SCIENCE, V246, P1614, DOI 10.1126/science.2480643; KLINKEN SP, 1988, J IMMUNOL, V140, P1123; LATARJET R, 1962, INT J RADIAT BIOL RE, V5, P339, DOI 10.1080/09553006214550911; LEGRAND E, 1981, LEUKEMIA RES, V5, P223, DOI 10.1016/0145-2126(81)90107-7; Maniatis T., 1982, MOL CLONING; MARCHALORIS JJ, 1988, LYMPHOCYTE STRUCTURE; MISTRY PB, 1973, B CANCER, V60, P287; MOMPARLER RL, 1985, PHARMACOL THERAPEUT, V30, P287, DOI 10.1016/0163-7258(85)90053-1; MOSIER DE, 1985, J EXP MED, V161, P766, DOI 10.1084/jem.161.4.766; MOSIER DE, 1986, IMMUNOL INVEST, V15, P233, DOI 10.3109/08820138609026687; PATTENGALE PK, 1982, AM J PATHOL, V107, P362; SIMARD C, UNPUB; TURK JL, 1972, CLIN EXP IMMUNOL, V10, P285; WONGSTAAL F, 1985, NATURE, V317, P395, DOI 10.1038/317395a0	24	39	39	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	JAN 18	1991	251	4991					305	308		10.1126/science.1987646	http://dx.doi.org/10.1126/science.1987646			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET678	1987646				2022-12-24	WOS:A1991ET67800031
J	MCDONNELL, TJ; KORSMEYER, SJ				MCDONNELL, TJ; KORSMEYER, SJ			PROGRESSION FROM LYMPHOID HYPERPLASIA TO HIGH-GRADE MALIGNANT-LYMPHOMA IN MICE TRANSGENIC FOR THE T(14, 18)	NATURE			English	Article							C-MYC ONCOGENE; CHROMOSOME TRANSLOCATIONS; NUCLEOTIDE-SEQUENCE; FOLLICULAR LYMPHOMA; BURKITT-LYMPHOMA; CELL SURVIVAL; GENE; REGION; LOCUS; ACTIVATION	FOLLICULAR lymphoma, the most common human lymphoma, characteristically has a t(14; 18) interchromosomal translocation 1,2. Its is typically an indolent disease comprised of small resting B cells, but frequently develops into a high-grade lymphoma 3. The t(14; 18) translocates the Bcl-2 gene, generating a deregulated Bcl-2-immunoglobulin fusion gene 4-8. Bcl-2 is a novel inner mitochondrial membrane protein 9 that extends the survival of certain cells by blocking programmed cell death 9-11. To determine the oncogenic potential of the t(14; 18) translocation, we produced transgenic mice bearing a Bcl-2-immunoglobulin minigene that structurally mimicked the t(14; 18) (ref. 12). An indolent follicular hyperplasia in these transgenic mice progressed to a malignant diffuse large-cell lymphoma. The long latency, progression from polyclonal to monoclonal disease, and histological conversion, are all suggestive of secondary changes. Half of the immunoblastic high-grade lymphomas had a rearranged c-myc gene. Our transgenic mice provide an animal model for tumour progression in t(14; 18) lymphoma and show that prolonged B-cell life increases tumour incidence.	WASHINGTON UNIV, SCH MED, DEPT MED, ST LOUIS, MO 63110 USA; WASHINGTON UNIV, SCH MED, DEPT MOLEC MICROBIOL, ST LOUIS, MO 63110 USA; WASHINGTON UNIV, SCH MED, DEPT PATHOL, ST LOUIS, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	MCDONNELL, TJ (corresponding author), WASHINGTON UNIV, SCH MED, HOWARD HUGHES MED INST, 660 S EUCLID, ST LOUIS, MO 63110 USA.							ADAMS JM, 1983, P NATL ACAD SCI-BIOL, V80, P1982, DOI 10.1073/pnas.80.7.1982; BAKHSHI A, 1985, CELL, V41, P899, DOI 10.1016/S0092-8674(85)80070-2; BISHOP JM, 1987, SCIENCE, V235, P305, DOI 10.1126/science.3541204; CLEARY ML, 1986, CELL, V47, P19, DOI 10.1016/0092-8674(86)90362-4; CLEARY ML, 1985, P NATL ACAD SCI USA, V82, P7439, DOI 10.1073/pnas.82.21.7439; CRISSMAN HA, 1973, J CELL BIOL, V59, P766, DOI 10.1083/jcb.59.3.766; DALLAFAVERA R, 1982, P NATL ACAD SCI-BIOL, V79, P7824, DOI 10.1073/pnas.79.24.7824; DEJONG D, 1988, NEW ENGL J MED, V318, P1373, DOI 10.1056/NEJM198805263182106; GAUWERKY CE, 1988, P NATL ACAD SCI USA, V85, P8548, DOI 10.1073/pnas.85.22.8548; HOCKENBERY D, 1990, NATURE, V348, P334, DOI 10.1038/348334a0; HORNING SJ, 1984, NEW ENGL J MED, V311, P1471, DOI 10.1056/NEJM198412063112303; LAND H, 1983, NATURE, V304, P596, DOI 10.1038/304596a0; LANGDON WY, 1986, CELL, V47, P11, DOI 10.1016/0092-8674(86)90361-2; MARCU KB, 1983, P NATL ACAD SCI-BIOL, V80, P519, DOI 10.1073/pnas.80.2.519; MCDONNELL TJ, 1989, CELL, V57, P79, DOI 10.1016/0092-8674(89)90174-8; MCDONNELL TJ, 1990, CELL, V10, P1901; NUNEZ G, 1990, J IMMUNOL, V144, P3602; NUNEZ G, 1989, P NATL ACAD SCI USA, V86, P4589, DOI 10.1073/pnas.86.12.4589; PATTENGALE PK, 1983, AM J PATHOL, V113, P235; REED JC, 1990, P NATL ACAD SCI USA, V87, P3660, DOI 10.1073/pnas.87.10.3660; ROWLEY JD, 1982, SCIENCE, V216, P749, DOI 10.1126/science.7079737; SAGER R, 1989, SCIENCE, V246, P1406, DOI 10.1126/science.2574499; SETO M, 1988, EMBO J, V7, P123, DOI 10.1002/j.1460-2075.1988.tb02791.x; STANTON LW, 1982, NUCLEIC ACIDS RES, V10, P5993, DOI 10.1093/nar/10.19.5993; TAUB R, 1982, P NATL ACAD SCI-BIOL, V79, P7837, DOI 10.1073/pnas.79.24.7837; TSUJIMOTO Y, 1985, SCIENCE, V229, P1390, DOI 10.1126/science.3929382; VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0; YUNIS JJ, 1983, SCIENCE, V221, P227, DOI 10.1126/science.6336310	28	811	838	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 17	1991	349	6306					254	256		10.1038/349254a0	http://dx.doi.org/10.1038/349254a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	ET519	1987477				2022-12-24	WOS:A1991ET51900061
J	NIGHTINGALE, SL				NIGHTINGALE, SL			CLOTRIMAZOLE AVAILABLE WITHOUT PRESCRIPTION FOR VAGINAL YEAST INFECTIONS	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material											NIGHTINGALE, SL (corresponding author), US FDA,OFF HLTH AFFAIRS,PARKLAWN BLDG,5600 FISHERS LN,ROCKVILLE,MD 20857, USA.								0	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 9	1991	265	2					182	182						1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EQ602	1984138				2022-12-24	WOS:A1991EQ60200010
J	TAKAYAMA, T; MAKUUCHI, M; HIROHASHI, S; SAKAMOTO, M; OKAZAKI, N; TAKAYASU, K; KOSUGE, T; MOTOO, Y; YAMAZAKI, S; HASEGAWA, H				TAKAYAMA, T; MAKUUCHI, M; HIROHASHI, S; SAKAMOTO, M; OKAZAKI, N; TAKAYASU, K; KOSUGE, T; MOTOO, Y; YAMAZAKI, S; HASEGAWA, H			MALIGNANT TRANSFORMATION OF ADENOMATOUS HYPERPLASIA TO HEPATOCELLULAR-CARCINOMA	LANCET			English	Article									NATL CANC CTR,DEPT INTERNAL MED,TOKYO 104,JAPAN; NATL CANC CTR,DEPT DIAGNOST RADIOL,TOKYO 104,JAPAN; NATL CANC CTR,RES INST,DIV PATHOL,TOKYO 104,JAPAN; SHINSHU UNIV,SCH MED,DEPT SURG 1,MATSUMOTO,NAGANO 390,JAPAN; KANAZAWA UNIV,CANC RES INST,DEPT INTERNAL MED,KANAZAWA,ISHIKAWA 920,JAPAN	National Cancer Center - Japan; National Cancer Center - Japan; National Cancer Center - Japan; Shinshu University; Kanazawa University	TAKAYAMA, T (corresponding author), NATL CANC CTR,DEPT SURG,TSUKIJI 5-1-1,CHUO KU,TOKYO 104,JAPAN.		Sakamoto, Michiie/N-2917-2015; Motoo, Yoshiharu/E-8277-2011					ARAKAWA M, 1986, GASTROENTEROLOGY, V91, P198, DOI 10.1016/0016-5085(86)90458-0; ARAKI T, 1980, AM J ROENTGENOL, V135, P1037, DOI 10.2214/ajr.135.5.1037; BANNASCH P, 1976, CANCER RES, V36, P2555; EDMONDSON HA, 1976, HEPATOCELLULAR CARCI, P309; FURUYA K, 1988, CANCER, V61, P99, DOI 10.1002/1097-0142(19880101)61:1<99::AID-CNCR2820610117>3.0.CO;2-U; KONDO F, 1989, HEPATOLOGY, V9, P751, DOI 10.1002/hep.1840090516; LIVRAGHI T, 1989, RADIOLOGY, V170, P155, DOI 10.1148/radiology.170.1.2642340; MAKUUCHI M, 1983, ULTRASOUND 82, P489; OKUDA K, 1986, J GASTROEN HEPATOL, V1, P79, DOI 10.1111/j.1440-1746.1986.tb01760.x; SAKAMOTO M, IN PRESS HUM PATHOL; SASAKI K, 1980, GANN MONOGR CANCER R, V25, P127; SCHWARTZ M, 1961, CANCER, V14, P1272, DOI 10.1002/1097-0142(196111/12)14:6<1272::AID-CNCR2820140618>3.0.CO;2-H; TAKAYASU K, 1986, AM J ROENTGENOL, V147, P525, DOI 10.2214/ajr.147.3.525; TKAAYASU K, 1990, AM J ROENTGENOL, V155, P49; TSUDA H, 1988, GASTROENTEROLOGY, V95, P1664, DOI 10.1016/S0016-5085(88)80093-3; [No title captured]	16	364	370	0	4	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 10	1990	336	8724					1150	1153		10.1016/0140-6736(90)92768-D	http://dx.doi.org/10.1016/0140-6736(90)92768-D			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EG701	1978027				2022-12-24	WOS:A1990EG70100004
J	FISCHER, A; LANDAIS, P; FRIEDRICH, W; MORGAN, G; GERRITSEN, B; FASTH, A; PORTA, F; GRISCELLI, C; GOLDMAN, SF; LEVINSKY, R; VOSSEN, J				FISCHER, A; LANDAIS, P; FRIEDRICH, W; MORGAN, G; GERRITSEN, B; FASTH, A; PORTA, F; GRISCELLI, C; GOLDMAN, SF; LEVINSKY, R; VOSSEN, J			EUROPEAN EXPERIENCE OF BONE-MARROW TRANSPLANTATION FOR SEVERE COMBINED IMMUNODEFICIENCY	LANCET			English	Article									UNIV ULM CLIN,DEPT CHILD HLTH,ULM,GERMANY; UNIV BRESCIA,PAEDIAT CLIN,PAVIA,ITALY; STATE UNIV LEIDEN HOSP,DEPT PAEDIAT,2333 AA LEIDEN,NETHERLANDS; GOTHENBURG UNIV,DEPT PAEDIAT,S-41124 GOTHENBURG,SWEDEN; HOP NECKER ENFANTS MALAD,DEPT STAT & INFORMAT,F-75743 PARIS 15,FRANCE; INST CHILD HLTH,DEPT IMMUNOL,LONDON WC1N 1EH,ENGLAND	Ulm University; University of Brescia; Leiden University; Leiden University Medical Center (LUMC); University of Gothenburg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; University of London; University College London	FISCHER, A (corresponding author), HOP NECKER ENFANTS MALAD,IMMUNOL & HAEMATOL UNIT,149 RUE SEVRES,F-75743 PARIS 15,FRANCE.		Fasth, Anders/I-1109-2019					BORTIN MM, 1987, PROGR BONE MARROW TR, P243; BUCKLEY RH, 1986, J IMMUNOL, V136, P2398; BUCKLEY RH, 1989, IMMUNOLOGIC DISORDER, P774; COWAN MJ, 1985, J CLIN IMMUNOL, V5, P370, DOI 10.1007/BF00915333; EIERMANN TH, 1986, PROGR IMMUNODEFICIEN, V2, P373; FISCHER A, 1986, LANCET, V2, P1080; FISCHER A, 1986, BLOOD, V67, P444; FRIEDRICH W, 1985, EUR J PEDIATR, V144, P125, DOI 10.1007/BF00451897; GATTI RA, 1968, LANCET, V2, P1366; GLUCKSBERG H, 1974, TRANSPLANTATION, V18, P295, DOI 10.1097/00007890-197410000-00001; GOULMY E, 1976, LANCET, V2, P1206; GRISCELLI C, 1981, BONE MARROW TRANSPL, P233; JEFFREYS AJ, 1985, NATURE, V314, P67, DOI 10.1038/314067a0; KALBFEISCH JD, 1980, STATISTICAL ANAL FAI; KENNY AB, 1979, EUR J PEDIATR, V131, P155, DOI 10.1007/BF00538940; KORVER K, 1987, TRANSPLANTATION, V44, P643, DOI 10.1097/00007890-198711000-00010; MOEN RC, 1987, BLOOD, V70, P664; MORGAN G, 1986, BRIT J HAEMATOL, V62, P421, DOI 10.1111/j.1365-2141.1986.tb02953.x; MURPHY WJ, 1987, J EXP MED, V165, P1212, DOI 10.1084/jem.165.4.1212; O'Reilly R J, 1983, Birth Defects Orig Artic Ser, V19, P129; OREILLY RJ, 1984, SEMIN HEMATOL, V21, P188; OREILLY RJ, 1990, IMMUNODEF REV, V1, P273; OREILLY RJ, 1986, PRIMARY IMMUNODEFICI, P301; OREILLY RJ, 1983, RECENT ADV BONE MARR, P799; PETER HH, 1986, PROGR IMMUNODEFICIEN, V2, P287; REINHERZ EL, 1982, P NATL ACAD SCI-BIOL, V79, P6047, DOI 10.1073/pnas.79.19.6047; REISNER Y, 1983, BLOOD, V61, P341; VOSSEN JM, 1984, PROGR IMMUNODEFICIEN, P417; WIJNAENDTS L, 1989, BLOOD, V74, P2212; 1989, IMMUNODEFICIENCY REV, V1, P173	30	245	247	0	4	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	OCT 6	1990	336	8719					850	854		10.1016/0140-6736(90)92348-L	http://dx.doi.org/10.1016/0140-6736(90)92348-L			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EB901	1976883				2022-12-24	WOS:A1990EB90100011
J	OSMERS, R; VOLKSEN, M; SCHAUER, A				OSMERS, R; VOLKSEN, M; SCHAUER, A			VAGINOSONOGRAPHY FOR EARLY DETECTION OF ENDOMETRIAL CARCINOMA	LANCET			English	Article									UNIV GOTTINGEN,DEPT PATHOL,W-3400 GOTTINGEN,GERMANY	University of Gottingen	OSMERS, R (corresponding author), UNIV GOTTINGEN,DEPT GYNAECOL & OBSTET,W-3400 GOTTINGEN,GERMANY.							BACHET W, 1983, GEBURTSH FRAUENHEILK, V43, P11, DOI 10.1055/s-2008-1037049; Bockman JV, 1983, GYNECOL ONCOL, V15, P10; CHAMLIAN DL, 1970, OBSTET GYNECOL, V36, P659; CHOO YC, 1985, OBSTET GYNECOL, V66, P225; CREASMAN W T, 1976, Gynecologic Oncology, V4, P239, DOI 10.1016/0090-8258(76)90028-7; CREASMAN WT, 1981, GYNECOL ONCOL, P562; DALLENBACHHELLW.G, 1987, HISTOPATHOLOGY ENDOM; Ferenczy A., 1987, BLAUSTEINS PATHOLOGY, P257, DOI DOI 10.1007/978-1-4757-1942-0_9; GUSBERG SB, 1986, CLIN OBSTET GYNAECOL, V13, P665; HOFFMEISTER H, 1987, BEVOKKERUNGSBEZOGENE; Iversen O E, 1985, Obstet Gynecol Surv, V40, P14, DOI 10.1097/00006254-198501000-00002; KOSS LG, 1981, OBSTET GYNECOL, V57, P681; KURMAN RJ, 1985, CANCER, V56, P403, DOI 10.1002/1097-0142(19850715)56:2<403::AID-CNCR2820560233>3.0.CO;2-X; KURMAN RJ, 1987, BLAUSTEINS PATHOLOGY; MESTWERDT W, 1983, GYNAKOLOGE, V16, P87; MORROW CP, 1973, OBSTET GYNECOL, V42, P399; MUHLNICKEL D, 1980, GYNAKOL, V102, P138; OSMERS R, 1989, GEBURTSH FRAUENHEILK, V49, P262, DOI 10.1055/s-2008-1035751; OSMERS R, IN PRESS INT J OBSTE; SHERMAN AI, 1979, AM J OBSTET GYNECOL, V135, P947, DOI 10.1016/0002-9378(79)90821-4; SILVERBERG E, 1984, CA-CANCER J CLIN, V34, P7; Vuopala S, 1977, Acta Obstet Gynecol Scand Suppl, V70, P1; WENTZ W B, 1974, Gynecologic Oncology, V2, P362, DOI 10.1016/0090-8258(74)90027-4; ZANDER J, 1985, KLINISCHE ONKOLOGIE	24	206	208	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JUN 30	1990	335	8705					1569	1571		10.1016/0140-6736(90)91387-P	http://dx.doi.org/10.1016/0140-6736(90)91387-P			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DL480	1972495				2022-12-24	WOS:A1990DL48000012
J	ZOCK, PL; KATAN, MB; MERKUS, MP; VANDUSSELDORP, M; HARRYVAN, JL				ZOCK, PL; KATAN, MB; MERKUS, MP; VANDUSSELDORP, M; HARRYVAN, JL			EFFECT OF A LIPID-RICH FRACTION FROM BOILED COFFEE ON SERUM-CHOLESTEROL	LANCET			English	Article									AGR UNIV WAGENINGEN,DEPT HUMAN NUTR,BOMENWEG 2,6703 HD WAGENINGEN,NETHERLANDS	Wageningen University & Research				Zock, Peter/0000-0002-0322-0565				ARNESEN E, 1984, BRIT MED J, V288, P1960, DOI 10.1136/bmj.288.6435.1960; ARO A, 1987, METABOLISM, V36, P1027, DOI 10.1016/0026-0495(87)90021-7; BAK AAA, 1989, NEW ENGL J MED, V321, P1432, DOI 10.1056/NEJM198911233212103; BONAA K, 1988, BRIT MED J, V297, P1103, DOI 10.1136/bmj.297.6656.1103; CAMERON ME, 1988, MANUAL METHODOLOGY F, P83; FOLLTAR P, 1976, THESIS AGR U WAGENIN; FORDE OH, 1985, BRIT MED J, V290, P893, DOI 10.1136/bmj.290.6472.893; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; KEYS A, 1965, METABOLIS, V14, P766, DOI 10.1016/0026-0495(65)90003-X; SULLIVAN DR, 1985, CLIN CHEM, V31, P1227; SUPERKO HR, 1989, CIRCULATION S2, V80, P86; THELLE DS, 1983, NEW ENGL J MED, V308, P1454, DOI 10.1056/NEJM198306163082405; VANDUSSELDORP M, IN PRESS AM J EPIDEM; WARNICK GR, 1987, CLIN CHEM, V33, P2323; WARNICK GR, 1982, CLIN CHEM, V28, P1379; WILLIAMS S, 1984, OFFICIAL METHODS ANA, P519	16	99	100	0	3	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	MAY 26	1990	335	8700					1235	1237		10.1016/0140-6736(90)91302-Q	http://dx.doi.org/10.1016/0140-6736(90)91302-Q			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF451	1971319	Green Submitted			2022-12-24	WOS:A1990DF45100002
J	SCHUTZER, SE; COYLE, PK; BELMAN, AL; GOLIGHTLY, MG; DRULLE, J				SCHUTZER, SE; COYLE, PK; BELMAN, AL; GOLIGHTLY, MG; DRULLE, J			SEQUESTRATION OF ANTIBODY TO BORRELIA-BURGDORFERI IN IMMUNE-COMPLEXES IN SERONEGATIVE LYME-DISEASE	LANCET			English	Article									SUNY STONY BROOK, HLTH SCI CTR, DEPT NEUROL, STONY BROOK, NY 11794 USA; SUNY STONY BROOK, HLTH SCI CTR, DEPT PATHOL, STONY BROOK, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	SCHUTZER, SE (corresponding author), UNIV MED & DENT NEW JERSEY, NEW JERSEY MED SCH, DEPT MED, DIV ALLERGY & IMMUNOL, 185 S ORANGE AVE, NEWARK, NJ 07103 USA.							BARBOUR AG, 1989, ANN INTERN MED, V110, P501, DOI 10.7326/0003-4819-110-7-501; BENACH JL, 1983, NEW ENGL J MED, V308, P740, DOI 10.1056/NEJM198303313081302; BLAKE MS, 1984, ANAL BIOCHEM, V136, P175, DOI 10.1016/0003-2697(84)90320-8; COYLE PK, 1985, NEUROLOGY, V35, P429, DOI 10.1212/WNL.35.3.429; COYLE PK, 1987, J NEUROIMMUNOL, V15, P97, DOI 10.1016/0165-5728(87)90009-9; DATTWYLER RJ, 1988, NEW ENGL J MED, V319, P1441, DOI 10.1056/NEJM198812013192203; DIGEON M, 1977, J IMMUNOL METHODS, V16, P165, DOI 10.1016/0022-1759(77)90051-5; DOBSON SRM, 1988, J INFECT DIS, V158, P940, DOI 10.1093/infdis/158.5.940; HARDIN JA, 1984, YALE J BIOL MED, V57, P589; HARDIN JA, 1979, NEW ENGL J MED, V301, P1358, DOI 10.1056/NEJM197912203012502; HERRMANN K, 1978, BRIT J DERMATOL, V99, P635, DOI 10.1111/j.1365-2133.1978.tb07057.x; HOFFKEN K, 1982, J IMMUNOL METHODS, V53, P51, DOI 10.1016/0022-1759(82)90239-3; JONES VE, 1981, J IMMUNOL METHODS, V44, P249, DOI 10.1016/0022-1759(81)90045-4; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; STEERE AC, 1988, ANN NY ACAD SCI, V539, P87, DOI 10.1111/j.1749-6632.1988.tb31841.x; STEERE AC, 1989, NEW ENGL J MED, V321, P586, DOI 10.1056/NEJM198908313210906; STEERE AC, 1983, NEW ENGL J MED, V308, P733, DOI 10.1056/NEJM198303313081301; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; 1989, LANCET, V2, P198; 1978, J CLIN IMMUNOL, V1, P1	20	139	144	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 10	1990	335	8685					312	315		10.1016/0140-6736(90)90606-6	http://dx.doi.org/10.1016/0140-6736(90)90606-6			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM846	1967770				2022-12-24	WOS:A1990CM84600004
J	JOHNSON, WA; HIRSH, J				JOHNSON, WA; HIRSH, J			BINDING OF A DROSOPHILA POU-DOMAIN PROTEIN TO A SEQUENCE ELEMENT REGULATING GENE-EXPRESSION IN SPECIFIC DOPAMINERGIC-NEURONS	NATURE			English	Article									HARVARD UNIV, SCH MED, DEPT BIOL CHEM & MOLEC PHARMACOL, BOSTON, MA 02115 USA	Harvard University; Harvard Medical School				Johnson, Wayne/0000-0002-6961-5498				ALTSCHUL SF, 1986, B MATH BIOL, V48, P603, DOI 10.1016/S0092-8240(86)90010-8; BEALL CJ, 1987, GENE DEV, V1, P510, DOI 10.1101/gad.1.5.510; BODNER M, 1988, CELL, V55, P505, DOI 10.1016/0092-8674(88)90037-2; BRAY SJ, 1989, GENE DEV, V3, P1130, DOI 10.1101/gad.3.8.1130; BRAY SJ, 1988, EMBO J, V7, P177, DOI 10.1002/j.1460-2075.1988.tb02798.x; BUDNIK V, 1988, J COMP NEUROL, V268, P400, DOI 10.1002/cne.902680309; CAMPOSORTEGA JA, 1988, TRENDS NEUROSCI, V11, P400, DOI 10.1016/0166-2236(88)90077-X; CLERC RG, 1988, GENE DEV, V2, P1570, DOI 10.1101/gad.2.12a.1570; DESAI C, 1988, NATURE, V336, P638, DOI 10.1038/336638a0; DOE CQ, 1988, NATURE, V333, P376, DOI 10.1038/333376a0; DOE CQ, 1985, COLD SPRING HARB SYM, V50, P891, DOI 10.1101/SQB.1985.050.01.106; DOE CQ, 1988, SCIENCE, V239, P170, DOI 10.1126/science.2892267; FINNEY M, 1988, CELL, V55, P757, DOI 10.1016/0092-8674(88)90132-8; GEHRING WJ, 1986, ANNU REV GENET, V20, P147, DOI 10.1146/annurev.ge.20.120186.001051; HEBERLEIN U, 1985, CELL, V41, P965, DOI 10.1016/S0092-8674(85)80077-5; HEBERLEIN U, 1988, NATURE, V331, P410, DOI 10.1038/331410a0; HERR W, 1988, GENE DEV, V2, P1513, DOI 10.1101/gad.2.12a.1513; INGRAHAM HA, 1988, CELL, V55, P519, DOI 10.1016/0092-8674(88)90038-4; JOHNSON WA, 1989, GENE DEV, V3, P676, DOI 10.1101/gad.3.5.676; KONRAD KD, 1987, DEV BIOL, V122, P172, DOI 10.1016/0012-1606(87)90343-5; LUNAN KD, 1969, ARCH BIOCHEM BIOPHYS, V132, P450, DOI 10.1016/0003-9861(69)90388-9; Maniatis T., 1982, MOL CLONING; NECKAMEYER WS, 1989, NEURON, V2, P1167, DOI 10.1016/0896-6273(89)90183-9; PATEL NH, 1989, GENE DEV, V3, P890, DOI 10.1101/gad.3.6.890; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; RUBIN GM, 1989, CELL, V57, P519, DOI 10.1016/0092-8674(89)90120-7; SCHOLNICK SB, 1983, CELL, V34, P37, DOI 10.1016/0092-8674(83)90134-4; SINGH H, 1988, CELL, V52, P415, DOI 10.1016/S0092-8674(88)80034-5; STURM RA, 1988, GENE DEV, V2, P1582, DOI 10.1101/gad.2.12a.1582; TABOR S, 1987, P NATL ACAD SCI USA, V84, P4767, DOI 10.1073/pnas.84.14.4767; TAYLOR JW, 1985, NUCLEIC ACIDS RES, V13, P8765; THOMAS JB, 1988, CELL, V52, P133, DOI 10.1016/0092-8674(88)90537-5; VINSON CR, 1988, GENE DEV, V2, P801, DOI 10.1101/gad.2.7.801; WRIGHT TRF, 1976, GENETICS, V84, P287; XI H, 1989, NATURE, V340, P35, DOI 10.1038/340035a0	35	165	167	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 1	1990	343	6257					467	470		10.1038/343467a0	http://dx.doi.org/10.1038/343467a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	CL818	1967821				2022-12-24	WOS:A1990CL81800062
J	CHAO, NJ; DUNCAN, SR; LONG, GD; HORNING, SJ; BLUME, KG				CHAO, NJ; DUNCAN, SR; LONG, GD; HORNING, SJ; BLUME, KG			CORTICOSTEROID-THERAPY FOR DIFFUSE ALVEOLAR HEMORRHAGE IN AUTOLOGOUS BONE-MARROW TRANSPLANT RECIPIENTS	ANNALS OF INTERNAL MEDICINE			English	Note											CHAO, NJ (corresponding author), STANFORD UNIV, MED CTR, BONE MARROW TRANSPLANT PROGRAM, H-1353, STANFORD, CA 94305 USA.				NATIONAL CANCER INSTITUTE [P01CA049605] Funding Source: NIH RePORTER; NCI NIH HHS [CA 49605] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		JULES-ELYSEE K, 1990, American Review of Respiratory Disease, V141, pA604; KAHN FW, 1987, AM REV RESPIR DIS, V136, P155, DOI 10.1164/ajrccm/136.1.155; LEATHERMAN JW, 1984, MEDICINE, V63, P343, DOI 10.1097/00005792-198411000-00002; ROBBINS RA, 1989, AM J MED, V87, P511	4	77	79	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 15	1991	114	2					145	146		10.7326/0003-4819-114-2-145	http://dx.doi.org/10.7326/0003-4819-114-2-145			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ER534	1984392				2022-12-24	WOS:A1991ER53400010
J	WIERSINGA, WM; TRIP, MD; VANBEEREN, MH; PLOMP, TA; OOSTING, H				WIERSINGA, WM; TRIP, MD; VANBEEREN, MH; PLOMP, TA; OOSTING, H			AN INCREASE IN PLASMA-CHOLESTEROL INDEPENDENT OF THYROID-FUNCTION DURING LONG-TERM AMIODARONE THERAPY - A DOSE-DEPENDENT RELATIONSHIP	ANNALS OF INTERNAL MEDICINE			English	Article							THYROTROPIN SECRETION; HORMONE METABOLISM; RAT MYOCARDIUM; SERUM-LIPIDS; DESETHYLAMIODARONE; THYROXINE; PITUITARY; TRIIODOTHYRONINE; DRUG; ELEVATION	Objective: To determine whether long-term amiodarone treatment is associated with a rise in plasma cholesterol, and, if so, to analyze its relation with thyroid function. Design: Consecutive entry trial, including cardiac patients who initiated amiodarone medication but excluding those with abnormal thyroid function (defined as peak thyroid-stimulating hormone [TSH] response to thyrotropin-releasing hormone [TRH] < 2.8 or > 22.0 mU/L) either before or during amiodarone treatment. Patients: Twenty-three patients who remained euthyroid were studied. Intervention: Oral administration of amiodarone (mean duration of treatment, 17 months; range, 6 to 30 months). Measurements: Fasting plasma lipids, thyroid hormones, and peak TSH to TRH values were recorded before and every 6 months during amiodarone treatment. Results: Plasma cholesterol gradually increased from 5.1 +/- 0.2 mmol/L before treatment to 6.9 +/- 0.8 mmol/L after 30 months of amiodarone medication (P < 0.001); the peak TSH response to TRH did not change. When age- and sex-specific reference values were applied, 30% of the patients had cholesterol values above the 75th percentile before treatment; this number rose to 69% after 2 years of treatment. The rise in plasma cholesterol was associated with an equal increase in apoprotein B. Plasma cholesterol was not related to the daily dose of amiodarone or to plasma concentrations of amiodarone, desethylamiodarone, thyroxine (T4), triiodothyronine (T3), or reverse triiodothyronine (rT3). Linear regression analysis indicated a positive relation between plasma cholesterol and the cumulative dose of amiodarone (r = 0.25, P < 0.05). Conclusion: Long-term amiodarone treatment is associated with a dose-dependent increase in plasma cholesterol that is independent of thyroid function.	NETHERLANDS INST DRUGS & DOPING RES, UTRECHT, NETHERLANDS		WIERSINGA, WM (corresponding author), UNIV AMSTERDAM, ACAD MED CENTRUM F5258, DEPT ENDOCRINOL, MEIBERGDREEF 9, 1105 AZ AMSTERDAM, NETHERLANDS.							ADAMS PC, 1985, CIRCULATION, V72, P1064, DOI 10.1161/01.CIR.72.5.1064; ALBERS JJ, 1989, CLIN LAB MED, V9, P137, DOI 10.1016/S0272-2712(18)30646-2; ALBERT SG, 1987, J AM COLL CARDIOL, V9, P175, DOI 10.1016/S0735-1097(87)80098-0; BURGER A, 1976, J CLIN INVEST, V58, P255, DOI 10.1172/JCI108466; CEPPI JA, 1989, J ENDOCRINOL, V121, P431, DOI 10.1677/joe.0.1210431; DEBBAS NMG, 1983, EUR J CLIN INVEST, V13, P123, DOI 10.1111/j.1365-2362.1983.tb00076.x; FALIK R, 1987, AM J MED, V82, P1102, DOI 10.1016/0002-9343(87)90211-7; FRANKLYN JA, 1989, CLIN SCI, V76, P463, DOI 10.1042/cs0760463; FRANKLYN JA, 1987, CLIN ENDOCRINOL, V27, P373, DOI 10.1111/j.1365-2265.1987.tb01164.x; FREEDBERG AS, 1970, J PHYSIOL-LONDON, V207, P357, DOI 10.1113/jphysiol.1970.sp009066; HARTONG R, 1989, NUCLEAR THYROID HORM, P51; HOLT DW, 1983, AM HEART J, V106, P840, DOI 10.1016/0002-8703(83)90006-6; KANNAN R, 1982, ATHEROSCLEROSIS, V44, P19, DOI 10.1016/0021-9150(82)90049-1; KASIM SE, 1987, ENDOCRINOLOGY, V120, P1991, DOI 10.1210/endo-120-5-1991; KATO R, 1988, AM HEART J, V115, P351, DOI 10.1016/0002-8703(88)90481-4; KRONE W, 1988, AM HEART J, V116, P1729, DOI 10.1016/0002-8703(88)90222-0; LAMBERT M, 1988, ACTA ENDOCRINOL-COP, V118, P449, DOI 10.1530/acta.0.1180449; LATHAM KR, 1987, J AM COLL CARDIOL, V9, P872, DOI 10.1016/S0735-1097(87)80244-9; LINDENMEYER M, 1984, BRIT J PHARMACOL, V82, P275, DOI 10.1111/j.1476-5381.1984.tb16468.x; MEESE R, 1985, AM J CARDIOL, V55, P849, DOI 10.1016/0002-9149(85)90173-0; MELMED S, 1981, J CLIN ENDOCR METAB, V53, P997, DOI 10.1210/jcem-53-5-997; NORMAN MF, 1989, J CLIN INVEST, V83, P306, DOI 10.1172/JCI113874; OREILLY DS, 1988, J ENDOCRINOL, V118, P349, DOI 10.1677/joe.0.1180349; PLOMP TA, 1983, J CHROMATOGR, V273, P379, DOI 10.1016/S0378-4347(00)80958-5; POLLAK PT, 1988, AM J CARDIOL, V62, P562, DOI 10.1016/0002-9149(88)90655-8; PRITCHARD DA, 1975, BRIT HEART J, V37, P856; RIFKIND BM, 1983, JAMA-J AM MED ASSOC, V250, P1869, DOI 10.1001/jama.250.14.1869; SAFRAN M, 1986, AM J MED SCI, V292, P136, DOI 10.1097/00000441-198609000-00003; SILVA JE, 1978, J CLIN INVEST, V61, P1247, DOI 10.1172/JCI109041; SINGH BN, 1989, PROG CARDIOVASC DIS, V31, P249, DOI 10.1016/0033-0620(89)90033-9; SINGH BN, 1970, BRIT J PHARMACOL, V39, P657, DOI 10.1111/j.1476-5381.1970.tb09891.x; SONNENBLICK M, 1986, CARDIOLOGY, V73, P147, DOI 10.1159/000173998; STAUBLI M, 1981, SCHWEIZ MED WSCHR, V111, P1590; WIEGAND V, 1986, BASIC RES CARDIOL, V81, P482, DOI 10.1007/BF01907754; WIERSINGA WM, 1982, METHOD ENZYMOL, V84, P272; WIERSINGA WM, 1986, POSTGRAD MED J, V62, P909, DOI 10.1136/pgmj.62.732.909; WIERSINGA WM, 1980, NETH J MED, V23, P162	37	20	21	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 15	1991	114	2					128	132		10.7326/0003-4819-114-2-128	http://dx.doi.org/10.7326/0003-4819-114-2-128			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ER534	1984387				2022-12-24	WOS:A1991ER53400005
J	KOZLOWSKI, S; TAKESHITA, T; BOEHNCKE, WH; TAKAHASHI, H; BOYD, LF; GERMAIN, RN; BERZOFSKY, JA; MARGULIES, DH				KOZLOWSKI, S; TAKESHITA, T; BOEHNCKE, WH; TAKAHASHI, H; BOYD, LF; GERMAIN, RN; BERZOFSKY, JA; MARGULIES, DH			EXCESS BETA-2 MICROGLOBULIN PROMOTING FUNCTIONAL PEPTIDE ASSOCIATION WITH PURIFIED SOLUBLE CLASS-I MHC MOLECULES	NATURE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; TOXIC LYMPHOCYTES-T; ENVELOPE PROTEIN; CELL HYBRIDOMAS; ANTIGEN; HLA; BETA-2-MICROGLOBULIN; RECOGNITION; H-2; DISSOCIATION	T LYMPHOCYTES expressing alpha-beta-receptors recognize antigenic peptide fragments bound to major histocompatibility complex class I (ref. 1) or class II (ref. 2) molecules present on the surface membranes of other cells. Peptide fragments are present in the two available HLA crystal structures3,4 and recent data indicate that peptide is required for the stable folding of the class I heavy chain and maintenance of its association with the class I light chain beta-2-microglobulin (beta-2-m), at physiological temperature5-7. To explain how the exogeneous peptide used to create targets for cytotoxic cells bearing CD8 antigen1 could associate with apparently peptide-filled extracellular class I molecules, we hypothesized that stable binding of exogenous peptide to mature class I molecules reflects either the replacement of previously bound peptide during the well documented beta-2m exchange process8 or the loading of 'empty' class I heavy chains dependent on the availability of excess beta-2m. In either case, free beta-2m should enhance peptide-class I binding. Using either isolated soluble class I molecules or living cells, we show here that free purified beta-2m markedly augments the generation of antigenic complexes capable of T-cell stimulation.	NIAID,IMMUNOL LAB,LYMPHOCYTE BIOL SECT,BETHESDA,MD 20892; NCI,METAB BRANCH,MOLEC IMMUNOGENET & VACCINE RES SECT,BETHESDA,MD 20892	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	KOZLOWSKI, S (corresponding author), NIAID,IMMUNOL LAB,MOLEC BIOL SECT,BETHESDA,MD 20892, USA.		Germain, Ronald/ABE-7090-2020; Germain, Ronald N./Z-1945-2019	Margulies, David/0000-0001-8530-7375				ASHWELL JD, 1987, J EXP MED, V165, P173, DOI 10.1084/jem.165.1.173; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; CEASE KB, 1987, P NATL ACAD SCI USA, V84, P4249, DOI 10.1073/pnas.84.12.4249; GARRETT TPJ, 1989, NATURE, V342, P692, DOI 10.1038/342692a0; HOCHMAN JH, 1988, J IMMUNOL, V140, P2322; HYAFIL F, 1979, P NATL ACAD SCI USA, V76, P5834, DOI 10.1073/pnas.76.11.5834; KANE KP, 1989, NATURE, V340, P157, DOI 10.1038/340157a0; KAPPLER JW, 1981, J EXP MED, V153, P1198, DOI 10.1084/jem.153.5.1198; LJUNGGREN HG, 1990, NATURE, V346, P476, DOI 10.1038/346476a0; MARGULIES DH, 1986, P NATL ACAD SCI USA, V83, P5252, DOI 10.1073/pnas.83.14.5252; MCCLUSKEY J, 1988, J IMMUNOL, V141, P1451; PARHAM P, 1983, HUM IMMUNOL, V8, P207, DOI 10.1016/0198-8859(83)90038-1; PARKER KC, 1985, BIOCHEMISTRY-US, V24, P5543, DOI 10.1021/bi00341a039; ROCK KL, 1990, P NATL ACAD SCI USA, V87, P7517, DOI 10.1073/pnas.87.19.7517; SCHUMACHER TNM, 1990, CELL, V62, P563, DOI 10.1016/0092-8674(90)90020-F; SCHWARTZ RH, 1985, ANNU REV IMMUNOL, V3, P237, DOI 10.1146/annurev.iy.03.040185.001321; TAKAHASHI H, 1989, J EXP MED, V170, P2023, DOI 10.1084/jem.170.6.2023; TAKAHASHI H, 1988, P NATL ACAD SCI USA, V85, P3105, DOI 10.1073/pnas.85.9.3105; TOWNSEND A, 1990, CELL, V62, P285, DOI 10.1016/0092-8674(90)90366-M; TOWNSEND A, 1989, NATURE, V340, P443, DOI 10.1038/340443a0; TOWNSEND ARM, 1986, CELL, V44, P959, DOI 10.1016/0092-8674(86)90019-X; WARD PJ, 1983, IMMUNOLOGY, V48, P87; WHITE J, 1989, J IMMUNOL, V143, P1822	23	151	164	0	0	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JAN 3	1991	349	6304					74	77		10.1038/349074a0	http://dx.doi.org/10.1038/349074a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EQ601	1985269				2022-12-24	WOS:A1991EQ60100055
J	WEBER, R; LEDERGERBER, B; OPRAVIL, M; SIEGENTHALER, W; LUTHY, R				WEBER, R; LEDERGERBER, B; OPRAVIL, M; SIEGENTHALER, W; LUTHY, R			PROGRESSION OF HIV-INFECTION IN MISUSERS OF INJECTED DRUGS WHO STOP INJECTING OR FOLLOW A PROGRAM OF MAINTENANCE TREATMENT WITH METHADONE	BRITISH MEDICAL JOURNAL			English	Article							HUMAN IMMUNODEFICIENCY VIRUS; CYTOMEGALO-VIRUS; AIDS; USERS; COHORT; CELLS	Objective - To see whether misusers of injected drugs who stop injecting or switch to a programme of maintenance treatment with methadone have a reduced risk of progression of HIV infection when compared with a group of persistent misusers. Design - Observational cohort study in HIV seropositive subjects with a group of current or past history of misusing injected drugs. Setting - HIV outpatient clinic at the University Hospital of Zurich, Switzerland. Patients - 297 Current and former parenteral drug misusers (median age 27) with asymptomatic HIV infection. During the observation period 80 subjects adhered to a programme of maintenance treatment with methadone, 124 continued with parenteral drug misuse, and 93 former misusers remained free of illicit drugs. No antiretroviral treatment was given during the study. Main outcome measures - Probability of progression of HIV infection from asymptomatic to symptomatic (Centers for Disease Control stage IV) as calculated by life table analysis and compared in the three groups of patients by means of a log rank test, and predictors of disease progression as analysed with a Cox proportional hazards regression model. Results - The 297 patients were followed up for a median of 16 months. The median duration of injecting drug misuse before enrolment was 7.1 years. There were no significant differences among the three groups with respect to CD4+ counts at the beginning of the study (median 0.44 x 10(9)/1). Life table analysis showed a significantly lower probability of progression of HIV disease in both the methadone treated group and former drug misusers than in persistent injecting drug misusers. Multivariate regression analysis showed a relative risk of progression of the disease of 1.78 (95% confidence interval 1.20 to 2.67; p < 0.01) in persistent injecting drug misusers, 0.48 (0.29 to 0.77; p < 0.01) in the methadone treated group, and 0.66 (0.41 to 1.06; p = 0.085) in former drug misusers. Conclusions - Stopping the misuse of injected drugs shows the progression of HIV disease in infected subjects. Drug treatment programmes are effective in secondary prevention of HIV associated morbidity.	UNIV HOSP ZURICH,DEPT MED,DIV INFECT DIS,CH-8091 ZURICH,SWITZERLAND	University of Zurich; University Zurich Hospital			Ledergerber, Bruno/B-5656-2009; Weber, Rainer/D-5175-2012	Ledergerber, Bruno/0000-0002-6881-4401; 				BONETTI A, 1989, ANN INTERN MED, V111, P293, DOI 10.7326/0003-4819-111-4-293; BRICKNER PW, 1989, ANN INTERN MED, V110, P833, DOI 10.7326/0003-4819-110-10-833; COOPER JR, 1989, JAMA-J AM MED ASSOC, V262, P1664, DOI 10.1001/jama.262.12.1664; DAVIS MG, 1987, P NATL ACAD SCI USA, V84, P8642, DOI 10.1073/pnas.84.23.8642; DEWOLF F, 1988, J INFECT DIS, V158, P615, DOI 10.1093/infdis/158.3.615; FAUCI AS, 1988, SCIENCE, V239, P617, DOI 10.1126/science.3277274; FINNEGAN LD, 1983, RES TREATMENT NARCOT, P392; GOEDERT JJ, 1988, AIDS ETIOLOGY DIAGNO, P33; GOEDERT JJ, 1988, BMJ, V296, P745; HUBBARD RL, 1988, REV INFECT DIS, V10, P377; JARLAIS DCD, 1987, AIDS, V1, P105; JARLAIS DCD, 1989, JAMA-J AM MED ASSOC, V261, P1008; KASLOW RA, 1989, JAMA-J AM MED ASSOC, V261, P3424, DOI 10.1001/jama.261.23.3424; KLEBER HF, 1980, MED EVALUATION LONGT; Kreek M. J., 1983, RES TREATMENT NARCOT, P456; SKOLNIK PR, 1988, J INFECT DIS, V157, P508, DOI 10.1093/infdis/157.3.508; SORENSEN JL, 1989, 5 INT C IDS MONTR, P707; ZAGURY D, 1986, SCIENCE, V231, P850, DOI 10.1126/science.2418502; 1989, MMWR, V38, P369; 1987, MMWR S2S, V36, pS1	20	83	84	0	1	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	DEC 15	1990	301	6765					1362	1365		10.1136/bmj.301.6765.1362	http://dx.doi.org/10.1136/bmj.301.6765.1362			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	EN919	1980219	Green Published, Bronze			2022-12-24	WOS:A1990EN91900022
J	HATTA, K; SCHILLING, TF; BREMILLER, RA; KIMMEL, CB				HATTA, K; SCHILLING, TF; BREMILLER, RA; KIMMEL, CB			SPECIFICATION OF JAW MUSCLE IDENTITY IN ZEBRAFISH - CORRELATION WITH ENGRAILED-HOMEOPROTEIN EXPRESSION	SCIENCE			English	Article											HATTA, K (corresponding author), UNIV OREGON,INST NEUROSCI,EUGENE,OR 97403, USA.				NICHD NIH HHS [HD22486] Funding Source: Medline; NINDS NIH HHS [NS17963] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD022486] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017963] Funding Source: NIH RePORTER	NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		BRIVANLOU AH, 1989, DEVELOPMENT, V106, P611; DAVIDSON D, 1988, DEVELOPMENT, V104, P305; DAVIS CA, 1988, GENE DEV, V2, P361, DOI 10.1101/gad.2.3.361; FJOSE A, 1988, FEBS LETT, V231, P355, DOI 10.1016/0014-5793(88)80849-4; GARDNER CA, 1988, J NEUROSCI RES, V21, P426, DOI 10.1002/jnr.490210234; HANNEMAN E, 1988, DEVELOPMENT, V103, P49; HEATON MB, 1986, J COMP NEUROL, V243, P381, DOI 10.1002/cne.902430308; HOLLAND PWH, 1988, GENE DEV, V2, P773, DOI 10.1101/gad.2.7.773; INGHAM PW, 1988, NATURE, V335, P25, DOI 10.1038/335025a0; Jarvik E., 1980, BASIC STRUCTURE EVOL, V1; JOYNER AL, 1989, NATURE, V338, P153, DOI 10.1038/338153a0; KIMMEL CB, 1990, DEVELOPMENT, V108, P581; LANDMESSER LT, 1980, ANNU REV NEUROSCI, V3, P279, DOI 10.1146/annurev.ne.03.030180.001431; METCALFE WK, 1985, J COMP NEUROL, V238, P218, DOI 10.1002/cne.902380208; MOODY SA, 1989, J COMP NEUROL, V283, P38, DOI 10.1002/cne.902830105; MURPHY P, 1989, NATURE, V341, P156, DOI 10.1038/341156a0; NJOLSTAD PR, 1988, BIOCHEM BIOPH RES CO, V157, P426, DOI 10.1016/S0006-291X(88)80266-3; NODEN DM, 1983, AM J ANAT, V168, P257, DOI 10.1002/aja.1001680302; PATEL NH, 1989, CELL, V58, P955, DOI 10.1016/0092-8674(89)90947-1; STREISINGER G, 1981, NATURE, V291, P293, DOI 10.1038/291293a0; TREVARROW B, 1990, NEURON, V4, P669, DOI 10.1016/0896-6273(90)90194-K; WILKINSON DG, 1989, NATURE, V341, P405, DOI 10.1038/341405a0; WILKINSON DG, 1989, NATURE, V337, P461, DOI 10.1038/337461a0; [No title captured]	24	88	89	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	NOV 9	1990	250	4982					802	805		10.1126/science.1978412	http://dx.doi.org/10.1126/science.1978412			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG883	1978412				2022-12-24	WOS:A1990EG88300034
J	DEOLIVEIRA, MSP; MATUTES, E; FAMADAS, LC; SCHULZ, TF; CALABRO, ML; NUCCI, M; ANDRADASERPA, MJ; TEDDER, RS; WEISS, RA; CATOVSKY, D				DEOLIVEIRA, MSP; MATUTES, E; FAMADAS, LC; SCHULZ, TF; CALABRO, ML; NUCCI, M; ANDRADASERPA, MJ; TEDDER, RS; WEISS, RA; CATOVSKY, D			ADULT T-CELL LEUKEMIA LYMPHOMA IN BRAZIL AND ITS RELATION TO HTLV-1	LANCET			English	Article									ROYAL MARSDEN HOSP, INST CANC RES, ACAD DEPT HAEMATOL & CYTOGENET, FULHAM RD, LONDON SW3 6JJ, ENGLAND; INST NACL CANC, RIO DE JANEIRO, BRAZIL; HOSP UNIV FUNDAO, RIO DE JANEIRO, BRAZIL; UNIV COLL & MIDDLESEX SCH MED, VIROL MED MICROBIOL SECT, LONDON, ENGLAND	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; National Cancer Institute (Inca); University of London; University College London			Nucci, Marcio/G-4515-2012; Pombo-de-Oliveira, Maria S./I-8884-2014; Schulz, Thomas/AAA-1634-2019; Calabrò, Maria Luisa/H-6015-2016	Nucci, Marcio/0000-0003-4867-0014; Pombo-de-Oliveira, Maria S./0000-0002-1507-004X; Calabrò, Maria Luisa/0000-0001-9401-6182; Tedder, Richard/0000-0002-9672-5721; Schulz, Thomas/0000-0001-8792-5345				ANDRADASERPA MJ, 1989, INT J CANCER, V44, P389, DOI 10.1002/ijc.2910440302; BLATTNER WA, 1982, INT J CANCER, V30, P257, DOI 10.1002/ijc.2910300302; BLAYNEY DW, 1983, ANN INTERN MED, V98, P144, DOI 10.7326/0003-4819-98-2-144; BRINDLE RJ, 1988, EPIDEMIOL INFECT, V100, P153, DOI 10.1017/S095026880006564X; BUNN PA, 1983, NEW ENGL J MED, V309, P257, DOI 10.1056/NEJM198308043090501; CARTIERROVIROSA L, 1989, LANCET, V1, P556; CATOVSKY D, 1982, LANCET, V1, P639; CORTES E, 1989, NEW ENGL J MED, V320, P953, DOI 10.1056/NEJM198904133201501; DELAPORTE E, 1988, INT J CANCER, V42, P687, DOI 10.1002/ijc.2910420509; FLEMING AF, 1986, INT J CANCER, V38, P809, DOI 10.1002/ijc.2910380605; GESSAIN A, 1985, LANCET, V2, P407; KITAGAWA T, 1986, JAMA-J AM MED ASSOC, V256, P2342, DOI 10.1001/jama.1986.03380170058009; LEE H, 1989, SCIENCE, V244, P471, DOI 10.1126/science.2655084; LEE H, 1989, BLOOD, V73, P1742; MATUJTES E, 1985, RETROVIRUS HUMAN LYM, P59; MATUTES E, 1986, INT J CANCER, V38, P41, DOI 10.1002/ijc.2910380108; Montserrat E, 1989, Leuk Lymphoma, V1, P47, DOI 10.3109/10428198909042458; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SEIKI M, 1984, NATURE, V309, P640, DOI 10.1038/309640a0; SEIKI M, 1983, P NATL ACAD SCI-BIOL, V80, P3618, DOI 10.1073/pnas.80.12.3618; SHIMOYAMA M, 1986, P NATL ACAD SCI USA, V83, P4524, DOI 10.1073/pnas.83.12.4524; TAJIMAN K, 1989, CANCER MTASTAS REV, V7, P223; TANNIR N, 1985, CANCER, V55, P615, DOI 10.1002/1097-0142(19850201)55:3<615::AID-CNCR2820550323>3.0.CO;2-X; UCHIYAMA T, 1977, BLOOD, V50, P481, DOI 10.1182/blood.V50.3.481.481; VILMER E, 1985, LANCET, V2, P1301; WEBER JN, 1989, J INFECT DIS, V159, P1025, DOI 10.1093/infdis/159.6.1025; WONGSTAAL F, 1983, NATURE, V302, P626, DOI 10.1038/302626a0; YAMAGUCHI K, 1984, BLOOD, V63, P1235; ZANINOVIC V, 1990, NATURE, V344, P299, DOI 10.1038/344299b0	29	60	63	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	OCT 20	1990	336	8721					987	990		10.1016/0140-6736(90)92432-H	http://dx.doi.org/10.1016/0140-6736(90)92432-H			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ED601	1977015				2022-12-24	WOS:A1990ED60100014
J	GROVER, LM; TEYLER, TJ				GROVER, LM; TEYLER, TJ			2 COMPONENTS OF LONG-TERM POTENTIATION INDUCED BY DIFFERENT PATTERNS OF AFFERENT ACTIVATION	NATURE			English	Article											GROVER, LM (corresponding author), NORTHEASTERN OHIO UNIV,COLL MED,DEPT NEUROBIOL,ROOTSTOWN,OH 44272, USA.							ARTOLA A, 1987, NATURE, V330, P649, DOI 10.1038/330649a0; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P357, DOI 10.1113/jphysiol.1973.sp010274; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; CORTES R, 1983, NEUROSCI LETT, V42, P249, DOI 10.1016/0304-3940(83)90270-7; DOLPHIN AC, 1982, NATURE, V297, P496, DOI 10.1038/297496a0; GROVER LM, 1990, BRAIN RES, V506, P53, DOI 10.1016/0006-8993(90)91198-P; HARRIS EW, 1986, NEUROSCI LETT, V70, P132, DOI 10.1016/0304-3940(86)90451-9; HARRIS EW, 1984, BRAIN RES, V323, P132, DOI 10.1016/0006-8993(84)90275-0; JONES RSG, 1987, BRAIN RES, V416, P257; KUBA K, 1990, PROG NEUROBIOL, V34, P197, DOI 10.1016/0301-0082(90)90012-6; LANCASTER B, 1987, J PHYSIOL-LONDON, V389, P187, DOI 10.1113/jphysiol.1987.sp016653; LYNCH G, 1983, NATURE, V305, P7719; MADISON DV, 1984, J PHYSIOL-LONDON, V354, P319, DOI 10.1113/jphysiol.1984.sp015378; MAYER ML, 1984, J PHYSIOL-LONDON, V354, P29, DOI 10.1113/jphysiol.1984.sp015360; MIDDLEMISS DN, 1985, NATURE, V314, P94, DOI 10.1038/314094a0; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; MULKEEN D, 1987, NEUROSCI LETT, V80, P351, DOI 10.1016/0304-3940(87)90481-2; NOWAK L, 1984, NATURE, V307, P462, DOI 10.1038/307462a0; RAGEHR WG, 1989, NATURE, V341, P533; RANE SG, 1987, PFLUG ARCH EUR J PHY, V409, P361, DOI 10.1007/BF00583789; TAUBE JS, 1986, BRAIN RES, V379, P275, DOI 10.1016/0006-8993(86)90781-X; TELER TJ, 1984, BRAIN RES REV, V7, P15; TEYLER TJ, 1987, ANNU REV NEUROSCI, V10, P131, DOI 10.1146/annurev.ne.10.030187.001023; TEYLER TJ, 1980, BRAIN RES BULL, V5, P391, DOI 10.1016/S0361-9230(80)80009-8; TSIEN RY, 1980, BIOCHEMISTRY-US, V19, P2396, DOI 10.1021/bi00552a018	26	587	593	0	14	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	OCT 4	1990	347	6292					477	479		10.1038/347477a0	http://dx.doi.org/10.1038/347477a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB446	1977084				2022-12-24	WOS:A1990EB44600072
J	SIMEONE, A; ACAMPORA, D; ARCIONI, L; ANDREWS, PW; BONCINELLI, E; MAVILIO, F				SIMEONE, A; ACAMPORA, D; ARCIONI, L; ANDREWS, PW; BONCINELLI, E; MAVILIO, F			SEQUENTIAL ACTIVATION OF HOX2 HOMEOBOX GENES BY RETINOIC ACID IN HUMAN EMBRYONAL CARCINOMA-CELLS	NATURE			English	Article									IST SCI HS RAFFAELE,VIA OLGETTINA 60,I-20132 MILAN,ITALY; CNR,INT INST GENET & BIOPHYS,I-80125 NAPLES,ITALY; WISTAR INST,PHILADELPHIA,PA 19104	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Consiglio Nazionale delle Ricerche (CNR); Istituto di Genetica e Biofisica "Adriano Buzzati-Traverso" (IGB-CNR); The Wistar Institute			Simeone, Antonio/ABG-5269-2020; Acampora, Dario/C-2156-2013	Simeone, Antonio/0000-0003-2693-9836; Mavilio, Fulvio/0000-0003-0459-4320; Andrews, Peter/0000-0001-7215-4410				ACAMPORA D, 1989, NUCLEIC ACIDS RES, V17, P10385, DOI 10.1093/nar/17.24.10385; ANDREWS PW, 1984, DEV BIOL, V103, P285, DOI 10.1016/0012-1606(84)90316-6; BRAND N, 1988, NATURE, V332, P850, DOI 10.1038/332850a0; BROCKES JP, 1989, NEURON, V2, P1285, DOI 10.1016/0896-6273(89)90066-4; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; DEROBERTIS EM, 1989, CELL, V57, P189, DOI 10.1016/0092-8674(89)90954-9; DUBOULE D, 1989, EMBO J, V8, P1497, DOI 10.1002/j.1460-2075.1989.tb03534.x; DURSTON AJ, 1989, NATURE, V340, P140, DOI 10.1038/340140a0; GEHRING WJ, 1987, SCIENCE, V236, P1245, DOI 10.1126/science.2884726; GIAMPAOLO A, 1989, DIFFERENTIATION, V40, P191, DOI 10.1111/j.1432-0436.1989.tb00598.x; GIGUERE V, 1987, NATURE, V330, P624, DOI 10.1038/330624a0; GRAHAM A, 1989, CELL, V57, P367, DOI 10.1016/0092-8674(89)90912-4; HOLLAND PWH, 1988, GENE DEV, V2, P773, DOI 10.1101/gad.2.7.773; INGHAM PW, 1988, NATURE, V335, P25, DOI 10.1038/335025a0; MANGELSDORF DJ, 1990, NATURE, V345, P224, DOI 10.1038/345224a0; MATTHAEI KI, 1983, EXP CELL RES, V143, P471, DOI 10.1016/0014-4827(83)90076-9; MAVILIO F, 1988, DIFFERENTIATION, V37, P73, DOI 10.1111/j.1432-0436.1988.tb00798.x; MAVILIO F, 1986, NATURE, V324, P664, DOI 10.1038/324664a0; MCCORMICK AM, 1982, J BIOL CHEM, V257, P1730; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; PETKOVICH M, 1987, NATURE, V330, P444, DOI 10.1038/330444a0; PONTE P, 1983, MOL CELL BIOL, V3, P1783, DOI 10.1128/MCB.3.10.1783; Sambrook J., 1989, MOL CLONING LAB MANU; SIMEONE A, 1987, P NATL ACAD SCI USA, V84, P4914, DOI 10.1073/pnas.84.14.4914; SIMEONE A, 1986, NATURE, V320, P763, DOI 10.1038/320763a0; THALLER C, 1987, NATURE, V327, P625, DOI 10.1038/327625a0; THALLER C, 1988, DEVELOPMENT, V103, P473; THOMAS PS, 1980, P NATL ACAD SCI-BIOL, V77, P5201, DOI 10.1073/pnas.77.9.5201; TICKLE C, 1982, NATURE, V296, P564, DOI 10.1038/296564a0; WILKINSON DG, 1989, NATURE, V341, P405, DOI 10.1038/341405a0; ZELENT A, 1989, NATURE, V339, P714, DOI 10.1038/339714a0	31	473	480	0	19	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	AUG 23	1990	346	6286					763	766		10.1038/346763a0	http://dx.doi.org/10.1038/346763a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV652	1975088				2022-12-24	WOS:A1990DV65200068
J	LU, CZ; QIAO, J; SHEN, T; LINK, H				LU, CZ; QIAO, J; SHEN, T; LINK, H			EARLY DIAGNOSIS OF TUBERCULOUS MENINGITIS BY DETECTION OF ANTI-BCG SECRETING CELLS IN CEREBROSPINAL-FLUID	LANCET			English	Article									SHANGHAI MED UNIV,INST NEUROL,SHANGHAI,PEOPLES R CHINA	Fudan University	LU, CZ (corresponding author), KAROLINSKA INST,HUDDINGE UNIV HOSP,DEPT NEUROL,S-14186 HUDDINGE,SWEDEN.							BAIG S, 1989, LANCET, V2, P71; BELL J, 1989, IMMUNOL TODAY, V10, P351, DOI 10.1016/0167-5699(89)90193-X; CHANDRAMUKI A, 1985, J MED MICROBIOL, V20, P239, DOI 10.1099/00222615-20-2-239; CHAPARAS SD, 1973, INFECT IMMUN, V7, P777, DOI 10.1128/IAI.7.5.777-780.1973; DANIEL IM, 1987, J INFECT DIS, V155, P659; DANIEL TM, 1988, J INFECT DIS, V158, P678, DOI 10.1093/infdis/158.4.678; HERNANDEZ R, 1984, J CLIN MICROBIOL, V20, P533; KADIVAL GV, 1987, J INFECT DIS, V155, P608, DOI 10.1093/infdis/155.4.608; KADIVAL GV, 1986, J CLIN MICROBIOL, V23, P901, DOI 10.1128/JCM.23.5.901-904.1986; KAPLOW LS, 1975, AM J CLIN PATHOL, V63, P451; KINNMAN J, 1981, J CLIN MICROBIOL, V13, P30, DOI 10.1128/JCM.13.1.30-35.1981; LINK H, 1987, ADV CSF PROTEIN RES, P49; LINK H, 1988, TRENDS EUROPEAN MULT, P173; OLSSON T, 1990, ANN NEUROL, V27, P132, DOI 10.1002/ana.410270207; PRABHAKAR S, 1987, J NEUROL SCI, V78, P203, DOI 10.1016/0022-510X(87)90061-X; RAJA A, 1988, J INFECT DIS, V158, P468, DOI 10.1093/infdis/158.2.468; SADA E, 1983, LANCET, V2, P651; WATT G, 1988, J INFECT DIS, V158, P681, DOI 10.1093/infdis/158.4.681; ZACHAU AC, 1989, J NEUROL SCI, V91, P323, DOI 10.1016/0022-510X(89)90061-0	19	17	19	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JUL 7	1990	336	8706					10	13		10.1016/0140-6736(90)91519-G	http://dx.doi.org/10.1016/0140-6736(90)91519-G			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DM385	1973209				2022-12-24	WOS:A1990DM38500003
J	TEITELBAUM, JS; ZATORRE, RJ; CARPENTER, S; GENDRON, D; EVANS, AC; GJEDDE, A; CASHMAN, NR				TEITELBAUM, JS; ZATORRE, RJ; CARPENTER, S; GENDRON, D; EVANS, AC; GJEDDE, A; CASHMAN, NR			NEUROLOGIC SEQUELAE OF DOMOIC ACID INTOXICATION DUE TO THE INGESTION OF CONTAMINATED MUSSELS	NEW ENGLAND JOURNAL OF MEDICINE			English	Article									MCGILL UNIV, MONTREAL NEUROL INST, DEPT NEUROL & NEUROSURG, 3801 UNIV ST, MONTREAL H3A 2B4, QUEBEC, CANADA; MCGILL UNIV, MONTREAL NEUROL INST, DEPT NEUROPSYCHOL, MONTREAL H3A 2T5, QUEBEC, CANADA; MCGILL UNIV, MONTREAL NEUROL INST, DEPT NEUROPATHOL, MONTREAL H3A 2T5, QUEBEC, CANADA; MCGILL UNIV, MONTREAL NEUROL INST, POSITRON IMAGING LABS, MONTREAL H3A 2T5, QUEBEC, CANADA	McGill University; McGill University; McGill University; McGill University			Gjedde, Albert/U-3751-2019; Gjedde, Albert/I-2452-2019	Gjedde, Albert/0000-0002-3756-7401; 				BISCOE TJ, 1976, BRIT J PHARMACOL, V58, P373, DOI 10.1111/j.1476-5381.1976.tb07714.x; CERMAK LS, 1983, NEUROPSYCHOLOGIA, V21, P213, DOI 10.1016/0028-3932(83)90039-8; CHOI DW, 1988, NEURON, V1, P623, DOI 10.1016/0896-6273(88)90162-6; COOKE BE, 1984, IEEE T NUCL SCI, V31, P640, DOI 10.1109/TNS.1984.4333335; COYLE JT, 1983, J NEUROCHEM, V41, P1; DEBONI U, 1985, J NEUROL SCI, V68, P105, DOI 10.1016/0022-510X(85)90093-0; DEBONNEL G, 1989, CAN J PHYSIOL PHARM, V67, P29, DOI 10.1139/y89-005; DEMONTIGNY C, 1981, LIFE SCI, V29, P2103, DOI 10.1016/0024-3205(81)90667-6; DERENZI E, 1962, BRAIN, V85, P665, DOI 10.1093/brain/85.4.665; EVANS AC, 1988, J CEREBR BLOOD F MET, V8, P513, DOI 10.1038/jcbfm.1988.92; FOSTER NL, 1984, ANN NEUROL, V16, P649, DOI 10.1002/ana.410160605; GREENAMYRE JT, 1986, ARCH NEUROL-CHICAGO, V43, P1058, DOI 10.1001/archneur.1986.00520100062016; HULICKA IM, 1966, J GENET PSYCHOL, V109, P135, DOI 10.1080/00221325.1966.10533690; KUWABARA H, 1990, J CEREBR BLOOD F MET, V10, P180, DOI 10.1038/jcbfm.1990.33; LUDOLPH AC, 1987, BRAIN, V110, P149, DOI 10.1093/brain/110.1.149; MARAGOS WF, 1987, TRENDS NEUROSCI, V10, P65, DOI 10.1016/0166-2236(87)90025-7; MCGEER EG, 1976, NATURE, V263, P517, DOI 10.1038/263517a0; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MILNER B, 1958, Res Publ Assoc Res Nerv Ment Dis, V36, P244; MILNER B, 1963, ARCH NEUROL-CHICAGO, V9, P90, DOI 10.1001/archneur.1963.00460070100010; Milner B., 1966, AMNESIA; OLDFIELD RC, 1965, Q J EXP PSYCHOL, V17, P273, DOI 10.1080/17470216508416445; OLNEY JW, 1974, BRAIN RES, V77, P507, DOI 10.1016/0006-8993(74)90640-4; OSBORNE D, 1978, J CLIN PSYCHOL, V34, P115, DOI 10.1002/1097-4679(197801)34:1<115::AID-JCLP2270340126>3.0.CO;2-J; Perl T., 1987, CAN DIS WKLY REP, V13, P224; PERL TM, 1990, NEW ENGL J MED, V322, P1775, DOI 10.1056/NEJM199006213222504; PLAITAKIS A, 1987, ANN NEUROL, V22, P575, DOI 10.1002/ana.410220503; PRICE DL, 1986, ANNU REV NEUROSCI, V9, P489; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; SCHWARCZ R, 1978, NEUROPHARMACOLOGY, V17, P145, DOI 10.1016/0028-3908(78)90127-2; SCHWOB JE, 1980, NEUROSCIENCE, V5, P991, DOI 10.1016/0306-4522(80)90181-5; SLOVITER RS, 1981, NEUROPHARMACOLOGY, V20, P1003, DOI 10.1016/0028-3908(81)90088-5; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; TANDAN R, 1985, ANN NEUROL, V18, P271, DOI 10.1002/ana.410180302; Thurstone LL, 1943, CHICAGO TESTS PRIMAR; TREMBLAY E, 1984, NEUROSCIENCE, V13, P1051, DOI 10.1016/0306-4522(84)90288-4; Victor M., 1971, WERNICKE KORSAKOFF S; Wechsler D, 1981, ADULT INTELLIGENCE S; WRIGHT JLC, 1989, CAN J CHEM, V67, P481, DOI 10.1139/v89-075; ZACZEK R, 1982, NEUROPHARMACOLOGY, V21, P15, DOI 10.1016/0028-3908(82)90205-2	40	421	431	0	20	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JUN 21	1990	322	25					1781	1787		10.1056/NEJM199006213222505	http://dx.doi.org/10.1056/NEJM199006213222505			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DJ232	1971710				2022-12-24	WOS:A1990DJ23200005
J	BOSHART, M; WEIH, F; SCHMIDT, A; FOURNIER, REK; SCHUTZ, G				BOSHART, M; WEIH, F; SCHMIDT, A; FOURNIER, REK; SCHUTZ, G			A CYCLIC-AMP RESPONSE ELEMENT MEDIATES REPRESSION OF TYROSINE AMINOTRANSFERASE GENE-TRANSCRIPTION BY THE TISSUE-SPECIFIC EXTINGUISHER LOCUS TSE-1	CELL			English	Article									FRED HUTCHINSON CANC RES CTR,DIV BASIC SCI,SEATTLE,WA 98104	Fred Hutchinson Cancer Center	BOSHART, M (corresponding author), GERMAN CANC RES CTR,INST CELL & TUMOR BIOL,IM NEUENHEIMER FELD 280,W-6900 HEIDELBERG,GERMANY.		Boshart, Michael/A-2700-2011	Boshart, Michael/0000-0002-5070-2663				Ausubel FM., 1988, CURRENT PROTOCOLS MO; BAEUERLE PA, 1988, SCIENCE, V242, P540, DOI 10.1126/science.3140380; BECKER PB, 1988, GENETIC ENG, V10, P1; BERGMAN Y, 1990, EMBO J, V9, P849, DOI 10.1002/j.1460-2075.1990.tb08182.x; BLAU HM, 1985, SCIENCE, V230, P758, DOI 10.1126/science.2414846; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROWN JE, 1975, CELL, V6, P481, DOI 10.1016/0092-8674(75)90037-9; CHEN EY, 1985, DNA-J MOLEC CELL BIO, V4, P165, DOI 10.1089/dna.1985.4.165; CHIN AC, 1987, P NATL ACAD SCI USA, V84, P1614, DOI 10.1073/pnas.84.6.1614; CHIN AC, 1989, MOL CELL BIOL, V9, P3736, DOI 10.1128/MCB.9.9.3736; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; CHU G, 1987, NUCLEIC ACIDS RES, V15, P1311, DOI 10.1093/nar/15.3.1311; CILIBERTO G, 1985, CELL, V41, P531, DOI 10.1016/S0092-8674(85)80026-X; COMB M, 1986, NATURE, V323, P353, DOI 10.1038/323353a0; CRABB DW, 1987, ANAL BIOCHEM, V163, P88, DOI 10.1016/0003-2697(87)90096-0; DAVIDSON RL, 1974, ANNU REV GENET, V8, P195, DOI 10.1146/annurev.ge.08.120174.001211; DAVIDSON RL, 1966, P NATL ACAD SCI USA, V56, P1437, DOI 10.1073/pnas.56.5.1437; DAVIS FM, 1973, BACTERIOL REV, V37, P197, DOI 10.1128/MMBR.37.2.197-214.1973; DELEGEANE AM, 1987, MOL CELL BIOL, V7, P3994, DOI 10.1128/MCB.7.11.3994; DEWET JR, 1987, MOL CELL BIOL, V7, P725, DOI 10.1128/MCB.7.2.725; DYNAN WS, 1989, CELL, V58, P1, DOI 10.1016/0092-8674(89)90393-0; EDELMAN AM, 1987, ANNU REV BIOCHEM, V56, P567, DOI 10.1146/annurev.biochem.56.1.567; FELGNER PL, 1987, P NATL ACAD SCI USA, V84, P7413, DOI 10.1073/pnas.84.21.7413; FISCH TM, 1989, GENE DEV, V3, P198, DOI 10.1101/gad.3.2.198; FROMM M, 1985, P NATL ACAD SCI USA, V82, P5824, DOI 10.1073/pnas.82.17.5824; GHISALBERTI AV, 1980, BIOCHEM J, V190, P685, DOI 10.1042/bj1900685; GONZALEZ GA, 1989, NATURE, V337, P749, DOI 10.1038/337749a0; GORMAN CM, 1982, MOL CELL BIOL, V2, P1044, DOI 10.1128/MCB.2.9.1044; GOURDEAU H, 1989, MOL CELL BIOL, V9, P1813, DOI 10.1128/MCB.9.5.1813; GRANNER DK, 1985, BIOCHEM ACTION HORM, V12, P89; GREENGARD O, 1970, BIOCHEMICAL ACTIONS, V1, P53; GRUNDSTROM T, 1985, NUCLEIC ACIDS RES, V13, P3305, DOI 10.1093/nar/13.9.3305; HAI TW, 1989, GENE DEV, V3, P2083, DOI 10.1101/gad.3.12b.2083; HARGROVE JL, 1985, TRANSAMINASES, P511; HASHIMOTO S, 1984, P NATL ACAD SCI-BIOL, V81, P6637, DOI 10.1073/pnas.81.21.6637; HEARD JM, 1987, MOL CELL BIOL, V7, P2425, DOI 10.1128/MCB.7.7.2425; HOEFFLER JP, 1988, SCIENCE, V242, P1430, DOI 10.1126/science.2974179; IGUCHIARIGA SMM, 1989, GENE DEV, V3, P612, DOI 10.1101/gad.3.5.612; JANTZEN HM, 1987, CELL, V49, P29, DOI 10.1016/0092-8674(87)90752-5; JUNKER S, 1988, EMBO J, V7, P3093, DOI 10.1002/j.1460-2075.1988.tb03175.x; KARIN M, 1989, TRENDS GENET, V5, P65, DOI 10.1016/0168-9525(89)90027-9; KILLARY AM, 1984, CELL, V38, P523, DOI 10.1016/0092-8674(84)90507-5; KILLARY AM, 1984, BIOCHEM GENET, V22, P201, DOI 10.1007/BF00484224; KNOWLES BB, 1980, SCIENCE, V209, P497, DOI 10.1126/science.6248960; LEACH RJ, 1989, GENOMICS, V5, P167, DOI 10.1016/0888-7543(89)90043-8; LEM J, 1988, P NATL ACAD SCI USA, V85, P7302, DOI 10.1073/pnas.85.19.7302; LUCKOW B, 1987, NUCLEIC ACIDS RES, V15, P5490, DOI 10.1093/nar/15.13.5490; MAEKAWA T, 1989, EMBO J, V8, P2023, DOI 10.1002/j.1460-2075.1989.tb03610.x; MCCORMICK A, 1988, CELL, V55, P379, DOI 10.1016/0092-8674(88)90061-X; MELTON DA, 1984, NUCLEIC ACIDS RES, V12, P7035, DOI 10.1093/nar/12.18.7035; MEVELNINIO M, 1981, J CELL BIOL, V90, P339, DOI 10.1083/jcb.90.2.339; MITCHELL PJ, 1989, SCIENCE, V245, P371, DOI 10.1126/science.2667136; MONTMINY MR, 1986, P NATL ACAD SCI USA, V83, P6682, DOI 10.1073/pnas.83.18.6682; MULLER G, 1985, J MOL BIOL, V184, P367, DOI 10.1016/0022-2836(85)90287-6; PETERSEN JA, 1972, P NATL ACAD SCI USA, V69, P571, DOI 10.1073/pnas.69.3.571; PETERSON TC, 1989, MOL BIOL MED, V6, P109; PETERSON TC, 1985, MOL CELL BIOL, V5, P2491, DOI 10.1128/MCB.5.9.2491; PETIT C, 1986, P NATL ACAD SCI USA, V83, P2561, DOI 10.1073/pnas.83.8.2561; QUINN PG, 1988, MOL CELL BIOL, V8, P3467, DOI 10.1128/MCB.8.8.3467; RUIZBRAVO N, 1982, P NATL ACAD SCI-BIOL, V79, P365, DOI 10.1073/pnas.79.2.365; RUPPERT S, 1990, CELL, V61, P895, DOI 10.1016/0092-8674(90)90200-X; SCHMID E, 1987, EUR J BIOCHEM, V165, P499, DOI 10.1111/j.1432-1033.1987.tb11467.x; SCHNEIDE.JA, 1971, P NATL ACAD SCI USA, V68, P127, DOI 10.1073/pnas.68.1.127; SEAMON KB, 1981, P NATL ACAD SCI-BIOL, V78, P3363, DOI 10.1073/pnas.78.6.3363; SERFLING E, 1985, TRENDS GENET, V1, P224, DOI 10.1016/0168-9525(85)90088-5; SHAUL Y, 1987, EMBO J, V6, P1913, DOI 10.1002/j.1460-2075.1987.tb02451.x; SILVER BJ, 1987, P NATL ACAD SCI USA, V84, P2198, DOI 10.1073/pnas.84.8.2198; SPARKES RS, 1973, P NATL ACAD SCI USA, V70, P377, DOI 10.1073/pnas.70.2.377; SVOBODA J, 1960, NATURE, V186, P980, DOI 10.1038/186980b0; THAYER MJ, 1989, MOL CELL BIOL, V9, P2837, DOI 10.1128/MCB.9.7.2837; THOMPSON EB, 1966, P NATL ACAD SCI USA, V56, P296, DOI 10.1073/pnas.56.1.296; TRIPPUTI P, 1988, SCIENCE, V241, P1205, DOI 10.1126/science.2842865; TSUKADA T, 1987, J BIOL CHEM, V262, P8743; WEIH F, 1988, NUCLEIC ACIDS RES, V16, P1628, DOI 10.1093/nar/16.4.1628; YAMAMOTO KK, 1988, NATURE, V334, P494, DOI 10.1038/334494a0; YEE JK, 1989, SCIENCE, V246, P658, DOI 10.1126/science.2554495; YU H, 1989, CELL, V58, P441, DOI 10.1016/0092-8674(89)90425-X; ZALLER DM, 1988, MOL CELL BIOL, V8, P1932, DOI 10.1128/MCB.8.5.1932	78	144	146	0	1	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	JUN 1	1990	61	5					905	916		10.1016/0092-8674(90)90201-O	http://dx.doi.org/10.1016/0092-8674(90)90201-O			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DG090	1971524	Green Published			2022-12-24	WOS:A1990DG09000020
J	RITTER, JM; DOKTOR, HS; BENJAMIN, N				RITTER, JM; DOKTOR, HS; BENJAMIN, N			PARADOXICAL EFFECT OF BICARBONATE ON CYTOPLASMIC PH	LANCET			English	Article											RITTER, JM (corresponding author), UNITED MED & DENT SCH GUYS & ST THOMAS HOSP,GUYS HOSP,DEPT CLIN PHARMACOL,LONDON BRIDGE,LONDON SE1 9RT,ENGLAND.							ANDREOLI TE, 1988, CECIL TXB MED, P549; AYUS JC, 1989, AM J MED, V87, P5, DOI 10.1016/S0002-9343(89)80475-9; BERSIN RM, 1989, AM J MED, V87, P7, DOI 10.1016/S0002-9343(89)80476-0; CAMERON IR, 1980, CLIN ENDOCRINOL META, V9, P529; CHAMBERLAIN DA, 1989, BRIT MED J, V299, P446, DOI 10.1136/bmj.299.6696.446; COHEN RD, 1987, OXFORD TXB MED, P164; GANZ MB, 1989, NATURE, V337, P648, DOI 10.1038/337648a0; Gesell R, 1926, AM J PHYSIOL, V78, P610, DOI 10.1152/ajplegacy.1926.78.3.610; HALE PJ, 1984, BMJ-BRIT MED J, V289, P1035, DOI 10.1136/bmj.289.6451.1035; JACOBS HH, 1920, AM J PHYSIOL, V53, P457; Jacobs MH, 1920, AM J PHYSIOL, V51, P321, DOI 10.1152/ajplegacy.1920.51.2.321; KNOX WE, 1972, ENZYME PATTERNS FETA; MAREN TH, 1967, MOL PHARMACOL, V3, P503; MORRIS LR, 1986, ANN INTERN MED, V105, P836, DOI 10.7326/0003-4819-105-6-836; RINK TJ, 1982, J CELL BIOL, V95, P189, DOI 10.1083/jcb.95.1.189; ROBERTSON CE, 1989, PRESCRIBERS J, V29, P101; ROOS A, 1981, PHYSIOL REV, V61, P296, DOI 10.1152/physrev.1981.61.2.296; ROUGHTON FJW, 1943, PHYSIOL REV, V15, P241; RYAN US, 1983, J APPL PHYSIOL, V53, P914; RYDER REJ, 1987, BRIT J CLIN PRACT, V41, P730; SAGE SO, 1990, J PHYSIOL-LONDON, V420, P31, DOI 10.1113/jphysiol.1990.sp017900; SIMCHOWITZ L, 1986, MOL PHARMACOL, V30, P112; STACPOOLE PW, 1986, ANN INTERN MED, V105, P276, DOI 10.7326/0003-4819-105-2-276; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; WEIL MH, 1985, CHEST, V88, P487, DOI 10.1378/chest.88.4.487; WRIGHT AD, 1989, PRESCRIBERS J, V29, P147	26	73	75	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	MAY 26	1990	335	8700					1243	1246		10.1016/0140-6736(90)91305-T	http://dx.doi.org/10.1016/0140-6736(90)91305-T			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF451	1971322				2022-12-24	WOS:A1990DF45100005
J	HARPER, PS; CLARKE, A				HARPER, PS; CLARKE, A			SHOULD WE TEST CHILDREN FOR ADULT GENETIC-DISEASES	LANCET			English	Editorial Material											HARPER, PS (corresponding author), UNIV COLL CARDIFF,INST MED GENET,CARDIFF CF4 4XN,S GLAM,WALES.							BLOCH M, 1990, AM J HUM GENET, V46, P1; BREUNING MH, 1987, LANCET, V2, P1359; CRAUFURD DIO, 1986, BRIT MED J, V293, P249, DOI 10.1136/bmj.293.6541.249; MORRIS M, 1988, LANCET, V2, P1069, DOI 10.1016/S0140-6736(88)90078-5; MORRIS MJ, 1989, LANCET, V2, P601; Nicholson RH, 1986, MED RES CHILDREN ETH; TOPS CMJ, 1989, LANCET, V2, P1361; 1990, J MED GENET, V27, P34	8	90	91	0	3	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	MAY 19	1990	335	8699					1205	1206		10.1016/0140-6736(90)92713-R	http://dx.doi.org/10.1016/0140-6736(90)92713-R			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE448	1971046				2022-12-24	WOS:A1990DE44800014
J	OHKUMA, Y; HORIKOSHI, M; ROEDER, RG; DESPLAN, C				OHKUMA, Y; HORIKOSHI, M; ROEDER, RG; DESPLAN, C			BINDING-SITE DEPENDENT DIRECT ACTIVATION AND REPRESSION OF INVITRO TRANSCRIPTION BY DROSOPHILA HOMEODOMAIN PROTEINS	CELL			English	Article									ROCKEFELLER UNIV,BIOCHEM & MOLEC BIOL LAB,NEW YORK,NY 10021	Rockefeller University	OHKUMA, Y (corresponding author), ROCKEFELLER UNIV,HOWARD HUGHES MED INST,NEW YORK,NY 10021, USA.			Desplan, Claude/0000-0002-6914-1413				BAKER NE, 1987, EMBO J, V6, P1765, DOI 10.1002/j.1460-2075.1987.tb02429.x; BEACHY PA, 1988, CELL, V55, P1069, DOI 10.1016/0092-8674(88)90251-6; BIGGIN MD, 1989, CELL, V58, P433, DOI 10.1016/0092-8674(89)90424-8; BODNER M, 1988, CELL, V55, P505, DOI 10.1016/0092-8674(88)90037-2; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; CARROLL SB, 1985, CELL, V43, P47, DOI 10.1016/0092-8674(85)90011-X; CLERC RG, 1988, GENE DEV, V2, P1570, DOI 10.1101/gad.2.12a.1570; DESPLAN C, 1988, CELL, V54, P1081, DOI 10.1016/0092-8674(88)90123-7; DESPLAN C, 1985, NATURE, V318, P630, DOI 10.1038/318630a0; DINARDO S, 1985, CELL, V43, P59, DOI 10.1016/0092-8674(85)90012-1; DRIEVER W, 1989, NATURE, V340, P363, DOI 10.1038/340363a0; DRIEVER W, 1989, NATURE, V337, P138, DOI 10.1038/337138a0; FITZPATRICK VD, 1989, NATURE, V337, P666, DOI 10.1038/337666a0; FJOSE A, 1985, NATURE, V313, P284, DOI 10.1038/313284a0; GEHRING WJ, 1986, ANNU REV GENET, V20, P147, DOI 10.1146/annurev.ge.20.120186.001051; GERGEN JP, 1988, GENE DEV, V2, P1179, DOI 10.1101/gad.2.9.1179; GOTO T, 1989, CELL, V57, P413, DOI 10.1016/0092-8674(89)90916-1; HAGER DA, 1980, ANAL BIOCHEM, V109, P76, DOI 10.1016/0003-2697(80)90013-5; HAI T, 1988, CELL, V54, P1043, DOI 10.1016/0092-8674(88)90119-5; HAN KH, 1989, CELL, V56, P573, DOI 10.1016/0092-8674(89)90580-1; HARDING K, 1989, EMBO J, V8, P1205, DOI 10.1002/j.1460-2075.1989.tb03493.x; HERR W, 1988, GENE DEV, V2, P1513, DOI 10.1101/gad.2.12a.1513; HIROMI Y, 1987, CELL, V50, P963, DOI 10.1016/0092-8674(87)90523-X; HOEY T, 1988, MOL CELL BIOL, V8, P4598, DOI 10.1128/MCB.8.11.4598; HOEY T, 1988, NATURE, V332, P858, DOI 10.1038/332858a0; HOWARD K, 1988, GENE DEV, V2, P1037, DOI 10.1101/gad.2.8.1037; INGHAM PW, 1988, NATURE, V335, P25, DOI 10.1038/335025a0; INGRAHAM HA, 1988, CELL, V55, P519, DOI 10.1016/0092-8674(88)90038-4; JAYNES JB, 1988, NATURE, V336, P744, DOI 10.1038/336744a0; KADONAGA JT, 1986, P NATL ACAD SCI USA, V83, P5889, DOI 10.1073/pnas.83.16.5889; KO HS, 1988, CELL, V55, P135, DOI 10.1016/0092-8674(88)90016-5; KORNBERG T, 1985, CELL, V40, P45, DOI 10.1016/0092-8674(85)90307-1; KRASNOW MA, 1989, CELL, V57, P1031, DOI 10.1016/0092-8674(89)90341-3; KRAUSE HM, 1988, GENE DEV, V2, P1021, DOI 10.1101/gad.2.8.1021; KUROIWA A, 1984, CELL, V37, P825, DOI 10.1016/0092-8674(84)90417-3; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LAUGHON A, 1984, NATURE, V310, P25, DOI 10.1038/310025a0; LAUGHON A, 1988, DEVELOPMENT S, V104, P85; LILLIE JW, 1986, CELL, V46, P1043, DOI 10.1016/0092-8674(86)90704-X; MAXAM AM, 1977, P NATL ACAD SCI USA, V74, P560, DOI 10.1073/pnas.74.2.560; MCGINNIS W, 1984, NATURE, V308, P428, DOI 10.1038/308428a0; MIHARA H, 1988, SCIENCE, V242, P925, DOI 10.1126/science.2903553; MULLER M, 1988, EMBO J, V7, P4299, DOI 10.1002/j.1460-2075.1988.tb03328.x; MULLER MM, 1988, NATURE, V336, P544, DOI 10.1038/336544a0; NAKAJIMA N, 1988, MOL CELL BIOL, V8, P4028, DOI 10.1128/MCB.8.10.4028; NUSSLEINVOLHARD C, 1987, SCIENCE, V238, P1675, DOI 10.1126/science.3686007; OHKUMA Y, 1990, P NATL ACAD SCI USA, V87, P2289, DOI 10.1073/pnas.87.6.2289; PABO CO, 1984, ANNU REV BIOCHEM, V53, P293, DOI 10.1146/annurev.bi.53.070184.001453; POOLE SJ, 1985, CELL, V40, P37, DOI 10.1016/0092-8674(85)90306-X; ROSENBERG AH, 1987, GENE, V56, P125, DOI 10.1016/0378-1119(87)90165-X; SAWADOGO M, 1985, P NATL ACAD SCI USA, V82, P4394, DOI 10.1073/pnas.82.13.4394; SCHEIDEREIT C, 1988, NATURE, V336, P551, DOI 10.1038/336551a0; SCOTT MP, 1984, P NATL ACAD SCI-BIOL, V81, P4115, DOI 10.1073/pnas.81.13.4115; SCOTT MP, 1989, BIOCHIM BIOPHYS ACTA, V989, P25, DOI 10.1016/0304-419X(89)90033-4; SEKIMIZU K, 1988, J BIOL CHEM, V263, P7136; SHEPHERD JCW, 1984, NATURE, V310, P70, DOI 10.1038/310070a0; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; STURM RA, 1988, NATURE, V336, P601, DOI 10.1038/336601a0; STURM RA, 1988, GENE DEV, V2, P1582, DOI 10.1101/gad.2.12a.1582; TREISMAN J, 1989, CELL, V59, P553; WINSLOW GM, 1989, CELL, V57, P1017, DOI 10.1016/0092-8674(89)90340-1	61	68	69	0	0	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	MAY 4	1990	61	3					475	484		10.1016/0092-8674(90)90529-N	http://dx.doi.org/10.1016/0092-8674(90)90529-N			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DC934	1970761				2022-12-24	WOS:A1990DC93400011
J	ANDREWS, PJD; PIPER, IR; DEARDEN, NM; MILLER, JD				ANDREWS, PJD; PIPER, IR; DEARDEN, NM; MILLER, JD			SECONDARY INSULTS DURING INTRAHOSPITAL TRANSPORT OF HEAD-INJURED PATIENTS	LANCET			English	Article											ANDREWS, PJD (corresponding author), UNIV EDINBURGH,WESTERN GEN HOSP,DEPT CLIN NEUROSCI,EDINBURGH EH4 2UX,SCOTLAND.							BION JF, 1985, BRIT MED J, V291, P432, DOI 10.1136/bmj.291.6493.432; BRAMAN SS, 1987, ANN INTERN MED, V107, P469, DOI 10.7326/0003-4819-107-4-469; EHRENWERTH J, 1986, CRIT CARE MED, V14, P543, DOI 10.1097/00003246-198606000-00005; FRANKEL LR, 1987, INT ANESTHESIOL CLIN, V25, P77, DOI 10.1097/00004311-198702520-00006; GENTLEMAN D, 1981, LANCET, V2, P853; GERVAIS HW, 1987, CRIT CARE MED, V15, P761, DOI 10.1097/00003246-198708000-00010; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; INSEL J, 1986, CRIT CARE MED, V14, P539, DOI 10.1097/00003246-198606000-00004; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; KOHI YM, 1984, INJURY, V16, P25, DOI 10.1016/0020-1383(84)90110-4; MILLER JD, 1981, J NEUROSURG, V54, P289, DOI 10.3171/jns.1981.54.3.0289; MILLER JD, 1978, JAMA-J AM MED ASSOC, V240, P439, DOI 10.1001/jama.240.5.439; PEARL RG, 1987, INT ANESTHESIOL CLIN, V25, P43, DOI 10.1097/00004311-198702520-00005; WADDELL G, 1975, BRIT MED J, V2, P417, DOI 10.1136/bmj.2.5968.417; WADDELL G, 1975, BRIT MED J, V1, P386, DOI 10.1136/bmj.1.5954.386; WRIGHT I, 1988, ANN INTERN MED, V108, P638, DOI 10.7326/0003-4819-108-4-638_1	16	185	192	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	FEB 10	1990	335	8685					327	330		10.1016/0140-6736(90)90614-B	http://dx.doi.org/10.1016/0140-6736(90)90614-B			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CM846	1967776				2022-12-24	WOS:A1990CM84600011
J	MELZER, D; HALE, AS; MALIK, SJ; HOGMAN, GA; WOOD, S				MELZER, D; HALE, AS; MALIK, SJ; HOGMAN, GA; WOOD, S			COMMUNITY CARE FOR PATIENTS WITH SCHIZOPHRENIA ONE YEAR AFTER HOSPITAL DISCHARGE	BRITISH MEDICAL JOURNAL			English	Article							FOLLOW-UP	Objectives - To document the circumstances and care of patients with schizophrenia who had recently been discharged from local psychiatric inpatient services, and to establish the extent to which misgivings about community care might be justified. Design - Cross sectional surveys with review of case notes. Follow up interviews with questionnaires administered one year after discharge. Setting - Two inner London districts (West Lambeth and Lewisham) with high levels of social deprivation and at different stages of developing community services. Patients - 90 and 50 patients in the two services respectively, aged 18 to 65, who satisfied the Research Diagnostic Criteria for schizophrenia and who were discharged from inpatient services. Main outcome measures - Diagnosis elicited by present state examination, global social disability rating, use of services during the three months before interview. Results - 89 of the 140 patients (64%) had been ill for five or more years, yet few were former long stay inpatients. 55% (50/91; 95% confidence interval 45% to 65%) of those interviewed had current psychotic mental states and 22% (27/124; 16% to 31%) were functioning socially at very poor or severely maladjusted levels. 86% (107/124) were unemployed. The majority of patients had seen a mental health or social service professional, yet only 16% (20/124) were in specialised accommodation (excluding hospitals) and only 23% (17/73) of those eligible had used day care. Small numbers of people had experienced homelessness (two) or imprisonment (four over six months). Conclusions - Many schizophrenic patients leaving local psychiatric inpatient care have active symptomatology and profound social disabilities. Community care was characterised by high rates of contact with service professionals but little supported accommodation or day activity. This group of clients may require dedicated provision, which would actively encourage them to use services protected from the demands of those with less severe illness.	ST THOMAS HOSP,W LAMBETH HLTH AUTHOR,DIRECTORATE PUBL HLTH,LONDON SE1 7EH,ENGLAND; UNITED MED & DENT SCH GUYS & ST THOMAS HOSP,ST THOMAS HOSP,LONDON SE1 7EH,ENGLAND; GUYS HOSP,PSYCHIAT,LONDON SE1 9RT,ENGLAND	Guy's & St Thomas' NHS Foundation Trust; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust				Melzer, David/0000-0002-0170-3838				BACHRACH LL, 1984, HOMELESS MENTALLY IL; BEECHAM J, IN PRESS SCHIZOPH B; CHEADLE AJ, 1978, BRIT J PSYCHIAT, V132, P221, DOI 10.1192/S0007125000283268; COID JW, 1988, BRIT MED J, V296, P1779, DOI 10.1136/bmj.296.6639.1779; CRAMER P, 1989, BRIT J PSYCHIAT, V155, P225, DOI 10.1192/bjp.155.2.225; Davis A., 1974, SCHIZOPHRENICS NEW C; DEAN AG, 1990, EPIINFO VERSION 5; ELLIS RH, 1984, COMMUNITY MENT HLT J, V20, P72; FRY AH, 1989, HLTH TRENDS, V21, P70; GROVES T, 1990, BRIT MED J, V300, P923, DOI 10.1136/bmj.300.6729.923; HOGG LI, 1990, ACTA PSYCHIAT SCAND, V81, P271, DOI 10.1111/j.1600-0447.1990.tb06495.x; JOHNSTONE EC, 1984, BRIT J PSYCHIAT, V145, P586, DOI 10.1192/bjp.145.6.586; JONES K, 1986, BRIT J PSYCHIAT, V149, P537, DOI 10.1192/bjp.149.5.537; KHOOSAL D, 1991, HLTH TRENDS, V22, P137; KNAPP M, 1990, CARE COMMUNITY LESSO; KNAPP M, IN PRESS PSYCHOL MED; KUIPERS L, 1988, PSYCHOL MED, V18, P893, DOI 10.1017/S0033291700009831; MCCREADIE RG, 1982, BRIT J PSYCHIAT, V140, P582, DOI 10.1192/bjp.140.6.582; MILNER G, 1991, HLTH TRENDS, V4, P141; NORUSIS MJ, 1986, STATISTICAL PACKAGE; OLFSON M, 1990, HOSP COMMUNITY PSYCH, V41, P634; RICE P, 1984, INFORMATION DISTRICT; SAYCE L, 1991, SOC PSYCH PSYCH EPID, V26, P14, DOI 10.1007/BF00783575; Spitzer RL, 1975, RES DIAGNOSTIC CRITE; TANTAM D, 1985, BRIT J PSYCHIAT, V146, P1, DOI 10.1192/bjp.146.1.1; THORNICROFT G, 1989, BRIT J PSYCHIAT, V155, P739, DOI 10.1192/bjp.155.6.739; WATT DC, 1983, PSYCHOL MED, V13, P663, DOI 10.1017/S0033291700048091; WELLER M, 1989, LANCET, V2, P1509; Wing J. K. C., 1974, MEASUREMENT CLASSIFI; WOOD S, 1990, CLOSURE MENTAL HOSPI; 1989, SLIPPING NET; 1990, CARE PROGRAMME APPRO; 1989, INFORMED ACTION HLTH; 1989, 4TH ANN C TEAM ASS P; 1988, WHO PSYCHIATRIC DISA	35	58	59	0	4	BRITISH MED JOURNAL PUBL GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON, ENGLAND WC1H 9JR	0959-8138			BRIT MED J	Br. Med. J.	OCT 26	1991	303	6809					1023	1026		10.1136/bmj.303.6809.1023	http://dx.doi.org/10.1136/bmj.303.6809.1023			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	GM478	1954452	Green Published, Bronze			2022-12-24	WOS:A1991GM47800018
J	HOFMANN, T; KASPER, W; MEINERTZ, T; GEIBEL, A; JUST, H				HOFMANN, T; KASPER, W; MEINERTZ, T; GEIBEL, A; JUST, H			ECHOCARDIOGRAPHIC EVALUATION OF PATIENTS WITH CLINICALLY SUSPECTED ARTERIAL EMBOLI	LANCET			English	Article									UNIV FREIBURG,MED KLIN 3,W-7800 FREIBURG,GERMANY	University of Freiburg	HOFMANN, T (corresponding author), ALLGEMEINES KRANKENHAUS ST GEORG,MED KLIN 2,W-2000 HAMBURG 1,GERMANY.							ASCHENBERG W, 1986, J AM COLL CARDIOL, V7, P163, DOI 10.1016/S0735-1097(86)80275-3; BEPPU S, 1985, J AM COLL CARDIOL, V6, P744, DOI 10.1016/S0735-1097(85)80476-9; BERGERON GA, 1981, NEW ENGL J MED, V304, P489; BRAND FN, 1985, JAMA-J AM MED ASSOC, V254, P3449, DOI 10.1001/jama.254.24.3449; Close J B, 1979, J R Coll Gen Pract, V29, P547; COULSHED N, 1970, BRIT HEART J, V32, P26; EGEBLAD H, 1987, AM HEART J, V114, P648, DOI 10.1016/0002-8703(87)90765-4; ERBEL R, 1987, BRIT HEART J, V58, P45; FOGELHOLM R, 1987, BRIT MED J, V295, P305, DOI 10.1136/bmj.295.6593.305; FULKERSON PK, 1979, AM J MED, V66, P967, DOI 10.1016/0002-9343(79)90452-2; FUSTER V, 1981, AM J CARDIOL, V47, P525, DOI 10.1016/0002-9149(81)90534-8; GREENLAND P, 1981, ANN INTERN MED, V95, P51, DOI 10.7326/0003-4819-95-1-51; GUSSENHOVEN EJ, 1986, J AM COLL CARDIOL, V8, P975, DOI 10.1016/S0735-1097(86)80444-2; HOWARD RS, 1987, J NEUROL NEUROSUR PS, V50, P1142, DOI 10.1136/jnnp.50.9.1142; JESPERSEN CM, 1987, ACTA MED SCAND, V222, P37; JOHANNESSEN KA, 1988, BRIT HEART J, V60, P104; JONES HR, 1983, ANN NEUROL, V13, P314, DOI 10.1002/ana.410130315; KASPER W, 1986, Z KARDIOL, V75, P609; KOCHAR G, 1987, AM HEART J, V113, P1510, DOI 10.1016/0002-8703(87)90670-3; KOMRAD MS, 1984, NEUROLOGY, V34, P1403, DOI 10.1212/WNL.34.11.1403; LARSON EB, 1981, ANN INTERN MED, V95, P112, DOI 10.7326/0003-4819-95-1-112; LOVETT JL, 1981, ANN INTERN MED, V95, P1, DOI 10.7326/0003-4819-95-1-1; MATSUZAKI M, 1985, AM HEART J, V109, P355, DOI 10.1016/0002-8703(85)90607-6; SCHLUTER M, 1984, DEUT MED WOCHENSCHR, V109, P722, DOI 10.1055/s-2008-1069263; SCHLUTER M, 1984, AM J CARDIOL, V53, P1173, DOI 10.1016/0002-9149(84)90657-X; SHENOY MM, 1987, ARCH INTERN MED, V147, P605, DOI 10.1001/archinte.147.3.605; SHERMAN DG, 1984, ARCH NEUROL-CHICAGO, V41, P708, DOI 10.1001/archneur.1984.04050180030011; SHRESTHA NK, 1983, CIRCULATION, V67, P341, DOI 10.1161/01.CIR.67.2.341; STAFFORD WJ, 1985, BRIT HEART J, V53, P310; STERN H, 1985, Z KARDIOL, V74, P480	30	108	108	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	DEC 8	1990	336	8728					1421	1424						4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL851	1978881				2022-12-24	WOS:A1990EL85100015
J	LOHR, JM; OLDSTONE, MBA				LOHR, JM; OLDSTONE, MBA			DETECTION OF CYTOMEGALOVIRUS NUCLEIC-ACID SEQUENCES IN PANCREAS IN TYPE-2 DIABETES	LANCET			English	Article									SCRIPPS CLIN & RES FDN,DEPT NEUROPHARMACOL,DIV VIROL,10666 N TORREY PINES RD,LA JOLLA,CA 92037	Scripps Research Institute			Löhr, Matthias/A-3692-2012	Löhr, Matthias/0000-0002-7647-198X	NCRR NIH HHS [MO1 RR00833] Funding Source: Medline; NIAID NIH HHS [AI-07007] Funding Source: Medline; NIA NIH HHS [AG-04342] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG004342] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		AKRIGG A, 1985, VIRUS RES, V2, P107, DOI 10.1016/0168-1702(85)90242-4; BOWLES NE, 1986, LANCET, V1, P1120; CIAMPOLILLO A, 1989, LANCET, V1, P1096; CORDELL B, 1979, CELL, V18, P533, DOI 10.1016/0092-8674(79)90070-9; CURRAN JA, 1985, J GEN VIROL, V66, P977, DOI 10.1099/0022-1317-66-5-977; FREY TK, 1988, GENE, V62, P85, DOI 10.1016/0378-1119(88)90582-3; GLADISCH R, 1976, Z KARDIOL, V65, P837; GNANN JW, 1988, AM J PATHOL, V132, P239; GOELZ SE, 1985, BIOCHEM BIOPH RES CO, V130, P118, DOI 10.1016/0006-291X(85)90390-0; HAASE AT, 1984, ANN NY ACAD SCI, V436, P103, DOI 10.1111/j.1749-6632.1984.tb14780.x; IMPRAIM CC, 1987, BIOCHEM BIOPH RES CO, V142, P710, DOI 10.1016/0006-291X(87)91472-0; JENSON AB, 1984, PROG MED VIROL, V29, P197; JENSON AB, 1980, LANCET, V2, P354; KANDOLF R, 1985, P NATL ACAD SCI USA, V82, P4818, DOI 10.1073/pnas.82.14.4818; LOHR JM, 1990, J VIROL, V64, P2168; LOHR M, 1987, DIABETOLOGIA, V30, P757; MACH M, 1989, J GEN VIROL, V70, P3117, DOI 10.1099/0022-1317-70-12-3117; MULLIS KB, 1987, METHOD ENZYMOL, V155, P335; NOTKINS AL, 1984, CONCEPTS VIRAL PATHO; NUMAZAKI K, 1988, AM J CLIN PATHOL, V90, P52, DOI 10.1093/ajcp/90.1.52; OLDSTONE MBA, 1984, NATURE, V307, P278, DOI 10.1038/307278a0; OLDSTONE MBA, 1989, SCI AM, V261, P42, DOI 10.1038/scientificamerican0889-42; ONODERA T, 1983, DIABETOLOGIA, V24, P218; PAK CY, 1988, LANCET, V2, P1; PATTERSON K, 1981, LANCET, V1, P1048; RUGER B, 1987, J VIROL, V61, P446; RUGER R, 1984, J GEN VIROL, V65, P1351, DOI 10.1099/0022-1317-65-8-1351; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SCHRIER RD, 1985, SCIENCE, V230, P1048, DOI 10.1126/science.2997930; VALSAMAKIS A, 1987, VIROLOGY, V156, P214, DOI 10.1016/0042-6822(87)90400-4; YOON JW, 1979, NEW ENGL J MED, V300, P1173, DOI 10.1056/NEJM197905243002102	31	43	46	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 15	1990	336	8716					644	648		10.1016/0140-6736(90)92145-8	http://dx.doi.org/10.1016/0140-6736(90)92145-8			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DY737	1975850				2022-12-24	WOS:A1990DY73700002
J	GUASTELLA, J; NELSON, N; NELSON, H; CZYZYK, L; KEYNAN, S; MIEDEL, MC; DAVIDSON, N; LESTER, HA; KANNER, BI				GUASTELLA, J; NELSON, N; NELSON, H; CZYZYK, L; KEYNAN, S; MIEDEL, MC; DAVIDSON, N; LESTER, HA; KANNER, BI			CLONING AND EXPRESSION OF A RAT-BRAIN GABA TRANSPORTER	SCIENCE			English	Article									HEBREW UNIV JERUSALEM,HADASSAH MED SCH,DEPT BIOCHEM,IL-91010 JERUSALEM,ISRAEL; ROCHE RES CTR,ROCHE INST MOLEC BIOL,NUTLEY,NJ 07110; CALTECH,DIV BIOL,PASADENA,CA 91125	Hebrew University of Jerusalem; Roche Holding; California Institute of Technology					NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029836] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS016708, R01NS016708] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM 10991, GM 29836] Funding Source: Medline; NINDS NIH HHS [NS 16708] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		AUFFRAY C, 1980, EUR J BIOCHEM, V107, P303; BLAKELY RD, 1988, P NATL ACAD SCI USA, V85, P9846, DOI 10.1073/pnas.85.24.9846; BOWERY NG, 1976, NATURE, V264, P281, DOI 10.1038/264281a0; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; EISENBERG D, 1984, J MOL BIOL, V179, P125, DOI 10.1016/0022-2836(84)90309-7; GRENNINGLOH G, 1987, NATURE, V328, P215, DOI 10.1038/328215a0; GUASTELLA J, UNPUB; HEDIGER MA, 1987, NATURE, V330, P379, DOI 10.1038/330379a0; HOSHINO T, 1990, MOL GEN GENET, V220, P461, DOI 10.1007/BF00391754; IVERSEN LL, 1975, BIOCHEM PHARMACOL, V24, P933, DOI 10.1016/0006-2952(75)90422-0; KANNER BI, 1978, BIOCHEMISTRY-US, V17, P1207, DOI 10.1021/bi00600a011; KANNER BI, 1989, BIOCHEMISTRY-US, V28, P3722, DOI 10.1021/bi00435a015; KOPITO RR, 1989, CELL, V59, P927, DOI 10.1016/0092-8674(89)90615-6; KOZAK M, 1984, NUCLEIC ACIDS RES, V12, P857, DOI 10.1093/nar/12.2.857; KOZAK M, 1986, CELL, V44, P283, DOI 10.1016/0092-8674(86)90762-2; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; LODISH HF, 1988, TRENDS BIOCHEM SCI, V13, P332, DOI 10.1016/0968-0004(88)90101-6; MANDEL M, 1988, P NATL ACAD SCI USA, V85, P5521, DOI 10.1073/pnas.85.15.5521; MARTIN D, 1976, GABA NERVOUS SYSTEM, P357; NAKAO T, 1987, MOL GEN GENET, V208, P70, DOI 10.1007/BF00330424; RADIAN R, 1986, J BIOL CHEM, V261, P5437; SARDET C, 1989, CELL, V56, P271, DOI 10.1016/0092-8674(89)90901-X; SCHOFIELD PR, 1987, NATURE, V328, P221, DOI 10.1038/328221a0; SCHON F, 1974, BRAIN RES, V66, P275, DOI 10.1016/0006-8993(74)90146-2; SCHON F, 1974, BRAIN RES, V66, P289, DOI 10.1016/0006-8993(74)90147-4; SCHOUSBOE A, 1979, J NEUROCHEM, V33, P181, DOI 10.1111/j.1471-4159.1979.tb11720.x; SCHOUSBOE A, 1986, J NEUROCHEM, V47, P758; SNUTCH TP, 1990, P NATL ACAD SCI USA, V87, P3391, DOI 10.1073/pnas.87.9.3391; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17; WOOD JD, 1987, J NEUROCHEM, V49, P1202, DOI 10.1111/j.1471-4159.1987.tb10011.x; ZALESKA MM, 1987, P NATL ACAD SCI USA, V84, P1709, DOI 10.1073/pnas.84.6.1709	32	744	781	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005	0036-8075			SCIENCE	Science	SEP 14	1990	249	4974					1303	1306		10.1126/science.1975955	http://dx.doi.org/10.1126/science.1975955			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DY351	1975955				2022-12-24	WOS:A1990DY35100041
J	WIRTZ, RA; ROSENBERG, R; SATTABONGKOT, J; WEBSTER, HK				WIRTZ, RA; ROSENBERG, R; SATTABONGKOT, J; WEBSTER, HK			PREVALENCE OF ANTIBODY TO HETEROLOGOUS CIRCUMSPOROZOITE PROTEIN OF PLASMODIUM-VIVAX IN THAILAND	LANCET			English	Article									USA,MED COMPONENT,BANGKOK,THAILAND	Walter Reed Army Institute of Research (WRAIR); Armed Forces Research Institute of Medical Science (AFRIMS)	WIRTZ, RA (corresponding author), WALTER REED ARMY MED CTR,DEPT ENTOMOL,WASHINGTON,DC 20307, USA.		Prachumsri, Jetsumon/AAZ-7732-2021	Sattabongkot, Jetsumon/0000-0002-3938-4588				COLLINS WE, 1989, AM J TROP MED HYG, V40, P455, DOI 10.4269/ajtmh.1989.40.455; ESPOSITO F, 1988, T ROY SOC TROP MED H, V82, P827, DOI 10.1016/0035-9203(88)90007-7; LOCKYER MJ, 1987, MOL BIOCHEM PARASIT, V22, P101, DOI 10.1016/0166-6851(87)90073-9; MITCHELL GH, 1989, PARASITOLOGY, V98, pS29, DOI 10.1017/S0031182000072231; ROSENBERG R, 1989, SCIENCE, V245, P973, DOI 10.1126/science.2672336; ROSENBERG R, 1990, T ROY SOC TROP MED H, V84, P14, DOI 10.1016/0035-9203(90)90366-M; WEBSTER HK, 1987, J CLIN MICROBIOL, V25, P1002, DOI 10.1128/JCM.25.6.1002-1008.1987; WEBSTER HK, 1988, J CLIN MICROBIOL, V26, P923, DOI 10.1128/JCM.26.5.923-927.1988; WIRTZ RA, 1990, B WORLD HEALTH ORGAN, V67, P535; YOSHIDA N, 1987, EXP PARASITOL, V64, P510, DOI 10.1016/0014-4894(87)90065-8; ZAVALA F, 1985, SCIENCE, V228, P1436, DOI 10.1126/science.2409595	11	39	41	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 8	1990	336	8715					593	595		10.1016/0140-6736(90)93393-4	http://dx.doi.org/10.1016/0140-6736(90)93393-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DX401	1975379				2022-12-24	WOS:A1990DX40100005
J	BRODIE, MJ				BRODIE, MJ			STATUS EPILEPTICUS IN ADULTS	LANCET			English	Note											BRODIE, MJ (corresponding author), WESTERN INFIRM & ASSOCIATED HOSP,DEPT MED & THERAPEUT,EPILEPSY RES UNIT,GLASGOW G11 6NT,SCOTLAND.							AMINOFF MJ, 1980, AM J MED, V69, P657, DOI 10.1016/0002-9343(80)90415-5; BRODIE MJ, 1989, PRESCRIBERS J, V29, P48; BRUNI J, 1983, CAN MED ASSOC J, V128, P531; CRANFORD RE, 1978, NEUROLOGY, V28, P874, DOI 10.1212/WNL.28.9.874; DUNNE JW, 1987, Q J MED, V62, P117; EARNEST MP, 1983, JAMA-J AM MED ASSOC, V249, P762, DOI 10.1001/jama.249.6.762; HOWELL SJL, 1989, Q J MED, V7, P509; PASCUAL J, 1988, EPILEPSIA, V29, P584, DOI 10.1111/j.1528-1157.1988.tb03766.x; SIMON PR, 1985, RECENT ADV EPILEPSY, V2, P137; SWARTZ BE, 1987, EPILEPSY, P417; TREIMAN DM, 1989, EPILEPSIA, V30, pS4, DOI 10.1111/j.1528-1157.1989.tb05824.x; UTHMAN BM, 1989, EPILEPSIA, V30, pS33, DOI 10.1111/j.1528-1157.1989.tb05823.x; Wilder B J, 1983, Adv Neurol, V34, P441; WINTER ME, 1986, APPLIED PHARMACOKINE, P493; 1989, LANCET, V2, P485	15	23	25	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 1	1990	336	8714					551	552						2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DW781	1975048				2022-12-24	WOS:A1990DW78100014
J	GILKS, CF; BRINDLE, RJ; OTIENO, LS; SIMANI, PM; NEWNHAM, RS; BHATT, SM; LULE, GN; OKELO, GBA; WATKINS, WM; WAIYAKI, PG; WERE, JBO; WARRELL, DA				GILKS, CF; BRINDLE, RJ; OTIENO, LS; SIMANI, PM; NEWNHAM, RS; BHATT, SM; LULE, GN; OKELO, GBA; WATKINS, WM; WAIYAKI, PG; WERE, JBO; WARRELL, DA			LIFE-THREATENING BACTEREMIA IN HIV-1 SEROPOSITIVE ADULTS ADMITTED TO HOSPITAL IN NAIROBI, KENYA	LANCET			English	Article									KENYA GOVT MED RES CTR,CTR MICROBIOL RES,NAIROBI,KENYA; PUBL HLTH LAB,OXFORD,ENGLAND; UNIV OXFORD,OXFORD,ENGLAND; UNIV NAIROBI,DEPT MED,NAIROBI,KENYA	Kenya Medical Research Institute; University of Oxford; University of Nairobi	GILKS, CF (corresponding author), KENYA GOVT MED RES CTR,CLIN RES CTR,WT RES PROGRAMME,POB 43640,NAIROBI,KENYA.		Gilks, Charles/B-4184-2012	Gilks, Charles/0000-0002-8953-3123	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Barr R D, 1972, East Afr Med J, V49, P772; BERKLEY S, 1989, AIDS, V3, P79, DOI 10.1097/00002030-198902000-00005; CELUM CL, 1987, J INFECT DIS, V156, P998, DOI 10.1093/infdis/156.6.998; Chaisson R E, 1988, Infect Dis Clin North Am, V2, P475; COLEBUNDERS R, 1987, LANCET, V1, P492; DECOCK KM, 1989, LANCET, V2, P408; DOBKIN J, 1989, 5 INT C AIDS MONTR; ENG RHK, 1986, AM J CLIN PATHOL, V86, P105, DOI 10.1093/ajcp/86.1.105; GLASER JB, 1985, ANN INTERN MED, V102, P189, DOI 10.7326/0003-4819-102-2-189; Huckstep RL, 1962, TYPHOID FEVER OTHER; KRUMHOLZ HM, 1989, AM J MED, V86, P776, DOI 10.1016/0002-9343(89)90472-5; NGALY B, 1988, 4TH INT C AIDS STOCK; PARRY EHO, 1986, PRINCIPLES MED AFRIC; PIOT P, 1988, SCIENCE, V239, P573, DOI 10.1126/science.3277271; SCHLAMM HT, 1989, AM J MED, V86, P11, DOI 10.1016/0002-9343(89)90222-2; SCHRAGER LK, 1988, AIDS, V2, pS183, DOI 10.1097/00002030-198800001-00027; SELWYN PA, 1988, AIDS, V2, P267, DOI 10.1097/00002030-198808000-00005; SHAPER A G, 1958, East Afr Med J, V35, P647; SLACK RCB, 1976, E AFR MED J, V53, P480; SMITH PD, 1985, ANN INTERN MED, V102, P207, DOI 10.7326/0003-4819-102-2-207; STONEBURNER RL, 1988, SCIENCE, V242, P916, DOI 10.1126/science.3187532; WAMOLA IA, 1981, E AFR MED J, V58, P677; WIDYWIRSKI R, 1988, JAMA-J AM MED ASSOC, V260, P3286, DOI 10.1001/jama.260.22.3286; WIMBREY E, 1986, ANN INTERN MED, V104, P511; 1986, WKLY EPIDEMIOLOGICAL, V61, P69; 1988, MMWR, V37, P593; 1988, E AFR MED J, V65, P505	27	282	282	0	8	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 1	1990	336	8714					545	549		10.1016/0140-6736(90)92096-Z	http://dx.doi.org/10.1016/0140-6736(90)92096-Z			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DW781	1975046				2022-12-24	WOS:A1990DW78100012
J	HEIM, M; MEYER, UA				HEIM, M; MEYER, UA			GENOTYPING OF POOR METABOLIZERS OF DEBRISOQUINE BY ALLELE-SPECIFIC PCR AMPLIFICATION	LANCET			English	Article									UNIV BASEL,BIOCTR,DEPT PHARMACOL,KLINGELBERGSTR 70,CH-4056 BASEL,SWITZERLAND	University of Basel			Heim, Markus/A-7526-2008	Heim, Markus/0000-0002-7523-4894				AYESH R, 1984, NATURE, V312, P169, DOI 10.1038/312169a0; BALANT LP, 1989, EUR J CLIN PHARMACOL, V36, P551, DOI 10.1007/BF00637734; BROLY F, 1990, BIOCHEM PHARMACOL, V39, P1045, DOI 10.1016/0006-2952(90)90283-Q; BROSEN K, 1989, EUR J CLIN PHARMACOL, V36, P537, DOI 10.1007/BF00637732; CAPORASO N, 1989, CANCER RES, V49, P3675; DAHLPUUSTINEN ML, 1989, CLIN PHARMACOL THER, V46, P78, DOI 10.1038/clpt.1989.109; EICHELBAUM M, 1988, ISI ATLAS-PHARMACOL, V2, P243; EISENSTEIN BI, 1990, NEW ENGL J MED, V322, P178; GAEDIGK A, 1990, NAUNYNSCHMIEDEBERG S, V341, P435; GASPARINI P, 1989, NEW ENGL J MED, V320, P809; GONZALEZ FJ, 1988, NATURE, V331, P442, DOI 10.1038/331442a0; GRAM LF, 1990, EUR CONS C PHARM, P87; KAGIMOTO M, IN PRESS J BIOL CHEM; KIMURA S, 1989, AM J HUM GENET, V45, P889; MAHGOUB A, 1977, LANCET, V2, P584, DOI 10.1016/S0140-6736(77)91430-1; MEYER UA, 1989, ADV DRUG RES, V19, P197; NEBERT DW, 1989, DNA-J MOLEC CELL BIO, V8, P1, DOI 10.1089/dna.1.1989.8.1; NEI M, 1987, MOL EVOLUTIONARY GEN, P151; SKODA RC, 1988, P NATL ACAD SCI USA, V85, P5240, DOI 10.1073/pnas.85.14.5240; TUCKER GT, 1977, LANCET, V2, P718; VONBAHR C, 1985, CLIN PHARM PSYCHIATR, P163; ZANGER UM, 1988, BIOCHEMISTRY-US, V27, P5447, DOI 10.1021/bi00415a010	22	502	511	0	7	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 1	1990	336	8714					529	532		10.1016/0140-6736(90)92086-W	http://dx.doi.org/10.1016/0140-6736(90)92086-W			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DW781	1975039				2022-12-24	WOS:A1990DW78100004
J	BRAHAMS, D				BRAHAMS, D			RELIGIOUS BELIEFS AND PARENTAL DUTY	LANCET			English	Editorial Material																			0	2	2	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JUL 14	1990	336	8707					107	108		10.1016/0140-6736(90)91612-E	http://dx.doi.org/10.1016/0140-6736(90)91612-E			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DN793	1975287				2022-12-24	WOS:A1990DN79300016
J	JORDAN, CT; MCKEARN, JP; LEMISCHKA, IR				JORDAN, CT; MCKEARN, JP; LEMISCHKA, IR			CELLULAR AND DEVELOPMENTAL PROPERTIES OF FETAL HEMATOPOIETIC STEM-CELLS	CELL			English	Article									MONSANTO CO, SEARLE RES & DEV, ST LOUIS, MO 63198 USA	Monsanto; Pfizer	JORDAN, CT (corresponding author), PRINCETON UNIV, DEPT BIOL, PRINCETON, NJ 08544 USA.		jordan, craig/D-7666-2014	jordan, craig/0000-0003-0869-3465	NCI NIH HHS [T32-CA09528, R01-CA45339] Funding Source: Medline; NATIONAL CANCER INSTITUTE [T32CA009528, R01CA045339] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		ABRAMSON S, 1977, J EXP MED, V145, P1567, DOI 10.1084/jem.145.6.1567; BERENSON RJ, 1988, J CLIN INVEST, V81, P951, DOI 10.1172/JCI113409; BERRIDGE MV, 1985, BLOOD, V66, P76; CAPEL B, 1989, P NATL ACAD SCI USA, V86, P4564, DOI 10.1073/pnas.86.12.4564; CARDARELLI PM, 1988, J CELL BIOL, V106, P2183, DOI 10.1083/jcb.106.6.2183; CIVIN CI, 1984, J IMMUNOL, V133, P157; CONE RD, 1987, MOL CELL BIOL, V7, P887, DOI 10.1128/MCB.7.2.887; DANOS O, 1988, P NATL ACAD SCI USA, V85, P6460, DOI 10.1073/pnas.85.17.6460; DEXTER TM, 1987, ANNU REV CELL BIOL, V3, P423; DICK JE, 1985, CELL, V42, P71, DOI 10.1016/S0092-8674(85)80102-1; FLEISCHMAN RA, 1979, P NATL ACAD SCI USA, V76, P5736, DOI 10.1073/pnas.76.11.5736; HASKILL JS, 1970, J CELL PHYSIOL, V75, P167, DOI 10.1002/jcp.1040750206; JOHNSON GR, 1984, J CELL PHYSIOL, V118, P45, DOI 10.1002/jcp.1041180110; JONES RJ, 1989, BLOOD, V73, P397; JORDAN CT, 1990, GENE DEV, V4, P220, DOI 10.1101/gad.4.2.220; KELLER G, 1985, NATURE, V318, P149, DOI 10.1038/318149a0; LEMISCHKA IR, 1986, CELL, V45, P917, DOI 10.1016/0092-8674(86)90566-0; LOKEN MR, 1988, PATHOL IMMUNOPATH R, V7, P357, DOI 10.1159/000157129; MAGLI MC, 1982, NATURE, V295, P527, DOI 10.1038/295527a0; Maniatis T., 1982, MOL CLONING; MANN R, 1983, CELL, V33, P153, DOI 10.1016/0092-8674(83)90344-6; MCKEARN JP, 1984, J IMMUNOL, V132, P332; MCKEARN JP, 1985, P NATL ACAD SCI USA, V82, P7414, DOI 10.1073/pnas.82.21.7414; METCALF D, 1971, HAEMOPOIETIC CELLS, P195; Metcalf D, 1988, MOL CONTROL BLOOD CE; MOORE MAS, 1970, J CELL PHYSIOL, V75, P181, DOI 10.1002/jcp.1040750207; NICOLA NA, 1981, BLOOD, V58, P376; PLOEMACHER RE, 1989, EXP HEMATOL, V17, P263; PRUMMER O, 1986, INT J CELL CLONING, V4, P237; SNODGRASS R, 1987, EMBO J, V6, P3955, DOI 10.1002/j.1460-2075.1987.tb02737.x; SPANGRUDE GJ, 1988, SCIENCE, V241, P58, DOI 10.1126/science.2898810; SZILVASSY SJ, 1989, P NATL ACAD SCI USA, V86, P8798, DOI 10.1073/pnas.86.22.8798; SZILVASSY SJ, 1989, BLOOD, V74, P930; VISSER JWM, 1984, J EXP MED, V159, P1576, DOI 10.1084/jem.159.6.1576; WYSOCKI LJ, 1978, P NATL ACAD SCI USA, V75, P2844, DOI 10.1073/pnas.75.6.2844; YOKOTA T, 1984, P NATL ACAD SCI-BIOL, V81, P1070, DOI 10.1073/pnas.81.4.1070	36	285	298	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JUN 15	1990	61	6					953	963		10.1016/0092-8674(90)90061-I	http://dx.doi.org/10.1016/0092-8674(90)90061-I			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	DK145	1972037				2022-12-24	WOS:A1990DK14500006
J	PACQUE, M; MUNOZ, B; GREENE, BM; WHITE, AT; DUKULY, Z; TAYLOR, HR				PACQUE, M; MUNOZ, B; GREENE, BM; WHITE, AT; DUKULY, Z; TAYLOR, HR			SAFETY OF AND COMPLIANCE WITH COMMUNITY-BASED IVERMECTIN THERAPY	LANCET			English	Article									JOHNS HOPKINS UNIV,SCH MED,WILMER INST,DANA CTR PREVENT OPHTHALMOL,BALTIMORE,MD 21205; UNIV ALABAMA,DEPT MED,DIV GEOG MED,BIRMINGHAM,AL; GEORGE WASHINGTON UNIV,MED CTR,DEPT PATHOL,WASHINGTON,DC 20037	Johns Hopkins University; University of Alabama System; University of Alabama Birmingham; George Washington University				Taylor, Hugh/0000-0002-9437-784X	NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR004060] Funding Source: NIH RePORTER; NCRR NIH HHS [ID S10-RR04060] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		AWADZI K, 1985, ANN TROP MED PARASIT, V79, P63, DOI 10.1080/00034983.1985.11811889; AZIZ MA, 1982, LANCET, V2, P171; FREEDMAN DO, 1989, J INFECT DIS, V159, P1151, DOI 10.1093/infdis/159.6.1151; Greene B. M., 1989, Ivermectin and abamectin., P311; GREENE BM, 1985, NEW ENGL J MED, V313, P133, DOI 10.1056/NEJM198507183130301; GREENE BM, 1987, T ASS AM PHYSICIAN C, P131; HOMEIDA MMA, 1988, LANCET, V1, P1346; LARIVIERE M, 1989, B SOC PATHOL EXOT, V82, P48; NAQUIRA C, 1989, AM J TROP MED HYG, V40, P304, DOI 10.4269/ajtmh.1989.40.304; PACQUE MC, 1989, LANCET, V1, P1140; PACQUE MC, 1989, B WORLD HEALTH ORGAN, V67, P721; PACQUEMARGOLIS S, IN PRESS SOC SCI MED; ROTHOVA A, 1989, LANCET, V1, P1439; TAYLOR HR, 1987, INT OPHTHALMOL, V11, P83, DOI 10.1007/BF00136735; WHITE AT, 1987, J INFECT DIS, V156, P463, DOI 10.1093/infdis/156.3.463; WHITWORTH JAG, 1988, LANCET, V2, P97; 1987, WHO TECH REP SER, P752	17	59	60	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JUN 9	1990	335	8702					1377	1380		10.1016/0140-6736(90)91253-7	http://dx.doi.org/10.1016/0140-6736(90)91253-7			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DH145	1971669				2022-12-24	WOS:A1990DH14500012
J	PURI, P				PURI, P			ENDOSCOPIC CORRECTION OF PRIMARY VESICOURETERAL REFLUX BY SUBURETERIC INJECTION OF POLYTETRAFLUOROETHYLENE	LANCET			English	Article									NATL CHILDRENS HOSP,DUBLIN,IRELAND	Trinity College Dublin								[Anonymous], 1981, PEDIATRICS, V67, P392; ARNOLD GE, 1963, ANN OTO RHINOL LARYN, V72, P384, DOI 10.1177/000348946307200209; DEDO HH, 1973, ANN OTO RHINOL LARYN, V82, P661, DOI 10.1177/000348947308200509; KAPLAN WE, 1987, J UROLOGY, V138, P953, DOI 10.1016/S0022-5347(17)43469-0; LEWY RB, 1976, ANN OTO RHINOL LARYN, V85, P440, DOI 10.1177/000348947608500404; MALIZIA AA, 1984, JAMA-J AM MED ASSOC, V251, P3277, DOI 10.1001/jama.251.24.3277; MANN CI, 1988, AM J ROENTGENOL, V151, P543, DOI 10.2214/ajr.151.3.543; ODONNELL B, 1984, BRIT MED J, V289, P7, DOI 10.1136/bmj.289.6436.7; POLITANO VA, 1974, J UROLOGY, V111, P180, DOI 10.1016/S0022-5347(17)59921-8; PURI P, 1987, J PEDIATR SURG, V22, P1087, DOI 10.1016/S0022-3468(87)80714-5; PURI P, 1986, BRIT J UROL, V58, P504, DOI 10.1111/j.1464-410X.1986.tb05455.x; PURI P, 1988, OPERATIVE SURGERY PA, P522; SCHULMAN CC, 1984, BRIT MED J, V288, P192, DOI 10.1136/bmj.288.6412.192; SPENCER J, 1988, 83RD ANN M AM UR ASS; VORSTMAN B, 1985, J UROLOGY, V133, P248, DOI 10.1016/S0022-5347(17)48903-8; 1984, BRIT MED J, V289, P5	16	40	40	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	JUN 2	1990	335	8701					1320	1322		10.1016/0140-6736(90)91197-I	http://dx.doi.org/10.1016/0140-6736(90)91197-I			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DG095	1971386				2022-12-24	WOS:A1990DG09500013
J	SHIMADA, F; TAIRA, M; SUZUKI, Y; HASHIMOTO, N; NOZAKI, O; TAIRA, M; TATIBANA, M; EBINA, Y; TAWATA, M; ONAYA, T; MAKINO, H; YOSHIDA, S				SHIMADA, F; TAIRA, M; SUZUKI, Y; HASHIMOTO, N; NOZAKI, O; TAIRA, M; TATIBANA, M; EBINA, Y; TAWATA, M; ONAYA, T; MAKINO, H; YOSHIDA, S			INSULIN-RESISTANT DIABETES ASSOCIATED WITH PARTIAL DELETION OF INSULIN-RECEPTOR GENE	LANCET			English	Article									CHIBA UNIV,SCH MED,DEPT INTERNAL MED 2,1-8-1 INOHANA,CHIBA 280,JAPAN; UNIV TOKUSHIMA,INST ENZYME RES,DEPT ENZYME GENET,TOKUSHIMA 770,JAPAN; YAMANASHI UNIV,SCH MED,DEPT INTERNAL MED 3,KOFU,YAMANASHI 400,JAPAN; CHIBA UNIV,SCH MED,DEPT BIOCHEM,CHIBA 280,JAPAN	Chiba University; Tokushima University; University of Yamanashi; Chiba University								ACCILI D, 1989, EMBO J, V8, P2509, DOI 10.1002/j.1460-2075.1989.tb08388.x; [Anonymous], 1985, WHO TECH REP SER, V727, P1; DEININGER PL, 1981, J MOL BIOL, V151, P17, DOI 10.1016/0022-2836(81)90219-9; EBINA Y, 1985, CELL, V40, P747, DOI 10.1016/0092-8674(85)90334-4; EBINA Y, 1987, P NATL ACAD SCI USA, V84, P704, DOI 10.1073/pnas.84.3.704; EBINA Y, 1985, P NATL ACAD SCI USA, V82, P8014, DOI 10.1073/pnas.82.23.8014; GOLDSTEIN BJ, 1989, J CLIN ENDOCR METAB, V69, P15, DOI 10.1210/jcem-69-1-15; JOHNSON JD, 1988, P NATL ACAD SCI USA, V85, P7516, DOI 10.1073/pnas.85.20.7516; KADOWAKI T, 1988, SCIENCE, V240, P787, DOI 10.1126/science.2834824; KAHN CR, 1976, NEW ENGL J MED, V294, P739, DOI 10.1056/NEJM197604012941401; KLINKHAMER MP, 1989, EMBO J, V8, P2503, DOI 10.1002/j.1460-2075.1989.tb08387.x; LEHRMAN MA, 1985, SCIENCE, V227, P140, DOI 10.1126/science.3155573; MOLLER DE, 1988, NEW ENGL J MED, V319, P1526, DOI 10.1056/NEJM198812083192306; NAKAMURA F, 1989, ENDOCRINOL JAPON, V36, P349; ODAWARA M, 1989, SCIENCE, V245, P66, DOI 10.1126/science.2544998; REAVEN GM, 1984, DIABETES CARE, V7, P17; SANGER F, 1977, P NATL ACAD SCI USA, V74, P5463, DOI 10.1073/pnas.74.12.5463; SEINO S, 1989, P NATL ACAD SCI USA, V86, P114, DOI 10.1073/pnas.86.1.114; TAIRA M, 1989, SCIENCE, V245, P63, DOI 10.1126/science.2544997; ULLRICH A, 1985, NATURE, V313, P756, DOI 10.1038/313756a0; YOSHIMASA Y, 1988, SCIENCE, V240, P784, DOI 10.1126/science.3283938	21	78	79	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	MAY 19	1990	335	8699					1179	1181		10.1016/0140-6736(90)92695-E	http://dx.doi.org/10.1016/0140-6736(90)92695-E			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DE448	1971035				2022-12-24	WOS:A1990DE44800003
J	BLUM, K; NOBLE, EP; SHERIDAN, PJ; MONTGOMERY, A; RITCHIE, T; JAGADEESWARAN, P; NOGAMI, H; BRIGGS, AH; COHN, JB				BLUM, K; NOBLE, EP; SHERIDAN, PJ; MONTGOMERY, A; RITCHIE, T; JAGADEESWARAN, P; NOGAMI, H; BRIGGS, AH; COHN, JB			ALLELIC ASSOCIATION OF HUMAN DOPAMINE-D2 RECEPTOR GENE IN ALCOHOLISM	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article									UNIV TEXAS, HLTH SCI CTR, DEPT CELLULAR & STRUCT BIOL, SAN ANTONIO, TX 78284 USA; UNIV CALIF LOS ANGELES, INST NEUROPSYCHIAT, ALCOHOL RES CTR, LOS ANGELES, CA 90024 USA; UNIV CALIF LOS ANGELES, BRAIN RES INST, LOS ANGELES, CA 90024 USA	University of Texas System; University of Texas Health San Antonio; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	BLUM, K (corresponding author), UNIV TEXAS, HLTH SCI CTR, DEPT PHARMACOL, DIV ADDICT DIS, PHARMACOGENET LAB, SAN ANTONIO, TX 78284 USA.							AGARWAL DP, 1981, ALCOHOL CLIN EXP RES, V5, P12; Alterman A I, 1986, Recent Dev Alcohol, V4, P169; Babor T F, 1986, Recent Dev Alcohol, V4, P113; BARBACCIA ML, 1981, PSYCHOPHARMACOLOGY, V74, P260, DOI 10.1007/BF00427106; BARON M, 1987, NATURE, V326, P289, DOI 10.1038/326289a0; BARTLETT RJ, 1987, SCIENCE, V235, P1648, DOI 10.1126/science.3029876; BEGLEITER H, 1984, SCIENCE, V225, P1493, DOI 10.1126/science.6474187; BLUM K, 1989, EXPERIENTIA, V45, P444, DOI 10.1007/BF01952026; BLUM K, 1987, EXPERIENTIA, V43, P408, DOI 10.1007/BF01940430; BLUM K, 1983, P NATL ACAD SCI-BIOL, V80, P6510, DOI 10.1073/pnas.80.21.6510; BLUM K, 1988, INTEGRATIVE PSYCHIAT, V6, P199; BOSRON WF, 1983, BIOCHEM GENET, V21, P735, DOI 10.1007/BF00498920; BOYD CD, 1988, AM J HUM GENET, V42, P309; BUNZOW JR, 1988, NATURE, V336, P783, DOI 10.1038/336783a0; BYERLEY WF, 1989, 142ND ANN M AM PSYCH, P117; CLONINGER CR, 1987, SCIENCE, V236, P410, DOI 10.1126/science.2882604; CLONINGER CR, 1981, ARCH GEN PSYCHIAT, V38, P861; DETERAWADLEIGH SD, 1987, NATURE, V325, P806, DOI 10.1038/325806a0; DIAMOND I, 1987, P NATL ACAD SCI USA, V84, P1413, DOI 10.1073/pnas.84.5.1413; DIBNER MD, 1980, PHARMACOL BIOCHEM BE, V12, P509, DOI 10.1016/0091-3057(80)90181-1; EGELAND JA, 1987, NATURE, V325, P783, DOI 10.1038/325783a0; FADDA F, 1989, LIFE SCI, V44, P281, DOI 10.1016/0024-3205(89)90186-0; FRANCES RJ, 1987, AM J DRUG ALCOHOL AB, V13, P327, DOI 10.3109/00952998709001517; FREZAL J, 1987, CYTOGENET CELL GENET, V46, P1, DOI 10.1159/000132469; GALLISTEL CR, 1983, PHARMACOL BIOCHEM BE, V19, P867, DOI 10.1016/0091-3057(83)90095-3; GANDHI CR, 1989, EXPERIENTIA, V45, P407, DOI 10.1007/BF01952021; GELERNTER J, 1989, 28TH ANN M AM COLL N, P216; GESSA GL, 1985, BRAIN RES, V348, P201, DOI 10.1016/0006-8993(85)90381-6; GIANOULAKIS C, 1986, LIFE SCI, V39, P2315, DOI 10.1016/0024-3205(86)90662-4; GOLDSTEIN DB, 1982, P NATL ACAD SCI-BIOL, V79, P4231, DOI 10.1073/pnas.79.13.4231; GOODWIN DW, 1979, ARCH GEN PSYCHIAT, V36, P57; GRANDY DK, 1989, AM J HUM GENET, V45, P778; GUSELLA JF, 1983, NATURE, V306, P234, DOI 10.1038/306234a0; HILL SY, 1987, ALCOHOL CLIN EXP RES, V11, P345, DOI 10.1111/j.1530-0277.1987.tb01323.x; HILL SY, 1975, J STUD ALCOHOL, V36, P981, DOI 10.15288/jsa.1975.36.981; HODGKINSON S, 1987, NATURE, V325, P805, DOI 10.1038/325805a0; IMPERATO A, 1986, J PHARMACOL EXP THER, V239, P219; ISRAEL Y, 1965, BIOCHEM PHARMACOL, V14, P1803, DOI 10.1016/0006-2952(65)90270-4; KIDD KK, 1989, GENOME MAPPING SEQUE, P66; KORPI ER, 1987, PHARMACOL TOXICOL, V61, P94, DOI 10.1111/j.1600-0773.1987.tb01782.x; LILJEQUIST S, 1978, ACTA PHARMACOL TOX, V43, P19; LIPPA A S, 1973, Pharmacology Biochemistry and Behavior, V1, P23, DOI 10.1016/0091-3057(73)90050-6; LUCCHI L, 1988, BRAIN RES, V449, P347, DOI 10.1016/0006-8993(88)91051-7; Maniatis T., 1982, MOL CLONING; MARTIN JB, 1989, TRENDS NEUROSCI, V12, P130, DOI 10.1016/0166-2236(89)90051-9; MELCHIOR CL, 1976, PHARMACOL BIOCHEM BE, V5, P63, DOI 10.1016/0091-3057(76)90289-6; MENDLEWICZ J, 1987, LANCET, V1, P1230; MEREU G, 1984, BRAIN RES, V292, P63, DOI 10.1016/0006-8993(84)90890-4; MURPHY JM, 1988, ALCOHOL, V5, P283, DOI 10.1016/0741-8329(88)90066-3; MYERS RD, 1989, EXPERIENTIA, V45, P436, DOI 10.1007/BF01952025; MYERS RD, 1985, ALDEHYDE ADDUCTS ALC, P201; NOBLE EP, IN PRESS BANBURY REP, V33; OCONNOR S, 1986, PROG NEURO-PSYCHOPH, V10, P211, DOI 10.1016/0278-5846(86)90075-8; PETRAKIS PL, 1985, ADN851426 US DEP HLT; POLLOCK VE, 1983, ARCH GEN PSYCHIAT, V40, P857; RITCHIE T, 1988, ALCOHOL, V5, P183, DOI 10.1016/0741-8329(88)90050-X; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; ROSNER B, 1986, FUNDAMENTALS BIOSTAT, P3346; RUSSELL VA, 1988, NEUROCHEM RES, V13, P487, DOI 10.1007/BF01268885; SCHUCKIT MA, 1986, PSYCHIATRY UPDATE, V3, P320; SHIGETA Y, 1980, PHARMACOL BIOCHEM BE, V13, P89, DOI 10.1016/S0091-3057(80)80014-1; Siggins G R, 1982, Prog Clin Biol Res, V90, P275; STEIN L, 1986, CLIN NEUROPHARMACOL, V9, P205; STGEORGEHYSLOP PH, 1987, SCIENCE, V235, P885, DOI 10.1126/science.2880399; TABAKOFF B, 1988, NEW ENGL J MED, V318, P134, DOI 10.1056/NEJM198801213180302; TICKU MK, 1980, J NEUROCHEM, V34, P417, DOI 10.1111/j.1471-4159.1980.tb06612.x; VALVERIUS P, 1989, J NEUROCHEM, V52, P492, DOI 10.1111/j.1471-4159.1989.tb09147.x; VOGELSTEIN B, 1989, SCIENCE, V244, P207, DOI 10.1126/science.2565047; VONKNORRING AL, 1985, ACTA PSYCHIAT SCAND, V72, P51; WHIPPLE SC, 1988, J STUD ALCOHOL, V49, P240, DOI 10.15288/jsa.1988.49.240; WISE RA, 1980, PHARMACOL BIOCHEM BE, V13, P213, DOI 10.1016/S0091-3057(80)80033-5; YOSHIDA A, 1984, P NATL ACAD SCI-BIOL, V81, P258, DOI 10.1073/pnas.81.1.258; 1987, DIAGNOSTIC STATISTIC	73	776	795	0	24	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	APR 18	1990	263	15					2055	2060		10.1001/jama.263.15.2055	http://dx.doi.org/10.1001/jama.263.15.2055			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY689	1969501				2022-12-24	WOS:A1990CY68900020
J	CHUTIVONGSE, S; WILDE, H; SUPICH, C; BAER, GM; FISHBEIN, DB				CHUTIVONGSE, S; WILDE, H; SUPICH, C; BAER, GM; FISHBEIN, DB			POSTEXPOSURE PROPHYLAXIS FOR RABIES WITH ANTISERUM AND INTRADERMAL VACCINATION	LANCET			English	Article									CTR DIS CONTROL,DIV VIRAL & RICKETTSIAL DIS,RICKETTSIAL ZOONOSES BRANCH,ATLANTA,GA 30333	Centers for Disease Control & Prevention - USA	CHUTIVONGSE, S (corresponding author), THAI RED CROSS SOC,DIV SCI,QUEEN SAOVABHA MEM INST,1871 RAMA IV RD,BANGKOK 10330,THAILAND.							ARNASON BGW, 1987, NEW ENGL J MED, V316, P406, DOI 10.1056/NEJM198702123160710; BALTAZARD M, 1955, Bull World Health Organ, V13, P747; CHANTHAVANICH P, 1987, T ROY SOC TROP MED H, V81, P260, DOI 10.1016/0035-9203(87)90234-3; Chutivongse S, 1988, Asia Pac J Public Health, V2, P179; FISHBEIN DB, 1987, J INFECT DIS, V156, P50, DOI 10.1093/infdis/156.1.50; HABEL KARL, 1954, BULL WORLD HEALTH ORGAN, V10, P781; HATTWICK MAW, 1975, NATURAL HISTORY RABI, V2, P281; HEMACHUDHA T, 1987, NEUROLOGY, V37, P550, DOI 10.1212/WNL.37.4.550; HEMACHUDHA T, 1989, HDB CLIN NEUROLOGY, P383; KOPROWSKI H, 1950, AM J MED, V8, P412, DOI 10.1016/0002-9343(50)90224-5; LIN FT, 1988, REV INFECT DIS, V10, pS766; NICHOLSON KG, 1981, LANCET, V2, P915; PHANUPHAK P, 1987, ASIAN PAC J ALLERGY, V5, P33; PHANUPHAK P, IN PRESS B WHO; SELIMOV M., 1959, JOUR HYG EPIDEMIOL MICROBIOL AND IMMUNOL, V3, P168; SITTHIAMORN C, 1987, INT J EPIDEMIOL, V16, P602, DOI 10.1093/ije/16.4.602; SMITH JS, 1973, B WORLD HEALTH ORGAN, V48, P535; STEELE JH, 1988, REV INFECT DIS, V10, pS585; SUNTHARASAMAI P, 1986, LANCET, V2, P129; VODOPIJA I, 1988, REV INFECT DIS, V10, pS758; WARRELL MJ, 1985, LANCET, V1, P1059; WILDE H, 1989, VACCINE, V7, P49, DOI 10.1016/0264-410X(89)90010-8	22	80	83	0	1	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	APR 14	1990	335	8694					896	898		10.1016/0140-6736(90)90488-Q	http://dx.doi.org/10.1016/0140-6736(90)90488-Q			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ135	1969993				2022-12-24	WOS:A1990CZ13500014
J	JACOB, J; KELSOE, G; RAJEWSKY, K; WEISS, U				JACOB, J; KELSOE, G; RAJEWSKY, K; WEISS, U			INTRACLONAL GENERATION OF ANTIBODY MUTANTS IN GERMINAL-CENTERS	NATURE			English	Article							B-CELL LINEAGES; IMMUNE-RESPONSE; SOMATIC HYPERMUTATION; PRIMARY IMMUNIZATION; MEMORY; AMPLIFICATION; POLYMERASE; FIDELITY; MICE; NP	THE generation and selection of somatic antibody mutants are key elements of acquired immunity, essential for the affinity maturation of antibody responses dependent on T cells. The mutants are generated through a mechanism that introduces point mutations at high rate into rearranged variable (V) region genes in the course of cell proliferation 1,2. Their appearance coincides with the generation of germinal centres, which are characterized by oligoclonal B-cell proliferation 3,4 and have been suggested to be the microenvironment in which antibody mutants are generated 5,6. We report here direct evidence for this hypothesis. Rearranged V-region genes were amplified from the genomic DNA of cells picked from individual germinal centres. The sequence analysis of these genes revealed that most represent cells of distinct B-cell clones which expanded locally, generating somatic antibody mutants at high rate. By contrast, antigen-induced proliferation of B cells at another site, periarteriolar lymphocyte sheath-associated foci, was not associated with somatic hypermutation.	UNIV COLOGNE,INST GENET,W-5000 COLOGNE 41,GERMANY	University of Cologne	JACOB, J (corresponding author), UNIV MARYLAND,SCH MED,DEPT MICROBIOL & IMMUNOL,BALTIMORE,MD 21201, USA.			Kelsoe, Garnett/0000-0002-8770-040X				ALLEN D, 1987, IMMUNOL REV, V96, P5, DOI 10.1111/j.1600-065X.1987.tb00506.x; APEL M, 1990, INT IMMUNOL, V2, P813, DOI 10.1093/intimm/2.9.813; BLIER PR, 1987, J IMMUNOL, V139, P3996; CUMANO A, 1985, EUR J IMMUNOL, V15, P512, DOI 10.1002/eji.1830150517; CUMANO A, 1986, EMBO J, V5, P2459, DOI 10.1002/j.1460-2075.1986.tb04522.x; DUNNING AM, 1988, NUCLEIC ACIDS RES, V16, P10393, DOI 10.1093/nar/16.21.10393; FOOTE J, 1991, NATURE, V352, P530, DOI 10.1038/352530a0; FRENCH DL, 1989, SCIENCE, V244, P1152, DOI 10.1126/science.2658060; JACOB J, 1991, J EXP MED, V173, P1165, DOI 10.1084/jem.173.5.1165; Kabat E. A., 1987, SEQUENCES PROTEINS I, DOI 10.1016/0003-2697(84)90805-4; KEOHAVONG P, 1989, P NATL ACAD SCI USA, V86, P9253, DOI 10.1073/pnas.86.23.9253; KOCKS C, 1989, ANNU REV IMMUNOL, V7, P537, DOI 10.1146/annurev.iy.07.040189.002541; Kroese F G, 1990, Curr Top Pathol, V84 ( Pt 1), P103; MACLENNAN ICM, 1986, IMMUNOL REV, V91, P61, DOI 10.1111/j.1600-065X.1986.tb01484.x; MANSER T, 1989, J EXP MED, V170, P1211, DOI 10.1084/jem.170.4.1211; MCKEAN D, 1984, P NATL ACAD SCI-BIOL, V81, P3180, DOI 10.1073/pnas.81.10.3180; PAABO S, 1990, J BIOL CHEM, V265, P4718; REYNAUD CA, 1991, CELL, V64, P995, DOI 10.1016/0092-8674(91)90323-Q; ROSE ML, 1980, NATURE, V284, P364, DOI 10.1038/284364a0; SCHITTEK B, 1990, NATURE, V346, P749, DOI 10.1038/346749a0; TAO W, 1990, J IMMUNOL, V145, P3216; TINDALL KR, 1988, BIOCHEMISTRY-US, V27, P6008, DOI 10.1021/bi00416a027; WEISS U, 1990, J EXP MED, V172, P1681, DOI 10.1084/jem.172.6.1681	23	902	913	1	30	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	DEC 5	1991	354	6352					389	392		10.1038/354389a0	http://dx.doi.org/10.1038/354389a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GT761	1956400				2022-12-24	WOS:A1991GT76100050
J	FLETCHER, JA; KOZAKEWICH, HP; HOFFER, FA; LAGE, JM; WEIDNER, N; TEPPER, R; PINKUS, GS; MORTON, CC; CORSON, JM				FLETCHER, JA; KOZAKEWICH, HP; HOFFER, FA; LAGE, JM; WEIDNER, N; TEPPER, R; PINKUS, GS; MORTON, CC; CORSON, JM			DIAGNOSTIC RELEVANCE OF CLONAL CYTOGENETIC ABERRATIONS IN MALIGNANT SOFT-TISSUE TUMORS	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHROMOSOME-ABNORMALITIES; EWINGS-SARCOMA; SOLID TUMORS; RHABDOMYOSARCOMA; TRANSLOCATION; EXPERIENCE; CHILDHOOD; LEUKEMIA	Background. Malignant soft-tissue tumors often present substantial diagnostic challenges. Chromosome aberrations that might be diagnostic have been identified in some types of soft-tissue tumors, but the overall frequency and diagnostic relevance of these aberrations have not been established. Methods. We attempted to determine the karyotypes of a series of 62 consecutive, unselected malignant spindle-cell or small round-cell soft-tissue tumors (from 46 adults and 16 children) after direct harvesting of cells or short-term culture. All tumors were examined independently by immunohistochemical staining in addition to routine light-microscopical evaluation, and all but two tumors were examined by electron microscopy. Results. Metaphases were obtained from 61 of the 62 tumors, and clonal chromosome aberrations were identified in 55 (89 percent). In the six tumors that yielded metaphases but lacked apparent clonal aberrations, the normal metaphases were found to originate from non-neoplastic stromal elements within the tumor specimens. Thus, all tumors in which karyotyping was successful contained clonal chromosome aberrations. Forty of 62 tumors (65 percent) contained clonal chromosome aberrations that either suggested or confirmed a specific diagnosis; in 15 of these tumors (24 percent of all tumors), the aberrations were important in establishing the final diagnosis. Cytogenetic analyses were particularly informative about small round-cell tumors from children: 8 of 14 round-cell tumors contained diagnostically important chromosome aberrations. Using the combined approaches of light and electron microscopy, immunohistochemistry, and cytogenetics, we established an unambiguous diagnosis for 60 of 62 tumors. Conclusions. Cytogenetic analyses reveal clonal chromosome aberrations in virtually all malignant soft-tissue tumors. These clonal chromosome aberrations, particularly in small round-cell tumors in children, often have diagnostic relevance.	CHILDRENS HOSP MED CTR,DIV HEMATOL ONCOL,BOSTON,MA 02115; CHILDRENS HOSP MED CTR,DEPT RADIOL,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DANA FARBER CANC INST,BOSTON,MA 02115; MASSACHUSETTS GEN HOSP,DIV HEMATOL ONCOL,BOSTON,MA 02114; HARVARD UNIV,SCH MED,DEPT PATHOL,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT PEDIAT,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT RADIOL,BOSTON,MA 02115; HARVARD UNIV,SCH MED,DEPT MED,BOSTON,MA 02115	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	FLETCHER, JA (corresponding author), BRIGHAM & WOMENS HOSP,DEPT PATHOL,75 FRANCIS ST,BOSTON,MA 02115, USA.				NATIONAL CANCER INSTITUTE [K11CA001498] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K12AG000294] Funding Source: NIH RePORTER; NCI NIH HHS [1-K11-CA-01498-01] Funding Source: Medline; NIA NIH HHS [AG-00294] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		ABELL MR, 1975, CANCER, V36, P2206, DOI 10.1002/cncr.2820360938; BECHER R, 1984, J NATL CANCER I, V72, P823; CHEN TR, 1988, CANCER GENET CYTOGEN, V33, P77, DOI 10.1016/0165-4608(88)90052-0; CRIST W, 1990, BLOOD, V76, P489; DOUGLASS EC, 1990, GENE CHROMOSOME CANC, V2, P210, DOI 10.1002/gcc.2870020308; FLEJTER WL, 1989, GENE CHROMOSOME CANC, V1, P148, DOI 10.1002/gcc.2870010207; FLETCHER J A, 1990, Current Opinion in Oncology, V2, P467; FLETCHER JA, 1989, CANCER GENET CYTOGEN, V41, P224, DOI 10.1016/0165-4608(89)90263-X; FLETCHER JA, 1990, CANCER RES, V50, P4092; HAYASHI Y, 1989, CANCER, V63, P126, DOI 10.1002/1097-0142(19890101)63:1<126::AID-CNCR2820630120>3.0.CO;2-Z; HOROWITZ ME, 1986, J CLIN ONCOL, V4, P559, DOI 10.1200/JCO.1986.4.4.559; LIMON J, 1986, CANCER GENET CYTOGEN, V23, P305, DOI 10.1016/0165-4608(86)90013-0; MANDAHL N, 1989, GENE CHROMOSOME CANC, V1, P9, DOI 10.1002/gcc.2870010104; MIETTINEN M, 1988, CANCER, V62, P2060, DOI 10.1002/1097-0142(19881101)62:9<2060::AID-CNCR2820620932>3.0.CO;2-Y; MOLENAAR WM, 1989, LAB INVEST, V60, P266; MUGNERET F, 1988, CANCER GENET CYTOGEN, V32, P239, DOI 10.1016/0165-4608(88)90286-5; NILBERT M, 1988, CANCER GENET CYTOGEN, V34, P209, DOI 10.1016/0165-4608(88)90262-2; NILBERT M, 1988, CANCER GENET CYTOGEN, V36, P141; PRESANT CA, 1986, J CLIN ONCOL, V4, P1658, DOI 10.1200/JCO.1986.4.11.1658; RICCARDI VM, 1986, CANCER GENET CYTOGEN, V23, P199, DOI 10.1016/0165-4608(86)90179-2; SANDBERG AA, 1988, CANCER RES, V48, P1049; SEABRIGH.M, 1971, LANCET, V2, P971; SHENG WW, 1988, CANCER RES, V48, P983; SHIRAKI M, 1989, CANCER-AM CANCER SOC, V64, P484, DOI 10.1002/1097-0142(19890715)64:2<484::AID-CNCR2820640223>3.0.CO;2-T; TRENT J, 1985, CANCER GENET CYTOGEN, V16, P189, DOI 10.1016/0165-4608(85)90045-7; TRICHE TJ, 1989, PRINCIPLES PRACTICE, P93; TURCCAREL C, 1987, P NATL ACAD SCI USA, V84, P1981, DOI 10.1073/pnas.84.7.1981; TURCCAREL C, 1988, CANCER GENET CYTOGEN, V32, P229, DOI 10.1016/0165-4608(88)90285-3; TURCCAREL C, 1986, CANCER GENET CYTOGEN, V23, P291, DOI 10.1016/0165-4608(86)90011-7; WHANGPENG J, 1986, CANCER GENET CYTOGEN, V21, P185, DOI 10.1016/0165-4608(86)90001-4; WHANGPENG J, 1984, NEW ENGL J MED, V311, P584, DOI 10.1056/NEJM198408303110907; WILLIAMS DL, 1985, NEW ENGL J MED, V313, P640; YUNIS JJ, 1982, NEW ENGL J MED, V307, P1231, DOI 10.1056/NEJM198211113072002; YUNIS JJ, 1981, NEW ENGL J MED, V305, P135, DOI 10.1056/NEJM198107163050304	34	278	280	0	1	MASS MEDICAL SOC	BOSTON	10 SHATTUCK, BOSTON, MA 02115	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 14	1991	324	7					436	442		10.1056/NEJM199102143240702	http://dx.doi.org/10.1056/NEJM199102143240702			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EX363	1988828	Bronze			2022-12-24	WOS:A1991EX36300002
J	SMITH, KA; GORMAN, PA; STARK, MB; GROVES, RP; STARK, GR				SMITH, KA; GORMAN, PA; STARK, MB; GROVES, RP; STARK, GR			DISTINCTIVE CHROMOSOMAL STRUCTURES ARE FORMED VERY EARLY IN THE AMPLIFICATION OF CAD GENES IN SYRIAN-HAMSTER CELLS	CELL			English	Article							1ST 3 ENZYMES; INSITU HYBRIDIZATION; DNA AMPLIFICATION; UMP SYNTHESIS; RESISTANT; TELOMERES; (TTAGGG)N; STABILITY; SEQUENCE; MUTANTS	As visualized by in situ hybridization with fluorescence detection, newly amplified CAD genes in 10(5) cell colonies are contained in multiple copies of very large regions of DNA, each tens of megabases long. The extra DNA is usually linked to the short arm of chromosome B9, which retains CAD at its normal site. The widely spaced genes are often interspersed with new G-negative regions. Individual cells within a clone have highly variable numbers of CAD genes (range 2-15). When resistant clones are examined later, at the 10(15) cell stage, the amplified genes are usually found in much more condensed structures. We propose that, in the initial event of CAD gene amplification, much of the short arm is transferred from one B9 chromosome to another. In subsequent cell cycles this initial duplication expands rapidly through unequal but homologous sister chromatid exchanges. Relatively rare secondary events lead to more condensed structures.			SMITH, KA (corresponding author), IMPERIAL CANC RES FUND,BOX 123,LINCOLNS INN FIELDS,LONDON WC2A 3PX,ENGLAND.							EDENBERG HJ, 1975, ANNU REV GENET, V9, P245, DOI 10.1146/annurev.ge.09.120175.001333; GIULOTTO E, 1986, EMBO J, V5, P2115, DOI 10.1002/j.1460-2075.1986.tb04474.x; GRODEN J, 1990, P NATL ACAD SCI USA, V87, P4315, DOI 10.1073/pnas.87.11.4315; HASTIE ND, 1989, TRENDS GENET, V5, P326, DOI 10.1016/0168-9525(89)90137-6; KEMPE TD, 1976, CELL, V9, P541, DOI 10.1016/0092-8674(76)90036-2; LAWRENCE JB, 1988, CELL, V52, P51; MEYNE J, 1989, P NATL ACAD SCI USA, V86, P7049, DOI 10.1073/pnas.86.18.7049; MEYNE J, 1990, CHROMOSOMA, V99, P3, DOI 10.1007/BF01737283; MIELE M, 1989, MUTAT RES, V219, P171, DOI 10.1016/0921-8734(89)90012-X; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; PADGETT RA, 1979, J BIOL CHEM, V254, P974; PAULETTI G, 1990, P NATL ACAD SCI USA, V87, P2955, DOI 10.1073/pnas.87.8.2955; PINKEL D, 1986, P NATL ACAD SCI USA, V83, P2934, DOI 10.1073/pnas.83.9.2934; PINKEL D, 1988, P NATL ACAD SCI USA, V85, P9138, DOI 10.1073/pnas.85.23.9138; RIGBY PWJ, 1977, J MOL BIOL, V113, P237, DOI 10.1016/0022-2836(77)90052-3; SAITO I, 1989, MOL CELL BIOL, V9, P2445, DOI 10.1128/MCB.9.6.2445; SCHIMKE RT, 1988, J BIOL CHEM, V263, P5989; SHIGESADA K, 1985, MOL CELL BIOL, V5, P1735, DOI 10.1128/MCB.5.7.1735; STARK GR, 1986, CANCER SURV, V5, P1; STARK GR, 1984, ANNU REV BIOCHEM, V53, P447, DOI 10.1146/annurev.bi.53.070184.002311; STARK GR, 1989, CELL, V57, P901, DOI 10.1016/0092-8674(89)90328-0; STARK GR, 1990, GENE REARRANGEMENT F, P99; Sutherland G, 1985, FRAGILE SITES HUMAN; TRASK BJ, 1989, GENE DEV, V3, P1913, DOI 10.1101/gad.3.12a.1913; WAHL GM, 1979, J BIOL CHEM, V254, P8679; WAHL GM, 1989, CANCER RES, V49, P1333; WAHL GM, 1982, MOL CELL BIOL, V2, P308, DOI 10.1128/MCB.2.3.308; ZIEG J, 1983, MOL CELL BIOL, V3, P2089, DOI 10.1128/MCB.3.11.2089	28	134	147	0	2	CELL PRESS	CAMBRIDGE	1050 MASSACHUSETTES AVE, CIRCULATION DEPT, CAMBRIDGE, MA 02138	0092-8674			CELL	Cell	DEC 21	1990	63	6					1219	1227		10.1016/0092-8674(90)90417-D	http://dx.doi.org/10.1016/0092-8674(90)90417-D			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	EN923	1979757				2022-12-24	WOS:A1990EN92300012
J	POWER, C; POLAND, SD; BLUME, WT; GIRVIN, JP; RICE, GPA				POWER, C; POLAND, SD; BLUME, WT; GIRVIN, JP; RICE, GPA			CYTOMEGALOVIRUS AND RASMUSSEN ENCEPHALITIS	LANCET			English	Article									UNIV WESTERN ONTARIO,DEPT CLIN NEUROL SCI,LONDON N6A 3K7,ONTARIO,CANADA	Western University (University of Western Ontario)			Power, Christopher/C-7181-2013	Power, Christopher/0000-0002-5131-9711				FLETCHER CV, 1989, DICP ANN PHARMAC, V23, P5, DOI 10.1177/106002808902300101; FREEDMAN H, 1977, LANCET, V2, P666; GONCZOL E, 1984, SCIENCE, V224, P159, DOI 10.1126/science.6322309; GUPTA PC, 1984, NEUROPEDIATRICS, V15, P191, DOI 10.1055/s-2008-1052365; JOHNSON RT, 1974, PROG MED VIROL, V18, P214; LEUNG K, 1988, NATURE, V333, P776, DOI 10.1038/333776a0; LYON G, 1980, NEUROPADIATRIE, V11, P57, DOI 10.1055/s-2008-1071375; NISHIZUKA Y, 1986, SCIENCE, V233, P305, DOI 10.1126/science.3014651; PARKER PJ, 1986, SCIENCE, V233, P853, DOI 10.1126/science.3755547; POLAND SD, IN PRESS J INFECT DI; POWER C, 1990, CAN J NEUROL SCI, V17, P378, DOI 10.1017/S0317167100030912; PRATT JH, 1988, EPILEPSIA, V29, P268; RASMUSSEN T, 1958, NEUROLOGY, V8, P435, DOI 10.1212/WNL.8.6.435; RASMUSSEN T, 1978, APPL NEUROPHYSIOL, V41, P1; SEISJO BB, 1986, ADV NEUROL, V44, P813; SEN R, 1986, CELL, V47, P921, DOI 10.1016/0092-8674(86)90807-X; VINTERS HV, 1989, BRAIN, V112, P127; WALTER GF, 1989, LANCET, V1, P279; WEINSHENKER BG, 1988, J IMMUNOL, V140, P1625; WOLBER RA, 1988, HUM PATHOL, V19, P736, DOI 10.1016/S0046-8177(88)80182-5	20	124	124	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 24	1990	336	8726					1282	1284		10.1016/0140-6736(90)92965-K	http://dx.doi.org/10.1016/0140-6736(90)92965-K			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ943	1978116				2022-12-24	WOS:A1990EJ94300005
J	CHEN, YMA; GOMEZLUCIA, E; OKAYAMA, A; TACHIBANA, N; LEE, TH; MUELLER, N; ESSEX, M				CHEN, YMA; GOMEZLUCIA, E; OKAYAMA, A; TACHIBANA, N; LEE, TH; MUELLER, N; ESSEX, M			ANTIBODY PROFILE OF EARLY HTLV-I INFECTION	LANCET			English	Article									HARVARD UNIV,SCH PUBL HLTH,DEPT CANC BIOL,665 HUNTINGTON AVE,BOSTON,MA 02115; MIYAZAKI MED COLL,DEPT INTERNAL MED 2,MIYAZAKI,JAPAN; HARVARD UNIV,SCH PUBL HLTH,DEPT EPIDEMIOL,BOSTON,MA 02115	Harvard University; Harvard T.H. Chan School of Public Health; University of Miyazaki; Harvard University; Harvard T.H. Chan School of Public Health			Gomez-Lucia, Esperanza/I-2058-2017	Gomez-Lucia, Esperanza/0000-0002-5261-0586	NATIONAL CANCER INSTITUTE [R01CA038450, R37CA038450] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL033774] Funding Source: NIH RePORTER; NCI NIH HHS [CA 38450] Funding Source: Medline; NHLBI NIH HHS [1-P50-HL-33774, HL 6356] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ANDERSON DW, 1989, BLOOD, V74, P2581; BARIN F, 1985, LANCET, V2, P1387; BIANCO C, 1990, 3RD P ANN RETR C HAW; CHEN YMA, 1989, J VIROL, V63, P4952, DOI 10.1128/JVI.63.11.4952-4957.1989; EHRLICH GD, 1989, BLOOD, V74, P1066; GESSAIN A, 1985, LANCET, V2, P407; HINUMA Y, 1981, P NATL ACAD SCI-BIOL, V78, P6476, DOI 10.1073/pnas.78.10.6476; IKEDA M, 1984, GANN, V75, P845; INABA S, 1989, TRANSFUSION, V29, P7, DOI 10.1046/j.1537-2995.1989.29189101168.x; JACOBSON S, 1988, NATURE, V331, P540, DOI 10.1038/331540a0; KOMURO A, 1983, LANCET, V1, P240; LEE HH, 1990, 3RD P ANN RETR C HAW; LEE TH, 1984, HUMAN T CELL LEUKEMI, P111; LEVINE PH, 1988, INT J CANCER, V42, P7, DOI 10.1002/ijc.2910420103; MIYOSHI I, 1981, NATURE, V294, P770, DOI 10.1038/294770a0; MUELLER N, 1990, HUMAN RETROVIROLOGY : HTLV, P281; OKAYAMA A, 1991, J INFECT DIS, V163, P106; OSAME M, 1986, LANCET, V1, P1031; POIESZ BJ, 1980, P NATL ACAD SCI-BIOL, V77, P7415, DOI 10.1073/pnas.77.12.7415; SAMUEL KP, 1984, SCIENCE, V226, P1094, DOI 10.1126/science.6208612; SEIKI M, 1983, P NATL ACAD SCI-BIOL, V80, P3618, DOI 10.1073/pnas.80.12.3618; YOSHIDA M, 1984, P NATL ACAD SCI-BIOL, V81, P2534, DOI 10.1073/pnas.81.8.2534	22	13	13	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	NOV 17	1990	336	8725					1214	1216		10.1016/0140-6736(90)92833-4	http://dx.doi.org/10.1016/0140-6736(90)92833-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EJ064	1978071				2022-12-24	WOS:A1990EJ06400004
J	BELL, EB; SPARSHOTT, SM				BELL, EB; SPARSHOTT, SM			INTERCONVERSION OF CD45R SUBSETS OF CD4 T-CELLS INVIVO	NATURE			English	Article											BELL, EB (corresponding author), UNIV MANCHESTER,SCH MED,DEPT CELL & STRUCT BIOL,IMMUNOL RES GRP,MANCHESTER M13 9PT,LANCS,ENGLAND.							ARTHUR RP, 1986, J EXP MED, V163, P774, DOI 10.1084/jem.163.4.774; BELL EB, 1989, IMMUNOLOGY, V68, P547; BELL EB, 1987, J IMMUNOL, V139, P1379; BIRKELAND ML, 1989, P NATL ACAD SCI USA, V86, P6734, DOI 10.1073/pnas.86.17.6734; BOTTOMLY K, 1989, EUR J IMMUNOL, V19, P617, DOI 10.1002/eji.1830190407; DRAYSON MT, 1989, J EXP MED, V170, P691, DOI 10.1084/jem.170.3.691; HUNIG T, 1989, J EXP MED, V169, P73, DOI 10.1084/jem.169.1.73; LAW DA, 1989, EUR J IMMUNOL, V19, P2289, DOI 10.1002/eji.1830191217; MERKENSCHLAGER M, 1988, EUR J IMMUNOL, V18, P1653, DOI 10.1002/eji.1830181102; MORIMOTO C, 1985, J IMMUNOL, V134, P1508; MOSMANN TR, 1987, IMMUNOL TODAY, V8, P223, DOI 10.1016/0167-5699(87)90171-X; POWRIE F, 1988, IMMUNOL TODAY, V9, P274, DOI 10.1016/0167-5699(88)91309-6; SANDERS ME, 1988, IMMUNOL TODAY, V9, P195, DOI 10.1016/0167-5699(88)91212-1; SARMIENTO M, 1982, J IMMUNOL, V128, P1676; SPICKETT GP, 1983, J EXP MED, V158, P795, DOI 10.1084/jem.158.3.795; STREULI M, 1987, J EXP MED, V166, P1548, DOI 10.1084/jem.166.5.1548; TERRY LA, 1988, IMMUNOLOGY, V64, P331; THOMAS ML, 1989, ANNU REV IMMUNOL, V7, P339, DOI 10.1146/annurev.immunol.7.1.339; WHITBY EH, 1990, IMMUNOLOGY, V69, P78; WOOLLETT GR, 1985, EUR J IMMUNOL, V15, P168, DOI 10.1002/eji.1830150211	20	360	361	0	0	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	NOV 8	1990	348	6297					163	166		10.1038/348163a0	http://dx.doi.org/10.1038/348163a0			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EG776	1978253				2022-12-24	WOS:A1990EG77600057
J	JONES, DB; HUNTER, NR; DUFF, GW				JONES, DB; HUNTER, NR; DUFF, GW			HEAT-SHOCK PROTEIN-65 AS A BETA-CELL ANTIGEN OF INSULIN-DEPENDENT DIABETES	LANCET			English	Article									SCOTTISH NATL BLOOD TRANSFUS SERV,EDINBURGH,SCOTLAND; NO GEN HOSP,DEPT MED,MOLEC IMMUNOL GRP,EDINBURGH EH5 2DQ,MIDLOTHIAN,SCOTLAND		JONES, DB (corresponding author), WESTERN GEN HOSP,DEPT MED,EDINBURGH EH4 2XU,MIDLOTHIAN,SCOTLAND.							ATKINSON MA, 1988, DIABETES, V37, P1587, DOI 10.2337/diabetes.37.11.1587; BAEKKESKOV S, 1984, SCIENCE, V224, P1348, DOI 10.1126/science.6374896; BAEKKESKOV S, 1982, NATURE, V298, P167, DOI 10.1038/298167a0; BAEKKESKOV S, 1987, J CLIN INVEST, V79, P926, DOI 10.1172/JCI112903; BURTON V, 1988, MOL CELL BIOL, V8, P3350; ELIAS D, 1990, P NATL ACAD SCI USA, V87, P1576, DOI 10.1073/pnas.87.4.1576; KAMPE O, 1989, DIABETES, V38, P1326, DOI 10.2337/diabetes.38.10.1326; LAMB JR, 1989, MOL BIOL MED, V6, P112; OLDSTONE MBA, 1987, CELL, V50, P819, DOI 10.1016/0092-8674(87)90507-1; RES PCM, 1988, LANCET, V2, P478, DOI 10.1016/S0140-6736(88)90123-7; YOUNG RA, 1989, CELL, V59, P5, DOI 10.1016/0092-8674(89)90861-1	11	106	109	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	SEP 8	1990	336	8715					583	585		10.1016/0140-6736(90)93390-B	http://dx.doi.org/10.1016/0140-6736(90)93390-B			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DX401	1975377				2022-12-24	WOS:A1990DX40100002
J	SHAHI, M; THOM, S; POULTER, N; SEVER, PS; FOALE, RA				SHAHI, M; THOM, S; POULTER, N; SEVER, PS; FOALE, RA			REGRESSION OF HYPERTENSIVE LEFT-VENTRICULAR HYPERTROPHY AND LEFT-VENTRICULAR DIASTOLIC FUNCTION	LANCET			English	Article									ST MARYS HOSP,DEPT CLIN PHARMACOL,LONDON W2 1NY,ENGLAND	Imperial College London	SHAHI, M (corresponding author), ST MARYS HOSP,DEPT CARDIOL,LONDON W2 1NY,ENGLAND.							BYRD BF, 1989, AM HEART J, V117, P113; DIANZUMBA SB, 1988, HYPERTENSION, V11, P98; DRAYER JIM, 1982, CLIN PHARMACOL THER, V32, P283, DOI 10.1038/clpt.1982.161; FOUAD FM, 1982, AM J CARDIOL, V49, P795, DOI 10.1016/0002-9149(82)91961-0; FOUAD FM, 1983, AM J CARDIOL, V51, P161, DOI 10.1016/S0002-9149(83)80029-0; FOUAD FM, 1984, J AM COLL CARDIOL, V3, P1500, DOI 10.1016/S0735-1097(84)80289-2; GARDIN J M, 1987, American Journal of Noninvasive Cardiology, V1, P3; GAY WA, 1967, CIRC RES, V21, P33, DOI 10.1161/01.RES.21.1.33; HELAK JW, 1981, CIRCULATION, V63, P1398, DOI 10.1161/01.CIR.63.6.1398; INOUYE I, 1984, AM J CARDIOL, V53, P120, DOI 10.1016/0002-9149(84)90695-7; INOUYE IK, 1984, AM J CARDIOL, V53, P1583, DOI 10.1016/0002-9149(84)90583-6; MUKHERJEE D, 1989, CIRCULATION S2, V80, P595; OBRIEN LJ, 1966, EXPERIENTIA, V22, P845, DOI 10.1007/BF01897456; PHILLIPS RA, 1989, J AM COLL CARDIOL, V14, P979, DOI 10.1016/0735-1097(89)90476-2; ROKEY R, 1985, CIRCULATION, V71, P543, DOI 10.1161/01.CIR.71.3.543; SEN S, 1979, AM J CARDIOL, V44, P954, DOI 10.1016/0002-9149(79)90228-5; SEN S, 1980, HYPERTENSION, V2, P169, DOI 10.1161/01.HYP.2.2.169; SHAHI M, 1989, CLIN SCI, V76, pP22; SMITH VE, 1986, J AM COLL CARDIOL, V8, P1449, DOI 10.1016/S0735-1097(86)80322-9; SPIRITO P, 1986, J AM COLL CARDIOL, V7, P518, DOI 10.1016/S0735-1097(86)80461-2; SPIRITO P, 1988, BRIT HEART J, V59, P672; SZLACHCIC J, 1989, AM J CARDIOL, V63, P198, DOI 10.1016/0002-9149(89)90285-3; TRIMARCO B, 1989, AM J CARDIOL, V64, P745, DOI 10.1016/0002-9149(89)90758-3; WEBER KT, 1989, J AM COLL CARDIOL, V13, P1637, DOI 10.1016/0735-1097(89)90360-4; WHITE WB, 1989, AM HEART J, V117, P145, DOI 10.1016/0002-8703(89)90669-8; ZUSMAN RM, 1989, AM J CARDIOL, V64, pF51, DOI 10.1016/0002-9149(89)90747-9	26	75	77	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	AUG 25	1990	336	8713					458	461		10.1016/0140-6736(90)92010-F	http://dx.doi.org/10.1016/0140-6736(90)92010-F			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DV754	1974989				2022-12-24	WOS:A1990DV75400003
J	MISERENDINO, MJD; SANANES, CB; MELIA, KR; DAVIS, M				MISERENDINO, MJD; SANANES, CB; MELIA, KR; DAVIS, M			BLOCKING OF ACQUISITION BUT NOT EXPRESSION OF CONDITIONED FEAR-POTENTIATED STARTLE BY NMDA ANTAGONISTS IN THE AMYGDALA	NATURE			English	Article									CONNECTICUT MENTAL HLTH CTR,NEW HAVEN,CT 06508		MISERENDINO, MJD (corresponding author), YALE UNIV,SCH MED,ABRAHAM RIBICOFF RES FACIL,34 PK ST,NEW HAVEN,CT 06508, USA.							ARTOLA A, 1987, NATURE, V330, P649, DOI 10.1038/330649a0; BENVENGA MJ, 1988, PHARMACOL BIOCHEM BE, V30, P205, DOI 10.1016/0091-3057(88)90445-5; BUTELMAN E, 1988, PHARM BIOCH BEHAVIOR, V34, P13; CASSELLA JV, 1986, PHYSIOL BEHAV, V36, P377, DOI 10.1016/0031-9384(86)90032-6; CHAPMAN P F, 1988, Society for Neuroscience Abstracts, V14, P566; CLINE HT, 1987, P NATL ACAD SCI USA, V84, P4342, DOI 10.1073/pnas.84.12.4342; COLLINGRIDGE GL, 1987, TRENDS NEUROSCI, V10, P288, DOI 10.1016/0166-2236(87)90175-5; COLLINGRIDGE GL, 1983, J PHYSIOL-LONDON, V334, P33, DOI 10.1113/jphysiol.1983.sp014478; COTMAN CW, 1988, ANNU REV NEUROSCI, V11, P61, DOI 10.1146/annurev.ne.11.030188.000425; COTMAN CW, 1987, TRENDS NEUROSCI, V10, P273, DOI 10.1016/0166-2236(87)90172-X; DANYSZ W, 1988, NEUROPHARMACOLOGY, V27, P653, DOI 10.1016/0028-3908(88)90189-X; DANYSZ W, 1989, NEUROSCI RES COMMUN, V5, P9; DAVIS M, 1982, J NEUROSCI, V2, P791; HAUBER W, 1989, J NEURAL TRANSM-GEN, V78, P29, DOI 10.1007/BF01247111; HITCHCOCK J, 1986, BEHAV NEUROSCI, V100, P11, DOI 10.1037/0735-7044.100.1.11; HITCHCOCK JM, 1989, BEHAV NEUROSCI, V103, P509, DOI 10.1037/0735-7044.103.3.509; KEHNE JH, 1988, PSYCHOPHARMACOLOGY, V94, P8, DOI 10.1007/BF00735872; KLEINSCHMIDT A, 1987, SCIENCE, V238, P355, DOI 10.1126/science.2443978; LIANG KC, 1986, BRAIN RES, V368, P125, DOI 10.1016/0006-8993(86)91049-8; MONDADORI C, 1989, EXP BRAIN RES, V75, P449; MORRIS RGM, 1989, J NEUROSCI, V9, P3040; MORRIS RGM, 1986, NATURE, V319, P774, DOI 10.1038/319774a0; ROBINSON GS, 1989, PSYCHOBIOLOGY, V17, P156; ROSEN JB, 1988, BEHAV NEUROSCI, V102, P195, DOI 10.1037/0735-7044.102.2.195; ROSEN JB, IN PRESS BEHAV NEURO; STAUBLI U, 1989, BEHAV NEUROSCI, V103, P54, DOI 10.1037/0735-7044.103.1.54; TAN S, 1989, PSYCHOPHARMACOLOGY, V98, P556, DOI 10.1007/BF00441959; THOMPSON RF, 1987, CLASSICAL CONDITIONI, V3; Weiner N., 1985, PHARM BASIS THERAPEU	29	659	668	0	21	MACMILLAN MAGAZINES LTD	LONDON	4 LITTLE ESSEX STREET, LONDON, ENGLAND WC2R 3LF	0028-0836			NATURE	Nature	JUN 21	1990	345	6277					716	718		10.1038/345716a0	http://dx.doi.org/10.1038/345716a0			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DK399	1972778				2022-12-24	WOS:A1990DK39900066
J	SINHA, AA; LOPEZ, MT; MCDEVITT, HO				SINHA, AA; LOPEZ, MT; MCDEVITT, HO			AUTOIMMUNE-DISEASES - THE FAILURE OF SELF TOLERANCE	SCIENCE			English	Article									STANFORD UNIV, MED CTR, SCH MED, DEPT MED, STANFORD, CA 94305 USA	Stanford University	SINHA, AA (corresponding author), STANFORD UNIV, MED CTR, SCH MED, DEPT MICROBIOL & IMMUNOL, STANFORD, CA 94305 USA.							ACHAORBEA H, 1989, ANNU REV IMMUNOL, V7, P371, DOI 10.1146/annurev.iy.07.040189.002103; ACHAORBEA H, 1987, P NATL ACAD SCI USA, V84, P2435, DOI 10.1073/pnas.84.8.2435; ACHAORBEA H, 1988, CELL, V54, P263, DOI 10.1016/0092-8674(88)90558-2; ALLISON JP, 1987, ANNU REV IMMUNOL, V5, P503, DOI 10.1146/annurev.iy.05.040187.002443; ALVAROGRACIA JM, 1989, J EXP MED, V170, P865, DOI 10.1084/jem.170.3.865; BABBITT BP, 1985, NATURE, V317, P359, DOI 10.1038/317359a0; BAEKKESKOV S, 1984, SCIENCE, V224, P1348, DOI 10.1126/science.6374896; BAEKKESKOV S, 1987, J CLIN INVEST, V79, P926, DOI 10.1172/JCI112903; BALKWILL FR, 1989, IMMUNOL TODAY, V10, P299, DOI 10.1016/0167-5699(89)90085-6; BANERJEE S, 1988, J EXP MED, V167, P832, DOI 10.1084/jem.167.3.832; BANKHURST AD, 1975, J CLIN INVEST, V56, P1378, DOI 10.1172/JCI108218; BEALL SS, 1989, J NEUROIMMUNOL, V21, P59, DOI 10.1016/0165-5728(89)90159-8; BEAUNE P, 1987, P NATL ACAD SCI USA, V84, P551, DOI 10.1073/pnas.84.2.551; BEHLKE MA, 1986, P NATL ACAD SCI USA, V83, P767, DOI 10.1073/pnas.83.3.767; BELL J, 1989, IMMUNOL TODAY, V10, P351, DOI 10.1016/0167-5699(89)90193-X; BELL JI, 1987, P NATL ACAD SCI USA, V84, P6234, DOI 10.1073/pnas.84.17.6234; BENDELAC A, 1987, J EXP MED, V166, P823, DOI 10.1084/jem.166.4.823; BENNUN A, 1982, J IMMUNOL, V129, P303; BENNUN A, 1981, EUR J IMMUNOL, V11, P195, DOI 10.1002/eji.1830110307; BESSEN D, 1989, J EXP MED, V169, P269, DOI 10.1084/jem.169.1.269; BEUTLER B, 1988, ADV IMMUNOL, V42, P213, DOI 10.1016/S0065-2776(08)60846-9; BEUTLER B, 1989, ANNU REV IMMUNOL, V7, P625, DOI 10.1146/annurev.immunol.7.1.625; BILL J, 1989, J EXP MED, V169, P1405, DOI 10.1084/jem.169.4.1405; BJORKMAN PJ, 1987, NATURE, V329, P506, DOI 10.1038/329506a0; BLACKMAN M, 1990, SCIENCE, V248, P1335, DOI 10.1126/science.1972592; BLOCH KJ, 1965, MEDICINE, V44, P187, DOI 10.1097/00005792-196505000-00001; BOITARD C, 1988, P NATL ACAD SCI USA, V85, P9719, DOI 10.1073/pnas.85.24.9719; BOTTAZZO GF, 1985, NEW ENGL J MED, V313, P353, DOI 10.1056/NEJM198508083130604; BOTTAZZO GF, 1983, LANCET, V2, P1115; BROSTOFF SW, 1984, J IMMUNOL, V133, P1938; BROWN JH, 1988, NATURE, V332, P845, DOI 10.1038/332845a0; BURKLY LC, 1990, SCIENCE, V248, P1364, DOI 10.1126/science.1694042; BURKLY LC, 1989, NATURE, V342, P564, DOI 10.1038/342564a0; BURNS FR, 1989, J EXP MED, V169, P27, DOI 10.1084/jem.169.1.27; CHEN JH, 1987, J IMMUNOL, V139, P3003; CHLUBA J, 1989, EUR J IMMUNOL, V19, P279, DOI 10.1002/eji.1830190210; CHRISTADOSS P, 1981, ANN NY ACAD SCI, V377, P258, DOI 10.1111/j.1749-6632.1981.tb33737.x; COHEN IR, 1985, J INVEST DERMATOL, V85, pS34, DOI 10.1111/1523-1747.ep12275436; COLE BC, 1989, J IMMUNOL, V142, P4131; CONCANNON P, 1987, J EXP MED, V165, P1130, DOI 10.1084/jem.165.4.1130; DALE JB, 1985, J EXP MED, V161, P113, DOI 10.1084/jem.161.1.113; DALE JB, 1986, J EXP MED, V164, P1785, DOI 10.1084/jem.164.5.1785; DALE JB, 1985, J EXP MED, V162, P583, DOI 10.1084/jem.162.2.583; DAVIDSON A, 1987, ANNU REV IMMUNOL, V5, P85, DOI 10.1146/annurev.iy.05.040187.000505; DAVIS MM, 1985, ANNU REV IMMUNOL, V3, P537, DOI 10.1146/annurev.iy.03.040185.002541; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; DAWKINS RL, 1983, IMMUNOL REV, V70, P5, DOI 10.1111/j.1600-065X.1983.tb00707.x; DEGRE M, 1983, ANN RHEUM DIS, V42, P672, DOI 10.1136/ard.42.6.672; DRUET P, 1982, ARCH TOXICOL, V50, P187, DOI 10.1007/BF00310850; DUBY AD, 1989, P NATL ACAD SCI USA, V86, P6206, DOI 10.1073/pnas.86.16.6206; EDMONDS J, 1981, ARTHRITIS RHEUM, V24, P1, DOI 10.1002/art.1780240101; EHRLICH P, 1900, COLLECTED PAPERS P E, P205; ELSON CJ, 1977, INT REV EXP PATHOL, V19, P137; FALLIS RJ, 1989, J NEUROIMMUNOL, V22, P93, DOI 10.1016/0165-5728(89)90039-8; FARRAR JJ, 1982, IMMUNOL REV, V63, P129, DOI 10.1111/j.1600-065X.1982.tb00414.x; FLEISCHER B, 1988, J EXP MED, V167, P1697, DOI 10.1084/jem.167.5.1697; Fong S, 1988, Concepts Immunopathol, V5, P168; FOX RI, 1984, SEMIN ARTHRITIS RHEU, V14, P77, DOI 10.1016/0049-0172(84)90001-5; FOX RI, 1986, J IMMUNOL, V137, P3162; FRITZ RB, 1985, J IMMUNOL, V134, P2328; FUJINAMI RS, 1985, SCIENCE, V230, P1043, DOI 10.1126/science.2414848; GARDNER SM, 1987, J IMMUNOL, V139, P476; GERMAIN RN, 1988, CELL, V54, P441, DOI 10.1016/0092-8674(88)90062-1; GLEICHMANN E, 1989, ARCH TOXICOL, V63, P257, DOI 10.1007/BF00278639; GOODNOW CC, 1990, SCIENCE, V248, P1373, DOI 10.1126/science.2356469; GREY HM, 1989, SCI AM, V261, P56, DOI 10.1038/scientificamerican1189-56; HAFLER DA, 1988, J EXP MED, V167, P1313, DOI 10.1084/jem.167.4.1313; HAFLER DA, 1989, IMMUNOL TODAY, V10, P104, DOI 10.1016/0167-5699(89)90236-3; HAPP MP, 1988, J NEUROIMMUNOL, V19, P191, DOI 10.1016/0165-5728(88)90002-1; HAQQI TM, 1989, IMMUNOGENETICS, V29, P180, DOI 10.1007/BF00373643; HAQQI TM, 1989, J EXP MED, V169, P1903, DOI 10.1084/jem.169.6.1903; HASKINS K, 1989, P NATL ACAD SCI USA, V86, P8000, DOI 10.1073/pnas.86.20.8000; HASKINS K, 1988, DIABETES, V37, P1444, DOI 10.2337/diabetes.37.10.1444; HAUSER SL, 1986, ANN NEUROL, V19, P578, DOI 10.1002/ana.410190610; HAYASHI T, 1988, ANN NEUROL, V24, P523, DOI 10.1002/ana.410240408; HEBERKATZ E, 1989, IMMUNOL TODAY, V10, P164, DOI 10.1016/0167-5699(89)90174-6; HEROLD KC, 1987, DIABETES, V36, P796, DOI 10.2337/diabetes.36.7.796; HOFMAN FM, 1989, J EXP MED, V170, P607, DOI 10.1084/jem.170.2.607; HOFMAN FM, 1986, J IMMUNOL, V136, P3239; HOLOSHITZ J, 1983, SCIENCE, V219, P56, DOI 10.1126/science.6336851; HOLOSHITZ J, 1986, LANCET, V2, P305; HOLOSHITZ J, 1989, NATURE, V339, P226, DOI 10.1038/339226a0; HOOD L, 1985, CELL, V40, P225, DOI 10.1016/0092-8674(85)90133-3; HOOVER ML, 1986, COLD SPRING HARB SYM, V51, P803, DOI 10.1101/SQB.1986.051.01.093; HOWELL MD, 1989, SCIENCE, V246, P668, DOI 10.1126/science.2814489; JACOB CO, 1989, J IMMUNOL, V142, P1500; JACOB CO, 1990, P NATL ACAD SCI USA, V87, P968, DOI 10.1073/pnas.87.3.968; JACOB CO, 1987, J EXP MED, V166, P798, DOI 10.1084/jem.166.3.798; JACOB CO, 1988, NATURE, V331, P356, DOI 10.1038/331356a0; JACOB CO, 1990, P NATL ACAD SCI USA, V87, P1233, DOI 10.1073/pnas.87.3.1233; JAHNKE U, 1985, SCIENCE, V229, P282, DOI 10.1126/science.2409602; KAGNOFF MF, 1989, CURR TOP MICROBIOL, V145, P67; KAGNOFF MF, 1984, J EXP MED, V160, P1544, DOI 10.1084/jem.160.5.1544; KAKIMOTO K, 1988, J IMMUNOL, V140, P78; KAPLAN MH, 1964, J EXP MED, V119, P651, DOI 10.1084/jem.119.4.651; KAPLAN MH, 1961, J EXP MED, V113, P1, DOI 10.1084/jem.113.1.1; KAPPLER J, 1989, SCIENCE, V244, P811, DOI 10.1126/science.2524876; KAPPLER JW, 1987, CELL, V49, P273, DOI 10.1016/0092-8674(87)90568-X; KAPPLER JW, 1988, NATURE, V332, P35, DOI 10.1038/332035a0; KAUFMAN JF, 1984, CELL, V36, P1, DOI 10.1016/0092-8674(84)90068-0; KEMP ME, 1987, ARTHRITIS RHEUM, V30, P1015, DOI 10.1002/art.1780300908; KLOTZ JL, 1989, IMMUNOGENETICS, V29, P191, DOI 10.1007/BF00373645; KOEVARY S, 1983, SCIENCE, V220, P727, DOI 10.1126/science.6836309; KOTZIN BL, 1987, J EXP MED, V165, P1237, DOI 10.1084/jem.165.5.1237; KOTZIN BL, 1985, SCIENCE, V229, P167, DOI 10.1126/science.2990044; KRAUS W, 1989, J EXP MED, V169, P481, DOI 10.1084/jem.169.2.481; KRISEL U, 1980, DIABETOLOGIA, V19, P516; KRISHER K, 1985, SCIENCE, V227, P413, DOI 10.1126/science.2578225; KUMAR V, 1989, ANNU REV IMMUNOL, V7, P657, DOI 10.1146/annurev.iy.07.040189.003301; LEITER EH, 1989, FASEB J, V3, P2231, DOI 10.1096/fasebj.3.11.2673897; LIKE AA, 1985, J IMMUNOL, V134, P1583; LINSTROM J, 1979, ADV IMMUNOL, V27, P1; LONDEI M, 1985, SCIENCE, V228, P85, DOI 10.1126/science.3871967; MACDONALD HR, 1988, NATURE, V332, P40, DOI 10.1038/332040a0; MARGOLICK JB, 1988, CLIN IMMUNOL IMMUNOP, V47, P208, DOI 10.1016/0090-1229(88)90073-6; MARON R, 1983, J IMMUNOL, V131, P2316; MAUL GG, 1989, P NATL ACAD SCI USA, V86, P8492, DOI 10.1073/pnas.86.21.8492; MCCUNE JM, 1988, SCIENCE, V241, P1632, DOI 10.1126/science.2971269; MCDERMOTT M, 1988, B RHEUM DIS, V38, P1; MCGUIGAN LE, 1985, SEMIN ARTHRITIS RHEU, V15, P81, DOI 10.1016/0049-0172(85)90027-7; MCINTOSH KR, 1986, SCIENCE, V232, P401, DOI 10.1126/science.2938256; MENGLEGAW L, 1985, ANNU REV IMMUNOL, V3, P367, DOI 10.1146/annurev.iy.03.040185.002055; MILLER BJ, 1988, J IMMUNOL, V140, P52; MILLWARD BA, 1987, CLIN EXP IMMUNOL, V70, P152; MOREL PA, 1988, P NATL ACAD SCI USA, V85, P8111, DOI 10.1073/pnas.85.21.8111; MULLER U, 1987, NATURE, V325, P265, DOI 10.1038/325265a0; MYERS LK, 1989, J IMMUNOL, V143, P3976; NEDOSPASOV SA, 1986, NUCLEIC ACIDS RES, V14, P7713, DOI 10.1093/nar/14.19.7713; NEDWIN GE, 1985, NUCLEIC ACIDS RES, V13, P6361, DOI 10.1093/nar/13.17.6361; NEPOM GT, 1987, J CLIN IMMUNOL, V7, P1, DOI 10.1007/BF00915418; OKSENBERG JR, 1988, HUM IMMUNOL, V22, P111, DOI 10.1016/0198-8859(88)90041-9; OKSENBERG JR, 1989, P NATL ACAD SCI USA, V86, P988, DOI 10.1073/pnas.86.3.988; OLDSTONE MBA, 1989, CURR TOP MICROBIOL, V145, P127; OLDSTONE MBA, 1987, CELL, V50, P819, DOI 10.1016/0092-8674(87)90507-1; OLDSTONE MBA, 1989, MOL MIMICRY; ORTIZORTIZ L, 1976, J EXP MED, V144, P604, DOI 10.1084/jem.144.3.604; OWHASHI M, 1988, J EXP MED, V168, P2153, DOI 10.1084/jem.168.6.2153; PALMER JP, 1983, SCIENCE, V222, P1337, DOI 10.1126/science.6362005; PATERSON PY, 1960, J EXP MED, V111, P119, DOI 10.1084/jem.111.1.119; PAUL NL, 1988, ANNU REV IMMUNOL, V6, P407, DOI 10.1146/annurev.iy.06.040188.002203; PESTKA S, 1987, ANNU REV BIOCHEM, V56, P727, DOI 10.1146/annurev.biochem.56.1.727; PETRI M, 1989, RHEUM DIS CLIN N AM, V15, P335; PETTINELLI CB, 1981, J IMMUNOL, V127, P1420; PROCHAZKA M, 1987, SCIENCE, V237, P286, DOI 10.1126/science.2885918; PULLEN AM, 1990, J EXP MED, V171, P49, DOI 10.1084/jem.171.1.49; PULLEN AM, 1988, NATURE, V335, P796, DOI 10.1038/335796a0; RAYBOURNE RB, 1988, J IMMUNOL, V140, P3489; REICH EP, 1989, NATURE, V341, P326, DOI 10.1038/341326a0; ROSENBAUM JT, 1981, J EXP MED, V154, P1694, DOI 10.1084/jem.154.5.1694; ROTTER JI, 1984, CLIN GENET, V26, P529; RUSCHEN S, 1988, BRIT J RHEUMATOL, V27, P350; SAIKI RK, 1988, SCIENCE, V239, P487, DOI 10.1126/science.2448875; SAITO I, 1989, J EXP MED, V169, P2191, DOI 10.1084/jem.169.6.2191; SAKAI K, 1988, P NATL ACAD SCI USA, V85, P8608, DOI 10.1073/pnas.85.22.8608; SARGENT CA, 1989, P NATL ACAD SCI USA, V86, P1968, DOI 10.1073/pnas.86.6.1968; SARVETNICK N, 1988, CELL, V52, P773, DOI 10.1016/0092-8674(88)90414-X; SAXNE T, 1988, ARTHRITIS RHEUM, V31, P1041, DOI 10.1002/art.1780310816; SCHUR PH, 1982, ARTHRITIS RHEUM-US, V25, P793, DOI 10.1002/art.1780250715; Schwartz R H, 1986, Adv Immunol, V38, P31, DOI 10.1016/S0065-2776(08)60006-1; SCHWIMMBECK PL, 1987, J EXP MED, V166, P173, DOI 10.1084/jem.166.1.173; SEBOUN E, 1989, CELL, V57, P1095, DOI 10.1016/0092-8674(89)90046-9; SHEEHY MJ, 1989, HUM IMMUNOL, V26, P261, DOI 10.1016/0198-8859(89)90004-9; SHIZURU JA, 1988, SCIENCE, V240, P659, DOI 10.1126/science.2966437; Sinha A., UNPUB; SINHA AA, 1988, SCIENCE, V239, P1026, DOI 10.1126/science.2894075; SINHA AA, IN PRESS IMMUNE RECO; SINHA AA, 1990, MOL BIOL HLA CLASS 2, P147; SMITH KA, 1980, IMMUNOL REV, V51, P337, DOI 10.1111/j.1600-065X.1980.tb00327.x; SPIES T, 1986, P NATL ACAD SCI USA, V83, P8699, DOI 10.1073/pnas.83.22.8699; SPIES T, 1989, SCIENCE, V243, P214, DOI 10.1126/science.2911734; STAMENKOVIC I, 1988, P NATL ACAD SCI USA, V85, P1179, DOI 10.1073/pnas.85.4.1179; STANLEY JR, 1984, J CLIN INVEST, V74, P313, DOI 10.1172/JCI111426; STEINMAN L, 1981, P NATL ACAD SCI-BIOL, V78, P7111, DOI 10.1073/pnas.78.11.7111; SUN D, 1988, NATURE, V332, P843, DOI 10.1038/332843a0; TALAL N, 1989, CLIN IMMUNOL IMMUNOP, V53, P355, DOI 10.1016/0090-1229(89)90001-9; TANIGUCHI T, 1988, ANNU REV IMMUNOL, V6, P439, DOI 10.1146/annurev.iy.06.040188.002255; THEOFILOPOULOS AN, 1981, IMMUNOL REV, V55, P179, DOI 10.1111/j.1600-065X.1981.tb00343.x; TIWARI JL, 1985, HLA DISEASE ASS; TODD JA, 1987, NATURE, V329, P599, DOI 10.1038/329599a0; TODD JA, 1988, SCIENCE, V240, P1003, DOI 10.1126/science.3368786; TOIVANEN A, 1985, IMMUNOL REV, V86, P47, DOI 10.1111/j.1600-065X.1985.tb01137.x; TRAUGOTT U, 1987, J NEUROIMMUNOL, V16, P283, DOI 10.1016/0165-5728(87)90082-8; TRAUGOTT U, 1983, SCIENCE, V219, P308, DOI 10.1126/science.6217550; TROTTER J, 1985, J IMMUNOL, V134, P2322; URBAN JL, 1988, CELL, V54, P577, DOI 10.1016/0092-8674(88)90079-7; URBAN JL, 1989, CELL, V59, P257, DOI 10.1016/0092-8674(89)90288-2; van Eden W, 1989, Br J Rheumatol, V28 Suppl 1, P51; VANDENBARK AA, 1989, NATURE, V341, P541, DOI 10.1038/341541a0; VANEDEN W, 1985, P NATL ACAD SCI USA, V82, P5117; VANEDEN W, 1988, NATURE, V331, P171, DOI 10.1038/331171a0; VANOUWERKERK BM, 1985, NETH J MED, V28, P32; WALDOR MK, 1985, SCIENCE, V227, P415, DOI 10.1126/science.3155574; WEETMAN AP, 1987, HUM IMMUNOL, V20, P167, DOI 10.1016/0198-8859(87)90030-9; Weinstein A, 1980, Prog Clin Immunol, V4, P1; WHITE J, 1989, CELL, V56, P27, DOI 10.1016/0092-8674(89)90980-X; WICKER LS, 1986, DIABETES, V35, P855, DOI 10.2337/diabetes.35.8.855; WILLMAN CL, 1989, J EXP MED, V170, P1559, DOI 10.1084/jem.170.5.1559; WILSON DB, 1989, IMMUNOL REV, V107, P159, DOI 10.1111/j.1600-065X.1989.tb00008.x; WOLF H, 1984, J VIROL, V51, P795, DOI 10.1128/JVI.51.3.795-798.1984; WRAITH DC, 1989, CELL, V59, P247, DOI 10.1016/0092-8674(89)90287-0; YAMAOKA K, 1988, ARTHRITIS RHEUM, V31, P1014, DOI 10.1002/art.1780310812; YOON JW, 1989, DIABETES RES CLIN PR, V7, pS47, DOI 10.1016/0168-8227(89)90088-0; YU DTY, 1985, IMMUNOL REV, V86, P27, DOI 10.1111/j.1600-065X.1985.tb01136.x; ZAMVIL S, 1985, NATURE, V317, P355, DOI 10.1038/317355a0; ZAMVIL SS, 1985, J EXP MED, V162, P2107, DOI 10.1084/jem.162.6.2107; ZWEIMAN B, 1986, ANN NEUROL, V19, P588, DOI 10.1002/ana.410190611	206	415	436	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JUN 15	1990	248	4961					1380	1388		10.1126/science.1972595	http://dx.doi.org/10.1126/science.1972595			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DJ501	1972595				2022-12-24	WOS:A1990DJ50100033
J	EXLEY, AR; COHEN, J; BUURMAN, W; OWEN, R; LUMLEY, J; BODMER, M; STEPHENS, S; HANSON, G; AULAKH, JM; RIDDELL, A; PERRY, M				EXLEY, AR; COHEN, J; BUURMAN, W; OWEN, R; LUMLEY, J; BODMER, M; STEPHENS, S; HANSON, G; AULAKH, JM; RIDDELL, A; PERRY, M			MONOCLONAL-ANTIBODY TO TNF IN SEVERE SEPTIC SHOCK	LANCET			English	Letter									STATE UNIV LIMBURG,DEPT SURG,6200 MD MAASTRICHT,NETHERLANDS; UNIV LONDON,W MIDDLESEX HOSP,INTENS CARE UNIT,LONDON,ENGLAND; UNIV LONDON,HAMMERSMITH HOSP,INTENS CARE UNIT,LONDON,ENGLAND; CELLTECH LTD,SLOUGH,ENGLAND; UNIV LONDON,EALING GEN HOSP,INTENS CARE UNIT,LONDON,ENGLAND; UNIV LONDON,WHIPPS CROSS HOSP,INTENS CARE UNIT,LONDON,ENGLAND	Maastricht University; University of London; Imperial College London; University of London; Celltech Group Ltd; Imperial College London; University of London; University of London	EXLEY, AR (corresponding author), HAMMERSMITH HOSP,INFECT DIS UNIT,LONDON W12 0NN,ENGLAND.			Exley, Andrew/0000-0002-2628-6129				BEUTLER B, 1985, SCIENCE, V229, P869, DOI 10.1126/science.3895437; DEBETS JMH, 1989, CRIT CARE MED, V17, P489, DOI 10.1097/00003246-198906000-00001; EXLEY AR, 1990, 1ST C INT END SOC SA; EXLEY AR, 1989, CLIN SCI, V76, P50; GIRARDIN E, 1988, NEW ENGL J MED, V319, P397, DOI 10.1056/NEJM198808183190703; GREENEBERG RN, 1989, 29TH INT C ANT AG CH; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; MCCABE WR, 1962, ARCH INTERN MED, V110, P847, DOI 10.1001/archinte.1962.03620240029006; SILVA AT, IN PRESS J INFECT DI; TRACEY KJ, 1987, NATURE, V330, P662, DOI 10.1038/330662a0; WAAGE A, 1987, LANCET, V1, P355; 1985, NEW ENGL J MED, V313, P337	12	181	201	0	2	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	MAY 26	1990	335	8700					1275	1277		10.1016/0140-6736(90)91337-A	http://dx.doi.org/10.1016/0140-6736(90)91337-A			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DF451	1971339				2022-12-24	WOS:A1990DF45100022
J	DANIELS, HM; MEAGER, A; EDDLESTON, ALWF; ALEXANDER, GJM; WILLIAMS, R				DANIELS, HM; MEAGER, A; EDDLESTON, ALWF; ALEXANDER, GJM; WILLIAMS, R			SPONTANEOUS PRODUCTION OF TUMOR NECROSIS FACTOR-ALPHA AND INTERLEUKIN-1-BETA DURING INTERFERON-ALPHA TREATMENT OF CHRONIC HBV INFECTION	LANCET			English	Article									UNIV LONDON KINGS COLL HOSP,SCH MED,LIVER UNIT,DENMARK HILL,LONDON SE5 9RS,ENGLAND; NATL INST BIOL STAND & CONTROLS,LONDON NW3 6RB,ENGLAND	King's College Hospital NHS Foundation Trust; King's College Hospital; University of London; King's College London; National Institute for Biological Standards & Control				opoku, anita/0000-0001-7243-8157				ABB J, 1985, J MED VIROL, V16, P171, DOI 10.1002/jmv.1890160209; ALEXANDER GJM, 1987, LANCET, V2, P66; ANASTASSAKOS C, 1987, CLIN EXP IMMUNOL, V68, P15; ANASTASSAKOS C, 1988, GASTROENTEROLOGY, V94, P999, DOI 10.1016/0016-5085(88)90559-8; ANDERSON MG, 1987, GUT, V28, P619, DOI 10.1136/gut.28.5.619; ARAKAWA T, 1987, J INTERFERON RES, V7, P103, DOI 10.1089/jir.1987.7.103; BAIN VG, 1989, HEPATOLOGY, V10, P642; CARSWELL EA, 1975, P NATL ACAD SCI USA, V72, P3666, DOI 10.1073/pnas.72.9.3666; DINARELLO CA, 1986, J EXP MED, V163, P1433, DOI 10.1084/jem.163.6.1433; GIFFORD GE, 1987, CIBA F SYMP, V131, P3; KOFF WC, 1986, LYMPHOKINE RES, V5, P215; MEAGER A, 1987, HYBRIDOMA, V6, P305, DOI 10.1089/hyb.1987.6.305; MESTAN J, 1986, NATURE, V323, P816, DOI 10.1038/323816a0; NEDWIN GE, 1985, J IMMUNOL, V135, P2492; NEWTON RC, 1985, IMMUNOLOGY, V56, P441; PHILIP R, 1986, NATURE, V323, P86, DOI 10.1038/323086a0; VANDAMME J, 1985, J GEN VIROL, V66, P693, DOI 10.1099/0022-1317-66-4-693; VANDAMME J, 1985, NATURE, V314, P266, DOI 10.1038/314266a0; WONG GHW, 1986, NATURE, V323, P819, DOI 10.1038/323819a0; YOSHIOKA K, 1989, HEPATOLOGY, V10, P769, DOI 10.1002/hep.1840100504	20	106	107	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	APR 14	1990	335	8694					875	877		10.1016/0140-6736(90)90475-K	http://dx.doi.org/10.1016/0140-6736(90)90475-K			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CZ135	1969983				2022-12-24	WOS:A1990CZ13500003
J	SERWADDA, D; KATONGOLEMBIDDE, E				SERWADDA, D; KATONGOLEMBIDDE, E			AIDS IN AFRICA - PROBLEMS FOR RESEARCH AND RESEARCHERS	LANCET			English	Editorial Material											SERWADDA, D (corresponding author), MAKERERE UNIV,MULAGO HOSP,SCH MED,DEPT MED,POB 7051,KAMPALA,UGANDA.							CLUMECK N, 1983, LANCET, V1, P642; KONOTEYAHULU FID, 1987, LANCET, V2, P206; SABATIER R, 1988, BLAME COUNTER BLAME, P85; SAXINGER W, 1984, SCIENCE, V225, P1473, DOI 10.1126/science.6089348; [No title captured]	5	7	7	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	APR 7	1990	335	8693					842	843		10.1016/0140-6736(90)90946-3	http://dx.doi.org/10.1016/0140-6736(90)90946-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CY371	1969569				2022-12-24	WOS:A1990CY37100013
J	LEHRER, S; SANCHEZ, M; SONG, HK; DALTON, J; LEVINE, E; SAVORETTI, P; THUNG, SN; SCHACHTER, B				LEHRER, S; SANCHEZ, M; SONG, HK; DALTON, J; LEVINE, E; SAVORETTI, P; THUNG, SN; SCHACHTER, B			ESTROGEN-RECEPTOR B-REGION POLYMORPHISM AND SPONTANEOUS-ABORTION IN WOMEN WITH BREAST-CANCER	LANCET			English	Article									CUNY MT SINAI SCH MED,STRATTON POPPER DEPT PATHOL,NEW YORK,NY 10029; CUNY MT SINAI SCH MED,DEPT RADIOTHERAPY,NEW YORK,NY 10029; CUNY MT SINAI SCH MED,DEPT OBSTET & GYNAECOL,NEW YORK,NY 10029; CUNY MT SINAI SCH MED,DEPT CELL BIOL & ANAT,NEW YORK,NY 10029	City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai; City University of New York (CUNY) System; Icahn School of Medicine at Mount Sinai					NCI NIH HHS [CA 45754, CA49506-01A1] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R55CA049506, R01CA049506, R01CA045754] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		BERKOTWITZ GS, 1986, BREAST DISEASE, P13; BRINTON LA, 1983, BRIT J CANCER, V47, P757, DOI 10.1038/bjc.1983.128; FITZSIMMONS J, 1984, AM J MED GENET, V18, P407, DOI 10.1002/ajmg.1320180308; FURR BJA, 1976, J REPROD FERTIL, V48, P367; GARCIA T, 1989, NUCLEIC ACIDS RES, V17, P8364; GARCIA T, 1988, MOL ENDOCRINOL, V2, P785, DOI 10.1210/mend-2-9-785; HADJIMICHAEL OC, 1986, BRIT J CANCER, V53, P281, DOI 10.1038/bjc.1986.46; HELMRICH SP, 1983, AM J EPIDEMIOL, V117, P35, DOI 10.1093/oxfordjournals.aje.a113513; KOIKE S, 1987, NUCLEIC ACIDS RES, V15, P2499, DOI 10.1093/nar/15.6.2499; KUMAR V, 1987, CELL, V51, P941, DOI 10.1016/0092-8674(87)90581-2; MAIER DB, 1987, PATHOLOGY INFERTILIT, P201; MILLS JL, 1988, NEW ENGL J MED, V319, P1617, DOI 10.1056/NEJM198812223192501; PAFFENBARGER RS, 1980, AM J EPIDEMIOL, V112, P258, DOI 10.1093/oxfordjournals.aje.a112992; PIKE MC, 1981, BRIT J CANCER, V43, P72, DOI 10.1038/bjc.1981.10; PONGLIKITMONGKOL M, 1988, EMBO J, V7, P3385, DOI 10.1002/j.1460-2075.1988.tb03211.x; RAVINDRANATH N, 1987, J REPROD FERTIL, V81, P327; SALBER EJ, 1969, JNCI-J NATL CANCER I, V43, P1013; SIMPSON JL, 1980, FERTIL STERIL, V33, P107; TORA L, 1988, EMBO J, V7, P3771, DOI 10.1002/j.1460-2075.1988.tb03261.x; WHITE R, 1987, MOL ENDOCRINOL, V1, P735, DOI 10.1210/mend-1-10-735; WILCOX AJ, 1988, NEW ENGL J MED, V319, P189, DOI 10.1056/NEJM198807283190401; WINER E, 1986, P NATL ACAD SCI USA, V82, P7575	22	100	105	0	0	LANCET LTD	LONDON	42 BEDFORD SQUARE, LONDON, ENGLAND WC1B 3SL	0140-6736			LANCET	Lancet	MAR 17	1990	335	8690					622	624		10.1016/0140-6736(90)90410-7	http://dx.doi.org/10.1016/0140-6736(90)90410-7			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CU314	1969015				2022-12-24	WOS:A1990CU31400003
